PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Agrawal, P; Blinka, S; Pulakanti, K; Reimer, MH; Stelloh, C; Meyer, AE; Rao, S				Agrawal, Puja; Blinka, Steven; Pulakanti, Kirthi; Reimer, Michael H.; Stelloh, Cary; Meyer, Alison E.; Rao, Sridhar			Genome editing demonstrates that the-5 kb Nanog enhancer regulates Nanog expression by modulating RNAPII initiation and/or recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL NETWORK; GENE-EXPRESSION; SUPER-ENHANCERS; PLURIPOTENCY; EPIBLAST; REVEALS; RELEASE; PROTEIN; LOCUS; OCT4	Transcriptional enhancers have been defined by their ability to operate independent of distance and orientation in plasmid-based reporter assays of gene expression. At present, histone marks are used to identify and define enhancers but do not consider the endogenous role of an enhancer in the context of native chromatin. We employed a combination of genomic editing, single cell analyses, and sequencing approaches to investigate a Nanog-associated cis-regulatory element, which has been reported by others to be either an alternative promoter or a super-enhancer. We first demonstrate both distance and orientation independence in native chromatin, eliminating the issues raised with plasmid-based approaches. We next demonstrate that the dominant super-enhancer modulates Nanog globally and operates by recruiting and/or initiating RNA Polymerase II. Our studies have important implications to how transcriptional enhancers are defined and how they regulate gene expression.	[Agrawal, Puja; Blinka, Steven; Rao, Sridhar] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Rao, Sridhar] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Agrawal, Puja; Blinka, Steven; Pulakanti, Kirthi; Reimer, Michael H.; Stelloh, Cary; Meyer, Alison E.; Rao, Sridhar] Versiti, Blood Res Inst, Milwaukee, WI 53226 USA; [Blinka, Steven] Univ Washington, Dept Internal Med, Seattle, WA 98105 USA	Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; University of Washington; University of Washington Seattle	Rao, S (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.; Rao, S (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Rao, S (corresponding author), Versiti, Blood Res Inst, Milwaukee, WI 53226 USA.	sridhar.rao@versiti.org		Blinka, Steven/0000-0002-0776-5677; Agrawal, Puja/0000-0002-3184-6645	NIDDK [DK120152, DK10350]; MCW MSTP T32 (NIGMS) [GM080202]; NIH [CA204231]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MCW MSTP T32 (NIGMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by funding from NIDDK (DK120152, DK10350) to P. A. and S. B., respectively, and the MCW MSTP T32 (NIGMS, GM080202) to P. A. and S. B. Additional support came from NIH (CA204231) to S. R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; Blinka S, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700086; Blinka S, 2016, CELL REP, V17, P19, DOI 10.1016/j.celrep.2016.09.002; Catarino RR, 2018, GENE DEV, V32, P202, DOI 10.1101/gad.310367.117; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen FX, 2018, NAT REV MOL CELL BIO, V19, P464, DOI 10.1038/s41580-018-0010-5; Chen FX, 2017, SCIENCE, V357, P1294, DOI 10.1126/science.aan3269; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Das S, 2011, J BIOL CHEM, V286, P42690, DOI 10.1074/jbc.M111.290189; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Guo YE, 2019, NATURE, V572, P543, DOI 10.1038/s41586-019-1464-0; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henriques T, 2018, GENE DEV, V32, P26, DOI 10.1101/gad.309351.117; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mikhaylichenko O, 2018, GENE DEV, V32, P42, DOI 10.1101/gad.308619.117; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MOREAU P, 1981, NUCLEIC ACIDS RES, V9, P6047, DOI 10.1093/nar/9.22.6047; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; Pfister R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00700; Pulakanti K, 2013, EPIGENETICS-US, V8, P1303, DOI 10.4161/epi.26597; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Rickels R, 2018, TRENDS CELL BIOL, V28, P608, DOI 10.1016/j.tcb.2018.04.003; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Volk A, 2018, CANCER CELL, V34, P707, DOI 10.1016/j.ccell.2018.10.004; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yu M, 2017, ANNU REV CELL DEV BI, V33, P265, DOI 10.1146/annurev-cellbio-100616-060531	50	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100189	10.1074/jbc.RA120.015152	http://dx.doi.org/10.1074/jbc.RA120.015152			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334884	Green Published, gold			2022-12-26	WOS:000672866400167
J	Latorre-Muro, P; Baeza, J; Hurtado-Guerrero, R; Hicks, T; Delso, I; Hernandez-Ruiz, C; Velazquez-Campoy, A; Lawton, AJ; Angulo, J; Denu, JM; Carrodeguas, JA				Latorre-Muro, Pedro; Baeza, Josue; Hurtado-Guerrero, Ramon; Hicks, Thomas; Delso, Ignacio; Hernandez-Ruiz, Cristina; Velazquez-Campoy, Adrian; Lawton, Alexis J.; Angulo, Jesus; Denu, John M.; Carrodeguas, Jose A.			Self-acetylation at the active site of phosphoenolpyruvate carboxykinase (PCK1) controls enzyme activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER DIFFERENCE NMR; HISTONE ACETYLTRANSFERASE; LYSINE ACETYLATION; CALORIE RESTRICTION; CCP4 SUITE; MECHANISM; LIGAND; AUTOACETYLATION; SUCCINYLATION; DEGRADATION	Acetylation is known to regulate the activity of cytosolic phosphoenolpyruvate carboxykinase (PCK1), a key enzyme in gluconeogenesis, by promoting the reverse reaction of the enzyme (converting phosphoenolpyruvate to oxaloacetate). It is also known that the histone acetyltransferase p300 can induce PCK1 acetylation in cells, but whether that is a direct or indirect function was not known. Here we initially set out to determine whether p300 can acetylate directly PCK1 in vitro. We report that p300 weakly acetylates PCK1, but surprisingly, using several techniques including protein crystallization, mass spectrometry, isothermal titration calorimetry, saturation-transfer difference nuclear magnetic resonance and molecular docking, we found that PCK1 is also able to acetylate itself using acetyl-CoA independently of p300. This reaction yielded an acetylated recombinant PCK1 with a 3-fold decrease in k(cat) without changes in K-m for all substrates. Acetylation stoichiometry was determined for 14 residues, including residues lining the active site. Structural and kinetic analyses determined that site-directed acetylation of K244, located inside the active site, altered this site and rendered the enzyme inactive. In addition, we found that acetyl-CoA binding to the active site is specific and metal dependent. Our findings provide direct evidence for acetyl-CoA binding and chemical reaction with the active site of PCK1 and suggest a newly discovered regulatory mechanism of PCK1 during metabolic stress.	[Latorre-Muro, Pedro; Hurtado-Guerrero, Ramon; Hernandez-Ruiz, Cristina; Velazquez-Campoy, Adrian; Carrodeguas, Jose A.] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain; [Hurtado-Guerrero, Ramon] Univ Zaragoza, Lab Microscopias Avanzadas LMA, Zaragoza, Spain; [Baeza, Josue; Lawton, Alexis J.; Denu, John M.] Wisconsin Inst Discovery, Madison, WI USA; [Baeza, Josue; Lawton, Alexis J.; Denu, John M.] Sch Med & Publ Hlth Madison, Dept Biomol Chem, Madison, WI USA; [Hurtado-Guerrero, Ramon] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Copenhagen, Denmark; [Hurtado-Guerrero, Ramon; Velazquez-Campoy, Adrian] Fdn ARAID, Zaragoza, Spain; [Hicks, Thomas; Angulo, Jesus] Univ East Anglia, Sch Pharm, Norwich, Norfolk, England; [Delso, Ignacio] Univ Zaragoza, CSIC, Inst Sintesis Quim & Catalisis Homogenea ISQCH, Zaragoza, Spain; [Velazquez-Campoy, Adrian; Carrodeguas, Jose A.] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Biomed Res Network Ctr Hepat & Digest Dis CIBEReh, Madrid, Spain; [Velazquez-Campoy, Adrian; Carrodeguas, Jose A.] IIS Aragon, Zaragoza, Spain; [Angulo, Jesus] Univ Seville, Dept Quim Organ, Seville, Spain; [Angulo, Jesus] Univ Seville, CSIC, Inst Invest Quim, Seville, Spain; [Latorre-Muro, Pedro] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	University of Zaragoza; University of Zaragoza; University of Copenhagen; University of East Anglia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC-UZA - Instituto de Sintesis Quimica y Catalisis Homogenea (ISQCH); University of Zaragoza; University of Zaragoza; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); Harvard University; Dana-Farber Cancer Institute	Latorre-Muro, P; Carrodeguas, JA (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain.; Latorre-Muro, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	pedroa_latorremuro@dfci.harvard.edu; carrode@unizar.es	Velazquez-Campoy, Adrian/E-7946-2012; Delso, Ignacio/AAW-2250-2021; Angulo, Jesus/H-1253-2011	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Delso, Ignacio/0000-0001-8355-2289; Baeza, Josue/0000-0003-4960-3905; Lawton, Alexis/0000-0002-1065-0846; Hicks, Thomas/0000-0002-5349-2454; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; Angulo, Jesus/0000-0001-7250-5639	"la Caixa'' Foundation; Universidad de Zaragoza; Fundacion Bancaria Ibercaja; Fundacion CAI [CM 1/16]; Ministerio de Economia, Industria y Competitividad [AGL2015-66177]; University of Zaragoza [UZ-2015-BIO-01]; OTRI (University of Zaragoza), Ministerio de Ciencia, Innovacion y Universidades [CTQ2013-44367-C2-2-P, BFU2016-75633-P, BFU2016-78232-P]; Gobierno de Aragon [E34_R17, LMP58_18, E45_17R]; FEDER (2014-2020) funds for "Building Europe from Aragon"; ARAID foundation; FP7 (2007-2013) under BioStruct-X [N283570, BIOSTRUCTX_5186]; Biotechnology and biological Sciences Research Council (BBSRC) [BB/P010660/1]; Spanish Ministry of Science, Innovation and Universities [PID 2019-109395GB-I00]; BBSRC DTP studentship; Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia); National Institutes of Health (NIH) [GM065386]; NIH National Research Service Award [T32 GM007215]; National Science Foundation Graduate Research Fellowship Program (NSF-GRFP) [DGE-1256259]; BBSRC [BB/P010660/1] Funding Source: UKRI	"la Caixa'' Foundation(La Caixa Foundation); Universidad de Zaragoza; Fundacion Bancaria Ibercaja; Fundacion CAI; Ministerio de Economia, Industria y Competitividad(Spanish Government); University of Zaragoza; OTRI (University of Zaragoza), Ministerio de Ciencia, Innovacion y Universidades; Gobierno de Aragon(Gobierno de Aragon); FEDER (2014-2020) funds for "Building Europe from Aragon"; ARAID foundation; FP7 (2007-2013) under BioStruct-X; Biotechnology and biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministry of Science, Innovation and Universities(Spanish Government); BBSRC DTP studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program (NSF-GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	P. L. -M. was funded by a PhD fellowship from the "la Caixa'' Foundation and received financial support from the Universidad de Zaragoza, Fundacion Bancaria Ibercaja, and Fundacion CAI (CM 1/16) during his stay at the UW-Madison. We acknowledge Ministerio de Economia, Industria y Competitividad for grant AGL2015-66177 (J. A. C.), the University of Zaragoza for grant UZ-2015-BIO-01 (J. A. C.), and OTRI (University of Zaragoza), Ministerio de Ciencia, Innovacion y Universidades for grants CTQ2013-44367-C2-2-P and BFU2016-75633-P (R. H. -G.) and BFU2016-78232-P (A. V. -C.), Gobierno de Aragon for grants E34_R17 and LMP58_18 (R. H. -G.) and E45_17R (J. A. CandA. V. -C.) and FEDER (2014-2020) funds for "Building Europe from Aragon". R. H. -G. and A. V. -C. thank the ARAID foundation for support. The research leading to these results also received funding from the FP7 (2007-2013) under BioStruct-X (grant agreement N283570 and BIOSTRUCTX_5186). We also thank the ALBA synchrotron radiation source, in particular, the beamline XALOC facility.r J. A. and I. D. acknowledge access to UEA Faculty of Science Research Facilities. J. A. acknowledges funding support from the Biotechnology and biological Sciences Research Council (BBSRC; BB/P010660/1) and the Spanish Ministry of Science, Innovation and Universities through grant PID2019-109395GB-100. T. H. acknowledges a BBSRC DTP studentship. Financial support from the Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia) is also acknowledged.r This work was also supported by National Institutes of Health (NIH) Grant GM065386 (J. M. D.), NIH National Research Service Award T32 GM007215 (J. B.) and the National Science Foundation Graduate Research Fellowship Program (NSF-GRFP) DGE-1256259 (J. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Black JC, 2008, MOL CELL, V32, P449, DOI 10.1016/j.molcel.2008.09.018; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; Case CL, 2007, BBA-GEN SUBJECTS, V1770, P1576, DOI 10.1016/j.bbagen.2007.07.012; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escos Miriam, 2016, Biochem Biophys Rep, V7, P124, DOI 10.1016/j.bbrep.2016.06.007; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim EY, 2012, J LIPID RES, V53, P1864, DOI 10.1194/jlr.M026567; Kulkarni RA, 2017, CELL CHEM BIOL, V24, P231, DOI 10.1016/j.chembiol.2017.01.002; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; Latorre-Muro P, 2018, MOL CELL, V71, P718, DOI 10.1016/j.molcel.2018.07.031; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Monaco S, 2017, ANGEW CHEM INT EDIT, V56, P15289, DOI 10.1002/anie.201707682; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nepravishta R, 2019, CHEMBIOCHEM, V20, P340, DOI 10.1002/cbic.201800568; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shen ZL, 2016, J PROTEOMICS, V142, P24, DOI 10.1016/j.jprot.2016.05.002; Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P11961, DOI 10.1021/bi001272h; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yang H, 2015, EMBO J, V34, P1110, DOI 10.15252/embj.201591041; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	51	0	1	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100205	10.1074/jbc.RA120.015103	http://dx.doi.org/10.1074/jbc.RA120.015103			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334880	Green Accepted, gold, Green Published			2022-12-26	WOS:000672866400183
J	Mao, YW; Zhang, XH; Peng, W; Liu, HM; Zhou, XC; Liang, LQ; Xiang, JY; Zhang, HF; Wang, D; Liu, LL; Zhou, YX; Zhang, F; Xiao, Y; Shi, MJ; Wang, YY; Guo, B				Mao, Yanwen; Zhang, Xiaohuan; Peng, Wei; Liu, Huiming; Zhou, Xingchen; Liang, Luqun; Xiang, Jiayi; Zhang, Huifang; Wang, Dan; Liu, Lingling; Zhou, Yuxia; Zhang, Fan; Xiao, Ying; Shi, Mingjun; Wang, Yuanyuan; Guo, Bing			EI24 alleviates renal interstitial fibrosis through inhibition of epithelial-mesenchymal transition and fibroblast activation	FASEB JOURNAL			English	Article						EI24; epithelial&#8208; mesenchymal transition; extracellular matrix; fibroblast activation; renal interstitial fibrosis	NF-KAPPA-B; AUTOPHAGY; GENE; APOPTOSIS; PROTEIN; MYOFIBROBLASTS; INTERLEUKIN-15; INFLAMMATION; REGULATOR; ORIGIN	Etoposide-induced 2.4 (EI24) exerts tumor suppressor activity through participating in cell apoptosis, autophagy, and inflammation. However, its role in renal diseases has not been elucidated. This study showed that the EI24 level decreased gradually in the kidneys of mice with unilateral ureteral obstruction (UUO) and in another fibrosis model induced by diabetic kidney disease. The overexpression of EI24 was used to investigate the possible role both in vivo and in vitro. The overexpression 1 day after UUO through tail vein injection alleviated the progression of renal interstitial fibrosis (RIF). EI24 inhibited epithelial-mesenchymal transition, excessive deposition of the extracellular matrix, and activation of fibroblasts. Furthermore, administration of EI24-overexpressing plasmids restrained the phosphorylation of nuclear factor-kappa B (NF-kappa B) and c-Jun kinase (JNK) through regulating the proteasome-dependent degradation of TRAF2, and then, inhibited the expression of downstream inflammation-associated cytokines (interleukin-6, tumor necrosis factor-alpha, and monocyte chemotactic protein-1) and infiltration of macrophages and neutrophils in mouse kidney after UUO. In conclusion, the data indicated that EI24, a novel anti-fibrosis regulator, was important in the progression of RIF.	[Mao, Yanwen; Zhang, Xiaohuan; Peng, Wei; Liu, Huiming; Zhou, Xingchen; Liang, Luqun; Xiang, Jiayi; Zhang, Huifang; Wang, Dan; Liu, Lingling; Zhou, Yuxia; Zhang, Fan; Xiao, Ying; Shi, Mingjun; Wang, Yuanyuan] Guizhou Med Univ, Dept Pathophysiol, Guiyang, Guizhou, Peoples R China; [Mao, Yanwen; Zhang, Xiaohuan; Peng, Wei; Liu, Huiming; Zhou, Xingchen; Liang, Luqun; Xiang, Jiayi; Zhang, Huifang; Wang, Dan; Liu, Lingling; Zhou, Yuxia; Zhang, Fan; Xiao, Ying; Shi, Mingjun; Wang, Yuanyuan; Guo, Bing] Guizhou Med Univ, Guizhou Prov Key Lab Pathogenesis & Drug Res Comm, Guiyang, Guizhou, Peoples R China; [Guo, Bing] Guizhou Med Univ, Guizhou Prov Key Lab Pharmaceut, State Key Lab Funct & Applicat Med Plants, Guiyang, Peoples R China	Guizhou Medical University; Guizhou Medical University; Guizhou Medical University	Wang, YY (corresponding author), Guizhou Med Univ, Dept Pathophysiol, Guiyang, Guizhou, Peoples R China.; Guo, B (corresponding author), Guizhou Med Univ, Guizhou Prov Key Lab Pathogenesis & Drug Res Comm, Guiyang, Guizhou, Peoples R China.	yuanyuanwang18180@gmc.edu.com; guobingbs@126.com	Wang, Yu/GZL-9655-2022; Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022; Wang, Yuan/HHC-1520-2022; Lv, Yuanjie/AER-0767-2022; wangwangwang, yuanyaun/HHN-6432-2022	guo, bing/0000-0001-8998-2597				Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Andrade-Oliveira V, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01192; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Azpilikueta A, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1368605; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Choi JM, 2013, ONCOTARGET, V4, P2383, DOI 10.18632/oncotarget.1434; Courtois G, 2008, CELL MOL LIFE SCI, V65, P1123, DOI 10.1007/s00018-007-7465-4; Devkota S, 2016, AUTOPHAGY, V12, P2038, DOI 10.1080/15548627.2016.1217371; Devocelle A, 2019, INT J CELL BIOL, V2019; Eini H, 2010, J INTERF CYTOK RES, V30, P1, DOI 10.1089/jir.2009.0005; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hefetz-Sela S, 2014, P NATL ACAD SCI USA, V111, P17582, DOI 10.1073/pnas.1409700111; Hung TW, 2016, CELL PHYSIOL BIOCHEM, V40, P1029, DOI 10.1159/000453159; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lehar SM, 1996, ONCOGENE, V12, P1181; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu B, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-017-0760-6; Liu RX, 2012, KIDNEY BLOOD PRESS R, V35, P517, DOI 10.1159/000339172; Liu XM, 2018, BIOCHEM BIOPH RES CO, V497, P1110, DOI 10.1016/j.bbrc.2018.02.187; Loeffler I, 2015, CELLS-BASEL, V4, P631, DOI 10.3390/cells4040631; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Ma JJ, 2016, CELL BIOL INT, V40, P448, DOI 10.1002/cbin.10585; Duong MTH, 2020, COMPUT STRUCT BIOTEC, V18, P1440, DOI 10.1016/j.csbj.2020.06.013; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Nam SA, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1356-0; Nam T, 2017, MOL CELLS, V40, P897, DOI 10.14348/molcells.2017.0226; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Shinozaki M, 2002, J CLIN INVEST, V109, P951, DOI 10.1172/JCI200214574; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Sung YH, 2013, J BIOL CHEM, V288, P31261, DOI 10.1074/jbc.M113.477570; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tubben A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122104; Yang M, 2018, INT J MED SCI, V15, P1433, DOI 10.7150/ijms.26954; Yuan L, 2018, J BIOL CHEM, V293, P10128, DOI 10.1074/jbc.RA118.002399; Yuan Q, 2019, ADV EXP MED BIOL, V1165, P253, DOI 10.1007/978-981-13-8871-2_12; Zang Y, 2018, GASTROENT RES PRACT, V2018, DOI [10.1080/00207543.2018.1471238, 10.1155/2018/2626545]; Zeisberg M, 2001, CURR OPIN NEPHROL HY, V10, P315, DOI 10.1097/00041552-200105000-00004; Zhao XS, 2005, CANCER RES, V65, P2125, DOI 10.1158/0008-5472.CAN-04-3377; Zhao YG, 2012, J BIOL CHEM, V287, P42053, DOI 10.1074/jbc.M112.415968; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zheng PL, 2018, CELL RES, V28, P833, DOI 10.1038/s41422-018-0065-z	46	0	2	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21239	10.1096/fj.202002089R	http://dx.doi.org/10.1096/fj.202002089R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368642				2022-12-26	WOS:000605626600024
J	Separovich, RJ; Wong, MWM; Chapman, TR; Slavich, E; Hamey, JJ; Wilkins, MR				Separovich, Ryan J.; Wong, Mandy W. M.; Chapman, Tyler R.; Slavich, Eve; Hamey, Joshua J.; Wilkins, Marc R.			Post-translational modification analysis of Saccharomyces cerevisiae histone methylation enzymes reveals phosphorylation sites of regulatory potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHARGE-BASED INTERACTION; ELONGATION-FACTOR 1A; GLOBAL ANALYSIS; PROTEIN-PHOSPHORYLATION; LYSINE METHYLTRANSFERASES; STRESS-RESPONSE; YEAST; ACETYLATION; STABILITY; PATHWAY	Histone methylation is central to the regulation of eukaryotic transcription. In Saccharomyces cerevisiae, it is controlled by a system of four methyltransferases (Set1p, Set2p, Set5p, and Dot1p) and four demethylases (Jhd1p, Jhd2p, Rph1p, and Gis1p). While the histone targets for these enzymes are well characterized, the connection of the enzymes with the intracellular signaling network and thus their regulation is poorly understood; this also applies to all other eukaryotes. Here we report the detailed characterization of the eight S. cerevisiae enzymes and show that they carry a total of 75 phosphorylation sites, 92 acetylation sites, and two ubiquitination sites. All enzymes are subject to phosphorylation, although demethylases Jhd1p and Jhd2p contained one and five sites respectively, whereas other enzymes carried 14 to 36 sites. Phosphorylation was absent or underrepresented on catalytic and other domains but strongly enriched for regions of disorder on methyltransferases, suggesnting a role in the modulation of proteinprotein interactions. Through mutagenesis studies, we show that phosphosites within the acidic and disordered N-terminus of Set2p affect H3K36 methylation levels in vivo, illustrating the functional importance of such sites. While most kinases upstream of the yeast histone methylation enzymes remain unknown, we model the possible connections between the cellular signaling network and the histone-based gene regulatory system and propose an integrated regulatory structure. Our results provide a foundation for future, detailed exploration of the role of specific kinases and phosphosites in the regulation of histone methylation.	[Separovich, Ryan J.; Wong, Mandy W. M.; Chapman, Tyler R.; Hamey, Joshua J.; Wilkins, Marc R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Slavich, Eve] Univ New South Wales, Stats Cent, Mark Wainwright Analyt Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Wilkins, MR (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	m.wilkins@unsw.edu.au		Separovich, Ryan/0000-0001-6310-8463; Wilkins, Marc/0000-0002-5700-5684; Hamey, Joshua/0000-0002-0463-8955; Chapman, Tyler/0000-0002-6486-7004	Australian Research Training Program Scholarship; Australian Research Council [DP170100108, DP200100129]	Australian Research Training Program Scholarship; Australian Research Council(Australian Research Council)	R. J. S. was the recipient of an Australian Research Training Program Scholarship. This work was supported by Australian Research Council Grants DP170100108 and DP200100129 to M. R. W.	Aguilar-Arnal L, 2015, NAT STRUCT MOL BIOL, V22, P312, DOI 10.1038/nsmb.2990; Akimov V, 2018, NAT STRUCT MOL BIOL, V25, P631, DOI 10.1038/s41594-018-0084-y; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bernard A, 2015, CURR BIOL, V25, P546, DOI 10.1016/j.cub.2014.12.049; Bilokapic S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11726-4; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Bontron S, 2013, CELL REP, V3, P16, DOI 10.1016/j.celrep.2012.11.025; Brademan DR, 2019, MOL CELL PROTEOMICS, V18, pS193, DOI 10.1074/mcp.TIR118.001209; Cao LL, 2016, ONCOGENE, V35, P301, DOI 10.1038/onc.2015.81; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Chang YY, 2011, BIOCHEM J, V433, P295, DOI 10.1042/BJ20101418; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fu LN, 2018, ONCOGENE, V37, P389, DOI 10.1038/onc.2017.345; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; Green EM, 2012, NAT STRUCT MOL BIOL, V19, P361, DOI 10.1038/nsmb.2252; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hamey JJ, 2018, J PROTEOME RES, V17, P3485, DOI 10.1021/acs.jproteome.8b00396; Hamey JJ, 2017, MOL CELL PROTEOMICS, V16, P2229, DOI 10.1074/mcp.M116.066308; Hamey JJ, 2016, MOL CELL PROTEOMICS, V15, P164, DOI 10.1074/mcp.M115.052449; Hart-Smith G, 2016, MOL CELL PROTEOMICS, V15, P989, DOI 10.1074/mcp.M115.055384; Hart-Smith G, 2012, J AM SOC MASS SPECTR, V23, P124, DOI 10.1007/s13361-011-0273-y; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hiragami-Hamada K, 2011, MOL CELL BIOL, V31, P1186, DOI 10.1128/MCB.01012-10; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Holt LJ, 2012, FEBS LETT, V586, P2773, DOI 10.1016/j.febslet.2012.05.045; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hsu WL, 2012, BIOCOMPUT-PAC SYM, P116; Huesgen PF, 2015, NAT METHODS, V12, P55, DOI 10.1038/nmeth.3177; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; Husmann D, 2019, NAT STRUCT MOL BIOL, V26, P880, DOI 10.1038/s41594-019-0298-7; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Jaiswal D, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00341-19; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang Lingyan, 2010, Mol Cell Pharmacol, V2, P69; Jin X, 2017, J BIOL CHEM, V292, P6269, DOI 10.1074/jbc.M116.764407; Kim H, 2018, P NATL ACAD SCI USA, V115, P11766, DOI 10.1073/pnas.1805662115; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lanz M. C., 2019, DEPTH 3 DIMENSIONAL, DOI [10.1101/700070, DOI 10.1101/700070]; Li F, 2017, NUCLEIC ACIDS RES, V45, P5183, DOI 10.1093/nar/gkx129; Li JM, 2019, CELL REP, V29, P2092, DOI 10.1016/j.celrep.2019.10.034; Li N, 2017, J CLIN INVEST, V127, P1284, DOI 10.1172/JCI91144; Liang CY, 2013, MOL BIOL CELL, V24, P3251, DOI 10.1091/mbc.E12-11-0820; Liang CY, 2011, NUCLEIC ACIDS RES, V39, P4151, DOI 10.1093/nar/gkr040; Lim MY, 2017, J PROTEOME RES, V16, P4217, DOI 10.1021/acs.jproteome.7b00571; Maile TM, 2015, MOL CELL PROTEOMICS, V14, P1148, DOI 10.1074/mcp.O114.046573; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mersman DP, 2012, J BIOL CHEM, V287, P2652, DOI 10.1074/jbc.M111.280867; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Messier V, 2013, CELL, V153, P1080, DOI 10.1016/j.cell.2013.04.035; Metcalfe EE, 2005, BIOCHEMISTRY-US, V44, P4386, DOI 10.1021/bi047571e; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Munshi S, 2018, NUCLEIC ACIDS RES, V46, P8700, DOI 10.1093/nar/gky732; Ochoa D, 2020, NAT BIOTECHNOL, V38, P365, DOI 10.1038/s41587-019-0344-3; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P2796, DOI 10.1074/mcp.M900285-MCP200; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Qu QH, 2018, CELL, V174, P1117, DOI 10.1016/j.cell.2018.07.020; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Salvatori Beatrice, 2011, Genes Cancer, V2, P585, DOI 10.1177/1947601911416357; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Separovich RJ, 2020, TRENDS BIOCHEM SCI, V45, P1035, DOI 10.1016/j.tibs.2020.08.004; Sharifpoor S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r39; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sidoli S, 2017, METHODS MOL BIOL, V1528, P121, DOI 10.1007/978-1-4939-6630-1_8; Smith DL, 2020, J MOL BIOL, V432, P448, DOI 10.1016/j.jmb.2019.11.006; Spangle JM, 2016, CELL REP, V15, P2692, DOI 10.1016/j.celrep.2016.05.046; Sun LP, 2015, J BIOL CHEM, V290, P4075, DOI 10.1074/jbc.M114.602532; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tompa P, 2014, CHEM REV, V114, P6715, DOI 10.1021/cr4005082; Tong ZT, 2014, MOL CELL PROTEOMICS, V13, P2871, DOI 10.1074/mcp.M114.040774; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wan LX, 2018, MOL CELL, V69, P279, DOI 10.1016/j.molcel.2017.12.024; Wang XY, 2019, GENE DEV, V33, P1416, DOI 10.1101/gad.328849.119; Wang Y, 2015, NUCLEIC ACIDS RES, V43, P4881, DOI 10.1093/nar/gkv393; Wang Z, 2011, MOL BIOL EVOL, V28, P1131, DOI 10.1093/molbev/msq268; Weiner A, 2015, MOL CELL, V58, P371, DOI 10.1016/j.molcel.2015.02.002; Winter DL, 2018, J MOL BIOL, V430, P102, DOI 10.1016/j.jmb.2017.11.009; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]; Ye CQ, 2019, MOL CELL, V73, P1115, DOI 10.1016/j.molcel.2019.01.012; Yeh I.-J., 2019, SCI REP-UK, V9, P1; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zhao YM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a025064; Zhou AD, 2016, NAT CELL BIOL, V18, P954, DOI 10.1038/ncb3396	105	7	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100192	10.1074/jbc.RA120.015995	http://dx.doi.org/10.1074/jbc.RA120.015995			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334889	gold, Green Published			2022-12-26	WOS:000672866400170
J	Josiassen, J; Helgestad, OKL; Moller, JE; Kjaergaard, J; Hoejgaard, HF; Schmidt, H; Jensen, LO; Holmvang, L; Ravn, HB; Hassager, C				Josiassen, Jakob; Lerche Helgestad, Ole Kristian; Moller, Jacob Eifer; Kjaergaard, Jesper; Hoejgaard, Henrik Frederiksen; Schmidt, Henrik; Jensen, Lisette Okkels; Holmvang, Lene; Ravn, Hanne Berg; Hassager, Christian			Hemodynamic and metabolic recovery in acute myocardial infarction-related cardiogenic shock is more rapid among patients presenting with out-of-hospital cardiac arrest	PLOS ONE			English	Article							TARGETED TEMPERATURE MANAGEMENT; VENOUS OXYGEN-SATURATION; VASOPRESSOR SUPPORT; LACTATE CLEARANCE; MORTALITY; 36-DEGREES-C; 33-DEGREES-C; TRENDS; RESUSCITATION; SURVIVAL	Background Most studies in acute myocardial infarction complicated by cardiogenic shock (AMICS) include patients presenting with and without out-of-hospital cardiac arrest (OHCA). The aim was to compare OHCA and non-OHCA AMICS patients in terms of hemodynamics, management in the intensive care unit (ICU) and outcome. Methods From a cohort corresponding to two thirds of the Danish population, all patients with AMICS admitted from 2010-2017 were individually identified through patient records. Results A total of 1716 AMICS patients were identified of which 723 (42%) presented with OHCA. A total of 1532 patients survived to ICU admission. At the time of ICU arrival, there were no differences between OHCA and non-OHCA AMICS patients in variables commonly used in the AMICS definition (mean arterial pressure (MAP) (72mmHg vs 70mmHg, p = 0.12), lactate (4.3mmol/L vs 4.0mmol/L, p = 0.09) and cardiac output (CO) (4.6L/min vs 4.4L/min, p = 0.30)) were observed. However, during the initial days of ICU treatment OHCA patients had a higher MAP despite a lower need for vasoactive drugs, higher CO, SVO2 and lactate clearance compared to non-OHCA patients (p<0.05 for all). In multivariable analysis outcome was similar but cause of death differed significantly with hypoxic brain injury being leading cause in OHCA and cardiac failure in non-OHCA AMICS patients. Conclusion OHCA and non-OHCA AMICS patients initially have comparable metabolic and hemodynamic profiles, but marked differences develop between the groups during the first days of ICU treatment. Thus, pooling of OHCA and non-OHCA patients as one clinical entity in studies should be done with caution.	[Josiassen, Jakob; Moller, Jacob Eifer; Kjaergaard, Jesper; Holmvang, Lene; Hassager, Christian] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Lerche Helgestad, Ole Kristian; Moller, Jacob Eifer; Jensen, Lisette Okkels] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Lerche Helgestad, Ole Kristian; Moller, Jacob Eifer] Univ Southern Denmark, Odense Patient Data Explorat Network, Odense, Denmark; [Hoejgaard, Henrik Frederiksen; Schmidt, Henrik] Odense Univ Hosp, Dept Cardiothorac Anesthesia, Odense, Denmark; [Holmvang, Lene; Ravn, Hanne Berg; Hassager, Christian] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Ravn, Hanne Berg] Copenhagen Univ Hosp, Dept Cardiothorac Anesthesia, Rigshosp, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen	Josiassen, J (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark.	Jakob.josiassen@regionh.dk	Josiassen, Jakob/AAF-9151-2021; Ravn, Hanne Berg/K-3118-2016	Kjaergaard, Jesper/0000-0001-5244-0399; Helgestad, Ole Kristian Lerche/0000-0003-3847-8758; Jensen, Lisette Okkels/0000-0002-4838-2429; Ravn, Hanne Berg/0000-0003-4702-5195; Hassager, Christian/0000-0002-1199-0981	Danish Heart Foundation; Jorgen Moller foundation; Abiomed	Danish Heart Foundation; Jorgen Moller foundation; Abiomed	The study was funded by The Danish Heart Foundation, The Jorgen Moller foundation and a research grant from Abiomed. The funding parts were not involved in any aspects of the creation or publishing of current study.	[Anonymous], 2017, J COLD WAR STUDIES, V19, P192; Attana P, 2012, EUR HEART J-ACUTE CA, V1, P115, DOI 10.1177/2048872612451168; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bro-Jeppesen J, 2015, CRIT CARE MED, V43, P318, DOI 10.1097/CCM.0000000000000691; Bro-Jeppesen J, 2014, CIRC-CARDIOVASC INTE, V7, P663, DOI 10.1161/CIRCINTERVENTIONS.114.001556; Bro-Jeppesen J, 2009, RESUSCITATION, V80, P171, DOI 10.1016/j.resuscitation.2008.09.009; Fuernau G, 2019, CIRCULATION, V139, P448, DOI 10.1161/CIRCULATIONAHA.117.032722; Goldberg RJ, 2016, CIRC-CARDIOVASC QUAL, V9, P117, DOI 10.1161/CIRCOUTCOMES.115.002359; Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947; Hassager C, 2018, LANCET, V391, P989, DOI 10.1016/S0140-6736(18)30315-5; Helgestad OKL, 2019, EUR J HEART FAIL, V21, P1370, DOI 10.1002/ejhf.1566; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Husain I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1887; Jentzer JC, 2020, CIRC-CARDIOVASC QUAL, V13, P607, DOI 10.1161/CIRCOUTCOMES.120.006692; Jentzer JC, 2019, J AM COLL CARDIOL, V74, P2117, DOI 10.1016/j.jacc.2019.07.077; Kern KB, 1996, J AM COLL CARDIOL, V28, P232, DOI 10.1016/0735-1097(96)00130-1; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Mentzelopoulos SD, 2017, RESUSCITATION, V121, pA12, DOI 10.1016/j.resuscitation.2017.10.013; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; NIMMO GR, 1994, ANAESTHESIA, V49, P485, DOI 10.1111/j.1365-2044.1994.tb03517.x; NIMMO GR, 1992, AM HEART J, V123, P1720, DOI 10.1016/0002-8703(92)90838-M; Obling L, 2018, EUR HEART J-ACUTE CA, V7, P7, DOI 10.1177/2048872617706503; Ostenfeld S, 2015, RESUSCITATION, V87, P57, DOI 10.1016/j.resuscitation.2014.11.010; Patterson T, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.005346; Samanta R, 2019, IJC HEART VASC, V22, P50, DOI 10.1016/j.ijcha.2018.12.001; Soholm H, 2015, ANN EMERG MED, V65, P523, DOI 10.1016/j.annemergmed.2014.12.009; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; SUMIMOTO T, 1991, AM HEART J, V122, P27, DOI 10.1016/0002-8703(91)90754-6; Thiele H, 2017, NEW ENGL J MED, V377, P2419, DOI 10.1056/NEJMoa1710261; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Ueki Y, 2016, CIRC J, V80, P852, DOI 10.1253/circj.CJ-16-0125; Vallabhajosyula S, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0459-6; Zhang ZH, 2014, CRIT CARE MED, V42, P2118, DOI 10.1097/CCM.0000000000000405	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244294	10.1371/journal.pone.0244294	http://dx.doi.org/10.1371/journal.pone.0244294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362228	Green Published, gold			2022-12-26	WOS:000603071600042
J	Ruba, AL; Pollak, SD				Ruba, Ashley L.; Pollak, Seth D.			Children's emotion inferences from masked faces: Implications for social interactions during COVID-19	PLOS ONE			English	Article							FACIAL EXPRESSIONS; RECOGNIZE EMOTIONS; EYES; HAPPY; MOUTH; CUES; DISCRIMINATION; COMPETENCE; EXPERIENCE; ABILITY	To slow the progression of COVID-19, the Centers for Disease Control (CDC) and the World Health Organization (WHO) have recommended wearing face coverings. However, very little is known about how occluding parts of the face might impact the emotion inferences that children make during social interactions. The current study recruited a racially diverse sample of school-aged (7- to 13-years) children from publicly funded after-school programs. Children made inferences from facial configurations that were not covered, wearing sunglasses to occlude the eyes, or wearing surgical masks to occlude the mouth. Children were still able to make accurate inferences about emotions, even when parts of the faces were covered. These data suggest that while there may be some challenges for children incurred by others wearing masks, in combination with other contextual cues, masks are unlikely to dramatically impair children's social interactions in their everyday lives.	[Ruba, Ashley L.; Pollak, Seth D.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Pollak, Seth D.] Univ Wisconsin, Waisman Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ruba, AL (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	ruba@wisc.edu	Ruba, Ashley L./S-9116-2019	Ruba, Ashley L./0000-0001-6213-6868	National Institute of Mental Health [R01 MH61285, T32 MH018931]; National Institute of Child Health and Human Development [U54 HD090256]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	SDP was supported by the National Institute of Mental Health (R01 MH61285) and a core grant to the Waisman Center from the National Institute of Child Health and Human Development (U54 HD090256). ALR was supported by an Emotion Research Training Grant (T32 MH018931) from the National Institute of Mental Health. Funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, J CONSUM PSYCHOL, V10, P83, DOI DOI 10.1361/105996301770349547; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Barrett LF, 2019, PSYCHOL SCI PUBL INT, V20, P1, DOI 10.1177/1529100619832930; Blais C, 2017, EMOTION, V17, P1107, DOI 10.1037/emo0000283; Bombari D, 2013, Q J EXP PSYCHOL, V66, P2426, DOI 10.1080/17470218.2013.789065; Calvo MG, 2013, MOTIV EMOTION, V37, P202, DOI 10.1007/s11031-012-9298-1; Denham SA, 2014, INFANT CHILD DEV, V23, P426, DOI 10.1002/icd.1840; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; Fischer AH, 2012, SOC PSYCHOL PERS SCI, V3, P266, DOI 10.1177/1948550611418534; Fortin Jacey, 2020, NY TIMES; Franco F, 2014, RES DEV DISABIL, V35, P1015, DOI 10.1016/j.ridd.2014.01.037; Gagnon M, 2014, J GENET PSYCHOL, V175, P416, DOI 10.1080/00221325.2014.941322; Green C, 2018, COGNITION EMOTION, V32, P37, DOI 10.1080/02699931.2016.1273200; Grossmann T, 2017, PERSPECT PSYCHOL SCI, V12, P107, DOI 10.1177/1745691616654457; Guarnera M, 2015, EUR J PSYCHOL, V11, P183, DOI 10.5964/ejop.v11i2.890; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jack Rachael E, 2009, Curr Biol, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Jessen S, 2016, COGNITION, V150, P163, DOI 10.1016/j.cognition.2016.02.010; Jessen S, 2014, P NATL ACAD SCI USA, V111, P16208, DOI 10.1073/pnas.1411333111; Kanat M, 2015, NEUROPSYCHOPHARMACOL, V40, P287, DOI 10.1038/npp.2014.183; Katz R, 2020, ARE YOU HAPPY SAD WE; KESTENBAUM R, 1992, DEV PSYCHOL, V28, P1132, DOI 10.1037/0012-1649.28.6.1132; Klass P, 2020, NY TIMES; Kret ME, 2018, COGNITION EMOTION, V32, P623, DOI 10.1080/02699931.2017.1330253; Kret ME, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00110; Krol KM, 2015, P NATL ACAD SCI USA, V112, pE5434, DOI 10.1073/pnas.1506352112; Leitzke BT, 2016, DEV PSYCHOL, V52, P572, DOI 10.1037/a0040067; Leppanen JM, 2007, VIS COGN, V15, P468, DOI 10.1080/13506280600765333; Morin-Lessard E, 2019, DEV PSYCHOL, V55, P1640, DOI 10.1037/dev0000750; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Ong S, 2020, BRIT BROADCASTING CO; Plate RC, 2019, J EXP PSYCHOL GEN, V148, P1814, DOI 10.1037/xge0000529; Pollak SD, 2002, DEV PSYCHOL, V38, P784, DOI 10.1037/0012-1649.38.5.784; RCore Team, 2020, R LANG ENV STAT COMP; Rigoulot S, 2014, SPEECH COMMUN, V65, P36, DOI 10.1016/j.specom.2014.05.006; Roberson D, 2012, COGNITION, V125, P195, DOI 10.1016/j.cognition.2012.06.018; Ruba A.L., 2020, ANN REV DEVELOPMENTA, V2, P503, DOI [10.1146/annurev-devpsych-060320-102556, DOI 10.1146/ANNUREV-DEVPSYCH-060320-102556]; Ruba Ashley L, 2020, Affect Sci, V1, P4, DOI 10.1007/s42761-020-00005-x; Ruba AL, 2020, EMOT REV, V12, P255, DOI 10.1177/1754073920931574; Ruba AL, 2020, EMOT REV, V12, P235, DOI 10.1177/1754073919871098; Ruba AL, 2019, DEV PSYCHOL, V55, P1138, DOI 10.1037/dev0000711; Scheller E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041792; Schwarzer G, 2007, DEVELOPMENTAL SCI, V10, P452, DOI 10.1111/j.1467-7687.2007.00599.x; Schyns PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005625; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Thorstenson CA, 2019, EMOTION, V19, P799, DOI 10.1037/emo0000485; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Wegrzyn M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177239; WICKHAM H, 2009, GGPLOT2 ELEGENT GRAP	50	45	45	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243708	10.1371/journal.pone.0243708	http://dx.doi.org/10.1371/journal.pone.0243708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362251	Green Published, gold			2022-12-26	WOS:000603071600032
J	Yavas, A; Weij, R; van Putten, M; Kourkouta, E; Beekman, C; Puolivali, J; Bragge, T; Ahtoniemi, T; Knijnenburg, J; Hoogenboom, ME; Ariyurek, Y; Aartsma-Rus, A; van Deutekom, J; Datson, N				Yavas, Alper; Weij, Rudie; van Putten, Maaike; Kourkouta, Eleni; Beekman, Chantal; Puolivali, Jukka; Bragge, Timo; Ahtoniemi, Toni; Knijnenburg, Jeroen; Hoogenboom, Marlies Elisabeth; Ariyurek, Yavuz; Aartsma-Rus, Annemieke; van Deutekom, Judith; Datson, Nicole			Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; EFFICACY; DATABASE	Duchenne muscular dystrophy (DMD) is a severe, progressive neuromuscular disorder caused by reading frame disrupting mutations in the DMD gene leading to absence of functional dystrophin. Antisense oligonucleotide (AON)-mediated exon skipping is a therapeutic approach aimed at restoring the reading frame at the pre-mRNA level, allowing the production of internally truncated partly functional dystrophin proteins. AONs work in a sequence specific manner, which warrants generating humanized mouse models for preclinical tests. To address this, we previously generated the hDMDdel52/mdx mouse model using transcription activator like effector nuclease (TALEN) technology. This model contains mutated murine and human DMD genes, and therefore lacks mouse and human dystrophin resulting in a dystrophic phenotype. It allows preclinical evaluation of AONs inducing the skipping of human DMD exons 51 and 53 and resulting in restoration of dystrophin synthesis. Here, we have further characterized this model genetically and functionally. We discovered that the hDMD and hDMDdel52 transgene is present twice per locus, in a tail-to-tail-orientation. Long-read sequencing revealed a partial deletion of exon 52 (first 25 bp), and a 2.3 kb inversion in intron 51 in both copies. These new findings on the genomic make-up of the hDMD and hDMDdel52 transgene do not affect exon 51 and/or 53 skipping, but do underline the need for extensive genetic analysis of mice generated with genome editing techniques to elucidate additional genetic changes that might have occurred. The hDMDdel52/mdx mice were also evaluated functionally using kinematic gait analysis. This revealed a clear and highly significant difference in overall gait between hDMDdel52/mdx mice and C57BL6/J controls. The motor deficit detected in the model confirms its suitability for preclinical testing of exon skipping AONs for human DMD at both the functional and molecular level.	[Yavas, Alper; van Putten, Maaike; Ariyurek, Yavuz; Aartsma-Rus, Annemieke] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Weij, Rudie; Kourkouta, Eleni; Beekman, Chantal; van Deutekom, Judith; Datson, Nicole] BioMarin Nederland BV, Leiden, Netherlands; [Puolivali, Jukka; Bragge, Timo; Ahtoniemi, Toni] Charles River Discovery Serv, Kuopio, Finland; [Knijnenburg, Jeroen; Hoogenboom, Marlies Elisabeth] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aartsma-Rus, A (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	a.m.rus@lumc.nl	Knijnenburg, Jeroen/AAC-1663-2022	Knijnenburg, Jeroen/0000-0001-5662-7054; Bragge, Timo/0000-0002-8634-0297; Kourkouta, Eleni/0000-0002-6178-0712; van Putten, Maaike/0000-0002-0683-8897				Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2020, NUCLEIC ACID THER, V30, P67, DOI 10.1089/nat.2020.0845; Aartsma-Rus A, 2019, NUCLEIC ACID THER, V29, P13, DOI 10.1089/nat.2018.0756; Aartsma-Rus A, 2018, NAT REV NEUROL, V14, P454, DOI 10.1038/s41582-018-0033-8; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Akpulat U, 2018, MOL THER-NUCL ACIDS, V13, P534, DOI 10.1016/j.omtn.2018.10.002; Andrews JG, 2018, ADOLESC HEALTH MED T, V9, P53, DOI 10.2147/AHMT.S125739; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; [Anonymous], 2019, J INORG ORGANOMET PO, V29, P1; Beekman C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195850; Bello L, 2016, NEUROLOGY, V87, P401, DOI 10.1212/WNL.0000000000002891; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Cold Snow Front, 2016, AUTOMATION TECHNOLOG, V35, P122; Datson NA, 2020, NUCLEIC ACID THER, V30, P50, DOI 10.1089/nat.2019.0824; Dhillon S, 2020, DRUGS, V80, P1027, DOI 10.1007/s40265-020-01339-3; Gao QQ, 2015, COMPR PHYSIOL, V5, P1223, DOI 10.1002/cphy.c140048; Gazzoli I, 2016, RNA BIOL, V13, P290, DOI 10.1080/15476286.2015.1125074; Hendriksen RGF, 2015, NEUROSCI BIOBEHAV R, V51, P255, DOI 10.1016/j.neubiorev.2015.01.023; Lim KRQ, 2017, DRUG DES DEV THER, V11, P533, DOI 10.2147/DDDT.S97635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama R, 2018, METHODS MOL BIOL, V1828, P165, DOI 10.1007/978-1-4939-8651-4_10; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Muntoni F, 2011, NAT REV DRUG DISCOV, V10, P621, DOI 10.1038/nrd3459; Nakamura A, 2016, J HUM GENET, V61, P663, DOI 10.1038/jhg.2016.28; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P451, DOI 10.1016/j.nmd.2013.02.012; Rader EP, 2016, P NATL ACAD SCI USA, V113, P10992, DOI 10.1073/pnas.1605265113; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; 't Hoen PAC, 2008, J BIOL CHEM, V283, P5899, DOI 10.1074/jbc.M709410200; Veltrop M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193289; Verheul RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162467; Young Courtney S, 2017, J Neuromuscul Dis, V4, P139, DOI 10.3233/JND-170218	34	9	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244215	10.1371/journal.pone.0244215	http://dx.doi.org/10.1371/journal.pone.0244215			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362201	gold, Green Published			2022-12-26	WOS:000603071600035
J	Schmidt, T; Cloete, A; Davids, A; Makola, L; Zondi, N; Jantjies, M				Schmidt, Tenielle; Cloete, Allanise; Davids, Adlai; Makola, Lehlogonolo; Zondi, Nokubonga; Jantjies, Monalisa			Myths, misconceptions, othering and stigmatizing responses to Covid-19 in South Africa: A rapid qualitative assessment	PLOS ONE			English	Article							DISCRIMINATION; EXPERIENCES; TRANSMISSION; MEN; SEX	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new strain of virus in the Coronavirus family that has not been previously identified. Since SARS-CoV-2 is a new virus, everyone is at risk of catching the Coronavirus disease 2019 (Covid-19). No one has immunity to the virus. Despite this, misconceptions about specific groups of people who are immune to Covid-19 emerged with the onset of the pandemic. This paper explores South African communities' misconceptions about who is most vulnerable to Covid-19. A rapid qualitative assessment was conducted remotely in Gauteng, KwaZulu-Natal and the Western Cape provinces of South Africa. Recruitment of study participants took place through established relationships with civil society organizations and contacts made by researchers. In total, 60 key informant interviews and one focus group discussion was conducted. Atlas.ti.8 Windows was used to facilitate qualitative data analysis. The qualitative data was coded, and thematic analysis used to identify themes. The results show a high level of awareness and knowledge of the transmission and prevention of SARS-CoV-2. Qualitative data revealed that there is awareness of elderly people and those with immunocompromised conditions being more vulnerable to catching Covid-19. However, misconceptions of being protected against the virus or having low or no risk were also evident in the data. We found that false information circulated on social media not only instigated confusion, fear and panic, but also contributed to the construction of misconceptions, othering and stigmatizing responses to Covid-19. The study findings bring attention to the importance of developing communication materials adapted to specific communities to help reduce misconceptions, othering and stigmatization around Covid-19.	[Schmidt, Tenielle; Cloete, Allanise; Davids, Adlai; Zondi, Nokubonga; Jantjies, Monalisa] Human Sci Res Council HSRC, Human & Social Capabil Div, Pretoria, South Africa; [Davids, Adlai] Nelson Mandela Univ, Fac Hlth Sci, Port Elizabeth, South Africa; [Makola, Lehlogonolo] Univ Cape Town UCT, Childrens Inst, Cape Town, South Africa	Human Sciences Research Council-South Africa; Nelson Mandela University	Cloete, A (corresponding author), Human Sci Res Council HSRC, Human & Social Capabil Div, Pretoria, South Africa.	acloete@hsrc.ac.za		Cloete, Allanise/0000-0001-6763-9675; Reddy, Priscilla/0000-0002-0432-9060; Zondi, Nokubonga/0000-0003-0027-1962	Human Sciences Research Council (HSRC)	Human Sciences Research Council (HSRC)	We received discretionary funding from the Office of the Chief Executive Officer (CEO), of the Human Sciences Research Council (HSRC), to implement this qualitative study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari M, 2006, J S AFR STUD, V32, P467, DOI 10.1080/03057070600829542; Adja KYC, 2020, PUBLIC HEALTH, V185, P39, DOI 10.1016/j.puhe.2020.05.054; [Anonymous], 2020, COMMUN BIOL, V3, P1; [Anonymous], PEDIAT RHEUMATOLOGY; [Anonymous], 2020, S AFRICAS ACTION COV; Arafat SMY, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113061; Arshad MS, 2020, FOOD SCI NUTR, V8, P3971, DOI 10.1002/fsn3.1719; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Bruns DP, 2020, J TRANSCULT NURS, V31, P326, DOI 10.1177/1043659620917724; Campbell C, 2005, AM J PUBLIC HEALTH, V95, P808, DOI 10.2105/AJPH.2003.037499; Chapter Beyers C., 2009, BURDENED RACE COLOUR, P79; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Chopra K K, 2020, Indian J Tuberc, V67, P284, DOI 10.1016/j.ijtb.2020.07.012; Cloete A, 2008, AIDS CARE, V20, P1105, DOI 10.1080/09540120701842720; Cloete A., 2018, INVENTION MOFFIE LIF; Cloete A, 2013, STIGMA DISCRIMINATIO, DOI [10.1007/978-94-007-6324-1_15, DOI 10.1007/978-94-007-6324-1_15]; Cloete A, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/420270; Cloete Kalichman S., 2013, STIGMA DISCRIMINATIO, P259; Craffert P. F., 2010, NEOT, V44, P292; Daniel Yaw Fiaveh, 2012, J MED RES; Devakumar D, 2020, LANCET, V395, P1194, DOI 10.1016/S0140-6736(20)30792-3; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Grobler R., 2020, NEWS24; Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; Hargreaves J, 2020, LANCET HIV, V7, pE309, DOI 10.1016/S2352-3018(20)30110-7; Harries AD, 2020, INT J TUBERC LUNG D, V24, P550, DOI 10.5588/ijtld.20.0176; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ibrahim OM, 2020, IJMS, DOI 10.20944/PREPRINTS202004.0492.V1; Johns Hopkins University & Medicine: Coronavirus Resource Center, 2020, REG WORLD COUNTR; Karim SSA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2014960; Khumalo TP, 2011, DEV S AFR, DOI [10.1080/0376835X.2011.605559, DOI 10.1080/0376835X.2011.605559]; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lingeswaran M, 2020, INDIAN J CLIN BIOCHE, V35, P260, DOI 10.1007/s12291-020-00897-3; Lithander FE, 2020, AGE AGEING, V49, P501, DOI 10.1093/ageing/afaa093; Logie CH, 2020, AIDS BEHAV, V24, P2003, DOI 10.1007/s10461-020-02856-8; Mwamwenda T.S., 2015, LIFE SCI J, V12, P1576; National Department of Health, 2020, COR VIR COVID 19 OUT; National Department of Health, 2020, FLATT CURV AR LOCKD; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Ngubane S, 2020, COVID 19 IN DEPTH AN; Patton MQ., 2015, BLACKWELL ENCY SOCIO, DOI [10.1002/9781405165518.wbeoss012.pub2, DOI 10.1002/9781405165518.WBEOSS012.PUB2]; Petros G, 2006, CULT HEALTH SEX, V8, P67, DOI 10.1080/13691050500391489; Presidency of South Africa, 2020, COVID 19 PLAN; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; RAS GJ, 1983, S AFR MED J, V64, P140; Rispel LC, 2015, SAHARA J-J SOC ASP H, V12, P10, DOI 10.1080/17290376.2015.1014403; Sahoo Swapnajeet, 2020, NARRATIVE REAL LIFE, DOI [10.1016/j.ajp.2020.102187, DOI 10.1016/J.AJP.2020.102187]; Sano Y, 2016, BMC INT HEALTH HUM R, V16, DOI 10.1186/s12914-016-0089-8; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Simbayi L. C., 2019, S AFRICAN NATL HIV P, DOI [10.1186/s12939-019-1055-6, DOI 10.1186/S12939-019-1055-6]; Singh Lisa, 2020, ArXiv; Singh R, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102222; Skinner D, 2004, SAHARA J, V1, P157; Stiegler N, 2020, ANN MED-PSYCHOL, V178, P695, DOI 10.1016/j.amp.2020.05.006; Tenkorang EY, 2013, CULT HEALTH SEX, V15, P296, DOI 10.1080/13691058.2012.752107; UNAIDS, 2017, CONFR DISCR OV HIV R; WHO U, 2020, SOC STIGM ASS COVID; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; World Health Organisation, 2020, WHO NEWSLETTER; World Health Organization, 2021, RADIOPAEDIA; World Health Organization (WHO), 2020, Q A CORONAVIRUSES CO; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	62	31	31	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244420	10.1371/journal.pone.0244420	http://dx.doi.org/10.1371/journal.pone.0244420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351852	Green Published, gold			2022-12-26	WOS:000603071400051
J	Yan, DQ; Ren, J; Liu, JM; Ding, Y; Niu, JM				Yan, Dongqing; Ren, Jing; Liu, Jiamei; Ding, Yu; Niu, Jianming			De novo assembly, annotation, marker discovery, and genetic diversity of the Stipa breviflora Griseb. (Poaceae) response to grazing	PLOS ONE			English	Article							SOIL PROPERTIES; INNER-MONGOLIA; RNA-SEQ; GRASSLAND; RESISTANCE; EXPRESSION; CHINA; IDENTIFICATION; CHECKLIST; GRASSES	Grassland is one of the most widely-distributed ecosystems on Earth and provides a variety of ecosystem services. Grasslands, however, currently suffer from severe degradation induced by human activities, overgrazing pressure and climate change. In the present study, we explored the transcriptome response of Stipa breviflora, a dominant species in the desert steppe, to grazing through transcriptome sequencing, the development of simple sequence repeat (SSR) markers, and analysis of genetic diversity. De novo assembly produced 111,018 unigenes, of which 88,164 (79.41%) unigenes were annotated. A total of 686 unigenes showed significantly different expression under grazing, including 304 and 382 that were upregulated and downregulated, respectively. These differentially expressed genes (DEGs) were significantly enriched in the "alpha-linolenic acid metabolism" and "plant-pathogen interaction" pathways. Based on transcriptome sequencing data, we developed eight SSR molecular markers and investigated the genetic diversity of S. breviflora in grazed and ungrazed sites. We found that a relatively high level of S. breviflora genetic diversity occurred under grazing. The findings of genes that improve resistance to grazing are helpful for the restoration, conservation, and management of desert steppe.	[Yan, Dongqing; Ren, Jing; Liu, Jiamei; Ding, Yu; Niu, Jianming] Inner Mongolia Univ, Sch Ecol & Environm, Hohhot, Peoples R China; [Niu, Jianming] Minist Sci & Technol, Inner Mongolia Key Lab Grassland Ecol, Hohhot, Peoples R China; [Niu, Jianming] Minist Sci & Technol, Candidate State Key Lab, Hohhot, Peoples R China; [Niu, Jianming] Minist Educ, Key Lab Ecol & Resource Use Mongolian Plateau, Hohhot, Peoples R China	Inner Mongolia University	Niu, JM (corresponding author), Inner Mongolia Univ, Sch Ecol & Environm, Hohhot, Peoples R China.; Niu, JM (corresponding author), Minist Sci & Technol, Inner Mongolia Key Lab Grassland Ecol, Hohhot, Peoples R China.; Niu, JM (corresponding author), Minist Sci & Technol, Candidate State Key Lab, Hohhot, Peoples R China.; Niu, JM (corresponding author), Minist Educ, Key Lab Ecol & Resource Use Mongolian Plateau, Hohhot, Peoples R China.	jmniu2005@163.com			Natural Science Foundation of China (NSFC) [31460154, 31860106]; Major Science and Technology Projects of Inner Mongolia Autonomous Region [2019ZD008]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Science and Technology Projects of Inner Mongolia Autonomous Region	This study was supported by Natural Science Foundation of China (NSFC) (31460154, 31860106), and Major Science and Technology Projects of Inner Mongolia Autonomous Region (2019ZD008). JN received the above three awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2012, BMC DERMATOLOGY, V12, P13; [Anonymous], 2020, DTSCH ARZTEBL, V117, pA312; [Anonymous], 2014, SELVEDGE MAGAZIN JAN, V56, P16; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Bai YF, 2012, J APPL ECOL, V49, P1204, DOI 10.1111/j.1365-2664.2012.02205.x; Baiakhmetov E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70582-1; Bi GZ, 2018, PLANT CELL, V30, P1543, DOI 10.1105/tpc.17.00981; Bruelheide H, 2019, J VEG SCI, V30, P161, DOI 10.1111/jvs.12710; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089495; Chen SY, 2009, CURR ISSUES MOL BIOL, V11, P81; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Evju M, 2009, OECOLOGIA, V161, P77, DOI 10.1007/s00442-009-1358-1; Fang JY, 2010, SCI CHINA LIFE SCI, V53, P757, DOI 10.1007/s11427-010-4029-x; FREITAG H, 1985, Notes from the Royal Botanic Garden Edinburgh, V42, P355; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Z, 2010, NZ J AGR RES, V46, P123, DOI [10.1080/00288233.2003.9513538, DOI 10.1080/00288233.2003.9513538]; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jamnadass R, 2006, EUPHYTICA, V151, P431, DOI 10.1007/s10681-006-9175-7; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Klichowska E, 2020, ECOL INDIC, V111, DOI 10.1016/j.ecolind.2019.105998; Klichowska E, 2019, APPL SOIL ECOL, V144, P22, DOI 10.1016/j.apsoil.2019.07.001; Klichowska E, 2018, MOL BIOL REP, V45, P639, DOI 10.1007/s11033-018-4192-x; Krawczyk K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20399-w; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu WT, 2020, GRASSL SCI, V66, P174, DOI 10.1111/grs.12263; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lu ShengLian, 1996, Acta Phytotaxonomica Sinica, V34, P242; Lv XM, 2019, ECOL EVOL, V9, P9061, DOI 10.1002/ece3.5452; Lv XM, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10103767; Marcotrigiano M, 2000, AM J BOT, V87, P355, DOI 10.2307/2656631; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Matlaga D, 2004, J RANGE MANAGE, V57, P275, DOI 10.2307/4003796; Meng J, 2018, PLANT SCI, V272, P235, DOI 10.1016/j.plantsci.2018.05.003; Nobis M, 2020, ANN MO BOT GARD, V105, P1, DOI 10.3417/2019378; Nobis M, 2019, PERSPECT PLANT ECOL, V39, DOI 10.1016/j.ppees.2019.05.001; Nobis M, 2016, PHYTOTAXA, V267, P29, DOI 10.11646/phytotaxa.267.1.3; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peng JT, 2015, LANDSCAPE ECOL, V30, P1783, DOI 10.1007/s10980-015-0227-z; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rico Y, 2014, MOL ECOL, V23, P832, DOI 10.1111/mec.12639; [珊丹 SHAN Dan], 2006, [生态学报, Acta Ecologica Sinica], V26, P3175, DOI 10.1016/S1872-2032(06)60048-6; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Singh HR, 2018, PLANT MOL BIOL REP, V36, P107, DOI 10.1007/s11105-017-1063-x; Smith SE, 2009, RANGELAND ECOL MANAG, V62, P356, DOI 10.2111/08-159.1; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Souto CP, 2019, ENVIRON CONSERV, V46, P59, DOI 10.1017/S0376892918000280; Suza WP, 2010, PLANTA, V231, P717, DOI 10.1007/s00425-009-1080-6; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Upadhyay RK, 2018, J PLANT PHYSIOL, V231, P318, DOI 10.1016/j.jplph.2018.10.001; Wang JS, 2017, BIOCHEM GENET, V55, P347, DOI 10.1007/s10528-017-9803-z; [王静 Wang Jing], 2004, [生态学报, Acta Ecologica Sinica], V24, P2465; Wang JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19438; WU ZY RP, 2006, FLORA CHINA; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Yang HJ, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2308-2; Yang YH, 2010, GLOBAL CHANGE BIOL, V16, P3036, DOI 10.1111/j.1365-2486.2009.02123.x; Zhai XY, 2015, BIOCHEM SYST ECOL, V62, P51, DOI 10.1016/j.bse.2015.07.036; Zhang B, 2018, GEODERMA, V318, P9, DOI 10.1016/j.geoderma.2017.12.019; Zhang Q, 2012, GENET MOL RES, V11, P2081, DOI 10.4238/2012.August.6.12; Zhang TH, 2004, NEW ZEAL J AGR RES, V47, P307, DOI 10.1080/00288233.2004.9513599; Zhao W, 2009, ECOL RES, V24, P99, DOI 10.1007/s11284-008-0486-0; Zhu XG, 2017, PLANT PHYSIOL, V175, P1853, DOI 10.1104/pp.17.01223; Zuo XA, 2018, ECOL INDIC, V93, P555, DOI 10.1016/j.ecolind.2018.05.032	73	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244222	10.1371/journal.pone.0244222	http://dx.doi.org/10.1371/journal.pone.0244222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351838	gold, Green Published			2022-12-26	WOS:000603071400050
J	Mosharaf, MP; Rahman, H; Ahsan, MA; Akond, Z; Ahmed, FF; Islam, MM; Moni, MA; Mollah, MNH				Mosharaf, Md. Parvez; Rahman, Hafizur; Ahsan, Md. Asif; Akond, Zobaer; Ahmed, Fee Faysal; Islam, Md. Mazharul; Moni, Mohammad Ali; Mollah, Md. Nurul Haque			In silico identification and characterization of AGO, DCL and RDR gene families and their associated regulatory elements in sweet orange (Citrus sinensis L.)	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASES; TRANSCRIPTION FACTOR FAMILY; DOUBLE-STRANDED-RNA; SALICYLIC-ACID; DICER-LIKE; MOLECULAR-MECHANISMS; ARGONAUTE PROTEINS; DNA-BINDING; G-BOX; ARABIDOPSIS	RNA interference (RNAi) plays key roles in post-transcriptional and chromatin modification levels as well as regulates various eukaryotic gene expressions which are involved in stress responses, development and maintenance of genome integrity during developmental stages. The whole mechanism of RNAi pathway is directly involved with the gene-silencing process by the interaction of Dicer-Like (DCL), Argonaute (AGO) and RNA-dependent RNA polymerase (RDR) gene families and their regulatory elements. However, these RNAi gene families and their sub-cellular locations, functional pathways and regulatory components were not extensively investigated in the case of economically and nutritionally important fruit plant sweet orange (Citrus sinensis L.). Therefore, in silico characterization, gene diversity and regulatory factor analysis of RNA silencing genes in C. sinensis were conducted by using the integrated bioinformatics approaches. Genome-wide comparison analysis based on phylogenetic tree approach detected 4 CsDCL, 8 CsAGO and 4 CsRDR as RNAi candidate genes in C. sinensis corresponding to the RNAi genes of model plant Arabidopsis thaliana. The domain and motif composition and gene structure analyses for all three gene families exhibited almost homogeneity within the same group members. The Gene Ontology enrichment analysis clearly indicated that the predicted genes have direct involvement into the gene-silencing and other important pathways. The key regulatory transcription factors (TFs) MYB, Dof, ERF, NAC, MIKC_MADS, WRKY and bZIP were identified by their interaction network analysis with the predicted genes. The cis-acting regulatory elements associated with the predicted genes were detected as responsive to light, stress and hormone functions. Furthermore, the expressed sequence tag (EST) analysis showed that these RNAi candidate genes were highly expressed in fruit and leaves indicating their organ specific functions. Our genome-wide comparison and integrated bioinformatics analyses provided some necessary information about sweet orange RNA silencing components that would pave a ground for further investigation of functional mechanism of the predicted genes and their regulatory factors.	[Mosharaf, Md. Parvez; Ahsan, Md. Asif; Akond, Zobaer; Ahmed, Fee Faysal; Islam, Md. Mazharul; Mollah, Md. Nurul Haque] Univ Rajshahi, Dept Stat, Bioinformat Lab, Rajshahi, Bangladesh; [Rahman, Hafizur] Univ Rajshahi, Rajshahi Inst Biosci, Dept Microbiol, Rajshahi, Bangladesh; [Akond, Zobaer] Univ Rajshahi, Inst Environm Sci, Rajshahi, Bangladesh; [Akond, Zobaer] Bangladesh Agr Res Inst BARI, Agr Stat & ICT Div, Gazipur, Bangladesh; [Ahmed, Fee Faysal] Jashore Univ Sci & Technol, Dept Math, Jashore, Bangladesh; [Moni, Mohammad Ali] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Biomed Sci, Sydney, NSW, Australia	University of Rajshahi; University of Rajshahi; University of Rajshahi; Bangladesh Agricultural Research Institute (BARI); University of Sydney	Mollah, MNH (corresponding author), Univ Rajshahi, Dept Stat, Bioinformat Lab, Rajshahi, Bangladesh.	mollah.stat.bio@ru.ac.bd	Moni, Mohammad Ali/ABG-3606-2020	Mollah, Md. Nurul Haque/0000-0002-3883-3396; Moni, Mohammad Ali/0000-0003-0756-1006; Akond, Dr. zobaer/0000-0002-8557-7145				Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; [Anonymous], 2006, PLOS CLIN TRIALS, V1, pe33, DOI 10.1371/journal.pctr.0010033; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2014, LANCET ONCOL, V15, pe475; [Anonymous], 2020, CANC DISCOV, V10, pOF8; [Anonymous], 2016, CANC DISCOV; [Anonymous], 2011, J NATL COMPR CANC NE, V9; ARIAS JA, 1993, PLANT CELL, V5, P485, DOI 10.1105/tpc.5.4.485; Arnaud MB, 2009, TRENDS MICROBIOL, V17, P295, DOI 10.1016/j.tim.2009.04.007; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cheng W, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02464-7; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Crowell PL, 1999, J NUTR, V129, p775S, DOI 10.1093/jn/129.3.775S; Csorba T, 2015, VIROLOGY, V479, P85, DOI 10.1016/j.virol.2015.02.028; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Devert A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120100; Di Majo D, 2005, FOOD RES INT, V38, P1161, DOI 10.1016/j.foodres.2005.05.001; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Dong QF, 2005, PLANT PHYSIOL, V139, P610, DOI 10.1104/pp.104.059212; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; du Plessis L, 2011, BRIEF BIOINFORM, V12, P723, DOI 10.1093/bib/bbr002; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ezcurra I, 2000, PLANT J, V24, P57, DOI 10.1046/j.1365-313x.2000.00857.x; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finnegan EJ, 2003, J CELL SCI, V116, P4689, DOI 10.1242/jcs.00838; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Perotti MF, 2017, IUBMB LIFE, V69, P280, DOI 10.1002/iub.1619; Gan DF, 2017, J GENET, V96, P235, DOI 10.1007/s12041-017-0758-y; Garg V, 2017, FRONT PLANT SCI, P8, DOI [10.3389/fpls.2017.00008, DOI 10.3389/FPLS.2017.00008]; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Gro<ss>hans H, 2008, NATURE, DOI 10.1038/451414a; Guo HY, 2017, PLANT BIOTECHNOL J, V15, P107, DOI 10.1111/pbi.12595; Hamar E, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060929; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Hunter LJR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23082; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jovel J, 2007, J VIROL, V81, P12285, DOI 10.1128/JVI.01192-07; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Katsarou K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005936; Kaur A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184523; Khan SA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061634; KIM SR, 1993, PLANT PHYSIOL, V103, P97, DOI 10.1104/pp.103.1.97; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Le Gourrierec J, 1999, PLANT J, V18, P663, DOI 10.1046/j.1365-313x.1999.00482.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lingel A, 2004, RNA, V10, P1675, DOI 10.1261/rna.7175704; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Liu JL, 2015, INT J MOL SCI, V16, P12131, DOI 10.3390/ijms160612131; Liu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075826; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Lutova LA, 2015, RUSS J GENET+, V51, P449, DOI 10.1134/S1022795415030084; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Millar Anthony A., 2005, Functional & Integrative Genomics, V5, P129, DOI 10.1007/s10142-005-0145-2; Mirzaei K, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/967461; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Mzid R, 2007, PHYSIOL PLANTARUM, V131, P434, DOI 10.1111/j.1399-3054.2007.00975.x; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nei M, 1987, MOL BIOL EVOL; Nicholson Allen W., 2003, P149; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; NISHIDA J, 1991, INT IMMUNOL, V3, P245, DOI 10.1093/intimm/3.3.245; Noguero M, 2013, PLANT SCI, V209, P32, DOI 10.1016/j.plantsci.2013.03.016; Oh SK, 2008, NEW PHYTOL, V177, P977, DOI 10.1111/j.1469-8137.2007.02310.x; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Prakash V, 2019, PHYSIOL MOL BIOL PLA, V25, P1055, DOI 10.1007/s12298-019-00660-w; Prakash Ved, 2017, Indian Journal of Plant Physiology, V22, P493, DOI 10.1007/s40502-017-0339-3; Qian YX, 2011, PLANT CELL REP, V30, P1347, DOI 10.1007/s00299-011-1046-6; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sabbione A, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1998-1; Sasaki K, 2018, BREEDING SCI, V68, P88, DOI 10.1270/jsbbs.17114; Schmitz RJ, 2007, GENETICS, V176, P1359, DOI 10.1534/genetics.107.070649; Seo PJ, 2010, NEW PHYTOL, V186, P471, DOI 10.1111/j.1469-8137.2010.03183.x; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shim JS, 2013, PLANT J, V73, P483, DOI 10.1111/tpj.12051; Skirycz A, 2007, NEW PHYTOL, V175, P425, DOI 10.1111/j.1469-8137.2007.02129.x; Skirycz A, 2006, PLANT J, V47, P10, DOI 10.1111/j.1365-313X.2006.02767.x; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Venkataraman S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020076; Venkatesh J, 2015, PLANT PHYSIOL BIOCH, V94, P73, DOI 10.1016/j.plaphy.2015.05.010; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang HC, 2016, PLANT PHYSIOL, V170, P2365, DOI 10.1104/pp.15.01283; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0107012]; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xia R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08543-0; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yadav CB, 2015, PLANT MOL BIOL REP, V33, P43, DOI 10.1007/s11105-014-0736-y; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang H, 2015, CURR OPIN PLANT BIOL, V27, P84, DOI 10.1016/j.pbi.2015.06.011; Zhang WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00286-0; Zhao HL, 2015, J PLANT GROWTH REGUL, V34, P108, DOI 10.1007/s00344-014-9448-7; Zhou Y, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/7243973; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	144	2	2	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0228233	10.1371/journal.pone.0228233	http://dx.doi.org/10.1371/journal.pone.0228233			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347517	Green Published, gold			2022-12-26	WOS:000603071100059
J	Kim, JW; Myung, SJ; Yoon, HB; Moon, SH; Ryu, H; Yim, JJ				Kim, Ju Whi; Myung, Sun Jung; Yoon, Hyun Bae; Moon, Sang Hui; Ryu, Hyunjin; Yim, Jae-Joon			How medical education survives and evolves during COVID-19: Our experience and future direction	PLOS ONE			English	Article								Background Due to the outbreak of coronavirus disease 2019 (COVID-19), school openings were postponed worldwide as a way to stop its spread. Most classes are moving online, and this includes medical school classes. The authors present their experience of running such online classes with offline clinical clerkship under pandemic conditions, and also present data on student satisfaction, academic performance, and preference. Methods The medical school changed every first-year to fourth-year course to an online format except the clinical clerkship, clinical skills training, and basic laboratory classes such as anatomy lab sessions. Online courses were pre-recorded video lectures or live-streamed using video communication software. At the end of each course, students and professors were asked to report their satisfaction with the online course and comment on it. The authors also compared students' academic performance before and after the introduction of online courses. Results A total of 69.7% (318/456) of students and 35.2% (44/125) of professors answered the questionnaire. Students were generally satisfied with the online course and 62.2% of them preferred the online course to the offline course. The majority (84.3%) of the students wanted to maintain the online course after the end of COVID-19. In contrast, just 13.6% of professors preferred online lectures and half (52.3%) wanted to go back to the offline course. With the introduction of online classes, students' academic achievement did not change significantly in four subjects, but decreased in two subjects. Conclusions The inevitable transformation of medical education caused by COVID-19 is still ongoing. As the safety of students and the training of competent physicians are the responsibilities of medical schools, further research into how future physicians will be educated is needed.	[Kim, Ju Whi; Myung, Sun Jung; Yoon, Hyun Bae; Moon, Sang Hui; Ryu, Hyunjin; Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Off Med Educ, Seoul, South Korea; [Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Myung, SJ (corresponding author), Seoul Natl Univ, Coll Med, Off Med Educ, Seoul, South Korea.	issac73@snu.ac.kr		Yim, Jae-Joon/0000-0002-9605-0074; Kim, Ju Whi/0000-0001-8011-3547; Myung, Sun Jung/0000-0001-7332-0126				[Anonymous], 2020, J SW U NATL SCIED, V42, P1, DOI 10.13718/j.cnki.xdzk.2020.07.001; Ashokka B, 2020, MED TEACH, V42, P762, DOI 10.1080/0142159X.2020.1757634; Brockfeld Thomas, 2018, Med Educ Online, V23, P1555434, DOI 10.1080/10872981.2018.1555434; Cheng B, 2014, EDUC RES REV-NETH, V11, P56, DOI 10.1016/j.edurev.2014.01.001; George PP, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010406; Huynh R, 2017, ACAD MED, V92, P430, DOI 10.1097/ACM.0000000000001596; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Lakhani M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2220; Lee H, 2006, 7 INT C ED RES SEOUL, P392; Liu Q, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4807; Ramlogan S, 2014, EUR J DENT EDUC, V18, P31, DOI 10.1111/eje.12053; Ranasinghe L, 2019, MED EDUC ONLINE, V24, DOI 10.1080/10872981.2019.1583970; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Shepherd SSG, 2004, RELATIONSHIPS COMPUT; Tolsgaard MG, 2020, MED TEACH, V42, P741, DOI 10.1080/0142159X.2020.1767769; WHO Thailand, 2020, JOINT INTR REV PUBL; Wolcott LL, 2003, HANDBOOK OF DISTANCE EDUCATION, P549; Woolliscroft JO, 2020, ACAD MED, V95, P1140, DOI 10.1097/ACM.0000000000003402	18	34	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243958	10.1371/journal.pone.0243958	http://dx.doi.org/10.1371/journal.pone.0243958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338045	Green Published, gold			2022-12-26	WOS:000601313500042
J	Matangila, JR; Nyembu, RK; Telo, GM; Ngoy, CD; Sakobo, TM; Massolo, JM; Muyembe, BM; Mvwala, RK; Ilunga, CK; Limbole, EB; Ntalaja, JM; Kongo, RM				Matangila, Junior Rika; Nyembu, Ritha Kibambe; Telo, Gloire Mosala; Ngoy, Christian Djuba; Sakobo, Taty Msueun; Massolo, Joel Mbembo; Muyembe, Blandine Mbo; Mvwala, Richard Kapela; Ilunga, Cedric Kabemba; Limbole, Emmanuel Bakilo; Ntalaja, Jeff Mukengeshay; Kongo, Roger Minga			Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study	PLOS ONE			English	Article								Objectives To describe the clinical characteristics of patients infected with SARS-CoV-2 at Clinique Ngaliema, a public hospital, in Kinshasa, in the Democratic Republic of Congo (DRC). Methods This retrospective study analyzed medical records including socio-demographics, past medical history, clinical manifestation, comorbidities, laboratory data, treatment and disease outcome of 160 hospitalized COVID-19 patients, with confirmed result of SARS-CoV-2 viral infection. Results The median age of patients was 54 years (IQR: 38-64), and there was no significant gender difference (51% of male). The most common comorbidities were hypertension (55 [34%]), diabetes (31 [19%]) and obesity (13 [8%]). Fever (93 [58%]), cough (92 [57%]), fatigue (87 [54%]), shortness of breath (72 [45%]) and myalgia (33 [21%]) were the most common symptoms, upon admission. Patients were categorized into mild (92 [57%]), moderate (19 [12%]) and severe (49 [31%]). Severe patients were older and were more likely to have comorbidities, compared to mild ones. The majority of patients (92% [147 of 160]) patients received hydroxychloroquine or chloroquine phosphate. Regression model revealed that older age, lower SpO2, higher heart rate and elevated AST at admission were all risk factors associated with in-hospital death. The prevalence of COVID-19 and malaria co-infection was 0.63% and 70 (44%) of all patients received antimalarial treatment before hospitalization. Conclusion Our findings indicated that the epidemiological and clinical feature of COVID-19 patients in Kinshasa are broadly similar to previous reports from other settings. Older age, lower SpO2, tachycardia, and elevated AST could help to identify patients at higher risk of death at an early stage of the illness. Plasmodium spp co-infection was not common in hospitalized COVID-19 patients.	[Matangila, Junior Rika; Nyembu, Ritha Kibambe; Telo, Gloire Mosala; Ngoy, Christian Djuba; Sakobo, Taty Msueun; Massolo, Joel Mbembo; Muyembe, Blandine Mbo; Mvwala, Richard Kapela; Ilunga, Cedric Kabemba; Limbole, Emmanuel Bakilo; Ntalaja, Jeff Mukengeshay; Kongo, Roger Minga] Clin Ngaliema, Kinshasa, DEM REP CONGO; [Matangila, Junior Rika] Univ Kinshasa, Dept Med Trop, Kinshasa, DEM REP CONGO; [Nyembu, Ritha Kibambe] Clin Univ Kinshasa, Dept Biol Med, Kinshasa, DEM REP CONGO; [Ilunga, Cedric Kabemba] Clin Univ Kinshasa, Dept Med Interne, Kinshasa, DEM REP CONGO	Universite de Kinshasa; Universite de Kinshasa; Universite de Kinshasa	Matangila, JR (corresponding author), Clin Ngaliema, Kinshasa, DEM REP CONGO.; Matangila, JR (corresponding author), Univ Kinshasa, Dept Med Trop, Kinshasa, DEM REP CONGO.	matangilaj@yahoo.fr						Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bezzio C, 2020, GUT, V69, P1213, DOI 10.1136/gutjnl-2020-321411; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Doumas M, 2020, J HUM HYPERTENS, V34, P764, DOI 10.1038/s41371-020-0380-y; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Giudicessi JR, 2020, HEART RHYTHM, V17, P1487, DOI 10.1016/j.hrthm.2020.04.045; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188; Iaccarino G, 2020, HYPERTENSION, V76, P366, DOI 10.1161/HYPERTENSIONAHA.120.15324; Ielapi N, 2020, BIOMARK MED, V14, P713, DOI 10.2217/bmm-2020-0201; Katherine Simbana-Rivera LG-BJGFS-GRFVOPL-CSrALVOPO-P, 2020, INT AN PAND COR DIS; Kazadi W, 2004, AM J TROP MED HYG, V71, P97, DOI 10.4269/ajtmh.2004.71.97; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Lei F, 2020, HEPATOLOGY, V72, P389, DOI 10.1002/hep.31301; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775; Mandina MN, 2020, ANN AFR MED; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Parohan M, 2020, HEPATOL RES, V50, P924, DOI 10.1111/hepr.13510; Republique democratique du Congo MdlSSG, 2020, PROT PRIS CHARG EP C; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; Wan SX, 2020, J MED VIROL, V92, P797, DOI 10.1002/jmv.25783; Wee Liang En, 2020, J Clin Virol, V128, P104436, DOI 10.1016/j.jcv.2020.104436; World Health Organization, 2020, TECHNICAL REPORT; World Health Organization (WHO), 2020, COR DIS COVID 19 OUT, DOI DOI 10.1016/S0140-6736(20)30566-3; Xie J, 2020, MAYO CLIN PROC, V95, P1138, DOI 10.1016/j.mayocp.2020.04.006; Zhao KC, 2020, EUR J CLIN MICROBIOL, V39, P2279, DOI 10.1007/s10096-020-03976-8; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu Y, 2020, J INFECTION, V81, P154, DOI [10.1016/j.jinf.2020.03.033, 10.1016/j.jinf.2020.02.022]	29	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244272	10.1371/journal.pone.0244272	http://dx.doi.org/10.1371/journal.pone.0244272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338063	gold, Green Published			2022-12-26	WOS:000601313500030
J	Arnadottir, SS; Mattesen, TB; Vang, S; Madsen, MR; Madsen, AH; Birkbak, NJ; Bramsen, JB; Andersen, CL				arnadottir, Sigrid Salling; Mattesen, Trine Block; Vang, Soren; Madsen, Mogens Rorbaek; Madsen, Anders Husted; Birkbak, Nicolai Juul; Bramsen, Jesper Bertram; Andersen, Claus Lindbjerg			Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum	PLOS ONE			English	Article							CONSENSUS MOLECULAR SUBTYPES; INTRATUMORAL HETEROGENEITY; COLON-CANCER; PACKAGE; DISTAL	Background Intra-tumor heterogeneity (ITH) of colorectal cancer (CRC) complicates molecular tumor classification, such as transcriptional subtyping. Differences in cellular states, biopsy cell composition, and tumor microenvironment may all lead to ITH. Here we analyze ITH at the transcriptomic and proteomic levels to ascertain whether subtype discordance between multiregional biopsies reflects relevant biological ITH or lack of classifier robustness. Further, we study the impact of tumor location on ITH. Methods Multiregional biopsies from stage II and III CRC tumors were analyzed by RNA sequencing (41 biopsies, 14 tumors) and multiplex immune protein analysis (89 biopsies, 29 tumors). CRC subtyping was performed using consensus molecular subtypes (CMS), CRC intrinsic subtypes (CRIS), and TUMOR types. ITH-scores and network maps were defined to determine the origin of heterogeneity. A validation cohort was used with one biopsy per tumor (162 tumors). Results Overall, inter-tumor transcriptional variation exceeded ITH, and subtyping calls were frequently concordant between multiregional biopsies. Still, some tumors had high transcriptional ITH and were classified discordantly. Subtyping of proximal MSS tumors were discordant for 50% of the tumors, this ITH was related to differences in the microenvironment. Subtyping of distal MSS tumors were less discordant, here the ITH was more cancer-cell related. The subtype discordancy reflected actual molecular ITH within the tumors. The relevance of the subtypes was reflected at protein level where several inflammation markers were significantly increased in immune related transcriptional subtypes, which was verified in an independent cohort (Wilcoxon rank sum test; p<0.05). Unsupervised hierarchical clustering of the protein data identified large ITH at protein level; as the multiregional biopsies clustered together for only 9 out of 29 tumors. Conclusion Our transcriptomic and proteomic analyses show that the tumor location along the colorectum influence the ITH of CRC, which again influence the concordance of subtyping.	[arnadottir, Sigrid Salling; Mattesen, Trine Block; Vang, Soren; Birkbak, Nicolai Juul; Bramsen, Jesper Bertram; Andersen, Claus Lindbjerg] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark; [arnadottir, Sigrid Salling; Mattesen, Trine Block; Vang, Soren; Madsen, Anders Husted; Birkbak, Nicolai Juul; Bramsen, Jesper Bertram; Andersen, Claus Lindbjerg] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Madsen, Mogens Rorbaek; Madsen, Anders Husted] Herning Reg Hosp, Dept Surg, Surg Res Unit, Herning, Denmark	Aarhus University; Aarhus University; Aarhus University	Andersen, CL (corresponding author), Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark.; Andersen, CL (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	cla@clin.au.dk	; Andersen, Claus Lindbjerg/A-9217-2012	Block Mattesen, Trine/0000-0002-8608-8589; Vang, Soren/0000-0002-1899-4205; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Birkbak, Nicolai/0000-0003-1613-9587	Aarhus University; Dagmar Marshalls Foundation; Aage and Johanne LouisHansen's Foundation; Novo Nordisk Foundation [NNF16OC0023182]; Danish Cancer Society [R40-A1965_11_S2, R56-A311012-S2, R107-A7035, R133-A8520]; Danish Council for Independent Research (Medical Sciences) [DFF-0602-02128B, DFF-4183-00619]; National Cancer Institute [R01 CA207467]	Aarhus University; Dagmar Marshalls Foundation; Aage and Johanne LouisHansen's Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Aarhus University (SSA), The Dagmar Marshalls Foundation (SSA), Aage and Johanne LouisHansen's Foundation (SSA), the Novo Nordisk Foundation (NNF16OC0023182) (JBB), the Danish Cancer Society (R40-A1965_11_S2, R56-A311012-S2, R107-A7035, R133-A8520), the Danish Council for Independent Research (Medical Sciences) (DFF-0602-02128B, DFF-4183-00619) (CLA), and the National Cancer Institute (R01 CA207467) (CLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnadottir SS, 2018, MOL ONCOL, V12, P132, DOI 10.1002/1878-0261.12156; Berntsson J, 2017, INT J CANCER, V141, P1654, DOI 10.1002/ijc.30869; Bramsen JB, 2017, CELL REP, V19, P1268, DOI 10.1016/j.celrep.2017.04.045; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cremonesi E, 2018, GUT, V67, P1984, DOI 10.1136/gutjnl-2016-313498; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Dunne PD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15657; Dunne PD, 2016, CLIN CANCER RES, V22, P4095, DOI 10.1158/1078-0432.CCR-16-0032; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Gallois C, 2018, DRUGS, V78, P789, DOI 10.1007/s40265-018-0921-7; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; Isella C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15107; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee GH, 2015, EJSO-EUR J SURG ONC, V41, P300, DOI 10.1016/j.ejso.2014.11.001; Lee WC, 2018, MODERN PATHOL, V31, P947, DOI 10.1038/s41379-018-0029-3; Lex A, 2012, COMPUT GRAPH FORUM, V31, P1175, DOI 10.1111/j.1467-8659.2012.03110.x; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Molinari C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123733; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NIH_GDC-Data-Portal, 2019, TCGA GEN LIST DOWNL; Paski SC, 2007, AM J GASTROENTEROL, V102, P2294, DOI 10.1111/j.1572-0241.2007.01389.x; Puppa G, 2010, ARCH PATHOL LAB MED, V134, P837, DOI 10.1043/1543-2165-134.6.837; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ribatti D, 2007, LEUKEMIA, V21, P2085, DOI 10.1038/sj.leu.2404900; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Suzuki Y, 2017, MOL ONCOL, V11, P124, DOI 10.1002/1878-0261.12012; Szmulowicz UM, 2011, J GASTROINTEST SURG, V15, P803, DOI 10.1007/s11605-011-1460-7; Tamas K, 2015, CANCER TREAT REV, V41, P671, DOI 10.1016/j.ctrv.2015.06.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uchi R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005778; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Yang SY, 2018, EXPERT REV ANTICANC, V18, P351, DOI 10.1080/14737140.2018.1442217	43	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0241148	10.1371/journal.pone.0241148	http://dx.doi.org/10.1371/journal.pone.0241148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332369	Green Published, gold			2022-12-26	WOS:000601310900095
J	Grima, N; Corcoran, W; Hill-James, C; Langton, B; Sommer, H; Fisher, B				Grima, Nelson; Corcoran, Will; Hill-James, Corinne; Langton, Benjamin; Sommer, Haley; Fisher, Brendan			The importance of urban natural areas and urban ecosystem services during the COVID-19 pandemic	PLOS ONE			English	Article							INNER-CITY; ENVIRONMENTS; VEGETATION; OUTCOMES; HEALTH	Urban, peri-urban forests and other natural areas provide a wide range of material and non-material benefits to people known as ecosystem services. Access to these areas has been linked to benefits for physical and mental health of local populations. In the spring of 2020, the COVID-19 global pandemic forced many governments to impose a set of restrictions including the closure of businesses, cancelation of public events and schooling, social distancing, limitations on the size of social gatherings, and travel restrictions. During this period of restrictions, we conducted a study assessing the importance of urban and peri-urban forests and other natural areas to people living in and around the city of Burlington, Vermont, USA. We evaluated the self-reported use and changes in personal importance related to these natural areas before and during the period of restrictions. We received over 400 responses to our field survey. The results show that 69.0% of the respondents had increased or greatly increased their visitation rate to our natural areas and urban forests, and 80.6% of respondents considered that the importance of these areas, and access to them, either increased or greatly increased. Moreover 25.8% of the sample had either never, or very rarely accessed their local natural areas before the pandemic, but 69.2% of the first time or infrequent visitors reported that having access to these areas during COVID-19 as 'very important'. People reported that these areas were important for a wide range of activities from exercise to birding, but also reported values related to reducing stress in a time of global chaos. Our results indicate the increasing demand and value of such areas in times of crisis such as COVID-19. Experts in zoonotic disease predict the potential for more frequent pandemic events, thus predicating the importance for continued funding for, maintenance of, and improved access to, natural areas to our largely urban civilization.	[Grima, Nelson; Corcoran, Will; Hill-James, Corinne; Langton, Benjamin; Sommer, Haley; Fisher, Brendan] Univ Vermont, Environm Program, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Fisher, Brendan] Univ Vermont, Gund Inst Environm, Burlington, VT USA	University of Vermont; University of Vermont	Grima, N (corresponding author), Univ Vermont, Environm Program, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.	nelson.grima@uvm.edu		Grima, Nelson/0000-0001-5563-691X	Ian Worley Award at the University of Vermont	Ian Worley Award at the University of Vermont	The Environmental Program and Ian Worley Award at the University of Vermont supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annerstedt M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-337; [Anonymous], 2005, MILLENNIUM ECOSYSTEM; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Bratman GN, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0903; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; CDC-Centers for Disease Control and Prevention, 2020, COVID 19 FOR; Chan KMA, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P206; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; de Bell S, 2020, LANDSCAPE URBAN PLAN, V200, DOI 10.1016/j.landurbplan.2020.103836; Eigenschenk B, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060937; Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210; Gladkikh TM, 2019, ECOSYST SERV, V40, DOI 10.1016/j.ecoser.2019.101036; Golding SE, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020300; Gomez-Baggethun Erik, 2013, P175; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Goodier M, 2020, CITYMETRIC; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Hitchings R, 2016, T I BRIT GEOGR, V41, P503, DOI 10.1111/tran.12138; Honey-Roses J., 2020, CITIES HLTH, V5, pS263, DOI [10., DOI 10.1080/23748834.2020.1780074, 10.1080/23748834.2020.1780074]; iek Slavoj., 2020, COVID 19 CORONAVIRUS; Jager J, 2017, MONOGR SOC RES CHILD, V82, P13, DOI 10.1111/mono.12296; Kaplan R, 2001, ENVIRON BEHAV, V33, P507, DOI 10.1177/00139160121973115; Keeler BL, 2019, NAT SUSTAIN, V2, P29, DOI 10.1038/s41893-018-0202-1; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Kuo FE, 2001, ENVIRON BEHAV, V33, P543, DOI 10.1177/00139160121973124; Lamdin C., 2020, SEVENDAYS VT    0320; Larson LR, 2016, ECOSYST SERV, V22, P111, DOI 10.1016/j.ecoser.2016.10.004; Lawson S. R., 2006, Journal of Sustainable Tourism, V14, P600, DOI 10.2167/jost625.0; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mabon L, 2019, LANDSCAPE URBAN PLAN, V187, P105, DOI 10.1016/j.landurbplan.2019.03.013; Mackenzie SH, 2021, LEISURE SCI, V43, P62, DOI 10.1080/01490400.2020.1773984; Marrone J, 1999, PSYCHIATR REHABIL J, V23, P187, DOI 10.1037/h0095171; Natural Areas Lab, 2019, DAT SPEC LIV U UNPUB; Nesbitt L, 2019, LANDSCAPE URBAN PLAN, V181, P51, DOI 10.1016/j.landurbplan.2018.08.007; Nguyen MN, 2010, PLOS ONE, V5, pe9907; OIA, 2017, VERM OUTD RECR EC RE; Ottosson J, 2008, LANDSCAPE RES, V33, P51, DOI 10.1080/01426390701773813; Poole W, 2006, SEVENTEENTH CENT, V21, P45, DOI 10.1080/0268117X.2006.10555567; Poulsen DV, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020064; Poulsen DV, 2017, J PUBLIC MENT HEALTH, V16, P15, DOI 10.1108/JPMH-08-2016-0039; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Sachdeva S, 2018, SOC NATUR RESOUR, V31, P977, DOI 10.1080/08941920.2018.1450914; Schwartz AJ, 2019, PEOPLE NAT, V1, P476, DOI 10.1002/pan3.10045; Servedio D., 2020, STAR LEDGER; Sinha CC, 2004, CAUTHE 2004 CREATING, V702; Slater SJ, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200204; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; Tamosiunas A, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-20; U.S. Census Bureau, 2019, POP EST VERM US; UN-WTO, 2002, SUST TOUR PROT AR GU, DOI DOI 10.18111/9789284405435; UVM, 2019, UVM NAT AR; Venter ZS, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abb396; Verkehrsclub Osterreich VCO - Mobilitat mit Zukunft, 2014, VOC MAGAZIN, V6, P5; Wang J, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab719f; Weed M., 2020, J SPORT TOUR, V24, P79, DOI [10.1080/14775085.2020.1794351, DOI 10.1080/14775085.2020.1794351, DOI 10.1080/14775085.2020.1794351,0]	57	82	82	21	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243344	10.1371/journal.pone.0243344	http://dx.doi.org/10.1371/journal.pone.0243344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332364	Green Published, gold, Green Submitted			2022-12-26	WOS:000601310900065
J	Hamedani, Y; Chakraborty, S; Sabarwal, A; Pal, S; Bhowmick, S; Balan, M				Hamedani, Yasaman; Chakraborty, Samik; Sabarwal, Akash; Pal, Soumitro; Bhowmick, Sankha; Balan, Murugabaskar			Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells	PLOS ONE			English	Article							CONTROLLED DRUG-DELIVERY; ELECTROSPUN NANOFIBERS; RELEASE	Renal Cell Carcinoma (RCC) often becomes resistant to targeted therapies, and in addition, dose-dependent toxicities limit the effectiveness of therapeutic agents. Therefore, identifying novel drug delivery approaches to achieve optimal dosing of therapeutic agents can be beneficial in managing toxicities and to attain optimal therapeutic effects. Previously, we have demonstrated that Honokiol, a natural compound with potent anti-tumorigenic and anti-inflammatory effects, can induce cancer cell apoptosis and inhibit the growth of renal tumors in vivo. In cancer treatment, implant-based drug delivery systems can be used for gradual and sustained delivery of therapeutic agents like Honokiol to minimize systemic toxicity. Electrospun polymeric fibrous scaffolds are ideal candidates to be used as drug implants due to their favorable morphological properties such as high surface to volume ratio, flexibility and ease of fabrication. In this study, we fabricated Honokiol-loaded Poly(lactide-co-glycolide) (PLGA) electrospun scaffolds; and evaluated their structural characterization and biological activity. Proton nuclear magnetic resonance data proved the existence of Honokiol in the drug loaded polymeric scaffolds. The release kinetics showed that only 24% of the loaded Honokiol were released in 24hr, suggesting that sustained delivery of Honokiol is feasible. We calculated the cumulative concentration of the Honokiol released from the scaffold in 24hr; and the extent of renal cancer cell apoptosis induced with the released Honokiol is similar to an equivalent concentration of direct application of Honokiol. Also, Honokiol-loaded scaffolds placed directly in renal cell culture inhibited renal cancer cell proliferation and migration. Together, we demonstrate that Honokiol delivered through electrospun PLGA-based scaffolds is effective in inhibiting the growth of renal cancer cells; and our data necessitates further in vivo studies to explore the potential of sustained release of therapeutic agents-loaded electrospun scaffolds in the treatment of RCC and other cancer types.	[Hamedani, Yasaman; Bhowmick, Sankha] Univ Massachusetts, Biomed Engn & Biotechnol Program, Dept Mech Engn, Dartmouth, MA 02747 USA; [Chakraborty, Samik; Sabarwal, Akash; Pal, Soumitro; Balan, Murugabaskar] Boston Childrens Hosp, Div Nephrol, Boston, MA USA; [Chakraborty, Samik; Sabarwal, Akash; Pal, Soumitro; Balan, Murugabaskar] Harvard Med Sch, Boston, MA 02115 USA	University of Massachusetts System; University Massachusetts Dartmouth; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bhowmick, S (corresponding author), Univ Massachusetts, Biomed Engn & Biotechnol Program, Dept Mech Engn, Dartmouth, MA 02747 USA.; Balan, M (corresponding author), Boston Childrens Hosp, Div Nephrol, Boston, MA USA.; Balan, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	murugabaskar.balan@childrens.harvard.edu; sbhowmick@umassd.edu	Sabarwal, Akash/AAD-3605-2021; Sabarwal, Akash/AAG-9554-2021; Chakraborty, Samik/Q-1779-2018	Sabarwal, Akash/0000-0003-1760-4903; Chakraborty, Samik/0000-0002-5232-0474	National Institute of Health [R01 CA193675, R01 CA222355, R03 CA219731, R03 CA230944]; Office of the Provost at University of Massachusetts Dartmouth; National Science Foundation [1726239]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Provost at University of Massachusetts Dartmouth; National Science Foundation(National Science Foundation (NSF))	The work has been funded by the National Institute of Health Grants R01 CA193675 and R01 CA222355 (to S.P.), R03 CA219731 and R03 CA230944 (to M.B.), as well as "Multiinstitutional Collaborative Seed Funding Program" (2019-2020) provided by the Office of the Provost at University of Massachusetts Dartmouth (to S. B.). The electron microscopy images in this work were obtained using a scanning electron microscope supported by the National Science Foundation under Grant No. 1726239.	Akhgari A, 2013, ADV PHARM BULL, V3, P85, DOI 10.5681/apb.2013.014; [Anonymous], 2017, ECONOMICS-KIEL, V6, P1, DOI 10.1057/s11369-017-0051-3; Balan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05455-1; Banerjee P, 2013, CANCER LETT, V338, P292, DOI 10.1016/j.canlet.2013.05.036; Bruneau M, 2019, J CONTROL RELEASE, V294, P355, DOI 10.1016/j.jconrel.2018.12.038; Chen SX, 2018, ADV DRUG DELIVER REV, V132, P188, DOI 10.1016/j.addr.2018.05.001; Chien YW, 1992, NOVEL DRUG DELIVERY, V1992; Chomachayi MD, 2018, J BIOMED MATER RES A, V106, P1092, DOI 10.1002/jbm.a.36303; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Crane C, 2009, J IMMUNOTHER, V32, P585, DOI 10.1097/CJI.0b013e3181a8efe6; Dag A, 2019, BIOMACROMOLECULES, V20, P2962, DOI 10.1021/acs.biomac.9b00528; Dana P, 2020, COLLOID SURFACE B, V196, DOI 10.1016/j.colsurfb.2020.111270; Davoodi P, 2018, ADV DRUG DELIVER REV, V132, P104, DOI 10.1016/j.addr.2018.07.002; Freitas LBD, 2017, MICROPOR MESOPOR MAT, V242, P271, DOI 10.1016/j.micromeso.2017.01.036; Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI 10.1089/ARS.2009.2440; Graham J, 2019, EUR UROL ONCOL; Guo Y, 2018, ACTA BIOMATER, V80, P308, DOI 10.1016/j.actbio.2018.09.024; Hahn AW, 2019, EUR UROL ONCOL, V2, P708, DOI 10.1016/j.euo.2019.09.002; Hamedani Y, 2017, IRANIAN J CHEM ENG, V14, P3; Hamedani Y, 2020, J BIOMED MATER RES A, V108, P829, DOI 10.1002/jbm.a.36861; Hillery AM, 2017, DRUG DELIVERY: FUNDAMENTALS AND APPLICATIONS, 2ND EDITION, P1; Hu J, 2016, J PHARM SCI-US, V105, P1104, DOI 10.1016/S0022-3549(15)00191-4; Hu XL, 2014, J CONTROL RELEASE, V185, P12, DOI 10.1016/j.jconrel.2014.04.018; Jassal M, 2015, J BIOMAT SCI-POLYM E, V26, P1425, DOI 10.1080/09205063.2015.1100495; Ji W, 2010, ACTA BIOMATER, V6, P4199, DOI 10.1016/j.actbio.2010.05.025; Kajdic S, 2019, J DRUG DELIV SCI TEC, V51, P672, DOI 10.1016/j.jddst.2019.03.038; Kaljevic O, 2017, INT J PHARMACEUT, V533, P445, DOI 10.1016/j.ijpharm.2017.05.017; Karimian SAM, 2016, INT J BIOL MACROMOL, V88, P288, DOI 10.1016/j.ijbiomac.2016.03.061; Khampieng T, 2014, J BIOMAT SCI-POLYM E, V25, P1292, DOI 10.1080/09205063.2014.929431; Kim YJ, 2013, ADV FUNCT MATER, V23, P5753, DOI 10.1002/adfm.201300746; Kwa YC, 2020, J DRUG DELIV SCI TEC, V59, DOI 10.1016/j.jddst.2020.101905; Kydonieus AF, 1992, TREATISE CONTROLLED, V1992; LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4; Li B, 2020, MATER TODAY CHEM, V17, DOI 10.1016/j.mtchem.2020.100308; Li XQ, 2013, COLLOID SURFACE B, V103, P182, DOI 10.1016/j.colsurfb.2012.10.016; Lu YJ, 2020, COLLOID SURFACE B, V189, DOI 10.1016/j.colsurfb.2020.110830; Nam S, 2017, INT J PHARMACEUT, P526, DOI 10.1016/j.ijpharm.2017.03.076; Paaver U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/789765; Perez RA, 2015, ACTA BIOMATER, V21, P2, DOI 10.1016/j.actbio.2015.03.013; Poller B, 2017, EUR J PHARM BIOPHARM, V114, P213, DOI 10.1016/j.ejpb.2017.01.022; Rajendran P, 2012, J CELL PHYSIOL, V227, P2184, DOI 10.1002/jcp.22954; Sabarwal A, CANCERS BASEL; Sang QQ, 2017, MAT SCI ENG C-MATER, V81, P359, DOI 10.1016/j.msec.2017.08.007; Sirc J, 2017, PHARM RES-DORDR, V34, P1391, DOI 10.1007/s11095-017-2155-x; Stratton S, 2016, BIOACT MATER, V1, P93, DOI 10.1016/j.bioactmat.2016.11.001; Vachhani P, 2016, CLIN ADV HEMATOL ONC, V14, P1016; Virlan MJR, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/525832; Wang S, 2014, MAT SCI ENG B, P190; Wang X, 2015, INT J PHARMACEUT, V490, P384, DOI 10.1016/j.ijpharm.2015.05.077; Wang YQ, 2020, CANCER BIOL MED, V17, P237, DOI 10.20892/j.issn.2095-3941.2019.0169; Wang YH, 2020, MATER DESIGN, V186, DOI 10.1016/j.matdes.2019.108336; Wright ME, 2017, J CONTROL RELEASE, V250, P107, DOI 10.1016/j.jconrel.2017.02.008; Yang YK, 2020, BIOMATERIALS, V230, DOI 10.1016/j.biomaterials.2019.119618; Yohe ST, 2012, J AM CHEM SOC, V134, P2016, DOI 10.1021/ja211148a; Yu SS, 2016, ONCOTARGETS THER, V9, P5825, DOI 10.2147/OTT.S97397; Yun J, 2011, EUR POLYM J, V47, P1893, DOI 10.1016/j.eurpolymj.2011.07.024; Zhang HY, 2020, ASIAN J PHARM SCI, V15, P397, DOI 10.1016/j.ajps.2019.11.004	57	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243837	10.1371/journal.pone.0243837	http://dx.doi.org/10.1371/journal.pone.0243837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332399	Green Published, gold			2022-12-26	WOS:000601310900100
J	Brunner, M; von Felten, J; Hinz, M; Hafner, A				Brunner, Mirco; von Felten, Jonas; Hinz, Martin; Hafner, Albert			Central European Early Bronze Age chronology revisited: A Bayesian examination of large-scale radiocarbon dating	PLOS ONE			English	Article							BERN	In archaeological research, changes in material culture and the evolution of styles are taken as major indicators for socio-cultural transformation. They form the basis for typo-chronological classification and the establishment of phases and periods. Central European Bronze Age material culture from burials reveals changes during the Bronze Age and represents a perfect case study for analyzing phenomena of cultural change and the adoption of innovation in the societies of prehistoric Europe. Our study focuses on the large-scale change in material culture which took place in the second millennium BC and the emergence at the same period of new burial rites: the shift from inhumation burials in flat graves to complex mounds and simple cremation burials. Paul Reinecke was the first to divide the European Bronze Age (EBA) into two phases, Bz A1 and A2. The shift from the first to the second phase has so far been ascribed to technical advances. Our study adopted an innovative approach to quantifying this phenomenon. Through regressive reciprocal averaging and Bayesian analysis of radiocarbon-dated grave contexts located in Switzerland and southern Germany, we modelled chronological changes in the material culture and changes in burial rites in these regions in a probabilistic way. We used kernel density models to summarize radiocarbon dates, with the aim of visualizing cultural changes in the third and second millennium BC. In 2015, Stockhammer et al. cast doubt on the chronological sequence of the Reinecke phases of the EBA on the basis of newly collected radiocarbon dates from southern Germany. Our intervention is a direct response to the results of that study. We fully agree with Stockhammer's et al. dating of the start of EBA, but propose a markedly different dating of the EBA/MBA transition. Our modelling of radiocarbon data demonstrates a statistically significant typological sequence of phases Bz A1, Bz A2 and Bz B and disproves their postulated chronological overlap. The linking of the archaeological relative-chronological system with absolute dates is of major importance to understanding the temporal dimension of the EBA phases.	[Brunner, Mirco; von Felten, Jonas; Hinz, Martin; Hafner, Albert] Univ Bern, Inst Archaeol Sci, Prehist Archaeol, Bern, Switzerland; [Brunner, Mirco; Hinz, Martin; Hafner, Albert] Univ Bern, Oeschger Ctr Climate Change Res OCCR, Bern, Switzerland; [Brunner, Mirco] Univ Kiel, Grad Sch Human Dev Landscapes, Kiel, Germany	University of Bern; University of Bern; University of Kiel	Brunner, M (corresponding author), Univ Bern, Inst Archaeol Sci, Prehist Archaeol, Bern, Switzerland.; Brunner, M (corresponding author), Univ Bern, Oeschger Ctr Climate Change Res OCCR, Bern, Switzerland.; Brunner, M (corresponding author), Univ Kiel, Grad Sch Human Dev Landscapes, Kiel, Germany.	mirco.brunner@iaw.unibe.ch	; Hinz, Martin/N-5549-2015	Brunner, Mirco/0000-0003-0655-7603; von Felten, Jonas/0000-0002-4572-4219; Hinz, Martin/0000-0002-9904-6548	Swiss National Science Foundation (SNSF) [165306]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The research (including all scientific analyses) was mostly funded by the Swiss National Science Foundation (SNSF) within the framework of the CMCT - Project "Chronology, mobility and cultural transfer based on the example of an innerAlpine settlement landscape. A landscape archaeological study of the central Alpine region" (SNSF-Grant number: 165306).	Abels B-U, 1972, RANDLEISTENBEILE BAD; [Anonymous], **DATA OBJECT**; Bayes M., 1763, PHILOS T, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Bayliss A., 2007, VERNAC ARCHIT, V38, P75, DOI DOI 10.1179/174962907X248074; Bayliss A, 2015, WORLD ARCHAEOL, V47, P677, DOI 10.1080/00438243.2015.1067640; Bayliss A, 2009, RADIOCARBON, V51, P123, DOI 10.1017/S0033822200033750; Becker B, 1989, GERMANIA, V67, P421; Bolohan N, 2015, BRONZ AG CHRON CARP; Buck C.E., 1996, BAYESIAN APPROACH IN; BUCK CE, 1994, ANTIQUITY, V68, P252, DOI 10.1017/S0003598X00046561; BUCK CE, 1991, ANTIQUITY, V65, P808, DOI 10.1017/S0003598X00080534; BUCK CE, 1992, J ARCHAEOL SCI, V19, P497, DOI 10.1016/0305-4403(92)90025-X; Burkart W, 1948, UR SCHWEIZ MITTEILUN, V12, P5; Burkart W, 1949, UR SCHWEIZ MITTEILUN, V13, P35; Capuzzo G, 2015, WORLD ARCHAEOL, V47, P622, DOI 10.1080/00438243.2015.1053571; CHRISTEN JA, 1994, J R STAT SOC C-APPL, V43, P489; CHRISTEN JA, 1995, J ARCHAEOL SCI, V22, P719, DOI 10.1016/0305-4403(95)90002-0; Christen JA, 1995, RADIOCARBON, V37, P431, DOI 10.1017/S0033822200030915; David-Elbiali M, 2000, SUISSE OCCIDENTALE I; David-Elbiali M, 2010, GRIFF NACH STERNEN E, P217; Duvanel L, 2018, NECROPOLE AGE BRONZE; Fischer C, 1997, GRABER SIEDLUNGEN NE; Gubler R, 2010, ANNUAIRE SERVICE ARC, V2010, P147; Gubler R, 2014, ARCHAOLOGIE BERN ARC, V2014, P165; Hafner A, 1998, TRADITION INNOVATION, P385; Hafner A, 1995, FRUHE BRONZEZEIT WES; HILL MO, 1973, J ECOL, V61, P237, DOI 10.2307/2258931; Kimmig W, 1954, WALDSHUT GERMANIA AN, V32, P147, DOI [10.11588/ger.1954.45176, DOI 10.11588/GER.1954.45176]; Kneisel J, 2019, HOLOCENE, V29, P1607, DOI 10.1177/0959683619857237; Knoll F, 2016, ARM REICH ZUR RESSOU, P283; Krause R, 1988, ENDNEOLITHISCHEN FRU; Lulewicz J, 2018, ADV ARCHAEOL PRACT, V6, P58, DOI 10.1017/aap.2017.29; Mader A, 2008, MITTELBRONZEZEITLICH; Massy K, 2019, STUDIA HERCYNIA, VXXIII, P22; Massy K, 2018, UNTERSUCHUNGEN BESTA; Massy K, 2018, VORTRAGE 36 NIEDERBA, P123; McLaughlin TR, 2019, J ARCHAEOL METHOD TH, V26, P479, DOI 10.1007/s10816-018-9381-3; Montelius O, 1903, METHODE; Muller J., 2004, ARCHAOLOGIE SACHSEN, V2, P21; Muller J., 2009, GERMANIA, V87, P25; Primas M, 1972, Z SCHWEIZERISCHE ARC, V29, P5, DOI [10.5169/seals-165805, DOI 10.5169/SEALS-165805]; Ramsey CB, 1998, RADIOCARBON, V40, P461; Ramsey CB, 2017, RADIOCARBON, V59, P1809, DOI 10.1017/RDC.2017.108; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Ramseyer D, 1990, JB SCHWEIZERISCHEN G, V73, P136, DOI [10.5169/seals-117267, DOI 10.5169/SEALS-117267]; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Reinecke P., 1924, GERMANIA ANZEIGER RO, V8, P43; RUBIN DB, 1981, ANN STAT, V9, P130, DOI 10.1214/aos/1176345338; Ruckdeschel W, 1978, BEITRAG KENNTNIS STR; Schmid C, 2020, ADAPT BEHAV, V28, P359, DOI 10.1177/1059712319860842; Spindler K, 1973, JB SCHWEIZERISCHEN G, V57, P17, DOI [10.5169/seals-115527, DOI 10.5169/SEALS-115527]; Stockhammer PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139705; Stockli WE, 2016, URGESCHICHTE SCHWEIZ; Suter PJ, 2003, ARCHAOLOGISCHES KORR, V33, P325; Szidat S, 2014, RADIOCARBON, V56, P561, DOI 10.2458/56.17457; Szidat S, 2017, RADIOCARBON, V59, P831, DOI 10.1017/RDC.2016.90; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Whittle A., 2011, GATHERING TIME DATIN	59	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243719	10.1371/journal.pone.0243719	http://dx.doi.org/10.1371/journal.pone.0243719			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370331	gold, Green Submitted, Green Published			2022-12-26	WOS:000603611900108
J	Shibata, K; Fujiwara, A; Hamasaki, I; Shimizu, T; Kono, R; Kanenaga, K; Nakazawa, M; Morizane, Y				Shibata, Kiyo; Fujiwara, Atsushi; Hamasaki, Ichiro; Shimizu, Takehiro; Kono, Reika; Kanenaga, Keisuke; Nakazawa, Masanori; Morizane, Yuki			Shape analysis of rectus extraocular muscles with age and axial length using anterior segment optical coherence tomography	PLOS ONE			English	Article							SAGGING EYE SYNDROME; INSERTION DISTANCE; STRABISMUS	Purpose This study aimed to evaluate the shape of the extraocular muscles (EOMs) in normal subjects using the en-face images of anterior segment optical coherence tomography (AS-OCT). The EOM insertion and the direction of the muscle fibers were investigated. Subjects and methods A total of 97 healthy normal subjects (194 eyes) at Okayama University Hospital (age, 47.1 +/- 21.5 years; range, 8-79 years) participated in the study. A series of 256 tomographic images of the rectus EOMs were captured using the C-scan function of the AS-OCT (CASIA2, TOMEY Co., Japan), and the images were converted to en-face images in multi-TIFF format. The anterior chamber angle to EOM insertion distance (AID) and the angle of the muscle fibers from the insertion site (angle of muscles) were measured from the images. The correlations of AID and angle of muscles with age and axial length were investigated and evaluated. Results AID and angle of muscles were significantly correlated with age or axial length in some EOMs. The AIDs of medial rectus (MR) (P = 0.000) and superior rectus (SR) (P = 0.005) shortened with age. The AIDs of MR (P = 0.001) and inferior rectus (IR) (P = 0.035) elongated with axial length, whereas lateral rectus (LR) (P = 0.013) shortened. The angles of MR (P = 0.001) and LR (P = 0.000) were found to have a more downward direction toward the posterior in older subjects. Conclusion En-face images can be created by AS-OCT, and the shape of the EOMs in normal subjects using these image measurements was available. With the ability to assess the EOMs, AID and angle of muscles are expected give useful information for treating and diagnosing strabismus-related diseases.	[Shibata, Kiyo; Hamasaki, Ichiro; Shimizu, Takehiro; Kono, Reika; Kanenaga, Keisuke; Morizane, Yuki] Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Okayama, Japan; [Fujiwara, Atsushi] Kawasaki Univ Med Welf, Fac Rehabil, Dept Orthopt, Kurashiki, Okayama, Japan; [Nakazawa, Masanori] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima, Japan	Okayama University; Kagoshima University	Hamasaki, I (corresponding author), Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Okayama, Japan.	hamasaki_16@okayama-u.ac.jp						Athavale S, 2015, ANAT CELL BIOL, V48, P201, DOI 10.5115/acb.2015.48.3.201; Chaudhuri Z, 2013, JAMA OPHTHALMOL, V131, P619, DOI 10.1001/jamaophthalmol.2013.783; Clark RA, 2002, AM J OPHTHALMOL, V134, P872, DOI 10.1016/S0002-9394(02)01695-1; Dhakal R, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.4.6; Villarreal-Silva EE, 2013, INT J MORPHOL, V31, P312, DOI 10.4067/S0717-95022013000100049; Goseki T, 2020, AM J OPHTHALMOL, V209, P55, DOI 10.1016/j.ajo.2019.09.006; Han Jung Yeob, 2018, Korean J Ophthalmol, V32, P83, DOI 10.3341/kjo.2017.0034; John J, 2017, KERALA J OPHTHALMOL, V29, P112, DOI [10.4103/kjo.kjo_32_17, DOI 10.4103/KJO.KJO_32_17]; Kono R, 2019, GRAEF ARCH CLIN EXP, V257, P657, DOI 10.1007/s00417-019-04250-0; Lai YH, 2012, BRIT J OPHTHALMOL, V96, P679, DOI 10.1136/bjophthalmol-2011-300632; Lee JY, 2017, EYE, V31, P1556, DOI 10.1038/eye.2017.89; Liu XQ, 2011, INVEST OPHTH VIS SCI, V52, P8370, DOI 10.1167/iovs.11-7752; Ngo CS, 2015, J AAPOS, V19, P233, DOI 10.1016/j.jaapos.2015.03.012; Ocak OB, 2019, INT OPHTHALMOL, V39, P1037, DOI 10.1007/s10792-018-0903-5; Park KA, 2014, J AAPOS, V18, P15, DOI 10.1016/j.jaapos.2013.11.005; Pihlblad MS, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101732; Pihlblad MS, 2016, J PEDIAT OPHTH STRAB, V53, P141, DOI 10.3928/01913913-20160405-05; Surawatsatien N, 2017, FOLIA MORPHOL, V76, P635, DOI 10.5603/FM.a2017.0024; Suzuki H, 2018, JPN J OPHTHALMOL, V62, P554, DOI 10.1007/s10384-018-0609-2; Tamburrelli C, 2003, INVEST OPHTH VIS SCI, V44, P618, DOI 10.1167/iovs.02-0112; Tan RJD, 2015, J AAPOS, V19, P500, DOI 10.1016/j.jaapos.2015.08.012; Tanaka Akiko, 2010, Journal of Medical and Dental Sciences, V57, P75; von Noorden GK, 2002, THEORY MANAGEMENT ST, P330	23	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243382	10.1371/journal.pone.0243382	http://dx.doi.org/10.1371/journal.pone.0243382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362229	Green Published, gold			2022-12-26	WOS:000603071600010
J	Vu, MQ; Tran, TTP; Hoang, TA; Khuong, LQ; Hoang, MV				Mai Quynh Vu; Thao Thi Phuong Tran; Thao Anh Hoang; Long Quynh Khuong; Minh Van Hoang			Health-related quality of life of the Vietnamese during the COVID-19 pandemic	PLOS ONE			English	Article							EUROQOL	Background Vietnam applied strict quarantine measures to mitigate the rapid transmission of the SARS-COV-2 virus. Central questions were how the COVID-19 pandemic affected health-related quality of life (HRQOL) of the Vietnamese general population, and whether there is any difference in HRQOL among people under different quarantine conditions. Methods This cross-sectional study was conducted during 1 April- 30 May 2020 when the COVID-19 pandemic was at its peak in Vietnam. Data was collected via an online survey using Google survey tool. A convenient sampling approach was employed, with participants being sorted into three groups: people who were in government quarantine facilities; people who were under self-isolation at their own place; and the general population who did not need enforced quarantine. The Vietnamese EQ-5D-5L instrument was used to measure HRQOL. Differences in HRQOL among people of isolation groups and their socio-demographic characteristics were statistically tested. Results A final sample was made of 406 people, including 10 persons from government quarantine facilities, 57 persons under self-isolation at private places, and the rest were the general population. The mean EQ-VAS was reported the highest at 90.5 (SD: 7.98) among people in government quarantine facilities, followed by 88.54 (SD: 12.24) among general population and 86.54 (SD 13.69) among people in self-isolation group. The EQ-5D-5L value was reported the highest among general population at 0.95 (SD: 0.07), followed by 0.94 (SD: 0.12) among people in government quarantine facilities, and 0.93 (SD: 0.13) among people who did self-isolation. Overall, most people, at any level, reported having problems with anxiety and/or depression in all groups. Conclusion While there have been some worries and debates on implementing strict quarantine measures can hinder people's quality of life, Vietnam showed an opposite tendency in people's HRQOL even under the highest level of enforcement in the prevention and control of COVID-19.	[Mai Quynh Vu; Thao Thi Phuong Tran; Thao Anh Hoang; Long Quynh Khuong] Hanoi Univ Publ Hlth, Ctr Populat Hlth Sci, Hanoi, Vietnam; [Minh Van Hoang] Hanoi Univ Publ Hlth, Hanoi, Vietnam	Hanoi University of Public Health; Hanoi University of Public Health	Vu, MQ (corresponding author), Hanoi Univ Publ Hlth, Ctr Populat Hlth Sci, Hanoi, Vietnam.	vqm@huph.edu.vn	Van Hoang, Minh/AET-0962-2022	Khuong, Quynh Long/0000-0002-1232-6230; Tran, Thi Phuong Thao/0000-0003-4708-6027; Hoang, Thao Anh/0000-0002-1235-1962; Vu, Mai/0000-0001-6962-0564				[Anonymous], 2020, UN NEWS; [Anonymous], 2020, VAL HUM LIF LOCKD EC; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; CDC, 2020, COR DIS 2019 COVID 1; Drummond MF, 2015, METHODS EC EVALUATIO; Garcia-Gordillo MA, 2016, QUAL LIFE RES, V25, P1313, DOI 10.1007/s11136-015-1164-7; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Nguyen LH, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0771-0; Mai VQ, 2020, EQ 5D 5L NORMATIVE D; Mai VQ, 2020, QUAL LIFE RES, V29, P1923, DOI 10.1007/s11136-020-02469-7; Marasca C, 2020, CLIN EXP DERMATOL, V45, P749, DOI 10.1111/ced.14245; Nguyen HC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040965; Ping WW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234850; Prime Minister, 2020, OFFICIAL DISPATCH 15; Pulvirenti F, 2020, J ALLER CL IMM-PRACT, V8, P1894, DOI 10.1016/j.jaip.2020.04.003; Rabin R, 2014, VALUE HEALTH, V17, P70, DOI 10.1016/j.jval.2013.10.006; Southeast Asia Covid-19 Tracker, 2020, SE AS COV 19 TRACK; The National Steering Committee for prevention and control the novel coronavirus disease, OFF DISP 1440 CV BCD; Vinh Phuc Provincial People Committe, 2020, IMPL EM RESP DEC 173; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wong ELY, 2019, VALUE HEALTH, V22, P916, DOI 10.1016/j.jval.2019.02.014; Yang ZH, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1036-2	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244170	10.1371/journal.pone.0244170	http://dx.doi.org/10.1371/journal.pone.0244170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338067	Green Published, gold			2022-12-26	WOS:000601313500015
J	Cao, HY; Zhang, XY; Ruan, YY; Zhang, LJ; Cui, ZH; Li, XX; Jia, B				Cao, Huiying; Zhang, Xinyue; Ruan, Yanye; Zhang, Lijun; Cui, Zhenhai; Li, Xuxiao; Jia, Bing			miRNA expression profiling and zeatin dynamic changes in a new model system of in vivo indirect regeneration of tomato	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; SBP-BOX GENE; SMALL RNAS; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; REGULATORY ROLES; MICRORNAS; AUXIN; CYTOKININ; DIFFERENTIATION	Callus formation and adventitious shoot differentiation could be observed on the cut surface of completely decapitated tomato plants. We propose that this process can be used as a model system to investigate the mechanisms that regulate indirect regeneration of higher plants without the addition of exogenous hormones. This study analyzed the patterns of trans-zeatin and miRNA expression during in vivo regeneration of tomato. Analysis of trans-zeatin revealed that the hormone cytokinin played an important role in in vivo regeneration of tomato. Among 183 miRNAs and 1168 predicted target genes sequences identified, 93 miRNAs and 505 potential targets were selected based on differential expression levels for further characterization. Expression patterns of six miRNAs, including sly-miR166, sly-miR167, sly-miR396, sly-miR397, novel 156, and novel 128, were further validated by qRT-PCR. We speculate that sly-miR156, sly-miR160, sly-miR166, and sly-miR397 play major roles in callus formation of tomato during in vivo regeneration by regulating cytokinin, IAA, and laccase levels. Overall, our microRNA sequence and target analyses of callus formation during in vivo regeneration of tomato provide novel insights into the regulation of regeneration in higher plants.	[Cao, Huiying; Zhang, Xinyue; Ruan, Yanye; Zhang, Lijun; Cui, Zhenhai; Li, Xuxiao; Jia, Bing] Shenyang Agr Univ, Coll Biol Sci & Technol, Liaoning Prov Res Ctr Plant Genet Engn Technol, Shenyang Key Lab Maize Genom Select Breeding, Shenyang, Peoples R China	Shenyang Agricultural University	Ruan, YY; Zhang, LJ (corresponding author), Shenyang Agr Univ, Coll Biol Sci & Technol, Liaoning Prov Res Ctr Plant Genet Engn Technol, Shenyang Key Lab Maize Genom Select Breeding, Shenyang, Peoples R China.	yanyeruan@syau.edu.cn; ljzhang@syau.edu.cn			National Natural Science Foundation of China [31300164]; Scientific and Technological Project of Shenyang [18-013-0-92]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Shenyang	This work was supported by the National Natural Science Foundation of China (grant numbers 31300164) and the Scientific and Technological Project of Shenyang (grant number 18-013-0-92) received from HC.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alejandri-Ramirez ND, 2018, PLANT PHYSIOL BIOCH, V122, P78, DOI 10.1016/j.plaphy.2017.11.013; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Amutha S, 2009, IN VITRO CELL DEV-PL, V45, P758, DOI 10.1007/s11627-009-9232-8; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2011, P 2011 NAT S PLANT B; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Brandt R, 2012, PLANT J, V72, P31, DOI 10.1111/j.1365-313X.2012.05049.x; Buechel S, 2010, EUR J CELL BIOL, V89, P279, DOI 10.1016/j.ejcb.2009.11.016; C. on O. Practice, 2016, AM COLL OBSTET GYNEC, V127, P1; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chavez-Hernandez EC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00555; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Chu ZL, 2016, FRONT PLANT SCI, V7, DOI [10.3359/fpls.2016.01302, 10.3389/fpls.2016.01302]; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Constabel CP, 2000, PLANT PHYSIOL, V124, P285, DOI 10.1104/pp.124.1.285; CROWELL DN, 1992, PLANT PHYSIOL, V100, P2090, DOI 10.1104/pp.100.4.2090; Dauwe R, 2007, PLANT J, V52, P263, DOI 10.1111/j.1365-313X.2007.03233.x; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Ehlert B, 2008, J EXP BOT, V59, P3635, DOI 10.1093/jxb/ern213; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gao C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3587-8; Gao Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56686-3; Ge F, 2016, PHYSIOL PLANTARUM, V158, P452, DOI 10.1111/ppl.12470; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Hartig K, 2005, PHYSIOL PLANTARUM, V125, P260, DOI 10.1111/j.1399-3054.2005.00556.x; Howell SH, 2003, TRENDS PLANT SCI, V8, P453, DOI 10.1016/S1360-1385(03)00191-2; Huang TB, 2014, PLANT CELL, V26, P246, DOI 10.1105/tpc.113.111526; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Li ZX, 2018, MOL GENET GENOMICS, V293, P1355, DOI 10.1007/s00438-018-1465-y; Li ZX, 2017, J PLANT GROWTH REGUL, V36, P889, DOI 10.1007/s00344-017-9693-7; Linares-Vasquez M, 2017, J SYST SOFTWARE, V130, P1, DOI 10.1016/j.jss.2017.04.018; Liu ZH, 2016, PLANT J, V87, P391, DOI 10.1111/tpj.13211; Long JM, 2018, J EXP BOT, V69, P2979, DOI 10.1093/jxb/ery132; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Ma JY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21061971; Maher MF, 2020, NAT BIOTECHNOL, V38, P84, DOI 10.1038/s41587-019-0337-2; Masafumi J, 2008, VIVO SHOOT REGENERAT, V43, P220, DOI 10.21273/HORTSCI.43.1.220; Motose H, 2001, PLANTA, V213, P121, DOI 10.1007/s004250000482; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nielsen MD, 2003, EUR J HORTIC SCI, V68, P161; Oda Y, 2005, PLANT PHYSIOL, V137, P1027, DOI 10.1104/pp.104.052613; Park J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0443-x; Plastira VA, 1997, ACTA HORTIC, P231, DOI 10.17660/ActaHortic.1997.447.47; Prakash AP, 2002, PLANT J, V29, P141, DOI 10.1046/j.0960-7412.2001.01206.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rodrigues AS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47789-y; Sabana AA, 2020, PLANTA, V251, DOI 10.1007/s00425-020-03368-4; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Siddiqui ZH, 2019, GENOMICS, V111, P1026, DOI 10.1016/j.ygeno.2018.11.022; Singh A, 2018, PLANTA, V248, P545, DOI 10.1007/s00425-018-2927-5; Smoczynska A, 2016, ACTA BIOCHIM POL, V63, P687, DOI 10.18388/abp.2016_1358; Su YH, 2016, PLANT CELL TISS ORG, V124, P405, DOI 10.1007/s11240-015-0903-3; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Tezuka T, 2011, HORTSCIENCE, V46, P1661, DOI 10.21273/HORTSCI.46.12.1661; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Turchi L, 2015, J EXP BOT, V66, P5043, DOI 10.1093/jxb/erv174; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang M, 2018, INT J BIOL SCI, V14, P565, DOI 10.7150/ijbs.24562; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wojcik AM, 2016, PLANTA, V244, P231, DOI 10.1007/s00425-016-2505-7; Wong CE, 2011, J EXP BOT, V62, P2495, DOI 10.1093/jxb/erq437; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Wu XM, 2015, PLANT BIOTECHNOL J, V13, P383, DOI 10.1111/pbi.12317; Xu XY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66025-6; Yakovlev IA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00674; Yang Q, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6250-8; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin L, 2008, PLANT MOL BIOL, V68, P597, DOI 10.1007/s11103-008-9395-4; Zhai LL, 2014, PLANT MOL BIOL REP, V32, P900, DOI 10.1007/s11105-014-0700-x; Zhang J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00566; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang TQ, 2015, PLANT CELL, V27, P349, DOI 10.1105/tpc.114.135186; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6; Zhong RQ, 2001, PLANT PHYSIOL, V126, P549, DOI 10.1104/pp.126.2.549; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	96	1	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237690	10.1371/journal.pone.0237690	http://dx.doi.org/10.1371/journal.pone.0237690			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332392	Green Published, Green Submitted, gold			2022-12-26	WOS:000601310900106
J	Palomares, A; Rebollo, M; Carrascosa, C				Palomares, A.; Rebollo, M.; Carrascosa, C.			Supportive consensus	PLOS ONE			English	Article							MULTIAGENT SYSTEMS	The paper is concerned with the consensus problem in a multi-agent system such that each agent has boundary constraints. Classical Olfati-Saber's consensus algorithm converges to the same value of the consensus variable, and all the agents reach the same value. These algorithms find an equality solution. However, what happens when this equality solution is out of the range of some of the agents? In this case, this solution is not adequate for the proposed problem. In this paper, we propose a new kind of algorithms called supportive consensus where some agents of the network can compensate for the lack of capacity of other agents to reach the average value, and so obtain an acceptable solution for the proposed problem. Supportive consensus finds an equity solution. In the rest of the paper, we define the supportive consensus, analyze and demonstrate the network's capacity to compensate out of boundaries agents, propose different supportive consensus algorithms, and finally, provide some simulations to show the performance of the proposed algorithms.	[Palomares, A.; Rebollo, M.; Carrascosa, C.] Univ Politecn Valencia, VRAIn Valencian Res Inst Artificial Intelligence, Valencia, Spain	Universitat Politecnica de Valencia	Palomares, A (corresponding author), Univ Politecn Valencia, VRAIn Valencian Res Inst Artificial Intelligence, Valencia, Spain.	apaloma@vrain.upv.es		Palomares Chust, Alberto/0000-0002-4583-467X	Valencian Research Institute for Artificial Intelligence (VRAIN); Spanish Government [RTI2018-095390-B-C31]; GVA-CEICE project [PROMETEO/2018/002]; TAILOR - EU Horizon 2020 research and innovation programme [952215]	Valencian Research Institute for Artificial Intelligence (VRAIN); Spanish Government(Spanish GovernmentEuropean Commission); GVA-CEICE project; TAILOR - EU Horizon 2020 research and innovation programme	The author(s) received specific funding for this work from the Valencian Research Institute for Artificial Intelligence (VRAIN) where the authors are currently working. This work is partially supported by the Spanish Government project RTI2018-095390-B-C31, GVA-CEICE project PROMETEO/2018/002, and TAILOR, a project funded by EU Horizon 2020 research and innovation programme under GA No 952215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso B, 2014, INFORM SYST FRONT, V16, P183, DOI 10.1007/s10796-013-9443-8; [Anonymous], 2012, MMWR-MORBID MORTAL W, V61, P918; Cavalcante R., 2011, P AAMAS 2011, P165; Du SF, 2016, J CLEAN PROD, V112, P1600, DOI 10.1016/j.jclepro.2014.08.086; Elhage N., 2010, 9 INT C AUT AG MULT, P907; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Fontan A., 2017, P 56 IEEE C DEC CONT, P4155; Hou WY, 2018, INT J SYST SCI, V49, P947, DOI 10.1080/00207721.2018.1433899; Hu HX, 2013, J FRANKLIN I, V350, P575, DOI 10.1016/j.jfranklin.2012.12.020; Jianting L, 2015, INT J ROBUST NONLIN, V26, P2977; Knorn F, 2011, IEEE DECIS CONTR P, P1299, DOI 10.1109/CDC.2011.6160599; Li YJ, 2019, SYST SCI CONTROL ENG, V7, P468, DOI 10.1080/21642583.2019.1695689; Liu S., 2016, INT J ROBUST NONLIN, V27, P3043; Mo LP, 2018, INT J ROBUST NONLIN, V28, P3657, DOI 10.1002/rnc.4076; Olfati-Saber R, 2004, IEEE T AUTOMAT CONTR, V49, P1520, DOI 10.1109/TAC.2004.834113; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Pedroche F, 2013, ABS13077562 CORR; Perez IJ, 2018, INFORM SCIENCES, V459, P20, DOI 10.1016/j.ins.2018.05.017; Qiu ZR, 2018, INT J ROBUST NONLIN, V28, P2619, DOI 10.1002/rnc.4040; Rebollo M, 2014, COMM COM INF SC, V430, P250; Ren W, 2005, IEEE T AUTOMAT CONTR, V50, P655, DOI 10.1109/TAC.2005.846556; Ren W, 2008, COMMUN CONTROL ENG, P3; Roy S, 2015, AUTOMATICA, V51, P259, DOI 10.1016/j.automatica.2014.10.073; Salazar N, 2010, AI COMMUN, V23, P357, DOI 10.3233/AIC-2010-0479; Wang QL, 2014, SYST SCI CONTROL ENG, V2, P275, DOI 10.1080/21642583.2014.897658; Xi JX, 2018, INFORM SCIENCES, V467, P1, DOI 10.1016/j.ins.2018.07.069; Zhao TQ, 2018, IEEE T SUSTAIN ENERG, V9, P443, DOI 10.1109/TSTE.2017.2740833	27	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243215	10.1371/journal.pone.0243215	http://dx.doi.org/10.1371/journal.pone.0243215			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332368	gold, Green Published			2022-12-26	WOS:000601310900108
J	Perisse, ARS; Souza-Santos, R; Duarte, R; Santos, F; de Andrade, CR; Rodrigues, NCP; Schramm, JMD; da Silva, ED; Jacobson, LDV; Lemos, MCF; Sobral, A				Perisse, Andre Reynaldo Santos; Souza-Santos, Reinaldo; Duarte, Rosemere; Santos, Fernanda; de Andrade, Celia Regina; Rodrigues, Nadia Cristina Pinheiro; Schramm, Joyce Mendes de Andrade; da Silva, Edimilson Domingues; Jacobson, Ludmilla da Silva Viana; Lemos, Maria Cristina Ferreira; Sobral, Andrea			Zika, dengue and chikungunya population prevalence in Rio de Janeiro city, Brazil, and the importance of seroprevalence studies to estimate the real number of infected individuals	PLOS ONE			English	Article							VIRUS-INFECTION; BURDEN; LIFE	In the last 40 years, Latin America countries, including Brazil, have suffered from the emergence and reemergence of arboviruses, first Dengue (DENV) and recently Zika (ZIKV) and Chikungunya (CHIKV). All three arboviruses are currently endemic in Brazil and have caused major outbreaks in recent years. Rio de Janeiro city, host of the last Summer Olympic Games and the Football World Cup, has been specially affected by them. A surveillance system based on symptomatic reports is in place in Rio, but the true number of affected individuals is unknown due to the great number of Zika, Dengue and Chikungunya asymptomatic cases. Seroprevalence studies are more suitable to evaluate the real number of cases in a given population. We performed a populational seroprevalence survey in Rio, with recruitment of a sample of volunteers of all ages and gender from July to October 2018, within randomly selected census tracts and household. A total of 2,120 volunteers were interviewed and tested with rapid immunochromatographic test for ZIKV, DENV and CHIKV. Individuals with positive results for IgG and/or IgM from only one virus were classified accordingly, while those with test results positive for both ZIKV and DENV were classified as flaviviruses. We corrected for sample design and non-response in data analysis, and calculated point estimate prevalence and 95% confidence intervals for each virus. Arbovirus prevalence in the Rio's population (n = 6,688,927) was estimated at 48.6% [95% CI 44.8-52.4] (n = 3,254,121) for flaviviruses and at 18.0% [95% CI 14.8-21.2] (n = 1,204,765) for CHIKV. Approximately 17.0% [95% CI 14.1-20.1] (n = 1,145,674) of Rio ' s population had no contact with any of the three arboviruses. The reported cases of Zika, Dengue and Chikungunya by the current surveillance system in place is insufficient to estimate their real numbers, and our data indicate that Zika seroprevalence could be at least five times and Chikungunya 45 times bigger. The high number of individuals having never been infected by any of the three arboviruses, may indicate a proper scenario for future outbreaks.	[Perisse, Andre Reynaldo Santos; Duarte, Rosemere; Santos, Fernanda] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Ciencias Biol, Rio De Janeiro, Brazil; [Perisse, Andre Reynaldo Santos; Souza-Santos, Reinaldo; Sobral, Andrea] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Endemias Samuel Pessoa, Rio De Janeiro, Brazil; [de Andrade, Celia Regina; Schramm, Joyce Mendes de Andrade] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitat, Rio De Janeiro, Brazil; [Rodrigues, Nadia Cristina Pinheiro] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Saude Escola Germano Sinval Faria, Rio De Janeiro, Brazil; [da Silva, Edimilson Domingues] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil; [Jacobson, Ludmilla da Silva Viana] Univ Fed Fluminense, Inst Matemat & Estat, Dept Estat, Niteroi, RJ, Brazil; [Lemos, Maria Cristina Ferreira] Secretaria Municipal Saude Rio de Janeiro, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Perisse, ARS (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Ciencias Biol, Rio De Janeiro, Brazil.; Perisse, ARS (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Endemias Samuel Pessoa, Rio De Janeiro, Brazil.	aperisse@ensp.fiocruz.br			"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil" (CAPES) [001]; Science and Technology Department of the Brazilian Ministry of Health (DECIT/Ministerio da Saude, Brasil) [33/2016]; Graduate Program in Public Health and the Environment at Sergio Arouca National School of Public Health/Fiocruz	"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil" (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Science and Technology Department of the Brazilian Ministry of Health (DECIT/Ministerio da Saude, Brasil); Graduate Program in Public Health and the Environment at Sergio Arouca National School of Public Health/Fiocruz	This study was funded in part by the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil" (CAPES) - Finance Code 001 granted to ARSP and AS. This study was also funded by a grant from the Science and Technology Department of the Brazilian Ministry of Health (DECIT/Ministerio da Saude, Brasil) (Grant number 33/2016) awarded to ARSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all field investigators, supervisors, drivers and laboratory and administrative personnel involved in the study for their efforts to make the project possible. We also thank the volunteers for welcoming us to their homes and participating in the research. This work was supported by the Graduate Program in Public Health and the Environment at Sergio Arouca National School of Public Health/Fiocruz.	Esposito DLA, 2016, REV SOC BRAS MED TRO, V49, P535, DOI 10.1590/0037-8682-0428-2016; Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015; [Anonymous], 2017, J PROSTHET DENT, V11, pe1; Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755; Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113; Chiaravalloti-Neto F, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4074-4; Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P485, DOI 10.4269/ajtmh.2008.79.485; Fritzell Camille, 2018, PLoS Negl Trop Dis, V12, pe0006533, DOI 10.1371/journal.pntd.0006533; Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541; Kerkhove MV, 2017, STANDARDIZED PROTOCO; Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773; de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013; Levy P, 1999, SAMPLING POPULATIONS; LITTLE RJA, 1986, INT STAT REV, V54, P139, DOI 10.2307/1403140; Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096; Luiz RR, 2000, CIENC SAUDE COLETIVA, V8, P9; LUMLEY T., 2010, COMPLEX SURVEYS GUID; Murhekar MV, 2019, LANCET GLOB HEALTH, V7, pE1065, DOI 10.1016/S2214-109X(19)30250-5; Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645; RATHGEBER EM, 1993, SOC SCI MED, V37, P513, DOI 10.1016/0277-9536(93)90286-D; Rodriguez-Barraquer I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003906; Sarndal CE, 2005, WILEY SER SURV METH, P1; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Soghaier MA, 2014, J INFECT PUBLIC HEAL, V7, P54, DOI 10.1016/j.jiph.2013.07.008; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vasconcellos Mauricio Teixeira Leite de, 2005, Cad. Saúde Pública, V21, pS89, DOI 10.1590/S0102-311X2005000700010; Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115; Waldman Eliseu Alves, 2008, Rev. bras. epidemiol., V11, P168, DOI 10.1590/S1415-790X2008000500018; 2019, J CROHNS COLITIS S1, V13	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243239	10.1371/journal.pone.0243239	http://dx.doi.org/10.1371/journal.pone.0243239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332373	Green Published, gold			2022-12-26	WOS:000601310900082
J	Abe, T; Okuyama, K; Kamada, M; Yano, S; Toyama, Y; Isomura, M; Nabika, T; Sakane, N; Ando, H; Miyazaki, R				Abe, Takafumi; Okuyama, Kenta; Kamada, Masamitsu; Yano, Shozo; Toyama, Yuta; Isomura, Minoru; Nabika, Toru; Sakane, Naoki; Ando, Hitoshi; Miyazaki, Ryo			Social participation and physical prefrailty in older Japanese adults: The Shimane CoHRE study	PLOS ONE			English	Article							ASIAN WORKING GROUP; LIFE-STYLE; FRAILTY; PREVALENCE; HEALTH; PEOPLE; ASSOCIATION; SARCOPENIA; CRITERIA	As older adults in an early stage (prefrailty) of frailty may return to a healthy state, it is necessary to examine the prevention of prefrailty. In this context, the number and types of social participation activities associated with physical prefrailty in community-dwelling older adults have remained relatively unexplored. This cross-sectional study investigates this issue by analyzing 616 participants living in Okinoshima, Shimane, a rural area of Japan, in 2019. Frailty was assessed using the 5-item frailty phenotype (unintentional weight loss, self-reported exhaustion, weakness, slow walking speed, and low physical activity). Data on social participation were obtained using a questionnaire based on participants' level of involvement with volunteer groups, sports clubs/groups, neighborhood associations, religious organizations/groups, and community elderly salons; their answers were categorized as "yes" if they answered "several times per year or more" and "no" if they answered "never." Binominal logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) of prefrailty by the number or types of social participation activities, adjusted for gender, age, body mass index, smoking, medication-taking, educational attainment, working status, and living arrangement. Of the 616 participants, 273 (44.3%) and 28 (4.5%) had prefrailty and frailty, respectively. The analysis showed that the number of social participation activities was significantly associated with lower odds of prefrailty (OR = 0.83; 95% CI, 0.74-0.94). Regarding the types of social participation, sports clubs/groups were associated with lower odds of prefrailty (OR = 0.47; 95% CI, 0.31-0.73). Participation in neighborhood associations was associated with prefrailty/frailty (OR = 0.57; 95% CI, 0.37-0.86). These results suggest that increasing the number of social participation activities or involvement in sports clubs/groups and neighborhood associations may be important to prevent physical prefrailty in the older population.	[Abe, Takafumi; Okuyama, Kenta; Yano, Shozo; Toyama, Yuta; Isomura, Minoru; Nabika, Toru; Miyazaki, Ryo] Shimane Univ, Ctr Community Based Healthcare Res & Educ CoHRE, Org Res & Acad Informat, Izumo, Shimane, Japan; [Okuyama, Kenta] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Kamada, Masamitsu] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Hlth & Social Behav,Bunkyo Ku, Tokyo, Japan; [Yano, Shozo] Shimane Univ, Fac Med, Dept Lab Med, Izumo, Shimane, Japan; [Isomura, Minoru; Miyazaki, Ryo] Shimane Univ, Fac Human Sci, Matsue, Shimane, Japan; [Nabika, Toru] Shimane Univ, Fac Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Sakane, Naoki] Kyoto Med Ctr, Natl Hosp Org, Clin Res Inst Endocrine & Metab Dis, Div Prevent Med,Fushimi Ku, Kyoto, Japan; [Ando, Hitoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Cellular & Mol Funct Anal, Kanazawa, Ishikawa, Japan	Shimane University; Lund University; University of Tokyo; Shimane University; Shimane University; Shimane University; Kanazawa University	Abe, T (corresponding author), Shimane Univ, Ctr Community Based Healthcare Res & Educ CoHRE, Org Res & Acad Informat, Izumo, Shimane, Japan.	t-abe@med.shimane-u.ac.jp	Miyazaki, Ryo/GPW-7412-2022; Kamada, Masamitsu/H-4411-2011	Miyazaki, Ryo/0000-0002-1996-709X; Kamada, Masamitsu/0000-0003-1703-076X	JSPS KAKENHI [19H03996, 19K11667]; Kieikai Research Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kieikai Research Foundation(Kieikai Research Foundation)	This study was supported by JSPS KAKENHI Grant Number 19H03996(MK) and 19K11667 (RM)and the Kieikai Research Foundation (RM). JSPS KAKENHI: https://kaken.nii.ac.jp/ja/index/Kiekai Research Foundation: https://www.nakashima-foundation.org/kieikai/research/index19.html The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2020, MATURITAS, V136, P54, DOI 10.1016/j.maturitas.2020.04.007; Allison PD, 2005, SUGI 30 P, P113; Barnard J, 1999, STAT METHODS MED RES, V8, P17, DOI 10.1191/096228099666230705; Bunt S, 2017, EUR J AGEING, V14, P323, DOI 10.1007/s10433-017-0414-7; Chen LJ, 2014, INT J GERONTOL, V8, P114, DOI 10.1016/j.ijge.2013.12.002; Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Choi J, 2015, J AM MED DIR ASSOC, V16, P548, DOI 10.1016/j.jamda.2015.02.004; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; Duppen D, 2019, J APPL GERONTOL, V38, P3, DOI 10.1177/0733464816688310; Etman A, 2015, EUR J PUBLIC HEALTH, V25, P345, DOI 10.1093/eurpub/cku093; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hajek A, 2016, J NUTR HEALTH AGING, V20, P952, DOI 10.1007/s12603-015-0634-5; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Hoogendijk EO, 2019, LANCET, V394, P1365, DOI 10.1016/S0140-6736(19)31786-6; Ide K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020617; Ito T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122142; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kikuchi H, 2017, GERIATR GERONTOL INT, V17, P1921, DOI 10.1111/ggi.12995; Kojima G, 2018, AGE AGEING, V47, P193, DOI 10.1093/ageing/afx162; Kojima G, 2017, DISABIL REHABIL, V39, P1897, DOI 10.1080/09638288.2016.1212282; Kojima G, 2017, J EPIDEMIOL, V27, P347, DOI 10.1016/j.je.2016.09.008; Kojima G, 2016, J EPIDEMIOL COMMUN H, V70, P716, DOI 10.1136/jech-2015-206717; Ministry of Health Labor and Welfare Japan, 2017, EST COMM BAS INT CAR; Nakagawa K, 2019, SOC SCI MED, V238, DOI 10.1016/j.socscimed.2019.112484; Paw MJMCA, 2008, SPORTS MED, V38, P781, DOI 10.2165/00007256-200838090-00006; Perruccio AV, 2021, ARTHRIT CARE RES, V73, P1638, DOI 10.1002/acr.24366; Satake S, 2017, GERIATR GERONTOL INT, V17, P2629, DOI 10.1111/ggi.13129; Satake S, 2016, GERIATR GERONTOL INT, V16, P709, DOI 10.1111/ggi.12543; Serrat R, 2020, GERONTOLOGIST, V60, pE38, DOI 10.1093/geront/gnz021; Takayanagi Naoto, 2018, J Phys Ther Sci, V30, P461, DOI 10.1589/jpts.30.461; Theou O, 2015, AGEING RES REV, V21, P78, DOI 10.1016/j.arr.2015.04.001; Tomioka K, 2017, J AM GERIATR SOC, V65, P107, DOI 10.1111/jgs.14447; Castell MV, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0807-8; Vogelsang EM, 2016, HEALTH PLACE, V42, P111, DOI 10.1016/j.healthplace.2016.09.010; Woo J, 2005, GERONTOLOGY, V51, P402, DOI 10.1159/000088705; Ye B, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0982-1	41	11	12	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243548	10.1371/journal.pone.0243548	http://dx.doi.org/10.1371/journal.pone.0243548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326452	Green Published, gold			2022-12-26	WOS:000600176400003
J	Borie, R; Savale, L; Dossier, A; Ghosn, J; Taille, C; Visseaux, B; Jebreen, K; Diallo, A; Tesmoingt, C; Morer, L; Goletto, T; Faucher, N; Hajouji, L; Neukirch, C; Phillips, M; Stelianides, S; Bouadma, L; Brosseau, S; Ottaviani, S; Pluvy, J; Le Pluart, D; Debray, MP; Raynaud-Simon, A; Descamps, D; Khalil, A; Timsit, JF; Lescure, FX; Descamps, V; Papo, T; Humbert, M; Crestani, B; Dieude, P; Vicaut, E; Zalcman, G				Borie, Raphael; Savale, Laurent; Dossier, Antoine; Ghosn, Jade; Taille, Camille; Visseaux, Benoit; Jebreen, Kamel; Diallo, Abourahmane; Tesmoingt, Chloe; Morer, Lise; Goletto, Tiphaine; Faucher, Nathalie; Hajouji, Linda; Neukirch, Catherine; Phillips, Mathilde; Stelianides, Sandrine; Bouadma, Lila; Brosseau, Solenn; Ottaviani, Sebastien; Pluvy, Johan; Le Pluart, Diane; Debray, Marie-Pierre; Raynaud-Simon, Agathe; Descamps, Diane; Khalil, Antoine; Timsit, Jean Francois; Lescure, Francois-Xavier; Descamps, Vincent; Papo, Thomas; Humbert, Marc; Crestani, Bruno; Dieude, Philippe; Vicaut, Eric; Zalcman, Gerard		Bichat Kremlin-Bicetre AP-HP COVID	Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study	PLOS ONE			English	Article							INTERLEUKIN-1; PNEUMONIA; MORTALITY; BLOCKADE; WUHAN; ARDS	Background The optimal treatment for patients with severe coronavirus-19 disease (COVID-19) and hyper-inflammation remains debated. Material and methods A cohort study was designed to evaluate whether a therapeutic algorithm using steroids with or without interleukin-1 antagonist (anakinra) could prevent death/invasive ventilation. Patients with a >= 5-day evolution since symptoms onset, with hyper-inflammation (CRP >= 50mg/L), requiring 3-5 L/min oxygen, received methylprednisolone alone. Patients needing >= 6 L/min received methylprednisolone + subcutaneous anakinra daily either frontline or in case clinical deterioration upon corticosteroids alone. Death rate and death or intensive care unit (ICU) invasive ventilation rate at Day 15, with Odds Ratio (OR) and 95% CIs, were determined according to logistic regression and propensity scores. A Bayesian analysis estimated the treatment effects. Results Of 108 consecutive patients, 70 patients received glucocorticoids alone. The control group comprised 63 patients receiving standard of care. In the corticosteroidstanakinra group (n = 108), death rate was 20.4%, versus 30.2% in the controls, indicating a 30% relative decrease in death risk and a number of 10 patients to treat to avoid a death (p = 0.15). Using propensity scores a per-protocol analysis showed an OR for COVID-19-related death of 0.9 (95%CI [0.80-1.01], p = 0.067). On Bayesian analysis, the posterior probability of any mortality benefit with corticosteroids+/-anakinra was 87.5%, with a 7.8% probability of treatment-related harm. Pre-existing diabetes exacerbation occurred in 29 of 108 patients (26.9%). Conclusion In COVID-19 non-ICU inpatients at the cytokine release phase, corticosteroids with or without anakinra were associated with a 30% decrease of death risk on Day 15.	[Borie, Raphael; Taille, Camille; Morer, Lise; Goletto, Tiphaine; Hajouji, Linda; Neukirch, Catherine; Phillips, Mathilde; Stelianides, Sandrine; Brosseau, Solenn; Pluvy, Johan; Crestani, Bruno; Zalcman, Gerard] Univ Paris, Univ Hosp Bichat Claude Bernard, Pulmonol & Thorac Oncol Dept, AP HP, Paris, France; [Savale, Laurent; Humbert, Marc] Paris Saclay Univ, Kremlin Bicetre Univ Hosp, Pulmonol Dept, AP HP, Le Kremlin Bicetre, France; [Dossier, Antoine; Papo, Thomas] Univ Paris, Univ Hosp Bichat Claude Bernard, Internal Med Dept, AP HP, Paris, France; [Ghosn, Jade; Le Pluart, Diane; Lescure, Francois-Xavier] Univ Paris, Univ Hosp Bichat Claude Bernard, Infect Dis Dept, AP HP, Paris, France; [Visseaux, Benoit; Descamps, Diane] Univ Paris, Univ Hosp Bichat Claude Bernard, Virol Dept, AP HP, Paris, France; [Jebreen, Kamel; Diallo, Abourahmane; Vicaut, Eric] Univ Paris, Univ Hosp Lariboisiere, Biostat & Clin Res Dept, AP HP, Paris, France; [Tesmoingt, Chloe; Raynaud-Simon, Agathe] Univ Paris, Univ Hosp Bichat Claude Bernard, Pharm Dept, AP HP, Paris, France; [Faucher, Nathalie] Univ Paris, Univ Hosp Bichat Claude Bernard, Geriatr Dept, AP HP, Paris, France; [Bouadma, Lila; Timsit, Jean Francois] Univ Paris, Univ Hosp Bichat Claude Bernard, Intens Care Dept, AP HP,Med & Infect Dis ICU, Paris, France; [Ottaviani, Sebastien; Dieude, Philippe] Univ Paris, Univ Hosp Bichat Claude Bernard, Rheumatol Dept, AP HP, Paris, France; [Debray, Marie-Pierre; Khalil, Antoine] Univ Paris, Univ Hosp Bichat Claude Bernard, Radiol Dept, AP HP, Paris, France; [Descamps, Vincent] Univ Paris, Univ Hosp Bichat Claude Bernard, Dermatol Dept, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Zalcman, G (corresponding author), Univ Paris, Univ Hosp Bichat Claude Bernard, Pulmonol & Thorac Oncol Dept, AP HP, Paris, France.	gerard.zalcman@aphp.fr	Dossier, Antoine/AGG-9850-2022; Humbert, Marc/ABD-5112-2021	Taille, Camille/0000-0001-9768-5728; Borie, Raphael/0000-0002-9906-0024				Alfaraj SH, 2019, TRAVEL MED INFECT DI, V29, P48, DOI 10.1016/j.tmaid.2019.03.004; Aouba A, 2020, ANN RHEUM DIS, V79, P1381, DOI 10.1136/annrheumdis-2020-217706; Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0; Beigel JH, 2020, N ENGL J MED, V383, P1813; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004; COVID19 APHP Grp, 2020, LANCET, V395, P1760, DOI 10.1016/S0140-6736(20)31210-1; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Fadel R, 2020, CLIN INFECT DIS, V71, P2114, DOI 10.1093/cid/ciaa601; Farag NS, 2020, INT J BIOCHEM CELL B, V122, DOI 10.1016/j.biocel.2020.105738; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273:24, DOI 10.1056/NEJMOA2021436, 10.1101/2020.06.22.20137273]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8; Kernan KF, 2019, GENES IMMUN, V20, P520, DOI 10.1038/s41435-018-0030-3; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lee N, 2004, J CLIN VIROL, V31, P304, DOI 10.1016/j.jcv.2004.07.006; McCandless LC, 2009, STAT MED, V28, P94, DOI 10.1002/sim.3460; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Navarro-Millan I, 2020, ARTHRITIS RHEUMATOL, V72, P1990, DOI 10.1002/art.41422; Ni YN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2395-8; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; ROBINS JM, 1994, J AM STAT ASSOC, V89, P846, DOI 10.2307/2290910; Rotz SJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26642; Seam N, 2016, INTENS CARE MED, V42, P924, DOI 10.1007/s00134-015-4160-z; Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang Y, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0158-2; Who Mers-Cov Research Group, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	41	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243961	10.1371/journal.pone.0243961	http://dx.doi.org/10.1371/journal.pone.0243961			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326457	Green Published, gold			2022-12-26	WOS:000600176400066
J	Doshi, S; Moorthi, RN; Fried, LF; Sarnak, MJ; Satterfield, S; Shlipak, M; Lange-Maia, BS; Newman, AB; Strotmeyer, ES				Doshi, Simit; Moorthi, Ranjani N.; Fried, Linda F.; Sarnak, Mark J.; Satterfield, Suzanne; Shlipak, Michael; Lange-Maia, Brittney S.; Newman, Anne B.; Strotmeyer, Elsa S.			Chronic kidney disease as a risk factor for peripheral nerve impairment in older adults: A longitudinal analysis of Health, Aging and Body Composition (Health ABC) study	PLOS ONE			English	Article							CONDUCTION-VELOCITY; AXONAL DYSFUNCTION; BLACK ADULTS; NEUROPATHY; ERYTHROPOIETIN; POLYNEUROPATHY; ASSOCIATION; PERFORMANCE; CREATININE; WALKING	Introduction Sensory and motor nerve deficits are prevalent in older adults and are associated with loss of functional independence. We hypothesize that chronic kidney disease predisposes to worsening sensorimotor nerve function over time. Materials and methods Participants were from the Health, Aging and Body Composition Study (N = 1121) with longitudinal data between 2000-01 (initial visit) and 2007-08 (follow-up visit). Only participants with non-impaired nerve function at the initial visit were included. The predictor was presence of CKD (estimated GFR <= 60 ml/min/1.73m(2)) from the 1999-2000 visit. Peripheral nerve function outcomes at 7-year follow-up were 1) Motor: "new" impairments in motor parameters (nerve conduction velocity NCV < 40 m/s or peroneal compound motor action potential < 1 mv) at follow-up, and 2) Sensory: "new" impairment defined as insensitivity to standard 10-g monofilament or light 1.4-g monofilament at the great toe and "worsening" as a change from light to standard touch insensitivity over time. The association between CKD and "new" or "worsening" peripheral nerve impairment was studied using logistic regression. Results The study population was 45.9% male, 34.3% Black and median age 75 y. CKD participants (15.6%) were older, more hypertensive, higher in BMI and had 2.37 (95% CI 1.30-4.34) fold higher adjusted odds of developing new motor nerve impairments in NCV. CKD was associated with a 2.02 (95% CI 1.01-4.03) fold higher odds of worsening monofilament insensitivity. CKD was not associated with development of new monofilament insensitivity. Conclusions Pre-existing CKD leads to new and worsening sensorimotor nerve impairments over a 7-year time period in community-dwelling older adults.	[Doshi, Simit; Moorthi, Ranjani N.] Indiana Univ, Div Nephrol, Indianapolis, IN 46204 USA; [Fried, Linda F.; Newman, Anne B.; Strotmeyer, Elsa S.] Univ Pittsburgh, Pittsburgh, PA USA; [Sarnak, Mark J.] Tufts Med Ctr, Boston, MA 02111 USA; [Satterfield, Suzanne] Univ Tennessee, Memphis, TN USA; [Shlipak, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lange-Maia, Brittney S.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California San Francisco; Rush University	Moorthi, RN (corresponding author), Indiana Univ, Div Nephrol, Indianapolis, IN 46204 USA.	rmoorthi@iu.edu		Strotmeyer, Elsa/0000-0002-4093-6036	National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; NINR [R01-NR012459]; Intramural Research Program of the NIH, National Institute on Aging; NIH NIDDK [K23 DK102824]; NIA [R01AG028050]	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging (NIA) Contracts N01-AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01AG028050, and NINR grant R01-NR012459. This research was funded in part by the Intramural Research Program of the NIH, National Institute on Aging. This work was also supported by NIH NIDDK K23 DK102824 (RNM).	Aggarwal HK, 2013, RENAL FAILURE, V35, P1105, DOI 10.3109/0886022X.2013.815102; Alam U, 2017, DIABETES THER, V8, P1253, DOI 10.1007/s13300-017-0295-y; Arnold R, 2017, CLIN J AM SOC NEPHRO, V12, P1569, DOI 10.2215/CJN.00670117; Arnold R, 2016, JRSM CARDIOVASC DIS, V5, DOI 10.1177/2048004016677687; Arnold R, 2014, CLIN NEUROPHYSIOL, V125, P179, DOI 10.1016/j.clinph.2013.06.022; Arnold R, 2013, DIABETES-METAB RES, V29, P53, DOI 10.1002/dmrr.2360; AVRAM MM, 1978, NEW ENGL J MED, V298, P1000, DOI 10.1056/NEJM197805042981805; Bowling CB, 2018, J GERONTOL A-BIOL, V73, P1216, DOI 10.1093/gerona/glx260; Bowling CB, 2016, CLIN J AM SOC NEPHRO, V11, P1236, DOI 10.2215/CJN.11111015; Brown SA, 2017, CLIN KIDNEY J, V10, P788, DOI 10.1093/ckj/sfx057; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Denislic M, 2015, INT UROL NEPHROL, V47, P1879, DOI 10.1007/s11255-015-1117-7; Deshpande N, 2016, AGE, V38, DOI 10.1007/s11357-016-9918-x; Fried LF, 2007, J AM SOC NEPHROL, V18, P282, DOI 10.1681/ASN.2006050546; Fried LF, 2006, J AM GERIATR SOC, V54, P750, DOI 10.1111/j.1532-5415.2006.00727.x; Hanewinckel R, 2016, NEUROLOGY, V87, P1892, DOI 10.1212/WNL.0000000000003293; Hassan K, 2003, J NEPHROL, V16, P121; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jasti DB, 2017, J NEUROSCI RURAL PRA, V8, P516, DOI 10.4103/jnrp.jnrp_186_17; Kistler BM, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170518; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Lange-Maia BS, 2017, EXP GERONTOL, V96, P38, DOI 10.1016/j.exger.2017.04.007; Lange-Maia BS, 2016, ARCH PHYS MED REHAB, V97, P45, DOI 10.1016/j.apmr.2015.08.423; Lange-Maia BS, 2015, J AM GERIATR SOC, V63, P1348, DOI 10.1111/jgs.13487; MASER R E, 1991, Journal of Diabetic Complications, V5, P6, DOI 10.1016/0891-6632(91)90003-8; Moorthi RN, 2017, CURR OPIN NEPHROL HY, V26, P219, DOI 10.1097/MNH.0000000000000318; Moorthi RN, 2018, NEPHROL DIAL TRANSPL; Roshanravan B, 2015, AM J KIDNEY DIS, V65, P737, DOI 10.1053/j.ajkd.2014.10.016; Said G, 2013, HAND CLINIC, V115, P607, DOI 10.1016/B978-0-444-52902-2.00035-7; Smyth A, 2013, AGE AGEING, V42, P488, DOI 10.1093/ageing/aft007; SOBH MA, 1992, SCAND J UROL NEPHROL, V26, P65, DOI 10.3109/00365599209180398; Strotmeyer ES, 2008, DIABETES CARE, V31, P1767, DOI 10.2337/dc08-0433; Strotmeyer ES, 2006, J BONE MINER RES, V21, P1803, DOI 10.1359/JBMR.060725; Strotmeyer ES, 2009, J AM GERIATR SOC, V57, P2004, DOI 10.1111/j.1532-5415.2009.02487.x; Walker Simon R, 2015, Can J Kidney Health Dis, V2, P32, DOI 10.1186/s40697-015-0067-4; Ward RE, 2016, AGING DIS, V7, P466, DOI 10.14336/AD.2015.1127; Ward RE, 2015, J GERONTOL A-BIOL, V70, P464, DOI 10.1093/gerona/glu183; Ward RE, 2014, J AM GERIATR SOC, V62, P2273, DOI 10.1111/jgs.13152; Ward RE, 2013, CLIN NEUROPHYSIOL, V124, P603, DOI 10.1016/j.clinph.2012.07.027; Wilson JR, 1998, MUSCLE NERVE, V21, P1228, DOI 10.1002/(SICI)1097-4598(199809)21:9<1228::AID-MUS20>3.0.CO;2-M	41	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242406	10.1371/journal.pone.0242406	http://dx.doi.org/10.1371/journal.pone.0242406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320861	Green Published, gold			2022-12-26	WOS:000600339800041
J	Gu, GW; Tian, L; Herzog, SK; Rechoum, Y; Gelsomino, L; Gao, M; Du, LL; Kim, JA; Dustin, D; Lo, HC; Beyer, AR; Edwards, DG; Gonzalez, T; Tsimelzon, A; Huang, HJ; Fernandez, NM; Grimm, SL; Hilsenbeck, SG; Liu, D; Xu, J; Alaniz, A; Li, SQ; Mills, GB; Janku, F; Kittler, R; Zhang, XHF; Coarfa, C; Foulds, CE; Symmans, WF; Ando, S; Fuqua, SAW				Gu, Guowei; Tian, Lin; Herzog, Sarah K.; Rechoum, Yassine; Gelsomino, Luca; Gao, Meng; Du, Lili; Kim, Jin-Ah; Dustin, Derek; Lo, Hin Ching; Beyer, Amanda R.; Edwards, David G.; Gonzalez, Thomas; Tsimelzon, Anna; Huang, Helen J.; Fernandez, Natalie M.; Grimm, Sandra L.; Hilsenbeck, Susan G.; Liu, Dan; Xu, Jun; Alaniz, Alyssa; Li, Shunqiang; Mills, Gordon B.; Janku, Filip; Kittler, Ralf; Zhang, Xiang H. -F.; Coarfa, Cristian; Foulds, Charles E.; Symmans, W. Fraser; Ando, Sebastiano; Fuqua, Suzanne A. W.			Hormonal modulation of ESR1 mutant metastasis	ONCOGENE			English	Article							BREAST-CANCER; ANDROGEN RECEPTOR; ER-ALPHA; TAMOXIFEN RESISTANCE; ESTROGEN-RECEPTORS; MUTATIONS; INHIBITOR; BIOMARKERS; THERAPY; SNAIL	Estrogen receptor alpha gene (ESR1) mutations occur frequently in ER-positive metastatic breast cancer, and confer clinical resistance to aromatase inhibitors. Expression of the ESR1 Y537S mutation induced an epithelial-mesenchymal transition (EMT) with cells exhibiting enhanced migration and invasion potential in vitro. When small subpopulations of Y537S ESR1 mutant cells were injected along with WT parental cells, tumor growth was enhanced with mutant cells becoming the predominant population in distant metastases. Y537S mutant primary xenograft tumors were resistant to the antiestrogen tamoxifen (Tam) as well as to estradiol (E-2) withdrawal. Y537S ESR1 mutant primary tumors metastasized efficiently in the absence of E-2; however, Tam treatment significantly inhibited metastasis to distant sites. We identified a nine-gene expression signature, which predicted clinical outcomes of ER-positive breast cancer patients, as well as breast cancer metastasis to the lung. Androgen receptor (AR) protein levels were increased in mutant models, and the AR agonist dihydrotestosterone significantly inhibited estrogen-regulated gene expression, EMT, and distant metastasis in vivo, suggesting that AR may play a role in distant metastatic progression of ESR1 mutant tumors.	[Gu, Guowei; Herzog, Sarah K.; Rechoum, Yassine; Kim, Jin-Ah; Dustin, Derek; Lo, Hin Ching; Beyer, Amanda R.; Edwards, David G.; Gonzalez, Thomas; Tsimelzon, Anna; Hilsenbeck, Susan G.; Alaniz, Alyssa; Zhang, Xiang H. -F.; Fuqua, Suzanne A. W.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Gu, Guowei; Zhang, Xiang H. -F.; Foulds, Charles E.; Fuqua, Suzanne A. W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gu, Guowei; Gelsomino, Luca; Ando, Sebastiano] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy; [Tian, Lin] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Herzog, Sarah K.] Baylor Coll Med, Integrat Mol & Biomed Sci Program, Houston, TX 77030 USA; [Gao, Meng] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Du, Lili; Symmans, W. Fraser] Univ Texas MD Anderson Canc Ctr, Dept Pathol & Translat Mol Pathol, Houston, TX 77030 USA; [Dustin, Derek] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Huang, Helen J.; Janku, Filip] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Fernandez, Natalie M.; Liu, Dan; Xu, Jun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Grimm, Sandra L.; Hilsenbeck, Susan G.; Zhang, Xiang H. -F.; Coarfa, Cristian; Foulds, Charles E.; Fuqua, Suzanne A. W.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Li, Shunqiang] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Mills, Gordon B.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Kittler, Ralf] UT Southwestern Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Kittler, Ralf] UT Southwestern Med Ctr, Dept Pharmacol, Dallas, TX USA; [Foulds, Charles E.] Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Calabria; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine	Fuqua, SAW (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA.; Fuqua, SAW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Fuqua, SAW (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	sfuqua@bcm.edu	Kittler, Ralf/I-4662-2013; Kittler, Ralf/AAD-4258-2020	Kittler, Ralf/0000-0002-0098-6792; Kittler, Ralf/0000-0002-0098-6792; Herzog, Sarah/0000-0003-3782-7389; Zhang, Xiang/0000-0002-5674-8670; Gonzalez, Thomas/0000-0003-4497-3106; Tian, Lin/0000-0003-3661-4453	Breast Cancer Research Foundation [BCRF 19-055, BCRF-19-110]; NIH [R01 CA207270, R01CA072038]; Cancer Prevention Institute of Texas CPRIT MIRA; Adrienne Helis Malvin Medical Research Foundation Cancer Program M-2017; Dan L Duncan Cancer Center Cell-based assay screening core [P30 CA125123-05]; Translational Breast Cancer Research Training Program [T32-CA203690-02]; Predoctoral Institutional Research Training Grant (T32) Training Grant [5T32GM008231-30]; Cancer Prevention Institute of Texas (CPRIT) [T32 2389301302, RP170005]; NIEHS [P30 ES030285, P42 ES027725]; Susan G. Komen Breast Cancer Foundation [U01 CA217842, SAC110052]	Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Institute of Texas CPRIT MIRA; Adrienne Helis Malvin Medical Research Foundation Cancer Program M-2017; Dan L Duncan Cancer Center Cell-based assay screening core; Translational Breast Cancer Research Training Program; Predoctoral Institutional Research Training Grant (T32) Training Grant; Cancer Prevention Institute of Texas (CPRIT); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation)	Breast Cancer Research Foundation BCRF 19-055, NIH R01 CA207270, NIH R01CA072038, Cancer Prevention Institute of Texas CPRIT MIRA (Kelly Hunt, PI) to SAWF; Adrienne Helis Malvin Medical Research Foundation Cancer Program M-2017 to CEF; P30 CA125123-05 Dan L Duncan Cancer Center Cell-based assay screening core; Translational Breast Cancer Research Training Program T32-CA203690-02; Predoctoral Institutional Research Training Grant (T32) Training Grant 5T32GM008231-30; T32 2389301302, Cancer Prevention Institute of Texas (CPRIT) RP170005; NIEHS grants P30 ES030285, P42 ES027725; U01 CA217842, Susan G. Komen Breast Cancer Foundation SAC110052, Breast Cancer Research Foundation BCRF-19-110.	Barone I, 2011, JNCI-J NATL CANCER I, V103, P538, DOI 10.1093/jnci/djr058; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chandarlapaty S, 2016, JAMA ONCOL, V2, P1310, DOI 10.1001/jamaoncol.2016.1279; Chiang KC, 2019, CANCER MANAG RES, V11, P1893, DOI 10.2147/CMAR.S196485; Ciupek A, 2015, BREAST CANCER RES TR, V154, P225, DOI 10.1007/s10549-015-3609-7; Cochrane DR, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3599; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; De Amicis F, 2010, BREAST CANCER RES TR, V121, P1, DOI 10.1007/s10549-009-0436-8; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Fuqua SAW, 2001, J MAMMARY GLAND BIOL, V6, P407, DOI 10.1023/A:1014782813943; Fuqua SAW, 2014, BREAST CANCER RES TR, V144, P11, DOI 10.1007/s10549-014-2847-4; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Gates LA, 2018, ONCOGENE, V37, P4581, DOI 10.1038/s41388-018-0284-2; Gelsomino L, 2016, BREAST CANCER RES TR, V157, P253, DOI 10.1007/s10549-016-3829-5; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Harris LN, 2016, J CLIN ONCOL, V34, P1134, DOI 10.1200/JCO.2015.65.2289; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Howlader N., 2016, SEER CANC STAT REV 1; Jeselsohn R, 2018, CANCER CELL, V33, P173, DOI 10.1016/j.ccell.2018.01.004; Jiang J, 2011, ONCOGENE, V30, P4498, DOI 10.1038/onc.2011.154; Jin LT, 2018, CANCER BIOL THER, V19, P858, DOI 10.1080/15384047.2018.1456599; Kim JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12991; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; Kollipara RK, 2015, GENOM DATA, V3, P80, DOI 10.1016/j.gdata.2014.11.015; Krop I, 2018, P 2017 SAN ANT BREAS; Lambert Jr, 2001, METH MOL B, V176, P273; Li C, 2014, ONCOTARGET, V5, P8429, DOI 10.18632/oncotarget.2316; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Li YQ, 2015, INT J ONCOL, V46, P1461, DOI 10.3892/ijo.2015.2878; Lima JF, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070065; Martin M, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15127, 10.1038/s41467-017-01864-y]; Mihaly Z, 2013, BREAST CANCER RES TR, V140, P219, DOI 10.1007/s10549-013-2622-y; Narayanan R, 2018, MOL CELL ENDOCRINOL, V465, P134, DOI 10.1016/j.mce.2017.06.013; O'Leary B, 2018, CANCER DISCOV, V8, P1390, DOI 10.1158/2159-8290.CD-18-0264; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Pidugu VK, 2019, ONCOGENE, V38, P3232, DOI 10.1038/s41388-018-0662-9; Ponnusamy S, 2019, ISCIENCE, V21, P341, DOI 10.1016/j.isci.2019.10.038; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rangel N, 2018, ENDOCR-RELAT CANCER, V25, P163, DOI 10.1530/ERC-17-0417; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; Rechoum Y, 2014, BREAST CANCER RES TR, V147, P473, DOI 10.1007/s10549-014-3082-8; Selever J, 2011, CLIN CANCER RES, V17, P6510, DOI 10.1158/1078-0432.CCR-11-1403; Sinn BV, 2019, NPJ BREAST CANCER, V5, DOI 10.1038/s41523-019-0111-0; Takeshita T, 2015, TRANSL RES, V166, P540, DOI 10.1016/j.trsl.2015.09.003; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Zhang QX, 1997, CANCER RES, V57, P1244	49	9	9	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					997	1011		10.1038/s41388-020-01563-x	http://dx.doi.org/10.1038/s41388-020-01563-x		DEC 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33323970	Green Accepted			2022-12-26	WOS:000599126500001
J	Kaufmann, M; Solderer, A; Gubler, A; Wegehaupt, FJ; Attin, T; Schmidlin, PR				Kaufmann, Manuela; Solderer, Alex; Gubler, Andrea; Wegehaupt, Florian J.; Attin, Thomas; Schmidlin, Patrick R.			Quantitative measurements of aerosols from air-polishing and ultrasonic devices: (How) can we protect ourselves?	PLOS ONE			English	Article							SPATTER-REDUCTION; INFECTION-CONTROL; CONTAMINATION; SPLATTER; EFFICACY; RISK	Aim To assess the distribution and deposition of aerosols during simulated periodontal therapy. Methods A manikin with simulated fluorescein salivation was treated by four experienced dentists applying two different periodontal treatment options, i.e. air-polishing with an airflow device or ultrasonic scaling in the upper and lower anterior front for 5 minutes, respectively. Aerosol deposition was quantitatively measured on 21 pre-defined locations with varying distances to the manikins mouth in triplicates using absorbent filter papers. Results The selected periodontal interventions resulted in different contamination levels around the patient's mouth. The highest contamination could be measured on probes on the patient's chest and forehead but also on the practitioner's glove. With increasing distance to the working site contamination of the probes decreased with both devices. Air-polishing led to greater contamination than ultrasonic. Conclusion Both devices showed contamination of the nearby structures, less contamination was detected when using the ultrasonic. Affirming the value of wearing protective equipment we support the need for universal barrier precautions and effective routine infection control in dental practice.	[Kaufmann, Manuela; Solderer, Alex; Gubler, Andrea; Wegehaupt, Florian J.; Attin, Thomas; Schmidlin, Patrick R.] Univ Zurich, Ctr Dent Med, Clin Conservat & Prevent Dent, Zurich, Switzerland	University of Zurich	Schmidlin, PR (corresponding author), Univ Zurich, Ctr Dent Med, Clin Conservat & Prevent Dent, Zurich, Switzerland.	patrick.schmidlin@zzm.uzh.ch	Attin, Thomas/ABF-9246-2020	Wegehaupt, Florian/0000-0002-3972-0561; Schmidlin, Patrick/0000-0002-1377-0325; Attin, Thomas/0000-0002-6141-1263				Bennett AM, 2000, BRIT DENT J, V189, P664, DOI 10.1038/sj.bdj.4800859a; BENTLEY CD, 1994, J AM DENT ASSOC, V125, P579, DOI 10.14219/jada.archive.1994.0093; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; COCHRAN MA, 1989, J AM DENT ASSOC, V119, P141, DOI 10.14219/jada.archive.1989.0131; Cottone J A, 1987, Tex Dent J, V104, P7; Dahlke WO, 2012, J AM DENT ASSOC, V143, P1199, DOI 10.14219/jada.archive.2012.0064; DEGRAAFF J, 1988, J DENT CHILD, V55, P56; Devker Nihal R, 2012, J Contemp Dent Pract, V13, P681; Gupta G, 2014, J PERIODONTOL, V85, P562, DOI 10.1902/jop.2013.120616; Harrel SK, 1999, QUINTESSENCE INT, V30, P623; Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207; Harrel SK, 1998, J AM DENT ASSOC, V129, P1241, DOI 10.14219/jada.archive.1998.0421; Holloman JL, 2015, J AM DENT ASSOC, V146, P27, DOI 10.1016/j.adaj.2014.10.001; Hunter A, 2014, IMAGNG SCI DENT, V44, P149, DOI 10.5624/isd.2014.44.2.149; Jacks Mary E, 2002, J Dent Hyg, V76, P202; Joshi Amruta Arun, 2017, J Int Acad Periodontol, V19, P138; Klyn Steven L., 2001, General Dentistry, V49, P648; Kohn WG, 2004, J AM DENT ASSOC, V135, P33, DOI 10.14219/jada.archive.2004.0019; Lewis D, 2020, NATURE, V580, P175, DOI 10.1038/d41586-020-00974-w; Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246; MICIK RE, 1969, J DENT RES, V48, P49, DOI 10.1177/00220345690480012401; Oshitani H., 2020, CLOSED ENV FACILITAT; Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008; Pereira RJ, 2020, PUBLIC HEALTH, V183, P42, DOI 10.1016/j.puhe.2020.04.042; Radcliffe RA, 2013, J AM DENT ASSOC, V144, P1110, DOI 10.14219/jada.archive.2013.0029; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Veena HR, 2015, J INFECT PUBLIC HEAL, V8, P260, DOI 10.1016/j.jiph.2014.11.004; Yoon JG, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e195; Zemouri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178007	30	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244020	10.1371/journal.pone.0244020	http://dx.doi.org/10.1371/journal.pone.0244020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320905	gold, Green Published			2022-12-26	WOS:000600339800059
J	Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hwu, CM; Hou, MC; Hsu, CC				Yen, Fu-Shun; Lai, Jung-Nien; Wei, James Cheng-Chung; Chiu, Lu-Ting; Hwu, Chii-Min; Hou, Ming-Chih; Hsu, Chih-Cheng			Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; CLAIMS DATA; MORTALITY; COMPLICATIONS; METAANALYSIS; RISK; ASSOCIATION; MELLITUS; THERAPY; DRUGS	This study aimed to investigate the long-term outcomes of sulfonylurea (SU) use in patients with T2DM and compensated liver cirrhosis. From January 1, 2000, to December 31, 2012, we selected the data of 3781 propensity-score-matched SU users and nonusers from Taiwan's National Health Insurance Research Database. The mean follow-up time for this study was 5.74 years. Cox proportional hazards models with robust sandwich standard error estimates were used to compare the risks of main outcomes between SU users and nonusers. The incidence of mortality during follow-up was 3.24 and 4.09 per 100 person-years for SU users and nonusers, respectively. The adjusted hazard ratios and 95% confidence intervals for all-cause mortality, major cardiovascular events, and decompensated cirrhosis in SU users relative to SU nonusers were 0.79 (0.71-0.88), 0.69 (0.61-0.80), and 0.82 (0.66-1.03), respectively. The SU-associated lower risks of death and cardiovascular events seemed to have a dose-response trend. This population-based cohort study demonstrated that SU use was associated with lower risks of death and major cardiovascular events compared with SU non-use in patients with T2DM and compensated liver cirrhosis. SUs may be useful for glycemic management for patients with liver cirrhosis.	[Yen, Fu-Shun] Dr Yens Clin, Taoyuan, Taiwan; [Lai, Jung-Nien] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Lai, Jung-Nien] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Dept Allergy Immunol & Rheumatol, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Coll Med, Taichung, Taiwan; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chiu, Lu-Ting] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chiu, Lu-Ting] China Med Univ, Coll Med, Taichung, Taiwan; [Hwu, Chii-Min] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Hwu, Chii-Min] Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan; [Hou, Ming-Chih] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan; [Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan; China Medical University Taiwan	Hou, MC (corresponding author), Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan.; Hsu, CC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.; Hsu, CC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Hsu, CC (corresponding author), Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan.	mchou@vghtpe.gov.tw; cch@nhri.edu.tw	Hwu, Chii-Min/AAZ-7384-2021	Hsu, Chih-Cheng/0000-0003-4563-4341	Taiwan's Ministry of Health and Welfare Clinical Trial Center [MOHW109-TDU-B-212-114004]; Ministry of Science and Technology Clinical Trial Consortium for Stroke [MOST 108-2321-B-039003]; Tseng-Lien Lin Foundation, Taichung, Taiwan	Taiwan's Ministry of Health and Welfare Clinical Trial Center; Ministry of Science and Technology Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan	This study is supported in part by Taiwan's Ministry of Health and Welfare Clinical Trial Center (MOHW109-TDU-B-212-114004), Ministry of Science and Technology Clinical Trial Consortium for Stroke (MOST 108-2321-B-039003), Tseng-Lien Lin Foundation, Taichung, Taiwan (URL of each funder website: https://www.taiwanclinicaltrials.tw/ctc; http://www.ltl-charity.org.tw/about.php?id=4).These funding agencies did not influence the study design, data collection and analysis, decision to publish, or manuscript preparation. The writing and preparation of this paper was not funded by any organization, and employees of funders or any author who received the funding did not undertake data analysis. The funders did not offer support for writing. The corresponding authors had complete access to all data in the study and final responsibility for the publication decision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2020, INT DIABETES FEDERAT; Bain S, 2017, DIABETES OBES METAB, V19, P329, DOI 10.1111/dom.12821; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Elkrief L, 2016, LIVER INT, V36, P936, DOI 10.1111/liv.13115; Gundling F, 2013, DIGESTION, V87, P75, DOI 10.1159/000343458; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kawaguchi T, 2010, LIVER INT, V30, P479, DOI 10.1111/j.1478-3231.2009.02191.x; Khunti K, 2018, LANCET DIABETES ENDO, V6, P821, DOI 10.1016/S2213-8587(18)30025-1; Klepzig H, 1999, EUR HEART J, V20, P439, DOI 10.1053/euhj.1998.1242; Koshiba K, 2006, J MED INVESTIG, V53, P87, DOI 10.2152/jmi.53.87; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Meduru P, 2007, J GEN INTERN MED, V22, P408, DOI 10.1007/s11606-007-0310-5; MEINERT CL, 1970, DIABETES, V19, P789; Monami M, 2013, DIABETES OBES METAB, V15, P938, DOI 10.1111/dom.12116; MOREAU R, 1994, GASTROENTEROLOGY, V106, P1016, DOI 10.1016/0016-5085(94)90762-5; Mukerji AN, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/318627; Nehra MS, 2013, J CLIN GASTROENTEROL, V47, pE50, DOI 10.1097/MCG.0b013e3182688d2f; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; PETRIDES AS, 1994, HEPATOLOGY, V19, P616, DOI 10.1002/hep.1840190312; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V322, P1155, DOI 10.1001/jama.2019.13772; Scheen AJ, 2014, EXPERT OPIN DRUG MET, V10, P839, DOI 10.1517/17425255.2014.902444; Simpson SH, 2015, LANCET DIABETES ENDO, V3, P43, DOI 10.1016/S2213-8587(14)70213-X; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Udell JA, 2015, LANCET DIABETES ENDO, V3, P356, DOI 10.1016/S2213-8587(15)00044-3; Vaccaro O, 2017, LANCET DIABETES ENDO, V5, P887, DOI 10.1016/S2213-8587(17)30317-0; Young BA, 2008, AM J MANAG CARE, V14, P15	32	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243783	10.1371/journal.pone.0243783	http://dx.doi.org/10.1371/journal.pone.0243783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315940	gold, Green Published			2022-12-26	WOS:000600186100008
J	Sun, R; Jang, JH; Lauzon, AM; Martin, JG				Sun, Rui; Jang, Joyce H.; Lauzon, Anne-Marie; Martin, James G.			Interferon-gamma amplifies airway smooth muscle-mediated CD4+T cell recruitment by promoting the secretion of C-X-C-motif chemokine receptor 3 ligands	FASEB JOURNAL			English	Article						airway smooth muscle; CXCL10; CXCL11; CXCR3; IFN&#8208; &#947; T cell chemotaxis	CD4(+) T-CELLS; IFN-GAMMA; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS; ASTHMA; CXCR3; ALPHA; HYPERPLASIA; EXPRESSION; ENDOTYPES	Asthmatic airways feature increased ASM mass that is largely attributable to hyperplasia, and which potentially contributes to excessive airway narrowing. T cells induce ASMC proliferation via contact-dependent mechanisms in vitro that may have importance for asthmatic ASM growth, as CD4+ T cells infiltrate ASM bundles in asthmatic human airways. In this study, we used an in vitro migration assay to investigate the pathways responsible for the trafficking of human CD4+ T cells to ASM. ASMCs induced chemotaxis of activated CD4+ T cells, which was inhibited by the CXCR3 antagonist AMG487 and neutralizing antibodies against its ligands CXCL10 and 11, but not CCR3 or CCR5 antagonists. CXCR3 expression was upregulated among all T cells following anti-CD3/CD28-activation. CD4+ T cells upregulated CXCL9, 10, and 11 expression in ASMCs in an IFN-gamma/STAT1-dependent manner. Disruption of IFN-gamma-signaling resulted in reduced T cell migration, along with the inhibition of CD4+ T cell-mediated STAT1 activation and CXCR3 ligand secretion by ASMCs. ASMCs derived from healthy and asthmatic donors demonstrated similar T cell-recruiting capacities. In vivo CXCL10 and 11 expression by asthmatic ASM was confirmed by immunostaining. We conclude that the CXCL10/11-CXCR3 axis causes CD4+ T cell recruitment to ASM that is amplified by T cell-derived IFN-gamma.	[Sun, Rui; Jang, Joyce H.; Lauzon, Anne-Marie; Martin, James G.] McGill Univ, Ctr Hlth, Res Inst, Meakins Christie Labs, 1001 Blvd Decarie,Room EM3-2210, Montreal, PQ H4A 3J1, Canada	McGill University	Martin, JG (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Meakins Christie Labs, 1001 Blvd Decarie,Room EM3-2210, Montreal, PQ H4A 3J1, Canada.	james.martin@mcgill.ca		Martin, James/0000-0001-7574-5363				Al Heialy S, 2015, J IMMUNOL, V194, P5626, DOI 10.4049/jimmunol.1401718; Al Heialy S, 2013, AM J RESP CELL MOL, V49, P563, DOI 10.1165/rcmb.2012-0356OC; Begueret H, 2007, THORAX, V62, P8, DOI 10.1136/thx.2006.062141; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Berair R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-145; Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Bochner BS, 2003, J ALLERGY CLIN IMMUN, V112, P930, DOI 10.1016/j.jaci.2003.08.012; Boniface S, 2003, CLIN EXP ALLERGY, V33, P1238, DOI 10.1046/j.1365-2222.2003.01762.x; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Cheong HS, 2005, BIOCHEM BIOPH RES CO, V334, P1219, DOI 10.1016/j.bbrc.2005.07.019; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Coyle AJ, 1996, J IMMUNOL, V156, P2680; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; Gregor CE, 2017, ADV IMMUNOL, V135, P119, DOI 10.1016/bs.ai.2017.03.001; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Koch M, 2006, AM J RESP CELL MOL, V35, P211, DOI 10.1165/rcmb.2005-0293OC; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Kumar RK, 2004, AM J RESP CRIT CARE, V170, P1043, DOI 10.1164/rccm.200405-681OC; Kuo CHS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02135-2016; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; Lack G, 1996, J IMMUNOL, V157, P1432; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mahnke YD, 2013, CYTOM PART A, V83A, P439, DOI 10.1002/cyto.a.22269; Matheson JM, 2005, TOXICOL SCI, V84, P99, DOI 10.1093/toxsci/kfi051; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Ramos-Barbon D, 2005, J CLIN INVEST, V115, P1580, DOI 10.1172/JCI19711; Ramos-Barbon D, 2010, AM J RESP CRIT CARE, V182, P317, DOI 10.1164/rccm.200905-0745OC; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Suzaki Y, 2008, EUR RESPIR J, V31, P783, DOI 10.1183/09031936.00111507; Takaku Yotaro, 2016, Asthma Res Pract, V2, P6, DOI 10.1186/s40733-016-0021-y; Tan X, 2013, AM J PHYSIOL-LUNG C, V304, pL790, DOI 10.1152/ajplung.00356.2012; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Weigt H, 2005, AM J RESP CRIT CARE, V172, P566, DOI 10.1164/rccm.200411-1490OC; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573	49	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21228	10.1096/fj.202001480R	http://dx.doi.org/10.1096/fj.202001480R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337555				2022-12-26	WOS:000605626600034
J	Bates, M; Spillane, CD; Gallagher, MF; McCann, A; Martin, C; Blackshields, G; Keegan, H; Gubbins, L; Brooks, R; Brooks, D; Selemidis, S; O'Toole, S; O'Leary, JJ				Bates, Mark; Spillane, Cathy D.; Gallagher, Michael F.; McCann, Amanda; Martin, Cara; Blackshields, Gordon; Keegan, Helen; Gubbins, Luke; Brooks, Robert; Brooks, Doug; Selemidis, Stavros; O'Toole, Sharon; O'Leary, John J.			The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SECRETORY PHENOTYPE; MAD2 EXPRESSION; TUMOR-GROWTH; TLR4; SENESCENCE; CELLS; CARCINOMA; MYD88; CHEMORESISTANCE	Despite the use of front-line anticancer drugs such as paclitaxel for ovarian cancer treatment, mortality rates have remained almost unchanged for the past three decades and the majority of patients will develop recurrent chemoresistant disease which remains largely untreatable. Overcoming chemoresistance or preventing its onset in the first instance remains one of the major challenges for ovarian cancer research. In this study, we demonstrate a key link between senescence and inflammation and how this complex network involving the biomarkers MAD2, TLR4 and MyD88 drives paclitaxel resistance in ovarian cancer. This was investigated using siRNA knockdown of MAD2, TLR4 and MyD88 in two ovarian cancer cell lines, A2780 and SKOV-3 cells and overexpression of MyD88 in A2780 cells. Interestingly, siRNA knockdown of MAD2 led to a significant increase in TLR4 gene expression, this was coupled with the development of a highly paclitaxel-resistant cell phenotype. Additionally, siRNA knockdown of MAD2 or TLR4 in the serous ovarian cell model OVCAR-3 resulted in a significant increase in TLR4 or MAD2 expression respectively. Microarray analysis of SKOV-3 cells following knockdown of TLR4 or MAD2 highlighted a number of significantly altered biological processes including EMT, complement, coagulation, proliferation and survival, ECM remodelling, olfactory receptor signalling, ErbB signalling, DNA packaging, Insulin-like growth factor signalling, ion transport and alteration of components of the cytoskeleton. Cross comparison of the microarray data sets identified 7 overlapping genes including MMP13, ACTBL2, AMTN, PLXDC2, LYZL1, CCBE1 and CKS2. These results demonstrate an important link between these biomarkers, which to our knowledge has never before been shown in ovarian cancer. In the future, we hope that triaging patients into alterative treatment groups based on the expression of these three biomarkers or therapeutic targeting of the mechanisms they are involved in will lead to improvements in patient outcome and prevent the development of chemoresistance.	[Bates, Mark; Spillane, Cathy D.; Gallagher, Michael F.; Martin, Cara; Keegan, Helen; O'Toole, Sharon; O'Leary, John J.] Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland; [Bates, Mark; Spillane, Cathy D.; Gallagher, Michael F.; Martin, Cara; Blackshields, Gordon; Keegan, Helen; O'Toole, Sharon; O'Leary, John J.] Coombe Women & Infants Univ Hosp, Emer Casey Mol Pathol Res Lab, Dublin, Ireland; [Bates, Mark; Spillane, Cathy D.; Gallagher, Michael F.; Martin, Cara; Blackshields, Gordon; Keegan, Helen; O'Toole, Sharon; O'Leary, John J.] Trinity St Jamess Canc Inst, Dublin, Ireland; [Bates, Mark; O'Toole, Sharon] Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland; [McCann, Amanda; Gubbins, Luke] Univ Coll Dublin, Coll Hlth Sci, Dublin, Ireland; [Martin, Cara; Blackshields, Gordon; Keegan, Helen; O'Leary, John J.] Coombe Women & Infants Univ Hosp, Dept Pathol, Dublin, Ireland; [Brooks, Robert; Brooks, Doug] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Selemidis, Stavros] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University College Dublin; Trinity College Dublin; University of South Australia; Royal Melbourne Institute of Technology (RMIT)	Bates, M (corresponding author), Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland.; Bates, M (corresponding author), Coombe Women & Infants Univ Hosp, Emer Casey Mol Pathol Res Lab, Dublin, Ireland.; Bates, M (corresponding author), Trinity St Jamess Canc Inst, Dublin, Ireland.; Bates, M (corresponding author), Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland.	batesm1@tcd.ie		Brooks, Doug/0000-0001-9098-3626; Bates, Mark/0000-0002-5916-5403; Selemidis, Stavros/0000-0002-3989-7615; O'Leary, John/0000-0001-7311-9326; Brooks, Robert/0000-0003-1535-8999; o toole, sharon/0000-0002-9260-3225	Royal City of Dublin Hospital Trust; Emer Casey Foundation, SOCK; Irish Ladies Golf Union	Royal City of Dublin Hospital Trust; Emer Casey Foundation, SOCK; Irish Ladies Golf Union	NO - This research was supported by a research grant from the Royal City of Dublin Hospital Trust, the Emer Casey Foundation, SOCK and the Irish Ladies Golf Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; [Anonymous], 2019, AESTHET SURG J, V39, P1, DOI 10.1093/asj/sjz164; [Anonymous], 2015, BMJ, V2015, ph1887; Arnason T, 2015, CANCERS, V7, P2063, DOI 10.3390/cancers7040877; Asakura H, 2001, BLOOD COAGUL FIBRIN, V12, P1, DOI 10.1097/00001721-200101000-00001; Bareke H, 2018, SCAND J IMMUNOL, V88, DOI 10.1111/sji.12672; Barton CA, 2010, BRIT J CANCER, V102, P87, DOI 10.1038/sj.bjc.6605429; Bates M, 2020, CANCER LETT, V469, P11, DOI 10.1016/j.canlet.2019.10.005; Block MS, 2018, MAYO CLIN PROC, V93, P307, DOI 10.1016/j.mayocp.2017.10.023; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Byrne T, 2018, INT J GYNECOL CANCER, V28, P472, DOI 10.1097/IGC.0000000000001214; Byrne T, 2017, ONCOTARGET, V8, P102223, DOI 10.18632/oncotarget.18414; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140918; Cheng G, 2014, ELIFE, V3, DOI 10.7554/eLife.05401; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; d'Adhemar CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100816; D'Amico L, 2013, BRIT J CANCER, V108, P2525, DOI 10.1038/bjc.2013.271; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Davies GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084611; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dias-Melicio LA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/236839; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Farfariello V., 2014, BIOCH BIOPHYS ACTA M, P1974; Furlong F, 2012, J PATHOL, V226, P746, DOI 10.1002/path.3035; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Guo JY, 2017, ONCOGENE, V36, P2457, DOI 10.1038/onc.2016.404; Hao Bo, 2018, Oncotarget, V9, P13088, DOI 10.18632/oncotarget.24178; Hao X, 2010, J HUAZHONG U SCI-MED, V30, P620, DOI 10.1007/s11596-010-0553-y; Hishida T, 2007, FEBS LETT, V581, P4272, DOI 10.1016/j.febslet.2007.07.074; Hodebeck M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00467; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Huang JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep03840; Huhta H, 2016, ONCOTARGET, V7, P23658, DOI 10.18632/oncotarget.8151; Iversen N, 1998, BRIT J HAEMATOL, V102, P889, DOI 10.1046/j.1365-2141.1998.00875.x; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kim KH, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-193; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Kitazono AA, 2002, J BIOL CHEM, V277, P48627, DOI 10.1074/jbc.M207247200; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; KRYSTOSEK A, 1976, CELL, V9, P675, DOI 10.1016/0092-8674(76)90131-8; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Kwon MJ, 2013, INT J MOL SCI, V14, P18148, DOI 10.3390/ijms140918148; Lacruz RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035200; Li Z, 2016, TUMOR BIOL, V37, P13279, DOI 10.1007/s13277-016-5163-2; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Lorenzini A, 2001, EXP GERONTOL, V36, P65, DOI 10.1016/S0531-5565(00)00192-3; Luo XZ, 2015, INT J CLIN EXP MED, V8, P14323; Maher SG, 2011, ANN SURG, V254, P809, DOI 10.1097/SLA.0b013e31823699f2; Marcus AI, 2006, CANCER RES, V66, P8838, DOI 10.1158/0008-5472.CAN-06-0699; McGrogan B, 2014, HUM PATHOL, V45, P1509, DOI 10.1016/j.humpath.2014.03.004; Meier W, 2012, GYNECOL ONCOL, V126, P236, DOI 10.1016/j.ygyno.2012.04.050; Miake J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183225; Nakano Y, 2012, ONCOL REP, V28, P1200, DOI 10.3892/or.2012.1907; Nakayasu C, 2000, PHYSIOL BEHAV, V70, P135, DOI 10.1016/S0031-9384(00)00234-1; Park PF, 2013, KOREAN J PATHOL, V47, P418, DOI 10.4132/KoreanJPathol.2013.47.5.418; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014; Prencipe M, 2009, BRIT J CANCER, V101, P1900, DOI 10.1038/sj.bjc.6605419; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Ran S, 2015, CANCER RES, V75, P2405, DOI 10.1158/0008-5472.CAN-14-3525; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Short S, 2019, EBIOMEDICINE, V41, P683, DOI 10.1016/j.ebiom.2019.01.056; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Silasi Dan-Arin, 2006, Yale J Biol Med, V79, P153; Sukhanova A, 2013, CANCER DISCOV, V3, P96, DOI 10.1158/2159-8290.CD-12-0031; Sulaiman G, 2017, CELL DEATH DIFFER, V24, P1975, DOI 10.1038/cdd.2017.124; Sun NK, 2018, J CELL PHYSIOL, V233, P2489, DOI 10.1002/jcp.26125; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamandl D, 2003, SHOCK, V20, P224, DOI 10.1097/00024382-200309000-00005; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Vathipadiekal V, 2015, CLIN CANCER RES, V21, P4960, DOI 10.1158/1078-0432.CCR-14-3173; Wang AC, 2009, EUR J CLIN INVEST, V39, P157, DOI 10.1111/j.1365-2362.2008.02070.x; Wang AC, 2014, ONCOL LETT, V7, P871, DOI 10.3892/ol.2013.1759; Yang WS, 2018, CELL PHYSIOL BIOCHEM, V51, P1632, DOI 10.1159/000495651; Yoneda M, 2019, ONCOL LETT, V17, P913, DOI 10.3892/ol.2018.9715; Zeng LC, 2020, J INT MED RES, V48, DOI 10.1177/0300060519825983; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	93	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243715	10.1371/journal.pone.0243715	http://dx.doi.org/10.1371/journal.pone.0243715			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370338	gold, Green Published			2022-12-26	WOS:000603611900107
J	Kushitor, SB; Owusu, L; Kushitor, MK				Kushitor, Sandra Boatemaa; Owusu, Lily; Kushitor, Mawuli Kobla			The prevalence and correlates of the double burden of malnutrition among women in Ghana	PLOS ONE			English	Article							IRON-DEFICIENCY; OBESITY; ANEMIA; PREGNANCY; FOOD	Anaemia and underweight or overweight/obesity are major public health problems driving maternal and child mortality in low- and middle-income countries. While the burden of these conditions is recognised, the evidence for the co-occurrence of these conditions is fragmented and mixed, especially at the individual level. Further, many studies have focused on families and communities. The different pathways for the occurrence of anaemia and BMI challenges indicate that an individual can potentially live with both conditions and suffer the complications. This study examined the prevalence and factors associated with the co-occurrence of anaemia and BMI challenges among a cohort of women in Ghana. Data from the 2014 Ghana Demographic and Health Survey were used. The sample size was 4 337 women aged 15-49 years who were not pregnant during the survey. Women who suffered simultaneously from underweight or overweight/obesity and anaemia were considered as having the double burden of malnutrition. The data were analysed using descriptive statistics, Chi-square test and logistic regression in STATA. One-fifth of the participants were overweight (21%), 4% were underweight and about one-tenth were obese (12%). The prevalence of anaemia was 41%. Only one in three women had normal weight and was not anaemic (34%). About 14% of the women experienced the double burden of malnutrition. Being overweight and anaemic (57%) was the most common form of this double burden. Age, marital status, parity, and wealth were t key risk factors associated with the double burden of malnutrition. The findings from this study show that women experience multiple nutritional challenges concurrently and that only a few women had healthy nutritional status. This information is particularly important and can be introduced into health education programmes to help address misconceptions about body weight and health.	[Kushitor, Sandra Boatemaa] Stellenbosch Univ, Food Secur Initiat, Stellenbosch, South Africa; [Kushitor, Sandra Boatemaa] Stellenbosch Univ, Ctr Complex Syst Transit, Stellenbosch, South Africa; [Owusu, Lily] Univ Ghana, Reg Inst Populat Studies, Accra, Ghana; [Kushitor, Mawuli Kobla] Univ Hlth & Allied Sci, Dept Hlth Policy Planning & Management, Hohoe, Ghana	Stellenbosch University; Stellenbosch University; University of Ghana	Kushitor, SB (corresponding author), Stellenbosch Univ, Food Secur Initiat, Stellenbosch, South Africa.; Kushitor, SB (corresponding author), Stellenbosch Univ, Ctr Complex Syst Transit, Stellenbosch, South Africa.	boatemaa@sun.ac.za	Kushitor, Sandra Boatemaa/CAG-8145-2022	Kushitor, Sandra Boatemaa/0000-0002-0638-6261	Dean's Division, Faculty of AgriSciences, Stellenbosch University, Stellenbosch, South Africa	Dean's Division, Faculty of AgriSciences, Stellenbosch University, Stellenbosch, South Africa	Sandra Boatemaa Kushitor was supported by the Dean's Division, Faculty of AgriSciences, Stellenbosch University, Stellenbosch, South Africa.	Agyemang C, 2015, METABOLIC SYNDROME C, P41, DOI 10.1007/978-3-319-12125-3; Aigner E, 2014, NUTRIENTS, V6, P3587, DOI 10.3390/nu6093587; Aikins AD, 2014, HEALTH CARE WOMEN IN, V35, P954, DOI 10.1080/07399332.2014.926902; Amugsi DA, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0053-1; Amugsi DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136748; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; Appiah C. A., 2016, PANAFRICAN MED J, V23, P1; Arshad M, 2017, ROM J INTERN MED, V55, P3, DOI 10.1515/rjim-2016-0046; Ayensu J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226026; Biritwum Rb, 2005, Ghana Med J, V39, P82; Cepeda-Lopez AC, 2011, AM J CLIN NUTR, V93, P975, DOI 10.3945/ajcn.110.005439; de-Graft Aikins A., 2011, FATNESS MATERNAL BOD; Ezzati M, 2015, COMP QUANTIFICATION; Mujica-Coopman MF, 2015, J TRACE ELEM MED BIO, V30, P215, DOI 10.1016/j.jtemb.2014.03.008; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; Ghana Statistical Service, 2013, 2010 POP HOUS CENS N; Global Nutrition Report, 2020, 2020 GLOB NUTR REP A; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; IFPRI, 2019, GLOB NUTR REP 2018; Kandala NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101103; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Kodaman N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162753; Lartey ST, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215045; Little M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08679-5; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; Minicuci N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.21292; Mocking M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5704-2; Mugisha JO, 2014, J AGING HEALTH, V26, P316, DOI 10.1177/0898264313516165; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Obai G, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0865-4; Olutayo AO, 2009, AFRICA, V79, P207, DOI 10.3366/E0001972009000692; Onyango AW, 2019, ANN NUTR METAB, V75, P127, DOI 10.1159/000503671; onzalez-Socoloske D., 2012, OPEN REMOTE SENS J, V5, P1, DOI DOI 10.2174/1875413901205010001; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Otoo GE, 2009, J HUM LACT, V25, P34, DOI 10.1177/0890334408325072; Pereko KKA, 2013, PUBLIC HEALTH NUTR, V16, P591, DOI 10.1017/S1368980012002698; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Wegmuller R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228258	39	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244362	10.1371/journal.pone.0244362	http://dx.doi.org/10.1371/journal.pone.0244362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370352	Green Published, gold			2022-12-26	WOS:000603611900029
J	Dong, RY; Liu, CJ; Tian, SY; Bai, JB; Yu, KL; Liu, L; Tian, DH				Dong, Ruiyi; Liu, Chunjie; Tian, Siyu; Bai, Jiangbo; Yu, Kunlun; Liu, Lei; Tian, Dehu			Electrospun polycaprolactone (PCL)-amnion nanofibrous membrane prevents adhesions and promotes nerve repair in a rat model of sciatic nerve compression	PLOS ONE			English	Article							AMNIOTIC MEMBRANE; GROWTH-FACTOR; INJURY; CELLS; REGENERATION; DELIVERY	Adhesion and scarring after neural surgery are detrimental to nerve regeneration and functional recovery. Amniotic membranes have been used in tissue repair due to their immunogenicity and richness in cytokines. In this study, an electrospun polycaprolactone (PCL)-amnion nanofibrous membrane was prepared for the treatment of sciatic nerve compression in a rat model. The effects of the PCL-amnion nanofibrous membrane on the prevention of adhesion formation and nerve regeneration were evaluated using electrophysiology and histological analyses. Compared with the medical chitosan hydrogel dressing, the PCL-amnion nanofibrous membrane significantly reduced peripheral nerve adhesion and promoted the rapid recovery of nerve conduction. Moreover, the immunohistochemical analysis identified more Schwann cells and less pro-inflammatory M1 macrophages in the PCL-amnion group. Western blot and RT-PCR results showed that the expression levels of type-? and ? collagen in the PCL-treated rats were half of those in the control group after 12 weeks, while the expression level of nerve growth factor was approximately 3.5 times that found in the rats treated with medical chitosan hydrogel. In summary, electrospun PCL-amnion nanofibrous membranes can effectively reduce adhesion after neural surgery and promote nerve repair and regeneration. The long-term retention in vivo and sustained release of cytokines make PCL-amnion a promising biomaterial for clinical application.	[Dong, Ruiyi; Tian, Dehu] Cangzhou Integrated Tradit Chinese & Western Med, Dept Orthoped, Cangzhou, Hebei, Peoples R China; [Liu, Chunjie] Tangshan Workers Hosp, Dept Orthoped, Tangshan, Hebei, Peoples R China; [Tian, Siyu; Bai, Jiangbo; Yu, Kunlun; Tian, Dehu] Hebei Med Univ, Affiliated Hosp 3, Dept Hand Surg, Shijiazhuang, Hebei, Peoples R China; [Liu, Lei] Changping Dist Hosp, Dept Orthoped, Beijing, Peoples R China	Hebei Medical University	Tian, DH (corresponding author), Hebei Med Univ, Affiliated Hosp 3, Dept Hand Surg, Shijiazhuang, Hebei, Peoples R China.	tiandehu899@outlook.com		tian, de hu/0000-0002-6065-0828				Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Braga-Silva J, 1999, J HAND SURG-BRIT EUR, V24B, P703, DOI 10.1054/jhsb.1999.0276; Braun DA, 2016, KIDNEY INT, V89, P468, DOI 10.1038/ki.2015.317; Brugmans MMCP, 2015, J TISSUE ENG REGEN M, V9, pE289, DOI 10.1002/term.1753; Brull R, 2015, REGION ANESTH PAIN M, V40, P479, DOI 10.1097/AAP.0000000000000125; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Carr MJ, 2017, CURR OPIN NEUROBIOL, V47, P52, DOI 10.1016/j.conb.2017.09.003; Chang DS, 2016, J PAIN RES, V9, P373, DOI 10.2147/JPR.S89061; Choi J, 2020, J PLAST RECONSTR AES, V73, P214, DOI 10.1016/j.bjps.2019.09.031; Dam-Hieu Phong, 2005, Neurosurgery, V56, P425, DOI 10.1227/01.NEU.0000156845.41626.E9; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; Dy CJ, 2018, J HAND SURG-AM, V43, P360, DOI 10.1016/j.jhsa.2018.01.013; Gaspar MP, 2016, J SHOULDER ELB SURG, V25, P2057, DOI 10.1016/j.jse.2016.09.013; Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015; Gobinathan S, 2018, J BIOMAT SCI-POLYM E, V29, P2051, DOI 10.1080/09205063.2018.1485814; Gonzalez-Andrades M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142099; Irifune H, 2018, J HAND SURG-ASIAN-PA, V23, P116, DOI 10.1142/S2424835518720025; Jirsova K, 2017, CELL TISSUE BANK, V18, P193, DOI 10.1007/s10561-017-9618-5; Kemp SWP, 2011, EXP NEUROL, V229, P460, DOI 10.1016/j.expneurol.2011.03.017; Kesting MR, 2008, J BURN CARE RES, V29, P907, DOI 10.1097/BCR.0b013e31818b9e40; Kim PD, 2010, MICROSURG, V30, P392, DOI 10.1002/micr.20760; Koob TJ, 2015, J BIOMED MATER RES B, V103, P1133, DOI 10.1002/jbm.b.33265; Kshersagar J, 2018, CELL TISSUE BANK, V19, P423, DOI 10.1007/s10561-018-9688-z; Lemke A, 2018, ACTA BIOMATER, V66, P335, DOI 10.1016/j.actbio.2017.11.042; Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057; Liu CJ, 2020, INT J NANOMED, V15, P927, DOI 10.2147/IJN.S231538; Lorenz J, 2016, J ORAL IMPLANTOL, V42, P273, DOI 10.1563/aaid-joi-D-15-00133; MACKINNON SE, 1984, ANN PLAS SURG, V13, P112, DOI 10.1097/00000637-198408000-00004; Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6; Mardanpour Keykhosro, 2019, Asian J Neurosurg, V14, P693, DOI 10.4103/ajns.AJNS_31_17; Nishimura T, 2008, HISTOL HISTOPATHOL, V23, P157, DOI 10.14670/HH-23.157; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Parolini O, 2014, ARTHRITIS RHEUMATOL, V66, P327, DOI 10.1002/art.38206; Petersen J, 1996, NEUROSURGERY, V38, P976, DOI 10.1097/00006123-199605000-00025; Rasulic L, 2018, ACTA NEUROCHIR, V160, P1587, DOI 10.1007/s00701-018-3569-x; Riccio M, 2019, J CELL PHYSIOL, V234, P3362, DOI 10.1002/jcp.27299; ROBSON MC, 1973, ANN SURG, V177, P144, DOI 10.1097/00000658-197302000-00003; Sanli E, 2021, J INVEST SURG, V34, P454, DOI 10.1080/08941939.2019.1644403; Sarker MD, 2018, PROG NEUROBIOL, V171, P125, DOI 10.1016/j.pneurobio.2018.07.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shintani K, 2018, J NEUROSURG, V129, P815, DOI 10.3171/2017.4.JNS162522; Urano H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164572; Usami S, 2019, MICROSURG, V39, P647, DOI 10.1002/micr.30496; Vijayavenkataraman S, 2020, ACTA BIOMATER, V106, P54, DOI 10.1016/j.actbio.2020.02.003; von Bergen TN, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118807131; Wang ML, 2019, CONNECT TISSUE RES, V60, P3, DOI 10.1080/03008207.2018.1489381; Wu QQ, 2017, INT J MOL MED, V39, P918, DOI 10.3892/ijmm.2017.2897; Yu HL, 2014, NEUROSCI LETT, V566, P177, DOI 10.1016/j.neulet.2014.02.065; Zatroch KK, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0982-y; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zuo EJ, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181122	51	5	5	8	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244301	10.1371/journal.pone.0244301	http://dx.doi.org/10.1371/journal.pone.0244301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338083	gold, Green Published			2022-12-26	WOS:000601313500044
J	Reilly, J; Gallagher, L; Leader, G; Shen, SB				Reilly, Jamie; Gallagher, Louise; Leader, Geraldine; Shen, Sanbing			Coupling of autism genes to tissue-wide expression and dysfunction of synapse, calcium signalling and transcriptional regulation	PLOS ONE			English	Article							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; CONGENITAL HEART-DISEASE; SPECTRUM DISORDER; INTELLECTUAL DISABILITY; SLEEP PROBLEMS; CHILDREN; CACNA1D; RISK; DYSREGULATION	Autism Spectrum Disorder (ASD) is a heterogeneous disorder that is often accompanied with many co-morbidities. Recent genetic studies have identified various pathways from hundreds of candidate risk genes with varying levels of association to ASD. However, it is unknown which pathways are specific to the core symptoms or which are shared by the co-morbidities. We hypothesised that critical ASD candidates should appear widely across different scoring systems, and that comorbidity pathways should be constituted by genes expressed in the relevant tissues. We analysed the Simons Foundation for Autism Research Initiative (SFARI) database and four independently published scoring systems and identified 292 overlapping genes. We examined their mRNA expression using the Genotype-Tissue Expression (GTEx) database and validated protein expression levels using the human protein atlas (HPA) dataset. This led to clustering of the overlapping ASD genes into 2 groups; one with 91 genes primarily expressed in the central nervous system (CNS geneset) and another with 201 genes expressed in both CNS and peripheral tissues (CNS+PT geneset). Bioinformatic analyses showed a high enrichment of CNS development and synaptic transmission in the CNS geneset, and an enrichment of synapse, chromatin remodelling, gene regulation and endocrine signalling in the CNS+PT geneset. Calcium signalling and the glutamatergic synapse were found to be highly interconnected among pathways in the combined geneset. Our analyses demonstrate that 2/3 of ASD genes are expressed beyond the brain, which may impact peripheral function and involve in ASD co-morbidities, and relevant pathways may be explored for the treatment of ASD co-morbidities.	[Reilly, Jamie; Shen, Sanbing] Natl Univ Ireland NUI Galway, Sch Med, Regenerat Med Inst, Biomed Sci Bldg, Galway, Ireland; [Gallagher, Louise] Trinity Coll Dublin, Sch Med, Discipline Psychiat, Dublin, Ireland; [Gallagher, Louise] Trinity Coll Dublin, St Jamess Hosp, Trinity Ctr Hlth Sci, Trinity Translat Med Inst, Dublin, Ireland; [Leader, Geraldine] Natl Univ Ireland NUI Galway, Dept Psychol, Irish Ctr Autism & Neurodev Res ICAN, Galway, Ireland; [Shen, Sanbing] Royal Coll Surg Ireland RCSI, FutureNeuro Res Ctr, Dublin, Ireland	Ollscoil na Gaillimhe-University of Galway; Trinity College Dublin; Trinity College Dublin; Ollscoil na Gaillimhe-University of Galway; Royal College of Surgeons - Ireland	Reilly, J; Shen, SB (corresponding author), Natl Univ Ireland NUI Galway, Sch Med, Regenerat Med Inst, Biomed Sci Bldg, Galway, Ireland.; Shen, SB (corresponding author), Royal Coll Surg Ireland RCSI, FutureNeuro Res Ctr, Dublin, Ireland.	J.Reilly12@nuigalway.ie; Sanbing.shen@nuigalway.ie		Leader, Geraldine/0000-0001-8719-0617; Shen, Sanbing/0000-0002-8217-9811; Reilly, Jamie/0000-0002-7474-127X; Gallagher, Louise/0000-0001-9462-2836	Science Foundation Ireland [13/IA/1787, 16/RC/3948]; National University of Ireland Galway [RSU002]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National University of Ireland Galway	Funding was provided by Science Foundation Ireland (Grant 13/IA/1787 to S.S. and L.G., 16/RC/3948 to FutureNeuro), and National University of Ireland Galway (Grant RSU002 to S. S.) for funding the research.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Al-jawahiri R, 2017, PEERJ, V5, DOI 10.7717/peerj.2880; Aldridge K, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-15; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Tran AN, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3059-z; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; [Anonymous], 2012, INSIGHT WORLD J INFR, V3, P18; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Avazzadeh S, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-019-0303-3; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Breen MS, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-020-00355-0; Breitenkamp AFS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095579; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Cervantes PE, 2015, J AUTISM DEV DISORD, V45, P3961, DOI 10.1007/s10803-015-2553-z; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-23; Cohen S, 2015, J CLIN CHILD ADOLESC, V44, P250, DOI 10.1080/15374416.2013.843462; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Daraio T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08082-y; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DeRosa BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26495-1; Djeddi DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083464; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Duda M, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0098-6; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ellenbroek B., 2017, HEAR MIND, V1, P78, DOI [10.4103/hm.hm_5_17, DOI 10.4103/HM.HM_5_17]; Flanagan SE, 2017, PEDIATR DIABETES, V18, P320, DOI 10.1111/pedi.12512; Frohlich H, 2019, P NATL ACAD SCI USA, V116, P22237, DOI 10.1073/pnas.1911429116; Fujiwara T, 2011, J NEUROENDOCRINOL, V23, P1222, DOI 10.1111/j.1365-2826.2011.02214.x; Gao R, 2015, CURR MOL MED, V15, P146, DOI 10.2174/1566524015666150303003028; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Garza-Lopez E, 2018, J BIOL CHEM, V293, P14444, DOI 10.1074/jbc.RA118.003681; Ginsberg MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044736; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Griesi-Oliveira K, 2021, MOL PSYCHIATR, V26, P1589, DOI 10.1038/s41380-020-0669-9; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Gupta S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6748; Gutierrez-Sacristan A, 2015, BIOINFORMATICS, V31, P3075, DOI 10.1093/bioinformatics/btv301; Herrero MJ, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-020-00346-1; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; James DM, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-018-0250-4; Jaworski JLB, 2017, CONGENIT HEART DIS, V12, P421, DOI 10.1111/chd.12461; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Kohler S, 2019, NUCLEIC ACIDS RES, V47, pD1018, DOI 10.1093/nar/gky1105; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Kose S, 2017, SLEEP MED, V40, P69, DOI 10.1016/j.sleep.2017.09.021; Krishnan A, 2016, NAT NEUROSCI, V19, P1454, DOI 10.1038/nn.4353; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Krumm N, 2013, AM J HUM GENET, V93, P595, DOI 10.1016/j.ajhg.2013.07.024; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lim ET, 2017, NAT NEUROSCI, V20, P1217, DOI 10.1038/nn.4598; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Lutz AK, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz3267; Mannion A, 2014, REV J AUTISM DEV DIS, V1, P101, DOI 10.1007/s40489-013-0009-y; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Masi A, 2017, NEUROSCI BULL, V33, P183, DOI 10.1007/s12264-017-0100-y; Milovanovic B, 2015, WORLD J GASTROENTERO, V21, P6982, DOI 10.3748/wjg.v21.i22.6982; Moshkovskii SA, 2020, BIOCHEMISTRY-MOSCOW+, V85, P140, DOI 10.1134/S0006297920020029; Myers CT, 2016, AM J HUM GENET, V99, P287, DOI 10.1016/j.ajhg.2016.06.003; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nguyen RL, 2018, BBA-MOL CELL RES, V1865, P1718, DOI 10.1016/j.bbamcr.2018.08.003; Niesler B, 2021, MOL PSYCHIATR, V26, P1442, DOI 10.1038/s41380-020-0778-5; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Panju S, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0057-5; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pinggera A, 2017, HUM MOL GENET, V26, P2923, DOI 10.1093/hmg/ddx175; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pramparo T, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156108; Quesnel-Vallieres M, 2019, NAT REV GENET, V20, P51, DOI 10.1038/s41576-018-0066-2; Rao M, 2016, NAT REV GASTRO HEPAT, V13, DOI 10.1038/nrgastro.2016.107; Regev A, 2019, HUMAN CELL ATLAS WHI, DOI [10.17863/cam.40032, DOI 10.17863/CAM.40032]; Rojas DC, 2014, J NEURAL TRANSM, V121, P891, DOI 10.1007/s00702-014-1216-0; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sauer AK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092134; Schmunk G, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.123; Schmunk G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40740; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shedlock K, 2016, J PEDIATR-US, V178, P183, DOI 10.1016/j.jpeds.2016.07.055; Sheinkopf SJ, 2019, BIOL PSYCHOL, V142, P13, DOI 10.1016/j.biopsycho.2019.01.003; Shi L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21181; Shteyer E, 2015, GASTROENTEROLOGY, V148, P533, DOI 10.1053/j.gastro.2014.11.044; Sirmaci A, 2011, AM J HUM GENET, V89, P289, DOI 10.1016/j.ajhg.2011.06.007; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Soldatov NM, 2015, CURR MOL PHARMACOL, V8, P32, DOI 10.2174/1874467208666150507093258; Spaeth JM, 2015, DIABETOLOGIA, V58, P1836, DOI 10.1007/s00125-015-3635-3; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Stessman HAF, 2016, AM J HUM GENET, V98, P541, DOI 10.1016/j.ajhg.2016.02.004; Tan DW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09939-y; Taylor DM, 2019, DEV CELL, V49, P10, DOI 10.1016/j.devcel.2019.03.001; Thapa R, 2019, AUTISM RES, V12, P922, DOI 10.1002/aur.2104; Tong XJ, 2017, NEURON, V95, P326, DOI 10.1016/j.neuron.2017.06.018; Trabzuni D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3771; Tripi G, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050641; Uzunova G, 2014, CURR NEUROPHARMACOL, V12, P71, DOI 10.2174/1570159X113116660046; van Bon BWM, 2016, MOL PSYCHIATR, V21, P126, DOI 10.1038/mp.2015.5; Velmeshev D, 2019, SCIENCE, V364, P685, DOI 10.1126/science.aav8130; Vergult S, 2015, EUR J HUM GENET, V23, P628, DOI 10.1038/ejhg.2014.141; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Walker SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35820; Walker SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058058; Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Wasilewska J, 2015, PEDIATR HEALTH MED T, V6, P153, DOI 10.2147/PHMT.S85717; Wen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153329; Werling DM, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0112-8; Werling DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10717; Werling DM, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0004-5; Wickham H., 2016, GGPLOT2; Xing JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27491; Xu XX, 2014, J NEUROSCI, V34, P1420, DOI 10.1523/JNEUROSCI.4488-13.2014; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zhang AH, 2007, BIOCHEM BIOPH RES CO, V358, P1034, DOI 10.1016/j.bbrc.2007.05.017; Zhang CL, 2017, HUM MUTAT, V38, P204, DOI 10.1002/humu.23147	136	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0242773	10.1371/journal.pone.0242773	http://dx.doi.org/10.1371/journal.pone.0242773			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338084	gold, Green Published			2022-12-26	WOS:000601313500031
J	Bermudez-Guzman, L; Jimenez-Huezo, G; Arguedas, A; Leal, A				Bermudez-Guzman, Luis; Jimenez-Huezo, Gabriel; Arguedas, Andres; Leal, Alejandro			Mutational survivorship bias: The case of PNKP	PLOS ONE			English	Article							POLYNUCLEOTIDE KINASE-PHOSPHATASE; PROTEIN-STRUCTURE; SINGLE-STRAND; DEVELOPMENTAL DELAY; REPAIR; SEQUENCE; DISEASE; PREDICTION; SEIZURES; GENE	The molecular function of a protein relies on its structure. Understanding how variants alter structure and function in multidomain proteins is key to elucidate the generation of a pathological phenotype. However, one may fall into the logical bias of assessing protein damage only based on the variants that are visible (survivorship bias), which can lead to partial conclusions. This is the case of PNKP, an important nuclear and mitochondrial DNA repair enzyme with both kinase and phosphatase function. Most variants in PNKP are confined to the kinase domain, leading to a pathological spectrum of three apparently distinct clinical entities. Since proteins and domains may have a different tolerability to variation, we evaluated whether variants in PNKP are under survivorship bias. Here, we provide the evidence that supports a higher tolerance in the kinase domain even when all variants reported are deleterious. Instead, the phosphatase domain is less tolerant due to its lower variant rates, a higher degree of sequence conservation, lower dN/dS ratios, and the presence of more disease-propensity hotspots. Together, our results support previous experimental evidence that demonstrated that the phosphatase domain is functionally more necessary and relevant for DNA repair, especially in the context of the development of the central nervous system. Finally, we propose the term "Wald's domain" for future studies analyzing the possible survivorship bias in multidomain proteins.	[Bermudez-Guzman, Luis; Jimenez-Huezo, Gabriel; Leal, Alejandro] Univ Costa Rica, Sch Biol, Sect Genet & Biotechnol, San Jose, Costa Rica; [Arguedas, Andres] Univ Costa Rica, Sch Stat, San Jose, Costa Rica	Universidad Costa Rica; Universidad Costa Rica	Leal, A (corresponding author), Univ Costa Rica, Sch Biol, Sect Genet & Biotechnol, San Jose, Costa Rica.	alejandro.leal@ucr.ac.cr		Leal, Alejandro/0000-0002-5384-8166; Bermudez-Guzman, Luis/0000-0002-0749-4010	University of Costa Rica [111-B8-372]	University of Costa Rica	Our project was founded by the University of Costa Rica, Vice-rectory of Research (Project 111-B8-372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alejandro Leal and Andres Arguedas received a salary from University of Costa Rica.	Aceytuno RD, 2017, NUCLEIC ACIDS RES, V45, P6238, DOI 10.1093/nar/gkx275; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andressoo JO, 2006, PLOS BIOL, V4, P1821, DOI 10.1371/journal.pbio.0040322; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bermudez-Guzman L, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0156-x; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Bras J, 2015, AM J HUM GENET, V96, P474, DOI 10.1016/j.ajhg.2015.01.005; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Campopiano R, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01331; Chalasani SL, 2018, DNA REPAIR, V68, P12, DOI 10.1016/j.dnarep.2018.05.002; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; David A, 2015, J MOL BIOL, V427, P2886, DOI 10.1016/j.jmb.2015.07.004; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; Della-Maria J, 2012, J BIOL CHEM, V287, P39233, DOI 10.1074/jbc.M112.369975; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dobson CJ, 2006, NUCLEIC ACIDS RES, V34, P2230, DOI 10.1093/nar/gkl275; Gao M, 2015, STRUCTURE, V23, P1362, DOI 10.1016/j.str.2015.03.028; Garces F, 2011, MOL CELL, V44, P385, DOI 10.1016/j.molcel.2011.08.036; Gatti M, 2019, AM J MED GENET A, V179, P2277, DOI 10.1002/ajmg.a.61339; Gussow AB, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0869-4; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huber CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05281-7; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Kalasova I, 2020, NUCLEIC ACIDS RES, V48, P6672, DOI 10.1093/nar/gkaa489; Kalasova I, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000320; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Leal A, 2018, NEUROGENETICS, V19, P215, DOI 10.1007/s10048-018-0555-7; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Liu JF, 2004, PROTEINS, V55, P678, DOI 10.1002/prot.20095; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; MANGEL M, 1984, J AM STAT ASSOC, V79, P259, DOI 10.2307/2288257; Nakashima M, 2014, J HUM GENET, V59, P471, DOI 10.1038/jhg.2014.51; Op 't Eyndee J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228802; Pais FSM, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-4; Pedroso JL, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000030; Petukh M, 2015, HUM MUTAT, V36, P524, DOI 10.1002/humu.22770; Reynolds JJ, 2013, BRAIN, V136, P14, DOI 10.1093/brain/aws310; Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Shimada M, 2019, J RADIAT RES, V60, P719, DOI 10.1093/jrr/rrz057; Shimada M, 2015, EMBO J, V34, P2465, DOI 10.15252/embj.201591363; Stoltzfus A, 2016, MOL BIOL EVOL, V33, P595, DOI 10.1093/molbev/msv274; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Veitia RA, 2018, CLIN GENET, V93, P419, DOI 10.1111/cge.13107; Veitia RA, 2010, J PATHOL, V220, P174, DOI 10.1002/path.2623; Ward JF, 1998, CONT CANC RES, P65; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Wiel L, 2019, HUM MUTAT, V40, P1030, DOI 10.1002/humu.23798; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yates CM, 2014, J MOL BIOL, V426, P2692, DOI 10.1016/j.jmb.2014.04.026; Yates CM, 2013, J MOL BIOL, V425, P1274, DOI 10.1016/j.jmb.2013.01.026; Zhang CX, 2017, NUCLEIC ACIDS RES, V45, pW291, DOI 10.1093/nar/gkx366; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	64	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237682	10.1371/journal.pone.0237682	http://dx.doi.org/10.1371/journal.pone.0237682			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332469	Green Published, Green Submitted, gold			2022-12-26	WOS:000601310900102
J	Fan, XM; Gao, YY; Zhang, XL; Lughmani, HY; Kennedy, DJ; Haller, ST; Pierre, SV; Shapiro, JI; Tian, J				Fan, Xiaoming; Gao, Yingnyu; Zhang, Xiaolu; Lughmani, Haroon Y.; Kennedy, David J.; Haller, Steven T.; Pierre, Sandrine V.; Shapiro, Joseph I.; Tian, Jiang			A strategic expression method of miR-29b and its anti-fibrotic effect based on RNA-sequencing analysis	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; GENE-THERAPY; MYOCARDIAL FIBROSIS; TGF-BETA; COLLAGEN; MYOFIBROBLASTS; FIBROBLASTS	Tissue fibrosis is a significant health issue associated with organ dysfunction and failure. Increased deposition of collagen and other extracellular matrix (ECM) proteins in the interstitial area is a major process in tissue fibrosis. The microRNA-29 (miR-29) family has been demonstrated as anti-fibrotic microRNAs. Our recent work showed that dysregulation of miR-29 contributes to the formation of cardiac fibrosis in animal models of uremic cardiomyopathy, whereas replenishing miR-29 attenuated cardiac fibrosis in these animals. However, excessive overexpression of miR-29 is a concern because microRNAs usually have multiple targets, which could result in unknown and unexpected side effect. In the current study, we constructed a novel Col1a1-miR-29b vector using collagen 1a1 (Col1a1) promoter, which can strategically express miR-29b-3p (miR-29b) in response to increased collagen synthesis and reach a dynamic balance between collagen and miR-29b. Our experimental results showed that in mouse embryonic fibroblasts (MEF cells) transfected with Col1a1-miR-29b vector, the miR-29b expression is about 1000 times less than that in cells transfected with CMV-miR-29b vector, which uses cytomegalovirus (CMV) as a promoter for miR-29b expression. Moreover, TGF-beta treatment increased the miR-29b expression by about 20 times in cells transfected with Col1a1-miR-29b, suggesting a dynamic response to fibrotic stimulation. Western blot using cell lysates and culture media demonstrated that transfection of Col1a1-miR-29b vector significantly reduced TGF-beta induced collagen synthesis and secretion, and the effect was as effective as the CMV-miR-29b vector. Using RNA-sequencing analysis, we found that 249 genes were significantly altered (180 upregulated and 69 downregulated, at least 2-fold change and adjusted p-value <0.05) after TGF-beta treatment in MEF cells transfected with empty vector. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis using GAGE R-package showed that the top 5 upregulated pathways after TGF-beta treatment were mostly fibrosis-related, including focal adhesion, ECM reaction, and TGF-beta signaling pathways. As expected, transfection of Col1a1-miR-29b or CMV-miR-29b vector partially reversed the activation of these pathways. We also analyzed the expression pattern of the top 100 miR-29b targeting genes in these cells using the RNA-sequencing data. We identified that miR-29b targeted a broad spectrum of ECM genes, but the inhibition effect is mostly moderate. In summary, our work demonstrated that the Col1a1-miR-29b vector can be used as a dynamic regulator of collagen and other ECM protein expression in response to fibrotic stimulation, which could potentially reduce unnecessary side effect due to excessive miR-29b levels while remaining an effective potential therapeutic approach for fibrosis.	[Fan, Xiaoming; Zhang, Xiaolu; Lughmani, Haroon Y.; Kennedy, David J.; Haller, Steven T.] Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gao, Yingnyu; Pierre, Sandrine V.] Marshall Univ, Marshall Inst Interdisciplinary Res, Huntington, WV USA; [Shapiro, Joseph I.; Tian, Jiang] Marshall Univ, Dept Biomed Sci, Joan C Edwards Sch Med, Huntington, WV 25755 USA	University System of Ohio; University of Toledo; Marshall University; Marshall University	Tian, J (corresponding author), Marshall Univ, Dept Biomed Sci, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	tianj@marshall.edu	Gao, Yingnyu/W-4311-2019; Fan, Xiaoming/AAU-7713-2021	Lughmani, Haroon/0000-0001-6483-0247; Tian, Jiang/0000-0002-0812-8135	National Institutes of Health [HL-105649, HL-137004, HL145666]; Marshall University; University of Toledo Biomedical Research Innovation Program; National Affiliate of the American Heart Association [12SDG12050473]; David and Helen Boone Foundation Research Fund; Central Society for Clinical and Translational Research; WV-INBRE grant from NIH [P20GM103434]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshall University; University of Toledo Biomedical Research Innovation Program; National Affiliate of the American Heart Association; David and Helen Boone Foundation Research Fund; Central Society for Clinical and Translational Research; WV-INBRE grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (HL-105649 to JT and JIS, HL-137004 to DJK, and HL145666 to SP). Additional support was from the Marshall University Startup Funding to JT, University of Toledo Biomedical Research Innovation Program to JT, the National Affiliate of the American Heart Association (12SDG12050473 to DJK), the David and Helen Boone Foundation Research Fund (DJK), an Early Career Development Award from the Central Society for Clinical and Translational Research (DJK). This work was also supported by the WV-INBRE grant from NIH (P20GM103434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259; [Anonymous], 2000, DATABASE MED PLANT U, V2, P112; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Athanasopoulos T, 2017, HEMATOL ONCOL CLIN N, V31, P753, DOI 10.1016/j.hoc.2017.06.007; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Calderone A, 2006, J CELL PHYSIOL, V207, P165, DOI 10.1002/jcp.20548; Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d; Derangeon M, 2017, CARDIOVASC RES, V113, P464, DOI 10.1093/cvr/cvx026; Drummond CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197688; Drummond CA, 2016, PHYSIOL GENOMICS, V48, P220, DOI 10.1152/physiolgenomics.00116.2015; Finocchiaro G, 2016, J AM COLL CARDIOL, V67, P2108, DOI 10.1016/j.jacc.2016.02.062; Gonzalez A, 2018, J AM COLL CARDIOL, V71, P1696, DOI 10.1016/j.jacc.2018.02.021; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Hookana E, 2011, HEART RHYTHM, V8, P1570, DOI 10.1016/j.hrthm.2011.06.031; Ikawa Y, 2019, HUM MOL GENET, V28, pR24, DOI 10.1093/hmg/ddz172; JALIL JE, 1989, CIRC RES, V64, P1041, DOI 10.1161/01.RES.64.6.1041; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Liu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34592; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mitra MS, 2020, TOXICOL SCI, V175, P24, DOI 10.1093/toxsci/kfaa024; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Morine KJ, 2018, CIRCULATION, V138, P513, DOI 10.1161/CIRCULATIONAHA.117.031635; Ramdas V, 2013, AM J PATHOL, V183, P1885, DOI 10.1016/j.ajpath.2013.08.027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201910865; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Valiente-Alandi I, 2018, CIRCULATION, V138, P1236, DOI 10.1161/CIRCULATIONAHA.118.034609; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006	43	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244065	10.1371/journal.pone.0244065	http://dx.doi.org/10.1371/journal.pone.0244065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332475	gold, Green Published			2022-12-26	WOS:000601310900053
J	Herzog, AL; Busch, J; Wanner, C; von Jouanne-Diedrich, HK				Herzog, Anna Laura; Busch, Jonas; Wanner, Christoph; von Jouanne-Diedrich, Holger K.			Survey about do-it-yourself closed loop systems in the treatment of diabetes in Germany	PLOS ONE			English	Article							ARTIFICIAL PANCREAS SYSTEMS; INSULIN PUMP THERAPY; COMPLICATIONS-TRIAL/EPIDEMIOLOGY; GLYCEMIC CONTROL; INTERVENTIONS; MELLITUS	Continuous glucose monitoring (CGM) improves treatment with lower blood glucose levels and less patient effort. In combination with continuous insulin application, glycemic control improves and hypoglycemic episodes should decrease. Direct feedback of CGM to continuous subcutaneous insulin application, using an algorithm is called a closed-loop (CL) artificial pancreas system. Commercial devices stop insulin application by predicting hypoglycemic blood glucose levels through direct interaction between the sensor and pump. The prediction is usually made for about 30 minutes and insulin delivery is restarted at the previous level if a rise in blood glucose is predicted within the next 30 minutes (hybrid closed loop system, HCL this is known as a predictive low glucose suspend system (PLGS)). In a fully CL system, sensor and pump communicate permanently with each other. Hybrid closed-loop (HCL) systems, which require the user to estimate the meal size and provide a meal insulin basis, are commercially available in Germany at the moment. These systems result in fewer hyperglycemic and hypoglycemic episodes with improved glucose control. Open source initiatives have provided support by building do-it-yourself CL (DIYCL) devices for automated insulin application since 2014, and are used by a tech-savvy subgroup of patients. The first commercial hybrid CL system has been available in Germany since September 2019. We surveyed 1054 patients to determine which devices are currently used, which features would be in demand by potential users, and the benefits of DIYCL systems. 9.7% of these used a DIYCL system, while 50% would most likely trust these systems but more than 85% of the patients would use a commercial closed loop system, if available. The DIYCL users had a better glucose control regarding their time in range (TIR) and glycated hemoglobin (HbA1c).	[Herzog, Anna Laura] Univ Wurzburg, Univ Klinikum, Div Nephrol, Transplantat Zentrum, Wurzburg, Germany; [Busch, Jonas] TH Aschaffenburg Univ Appl Sci, Aschaffenburg, Germany; [Wanner, Christoph] Univ Wurzburg, Univ Klinikum, Div Nephrol, Med Klin 1, Wurzburg, Germany; [von Jouanne-Diedrich, Holger K.] TH Aschaffenburg Univ Appl Sci, Competence Ctr Artificial Intelligence, Fac Engn, Aschaffenburg, Germany	University of Wurzburg; University of Wurzburg	Herzog, AL (corresponding author), Univ Wurzburg, Univ Klinikum, Div Nephrol, Transplantat Zentrum, Wurzburg, Germany.	Herzog_A1@ukw.de		von Jouanne-Diedrich, Holger K./0000-0002-5787-7351				Ang KH, 2015, EXPERT OPIN DRUG DEL, V12, P1579, DOI 10.1517/17425247.2015.1074174; [Anonymous], AM DIAB ASS SCI SESS; [Anonymous], 2016, GES; [Anonymous], FDA WARNS USE UN DIA; Barnard Katharine D, 2018, J Diabetes Sci Technol, V12, P1223, DOI 10.1177/1932296818792577; Beck Roy W, 2019, J Diabetes Sci Technol, V13, P614, DOI 10.1177/1932296818822496; Bekiari E, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1310; Blauw H, 2016, DIABETES OBES METAB, V18, P671, DOI 10.1111/dom.12663; Cleary PA, 2006, DIABETES, V55, P3556, DOI 10.2337/db06-0653; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Deshpande S, 2020, INT J THER REHABIL, V27, DOI 10.12968/ijtr.2019.0072; Doyle FJ, 2014, DIABETES CARE, V37, P1191, DOI 10.2337/dc13-2108; Farrington C, 2017, LANCET DIABETES ENDO, V5, P332, DOI 10.1016/S2213-8587(16)30397-7; Haidar A, 2015, LANCET DIABETES ENDO, V3, P17, DOI 10.1016/S2213-8587(14)70226-8; Jacob R., 2014, UMFRAGE EINFUHRUNG M, V3; Jacobson AM, 2013, DIABETES CARE, V36, P3131, DOI 10.2337/dc12-2109; Koster I, 2014, EXP CLIN ENDOCR DIAB, V122, P510, DOI 10.1055/s-0034-1375675; Lewis Dana, 2019, J Diabetes Sci Technol, V13, P790, DOI 10.1177/1932296818808307; Lewis Dana, 2016, J Diabetes Sci Technol, V10, P1411; Ly TT, 2015, DIABETES CARE, V38, P1205, DOI 10.2337/dc14-3073; Medtronic, REIMB KOST; Musolino G, 2019, PEDIATR DIABETES, V20, P794, DOI 10.1111/pedi.12872; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Oubre AY, 1997, DIABETOLOGIA, V40, P614, DOI 10.1007/s001250050724; Oukes Tamara, 2019, J Diabetes Sci Technol, V13, P899, DOI 10.1177/1932296818823728; Porst R., 2014, FRAGEBOGEN ARBEITSBU, V4th ed.; Quianzon CC, 2012, J COMMUNITY HOSP INT, V2, DOI 10.3402/jchimp.v2i2.18701; Ruedy KJ, 2012, J CARDIOVASC TRANSL, V5, P380, DOI 10.1007/s12265-012-9364-9; Russell SJ, 2016, LANCET DIABETES ENDO, V4, P233, DOI 10.1016/S2213-8587(15)00489-1; Thomas A, 2017, DIABETES C REPORT, V2017, P34; Trevitt Sara, 2016, J Diabetes Sci Technol, V10, P714, DOI 10.1177/1932296815617968; Turksoy K, 2014, J HEALTHC ENG, V5, P1, DOI 10.1260/2040-2295.5.1.1; Vasiloglou MF, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060741; Vigersky RA, 2019, DIABETES TECHNOL THE, V21, P81, DOI 10.1089/dia.2018.0310; Waugh N, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1613; Weaver KW, 2018, DIABETES TECHNOL THE, V20, P16, DOI 10.1089/dia.2018.0091; Weisman A, 2017, LANCET DIABETES ENDO, V5, P501, DOI 10.1016/S2213-8587(17)30167-5; Weiss R, 2015, DIABETES TECHNOL THE, V17, P542, DOI 10.1089/dia.2014.0306	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243465	10.1371/journal.pone.0243465	http://dx.doi.org/10.1371/journal.pone.0243465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332410	Green Published, gold			2022-12-26	WOS:000601310900066
J	Macedo, MCF; Pinheiro, IM; Carvalho, CJL; Fraga, HCJR; Araujo, IPC; Montes, SS; Araujo, OAC; Alves, LA; Saba, H; Araujo, MLV; Queiroz, ITL; Sampaio, RL; Souza, MSPL; da Silva, ACFN; Souza, ACS				Macedo, Marcio C. F.; Pinheiro, Isabelle M.; Carvalho, Caio J. L.; Fraga, Hilda C. J. R.; Araujo, Isaac P. C.; Montes, Simone S.; Araujo, Otavio A. C.; Alves, Lucas A.; Saba, Hugo; Araujo, Marcio L. V.; Queiroz, Ivonete T. L.; Sampaio, Romilson L.; Souza, Marcia S. P. L.; da Silva, Ana Claudia F. N.; Souza, Antonio C. S.			Correlation between hospitalized patients' demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil	PLOS ONE			English	Article								In this paper, we provide a retrospective cohort study with patients that have been hospitalized for general or intensive care unit admission due to COVID-19, between March 3 and July 29, 2020, in the state of Bahia, Brazil. We aim to correlate those patients' demographics, symptoms and comorbidities, with the risk of mortality from COVID-19, length of hospital stay, and time from diagnosis to definitive outcome. On the basis of a dataset provided by the Health Secretary of the State of Bahia, we selected 3,896 hospitalized patients from a total of 154,868 COVID-19 patients that included non-hospitalized patients and patients with invalid registration in the dataset. Then, we statistically analyzed whether there was a significant correlation between the patient record data and the COVID-19 pandemic, and our main findings reinforced by the use of a multivariable logistic regression were that older age (Odds Ratio [OR] = 1.03, 95% Confidence Interval [CI] = 1.03-1.04, p-value (p) <0.001), an initial symptom of shortness of breath (OR = 1.88, 95% CI = 1.60-2.20, p < 0.001), and the presence of comorbidities, mainly chronic kidney disease (OR = 2.41, 95% CI = 1.67-3.48, p < 0.001) are related to an increased risk of mortality from COVID-19. On the other hand, sore throat (OR = 0.74, 95% CI = 0.58-0.95, p = 0.02) and length of hospital stay (OR = 0.96, 95% CI = 0.58-0.95, p < 0.001) are more related to a reduced risk of mortality from COVID-19. Moreover, a multivariable linear regression conducted with statistically significant variables (p < 0.05) showed that age (OR = 0.97, 95% CI = 0.95-0.98, p < 0.001) and time from diagnosis to definitive outcome (OR = 1.67, 95% CI = 1.64-1.71, p < 0.001) are associated with the length of hospital stay.	[Macedo, Marcio C. F.; Carvalho, Caio J. L.; Araujo, Otavio A. C.] Univ Fed Bahia, Dept Comp Sci, Salvador, BA, Brazil; [Pinheiro, Isabelle M.] Univ Fed Bahia, Dept Radiol, Salvador, BA, Brazil; [Pinheiro, Isabelle M.; Fraga, Hilda C. J. R.; Montes, Simone S.; Saba, Hugo; Araujo, Marcio L. V.; Sampaio, Romilson L.; Souza, Antonio C. S.] Univ Fed Bahia, Grad Program Knowledge Diffus, Salvador, BA, Brazil; [Carvalho, Caio J. L.] SENAI CIMATEC, Supercomp Ctr Ind Innovat, Salvador, BA, Brazil; [Fraga, Hilda C. J. R.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil; [Araujo, Isaac P. C.; Alves, Lucas A.] Univ Fed Bahia, Dept Elect Engn, Salvador, BA, Brazil; [Saba, Hugo] Univ Estado Bahia, Dept Exact & Earth Sci, Salvador, BA, Brazil; [Araujo, Marcio L. V.] Fed Inst Bahia, Dept Tech Educ, Santo Amaro, BA, Brazil; [Araujo, Marcio L. V.; Souza, Marcia S. P. L.; da Silva, Ana Claudia F. N.] Hlth Secretary State Bahia, Salvador, BA, Brazil; [Queiroz, Ivonete T. L.] Fed Inst Bahia, Dept Tech Educ, Barreiras, BA, Brazil; [Sampaio, Romilson L.; Souza, Antonio C. S.] Fed Inst Bahia, Dept Comp Sci, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Faculdade de Tecnologia Senai Cimatec; Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade do Estado Bahia; Instituto Federal da Bahia (IFBA); Instituto Federal da Bahia (IFBA); Instituto Federal da Bahia (IFBA)	Macedo, MCF (corresponding author), Univ Fed Bahia, Dept Comp Sci, Salvador, BA, Brazil.	marcio.cerqueira@ufba.br	Luis Valença Araújo, Marcio/C-4916-2016; Araújo, Marcio Luis Valença/ABC-7718-2021; Saba, Hugo/H-5594-2012	Luis Valença Araújo, Marcio/0000-0003-2376-0160; Araújo, Marcio Luis Valença/0000-0003-2376-0160; Saba, Hugo/0000-0001-8402-6416; Macedo, Marcio/0000-0003-2729-7193; de Lima Carvalho, Caio Jordao/0000-0002-1112-7600; Araujo, Isaac/0000-0001-8275-0101; Fraga, Hilda/0000-0002-1191-5789	National Council for Scientific and Technological Development - CNPq [431990/2018-2, 313423/2019-9]; Postdoctoral National Program of the Coordination for the Improvement of Higher Education Personnel - CAPES [88882.306277/2018-01]; National Council of Institutions of the Federal Network of Vocational, Scientific and Technological Education - CONIF; Secretariat of Professional and Technological Education - SETEC	National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Postdoctoral National Program of the Coordination for the Improvement of Higher Education Personnel - CAPES; National Council of Institutions of the Federal Network of Vocational, Scientific and Technological Education - CONIF; Secretariat of Professional and Technological Education - SETEC	Hugo Saba received financial support from the National Council for Scientific and Technological Development - CNPq (http://cnpq.br/), grant numbers 431990/2018-2 and 313423/2019-9 Marcio C. F. Macedo received financial support from the Postdoctoral National Program of the Coordination for the Improvement of Higher Education Personnel - CAPES (https://www.capes.gov.br/), grant number 88882.306277/2018-01. This work was supported by the National Council of Institutions of the Federal Network of Vocational, Scientific and Technological Education - CONIF (http://portal.conif.org.br/br/).This work was also supported by the Secretariat of Professional and Technological Education - SETEC (http://portal.mec.gov.br/setec-secretaria-de-educacaoprofissional-e-tecnologica).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar H, 2020, EUR REV MED PHARMACO, V24, P3400, DOI 10.26355/eurrev_202003_20709; Barda N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18297-9; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Colombi D, 2020, RADIOLOGY, V296, pE86, DOI 10.1148/radiol.2020201433; Hu H, 2020, ACAD EMERG MED, V27, P461, DOI 10.1111/acem.13992; Imam Z, 2020, J INTERN MED, V288, P469, DOI 10.1111/joim.13119; KIM L, 2020, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAA1012; Liu XK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235459; Soares RDM, 2020, AM J TROP MED HYG, V103, P1184, DOI 10.4269/ajtmh.20-0483; Pinheiro ALS, 2016, TEXTO CONTEXTO ENFER, V25; Rivera-Izquierdo M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235107; Shi Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2833-7; Smith V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234187; Souza FSH, 2020, ANAL MORTALITY RISK, DOI [10.1101/2020.09.24.20200768, DOI 10.1101/2020.09.24.20200768]; Wang S, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00775-2020; World Health Organization, 2020, TECH REP; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7; Bello-Chavolla OY, 2020, J CLIN ENDOCR METAB, V105, P2752, DOI 10.1210/clinem/dgaa346; Yuan ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230548; Yue HM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3026; Zhang BiCheng, 2020, PLoS ONE, V15, DOI 10.1371/journal.pone.0235458; Zhao ZR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236618	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243966	10.1371/journal.pone.0243966	http://dx.doi.org/10.1371/journal.pone.0243966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33318711	gold, Green Published			2022-12-26	WOS:000600186100072
J	Liu, FK; Yuan, MT; Li, CL; Guan, X; Li, B				Liu, Fukai; Yuan, Mengtong; Li, Chenlong; Guan, Xue; Li, Bai			The protective function of taurine on pesticide-induced permanent neurodevelopmental toxicity in juvenile rats	FASEB JOURNAL			English	Article						hippocampal; maneb; neuroprotection; paraqua	TRANSCRIPTION FACTORS; PARKINSONS-DISEASE; DEVELOPMENTAL EXPOSURE; SYNAPTIC PLASTICITY; C-FOS; PARAQUAT; MEMORY; MANEB; NEUROGENESIS; HIPPOCAMPAL	Numerous studies have confirmed that prenatal or early postnatal exposure to pesticides can lead to functional deficits in the developing brain. This study aimed to investigate whether combined exposure to paraquat (PQ) and maneb (MB) during puberty could cause permanent toxic effects in the neural system of rats. In addition, the neuroprotective function of taurine (T) and its possible mechanism were investigated. Rats were administered PQ + MB intragastrically for 12 continuous weeks, while taurine dissolved in water was fed to the rats for 24 continuous weeks. In the behavioral tests, the rats' trajectories became complex, and the reaction latencies and mistake frequencies increased. Significant changes were found in the hippocampal neurons of the PQ + MB groups but not in the taurine treatment groups. PQ + MB stimulated cAMP to reduce the production of protein kinase A (PKA) and inhibited the activation of other elements, such as brain-derived neurotrophic factor (BDNF), cAMP response element binding protein (CREB), phospho-CREB (p-CREB), immediate-early genes (IEGs)Arc, and c-Fos. Importantly, taurine regulated the level of cAMP and the expression of the abovementioned proteins. Together, our findings implied that adolescent exposure to PQ + MB may impact the behavior and cognitive function of rats via the cAMP-PKA-CREB signaling pathway, while taurine may in turn exert neuroprotection by diminishing these impacts.	[Liu, Fukai] Harbin Med Univ, Affiliated Hosp 1, Anim Lab Ctr, Harbin, Peoples R China; [Yuan, Mengtong] Harbin Med Univ, Affiliated Hosp 2, Dept Prosthodont, Harbin, Peoples R China; [Li, Chenlong] Harbin Med Univ, Canc Hosp, Dept Neurosurg, Harbin, Peoples R China; [Guan, Xue] Harbin Med Univ, Affiliated Hosp 2, Anim Lab Ctr, Harbin, Peoples R China; [Li, Bai] Harbin Med Univ, Coll Publ Hlth, Dept Toxicol, Harbin 150081, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, B (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Toxicol, Harbin 150081, Peoples R China.; Guan, X (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Anim Lab Ctr, Xuefu Rd 246, Harbin 150081, Peoples R China.	guanxue2019@163.com; hmuleetina@163.com	li, bai/GRJ-4913-2022; li, bz/GVR-7133-2022					ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; Andersen HR, 2015, NEUROTOXICOL TERATOL, V47, P1, DOI 10.1016/j.ntt.2014.10.006; Che YN, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0468-2; Chen WQ, 2001, J NEUROSCI RES, V66, P612, DOI 10.1002/jnr.10027; Colle D, 2020, NEUROTOX RES, V37, P210, DOI 10.1007/s12640-019-00097-9; Colle D, 2018, NEUROTOX RES, V34, P820, DOI 10.1007/s12640-018-9916-0; De Felice A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0617-4; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; El Idrissi A, 2019, ADV EXP MED BIOL, V1155, P977, DOI 10.1007/978-981-13-8023-5_81; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Gonzalez-Alzaga B, 2015, ENVIRON INT, V85, P229, DOI 10.1016/j.envint.2015.09.019; GULDNER FH, 1980, NEUROSCI LETT, V17, P27, DOI 10.1016/0304-3940(80)90056-7; Guo BQ, 2013, TOXICOLOGY, V304, P57, DOI 10.1016/j.tox.2012.11.019; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hagler DJ, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116091; Han Z, 2016, EUR J PHARMACOL, V777, P129, DOI 10.1016/j.ejphar.2016.03.006; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Hou LY, 2019, TOXICOLOGY, V417, P64, DOI 10.1016/j.tox.2019.02.011; Hou LY, 2018, AMINO ACIDS, V50, P547, DOI 10.1007/s00726-018-2547-1; Huang YH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01754; JONES DG, 1978, BRAIN RES, V147, P47, DOI 10.1016/0006-8993(78)90771-0; KACZMAREK L, 1993, J NEUROSCI RES, V34, P377, DOI 10.1002/jnr.490340402; Kaptan Z, 2015, BRAIN RES, V1618, P194, DOI 10.1016/j.brainres.2015.05.041; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kumari R, 2016, J SEP SCI, V39, P1725, DOI 10.1002/jssc.201501048; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Li B, 2016, MOL BIOSYST, V12, P3088, DOI 10.1039/c6mb00284f; Liu J, 2013, NUTR NEUROSCI, V16, P282, DOI 10.1179/1476830513Y.0000000057; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luciana M, 2018, DEV COGN NEUROS-NETH, V32, P67, DOI 10.1016/j.dcn.2018.02.006; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Ma J, 2013, NEUROCHEM INT, V62, P84, DOI 10.1016/j.neuint.2012.11.010; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Mersman B, 2020, FRONT SYNAPTIC NEURO, V12, DOI 10.3389/fnsyn.2020.00029; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Narayan S, 2017, ENVIRON INT, V107, P266, DOI 10.1016/j.envint.2017.04.010; Nicol X, 2014, EUR J NEUROSCI, V39, P1742, DOI 10.1111/ejn.12543; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Rashid MA, 2016, NEUROPHARMACOLOGY, V102, P174, DOI 10.1016/j.neuropharm.2015.11.011; Roede JR, 2011, TOXICOL SCI, V121, P368, DOI 10.1093/toxsci/kfr058; Rosa AI, 2018, MOL NEUROBIOL, V55, P9139, DOI 10.1007/s12035-018-1062-4; Rudyk CA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00222; Sadeghian A, 2019, BASIC CLIN NEUROSCI, V10, P461, DOI 10.32598/bcn.9.10.330; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Shimizu-Sasamata M, 1998, J NEUROSCI, V18, P9564; Sobrido-Camean D, 2020, J NEUROTRAUM, V37, P899, DOI 10.1089/neu.2019.6604; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Sudhof TC, 2017, CELL, V171, P745, DOI 10.1016/j.cell.2017.10.024; Thiruchelvam M, 2002, NEUROTOXICOLOGY, V23, P621, DOI 10.1016/S0161-813X(02)00092-X; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Wu W, 2013, BEHAV BRAIN RES, V253, P212, DOI 10.1016/j.bbr.2013.07.052; Zhu XY, 2016, BRAIN RES BULL, V124, P295, DOI 10.1016/j.brainresbull.2016.06.010	57	4	4	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21273	10.1096/fj.202001290R	http://dx.doi.org/10.1096/fj.202001290R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368748				2022-12-26	WOS:000605626600019
J	Forte, CC; Pedrollo, EF; Nicoletto, BB; Lopes, JB; Manfro, RC; Souza, GC; Leitao, CB				Forte, Cristina Carra; Pedrollo, Elis Forcellini; Nicoletto, Bruna Bellincanta; Lopes, Jessica Blatt; Manfro, Roberto Ceratti; Souza, Gabriela Correa; Leitao, Cristiane Bauermann			Risk factors associated with weight gain after kidney transplantation: A cohort study	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; OBESITY; PREVALENCE; PREDICTORS; RECIPIENTS; DIALYSIS	Background Renal transplantation is the best modality of renal replacement therapy for patients with end-stage renal disease. However, it is associated with weight gain and metabolic abnormalities, which adversely impact transplant outcomes. Objective The objective of this study was to identify the risk factors of one-year weight gain after renal transplantation. Methods A retrospective cohort study was conducted with 374 patients that underwent kidney transplantation between January 2006 and July 2013. Clinical and laboratory variables were collected from electronic records, and the outcome of interest was weight gain during the first year after renal transplantation. The data were reported as mean +/- standard deviation, median (interquartile range) or number of subjects (%). The association between variables were assessed via chi-square test and ANOVA. For analysis of risk factors related to the outcomes of interest, multivariable logistic regression models were used. Results There were 181 (48.4%) female patients, 334 (89.3%) with white ethnicity and the mean age was 44.4 +/- 12.8 years. The mean BMI pre-transplant was 24.7 +/- 4.1 kg/m(2), and 35 (9.9%) patients were classified as obese; 119 (33.6%) as overweight; 187 (52.8%) as normal weight; and 13 (3.7%) as malnourished. After one year of follow-up, the mean BMI was 26.2 +/- 5.0 kg/m(2), and 61 (17.3%) patients were classified as obese; 133 (37.8%) as overweight; 148 (42.0%) as normal weight; and 10 (2.8%) as malnourished. Weight gain was observed in 72.7% patients, and the average increase was 7.12 +/- 5.9 kg. The female gender, lower pre-transplant body weight, lower number of hospitalizations, and a kidney received from a living donor were associated with weight gain by more than 5% in the first year post-transplant. Conclusion Female gender and lower pre-transplant body weight were independently associated with weight gain by more than 5% in the first year after kidney transplantation; lower rates of hospitalization and donation from living donors were also risk factors for this outcome.	[Forte, Cristina Carra; Pedrollo, Elis Forcellini; Leitao, Cristiane Bauermann] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Program Med Sci Endocrinol, Fac Med, Porto Alegre, RS, Brazil; [Forte, Cristina Carra; Pedrollo, Elis Forcellini; Nicoletto, Bruna Bellincanta; Lopes, Jessica Blatt; Manfro, Roberto Ceratti; Souza, Gabriela Correa; Leitao, Cristiane Bauermann] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Nicoletto, Bruna Bellincanta] Univ Caxias Do Sul, Life Sci Knowledge Area, Caxias Do Sul, RS, Brazil; [Lopes, Jessica Blatt] Univ Fed Rio Grande do Sul, Sch Med, Nutr Grad Course, Porto Alegre, RS, Brazil; [Manfro, Roberto Ceratti] Univ Fed Rio Grande do Sul, Postgrad Med Med Sci, Porto Alegre, RS, Brazil; [Manfro, Roberto Ceratti] Hosp Clin Porto Alegre, Div Nephrol, Porto Alegre, RS, Brazil; [Souza, Gabriela Correa] Hosp Clin Porto Alegre, Div Nutr, Porto Alegre, RS, Brazil; [Leitao, Cristiane Bauermann] Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade de Caxias do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Forte, CC (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Postgrad Program Med Sci Endocrinol, Fac Med, Porto Alegre, RS, Brazil.; Forte, CC (corresponding author), Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.	cristinacarraforte@gmail.com		Leitao, Cristiane/0000-0002-2106-309X	Research Incentive Fund (FIPE) of Hospital de Clinicas de Porto Alegre (HCPA); National Council for Scientific and Technological Development (CNPq); Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS); Coordination of Improvement of Superior Education Personnel (CAPES)	Research Incentive Fund (FIPE) of Hospital de Clinicas de Porto Alegre (HCPA); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Coordination of Improvement of Superior Education Personnel (CAPES)	This work was supported by from the Research Incentive Fund (FIPE) of Hospital de Clinicas de Porto Alegre (HCPA), National Council for Scientific and Technological Development (CNPq), Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS) as well as the Coordination of Improvement of Superior Education Personnel (CAPES).	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2017, GODT 2015 REP; [Anonymous], 2017, SURV RISK PROT FACT; Armstrong KA, 2005, NEPHROLOGY, V10, P405, DOI 10.1111/j.1440-1797.2005.00406.x; Baum CL, 2002, NUTRITION, V18, P139, DOI 10.1016/S0899-9007(01)00723-7; Baum CL, 2001, JPEN-PARENTER ENTER, V25, P114, DOI 10.1177/0148607101025003114; Beckmann S, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12896; Bloodworth RF, 2014, RES NURS HEALTH, V37, P253, DOI 10.1002/nur.21599; Brito TNS, 2016, REV BRASILEIRA ANALI; Cashion AK, 2014, CLIN TRANSPLANT, V28, P1271, DOI 10.1111/ctr.12456; Chan W, 2014, J RENAL NUTR, V24, P1, DOI 10.1053/j.jrn.2013.09.002; Chang A, 2015, NEPHROL DIAL TRANSPL, V30, P1870, DOI 10.1093/ndt/gfv219; Costa B, 2014, TRANSPL P, V46, P1750, DOI 10.1016/j.transproceed.2014.05.021; de Oliveira CMC, 2014, TRANSPL P, V46, P1735, DOI 10.1016/j.transproceed.2014.05.027; DeclaracAo de Helsinque da AssociacAo Medica Mundial (WMA), 2013, PRINC ET PESQ MED EN; Diaz JM, 2005, TRANSPL P, V37, P3839, DOI 10.1016/j.transproceed.2005.09.200; Dimeny EM, 2002, KIDNEY INT, V61, pS78, DOI 10.1046/j.1523-1755.61.s80.14.x; Hap K, 2019, ANN TRANSPL, V24, P57, DOI 10.12659/AOT.912096; Heng AE, 2015, CLIN NUTR, V34, P457, DOI 10.1016/j.clnu.2014.05.003; Henggeler CK, 2018, J RENAL NUTR, V28, P340, DOI 10.1053/j.jrn.2018.03.001; Hricik DE, 2001, AM J KIDNEY DIS, V38, P409, DOI 10.1053/ajkd.2001.27006; JOHNSON CP, 1993, TRANSPLANTATION, V56, P822, DOI 10.1097/00007890-199310000-00008; Kim IK, 2016, TRANSPL P, V48, P893, DOI 10.1016/j.transproceed.2015.10.064; Mehrabi A, 2006, CLIN TRANSPLANT, V20, P97, DOI 10.1111/j.1399-0012.2006.00608.x; Moreso F, 2013, NEFROLOGIA, V33, P14, DOI 10.3265/Nefrologia.pre2012.Oct.11739; Mucha K, 2015, ANN TRANSPL, V20, P16, DOI 10.12659/AOT.892754; Nicoletto BB, 2012, J RENAL NUTR, V22, P440, DOI 10.1053/j.jrn.2011.09.003; Palepu S, 2015, WORLD J DIABETES, V6, P445, DOI 10.4239/wjd.v6.i3.445; Pantik C, 2017, PROG TRANSPLANT, V27, P10, DOI 10.1177/1526924816681007; Pedrollo EF, 2016, TRANSPL INT, V29, P1059, DOI 10.1111/tri.12805; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pirsch JD, 2008, TRANSPLANTATION, V85, P1387, DOI 10.1097/TP.0b013e31816f1d58; Pischon T, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.1.14; Souza GC, 2008, J RENAL NUTR, V18, P479, DOI 10.1053/j.jrn.2008.05.008; Thoma B, 2006, CLIN NEPHROL, V65, P408; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wissing KM, 2014, TRANSPLANT REV-ORLAN, V28, P37, DOI 10.1016/j.trre.2013.12.004; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Workeneh B, 2019, J RENAL NUTR, V29, P548, DOI 10.1053/j.jrn.2019.01.009	40	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243394	10.1371/journal.pone.0243394	http://dx.doi.org/10.1371/journal.pone.0243394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370293	Green Published, gold			2022-12-26	WOS:000603611900028
J	Ramirez, JL; Rosas-Puchuri, U; Canedo, RM; Alfaro-Shigueto, J; Ayon, P; Zelada-Mazmela, E; Siccha-Ramirez, R; Velez-Zuazo, X				Ramirez, Jorge L.; Rosas-Puchuri, Ulises; Canedo, Rosa Maria; Alfaro-Shigueto, Joanna; Ayon, Patricia; Zelada-Mazmela, Eliana; Siccha-Ramirez, Raquel; Velez-Zuazo, Ximena			DNA barcoding in the Southeast Pacific marine realm: Low coverage and geographic representation despite high diversity	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; CONSERVATION	The Southeast Pacific comprises two Large Marine Ecosystems, the Pacific Central-American Coastal and the Humboldt Current System; and is one of the less well known in the tropical subregions in terms of biodiversity. To address this, we compared DNA barcoding repositories with the marine biodiversity species for the Southeast Pacific. We obtained a checklist of marine species in the Southeast Pacific (i.e. Colombia, Ecuador, Chile, and Peru) from the Ocean Biodiversity Information System (OBIS) database and compared it with species available at the Barcoding of Life Data System (BOLD) repository. Of the 5504 species records retrieved from OBIS, 42% of them had at least one registered specimen in BOLD (including specimens around the world); however, only 4.5% of records corresponded to publicly available DNA barcodes including specimens collected from a Southeast Pacific country. The low representation of barcoded species does not vary much across the different taxonomic groups or within countries, but we observed an asymmetric distribution of DNA barcoding records for taxonomic groups along the coast, being more abundant for the Humboldt Current System than the Pacific Central-American Coastal. We observed high-level of barcode records with Barcode Index Number (BIN) incongruences, particularly for fishes (Actinopterygii = 30.27% and Elasmobranchii = 24.71%), reflecting taxonomic uncertainties for fishes, whereas for Invertebrates and Mammalia more than 85% of records were classified as data deficient or inadequate procedure for DNA barcoding. DNA barcoding is a powerful tool to study biodiversity, with a great potential to increase the knowledge of the Southeast Pacific marine biodiversity. Our results highlight the critical need for increasing taxonomic sampling effort, the number of trained taxonomic specialists, laboratory facilities, scientific collections, and genetic reference libraries.	[Ramirez, Jorge L.; Canedo, Rosa Maria] Univ Nacl Mayor San Marcos, Fac Ciencias Biol, Lima, Peru; [Rosas-Puchuri, Ulises; Velez-Zuazo, Ximena] Smithsonian Conservat Biol Inst, Ctr Conservat & Sustainabil, Natl Zool Pk, Washington, DC USA; [Rosas-Puchuri, Ulises] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Alfaro-Shigueto, Joanna] Univ Cient Lima, Fac Biol Marina, Lima, Peru; [Alfaro-Shigueto, Joanna] ProDelphinus, Lima, Peru; [Ayon, Patricia] Inst Mar Peru, Callao, Peru; [Zelada-Mazmela, Eliana] Univ Nacl Santa, Fac Ciencias, Lab Genet Fisiol & Reprod, Chimbote, Peru; [Siccha-Ramirez, Raquel] Inst Mar Peru, Lab Costero Tumbes, Zorritos, Peru; [Velez-Zuazo, Ximena] Asociac Peruana Conservac Nat, Lima, Peru	Universidad Nacional Mayor de San Marcos; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Washington University; Universidad Cientifica del Sur (CIENTIFICA); Instituto del Mar del Peru; Instituto del Mar del Peru	Ramirez, JL (corresponding author), Univ Nacl Mayor San Marcos, Fac Ciencias Biol, Lima, Peru.	jramirezma@unmsm.edu.pe	; Ramirez, Jorge L/F-4984-2011	Zelada, Eliana/0000-0002-5813-0954; Canedo Apolaya, Rosa Maria Lorena/0000-0002-6207-9530; Rosas, Ulises/0000-0003-0529-2623; Siccha-Ramirez, Raquel/0000-0002-5597-3948; Ramirez, Jorge L/0000-0001-8138-9203	Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) - Peru (Circulos de Investigacion) [023-2016-FONDECYT]	Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) - Peru (Circulos de Investigacion)	This research was supported by the Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) - Peru (Circulos de Investigacion 023-2016-FONDECYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Alfaro Shigueto Joanna, 2008, Endangered Species Research, V5, P129, DOI 10.3354/esr00142; [Anonymous], 2015, J CASE REP STUD, V3, P2; [Anonymous], 2020, OBIS OC BIOD INF SYS; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Asis AMJM, 2016, MITOCHONDRIAL DNA A, V27, P659, DOI 10.3109/19401736.2014.913138; Barahona SP, 2019, MAR ECOL-EVOL PERSP, V40, DOI 10.1111/maec.12556; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Cheng J, 2015, BIOCHEM SYST ECOL, V61, P376, DOI 10.1016/j.bse.2015.07.005; Ciocca DR, 2017, CELL STRESS CHAPERON, V22, P847, DOI 10.1007/s12192-017-0815-8; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Diaz S, 2019, IPBES 2019 SUMMARY P, DOI [10.1111/padr.12283, DOI 10.1111/PADR.12283]; Evans Nathaniel, 2012, Methods Mol Biol, V858, P47, DOI 10.1007/978-1-61779-591-6_4; FAO, 2016, CONTR SEG AL NUTR TO; FAO, 2018, STAT WORLD FISH AQ 2, DOI [10.1093/japr/3.1.101, DOI 10.1093/JAPR/3.1.101]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoover AL, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2644; KUSANAGI K, 1992, J VET MED SCI, V54, P313, DOI 10.1292/jvms.54.313; Lukhtanov V.A., 2019, ENTOMOL REV, V99, P463, DOI 10.1134/S0013873819040055; Mangel JC, 2011, MAR ECOL PROG SER, V433, P261, DOI 10.3354/meps09152; Miloslavich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014631; Oliveira LM, 2016, J FISH BIOL, V89, P2741, DOI 10.1111/jfb.13169; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2015, ZOOKEYS, P53, DOI 10.3897/zookeys.539.6530; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Rosas U, 2018, MITOCHONDRIAL DNA A, V29, P1174, DOI 10.1080/24701394.2018.1431225; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sherman K, 2019, ENCYCLOPEDIA OF OCEAN SCIENCES, VOL 1: MARINE BIOGEOCHEMISTRY, 3RD EDITION, P709, DOI 10.1016/B978-0-12-409548-9.11117-0; Stat M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12501-5; Tarazona J, 2001, PERUVIAN COASTAL UPW, P229, DOI DOI 10.1007/978-3-662-04482-7_17; Tarazona Juan, 2003, Gayana (Concepc.), V67, P206; Thomas VG, 2016, GENOME, V59, P1023, DOI 10.1139/gen-2016-0022; Trivedi S, 2016, SAUDI J BIOL SCI, V23, P161, DOI 10.1016/j.sjbs.2015.01.001; Velez-Zuazo X, 2015, FISH RES, V161, P34, DOI 10.1016/j.fishres.2014.06.005; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Webb KE, 2006, DEEP-SEA RES PT II, V53, P1053, DOI 10.1016/j.dsr2.2006.02.013; Weigand Hannah, 2019, Sci Total Environ, V678, P499, DOI 10.1016/j.scitotenv.2019.04.247	41	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244323	10.1371/journal.pone.0244323	http://dx.doi.org/10.1371/journal.pone.0244323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370342	Green Published, gold			2022-12-26	WOS:000603611900079
J	Efstathiou, NE; Moustafa, GA; Maidana, DE; Konstantinou, EK; Notomi, S; Barbisan, PRT; Georgakopoulos, CD; Miller, JW; Vavvas, DG				Efstathiou, Nikolaos E.; Moustafa, Giannis A.; Maidana, Daniel E.; Konstantinou, Eleni K.; Notomi, Shoji; Barbisan, Paulo R. T.; Georgakopoulos, Constantine D.; Miller, Joan W.; Vavvas, Demetrios G.			Acadesine suppresses TNF-alpha induced complement component 3 (C3), in retinal pigment epithelial (RPE) cells	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; HIGH-RISK; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; CHOROIDAL NEOVASCULARIZATION; GENE-EXPRESSION; RARE VARIANTS; FACTOR-B; ACTIVATION; AMPK	Rationale Age-related macular degeneration (AMD) is the most prevalent form of irreversible blindness in the developed world. Aging, inflammation and complement dysregulation affecting the retinal pigment epithelium (RPE), are considered significant contributors in its pathogenesis and several evidences have linked tumor necrosis factor alpha (TNF-alpha) and complement component 3 (C3) with AMD. Acadesine, an analog of AMP and an AMP-activated protein kinase (AMPK) activator, has been shown to have cytoprotective effects in human clinical trials as well as having anti-inflammatory and anti-vascular exudative effects in animals. The purpose of this study was to evaluate if acadesine is able to suppress TNF-alpha induced C3 in RPE cells. Methods ARPE-19 and human primary RPE cells were cultured and allowed to grow to confluence. TNF-alpha was used for C3 induction in the presence or absence of acadesine. Small molecule inhibitors and siRNA were used to determine if acadesine exerts its effect via the extracellular or intracellular pathway and to evaluate the importance of AMPK for these effects. The expression level of C3 was determined by immunoblot analysis. Results Acadesine suppresses TNF-alpha induced C3 in a dose dependent manner. When we utilized the adenosine receptor inhibitor dipyridamole (DPY) along with acadesine, acadesine's effects were abolished, indicating the necessity of acadesine to enter the cell in order to exert it's action. However, pretreatment with 5-iodotubericidin (5-Iodo), an adenosine kinase (AK) inhibitor, didn't prevent acadesine from decreasing TNF-alpha induced C3 expression suggesting that acadesine does not exert its effect through AMP conversion and subsequent activation of AMPK. Consistent with this, knockdown of AMPK alpha catalytic subunit did not affect the inhibitory effect of acadesine on TNF-alpha upregulation of C3. Conclusions Our results suggest that acadesine suppresses TNF-alpha induced C3, likely through an AMPK-independent pathway, and could have potential use in complement over activation diseases.	[Efstathiou, Nikolaos E.; Moustafa, Giannis A.; Maidana, Daniel E.; Konstantinou, Eleni K.; Notomi, Shoji; Barbisan, Paulo R. T.; Miller, Joan W.; Vavvas, Demetrios G.] Harvard Med Sch, Massachusetts Eye & Ear, Retina Serv, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA; [Georgakopoulos, Constantine D.] Univ Patras, Med Sch, Dept Ophthalmol, Patras, Greece	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Patras	Vavvas, DG (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear, Retina Serv, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA.	Demetrios_Vavvas@MEEI.HARVARD.EDU		Efstathiou, Nikolaos/0000-0002-6635-0391	STAMATIOU Foundation; New England Hellenic Medical and Dental Society; National Eye Institute [R01EY025362-01, R21EY023079-01/A1]	STAMATIOU Foundation; New England Hellenic Medical and Dental Society; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by STAMATIOU Foundation Scholarship (N.E.E), New England Hellenic Medical and Dental Society Scholarship (N.E.E), National Eye Institute, R01EY025362-01 (D.G.V), National Eye Institute, R21EY023079-01/A1 (D.G.V).	Al-Moujahed A, 2019, STEM CELL RES, V35, DOI 10.1016/j.scr.2019.101387; Al-Moujahed A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07632-8; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BAUDOUIN C, 1992, JPN J OPHTHALMOL, V36, P443; Boss M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32111; Cao SJ, 2013, AM J OPHTHALMOL, V156, P1176, DOI 10.1016/j.ajo.2013.08.003; Chung EJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17744-w; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716; Despriet DDG, 2009, OPHTHALMOLOGY, V116, P474, DOI 10.1016/j.ophtha.2008.09.055; Duvvari MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094165; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Geerlings MJ, 2017, MOL IMMUNOL, V84, P65, DOI 10.1016/j.molimm.2016.11.016; Geerlings MJ, 2017, JAMA OPHTHALMOL, V135, P39, DOI 10.1001/jamaophthalmol.2016.4604; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hamdulay SS, 2014, J IMMUNOL, V192, P4316, DOI 10.4049/jimmunol.1301702; Handa JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11262-1; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Holz FG, 2018, JAMA OPHTHALMOL, V136, P666, DOI 10.1001/jamaophthalmol.2018.1544; Jakobsdottir J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002199; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kawakami Y, 1997, CANCER LETT, V116, P21, DOI 10.1016/S0304-3835(97)04737-X; Kim JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.115; Kirchner J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26102-3; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kosmidou C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17634-1; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kumase F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147279; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Law SKA, 1997, PROTEIN SCI, V6, P263; Lechner J, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0060-5; LEUNG JM, 1994, ANESTH ANALG, V78, P420; Liao DS, 2020, OPHTHALMOLOGY, V127, P186, DOI 10.1016/j.ophtha.2019.07.011; Lores-Motta L, 2018, OPHTHALMOLOGY, V125, P1064, DOI 10.1016/j.ophtha.2017.12.023; Luo C, 2011, MOL VIS, V17, P1588; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; MENASCHE P, 1995, J THORAC CARDIOV SUR, V110, P1096, DOI 10.1016/S0022-5223(05)80179-5; Miller Joan W, 2017, US Ophthalmic Rev, V10, P119, DOI 10.17925/USOR.2017.10.02.119; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Natoli R, 2017, INVEST OPHTH VIS SCI, V58, P2977, DOI 10.1167/iovs.17-21672; Newman MF, 2012, JAMA-J AM MED ASSOC, V308, P157, DOI 10.1001/jama.2012.7633; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Notomi S, 2019, P NATL ACAD SCI USA, V116, P23724, DOI 10.1073/pnas.1906643116; Nymo S, 2014, IMMUNOBIOLOGY, V219, P786, DOI 10.1016/j.imbio.2014.06.006; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Park KH, 2009, INVEST OPHTH VIS SCI, V50, P3386, DOI 10.1167/iovs.08-3231; Poor SH, 2014, INVEST OPHTH VIS SCI, V55, P6525, DOI 10.1167/iovs.14-15067; Ratnapriya R, 2019, NAT GENET, V51, P606, DOI 10.1038/s41588-019-0351-9; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ristau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093459; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Samuel MA, 2014, NAT NEUROSCI, V17, P1190, DOI 10.1038/nn.3772; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Stanton CM, 2011, INVEST OPHTH VIS SCI, V52, P8828, DOI 10.1167/iovs.11-7933; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Takeuchi K, 2013, J BIOL CHEM, V288, P20581, DOI 10.1074/jbc.M113.460832; Touhami S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1106-8; Ueta T, 2019, P NATL ACAD SCI USA, V116, P23705, DOI 10.1073/pnas.1908355116; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657; Vavvas DG, 2018, P NATL ACAD SCI USA, V115, pE696, DOI 10.1073/pnas.1718059115; Vavvas DG, 2016, EBIOMEDICINE, V5, P198, DOI 10.1016/j.ebiom.2016.01.033; Wen ZK, 2019, NAT IMMUNOL, V20, P313, DOI 10.1038/s41590-018-0296-7; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yehoshua Z, 2014, OPHTHALMOLOGY, V121, P693, DOI 10.1016/j.ophtha.2013.09.044; Ying Y, 2017, ONCOTARGET, V8, P32794, DOI 10.18632/oncotarget.15825; Yu JR, 2014, CONTEMP CHIN THOUGHT, V45, P18, DOI 10.2753/CSP1097-1467450401; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zhang J, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0945-5; 2008, DRUGS R&D, V9, P169; 2018, CURR OPIN TOXICOL, V10	87	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244307	10.1371/journal.pone.0244307	http://dx.doi.org/10.1371/journal.pone.0244307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362238	Green Published, gold			2022-12-26	WOS:000603071600062
J	Iglesias, K; Lannoy, S; Sporkert, F; Daeppen, JB; Gmel, G; Baggio, S				Iglesias, Katia; Lannoy, Severine; Sporkert, Frank; Daeppen, Jean-Bernard; Gmel, Gerhard; Baggio, Stephanie			Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; CONSUMPTION; INSTRUMENTS; VALIDITY; MARKERS; STATE	Background There is a need for empirical studies assessing the psychometric properties of self-reported alcohol use as measures of excessive chronic drinking (ECD) compared to those of objective measures, such as ethyl glucuronide (EtG). Objectives To test the quality of self-reported measures of alcohol use and of risky single-occasion drinking (RSOD) to detect ECD assessed by EtG. Methods A total of 227 samples of hair from young Swiss men were used for the determination of EtG. Self-reported measures of alcohol use (previous twelve-month and previous-week alcohol use) and RSOD were assessed. Using EtG (<30 pg/mg) as the gold standard of ECD assessment, the sensitivity and specificity were computed, and the AUROC were compared for alcohol use measures and RSOD. Logistic regressions were used to test the contribution of RSOD to the understanding of ECD after controlling for alcohol use. Results A total of 23.3% of participants presented with ECD. Previous twelve-month alcohol use with a cut-off of >15 drinks per week (sensitivity = 75.5%, specificity = 78.7%) and weekly RSOD (sensitivity = 75.5%, specificity = 70.1%) yielded acceptable psychometric properties. No cut-off for previous-week alcohol use gave acceptable results. In the multivariate logistic regression, after controlling for the previous twelve months of alcohol use, RSOD was still significantly associated with EtG (p = .016). Conclusion Self-reported measures of the previous twelve months of alcohol use and RSOD were acceptable measures of ECD for population-based screening. Self-reported RSOD appeared to be an interesting screening measure, in addition to the previous twelve months of alcohol use, to understand ECD among young people.	[Iglesias, Katia] HES SO Univ Appl Sci & Arts Western Switzerland, Sch Hlth Sci HEdS FR, Fribourg, Switzerland; [Lannoy, Severine] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Lannoy, Severine] Catholic Univ Louvain, Lab Expt Psychopathol, Psychol Sci Res Inst, Louvain La Neuve, Brabant Wallon, Belgium; [Sporkert, Frank] Lausanne Univ, Ctr Legal Med, Forens Toxicol & Chem Unit, Lausanne, Vaud, Switzerland; [Sporkert, Frank] Univ Geneva, Ctr Legal Med, Forens Toxicol & Chem Unit, Lausanne, Vaud, Switzerland; [Daeppen, Jean-Bernard; Gmel, Gerhard] Lausanne Univ Hosp, Dept Psychiat, Addict Med, Lausanne, Vaud, Switzerland; [Gmel, Gerhard] Addict Switzerland, Lausanne, Vaud, Switzerland; [Gmel, Gerhard] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Gmel, Gerhard] Univ West England, Bristol, Avon, England; [Baggio, Stephanie] Geneva Univ Hosp, Div Prison Hlth, Geneva, Switzerland; [Baggio, Stephanie] Univ Geneva, Geneva, Switzerland; [Baggio, Stephanie] Dept Justice & Home Affairs Canton Zurich, Off Correct, Zurich, Switzerland	University of Applied Sciences & Arts Western Switzerland; Stanford University; Universite Catholique Louvain; University of Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of West England; University of Geneva; University of Geneva	Iglesias, K (corresponding author), HES SO Univ Appl Sci & Arts Western Switzerland, Sch Hlth Sci HEdS FR, Fribourg, Switzerland.	Katia.Iglesias@hefr.ch	Gachoud, Céline/K-1104-2018; Lannoy, Séverine/AAN-8312-2021; Baggio, Stephanie/J-6009-2017	Iglesias, Katia/0000-0003-1308-1631; Baggio, Stephanie/0000-0002-5347-5937	Swiss National Science Foundation [10001C_173418/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Grant awarded to SB and KI: Swiss National Science Foundation, no. 10001C_173418/1 URL: www.snf.ch/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Andreasson S, 2016, ADDICTION, V111, P1727, DOI 10.1111/add.13278; Baggio S, ADDICTION; Biondi A, 2019, FORENSIC SCI INT, V300, P106, DOI 10.1016/j.forsciint.2019.05.004; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Boscolo-Berto R, 2013, INT J LEGAL MED, V127, P611, DOI 10.1007/s00414-012-0809-0; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cabarcos P, 2015, ANAL BIOANAL CHEM, V407, P4907, DOI 10.1007/s00216-015-8701-7; Crunelle CL, 2014, DRUG ALCOHOL DEPEN, V134, P1, DOI 10.1016/j.drugalcdep.2013.10.008; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Delker E, 2016, ALCOHOL RES-CURR REV, V38, P7; Dupuis M, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14017; Enoch MA, 2006, ANN NY ACAD SCI, V1094, P193, DOI 10.1196/annals.1376.019; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Gmel G., 2015, SUCHT, V61, P251, DOI [10.1024/0939-5911.a000380, DOI 10.1024/0939-5911.A000380]; Gmel G, 2014, J STUD ALCOHOL DRUGS, V75, P880, DOI 10.15288/jsad.2014.75.880; Iglesias K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023632; Kharbouche H, 2009, J CHROMATOGR B, V877, P2337, DOI 10.1016/j.jchromb.2008.11.046; Kuntsche E, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13826; Leigh BC, 2000, J SUBST ABUSE, V12, P51, DOI 10.1016/S0899-3289(00)00040-7; Liskola J, 2018, DRUG ALCOHOL DEPEN, V188, P266, DOI 10.1016/j.drugalcdep.2018.04.015; Moss HB, 2013, SOC WORK PUBLIC HLTH, V28, P175, DOI 10.1080/19371918.2013.758987; Oppolzer D, 2019, FORENSIC SCI INT, V294, P39, DOI 10.1016/j.forsciint.2018.10.028; Pearson MR, 2016, ADDICTION, V111, P1720, DOI 10.1111/add.13210; Pirro V, 2011, FORENSIC SCI INT, V210, P271, DOI 10.1016/j.forsciint.2011.03.026; Pragst F, 1998, Forensic Sci Rev, V10, P81; Pragst F, 2017, FORENSIC SCI INT, V278, P326, DOI 10.1016/j.forsciint.2017.07.023; Regie federale des alcools (RFA), 2017, ALC CHIFFR 2017; Sacks Jeffrey J, 2015, Am J Prev Med, V49, pe73, DOI 10.1016/j.amepre.2015.05.031; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Society of Hair Testing, 2016, GLOB STRAT RED HARMF; Studer J, 2013, DRUG ALCOHOL DEPEN, V132, P316, DOI 10.1016/j.drugalcdep.2013.02.029; Tuunanen M, 2007, DRUG ALCOHOL REV, V26, P295, DOI 10.1080/09595230701247756; World Health Organization, 2018, AIR POLL CHILD HLTH; 2019, WHO TECH REP SER, V1022, P1	35	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244336	10.1371/journal.pone.0244336	http://dx.doi.org/10.1371/journal.pone.0244336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362226	Green Published, gold			2022-12-26	WOS:000603071600036
J	Kim, T; Bahk, J; Lim, HK; Khang, YH				Kim, Taejae; Bahk, Jinwook; Lim, Hwa Kyung; Khang, Young-Ho			Stagnation of life expectancy in Korea in 2018: A cause-specific decomposition analysis	PLOS ONE			English	Article							PNEUMONIA	According to the most recent annual report released by Korea Statistics, the life expectancy at birth (for both sexes) in 2018 was 82.7 years, an increase of 0.0 years over 2017, reflecting the first stagnation in life expectancy since 1960. In this study, a time-series analysis was conducted of trends in life expectancy from 2003 to 2018, and causes of death were analyzed using the Kannisto-Thatcher method and the Arriaga decomposition method. The time trend analysis of yearly life expectancy changes indicated that, in Korea, there was a tendency for the yearly increase in life expectancy between 2003 and 2018 to decrease by 0.0211 years per calendar year. The contribution of cardiovascular diseases, the most important contributor to the life expectancy increase in Korea, gradually decreased over this period. The contribution of cardiovascular diseases to the life expectancy increase was 0.506 years in 2003-2006, but this contribution decreased to 0.218 years in 2015-2018. The positive contributions of ill-defined causes and external causes to life expectancy increase detected in previous periods were not evident in 2015-2018. Diseases of the respiratory system made the largest negative contribution both between 2015 and 2018 and between 2017-2018. The life expectancy stagnation in 2018 could be understood as the combined effect of (a) decreasing momentum in the increase of life expectancy and (b) a chance event in 2018 involving life expectancy. Currently, it is difficult to judge whether the stagnation of life expectancy in 2018 is temporary, and further analyses of life expectancy and contributing causes of death in the future are needed.	[Kim, Taejae; Khang, Young-Ho] Seoul Natl Univ, Dept Hlth Policy & Management, Coll Med, Seoul, South Korea; [Bahk, Jinwook] Keimyung Univ, Dept Publ Hlth, Daegu, South Korea; [Lim, Hwa Kyung; Khang, Young-Ho] Seoul Natl Univ, Inst Hlth Policy & Management, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Keimyung University; Seoul National University (SNU)	Khang, YH (corresponding author), Seoul Natl Univ, Dept Hlth Policy & Management, Coll Med, Seoul, South Korea.; Khang, YH (corresponding author), Seoul Natl Univ, Inst Hlth Policy & Management, Med Res Ctr, Seoul, South Korea.	yhkhang@snu.ac.kr		KIM, TAEJAE/0000-0001-9409-9352	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI18C0446]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0446). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Bergeron-Boucher MP, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173093; Byeon KH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e121; Cho YJ, 2011, TUBERC RESPIR DIS, V70, P224, DOI 10.4046/trd.2011.70.3.224; Khang YH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030683; Khang YH, 2019, YONSEI MED J, V60, P687, DOI 10.3349/ymj.2019.60.7.687; Kim CH, 2015, ANN GERIATR MED RES, V19, P80, DOI 10.4235/jkgs.2015.19.2.80; Korea CDC, 2019, 2018 INF DIS SURV YB; Lee HB, 2011, TUBERC RESPIR DIS, V70, P105, DOI 10.4046/trd.2011.70.2.105; OECD, 2019, NEG OUR WAY UP; Park Kyung Ae, 2001, [Korea Journal of Population Studies, 한국인구학], V24, P67; Statistics Korea, 2019, 2018 ANN REP CAUS DE; Statistics Korea, 2019, 2018 LIF TABL BRIEF; Statistics Korea, 2017, 2017 ANN REP CAUS DA; Thatcher A. R., 1998, FORCE MORTALITY AGES; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; Yang S, 2010, AM J PUBLIC HEALTH, V100, P896, DOI 10.2105/AJPH.2009.160341	17	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244380	10.1371/journal.pone.0244380	http://dx.doi.org/10.1371/journal.pone.0244380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347505	Green Published, gold			2022-12-26	WOS:000603071100064
J	Jamshidi, S; Yadollahi, A; Arab, MM; Soltani, M; Eftekhari, M; Shiri, J				Jamshidi, Saeid; Yadollahi, Abbas; Arab, Mohammad Mehdi; Soltani, Mohammad; Eftekhari, Maliheh; Shiri, Jalal			High throughput mathematical modeling and multi-objective evolutionary algorithms for plant tissue culture media formulation: Case study of pear rootstocks	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; ARTIFICIAL NEURAL-NETWORK; SURFACE METHODOLOGY RSM; REFERENCE EVAPOTRANSPIRATION; INORGANIC NITROGEN; GEP MODEL; TREE; MICROPROPAGATION; PROLIFERATION; GROWTH	Simplified prediction of the interactions of plant tissue culture media components is of critical importance to efficient development and optimization of new media. We applied two algorithms, gene expression programming (GEP) and M5' model tree, to predict the effects of media components on in vitro proliferation rate (PR), shoot length (SL), shoot tip necrosis (STN), vitrification (Vitri) and quality index (QI) in pear rootstocks (Pyrodwarf and OHF 69). In order to optimize the selected prediction models, as well as achieving a precise multi-optimization method, multi-objective evolutionary optimization algorithms using genetic algorithm (GA) and particle swarm optimization (PSO) techniques were compared to the mono-objective GA optimization technique. A Gamma test (GT) was used to find the most important determinant input for optimizing each output factor. GEP had a higher prediction accuracy than M5' model tree. GT results showed that BA (Gamma = 4.0178), Mesos (Gamma = 0.5482), Mesos (Gamma = 184.0100), Micros (Gamma = 136.6100) and Mesos (Gamma = 1.1146), for PR, SL, STN, Vitri and QI respectively, were the most important factors in culturing OHF 69, while for Pyrodwarf culture, BA (Gamma = 10.2920), Micros (Gamma = 0.7874), NH4NO3 (Gamma = 166.410), KNO3 (Gamma = 168.4400), and Mesos (Gamma = 1.4860) were the most important influences on PR, SL, STN, Vitri and QI respectively. The PSO optimized GEP models produced the best outputs for both rootstocks.	[Jamshidi, Saeid; Yadollahi, Abbas; Arab, Mohammad Mehdi; Eftekhari, Maliheh] Tarbiat Modares Univ TMU, Dept Hort Sci, Fac Agr, Tehran, Iran; [Arab, Mohammad Mehdi] Univ Tehran UT, Dept Hort Sci, Coll Aburaihan, Tehran, Iran; [Soltani, Mohammad] Univ Tehran, Dept Irrigat & Drainage Engn, Coll Aburaihan, Tehran, Iran; [Shiri, Jalal] Univ Tabriz, Dept Water Engn, Fac Agr, Tabriz, Iran	Tarbiat Modares University; University of Tehran; University of Tabriz	Yadollahi, A (corresponding author), Tarbiat Modares Univ TMU, Dept Hort Sci, Fac Agr, Tehran, Iran.	yadollah@modares.ac.ir	Soltani, Mohammad/CAF-8113-2022		Tarbiat Modares University Technological Research Core [IG-461 39806]	Tarbiat Modares University Technological Research Core	This work was supported by the Tarbiat Modares University Technological Research Core [grant number IG-461 39806].	Ali I, 2018, J MOL LIQ, V250, P1, DOI 10.1016/j.molliq.2017.11.163; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2006, GENE EXPRESSION PROG; Arab MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01853; Arab MM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01526; Arab MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27858-4; Aygun A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00225; Bajaj YPS., 1986, BIOTECHNOLOGY AGR FO; Banzhaf W, 1998, GEN PROGR 1 EUR WORK, V1; Baviera JA, 1988, 5 INT S PEAR GROW, V256, P63; Behnood A, 2015, CONSTR BUILD MATER, V94, P137, DOI 10.1016/j.conbuildmat.2015.06.055; Benali L, 2019, RENEW ENERG, V132, P871, DOI 10.1016/j.renene.2018.08.044; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bhowmik S, 2019, FUEL, V235, P317, DOI 10.1016/j.fuel.2018.07.116; Bilgili M, 2010, METEOROL ATMOS PHYS, V110, P59, DOI 10.1007/s00703-010-0104-x; Burgac A, 2019, ENERGY, V170, P1202, DOI 10.1016/j.energy.2018.12.090; Cassells AC., 2011, PLANT TISSUE CULT DE, V378, P223; Damiano C., 2009, Italus Hortus, V16, P113; Dey P, 2016, ENERGY, V95, P447, DOI 10.1016/j.energy.2015.12.021; Dikmen E, 2015, NEURAL COMPUT APPL, V26, P409, DOI 10.1007/s00521-014-1723-9; Durillo JJ, 2010, IEEE T EVOLUT COMPUT, V14, P618, DOI 10.1109/TEVC.2009.2034647; Eftekhari M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00837; Emamipour N, 2019, APPL MICROBIOL BIOT, P1; Esha R, 2020, ECOHYDROLOGY, V13, DOI 10.1002/eco.2242; Etemad-Shahidi A, 2012, J HYDRAUL ENG, V138, P542, DOI 10.1061/(ASCE)HY.1943-7900.0000550; Evans D, 2002, P ROY SOC A-MATH PHY, V458, P2759, DOI 10.1098/rspa.2002.1010; Ferreira C., 2001, Complex Systems, V13, P87; Ferreira C., 2001, CS0102027 ARXIV; Gago J, 2010, J PLANT PHYSIOL, V167, P23, DOI 10.1016/j.jplph.2009.07.007; Gago J, 2010, VITIS VINIFERA, P241; Gago J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085989; Gago J, 2011, J PLANT PHYSIOL, V168, P1858, DOI 10.1016/j.jplph.2011.04.008; Gallego PP, 2011, ARTIFICIAL NEURAL NETWORKS - METHODOLOGICAL ADVANCES AND BIOMEDICAL APPLICATIONS, P197; Gandomi AH, 2012, NEURAL COMPUT APPL, V21, P171, DOI 10.1007/s00521-011-0734-z; Gandomi AH, 2010, J MECH MATER STRUCT, V5, P735, DOI 10.2140/jomms.2010.5.735; Garcia-Nieto PJ, 2019, ECOL ENG, V130, P198, DOI 10.1016/j.ecoleng.2019.02.020; Ghaedrahmat Z, 2019, ENVIRON SCI POLLUT R, P1; Goldberg D. E., 1989, COMPLEX SYST, V3, P493, DOI DOI 10.1007/978-1-4757-3643-4; Grigoriadou K, 1998, 25 INT HORT C 10, V520, P103; Hashemi SH, 2019, ANALYST, V144, P3525, DOI [10.1039/c9an00165d, 10.1039/C9AN00165D]; Hong T, 2018, APPL ENERG, V228, P808, DOI 10.1016/j.apenergy.2018.06.106; Huang SM, 2017, ULTRASON SONOCHEM, V36, P112, DOI 10.1016/j.ultsonch.2016.11.016; Ikinci A, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-71; Ivanova M, 2009, PLANT CELL TISS ORG, V99, P167, DOI 10.1007/s11240-009-9589-8; Jacob H. B., 1997, ISHS ACTA HORT, V475, P169; Jamshidi S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00274; Jamshidi S, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0520-y; Janani P, 2020, CURR J APPL SCI TECH, P1; Kadota M, 2003, PLANT CELL TISS ORG, V72, P261, DOI 10.1023/A:1022378511659; Karimaldini F, 2012, J IRRIG DRAIN ENG, V138, P21, DOI 10.1061/(ASCE)IR.1943-4774.0000343; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kumar A, 2019, WATER RESOUR MANAG, V33, P1217, DOI 10.1007/s11269-018-2178-z; Leon LP, 2019, CONSTR BUILD MATER, V211, P470, DOI 10.1016/j.conbuildmat.2019.03.225; Li LJ, 2019, APPL SOFT COMPUT, V81, DOI 10.1016/j.asoc.2019.105490; Lotfi M, 2019, PLANT GROWTH REGUL, V88, P173, DOI 10.1007/s10725-019-00498-y; Lv L, 2019, FUTURE GENER COMP SY, V91, P37, DOI 10.1016/j.future.2018.07.047; Malik A, 2018, J IRRIG DRAIN ENG, V144, DOI [10.1061/(ASCE)IR.1943-4774.0001336, 10.1061/(asce)ir.1943-4774.0001336]; Mansseri-Lamrioui A, 2009, EFFECT MEDIUM CULTUR; Maran JP, 2013, CARBOHYD POLYM, V92, P604, DOI 10.1016/j.carbpol.2012.09.020; Mazhar S, 2019, CHEMOSPHERE, V227, P256, DOI 10.1016/j.chemosphere.2019.04.022; Micieli D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38903-1; Antonio LM, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P2758; Mirjalili S, 2019, STUD COMPUT INTELL, V780, P43, DOI 10.1007/978-3-319-93025-1_4; Moghaddamnia A, 2009, J ATMOS SOL-TERR PHY, V71, P975, DOI 10.1016/j.jastp.2009.04.009; MURASHIGE T, 1974, ANNU REV PLANT PHYS, V25, P135, DOI 10.1146/annurev.pp.25.060174.001031; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nas MN, 2004, SCI HORTIC-AMSTERDAM, V101, P189, DOI 10.1016/j.scienta.2003.10.004; Nazari A, 2019, NEURAL COMPUT APPL, V31, P767, DOI 10.1007/s00521-012-1137-5; Nazari A, 2013, NEURAL COMPUT APPL, V23, P1677, DOI 10.1007/s00521-012-1127-7; Niedz RP, 2007, IN VITRO CELL DEV-PL, V43, P370, DOI 10.1007/s11627-007-9062-5; Niu WJ, 2018, APPL SOFT COMPUT, V70, P562, DOI 10.1016/j.asoc.2018.06.011; Nowak B, 2007, ACTA PHYSIOL PLANT, V29, P479, DOI 10.1007/s11738-007-0058-x; Oliveira V, 2019, J CLEAN PROD, V210, P401, DOI 10.1016/j.jclepro.2018.11.063; Pal M, 2009, HYDROL PROCESS, V23, P1437, DOI 10.1002/hyp.7266; Petri C, 2010, ANN APPL BIOL, V156, P79, DOI 10.1111/j.1744-7348.2009.00364.x; Pilkington JL, 2014, IND CROP PROD, V58, P15, DOI 10.1016/j.indcrop.2014.03.016; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Rahimikhoob A, 2013, WATER RESOUR MANAG, V27, P4815, DOI 10.1007/s11269-013-0440-y; Ramage CM, 2002, IN VITRO CELL DEV-PL, V38, P116, DOI [10.1079/IVP2002269, 10.1079/IVP2001269]; Reed BM, 2013, IN VITRO CELL DEV-PL, V49, P343, DOI [10.1007/s11627-013-9556-2, 10.1007/s11627-013-9504-1]; Remesan R, 2008, HYDROL PROCESS, V22, P4301, DOI 10.1002/hyp.7044; Roy S, 2015, APPL ENERG, V140, P52, DOI 10.1016/j.apenergy.2014.11.065; Rui D, 2011, ROM BIOTECH LETT, V16, P6631; Sedghi M, 2012, BRAZ J POULTRY SCI, V14, P57, DOI 10.1590/S1516-635X2012000100010; Shirdel M, 2011, J MED PLANTS RES, V5, P4605; Shiri J, 2014, COMPUT ELECTRON AGR, V108, P230, DOI 10.1016/j.compag.2014.08.007; Shiri J, 2012, J HYDROL, V414, P302, DOI 10.1016/j.jhydrol.2011.11.004; Stefansson A, 1997, NEURAL COMPUT APPL, V5, P131, DOI 10.1007/BF01413858; Thakur A, 2008, NOT BOT HORTI AGROBO, V36, P104; Wada S, 2015, IN VITRO CELL DEV-PL, V51, P19, DOI 10.1007/s11627-015-9662-4; Wada S, 2013, IN VITRO CELL DEV-PL, V49, P356, DOI 10.1007/s11627-013-9508-x; Wang Y, 1997, P EUR C MACH LEARN; Zhong JH, 2017, IEEE COMPUT INTELL M, V12, P54, DOI 10.1109/MCI.2017.2708618; Zou DX, 2019, APPL ENERG, V237, P646, DOI 10.1016/j.apenergy.2019.01.056	95	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243940	10.1371/journal.pone.0243940	http://dx.doi.org/10.1371/journal.pone.0243940			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338074	gold, Green Published			2022-12-26	WOS:000601313500001
J	Grillo, M; Palmer, C; Holmes, N; Sang, F; Larner, AC; Bhosale, R; Shaw, PE				Grillo, Michela; Palmer, Carolyn; Holmes, Nadine; Sang, Fei; Larner, Andrew C.; Bhosale, Rahul; Shaw, Peter E.			Stat3 oxidation-dependent regulation of gene expression impacts on developmental processes and involves cooperation with Hif-1 alpha	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; SIGNAL TRANSDUCER; BINDING-SITES; UNPHOSPHORYLATED STAT3; VEGF EXPRESSION; TARGET GENES; TRANSCRIPTION; ACTIVATION; GROWTH; TRANSFORMATION	Reactive oxygen species are bona fide intracellular second messengers that influence cell metabolism and aging by mechanisms that are incompletely resolved. Mitochondria generate superoxide that is dis-mutated to hydrogen peroxide, which in turn oxidises cysteine-based enzymes such as phosphatases, peroxiredoxins and redox-sensitive transcription factors to modulate their activity. Signal Transducer and Activator of Transcription 3 (Stat3) has been shown to participate in an oxidative relay with peroxiredoxin II but the impact of Stat3 oxidation on target gene expression and its biological consequences remain to be established. Thus, we created murine embryonic fibroblasts (MEFs) that express either WT-Stat3 or a redox-insensitive mutant of Stat3 (Stat3-C3S). The Stat3-C3S cells differed from WT-Stat3 cells in morphology, proliferation and resistance to oxidative stress; in response to cytokine stimulation, they displayed elevated Stat3 tyrosine phosphorylation and Socs3 expression, implying that Stat3-C3S is insensitive to oxidative inhibition. Comparative analysis of global gene expression in WT-Stat3 and Stat3-C3S cells revealed differential expression (DE) of genes both under basal conditions and during oxidative stress. Using differential gene regulation pattern analysis, we identified 199 genes clustered into 10 distinct patterns that were selectively responsive to Stat3 oxidation. GO term analysis identified down-regulated genes to be enriched for tissue/organ development and morphogenesis and up-regulated genes to be enriched for cell-cell adhesion, immune responses and transport related processes. Although most DE gene promoters contain consensus Stat3 inducible elements (SIEs), our chromatin immunoprecipitation (ChIP) and ChIP-seq analyses did not detect Stat3 binding at these sites in control or oxidant-stimulated cells, suggesting that oxidised Stat3 regulates these genes indirectly. Our further computational analysis revealed enrichment of hypoxia response elements (HREs) within DE gene promoters, implying a role for Hif-1. Experimental validation revealed that efficient stabilisation of Hif-1 alpha in response to oxidative stress or hypoxia required an oxidation-competent Stat3 and that depletion of Hif-1 alpha suppressed the inducible expression of Kcnb1, a representative DE gene. Our data suggest that Stat3 and Hif-1 alpha cooperate to regulate genes involved in immune functions and developmental processes in response to oxidative stress.	[Grillo, Michela; Palmer, Carolyn; Shaw, Peter E.] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham, England; [Holmes, Nadine; Sang, Fei] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Deep Seq Unit, Nottingham, England; [Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Massey Canc Ctr, Richmond, VA USA; [Bhosale, Rahul] Univ Nottingham, Sch Biosci, Loughborough, England	University of Nottingham; University of Nottingham; Virginia Commonwealth University; University of Nottingham	Shaw, PE (corresponding author), Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham, England.	peter.shaw1@nottingham.ac.uk		Sang, Fei/0000-0002-8746-5868; Bhosale, Rahul/0000-0001-6515-4922	British Heart Foundation [FS/11/58/28937, FS/15/43/3156]; BBSRC Discovery Fellowship [BB/S011102/1]; University of Nottingham Future Food Beacon of Excellence Nottingham Research; Massey Cancer Center; NIH [R01GM129260]	British Heart Foundation(British Heart Foundation); BBSRC Discovery Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham Future Food Beacon of Excellence Nottingham Research; Massey Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded with British Heart Foundation PhD Fellowships to CP (FS/11/58/28937) and MG (FS/15/43/3156); RB is supported by a BBSRC Discovery Fellowship (BB/S011102/1) and University of Nottingham Future Food Beacon of Excellence Nottingham Research. Work from ACL's lab was funded by the Massey Cancer Center and a grant from NIH (R01GM129260). https://www.bhf.org.uk/https://bbsrc.ukri.org/https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2006, CARDIOVASC RES, V71, P195, DOI 10.1016/j.cardiores.2006.04.008; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; [Anonymous], 2011, AM J PHYSIOL-HEART C, V301, pH287; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Barry SP, 2013, INT J CARDIOL, V163, P326, DOI 10.1016/j.ijcard.2011.08.849; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Boyden LM, 2020, AM J HUM GENET, V107, P158, DOI 10.1016/j.ajhg.2020.05.013; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cadenas S, 2018, FREE RADICAL BIO MED, V117, P76, DOI 10.1016/j.freeradbiomed.2018.01.024; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Calautti E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010171; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Cui Y, 2016, ONCOL REP, V36, P108, DOI 10.3892/or.2016.4822; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Dong Q, 2012, BOSNIAN J BASIC MED, V12, P158, DOI 10.17305/bjbms.2012.2463; Fishel ML, 2015, J BIOL CHEM, V290, P3057, DOI 10.1074/jbc.M114.621995; Foxler DE, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708304; Galbraith MD, 2013, NUCLEIC ACIDS RES, V41, P10241, DOI 10.1093/nar/gkt837; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Hu HX, 2017, P NATL ACAD SCI USA, V114, P11908, DOI 10.1073/pnas.1704723114; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kang K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-4; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li L, 2006, J BIOL CHEM, V281, P33172, DOI 10.1074/jbc.M606940200; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mehta NU, 2016, ARTERIOSCL THROM VAS, V36, P1152, DOI 10.1161/ATVBAHA.115.306991; Meier JA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2588; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nechemia-Arbely Y, 2013, CLIN EXP PHARMACOL P, V40, P262, DOI 10.1111/1440-1681.12064; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Pawlus MR, 2014, ONCOGENE, V33, P1670, DOI 10.1038/onc.2013.115; Paz K, 2004, ONCOGENE, V23, P8455, DOI 10.1038/sj.onc.1207803; Poli V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00121; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Roder K, 2006, BIOL CHEM, V387, P1237, DOI 10.1515/BC.2006.153; Sakamoto T, 2020, CIRC RES, V126, P1685, DOI 10.1161/CIRCRESAHA.119.316100; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sekkai D, 2005, STEM CELLS, V23, P1634, DOI 10.1634/stemcells.2005-0182; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sesti F, 2016, AGING DIS, V7, P130, DOI 10.14336/AD.2015.0901; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suply T, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal0180; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Tempel D, 2012, CIRC RES, V111, P585, DOI 10.1161/CIRCRESAHA.111.262097; Torbica T, 2019, J INVEST DERMATOL, V139, P1583, DOI 10.1016/j.jid.2018.12.030; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; Vougier S, 2007, BIOCHEM BIOPH RES CO, V364, P627, DOI 10.1016/j.bbrc.2007.10.044; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xu L, 2015, NUCLEIC ACIDS RES, V43, P8898, DOI 10.1093/nar/gkv911; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100	78	2	2	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244255	10.1371/journal.pone.0244255	http://dx.doi.org/10.1371/journal.pone.0244255			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332446	Green Published, gold			2022-12-26	WOS:000601310900098
J	Hasan, NI; Taib, AM; Muhammad, NS; Yazid, MRM; Mutalib, AA; Hasbollah, DZA				Hasan, Noor Ibrahim; Mohd Taib, Aizat; Muhammad, Nur Shazwani; Mat Yazid, Muhamad Razuhanafi; Mutalib, Azrul A.; Abang Hasbollah, Dayang Zulaika			Effectiveness of strip footing with geogrid reinforcement for different types of soils in Mosul, Iraq	PLOS ONE			English	Article							ULTIMATE BEARING CAPACITY; SAND; BEHAVIOR; MODEL; FOUNDATIONS; SETTLEMENT; DESIGN	The main cause of problematic soil failure under a certain load is due to low bearing capacity and excessive settlement. With a growing interest in employing shallow foundation to support heavy structures, it is important to study the soil improvement techniques. The technique of using geosynthetic reinforcement is commonly applied over the last few decades. This paper aims to determine the effect of using geogrid Tensar BX1500 on the bearing capacity and settlement of strip footing for different types of soils, namely Al-Hamedat, Ba'shiqah, and Al-Rashidia in Mosul, Iraq. The analysis of reinforced and unreinforced soil foundations was conducted numerically and analytically. A series of conditions were tested by varying the number (N) and the width (b) of the geogrid layers. The results showed that the geogrid could improve the footing's bearing capacity and reduce settlement. The soil of the Al-Rashidia site was sandy and indicated better improvement than the other two sites' soils (clayey soils). The optimum geogrid width (b) was five times the footing width (B), while no optimum geogrid number (N) was obtained. Finally, the numerical results of the ultimate bearing capacity were compared with the analytical results, and the comparison showed good agreement between both the analyses and the optimum range published in the literature. The significant findings reveal that the geogrid reinforcement may induce improvement to the soil foundation, however, not directly subject to the width and number of the geogrid alone. The varying soil properties and footing size also contribute to both BCR and SRR values supported by the improvement factor calculations. Hence, the output complemented the benefit of applying reinforced soil foundations effectively.	[Hasan, Noor Ibrahim; Mohd Taib, Aizat; Muhammad, Nur Shazwani; Mat Yazid, Muhamad Razuhanafi; Mutalib, Azrul A.] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Bangi Ukm, Selangor, Malaysia; [Abang Hasbollah, Dayang Zulaika] Univ Teknol Malaysia, Sch Civil Engn, Fac Engn, Skudai, Johor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Teknologi Malaysia	Taib, AM (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Bangi Ukm, Selangor, Malaysia.	amohdtaib@ukm.edu.my	Hasbollah, Dayang Zulaika Abang/AAL-7628-2021; Mohd Taib, Aizat/GLN-4759-2022	Mohd Taib, Aizat/0000-0002-0307-3016	Universiti Kebangsaan Malaysia [GGPM-2018-039]	Universiti Kebangsaan Malaysia	Initials of author: AMT Grant number: GGPM-2018-039 Funder: Universiti Kebangsaan Malaysia URL: https://www.ukm.my/portal/Sponsors role: Pay publication fees and provide project equipment.	Adams M. T., 1997, J GEOTECHNICAL GEOEN, V123; Ahmed A, 2008, GEOTECHNICAL ENGINEERING FOR DISASTER MITIGATION AND REHABILITATION, P1003, DOI 10.1007/978-3-540-79846-0_133; Akinmusuru J. O., 1981, J GEOTECHNICAL GEOEN, V107; Alawaji H. A., 1998, J KING SAUD U ENG SC, V10; [Anonymous], 2012, Kidney Int Suppl (2011), V2, P156; [Anonymous], 2008, ELECTRON J GEOTECH E; [Anonymous], 1883, APPL POTENTIALS ETUD; [Anonymous], 2009, DIABETES CARE S1, V27, ps5; [Anonymous], 2003, FRONT BIOSCI J VIS L, V8, pd1128; [Anonymous], 1997, J ENERGY NATURAL RES, V15, P313; [Anonymous], 2017, CIRC RES, V120, pe6; Azrief M., 2019, EAGE GSM 2 AS PAC M; Azzam WR, 2015, J ADV RES, V6, P727, DOI 10.1016/j.jare.2014.04.003; Binquet J., 1975, J GEOTECHNICAL GEOEN, V101; Boushehrian AH, 2011, GEOTEXT GEOMEMBRANES, V29, P242, DOI 10.1016/j.geotexmem.2010.11.008; Brinkgreve R., 2014, PLAXIS 2014; Brinkgreve R. B. J., 1998, FINITE ELEMENT CODE; Chen Q., 2011, ASCE P GEOFR 2011 C; Chen QM, 2007, TRANSPORT RES REC, P28, DOI 10.3141/2004-04; Chen QM, 2015, SOILS FOUND, V55, P74, DOI 10.1016/j.sandf.2014.12.006; Chik Z, 2014, ARAB J GEOSCI, V7, P4877, DOI 10.1007/s12517-013-1128-6; Das B. M., 1996, INT SOC OFFSH POL EN; El Sawwaf MA, 2007, GEOTEXT GEOMEMBRANES, V25, P50, DOI 10.1016/j.geotexmem.2006.06.001; Gabr M. A., 1998, GEOSYNTHETICS FDN RE; Goldscheider M, 1982, WORKSH CONST REL SOI, P11; GUIDO VA, 1986, CAN GEOTECH J, V23, P435, DOI 10.1139/t86-073; Han J, 2011, J MATER CIVIL ENG, V23, P1525, DOI 10.1061/(ASCE)MT.1943-5533.0000286; HUANG CC, 1990, GEOTEXT GEOMEMBRANES, V9, P51, DOI 10.1016/0266-1144(90)90005-W; Huang ZF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229532; Hussein MG, 2016, GEOTEXT GEOMEMBRANES, V44, P295, DOI 10.1016/j.geotexmem.2015.12.004; JohSungHo, 2011, [JOURNAL OF THE KOREAN SOCIETY FOR RAILWAY, 한국철도학회논문집], V14, P256; Khajehzadeh M, 2011, J ZHEJIANG UNIV-SC A, V12, P415, DOI 10.1631/jzus.A1000252; KHING KH, 1993, GEOTEXT GEOMEMBRANES, V12, P351, DOI 10.1016/0266-1144(93)90009-D; Kumar N., 2012, AM J MAT SCI, V2, P41, DOI DOI 10.5923/j.materials.20120201.08; Kurian NP, 1997, J GEOTECH GEOENVIRON, V123, P818, DOI 10.1061/(ASCE)1090-0241(1997)123:9(818); Lee K., 2011, CANADIAN GEOTECHNICA, V36, P793; Leshchinsky D, 2009, J GEOTECH GEOENVIRON, V135, P309, DOI 10.1061/(ASCE)1090-0241(2009)135:3(309); Li YP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206626; Liu SY, 2008, GEOSYNTH INT, V15, P43, DOI 10.1680/gein.2008.15.1.43; LOVE JP, 1987, CAN GEOTECH J, V24, P611, DOI 10.1139/t87-075; MANDAL JN, 1992, GEOTEXT GEOMEMBRANES, V11, P327, DOI 10.1016/0266-1144(92)90007-W; Meyerhof G. G, 1963, ULTIMATE BEARING CAP; Michalowski RL, 2004, J GEOTECH GEOENVIRON, V130, P381, DOI 10.1061/(ASCE)1090-0241(2004)130:4(381); OMAR MT, 1993, CAN GEOTECH J, V30, P545, DOI 10.1139/t93-046; Pelton M. R., 1994, P E WORKSH BLACK RES, V12, P133; Raftari M., 2013, ELECT J GEOTECHNICAL, V18; Ren Y., 2015, IMMEDIATE LOAD SETTL; Rosyidi SA, 2010, J KEJURUTER, V22, P75, DOI 10.17576/jkukm-2010-22-08; Rowe RK, 2008, GEOTEXT GEOMEMBRANES, V26, P239, DOI 10.1016/j.geotexmem.2007.10.001; Sakti J. P., 1987, TRANSPORTATION RES B; Sharma R, 2009, GEOTEXT GEOMEMBRANES, V27, P63, DOI 10.1016/j.geotexmem.2008.07.002; Shin E.C., 1993, GEOTECH TEST J, V16, P534, DOI DOI 10.1520/GTJ10293J; Sieira ACF, 2016, INT J ENG RES APPL, V6, P15; TRAUTMANN CH, 1988, J GEOTECH ENG-ASCE, V114, P168, DOI 10.1061/(ASCE)0733-9410(1988)114:2(168); Vidal M. H, 1978, P S EARTH REINF ASCE, P1; Wang C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220643; Wang JQ, 2018, GEOTEXT GEOMEMBRANES, V46, P586, DOI 10.1016/j.geotexmem.2018.04.009; Wang YK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227957; Wayne M. H., 1998, DESIGN GEOSYNTHETIC; Xie LQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211312; Yang K.-H., 2013, J GEO ENG, V8, P41, DOI DOI 10.6310/JOG.2013.8(2).2; YETIMOGLU T, 1994, J GEOTECH ENG-ASCE, V120, P2083, DOI 10.1061/(ASCE)0733-9410(1994)120:12(2083); Zhou HB, 2008, GEOTEXT GEOMEMBRANES, V26, P231, DOI 10.1016/j.geotexmem.2007.10.002; Zornberg JG, 2003, P INT S EARTH REINF, V2, P1095	64	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243293	10.1371/journal.pone.0243293	http://dx.doi.org/10.1371/journal.pone.0243293			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332375	Green Published, gold			2022-12-26	WOS:000601310900113
J	Titinchi, F; Morkel, J				Titinchi, Fadi; Morkel, Jean			Residual cyst of the jaws: A clinico-pathologic study of this seemingly inconspicuous lesion	PLOS ONE			English	Article							ODONTOGENIC CYST; PREVALENCE	Objectives Residual cysts are relatively rare inflammatory cysts of the jaws. They are essentially radicular cysts without the presence of the offending dentition. These lesions have the ability to destroy bone within the jaws without any symptoms. Moreover, they can mimic more aggressive cysts and tumours on radiographs. The aim of this study was to describe the clinico-pathological features of residual cysts in order to discern them from other cystic lesions as well as analyse their management and recurrence patterns. Materials and methods Sixty-four histopathologically confirmed residual cysts were analysed based on their clinical, radiological and histopathological features. Their management and follow-up were also noted. Results The majority of lesions presented in elderly (46.8%), edentulous patients (60.9%) and were most commonly found in the posterior regions of the mandible (51.6%). Clinico-pathological features that aided in their diagnosis included long-standing history with slow growing swelling and presence of well-defined, unilocular cystic lesion associated with previously extracted dentition. Enucleation was a successful method in the management of residual cysts with very low recurrence rate (1.6%). Two patients (3.1%) developed squamous cell carcinoma from the cyst lining. Conclusion Residual cysts should be high on the list of differential diagnosis when elderly, edentulous patients present with cystic lesions in the jaws compared to dentate patients (P<0.01). All lesions should by biopsied and sent for histopathological examination along with radiological correlation as they have the potential to transform into primary intra-osseous squamous cell carcinoma with devastating consequences to the patient.	[Titinchi, Fadi; Morkel, Jean] Univ Western Cape, Tygerberg Oral Hlth Ctr, Dept Maxillofacial & Oral Surg, Fac Dent, Cape Town, South Africa; [Titinchi, Fadi; Morkel, Jean] Univ Western Cape, Tygerberg Oral Hlth Ctr, WHO Collaborating Ctr, Cape Town, South Africa	University of Limpopo; University of the Western Cape; University of the Western Cape; World Health Organization	Titinchi, F (corresponding author), Univ Western Cape, Tygerberg Oral Hlth Ctr, Dept Maxillofacial & Oral Surg, Fac Dent, Cape Town, South Africa.	ftitinchi@uwc.ac.za	Titinchi, Fadi/ABI-3758-2020	Titinchi, Fadi/0000-0003-3182-7038				Acikgoz A, 2012, MED ORAL PATOL ORAL, V17, pE108, DOI 10.4317/medoral.17088; Allon DM, 2015, J ORAL MAXIL SURG, V73, P649, DOI 10.1016/j.joms.2014.10.024; [Anonymous], 2011, NAT PHOTONICS, p[5, 15]; [Anonymous], 2014, THEORETICAL EMPIRICA, V1, P24; Avelar Rafael L, 2009, J Oral Sci, V51, P581; Bodner L, 2011, BRIT J ORAL MAX SURG, V49, P643, DOI 10.1016/j.bjoms.2010.10.009; Bodner L, 2011, J ORAL PATHOL MED, V40, P733, DOI 10.1111/j.1600-0714.2011.01058.x; Boffano P, 2010, J CRANIOFAC SURG, V21, P270, DOI 10.1097/SCS.0b013e3181c5a42b; Enislidis G, 2004, BRIT J ORAL MAX SURG, V42, P546, DOI 10.1016/j.bjoms.2004.06.020; Fomete Benjamin, 2016, Oman Med J, V31, P434, DOI 10.5001/omj.2016.87; HIGH AS, 1986, J ORAL PATHOL MED, V15, P524, DOI 10.1111/j.1600-0714.1986.tb00570.x; Hu KS, 1989, KOREAN J ORAL MAXILL, V19, P163; Jamdade A, 2012, CASE REP DENT, V2012, DOI 10.1155/2012/760571; Kambalimath DH, 2014, J MAXILLOFAC ORAL SU, V13, P10, DOI 10.1007/s12663-012-0450-y; Khosravi Negin, 2013, Dent Res J (Isfahan), V10, P162; Ledesma-Montes C, 2000, ARCH MED RES, V31, P373, DOI 10.1016/S0188-4409(00)00069-2; Mosqueda-Taylor A, 2002, Med Oral, V7, P89; Nortjé Christoffel J, 2020, S. Afr. dent. j., V75, P100, DOI 10.17159/2519-0105/2020/v75no2a7; Nunez-Urrutia S, 2010, MED ORAL PATOL ORAL, V15, pE767, DOI 10.4317/medoral.15.e767; Ochsenius German, 2007, Med Oral Patol Oral Cir Bucal, V12, pE85; Schaffer AB, 1997, ORAL SURG ORAL MED O, V83, P640, DOI 10.1016/S1079-2104(97)90309-7; Shear M., 2007, CYSTS ORAL MAXILLOFA, P123; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sridevi K, 2014, J CLIN DIAGN RES, V8, P246, DOI 10.7860/JCDR/2014/7593.4072; Torul D., 2018, BALK J DENT MED, V22, P171; Tsvetanov TS., 2016, INT J MED DENT SCI, V1, P1341	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244250	10.1371/journal.pone.0244250	http://dx.doi.org/10.1371/journal.pone.0244250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332452	Green Published, gold			2022-12-26	WOS:000601310900093
J	Mathew, EN; Hurst, MN; Wang, BL; Murthy, V; Zhang, YT; DeLong, RK				Mathew, Elza Neelima; Hurst, Miranda N.; Wang, Baolin; Murthy, Vaibhav; Zhang, Yuntao; DeLong, Robert K.			Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interference	PLOS ONE			English	Article							POLY IC RNA; MECHANISMS; ENZYME; CELLS	Zinc oxide (ZnO) NP is considered as a nanoscale chemotherapeutic. Thus, the drug delivery of this inorganic NP is of considerable importance. Ras mutations are common in cancer and the activation of this signaling pathway is a hallmark in carcinoma, melanoma and many other aggressive malignancies. Thus, here we examined the binding and delivery of Ras binding domain (RBD), a model cancer-relevant protein and effector of Ras by ZnO NP. Shifts in zeta potential in water, PBS, DMEM and DMEM supplemented with FBS supported NP interaction to RBD. Fluorescence quenching of the NP was concentration-dependent for RBD, Stern-Volmer analysis of this data was used to estimate binding strength which was significant for ZnO-RBD (K-d < 10(-5)). ZnO NP interaction to RBD was further confirmed by pull-down assay demonstrated by SDS-PAGE analysis. The ability of ZnO NP to inhibit 3-D tumor spheroid was demonstrated in HeLa cell spheroids-the ZnO NP breaking apart these structures revealing a significant (>50%) zone of killing as shown by light and fluorescence microscopy after intra-vital staining. ZnO 100 nm was superior to ZnO 14 nm in terms of anticancer activity. When bound to ZnO NP, the anticancer activity of RBD was enhanced. These data indicate the potential diagnostic application or therapeutic activity of RBD-NP complexes in vivo which demands further investigation.	[Mathew, Elza Neelima; Wang, Baolin; Zhang, Yuntao; DeLong, Robert K.] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Nanotechnol Innovat Ctr Kansas State, Manhattan, KS 66506 USA; [Hurst, Miranda N.] Johns Hopkins Univ, Mol Biophys, Kreiger Sch Arts & Sci, Baltimore, MD USA; [Murthy, Vaibhav] Ohio State Univ, Coll Vet Med, Ctr Retrovirus Res, Columbus, OH 43210 USA	Kansas State University; Johns Hopkins University; University System of Ohio; Ohio State University	Mathew, EN (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Nanotechnol Innovat Ctr Kansas State, Manhattan, KS 66506 USA.	elzamathew@ksu.edu		Mathew, Elza Neelima/0000-0002-4156-8183	Johnson Cancer Research Center Innovative Cancer Research Award; Nanotechnology Innovation Center of Kansas State; National Cancer Institute [7R15CA13939003]	Johnson Cancer Research Center Innovative Cancer Research Award; Nanotechnology Innovation Center of Kansas State; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Johnson Cancer Research Center Innovative Cancer Research Award, start-up fund from Nanotechnology Innovation Center of Kansas State and National Cancer Institute (Grant No: 7R15CA13939003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani G, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0186-x; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; [Anonymous], 2012, REGEN MED S3, V7, pS14; Braun K, 2018, TOXICOL IN VITRO, V52, P214, DOI 10.1016/j.tiv.2018.06.019; Carver K, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.5; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/NNANO.2011.58, 10.1038/nnano.2011.58]; Clogston JD, 2011, METHODS MOL BIOL, V697, P63, DOI 10.1007/978-1-60327-198-1_6; Das BK, 2019, CHEM-BIOL INTERACT, V297, P141, DOI 10.1016/j.cbi.2018.11.004; DeLong RK, 2019, J PHARMACOL EXP THER, V370, P671, DOI 10.1124/jpet.118.256230; DeLong RK, 2017, J BIOMED NANOTECHNOL, V13, P221, DOI 10.1166/jbn.2017.2336; El-Boubbou K, 2018, NANOMEDICINE-UK, V13, P953, DOI 10.2217/nnm-2017-0336; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Garcia-Alvarez R, 2018, NANOSCALE, V10, P1256, DOI 10.1039/c7nr08322j; Manshian BB, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601379; Mishra PK, 2017, DRUG DISCOV TODAY, V22, P1825, DOI 10.1016/j.drudis.2017.08.006; Vinardell MP, 2015, NANOMATERIALS-BASEL, V5, P1004, DOI 10.3390/nano5021004; Ramani M, 2017, J PHYS CHEM C, V121, P15702, DOI 10.1021/acs.jpcc.7b02954; Ramani M, 2017, MOL PHARMACEUT, V14, P614, DOI 10.1021/acs.molpharmaceut.6b00795; Rasmussen JW, 2010, EXPERT OPIN DRUG DEL, V7, P1063, DOI 10.1517/17425247.2010.502560; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sousa AA, 2015, J FLUORESC, V25, P1567, DOI 10.1007/s10895-015-1665-3; Stern O, 1919, PHYS Z, V20, P183; Thomas SE, 2018, INT J NANOMED, V13, P4523, DOI 10.2147/IJN.S152222; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Zhang Y, 2013, CURR MOL MED, V13, P1633, DOI 10.2174/1566524013666131111130058	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243802	10.1371/journal.pone.0243802	http://dx.doi.org/10.1371/journal.pone.0243802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326476	Green Published, gold			2022-12-26	WOS:000600176400045
J	Pirim, D; Bunker, CH; Hokanson, JE; Hamman, RF; Demirci, FY; Kamboh, MI				Pirim, Dilek; Bunker, Clareann H.; Hokanson, John E.; Hamman, Richard F.; Demirci, F. Yesim; Kamboh, M. Ilyas			Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels	PLOS ONE			English	Article							AFRICAN BLACKS; RARE VARIANTS; PLASMA-LIPIDS; RISK; LOCI; HDL; POLYMORPHISM; ASSOCIATION; DISEASE; POPULATION	Common variants in the hepatic lipase (LIPC) gene have been shown to be associated with plasma lipid levels; however, the distribution and functional features of rare and regulatory LIPC variants contributing to the extreme lipid phenotypes are not well known. This study was aimed to catalogue LIPC variants by resequencing the entire LIPC gene in 95 non-Hispanic Whites (NHWs) and 95 African blacks (ABs) with extreme HDL-C levels followed by in silico functional analyses. A total of 412 variants, including 43 novel variants were identified; 56 were unique to NHWs and 234 were unique to ABs. Seventy-eight variants in NHWs and 89 variants in ABs were present either in high HDL-C group or low HDL-C group. Two non-synonymous variants (p.S289F, p.T405M), found in NHWs with high HDL-C group were predicted to have damaging effect on LIPC protein by SIFT, MT2 and PP2. We also found several non-coding variants that possibly reside in the circRNA and lncRNA binding sites and may have regulatory potential, as identified in rSNPbase and RegulomeDB databases. Our results shed light on the regulatory nature of rare and non-coding LIPC variants as well as suggest their important contributions in affecting the extreme HDL-C phenotypes.	[Pirim, Dilek; Demirci, F. Yesim; Kamboh, M. Ilyas] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Pirim, Dilek] Bursa Uludag Univ, Dept Mol Biol & Genet, Fac Arts & Sci, Bursa, Turkey; [Bunker, Clareann H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Hokanson, John E.; Hamman, Richard F.] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Uludag University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Kamboh, MI (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	kamboh@pitt.edu	PIRIM, DILEK/ABA-4957-2020	PIRIM, DILEK/0000-0002-0522-9432	National Heart, Lung and Blood Institute (NHLBI) [HL084613]	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung and Blood Institute (NHLBI) grant, HL084613 (M. Ilyas Kamboh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AMEIS D, 1990, J BIOL CHEM, V265, P6552; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2017, J OBSTET GYNECOL NEO, V46, pe125; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Below JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19429; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BUNKER CH, 1995, HYPERTENSION, V26, P616, DOI 10.1161/01.HYP.26.4.616; Bunker CH, 1996, ATHEROSCLEROSIS, V123, P215, DOI 10.1016/0021-9150(96)05810-8; CAI SJ, 1989, BIOCHEMISTRY-US, V28, P8966, DOI 10.1021/bi00449a002; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; COHEN JC, 1994, J CLIN INVEST, V94, P2377, DOI 10.1172/JCI117603; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Connelly PW, 1999, CLIN CHIM ACTA, V286, P243, DOI 10.1016/S0009-8981(99)00105-9; Dugi KA, 2001, CIRCULATION, V104, P3057, DOI 10.1161/hc5001.100795; Evans D, 2011, ATHEROSCLEROSIS, V214, P386, DOI 10.1016/j.atherosclerosis.2010.11.026; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goodarzynejad Hamidreza, 2017, J Tehran Heart Cent, V12, P119; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Harris MR, 1998, ATHEROSCLEROSIS, V137, P187, DOI 10.1016/S0021-9150(97)00230-X; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Isaacs A, 2004, J CLIN ENDOCR METAB, V89, P3858, DOI 10.1210/jc.2004-0188; Jansen H, 2002, J LIPID RES, V43, P1352, DOI 10.1194/jlr.R200008-JLR200; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Katneni UK, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.840; Khovidhunkit W, 2012, AM J CARDIOL, V110, P62, DOI 10.1016/j.amjcard.2012.02.052; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kulminski AM, 2018, AGING-US, V10, P492, DOI 10.18632/aging.101407; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Lu XF, 2016, CIRC-CARDIOVASC GENE, V9, P37, DOI 10.1161/CIRCGENETICS.115.001096; McCaskie PA, 2006, CLIN GENET, V70, P114, DOI 10.1111/j.1399-0004.2006.00659.x; Mohammadzadeh Ghorban, 2016, Adv Biomed Res, V5, P27, DOI 10.4103/2277-9175.176366; Moon S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37832-9; Niemsiri V, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0250-6; Niemsiri V, 2014, CIRC-CARDIOVASC GENE, V7, P838, DOI 10.1161/CIRCGENETICS.114.000559; Patel AP, 2016, ATHEROSCLEROSIS, V250, P63, DOI 10.1016/j.atherosclerosis.2016.04.011; Perret B, 2002, J LIPID RES, V43, P1163, DOI 10.1194/jlr.R100020-JLR200; Pirim D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214060; Pirim D, 2016, METABOLISM, V65, P36, DOI 10.1016/j.metabol.2015.09.020; Pirim D, 2015, EUR J HUM GENET, V23, P1244, DOI 10.1038/ejhg.2014.268; Pirim D, 2014, J LIPID RES, V55, P85, DOI 10.1194/jlr.M043265; Radwan ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114618; Rewers Marian, 1993, Ethnicity and Disease, V3, P44; RICHMOND W, 1973, CLIN CHEM, V19, P1350; Rosenson RS, 2018, NAT REV CARDIOL, V15, P9, DOI 10.1038/nrcardio.2017.115; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Spracklen CN, 2017, HUM MOL GENET, V26, P1770, DOI 10.1093/hmg/ddx062; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Verdier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067805; Verma P, 2016, J CLIN DIAGN RES, V10, pGC1, DOI 10.7860/JCDR/2016/20496.8378; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P2450, DOI 10.1161/ATVBAHA.107.150680; Weissglas-Volkov D, 2013, J MED GENET, V50, P298, DOI 10.1136/jmedgenet-2012-101461; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zhao XS, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0884-4	59	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243919	10.1371/journal.pone.0243919	http://dx.doi.org/10.1371/journal.pone.0243919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326441	Green Published, gold			2022-12-26	WOS:000600176400047
J	Yazdani, M; Shahdadfar, A; Reppe, S; Sapkota, D; Vallenari, EM; Lako, M; Connon, CJ; Figueiredo, FC; Utheim, TP				Yazdani, Mazyar; Shahdadfar, Aboulghassem; Reppe, Sjur; Sapkota, Dipak; Vallenari, Evan M.; Lako, Majlinda; Connon, Che J.; Figueiredo, Francisco C.; Utheim, Tor Paaske			Response of human oral mucosal epithelial cells to different storage temperatures: A structural and transcriptional study	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CULTIVATED LIMBAL; CULTURED LIMBAL; VIABILITY; TRANSPLANTATION; APOPTOSIS; THERAPY; CONJUNCTIVAL; METABOLISM; EXPRESSION	Purpose Seeking to improve the access to regenerative medicine, this study investigated the structural and transcriptional effects of storage temperature on human oral mucosal epithelial cells (OMECs). Methods Cells were stored at four different temperatures (4 degrees C, 12 degrees C, 24 degrees C and 37 degrees C) for two weeks. Then, the morphology, cell viability and differential gene expression were examined using light and scanning electron microscopy, trypan blue exclusion test and TaqMan gene expression array cards, respectively. Results Cells stored at 4 degrees C had the most similar morphology to non-stored controls with the highest viability rate (58%), whereas the 37 degrees C group was most dissimilar with no living cells. The genes involved in stress-induced growth arrest (GADD45B) and cell proliferation inhibition (TGFB2) were upregulated at 12 degrees C and 24 degrees C. Upregulation was also observed in multifunctional genes responsible for morphology, growth, adhesion and motility such as EFEMP1 (12 degrees C) and EPHA4 (4 degrees C-24 degrees C). Among genes used as differentiation markers, PPARA and TP53 (along with its associated gene CDKN1A) were downregulated in all temperature conditions, whereas KRT1 and KRT10 were either unchanged (4 degrees C) or downregulated (24 degrees C and 12 degrees C; and 24 degrees C, respectively), except for upregulation at 12 degrees C for KRT1. Conclusions Cells stored at 12 degrees C and 24 degrees C were stressed, although the expression levels of some adhesion-, growth- and apoptosis-related genes were favourable. Collectively, this study suggests that 4 degrees C is the optimal storage temperature for maintenance of structure, viability and function of OMECs after two weeks.	[Yazdani, Mazyar; Reppe, Sjur; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Yazdani, Mazyar; Shahdadfar, Aboulghassem] Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway; [Reppe, Sjur; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Oslo, Norway; [Reppe, Sjur] Unger Vetlesen Inst, Lovisenberg Diaconal Hosp, Oslo, Norway; [Sapkota, Dipak; Vallenari, Evan M.; Utheim, Tor Paaske] Univ Oslo, Inst Oral Biol, Fac Dent, Oslo, Norway; [Lako, Majlinda; Connon, Che J.; Figueiredo, Francisco C.] Newcastle Univ, Int Ctr Life, Biosci Inst, Fac Med Sci, Biosci West Bldg, Newcastle Upon Tyne, Tyne & Wear, England; [Figueiredo, Francisco C.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne, Tyne & Wear, England; [Figueiredo, Francisco C.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Utheim, Tor Paaske] Stavanger Univ Hosp, Dept Ophthalmol, Stavanger, Norway; [Utheim, Tor Paaske] Sorlandet Hosp Arendal, Dept Ophthalmol, Arendal, Norway; [Utheim, Tor Paaske] Oslo Metropolitan Univ, Dept Comp Sci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Stavanger University Hospital; Oslo Metropolitan University (OsloMet)	Yazdani, M (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.; Yazdani, M (corresponding author), Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway.	mazyar.yazdani.edu@gmail.com	Yazdani, Mazyar/GRJ-3086-2022	Yazdani, Mazyar/0000-0002-9187-3231; Figueiredo, Francisco/0000-0002-5876-288X; Sapkota, Dipak/0000-0003-0061-825X; Shahdadfar, Aboulghassem/0000-0001-9488-6188	South-Eastern Norway Health Authority [2017054]; MRC [G0900879, MR/S035826/1, MC_PC_16054] Funding Source: UKRI	South-Eastern Norway Health Authority; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is financially supported by grants (Project number 2017054) from the South-Eastern Norway Health Authority (www.helsesorost.no) to Professor Tor Paaske Utheim and Dr. Aboulghassem Shahdadfar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmad S, 2012, STEM CELL TRANSL MED, V1, P110, DOI 10.5966/sctm.2011-0037; Ahmad S, 2010, J CELL PHYSIOL, V225, P15, DOI 10.1002/jcp.22251; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2012, BIOMETRY PRINCIPLES; [Anonymous], 1998, DIABETES CARE S, V21, pB1; [Anonymous], 2008, SIGNO PENSAM, V27, P327; Armitage WJ, 2011, TRANSFUS MED HEMOTH, V38, P143, DOI 10.1159/000326632; Atallah MR, 2016, CLIN OPHTHALMOL, V10, P593, DOI 10.2147/OPTH.S83676; Atiyeh BS, 2007, BURNS, V33, P405, DOI 10.1016/j.burns.2006.11.002; Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; Baris OR, 2011, STEM CELLS, V29, P1459, DOI 10.1002/stem.695; Baylis O, 2013, J CELL PHYSIOL, V228, P1025, DOI 10.1002/jcp.24249; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierbaumer L, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1479568; Buschbeck M, 2017, NAT REV MOL CELL BIO, V18, P299, DOI 10.1038/nrm.2016.166; Daniels JT, 2006, REGEN MED, V1, P715, DOI 10.2217/17460751.1.5.715; Dhamodaran K, 2015, MOL VIS, V21, P828; Dolgin E., 2015, NEXT GENERATION STEM, DOI [10.1038/nbt0315-224, DOI 10.1038/NBT0315-224]; Dragunova J, 2012, CELL TISSUE BANK, V13, P471, DOI 10.1007/s10561-011-9275-z; Eidet JR, 2012, EXP EYE RES, V94, P109, DOI 10.1016/j.exer.2011.11.015; Eidet JR, 2015, CURR EYE RES, V40, P30, DOI 10.3109/02713683.2014.909497; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; He H, 2014, SAUDI J OPHTHALMOL, V28, P188, DOI 10.1016/j.sjopt.2014.06.003; Henderson TRM, 2001, BRIT J OPHTHALMOL, V85, P604, DOI 10.1136/bjo.85.5.604; Hibino Y, 1996, J CRANIO MAXILL SURG, V24, P346, DOI 10.1016/S1010-5182(96)80035-7; Hu JF, 2019, CANCER MED-US, V8, P3152, DOI 10.1002/cam4.2144; HUNTER T, 1993, CELL, V75, P839, DOI 10.1016/0092-8674(93)90528-X; Islam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128306; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105808; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kimura J, 2008, NUCLEIC ACIDS RES, V36, P5250, DOI 10.1093/nar/gkn506; Kito K, 2005, CORNEA, V24, P735, DOI 10.1097/01.ico.0000154405.68536.a4; Knapik A, 2013, J PLAST RECONSTR AES, V66, P827, DOI 10.1016/j.bjps.2013.02.003; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Lee EJ, 2005, CRYOBIOLOGY, V50, P103, DOI 10.1016/j.cryobiol.2004.12.001; Liu B, 2015, INT J BIOL SCI, V11, P353, DOI 10.7150/ijbs.9813; Madhira SL, 2008, MOL VIS, V14, P189; Marino-Ramirez L, 2005, EXPERT REV PROTEOMIC, V2, P719, DOI 10.1586/14789450.2.5.719; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Oh JY, 2007, CORNEA, V26, P840, DOI 10.1097/ICO.0b013e318073c1ed; Oie Y, 2014, TISSUE ENG PART C-ME, V20, P373, DOI [10.1089/ten.tec.2013.0266, 10.1089/ten.TEC.2013.0266]; Pasovic L, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/216359; PEGG DE, 1976, J CLIN PATHOL, V29, P271, DOI 10.1136/jcp.29.4.271; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raeder S, 2009, INVEST OPHTH VIS SCI, V50, P1773; Raeder S, 2007, INVEST OPHTH VIS SCI, V48, P5484, DOI 10.1167/iovs.07-0494; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; REIM M, 1988, GRAEF ARCH CLIN EXP, V226, P353, DOI 10.1007/BF02172966; Ronquist G, 2003, EXP DERMATOL, V12, P572, DOI 10.1034/j.1600-0625.2003.00018.x; Schiozer WA, 2013, ACTA CIR BRAS, V28, P824, DOI 10.1590/S0102-86502013001200004; Sehic A, 2015, J FUNCT BIOMATER, V6, P863, DOI 10.3390/jfb6030863; Sejpal Kunjal, 2013, Middle East Afr J Ophthalmol, V20, P5, DOI 10.4103/0974-9233.106381; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Shimazaki J, 2009, INVEST OPHTH VIS SCI, V50, P5672, DOI 10.1167/iovs.09-3820; Smith ADH, 2010, PHYSIOL MEAS, V31, P95, DOI 10.1088/0967-3334/31/1/007; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stoner ML, 1996, BURNS, V22, P197, DOI 10.1016/0305-4179(95)00126-3; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Utheim O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118517; Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591; Utheim TP, 2007, BRIT J OPHTHALMOL, V91, P797, DOI 10.1136/bjo.2006.103218; Utheim TP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152526; Utheim TP, 2015, STEM CELLS, V33, P1685, DOI 10.1002/stem.1999; Vasania Viraf Sam, 2014, J Ophthalmic Vis Res, V9, P407, DOI 10.4103/2008-322X.150800; Wright B, 2012, REGEN MED, V7, P295, DOI [10.2217/RME.12.7, 10.2217/rme.12.7]; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zar JH., 2010, BIOSTAT ANAL, V5th	76	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243914	10.1371/journal.pone.0243914	http://dx.doi.org/10.1371/journal.pone.0243914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326470	Green Published, gold			2022-12-26	WOS:000600176400046
J	Burns, JE; Perez, DR; Li, YM; Garcia, WG; Garcia, FJ; Jimenez, JPG; Sanchez, J; Bueno, MC; Hunger, SP; Reaves, L; Gonzalez, JC; Coffin, SE; Deverlis, A; Steenhoff, AP; Fisher, BT				Burns, Julianne E.; Reyes Perez, Dominga; Li, Yimei; Gomez Garcia, Wendy; Garcia, F. Jay; Gil Jimenez, Johanna Penelope; Sanchez, Jacqueline; Castillo Bueno, Maria; Hunger, Stephen P.; Reaves, Lisa; Contreras Gonzalez, Johanny; Coffin, Susan E.; Deverlis, Adriana; Steenhoff, Andrew P.; Fisher, Brian T.			Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican Republic	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TREATMENT-RELATED MORTALITY; INCOME COUNTRIES; CENTRAL-AMERICA	Survival rates for pediatric acute leukemia vary dramatically worldwide. Infections are a leading cause of morbidity and mortality, and the impact is amplified in low and middle-income countries. Defining the epidemiology of infection in a specific health care setting is paramount to developing effective interventions. This study aimed to define the epidemiology of and outcomes from infection in children with acute leukemia treated in a large public pediatric hospital in the Dominican Republic. A retrospective cohort was assembled of children newly diagnosed with acute leukemia between July 1, 2015 to June 30, 2017 at Hospital Infantil Dr. Robert Reid Cabral in Santo Domingo. Patients were identified from the Pediatric Oncology Network Database (PONDTM) and hospital admissions from the Oncology admissions logbook. Medical records and microbiology results were reviewed to identify all inpatient invasive infections. Distance from a child's home to the hospital was determined using ArcGIS by Esri. Infection rates were described in discrete time periods after diagnosis and risk factors for invasive infection were explored using negative binomial regression. Overall, invasive infections were common and a prominent source of death in this cohort. Rates were highest in the first 60 days after diagnosis. Gastroenteritis/colitis, cellulitis, and pneumonia were most frequent, with bacteremia common early on. Multidrug resistant bacteria were prevalent among a small number of positive cultures. In a multivariate negative binomial regression model, age >= 10 years and distance from the hospital > 100 km were each protective against invasive infection in the first 180 days after diagnosis, findings that were unexpected and warrant further investigation. Over one-third of patient deaths were related to infection. Interventions aimed at reducing infection should target the first 60 days after diagnosis, improved supportive care inside and outside the hospital, and increased antimicrobial stewardship and infection prevention and control measures.	[Burns, Julianne E.; Coffin, Susan E.; Steenhoff, Andrew P.; Fisher, Brian T.] Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA; [Burns, Julianne E.] Childrens Hosp Philadelphia, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; [Burns, Julianne E.; Garcia, F. Jay; Coffin, Susan E.; Steenhoff, Andrew P.; Fisher, Brian T.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reyes Perez, Dominga; Gomez Garcia, Wendy; Gil Jimenez, Johanna Penelope; Castillo Bueno, Maria; Contreras Gonzalez, Johanny] Hosp Infantil Dr Robert Reid Cabral, Dept Oncol, Santo Domingo, National Distri, Dominican Rep; [Li, Yimei] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Yimei; Hunger, Stephen P.] Childrens Hosp Philadelphia, Dept Pediat, Div Oncol, Philadelphia, PA 19104 USA; [Li, Yimei; Hunger, Stephen P.] Childrens Hosp Philadelphia, Dept Pediat, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Sanchez, Jacqueline] Hosp Infantil Dr Robert Reid Cabral, Dept Infect Dis, Microbiol Lab, Santo Domingo, National Distri, Dominican Rep; [Reaves, Lisa] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Colorado Springs, CO USA; [Deverlis, Adriana; Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Global Hlth Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Colorado; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Burns, JE (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA.; Burns, JE (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA.; Burns, JE (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	burnsje@email.chop.edu		Fisher, Brian/0000-0002-8224-4281; Gomez Garcia, Wendy Cristhyna/0000-0002-6457-3559; Burns, Julianne/0000-0003-4154-2802	T32 Infectious Diseases Epidemiology Training Grant [T32-AI-055435]; NIH National Research Service Award; Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania Perelman School of Medicine; University of Pennsylvania Center for Global Health; La Fundacion Amigos Contra el Cancer Infantil; Keira Grace Foundation	T32 Infectious Diseases Epidemiology Training Grant; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania Perelman School of Medicine; University of Pennsylvania Center for Global Health; La Fundacion Amigos Contra el Cancer Infantil; Keira Grace Foundation	JEB received funding though a T32 Infectious Diseases Epidemiology Training Grant (T32-AI-055435), NIH National Research Service Award, Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania Perelman School of Medicine (https://www.cceb.med.upenn.edu).FJG received a travel stipend through the University of Pennsylvania Center for Global Health (https://www.med.upenn.edu/globalhealth/).SPH is the Jeffrey E. Perelman Distinguished Chair in Pediatrics at the Children's Hospital of Philadelphia. The oncology program at Hospital Infantil Dr. Robert Reid Cabral was supported by La Fundacion Amigos Contra el Cancer Infantil (https://www.facci.org.do) and the Keira Grace Foundation (https://www.keiragracefoundation.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, CHRONICLE HIGHER ED, V64, pA2; Asociacion de Hemato Oncologia Pediatrica de Centro America (AHOPCA) Protocolo AHOPCA-LMA 2007, 2009, PROT TRAT NIN CON LE; Caniza MA, 2015, EXPERT REV HEMATOL, V8, P627, DOI 10.1586/17474086.2015.1071186; Centers for Disease Control and Prevention, 2019, GROWTH CHART TRAIN S; Centers for Disease Control and Prevention (CDC) Division of Nutrition Physical Activity and Obesity National Center for Chronic Disease Prevention and Health Promotion, 2014, GROWTH CHART TRAIN R; Ceppi F, 2015, EXPERT REV HEMATOL, V8, P613, DOI 10.1586/17474086.2015.1049594; Esri. Topographic, 2012, TOP; Gavidia R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043639; Gupta S, 2009, BRIT J CANCER, V100, P1026, DOI 10.1038/sj.bjc.6604895; Gupta S, 2012, EUR J CANCER, V48, P1363, DOI 10.1016/j.ejca.2011.10.009; Gupta S, 2011, CANCER-AM CANCER SOC, V117, P4788, DOI 10.1002/cncr.26107; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Hunger SP, 2009, PEDIATR BLOOD CANCER, V52, P559, DOI 10.1002/pbc.21889; Lam CG, 2019, SCIENCE, V363, P1182, DOI 10.1126/science.aaw4892; National Health Council, 2019, GLOSS PAT ENG TERMS; Navarrete M, 2014, PEDIATR BLOOD CANCER, V61, P803, DOI 10.1002/pbc.24911; Quintana Y, 2013, STUD HEALTH TECHNOL, V183, P251, DOI 10.3233/978-1-61499-203-5-251; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Ward ZJ, 2019, LANCET ONCOL, V20, P972, DOI 10.1016/S1470-2045(19)30273-6	20	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243795	10.1371/journal.pone.0243795	http://dx.doi.org/10.1371/journal.pone.0243795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320881	gold, Green Published			2022-12-26	WOS:000600339800003
J	Kim, YS; Kim, DW; Kim, SG; Lee, SK				Kim, Yeon Sook; Kim, Dae Won; Kim, Seong-Gon; Lee, Suk Keun			4-hexylresorcinol-induced protein expression changes in human umbilical cord vein endothelial cells as determined by immunoprecipitation high-performance liquid chromatography	PLOS ONE			English	Article							SUPPRESSION; INHIBITION; CISPLATIN; APOPTOSIS; MEMBRANE; AGENT	4-Hexylresorcinol (4HR) is used as a food preservative and an ingredient of toothpaste and cosmetics. The present study was performed using 233 antisera to determine the changes in protein expression induced by 4HR in human umbilical cord vein endothelial cells (HUVECs), and evaluated the 4HR-induced effects in comparison with previous results (Kim et al., 2019). Similar to RAW 264.7 cells, 4HR-treated HUVECs showed decreases in the expression of the proliferation-related proteins, cMyc/MAX/MAD network proteins, p53/RB and Wnt/beta-catenin signaling, and they showed inactivation of DNA transcription and protein translation compared to the untreated controls. 4HR upregulated growth factors (TGF-beta 1, beta 2, beta 3, SMAD2/3, SMAD4, HGF-alpha, Met, IGF-1) and RAS signaling proteins (RAF-B, p38, p-p38, p-ERK-1, and Rab-1), and induced stronger expression of the cellular protection-, survival-, and differentiation-related proteins in HUVECs than in RAW 264.7 cells. 4HR suppressed NFkB signaling in a manner that suggests potential anti-inflammatory and wound healing effects by reducing M1 macrophage polarization and increasing M2 macrophage polarization in both cells. 4HR-treated HUVECs tended to increase the ER stress mediators by upregulating eIF2AK3, ATF4, ATF6, lysozyme, and LC3 and downregulating eIF2 alpha and GADD153 (CHOP), resulting in PARP-1/AIF-mediated apoptosis. These results indicate that 4HR has similar effects on the protein expression of HUVECs and RAW 264.7 cells, but their protein expression levels differ according to cell types. The 4HR-treated cells showed global protein expression characteristic of anticancer and wound healing effects, which could be alleviated simultaneously by other proteins exerting opposite functions. These results suggest that although 4HR has similar effects on the global protein expression of HUVECs and RAW 264.7 cells, the 4HR-induced molecular interferences in those cells are complex enough to produce variable protein expression, leading different cell functions. Moreover, HUVECs have stronger wound healing potential to overcome the impact induced by 4HR than RAW 264.7 cells.	[Kim, Yeon Sook; Kim, Seong-Gon; Lee, Suk Keun] Cheongju Univ, Coll Hlth & Med Sci, Dept Dent Hyg, Cheongju, South Korea; [Kim, Dae Won] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Biochem, Kangnung, South Korea; [Kim, Seong-Gon] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Kangnung, South Korea; [Lee, Suk Keun] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Pathol, Kangnung, South Korea; [Lee, Suk Keun] Inst Hydrogen Magnet React Gene Regulat, Kangnung, South Korea	Cheongju University; Kangnung Wonju National University; Kangnung Wonju National University; Kangnung Wonju National University	Kim, SG (corresponding author), Gangneung Wonju Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Kangnung, South Korea.; Lee, SK (corresponding author), Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Pathol, Kangnung, South Korea.; Lee, SK (corresponding author), Inst Hydrogen Magnet React Gene Regulat, Kangnung, South Korea.	sukkeunlee2@naver.com; kimsg@gwnu.ac.kr		Kim, Seong-Gon/0000-0001-5088-2732				Ahn J, 2016, BURNS, V42, P1534, DOI 10.1016/j.burns.2016.04.016; American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; Anderson HH, 1931, P SOC EXP BIOL MED, V28, P0609; Clarke NJ, 1998, FEBS LETT, V430, P419, DOI 10.1016/S0014-5793(98)00706-6; Dam AD, 2013, BBA-MOL CELL RES, V1833, P3426, DOI 10.1016/j.bbamcr.2013.04.014; Dittmer D, 1959, HDB TOXICOLOGY; Faust JJ, 2017, BIOMATERIALS, V128, P160, DOI 10.1016/j.biomaterials.2017.02.031; Feng S, 2012, FEBS LETT, V586, P3951, DOI 10.1016/j.febslet.2012.09.037; Feng XL, 2019, LASER SURG MED, V51, P352, DOI 10.1002/lsm.23020; Goodman L., 1975, PHARM BASIS THERAPEU; Gosselin RE, 1984, CLIN TOXICOLOGY COMM; Guandalini E, 1998, FOOD ADDIT CONTAM, V15, P171; He JF, 2017, FOOD CHEM, V214, P269, DOI 10.1016/j.foodchem.2016.07.095; Jo YY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40027-5; Kim MK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38946-4; Kim MK, 2020, MAX PLAST RECONSTR S, V42, DOI 10.1186/s40902-020-00267-2; Kim SG, 2013, ONCOL REP, V29, P1835, DOI 10.3892/or.2013.2292; Kim SG, 2012, ONCOL REP, V28, P677, DOI 10.3892/or.2012.1845; Kim SG, 2011, ONCOL REP, V26, P1527, DOI 10.3892/or.2011.1436; Kim SG, 2011, ONCOL REP, V25, P1597, DOI 10.3892/or.2011.1218; Kim SM, 2018, J CRANIO MAXILL SURG, V46, P119, DOI 10.1016/j.jcms.2017.10.017; Kim SM, 2017, EUR ARCH OTO-RHINO-L, V274, P3485, DOI 10.1007/s00405-017-4657-x; Kim SM, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1213-5; Kim SM, 2017, EUR ARCH OTO-RHINO-L, V274, P215, DOI 10.1007/s00405-016-4167-2; Kim Yeon Sook, 2015, [The Korean Journal of Oral and Maxillofacial Pathology, 대한구강악안면병리학회지], V39, P615; Kozubek A, 1999, CHEM REV, V99, P1, DOI 10.1021/cr970464o; Kweon H, 2014, BIOMATERIALS, V35, P8576, DOI 10.1016/j.biomaterials.2014.06.050; Lamson PD, 1935, J PHARMACOL EXP THER, V53, P198; Lee Sang-Woon, 2015, Maxillofac Plast Reconstr Surg, V37, P32, DOI 10.1186/s40902-015-0034-0; Lee SW, 2013, J CRANIOFAC SURG, V24, P1927, DOI 10.1097/SCS.0b013e3182a3050c; Lee SW, 2013, TUMOR BIOL, V34, P1595, DOI 10.1007/s13277-013-0690-6; Luo LP, 2013, FOOD CHEM, V138, P315, DOI 10.1016/j.foodchem.2012.10.043; Madungwe NB, 2018, AM J PHYSIOL-CELL PH, V315, pC28, DOI 10.1152/ajpcell.00230.2017; MAPLESTONE P. A., 1934, Indian Journal of Medical Research, V21, P519; McConnell VF, 1953, J CHEM EDUC, V30, P380, DOI [10.1021/ed030p380, DOI 10.1021/ED030P380]; National Toxicology Program, 1988, Natl Toxicol Program Tech Rep Ser, V330, P1; Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341; Robbins BH, 1931, J PHARMACOL EXP THER, V43, P325; Robbins BH, 1935, J PHARMACOL EXP THER, V53, P54; Seok H, 2016, J KOR ASSOC ORAL MAX, V42, P370, DOI 10.5125/jkaoms.2016.42.6.370; Sunshine I, 1969, CRC HDB ANAL TOXICOL; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545; UJIIE T, 1968, CHEM PHARM BULL, V16, P165; Ortiz-Ruiz CV, 2015, J AGR FOOD CHEM, V63, P7032, DOI 10.1021/acs.jafc.5b02523; Weber R, 2016, MUSICOL AUST, V38, P29, DOI 10.1080/08145857.2016.1159649; Yamaguchi R, 2018, CYTOKINE, V108, P24, DOI 10.1016/j.cyto.2018.03.011; Yen GC, 2003, FREE RADICAL RES, V37, P509, DOI 10.1080/1071576031000083099; Yoon CS, 2018, MAX PLAST RECONSTR S, V40, DOI 10.1186/s40902-018-0183-z; Yoon CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32014-z; Zhang FJ, 2012, TOXICOL SCI, V128, P103, DOI 10.1093/toxsci/kfs142; Zhang QH, 2019, CANCER SCI, V110, P2507, DOI 10.1111/cas.14101	51	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243975	10.1371/journal.pone.0243975	http://dx.doi.org/10.1371/journal.pone.0243975			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320912	gold, Green Published			2022-12-26	WOS:000600339800058
J	Roggero, CM; Jin, LJ; Cao, SB; Sonavane, R; Kopplin, NG; Ta, HQ; Ekoue, DN; Witwer, M; Ma, SH; Liu, H; Ma, TF; Gioeli, D; Raj, GV; Dong, Y				Roggero, Carlos M.; Jin, Lianjin; Cao, Subing; Sonavane, Rajni; Kopplin, Noa G.; Ta, Huy Q.; Ekoue, Dede N.; Witwer, Michael; Ma, Shihong; Liu, Hong; Ma, Tianfang; Gioeli, Daniel; Raj, Ganesh V.; Dong, Yan			A detailed characterization of stepwise activation of the androgen receptor variant 7 in prostate cancer cells	ONCOGENE			English	Article							SPLICE VARIANTS; RESISTANCE; ENZALUTAMIDE; ABIRATERONE; AR-V7; AR; BINDING; GROWTH; INHIBITION; EXPRESSION	Expression of the androgen receptor splice variant 7 (AR-V7) is frequently detected in castrate resistant prostate cancer and associated with resistance to AR-targeted therapies. While we have previously noted that homodimerization is required for the transcriptional activity of AR-V7 and that AR-V7 can also form heterodimers with the full-length AR (AR-FL), there are still many gaps of knowledge in AR-V7 stepwise activation. In the present study, we show that neither AR-V7 homodimerization nor AR-V7/AR-FL heterodimerization requires cofactors or DNA binding. AR-V7 can enter the nucleus as a monomer and drive a transcriptional program and DNA-damage repair as a homodimer. While forming a heterodimer with AR-FL to induce nuclear localization of unliganded AR-FL, AR-V7 does not need to interact with AR-FL to drive gene transcription or DNA-damage repair in prostate cancer cells that co-express AR-V7 and AR-FL. These data indicate that AR-V7 can function independently of its interaction with AR-FL in the true castrate state or "absence of ligand", providing support for the utility of targeting AR-V7 in improving outcomes of patients with castrate resistant prostate cancer.	[Roggero, Carlos M.; Sonavane, Rajni; Kopplin, Noa G.; Ekoue, Dede N.; Witwer, Michael; Ma, Shihong; Raj, Ganesh V.] UT SouthWestern Med Ctr Dallas, Dept Urol, Dallas, TX USA; [Jin, Lianjin; Cao, Subing; Ma, Tianfang; Dong, Yan] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Ta, Huy Q.; Gioeli, Daniel] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Liu, Hong] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Raj, Ganesh V.] UT Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Tulane University; University of Virginia; Tulane University	Raj, GV (corresponding author), UT SouthWestern Med Ctr Dallas, Dept Urol, Dallas, TX USA.; Dong, Y (corresponding author), Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.; Raj, GV (corresponding author), UT Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	ganesh.raj@utsouthwestern.edu; ydong@tulane.edu		Ma, Tianfang/0000-0003-4161-882X	Department of Defense [W81XWH-19-1-0363, W81XWH-17-10674, W81XWH-15-1-0439, W81XWH-16-1-0317]; Prostate Cancer Foundation Challenge Award; Mimi and John Cole Foundation; Charles Y. Pak grant; National Institutes of Health [R01CA188609, R01 CA178338]	Department of Defense(United States Department of Defense); Prostate Cancer Foundation Challenge Award; Mimi and John Cole Foundation; Charles Y. Pak grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the Department of Defense (W81XWH-19-1-0363, W81XWH-17-10674), Prostate Cancer Foundation Challenge Award, Mimi and John Cole Foundation and Charles Y. Pak grant to GVR, from the National Institutes of Health (R01CA188609) and the Department of Defense (W81XWH-15-1-0439 and W81XWH-16-1-0317) to YD, and from the National Institutes of Health (R01 CA178338) to DG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Bai SS, 2019, ONCOGENE, V38, P4977, DOI 10.1038/s41388-019-0768-8; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Cai L, 2018, MOL CELL, V72, P341, DOI 10.1016/j.molcel.2018.08.029; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Cao SB, 2019, ONCOGENE, V38, P7060, DOI 10.1038/s41388-019-0947-7; Cao SB, 2016, ENDOCR-RELAT CANCER, V23, pT199, DOI 10.1530/ERC-16-0298; Cato L, 2019, CANCER CELL, V35, P401, DOI 10.1016/j.ccell.2019.01.008; Chan SC, 2015, NUCLEIC ACIDS RES, V43, P5880, DOI 10.1093/nar/gkv262; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chen Z, 2018, P NATL ACAD SCI USA, V115, P6810, DOI 10.1073/pnas.1718811115; Davis ID, 2019, NEW ENGL J MED, V381, P121, DOI 10.1056/NEJMoa1903835; de Bono J, 2017, NEW ENGL J MED, V377, P1694; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dong Y, 2004, CANCER RES, V64, P19, DOI 10.1158/0008-5472.CAN-03-2789; Dong Y, 2005, MOL CANCER THER, V4, P1047, DOI 10.1158/1535-7163.MCT-05-0124; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; He YD, 2018, NUCLEIC ACIDS RES, V46, P1895, DOI 10.1093/nar/gkx1306; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Kohli M, 2017, CLIN CANCER RES, V23, P4704, DOI 10.1158/1078-0432.CCR-17-0017; Kounatidou E, 2019, NUCLEIC ACIDS RES, V47, P5634, DOI 10.1093/nar/gkz286; Krause WC, 2014, INT J BIOCHEM CELL B, V54, P49, DOI 10.1016/j.biocel.2014.06.013; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Loriot Y, 2017, CANCER-AM CANCER SOC, V123, P253, DOI 10.1002/cncr.30336; Lu J, 2015, J UROLOGY, V193, P690, DOI 10.1016/j.juro.2014.08.043; Magani F, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188202; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Nyquist MD, 2013, P NATL ACAD SCI USA, V110, P17492, DOI 10.1073/pnas.1308587110; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sartor O, 2018, NEW ENGL J MED, V378, P645, DOI 10.1056/NEJMra1701695; Scher HI, 2016, JAMA ONCOL, V2, P1441, DOI 10.1001/jamaoncol.2016.1828; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shafi AA, 2015, ONCOTARGET, V6, P31997, DOI 10.18632/oncotarget.5585; Sharp A, 2019, EUR UROL, V76, P676, DOI 10.1016/j.eururo.2019.04.006; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Ta HQ, 2020, ELIFE, V9, DOI 10.7554/eLife.51378; Todenhofer T, 2017, J UROLOGY, V197, P135, DOI 10.1016/j.juro.2016.06.094; Uo T, 2017, ONCOGENE, V36, P1440, DOI 10.1038/onc.2016.313; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Welti J, 2016, EUR UROL, V70, P599, DOI 10.1016/j.eururo.2016.03.049; Xu D, 2015, CANCER RES, V75, P3663, DOI 10.1158/0008-5472.CAN-15-0381; Yin Y, 2017, CANCER RES, V77, P4745, DOI 10.1158/0008-5472.CAN-17-0164; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zhan Y, 2017, MOL CANCER RES, V15, P59, DOI 10.1158/1541-7786.MCR-16-0236	54	13	13	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1106	1117		10.1038/s41388-020-01585-5	http://dx.doi.org/10.1038/s41388-020-01585-5		DEC 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33323969	Green Accepted			2022-12-26	WOS:000599126500002
J	Norris, K; Hodgson, RE; Dornelles, T; Allen, KE; Abell, B; Ashe, MP; Campbell, SG				Norris, Karl; Hodgson, Rachel E.; Dornelles, Tawni; Allen, K. Elizabeth; Abell, Ben M.; Ashe, Mark P.; Campbell, Susan G.			Mutational analysis of the alpha subunit of eIF2B provides insights into the role of eIF2B bodies in translational control and VWM disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; SACCHAROMYCES-CEREVISIAE; INITIATION; COMPLEX; PHOSPHORYLATION; IDENTIFICATION; INHIBITION; INTEGRITY; PATHWAY; GCN2	Eukaryotic initiation factor 2B (eIF2B) serves as a vital control point within protein synthesis and regulates translation initiation in response to cellular stress. Mutations within eIF2B result in the fatal disease, leukoencephalopathy with vanishing white matter (VWM). Previous biochemical studies on VWM mutations have illustrated that changes in the activity of eIF2B poorly correlate with disease severity. This suggests that there may be additional characteristics of eIF2B contributing to VWM pathogenesis. Here, we investigated whether the localization of eIF2B to eIF2B bodies was integral for function and whether this localization could provide insight into the pathogenesis of VWM. We demonstrate that the regulatory subunit, eIF2B alpha, is required for the assembly of eIF2B bodies in yeast and that loss of eIF2B bodies correlates with an inability of cells to regulate eIF2B activity. Mutational analysis of eIF2B alpha showed that missense mutations that disrupt the regulation of eIF2B similarly disrupt the assembly of eIF2B bodies. In contrast, when eIF2B alpha mutations that impact the catalytic activity of eIF2B were analyzed, eIF2B bodies were absent and instead eIF2B localized to small foci, termed microfoci. Fluorescence recovery after photobleaching analysis highlighted that within these microfoci, eIF2 shuttles more slowly indicating that formation of eIF2B bodies correlates with full eIF2B activity. When eIF2B alpha VWM mutations were analyzed, a diverse impact on localization was observed, which did not seem to correlate with eIF2B activity. These findings provide key insights into how the eIF2B body assembles and suggest that the body is a fundamental part of the translational regulation via eIF2 alpha phosphorylation.	[Norris, Karl; Hodgson, Rachel E.; Allen, K. Elizabeth; Abell, Ben M.; Campbell, Susan G.] Sheffield Hallam Univ, Biomol Sci Res Ctr, Sheffield, S Yorkshire, England; [Dornelles, Tawni; Ashe, Mark P.] Univ Manchester, Fac Biol Med & Hlth, Div Mol & Cellular Funct, Manchester, Lancs, England	Sheffield Hallam University; University of Manchester	Campbell, SG (corresponding author), Sheffield Hallam Univ, Biomol Sci Res Ctr, Sheffield, S Yorkshire, England.	susan.campbell@shu.ac.uk	Campbell, Susan/ABI-6746-2020; Campbell, Susan/AAE-4611-2021	Campbell, Susan/0000-0002-6740-1445; Allen, Liz/0000-0001-8579-7730; Dornelles, Tawni/0000-0003-4571-4982; Abell, Ben/0000-0002-0953-0046; Norris, Karl/0000-0001-5583-8298	Biomedical Sciences Research Centre, Sheffield Hallam University; Great Ormond Street Hospital/Sparks charity award [V4119]	Biomedical Sciences Research Centre, Sheffield Hallam University; Great Ormond Street Hospital/Sparks charity award	K. N. was funded through a PhD studentship awarded by the Biomedical Sciences Research Centre, Sheffield Hallam University. R. E. H. is funded by a Great Ormond Street Hospital/Sparks charity award V4119.	Adomavicius T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10167-3; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bogorad AM, 2017, NUCLEIC ACIDS RES, V45, P11962, DOI 10.1093/nar/gkx845; Bogorad AM, 2014, BIOCHEMISTRY-US, V53, P3432, DOI 10.1021/bi500346u; Bresson S, 2020, MOL CELL, V80, P470, DOI 10.1016/j.molcel.2020.09.021; Browne CM, 2013, MOL CELL BIOL, V33, P1041, DOI 10.1128/MCB.00811-12; Campbell SG, 2005, J CELL BIOL, V170, P925, DOI 10.1083/jcb.200503162; Castelli LM, 2011, MOL BIOL CELL, V22, P3379, DOI 10.1091/mbc.E11-02-0153; De Franco E, 2020, DIABETES, V69, P477, DOI 10.2337/db19-1029; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Egbe NE, 2015, FUNGAL GENET BIOL, V77, P50, DOI 10.1016/j.fgb.2015.03.008; Erickson FL, 1996, EMBO J, V15, P6311, DOI 10.1002/j.1460-2075.1996.tb01021.x; Gordiyenko Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10606-1; Gordiyenko Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4902; Guthrie C, 1991, METHODS ENZYMOL, V194, P9; Hamilton EMC, 2018, ANN NEUROL, V84, P274, DOI 10.1002/ana.25287; HANNIG EM, 1990, GENETICS, V126, P549; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hodgson RE, 2019, MOL BIOL CELL, V30, P942, DOI 10.1091/mbc.E18-08-0538; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Jennings MD, 2013, GENE DEV, V27, P2696, DOI 10.1101/gad.231514.113; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Kashiwagi K, 2019, SCIENCE, V364, P495, DOI 10.1126/science.aaw4104; Kashiwagi K, 2016, NATURE, V531, P122, DOI 10.1038/nature16991; Kenner LR, 2019, SCIENCE, V364, P491, DOI 10.1126/science.aaw2922; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; LUCCHINI G, 1984, MOL CELL BIOL, V4, P1326, DOI 10.1128/MCB.4.7.1326; Marini G, 2020, MOL BIOL CELL, V31, P1232, DOI 10.1091/mbc.E20-02-0125; Matheson K, 2017, G3-GENES GENOM GENET, V7, P2219, DOI 10.1534/g3.117.040022; Merrick WC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033092; Moon SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30805-y; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Nuske E, 2020, BIOL OPEN, V9, DOI 10.1242/bio.046391; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pavitt GD, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1491; Petrezselyova S, 2010, FUNGAL BIOL-UK, V114, P144, DOI 10.1016/j.funbio.2009.11.002; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Richardson JP, 2004, MOL CELL BIOL, V24, P2352, DOI 10.1128/MCB.24.6.2352-2363.2004; Sauert M, 2015, BIOCHIMIE, V114, P39, DOI 10.1016/j.biochi.2014.12.011; Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322; Taylor EJ, 2010, MOL BIOL CELL, V21, P2202, DOI 10.1091/mbc.E09-11-0962; Tsai JC, 2018, SCIENCE, V359, P1483, DOI 10.1126/science.aaq0939; Wang XM, 2012, J BIOL CHEM, V287, P8263, DOI 10.1074/jbc.M111.331553; Wortham NC, 2016, BIOCHEM J, V473, P571, DOI 10.1042/BJ20150828; Wortham NC, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0204-z; Wortham NC, 2014, FASEB J, V28, P2225, DOI 10.1096/fj.13-243329; Yoshikawa K, 2011, YEAST, V28, P349, DOI 10.1002/yea.1843; Zhang HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118001	53	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100207	10.1074/jbc.RA120.014956	http://dx.doi.org/10.1074/jbc.RA120.014956			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334879	gold, Green Published, Green Accepted			2022-12-26	WOS:000672866400185
J	Park, JW; Kim, JE; Choi, YJ; Kang, MJ; Choi, HJ; Bae, SJ; Hong, JT; Lee, H; Hwang, DY				Park, Ji Won; Kim, Ji Eun; Choi, Yun Ju; Kang, Mi Ju; Choi, Hyeon Jun; Bae, Su Ji; Hong, Jin Tae; Lee, Ho; Hwang, Dae Youn			Deficiency of complement component 3 may be linked to the development of constipation in FVB/N-C3(em1Hlee)/Korl mice	FASEB JOURNAL			English	Article						complement C3; constipation; knockout mice; mucin; stool; transverse colon	LOPERAMIDE-INDUCED CONSTIPATION; C3-DEFICIENT MICE; C3A; ACTIVATION; RECEPTOR; CELLS; SECRETION; COLITIS; PATHWAY; INNATE	Alterations in complement component 3 (C3) expression has been reported to be linked to several bowel diseases including Crohn's disease, inflammatory bowel disease, and ulcerative colitis; however, the association with constipation has never been investigated. In this study, we aimed to investigate the correlation between C3 regulation and constipation development using a C3 deficiency model. To achieve these, alterations in stool excretion, transverse colon histological structure, and mucin secretion were analyzed in FVB/N-C3(em1Hlee)/Korl (C3 knockout, C3 KO) mice with the deletion of 11 nucleotides in exon 2 of the C3 gene. The stool excretion parameters, gastrointestinal transit, and intestine length were remarkably decreased in C3 KO mice compared with wild-type (WT) mice, although there was no specific change in feeding behavior. Furthermore, C3 KO mice showed a decrease in mucosal and muscle layer thickness, alterations in crypt structure, irregular distribution of goblet cells, and an increase of mucin droplets in the transverse colon. Mucin secretion was suppressed, and they accumulated in the crypts of C3 KO mice. In addition, the constipation phenotypes detected during C3 deficiency were confirmed in FVB/N mice treated with C3 convertase inhibitor (rosmarinic acid (RA)). Similar phenotypes were observed with respect to stool excretion parameters, gastrointestinal transit, intestine length, alterations in crypt structure, and mucin secretion in RA-treated FVB/N mice. Therefore, the results of the present study provide the first scientific evidence that C3 deficiency may play an important role in the development of constipation phenotypes in C3 KO mice.	[Park, Ji Won; Kim, Ji Eun; Choi, Yun Ju; Kang, Mi Ju; Choi, Hyeon Jun; Bae, Su Ji; Hwang, Dae Youn] Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci,Program BK21 FOUR, Miryang, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungju, South Korea; [Lee, Ho] Natl Canc Ctr, Res Inst, Grad Sch Canc Sci & Policy, Goyang, South Korea	Pusan National University; Chungbuk National University; National Cancer Center - Korea (NCC)	Hwang, DY (corresponding author), Pusan Natl Univ, Lab Anim Resources Ctr, Coll Nat Resources & Life Sci, Dept Biomat Sci,Program BK21 FOUR, 50 Cheonghak Ri, Miryang Si 627706, Gyeongsangnam D, South Korea.	dyhwang@pusan.ac.kr		Lee, Ho/0000-0001-5573-742X				AHRENSTEDT O, 1990, NEW ENGL J MED, V322, P1345, DOI 10.1056/NEJM199005103221903; Andoh A, 1996, GASTROENTEROLOGY, V110, P1919, DOI 10.1053/gast.1996.v110.pm8964419; Andrews Christopher N, 2011, Can J Gastroenterol, V25 Suppl B, p16B; Bassotti Gabrio, 2011, Gastroenterol Hepatol Bed Bench, V4, P109; Boos L, 2005, NEUROSCI LETT, V387, P68, DOI 10.1016/j.neulet.2005.07.015; Choi JS, 2014, EXP THER MED, V8, P1847, DOI 10.3892/etm.2014.2030; Choi JS, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/878503; Choi JY, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100377; Chumpitazi BP, 2016, NEUROGASTROENT MOTIL, V28, P443, DOI 10.1111/nmo.12738; COLTEN HR, 1986, BIOESSAYS, V4, P249, DOI 10.1002/bies.950040604; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Davoust N, 1999, GLIA, V26, P201, DOI 10.1002/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M; Dinasarapu AR, 2012, MOL PAGE, V1, P34; Emmanuel AV, 2009, NEUROGASTROENT MOTIL, V21, P41, DOI 10.1111/j.1365-2982.2009.01403.x; ENGLBERGER W, 1988, INT J IMMUNOPHARMACO, V10, P729, DOI 10.1016/0192-0561(88)90026-4; ERDEI A, 1991, IMMUNOL TODAY, V12, P332, DOI 10.1016/0167-5699(91)90011-H; Fischer WH, 1997, J IMMUNOL, V159, P4279; Forootan M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010631; HALSTENSEN TS, 1992, GUT, V33, P902, DOI 10.1136/gut.33.7.902; Honczarenko M, 2005, J IMMUNOL, V175, P3698, DOI 10.4049/jimmunol.175.6.3698; Kim JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215205; Kim JE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040946; Kim JE, 2019, J MED FOOD, V22, P294, DOI 10.1089/jmf.2018.4234; Kim JE, 2018, PHARM BIOL, V56, P309, DOI 10.1080/13880209.2018.1474932; Kim JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161144; Kim JE, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-333; Laufer J, 2000, CLIN EXP IMMUNOL, V120, P30, DOI 10.1046/j.1365-2249.2000.01168.x; Lee HY, 2012, FOOD CHEM TOXICOL, V50, P895, DOI 10.1016/j.fct.2011.12.001; Lembo A, 2003, NEW ENGL J MED, V349, P1360, DOI 10.1056/NEJMra020995; Liang C, 2016, WORLD J GASTROENTERO, V22, P2799, DOI 10.3748/wjg.v22.i9.2799; Lin F, 2004, J IMMUNOL, V172, P3836, DOI 10.4049/jimmunol.172.6.3836; McCallum IJD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b831; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Prather CM, 1998, MAYO CLIN PROC, V73, P881, DOI 10.4065/73.9.881; Ratajczak J, 2004, BLOOD, V103, P2071, DOI 10.1182/blood-2003-06-2099; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Ricklin D, 2016, IMMUNOL REV, V274, P33, DOI 10.1111/imr.12500; Riordan SM, 1996, SCAND J GASTROENTERO, V31, P1098, DOI 10.3109/00365529609036893; Schiller LR, 2001, ALIMENT PHARM THER, V15, P749, DOI 10.1046/j.1365-2036.2001.00982.x; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Sugihara T, 2010, CLIN EXP IMMUNOL, V160, P386, DOI 10.1111/j.1365-2249.2010.04093.x; Ueki T, 1996, CLIN EXP IMMUNOL, V104, P286, DOI 10.1046/j.1365-2249.1996.17721.x; Verdeguer F, 2007, CARDIOVASC RES, V76, P340, DOI 10.1016/j.cardiores.2007.06.028; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Wintola OA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-95; Yao EH, 2008, BIOCHEM BIOPH RES CO, V367, P468, DOI 10.1016/j.bbrc.2007.12.160; Zhang YG, 2018, DRUG DES DEV THER, V12, P2403, DOI 10.2147/DDDT.S160628; Zhou WD, 2006, BLOOD, V107, P2461, DOI 10.1182/blood-2005-08-3144	53	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21221	10.1096/fj.202000376R	http://dx.doi.org/10.1096/fj.202000376R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337564	hybrid			2022-12-26	WOS:000605626600040
J	Vanzyl, EJ; Sayed, H; Blackmore, AB; Rick, KRC; Fernando, P; McKay, BC				Vanzyl, Erin J.; Sayed, Hadil; Blackmore, Alex B.; Rick, Kayleigh R. C.; Fernando, Pasan; McKay, Bruce C.			The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death	PLOS ONE			English	Article							PROTEIN; TARGET; SF3B	The spliceosome assembles on pre-mRNA in a stepwise manner through five successive pre-spliceosome complexes. The spliceosome functions to remove introns from pre-mRNAs to generate mature mRNAs that encode functional proteins. Many small molecule inhibitors of the spliceosome have been identified and they are cytotoxic. However, little is known about genetic determinants of cell sensitivity. Activating transcription factor 3 (ATF3) is a transcription factor that can stimulate apoptotic cell death in response to a variety of cellular stresses. Here, we used a genetic approach to determine if ATF3 was important in determining the sensitivity of mouse embryonic fibroblasts (MEFs) to two splicing inhibitors: pladienolide B (PB) and isoginkgetin (IGG), that target different pre-spliceosome complexes. Both compounds led to increased ATF3 expression and apoptosis in control MEFs while ATF3 null cells were significantly protected from the cytotoxic effects of these drugs. Similarly, ATF3 was induced in response to IGG and PB in the two human tumour cell lines tested while knockdown of ATF3 protected cells from both drugs. Taken together, ATF3 appears to contribute to the cytotoxicity elicited by these spliceosome inhibitors in both murine and human cells.	[Vanzyl, Erin J.; Sayed, Hadil; Blackmore, Alex B.; Rick, Kayleigh R. C.; Fernando, Pasan; McKay, Bruce C.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [McKay, Bruce C.] Carleton Univ, Inst Biochem, Ottawa, ON, Canada	Carleton University; Carleton University	McKay, BC (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.; McKay, BC (corresponding author), Carleton Univ, Inst Biochem, Ottawa, ON, Canada.	bruce_mckay@carleton.ca	McKay, Bruce Campbell/I-4081-2013	McKay, Bruce Campbell/0000-0002-7921-1331	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-03645, RGPIN-2019-06146]; J.P. Bickell Foundation; Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); J.P. Bickell Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded through the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp)[RGPIN-2014-03645 and RGPIN-2019-06146] to B.C.M. and a J.P. Bickell Foundation grant (https://www.scotiawealthmanagement.com/ca/en/home/resource-centre/jp-bickell-foundation.html) to P.F. E.J.V. is supported with a Vanier Canada Graduate Scholarship through the Natural Sciences and Engineering Research Council of Canada.	Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; [Anonymous], 2007, GYNECOL ONCOL, V107, pS56; [Anonymous], 2014, INSIGHTS IMAGING, V5, P1, DOI [10.1007/s13244-013-0307-z, DOI 10.1007/S13244-013-0307-Z.]; Bai B, 2018, ACS OMEGA, V3, P2798, DOI 10.1021/acsomega.7b02073; Boswell SA, 2017, NAT CHEM BIOL, V13, P501, DOI [10.1038/NCHEMBIO.2317, 10.1038/nchembio.2317]; Effenberger KA, 2014, J BIOL CHEM, V289, P1938, DOI 10.1074/jbc.M113.515536; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; Gurzov EN, 2012, ONCOGENE, V31, P1723, DOI 10.1038/onc.2011.353; Hoskins AA, 2016, ELIFE, V5, DOI 10.7554/eLife.14166; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lee KM, 2013, RNA BIOL, V10, P386, DOI 10.4161/rna.23697; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nowak E, 2018, CLIN HEMORHEOL MICRO, V69, P327, DOI 10.3233/CH-189120; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; St Germain C, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-32; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tsalikis J, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00489-18; Vanzyl EJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191178; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Yoon SO, 2006, MOL CANCER THER, V5, P2666, DOI 10.1158/1535-7163.MCT-06-0321	24	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0224953	10.1371/journal.pone.0224953	http://dx.doi.org/10.1371/journal.pone.0224953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370278	Green Submitted, gold, Green Published			2022-12-26	WOS:000603611900119
J	Koyama, A; Hirata, T; Kawahara, Y; Iyooka, H; Kubozono, H; Onikura, N; Itaya, S; Minagawa, T				Koyama, Akihiko; Hirata, Taiga; Kawahara, Yuki; Iyooka, Hiroki; Kubozono, Haruka; Onikura, Norio; Itaya, Shinji; Minagawa, Tomoko			Habitat suitability maps for juvenile tri-spine horseshoe crabs in Japanese intertidal zones: A model approach using unmanned aerial vehicles and the Structure from Motion technique	PLOS ONE			English	Article							HONG-KONG SAR; TACHYPLEUS-TRIDENTATUS; SPECIES DISTRIBUTIONS; GLOBAL PATTERNS; BEACH; CONSERVATION; ECOLOGY	The tri-spine horseshoe crab, Tachypleus tridentatus, is a threatened species that inhabits coastal areas from South to East Asia. A Conservation management system is urgently required for managing its nursery habitats, i.e., intertidal flats, especially in Japan. Habitat suitability maps are useful in drafting conservation plans; however, they have rarely been prepared for juvenile T. tridentatus. In this study, we examined the possibility of constructing robust habitat suitability models (HSMs) for juveniles based on topographical data acquired using unmanned aerial vehicles and the Structure from Motion (UAV-SfM) technique. The distribution data of the juveniles in the Tsuyazaki and Imazu intertidal flats from 2017 to 2019 were determined. The data were divided into a training dataset for HSM construction and three test datasets for model evaluation. High accuracy digital surface models were built for each region using the UAV-SfM technique. Normalized elevation was assessed by converting the topographical models that consider the tidal range in each region, and the slope was calculated based on these models. Using the training data, HSMs of the juveniles were constructed with normalized elevation and slope as the predictor variables. The HSMs were evaluated using the test data. The results showed that HSMs exhibited acceptable discrimination performance for each region. Habitat suitability maps were built for the juveniles in each region, and the suitable areas were estimated to be approximately 6.1 ha of the total 19.5 ha in Tuyazaki, and 3.7 ha of the total 7.9 ha area in Imazu. In conclusion, our findings support the usefulness of the UAV-SfM technique in constructing HSMs for juvenile T. tridentatus. The monitoring of suitable habitat areas for the juveniles using the UAV-SfM technique is expected to reduce survey costs, as it can be conducted with fewer investigators over vast intertidal zones within a short period of time.	[Koyama, Akihiko; Minagawa, Tomoko] Kumamoto Univ, Fac Adv Sci & Technol, Chuo Ku, Kumamoto, Japan; [Hirata, Taiga; Kawahara, Yuki] Kumamoto Univ, Dept Civil & Environm Engn, Chuo Ku, Kumamoto, Japan; [Iyooka, Hiroki] Fukuoka Univ, Dept Civil Engn, Jonan Ku, Fukuoka, Japan; [Kubozono, Haruka] Kyushu Univ, 21st Century Program, Nishi Ku, Fukuoka, Japan; [Onikura, Norio] Kyushu Univ, Fishery Res Lab, Tsuyazaki, Fukutsu, Japan; [Itaya, Shinji] Tsuyazaki Seaside Nat Sch, Tsuyazaki, Fukutsu, Japan; [Kawahara, Yuki] Kobe Univ, Fac Civil Engn, Nada Ku, Rokkodai Cho, Kobe, Hyogo, Japan; [Kubozono, Haruka] Arithmer Inc, Off President Publ Relat, Minato Ku, Tokyo, Japan	Kumamoto University; Kumamoto University; Fukuoka University; Kyushu University; Kyushu University; Kobe University	Koyama, A (corresponding author), Kumamoto Univ, Fac Adv Sci & Technol, Chuo Ku, Kumamoto, Japan.	koyamaakihiko15@gmail.com			Japan Society for the Promotion of Science [JP18K14482, JP18J00211, JP15H02456]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Program (KAKENHI), Grant Numbers JP18K14482 (AK), JP18J00211 (AK), and JP15H02456 (NO, HI, and TM). Arithmer Inc. provided support in the form of salary for author HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2015, MED J ARMED FORCES I, V71, pS221; [Anonymous], 2019, R PACKAGE VERSION, DOI DOI 10.1007/s00114-004-0520-1; Baejowski B, 2015, OLDEST SPECIES GENUS, P3; Ballesteros JA, 2019, SYST BIOL, V68, P896, DOI 10.1093/sysbio/syz011; Botton M. L, 2015, CHANGING GLOBAL PERS, P369, DOI DOI 10.1007/978-3-319-19542-1_21; Chen CP, 2004, BIODIVERS CONSERV, V13, P1889, DOI 10.1023/B:BIOC.0000035868.11083.84; Chiu HMC, 2004, HYDROBIOLOGIA, V523, P29, DOI 10.1023/B:HYDR.0000033085.71861.63; Cote IM, 2002, SCIENCE, V298, P1181; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Gogol-Prokurat M, 2011, ECOL APPL, V21, P33, DOI 10.1890/09-1190.1; Gong L, 2019, MOL ECOL RESOUR, V19, P744, DOI 10.1111/1755-0998.12988; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hanawa S., 2006, GLOB ENV RES, V11, P235; Hara Y, 2007, PROC CIV ENG OCEAN, V23, P447; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hsieh HL, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P417, DOI 10.1007/978-0-387-89959-6_26; Hu MH, 2009, AQUAT BIOL, V7, P107, DOI 10.3354/ab00194; Inoue H., 2014, REPORT NATL RES INST, V81, P61; Itaya S, 2019, JPN J CONSERV ECOL, V24, P1817; Iyooka H, 2019, J JPN SOC WATER ENV, V42, P164; Jaud M, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5040050; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Kalacska M, 2017, REMOTE SENS ENVIRON, V199, P14, DOI 10.1016/j.rse.2017.06.023; Kawahara D., 1982, AQUABIOLOGY KAIYOU S, V4, P380; Koljonen S, 2013, RESTOR ECOL, V21, P344, DOI 10.1111/j.1526-100X.2012.00908.x; Krisfalusi-Gannon J, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00185; KUROYANAGI K., 2015, CHANGING GLOBAL PERS, P129; Kwan BKY, 2016, BIODIVERS CONSERV, V25, P673, DOI 10.1007/s10531-016-1084-z; Kwan BKY., 2015, CHANGING GLOBAL PERS, P149, DOI [10.1007/978-3-319-19542-1_7, DOI 10.1007/978-3-319-19542-1_7]; Kwan KY, 2020, J ENVIRON MANAGE, V271, DOI 10.1016/j.jenvman.2020.110925; Laurie K., 2019, IUCN RED LIST THREAT; Lee CN, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P275, DOI 10.1007/978-0-387-89959-6_17; Lee CNW, 2016, MAR POLLUT BULL, V108, P134, DOI 10.1016/j.marpolbul.2016.04.037; Loveland R.E., 2015, CHANGING GLOBAL PERS, P41; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; Ministry of the Environment, 2014, RED DATA BOOK 2014 T, V7; Mizota Chitoshi, 1999, Benthos Research, V54, P81; Mizrahi DS, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P65, DOI 10.1007/978-0-387-89959-6_4; Mod HK, 2016, J VEG SCI, V27, P1308, DOI 10.1111/jvs.12444; Morton B, 2011, J NAT HIST, V45, P227, DOI 10.1080/00222933.2010.522263; Murray NJ, 2015, AUSTRAL ECOL, V40, P472, DOI 10.1111/aec.12211; Ohtsubo M., 2005, JAPANESE SOC SOIL PH, V99, P55; Ohtsuka Susumu, 2017, Japanese Journal of Benthology, V72, P16; Onikura N, 2015, ICHTHYOL RES, V62, P197, DOI 10.1007/s10228-014-0427-6; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; R Core Team, 2013, R LANG ENV STAT COMP; Rasband W., 2006, IMAGEJ; Ricciardi A, 1999, MAR ECOL PROG SER, V185, P21, DOI 10.3354/meps185021; Sato Masanori, 2010, Plankton & Benthos Research, V5, P202; Sekiguchi K., 1999, BIOL HORSESHOE CRABS; Shin PKS, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P347, DOI 10.1007/978-0-387-89959-6_22; Smith DR, 2017, REV FISH BIOL FISHER, V27, P135, DOI 10.1007/s11160-016-9461-y; Turner D, 2012, REMOTE SENS-BASEL, V4, P1392, DOI 10.3390/rs4051392; Vestbo S, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00164; Wada T, 2008, JPN J CONSERV ECOL, V13, P199; Wada T., 2010, JAPANESE J CONSERVAT, V15, P163; Wada T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147429; Wang CC, 2019, ENDANGER SPECIES RES, V40, P369, DOI 10.3354/esr01003; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Xie XY, 2020, AQUAT CONSERV, V30, P260, DOI 10.1002/aqc.3259; Yang H, 2019, SCIENCE, V366, P813, DOI 10.1126/science.aaz8654	63	2	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244494	10.1371/journal.pone.0244494	http://dx.doi.org/10.1371/journal.pone.0244494			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362230	Green Published, gold			2022-12-26	WOS:000603071600045
J	Ryu, H; Kim, JH; Lee, S; Han, JK				Ryu, Hwaseong; Kim, Jung Hoon; Lee, Seunghyun; Han, Joon Koo			Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility	PLOS ONE			English	Article							QUANTITATIVE-EVALUATION; CEUS; SORAFENIB; PERFUSION; MICROCIRCULATION; QUANTIFICATION; MICE	Purpose To assess therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma (HCC) using CEUS with focusing on inter-scanner and inter-operator reproducibility. Materials and methods For reproducibility, CEUS was performed using two different US scanners by two operators in sixteen rat models of HCC. Using perfusion analysis software (VueBox (R)), eleven parameters were collected, and intra-class correlation coefficient (ICC) was used to analyze reproducibility. Then seventeen rat models of HCC were divided into treatment group (n = 8, 30 mg/kg/day sorafenib for five days) and control group (n = 9). CEUS was performed at baseline and 14 days after first treatment, and changes of perfusion parameters were analyzed. Results In treatment group, CEUS perfusion parameters showed a significant change. The peak enhancement (PE, 2.50 x10(3)+/- 1.68 x10(3) vs 5.55x10(2)+/- 4.65x10(2), p = 0.010) and wash-in and wash out AUC ((WiWo)AUC, 1.07x10(5)+/- 6.48 x10(4) vs 2.65x10(4)+/- 2.25x10(4), p = 0.009) had significantly decreased two weeks after treatment. On the contrary, control group did not show a significant change, including PE (1.15 x10(3)+/- 7.53x10(2) vs 9.43x10(2)+/- 7.81 x10(2), p = 0.632) and (WiWo)AUC (5.09 x10(4)+/- 3.25x10(4) vs 5.92 x10(4)+/- 3.20x10(4), p = 0.646). For reproducibility, the various degrees of inter-scanner reproducibility were from poor to good (ICC: <0.01-0.63). However, inter-operator reproducibility of important perfusion parameters, including (Wi)AUC, (Wo)AUC, and (WiWo)AUC, ranged from fair to excellent (ICC: 0.59-0.93) in a different scanner. Conclusion Our results suggest that CEUS is useful for assessment of the treatment response after targeted therapy and with fair to excellent inter-operator reproducibility.	[Ryu, Hwaseong] Pusan Natl Univ, Yangsan Hosp, Dept Radiol, Yangsan Si, Gyeongsangnam D, South Korea; [Kim, Jung Hoon; Lee, Seunghyun; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Lee, Seunghyun; Han, Joon Koo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Pusan National University; Pusan National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	jhkim2008@gmail.com		Lee, Seunghyun/0000-0003-1858-0640	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017R1A2B4004951]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by a grant from the research supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2017R1A2B4004951). JHK.	Arditi M, 2006, IEEE T ULTRASON FERR, V53, P1118, DOI 10.1109/TUFFC.2006.1642510; Averkiou MA, 2020, INVEST RADIOL, V55, P643, DOI 10.1097/RLI.0000000000000702; Chen MYM, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1791059; Dizeux A, 2016, MOL IMAGING BIOL, V18, P651, DOI 10.1007/s11307-016-0952-y; Ghulam QM, 2018, EUR J VASC ENDOVASC, V56, P673, DOI 10.1016/j.ejvs.2018.07.029; Greis C, 2011, CLIN HEMORHEOL MICRO, V49, P137, DOI 10.3233/CH-2011-1464; Guibal A, 2010, RADIOLOGY, V254, P420, DOI 10.1148/radiol.09090728; Hoff L, 2013, ACOUSTIC CHARACTERIZ; Hornung M, 2011, CLIN HEMORHEOL MICRO, V49, P83, DOI 10.3233/CH-2011-1459; Hudson JM, 2009, ULTRASOUND MED BIOL, V35, P2007, DOI 10.1016/j.ultrasmedbio.2009.06.1102; Jung EM, 2010, CLIN HEMORHEOL MICRO, V46, P89, DOI 10.3233/CH-2010-1336; Kuzuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138776; Lamby P, 2011, CLIN HEMORHEOL MICRO, V48, P105, DOI 10.3233/CH-2011-1405; Lamuraglia M, 2010, CRIT REV ONCOL HEMAT, V73, P202, DOI 10.1016/j.critrevonc.2009.06.001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lassau N, 2004, J RADIOL, V85, P704, DOI 10.1016/S0221-0363(04)97651-2; Lavisse S, 2008, INVEST RADIOL, V43, P100, DOI 10.1097/RLI.0b013e3181577cfc; Lee S, 2018, EUR RADIOL, V28, P372, DOI 10.1007/s00330-017-4960-3; Leen E, 2012, EUR RADIOL, V22, P1442, DOI 10.1007/s00330-011-2373-2; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mueller-Peltzer K, 2019, CLIN HEMORHEOL MICRO, V71, P159, DOI 10.3233/CH-189406; Pysz MA, 2011, INVEST RADIOL, V46, P187, DOI 10.1097/RLI.0b013e3181f9202d; Quaia E, 2016, RADIOLOGY, V281, P606, DOI 10.1148/radiol.2016152461; Rubenthaler J, 2017, CLIN HEMORHEOL MICRO, V66, P283, DOI 10.3233/CH-179102; Sullivan DC, 2015, RADIOLOGY, V277, P813, DOI 10.1148/radiol.2015142202; Tang MX, 2011, INTERFACE FOCUS, V1, P520, DOI 10.1098/rsfs.2011.0026; Wang HJ, 2015, RADIOLOGY, V277, P424, DOI 10.1148/radiol.2015142824; WEIDNER N, 1995, AM J PATHOL, V147, P9; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007; Yamashita Y, 2001, CANCER RES, V61, P1005; Zhou JH, 2010, ACAD RADIOL, V17, P646, DOI 10.1016/j.acra.2010.01.008; Zocco MA, 2013, J HEPATOL, V59, P1014, DOI 10.1016/j.jhep.2013.06.011; Zoppellaro G, 2016, ECHOCARDIOGR-J CARD, V33, P889, DOI 10.1111/echo.13190	33	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244304	10.1371/journal.pone.0244304	http://dx.doi.org/10.1371/journal.pone.0244304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362203	Green Published, gold			2022-12-26	WOS:000603071600059
J	Zhang, BB; Kreps, S; McMurry, N; McCain, RM				Zhang, Baobao; Kreps, Sarah; McMurry, Nina; McCain, R. Miles			Americans' perceptions of privacy and surveillance in the COVID-19 pandemic	PLOS ONE			English	Article								Objective To study the U.S. public's attitudes toward surveillance measures aimed at curbing the spread of COVID-19, particularly smartphone applications (apps) that supplement traditional contact tracing. Method We deployed a survey of approximately 2,000 American adults to measure support for nine COVID-19 surveillance measures. We assessed attitudes toward contact tracing apps by manipulating six different attributes of a hypothetical app through a conjoint analysis experiment. Results A smaller percentage of respondents support the government encouraging everyone to download and use contact tracing apps (42%) compared with other surveillance measures such as enforcing temperature checks (62%), expanding traditional contact tracing (57%), carrying out centralized quarantine (49%), deploying electronic device monitoring (44%), or implementing immunity passes (44%). Despite partisan differences on a range of surveillance measures, support for the government encouraging digital contact tracing is indistinguishable between Democrats (47%) and Republicans (46%), although more Republicans oppose the policy (39%) compared to Democrats (27%). Of the app features we tested in our conjoint analysis experiment, only one had statistically significant effects on the self-reported likelihood of downloading the app: decentralized data architecture increased the likelihood by 5.4 percentage points. Conclusion Support for public health surveillance policies to curb the spread of COVID-19 is relatively low in the U.S. Contact tracing apps that use decentralized data storage, compared with those that use centralized data storage, are more accepted by the public. While respondents' support for expanding traditional contact tracing is greater than their support for the government encouraging the public to download and use contact tracing apps, there are smaller partisan differences in support for the latter policy.	[Zhang, Baobao; Kreps, Sarah] Cornell Univ, Dept Govt, Ithaca, NY USA; [McMurry, Nina] WZB Berlin Social Sci Ctr, Inst & Polit Inequal Unit, Berlin, Germany; [McCain, R. Miles] Stanford Univ, Palo Alto, CA 94304 USA	Cornell University; Stanford University	McMurry, N (corresponding author), WZB Berlin Social Sci Ctr, Inst & Polit Inequal Unit, Berlin, Germany.	nina.mcmurry@wzb.eu		McCain, R. Miles/0000-0001-5326-9212	Berkman Klein Center for Internet and Society, Harvard University	Berkman Klein Center for Internet and Society, Harvard University	The study was supported by the Berkman Klein Center for Internet and Society, Harvard University received by Dr. Baobao Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann S., 2020, ACCEPTABILITY APP BA, DOI [10.1101/2020.05.05.20091587, DOI 10.1101/2020.05.05.20091587]; Anderson M., 2020, MOST AM DONT THINK C; Begley Sharon, 2020, STAT NEWS; CATTIN P, 1982, J MARKETING, V46, P44, DOI 10.2307/1251701; Cheung H, 2020, BBC NEWS 0123; Coppock A, 2019, RES POLITICS, V6, DOI 10.1177/2053168018822174; Fairbank NA., 2020, THERES APP DIGITAL C; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Forsyth DR, 2020, GROUP DYNAMICS THEOR; Hainmueller J, 2014, POLIT ANAL, V22, P1, DOI 10.1093/pan/mpt024; Hargittai Eszter, 2020, SCI AM; Hinch R, 2020, DIGITAL CONTACT TRAC; Hurst D., 2020, GUARDIAN; Kaptchuk G., 2020, GOOD IS GOOD ENOUGH; Khazan O., 2020, ATLANTIC; Landau S, 2020, IMPORTANCE EQUITY CO; Lesser B, 2020, REUTERS; Lomas N., 2020, TECH CRUNCH; Newzoo, 2019, GLOB MOB MARK REP; ONeill P. H., 2020, MIT TECHNOL REV; Opsahl K., 2020, CHALLENGE PROXIMITY; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Simko L, 2020, COVID 19 CONTACT TRA; Timberg C., 2020, WASHINGTON POST	25	43	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242652	10.1371/journal.pone.0242652	http://dx.doi.org/10.1371/journal.pone.0242652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362218	Green Submitted, gold, Green Published			2022-12-26	WOS:000603071600015
J	Zhen, JH; Liang, G; Chen, RC; Jia, WS				Zhen, Jianhui; Liang, Gang; Chen, Ruichun; Jia, Wenshen			Label-free hairpin-like aptamer and EIS-based practical, biostable sensor for acetamiprid detection	PLOS ONE			English	Article							ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; SENSITIVE DETECTION; LIQUID-CHROMATOGRAPHY; COLORIMETRIC APTASENSOR; IMPEDIMETRIC APTASENSOR; DNA; BIOSENSOR; PESTICIDES; ELECTRODE; RESIDUES	Acetamiprid (ACE) is a kind of broad-spectrum pesticide that has potential health risk to human beings. Aptamers (Ap-DNA (1)) have a great potential as analytical tools for pesticide detection. In this work, a label-free electrochemical sensing assay for ACE determination is presented by electrochemical impedance spectroscopy (EIS). And the specific binding model between ACE and Ap-DNA (1) was further investigated for the first time. Circular dichroism (CD) spectroscopy and EIS demonstrated that the single strand AP-DNA (1) first formed a loosely secondary structure in Tris-HClO4 (20 mM, pH = 7.4), and then transformed into a more stable hairpin-like structure when incubated in binding buffer (B-buffer). The formed stem-loop bulge provides the specific capturing sites for ACE, forming ACE/AP-DNA (1) complex, and induced the R-CT (charge transfer resistance) increase between the solution-based redox probe [Fe(CN)(6)](3-/4-) and the electrode surface. The change of Delta R-CT (charge transfer resistance change, Delta R-CT = R-CT(after)-R-CT(before)) is positively related to the ACE level. As a result, the AP-DNA (1) biosensor showed a high sensitivity with the ACE concentration range spanning from 5 nM to 200 mM and a detection limit of 1 nM. The impedimetric AP-DNA (1) sensor also showed good selectivity to ACE over other selected pesticides and exhbited excellent performance in environmental water and orange juice samples analysis, with spiked recoveries in the range of 85.8% to 93.4% in lake water and 83.7% to 89.4% in orange juice. With good performance characteristics of practicality, sensitivity and selectivity, the AP-DNA (1) sensor holds a promising application for the on-site ACE detection.	[Zhen, Jianhui; Chen, Ruichun] Shijiazhuang Customs Technol Ctr PR China, Shijiazhuang, Hebei, Peoples R China; [Liang, Gang; Jia, Wenshen] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Agr Stand & Testing, Beijing, Peoples R China; [Liang, Gang; Jia, Wenshen] Minist Agr, Risk Assessment Lab Agroprod Beijing, Beijing, Peoples R China; [Liang, Gang; Jia, Wenshen] Beijing Municipal Key Lab Agr Environm Monitoring, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs	Liang, G (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Agr Stand & Testing, Beijing, Peoples R China.; Liang, G (corresponding author), Minist Agr, Risk Assessment Lab Agroprod Beijing, Beijing, Peoples R China.; Liang, G (corresponding author), Beijing Municipal Key Lab Agr Environm Monitoring, Beijing, Peoples R China.	liangg@brcast.org.cn	liang, gang/ACU-9853-2022	Liang, Gang/0000-0001-6543-1248	Beijing Natural Science Foundation [L182031]; National Natural Science Foundation of China [21806013]; Hebei Province Key Research and Development Program [20325502D]; Project of Beijing Excellent Talents [2017000020060G127]; Special Projects of Construction of Science and Technology Innovation Ability of Beijing Academy of Agriculture and Forestry Sciences [KJCX20170420]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Key Research and Development Program; Project of Beijing Excellent Talents; Special Projects of Construction of Science and Technology Innovation Ability of Beijing Academy of Agriculture and Forestry Sciences	We are grateful for financial support from the Beijing Natural Science Foundation (NO. L182031), the National Natural Science Foundation of China (NO. 21806013), Hebei Province Key Research and Development Program (NO. 20325502D), the Project of Beijing Excellent Talents (NO. 2017000020060G127), the Special Projects of Construction of Science and Technology Innovation Ability of Beijing Academy of Agriculture and Forestry Sciences (NO. KJCX20170420).	Akiyama Y, 2002, J AOAC INT, V85, P692; [Anonymous], 2018, CANC DISCOV, V8, pOF6; Bai WH, 2015, ENVIRON TOXICOL CHEM, V34, P2244, DOI 10.1002/etc.3088; Bogomolova A, 2009, ANAL CHEM, V81, P3944, DOI 10.1021/ac9002358; Dharuman V, 2011, ELECTROCHIM ACTA, V56, P8147, DOI 10.1016/j.electacta.2011.05.115; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Fan KM, 2019, TALANTA, V197, P645, DOI 10.1016/j.talanta.2019.01.069; Fan LF, 2013, BIOSENS BIOELECTRON, V43, P12, DOI 10.1016/j.bios.2012.11.033; Faraji M, 2018, FOOD CHEM, V240, P634, DOI 10.1016/j.foodchem.2017.08.012; Fei AR, 2015, BIOSENS BIOELECTRON, V70, P122, DOI 10.1016/j.bios.2015.03.028; Feng C, 2020, FOOD CHEM, V320, DOI 10.1016/j.foodchem.2020.126576; Fu JY, 2019, SENSOR ACTUAT B-CHEM, V287, P503, DOI 10.1016/j.snb.2019.02.057; Guzsvany V, 2007, ENVIRON CHEM LETT, V5, P203, DOI 10.1007/s10311-007-0102-5; Han LJ, 2020, FOOD CHEM, V319, DOI 10.1016/j.foodchem.2020.126592; Hassani S, 2018, BIOSENS BIOELECTRON, V120, P122, DOI 10.1016/j.bios.2018.08.041; He JA, 2011, J AGR FOOD CHEM, V59, P1582, DOI 10.1021/jf104189g; Jin DQ, 2016, FOOD CHEM, V194, P959, DOI 10.1016/j.foodchem.2015.08.118; Kerman K, 2004, MEAS SCI TECHNOL, V15, pR1, DOI 10.1088/0957-0233/15/2/R01; Lee HS, 2017, J CHROMATOGR B, V1055, P172, DOI 10.1016/j.jchromb.2017.04.021; Li L, 2018, J AM CHEM SOC, V140, P13335, DOI 10.1021/jacs.8b08047; Li T, 2013, ANALYST, V138, P1898, DOI 10.1039/c3an36673a; Li ZY, 2019, BIOSENS BIOELECTRON, V126, P632, DOI 10.1016/j.bios.2018.10.025; Liang G, 2016, ANAL CHIM ACTA, V936, P222, DOI 10.1016/j.aca.2016.06.056; Liang G, 2015, MICROCHIM ACTA, V182, P2233, DOI 10.1007/s00604-015-1565-x; Liang G, 2013, BIOSENS BIOELECTRON, V48, P238, DOI 10.1016/j.bios.2013.04.008; Liang G, 2013, BIOSENS BIOELECTRON, V45, P46, DOI 10.1016/j.bios.2013.01.046; Liang G, 2013, ANALYST, V138, P1032, DOI 10.1039/c2an36255d; Liu X, 2016, TALANTA, V160, P99, DOI 10.1016/j.talanta.2016.07.010; Ma XY, 2020, FOOD CHEM, V302, DOI 10.1016/j.foodchem.2019.125359; Madianos L, 2018, BIOSENS BIOELECTRON, V101, P268, DOI 10.1016/j.bios.2017.10.034; Mostafalou S, 2017, ARCH TOXICOL, V91, P549, DOI 10.1007/s00204-016-1849-x; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Qi YY, 2020, SENSOR ACTUAT B-CHEM, V304, DOI 10.1016/j.snb.2019.127359; Qi YY, 2016, BIOSENS BIOELECTRON, V83, P243, DOI 10.1016/j.bios.2016.04.074; Rapini R, 2016, TALANTA, V161, P15, DOI 10.1016/j.talanta.2016.08.026; Rhouati A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122178; Shadboorestan A, 2016, J ENVIRON SCI HEAL C, V34, P187, DOI 10.1080/10590501.2016.1202756; Shi L, 2012, ANAL METHODS-UK, V4, P1036, DOI 10.1039/c2ay05758a; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Sui CJ, 2018, SENSOR ACTUAT B-CHEM, V266, P514, DOI 10.1016/j.snb.2018.03.171; Tang XM, 2018, TALANTA, V189, P599, DOI 10.1016/j.talanta.2018.07.025; Tian Y, 2016, ANAL BIOCHEM, V513, P87, DOI 10.1016/j.ab.2016.09.004; Verdian A, 2018, TALANTA, V176, P456, DOI 10.1016/j.talanta.2017.08.070; Verma N, 2015, APPL BIOCHEM BIOTECH, V175, P3093, DOI 10.1007/s12010-015-1489-2; Wang TT, 2020, FOOD CHEM, V318, DOI 10.1016/j.foodchem.2020.126460; Xu HC, 2015, ANAL METHODS-UK, V7, P6260, DOI 10.1039/c5ay01282a; Yang ZT, 2015, BIOSENS BIOELECTRON, V65, P39, DOI 10.1016/j.bios.2014.10.004; Yao YW, 2019, SEP PURIF TECHNOL, V211, P456, DOI 10.1016/j.seppur.2018.10.021; Yi JL, 2020, BIOSENS BIOELECTRON, V148, DOI 10.1016/j.bios.2019.111827; Zhang BH, 2008, TALANTA, V75, P1055, DOI 10.1016/j.talanta.2008.01.032; Zhang J, 2018, ELECTROANAL, V30, P955, DOI 10.1002/elan.201700818; Zhang W, 2018, MOLECULES, V23, DOI 10.3390/molecules23020344; Zhao MM, 2018, TALANTA, V176, P34, DOI 10.1016/j.talanta.2017.08.006	53	5	6	12	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244297	10.1371/journal.pone.0244297	http://dx.doi.org/10.1371/journal.pone.0244297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362222	Green Published, gold			2022-12-26	WOS:000603071600049
J	Kruik-Kolloffel, WJ; van der Palen, J; Doggen, CJM; van Maaren, MC; Kruik, HJ; Heintjes, EM; Movig, KLL; Linssen, GCM				Kruik-Kolloffel, Willemien J.; van der Palen, Job; Doggen, Carine J. M.; van Maaren, Marissa C.; Kruik, H. Joost; Heintjes, Edith M.; Movig, Kris L. L.; Linssen, Gerard C. M.			Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases	PLOS ONE			English	Article							INITIATE LIFESAVING TREATMENT; ORGANIZED PROGRAM; MORTALITY; CARVEDILOL; ASSOCIATION; METOPROLOL; MORBIDITY; COMET; REHOSPITALIZATION; MANAGEMENT	Background This study assessed the association between heart failure (HF) medication (angiotensin-converting-enzyme inhibitors (ACEI)/angiotensin-receptor blockers (ARB), beta-blockers (BB), mineralocorticoid-receptor antagonists (MRA) and diuretics) and HF readmissions in a real-world unselected group of patients after a first hospital admission for HF. Furthermore we analysed readmission rates for ACEI versus ARB and for carvedilol versus beta 1-selective BB and we investigated the effect of HF medication in relation to time since discharge. Methods and findings Medication at discharge was determined with dispensing data from the Dutch PHARMO Database Network including 22,476 patients with HF between 2001 and 2015. After adjustment for age, gender, number of medications and year of admission no associations were found for users versus non-users of ACEI/ARB (hazard ratio, HR = 1.01; 95%CI 0.96-1.06), BB (HR = 1.00; 95%CI 0.95-1.05) and readmissions. The risk of readmission for patients prescribed MRA (HR = 1.11; 95%CI 1.05-1.16) or diuretics (HR = 1.17; 95%CI 1.09-1.25) was higher than for non-users. The HR for ARB relative to ACEI was 1.04 (95%CI 0.97-1.12) and for carvedilol relative to beta 1-selective BB 1.33 (95%CI 1.20-1.46). Post-hoc analyses showed a protective effect shortly after discharge for most medications. For example one month post discharge the HR for ACEI/ARB was 0.77 (95%CI 0.69-0.86). Although we did try to adjust for confounding by indication, probably residual confounding is still present. Conclusions Patients who were prescribed carvedilol have a higher or at least a similar risk of HF readmission compared to beta 1-selective BB. This study showed that all groups of HF medication -some more pronounced than others- were more effective immediately following discharge.	[Kruik-Kolloffel, Willemien J.] Ziekenhuisgrp Twente Hosp Grp Twente, Dept Clin Pharm, Almelo, Netherlands; [Kruik-Kolloffel, Willemien J.] Ziekenhuisgrp Twente Hosp Grp Twente, Dept Clin Pharm, Hengelo, Netherlands; [van der Palen, Job] Med Spectrum Twente, Med Sch Twente, Enschede, Netherlands; [van der Palen, Job] Univ Twente, Dept Res Methodol Measurement & Data Anal, Enschede, Netherlands; [Doggen, Carine J. M.; van Maaren, Marissa C.] Univ Twente, Dept Hlth Technol & Serv Res, Tech Med Ctr, Enschede, Netherlands; [van Maaren, Marissa C.] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands; [Kruik, H. Joost; Linssen, Gerard C. M.] Ziekenhuisgrp Twente Hosp Grp Twente, Dept Cardiol, Almelo, Netherlands; [Kruik, H. Joost; Linssen, Gerard C. M.] Ziekenhuisgrp Twente Hosp Grp Twente, Dept Cardiol, Hengelo, Netherlands; [Heintjes, Edith M.] PHARMO Inst, Utrecht, Netherlands; [Movig, Kris L. L.] Med Spectrum Twente, Dept Clin Pharm, Enschede, Netherlands	Medical Spectrum Twente; University of Twente; University of Twente; Medical Spectrum Twente	Kruik-Kolloffel, WJ (corresponding author), Ziekenhuisgrp Twente Hosp Grp Twente, Dept Clin Pharm, Almelo, Netherlands.; Kruik-Kolloffel, WJ (corresponding author), Ziekenhuisgrp Twente Hosp Grp Twente, Dept Clin Pharm, Hengelo, Netherlands.	w.kruik@sxb.nl		Heintjes, Edith/0000-0002-2617-3845; van der Palen, Job/0000-0003-1071-6769				[Anonymous], 2019, DIABETES CARE, V40, pS13; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bolling R, 2014, EUR J HEART FAIL, V16, P678, DOI 10.1002/ejhf.81; Bowman L, 2020, EUR HEART J, V41, P2571, DOI 10.1093/eurheartj/ehaa020; Bristow MR, 2003, J CARD FAIL, V9, P444, DOI 10.1016/j.cardfail.2003.10.009; Camm AJ, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2018-000788; Chatterjee S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f55; Cleland JGF, 2018, EUR HEART J, V39, P26, DOI 10.1093/eurheartj/ehx564; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Crespo-Leiro MG, 2016, EUR J HEART FAIL, V18, P613, DOI 10.1002/ejhf.566; Dargie HJ, 2003, LANCET, V362, P2, DOI 10.1016/S0140-6736(03)13842-1; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Eschalier R, 2015, CARDIOVASC DRUG THER, V29, P89, DOI 10.1007/s10557-015-6572-y; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Go AS, 2007, AM J CARDIOL, V100, P690, DOI 10.1016/j.amjcard.2007.03.084; Goldgrab D, 2019, HEART FAIL REV, V24, P177, DOI 10.1007/s10741-018-9754-4; Herings RMC, 2012, PHARMACOEPIDEM DR S; Hernandez AF, 2009, J AM COLL CARDIOL, V53, P184, DOI 10.1016/j.jacc.2008.09.031; Jhund PS, 2020, EUR J HEART FAIL, V22, P249, DOI 10.1002/ejhf.1721; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kapelios CJ, 2018, EUR HEART J-CARD PHA, V4, P54, DOI 10.1093/ehjcvp/pvx020; KOTECHA D, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I1855; Kruik-Kolloffel WJ, 2019, HEART FAIL REV, V24, P499, DOI 10.1007/s10741-019-09777-2; Kruik-Kolloffel WJ, 2019, THESIS; Lazarus DL, 2011, AM J CARDIOL, V107, P1196, DOI 10.1016/j.amjcard.2010.12.017; Lund LH, 2018, EUR J HEART FAIL, V20, P511, DOI 10.1002/ejhf.1107; Mullens W, 2019, EUR J HEART FAIL, V21, P137, DOI 10.1002/ejhf.1369; Network Equator, 2019, REPORTING STUD COND; O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 2003, J CARD FAIL, V9, P429, DOI 10.1016/j.cardfail.2003.08.003; Page RL, 2016, CIRCULATION, V134, pE32, DOI 10.1161/CIR.0000000000000426; Paolillo S, 2017, EUR J HEART FAIL, V19, P904, DOI 10.1002/ejhf.775; Pasternak B, 2014, JAMA INTERN MED, V174, P1597, DOI 10.1001/jamainternmed.2014.3258; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rush CJ, 2018, EUR HEART J, V39, P3417, DOI 10.1093/eurheartj/ehy407; Sanam K, 2016, AM J MED, V129, P1067, DOI 10.1016/j.amjmed.2016.05.008; Schmidt M, 2016, EUR J HEART FAIL, V18, P490, DOI 10.1002/ejhf.486; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; Stolfo D, 2020, EUR J HEART FAIL, V22, P103, DOI 10.1002/ejhf.1615; Sulo G, 2020, EUR J HEART FAIL, V22, P241, DOI 10.1002/ejhf.1609; van Herk-Sukel MPP, 2010, EUR J CANCER, V46, P395, DOI 10.1016/j.ejca.2009.09.010; Wolsk E, 2018, EUR J HEART FAIL, V20, P1267, DOI 10.1002/ejhf.1225; Yamaguchi T, 2018, AM J CARDIOL, V121, P969, DOI 10.1016/j.amjcard.2018.01.006; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244231	10.1371/journal.pone.0244231	http://dx.doi.org/10.1371/journal.pone.0244231			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351823	Green Published, gold			2022-12-26	WOS:000603071400011
J	Li, ZW; Wang, JH				Li, Zhangwei; Wang, Juhong			Identification and similarity analysis of aroma substances in main types of Fenghuang Dancong tea	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; PU-ERH TEA; CAMELLIA-SINENSIS; OOLONG TEA; VOLATILE PROFILES; ACTIVE COMPOUNDS; ELECTRONIC NOSE; BLACK TEA; HS-SPME; GC-MS	Fenghuang Dancong tea covers the oolong tea category and is widely acknowledged for its unique floral and honey flavor. In order to characterize the volatile components in nine different aroma types of Fenghuang Dancong tea, the Headspace solid-phase microextraction (HS-SPME) coupled with gas chromatography-mass spectrometry (GC- MS) were employed. In addition, the similarity analysis and cluster analysis (CA) were performed to compare the aroma characteristics and establish the correlation between the nine types of teas. The principal component analysis (PCA) and orthogonal partial least squares discrimination analysis (OPLS-DA) method were employed to determine the volatile components with a high contribution to the overall aroma of each type of tea. The results presented a total of 122 volatile aroma components including 24 kinds of alcohol, 23 kinds of esters, 15 kinds of olefins, 12 kinds of aldehydes, 12 kinds of ketones, 13 kinds of alkanes and 23 kinds of other components from the nine types of Fenghuang Dancong tea. Of these volatile aroma components, 22 types were common with linalool, dehydrolinalool, linalool oxide I, linalool oxide II, etc. The similarity of the nine types of Fenghuang Dancong tea was found between 46.79% and 95.94%. The CA indicated that the nine types of Fenghuang Dancong tea could be clustered into four categories when the ordinate distance reached to 10. The PCA demonstrated that decane, octadecane, 2,2,4,6,6-pentamethylheptane, dehydrolinalool, geraniol and nerol were the important aroma components to Fenghuang Dancong Tea. OPLS-DA proved that 2,2,4,6,6-pentamethylheptane, dehydrolinalool, phenylacetaldehyde, nerolidol, linalool oxide I and hexanal were the key differential compounds between the various types of tea samples. This study provides a theoretical basis for characterizing the volatile aroma components in the main types of Fenghuang Dancong tea as well as the similarity and correlation between various types of Fenghuang Dancong tea.	[Li, Zhangwei] Hanshan Normal Univ, Inst Chem & Environm Engn, Chaozhou, Peoples R China; [Wang, Juhong] Hanshan Normal Univ, Inst Food Engn & Biotechnol, Chaozhou, Peoples R China	Hanshan Normal University; Hanshan Normal University	Li, ZW (corresponding author), Hanshan Normal Univ, Inst Chem & Environm Engn, Chaozhou, Peoples R China.	99094001@163.com	LI, Zhangwei/HGV-1926-2022	LI, Zhangwei/0000-0001-8456-7386	Science and Technology Planing Project of Guangdong Province, China [2017A030303086]; National Natural Science Foundation of China [31770584]; Science and Technology Planing Project of Chaozhou City [2017GY04]	Science and Technology Planing Project of Guangdong Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planing Project of Chaozhou City	1.Science and Technology Planing Project of Guangdong Province, China (2017A030303086), 2.National Natural Science Foundation of China(31770584) 3.Science and Technology Planing Project of Chaozhou City (2017GY04).	Baldermann S., 2014, AM J ANAL CHEM, V5, P620, DOI DOI 10.4236/ajac.2014.59070; Chen XH, 2019, FOOD CHEM, V274, P130, DOI 10.1016/j.foodchem.2018.08.124; Dong WJ, 2019, FOOD CHEM, V272, P723, DOI 10.1016/j.foodchem.2018.08.068; Du LP, 2019, MICROCHEM J, V146, P986, DOI 10.1016/j.microc.2019.02.036; Gao XM, 2017, INT J FOOD PROP, V20, pS240, DOI 10.1080/10942912.2017.1295256; Guo XY, 2018, FOOD CHEM, V263, P18, DOI 10.1016/j.foodchem.2018.04.117; Haeck C, 2015, LABOUR ECON, V36, P137, DOI 10.1016/j.labeco.2015.05.002; Jang J, 2010, INT J FOOD PROP, V13, P608, DOI 10.1080/10942910902716976; Jeon DB, 2017, FOOD CHEM, V219, P443, DOI 10.1016/j.foodchem.2016.09.184; Landmann C, 2007, ARCH BIOCHEM BIOPHYS, V465, P417, DOI 10.1016/j.abb.2007.06.011; Lin J, 2012, J ZHEJIANG UNIV-SC B, V13, P972, DOI 10.1631/jzus.B1200086; Lin SY, 2013, J HORTIC SCI BIOTECH, V88, P159, DOI 10.1080/14620316.2013.11512951; Lv SD, 2015, RSC ADV, V5, P87806, DOI 10.1039/c5ra15381f; Ma CY, 2018, FOOD RES INT, V108, P413, DOI 10.1016/j.foodres.2018.03.052; Ma CH, 2014, FOOD CHEM, V152, P285, DOI 10.1016/j.foodchem.2013.11.010; Ma CH, 2013, J AGR FOOD CHEM, V61, P3548, DOI 10.1021/jf400515g; Mondal TK, 2004, PLANT CELL TISS ORG, V76, P195, DOI 10.1023/B:TICU.0000009254.87882.71; Morales-Hidalgo P, 2017, INT J CLIN HLTH PSYC, V17, P269, DOI 10.1016/j.ijchp.2017.05.002; Mukhopadhyay M, 2016, PLANT CELL REP, V35, P255, DOI 10.1007/s00299-015-1884-8; Nie CN, 2019, EUR FOOD RES TECHNOL, V245, P1963, DOI 10.1007/s00217-019-03304-1; Qin ZH, 2013, FOOD RES INT, V53, P864, DOI 10.1016/j.foodres.2013.02.005; Schuh C, 2006, J AGR FOOD CHEM, V54, P916, DOI 10.1021/jf052495n; Sheibani E, 2016, J FOOD SCI, V81, pC348, DOI 10.1111/1750-3841.13203; Shen CJ, 2012, BIOTECHNOL & BIOPROC, V34, P165; [史敬芳 Shi Jingfang], 2016, [食品科学, Food Science], V37, P111; Song SQ, 2013, J CHROMATOGR A, V1278, P145, DOI 10.1016/j.chroma.2012.12.062; Su XG, 2006, J FOOD COMPOS ANAL, V19, P348, DOI 10.1016/j.jfca.2005.02.005; Tan HR, 2019, LWT-FOOD SCI TECHNOL, V108, P221, DOI 10.1016/j.lwt.2019.03.054; Wang C, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2229-y; Wang YF, 2012, FOOD RES INT, V46, P158, DOI 10.1016/j.foodres.2011.11.027; Wu SB, 2013, J CHROMATOGR A, V1314, P154, DOI 10.1016/j.chroma.2013.09.017; Wu SBA, 2012, J AGR FOOD CHEM, V60, P7513, DOI 10.1021/jf301888y; [肖凌 Xiao Ling], 2018, [食品科学, Food Science], V39, P233; Xu YQ, 2016, FOOD ANAL METHOD, V9, P1188, DOI 10.1007/s12161-015-0303-7; Yang ZY, 2013, FOOD RES INT, V53, P585, DOI 10.1016/j.foodres.2013.02.011; Yang ZY, 2009, J PLANT PHYSIOL, V166, P887, DOI 10.1016/j.jplph.2008.11.001; Zhang WJ, 2019, J ZHEJIANG UNIV-SC B, V20, P563, DOI 10.1631/jzus.B1800183; Zhou ChunJuan, 2014, Journal of Tea Science, V34, P609	38	9	9	17	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244224	10.1371/journal.pone.0244224	http://dx.doi.org/10.1371/journal.pone.0244224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347483	gold, Green Published			2022-12-26	WOS:000603071100043
J	Migita, K; Nakamura, M; Aiba, Y; Kozuru, H; Abiru, S; Komori, A; Fujita, Y; Temmoku, J; Asano, T; Sato, S; Furuya, M; Naganuma, A; Yoshizawa, K; Shimada, M; Ario, K; Mannami, T; Kohno, H; Kaneyoshi, T; Komura, T; Ohira, H; Yatsuhashi, H				Migita, Kiyoshi; Nakamura, Minoru; Aiba, Yoshihiro; Kozuru, Hideko; Abiru, Seigo; Komori, Atsumasa; Fujita, Yuya; Temmoku, Junpei; Asano, Tomoyuki; Sato, Shuzo; Furuya, Makiko; Naganuma, Atsushi; Yoshizawa, Kaname; Shimada, Masaaki; Ario, Keisuke; Mannami, Tomohiko; Kohno, Hiroshi; Kaneyoshi, Toshihiko; Komura, Takuya; Ohira, Hiromasa; Yatsuhashi, Hiroshi			Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TIM-3; DIAGNOSIS	Background Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma (HCC). The aim of the present study was to determine whether circulating soluble TIM3 (sTIM3) is elevated in patients with AIH patients and whether sTIM-3 levels are associated with clinical parameters of AIH. Methods We enrolled 123 Japanese patients with AIH who were identified from the National Hospital Organization-AIH-liver-network database, as well as 32 patients with chronic hepatitis C (CHC), 30 patients with primary biliary cholangitis (PBC) and healthy control subjects. Serum sTIM-3 concentrations were quantified by ELISA. Results Serum levels of sTIM-3 were significantly higher in AIH patients (median 4865 pg/ml; [interquartile range (IQR); 3122-7471]) compared to those in CHC (1026 pg/ml [IQR: 806-1283] p<0.001), PBC (2395 pg/ml [IQR: 2012-3422] p<0.001) or healthy controls (1285 pg/ml [IQR: 1098-1812] p<0.001). In AIH group, serum sTIM-3 were correlated with alanine aminotransferase (ALT), or total bilirubin (TB) and negatively correlated with serum levels of albumin (Alb). Serum levels of sTIM-3 were also strongly correlated with Mac-2 binding protein glycosylation isomer (M2BPGi) levels, but did not correlate with the histological grade of liver fibrosis. Steroid treatment of AIH patients significantly reduced serum sTIM-3 levels (2147 +/- 623pg/ml versus 1321 +/- 378pg/ml, p<0.001). Conclusions Circulating sTIM-3 levels were elevated in AIH patients and are associated with AIH disease activity and AIH-related liver damage. These findings indicate that serum sTIM-3 correlated with disease status of AIH and could be useful biomarkers to detect autoimmune-mediated liver injury. Our data suggest a possible link between the TIM-3/GAL-9 pathway and AIH severity or phenotype, and further investigations of the TIM-3 pathway and AIH pathophysiology is warranted.	[Migita, Kiyoshi; Nakamura, Minoru; Aiba, Yoshihiro; Kozuru, Hideko; Abiru, Seigo; Komori, Atsumasa; Yatsuhashi, Hiroshi] Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan; [Migita, Kiyoshi; Fujita, Yuya; Temmoku, Junpei; Asano, Tomoyuki; Sato, Shuzo; Furuya, Makiko] Fukushima Med Univ, Dept Rheumatol, Fukushima, Japan; [Naganuma, Atsushi] Natl Hosp Org, Takasaki Med Ctr, Takasaki, Gumma, Japan; [Yoshizawa, Kaname] Natl Hosp Org, Shinsyu Ueda Med Ctr, Ueda, Nagano, Japan; [Shimada, Masaaki] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Ario, Keisuke] Natl Hosp Org, Ureshino Med Ctr, Ureshino, Saga, Japan; [Mannami, Tomohiko] Natl Hosp Org, Okayama Med Ctr, Okayama, Okayama, Japan; [Kohno, Hiroshi] Natl Hosp Org, Kure Med Ctr, Kure, Hiroshima, Japan; [Kaneyoshi, Toshihiko] Natl Hosp Org, Fukuyama Med Ctr, Kanazawa, Ishikawa, Japan; [Komura, Takuya] Natl Hosp Org, Kanazawa Med Ctr, Kanazawa, Ishikawa, Japan; [Ohira, Hiromasa] Fukushima Med Univ, Dept Gastroenterol, Fukushima, Japan	Fukushima Medical University; Nagoya Medical Center; Fukushima Medical University	Migita, K (corresponding author), Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan.; Migita, K (corresponding author), Fukushima Med Univ, Dept Rheumatol, Fukushima, Japan.	migita@fmu.ac.jp			National Hospital Organization [H29-NHOL-01]	National Hospital Organization	The study was supported by a grant from the National Hospital Organization (grant number H29-NHOL-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Bekki Y, 2017, J GASTROEN HEPATOL, V32, P1387, DOI 10.1111/jgh.13708; Cox MA, 2017, CURR OPIN IMMUNOL, V48, P61, DOI 10.1016/j.coi.2017.07.016; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; de Boer YS, 2014, GASTROENTEROLOGY, V147, P443, DOI 10.1053/j.gastro.2014.04.022; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fleury M, 2018, ARTHRITIS RHEUMATOL, V70, P566, DOI 10.1002/art.40399; Floreani A, 2018, J AUTOIMMUN, V95, P133, DOI 10.1016/j.jaut.2018.10.020; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Golden-Mason L, 2015, CLIN IMMUNOL, V158, P114, DOI 10.1016/j.clim.2015.03.008; Han GC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00449; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Heneghan MA, 2013, LANCET, V382, P1433, DOI 10.1016/S0140-6736(12)62163-1; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2014, MOL IMMUNOL, V58, P85, DOI 10.1016/j.molimm.2013.11.001; Kocer B, 2018, TURK J NEUROL, V24, P168, DOI 10.4274/tnd.65624; Liberal R, 2017, HEPATOLOGY, V66, P1570, DOI 10.1002/hep.29307; Liberal R, 2012, HEPATOLOGY, V56, P677, DOI 10.1002/hep.25682; Longhi MS, 2010, DIGEST DIS, V28, P63, DOI 10.1159/000282066; Longhi MS, 2010, J AUTOIMMUN, V34, P7, DOI 10.1016/j.jaut.2009.08.010; Matsuoka N, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016924; McGrath MM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00047; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Moller-Hackbarth K, 2013, J BIOL CHEM, V288, P34529, DOI 10.1074/jbc.M113.488478; Oka S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187325; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Song LJ, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0306-0; Tang RH, 2019, SEMIN IMMUNOL, V42, DOI 10.1016/j.smim.2019.101302; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu C, 2011, CURR TOP MICROBIOL, V350, P1, DOI 10.1007/82_2010_84	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0238540	10.1371/journal.pone.0238540	http://dx.doi.org/10.1371/journal.pone.0238540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347507	gold, Green Published			2022-12-26	WOS:000603071100066
J	Miyagi, M; Wilson, R; Saigusa, D; Umeda, K; Saijo, R; Hager, CL; Li, YJ; McCormick, T; Ghannoum, MA				Miyagi, Masaru; Wilson, Rachel; Saigusa, Daisuke; Umeda, Keiko; Saijo, Reina; Hager, Christopher L.; Li, Yuejin; McCormick, Thomas; Ghannoum, Mahmoud A.			Indole-3-acetic acid synthesized through the indole-3-pyruvate pathway promotes Candida tropicalis biofilm formation	PLOS ONE			English	Article							QUORUM; COMMUNICATION; GROWTH; FUNGI	We previously found that the elevated abundance of the fungus Candida tropicalis is positively correlated with the bacteria Escherichia coli and Serratia marcescens in Crohn's disease patients and the three pathogens, when co-cultured, form a robust mixed-species biofilm. The finding suggests that these three pathogens communicate and promote biofilm formation, possibly through secretion of small signaling molecules. To identify candidate signaling molecules, we carried out a metabolomic analysis of the single-species and triple-species cultures of the three pathogens. This analysis identified 15 metabolites that were highly increased in the triple-species culture. One highly induced metabolite was indole-3-acetic acid (IAA), which has been shown to induce filamentation of certain fungi. We thus tested the effect of IAA on biofilm formation of C. tropicalis and demonstrated that IAA promotes biofilm formation of C. tropicalis. Then, we carried out isotope tracing experiments using C-13-labeled-tryptophan as a precursor to uncover the biosynthesis pathway of IAA in C. tropicalis. The results indicated that C. tropicalis synthesizes IAA through the indole-3-pyruvate pathway. Further studies using inhibitors of the indole-3-pyruvate pathway are warranted to decipher the mechanisms by which IAA influences biofilm formation.	[Miyagi, Masaru] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Wilson, Rachel; Hager, Christopher L.; Li, Yuejin; McCormick, Thomas; Ghannoum, Mahmoud A.] Case Western Reserve Univ, Ctr Med Mycol, Dept Dermatol, Cleveland, OH 44106 USA; [Saigusa, Daisuke; Umeda, Keiko; Saijo, Reina] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Ghannoum, Mahmoud A.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Tohoku University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Miyagi, M (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.; Ghannoum, MA (corresponding author), Case Western Reserve Univ, Ctr Med Mycol, Dept Dermatol, Cleveland, OH 44106 USA.; Ghannoum, MA (corresponding author), Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA.	mxm356@case.edu; mag3@case.edu	LI, Yue/GRS-8071-2022		National Institutes of Health [R01AI145289-01A1]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [JP20km0105001, JP20km0105002]; Japan Agency for Medical Research and Development (AMED); Project for Promoting Public Utilization of Advanced Research Infrastructure from MEXT	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Project for Promoting Public Utilization of Advanced Research Infrastructure from MEXT	This work was supported in part by a National Institutes of Health Grant #R01AI145289-01A1 to M.A.G., the Tohoku Medical Megabank Project (Grant #JP20km0105001 and JP20km0105002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and Japan Agency for Medical Research and Development (AMED), and Project for Promoting Public Utilization of Advanced Research Infrastructure from MEXT.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Albuquerque P, 2012, MED MYCOL, V50, P337, DOI 10.3109/13693786.2011.652201; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chiara MM, 2020, NUTRIENTS, V12; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; Hoarau G, 2016, MBIO, V7, DOI [10.1128/mBio.01250-16, 10.1128/mbio.01250-16]; Krause K, 2015, APPL ENVIRON MICROB, V81, P7003, DOI 10.1128/AEM.01991-15; Li F, 2016, P NATL ACAD SCI USA, V113, P13450, DOI 10.1073/pnas.1614947113; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Nadal M, 2008, FEMS MICROBIOL LETT, V284, P127, DOI 10.1111/j.1574-6968.2008.01173.x; OBERHANSLI T, 1991, J GEN MICROBIOL, V137, P2273, DOI 10.1099/00221287-137-10-2273; Padder SA, 2018, MICROBIOL RES, V210, P51, DOI 10.1016/j.micres.2018.03.007; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Raboni S, 2009, CELL MOL LIFE SCI, V66, P2391, DOI 10.1007/s00018-009-0028-0; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Rao RP, 2010, GENETICS, V185, P211, DOI 10.1534/genetics.109.112854; Sardar P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192293; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0	26	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244246	10.1371/journal.pone.0244246	http://dx.doi.org/10.1371/journal.pone.0244246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332404	gold, Green Published			2022-12-26	WOS:000601310900021
J	Dubois, F; Gaignerie, A; Flippe, L; Heslan, JM; Tesson, L; Chesneau, M; Haspot, F; Conchon, S; David, L; Brouard, S				Dubois, Florian; Gaignerie, Anne; Flippe, Lea; Heslan, Jean-Marie; Tesson, Laurent; Chesneau, Melanie; Haspot, Fabienne; Conchon, Sophie; David, Laurent; Brouard, Sophie			Toward a better definition of hematopoietic progenitors suitable for B cell differentiation	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ORIGIN; PHENOTYPE; DEFINES; SYSTEM	The success of inducing human pluripotent stem cells (hIPSC) offers new opportunities for cell-based therapy. Since B cells exert roles as effector and as regulator of immune responses in different clinical settings, we were interested in generating B cells from hIPSC. We differentiated human embryonic stem cells (hESC) and hIPSC into B cells onto OP9 and MS-5 stromal cells successively. We overcame issues in generating CD34(+)CD43(+) hematopoietic progenitors with appropriate cytokine conditions and emphasized the difficulties to generate proper hematopoietic progenitors. We highlight CD31(int)CD45(int) phenotype as a possible marker of hematopoietic progenitors suitable for B cell differentiation. Defining precisely proper lymphoid progenitors will improve the study of their lineage commitment and the signals needed during the in vitro process.	[Dubois, Florian; Flippe, Lea; Heslan, Jean-Marie; Tesson, Laurent; Chesneau, Melanie; Haspot, Fabienne; Conchon, Sophie; David, Laurent; Brouard, Sophie] Univ Nantes, CHU Nantes, Ctr Rech Transplantat & Immunol, INSERM,UMR 1064,ITUN, Nantes, France; [Gaignerie, Anne; Heslan, Jean-Marie; David, Laurent] Univ Nantes, CHU Nantes, SFR Sante, FED 4203,INSERM,UMS 016,CNRS,UMS 3556, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Brouard, S (corresponding author), Univ Nantes, CHU Nantes, Ctr Rech Transplantat & Immunol, INSERM,UMR 1064,ITUN, Nantes, France.	sophie.brouard@univ-nantes.fr	Dubois, Florian/GYA-0494-2022; HASPOT, Fabienne/AAD-5698-2021	Haspot, Fabienne/0000-0003-0513-1387; DUBOIS, Florian/0000-0002-7034-0866; Conchon, Sophie/0000-0003-2602-3385; Flippe, Lea/0000-0002-8521-5267	French government [ANR-11-LABX-0016-01]; ANR project BIKET [ANR-17CE17-0008];  [RP10083]	French government; ANR project BIKET(French National Research Agency (ANR)); 	This work was supported in the context of the Centaure project (RP10083) and the LabEX IGO thanks to French government financial support managed by the National Research Agency via the "Investment into the Future" program (ANR-11-LABX-0016-01). The ANR project BIKET (ANR-17CE17-0008) also financially support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, REGEN MED S3, V7, pS14; Bar S, 2017, CELL REP, V19, P957, DOI 10.1016/j.celrep.2017.04.020; Bueno C, 2016, LEUKEMIA, V30, P674, DOI 10.1038/leu.2015.294; Carpenter L, 2011, BLOOD, V117, P4008, DOI 10.1182/blood-2010-08-299941; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chesneau M, 2014, AM J TRANSPLANT, V14, P144, DOI 10.1111/ajt.12508; Chesneau M, 2015, J AM SOC NEPHROL, V26, P2588, DOI 10.1681/ASN.2014040404; Chicha L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014733; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fort A, 2015, CELL CYCLE, V14, P1148, DOI 10.4161/15384101.2014.988031; French A, 2015, STEM CELLS DEV, V24, P1082, DOI 10.1089/scd.2014.0318; Gaignerie A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32645-2; Huang K, 2014, STEM CELL REP, V2, P36, DOI 10.1016/j.stemcr.2013.11.003; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Julien E, 2016, FEBS LETT, V590, P3987, DOI 10.1002/1873-3468.12389; Kaufman DS, 2009, BLOOD, V114, P3513, DOI 10.1182/blood-2009-03-191304; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kumar A, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/2141475; Larbi A, 2014, STEM CELLS DEV, V23, P2983, DOI 10.1089/scd.2014.0171; Mauri C, 2015, INT IMMUNOL, V27, P479, DOI 10.1093/intimm/dxv038; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nishihara M, 1998, EUR J IMMUNOL, V28, P855, DOI 10.1002/(SICI)1521-4141(199803)28:03<855::AID-IMMU855>3.0.CO;2-X; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Ohkawara JI, 1998, LEUKEMIA, V12, P764, DOI 10.1038/sj.leu.2401004; Oleinika K, 2019, NAT REV NEPHROL, V15, P11, DOI 10.1038/s41581-018-0074-7; Palpant NJ, 2017, CELL REP, V20, P1597, DOI 10.1016/j.celrep.2017.07.067; Palpant NJ, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.153; Parrotta E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0720-1; Pettinato G, 2014, SCI REP-UK, V4, DOI 10.1038/srep07402; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rodriguez-Pinto D, 2005, CELL IMMUNOL, V238, P67, DOI 10.1016/j.cellimm.2006.02.005; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sanz E, 2010, P NATL ACAD SCI USA, V107, P5925, DOI 10.1073/pnas.0907942107; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Slukvin II, 2016, FEBS LETT, V590, P4126, DOI 10.1002/1873-3468.12283; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wasik M, 2018, MICROBIOL IMMUNOL, V62, P485, DOI 10.1111/1348-0421.12636	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243769	10.1371/journal.pone.0243769	http://dx.doi.org/10.1371/journal.pone.0243769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320872	gold, Green Published			2022-12-26	WOS:000600339800007
J	Ishitani, H; Tamura, T; Kanaya, S; Fujimoto, H				Ishitani, Hayato; Tamura, Toshiyo; Kanaya, Shigehiko; Fujimoto, Hiroshi			Examination of the regression model to quantify the degree of low back pain and lower limb symptoms in patients with lumbar disc herniation by the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ)	PLOS ONE			English	Article								The Japanese Orthopedic Association Back Pain Evaluation Questionnaire (JOABPEQ) was created to evaluate specific treatment outcomes in terms of physical functioning, social ability, and mental health in patients with back pain-related diseases. In this study, we investigated whether the JOABPEQ could be used to construct a regression model to quantify low back pain and lower limb symptoms in patients with lumbar disc herniation (LDH). We reviewed 114 patients with LDH scheduled to undergo surgery at our hospital. We measured the degrees of 1) lower back pain, 2) lower limb pain, and 3) lower limb numbness using the visual analog scale before the surgery. All answers and physical function data were subjected to partial least squares regression analysis. The degrees of lower back and lower limb pain could be used as a regression model from the JOABPEQ and had a significant causal relationship with them. However, the degree of lower limb numbness could not be used for the same. Based on our results, the questions of the JOABPEQ can be used to multilaterally understand the degree of lower back pain and lower limb pain in patients with LDH. However, the degree of lower limb numbness has no causal relationship, so actual measurement is essential.	[Ishitani, Hayato] Funabashi Orthoped Hosp, Nishifuna Clin, Dept Rehabil, Funabashi, Chiba, Japan; [Tamura, Toshiyo; Fujimoto, Hiroshi] Waseda Univ, Future Robot Org, Inst Healthcare Robot, Shinjuku Ku, Tokyo, Japan; [Kanaya, Shigehiko] Nara Inst Sci & Technol, Computat Syst Biol Lab, Ikoma City, Nara, Japan	Waseda University; Nara Institute of Science & Technology	Ishitani, H (corresponding author), Funabashi Orthoped Hosp, Nishifuna Clin, Dept Rehabil, Funabashi, Chiba, Japan.	hayato2020@gmail.com	Tamura, Toshiyo/C-7673-2014	Tamura, Toshiyo/0000-0002-8514-4200; Ishitani, Hayato/0000-0002-6310-3088				AFFLECK G, 1994, J PERS SOC PSYCHOL, V66, P329, DOI 10.1037/0022-3514.66.2.329; Azimi P, 2012, J ORTHOP SCI, V17, P341, DOI 10.1007/s00776-012-0232-x; Block A R, 2001, Spine J, V1, P274, DOI 10.1016/S1529-9430(01)00054-7; Chin WW, 1998, QUANT METH SER, P295; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Dorow M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156647; Fors M, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2850-3; Hockings RL, 2008, SPINE, V33, pE494, DOI 10.1097/BRS.0b013e31817ba3bb; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Li LQ, 2016, J INT MED RES, V44, P1424, DOI 10.1177/0300060516645419; Lindback Y, 2018, SPINE J, V18, P1347, DOI 10.1016/j.spinee.2017.12.009; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Mannion AF, 2007, EUR SPINE J, V16, P777, DOI 10.1007/s00586-006-0255-0; Poosiripinyo T, 2017, J ORTHOP SCI, V22, P34, DOI 10.1016/j.jos.2016.10.001; Sinikallio S, 2007, EUR SPINE J, V16, P905, DOI 10.1007/s00586-007-0349-3; Zanaboni P, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-1	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243861	10.1371/journal.pone.0243861	http://dx.doi.org/10.1371/journal.pone.0243861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315945	gold, Green Published			2022-12-26	WOS:000600186100053
J	Ilangovan, G; Khaleel, SA; Kundu, T; Hemann, C; El-Mahdy, MA; Zweier, JL				Ilangovan, Govindasamy; Khaleel, Sahar A.; Kundu, Tapan; Hemann, Craig; El-Mahdy, Mohamed A.; Zweier, Jay L.			Defining the reducing system of the NO dioxygenase cytoglobin in vascular smooth muscle cells and its critical role in regulating cellular NO decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE METABOLISM; ASCORBIC-ACID; PEROXYNITRITE; GENERATION; REDUCTION; PHYSIOLOGY; DEPLETION; HYPOXIA	In smooth muscle, cytoglobin (Cygb) functions as a potent nitric oxide (NO) dioxygenase and regulates NO metabolism and vascular tone. Major questions remain regarding which cellular reducing systems regulate Cygb-mediated NO metabolism. To better define the Cygb-mediated NO dioxygenation process in vascular smooth muscle cells (SMCs), and the requisite reducing systems that regulate cellular NO decay, we assessed the intracellular concentrations of Cygb and its putative reducing systems and examined their roles in the process of NO decay. Cygb and the reducing systems, cytochrome b5 (B5)/cytochrome b5 reductase (B5R) and cytochrome P450 reductase (CPR) were measured in aortic SMCs. Intracellular Cygb concentration was estimated as 3.5 mu M, while B5R, B5, and CPR were 0.88, 0.38, and 0.15 mu M, respectively. NO decay in SMCs was measured following bolus addition of NO to air-equilibrated cells. siRNA-mediated knockdown experiments indicated that similar to 78% of NO metabolism in SMCs is Cygb-dependent. Of this, similar to 87% was B5R- and B5-dependent. CPR knockdown resulted in a small decrease in the NO dioxygenation rate (V-NO), while depletion of ascorbate had no effect. Kinetic analysis of V-NO for the B5/B5R/Cygb system with variation of B5 or B5R concentrations from their SMC levels showed that V-NO exhibits apparent Michaelis-Menten behavior for B5 and B5R. In contrast, linear variation was seen with change in Cygb concentration. Overall, B5/B5R was demonstrated to be the major reducing system supporting Cygb-mediated NO metabolism in SMCs with changes in cellular B5/B5R levels modulating the process of NO decay.	[Ilangovan, Govindasamy; Khaleel, Sahar A.; Kundu, Tapan; Hemann, Craig; El-Mahdy, Mohamed A.; Zweier, Jay L.] Ohio State Univ, Coll Med, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA; [Ilangovan, Govindasamy; Khaleel, Sahar A.; Kundu, Tapan; Hemann, Craig; El-Mahdy, Mohamed A.; Zweier, Jay L.] Ohio State Univ, Coll Med, EPR Ctr, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Khaleel, Sahar A.] Al Azhar Univ, Coll Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Al Azhar University	Zweier, JL (corresponding author), Ohio State Univ, Coll Med, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA.; Zweier, JL (corresponding author), Ohio State Univ, Coll Med, EPR Ctr, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	jay.zweier@osumc.edu		Kaheel, Sahar/0000-0002-6034-2585	NIH/NHLBI [R01HL131941, R01HL135648]	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH/NHLBI grants R01HL131941 and R01HL135648. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amdahl MB, 2019, BIOCHEMISTRY-US, V58, P3212, DOI 10.1021/acs.biochem.9b00406; Amdahl MB, 2017, BIOCHEMISTRY-US, V56, P3993, DOI 10.1021/acs.biochem.7b00224; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BERGSTEN P, 1990, J BIOL CHEM, V265, P2584; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Chen JY, 2018, BIOMED PHARMACOTHER, V97, P423, DOI 10.1016/j.biopha.2017.10.122; Corti P, 2016, NITRIC OXIDE-BIOL CH, V53, P22, DOI 10.1016/j.niox.2015.12.004; Estrin DA, 2020, ANTIOXID REDOX SIGN, V32, P1151, DOI 10.1089/ars.2020.8034; Fujita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094772; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Gorr TA, 2011, ACTA PHYSIOL, V202, P563, DOI 10.1111/j.1748-1716.2010.02205.x; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Heberlein KR, 2009, MICROCIRCULATION, V16, P307, DOI 10.1080/10739680902744404; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; Ignarro LJ, 2019, BRIT J PHARMACOL, V176, P131, DOI 10.1111/bph.14540; Jourd'heuil FL, 2017, ARTERIOSCL THROM VAS, V37, P1944, DOI 10.1161/ATVBAHA.117.309410; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Karaczyn A, 2006, J CELL BIOCHEM, V97, P1025, DOI 10.1002/jcb.20705; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; Liu XP, 2008, BIOPHYS J, V94, P1880, DOI 10.1529/biophysj.107.120626; Liu XP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14807; Liu XP, 2013, FEBS J, V280, P3621, DOI 10.1111/febs.12352; Liu XP, 2013, J ELECTROANAL CHEM, V688, P32, DOI 10.1016/j.jelechem.2012.09.038; Liu XP, 2012, BIOCHEMISTRY-US, V51, P5072, DOI 10.1021/bi300291h; Liu XP, 2010, FREE RADICAL BIO MED, V48, P554, DOI 10.1016/j.freeradbiomed.2009.11.024; Liu XP, 2004, AM J PHYSIOL-HEART C, V287, pH2421, DOI 10.1152/ajpheart.00487.2004; Mathai C, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101468; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5; MONCADA S, 1991, PHARMACOL REV, V43, P109; Hai NTT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36215-4; Oleksiewicz U, 2013, HUM MOL GENET, V22, P3207, DOI 10.1093/hmg/ddt174; Oleksiewicz U, 2011, CELL MOL LIFE SCI, V68, P3869, DOI 10.1007/s00018-011-0764-9; Olson JS, 2020, ANTIOXID REDOX SIGN, V32, P228, DOI 10.1089/ars.2019.7876; Qiao H, 2009, J VASC RES, V46, P15, DOI 10.1159/000135661; Radi R, 2018, P NATL ACAD SCI USA, V115, P5839, DOI 10.1073/pnas.1804932115; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Rahaman MM, 2017, CIRC RES, V121, P137, DOI 10.1161/CIRCRESAHA.117.310705; Shaw RJ, 2009, BRIT J CANCER, V101, P139, DOI 10.1038/sj.bjc.6605121; Straub AC, 2014, PHYSIOLOGY, V29, P242, DOI 10.1152/physiol.00042.2013; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Tong JJ, 2014, ARCH BIOCHEM BIOPHYS, V554, P1, DOI 10.1016/j.abb.2014.04.011; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Yoshizato K, 2016, P JPN ACAD B-PHYS, V92, P77, DOI 10.2183/pjab.92.77; Zhang SN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11342-6; Zhou DL, 2017, FEBS OPEN BIO, V7, P845, DOI 10.1002/2211-5463.12230; Zweier JL, 2020, ANTIOXID REDOX SIGN, V32, P1172, DOI 10.1089/ars.2019.7881	50	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100196	10.1074/jbc.RA120.016394	http://dx.doi.org/10.1074/jbc.RA120.016394			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334890	Green Published, gold			2022-12-26	WOS:000672866400174
J	Lai, YH; Lee, PY; Lu, CY; Liu, YR; Wang, SC; Liu, CC; Chang, YC; Chen, YH; Su, CC; Li, CY; Liu, PL				Lai, Yu-Hung; Lee, Po-Yen; Lu, Chi-Yu; Liu, Yu-Ru; Wang, Shu-Chi; Liu, Ching-Chih; Chang, Yo-Chen; Chen, Yung-Hsiang; Su, Chia-Cheng; Li, Chia-Yang; Liu, Po-Len			Thrombospondin 1-induced exosomal proteins attenuate hypoxia-induced paraptosis in corneal epithelial cells and promote wound healing	FASEB JOURNAL			English	Article						exosomes; human corneal epithelium; hypoxia; paraptosis; thrombospondin&#8208; 1	POTENTIAL ROLE; RECEPTOR; NEOVASCULARIZATION; LOCALIZATION; APOPTOSIS; MIGRATION; PATHWAYS; TISSUES; REPAIR; EYE	Thrombospondin-1 (TSP1) is involved in corneal wound healing caused by chemical injury. Herein, we examined the effects of TSP1 on hypoxia-induced damages and wound-healing activity in human corneal epithelial (HCE) cells. Exosomal protein expression was determined using liquid chromatography-tandem mass spectrometry, and HCE cell migration and motility were examined through wound-healing assay and time-lapse microscopy. Reestablishment of cell junctions by TSP1 was assessed through confocal microscopy and 3D image reconstruction. Our results show that CoCl2-induced hypoxia promoted HCE cell death by paraptosis. TSP1 protected these cells against paraptosis by attenuating mitochondrial membrane potential depletion, swelling and dilation of endoplasmic reticulum and mitochondria, and mitochondrial fission. Exosomes isolated from HCE cells treated with TSP1 contained wound healing-associated proteins that were taken up by HCE cells to promote tissue remodeling and repair. TSP1 protected HCE cells against hypoxia-induced damages and inhibited paraptosis progression by promoting cell migration, cell-cell adhesion, and extracellular matrix remodeling. These findings indicate that TSP1 ameliorates hypoxia-induced paraptosis in HCE cells and promotes wound healing and remodeling by regulating exosomal protein expression. TSP1 may, therefore, play important roles in the treatment of hypoxia-associated corneal diseases.	[Lai, Yu-Hung; Lee, Po-Yen; Chang, Yo-Chen; Su, Chia-Cheng; Li, Chia-Yang] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80708, Taiwan; [Lai, Yu-Hung; Lee, Po-Yen; Chang, Yo-Chen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Lai, Yu-Hung; Chang, Yo-Chen] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Kaohsiung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Coll Med, Dept Biochem, Kaohsiung, Taiwan; [Liu, Yu-Ru; Liu, Po-Len] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung 80708, Taiwan; [Wang, Shu-Chi] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Liu, Ching-Chih] Chi Mei Med Ctr, Dept Ophthalmol, Tainan, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Li, Chia-Yang; Liu, Po-Len] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan; [Liu, Po-Len] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Chi Mei Hospital; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Li, CY (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80708, Taiwan.; Liu, PL (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung 80708, Taiwan.	chiayangli@kmu.edu.tw; kisa@kmu.edu.tw	Lai, Yu-Hung/HGA-2767-2022; Chen, Yung-Hsiang/K-6766-2015	Lai, Yu-Hung/0000-0003-1997-0587; Chen, Yung-Hsiang/0000-0002-8756-5113; LI, CHIA-YANG/0000-0001-5689-9850; Lee, Po Yen/0000-0002-1825-0003				Adams J.C., 2011, CSH PERSPECT BIOL, V3, pA009712, DOI [10.1101/cshperspect.a009712, DOI 10.1101/cshperspect.a009712]; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Akberova SI, 2016, DOKL BIOCHEM BIOPHYS, V467, P150, DOI 10.1134/S1607672916020198; Armstrong DJ, 2002, INT J BIOCHEM CELL B, V34, P588, DOI 10.1016/S1357-2725(01)00157-1; Bashir Hasan, 2017, J Ophthalmic Vis Res, V12, P305, DOI 10.4103/jovr.jovr_114_17; Boost M, 2017, CLIN EXP OPTOM, V100, P459, DOI 10.1111/cxo.12582; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; EPSTEIN RJ, 1987, CORNEA, V6, P250, DOI 10.1097/00003226-198706040-00004; Esco MA, 2001, J CELL SCI, V114, P4033; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Foulsham W, 2019, OCUL SURF, V17, P374, DOI 10.1016/j.jtos.2019.06.001; Guo XQ, 2016, EXP EYE RES, V146, P233, DOI 10.1016/j.exer.2016.03.011; Han KY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40548; Hannan MA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030223; Hara Y, 2009, MOL VIS, V15, P2515; Hessen Michelle, 2014, J Ophthalmic Vis Res, V9, P240; Hiscott P, 2006, PROG RETIN EYE RES, V25, P1, DOI 10.1016/j.preteyeres.2005.05.001; Hiscott P, 1997, CELL TISSUE RES, V289, P307, DOI 10.1007/s004410050877; Hiscott P, 1999, HISTOL HISTOPATHOL, V14, P1309, DOI 10.14670/HH-14.1309; Hornung S, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00038; HOYNG PFJ, 1986, INVEST OPHTH VIS SCI, V27, P1217; Huang WT, 2019, CANCER LETT, V442, P287, DOI 10.1016/j.canlet.2018.10.031; Kanda A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16499-8; Kang S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0023-4; Kim HK, 2017, CORNEA, V36, P1116, DOI 10.1097/ICO.0000000000001268; Kuo HF, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060794; Kurpakus-Wheater M, 2003, APOPTOSIS, V8, P681, DOI 10.1023/A:1026164332473; Li H, 2006, IMMUNOLOGY, V117, P167, DOI 10.1111/j.1365-2567.2005.02275.x; Liu PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179321; Masli S, 2014, CURR EYE RES, V39, P759, DOI 10.3109/02713683.2013.877936; Matsuba M, 2011, EXP EYE RES, V93, P534, DOI 10.1016/j.exer.2011.06.018; Matsuda A, 1999, CURR EYE RES, V19, P368, DOI 10.1076/ceyr.19.4.368.5306; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Rao P, 2019, J IMMUNOL, V202, P514, DOI 10.4049/jimmunol.1800422; Safvati A, 2009, CURR EYE RES, V34, P501, DOI 10.1080/02713680902919557; Sanyal S, 2017, EXP EYE RES, V164, P1, DOI 10.1016/j.exer.2017.08.002; Shanmughapriya S, 2015, MOL CELL, V60, P47, DOI 10.1016/j.molcel.2015.08.009; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Teranishi S, 2008, INVEST OPHTH VIS SCI, V49, P2432, DOI 10.1167/iovs.07-1464; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tsai JR, 2014, ARCH PHARM RES, V37, P548, DOI 10.1007/s12272-013-0232-1; Uno K, 2004, BIOCHEM BIOPH RES CO, V315, P928, DOI 10.1016/j.bbrc.2004.01.146; Voiculescu O B, 2015, J Med Life, V8, P444; Wang G, 2016, INT HEART J, V57, P483, DOI 10.1536/ihj.16-091; Wang YJ, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109203; WEISS L, 1988, BONE MARROW TRANSPL, V3, P207; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Zhu JD, 2019, INT J OPHTHALMOL-CHI, V12, P66, DOI 10.18240/ijo.2019.01.10; Zieske JD, 2020, ANAT REC, V303, P1727, DOI 10.1002/ar.24181	51	4	6	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21200	10.1096/fj.202001106RRR	http://dx.doi.org/10.1096/fj.202001106RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33341997	hybrid			2022-12-26	WOS:000605626600011
J	Jayawardana, S; Arambepola, C; Chang, TS; Gnanathasan, A				Jayawardana, Subashini; Arambepola, Carukshi; Chang, Thashi; Gnanathasan, Ariaranee			Prevalence, vulnerability and epidemiological characteristics of snakebite in agricultural settings in rural Sri Lanka: A population-based study from South Asia	PLOS ONE			English	Article							BITES	Background The burden of snakebite remains poorly characterised because of the paucity of population-based data. Further, factors determining the vulnerability of individuals within rural communities to snakebite have been rarely investigated. We undertook a population-based study to determine the prevalence, vulnerability and epidemiological characteristics of snakebite in rural Sri Lanka. Methods and findings A population-based cross-sectional study was conducted among 8707 current residents in the district of Ampara, representing typical rural Sri Lanka. The sample was recruited using multi-stage cluster sampling with probability proportionate-to-size. Snakebite victims were identified using the WHO criteria. Data were collected using a pre-tested interviewer-administered questionnaire. Each household had on average 3.8 persons; mean age 28.3 years (SD = 18.2); 51.3% males. The one-year point prevalence of snakebites was 17.6 per 1000 residents (95% CI: 15-20.6) and 6.12 per 100 households (95% CI: 5.25-7.13), while the lifetime prevalence was 9.4 per 100 residents (95% CI: 8.8-10.0) and 30.5 per 100 households (95% CI: 28.6-32.2) with a case fatality ratio of 0.033. Venomous snakebites accounted for 28.1%; snakes were unidentified among 30.1%. Compared to the non-snakebite victims, being single, males, of Sinhala ethnicity, aged >19 years, low education and socioeconomic status, engaging in farming or unskilled outdoor occupations denoted vulnerability to snakebites. Outdoor bites (77.8%) were more common among males; during daytime; mostly while walking; within the rural terrains and home gardens; on lower limbs; mostly by hump-nosed and Russell viper. Indoor bites were more common among females; during night-time; while sleeping and barefooted; on lower limbs; mostly by hump-nosed vipers, kraits and non-venomous snakes. Conclusions The burden of snakebite is considerably high among rural populations. The concept of vulnerability can be useful in healthcare decision-making and resource allocation.	[Jayawardana, Subashini] Univ Colombo, Dept Allied Hlth Sci, Fac Med, Colombo, Sri Lanka; [Arambepola, Carukshi] Univ Colombo, Dept Community Med, Fac Med, Colombo, Sri Lanka; [Chang, Thashi; Gnanathasan, Ariaranee] Univ Colombo, Dept Clin Med, Fac Med, Colombo, Sri Lanka	University of Colombo; University of Colombo; University of Colombo	Arambepola, C (corresponding author), Univ Colombo, Dept Community Med, Fac Med, Colombo, Sri Lanka.	gnanathasanca@clinmed.cmb.ac.lk			World Bank through Higher Education for Twenty first Century, Quality and Innovative grant (HETC QIG W3)	World Bank through Higher Education for Twenty first Century, Quality and Innovative grant (HETC QIG W3)	The study was supported by World Bank funds through Higher Education for Twenty first Century, Quality and Innovative grant (HETC QIG W3) (http://www.worldbank.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; Anjum Arshad, 2012, J FORENSIC RES, V3, P4; Ariaratnam CA, 2008, T ROY SOC TROP MED H, V102, P1120, DOI 10.1016/j.trstmh.2008.03.023; Ariaratnam CA, 2008, AM J TROP MED HYG, V79, P458, DOI 10.4269/ajtmh.2008.79.458; Ariaratnam CA, 2009, AM J TROP MED HYG, V81, P725, DOI 10.4269/ajtmh.2009.09-0225; Arnott I, 2016, J CROHNS COLITIS, V10, pS21; Bertolozzi MR, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005839; Chew KS, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-41; de Silva A., 1981, Snake, V13, P117; De Silva A, 1990, VENOMOUS SNAKES THEI, P479; de Silva HJ, 2013, CEYLON MED J, V58, P93, DOI 10.4038/cmj.v58i3.6101; Fernando M, 2019, MED IMPORTANT SNAKES; Jamaiah I., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P200; Jarwani Bhavesh, 2013, J Emerg Trauma Shock, V6, P199, DOI 10.4103/0974-2700.115343; Jayawardana S, 2018, J MULTIDISCIP HEALTH, V11, P279, DOI 10.2147/JMDH.S126648; Jayawardena SK, 2017, THESIS; Kasturiratne A., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P733; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Keyler DE, 2013, TOXICON, V69, P90, DOI 10.1016/j.toxicon.2013.01.022; Kularatne S A M, 2003, Southeast Asian J Trop Med Public Health, V34, P855; Leesberg, 2012, THE NEW HOLLSTEIN, V1, plvi; Longbottom J, 2018, LANCET, V392, P673, DOI 10.1016/S0140-6736(18)31224-8; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Miah M. T., 2009, J BANGLADESH COLL PH, V27, P70; Pandey DP, 2007, J MED TOXICOL, V3, P164, DOI 10.1007/BF03160933; Parekh U, 2019, J FORENSIC LEG MED, V65, P124, DOI 10.1016/j.jflm.2019.05.013; Rahman R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000860; RATNAPALA R, 1983, Ceylon Medical Journal, V28, P112; Sharma N, 2005, EMERG MED J, V22, P118, DOI 10.1136/emj.2003.008458; Sharma SK, 2004, AM J TROP MED HYG, V71, P234, DOI 10.4269/ajtmh.2004.71.234; Sharma SK, 2003, TOXICON, V41, P285, DOI 10.1016/S0041-0101(02)00289-1; Vaiyapuri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080090; Warrell D., 2016, GUID MAN SNAK, V2; Welton RE, 2017, TOXICON, V131, P11, DOI 10.1016/j.toxicon.2017.03.008; World Health Organization, 2010, GUIDELINES MANAGEMEN	35	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243991	10.1371/journal.pone.0243991	http://dx.doi.org/10.1371/journal.pone.0243991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370325	gold, Green Published			2022-12-26	WOS:000603611900090
J	Kamali, S; Mehraban, A				Kamali, Shirzad; Mehraban, Ahmad			Effects of Nitroxin and arbuscular mycorrhizal fungi on the agro-physiological traits and grain yield of sorghum (Sorghum bicolor L.) under drought stress conditions	PLOS ONE			English	Article							WATER-USE EFFICIENCY; OXIDATIVE DAMAGE; GROWTH; MAIZE; WHEAT; BACTERIA; LEAVES; PHOTOSYNTHESIS; ACCUMULATION; TOLERANCE	The use of bio-fertilizers in agro-ecosystems is considered to have the potential to improve plant growth in extreme environments featuring water shortages. However, while arbuscular mycorrhizal fungi (AMF) and bacteria bio-fertilizers have been used in other plants to enhance stress tolerance, little is known about their symbiotic effect on sorghum (Sorghum bicolor L.) growth under drought stress conditions. Therefore the aim of this study was to investigate the inoculation of sorghum with Nitroxin and Glomus mosseae and their interaction effects on the agro-physiological characteristics and grain yield of sorghum under drought stress conditions. Nitroxin is a bio-fertilizer that consists of a mixture of Azospirillum and Azotobacter bacteria. The results showed that co-inoculation of sorghum seeds with Nitroxin and AMF improved the chlorophyll (a, b and total) content, soluble proteins, water use efficiency) WUE(, relative water content (RWC), nitrogen (N) content in the plant, AMF spore density, proline content, grain yield, panicle length, the number of panicles per plant, grain number per panicle, 1000-grain weight and decreased the electrolyte leakage and water saturation deficit (WSD) in drought stress and non-stress conditions. Under drought stress conditions, there was a 27% increase in grain yield under the synergistic effects of bacteria and fungi compared to the non-application of these microorganisms. The results of this experiment show that Nitroxin and AMF bio-fertilizers can mitigate the negative effects of stress on plants in drought stress conditions by increasing the amount of photosynthetic pigments, soluble proteins and osmotic regulation and decreasing electrolyte leakage. We found that the combination of bacteria and AMF for sorghum growth and yield increment is a promising method to cope with the stress caused by drought.	[Kamali, Shirzad; Mehraban, Ahmad] Islamic Azad Univ, Zahedan Branch, Dept Agr, Zahedan, Iran	Islamic Azad University	Mehraban, A (corresponding author), Islamic Azad Univ, Zahedan Branch, Dept Agr, Zahedan, Iran.	Ahmadmehraban127@gmail.com						Abdelraouf R. E., 2013, Journal of Applied Sciences Research, V9, P2135; [Anonymous], 2017, Aesthet Surg J, V37, P1, DOI 10.1093/asj/sjx076; [Anonymous], 2017, INT J TECHNOL ASSESS, V33, P1, DOI 10.1017/S0266078417000050; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2016, BMJ-BRIT MED J, V354, pi5130; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; [Anonymous], 2017, MORBIDITY MORTALITY, V66, P1; Antonelli M, 2014, BLOOD PURIFICAT, V37, P22, DOI 10.1159/000356835; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Azarpour E, 2012, J AGR RES, V7, P1534, DOI [10.5897/AJAR11.1767, DOI 10.5897/AJAR11.1767]; Bagheri V, 2019, J PLANT PROD, V41, P83; Barati V, 2020, J AGR SCI TECH-IRAN, V22, P1295; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Behl RK, 2007, J APPL BOT FOOD QUAL, V81, P95; Behrooz A, 2019, HORTSCIENCE, V54, P1087, DOI [10.21273/HORTSCI13961-19, 10.21273/HORTSCI13961-1]; Bouchemal K, 2017, ARCH AGRON SOIL SCI, V63, P710, DOI 10.1080/03650340.2016.1235267; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buranova S, 2015, INT J PLANT PROD, V9, P257; Cakir R, 2004, FIELD CROP RES, V89, P1, DOI 10.1016/j.fcr.2004.01.005; Carina V. T., 2016, Journal of Applied Pharmaceutical Science, V6, P131; Cely MVT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00720; Cheng NH, 2004, J BIOL CHEM, V279, P2922, DOI 10.1074/jbc.M309084200; Chu XT, 2016, S AFR J BOT, V104, P21, DOI 10.1016/j.sajb.2015.10.001; Chutipaijit S, 2016, CHIL J AGR RES, V76, DOI 10.4067/S0718-583920160004-00009; Copetta A, 2006, MYCORRHIZA, V16, P485, DOI 10.1007/s00572-006-0065-6; Daniels BA, 1982, METHODS PRINCIPLES M; Darbani M., 2017, Journal of Chemical Health Risks, V7, P313; DEHKHODA A, 2013, INT J FARMING ALLIED, V2, P1319; Dordas CA, 2008, IND CROP PROD, V27, P75, DOI 10.1016/j.indcrop.2007.07.020; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Evelin H, 2009, ANN BOT-LONDON, V104, P1263, DOI 10.1093/aob/mcp251; Farnia A, 2015, INT J BIOL PHARM ALL, V4, P661; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Gholiloo MJ, 2019, J PLANT NUTR, V42, P1417, DOI 10.1080/01904167.2019.1628972; Harishkumar JM, 2019, INT J CURR MICROBIOL, V8, P1316, DOI [10.20546/ijcmas.2019.806.159, DOI 10.20546/IJCMAS.2019.806.159]; Hashem A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01089; Hopkins W. G, 2008, INTRO PLANT PHYSL; Jabereldar A. A., 2017, International Journal of Agriculture and Forestry, V7, P1; JAIN DK, 1985, CAN J MICROBIOL, V31, P206, DOI 10.1139/m85-039; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Kahil A., 2017, ANN RES REV BIOL, V17, P1, DOI DOI 10.9734/ARRB/2017/36099; Kazemi J. S., 2018, Journal of Agronomy, V17, P18; Khaitov B, 2015, ECOL EVOL, V5, P3756, DOI 10.1002/ece3.1654; Kishor K, 2017, J PHARMACOGN PHYTOCH, V6; Lamochi S, 2018, J CROP NUTR SCI, V4, P2423; LEVY D, 1983, POTATO RES, V26, P315, DOI 10.1007/BF02356153; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Miller MH, 2000, CAN J PLANT SCI, V80, P47, DOI 10.4141/P98-130; Morgan JM, 1999, AUST J AGR RES, V50, P953, DOI 10.1071/AR98143; NAIK VV, 2015, INT J PLANT BIOL RES, V3, P1031; Nanjundappa Anuroopa, 2019, Fungal Biol Biotechnol, V6, P23, DOI 10.1186/s40694-019-0086-5; Niu XG, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02580; Nosheen A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00104; Nxele X, 2017, S AFR J BOT, V108, P261, DOI 10.1016/j.sajb.2016.11.003; Oliveira L. A. R. de, 2018, Journal of Agricultural Science (Toronto), V10, P135, DOI 10.5539/jas.v10n5p135; Oliveira Neto CF-D, 2014, J FOOD AGRIC ENVIRON, V12, P223; Omae H, 2007, PLANT PROD SCI, V10, P28, DOI 10.1626/pps.10.28; Promita Datta, 2014, Notulae Scientia Biologicae, V6, P381; Rahimi A, 2019, AGRICULTURE-BASEL, V9, DOI 10.3390/agriculture9060122; Rane J., 2001, Indian Journal of Plant Physiology, V6, P53; Rani B., 2017, INT J CURR MICROBIOL, V6, P916, DOI [10.20546/ijcmas.2017.610.110, DOI 10.20546/IJCMAS.2017.610.110]; Ribaut JM, 2012, HDB MAIZE ITS BIOL, P11; Rouphael Y, 2008, HORTSCIENCE, V43, P730, DOI 10.21273/HORTSCI.43.3.730; Russo A, 2005, BIOL FERT SOILS, V41, P301, DOI 10.1007/s00374-005-0854-7; SAADALLA MM, 1990, CROP SCI, V30, P1243, DOI 10.2135/cropsci1990.0011183X003000060017x; Saud S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00983; Shi ZY, 2020, J FUNGI, V6, DOI 10.3390/jof6020044; Szopinski M., 2019, FRONT PLANT SCI, P1; Tambussi EA, 2000, PHYSIOL PLANTARUM, V108, P398, DOI 10.1034/j.1399-3054.2000.108004398.x; Vamerali T, 2003, PLANT SOIL, V255, P157, DOI 10.1023/A:1026123129575; Van Oosten MJ, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1411-5; Wang FY, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090289; Xiong X, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8050066; Xu HW, 2018, EMIR J FOOD AGR, V30, P199, DOI 10.9755/ejfa.2018.v30.i3.1642; Yadav R. S., 2001, Indian Journal of Agricultural Research, V35, P104; Yan WM, 2016, ACTA AGR SCAND B-S P, V66, P133, DOI 10.1080/09064710.2015.1083610; Yang X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37161-x; Zahir ZA, 2004, ADV AGRON, V81, P97, DOI 10.1016/S0065-2113(03)81003-9; Zarei M, 2014, ARCH AGRON SOIL SCI, V60, P993, DOI 10.1080/03650340.2013.853289; Zhang JT, 2007, ECOL ENG, V31, P115, DOI 10.1016/j.ecoleng.2007.06.003; Zhang ZJ, 2006, BIOL PLANTARUM, V50, P453, DOI 10.1007/s10535-006-0069-2; Zhao Z., 2012, J COMPUTER SCI COMPU, V2, P35; Zhong C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01079; 2015, J BRIT ACAD, V3, P24; 2005, BIOL SCI SER, P1	86	9	9	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243824	10.1371/journal.pone.0243824	http://dx.doi.org/10.1371/journal.pone.0243824			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370318	Green Published, gold			2022-12-26	WOS:000603611900006
J	Shirasuna, K; Ito, M; Matsuda, T; Enomoto, T; Ohara, Y; Yamamoto, M; Nishijima, S; Ohkohchi, N; Kuromitsu, S				Shirasuna, Kenna; Ito, Masayuki; Matsuda, Takashi; Enomoto, Tsuyoshi; Ohara, Yusuke; Yamamoto, Masayoshi; Nishijima, Satomi; Ohkohchi, Nobuhiro; Kuromitsu, Sadao			Correlation analysis of the proportion of monocytic myeloid-derived suppressor cells in colorectal cancer patients	PLOS ONE			English	Article							T-CELLS; STAGE; PROGRESSION; CHEMOTHERAPY; SURVIVAL	Monocytic myeloid-derived suppressor cells (mMDSCs) are a class of immunosuppressive immune cells with prognostic value in many solid tumors. It is reported that the proportion of mMDSCs in the peripheral blood can be a predictive marker for response to cancer immunotherapy. In this study, we performed a correlation analysis of the proportion of mMDSCs in freshly-drawn peripheral blood, levels of plasma proteins, and demographic factors in colorectal cancer (CRC) patients, to find factors that could be used to predict mMDSC proportions. Freshly-drawn mMDSCs were measured using flow cytometry on peripheral blood mononuclear cells (PBMCs) from healthy donors (n = 24) and CRC patients (n = 78). The plasma concentrations of 29 different cytokines, chemokines, growth factors, and enzymes were measured using a multiplex assay or enzyme-linked immunosorbent assay. Correlation analysis to find mMDSC-associated factors was conducted using univariate and multivariate models. In univariate correlation analysis, there were no plasma proteins that were associated with mMDSC proportions in CRC patients. In multivariate analysis, considering all variables including age, sex, and plasma proteins, levels of inducible nitric acid synthase (iNOS) (p = 0.013) and platelet-derived growth factor (PDGF)-BB (p = 0.035) were associated with mMDSC proportion in PBMCs (mMDSC proportion [%] = 0.2929 - 0.2389 * PDGF-BB + 0.3582 * iNOS) (p < 0.005, r = 0.32). Measuring the plasma concentrations of iNOS and PDGF-BB may be useful in predicting the proportion of mMDSCs in CRC patients' peripheral blood. Further research is required to establish and validate these predictive factors. Data registration Patient data were registered in an anonymization system at Tsukuba Clinical Research & Development Organization (T-CReDO).	[Shirasuna, Kenna; Ito, Masayuki; Matsuda, Takashi; Nishijima, Satomi; Kuromitsu, Sadao] Astellas Pharma Inc, Drug Discovery Res, Ibaraki, Japan; [Enomoto, Tsuyoshi; Ohara, Yusuke; Ohkohchi, Nobuhiro] Univ Tsukuba Hosp, Fac Med, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Ibaraki, Japan; [Yamamoto, Masayoshi] Ibaraki Western Med Ctr, Ibaraki, Japan	Astellas Pharmaceuticals; University of Tsukuba	Shirasuna, K (corresponding author), Astellas Pharma Inc, Drug Discovery Res, Ibaraki, Japan.	kenna.shirasuna@astellas.com			Astellas Pharma, Inc.	Astellas Pharma, Inc.(Astellas Pharmaceuticals)	The authors declare that, other than income received from our primary employers, no financial support or compensation has been received for this research and that there are no personal conflicts of interest to declare. This research did not receive any specific grant from funding agencies in the public, commercial, or not for profit sectors. The funding organization (Astellas Pharma, Inc.) did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of author's salaries and/or research materials.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bruger AM, 2019, CANCER IMMUNOL IMMUN, V68, P631, DOI 10.1007/s00262-018-2170-8; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Florcken A, 2015, IMMUNOL LETT, V168, P260, DOI 10.1016/j.imlet.2015.10.001; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gebhardt C, 2015, CLIN CANCER RES, V21, P5453, DOI 10.1158/1078-0432.CCR-15-0676; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grutzner E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0755-y; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Kanterman J, 2014, CANCER RES, V74, P6022, DOI 10.1158/0008-5472.CAN-14-0657; Kitano S, 2014, CANCER IMMUNOL RES, V2, P812, DOI 10.1158/2326-6066.CIR-14-0013; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Ma PW, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01401; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, EUR J IMMUNOL, V40, P3317, DOI 10.1002/eji.201041170; Markowitz J, 2015, CANCER IMMUNOL IMMUN, V64, P149, DOI 10.1007/s00262-014-1618-8; Martens A, 2016, CLIN CANCER RES, V22, P2908, DOI 10.1158/1078-0432.CCR-15-2412; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; R Core Team, 2019, R LANG ENV STAT COMP; Sade-Feldman M, 2016, CLIN CANCER RES, V22, P5661, DOI 10.1158/1078-0432.CCR-15-3104; Santegoetst SJAM, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0031-3; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Stanojevic I, 2016, INT IMMUNOL, V28, P87, DOI 10.1093/intimm/dxv053; Tada K, 2016, CANCER IMMUNOL RES, V4, P592, DOI 10.1158/2326-6066.CIR-15-0298; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Weber J, 2016, CANCER IMMUNOL RES, V4, P345, DOI 10.1158/2326-6066.CIR-15-0193; Weide B, 2014, CLIN CANCER RES, V20, P1601, DOI 10.1158/1078-0432.CCR-13-2508; Yaddanapudi K, 2016, CANCER IMMUNOL RES, V4, P101, DOI 10.1158/2326-6066.CIR-15-0070-T; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057114	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243643	10.1371/journal.pone.0243643	http://dx.doi.org/10.1371/journal.pone.0243643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370317	Green Published, gold			2022-12-26	WOS:000603611900044
J	Kwon, HC; Yu, YW; Fairclough, RH; Chen, TY				Kwon, Hwoi Chan; Yu, Yawei; Fairclough, Robert H.; Chen, Tsung-Yu			Proton-dependent inhibition, inverted voltage activation, and slow gating of CLC-0 Chloride Channel	PLOS ONE			English	Article							TORPEDO ELECTROPLAX; C-TERMINUS; EXPRESSION; CLONING; STATE; RECONSTITUTION; DISRUPTION; MUTATIONS; DISEASE; RESIDUE	CLC-0, a prototype Cl- channel in the CLC family, employs two gating mechanisms that control its ion-permeation pore: fast gating and slow gating. The negatively-charged sidechain of a pore glutamate residue, E166, is known to be the fast gate, and the swinging of this sidechain opens or closes the pore of CLC-0 on the millisecond time scale. The other gating mechanism, slow gating, operates with much slower kinetics in the range of seconds to tens or even hundreds of seconds, and it is thought to involve still-unknown conformational rearrangements. Here, we find that low intracellular pH (pH(i)) facilitates the closure of the CLC-0's slow gate, thus generating current inhibition. The rate of low pH(i)-induced current inhibition increases with intracellular H+ concentration ([H+](i))-the time constants of current inhibition by low pH(i) = 4.5, 5.5 and 6 are roughly 0.1, 1 and 10 sec, respectively, at room temperature. In comparison, the time constant of the slow gate closure at pH(i) = 7.4 at room temperature is hundreds of seconds. The inhibition by low pH(i) is significantly less prominent in mutants favoring the slow-gate open state (such as C212S and Y512A), further supporting the fact that intracellular H+ enhances the slow-gate closure in CLC-0. A fast inhibition by low pH(i) causes an apparent inverted voltage-dependent activation in the wild-type CLC-0, a behavior similar to those in some channel mutants such as V490W in which only membrane hyperpolarization can open the channel. Interestingly, when V490W mutation is constructed in the background of C212S or Y512A mutation, the inverted voltage-dependent activation disappears. We propose that the slow kinetics of CLC-0's slow-gate closure may be due to low [H+](i) rather than due to the proposed large conformational change of the channel protein. Our results also suggest that the inverted voltage-dependent opening observed in some mutant channels may result from fast closure of the slow gate by the mutations.	[Kwon, Hwoi Chan; Fairclough, Robert H.; Chen, Tsung-Yu] Univ Calif Davis, Biophys Grad Program, Davis, CA 95616 USA; [Yu, Yawei; Fairclough, Robert H.; Chen, Tsung-Yu] Univ Calif Davis, BMCDB Grad Program, Davis, CA 95616 USA; [Fairclough, Robert H.; Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Yu, Yawei] Univ Calif Berkeley, Dept Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley	Chen, TY (corresponding author), Univ Calif Davis, Biophys Grad Program, Davis, CA 95616 USA.; Chen, TY (corresponding author), Univ Calif Davis, BMCDB Grad Program, Davis, CA 95616 USA.; Chen, TY (corresponding author), Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA.; Chen, TY (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	tycchen@ucdavis.edu			NIH [R01GM065447]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an NIH grant R01GM065447. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts of the American Society of Hematology, 2003, BLOOD, V2003, p1a; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Awards Arbitral, 1999, ILR, V114, P1; Bennetts B, 2007, J BIOL CHEM, V282, P32780, DOI 10.1074/jbc.M703259200; Bennetts B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3507; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Chen TY, 2012, J PHYSIOL-LONDON, V590, P3407, DOI 10.1113/jphysiol.2012.238337; Chen TY, 1998, J GEN PHYSIOL, V112, P715, DOI 10.1085/jgp.112.6.715; Chen TY, 2005, ANNU REV PHYSIOL, V67, P809, DOI 10.1146/annurev.physiol.67.032003.153012; Chen TY, 2003, J GEN PHYSIOL, V122, P641, DOI 10.1085/jgp.200308846; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Dutzler R, 2004, FEBS LETT, V564, P229, DOI 10.1016/S0014-5793(04)00210-8; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Engh AM, 2007, J GEN PHYSIOL, V130, P335, DOI 10.1085/jgp.200709759; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fong PY, 1998, AM J PHYSIOL-CELL PH, V274, pC966, DOI 10.1152/ajpcell.1998.274.4.C966; Gradogna A, 2013, BIOPHYS J, V105, P80, DOI 10.1016/j.bpj.2013.05.044; HANKE W, 1983, J GEN PHYSIOL, V82, P25, DOI 10.1085/jgp.82.1.25; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jentsch TJ, 2018, PHYSIOL REV, V98, P1493, DOI 10.1152/physrev.00047.2017; Jentsch TJ, 2015, J PHYSIOL-LONDON, V593, P4091, DOI 10.1113/JP270043; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lin CW, 2000, J GEN PHYSIOL, V116, P535, DOI 10.1085/jgp.116.4.535; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Lloyd SE, 1997, HUM MOL GENET, V6, P1233, DOI 10.1093/hmg/6.8.1233; Macias MJ, 2007, BIOCHEM J, V403, P79, DOI 10.1042/BJ20061230; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Matsumoto A, 2018, INTERNAL MED, V57, P3603, DOI 10.2169/internalmedicine.1272-18; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Miller C., 1980, Annals of the New York Academy of Sciences, V341, P534, DOI 10.1111/j.1749-6632.1980.tb47197.x; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Park E, 2018, ELIFE, V7, DOI 10.7554/eLife.36629; Park E, 2017, NATURE, V541, P500, DOI 10.1038/nature20812; Pedersen TH, 2016, J GEN PHYSIOL, V147, P291, DOI 10.1085/jgp.201611582; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Pusch M, 1997, J GEN PHYSIOL, V109, P105, DOI 10.1085/jgp.109.1.105; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Schrecker M, 2020, ELIFE, V9, DOI 10.7554/eLife.59555; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Tseng PY, 2007, J GEN PHYSIOL, V130, P217, DOI 10.1085/jgp.200709817; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Wang KT, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000218; WHITE MM, 1979, J BIOL CHEM, V254, P161; Yu YW, 2015, J GEN PHYSIOL, V146, P495, DOI 10.1085/jgp.201511413; Zhang SS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb4747; Zifarelli G, 2008, J GEN PHYSIOL, V132, P185, DOI 10.1085/jgp.200809999; Zifarelli G, 2010, EUR BIOPHYS J BIOPHY, V39, P869, DOI 10.1007/s00249-008-0393-x	60	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0240704	10.1371/journal.pone.0240704	http://dx.doi.org/10.1371/journal.pone.0240704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362212	Green Published, Green Submitted, gold			2022-12-26	WOS:000603071600018
J	Finn, PB; Bhimsaria, D; Ali, A; Eguchi, A; Ansari, AZ; Dervan, PB				Finn, Paul B.; Bhimsaria, Devesh; Ali, Asfa; Eguchi, Asuka; Ansari, Aseem Z.; Dervan, Peter B.			Single position substitution of hairpin pyrrole-imidazole polyamides imparts distinct DNA-binding profiles across the human genome	PLOS ONE			English	Article							SEQUENCE-SPECIFIC RECOGNITION; MINOR-GROOVE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; STRUCTURAL BASIS; OPEN CHROMATIN; BASE-PAIRS; DESIGN; SPECIFICITY	Pyrrole-imidazole (Py-Im) polyamides are synthetic molecules that can be rationally designed to target specific DNA sequences to both disrupt and recruit transcriptional machinery. While in vitro binding has been extensively studied, in vivo effects are often difficult to predict using current models of DNA binding. Determining the impact of genomic architecture and the local chromatin landscape on polyamide-DNA sequence specificity remains an unresolved question that impedes their effective deployment in vivo. In this report we identified polyamide-DNA interaction sites across the entire genome, by covalently crosslinking and capturing these events in the nuclei of human LNCaP cells. This technique confirms the ability of two eight ring hairpin-polyamides, with similar architectures but differing at a single ring position (Py to Im), to retain in vitro specificities and display distinct genome-wide binding profiles.	[Finn, Paul B.; Dervan, Peter B.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Bhimsaria, Devesh] Bio Informat, Jaipur, Rajasthan, India; [Ali, Asfa] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Eguchi, Asuka] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Ansari, Aseem Z.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Finn, Paul B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; St Jude Children's Research Hospital; Stanford University	Finn, PB; Dervan, PB (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.; Finn, PB (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	pbfinn@stanford.edu; dervan@caltech.edu		Bhimsaria, Devesh/0000-0001-8413-3801				Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Ansari AZ, 2001, CHEM BIOL, V8, P583, DOI 10.1016/S1074-5521(01)00037-0; Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Best TP, 2003, P NATL ACAD SCI USA, V100, P12063, DOI 10.1073/pnas.2035074100; Bhimsaria D, 2018, P NATL ACAD SCI USA, V115, pE10586, DOI 10.1073/pnas.1811431115; Black JB, 2018, CURR OPIN GENET DEV, V52, P13, DOI 10.1016/j.gde.2018.05.001; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Chandran A, 2016, NUCLEIC ACIDS RES, V44, P4014, DOI 10.1093/nar/gkw283; Charlesworth CT, 2019, NAT MED, V25, P249, DOI 10.1038/s41591-018-0326-x; Chenoweth DM, 2010, J AM CHEM SOC, V132, P14521, DOI 10.1021/ja105068b; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Crudele JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05843-9; Dervan PB, 2018, DNA TARGETING MOL TH, P298, DOI 10.1039/; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edayathumangalam RS, 2004, P NATL ACAD SCI USA, V101, P6864, DOI 10.1073/pnas.0401743101; Erwin GS, 2017, SCIENCE, V358, P1617, DOI 10.1126/science.aan6414; Erwin GS, 2016, P NATL ACAD SCI USA, V113, pE7418, DOI 10.1073/pnas.1604847113; Erwin GS, 2014, ANGEW CHEM INT EDIT, V53, P10124, DOI 10.1002/anie.201405497; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Gottesfeld JM, 2001, J MOL BIOL, V309, P615, DOI 10.1006/jmbi.2001.4694; Heiderscheit EA, 2018, FEBS LETT, V592, P888, DOI 10.1002/1873-3468.12993; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsu CF, 2007, TETRAHEDRON, V63, P6146, DOI 10.1016/j.tet.2007.03.041; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kabadi AM, 2014, METHODS, V69, P188, DOI 10.1016/j.ymeth.2014.06.014; Kashiwazaki G, 2016, CHEMBIOCHEM, V17, P1752, DOI 10.1002/cbic.201600282; Kawamoto Y, 2018, BIOORGAN MED CHEM, V26, P1393, DOI 10.1016/j.bmc.2018.01.026; Kielkopf CL, 1998, SCIENCE, V282, P111, DOI 10.1126/science.282.5386.111; Kurmis AA, 2019, NUCLEIC ACIDS RES, V47, P3828, DOI 10.1093/nar/gkz153; Kurmis AA, 2017, CANCER RES, V77, P2207, DOI 10.1158/0008-5472.CAN-16-2503; Kwonj Y, 2004, J AM CHEM SOC, V126, P15940, DOI 10.1021/ja0445140; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165581; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; Martinez TF, 2014, NUCLEIC ACIDS RES, V42, P11546, DOI 10.1093/nar/gku866; Meier JL, 2012, J AM CHEM SOC, V134, P17814, DOI 10.1021/ja308888c; Minoshima M, 2008, NUCLEIC ACIDS RES, V36, P2889, DOI 10.1093/nar/gkn116; Moretti R, 2008, ACS CHEM BIOL, V3, P220, DOI 10.1021/cb700258r; MRKSICH M, 1992, P NATL ACAD SCI USA, V89, P7586, DOI 10.1073/pnas.89.16.7586; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Nickols NG, 2007, NUCLEIC ACIDS RES, V35, P363, DOI 10.1093/nar/gkl1042; Nickols NG, 2013, MOL CANCER THER, V12, P675, DOI 10.1158/1535-7163.MCT-12-1040; Olenyuk BZ, 2004, P NATL ACAD SCI USA, V101, P16768, DOI 10.1073/pnas.0407617101; Puckett JW, 2007, J AM CHEM SOC, V129, P12310, DOI 10.1021/ja0744899; Puckett JW, 2012, ORG LETT, V14, P2774, DOI 10.1021/ol3010003; Rodriguez-Martinez JA, 2017, ELIFE, V6, DOI 10.7554/elife.19272.001; Sastry SS, 1997, J BIOL CHEM, V272, P3715, DOI 10.1074/jbc.272.6.3715; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Tietjen JR, 2011, METHOD ENZYMOL, V497, P3, DOI 10.1016/B978-0-12-385075-1.00001-9; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Urbach AR, 2002, J MOL BIOL, V320, P55, DOI 10.1016/S0022-2836(02)00430-8; Urbach AR, 2001, P NATL ACAD SCI USA, V98, P4343, DOI 10.1073/pnas.081070798; WADE WS, 1992, J AM CHEM SOC, V114, P8783, DOI 10.1021/ja00049a006; WADE WS, 1993, BIOCHEMISTRY-US, V32, P11385, DOI 10.1021/bi00093a015; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; White S, 1998, NATURE, V391, P468, DOI 10.1038/35106; White S, 1997, CHEM BIOL, V4, P569, DOI 10.1016/S1074-5521(97)90243-X; Wurtz NR, 2001, ORG LETT, V3, P1201, DOI 10.1021/ol0156796; Xu L, 2016, P NATL ACAD SCI USA, V113, P12426, DOI 10.1073/pnas.1612745113; Yang F, 2013, P NATL ACAD SCI USA, V110, P1863, DOI 10.1073/pnas.1222035110	67	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243905	10.1371/journal.pone.0243905	http://dx.doi.org/10.1371/journal.pone.0243905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351840	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000603071400029
J	Mainardi, F; Prozorovscaia, D; Sweeney, G; Green, H				Mainardi, Fabio; Prozorovscaia, Daniela; Sweeney, Gary; Green, Hilary			Development and validation of a meal quality index with applications to NHANES 2005-2014	PLOS ONE			English	Article							METHODOLOGY; PATTERNS	The Meal Balance Index (MBI) assesses the nutritional quality and balance of meals. It is a score between 0 and 100 that takes into account both shortfall and excess nutrients, adjusted for the energy content of the meal. In the present study the score was applied to 147849 meals reported in the National Health and Nutrition Examination Surveys (NHANES) 2005-2014 in order to evaluate its validity and compare against exemplary meals designed as part of 24h diets that meet US dietary guidelines. Meals from exemplary menu plans developed by nutrition experts scored on average 76 +/- 14 (mean +/- standard deviation) whereas those of NHANES participants scored 45 +/- 14. Scores of breakfast, lunch, dinner, snack, considered jointly as independent variables, were moderately but positively and significantly associated with the Healthy Eating Index (Pearson correlation 0.6). MBI scores were significantly associated with the density of positive micronutrients (e.g. Vit A, Vit C) and favorable food groups (e.g. fruits, whole grains) not directly included in the MBI algorithm. The MBI is a valid tool to assess the nutritional quality of meals reported in the US population and if applied to culinary recipe websites could potentially help users to understand which meals are nutritionally balanced. Choice of more balanced individual meals can guide healthier cooking and eating.	[Mainardi, Fabio; Prozorovscaia, Daniela; Green, Hilary] Nestle Res, Lausanne, Switzerland; [Sweeney, Gary] British Dietet Assoc, Birmingham, W Midlands, England	Nestle SA	Mainardi, F (corresponding author), Nestle Res, Lausanne, Switzerland.	fabio.mainardi@rd.nestle.com		Mainardi, Fabio/0000-0002-4825-4283				Cule E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-372; Drewnowski A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091200; Food and Agriculture Organization of the United Nations (FAO), FOOD BAS DIET GUID; Gorgulho BM, 2016, BRIT J NUTR, V115, P2017, DOI 10.1017/S0007114516000994; Gorgulho B, 2018, REV NUTR, V31, P567, DOI 10.1590/1678-98652018000600006; Gorski MT, 2015, J HEALTHC LEADERSH, V7, P81, DOI 10.2147/JHL.S69188; Guenther PM, 2014, J NUTR, V144, P399, DOI 10.3945/jn.113.183079; Herforth A, 2019, ADV NUTR, V10, P590, DOI 10.1093/advances/nmy130; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hyseni L, 2017, EUR J CLIN NUTR, V71, P694, DOI 10.1038/ejcn.2016.234; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Louie JCY, 2015, EUR J CLIN NUTR, V69, P154, DOI 10.1038/ejcn.2014.256; Mainardi F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020379; McGuire S, 2016, ADV NUTR, V7, P202, DOI 10.3945/an.115.011684; Murakami K, 2019, NUTRITION, V59, P108, DOI 10.1016/j.nut.2018.07.110; Murakami K, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0283-0; Perez-Escamilla R, 2016, J NUTR, V146, P1924, DOI 10.3945/jn.115.218784; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Trattner C, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00016	21	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244391	10.1371/journal.pone.0244391	http://dx.doi.org/10.1371/journal.pone.0244391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351843	Green Published, gold			2022-12-26	WOS:000603071400013
J	Zhou, ZY; Yu, MH; Ding, GD; Gao, GL; He, YY				Zhou, Ziyuan; Yu, Minghan; Ding, Guodong; Gao, Guanglei; He, Yingying			Diversity and structural differences of bacterial microbial communities in rhizocompartments of desert leguminous plants	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; CARAGANA-KORSHINSKII; SUGAR-BEET; RHIZOSPHERE; ROOT; ESTABLISHMENT; AMENDMENT; GROWTH; SYMBIOSIS; SEEDLINGS	By assessing diversity variations of bacterial communities under different rhizocompartment types (i.e., roots, rhizosphere soil, root zone soil, and inter-shrub bulk soil), we explore the structural difference of bacterial communities in different root microenvironments under desert leguminous plant shrubs. Results will enable the influence of niche differentiation of plant roots and root soil on the structural stability of bacterial communities under three desert leguminous plant shrubs to be examined. High-throughput 16S rRNA genome sequencing was used to characterize diversity and structural differences of bacterial microbes in the rhizocompartments of three xeric leguminous plants. Results from this study confirm previous findings relating to niche differentiation in rhizocompartments under related shrubs, and they demonstrate that diversity and structural composition of bacterial communities have significant hierarchical differences across four rhizocompartment types under leguminous plant shrubs. Desert leguminous plants showed significant hierarchical filtration and enrichment of the specific bacterial microbiome across different rhizocompartments (P < 0.05). The dominant bacterial microbiome responsible for the differences in microbial community structure and composition across different niches of desert leguminous plants mainly consisted of Proteobacteria, Actinobacteria, and Bacteroidetes. All soil factors of rhizosphere and root zone soils, except for NO3-N and TP under C. microphylla and the two Hedysarum spp., recorded significant differences (P < 0.05). Moreover, soil physicochemical factors have a significant impact on driving the differentiation of bacterial communities under desert leguminous plant shrubs. By investigating the influence of niches on the structural difference of soil bacterial communities with the differentiation of rhizocompartments under desert leguminous plant shrubs, we provide data support for the identification of dominant bacteria and future preparation of inocula, and provide a foundation for further study of the host plants-microbial interactions.	[Zhou, Ziyuan; Yu, Minghan; Ding, Guodong; Gao, Guanglei; He, Yingying] Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing, Peoples R China; [Zhou, Ziyuan; Yu, Minghan; Ding, Guodong; Gao, Guanglei; He, Yingying] Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Yu, MH; Ding, GD (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing, Peoples R China.; Yu, MH; Ding, GD (corresponding author), Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Beijing, Peoples R China.	yuminghan@bjfu.edu.cn; dingguodong@bjfu.edu.cn			National Key Research and Development Program of China [2016YFC0500905, 2018YFC0507102]; National Natural Science Foundation of China [31270749]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Research and Development Program of China (no. 2016YFC0500905 and 2018YFC0507102), and the National Natural Science Foundation of China (no. 31270749).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Alguacil MM, 2003, SOIL USE MANAGE, V19, P277, DOI 10.1079/SUM2003206; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Azcon R, 2009, CHEMOSPHERE, V75, P327, DOI 10.1016/j.chemosphere.2008.12.029; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Barrett LG, 2015, J ECOL, V103, P130, DOI 10.1111/1365-2745.12336; Bashan Y, 2004, CAN J MICROBIOL, V50, P521, DOI 10.1139/W04-035; Beckers B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0241-2; Beckers B, 2016, P NATL ACAD SCI USA, V113, P2312, DOI 10.1073/pnas.1523264113; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2006, FEMS MICROBIOL ECOL, V56, P250, DOI 10.1111/j.1574-6941.2005.00025.x; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bever JD, 2013, ECOL LETT, V16, P167, DOI 10.1111/ele.12024; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Bruneau A, 2013, TAXON, V62, P217, DOI 10.12705/622.8; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caravaca F, 2005, MICROB ECOL, V49, P73, DOI 10.1007/s00248-003-0131-y; Caravaca F, 2003, ENVIRON MANAGE, V31, P412, DOI 10.1007/s00267-002-2879-0; Caravaca F, 2002, SOIL BIOL BIOCHEM, V34, P1139, DOI 10.1016/S0038-0717(02)00047-0; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Deng ZS, 2011, FEMS MICROBIOL ECOL, V76, P463, DOI 10.1111/j.1574-6941.2011.01063.x; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; Dinnage R, 2019, J ECOL, V107, P977, DOI 10.1111/1365-2745.13083; Du YX, 2011, ENVIRON EARTH SCI, V64, P299, DOI 10.1007/s12665-010-0847-1; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Egamberdieva D, 2008, ENVIRON MICROBIOL, V10, P1, DOI 10.1111/j.1462-2920.2007.01424.x; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gao GL, 2014, ECOL INDIC, V43, P236, DOI 10.1016/j.ecolind.2014.03.001; Gao LF, 2002, LETT APPL MICROBIOL, V35, P347, DOI 10.1046/j.1472-765X.2002.01192.x; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; Garbeva P, 2011, SOIL BIOL BIOCHEM, V43, P469, DOI 10.1016/j.soilbio.2010.11.020; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Heath KD, 2010, EVOLUTION, V64, P1446, DOI 10.1111/j.1558-5646.2009.00913.x; Hein JW, 2008, MICROB ECOL, V55, P333, DOI 10.1007/s00248-007-9279-1; Hoque MS, 2011, INT J SYST EVOL MICR, V61, P299, DOI 10.1099/ijs.0.021014-0; JENKINSON DS, 1989, SOIL BIOL BIOCHEM, V21, P535, DOI 10.1016/0038-0717(89)90127-2; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lai FR, 2010, CARBOHYD POLYM, V81, P323, DOI 10.1016/j.carbpol.2010.02.011; Lai ZR, 2016, FOREST ECOL MANAG, V359, P381, DOI 10.1016/j.foreco.2015.04.025; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li XZ, 2014, SOIL BIOL BIOCHEM, V68, P392, DOI 10.1016/j.soilbio.2013.10.017; Liu HW, 2017, SCI REP-UK, V7, DOI 10.1038/srep41766; Lu YL, 2009, INT J SYST EVOL MICR, V59, P3006, DOI 10.1099/ijs.0.007237-0; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Luo GW, 2018, FUNCT ECOL, V32, P1103, DOI 10.1111/1365-2435.13039; Lybrand RA, 2015, SOIL SCI SOC AM J, V79, P104, DOI 10.2136/sssaj2014.06.0242; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Medina A, 2004, CHEMOSPHERE, V56, P449, DOI 10.1016/j.chemosphere.2004.04.003; Mengual C, 2014, J ENVIRON MANAGE, V134, P1, DOI 10.1016/j.jenvman.2014.01.008; Mercado-Blanco J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01006; Merila P, 2010, APPL SOIL ECOL, V46, P259, DOI 10.1016/j.apsoil.2010.08.003; Miao L, 2016, WATER RES, V100, P405, DOI 10.1016/j.watres.2016.05.010; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Narteh LT, 1997, GEODERMA, V76, P145, DOI 10.1016/S0016-7061(96)00097-3; Nemergut DR, 2010, SOIL BIOL BIOCHEM, V42, P2153, DOI 10.1016/j.soilbio.2010.08.011; Ofek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040117; Ojo VOA, 2019, TROP ANIM HEALTH PRO, V51, P867, DOI 10.1007/s11250-018-1767-4; Perez-Bejarano A, 2010, EUR J FOREST RES, V129, P15, DOI 10.1007/s10342-008-0246-2; R Core Team, 2016, R FDN STAT COMP; RECOUS S, 1990, SOIL BIOL BIOCHEM, V22, P913, DOI 10.1016/0038-0717(90)90129-N; Reinhold-Hurek B, 2006, MOL PLANT MICROBE IN, V19, P181, DOI 10.1094/MPMI-19-0181; Rilling JI, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02710; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; Sablok G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01348; Sanchez-Lopez AS, 2018, PLANT SOIL, V422, P51, DOI 10.1007/s11104-017-3176-2; Saul-Tcherkas V, 2011, MICROB ECOL, V61, P64, DOI 10.1007/s00248-010-9763-x; Sun YF, 2017, PLANT SOIL, V414, P281, DOI 10.1007/s11104-016-3111-y; Tang GY, 2008, MOLECULES, V13, P1189, DOI 10.3390/molecules13051189; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Van Horn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066103; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang D, 2012, CELL MICROBIOL, V14, P334, DOI 10.1111/j.1462-5822.2011.01736.x; Wang GH, 2015, ECOL RES, V30, P639, DOI 10.1007/s11284-015-1267-1; Wang JM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02126; Wang YB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00588; WICKRAMASINGHE KN, 1985, SOIL BIOL BIOCHEM, V17, P249, DOI 10.1016/0038-0717(85)90123-3; Xiao X, 2017, APPL MICROBIOL BIOT, V101, P8485, DOI 10.1007/s00253-017-8550-8; Xiao X, 2017, MOL ECOL, V26, P1641, DOI 10.1111/mec.14027; Yates R, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0020-2; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zgadzaj R, 2016, P NATL ACAD SCI USA, V113, pE7996, DOI 10.1073/pnas.1616564113; Zhang ZS, 2009, J PLANT RES, V122, P109, DOI 10.1007/s10265-008-0196-2; Zhu FX, 2018, SCI TOTAL ENVIRON, V637, P460, DOI 10.1016/j.scitotenv.2018.05.055	97	6	6	9	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0241057	10.1371/journal.pone.0241057	http://dx.doi.org/10.1371/journal.pone.0241057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351824	gold, Green Published			2022-12-26	WOS:000603071400025
J	Gildner, TE; Laugier, EJ; Thayer, ZM				Gildner, Theresa E.; Laugier, Elise J.; Thayer, Zaneta M.			Exercise routine change is associated with prenatal depression scores during the COVID-19 pandemic among pregnant women across the United States	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; POSTPARTUM DEPRESSION; AEROBIC EXERCISE; BENEFITS; RISK; ANXIETY; SAFETY	Background The COVID-19 pandemic has negatively affected physical and mental health worldwide. Pregnant women already exhibit an elevated risk for depression compared to the general public, a pattern expected to be exacerbated by the pandemic. Certain lifestyle factors, including moderate exercise, may help support mental health during pregnancy, but it is unclear how the pandemic may impact these associations across different locations. Here, we test whether: (i) reported exercise routine alterations during the pandemic are associated with depression scores; and, (ii) the likelihood of reporting pandemic-related exercise changes varies between women living in metro areas and those in non-metro areas. Methods This cross-sectional study used data from the COVID-19 And Reproductive Effects (CARE) study, an online survey of pregnant women in the United States. Participants were recruited April-June 2020 (n = 1,856). Linear regression analyses assessed whether reported COVID-19-related exercise change was associated with depression score as measured by the Edinburgh Postnatal Depression Survey. Logistic regression analyses tested whether a participant's Rural-Urban Continuum Code classification of "metro" was linked with higher odds of reporting exercise changes compared to a "non-metro" classification. Results Women who reported exercise changes during the pandemic exhibited significantly higher depression scores compared to those reporting no changes. Moreover, individuals living in metro areas of all sizes were significantly more likely to report exercise changes compared to women living in non-metro areas. Conclusions These results suggest that the ability to maintain an exercise routine during the pandemic may help support maternal mental health. It may therefore be prudent for providers to explicitly ask patients how the pandemic has impacted their exercise routines and consider altered exercise routines a potential risk factor for depression. An effort should also be made to recommend exercises that are tailored to individual space restrictions and physical health.	[Gildner, Theresa E.; Laugier, Elise J.; Thayer, Zaneta M.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Gildner, Theresa E.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Laugier, Elise J.; Thayer, Zaneta M.] Dartmouth Coll, Ecol Evolut Environm & Soc Program, Hanover, NH 03755 USA	Dartmouth College; Washington University (WUSTL); Dartmouth College	Gildner, TE (corresponding author), Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA.; Gildner, TE (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	Theresa.E.Gildner@dartmouth.edu		Laugier, Elise/0000-0002-4313-4821				Abbas AM, 2020, SCAND J IMMUNOL, V92, DOI 10.1111/sji.12918; American College of Obstetricians and Gynecologists (ACOG), 2019, EX PREGN; [Anonymous], 2019, NATL VITAL STAT REP; Boscaglia N, 2003, AUST NZ J OBSTET GYN, V43, P41, DOI 10.1046/j.0004-8666.2003.00016.x; Brun CR, 2011, APPL PHYSIOL NUTR ME, V36, P577, DOI [10.1139/h11-036, 10.1139/H11-036]; Campolong K, 2018, ARCH WOMEN MENT HLTH, V21, P215, DOI 10.1007/s00737-017-0783-0; Center for Systems Science and Engineering (CSSE), 2020, COVID 19 DASHB; Centers for Disease Control and Prevention, 2020, COR DIS 2019 PEOPL C; Centers for Disease Control and Prevention (CDC), 2020, REPR HLTH DEPR PREGN; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cramp AG, 2009, ANN BEHAV MED, V37, P325, DOI 10.1007/s12160-009-9102-y; Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021; Davenport Margie H, 2020, Front Glob Womens Health, V1, P1, DOI 10.3389/fgwh.2020.00001; DiPietro L, 2019, MED SCI SPORT EXER, V51, P1292, DOI 10.1249/MSS.0000000000001941; El-Rafie MM, 2016, INT J WOMENS HEALTH, V8, P53, DOI 10.2147/IJWH.S94112; Fell DB, 2009, MATERN CHILD HLTH J, V13, P597, DOI 10.1007/s10995-008-0404-7; Robledo-Colonia AF, 2012, J PHYSIOTHER, V58, P9, DOI 10.1016/S1836-9553(12)70067-X; Haakstad LAH, 2020, ACTA OBSTET GYN SCAN, V99, P240, DOI 10.1111/aogs.13738; Hadi AS, 2006, REGRESSION ANAL EXAM, P281, DOI [10.1002/0470055464.ch11, DOI 10.1002/0470055464.CH11]; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hinton P S, 2001, Matern Child Health J, V5, P7, DOI 10.1023/A:1011315616694; Horwitz SM, 2007, J WOMENS HEALTH, V16, P678, DOI 10.1089/jwh.2006.0185; Mandolesi L, 2018, FRONT PSYCHOL, P9, DOI [10.3389/fpsyg.2018.00009, DOI 10.3389/FPSYG.2018.00009]; Mappa I, 2020, J PERINAT MED, V48, P545, DOI 10.1515/jpm-2020-0182; Marshall ES, 2013, PUBLIC HEALTH NURS, V30, P361, DOI 10.1111/phn.12006; Melton B, 2013, NURS HEALTH SCI, V15, P468, DOI 10.1111/nhs.12057; Mikkelsen K, 2017, MATURITAS, V106, P48, DOI 10.1016/j.maturitas.2017.09.003; Moreland A, 2020, MMWR-MORBID MORTAL W, V69, P1198, DOI 10.15585/mmwr.mm6935a2; Mudd LM, 2009, PREV MED, V49, P194, DOI 10.1016/j.ypmed.2009.06.004; Nakamura A, 2019, J AFFECT DISORDERS, V246, P29, DOI 10.1016/j.jad.2018.12.009; Narang K, 2020, MAYO CLIN PROC, V95, P1750, DOI 10.1016/j.mayocp.2020.05.011; Nascimento SL, 2012, CURR OPIN OBSTET GYN, V24, P387, DOI 10.1097/GCO.0b013e328359f131; Office of Management and Budget Standards, 1997, REV STAND CLASS FED; OpenStreetMap, 2017, TIGER LIN SHAP 2017; Poyatos-Leon R, 2017, BIRTH-ISS PERINAT C, V44, P200, DOI 10.1111/birt.12294; Prather H, 2012, PM&R, V4, P845, DOI 10.1016/j.pmrj.2012.07.012; Rallis S, 2014, WOMEN BIRTH, V27, pE36, DOI 10.1016/j.wombi.2014.08.002; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Santos-Rocha R., 2019, EXERCISE SPORTING AC, P95, DOI [10.1007/978-3-319-91032-1_5, DOI 10.1007/978-3-319-91032-1_5]; Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089; Sherin M, OBSTET GYNECOLOGY; Songoygard KM, 2012, ACTA OBSTET GYN SCAN, V91, P62, DOI 10.1111/j.1600-0412.2011.01262.x; Taylor Wendell C, 2006, J Phys Act Health, V3, pS30, DOI 10.1123/jpah.3.s1.s30; Thayer ZM, 2021, AM J HUM BIOL, V33, DOI 10.1002/ajhb.23508; Tinloy J, 2014, WOMEN HEALTH ISS, V24, pE99, DOI 10.1016/j.whi.2013.11.003; Tsakiridis I, 2019, ARCH GYNECOL OBSTET, V300, P849, DOI 10.1007/s00404-019-05270-1; United States Department of Agriculture, 2013, RUR URB CONT COD; Vargas-Terrones M, 2019, BRIT J SPORT MED, V53, P348, DOI 10.1136/bjsports-2017-098926; Weinberg R. S., 2014, HUMAN KINETICS	51	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243188	10.1371/journal.pone.0243188	http://dx.doi.org/10.1371/journal.pone.0243188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347484	Green Published, gold			2022-12-26	WOS:000603071100012
J	Murakami, M; Toyama, Y; Yonekura, M; Ohba, T; Matsuzaki, Y; Sawamura, D; Murakami, AM; Nishi, M; Itagaki, S; Tomita, H; Takeshima, H				Murakami, Manabu; Toyama, Yuichi; Yonekura, Manabu; Ohba, Takayoshi; Matsuzaki, Yasushi; Sawamura, Daisuke; Murakami, Agnieszka M.; Nishi, Miyuki; Itagaki, Shirou; Tomita, Hirofumi; Takeshima, Hiroshi			Decreased cardiac pacemaking and attenuated beta-adrenergic response in TRIC-A knockout mice	PLOS ONE			English	Article							BLOOD-PRESSURE; RYANODINE RECEPTOR; HEART-RATE; CHANNELS; MECHANISM; BASAL	Changes in intracellular calcium levels in the sinus node modulate cardiac pacemaking (the calcium clock). Trimeric intracellular cation (TRIC) channels are counterion channels on the surface of the sarcoplasmic reticulum and compensate for calcium release from ryanodine receptors, which play a major role in calcium-induced calcium release (CICR) and the calcium clock. TRIC channels are expected to affect the calcium clock in the sinus node. However, their physiological importance in cardiac rhythm formation remains unclear. We evaluated the importance of TRIC channels on cardiac pacemaking using TRIC-A-null (TRIC-A(-/-)) as well as TRIC-B(+/-)mice. Although systolic blood pressure (SBP) was not significantly different between wild-type (WT), TRIC-B+/-, and TRIC-A(-/-)mice, heart rate (HR) was significantly lower in TRIC-A(-/-)mice than other lines. Interestingly, HR and SBP showed a positive correlation in WT and TRIC-B(+/-)mice, while no such correlation was observed in TRIC-A(-/-)mice, suggesting modification of the blood pressure regulatory system in these mice. Isoproterenol (0.3 mg/kg) increased the HR in WT mice (98.8 +/- 15.1 bpm), whereas a decreased response in HR was observed in TRIC-A(-/-)mice (23.8 +/- 5.8 bpm), suggesting decreased sympathetic responses in TRIC-A(-/-)mice. Electrocardiography revealed unstable R-R intervals in TRIC-A(-/-)mice. Furthermore, TRIC-A(-/-)mice sometimes showed sinus pauses, suggesting a significant role of TRIC-A channels in cardiac pacemaking. In isolated atrium contraction or action potential recording, TRIC-A(-/-)mice showed decreased response to a beta-adrenergic sympathetic nerve agonist (isoproterenol, 100 nM), indicating decreased sympathetic responses. In summary, TRIC-A(-/-)mice showed decreased cardiac pacemaking in the sinus node and attenuated responses to beta-adrenergic stimulation, indicating the involvement of TRIC-A channels in cardiac rhythm formation and decreased sympathetic responses.	[Murakami, Manabu; Murakami, Agnieszka M.] Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori, Japan; [Toyama, Yuichi; Yonekura, Manabu; Tomita, Hirofumi] Hirosaki Univ, Grad Sch Med, Dept Cardiol & Nephrol, Hirosaki, Aomori, Japan; [Ohba, Takayoshi] Akita Univ, Grad Sch Med, Dept Cellular Physiol, Akita, Japan; [Matsuzaki, Yasushi; Sawamura, Daisuke] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch, Dept Biol Chem, Kyoto, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Fac Pharmaceut Sci, Kyoto, Japan; [Itagaki, Shirou] Sapporo Med Univ, Collaborat Ctr Community & Ind, Sapporo, Hokkaido, Japan	Hirosaki University; Hirosaki University; Akita University; Hirosaki University; Kyoto University; Sapporo Medical University	Murakami, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori, Japan.	mmura0123@hotmail.co.jp	Tomita, Hirofumi/E-8627-2013	murakami, manabu/0000-0001-6704-1796	JSPS, KAKENHI [17K08527, 17H04319, 16K09489, 20K07255]	JSPS, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was sponsored in part by Grants-in-Aid for Scientific Research from JSPS, KAKENHI (17K08527(MM), 17H04319(MM), 16K09489(HT), and 20K07255(MM)).	[Anonymous], 2014, AM J PHYSIOL-RENAL, V307, pF891; Bitar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130487; Christofaro DGD, 2017, ARQ BRAS CARDIOL, V108, P405, DOI 10.5935/abc.20170050; EBASHI S, 1991, ANNU REV PHYSIOL, V53, P1, DOI 10.1146/annurev.ph.53.030191.000245; El-Ajouz S, 2017, J PHYSIOL-LONDON, V595, P4769, DOI 10.1113/JP273550; Han C, 2016, BIOCHEM BIOPH RES CO, V469, P897, DOI 10.1016/j.bbrc.2015.12.057; Huang CLH, 2017, PHYSIOL REV, V97, P283, DOI 10.1152/physrev.00007.2016; Imlach WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008698; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Larsson HP, 2010, J GEN PHYSIOL, V136, P237, DOI 10.1085/jgp.201010506; Murakami Manabu, 2008, J Biol Chem, V283, P24554, DOI 10.1074/jbc.M802319200; Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899; Shrestha N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000700; TOCHIKUBO O, 1993, JPN CIRC J, V57, P1128, DOI 10.1253/jcj.57.1128; Vinogradova TM, 2009, J MOL CELL CARDIOL, V47, P456, DOI 10.1016/j.yjmcc.2009.06.014; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yonekura M, 2018, J PHARMACOL SCI, V137, P55, DOI 10.1016/j.jphs.2018.04.003; Zhou XY, 2020, CIRC RES, V126, P417, DOI 10.1161/CIRCRESAHA.119.316241; ZHOU ZF, 1993, J PHYSIOL-LONDON, V466, P263	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244254	10.1371/journal.pone.0244254	http://dx.doi.org/10.1371/journal.pone.0244254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347504	gold, Green Published			2022-12-26	WOS:000603071100034
J	Monkley, S; Krishnaswamy, JK; Goransson, M; Clausen, M; Meuller, J; Thorn, K; Hicks, R; Delaney, S; Stjernborg, L				Monkley, Susan; Krishnaswamy, Jayendra Kumar; Goransson, Melker; Clausen, Maryam; Meuller, Johan; Thorn, Kristofer; Hicks, Ryan; Delaney, Stephen; Stjernborg, Louise			Optimised generation of iPSC-derived macrophages and dendritic cells that are functionally and transcriptionally similar to their primary counterparts	PLOS ONE			English	Article							IN-VITRO; MONOCYTES; EXPRESSION; LINES	Induced pluripotent stem cells (iPSC) offer the possibility to generate diverse disease-relevant cell types, from any genetic background with the use of cellular reprogramming and directed differentiation. This provides a powerful platform for disease modeling, drug screening and cell therapeutics. The critical question is how the differentiated iPSC-derived cells translate to their primary counterparts. Our refinement of a published differentiation protocol produces a CD14+ monocytic lineage at a higher yield, in a smaller format and at a lower cost. These iPSC-derived monocytes can be further differentiated into macrophages or dendritic cells (DC), both with similar morphological and functional profiles as compared to their primary counterparts. Transcriptomic analysis of iPSC-derived cells at different stages of differentiation as well as comparison to their blood-derived counterparts demonstrates a complete switch of iPSCs to cells expressing a monocyte, macrophage or DC specific gene profile. iPSC-derived macrophages respond to LPS treatment by inducing expression of classic macrophage pro-inflammatory response markers. Interestingly, though iPSC-derived DC show similarities to monocyte derived DC, they are more similar transcriptionally to a newly described subpopulation of AXL(+) DC. Thus, our study provides a detailed and accurate profile of iPSC-derived monocytic lineage cells.	[Monkley, Susan; Thorn, Kristofer] AstraZeneca, BioPharmaceut R&D, Translat Sci & Expt Med Res & Early Dev, Resp & Immunol R&I, Gothenburg, Sweden; [Krishnaswamy, Jayendra Kumar; Goransson, Melker; Delaney, Stephen] AstraZeneca, BioPharmaceut R&D, Biosci Res & Early Dev, Resp & Immunol R&I, Gothenburg, Sweden; [Clausen, Maryam; Meuller, Johan; Stjernborg, Louise] AstraZeneca, Discovery Biol, Discovery Sci, BioPharmaceut R&D, Gothenburg, Sweden; [Hicks, Ryan] AstraZeneca, Res & Early Dev, Cardiovasc Renal & Metab CVRM, BioPharmaceut R&D Cell Therapy, Gothenburg, Sweden; [Krishnaswamy, Jayendra Kumar] Galderma Pharma SA, Lausanne, Switzerland; [Meuller, Johan] Molnlycke Healthcare, Gothenburg, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Monkley, S (corresponding author), AstraZeneca, BioPharmaceut R&D, Translat Sci & Expt Med Res & Early Dev, Resp & Immunol R&I, Gothenburg, Sweden.	susan.monkley1@astrazeneca.com		Hicks, Ryan/0000-0002-3367-6272; Monkley, Susan/0000-0001-9174-6278; Krishnaswamy, Jayendra Kumar/0000-0002-7939-6559				Ajami B, 2018, IMMUNOL CELL BIOL, V96, P125, DOI 10.1111/imcb.12004; Alasoo K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12524; [Anonymous], 2012, P NATL ACAD SCI USA, V109, pE1377; Balan S, 2014, J IMMUNOL, V193, P1622, DOI 10.4049/jimmunol.1401243; BAUER J, 1988, BLOOD, V72, P1134; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; Buchrieser J, 2017, STEM CELL REP, V8, P334, DOI 10.1016/j.stemcr.2016.12.020; Dieterlen MT, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5946807; Elkord E, 2005, IMMUNOLOGY, V114, P204, DOI 10.1111/j.1365-2567.2004.02076.x; Fugitive Literacies Collective, 2020, ENGLISH ED, V52, pN3; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Guerriero JL, 2018, TRENDS MOL MED, V24, P472, DOI 10.1016/j.molmed.2018.03.006; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gutbier S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134808; Haideri SS, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0017-0; Helft J, 2017, CELL REP, V20, P529, DOI 10.1016/j.celrep.2017.06.075; Huang Y, 2017, CELL TRANSPLANT, V26, P1380, DOI 10.1177/0963689717720281; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kitadani J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23120-z; Knowles A, 2015, PHILOSOPHIA-J CONT F, V5, P1; Lee CZW, 2018, NAT REV IMMUNOL, V18, P716, DOI 10.1038/s41577-018-0054-y; Lee SWL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00416; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li JN, 2007, J LEUKOCYTE BIOL, V81, P328, DOI 10.1189/jlb.0206124; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malpass Katy, 2012, Nat Rev Neurol, V8, P533, DOI 10.1038/nrneurol.2012.185; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mills CD, 2016, CANCER RES, V76, P513, DOI 10.1158/0008-5472.CAN-15-1737; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; Nikolic MZ, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00194-2018; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Qu CF, 2014, INT J INFECT DIS, V19, P1, DOI 10.1016/j.ijid.2013.09.023; Shi Jianting, 2019, Curr Protoc Stem Cell Biol, V48, pe74, DOI 10.1002/cpsc.74; Sjogren AKM, 2014, ARCH TOXICOL, V88, P1427, DOI 10.1007/s00204-014-1265-z; Victoni T, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0613-y; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Young LJ, 2007, P NATL ACAD SCI USA, V104, P17753, DOI 10.1073/pnas.0708622104; Zhang HR, 2017, ARTERIOSCL THROM VAS, V37, P2000, DOI 10.1161/ATVBAHA.117.309195; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023	42	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243807	10.1371/journal.pone.0243807	http://dx.doi.org/10.1371/journal.pone.0243807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332401	Green Published, gold			2022-12-26	WOS:000601310900064
J	Zhou, SQ; Sakamoto, K				Zhou, Siqi; Sakamoto, Kazuichi			Citric acid promoted melanin synthesis in B16F10 mouse melanoma cells, but inhibited it in human epidermal melanocytes and HMV-II melanoma cells via the GSK3 beta/beta-catenin signaling pathway	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; OXIDATIVE STRESS; BETA-CATENIN; MELANOGENESIS; CYCLE; MITF; SKIN; PHOTOPROTECTION; APOPTOSIS; CITRATE	Melanin, a pigment synthesized by melanocytes in the skin, resists the damage caused by ultraviolet rays to cells. Citric acid, a well-known food additive, is commonly used as an antioxidant and is an important part of the tricarboxylic acid (TCA) cycle for energy production during cellular metabolism. Here, we aimed to investigate whether the addition of excess citric acid regulates melanin synthesis, and to delineate the underlying mechanism. First, we observed that citric acid exerts opposite redox effects on mouse and human cells. Interestingly, treatment with excess citric acid increased the melanin content in mouse cells but decreased it in human cells. Furthermore, the expression of factors important for melanin synthesis, such as microphthalmia-associated transcription factor (MITF), was also regulated by citric acid treatment-it was promoted in mouse cells and suppressed in human cells. Citric acid also impacted the upstream regulators of MITF, glycogen synthase kinase 3 beta (GSK3 beta), and beta-catenin. Second, we determined the importance of GSK3 beta in the citric acid-mediated regulation of melanin synthesis, using a GSK3 beta inhibitor (BIO). To the best of our knowledge, this is the first study to show that citric acid regulates melanin synthesis via the GSK3 beta/beta-catenin signaling pathway, and that equal amounts of exogenous citric acid exert opposing effects on mouse and human cells.	[Zhou, Siqi; Sakamoto, Kazuichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Sakamoto, K (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	sakamoto@biol.tsukuba.ac.jp		ZHOU, SIQI/0000-0002-5024-7269				Abdel-Salam OME, 2014, J MED FOOD, V17, P588, DOI 10.1089/jmf.2013.0065; Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2020, WHY MOUSE MATTERS; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Barillas R, 2007, ANN THORAC SURG, V84, P126, DOI 10.1016/j.athoracsur.2007.02.015; Bhatnagar V, 1998, MOL CELL BIOCHEM, V187, P57, DOI 10.1023/A:1006870621424; Brash DE, 2016, TOXICOL PATHOL, V44, P552, DOI 10.1177/0192623316632072; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Chen XG, 2017, CELL J, V18, P493; Choe E, 2009, COMPR REV FOOD SCI F, V8, P345, DOI 10.1111/j.1541-4337.2009.00085.x; Cunha ES, 2012, EXP CELL RES, V318, P1913, DOI 10.1016/j.yexcr.2012.05.019; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Domoto T, 2016, CANCER SCI, V107, P1363, DOI 10.1111/cas.13028; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Geng J, 2008, J EUR ACAD DERMATOL, V22, P852, DOI 10.1111/j.1468-3083.2007.02574.x; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Hou L, 2006, P NATL ACAD SCI USA, V103, P9081, DOI 10.1073/pnas.0603114103; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Hu SH, 2019, J CELL PHYSIOL, V234, P7330, DOI 10.1002/jcp.27492; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kim ES, 2014, PIGM CELL MELANOMA R, V27, P1051, DOI 10.1111/pcmr.12298; KOLLIAS N, 1991, J PHOTOCH PHOTOBIO B, V9, P135, DOI 10.1016/1011-1344(91)80147-A; Kumari S, 2018, ACTA DERM-VENEREOL, V98, P924, DOI 10.2340/00015555-3002; Lane BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049357; Levy C, 2003, MOL CELL BIOL, V23, P9073, DOI 10.1128/MCB.23.24.9073-9080.2003; Lu YF, 2011, ANTICANCER RES, V31, P797; Makbal R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072539; McNaughton BR, 2009, CHEMMEDCHEM, V4, P1583, DOI 10.1002/cmdc.200900194; Meierjohann S, 2014, EUR J CELL BIOL, V93, P36, DOI 10.1016/j.ejcb.2013.11.005; Niu C, 2017, MOLECULES, V22, DOI 10.3390/molecules22081303; Ortonne JP, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.146.s61.3.x; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; Pillaiyar T, 2017, J ENZYM INHIB MED CH, V32, P403, DOI 10.1080/14756366.2016.1256882; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Premi S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1033588; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Wang TA, 2016, ONCOL REP, V35, P1287, DOI 10.3892/or.2015.4511; Wang XP, 2018, J HUM GENET, V63, P639, DOI 10.1038/s10038-018-0425-z; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Yamaguchi Y, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017046; Yang K, 2017, CELL PHYSIOL BIOCHEM, V44, P1445, DOI 10.1159/000485580; Ying TH, 2013, ANTICANCER RES, V33, P4411; Zeng H., 2017, COSMETICS-BASEL, V4, P43, DOI [10.3390/cosmetics4040043, DOI 10.3390/COSMETICS4040043]; Zhou HY, 2019, MOLECULES, V24, DOI 10.3390/molecules24183303; Zhou SQ, 2019, GENES CELLS, V24, P60, DOI 10.1111/gtc.12654	54	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243565	10.1371/journal.pone.0243565	http://dx.doi.org/10.1371/journal.pone.0243565			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332393	gold, Green Published			2022-12-26	WOS:000601310900088
J	de Oliveira, JVB; Lima, RPA; Luna, RCP; Diniz, AD; de Almeida, ATC; de Oliveira, NFP; Goncalves, MDR; de Lima, RT; Ferreira, FELD; Diniz, SCPDR; Silva, AS; Silva, AHAE; Persuhn, DC; Costa, MJD				Bernardo de Oliveira, Jessica Vicky; Ataide Lima, Raquel Patricia; Cristhine Pordeus Luna, Rafaella; Diniz, Alcides da Silva; Cavalcanti de Almeida, Alessio Tony; Paulo de Oliveira, Naila Francis; Goncalves, Maria da Conceicao Rodrigues; de Lima, Roberto Texeira; de Lima Ferreira, Flavia Emilia Leite; de Oliveira Ramalho Diniz, Sonia Cristina Pereira; Silva, Alexandre Sergio; Andrade e Silva, Ana Herminia; Persuhn, Darlene Camati; de Carvalho Costa, Maria Jose			The direct correlation between oxidative stress and LDL-C levels in adults is maintained by the Friedewald and Martin equations, but the methylation levels in the MTHFR and ADRB3 genes differ	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; DNA METHYLATION; CARDIOVASCULAR RISK; AMERICAN-COLLEGE; DYSLIPIDEMIA; ASSOCIATION; BLOOD; CONSUMPTION; MANAGEMENT; RECOMMENDATIONS	Low-density lipoprotein (LDL-C) concentrations are a standard of care in the prevention of cardiovascular disease and are influenced by different factors. This study compared the LDL-C concentrations estimated by two different equations and determined their associations with inflammatory status, oxidative stress, anthropometric variables, food intake and DNA methylation levels in the LPL, ADRB3 and MTHFR genes. A cross-sectional population-based study was conducted with 236 adults (median age 37.5 years) of both sexes from the municipality of JoAo Pessoa, Paraiba, Brazil. The LDL-C concentrations were estimated according to the Friedewald and Martin equations. LPL, ADRB3 and MTHFR gene methylation levels; malondialdehyde levels; total antioxidant capacity; ultra-sensitive C-reactive protein, alpha-1-acid glycoprotein, homocysteine, cobalamin, and folic acid levels; usual dietary intake; and epidemiological variables were also determined. For each unit increase in malondialdehyde concentration there was an increase in the LDL-C concentration from 6.25 to 10.29 mg/dL (p <0.000). Based on the Martin equation (<greater than or equal to>70 mg/dL), there was a decrease in the DNA methylation levels in the ADRB3 gene and an increase in the DNA methylation levels in the MTHFR gene (p <0.05). There was a positive relation of homocysteine and cholesterol intake on LDL-C concentrations estimated according to the Friedewald equation and of waist circumference and age based on the two estimates. It is concluded the LDL-C concentrations estimated by the Friedewald and Martin equations were different, and the Friedewald equation values were significantly lower than those obtained by the Martin equation. MDA was the variable that was most positively associated with the estimated LDL-C levels in all multivariate models. Significant relationships were observed based on the two estimates and occurred for most variables. The methylation levels of the ADRB3 and MTHFR genes were different according to the Martin equation at low LDL-C concentrations (70 mg/dL).	[Bernardo de Oliveira, Jessica Vicky; Ataide Lima, Raquel Patricia; Cristhine Pordeus Luna, Rafaella; Goncalves, Maria da Conceicao Rodrigues; de Lima, Roberto Texeira; de Lima Ferreira, Flavia Emilia Leite; de Oliveira Ramalho Diniz, Sonia Cristina Pereira; Silva, Alexandre Sergio; de Carvalho Costa, Maria Jose] Univ Fed Paraiba UFPB, Fed Univ Paraiba, Postgrad Program Nutr Sci, Dept Nutr,Hlth Sci Ctr, Joao Pessoa, Paraiba, Brazil; [Diniz, Alcides da Silva] Univ Fed Pernambuco UFPE, Fed Univ Pernambuco, Postgrad Program Nutr Sci, Dept Nutr,Hlth Sci Ctr, Recife, PE, Brazil; [Cavalcanti de Almeida, Alessio Tony] Univ Fed Paraiba, Postgrad Program Appl Econ, Dept Econ, Ctr Appl Social Sci, Joao Pessoa, Paraiba, Brazil; [Paulo de Oliveira, Naila Francis; Persuhn, Darlene Camati] Univ Fed Paraiba, Dept Mol Biol, Ctr Exact & Nat Sci, Joao Pessoa, Paraiba, Brazil; [Andrade e Silva, Ana Herminia] Univ Fed Paraiba, Dept Stat, Ctr Exact & Nat Sci, Joao Pessoa, Paraiba, Brazil	Universidade Federal da Paraiba; Universidade Federal de Pernambuco; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba	de Oliveira, JVB (corresponding author), Univ Fed Paraiba UFPB, Fed Univ Paraiba, Postgrad Program Nutr Sci, Dept Nutr,Hlth Sci Ctr, Joao Pessoa, Paraiba, Brazil.	jessicavickynutri@gmail.com	Silva, Alexandre S/N-8883-2014; de Oliveira, Naila FP/I-8310-2012; PERSUHN, DARLENE CAMATI/AAB-2481-2021; Paulo de Oliveira, Naila Francis/S-5993-2019; Luna, Rafaella Cristhine Pordeus/L-1733-2015	Silva, Alexandre S/0000-0003-3576-9023; de Oliveira, Naila FP/0000-0002-0855-2518; PERSUHN, DARLENE CAMATI/0000-0001-5291-5454; Paulo de Oliveira, Naila Francis/0000-0002-0855-2518; Luna, Rafaella Cristhine Pordeus/0000-0003-2477-8258				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2000, WHO TECH REP SER, P894; [Anonymous], 2002, UVAMGASUTTANI, V4, P1; [Anonymous], 2018, J HIST MODERN THEOLO, V25, p[1, 21]; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Arnett DK, 2019, J AM COLL CARDIOL, V74, P1376, DOI 10.1016/j.jacc.2019.03.009; Asciutti L.S.R, 2005, MANUAL PORCOES MEDIA; Lima RPA, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0407-6; Bradshaw G, 2015, META GENE, V6, P91, DOI 10.1016/j.mgene.2015.09.004; Castellano-Castillo D, 2018, CLIN CHEM, V64, P210, DOI 10.1373/clinchem.2017.277921; Catapano Alberico L, 2017, Rev Esp Cardiol (Engl Ed), V70, P115, DOI 10.1016/j.rec.2017.01.002; Chen NY, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-104; Chiu HF, 2017, PHARM BIOL, V55, P974, DOI 10.1080/13880209.2017.1285323; Coffey Michelle, 2003, Crit Care Nurse, V23, P25; Costa CJM, 2014, 2 CICLO DIAGNOSTICO; Costa MJ C., 1986, ANN NUTR METAB, V30, P21, DOI [10.1159/000177173, DOI 10.1159/000177173]; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Cavalcante IGD, 2015, EXP GERONTOL, V66, P10, DOI 10.1016/j.exger.2015.03.011; de Oliveira Y, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1529-0; Dong YH, 2018, INT J BIOL MACROMOL, V120, P1490, DOI 10.1016/j.ijbiomac.2018.09.134; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garg G, 2018, J PHARM PHARMACOL, V70, P1572, DOI 10.1111/jphp.13004; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guay SP, 2013, ATHEROSCLEROSIS, V228, P413, DOI 10.1016/j.atherosclerosis.2013.03.033; Guay SP, 2014, EPIGENOMICS-UK, V6, P33, DOI 10.2217/epi.13.82; Hamulka J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112530; Hong S, 2018, MOL METAB, V12, P25, DOI 10.1016/j.molmet.2018.03.012; Houde AA, 2014, J DEV ORIG HLTH DIS, V5, P132, DOI 10.1017/S2040174414000038; Jacobson TA, 2015, J CLIN LIPIDOL, V9, P129, DOI 10.1016/j.jacl.2015.02.003; Jellinger PS, 2017, ENDOCR PRACT, V23, P479, DOI 10.4158/EP171764.GL; Khan RA, 2015, TOXICOL IND HEALTH, V31, P546, DOI 10.1177/0748233713475503; Kishimoto Y, 2016, J NUTR SCI VITAMINOL, V62, P361, DOI 10.3177/jnsv.62.361; Kuo K, 1997, CLIN CHEM, V43, P1653; Kurylowicz A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0395-2; Laclaustra M, 2018, DIABETES CARE, V41, P2195, DOI 10.2337/dc18-0372; de Lima FEL, 2008, CAD SAUDE PUBLICA, V24, P820, DOI 10.1590/S0102-311X2008000400012; Li WX, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0099-x; Lopes-Virella MF, 2012, ATHEROSCLEROSIS, V224, P526, DOI 10.1016/j.atherosclerosis.2012.08.006; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Martin SS, 2018, JAMA CARDIOL, V3, P749, DOI 10.1001/jamacardio.2018.1533; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; Mikael LG, 2009, MOL GENET METAB, V98, P187, DOI 10.1016/j.ymgme.2009.05.011; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohammadpour-Gharehbagh A, 2018, J CELL BIOCHEM, V119, P1346, DOI 10.1002/jcb.26290; Moll S, 2015, CIRCULATION, V132, pe6, DOI 10.1161/CIRCULATIONAHA.114.013311; Mora S, 2014, CIRCULATION, V129, P553, DOI 10.1161/CIRCULATIONAHA.113.005873; MSM, MULT SOURC METH; O TM, 2018, OTOLARYNGOL CLIN N A, V51, pxvii; Oliveira Cleiton da Silva, 2015, Rev. Col. Bras. Cir., V42, P305, DOI 10.1590/0100-69912015005007; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Patel Y, 2018, MATER RELIG, V14, P1, DOI 10.1080/17432200.2017.1417215; Pletcher MJ, 2017, MED CLIN N AM, V101, P673, DOI 10.1016/j.mcna.2017.03.002; Pokharel Y, 2017, ATHEROSCLEROSIS, V266, P16, DOI 10.1016/j.atherosclerosis.2017.09.019; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Retterstol K, 2018, ATHEROSCLEROSIS, V279, P52, DOI 10.1016/j.atherosclerosis.2018.10.013; Sathiyakumar V, 2018, CIRCULATION, V138, P244, DOI 10.1161/CIRCULATIONAHA.117.032463; Siegel S., 1977, NONPARAMETRIC STAT B; Stanger O, 2002, J PHARMACOL EXP THER, V303, P158, DOI 10.1124/jpet.102.036715; Taguchi C, 2018, ASIA PAC J CLIN NUTR, V27, P359, DOI 10.6133/apjcn.042017.17; Tsai IJ, 2018, APPL PHYSIOL NUTR ME, V43, P669, DOI 10.1139/apnm-2017-0670; Vinci MC, 2013, STEM CELL REV REP, V9, P241, DOI 10.1007/s12015-012-9398-z; Wang YC, 2018, PHARM BIOL, V56, P325, DOI 10.1080/13880209.2018.1479868; Whelton SP, 2017, J CLIN LIPIDOL, V11, P1065, DOI 10.1016/j.jacl.2017.05.005; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Wu Y, 2007, TOXICOLOGY, V232, P50, DOI 10.1016/j.tox.2006.12.013; Wu YL, 2018, INT J BIOL MACROMOL, V118, P886, DOI 10.1016/j.ijbiomac.2018.06.140; Yang TC, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-11; Zhang QP, 2018, CHEM BIODIVERS, V15, DOI 10.1002/cbdv.201800219; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200	74	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0239989	10.1371/journal.pone.0239989	http://dx.doi.org/10.1371/journal.pone.0239989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326437	gold, Green Published			2022-12-26	WOS:000600176400033
J	Pihlstrom, HK; Ueland, T; Michelsen, AE; Aukrust, P; Gatti, F; Hammarstrom, C; Kasprzycka, M; Wang, JB; Haraldsen, G; Mjoen, G; Dahle, DO; Midtvedt, K; Eide, IA; Hartmann, A; Holdaas, H				Pihlstrom, Hege Kampen; Ueland, Thor; Michelsen, Annika E.; Aukrust, Pal; Gatti, Franscesca; Hammarstrom, Clara; Kasprzycka, Monika; Wang, Junbai; Haraldsen, Guttorm; Mjoen, Geir; Dahle, Dag Olav; Midtvedt, Karsten; Eide, Ivar Anders; Hartmann, Anders; Holdaas, Hallvard			Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; CHRONIC KIDNEY-DISEASE; ORAL PARICALCITOL; OPEN-LABEL; ANTIINFLAMMATORY PROFILE; OXIDATIVE STRESS; ALL-CAUSE; MORTALITY; ACTIVATION; RECEPTOR	Following a successful renal transplantation circulating markers of inflammation may remain elevated, and systemic inflammation is associated with worse clinical outcome in renal transplant recipients (RTRs). Vitamin D-receptor (VDR) activation is postulated to modulate inflammation and endothelial function. We aimed to explore if a synthetic vitamin D, paricalcitol, could influence systemic inflammation and immune activation in RTRs. Newly transplanted RTRs were included in an open-label randomized controlled trial on the effect of paricalcitol on top of standard care over the first post-transplant year. Fourteen pre-defined circulating biomarkers reflecting leukocyte activation, endothelial activation, fibrosis and general inflammatory burden were analyzed in 74 RTRs at 8 weeks (baseline) and 1 year post-engraftment. Mean changes in plasma biomarker concentrations were compared by t-test. The expression of genes coding for the same biomarkers were investigated in 1-year surveillance graft biopsies (n = 60). In patients treated with paricalcitol circulating osteoprotegerin levels increased by 0.19 ng/ml, compared with a 0.05 ng/ml increase in controls (p = 0.030). In graft tissue, a 21% higher median gene expression level of TNFRSF11B coding for osteoprotegerin was found in paricalcitol-treated patients compared with controls (p = 0.026). Paricalcitol treatment did not significantly affect the blood- or tissue levels of any other investigated inflammatory marker. In RTRs, paricalcitol treatment might increase both circulating and tissue levels of osteoprotegerin, a modulator of calcification, but potential anti-inflammatory treatment effects in RTRs are likely very modest. [NCT01694160 (2012/107D)]; [www.clinicaltrials.gov].	[Pihlstrom, Hege Kampen; Mjoen, Geir; Dahle, Dag Olav; Midtvedt, Karsten; Hartmann, Anders; Holdaas, Hallvard] Oslo Univ Hosp, Rikshosp, Dept Surg Inflammat Med & Transplantat, Sect Nephrol, Oslo, Norway; [Ueland, Thor; Michelsen, Annika E.; Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Res Inst Internal Med, Oslo, Norway; [Ueland, Thor; Michelsen, Annika E.; Aukrust, Pal; Hartmann, Anders] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Ueland, Thor] Univ Tromso, KG Jebsen Thrombosis Res & Expertise Ctr, Tromso, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Dept Surg Inflammat Med & Transplantat, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Gatti, Franscesca; Hammarstrom, Clara; Kasprzycka, Monika; Wang, Junbai; Haraldsen, Guttorm] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Gatti, Franscesca; Hammarstrom, Clara; Kasprzycka, Monika; Haraldsen, Guttorm] Univ Oslo, KG Jebsen Inflammat Res Ctr, Lab Immunohistochem & Immunopathol, Oslo, Norway; [Eide, Ivar Anders; Hartmann, Anders] Akershus Univ Hosp, Dept Nephrol, Div Med, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo	Pihlstrom, HK (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Surg Inflammat Med & Transplantat, Sect Nephrol, Oslo, Norway.	hegphi@ous-hf.no	wang, junbai/AFQ-5325-2022; wang, junbai/B-2093-2008	wang, junbai/0000-0001-5505-5613; 	Norwegian Society of Nephrology; South Eastern Norway Regional Health Authority	Norwegian Society of Nephrology; South Eastern Norway Regional Health Authority	The trial was funded via a PhD grant to Hege K Pihlstromfrom South Eastern Norway Regional Health Authority (https://www.helsesorost.no) and received an additional research grant from the Norwegian Society of Nephrology (https://nephro.no).Norwegian Health Authorities (https://helfo.no) also funded the trial by covering all expenses associated with paricalcitol treatment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini S, 2009, CLIN J AM SOC NEPHRO, V4, P1246, DOI 10.2215/CJN.00930209; Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; Amer H, 2013, AM J TRANSPLANT, V13, P1576, DOI 10.1111/ajt.12227; [Anonymous], 2015, BMJ, V2015, ph1887; Batmanov K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07226-4; Berridge MJ, 2017, BIOCHEM J, V474, P1321, DOI 10.1042/BCJ20170042; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Cannas L, 2017, INT UROL NEPHROL, V49, P533, DOI 10.1007/s11255-016-1435-4; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Donate-Correa J, 2017, NEFROLOGIA, V37, P622, DOI 10.1016/j.nefro.2017.03.028; Dunkler D, 2020, TRANSPL INT, V33, P50, DOI 10.1111/tri.13535; Eleftheriadis T, 2010, INT UROL NEPHROL, V42, P181, DOI 10.1007/s11255-009-9541-1; Feng XK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/160123; Gonzalez E, 2013, TRANSPLANTATION, V95, pE49, DOI 10.1097/TP.0b013e3182855565; Grebe SO, 2011, CLIN TRANSPLANT, V25, P744, DOI 10.1111/j.1399-0012.2010.01345.x; Hansen D, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-130; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Kalluri HV, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12955; Kawahara T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011183; Lee J, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0647-6; Lund KP, 2019, TRANSPL INT, V32, P933, DOI 10.1111/tri.13425; Mansell H, 2013, CLIN TRANSPLANT, V27, pE391, DOI 10.1111/ctr.12159; Mansouri L, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0576-8; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; Morrison MA, 2012, EUGENE O NEILL REV, V33, P159; Mortlock S, 2016, SCH J APP MED SCI, V4, P4146; Muscogiuri G, 2017, INT J CARDIOL, V230, P577, DOI 10.1016/j.ijcard.2016.12.053; Navarro-Gonzalez JF, 2013, J CLIN PHARMACOL, V53, P421, DOI 10.1002/jcph.19; Neale RE, 2016, CONTEMP CLIN TRIALS, V48, P83, DOI 10.1016/j.cct.2016.04.005; Nieuwland AJ, 2016, LAB INVEST, V96, P784, DOI 10.1038/labinvest.2016.55; Oblak M, 2017, CLIN NEPHROL, V88, pS119, DOI 10.5414/CNP88FX26; Park JW, 2010, KIDNEY INT, V77, P1076, DOI 10.1038/ki.2010.69; Perez V, 2013, EUR J PHARMACOL, V709, P72, DOI 10.1016/j.ejphar.2013.03.040; Pihlstrom H, 2014, CLIN TRANSPLANT, V28, P111, DOI 10.1111/ctr.12285; Pihlstrom HK, 2017, TRANSPL INT, V30, P827, DOI 10.1111/tri.12973; Pinera-Haces C, 2013, NEFROLOGIA, V33, P77, DOI 10.3265/Nefrologia.pre2012.Sep.11533; Ponticelli C, 2014, EXPERT REV CLIN IMMU, V10, P1375, DOI 10.1586/1744666X.2014.949674; Rochette L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030705; Rochette L, 2018, PHARMACOL THERAPEUT, V182, P115, DOI 10.1016/j.pharmthera.2017.08.015; Sarno G, 2015, ENDOCRINE, V50, P568, DOI 10.1007/s12020-015-0632-8; Swetha R, 2018, FUTURE MED CHEM, V10, P1093, DOI 10.4155/fmc-2017-0236; Tabriziani H, 2018, CLIN KIDNEY J, V11, P130, DOI 10.1093/ckj/sfx091; Tagliabue Elena, 2015, Adv Food Nutr Res, V75, P1, DOI 10.1016/bs.afnr.2015.06.003; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; Toffoli B, 2011, ATHEROSCLEROSIS, V218, P61, DOI 10.1016/j.atherosclerosis.2011.05.019; Tomlinson JAP, 2017, KIDNEY INT, V92, P809, DOI 10.1016/j.kint.2017.03.053; van Gennip ACE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222547; van Riemsdijk-van Overbeeke I C, 1998, Transpl Int, V11 Suppl 1, pS46; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Walsh JS, 2017, CURR OPIN ENDOCRINOL, V24, P389, DOI 10.1097/MED.0000000000000371; Wang J, 2008, J ENVIRON PATHOL TOX, V27, P157, DOI 10.1615/JEnvironPatholToxicolOncol.v27.i3.10; Ishikawa LLW, 2017, CLIN REV ALLERG IMMU, V52, P373, DOI 10.1007/s12016-016-8577-0; Watkins RR, 2015, CAN J PHYSIOL PHARM, V93, P363, DOI 10.1139/cjpp-2014-0352; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9	55	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243759	10.1371/journal.pone.0243759	http://dx.doi.org/10.1371/journal.pone.0243759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326471	gold, Green Published			2022-12-26	WOS:000600176400015
J	Viana, ECRD; Oliveira, ID; Rechinelli, AB; Marques, IL; de Souza, VF; Spexoto, MCB; Pereira, TSS; Guandalini, VR				Rodrigues de Morais Viana, Eduarda Cristina; Oliveira, Isadora da Silva; Rechinelli, Ana Beatriz; Marques, Isabele Lessa; de Souza, Vanusa Felicio; Bernardes Spexoto, Maria Claudia; Silva Pereira, Taisa Sabrina; Guandalini, Valdete Regina			Malnutrition and nutrition impact symptoms (NIS) in surgical patients with cancer	PLOS ONE			English	Article								Background and aim Nutrition impact symptoms (NIS) are common in cancer patients and the negative impacts on nutritional status indicate the need for research, diagnosis and nutritional intervention in order to reduce the risk of malnutrition. We aimed to verify the presence of malnutrition, the need for nutritional intervention, NIS and their influence on the nutritional status of surgical patients with cancer. Methods This cross-sectional study was carried out in a public tertiary hospital, from March 2017 to October 2019. Nutritional status, the need for nutritional intervention and NIS were assessed through the Patient-Generated Subjective Global Assessment (PG-SGA) in the first 48 hours of hospital admission. Results Among the 135 patients evaluated, 55.6% were elderly and 51.1% were male; patients had a median age of 62 years and a predominance of cancer located in the lower gastrointestinal tract (35.6%). Malnutrition and the need for nutritional intervention were identified in 60.0% and 90.4% of cases, respectively. The presence of three or more NIS was reported by 51.9% of patients. Significant differences in NIS were observed according to sex, PG-SGA classification and PG-SGA score. After logistic regression analysis, it was determined that the symptoms that increased the chances of malnutrition were anorexia, constipation, strange taste, mouth sores and others (depression, dental or financial problems). Conclusion Malnutrition, the need for nutritional intervention and the presence of three or more NIS were elevated in the patients evaluated. Malnutrition was associated with the presence of NIS, indicating the need for attention and care in antineoplastic treatment.	[Rodrigues de Morais Viana, Eduarda Cristina; Oliveira, Isadora da Silva; Rechinelli, Ana Beatriz; Marques, Isabele Lessa; de Souza, Vanusa Felicio; Guandalini, Valdete Regina] Univ Fed Espirito Santo, Dept Integrated Educ, Vitoria, ES, Brazil; [Bernardes Spexoto, Maria Claudia] Fed Univ Grande Dourados, Fac Pharmaceut Sci, Nutr Course, Dourados, MS, Brazil; [Silva Pereira, Taisa Sabrina] Univ Americas Puebla, Cholula, Mexico; [Guandalini, Valdete Regina] Univ Fed Espirito Santo, Postgrad Program Nutr & Hlth, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal da Grande Dourados; Universidad Americas Puebla (UDLAP); Universidade Federal do Espirito Santo	Guandalini, VR (corresponding author), Univ Fed Espirito Santo, Dept Integrated Educ, Vitoria, ES, Brazil.; Guandalini, VR (corresponding author), Univ Fed Espirito Santo, Postgrad Program Nutr & Hlth, Vitoria, ES, Brazil.	valdete.guandalini@ufes.br	Guandalini, Valdete Regina/E-5165-2017	Guandalini, Valdete Regina/0000-0003-2266-6113	Research and Innovation Support Foundation of Espirito Santo (FAPES)	Research and Innovation Support Foundation of Espirito Santo (FAPES)	The authors thank the Research and Innovation Support Foundation of Espirito Santo (FAPES) for their financial support.	Abernethy Amy P, 2010, Curr Opin Support Palliat Care, V4, P36, DOI 10.1097/SPC.0b013e32833575fd; Anandavadivelan P, 2018, CANCERS, V10, DOI 10.3390/cancers10090318; [Anonymous], 2006, JSP, V15, P39; [Anonymous], 2019, CONFLUENCIA, V34, P2; Galindo DEB, 2017, APPETITE, V114, P23, DOI 10.1016/j.appet.2017.03.020; Bauer J, 2002, EUR J CLIN NUTR, V56, P779, DOI 10.1038/sj.ejcn.1601412; Martins FFC, 2019, CLIN NUTR ESPEN, V31, P17, DOI 10.1016/j.clnesp.2019.03.013; de Pinho NB, 2019, CLIN NUTR, V38, P1274, DOI 10.1016/j.clnu.2018.05.010; Gervais C, 2016, B CANCER, V103, P794, DOI 10.1016/j.bulcan.2016.05.010; Gonzalez MC, 2010, REV BRAS NUTR CLIN, V25, P102; Harter J, 2017, SUPPORT CARE CANCER, V25, P2525, DOI 10.1007/s00520-017-3661-4; Knudsen AW, 2015, SCAND J GASTROENTERO, V50, P1191, DOI 10.3109/00365521.2015.1028994; Kubrak C, 2010, HEAD NECK-J SCI SPEC, V32, P290, DOI 10.1002/hed.21174; Lindqvist C, 2020, CLIN NUTR, V39, P1840, DOI 10.1016/j.clnu.2019.07.024; Lohman T. G., 1998, ANTROPOMETRIC STANDA; MacLaughlin HL, 2018, J HUM NUTR DIET, V31, P683, DOI 10.1111/jhn.12553; Omlin A, 2013, J CACHEXIA SARCOPENI, V4, P55, DOI 10.1007/s13539-012-0099-x; Pan American Health Organization/World Health Organization, FACT SHEET CANC; Pereira PL, 2015, REV BRASILEIRA CANCE, V61, P243; Planas M, 2016, SUPPORT CARE CANCER, V24, P429, DOI 10.1007/s00520-015-2813-7; Teixeira AC, 2019, NUTR CLIN DIET HOSP, V38, P95, DOI 10.12873/384valdete; Vale IA, 2015, REV BRAS CANCEROL, V61, P367; WHO, 2017, HLTH TOP AG LIF COUR; World Health Organization, 1995, PHYS STAT US INT ANT; Yang sgron, 2015, ZANGXUE YANJIU, V14, P123	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0241305	10.1371/journal.pone.0241305	http://dx.doi.org/10.1371/journal.pone.0241305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320857	Green Published, gold			2022-12-26	WOS:000600339800052
J	Sohn, W; Ham, CB; Kim, NH; Kim, HJ; Cho, YK; Jeon, WK; Kim, BI				Sohn, Won; Ham, Cheol Bae; Kim, Nam Hee; Kim, Hong Joo; Cho, Yong Kyun; Jeon, Woo Kyu; Kim, Byung Ik			Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CIRRHOTIC-PATIENTS; DEFINITION; DIAGNOSIS; MORTALITY; RISK	The purpose of this study was to investigate the effect of acute kidney injury (AKI) on the prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). A total of 347 HCC patients with Child-Pugh class A and pre-TACE serum creatinine (SCr) <= 1.5 mg/dL undergoing TACE as an initial therapy 2000-2014 were analyzed. Overall survival with related risk factors including AKI was investigated. We assessed AKI based on the International Club of Ascites (ICA)-AKI criteria. The mean age was 60.9 years. Of 347 patients, death was observed in 109 patients (31.4%). The mean SCr levels at pre-TACE, one day, two months, and four months after TACE were 0.9, 0.9, 0.9, and 1.1 mg/dL, respectively. The AKI within four months after TACE developed in 37 patients (11%). The AKI stages were non-AKI in 310 (89%), stage 1 in 10 (3%), stage 2 in 10 (3%), and stage 3 in 17 patients (5%). Multivariable analysis showed that the risk factors for overall survival were serum albumin <= 3.5 g/dL (hazard ratio [HR] 1.58, p = 0.027), BCLC stage B (HR 2.07, p = 0.008), BCLC stage C (HR 3.96, p<0.001), bilobar tumor location (HR 1.66, p = 0.022), AKI stage 1 (HR 6.09, p<0.001), AKI stage 2 (HR 8.51, p<0.001), and AKI stage 3 (HR 17.64, p<0.001). AKI is a crucial prognostic factor for overall survival in HCC patients undergoing TACE. The assessment of AKI based on the ICA-AKI criteria can facilitate evaluation of the prognosis of HCC patients undergoing TACE.	[Sohn, Won; Ham, Cheol Bae; Kim, Nam Hee; Kim, Hong Joo; Cho, Yong Kyun; Jeon, Woo Kyu; Kim, Byung Ik] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Gastroenterol, Dept Internal Med,Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, BI (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Gastroenterol, Dept Internal Med,Sch Med, Seoul, South Korea.	bik.kim@samsung.com		Sohn, Won/0000-0003-3284-2715; Kim, Hong Joo/0000-0003-4121-6329				Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; [Anonymous], 2015, ARCH BRONCONEUMOL S, V51, pS1; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bucsics T, 2017, GASTROENTEROL REP, V5, P127, DOI 10.1093/gastro/gox009; de Carvalho JR, 2012, J CLIN GASTROENTEROL, V46, pE21, DOI 10.1097/MCG.0b013e31822e8e12; Desai AP, 2020, J HEPATOL, V73, P1092, DOI 10.1016/j.jhep.2020.04.043; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; de Paredes AGG, 2018, LIVER INT, V38, P285, DOI 10.1111/liv.13515; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Hayashi M, 2020, JPN J CLIN ONCOL, V50, P36, DOI 10.1093/jjco/hyz129; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hsieh YC, 2017, J GASTROEN HEPATOL, V32, P1859, DOI 10.1111/jgh.13777; Hsu CY, 2010, LIVER INT, V30, P77, DOI 10.1111/j.1478-3231.2009.02128.x; Huo TI, 2004, ALIMENT PHARM THER, V19, P999, DOI 10.1111/j.1365-2036.2004.01936.x; Kim NH, 2018, J GASTROEN HEPATOL, V33, P1397, DOI 10.1111/jgh.14083; Lee BC, 2017, EUR RADIOL, V27, P4482, DOI 10.1007/s00330-017-4893-x; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Mehran R, 2019, NEW ENGL J MED, V380, P2146, DOI 10.1056/NEJMra1805256; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Ronco C, 2019, LANCET, V394, P1949, DOI 10.1016/S0140-6736(19)32563-2; Russ KB, 2015, J CLIN TRANSL HEPATO, V3, P195, DOI 10.14218/JCTH.2015.00015; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Sieghart W, 2015, J HEPATOL, V62, P1187, DOI 10.1016/j.jhep.2015.02.010; Sohn W, 2020, J GASTROEN HEPATOL, V35, P870, DOI 10.1111/jgh.14871; Wong F, 2016, CLIN MOL HEPATOL, V22, P415, DOI 10.3350/cmh.2016.0056; Xiong J, 2018, SCAND J GASTROENTERO, V53, P1590, DOI 10.1080/00365521.2018.1545423; Zhou CZ, 2014, INT J CLIN EXP PATHO, V7, P2579	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243780	10.1371/journal.pone.0243780	http://dx.doi.org/10.1371/journal.pone.0243780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315944	Green Published, gold			2022-12-26	WOS:000600186100005
J	Farmer, T; Xie, SW; Naslavsky, N; Stockli, J; James, DE; Caplan, S				Farmer, Trey; Xie, Shuwei; Naslavsky, Naava; Stockli, Jacqueline; James, David E.; Caplan, Steve			Defining the protein and lipid constituents of tubular recycling endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE C-DELTA-1; VESICLE FORMATION; MEMBRANE HUB; BAR DOMAIN; SYNDAPIN-I; BINDING; EHD1; MICAL-L1; ROLES; RAB35	Once internalized, receptors reach the sorting endosome and are either targeted for degradation or recycled to the plasma membrane, a process mediated at least in part by tubular recycling endosomes (TREs). TREs may be efficient for sorting owing to the ratio of large surface membrane area to luminal volume; following receptor segregation, TRE fission likely releases receptor-laden tubules and vesicles for recycling. Despite the importance of TRE networks for recycling, these unique structures remain poorly understood, and unresolved questions relate to their lipid and protein composition and biogenesis. Our previous studies have depicted the endocytic protein MICAL-L1 as an essential TRE constituent, and newer studies show a similar localization for the GTP-binding protein Rab10. We demonstrate that TREs are enriched in both phosphatidic acid (PA) and phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), supporting the idea of MICAL-L1 recruitment by PA and Rab10 recruitment via PI(4,5)P2. Using siRNA knock-down, we demonstrate that Rab10-marked TREs remain prominent in cells upon MICAL-L1 or Syndapin2 depletion. However, depletion of Rab10 or its interaction partner, EHBP1, led to loss of MICAL-L1-marked TREs. We next used phospholipase D inhibitors to decrease PA synthesis, acutely disrupt TREs, and enable monitoring of TRE regeneration after inhibitor washout. Rab10 depletion prevented TRE regeneration, whereas MICAL-L1 knock-down did not. It is surprising that EHBP1 depletion did not affect TRE regeneration under these conditions. Overall, our study supports a primary role for Rab10 and the requirement for PA and PI(4,5) P2 in TRE biogenesis and regeneration, with Rab10 likely linking the sorting endosome to motor proteins and the microtubule network.	[Farmer, Trey; Xie, Shuwei; Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Stockli, Jacqueline; James, David E.] Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Sydney Med Sch, Sydney, NSW, Australia; [Caplan, Steve] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Sydney; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Caplan, S (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	scaplan@unmc.edu	Xie, Shuwei/ABA-4923-2021	James, David/0000-0001-5946-5257	National Institute of General Medical Sciences (NIGMS) [R01GM123557, R01GM133915]; National Cancer Institute [F31CA236290]; NIGMS [INBRE P20 GM103427, COBRE P30 GM106397]; National Cancer Institute for The Fred & Pamela Buffett Cancer Center Support Grant [P30 CA036727]; Nebraska Research Initiative	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute for The Fred & Pamela Buffett Cancer Center Support Grant; Nebraska Research Initiative	The authors gratefully acknowledge funding support from the National Institute of General Medical Sciences (NIGMS) (S. C.; R01GM123557 and R01GM133915) and thes National Cancer Institute (T. F.; F31CA236290). The authors thank the University of Nebraska Medical Center Advanced Microscopy Core Facility, which receives partial support from NIGMS: INBRE P20 GM103427 and COBRE P30 GM106397 grants, as well as support from the National Cancer Institute for The Fred & Pamela Buffett Cancer Center Support Grant P30 CA036727, and the Nebraska Research Initiative. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abou-Zeid N, 2011, MOL BIOL CELL, V22, P3431, DOI 10.1091/mbc.E11-01-0030; Bai M, 2012, J BIOL CHEM, V287, P28675, DOI 10.1074/jbc.M112.378810; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Cai BS, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00022; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chua CEL, 2018, J CELL PHYSIOL, V233, P6483, DOI 10.1002/jcp.26503; Clairfeuille T, 2016, NAT STRUCT MOL BIOL, V23, P921, DOI 10.1038/nsmb.3290; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Delevoye C, 2014, CELL REP, V6, P445, DOI 10.1016/j.celrep.2014.01.002; Deo R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07586-z; Dhawan K, 2020, J BIOL CHEM, V295, P3837, DOI 10.1074/jbc.RA119.011368; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Etoh K, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226977; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gao JH, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008763; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Giridharan Sai Srinivas Panapakkam, 2012, Commun Integr Biol, V5, P384, DOI 10.4161/cib.20064; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hasler SLA, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201811014; Hsu JW, 2020, NAT CELL BIOL, V22, P927, DOI 10.1038/s41556-020-0530-z; Kamerkar SC, 2019, BIOCHEMISTRY-US, V58, P65, DOI 10.1021/acs.biochem.8b00925; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Koch D, 2011, EMBO J, V30, P4955, DOI 10.1038/emboj.2011.339; Kohnke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081758; Li ZP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601470; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McKenzie JE, 2012, TRAFFIC, V13, P1140, DOI 10.1111/j.1600-0854.2012.01374.x; Naslavsky N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216499; Quana A, 2012, P NATL ACAD SCI USA, V109, P3760, DOI 10.1073/pnas.1108294109; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12742, DOI 10.1021/bi00166a005; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12748, DOI 10.1021/bi00166a006; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Sharma Mahak, 2010, Commun Integr Biol, V3, P181; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wang PX, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006093; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Xie SW, 2016, MOL BIOL CELL, V27, P108, DOI 10.1091/mbc.E15-07-0514; Xu Y, 2004, MOL MEMBR BIOL, V21, P269, DOI 10.1080/09687680410001716871	51	9	9	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100190	10.1074/jbc.RA120.015992	http://dx.doi.org/10.1074/jbc.RA120.015992			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334886	gold, Green Published			2022-12-26	WOS:000672866400168
J	Jo, YR; Kim, HR; Jang, SY; Go, H; Song, MY; Park, DK; Oh, Y; Jo, J; Shin, YK; Lee, SJ; Cheon, SM; Lee, HK; Lee, KE; Kim, YH; Park, HT				Jo, Young Rae; Kim, Hye Ran; Jang, So Young; Go, Hana; Song, Min-Young; Park, Da Kyeong; Oh, Yuna; Jo, Juyeon; Shin, Yoon Kyung; Lee, Sung Joong; Cheon, Sang-Myung; Lee, Hyun Kyoung; Lee, Kyung Eun; Kim, Young Hye; Park, Hwan Tae			Potential neuron-autonomous Purkinje cell degeneration by 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase promoter/Cre-mediated autophagy impairments	FASEB JOURNAL			English	Article						CNP; myelination; neurodegeneration; oligodendrocyte; p62	ALPHA-SYNUCLEIN; MOUSE MODEL; OLIGODENDROCYTES; MYELIN; EXPRESSION; PROTEIN; CNP	Studies of neuroglial interaction largely depend on cell-specific gene knockout (KO) experiments using Cre recombinase. However, genes known as glial-specific genes have recently been reported to be expressed in neuroglial stem cells, leading to the possibility that a glia-specific Cre driver results in unwanted gene deletion in neurons, which may affect sound interpretation. 2 ',3 '-Cyclic nucleotide 3 '-phosphodiesterase (CNP) is generally considered to be an oligodendrocyte (OL) marker. Accordingly, Cnp promoter-controlled Cre recombinase has been used to create OL-specific gene targeting mice. However, in this study, using Rosa26-tdTomato-reporter/Cnp-Cre mice, we found that many forebrain neurons and cerebellar Purkinje neurons belong to the lineages of Cnp-expressing neuroglial stem cells. To answer whether gene targeting by Cnp-Cre can induce neuron-autonomous defects, we conditionally deleted an essential autophagy gene, Atg7, in Cnp-Cre mice. The Cnp-Cre-mediated Atg7 KO mice showed extensive p62 inclusion in neurons, including cerebellar Purkinje neurons with extensive neurodegeneration. Furthermore, neuronal areas showing p62 inclusion in Cnp-Cre-mediated Atg7 KO mice overlapped with the neuronal lineage of Cnp-expressing neuroglial stem cells. Moreover, Cnp-Cre-mediated Atg7-KO mice did not develop critical defects in myelination. Our results demonstrate that a large population of central neurons are derived from Cnp-expressing neuroglial stem cells; thus, conditional gene targeting using the Cnp promoter, which is known to be OL-specific, can induce neuron-autonomous phenotypes.	[Jo, Young Rae; Kim, Hye Ran; Jang, So Young; Go, Hana; Shin, Yoon Kyung; Park, Hwan Tae] Dong A Univ, Peripheral Neuropathy Res Ctr PNRC, Dept Mol Neurosci, Coll Med,Dept Translat Biomed Sci,Grad Sch, Busan, South Korea; [Song, Min-Young; Park, Da Kyeong; Kim, Young Hye] Korea Basic Sci Inst, Biomed Om Grp, Cheongju 363883, Chungbuk, South Korea; [Oh, Yuna; Lee, Kyung Eun] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul, South Korea; [Jo, Juyeon; Lee, Hyun Kyoung] Texas Childrens Hosp, Baylor Coll Med, Neurol Res Inst, Dept Pediat, Houston, TX 77030 USA; [Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul, South Korea; [Cheon, Sang-Myung] Dong A Univ, Coll Med, Dept Neurol, Busan, South Korea	Dong A University; Korea Basic Science Institute (KBSI); Korea Institute of Science & Technology (KIST); Baylor College of Medicine; Seoul National University (SNU); Dong A University	Kim, YH (corresponding author), Korea Basic Sci Inst, Biomed Om Grp, Cheongju 363883, Chungbuk, South Korea.; Park, HT (corresponding author), Dong A Univ, Coll Med, Dept Mol Neurosci, Peripheral Neuropathy Res Ctr PNRC, Busan, South Korea.	yhkim74@kbsi.re.kr; phwantae@dau.ac.kr		Lee, Hyun Kyoung/0000-0001-5793-4398				Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Baburina Y, 2017, BBA-BIOMEMBRANES, V1859, P94, DOI 10.1016/j.bbamem.2016.11.003; Bankston AN, 2019, GLIA, V67, P1745, DOI 10.1002/glia.23646; Cho SJ, 2003, MOL CELLS, V16, P128; Fellner L, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0431-2; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Gravel M, 1997, ALTSCHUL SY, V4, P75; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230; Hayashi C, 2019, ADV EXP MED BIOL, V1190, P53, DOI 10.1007/978-981-32-9636-7_5; Jang SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116624; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Luders KA, 2017, GLIA, V65, P1762, DOI 10.1002/glia.23193; Meireles AM, 2018, DEV CELL, V47, P319, DOI 10.1016/j.devcel.2018.10.003; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; Nixon Ralph A, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a008839; Nunes GDF, 2017, GLIA, V65, P1626, DOI 10.1002/glia.23184; Pukass K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00163; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Saab AS, 2016, NEURON, V91, P119, DOI 10.1016/j.neuron.2016.05.016; Sato S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21325-w; Sun LO, 2018, CELL, V175, P1811, DOI 10.1016/j.cell.2018.10.044; Tognatta R, 2017, GLIA, V65, P342, DOI 10.1002/glia.23095; Viader A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027727; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zuchero JB, 2015, DEV CELL, V34, P152, DOI 10.1016/j.devcel.2015.06.011	36	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21225	10.1096/fj.202001366RR	http://dx.doi.org/10.1096/fj.202001366RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337568				2022-12-26	WOS:000605626600036
J	Guyon, A; Rousseau, J; Lamothe, G; Tremblay, JP				Guyon, Antoine; Rousseau, Joel; Lamothe, Gabriel; Tremblay, Jacques P.			The protective mutation A673T in amyloid precursor protein gene decreases A beta peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells	PLOS ONE			English	Article							DEMENTIA; PREVALENCE; SECRETASE; ALLELE; A2T	The deposition of A beta plaques in the brain leads to the onset and development of Alzheimer's disease. The Amyloid precursor protein (APP) is cleaved by alpha-secretase (non-amyloidogenic processing of APP), however increased cleavage by beta-secretase (BACE1) leads to the accumulation of A beta peptides, which forms plaques. APP mutations mapping to exons 16 and 17 favor plaque accumulation and cause Familial Alzheimer Disease (FAD). However, a variant of the APP gene (A673T) originally found in an Icelandic population reduces BACE1 cleavage by 40%. A series of plasmids containing the APP gene, each with one of 29 different FAD mutations mapping to exon 16 and exon 17 was created. These plasmids were then replicated with the addition of the A673T mutation. Combined these formed the library of plasmids that was used in this study. The plasmids were transfected in neuroblastomas to assess the effect of this mutation on A beta peptide production. The production of A beta peptides was decreased for some FAD mutations due to the presence of the co-dominant A673T mutation. The reduction of A beta peptide concentrations for the London mutation (V717I) even reached the same level as for A673T control in SH-SY5Y cells. These preliminary results suggest that the insertion of A673T in APP genes containing FAD mutations might confer a clinical benefit in preventing or delaying the onset of some FADs.	[Guyon, Antoine; Rousseau, Joel; Lamothe, Gabriel; Tremblay, Jacques P.] Quebec Univ Laval, CHU, Ctr Rech, Quebec City, PQ, Canada; [Guyon, Antoine; Rousseau, Joel; Lamothe, Gabriel; Tremblay, Jacques P.] Univ Laval Quebec, Dept Med Mol, Quebec City, PQ, Canada	Laval University; Laval University	Guyon, A (corresponding author), Quebec Univ Laval, CHU, Ctr Rech, Quebec City, PQ, Canada.; Guyon, A (corresponding author), Univ Laval Quebec, Dept Med Mol, Quebec City, PQ, Canada.	antoine.guyon.1@ulaval.ca		Tremblay, Jacques P./0000-0001-9404-9195	Weston Brain Institute (WBI); CIHR	Weston Brain Institute (WBI); CIHR(Canadian Institutes of Health Research (CIHR))	This project was funded by the Weston Brain Institute (WBI). AG holds a Bourse de la Fondation du CHU de Quebec. GL holds a Training award from the CIHR. https://westonbraininstitute.ca/home/https://fondationduchudequebec.org/?gclid=Cj0KCQjw9b_4BRCMARIsADMUIyrETbZQ7IdT9XBUtrTNt8ivE7VxeTfFOz33hLRR1h8MizZH8NoGnwoaAjS1EALw_wcBhttps://cihr-irsc.gc.ca/e/193.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vilatela MEA, 2012, ARCH MED RES, V43, P622, DOI 10.1016/j.arcmed.2012.10.017; Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Das B, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0093-5; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fogel DB, 2018, CONT CLIN TRIAL COMM, V11, P156, DOI 10.1016/j.conctc.2018.08.001; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gyorgy B, 2018, MOL THER-NUCL ACIDS, V11, P429, DOI 10.1016/j.omtn.2018.03.007; Hartmann S, 2018, J NEUROSCI, V38, P3480, DOI 10.1523/JNEUROSCI.2643-17.2018; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hu XY, 2016, J NEUROCHEM, V136, P234, DOI 10.1111/jnc.13395; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kero M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.017; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lehmann S, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00138; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Limegrover CS, 2021, J NEUROCHEM, V157, P1316, DOI 10.1111/jnc.15212; Maloney JA, 2014, J BIOL CHEM, V289, P30990, DOI 10.1074/jbc.M114.589069; Mann DMA, 1996, AM J PATHOL, V148, P1257; Martiskainen H, 2017, ANN NEUROL, V82, P128, DOI 10.1002/ana.24969; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8; Mohr NM, 2011, ACAD EMERG MED, V18, P190, DOI 10.1111/j.1553-2712.2010.00985.x; Murray B, 2016, PROTEINS, V84, P488, DOI 10.1002/prot.24995; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Urbanc B, 2004, BIOPHYS J, V87, P2310, DOI 10.1529/biophysj.104.040980; World health organization, DEM 2020; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0237122	10.1371/journal.pone.0237122	http://dx.doi.org/10.1371/journal.pone.0237122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370284	gold, Green Published			2022-12-26	WOS:000603611900053
J	Rowe, GT; Fernando, H; Elferink, C; Ansari, GAS; Sullivan, J; Heathman, T; Quigg, A; Croisant, SP; Wade, TL; Santschi, PH				Rowe, Gilbert T.; Fernando, Harshica; Elferink, Cornelis; Ansari, G. A. Shakeel; Sullivan, John; Heathman, Thomas; Quigg, Antonietta; Petronella Croisant, Sharon; Wade, Terry L.; Santschi, Peter H.			Polycyclic aromatic hydrocarbons (PAHs) cycling and fates in Galveston Bay, Texas, USA	PLOS ONE			English	Article							HOUSTON SHIP CHANNEL; VERTICAL FLUXES; SURFACE WATERS; ORGANIC-CARBON; TRINITY RIVER; ATMOSPHERIC DEPOSITION; COMMUNITY COMPOSITION; ESTUARINE WATERS; AQUATIC SYSTEMS; CHESAPEAKE BAY	The cycling and fate of polycyclic aromatic hydrocarbons (PAHs) is not well understood in estuarine systems. It is critical now more than ever given the increased ecosystem pressures on these critical coastal habitats. A budget of PAHs and cycling has been created for Galveston Bay (Texas) in the northwestern Gulf of Mexico, an estuary surrounded by 30-50% of the US capacity of oil refineries and chemical industry. We estimate that approximately 3 to 4 mt per year of pyrogenic PAHs are introduced to Galveston Bay via gaseous exchange from the atmosphere (ca. 2 mt/year) in addition to numerous spills of petrogenic PAHs from oil and gas operations (ca. 1.0 to 1.9 mt/year). PAHs are cycled through and stored in the biota, and ca. 20 to 30% of the total (0.8 to 1.5 mt per year) are estimated to be buried in the sediments. Oysters concentrate PAHs to levels above their surroundings (water and sediments) and contain substantially greater concentrations than other fish catch (shrimp, blue crabs and fin fish). Smaller organisms (infaunal invertebrates, phytoplankton and zooplankton) might also retain a significant fraction of the total, but direct evidence for this is lacking. The amount of PAHs delivered to humans in seafood, based on reported landings, is trivially small compared to the total inputs, sediment accumulation and other possible fates (metabolic remineralization, export in tides, etc.), which remain poorly known. The generally higher concentrations in biota from Galveston Bay compared to other coastal habitats can be attributed to both intermittent spills of gas and oil and the bay's close proximity to high production of pyrogenic PAHs within the urban industrial complex of the city of Houston as well as periodic flood events that transport PAHs from land surfaces to the Bay.	[Rowe, Gilbert T.; Heathman, Thomas; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Fernando, Harshica] Prairie View A&M Univ, Dept Chem, Prairie View, TX USA; [Elferink, Cornelis; Ansari, G. A. Shakeel; Sullivan, John; Petronella Croisant, Sharon] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Quigg, Antonietta; Wade, Terry L.; Santschi, Peter H.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Santschi, Peter H.] Texas A&M Univ, Dept Marine & Coastal Environm Sci, Galveston, TX 77554 USA	Texas A&M University System; Texas A&M University System; Prairie View A&M University; University of Texas System; University of Texas Medical Branch Galveston; Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Santschi, PH (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.; Santschi, PH (corresponding author), Texas A&M Univ, Dept Marine & Coastal Environm Sci, Galveston, TX 77554 USA.	Santschi@tamug.edu	Santschi, Peter H/D-5712-2012	Santschi, Peter H/0000-0001-8188-7691; Quigg, Antonietta/0000-0001-5640-1426	US National Institute of Environmental Health Sciences (NIEHS) [5U19ES020676]; Gulf of Mexico Research Initiative (GOMRI); NIH [P42 ES027704]; Texas General Land Office [20-057-000-B908]	US National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Gulf of Mexico Research Initiative (GOMRI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas General Land Office	This summary of PAH concentrations and fluxes was initiated with support from the US National Institute of Environmental Health Sciences (NIEHS) grant entitled "Gulf Coast Health Alliance: health risks related to the Macondo Spill (GCHARMS)", Grant Number: 5U19ES020676. It provided funding to co-authors GTR, HF, CE, SA, JS, TH, and SP. TW, PS and AQ are being supported by a grant from the Gulf of Mexico Research Initiative (GOMRI) to support the ADDOMEx and ADDOMEx-2 consortia research (Aggregation and Degradation of Dispersants and Oil by Microbial Exopolymers). Data from ADDOMEx/ADDOMEx-2 is publicly available through the Gulf of Mexico Research Initiative Information and Data Cooperative (GRIIDC; https://gulfresearchinitiative.org/); however, no new data was deposited in relation to the current study. TW's participation on this publication was made possible, in part, by NIH grant P42 ES027704. Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the NIH. Further, the NIH does not endorse the purchase of any commercial products or services mentioned in the publication. TW's participation on this publication was made possible, in part, by NIH grant P42 ES027704. This research was partially funded by Texas General Land Office grant number 20-057-000-B908 to AQ. None of the authors have received salary for preparing this manuscript from the above sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adhikari PL, 2015, MAR CHEM, V168, P60, DOI 10.1016/j.marchem.2014.11.001; Al Mukaimi ME, 2018, ENVIRON POLLUT, V237, P887, DOI 10.1016/j.envpol.2018.01.027; Anderson JW, 1987, TOXICITY DISPERSED U; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2019, NAT STAT TRENDS BIOE; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Bacosa HP, 2020, ENVIRON SCI POLLUT R, V27, P34987, DOI 10.1007/s11356-020-09754-5; Bacosa HP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01325; BASKARAN M, 1993, MAR CHEM, V43, P95, DOI 10.1016/0304-4203(93)90218-D; BENOIT G, 1994, MAR CHEM, V45, P307, DOI 10.1016/0304-4203(94)90076-0; Berrojalbiz N, 2009, ENVIRON SCI TECHNOL, V43, P2295, DOI 10.1021/es8018226; Broach L, 2001, LONG TERM CHARACTERI; Carls MG, 2005, ACCUMULATION POLYCYC; Choi H, 2010, POLYCYCL AROMAT COMP; Colombo JC, 2006, ENVIRON SCI TECHNOL, V40, P734, DOI 10.1021/es051672y; D'Andrea MA, 2014, J OCCUP ENVIRON MED, V56, P1029, DOI 10.1097/JOM.0000000000000217; Dekshenieks MM, 2000, ESTUARIES, V23, P593, DOI 10.2307/1352887; Del Vento S, 2002, ENVIRON TOXICOL CHEM, V21, P2099, DOI 10.1002/etc.5620211013; Deyme R, 2011, ENVIRON POLLUT, V159, P3681, DOI 10.1016/j.envpol.2011.07.017; Doyle SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00689; Du JB, 2019, SCI TOTAL ENVIRON, V653, P554, DOI 10.1016/j.scitotenv.2018.10.403; Fan CW, 2003, ENVIRON SCI TECHNOL, V37, P3405, DOI 10.1021/es026367g; Fernando H, 2019, MAR POLLUT BULL, V145, P200, DOI 10.1016/j.marpolbul.2019.05.015; FONTAINE CT, 1971, T AM FISH SOC, V100, P584, DOI 10.1577/1548-8659(1971)100<584:LRFTCI>2.0.CO;2; Freeman LA, 2019, ESTUAR COAST, V42, P1821, DOI 10.1007/s12237-019-00597-z; Galveston Bay Estuary Program, 2018, GALVESTON BAY ESTUAR; Galveston Bay National Estuary Program, 1993, 2 NAT COAST COND; Galveston Bay National Estuary Program, 1992, GALVESTON BAY NATL E; GoldBouchot G, 1995, MAR POLLUT BULL, V31, P439, DOI 10.1016/0025-326X(95)00171-I; Gonzalez LA, 2011, STATE BAY CHARACTERI; Guo LD, 1997, MAR CHEM, V59, P1, DOI 10.1016/S0304-4203(97)00072-8; Harris R.P., 1977, FACTORS AFFECTING RE; HARRIS RP, 1977, MAR BIOL, V42, P187, DOI 10.1007/BF00397743; Hayes CT, 2019, TRACE METALS GULF ME; Hieke ASC, 2016, MAR BIOTECHNOL, V18, P630, DOI 10.1007/s10126-016-9723-7; Hofstetter RP, 1983, OYSTER POPULATION TR; Hung CC, 2001, MAR CHEM, V73, P305, DOI 10.1016/S0304-4203(00)00114-6; IVERSON DG, 1979, ABSTR PAP AM CHEM S, P3; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; Jiann KT, 2013, AQUAT GEOCHEM, V19, P173, DOI 10.1007/s10498-013-9187-6; Jonsson G, 2004, ENVIRON TOXICOL CHEM, V23, P1538, DOI 10.1897/03-173; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Ko FC, 2003, MAR CHEM, V81, P163, DOI 10.1016/S0304-4203(03)00027-6; LANDRUM PF, 1992, ENVIRON TOXICOL CHEM, V11, P1709, DOI 10.1897/1552-8618(1992)11[1709:TIASMC]2.0.CO;2; Lei AP, 2002, WATER SCI TECHNOL, V46, P195, DOI 10.2166/wst.2002.0738; LIPIATOU E, 1993, MAR CHEM, V44, P43, DOI 10.1016/0304-4203(93)90005-9; Louchouarn P, 2009, 582572502WO13 TEX CO; Louchouarn P, 2018, ENVIRON POLLUT, V238, P988, DOI 10.1016/j.envpol.2018.02.003; MACKAY D, 1979, ENVIRON SCI TECHNOL, V13, P333, DOI 10.1021/es60151a012; McDonald SJ, 1991, ASSESSING EXPOSURE F; MCVEETY BD, 1988, ATMOS ENVIRON, V22, P511, DOI 10.1016/0004-6981(88)90196-5; MINELLO TJ, 1981, CONTRIB MAR SCI, V24, P81; MORSE JW, 1993, MAR ENVIRON RES, V36, P1, DOI 10.1016/0141-1136(93)90087-G; Ornolfsdottir EB, 2004, J PLANKTON RES, V26, P325, DOI 10.1093/plankt/fbh035; Overton EB, 2016, OCEANOGRAPHY, V29, P50, DOI 10.5670/oceanog.2016.62; Pampanin D, 2013, HYDROCARBON INTECHOP; Park JS, 2001, ATMOS ENVIRON, V35, P3241, DOI 10.1016/S1352-2310(01)00080-2; Powell EN, 2007, N AM J FISH MANAGE, V27, P492, DOI 10.1577/M04-205.1; PULLEN EJ, 1970, T AM FISH SOC, V99, P795, DOI 10.1577/1548-8659(1970)99<795:CWWROB>2.0.CO;2; Qian YR, 2001, ESTUARIES, V24, P817, DOI 10.2307/1353173; Qu F, 2015, J MARINE BIOL; Raoux C, 1999, ESTUAR COAST SHELF S, V48, P605, DOI 10.1006/ecss.1998.0458; Ravens TM, 2009, J COASTAL RES, V25, P265, DOI 10.2112/07-0942.1; Roelke DL, 2013, MAR ECOL PROG SER, V477, P61, DOI 10.3354/meps10182; Salas-Monreal D, 2018, OCEANOLOGIA, V60, P232, DOI 10.1016/j.oceano.2017.10.005; Santschi PH, 2018, MAR CHEM, V207, P124, DOI 10.1016/j.marchem.2018.11.003; Santschi PH, 2001, MAR ENVIRON RES, V52, P51, DOI 10.1016/S0141-1136(00)00260-9; SANTSCHI PH, 1995, GEOCHIM COSMOCHIM AC, V59, P625, DOI 10.1016/0016-7037(94)00378-Y; Santschi PH, 1997, MAR CHEM, V58, P99, DOI 10.1016/S0304-4203(97)00029-7; SANTSCHI PH, 1995, MAR ENVIRON RES, V40, P337, DOI 10.1016/0141-1136(95)92644-J; Santschi PH, 2020, MARINE CHEM; Santschi PH, 2009, FACTORS REGULATING M; Sediment contamination toxicity and macroinvertbrates infaunal community in Galveston Bay., 2003, 122 NOAA NOS NCCOS C, P122; Sinaei M, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-59; Soliman YS, 2008, DEEP-SEA RES PT II, V55, P2577, DOI 10.1016/j.dsr2.2008.07.007; Solis R., 1999, HYDROGRAPHY MIXING C; Steichen JL, 2012, MAR POLLUT BULL, V64, P779, DOI 10.1016/j.marpolbul.2012.01.028; Stordal MC, 1996, LIMNOL OCEANOGR, V41, P52, DOI 10.4319/lo.1996.41.1.0052; Sverdrup LE, 2002, ENVIRON SCI TECHNOL, V36, P2429, DOI 10.1021/es010180s; Tang DG, 2002, MAR CHEM, V78, P29, DOI 10.1016/S0304-4203(02)00007-5; Tang DG, 2001, LIMNOL OCEANOGR, V46, P321, DOI 10.4319/lo.2001.46.2.0321; Tang DG, 2000, LIMNOL OCEANOGR, V45, P1289, DOI 10.4319/lo.2000.45.6.1289; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Tsapakis M, 2006, ENVIRON SCI TECHNOL, V40, P4922, DOI 10.1021/es060487x; Ventikos NP, 2014, MAR POLLUT BULL, V81, P116, DOI 10.1016/j.marpolbul.2014.02.007; Wang XH, 2006, MAR ECOL PROG SER, V312, P101, DOI 10.3354/meps312101; Warnken KW, 2008, ESTUAR COAST SHELF S, V76, P69, DOI 10.1016/j.ecss.2007.06.010; Warnken KW, 2009, ESTUAR COAST, V32, P158, DOI 10.1007/s12237-008-9088-x; Warnken KW, 2004, SCI TOTAL ENVIRON, V329, P131, DOI 10.1016/j.scitotenv.2004.02.017; Warnken KW, 2001, MAR CHEM, V73, P215, DOI 10.1016/S0304-4203(00)00108-0; Warnken KW, 2000, ESTUARIES, V23, P647, DOI 10.2307/1352891; Wen LS, 2008, MAR CHEM, V112, P20, DOI 10.1016/j.marchem.2008.06.003; Wen LS, 1999, MAR CHEM, V63, P185, DOI 10.1016/S0304-4203(98)00062-0; Wen LS, 1997, ENVIRON SCI TECHNOL, V31, P723, DOI 10.1021/es9603057; Williams AK, 2017, MAR POLLUT BULL, V121, P32, DOI 10.1016/j.marpolbul.2017.05.033; Wozniak AS, 2019, ENVIRON SCI TECHNOL, V53, P3441, DOI 10.1021/acs.est.8b06532; Yeager KM, 2007, ENVIRON SCI TECHNOL, V41, P5291, DOI 10.1021/es062917p; Yeager KM, 2010, J COASTAL RES, V26, P743, DOI 10.2112/JCOASTRES-D-09-00009.1; Zaugg SD, 2006, DETERMINATION SEMIVO; Zhang C, 2003, CHARACTERIZATION DES	101	4	4	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243734	10.1371/journal.pone.0243734	http://dx.doi.org/10.1371/journal.pone.0243734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370322	Green Published, gold			2022-12-26	WOS:000603611900118
J	Anger, M; Scheufele, F; Ramanujam, D; Meyer, K; Nakajima, H; Field, LJ; Engelhardt, S; Sarikas, A				Anger, Melanie; Scheufele, Florian; Ramanujam, Deepak; Meyer, Kathleen; Nakajima, Hidehiro; Field, Loren J.; Engelhardt, Stefan; Sarikas, Antonio			Genetic ablation of Cullin-RING E3 ubiquitin ligase 7 restrains pressure overload-induced myocardial fibrosis	PLOS ONE			English	Article							PRESERVES CARDIAC-FUNCTION; RECEPTOR SUBSTRATE 1; HEART-FAILURE; PROTEASOME SYSTEM; TGF-BETA; AKT; EXPRESSION; PROTEIN; CARDIOMYOCYTES; ACTIVATION	Fibrosis is a pathognomonic feature of structural heart disease and counteracted by distinct cardioprotective mechanisms, e.g. activation of the phosphoinositide 3-kinase (PI3K) / AKT pro-survival pathway. The Cullin-RING E3 ubiquitin ligase 7 (CRL7) was identified as negative regulator of PI3K/AKT signalling in skeletal muscle, but its role in the heart remains to be elucidated. Here, we sought to determine whether CRL7 modulates to cardiac fibrosis following pressure overload and dissect its underlying mechanisms. For inactivation of CRL7, the Cullin 7 (Cul7) gene was deleted in cardiac myocytes (CM) by injection of adeno-associated virus subtype 9 (AAV9) vectors encoding codon improved Cre-recombinase (AAV9-CMV-iCre) in Cul7(flox/flox) mice. In addition, Myosin Heavy Chain 6 (Myh6; alpha-MHC)-MerCreMer transgenic mice with tamoxifen-induced CM-specific expression of iCre were used as alternate model. After transverse aortic constriction (TAC), causing chronic pressure overload and fibrosis, AAV9-CMV-iCre induced Cul7-/- mice displayed a similar to 50% reduction of interstitial cardiac fibrosis when compared to Cul7+/+ animals (6.7% vs. 3.4%, p<0.01). Similar results were obtained with Cul7(flox/flox) Myh6-Mer-Cre-Mer(Tg(1/0)) mice which displayed a similar to 30% reduction of cardiac fibrosis after TAC when compared to Cul7(+/+) Myh6-Mer-Cre-Mer(Tg(1/0)) controls after TAC surgery (12.4% vs. 8.7%, p<0.05). No hemodynamic alterations were observed. AKT(Ser473) phosphorylation was increased 3-fold (p<0.01) in Cul7-/- vs. control mice, together with a similar to 78% (p<0.001) reduction of TUNEL-positive apoptotic cells three weeks after TAC. In addition, CM-specific expression of a dominant-negative CUL7(1152stop) mutant resulted in a 16.3-fold decrease (p<0.001) of in situ end-labelling (ISEL) positive apoptotic cells. Collectively, our data demonstrate that CM-specific ablation of Cul7 restrains myocardial fibrosis and apoptosis upon pressure overload, and introduce CRL7 as a potential target for anti-fibrotic therapeutic strategies of the heart.	[Anger, Melanie; Scheufele, Florian; Ramanujam, Deepak; Meyer, Kathleen; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, Munich, Germany; [Anger, Melanie; Scheufele, Florian; Ramanujam, Deepak; Meyer, Kathleen; Engelhardt, Stefan] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany; [Nakajima, Hidehiro; Field, Loren J.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Nakajima, Hidehiro; Field, Loren J.] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Sarikas, Antonio] Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria	Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Paracelsus Private Medical University	Sarikas, A (corresponding author), Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria.	antonio.sarikas@pmu.ac.at		Ramanujam, Deepak Prabhu/0000-0003-4854-6355; Meyer, Kathleen/0000-0002-5128-3616	Marie Curie International Reintegration Grant [256584]	Marie Curie International Reintegration Grant(European Commission)	AS: Marie Curie International Reintegration Grant https://ec.europa.eu (#256584) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan R, 2005, MOL CELL BIOCHEM, V268, P103, DOI 10.1007/s11010-005-3699-3; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; Ceci M, 2007, CELL DEATH DIFFER, V14, P1060, DOI 10.1038/sj.cdd.4402095; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; DAUD AI, 1993, AM J PHYSIOL, V264, pH1693, DOI 10.1152/ajpheart.1993.264.5.H1693; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Hartmann T, 2014, P NATL ACAD SCI USA, V111, P3371, DOI 10.1073/pnas.1401556111; Hassink RJ, 2009, HEART, V95, P1159, DOI 10.1136/hrt.2008.150128; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hong F, 2000, BIOCHEM BIOPH RES CO, V279, P974, DOI 10.1006/bbrc.2000.4044; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; KIM KK, 1994, J BIOL CHEM, V269, P22607; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meyer K, 2016, J AM COLL CARDIOL, V67, P2018, DOI 10.1016/j.jacc.2016.02.047; Nakajima H, 2004, CIRC RES, V94, P1606, DOI 10.1161/01.RES.0000132279.99249.f4; Paradis V, 2013, GUT, V62, P911, DOI 10.1136/gutjnl-2012-302091; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 2001, CIRC RES, V88, P1004, DOI 10.1161/hh1001.090878; Piek A, 2016, HEART FAIL REV, V21, P199, DOI 10.1007/s10741-016-9536-9; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sarikas A, 2008, CELL CYCLE, V7, P3154, DOI 10.4161/cc.7.20.6922; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Scheufele F, 2014, CELL SIGNAL, V26, P233, DOI 10.1016/j.cellsig.2013.11.005; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tanaka S, 1996, CANCER RES, V56, P3391; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Tsai SC, 2000, J BIOL CHEM, V275, P3239, DOI 10.1074/jbc.275.5.3239; Wu K, 2016, P NATL ACAD SCI USA, V113, pE2011, DOI 10.1073/pnas.1601089113; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Xu XS, 2012, J BIOL CHEM, V287, P40758, DOI 10.1074/jbc.M112.405209; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	45	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244096	10.1371/journal.pone.0244096	http://dx.doi.org/10.1371/journal.pone.0244096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351822	Green Published, gold			2022-12-26	WOS:000603071400036
J	de Wolff, T; Pfluger, D; Rehme, M; Heuer, J; Bittner, MI				de Wolff, Timo; Pfluger, Dirk; Rehme, Michael; Heuer, Janin; Bittner, Martin-Immanuel			Evaluation of pool-based testing approaches to enable population-wide screening for COVID-19	PLOS ONE			English	Article							DEFECTIVE MEMBERS	Objective Rapid testing is paramount during a pandemic to prevent continued viral spread and excess morbidity and mortality. This study investigates whether testing strategies based on sample pooling can increase the speed and throughput of screening for SARS-CoV-2, especially in resource-limited settings. Methods In a mathematical modelling approach conducted in May 2020, six different testing strategies were simulated based on key input parameters such as infection rate, test characteristics, population size, and testing capacity. The situations in five countries were simulated, reflecting a broad variety of population sizes and testing capacities. The primary study outcome measurements were time and number of tests required, number of cases identified, and number of false positives. Findings The performance of all tested methods depends on the input parameters, i.e. the specific circumstances of a screening campaign. To screen one tenth of each country's population at an infection rate of 1%, realistic optimised testing strategies enable such a campaign to be completed in ca. 29 days in the US, 71 in the UK, 25 in Singapore, 17 in Italy, and 10 in Germany. This is ca. eight times faster compared to individual testing. When infection rates are lower, or when employing an optimal, yet more complex pooling method, the gains are more pronounced. Pool-based approaches also reduce the number of false positive diagnoses by a factor of up to 100. Conclusions The results of this study provide a rationale for adoption of pool-based testing strategies to increase speed and throughput of testing for SARS-CoV-2, hence saving time and resources compared with individual testing.	[de Wolff, Timo; Pfluger, Dirk; Bittner, Martin-Immanuel] German Natl Acad Sci, Young Acad, Junge Akad, Berlin, Germany; [de Wolff, Timo; Rehme, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Anal & Algebra, Braunschweig, Germany; [Pfluger, Dirk; Heuer, Janin] Univ Stuttgart, Inst Parallel & Distributed Syst, Stuttgart, Germany; [Bittner, Martin-Immanuel] Arctoris, Oxford, England	Braunschweig University of Technology; University of Stuttgart	Bittner, MI (corresponding author), German Natl Acad Sci, Young Acad, Junge Akad, Berlin, Germany.; Bittner, MI (corresponding author), Arctoris, Oxford, England.	martin-immanuel.bittner@arctoris.com		Pfluger, Dirk/0000-0002-4360-0212; Heuer, Janin/0000-0003-2386-8294	Young Academy of the German National Academy of Sciences; German Research Foundation (DFG) [WO 2206/1-1]; Cluster of Excellence Data Integrated Simulation Science under Germany's Excellence Strategy [EXC 2075, 390740016]	Young Academy of the German National Academy of Sciences; German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence Data Integrated Simulation Science under Germany's Excellence Strategy	TdW, DP and MIB are supported by the Young Academy of the German National Academy of Sciences. TdW is funded by the German Research Foundation (DFG) grant WO 2206/1-1 under the Emmy Noether Programme. DP is funded by the Cluster of Excellence Data Integrated Simulation Science under Germany's Excellence Strategy (EXC 2075 -DFG grant 390740016). MIB receives a salary from Arctoris Ltd. The funders provided support in the form of salaries for TdW, DP and MIB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	[Anonymous], 2019, CIRCULATION, V2019; Burki TK, 2020, LANCET RESP MED, V8, pE63, DOI 10.1016/S2213-2600(20)30247-2; Busenberg GJ, 2020, POLICY LESSONS HIST; Cheng Y, NEW STRONGLY COMPETI; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Fargion BI, 2020, 200311975 ARXIV; Hanel R, 2020, 200309944 ARXIV; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; Kelly-Cirino CD, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001179; LabCorp, 2020, ACC EM US AUTH EUA S; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1063, DOI 10.1515/cclm-2020-0240; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Narayanan KR, 2020, POOLING RT PCR NGS S, DOI [10.1101/2020.04.03.20051995, DOI 10.1101/2020.04.03.20051995]; Noriega R., 2020, INCREASING TESTING T, DOI [10.1101/2020.04.03.024216v1.full.pdf, DOI 10.1101/2020.04.03.024216V1.FULL.PDF]; Peto J, 2020, LANCET, V395, P1420, DOI 10.1016/S0140-6736(20)30936-3; Peto J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1163; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Prakash S, 2020, ADVISORY FEASIBILITY; Pulia MS, 2020, ANN MED, V52, P207, DOI 10.1080/07853890.2020.1763449; Rubin Eric J, 2020, N Engl J Med, V382, pe67, DOI 10.1056/NEJMe2014793; Shah P, 2020, TESTING IS OUR WAY O; Shani-Narkiss H., 2020, EFFICIENT PRACTICAL, DOI [10.1101/2020.04.06.20052159., DOI 10.1101/2020.04.06.20052159]; Silvis L, 2020, DUKE MARGOLIS CTR HL; Simpson S, 2020, LANCET INFECT DIS, V20, pE108, DOI 10.1016/S1473-3099(20)30123-7; Sinnott-Armstrong N, 2020, EVALUATION GROUP TES, DOI [DOI 10.1101/2020.03.27.20043968, 10.1101/2020.03.27.20043968]; SOBEL M, 1959, AT&T TECH J, V38, P1179, DOI 10.1002/j.1538-7305.1959.tb03914.x; STERRETT A, 1957, ANN MATH STAT, V28, P1033, DOI 10.1214/aoms/1177706807; Taufer M, 2020, J THEOR BIOL, V506, DOI 10.1016/j.jtbi.2020.110450; Yang Y, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100061; Yelin I, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa53132358960, DOI 10.1093/CID/CIAA53132358960]	31	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243692	10.1371/journal.pone.0243692	http://dx.doi.org/10.1371/journal.pone.0243692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347458	Green Submitted, gold, Green Published			2022-12-26	WOS:000603071100050
J	Parraga, DG; Tyack, PL; Marco-Cabedo, V; Crespo-Picazo, JL; Manteca, X; Marti-Bonmati, L				Garcia Parraga, Daniel; Tyack, Peter L.; Marco-Cabedo, Vicente; Luis Crespo-Picazo, Jose; Manteca, Xavier; Marti-Bonmati, Luis			Effects of 3 Tesla magnetic resonance imaging exposure on the behavior and orientation of homing pigeons Columba livia domestica	PLOS ONE			English	Article							MAGNETORECEPTION; COMPASS	Homing pigeons (Columba livia domestica) were used to test whether clinical magnetic resonance (MR) imaging disrupts orientation of animals that sense the earth's magnetic field. Thirty young pigeons were randomly separated into three groups (n = 10/group). Two groups were anaesthetized and exposed to either a constant (no sequence) or a varying (gradient echo and echo planar sequences) magnetic field within a 3 Tesla MR unit for 15 minutes. The control group was not exposed to the MR field but shared all other aspects of the procedure. One day later, animals were released from a site they had never visited, 15 km from the home loft. Three weeks after the procedure, animals were released from a different unfamiliar site 30 km from the loft. Measured variables included the time to disappear from sight (seconds), vanishing bearing (angle), and the time interval from release to entering the home loft (hours). On first release, the group exposed to varying field gradients during image acquisition using 2 different standard sequences showed more variability in the vanishing bearing compared to the other groups (p = 0.0003 compared to control group), suggesting interference with orientation. Other measures did not show significant differences between groups. On second release, there were no significant differences between groups. Our results on homing pigeons show that regular clinical MR imaging exposure may temporarily affect the orientation of species that have magnetoreception capabilities. If exposure to MR imaging disrupted processes that are not specific to magnetoreception, then it may affect other species and other capabilities as well.	[Garcia Parraga, Daniel; Marco-Cabedo, Vicente; Luis Crespo-Picazo, Jose] Fdn Oceanog Comunidad Valenciana, Res Dept, Valencia, Spain; [Garcia Parraga, Daniel] Avanqua Oceanog SL, Biol Dept, Valencia, Spain; [Tyack, Peter L.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Manteca, Xavier] Univ Autonoma Barcelona, Sch Vet Sci, Barcelona, Spain; [Marti-Bonmati, Luis] La Fe Univ, Med Imaging Dept, Valencia, Spain; [Marti-Bonmati, Luis] La Fe Univ, Biomed Imaging Res Grp, Valencia, Spain; [Marti-Bonmati, Luis] Polytech Hosp & Hlth Res Inst, Valencia, Spain	University of St Andrews; Autonomous University of Barcelona	Tyack, PL (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sch Biol, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	plt@st-andrews.ac.uk	Marti-Bonmati, Luis/A-1147-2015; Tyack, Peter/D-6209-2013	Marti-Bonmati, Luis/0000-0002-8234-010X; Crespo Picazo, Jose Luis/0000-0002-5216-044X; Tyack, Peter/0000-0002-8409-4790	US Office of Naval Research [N00014-18-1-2062, N00014-20-12709]; Fundacion Oceanografic de la Comunidad Valenciana	US Office of Naval Research(Office of Naval Research); Fundacion Oceanografic de la Comunidad Valenciana	PLT was funded by the US Office of Naval Research (https://www.onr.navy.mil) Grant Number N00014-18-1-2062 and N00014-20-12709. The employees of the Fundacion Oceanografic de la Comunidad Valenciana were funded by the Fundacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, J CARDIOVASC MAGN R, V3, P171, DOI 10.1081/JCMR-100107466; [Anonymous], 2007, PLOS ONE, V2, pe779; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Chakeres DW, 2005, PROG BIOPHYS MOL BIO, V87, P255, DOI 10.1016/j.pbiomolbio.2004.08.012; de Vocht F, 2006, J MAGN RESON IMAGING, V23, P197, DOI 10.1002/jmri.20485; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; GOULD JL, 1984, ANNU REV PHYSIOL, V46, P585, DOI 10.1146/annurev.ph.46.030184.003101; Lohmann KJ, 2008, J EXP MAR BIOL ECOL, V356, P83, DOI 10.1016/j.jembe.2007.12.017; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Meyer CG, 2005, J R SOC INTERFACE, V2, P129, DOI 10.1098/rsif.2004.0021; Modo M, 2011, METHODS MOL BIOL; Pewsey A, 2013, CIRCULAR STAT R; Steinmetz HW, 2014, ZOO WILD ANIMAL MED, P661; Strbak O, 2011, MEAS SCI REV, V11, P85, DOI 10.2478/v10048-011-0014-1; Tsuji Y, 1996, IND HEALTH, V34, P347, DOI 10.2486/indhealth.34.347; Vacha M, 2009, J EXP BIOL, V212, P3473, DOI 10.1242/jeb.028670; Valente ALS, 2006, AM J VET RES, V67, P1347, DOI 10.2460/ajvr.67.8.1347; WALLRAFF HG, 1979, BEHAV ECOL SOCIOBIOL, V5, P201, DOI 10.1007/BF00293306; Wallraff HG., 2005, AVIAN NAVIGATION PIG; Wiltschko R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1103; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wiltschko W, 2017, J AVIAN BIOL, V48, P66, DOI 10.1111/jav.01270; Wyneken J, 2013, CURRENT THERAPY REPT, P93	24	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0241280	10.1371/journal.pone.0241280	http://dx.doi.org/10.1371/journal.pone.0241280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338040	gold, Green Published			2022-12-26	WOS:000601313500027
J	Friedrich, MS; Studt, JD; Braun, J; Spahn, DR; Kaserer, A				Friedrich, Marie Sophie; Studt, Jan-Dirk; Braun, Julia; Spahn, Donat R.; Kaserer, Alexander			Coronavirus-induced coagulopathy during the course of disease	PLOS ONE			English	Article							FIBRINOGEN	Background A significant proportion of patients with coronavirus disease 19 (COVID-19) suffer from excessive coagulation activation and coagulopathy which is associated with an increased risk of venous and arterial thromboembolism and adverse outcome. Our study investigates coagulation markers and the incidence of thromboembolic events in COVID-19 patients receiving recommended anticoagulation strategies. Methods In a retrospective single-center analysis at the University Hospital Zurich, Switzerland, we investigated 31 adult COVID-19 patients between April 6(th) and May 13(th), 2020 and with at least one laboratory assessment of the coagulation markers prothrombin time/Quick, thrombin time, fibrinogen and D-dimers. For antithrombotic prophylaxis low-molecular-weight-heparin or unfractionated heparin was administered and two patients with heparin-induced thrombocytopenia received argatroban. Results We analyzed 31 patients (68% male, mean age 60 +/- SD 15 years). 22 (71%) of these required intensive care unit treatment, 5 (16%) were hospitalized in a ward, and 4 (13%) were outpatients. Mean fibrinogen levels were markedly elevated to 6.4 +/- SD 1.8g/l, with a peak in the third week of the disease and no significant decrease over time. D-dimers were elevated to a mean value of 5.1 +/- 4.4mg/l with peak levels of 6.8 +/- 5.3mg/l in the fourth week of disease, and a subsequent decrease. Platelet count (308 +/- 136G/l) and PT/Quick (85 +/- 22%) showed no significant changes over time. Sensitivity analyses for patients treated in the ICU showed that D-dimer levels were higher in this group. The results of other sensitivity analyses were comparable. Thromboembolic events were diagnosed in 4 (13%) patients and 5 (16%) patients died during the observation period. Conclusion We find coagulation alterations in COVID-19 patients indicating significant hypercoagulability. These alterations are visible despite antithrombotic treatment, and peak around week 3-4 of the disease.	[Friedrich, Marie Sophie; Spahn, Donat R.; Kaserer, Alexander] Univ Zurich, Inst Anesthesiol, Zurich, Switzerland; [Friedrich, Marie Sophie; Studt, Jan-Dirk; Spahn, Donat R.; Kaserer, Alexander] Univ Hosp Zurich, Zurich, Switzerland; [Studt, Jan-Dirk] Univ Zurich, Div Med Oncol & Hematol, Zurich, Switzerland; [Braun, Julia] Univ Zurich, Biostat & Prevent Inst, Dept Epidemiol & Biostat, Zurich, Switzerland; [Braun, Julia] Univ Zurich, Biostat & Prevent Inst, Dept Epidemiol, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University of Zurich	Kaserer, A (corresponding author), Univ Zurich, Inst Anesthesiol, Zurich, Switzerland.; Kaserer, A (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	alexander.kaserer@usz.ch		Kaserer, Alexander/0000-0001-9105-8328				Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520; Atallah B, 2021, ANAESTHESIA, V76, P327, DOI 10.1111/anae.15300; BAUMANN H, 1990, MOL BIOL MED, V7, P147; Casini Alessandro, 2020, Swiss Med Wkly, V150, pw20247, DOI 10.4414/smw.2020.20247; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Franchini M, 2020, DIAGNOSIS, V7, P357, DOI 10.1515/dx-2020-0078; Gesellschaft fur Thrombose und Hamostaseforschung, AKT EMPF ZUR THROMB; Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Iba T, 2020, J THROMB HAEMOST, V18, P2103, DOI 10.1111/jth.14975; Ikewaki N, 2020, THROMB J, V18, DOI 10.1186/s12959-020-00239-6; Kattula S, 2017, ARTERIOSCL THROM VAS, V37, pE13, DOI 10.1161/ATVBAHA.117.308564; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Liao S, 2014, J THROMB HAEMOST, V12, P214, DOI 10.1111/jth.12464; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Maatman TK, 2020, CRIT CARE MED, V48, pE783, DOI 10.1097/CCM.0000000000004466; Machlus KR, 2011, BLOOD, V117, P4953, DOI 10.1182/blood-2010-11-316885; Poterucha TJ, 2017, THROMB HAEMOSTASIS, V117, P437, DOI 10.1160/TH16-08-0620; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Susen S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03000-7; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Thachil J, 2020, J THROMB HAEMOST, V18, P1849, DOI 10.1111/jth.14942; Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Walton BL, 2015, J THROMB HAEMOST, V13, pS208, DOI 10.1111/jth.12918; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wool GD, 2021, PATHOBIOLOGY, V88, P15, DOI 10.1159/000512007; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243409	10.1371/journal.pone.0243409	http://dx.doi.org/10.1371/journal.pone.0243409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332362	Green Accepted, Green Published, gold			2022-12-26	WOS:000601310900061
J	Yu, HL; Gu, DY; Qian, PD				Yu, Hongliang; Gu, Dayong; Qian, Pudong			Prognostic value of ESR2 expression on adjuvant chemotherapy in completely resected NSCLC	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; CELL LUNG-CANCER; VINORELBINE PLUS CISPLATIN; MESSENGER-RNA EXPRESSION; SURVIVAL; IDENTIFICATION; ASSOCIATION; SIGNATURES; GENES	Background Prognostic biomarker, which can inform the treatment outcome of adjuvant chemotherapy (ACT) after complete resection of early-stage non-small cell lung cancer (NSCLC), is urgently needed for the personalized treatment of these patients. Patients and methods The prognostic value of gene expression of the estrogen receptor (ER) on the effect of ACT in completely resected NSCLC was investigated in the present study. Two independent datasets from Gene Expression Omnibus (GEO) with a total of 309 patients were included in this study. The prognostic value of ER gene expression on ACT's efficacy was evaluated by survival analysis and Cox hazards models. Results We found a consistent and significant prognostic value of ER beta (ESR2) expression for ACT's efficacy in completely resected NSCLC in both of the two independent cohorts. After multivariate adjustment, a significant survival benefit of ACT was observed in patients with low expression of ESR2, with a hazard ratio (HR) of 0.19 (95%CI 0.05-0.82, p = 0.026) in the discovery cohort and an HR of 0.27 (95%CI 0.10-0.76, p = 0.012) in the validation group. No significant benefit of ACT in the subgroup of patients with high expression of ESR2 was observed, with an HR of 0.80 (95%CI 0.31-2.09, p = 0.644) in the discovery cohort and an HR of 1.05 (95%CI 0.48-2.29, p = 0.896) in the validation group. Conclusion A significant survival benefit from ACT was observed in patients with low ESR2 expression. No significant survival benefit was observed in patients with high ESR2 expression. Detection of ESR2 expression in NSCLC may help personalize its treatment after complete resection.	[Qian, Pudong] Nanjing Med Univ, Dept Radiat Oncol, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Qian, PD (corresponding author), Nanjing Med Univ, Dept Radiat Oncol, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China.	qpd201210@163.com	Qian, Pu/GZM-2400-2022	Yu, Hongliang/0000-0003-2404-4158	fund of key project of Jiangsu Cancer Hospital [ZK201607]; Natural Science Foundation of China [81701722]	fund of key project of Jiangsu Cancer Hospital; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the fund of key project of Jiangsu Cancer Hospital (No. ZK201607), and the Natural Science Foundation of China (No.81701722).	Atmaca A, 2014, INT J CANCER, V134, P2314, DOI 10.1002/ijc.28571; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Fan S, 2017, ONCOTARGET, V8, P56443, DOI 10.18632/oncotarget.16992; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li WT, 2015, STEROIDS, V104, P129, DOI 10.1016/j.steroids.2015.09.005; Liu ZG, 2013, ENDOCRINE, V44, P517, DOI 10.1007/s12020-013-9916-z; Luo Z, 2015, INT J CLIN EXP MED, V8, P8686; Nose N, 2009, J CLIN ONCOL, V27, P411, DOI 10.1200/JCO.2008.18.3251; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Schwartz AG, 2005, CLIN CANCER RES, V11, P7280, DOI 10.1158/1078-0432.CCR-05-0498; Siegfried JM, 2009, SEMIN ONCOL, V36, P524, DOI 10.1053/j.seminoncol.2009.10.004; Smida T, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00137; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; Stabile LP, 2002, CANCER RES, V62, P2141; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Verma MK, 2012, LIFE SCI, V91, P800, DOI 10.1016/j.lfs.2012.08.029; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Wu CT, 2005, J THORAC CARDIOV SUR, V130, P979, DOI 10.1016/j.jtcvs.2005.06.012; Yu HL, 2017, ONCOTARGETS THER, V10, P3017, DOI 10.2147/OTT.S132071; Zhang GF, 2010, MOL ENDOCRINOL, V24, P1737, DOI 10.1210/me.2010-0125; Zhao GF, 2012, MOL ENDOCRINOL, V26, P1304, DOI 10.1210/me.2012-1028; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325; Zhu CQ, 2009, CLIN LUNG CANCER, V10, P331, DOI 10.3816/CLC.2009.n.045	28	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243891	10.1371/journal.pone.0243891	http://dx.doi.org/10.1371/journal.pone.0243891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332474	Green Published, gold			2022-12-26	WOS:000601310900054
J	Chibi, B; Yende-Zuma, N; Mashamba-Thompson, TP				Chibi, Buyisile; Yende-Zuma, Nonhlanhla; Mashamba-Thompson, Tivani P.			Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa	PLOS ONE			English	Article							COMMUNITY-BASED COHORT; POSITIVE SUBSTANCE-ABUSERS; OPIOID ANALGESIC MISUSE; MEDICATION ADHERENCE; USE HISTORY; POPULATIONS; DEPENDENCE; BEHAVIORS; MODEL; PAIN	Background Prescription drug diversion, and misuse has increased over the past decade and is notably in high-income-countries and significantly contributes to the opioid epidemic. People living with HIV (PLWH) are particularly vulnerable to prescription drug diversion, and misuse as most experience chronic pain, mental health problems and HIV-related illnesses. The researchers investigated the prevalence and correlates of prescription drug diversion, and misuse among PLWH in the eThekwini district, KwaZulu-Natal. Methods A cross-sectional study was conducted among 392 PLWH, conveniently recruited from the public healthcare facilities located in rural, semi-urban and urban areas of the eThekwini district. Participants answered questions about their background, prescription medications, substance use, and prescription drug diversion, and misuse. Descriptive analysis was performed to estimate the prevalence of prescription drug diversion, and misuse. Multivariable logistic regression was used to identify predictors of prescription drug diversion, and misuse. Findings Overall, 13% of the participants reported lifetime prescription drug diversion. The most common type of diversion was using prescription medication not prescribed by a healthcare provider (11%), followed by sharing of prescription medication (9%) and buying prescription medication without a medical script (5%). Twenty-three per cent of the participants reported prescription drug misuse in the past 90 days, with using prescription medication without a healthcare providers' guidance (9%) and not following the scheduled time periods (8%) being the most common reported types of misuse. Self-medicating was identified as a risk factor for prescription drug misuse. There was no association between ART adherence and prescription drug diversion, and misuse. Conclusion The study findings contribute to improving the limited data available on prescription drug diversion, and misuse among PLWH in South Africa. The prevalence underscores a need for urgent interventions when prescribing medications with potential risks. Addressing the risk of self-medicating is imperative for HIV care outcomes and to avert death.	[Chibi, Buyisile; Mashamba-Thompson, Tivani P.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Chibi, Buyisile; Yende-Zuma, Nonhlanhla] Doris Duke Med Res Inst, Ctr AIDS Programme Res South Africa, Durban, South Africa; [Mashamba-Thompson, Tivani P.] Univ Limpopo, Dept Publ Hlth, Fac Hlth Sci, Mankweng, Limpopo Provinc, South Africa	University of Kwazulu Natal; University of Limpopo	Chibi, B (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.; Chibi, B (corresponding author), Doris Duke Med Res Inst, Ctr AIDS Programme Res South Africa, Durban, South Africa.	chibuyi@gmail.com	Mashamba-Thompson, Tivani/GRO-3709-2022	Mashamba-Thompson, Tivani/0000-0002-4193-2416; Chibi, Buyisile/0000-0003-1912-8402	Buyisile Chibi Grant [107620]; National Research Foundation Buyisile Chibi Grant	Buyisile Chibi Grant; National Research Foundation Buyisile Chibi Grant	Buyisile Chibi Grant no. 107620 National Research Foundation Buyisile Chibi Grant no. N/A University of KwaZulu-Natal, College of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdool Karim SS, 2015, OVERCOMING IMPEDIMEN; [Anonymous], 2018, BRIEF REPORTS REV, V13, P12, DOI [10.1142/S1793292018500704, DOI 10.1142/S17932920185007041850070]; Assembly UN General, 2016, POL DECL HIV AIDS FA; Bulbul F, 2014, KLIN PSIKOFARMAKOL B, V24, P135, DOI 10.5455/bcp.20130925022443; Casati A, 2012, EUR ADDICT RES, V18, P228, DOI 10.1159/000337028; Centers for Disease Control and Prevention (CDC), 2012, MMWR MORB MORTAL WKL, V61, P10; Chibi B, 2019, PUBLIC HEALTH, V177, P26, DOI 10.1016/j.puhe.2019.07.017; Chibi B, 2020, INT J EVID-BASED HEA, V18, P5, DOI 10.1097/XEB.0000000000000167; Council HSR, 2018, 5 S AFR NAT HIV PREV; Dada S, 2015, SAMJ, S. Afr. med. j., V105, P776, DOI [10.7196/SAMJNEW.8172, 10.7196/SAMJnew.8172]; Daniel W. W., 2009, BIOSTATISTICS FDN AN; Deeks A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-213; Deiss R, 2018, OPEN FORUM INFECT DI, P5; Ruiz ME, 2010, CURR DRUG SAF, V5, P315, DOI 10.2174/157488610792245966; Flores J, 2018, AIDS BEHAV, V22, P1323, DOI 10.1007/s10461-017-1842-2; Foley M, 2018, SAJP-S AFR J PSYCHI, V24, DOI 10.4102/sajpsychiatry.v24.i0.1162; Ford J, 2017, SUBST USE MISUSE, V52, P1772, DOI 10.1080/10826084.2017.1311348; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Genberg BL, 2013, ADDICT BEHAV, V38, P2868, DOI 10.1016/j.addbeh.2013.08.008; Gumede-Moyo S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008055; Haddad M, 2017, J PUBLIC HEALTH RES, V6, P24, DOI 10.4081/jphr.2017.818; Hansen L, 2011, J PAIN SYMPTOM MANAG, V42, P893, DOI 10.1016/j.jpainsymman.2011.02.026; Inciardi JA, 2006, SUBST USE MISUSE, V41, P255, DOI 10.1080/10826080500391829; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; Jeevanjee S, 2014, AIDS BEHAV, V18, P1352, DOI 10.1007/s10461-013-0619-5; Kamangar F, 2012, ARCH IRAN MED, V15, P508, DOI 012158/AIM.0014; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kurtz SP, 2014, AIDS CARE, V26, P411, DOI 10.1080/09540121.2013.837139; National Department of Health (NDoH) SSASS South African Medical Research Council (SAMRC) and ICF, 2019, S AFR DEM HLTH SURV; Newville H, 2015, J SUBST ABUSE TREAT, V48, P56, DOI 10.1016/j.jsat.2014.07.013; NIDA, 2020, GLOSSARY; OGRADY CL, 2014, DRUG ALCOHOL DEPEN, V140, pE164; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Parry CDH, 2017, SAMJ S AFR MED J, V107, P451, DOI [10.7196/SAMJ.2017.v107i5.12242, 10.7196/samj.2017.v107i5.12242]; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Peng DD, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1496973; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Robinson-Papp J, 2012, JAIDS-J ACQ IMM DEF, V61, P187, DOI 10.1097/QAI.0b013e3182683c98; Rough K, 2014, AIDS BEHAV, V18, P1378, DOI 10.1007/s10461-013-0683-x; Roux P, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-31; Shirzadeh E, 2016, ACTA FAC MEDICAE NAI, V33, P287, DOI 10.1515/afmnai-2016-0030; Substance Abuse and Mental Health Services Administration, 2019, KEY SUBSTANCE USE ME, VH-54; Surratt HL, 2015, AM J PUBLIC HEALTH, V105, P1660, DOI 10.2105/AJPH.2015.302612; Surratt HL, 2015, AIDS CARE, V27, P307, DOI 10.1080/09540121.2014.967656; Surratt HL, 2013, AM J PUBLIC HEALTH, V103, P1026, DOI 10.2105/AJPH.2012.301092; Tsao JCI, 2007, PAIN, V133, P128, DOI 10.1016/j.pain.2007.03.016; Tsao Jennie C I, 2012, J Pain Manag, V5, P111; Tsao JCI, 2010, PAIN MED, V11, P815, DOI 10.1111/j.1526-4637.2010.00858.x; Tsuyuki K, 2015, AIDS BEHAV, V19, P869, DOI 10.1007/s10461-014-0969-7; Tsuyuki K, 2015, AIDS BEHAV, V19, P857, DOI 10.1007/s10461-014-0856-2; Turner AN, 2016, AIDS CARE, V28, P1559, DOI 10.1080/09540121.2016.1198746; United Nations Joint Programme on HIV/AIDS (UNAIDS), GLOB AIDS UPD 2019 C; Van Hout MC, 2017, BEHAV COGN PSYCHOTH, V45, P238, DOI 10.1017/S1352465817000030; Van Hout MC, 2017, QUAL HEALTH RES, V27, P341, DOI 10.1177/1049732315613764; Venables W, 1997, INTRO R NOTES R PROG; Vijayaraghavan M, 2014, DRUG ALCOHOL DEPEN, V143, P263, DOI 10.1016/j.drugalcdep.2014.06.044; Vijayaraghavan M, 2013, JAMA INTERN MED, V173, P235, DOI 10.1001/jamainternmed.2013.1576; Vijayaraghavan M, 2011, J GEN INTERN MED, V26, P412, DOI 10.1007/s11606-010-1555-y; Wang XM, 2017, INT J ANTIMICROB AG, V50, P441, DOI 10.1016/j.ijantimicag.2017.04.009; Wazaify M, 2014, SUBST USE MISUSE, V49, P1296, DOI 10.3109/10826084.2014.891625; Wells JSG, 2018, J PHARM PHARM SCI, V21, P286, DOI 10.18433/jpps30049; Wixson SE, 2015, MEDICATION MISADVENT; Yaylaci S, 2017, BIOMED RES-INDIA, V28, P2661	63	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243718	10.1371/journal.pone.0243718	http://dx.doi.org/10.1371/journal.pone.0243718			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326499	Green Published, gold			2022-12-26	WOS:000600176400072
J	Jiang, SY; Peng, M; Wang, XH				Jiang, Siyu; Peng, Ming; Wang, Xiaohui			Different influences of moral violation with and without physical impurity on face processing: An event-related potentials study	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTIONAL EXPRESSION; ATTENTIONAL CAPTURE; SPATIAL ATTENTION; NEURAL BASIS; TIME-COURSE; DISGUST; ANGER; ACTIVATION; ATTITUDES	It has been widely accepted that moral violations that involve impurity (such as spitting in public) induce the emotion of disgust, but there has been a debate about whether moral violations that do not involve impurity (such as swearing in public) also induce the same emotion. The answer to this question may have implication for understanding where morality comes from and how people make moral judgments. This study aimed to compared the neural mechanisms underlying two kinds of moral violation by using an affective priming task to test the effect of sentences depicting moral violation behaviors with and without physical impurity on subsequent detection of disgusted faces in a visual search task. After reading each sentence, participants completed the face search task. Behavioral and electrophysiological (event-related potential, or ERP) indices of affective priming (P2, N400, LPP) and attention allocation (N2pc) were analyzed. Results of behavioral data and ERP data showed that moral violations both with and without impurity promoted the detection of disgusted faces (RT, N2pc); moral violations without impurity impeded the detection of neutral faces (N400). No priming effect was found on P2 and LPP. The results suggest both types of moral violation influenced the processing of disgusted faces and neutral faces, but the neural activity with temporal characteristics was different.	[Jiang, Siyu; Peng, Ming; Wang, Xiaohui] Cent China Normal Univ, Minist Educ, Key Lab Adolescent Cyberpsychol & Behav, Wuhan, Peoples R China; [Jiang, Siyu; Peng, Ming; Wang, Xiaohui] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Peng, M (corresponding author), Cent China Normal Univ, Minist Educ, Key Lab Adolescent Cyberpsychol & Behav, Wuhan, Peoples R China.	pengm2015@mail.ccnu.edu.cn			MOE (Ministry of Education in China) Project of Humanities and Social Sciences [18YJC90018]; self-determined research funds of CCNU from the colleges' basic research and operation of MOE [CCNU19TD018]; Fundamental Research Funds for the Central Universities [CCNU20QN024]	MOE (Ministry of Education in China) Project of Humanities and Social Sciences; self-determined research funds of CCNU from the colleges' basic research and operation of MOE; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the MOE (Ministry of Education in China) Project of Humanities and Social Sciences (No.18YJC90018), self-determined research funds of CCNU from the colleges' basic research and operation of MOE (CCNU19TD018), and Fundamental Research Funds for the Central Universities (CCNU20QN024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 2013, COGN AFFECT BEHAV NE, V13, P284, DOI 10.3758/s13415-012-0137-3; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Cannon PR, 2011, SOC PSYCHOL PERS SCI, V2, P325, DOI 10.1177/1948550610390525; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Clark JA, 2010, BIOL PHILOS, V25, P75, DOI 10.1007/s10539-009-9170-1; [姚树霞 Yao Shuxia], 2012, [心理科学进展, Advances in Psychological Science], V20, P365; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2001, PERSPECT BIOL MED, V44, P17, DOI 10.1353/pbm.2001.0001; Dieguez-Risco T, 2013, SOC NEUROSCI-UK, V8, P601, DOI 10.1080/17470919.2013.834842; Duncan LA, 2009, ANAL SOC ISS PUB POL, V9, P97, DOI 10.1111/j.1530-2415.2009.01188.x; Eimer M, 2008, J COGNITIVE NEUROSCI, V20, P1423, DOI 10.1162/jocn.2008.20099; Eimer M, 2007, BIOL PSYCHOL, V74, P108, DOI 10.1016/j.biopsycho.2006.06.008; Eskine KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041159; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Frenkel TI, 2011, BIOL PSYCHOL, V88, P188, DOI 10.1016/j.biopsycho.2011.08.001; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Gibbons H, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13009; Giner-Sorolla R, 2017, PSYCHOL SCI, V28, P80, DOI 10.1177/0956797616673193; Gong H, 2012, JUDGM DECIS MAK, V7, P628; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Gui DY, 2016, SOC NEUROSCI-UK, V11, P380, DOI 10.1080/17470919.2015.1081401; Gutierrez A, 2009, SPAN J PSYCHOL, V12, P414, DOI 10.1017/S1138741600001803; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Hietanen JK, 2013, BIOL PSYCHOL, V92, P114, DOI 10.1016/j.biopsycho.2012.10.005; Hirai M, 2008, BRAIN RES BULL, V77, P264, DOI 10.1016/j.brainresbull.2008.08.011; Horberg EJ, 2009, J PERS SOC PSYCHOL, V97, P963, DOI 10.1037/a0017423; Hutcherson CA, 2011, J PERS SOC PSYCHOL, V100, P719, DOI 10.1037/a0022408; Kaptein M, 2008, J MANAGE, V34, P978, DOI 10.1177/0149206308318614; Karinen AK, 2019, EMOTION, V19, P889, DOI 10.1037/emo0000489; Kelly DR, 2013, LIFE MIND-PHILOS ISS, P503; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Klein F, 2015, COGN AFFECT BEHAV NE, V15, P736, DOI 10.3758/s13415-015-0361-8; Kobylinska D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00498; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Leffel GM, 2008, J PSYCHOL THEOL, V36, P182, DOI 10.1177/009164710803600303; Li SX, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13039; Lipp OV, 2014, COGNITION EMOTION, V28, P1100, DOI 10.1080/02699931.2013.867831; Lu Y, 2011, NEUROSCI LETT, V502, P182, DOI 10.1016/j.neulet.2011.07.040; Luck S.J., 2005, INTRO EVENT RELATED; Luo Y, 2013, BIOL PSYCHOL, V94, P242, DOI 10.1016/j.biopsycho.2013.06.005; Meaux E, 2014, EUR J NEUROSCI, V39, P1349, DOI 10.1111/ejn.12496; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Nabi RL, 2002, COMMUN MONOGR, V69, P204, DOI 10.1080/03637750216541; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Park JH, 2007, EVOL HUM BEHAV, V28, P410, DOI 10.1016/j.evolhumbehav.2007.05.008; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paxton JM, 2010, TOP COGN SCI, V2, P511, DOI 10.1111/j.1756-8765.2010.01096.x; Peng M, 2013, EVOL HUM BEHAV, V34, P94, DOI 10.1016/j.evolhumbehav.2012.10.002; Peng XZ, 2017, PSYCHOPHYSIOLOGY, V54, P1459, DOI 10.1111/psyp.12893; Piaget J., 1965, MORAL JUDGEMENT CHIL; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Rozin P., 2008, HDB EMOTIONS, P637; Russell PS, 2013, PSYCHOL BULL, V139, P328, DOI 10.1037/a0029319; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Skarlicki DP, 2013, J EXP SOC PSYCHOL, V49, P852, DOI 10.1016/j.jesp.2013.03.011; Smith FW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197160; [田学红 Tian Xuehong], 2011, [心理科学进展, Advances in Psychological Science], V19, P1426; Tracy JL, 2019, J PERS SOC PSYCHOL, V116, P15, DOI 10.1037/pspa0000141; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Werheid K, 2005, INT J PSYCHOPHYSIOL, V55, P209, DOI 10.1016/j.ijpsycho.2004.07.006; Wessing I, 2013, NEUROIMAGE, V81, P15, DOI 10.1016/j.neuroimage.2013.04.117; Weymar M, 2011, NEUROIMAGE, V58, P946, DOI 10.1016/j.neuroimage.2011.06.061; Yang QQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01555-0; Yang Q, 2014, INT J PSYCHOPHYSIOL, V94, P84, DOI 10.1016/j.ijpsycho.2014.07.008; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065094; Zhang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128531	76	2	2	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243929	10.1371/journal.pone.0243929	http://dx.doi.org/10.1371/journal.pone.0243929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326458	Green Published, gold			2022-12-26	WOS:000600176400052
J	Khayat, AS; de Assumpcao, PP; Khayat, BCM; Araujo, TMT; Batista-Gomes, JA; Imbiriba, LC; Ishak, G; de Assumpcao, PB; Moreira, FC; Burbano, RR; Ribeiro-dos-Santos, A; Ribeiro-dos-Santos, AK; dos Santos, NPC; dos Santos, SEB				Khayat, Andre Salim; de Assumpcao, Paulo Pimentel; Meireles Khayat, Bruna Claudia; Thomaz Araujo, Taissa Maira; Batista-Gomes, Jessica Almeida; Imbiriba, Luciana Carvalho; Ishak, Geraldo; de Assumpcao, Paula Barauna; Moreira, Fabiano Cordeiro; Burbano, Rommel Rodriguez; Ribeiro-dos-Santos, Andre; Ribeiro-dos-Santos, Andrea Kelly; dos Santos, Ney Pereira Carneiro; dos Santos, Sidney Emmanuel Batista			ACE2 polymorphisms as potential players in COVID-19 outcome	PLOS ONE			English	Article							INTERETHNIC ADMIXTURE; ASSOCIATION; POPULATION; ANCESTRY; SYSTEM	The clinical condition COVID-19, caused by SARS-CoV-2, was declared a pandemic by the WHO in March 2020. Currently, there are more than 5 million cases worldwide, and the pandemic has increased exponentially in many countries, with different incidences and death rates among regions/ethnicities and, intriguingly, between sexes. In addition to the many factors that can influence these discrepancies, we suggest a biological aspect, the genetic variation at the viral S protein receptor in human cells, ACE2 (angiotensin I-converting enzyme 2), which may contribute to the worse clinical outcome in males and in some regions worldwide. We performed exomics analysis in native and admixed South American populations, and we also conducted in silico genomics databank investigations in populations from other continents. Interestingly, at least ten polymorphisms in coding, noncoding and regulatory sites were found that can shed light on this issue and offer a plausible biological explanation for these epidemiological differences. In conclusion, there are ACE2 polymorphisms that could influence epidemiological discrepancies observed among ancestry and, moreover, between sexes.	[Khayat, Andre Salim; Meireles Khayat, Bruna Claudia; Batista-Gomes, Jessica Almeida; Ribeiro-dos-Santos, Andre; Ribeiro-dos-Santos, Andrea Kelly; dos Santos, Ney Pereira Carneiro; dos Santos, Sidney Emmanuel Batista] Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil; [Khayat, Andre Salim; de Assumpcao, Paulo Pimentel; Thomaz Araujo, Taissa Maira; Imbiriba, Luciana Carvalho; Ishak, Geraldo; de Assumpcao, Paula Barauna; Moreira, Fabiano Cordeiro; Burbano, Rommel Rodriguez; Ribeiro-dos-Santos, Andrea Kelly; dos Santos, Ney Pereira Carneiro; dos Santos, Sidney Emmanuel Batista] Univ Fed Para, Nucleo Pesquisas Oncol, Belem, Para, Brazil; [Burbano, Rommel Rodriguez] Hosp Ophir Loyola, Lab Biol Mol, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Khayat, AS (corresponding author), Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil.; Khayat, AS (corresponding author), Univ Fed Para, Nucleo Pesquisas Oncol, Belem, Para, Brazil.	khayatas@gmail.com	Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Burbano, Rommel R/C-4149-2012; Moreira, Fabiano/I-2817-2015	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Burbano, Rommel R/0000-0002-4872-234X; Moreira, Fabiano/0000-0002-2799-3546; Santos, Ney Pereira Carneiro dos/0000-0001-8087-7037; Araujo, Taissa Maira/0000-0002-1716-4445	Brazilian National Council for Scientific and Technological Development (CNPq) [431488/2016-9]; Coordination for the Improvement of Higher Education Personnel (CAPES); CNPq; Federal University of Para (UFPA)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Para (UFPA)	S.E.B.S. received from The Brazilian National Council for Scientific and Technological Development (CNPq, www.cnpq.br) financial support (number 431488/2016-9) to perform exome sequencing assays. J.A.B.G. received a Doctoral fellowship from Coordination for the Improvement of Higher Education Personnel (CAPES, www.gov.br/capes). A.S.K., P.P.A, R.M.R.R., A.K.R.S., S.E.B.S. received Researcher Fellowship (PQ), and L.C.I. received Master fellowship from CNPq. the Federal University of Para (UFPA, www.ufpa.br) financial support part of this work. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Carvalho DC, 2015, LEUKEMIA RES, V39, P1239, DOI 10.1016/j.leukres.2015.08.008; Chan KK, 2020, SCIENCE, V369, P1261, DOI 10.1126/science.abc0870; Chen JW, 2020, AGING CELL, V19, DOI 10.1111/acel.13168; Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Rodrigues JCG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43610-y; Gouveia MH, 2020, MOL BIOL EVOL, V37, P1647, DOI 10.1093/molbev/msaa033; GTEx Portal, GEN TISS EXPR GTEX; Kemp JR, 2014, J MOL CELL CARDIOL, V75, P25, DOI 10.1016/j.yjmcc.2014.06.008; Leitao LPC, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030262; Li YW, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104833; Lindenau JD, 2014, TISSUE ANTIGENS, V84, P479, DOI 10.1111/tan.12451; Lindenau JD, 2016, AM J PHYS ANTHROPOL, V159, P722, DOI 10.1002/ajpa.22917; Luo Y, 2019, HYPERTENS RES, V42, P681, DOI 10.1038/s41440-018-0166-6; Merriwether A, 2003, AM J HUM BIOL, V15, P595, DOI 10.1002/ajhb.10174; Mingroni-Netto RC, 2002, AM J MED GENET, V111, P243, DOI 10.1002/ajmg.10572; NCBI, ACE2 ANG I CONV ENZ; Ortega JT, 2020, EXCLI J, V19, P410, DOI 10.17179/excli2020-1167; Othman H, INTERACTION SPIKE PR, DOI [10.1101/2020.03.04.976027, DOI 10.1101/2020.03.04.976027]; Rozenberg S, 2020, MATURITAS, V138, P62, DOI 10.1016/j.maturitas.2020.05.009; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; WHO, WHO MEMB STAT REG; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhao Q, 2010, AM J HYPERTENS, V23, P606, DOI 10.1038/ajh.2010.36; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	35	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243887	10.1371/journal.pone.0243887	http://dx.doi.org/10.1371/journal.pone.0243887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370311	Green Published, gold, Green Submitted			2022-12-26	WOS:000603611900046
J	Ibanez-Peinado, D; Ubeda-Manzanaro, M; Martinez, A; Rodrigo, D				Ibanez-Peinado, Diana; Ubeda-Manzanaro, Maria; Martinez, Antonio; Rodrigo, Dolores			Antimicrobial effect of insect chitosan on Salmonella Typhimurium, Escherichia coli O157:H7 and Listeria monocytogenes survival	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; UNITED-STATES; FOOD; RESISTANCE; PREVALENCE; CHITIN	The antimicrobial capability of chitosan from Tenebrio molitor as compared with chitosan from crustacean (Penaeus monodon) on different pathogenic microorganisms of concern in food safety was studied. The antimicrobial effect was tested at pH 5 and pH 6.2 and at two different initial concentrations (10(3) or 10(6) CFU/mL). Results indicated that chitosan from both sources have antimicrobial activity, although the effect depended on the microorganism considered (Salmonella Typhimurium, Listeria monocytogenes and Escherichia coli O157:H7). Our results indicated that Salmonella was the most resistant bacteria, and that chitosan from insect was less active than chitosan from crustacean, especially against Salmonella. Another important factor on antimicrobial activity was the pH of the sample. When chitosan was added to a solution with a pH of 6.2 it was more active against Listeria and Escherichia coli, than at pH 5.00. Besides, the effect of chitosan appears to decrease with the incubation time, since some increases in counts were observed on E. coli and Salmonella after the 24 and 49 hours of incubation.	[Ibanez-Peinado, Diana; Ubeda-Manzanaro, Maria; Martinez, Antonio; Rodrigo, Dolores] Inst Agroquim & Tecnol Alimentos IATA CSIC, Dept Preservat & Food Safety, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Rodrigo, D (corresponding author), Inst Agroquim & Tecnol Alimentos IATA CSIC, Dept Preservat & Food Safety, Valencia, Spain.	lolesra@iata.csic.es	Rodrigo, Dolores/H-6083-2012	Rodrigo, Dolores/0000-0001-9854-111X	Spanish Ministry of Science [AGL2017-86840-C2-2-R]; EU	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU(European Commission)	The authors are grateful to the Spanish Ministry of Science for funding through project AGL2017-86840-C2-2-R, and to FEDER funds from EU. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Agencia Espanola de Seguridad Alimentaria y Nutricion (AESAN), 2011, 14 AESAN, P43; Allan G. G., 1984, CHITIN CHITOSAN RELA, V1, P119; [Anonymous], 2020, LANCET PLANET HEALTH, V4, pE168, DOI 10.1016/S2542-5196(20)30110-8; [Anonymous], 2017, Med Lett Drugs Ther, V59, pe56; [Anonymous], 2018, 7 SER FPGAS DAT SHEE, V2, P1; Ardila N, 2017, J FOOD SCI, V82, P679, DOI 10.1111/1750-3841.13635; Badwal SPS, 2018, WIRES ENERGY ENVIRON, V7, DOI 10.1002/wene.286; Barroso FG, 2014, AQUACULTURE, V422, P193, DOI 10.1016/j.aquaculture.2013.12.024; Munoz AB, 2013, BIOMEDICA, V33, P283, DOI 10.7705/biomedica.v33i2.716; Buchanan RL, 1997, FOOD TECHNOL-CHICAGO, V51, P69; Chaudhary S, 2020, INT J BIOL MACROMOL, V152, P154, DOI 10.1016/j.ijbiomac.2020.02.276; Cho YI, 1998, J AGR FOOD CHEM, V46, P3839, DOI 10.1021/jf971047f; Du YJ, 2009, INNOV FOOD SCI EMERG, V10, P103, DOI 10.1016/j.ifset.2008.07.004; Ed-dra A, 2017, MICROB PATHOGENESIS, V105, P340, DOI 10.1016/j.micpath.2017.02.042; EFSA European Food Safety Authority, 2007, EFSA J, V599, P1; European Food Safety Authority, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5926; European Food Safety Authority, 2007, EFSA J, V5, P579, DOI [10.2903/j.efsa.2007.579, DOI 10.2903/J.EFSA.2007.579]; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fernandes JC, 2008, FOOD MICROBIOL, V25, P922, DOI 10.1016/j.fm.2008.05.003; Gerasimenko D. V., 2004, Prikladnaya Biokhimiya i Mikrobiologiya, V40, P301; Goy RC, 2014, BRAZ J CHEM ENG, V31, P643, DOI 10.1590/0104-6632.20140313s00003014; Goy RC, 2009, POLIMEROS, V19, P241, DOI 10.1590/S0104-14282009000300013; Gucukoglu A., 2016, Erciyes Universitesi Veteriner Fakultesi Dergisi, V13, P11; Hu ZY, 2019, J APPL MICROBIOL, V126, P1318, DOI 10.1111/jam.14131; Ibitoye EB, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aa9dde; Jia ZS, 2001, CARBOHYD RES, V333, P1, DOI 10.1016/S0008-6215(01)00112-4; Jumaa M, 2002, EUR J PHARM BIOPHARM, V53, P115, DOI 10.1016/S0939-6411(01)00191-6; Kasaal MR, 2008, CARBOHYD POLYM, V71, P497, DOI 10.1016/j.carbpol.2007.07.009; Kulawik P, 2020, ENVIRON CHEM LETT, V18, P61, DOI 10.1007/s10311-019-00935-4; Liu QX, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00617; Luber P, 2011, FOOD CONTROL, V22, P1535, DOI 10.1016/j.foodcont.2011.01.008; Mora A, 2011, INT MICROBIOL, V14, P121, DOI 10.2436/20.1501.01.142; No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Raafat D, 2004, THESIS; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Rajoka MSR, 2020, CRIT REV BIOTECHNOL, V40, P365, DOI 10.1080/07388551.2020.1713719; Rehman A, 2020, TRENDS FOOD SCI TECH, V101, P106, DOI 10.1016/j.tifs.2020.05.001; Sanz-Puig M, 2019, INNOV FOOD SCI EMERG, V51, P51, DOI 10.1016/j.ifset.2018.04.002; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Shin CS, 2019, INT J BIOL MACROMOL, V125, P72, DOI 10.1016/j.ijbiomac.2018.11.242; Tian BR, 2020, POLYM ADVAN TECHNOL, V31, P2408, DOI 10.1002/pat.5010; Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239; Venter T. van de, 2000, Food, Nutrition and Agriculture, P4; WANG GH, 1992, J FOOD PROTECT, V55, P916, DOI 10.4315/0362-028X-55.11.916; WHO (World Health Organization) /Food and Agriculture Organization (FAO), 2004, MICR RISK ASS SER, V4; Xu XB, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000401; Yang XJ, 2016, FOOD CONTROL, V60, P50, DOI 10.1016/j.foodcont.2015.07.019; Yilmaz Atay H., 2020, FUNCTIONAL CHITOSAN, P457, DOI [DOI 10.1007/978-981-15-0263-7_15, 10.1007/978-981-15-0263-7_15]	49	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244153	10.1371/journal.pone.0244153	http://dx.doi.org/10.1371/journal.pone.0244153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351851	gold, Green Published			2022-12-26	WOS:000603071400009
J	Sagbakken, M; Ingebretsen, R; Spilker, RS				Sagbakken, Mette; Ingebretsen, Reidun; Spilker, Ragnhild Storstein			How to adapt caring services to migration-driven diversity? A qualitative study exploring challenges and possible adjustments in the care of people living with dementia	PLOS ONE			English	Article							RESIDENTIAL CARE; FAMILY CARE; CULTURE; COMMUNICATION; IMMIGRANTS; ETHNICITY; SWEDEN; MAINSTREAM; PROVISION; COMMUNITY	Background Research on how services can be adapted to meet the needs of people with dementia with an immigrant or minority ethnic background is scarce. Several approaches have been discussed: offering services adapted to language and culture, adding bilingual staff to mainstream services, and providing cultural awareness and sensitivity training to health personnel in mainstream services. This study seeks to develop more knowledge of challenges and possible adjustments related to receive and provide public care for people living with dementia with an immigrant or minority ethnic background. Methods and materials Through a qualitative design, including 19 single interviews, 3 dyad interviews and 16 focus groups with older immigrants, relatives of immigrants with dementia, and health personnel, we explored experiences and perceptions related to receive and provide care for people with immigrant backgrounds living with dementia in Norway. The analysis were conducted inspired by Kvale and Brinkmann's three contexts of interpretations. Results Challenges related to language and communication were emphasized as the most fundamental barrier to provide adjusted care; exemplified through cases of isolation and agitation among patients not able to communicate. Care services framed by the majority culture creates feelings of alienation and exclusion. Not having access to specific types of food and the possibility to listen to songs, music, literature or TV programs representing a familiar and homely context may prevent use of public dementia care. Findings also point to differences in moral views regarding life-prolonging treatment in advanced stages of dementia. Conclusion This study argues that to be able to address challenges related to migration-driven diversity one needs holistic care services that addresses individual as well as socio-cultural needs. A linguistically and culturally diverse workforce may represent an important resource, potentially reducing some of the problems related to communication. On a structural level, it seems necessary to allocate more time and resources, including the use of interpreters, when assessing and getting to know persons with dementia with another linguistic and cultural background. However, shared language does not guarantee understanding. Rather, one needs to become familiar with each person's way of being ill, on a cultural and individual level, including changes occurring living with progressive dementia. Getting to know a person and his/her family will also facilitate the possibility to ensure a more familiar and homely context. Thus, continuity in relation to language and culture is important, but continuity in relations may be equally important ensuring that people with dementia receive equitable care.	[Sagbakken, Mette] OsloMet Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, Fac Hlth Sci, Oslo, Norway; [Ingebretsen, Reidun] OsloMet Oslo Metropolitan Univ, Norwegian Social Res NOVA, Oslo, Norway; [Spilker, Ragnhild Storstein] Norwegian Inst Publ Hlth, Unit Migrat & Hlth, Oslo, Norway	Oslo Metropolitan University (OsloMet); Oslo Metropolitan University (OsloMet); Norwegian Institute of Public Health (NIPH)	Sagbakken, M (corresponding author), OsloMet Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, Fac Hlth Sci, Oslo, Norway.	metsa@oslomet.no	Giacalone, Laura/AHD-0203-2022		Norwegian Directorate of Health	Norwegian Directorate of Health	The study was supported by the Norwegian Directorate of Health. The financial sponsor played no role in the design, execution, analysis and interpretation of data.	Agotnes G., 2017, I PRACTICE NURSING H; [Anonymous], 2014, 20148 NOU MIN CHILDR; [Anonymous], 2002, 200229 SOU SWED GOV; Antelius E, 2016, ANTHROPOL AGING, V37, P9, DOI 10.5195/aa.2016.107; Antelius Eleonor, 2015, Care Manag J, V16, P79; Barrett AE, 2003, J GERONTOL B-PSYCHOL, V58, pS101, DOI 10.1093/geronb/58.2.S101; BAUM SK, 1983, GERONTOLOGIST, V23, P532, DOI 10.1093/geront/23.5.532; Botsford J, 2011, J RES NURS, V16, P437, DOI 10.1177/1744987111414531; Bowes A, 2003, HEALTH SOC CARE COMM, V11, P387, DOI 10.1046/j.1365-2524.2003.00440.x; COLLINS Patricia Hill, 1990, BLACK FEMINIST THOUG; Connolly A, 2012, J AM GERIATR SOC, V60, P351, DOI 10.1111/j.1532-5415.2011.03754.x; Cooper C, 2018, INT J GERIATR PSYCH, V33, P504, DOI 10.1002/gps.4786; Cooper C, 2010, AM J GERIAT PSYCHIAT, V18, P193, DOI 10.1097/JGP.0b013e3181bf9caf; Daker-White G, 2002, AGING MENT HEALTH, V6, P101, DOI 10.1080/13607860220126835; Davies AA, 2014, MIGRATION SOCIAL DET; Debesay J, 2014, J ADV NURS, V70, P2107, DOI 10.1111/jan.12369; Diaz E, 2015, DEMENT GERIATR COGN, V39, P321, DOI 10.1159/000375526; Ekman S L, 1994, Int Psychogeriatr, V6, P105, DOI 10.1017/S1041610294001675; EKMAN SL, 1993, INT J AGING HUM DEV, V37, P37, DOI 10.2190/NU87-FGP0-CNEU-DCH5; Erikson E, 1986, VITAL INVOLVEMENT OL; European Parliament and Council of the European Union, 2002, OFF J EUR UNION L, V037, P19; Folkehelseinstituttet [Norwegian Institute of Public Health], 2018, FOLK; Goral M, 2013, ANNU REV APPL LINGUI, V33, P128, DOI 10.1017/S026719051300010X; Harper S, 2005, SOC POLICY SOC, V4, P157, DOI 10.1017/S1474746404002295; Heikkila K, 2007, SCAND J CARING SCI, V21, P354, DOI 10.1111/j.1471-6712.2007.00480.x; Hossain M, 2020, DEMENTIA-LONDON, V19, P1441, DOI 10.1177/1471301218800641; Hossain MZ, 2020, J EVAL CLIN PRACT, V26, P1629, DOI 10.1111/jep.13361; Hossain MZ, 2019, J EVAL CLIN PRACT, V25, P769, DOI 10.1111/jep.13117; Hyden LC, 2013, J INTERACT RES COM D, V4, P211, DOI 10.1558/jircd.v4i2.211; Iliffe S, 2004, AGING MENT HEALTH, V8, P283, DOI 10.1080/13607860410001709656; IMDi, 2020, INNV ARB; JONES DC, 1986, J ADV NURS, V11, P265, DOI 10.1111/j.1365-2648.1986.tb01247.x; Jonson H, 2018, EUR J SOC WORK, V21, P235, DOI 10.1080/13691457.2017.1288087; Jutlla K., 2013, J DEMENTIA CARE, V21, P33; Kiwi M, 2018, J CROSS-CULT GERONTO, V33, P21, DOI 10.1007/s10823-017-9337-1; KOENIG BA, 1995, WESTERN J MED, V163, P244; Kvale S., 2015, INTERVIEW LEARNING C, V3rd; Leininger M, 1991, J Transcult Nurs, V2, P32, DOI 10.1177/104365969100200205; Leininger M, 2007, NURS SCI QUART, V20, P9, DOI 10.1177/0894318406296784; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lucy JA, 1997, ANNU REV ANTHROPOL, V26, P291, DOI 10.1146/annurev.anthro.26.1.291; Mackenzie J., 2006, DEMENTIA, V5, P233, DOI [10.1177/1471301206062252, DOI 10.1177/1471301206062252]; MacLean MJ, 1986, INT SOCIAL WORK, V29, P227; McCleary L., 2013, INDIAN J GERONTOL, V27, P178; McFarland MR, 1997, NURS SCI QUART, V10, P186, DOI 10.1177/089431849701000412; Mold F, 2005, AGE AGEING, V34, P107, DOI 10.1093/ageing/afi009; Moriarty J., 2011, BLACK MINORITY ETHNI; Mukadam N, 2011, INT J GERIATR PSYCH, V26, P12, DOI 10.1002/gps.2484; Nielsen TR, 2011, DEMENT GERIATR COGN, V31, P388, DOI 10.1159/000327362; Norwegian Directorate of Health, 2015, ALZH ANDR DEM; Norwegian Directorate of Health, 2017, NASJ FAGL RETN DEM; Norwegian Institute of Public Health, 2016, DEM NORW PUBL HLTH R; Patton MQ, 2002, QUALITATIVE RES EVAL; Phillimore J, 2016, IRIS WORKING PAPER S, V15; Plejert C, 2014, J CROSS-CULT GERONTO, V29, P1, DOI 10.1007/s10823-013-9217-2; Prince R, 2017, DEMENTIA ETHNIC MINO; Ringard A, 2013, HEALT SYST TRANSIT, V15, P1; Rosendahl SP, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0200-y; Runci S, 1999, Int Psychogeriatr, V11, P301, DOI 10.1017/S1041610299005864; Runci SJ, 2005, INT PSYCHOGERIATR, V17, P699, DOI 10.1017/S1041610205002309; Runci SJ, 2005, AUSTRALAS J AGEING, V24, P157, DOI 10.1111/j.1741-6612.2005.00106.x; Runci SJ, 2012, INT PSYCHOGERIATR, V24, P733, DOI 10.1017/S1041610211002134; Sagbakken M, 2019, AGEING SOC, P1; Sagbakken M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3720-7; Sagbakken M, 2018, QUAL HEALTH RES, V28, P16, DOI 10.1177/1049732317730818; Seeberg ML, 2012, EUR J WOMENS STUD, V19, P173, DOI 10.1177/1350506811434665; Sjogren K, 2013, J ADV NURS, V69, P2196, DOI 10.1111/jan.12085; Strandroos L, 2017, HEALTH-LONDON, V21, P538, DOI 10.1177/1363459316677626; TOnnessen M, OKONOMISKE ANAL 3 20; Torres S, 2006, J ETHN MIGR STUD, V32, P1341, DOI 10.1080/13691830600928730; Uppal G, 2014, MENT HEALTH RELIG CU, V17, P143, DOI 10.1080/13674676.2013.764515; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Yee D L, 1992, J Health Care Poor Underserved, V2, P448	73	0	0	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243803	10.1371/journal.pone.0243803	http://dx.doi.org/10.1371/journal.pone.0243803			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351820	Green Published, gold			2022-12-26	WOS:000603071400054
J	Cheng, FJ; Chen, CH; Tsai, WC; Wang, BW; Yu, MC; Hsia, TC; Wei, YL; Hsiao, YC; Hu, DW; Ho, CY; Li, TS; Wu, CY; Chou, WY; Yu, YL; Tang, CH; Chen, CY; Chen, CM; Hsu, JL; Chen, HF; Chen, Y; Tu, CY; Hung, MC; Huang, WC				Cheng, Fang-Ju; Chen, Chia-Hung; Tsai, Wen-Chen; Wang, Bo-Wei; Yu, Meng-Chieh; Hsia, Te-Chun; Wei, Ya-Ling; Hsiao, Yu-Chun; Hu, Dai-Wei; Ho, Chien-Yi; Li, Tzong-Shiun; Wu, Chun-Yi; Chou, Wen-Yu; Yu, Yung-Luen; Tang, Chih-Hsin; Chen, Chih-Yi; Chen, Chuan-Mu; Hsu, Jennifer L.; Chen, Hsiao-Fan; Chen, Yeh; Tu, Chih-Yen; Hung, Mien-Chie; Huang, Wei-Chien			Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC	ONCOGENE			English	Article							CELL LUNG-CANCER; MUTATIONS; ERLOTINIB; PREDICTORS; EXPRESSION; SIGNATURE; GEFITINIB; LKB1; TRANSFORMATION; ACTIVATION	Smoker patients with non-small cell lung cancer (NSCLC) have poorer prognosis and survival than those without smoking history. However, the mechanisms underlying the low response rate of those patients to EGFR tyrosine kinase inhibitors (TKIs) are not well understood. Here we report that exposure to cigarette smoke extract enhances glycolysis and attenuates AMP-activated protein kinase (AMPK)-dependent inhibition of mTOR; this in turn reduces the sensitivity of NSCLC cells with wild-type EGFR (EGFR(WT)) to EGFR TKI by repressing expression of liver kinase B1 (LKB1), a master kinase of the AMPK subfamily, via CpG island methylation. In addition, LKB1 expression is correlated positively with sensitivity to TKI in patients with NSCLC. Moreover, combined treatment of EGFR TKI with AMPK activators synergistically increases EGFR TKI sensitivity. Collectively, the current study suggests that LKB1 may serve as a marker to predict EGFR TKI sensitivity in smokers with NSCLC carrying EGFR(WT) and that the combination of EGFR TKI and AMPK activator may be a potentially effective therapeutic strategy against NSCLC with EGFR(WT).	[Cheng, Fang-Ju; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan; [Cheng, Fang-Ju; Hsu, Jennifer L.; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Cheng, Fang-Ju; Wang, Bo-Wei; Hu, Dai-Wei; Yu, Yung-Luen; Tang, Chih-Hsin; Hsu, Jennifer L.; Hung, Mien-Chie; Huang, Wei-Chien] China Med Univ, Grad Inst Biomed Sci, Taichung 404, Taiwan; [Chen, Chia-Hung; Hsia, Te-Chun; Tu, Chih-Yen] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung 404, Taiwan; [Chen, Chia-Hung; Tang, Chih-Hsin; Tu, Chih-Yen] China Med Univ, Sch Med, Taichung 404, Taiwan; [Chen, Chia-Hung] China Med Univ, Dept Resp Therapy, Taichung 404, Taiwan; [Chen, Chia-Hung] Taiwan Clin Trial Consortium Lung Dis TCoC, Taichung 404, Taiwan; [Tsai, Wen-Chen; Chou, Wen-Yu] China Med Univ, Dept Hlth Serv Adm, Taichung 406, Taiwan; [Yu, Meng-Chieh; Wei, Ya-Ling; Hsiao, Yu-Chun; Yu, Yung-Luen; Chen, Hsiao-Fan; Hung, Mien-Chie; Huang, Wei-Chien] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Ho, Chien-Yi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung 404, Taiwan; [Ho, Chien-Yi] China Med Univ, Hsinchu Hosp, Phys Examinat Ctr, Div Family Med, Hsinchu 302, Taiwan; [Ho, Chien-Yi] China Med Univ, Hsinchu Hosp, Dept Med Res, Hsinchu 302, Taiwan; [Li, Tzong-Shiun] Show Chwan Mem Hosp, Dept Plast Surg, Changhua 500, Taiwan; [Li, Tzong-Shiun] Show Chwan Mem Hosp, Innovat Res Ctr, Changhua 500, Taiwan; [Wu, Chun-Yi] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yu, Yung-Luen; Hung, Mien-Chie; Huang, Wei-Chien] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung 404, Taiwan; [Yu, Yung-Luen; Chen, Hsiao-Fan; Chen, Yeh; Hung, Mien-Chie] China Med Univ, Inst New Drug Dev, Taichung 404, Taiwan; [Yu, Yung-Luen; Chen, Yeh; Huang, Wei-Chien] China Med Univ, Res Ctr Canc Biol, Drug Dev Ctr, Taichung 404, Taiwan; [Yu, Yung-Luen; Chen, Yeh; Hung, Mien-Chie; Huang, Wei-Chien] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Tang, Chih-Hsin] China Med Univ, Chinese Med Res Ctr, Taichung 404, Taiwan; [Chen, Chih-Yi] Chung Shan Med Univ, Inst Med, Taichung 402, Taiwan; [Chen, Chih-Yi] Chung Shan Med Univ Hosp, Dept Surg, Div Thorac Surg, Taichung 402, Taiwan; [Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Chen, Chuan-Mu] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung 402, Taiwan; [Chen, Chuan-Mu] Natl Chung Hsing Univ, IEGG & Anim Biotechnol Ctr, Taichung 402, Taiwan	China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Show Chwan Memorial Hospital; Show Chwan Memorial Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Hung, MC; Huang, WC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung 404, Taiwan.; Tu, CY (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung 404, Taiwan.; Tu, CY (corresponding author), China Med Univ, Sch Med, Taichung 404, Taiwan.; Hung, MC; Huang, WC (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan.; Hung, MC; Huang, WC (corresponding author), China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung 404, Taiwan.; Hung, MC (corresponding author), China Med Univ, Inst New Drug Dev, Taichung 404, Taiwan.; Huang, WC (corresponding author), China Med Univ, Res Ctr Canc Biol, Drug Dev Ctr, Taichung 404, Taiwan.; Hung, MC; Huang, WC (corresponding author), Asia Univ, Dept Biotechnol, Taichung 413, Taiwan.	chesttu@gmail.com; mhung@cmu.edu.tw; whuang@mail.cmu.edu.tw	Wang, Bo/AAU-1329-2021; Wu, Chun-Yi/AAD-4184-2021; Chen, Chuan-Mu/K-7049-2013; Hung, Mien-Chie/ABD-5911-2021; Tsai, Wen-Chen/O-3095-2015; Huang, Wei-Chien/D-1740-2012	Wang, Bo/0000-0001-8947-8526; Wu, Chun-Yi/0000-0002-8217-1692; Chen, Chuan-Mu/0000-0003-2461-9150; Hung, Mien-Chie/0000-0003-4317-4740; Cheng, Fang-Ju/0000-0001-6104-7185; Tsai, Wen-Chen/0000-0002-9684-0789; Huang, Wei-Chien/0000-0001-6467-8716	Ministry of Science Technology, Taiwan [MOST 108-2314-B-039-056, MOST 108-2314-B-039-053]; Ministry of Education (The International Co-cultivation of Talent), China Medical University [CMU106-ASIA-18, CMU107-TU-06]; China Medical University Hospital [DMR-107-023, DMR-108-021]	Ministry of Science Technology, Taiwan; Ministry of Education (The International Co-cultivation of Talent), China Medical University; China Medical University Hospital	This study was supported in part by grants from the Ministry of Science Technology, Taiwan (MOST 108-2314-B-039-056 and MOST 108-2314-B-039-053), the Ministry of Education (The International Co-cultivation of Talent), China Medical University (CMU106-ASIA-18 and CMU107-TU-06), and China Medical University Hospital (DMR-107-023 and DMR-108-021). Experiments and data analysis were performed in part through the use of the Medical Research Core Facilities, Office of Research & Development at China Medical University, Taichung, Taiwan, R.O.C. We thank Chung Shan Medical University for the Seahorse XF24<SUP>e</SUP> Analysis and the Center for Advanced Molecular Imaging and Translation of Chang Gung Memorial Hospital for the analysis with Micro Positron Emission Tomography (MicroPET) system.	An Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047919; Arrieta O, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2658-6; Barupal DK, 2016, CHEM RES TOXICOL, V29, P1818, DOI 10.1021/acs.chemrestox.6b00187; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Cha JH, 2018, MOL CELL, V71, P606, DOI 10.1016/j.molcel.2018.07.030; Clark GM, 2006, CLIN LUNG CANCER, V7, P389, DOI 10.3816/CLC.2006.n.022; Daijo H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34424; Der SD, 2014, J THORAC ONCOL, V9, P59, DOI 10.1097/JTO.0000000000000042; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Filosto S, 2012, MOL CANCER THER, V11, P795, DOI 10.1158/1535-7163.MCT-11-0698; Fueger BJ, 2006, J NUCL MED, V47, P999; Gao B, 2010, J THORAC ONCOL, V5, P1130, DOI 10.1097/JTO.0b013e3181e05016; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gleeson FC, 2015, J THORAC ONCOL, V10, P531, DOI 10.1097/JTO.0000000000000391; He TY, 2014, ANN SURG ONCOL, V21, pS703, DOI 10.1245/s10434-014-3824-1; Huang YH, 2013, ASIAN PAC J CANCER P, V14, P1985, DOI 10.7314/APJCP.2013.14.3.1985; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kim MS, 2010, INT J CANCER, V127, P269, DOI 10.1002/ijc.25057; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Li YY, 2018, J CELL BIOCHEM, V119, P8909, DOI 10.1002/jcb.27144; Midha A, 2015, AM J CANCER RES, V5, P2892; Min HY, 2017, CLIN CANCER RES, V23, P1299, DOI 10.1158/1078-0432.CCR-16-0534; Mitsudomi T, 2014, TRANSL LUNG CANCER R, V3, P205, DOI 10.3978/j.issn.2218-6751.2014.08.04; Morgillo F, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2016-000132; Nakamura Y, 2010, J THORAC ONCOL, V5, P1404, DOI 10.1097/JTO.0b013e3181e59a7b; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shiah SG, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00644-z; Siu LL, 2007, J CLIN ONCOL, V25, P2178, DOI 10.1200/JCO.2006.07.6547; Song M.A., 2017, JNCI-J NATL CANCER I, V109; Sun RJ, 2015, INT J CLIN EXP MED, V8, P14070; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tarca AL, 2013, BIOINFORMATICS, V29, P2892, DOI 10.1093/bioinformatics/btt492; Tennis MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032921; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Tu CY, 2018, MOL ONCOL, V12, P705, DOI 10.1002/1878-0261.12193; Vanden Heuvel JP, 2018, ELIFE, V7; Vaz M, 2017, CANCER CELL, V32, P360, DOI 10.1016/j.ccell.2017.08.006; Wu JY, 2011, LUNG CANCER, V72, P205, DOI 10.1016/j.lungcan.2010.08.013; Xie Y, 2011, CLIN CANCER RES, V17, P5705, DOI 10.1158/1078-0432.CCR-11-0196; Zeng J, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/658126; Zeng Q, 2019, THORAC CANCER, V10, P1717, DOI 10.1111/1759-7714.13141; Zhang HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25702-3; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	47	4	4	3	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1162	1175		10.1038/s41388-020-01597-1	http://dx.doi.org/10.1038/s41388-020-01597-1		DEC 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33335306	Green Published, hybrid			2022-12-26	WOS:000599788200001
J	Wells, N; Quigley, J; Pascua, J; Pinkowski, N; Almaiman, L; Brasser, SM; Hong, MY				Wells, Nicole; Quigley, Jacqueline; Pascua, Jeremy; Pinkowski, Natalie; Almaiman, Lama; Brasser, Susan M.; Hong, Mee Young			Effects of low-to-moderate ethanol consumption on colonic growth and gene expression in young adult and middle-aged male rats	PLOS ONE			English	Article							COLORECTAL-CANCER; ALCOHOL-CONSUMPTION; LIFE-STYLE; CYCLIN-E; APOPTOSIS; DIFFERENTIATION; PROLIFERATION; RISK; CELLS; INFLAMMATION	Excessive alcohol consumption is a risk factor associated with colorectal cancer; however, some epidemiological studies have reported that moderate alcohol consumption may not contribute additional risk or may provide a protective effect reducing colorectal cancer risk. Prior research highlights the importance of proliferation, differentiation, and apoptosis as parameters to consider when evaluating colonic cell growth and tumorigenesis. The present study investigated whether chronic low-to-moderate ethanol consumption altered these parameters of colonic cell growth and expression of related genes. Twenty-four nondeprived young adult (109 days old) and 24 nondeprived middle-aged (420 days old) Wistar rats were randomly assigned to an ethanol-exposed or a water control group (n = 12/group). The ethanol group was provided voluntary access to a 20% v/v ethanol solution on alternate days for 13 weeks. Colon tissues were collected for quantitative immunohistochemical analyses of cell proliferation, differentiation and apoptosis using Ki-67, goblet cell and TUNEL, respectively. Gene expression of cyclin D1 (Ccnd1), Cdk2, Cdk4, p21(waf1/cip1) (Cdkn1a), E-cadherin (Cdh1) and p53 were determined by quantitative real-time polymerase chain reaction in colonic scraped mucosa. Ethanol treatment resulted in a lower cell proliferation index and proliferative zone, and lower Cdk2 expression in both age groups, as well as trends toward lower Ccnd1 and higher Cdkn1a expression. Cell differentiation was modestly but significantly reduced by ethanol treatment only in older animals. Overall, older rats showed decreases in apoptosis and gene expression of Cdk4, Cdh1, and p53 compared to younger rats, but there was no observed effect of ethanol exposure on these measures. These findings suggest that low-to-moderate ethanol consumption improves at least one notable parameter in colonic tumorigenesis (cell proliferation) and associated gene expression regardless of age, however, selectively decreased cell differentiation among older subjects.	[Wells, Nicole; Hong, Mee Young] San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA; [Quigley, Jacqueline; Pascua, Jeremy; Pinkowski, Natalie; Almaiman, Lama; Brasser, Susan M.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Hong, MY (corresponding author), San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA.	mhong2@sdsu.edu		Hong, Mee Young/0000-0003-1262-0074	National Institutes of Health [R21 AA023291]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [R21 AA023291] (SMB's grant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1979, PHYSIOL PSYCHOL, V7, P391; Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; American Cancer Society, 2017, COL CANC FACTS FIG; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Bishehsari F, 2017, ALCOHOL RES-CURR REV, V38, P163; Boissoneault J, 2016, CURR ADDICT REP, V3, P62, DOI DOI 10.1007/s40429-016-0087-x; BOLAND CR, 1992, J CELL BIOCHEM, P103; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Brasser SM, 2004, ALCOHOL CLIN EXP RES, V28, P1074, DOI 10.1097/01.ALC.0000130802.07692.29; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Chang WCL, 1997, CARCINOGENESIS, V18, P721, DOI 10.1093/carcin/18.4.721; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cippitelli A, 2012, PHARMACOL BIOCHEM BE, V100, P522, DOI 10.1016/j.pbb.2011.10.016; Crockett SD, 2011, DIS COLON RECTUM, V54, P887, DOI 10.1007/DCR.0b013e3182125577; Douaiher J, 2017, J SURG ONCOL, V115, P619, DOI 10.1002/jso.24578; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; George O, 2012, P NATL ACAD SCI USA, V109, P18156, DOI 10.1073/pnas.1116523109; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Hong MY, 2019, J FUNCT FOODS, V54, P520, DOI 10.1016/j.jff.2019.02.005; Hong MY, 1997, NUTR CANCER, V28, P20, DOI 10.1080/01635589709514548; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Klarich DS, 2017, ALCOHOL, V61, P25, DOI 10.1016/j.alcohol.2017.02.179; Klarich DS, 2015, ALCOHOL CLIN EXP RES, V39, P1280, DOI 10.1111/acer.12778; Koivisto T, 1998, CARCINOGENESIS, V19, P2031, DOI 10.1093/carcin/19.11.2031; Kontou N, 2012, DIS COLON RECTUM, V55, P703, DOI 10.1097/DCR.0b013e31824e612a; Kyrylkova Kateryna, 2012, Methods Mol Biol, V887, P41, DOI 10.1007/978-1-61779-860-3_5; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279; Nan HM, 2013, ANN EPIDEMIOL, V23, P558, DOI 10.1016/j.annepidem.2013.04.011; National Institute of Alcohol Abuse and Alcoholism, DRINK LEV DEF; OTT JF, 1985, ALCOHOL CLIN EXP RES, V9, P59, DOI 10.1111/j.1530-0277.1985.tb05051.x; Park JY, 2009, CANCER EPIDEMIOL, V33, P347, DOI 10.1016/j.canep.2009.10.015; Poullis A, 2004, CANCER EPIDEM BIOMAR, V13, P279, DOI 10.1158/1055-9965.EPI-03-0160; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shin J, 2014, J BIOL CHEM, V289, P25306, DOI 10.1074/jbc.M114.557546; Shukla PK, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2180-x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Truter D, 2017, ACTA HISTOCHEM, V119, P122, DOI 10.1016/j.acthis.2016.11.014; Wang LR, 2016, CELL HOST MICROBE, V19, P227, DOI 10.1016/j.chom.2016.01.003; Wells N, 2020, FASEB J, V34, DOI [10.1096/fsb2.v34.S1, DOI 10.1096/FSB2.V34.S1]; White A, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4786-7; Xiao ZQ, 2001, MECH AGEING DEV, V122, P1849, DOI 10.1016/S0047-6374(01)00323-2	51	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243499	10.1371/journal.pone.0243499	http://dx.doi.org/10.1371/journal.pone.0243499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326448	Green Published, gold			2022-12-26	WOS:000600176400048
J	Su, J; Zhou, ZH; Li, YD; Hao, B; Dong, Q; Li, XJ				Su, Jie; Zhou, Zhenghua; Li, Yuandong; Hao, Bing; Dong, Qing; Li, Xiaojun			A stable implementation measure of multi-transmitting formula in the numerical simulation of wave motion	PLOS ONE			English	Article							SATURATED POROUS-MEDIA; ABSORBING BOUNDARY-CONDITIONS; FIELD SIMULATION; PROPAGATION	The Multi-Transmitting Formula (MTF) proposed by Liao et al. is a local artificial boundary condition widely used in numerical simulations of wave propagation in an infinite medium, while the drift instability is usually caused in its numerical implementation. In view of a physical interpretation of the Gustafsson, Kreiss and Sundstrom criterion on numerical solutions of initial-boundary value problems in the hyperbolic partial differential equations, the mechanism of the drift instability of MTF was discussed, and a simple measure for eliminating the drift instability was proposed by introducing a modified operator into the MTF. Based on the theory of spherical wave propagation and damping effect of medium, the physical implication on modified operator was interpreted. And the effect of the modified operator on the reflection coefficient of MTF was discussed. Finally, the validity of the proposed stable implementation measure was verified by numerical tests of wave source problem and scattering problem.	[Su, Jie; Zhou, Zhenghua; Li, Yuandong; Hao, Bing; Dong, Qing; Li, Xiaojun] Nanjing Tech Univ, Coll Transportat Sci & Engn, Nanjing, Peoples R China; [Li, Xiaojun] Beijing Univ Technol, Fac Urban Construct, Beijing, Peoples R China	Nanjing Tech University; Beijing University of Technology	Li, XJ (corresponding author), Beijing Univ Technol, Fac Urban Construct, Beijing, Peoples R China.	beerli@vip.sina.com			National Natural Science Foundation of China [U1839202, 41374049]; National Key Research and Development Program of China [2017YFC1500400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	National Natural Science Foundation of China (U1839202, 41374049) and the National Key Research and Development Program of China (2017YFC1500400).	Achenbach J. D., 1973, WAVE PROPAGATION ELA; [Anonymous], 2020, BR J ANAESTH ADV, V125; [Anonymous], 2010, DREXEL L REV, V3, P1; Ba J, 2017, J GEOPHYS RES-SOL EA, V122, P1949, DOI 10.1002/2016JB013882; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Cao SH, 1998, GEOPHYSICS, V63, P231, DOI 10.1190/1.1444317; CERJAN C, 1985, GEOPHYSICS, V50, P705, DOI 10.1190/1.1441945; [董青 Dong Qing], 2018, [震灾防御技术, Technology for Earthquake Disaster Prevention], V13, P571; GUSTAFSSON B, 1972, MATH COMPUT, V26, P649, DOI 10.1090/S0025-5718-1972-0341888-3; Heider Y, 2012, COMPUT MECH, V49, P319, DOI 10.1007/s00466-011-0647-9; HIGDON RL, 1987, MATH COMPUT, V49, P65, DOI 10.1090/S0025-5718-1987-0890254-1; Kim SH, 2002, COMPUT METHOD APPL M, V191, P4061, DOI 10.1016/S0045-7825(02)00339-0; Lan HQ, 2011, B SEISMOL SOC AM, V101, P1354, DOI 10.1785/0120100194; Li Xiao-jun, 1996, CHIN J THEOR APPL ME, V28, P627; [廉西猛 Lian Ximeng], 2015, [地球物理学进展, Progress in Geophysiscs], V30, P1725; Liao Z, 1996, INTRO WAVE MOTION TH; Liao Z.P., 1984, SCI CHINA A, V27, P556, DOI [10.1360/ya1984-27-10-1063, DOI 10.1360/YA1984-27-10-1063]; Liao Z P, 1984, EARTHQ ENG ENG VIB, V4, P1; LIAO ZP, 1992, EARTHQUAKE ENG STRUC, V21, P65, DOI 10.1002/eqe.4290210105; Liao ZP, 1998, DEV GEOTECH ENG, V83, P125; Liao ZP, 1996, WAVE MOTION, V24, P117, DOI 10.1016/0165-2125(96)00010-8; Liao ZP., 1999, EARTHQ RES CHINA, P367; Liao ZP, 1984, INT J SOIL DYNAM EAR, P174, DOI [10.1016/0261-7277(84)90033-0, DOI 10.1016/0261-7277(84)90033-0]; Liao ZP, 1992, SCIENTIA SINICA B, V8, P874; Liu Y, 2018, J GEOPHYS ENG, V15, P2602, DOI 10.1088/1742-2140/aadd31; Shi L, 2016, SOIL DYN EARTHQ ENG, V80, P11, DOI 10.1016/j.soildyn.2015.09.021; SOCHACKI J, 1987, GEOPHYSICS, V52, P60, DOI 10.1190/1.1442241; Sun ZZ, 2012, APPL MATH COMPUT, V218, P5187, DOI 10.1016/j.amc.2011.10.083; Wang XM, 2010, INT J MULTISCALE COM, V8, P207, DOI 10.1615/IntJMultCompEng.v8.i2.60; Wei CF, 2002, INT J ENG SCI, V40, P1807, DOI 10.1016/S0020-7225(02)00068-X; [谢志南 Xie Zhinan], 2008, [地震学报, Acta Seismologica Sinica], V30, P302; Xu CS, 2017, INT J NUMER METH ENG, V112, P529, DOI 10.1002/nme.5525; Yang DH, 2002, GEOPHYS J INT, V148, P320, DOI 10.1046/j.0956-540x.2001.01575.x; Zhang ZJ, 1999, PHYS EARTH PLANET IN, V114, P25, DOI 10.1016/S0031-9201(99)00043-6; 廖振鹏, 1997, 力学进展, V27, P193	35	0	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243979	10.1371/journal.pone.0243979	http://dx.doi.org/10.1371/journal.pone.0243979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320914	Green Published, gold			2022-12-26	WOS:000600339800042
J	Checa, C; Medina-Perucha, L; Munoz, MA; Verdu-Rotellar, JM; Berenguera, A				Checa, Caterina; Medina-Perucha, Laura; Munoz, Miguel-Angel; Maria Verdu-Rotellar, Jose; Berenguera, Anna			Living with advanced heart failure: A qualitative study	PLOS ONE			English	Article							SELF-CARE; SOCIAL SUPPORT; BAD-NEWS; HEALTH; ILLNESS; GENDER; EXPERIENCES	Introduction Information about how patients with advanced heart failure (HF) live and cope with their disease remains scarce. The objective of this study was to explore, from phenomenological and holistic perspectives, the experiences of patients suffering from advanced HF, attended at home in the primary care setting in 2018. Materials and methods Qualitative study conducted in 4 primary healthcare centers in Barcelona (Spain). Twelve in-depth interviews were conducted in advanced HF patients, aged over 65 and visited regularly at home. We developed a purposeful sampling, accounting for variability in gender, age, and socioeconomic level. Leventhal's framework was used to analyze the interviews. Results Participants received insufficient and contradictory information about HF. They talked about their cognitive representation and claimed a better communication with healthcare professionals. Due to their advanced age, subjects considered their daily living limitations to be normal rather than as a consequence of HF. Gender differences in emotional representation were clearly observed. Women considered themselves the keystone of correct family "functioning" and thought that they were not useful if they could not correspond to gendered societal expectations. Cognitive coping strategies included specific diets, taking medication, and registering weight and blood pressure. Nevertheless, they perceived the locus of control as external and felt unable to manage HF progression. Their emotional coping strategies included some activities at home such as watching television and reading. Social support was perceived crucial to the whole process. Conclusions Locus of control in advanced HF was perceived as external. Healthcare professionals should adapt emotional health interventions in patients with advanced HF based on a gender perspective. Social support was found to be crucial in facing the disease. Patients reported poor communication with healthcare professionals.	[Checa, Caterina; Medina-Perucha, Laura; Munoz, Miguel-Angel; Maria Verdu-Rotellar, Jose; Berenguera, Anna] Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain; [Checa, Caterina] Primary Healthcare Ctr Dreta Eixample, Barcelona, Spain; [Checa, Caterina; Munoz, Miguel-Angel; Maria Verdu-Rotellar, Jose; Berenguera, Anna] Univ Autonoma Barcelona, Dept Pediatria, Obstet & Ginecol & Med Prevent, Bellaterra, Spain; [Munoz, Miguel-Angel; Maria Verdu-Rotellar, Jose] Inst Catala Salut, Barcelona, Spain	Autonomous University of Barcelona	Checa, C (corresponding author), Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain.; Checa, C (corresponding author), Primary Healthcare Ctr Dreta Eixample, Barcelona, Spain.; Checa, C (corresponding author), Univ Autonoma Barcelona, Dept Pediatria, Obstet & Ginecol & Med Prevent, Bellaterra, Spain.	ccheca@eapdretaeixample.cat	Muñoz, Miguel Angel/X-3511-2019; perez, miguel/GXF-5077-2022	Muñoz, Miguel Angel/0000-0002-4083-3248; Berenguera, Anna/0000-0002-0889-2002; Checa Jimenez, Caterina/0000-0003-0399-0532; Medina-Perucha, Laura/0000-0002-2981-2614	IDIAP Jordi Gol i Gurina [4R17/010]; Departament de Salut de la Generalitat de Catalunya [SLT008/18/00130]	IDIAP Jordi Gol i Gurina; Departament de Salut de la Generalitat de Catalunya(Generalitat de Catalunya)	The principal investigator (Checa C) received the following awards: This study was funded by a grant from IDIAP Jordi Gol i Gurina (reference number 4R17/010) Webpage: https://www.idiapjgol.org/index.php/ca/This study was developed with the support of the Departament de Salut de la Generalitat de Catalunya, in the call corresponding to 2018 for the granting of subsidies from the Pla Estrategic de Recerca i Innovacioen Salut (PERIS) 2019-2021, modality of "Grants for the intensification of the research activity of health professionals without specialized health training", with the file code SLT008/18/00130. Webpage: http://salutweb.gencat.cat/ca/inici/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemann H, 2018, J CARDIOVASC NURS, V33, pE1, DOI 10.1097/JCN.0000000000000523; Aminiahidashti H, 2016, EMERGENCY, V4, P34; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Berenguera Osso A., 2014, APORTACIONES INVESTI; Bjork JB, 2016, J CARD FAIL, V22, P569, DOI 10.1016/j.cardfail.2016.03.003; Blumenthal JA, 2019, HEALTH PSYCHOL, V38, P502, DOI 10.1037/hea0000716; Centers for Disease Control and Prevention, 2017, SOCIAL DETERMINANTS; Checa C, 2019, J CARDIOVASC NURS, V34, pE8, DOI 10.1097/JCN.0000000000000538; Conde-Martel A, 2015, REV CLIN ESP, V215, P363, DOI 10.1016/j.rce.2015.02.010; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Cowie MR, 2014, ESC HEART FAIL, V1, P110, DOI 10.1002/ehf2.12021; Daley C, 2019, HEART LUNG, V49, P477, DOI 10.1016/j.hrtlng.2019.05.012; Garcia-Calvente MD, 2012, SOCIOL HEALTH ILL, V34, P911, DOI 10.1111/j.1467-9566.2011.01440.x; Dempster M, 2015, J PSYCHOSOM RES, V79, P506, DOI 10.1016/j.jpsychores.2015.10.006; den Herder-van der Eerden M, 2017, PALLIATIVE MED, V31, P946, DOI 10.1177/0269216317697898; Fivecoat HC, 2018, EUR J CARDIOVASC NUR, V17, P598, DOI 10.1177/1474515118762800; Generalitat de Catalunya, 2017, OBS SIST SAL CAT; Gerlich MG, 2012, EUR J AGEING, V9, P297, DOI 10.1007/s10433-012-0244-6; Glogowska M, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0074-y; Graven LJ, 2014, INT J NURS STUD, V51, P320, DOI 10.1016/j.ijnurstu.2013.06.013; Greco A, 2015, BEHAV MED, V41, P9, DOI 10.1080/08964289.2013.855159; Hahn-Goldberg S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197831; Im J, 2019, HEALTH EXPECT, V22, P1331, DOI 10.1111/hex.12980; Irani E, 2019, J CARDIOVASC NURS, V34, P319, DOI 10.1097/JCN.0000000000000581; Bermejo-Caja CJ, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4185-z; Karimi M, 2016, INT J NURS STUD, V59, P89, DOI 10.1016/j.ijnurstu.2016.03.010; Klindtworth K, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0124-y; Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2; Metra Marco, 2019, Card Fail Rev, V5, P5, DOI 10.15420/cfr.2018.43.1; Morgan Karen, 2014, BMC Psychol, V2, P50, DOI 10.1186/s40359-014-0050-3; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Olano-Lizarraga M, 2016, J CLIN NURS, V25, P2413, DOI 10.1111/jocn.13285; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a949; Ruiz-Romero V, 2016, REV ESP SALUD PUBLIC, V90; Samulowitz A, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/6358624; Sandoval J, 2013, CINTA MOEBIO, V46, P37, DOI 10.4067/S0717-554X2013000100004; Seah ACW, 2016, J TRANSCULT NURS, V27, P392, DOI 10.1177/1043659615573840; Sevilla-Cazes J, 2018, J GEN INTERN MED, V33, P1700, DOI 10.1007/s11606-018-4542-3; Sobczak K, 2018, PATIENT PREFER ADHER, V12, P2397, DOI 10.2147/PPA.S183106; Spaling MA, 2015, J ADV NURS, V71, P2478, DOI 10.1111/jan.12712; Strachan PH, 2014, J CARD FAIL, V20, P448, DOI 10.1016/j.cardfail.2014.03.010; Taylor CJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013648; Tiede M, 2017, J TELEMED TELECARE, V23, P716, DOI 10.1177/1357633X16668436; Verulava T, 2017, Georgian Med News, P135; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Wildeboer JA, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-017-0688-z	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243974	10.1371/journal.pone.0243974	http://dx.doi.org/10.1371/journal.pone.0243974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315935	Green Published, gold			2022-12-26	WOS:000600186100078
J	Young, CKJ; Wheeler, JH; Rahman, MM; Young, MJ				Young, Carolyn K. J.; Wheeler, Joel H.; Rahman, Md Mostafijur; Young, Matthew J.			The antiretroviral 2 ',3 '-dideoxycytidine causes mitochondrial dysfunction in proliferating and differentiated HepaRG human cell cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL NUCLEOSIDE ANALOGS; DNA DEPLETION; OXIDATIVE-PHOSPHORYLATION; THYMIDINE KINASE; CYTOCHROMES P450; TOXICITY; POLYMERASE; REPLICATION; EXPRESSION; MTDNA	Nucleoside reverse transcriptase inhibitors (NRTIs) were the first drugs used to treat human immunodeficiency virus infection, and their use can cause mitochondrial toxicity, including mitochondrial DNA (mtDNA) depletion in several cases. The first-generation NRTIs, including 2',3'-dideoxycytidine (ddC), were originally and are still pursued as anticancer agents. NRTI-sensitive DNA polymerases localizing to mitochondria allow for the opportunity to poison proliferating cancer cell mtDNA replication as certain cancers rely heavily on mitochondrial functions. However, mtDNA replication is independent of the cell cycle creating a significant concern that toxicants such as ddC impair mtDNA maintenance in both proliferating and nonproliferating cells. To examine this possibility, we tested the utility of the HepaRG cell line to study ddC-induced toxicity in isogenic proliferating (undifferentiated) and nonproliferating (differentiated) cells. Following ddC exposures, we measured cell viability, mtDNA copy number, and mitochondrial bioenergetics utilizing trypan blue, Southern blotting, and extracellular flux analysis, respectively. After 13 days of 1 mu M ddC exposure, proliferating and differentiated HepaRG harbored mtDNA levels of 0.9% and 17.9% compared with control cells, respectively. Cells exposed to 12 mu M ddC contained even less mtDNA. By day 13, differentiated cell viability was maintained but declined for proliferating cells. Proliferating HepaRG bioenergetic parameters were severely impaired by day 8, with 1 and 12 mu M ddC, whereas differentiated cells displayed defects of spare and maximal respiratory capacities (day 8) and proton-leak linked respiration (day 14) with 12 mu M ddC. These results indicate HepaRG is a useful model to study proliferating and differentiated cell mitochondrial toxicant exposures.	[Young, Carolyn K. J.; Wheeler, Joel H.; Rahman, Md Mostafijur; Young, Matthew J.] Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Young, MJ (corresponding author), Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.	matthew.young@siu.edu	Rahman, Md Mostafijur/GPC-8781-2022	Rahman, Md Mostafijur/0000-0002-2857-0369; Young, Carolyn/0000-0001-9678-7327; Young, Matthew/0000-0002-5109-4719	National Institute of Environmental Health Sciences Pathway to Independence Award [5R00ES022638-04]; SIU School of Medicine; SIU Carbondale Doctoral Research Fellowship	National Institute of Environmental Health Sciences Pathway to Independence Award; SIU School of Medicine; SIU Carbondale Doctoral Research Fellowship	This research was supported by a National Institute of Environmental Health Sciences Pathway to Independence Award to M. J. Y. (5R00ES022638-04), by start-up funds from SIU School of Medicine to M.J.Y, and by an SIU Carbondale Doctoral Research Fellowship to M. M. R.	Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; ANTONELLI G, 1992, AIDS RES HUM RETROV, V8, P1839, DOI 10.1089/aid.1992.8.1839; Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030; Aschacher T, 2012, NEOPLASIA, V14, P44, DOI 10.1593/neo.11426; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Attene-Ramos MS, 2013, CHEM RES TOXICOL, V26, P1323, DOI 10.1021/tx4001754; Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08; Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8; BERGER AR, 1993, NEUROLOGY, V43, P358, DOI 10.1212/WNL.43.2.358; Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Borg N, 1998, ANTIMICROB AGENTS CH, V42, P2174, DOI 10.1128/AAC.42.9.2174; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Bratic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9808; Brown JA, 2012, CHEM RES TOXICOL, V25, P225, DOI 10.1021/tx200458s; Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409; De Clercq E, 2011, ANNU REV PHARMACOL, V51, P1, DOI 10.1146/annurev-pharmtox-010510-100228; DECLERCQ E, 1980, BIOCHEM PHARMACOL, V29, P1849, DOI 10.1016/0006-2952(80)90149-5; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Duong VN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66153-z; Eggleton J. S., 2022, STATPEARLS; ELWELL LP, 1987, ANTIMICROB AGENTS CH, V31, P274, DOI 10.1128/AAC.31.2.274; Feng Joy Y., 2018, Antiviral Chemistry & Chemotherapy, V26, p2040206618758524, DOI 10.1177/2040206618758524; Feng JY, 2016, ANTIMICROB AGENTS CH, V60, P806, DOI 10.1128/AAC.01922-15; Feng JY, 2014, ANTIMICROB AGENTS CH, V58, P1930, DOI 10.1128/AAC.02351-13; Fernandez-Moreno M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164199; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hanes JW, 2008, ANTIMICROB AGENTS CH, V52, P253, DOI 10.1128/AAC.00778-07; Huang RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10425; Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Kholodenko IV, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8910821; KLECKER RW, 1988, J CLIN PHARMACOL, V28, P837, DOI 10.1002/j.1552-4604.1988.tb03225.x; Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324; Le Guillou D, 2018, J PHARMACOL EXP THER, V365, P711, DOI 10.1124/jpet.117.246751; Le Vee M, 2013, TOXICOL IN VITRO, V27, P1979, DOI 10.1016/j.tiv.2013.07.003; Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288; Li M, 2016, ANTIMICROB AGENTS CH, V60, P5608, DOI 10.1128/AAC.00976-16; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Liyanage SU, 2017, BLOOD, V129, P2657, DOI 10.1182/blood-2016-10-741207; Louat T, 2001, MOL PHARMACOL, V60, P553; Marion MJ, 2010, METHODS MOL BIOL, V640, P261, DOI 10.1007/978-1-60761-688-7_13; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824; Meyer JN, 2018, TOXICOL SCI, V162, P15, DOI 10.1093/toxsci/kfy008; Meyer JN, 2017, TOXICOLOGY, V391, P2, DOI 10.1016/j.tox.2017.06.002; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Nadanaciva S, 2012, J BIOENERG BIOMEMBR, V44, P421, DOI 10.1007/s10863-012-9446-z; Nadanaciva S, 2010, J BIOMOL SCREEN, V15, P937, DOI 10.1177/1087057110373547; Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1; Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5; Roubicek DA, 2017, TOXICOLOGY, V391, P100, DOI 10.1016/j.tox.2017.06.012; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Seley-Radtke KL, 2018, ANTIVIR RES, V154, P66, DOI 10.1016/j.antiviral.2018.04.004; Setzer B, 2005, ANTIVIR THER, V10, P327; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Stephan T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48838-2; Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471; Tascher G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020192; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Wenum M, 2016, INT J BIOL SCI, V12, P964, DOI 10.7150/ijbs.15165; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wheeler Joel H, 2019, Curr Protoc Toxicol, V80, pe75, DOI 10.1002/cptx.75; Will Y, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020032; Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872; Young CKJ, 2019, CELL CYCLE, V18, P476, DOI 10.1080/15384101.2019.1578133; Young MJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133245; Young MJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00074; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Zhu CY, 2000, J BIOL CHEM, V275, P26727; Zolkipli-Cunningham Z, 2017, TOXICOLOGY, V391, P90, DOI 10.1016/j.tox.2017.07.009	79	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100206	10.1074/jbc.RA120.014885	http://dx.doi.org/10.1074/jbc.RA120.014885			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334881	Green Published, gold			2022-12-26	WOS:000672866400184
J	Darba, J; Marsa, A				Darba, Josep; Marsa, Alicia			Evaluation of productivity losses due to premature mortality from colorectal cancer	PLOS ONE			English	Article							SPAIN; COST; TRENDS; BURDEN	Cancer is responsible annually for around 27% of all deaths in Spain, 15% of which are caused by colorectal cancer. This malignancy has increased its incidence considerably over the past years, which surely impacts global productivity losses. The evaluation of lost productivity due to premature mortality provides valuable information that guides healthcare policies into the establishment of prevention and screening programs. The purpose of this study was to assess the productivity losses from premature deaths due to colorectal cancer over a ten year period (2008-2017). The costs derived from premature mortality due to this highly prevalent cancer were estimated using data on mortality, age- and sex-specific reference salaries and unemployment rates in Spain via the human capital approach. Between 2008 and 2017, 15,103 persons died per year from colorectal cancer, representing almost 15% of all cancer-related deaths. Annually, 25,333 years of potential productive life were estimated to be lost on average, 14,992 in males and 10,341 in females. Productivity losses summed euro510.8 million in in 2017, and the cancers of the colon and rectum accounted for 9.6% of cancer-related productivity losses in 2017 in Spain. Colorectal cancer has an important weight in terms of productivity losses within the Spanish population, consequently, prevention and early detection programmes should be promoted and implemented to achieve significant reductions in mortality and productivity losses.	[Darba, Josep] Univ Barcelona, Dept Econ, Barcelona, Spain; [Marsa, Alicia] BCN Hlth Econ & Outcomes Res SL, Dept Hlth Econ, Barcelona, Spain	University of Barcelona	Darba, J (corresponding author), Univ Barcelona, Dept Econ, Barcelona, Spain.	darba@ub.edu		Darba, Josep/0000-0003-2371-0999				Binefa G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19532; Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P1763, DOI 10.1093/jnci/djn384; Cabanes A, 2010, ANN ONCOL, V21, piii14, DOI 10.1093/annonc/mdq089; Corral J, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1297-6; Darba J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6243-7; Esteva M, 2014, CANCER EPIDEMIOL, V38, P346, DOI 10.1016/j.canep.2014.05.002; Ferlay J, 2018, EUR J CANCER, V103, P356, DOI 10.1016/j.ejca.2018.07.005; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Galceran J, 2017, CLIN TRANSL ONCOL, V19, P799, DOI 10.1007/s12094-016-1607-9; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hanly P, 2014, EXPERT REV PHARM OUT, V14, P355, DOI 10.1586/14737167.2014.909287; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Lopez-Bastida J, 2010, EUR J HEALTH ECON, V11, P513, DOI 10.1007/s10198-010-0244-4; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Oliva-Moreno J, 2018, BREAST CANCER RES TR, V172, P571, DOI 10.1007/s10549-018-4963-z; Oliva-Moreno J, 2012, EUR J HEALTH ECON, V13, P605, DOI 10.1007/s10198-011-0344-9; Pearce A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2854-4; Longobardo LMP, 2015, REV ESP SALUD PUBLIC, V89, P39, DOI 10.4321/S1135-57272015000100005; Ribes J, 2009, EUR J GASTROEN HEPAT, V21, P92, DOI 10.1097/MEG.0b013e32830b5f39; Schofield D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011151; Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035; Tengo M, 2017, CURR OPIN ENV SUST, V26-27, P17, DOI 10.1016/j.cosust.2016.12.005; World Health Organization (WHO) Mortality Database, HLTH STAT INF SYST; Yabroff K. Robin, 2013, Journal of the National Cancer Institute Monographs, P62, DOI 10.1093/jncimonographs/lgt001; Zhang W, 2011, SOC SCI MED, V72, P185, DOI 10.1016/j.socscimed.2010.10.026	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244375	10.1371/journal.pone.0244375	http://dx.doi.org/10.1371/journal.pone.0244375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362274	Green Published, gold			2022-12-26	WOS:000603071600050
J	Aisyah, DN; Mayadewi, CA; Diva, H; Kozlakidis, Z; Siswanto; Adisasmito, W				Aisyah, Dewi Nur; Mayadewi, Chyntia Aryanti; Diva, Haniena; Kozlakidis, Zisis; Siswanto; Adisasmito, Wiku			A spatial-temporal description of the SARS-CoV-2 infections in Indonesia during the first six months of outbreak	PLOS ONE			English	Article							COVID-19	Background Since the first cases reported in Wuhan, China, in December 2019, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread worldwide. In Indonesia, the first case was reported in early March 2020, and the numbers of confirmed infections have been increasing until now. Efforts to contain the virus globally and in Indonesia are ongoing. This is the very first manuscript using a spatial-temporal model to describe the SARS-CoV-2 transmission in Indonesia, as well as providing a patient profile for all confirmed COVID-19 cases. Method Data was collected from the official website of the Indonesia National Task Force for the Acceleration of COVID-19, from the period of 02 March 2020-02 August 2020. The data from RT-PCR confirmed, SARS-CoV-2 positive patients was categorized according to demographics, symptoms and comorbidities based on case categorization (confirmed, recovered, dead). The data collected provides granular and thorough information on time and geographical location for all 34 Provinces across Indonesia. Results A cumulative total of 111,450 confirmed cases of were reported in Indonesia during the study period. Of those confirmed cases 67.79% (75,551/111,450) were shown as recovered and 4.83% (5,382/111,450) of them as died. Patients were mostly male (50.52%; 56,300/111,450) and adults aged 31 to 45 years old (29.73%; 33,132/111,450). Overall patient presentation symptoms of cough and fever, as well as chronic disease comorbidities were in line with previously published data from elsewhere in South-East Asia. The data reported here, shows that from the detection of the first confirmed case and within a short time period of 40 days, all the provinces of Indonesia were affected by COVID-19. Conclusions This study is the first to provide detailed characteristics of the confirmed SARS-CoV-2 patients in Indonesia, including their demographic profile and COVID-19 presentation history. It used a spatial-temporal analysis to present the epidemic spread from the very beginning of the outbreak throughout all provinces in the country. The increase of new confirmed cases has been consistent during this time period for all provinces, with some demonstrating a sharp increase, in part due to the surge in national diagnostic capacity. This information delivers a ready resource that can be used for prediction modelling, and is utilized continuously by the current Indonesian Task Force in order to advise on potential implementation or removal of public distancing measures, and on potential availability of healthcare capacity in their efforts to ultimately manage the outbreak.	[Aisyah, Dewi Nur; Mayadewi, Chyntia Aryanti; Diva, Haniena; Adisasmito, Wiku] Indonesia One Hlth Univ Network, Depok, West Java, Indonesia; [Aisyah, Dewi Nur] UCL, Inst Epidmiol & Hlth Care, London, England; [Kozlakidis, Zisis] World Hlth Org, Int Agcy Res Canc, Lyon, France; [Siswanto] Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Adisasmito, Wiku] Univ Indonesia, Fac Publ Hlth, Depok, West Java, Indonesia; [Adisasmito, Wiku] Indonesia Natl Task Force Accelerat COVID 19, Jakarta, Indonesia	University of London; University College London; World Health Organization; International Agency for Research on Cancer (IARC); National Institute of Health Research & Development - Indonesia; University of Indonesia	Aisyah, DN (corresponding author), Indonesia One Hlth Univ Network, Depok, West Java, Indonesia.; Aisyah, DN (corresponding author), UCL, Inst Epidmiol & Hlth Care, London, England.	dewi.aisyah@indohun.org	Kozlakidis, Zisis/AAX-8081-2020	Kozlakidis, Zisis/0000-0002-3836-7209				Adioetomo Sri Moertiningsih, 2014, UNFPA INDONESIA MONO, V1; AL-Rousan N, 2020, J MED VIROL, V92, P1603, DOI 10.1002/jmv.25850; [Anonymous], 2020, LANCET, V395, P1089, DOI 10.1016/S0140-6736(20)30757-1; [Anonymous], 2020, KOMPAS; [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961; [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961; Cowling BJ, 2020, J INFECT DIS, V221, P1749, DOI 10.1093/infdis/jiaa123; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Government of Indonesia, 2020, LIST COVID 19 REF HO; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Indonesian Government, TASK FORC ACC HANDL; Indonesian Ministry of Health, 2020, GUID PREV CONTR COVI; Indonesian News Agency, JAKARTA GLOBE NEWS; Kelvin AA, 2020, LANCET INFECT DIS, V20, P633, DOI 10.1016/S1473-3099(20)30236-X; Konstantinoudis G, 2020, SPAT SPATIO-TEMPORAL, V32, DOI 10.1016/j.sste.2019.100319; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lippi G, 2020, ANN CLIN BIOCHEM, V57, P262, DOI 10.1177/0004563220922255; Liu Y, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100354; MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1327; Morand A, 2020, ARCH PEDIATRIE, V27, P117, DOI 10.1016/j.arcped.2020.03.001; Nanni M, 2005, LECT NOTES COMPUT SC, V3392, P98, DOI 10.1007/11415763_7; Nguyen THD, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101651; Okada P, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.8.2000097; Riccardo F, 2020, MEDRXIV, DOI [10.1101/2020.04.08.20056861, DOI 10.1101/2020.04.08.20056861V1]; Setiati S, 2020, ACTA MED INDONES, V52, P84; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; The World Bank, POP FEM TOTO POP IND; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; Tsang TK, LANCET PUBLIC HELATH, V5, pe289, DOI DOI 10.1016/S2468-2667(20)30089-X32330458; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; WHO, COVID 19 STRAT UPD; World Health Organization, 2019, COVID 19 WEEKL EP UP; World Health Organization, 2020, CRIT PREP READ RESP; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	39	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243703	10.1371/journal.pone.0243703	http://dx.doi.org/10.1371/journal.pone.0243703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351801	Green Published, gold			2022-12-26	WOS:000603071400007
J	Goldsztejn, U; Schwartzman, D; Nehorai, A				Goldsztejn, Uri; Schwartzman, David; Nehorai, Arye			Public policy and economic dynamics of COVID-19 spread: A mathematical modeling study	PLOS ONE			English	Article							OUTBREAKS; LIFE	With the COVID-19 pandemic infecting millions of people, large-scale isolation policies have been enacted across the globe. To assess the impact of isolation measures on deaths, hospitalizations, and economic output, we create a mathematical model to simulate the spread of COVID-19, incorporating effects of restrictive measures and segmenting the population based on health risk and economic vulnerability. Policymakers make isolation policy decisions based on current levels of disease spread and economic damage. For 76 weeks in a population of 330 million, we simulate a baseline scenario leaving strong isolation restrictions in place, rapidly reducing isolation restrictions for non-seniors shortly after outbreak containment, and gradually relaxing isolation restrictions for non-seniors. We use 76 weeks as an approximation of the time at which a vaccine will be available. In the baseline scenario, there are 235,724 deaths and the economy shrinks by 34.0%. With a rapid relaxation, a second outbreak takes place, with 525,558 deaths, and the economy shrinks by 32.3%. With a gradual relaxation, there are 262,917 deaths, and the economy shrinks by 29.8%. We also show that hospitalizations, deaths, and economic output are quite sensitive to disease spread by asymptomatic people. Strict restrictions on seniors with very gradual lifting of isolation for non-seniors results in a limited number of deaths and lesser economic damage. Therefore, we recommend this strategy and measures that reduce non-isolated disease spread to control the pandemic while making isolation economically viable.	[Goldsztejn, Uri] Washington Univ, McKelvey Sch Engn, Dept Biomed Engn, St Louis, MO 63110 USA; [Schwartzman, David] Washington Univ, Olin Sch Business, St Louis, MO 63110 USA; [Nehorai, Arye] Washington Univ, McKelvey Sch Engn, Preston M Green Dept Elect & Syst Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Nehorai, A (corresponding author), Washington Univ, McKelvey Sch Engn, Preston M Green Dept Elect & Syst Engn, St Louis, MO 63110 USA.	nehorai@wustl.edu	Goldsztejn, Uri/ABG-8779-2021	Goldsztejn, Uri/0000-0001-7040-7007; Nehorai, Arye/0000-0002-9055-9865				Acemoglu D., 2020, MULTIRISK SIR MODEL, DOI [10.1920/wp.cem.2020.1420, DOI 10.1920/WP.CEM.2020.1420]; Alva-Manchego F, 2020, COMPUT LINGUIST, V46, P135, DOI [10.1162/coli_a_00370, 10.1162/COLI_a_00370]; Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; Baqaee D., 2020, 27244 NBER, DOI [10.3386/w27244, DOI 10.3386/W27244]; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Berger D. W., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w26901; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; Cutler DM., 2016, EC CONDITIONS MORTAL; Deb S, 2020, ARXIV; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Enserink M, 2020, SCIENCE, V367, P1414, DOI 10.1126/science.367.6485.1414-b; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Glover A., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hu Z., 2020, INT J ED EXCELL, DOI DOI 10.18562/IJEE.054; Jamieson-Lane AD, 2020, EFFECTIVENESS TARGET; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lipsitch M, 2020, CTR COMMUNICABLE DIS; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Mongey S, 2020, BECKER FRIEDMAN I EC; Noorbhai H, 2020, ANN MED SURG, V57, P5, DOI 10.1016/j.amsu.2020.06.041; Panovska-Griffiths J, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08671-z; Potter GE, 2011, ANN APPL STAT, V5, P1816, DOI 10.1214/11-AOAS474; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Stock JH., 2020, REOPENING CORONAVIRU; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	39	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244174	10.1371/journal.pone.0244174	http://dx.doi.org/10.1371/journal.pone.0244174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351835	Green Published, gold, Green Submitted			2022-12-26	WOS:000603071400037
J	Busse, E; Hickey, C; Vasilakos, N; Stewart, K; O'Brien, F; Rivera, J; Marrero, L; Lacey, M; Schroll, R; Van Meter, K; Sammarco, MC				Busse, Emily; Hickey, Cheryl; Vasilakos, Nicole; Stewart, Kennon; O'Brien, Fred; Rivera, Jessica; Marrero, Luis; Lacey, Michelle; Schroll, Rebecca; Van Meter, Keith; Sammarco, Mimi C.			Plasma flow distal to tourniquet placement provides a physiological mechanism for tissue salvage	PLOS ONE			English	Article							HYPERBARIC-OXYGEN THERAPY; INDOCYANINE GREEN; PULMONARY SEQUESTRATION; REPERFUSION; ANGIOGRAPHY; OBESITY; INJURY; MODEL	Military literature has demonstrated the utility and safety of tourniquets in preventing mortality for some time, paving the way for increased use of tourniquets in civilian settings, including perioperatively to provide a bloodless surgical field. However, tourniquet use is not without risk and the subsequent effects of tissue ischemia can impede downstream rehabilitative efforts to regenerate and salvage nerve, muscle, tissue and bone in the limb. Limb ischemia studies in both the mouse and pig models have indicated not only that there is residual flow past the tourniquet by means of microcirculation, but also that recovery from tissue ischemia is dependent upon this microcirculation. Here we expand upon these previous studies using portable Near-Infrared Imaging to quantify residual plasma flow distal to the tourniquet in mice, pigs, and humans and leverage this flow to show that plasma can be supersaturated with oxygen to reduce intracellular hypoxia and promote tissue salvage following tourniquet placement. Our findings provide a mechanism of delivery for the application of oxygen, tissue preservation solutions, and anti-microbial agents prior to tourniquet release to improve postoperative recovery. In the current environment of increased tourniquet use, techniques which promote distal tissue preservation and limb salvage rates are crucial.	[Busse, Emily; Schroll, Rebecca; Sammarco, Mimi C.] Tulane Sch Med, Dept Surg, New Orleans, LA 70112 USA; [Hickey, Cheryl; Van Meter, Keith] Louisiana State Univ, Hlth Sci Ctr, Dept Emergency Med, New Orleans, LA USA; [Vasilakos, Nicole] Tulane Sch Med, Dept Physiol, New Orleans, LA USA; [Stewart, Kennon; Lacey, Michelle] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [O'Brien, Fred] Dwight D Eisenhower Army Med Ctr, Orthopaed Surg Serv, Ft Gordon, GA USA; [Rivera, Jessica; Marrero, Luis] Louisiana State Univ, Hlth Sci Ctr, Dept Orthoped, New Orleans, LA USA; [Busse, Emily] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA	Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; Tulane University; United States Department of Defense; United States Army; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Baylor College of Medicine	Sammarco, MC (corresponding author), Tulane Sch Med, Dept Surg, New Orleans, LA 70112 USA.	msammarc@tulane.edu		Busse, Emily/0000-0002-8555-0612	National Institutes of Health, NIGMS [U54GM104940, P20GM103629]	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MCS: National Institutes of Health, NIGMS, P20GM103629 nigms.nih.gov MCS: National Institutes of Health, NIGMS, U54GM104940. nigms.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39; B D, 2013, AORN J, P653; Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; Cho SS, 2019, FRONT SURG, V6, DOI 10.3389/fsurg.2019.00011; Choudhury R, 2018, INT J GEN MED, V11, P431, DOI 10.2147/IJGM.S172460; Cleveland Andrew, 2013, J Surg Orthop Adv, V22, P310; Connolly PH, 2015, ANN VASC SURG, V29, DOI 10.1016/j.avsg.2015.04.090; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; Drysch M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210961; DSouza AV, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.8.080901; GABB G, 1987, CHEST, V92, P1074, DOI 10.1378/chest.92.6.1074; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gruneboom A, 2019, NAT METAB, V1, P236, DOI 10.1038/s42255-018-0016-5; Heyboer M, 2017, ADV WOUND CARE, V6, P210, DOI 10.1089/wound.2016.0718; Howard JT, 2019, JAMA SURG, V154, P600, DOI 10.1001/jamasurg.2019.0151; HUTCHINSON DT, 1993, J HAND SURG-AM, V18A, P206, DOI 10.1016/0363-5023(93)90347-6; Joh JH, 2016, ANN SURG TREAT RES, V90, P279, DOI 10.4174/astr.2016.90.5.279; Kamolz LP, 2006, J TRAUMA, V61, P635, DOI 10.1097/01.ta.0000233910.47550.9c; Kumar Kamal, 2016, J Anaesthesiol Clin Pharmacol, V32, P424, DOI 10.4103/0970-9185.168174; Leach RM, 1998, BRIT MED J, V317, P1140; Lee C, 2007, EMERG MED J, V24, P584, DOI 10.1136/emj.2007.046359; Lin JS, 2019, ACTA CARDIOL SIN, V35, P65, DOI 10.6515/ACS.201901_35(1).20180731A; Marenzana M, 2013, BONE RES, V1, P203, DOI 10.4248/BR201303001; McCormack MC, 2008, SURGERY, V143, P126, DOI 10.1016/j.surg.2007.06.005; MESSERLI FH, 1983, ANN INTERN MED, V99, P757, DOI 10.7326/0003-4819-99-6-757; MESSERLI FH, 1982, CIRCULATION, V66, P55, DOI 10.1161/01.CIR.66.1.55; Muller S, 2013, J SURG RES, V181, P170, DOI 10.1016/j.jss.2012.05.088; Ohyama Yoshiaki, 2013, J Cardiol Cases, V8, pe13, DOI 10.1016/j.jccase.2013.02.015; Radowsky JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137430; Saenz-Jalon M, 2018, J PERIANESTH NURS, V33, P699, DOI 10.1016/j.jopan.2016.08.017; Sammarco MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140156; Sammarco MC, 2014, J BONE MINER RES, V29, P2336, DOI 10.1002/jbmr.2261; Schroll R, 2015, J TRAUMA ACUTE CARE, V79, P10, DOI 10.1097/TA.0000000000000689; Shackelford Stacy A, 2015, J Spec Oper Med, V15, P17; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Tjarnstrom J, 1999, EUR SURG RES, V31, P147, DOI 10.1159/000008633; Tomita Masato, 2007, Mod Rheumatol, V17, P409, DOI 10.1007/s10165-007-0609-4; Tran TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043410; Tu HY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00207; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; Zamboni WA, 1996, ARCH SURG-CHICAGO, V131, P756; Zhang D, 2017, ACTA PHYSIOL, V219, P453, DOI 10.1111/apha.12737	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244236	10.1371/journal.pone.0244236	http://dx.doi.org/10.1371/journal.pone.0244236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347516	Green Published, gold			2022-12-26	WOS:000603071100003
J	Helgoy, KV; Smeby, JC; Bonsaksen, T; Olsen, NR				Helgoy, Kjersti Velde; Smeby, Jens-Christian; Bonsaksen, Tore; Rydland Olsen, Nina			Research-based occupational therapy education: An exploration of students' and faculty members' experiences and perceptions	PLOS ONE			English	Article							UNDERGRADUATE RESEARCH EXPERIENCES; ACADEMICS PERCEPTIONS; ATTITUDES; KNOWLEDGE; ENVIRONMENT; BARRIERS	Introduction One argument for introducing research in bachelor`s degree in health care is to ensure the quality of future health care delivery. The requirements for research-based education have increased, and research on how research-based education is experienced is limited, especially in bachelor health care education programmes. The aim of this study was to explore how occupational therapy students and faculty members experienced and perceived research-based education. Methods This qualitative, interpretative description consisted of three focus group interviews with occupational therapy students in their final year (n = 8, 6 and 4), and three focus group interviews with faculty members affiliated with occupational therapy programmes in Norway (n = 5, 2 and 5). Interviewing both students and faculty members enabled us to explore the differences in their experiences and perceptions. Results Five integrative themes emerged from the analysis: "introducing research early", "setting higher expectations", "ensuring competence in research methods", "having role models" and "providing future best practice". Research was described as an important aspect of the occupational therapy bachelor program as it helps ensure that students achieve the necessary competence for offering future best practice. Students expressed a need to be introduced to research early in the program, and they preferred to have higher expectations regarding use of research. Competence in research methods and the importance of role models were also highlighted. Conclusions Undergraduate health care students are expected to be competent in using research. Findings from our study demonstrated that the participants perceived the use of research during training as important to ensure future best practice. Increasing the focus on research in the programme's curricula and efforts to improve students' formal training in research-specific skills could be a starting point towards increased use of research in the occupational therapy profession.	[Helgoy, Kjersti Velde] VID Specialized Univ, Ctr Diakonia & Profess Practice, Stavanger, Norway; [Smeby, Jens-Christian] OsloMet Oslo Metropolitan Univ, Ctr Study Profess, Oslo, Norway; [Bonsaksen, Tore] Inland Norway Univ Appl Sci, Fac Social & Hlth Sci, Dept Hlth & Nursing Sci, Elverum, Norway; [Bonsaksen, Tore] VID Specialized Univ, Fac Hlth Studies, Sandnes, Norway; [Rydland Olsen, Nina] Western Norway Univ Appl Sci, Fac Hlth & Social Sci, Dept Hlth & Functioning, Bergen, Norway	VID Specialised University; Oslo Metropolitan University (OsloMet); Inland Norway University of Applied Sciences; VID Specialised University; Western Norway University of Applied Sciences	Helgoy, KV (corresponding author), VID Specialized Univ, Ctr Diakonia & Profess Practice, Stavanger, Norway.	kjersti.velde.helgoy@vid.no	Bonsaksen, Tore/U-5148-2018	Bonsaksen, Tore/0000-0001-6315-1111; Olsen, Nina Rydland/0000-0002-5173-1597; Helgoy, Kjersti Velde/0000-0001-9615-9881				[Anonymous], 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14123; [Anonymous], 2015, JMIR MED INFORM, V3, pe22; [Anonymous], 2017, FORSKRIFT TILSYN MED, V2-3; [Anonymous], 2018, 7 SER FPGAS DAT SHEE, V2, P1; [Anonymous], 2016, EVIDENCE, V8, pe1000; Auchincloss LC, 2014, CBE-LIFE SCI EDUC, V13, P29, DOI 10.1187/cbe.14-01-0004; Brew A, 2017, TEACH HIGH EDUC, V22, P551, DOI 10.1080/13562517.2016.1273216; Chang YJ, 2015, ACAD MED, V90, P1162, DOI 10.1097/ACM.0000000000000702; Deicke W., 2014, CUR Q, V35, P27; Griffiths R, 2004, STUD HIGH EDUC, V29, P709, DOI 10.1080/0307507042000287212; Halabi JO., 2016, SAUDI J HLTH SCI, V5, P118, DOI [10. 4103/2278-0521. 195813, DOI 10.4103/2278-0521.195813, 10.4103/2278-0521.195813]; Healey Mick., 2005, RESHAPING U NEW RELA, P67, DOI DOI 10.1371/JOURNAL.PMED.0020124; Healey Mick., 2009, HIGH EDUC; Huet I, 2018, EUR J ENG EDUC, V43, P725, DOI 10.1080/03043797.2017.1415299; Jackson L, 2018, AM J OCCUP THER, V72, DOI 10.5014/ajot.2018.72S1-PO8029; Jenkins A., 2015, COUNC UNDERGRAD RES, V35, P31; Jenkins A., 2007, LINKING RES TEACHING; Jenkins A, 2013, UNIVERSITY TEACHING IN FOCUS: A LEARNING-CENTRED APPROACH, P128; Johansson B, 2010, J NURS MANAGE, V18, P70, DOI 10.1111/j.1365-2834.2009.01060.x; Kamwendo K, 2001, SCAND J CARING SCI, V15, P295, DOI 10.1046/j.1471-6712.2001.00041.x; Kandell GV, 2019, MED STUDENTS UNDERST, P1; Keib CN, 2017, NURS EDUC TODAY, V54, P37, DOI 10.1016/j.nedt.2017.04.007; Krueger R., 2014, PRACTICAL GUIDE APPL; Kunnskapsdepartementet, 2017, KULT KVAL HOYER UTD, P130; Kyvik S., 2014, FORSKNINGSBASERT UTD; Kyvik S, 2015, VOCATIONAL PROFESSIO, P105; Leach MJ, 2016, J CLIN NURS, V25, P194, DOI 10.1111/jocn.13103; Lomborg K., 2010, KLIN SYGEPLEJE, V24, P7; Lopatto D., 2010, SCI SOLUTION IMPACT; Malterud K., 2018, FOKUSGRUPPER SOM FOR; McCluskey A., 2003, AUST OCCUP THER J, V50, P3, DOI [10.1046/j.1440-1630.2003.00303.x, DOI 10.1046/J.1440-1630.2003.00303.X]; Ofsted, 2016, UNKN CHILDR DEST DIS; Olsen NR, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-52; Ordinetz SA., 2009, THESIS; Ozay SB, 2012, TEACH HIGH EDUC, V17, P453, DOI 10.1080/13562517.2011.641009; Paudel S, 2019, MED STUDENTS KNOWLED, P162; Rodenbusch SE, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-03-0117; Ross JG, 2019, NURS EDUC TODAY, V82, P79, DOI 10.1016/j.nedt.2019.08.006; Ryan EJ, 2016, J CLIN NURS, V25, P1548, DOI 10.1111/jocn.13229; Sabzwari S, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-68; Samuelsson K, 2015, BRIT J OCCUP THER, V78, P175, DOI 10.1177/0308022615569511; Smyth L, 2016, HIGH EDUC, V72, P191, DOI 10.1007/s10734-015-9945-z; Stronge M, 2012, OCCUP THER INT, V19, P7, DOI 10.1002/oti.328; Stube JE, 2007, AM J OCCUP THER, V61, P53, DOI 10.5014/ajot.61.1.53; Thorne S, 2016, DEV QUAL INQ, V2; Trowler P., 2007, TRIBES TERRITORIES R; Upton D, 2014, BRIT J OCCUP THER, V77, P24, DOI 10.4276/030802214X13887685335544; Utdannings- og forskningsdepartementet, 2005, RAMM ERG, P1; Utdanningsforbundet, 2020, TID FORSK UTV KARTL; Vereijken MWC, 2018, ADV HEALTH SCI EDUC, V23, P371, DOI 10.1007/s10459-017-9803-0; VID Specialized University, 2012, FAGPL BACH ERG 180 S; Visser-Wijnveen G., 2013, INTEGRATIE ONDERZOEK; Walkington H, 2011, J GEOGR HIGHER EDUC, V35, P315, DOI 10.1080/03098265.2011.563377; Wilson A, 2012, STUD HIGH EDUC, V37, P513, DOI 10.1080/03075079.2010.527933	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243544	10.1371/journal.pone.0243544	http://dx.doi.org/10.1371/journal.pone.0243544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347466	Green Published, gold			2022-12-26	WOS:000603071100004
J	Sugishita, Y; Kurita, J; Sugawara, T; Ohkusa, Y				Sugishita, Yoshiyuki; Kurita, Junko; Sugawara, Tamie; Ohkusa, Yasushi			Effects of voluntary event cancellation and school closure as countermeasures against COVID-19 outbreak in Japan	PLOS ONE			English	Article							PANDEMIC INFLUENZA; STRATEGIES	Background To control the COVID-19 outbreak in Japan, sports and entertainment events were canceled and schools were closed throughout Japan from February 26 through March 19. That policy has been designated as voluntary event cancellation and school closure (VECSC). Object This study assesses VECSC effectiveness based on predicted outcomes. Methods A simple susceptible-infected-recovered model was applied to data of patients with symptoms in Japan during January 14 through March 26. The respective reproduction numbers for periods before VECSC (R-0), during VECSC (R-e), and after VECSC (R-a) were estimated. Results Results suggest R-0 before VECSC as 2.534 [2.449, 2.598], R-e during VECSC as 1.077 [0.948, 1.228], and R-a after VECSC as 4.455 [3.615, 5.255]. Discussion and conclusion Results demonstrated that VECSC can reduce COVID-19 infectiousness considerably, but after VECSC, the value of the reproduction number rose to exceed 4.0.	[Sugishita, Yoshiyuki; Sugawara, Tamie] Natl Inst Infect Dis, Tokyo, Japan; [Kurita, Junko; Ohkusa, Yasushi] Tokiwa Univ, Collage Nursing, Dept Nursing, Ibaraki, Japan	National Institute of Infectious Diseases (NIID)	Sugishita, Y (corresponding author), Natl Inst Infect Dis, Tokyo, Japan.	yoshiyuk@gmail.com						[Anonymous], 2020, JAPAN TIMES; Britton T, 2009, STOCHASTIC EPIDEMIC; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glockner S, 2020, NOW CASTING COVID 19, DOI [10.1101/2020.03.18.20037473, DOI 10.1101/2020.03.18.20037473]; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Hohle M, 2014, BIOMETRICS, V70, P993, DOI 10.1111/biom.12194; Kelvin AA, 2020, LANCET INFECT DIS, V20, P633, DOI 10.1016/S1473-3099(20)30236-X; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kurita J., 2020, FORECAST COVID 19 OU, DOI [10.1101/2020.04.02.20051490, DOI 10.1101/2020.04.02.20051490]; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee PI, 2020, J MICROBIOL IMMUNOL, V53, P371, DOI 10.1016/j.jmii.2020.02.011; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; NARULA SC, 1982, INT STAT REV, V50, P317, DOI 10.2307/1402501; Nishiura H., 2020, MEDRXIV, DOI 10.1101/2020.02.28.20029272; Ohkusa Y, 2011, J INFECT CHEMOTHER, V17, P468, DOI 10.1007/s10156-010-0200-3; Ohkusa Y, 2009, JPN J INFECT DIS, V62, P98; Oshitani H, 2020, CONCEPT COUNTER MEAS; Phillips RF, 2002, STAT COMPUT, V12, P281, DOI 10.1023/A:1020759012226; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Siemsen E, 2007, SOCIOL METHOD RES, V36, P227, DOI 10.1177/0049124107301946; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	25	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0239455	10.1371/journal.pone.0239455	http://dx.doi.org/10.1371/journal.pone.0239455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347444	gold, Green Published, Green Submitted			2022-12-26	WOS:000603071100027
J	Joshi, P; Skromne, I				Joshi, Piyush; Skromne, Isaac			A theoretical model of neural maturation in the developing chick spinal cord	PLOS ONE			English	Article							HOX GENE-EXPRESSION; NEUROMESODERMAL PROGENITORS; NEURONAL DIFFERENTIATION; RESTRICTED EXPRESSION; TRANSCRIPTION FACTORS; PARAXIAL MESODERM; RETINOID PATHWAYS; OPPOSING FGF; T BRACHYURY; ACTIVATION	Cellular differentiation is a tightly regulated process under the control of intricate signaling and transcription factors interaction network working in coordination. These interactions make the systems dynamic, robust and stable but also difficult to dissect. In the spinal cord, recent work has shown that a network of FGF, WNT and Retinoic Acid (RA) signaling factors regulate neural maturation by directing the activity of a transcription factor network that contains CDX at its core. Here we have used partial and ordinary (Hill) differential equation based models to understand the spatiotemporal dynamics of the FGF/WNT/RA and the CDX/transcription factor networks, alone and in combination. We show that in both networks, the strength of interaction among network partners impacts the dynamics, behavior and output of the system. In the signaling network, interaction strength determine the position and size of discrete regions of cell differentiation and small changes in the strength of the interactions among networking partners can result in a signal overriding, balancing or oscillating with another signal. We also show that the spatiotemporal information generated by the signaling network can be conveyed to the CDX/transcription network to produces a transition zone that separates regions of high cell potency from regions of cell differentiation, in agreement with most in vivo observations. Importantly, one emerging property of the networks is their robustness to extrinsic disturbances, which allows the system to retain or canalize NP cells in developmental trajectories. This analysis provides a model for the interaction conditions underlying spinal cord cell maturation during embryonic axial elongation.	[Joshi, Piyush; Skromne, Isaac] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Skromne, Isaac] Univ Richmond, Dept Biol, Richmond, VA 23173 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Richmond	Skromne, I (corresponding author), Univ Richmond, Dept Biol, Richmond, VA 23173 USA.	iskromne@richmond.edu		Skromne, Isaac/0000-0003-2369-7210	Sigma XI GIAR; University of Richmond School of Arts and Sciences; National Science Foundation [IOS-1755386]	Sigma XI GIAR; University of Richmond School of Arts and Sciences; National Science Foundation(National Science Foundation (NSF))	P.J. was supported by Sigma XI GIAR, and I.S. was supported by University of Richmond School of Arts and Sciences and by the National Science Foundation (IOS-1755386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires R, 2019, DEV CELL, V48, P383, DOI 10.1016/j.devcel.2018.12.004; Akai J, 2005, GENE DEV, V19, P2877, DOI 10.1101/gad.357705; Amin S, 2016, CELL REP, V17, P3165, DOI 10.1016/j.celrep.2016.11.069; Atsuta Y, 2015, DEVELOPMENT, V142, P2329, DOI 10.1242/dev.122408; Basson MA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008151; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Castillo HA, 2010, DEVELOPMENT, V137, P507, DOI 10.1242/dev.043257; CATALA M, 1995, MECH DEVELOP, V51, P51, DOI 10.1016/0925-4773(95)00350-A; Cunningham TJ, 2016, BIOL OPEN, V5, P1821, DOI 10.1242/bio.020891; Delfino-Machin M, 2005, DEVELOPMENT, V132, P4273, DOI 10.1242/dev.02009; Denans N, 2015, ELIFE, V4, DOI 10.7554/eLife.04379; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; del Corral RD, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00058; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Eroshkin FM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23049; Gaunt SJ, 2005, INT J DEV BIOL, V49, P901, DOI 10.1387/ijdb.052021sg; Goto H, 2017, DEVELOPMENT, V144, P1412, DOI 10.1242/dev.143578; Gouti M, 2015, TRENDS GENET, V31, P282, DOI 10.1016/j.tig.2015.03.001; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gregory PA, 2006, PHARMACOGENET GENOM, V16, P527, DOI 10.1097/01.fpc.0000215068.06471.35; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Henrique D, 2015, DEVELOPMENT, V142, P2864, DOI 10.1242/dev.119768; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hou LL, 2017, SEMIN CELL DEV BIOL, V63, P2, DOI 10.1016/j.semcdb.2016.08.005; Housden BE, 2014, TRENDS BIOCHEM SCI, V39, P457, DOI 10.1016/j.tibs.2014.07.008; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Joshi P, 2019, DEV BIOL, V449, P132, DOI 10.1016/j.ydbio.2019.02.014; Jurberg AD, 2013, DEV CELL, V25, P451, DOI 10.1016/j.devcel.2013.05.009; Kawachi T, 2020, DEV BIOL, V461, P160, DOI 10.1016/j.ydbio.2020.02.007; Kiparissides A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014668; Koch F, 2017, DEV CELL, V42, P514, DOI 10.1016/j.devcel.2017.07.021; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep38665; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Olivera-Martinez I, 2014, DEVELOPMENT, V141, P3266, DOI 10.1242/dev.112623; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Pituello F, 1999, DEVELOPMENT, V126, P587; Pogenberg V, 2005, J BIOL CHEM, V280, P1625, DOI 10.1074/jbc.M409302200; Pownall ME, 1998, CURR BIOL, V8, P673, DOI 10.1016/S0960-9822(98)70257-X; Santillan M, 2008, MATH MODEL NAT PHENO, V3, P85, DOI 10.1051/mmnp:2008056; Sasai N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001907; SCHOENWOLF GC, 1979, AM J ANAT, V155, P445, DOI 10.1002/aja.1001550404; Sherman MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002407; Shi WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42648; Singh S, 2000, J BIOL CHEM, V275, P17306, DOI 10.1074/jbc.M000359200; Takada S, 2017, J BIOCHEM, V161, P1, DOI 10.1093/jb/mvw071; Takemoto T, 2006, DEVELOPMENT, V133, P297, DOI 10.1242/dev.02196; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tamashiro DAA, 2012, DIFFERENTIATION, V83, P282, DOI 10.1016/j.diff.2012.02.010; Tiedemann HB, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002586; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; Vitobello A, 2011, DEV CELL, V20, P469, DOI 10.1016/j.devcel.2011.03.011; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	75	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244219	10.1371/journal.pone.0244219	http://dx.doi.org/10.1371/journal.pone.0244219			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338079	Green Published, gold			2022-12-26	WOS:000601313500011
J	Riaz, S; Tenscher, AC; Heinitz, CC; Huerta-Acosta, KG; Walker, MA				Riaz, Summaira; Tenscher, Alan C.; Heinitz, Claire C.; Huerta-Acosta, Karla G.; Walker, M. Andrew			Genetic analysis reveals an east-west divide within North American Vitis species that mirrors their resistance to Pierce's disease	PLOS ONE			English	Article							XYLELLA-FASTIDIOSA; GRAPEVINES; COLONIZATION; SOFTWARE; PDR1	Pierce's disease (PD) caused by the bacterium Xylella fastidiosa is a deadly disease of grapevines. This study used 20 SSR markers to genotype 326 accessions of grape species collected from the southeastern and southwestern United States, Mexico and Costa Rica. Two hundred sixty-six of these accessions, and an additional 12 PD resistant hybrid cultivars developed from southeastern US grape species, were evaluated for PD resistance. Disease resistance was evaluated by quantifying the level of bacteria in stems and measuring PD symptoms on the canes and leaves. Both Bayesian clustering and principal coordinate analyses identified two groups with an east-west divide: group 1 consisted of grape species from the southeastern US and Mexico, and group 2 consisted of accessions collected from the southwestern US and Mexico. The Sierra Madre Oriental mountain range appeared to be a phylogeographic barrier. The state of Texas was identified as a potential hybridization zone. The hierarchal STRUCTURE analysis on each group showed clustering of unique grape species. An east-west divide was also observed for PD resistance. With the exception of Vitis candicans and V. cinerea accessions collected from Mexico, all other grape species as well as the resistant southeastern hybrid cultivars were susceptible to the disease. Southwestern US grape accessions from drier desert regions showed stronger resistance to the disease. Strong PD resistance was observed within three distinct genetic clusters of V. arizonica which is adapted to drier environments and hybridizes freely with other species across its wide range.	[Riaz, Summaira; Tenscher, Alan C.; Heinitz, Claire C.; Huerta-Acosta, Karla G.; Walker, M. Andrew] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	University of California System; University of California Davis	Walker, MA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	awalker@ucdavis.edu		Heinitz, Claire/0000-0003-0341-5538; Riaz, Summaira/0000-0001-7739-144X; Walker, M. Andrew/0000-0001-5422-821X	California Department of Food and Agriculture PD/GWSS Board; Rossi Endowed Chair in Viticulture funds	California Department of Food and Agriculture PD/GWSS Board; Rossi Endowed Chair in Viticulture funds	MAW received funding for this study from the California Department of Food and Agriculture PD/GWSS Board (https://www.cdfa.ca.gov/pdcp/PD_GWSS_Board.html) and the Rossi Endowed Chair in Viticulture funds were also used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LH, 1934, GENET HERB, V3, P149; Callen ST, 2016, AM J ENOL VITICULT, V67, P339, DOI 10.5344/ajev.2016.15110; Chatterjee S, 2008, MOL PLANT MICROBE IN, V21, P1309, DOI 10.1094/MPMI-21-10-1309; Clarke E. E., 2003, Proceedings of the Florida State Horticultural Society, V116, P32; COMEAUX B L, 1991, SIDA Contributions to Botany, V14, P459; COMEAUX B L, 1987, SIDA Contributions to Botany, V12, P273; Comeaux Barry L., 2000, SIDA Contributions to Botany, V19, P123; CRALL JM, 1957, PHYTOPATHOLOGY, V47, P518; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Escalante T, 2007, NATURWISSENSCHAFTEN, V94, P561, DOI 10.1007/s00114-007-0228-0; ESRI, 2011, ARCGIS DESKT REL 10; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Galet P., 1988, CEPAGES VIGNOBLES FR, V1; Giampetruzzi A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2833-9; GOHEEN AC, 1979, PLANT DIS REP, V63, P788; HALFFTER G, 1987, ANNU REV ENTOMOL, V32, P95, DOI 10.1146/annurev.ento.32.1.95; HEWITT W. B., 1958, PLANT DIS REPORTER, V42, P211; Hewitt WB, 1972, VIRUS DISEASES SMALL, P196; HOPKINS DL, 1974, J AM SOC HORTIC SCI, V99, P436; Hopkins DL, 1980, P 7 INT C VIRUSES GR, P177; JIMENEZ LG, 1985, TURRIALBA, V35, P243; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krivanek A, 2006, THEOR APPL GENET, V112, P1125, DOI 10.1007/s00122-006-0214-5; Krivanek AF, 2005, THEOR APPL GENET, V111, P110, DOI 10.1007/s00122-005-1999-3; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P44, DOI 10.1094/PHYTO-95-0044; LOOMIS N. H., 1958, PLANT DIS REPORTER, V42, P833; Loucks KW, 1938, INVESTIGATIONS FRUIT, P118; Loucks KW, 1942, INVESTIGATIONS FRUIT, P124; Morrone JJ, 2010, ECOGRAPHY, V33, P355, DOI 10.1111/j.1600-0587.2010.06266.x; MORTENSE.JA, 1968, P AM SOC HORTIC SCI, V92, P331; Mortensen JA, 1990, VITIS, P271; MORTENSEN JA, 1977, J AM SOC HORTIC SCI, V102, P695; Munson T.V., 1909, FDN AM GRAPE CULTURE; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Nunney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015488; OLMO HP, 1986, EXPERIENTIA, V42, P921, DOI 10.1007/BF01941769; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; PERRY RL, 1974, PLANT DIS REP, V58, P780; Pritchard JK, 2000, GENETICS, V155, P945; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; Riaz S, 2008, THEOR APPL GENET, V117, P671, DOI 10.1007/s00122-008-0802-7; Riaz S, 2006, THEOR APPL GENET, V113, P1317, DOI 10.1007/s00122-006-0385-0; Riaz S, 2018, THEOR APPL GENET, V131, P1589, DOI 10.1007/s00122-018-3100-z; Riaz S, 2020, AM J ENOLOGY VITICUL; Riaz S, 2007, AM J ENOL VITICULT, V58, P494; Schuenzel EL, 2005, APPL ENVIRON MICROB, V71, P3832, DOI 10.1128/AEM.71.7.3832-3839.2005; STONER WARREN N., 1952, FLORIDA ENT, V35, P62, DOI 10.2307/3492278; STONER WN, 1953, PHYTOPATHOLOGY, V43, P611; Sun Q, 2013, PLANT PHYSIOL, V161, P1529, DOI 10.1104/pp.112.208157; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Varela LG, 2001, AGR NATURAL RESOURCE, V21600; Walker MA, 2019, COMPENDIUM PLANT GEN; Wan YZ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-141; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243445	10.1371/journal.pone.0243445	http://dx.doi.org/10.1371/journal.pone.0243445			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338052	gold, Green Published			2022-12-26	WOS:000601313500040
J	Frost, RLA; Dunn, K; Christiansen, MH; Gomez, RL; Monaghan, P				Frost, Rebecca L. A.; Dunn, Kirsty; Christiansen, Morten H.; Gomez, Rebecca L.; Monaghan, Padraic			Exploring the "anchor word" effect in infants: Segmentation and categorisation of speech with and without high frequency words	PLOS ONE			English	Article							DISTRIBUTIONAL CUES; VOWEL HARMONY; GRAMMATICAL CATEGORIES; PHONOTACTIC KNOWLEDGE; PRIOR EXPERIENCE; LANGUAGE; INFORMATION; STATISTICS; SOUND; MOMMY	High frequency words play a key role in language acquisition, with recent work suggesting they may serve both speech segmentation and lexical categorisation. However, it is not yet known whether infants can detect novel high frequency words in continuous speech, nor whether they can use them to help learning for segmentation and categorisation at the same time. For instance, when hearing "you eat the biscuit", can children use the high-frequency words "you" and "the" to segment out "eat" and "biscuit", and determine their respective lexical categories? We tested this in two experiments. In Experiment 1, we familiarised 12-month-old infants with continuous artificial speech comprising repetitions of target words, which were preceded by high-frequency marker words that distinguished the targets into two distributional categories. In Experiment 2, we repeated the task using the same language but with additional phonological cues to word and category structure. In both studies, we measured learning with head-turn preference tests of segmentation and categorisation, and compared performance against a control group that heard the artificial speech without the marker words (i.e., just the targets). There was no evidence that high frequency words helped either speech segmentation or grammatical categorisation. However, segmentation was seen to improve when the distributional information was supplemented with phonological cues (Experiment 2). In both experiments, exploratory analysis indicated that infants' looking behaviour was related to their linguistic maturity (indexed by infants' vocabulary scores) with infants with high versus low vocabulary scores displaying novelty and familiarity preferences, respectively. We propose that high-frequency words must reach a critical threshold of familiarity before they can be of significant benefit to learning.	[Frost, Rebecca L. A.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Dunn, Kirsty; Monaghan, Padraic] Univ Lancaster, Lancaster, England; [Christiansen, Morten H.] Cornell Univ, Ithaca, NY USA; [Gomez, Rebecca L.] Univ Arizona, Tucson, AZ USA	Max Planck Society; Lancaster University; Cornell University; University of Arizona	Frost, RLA (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	Rebecca.Frost@mpi.nl	Monaghan, Padraic/E-6812-2010	Monaghan, Padraic/0000-0003-3965-2682; Frost, Rebecca/0000-0002-5556-4466; Christiansen, Morten H./0000-0002-3850-0655; Dunn, Kirsty Jayne/0000-0003-0863-8757	International Centre for Language and Communicative Development (LuCiD); Economic and Social Research Council [ES/L008955/1]; ESRC [ES/L008955/1] Funding Source: UKRI	International Centre for Language and Communicative Development (LuCiD); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the International Centre for Language and Communicative Development (LuCiD). The support of the Economic and Social Research Council [ES/L008955/1] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaans F, 2010, J MEM LANG, V62, P311, DOI 10.1016/j.jml.2009.11.007; Alcock K.J, 2017, UK CDI WORDS GESTURE; Altan A., 2016, P 40 BOST U C LANG D; Altvater-Mackensen N, 2013, DEVELOPMENTAL SCI, V16, P980, DOI 10.1111/desc.12071; Ambridge B, 2015, J CHILD LANG, V42, P239, DOI 10.1017/S030500091400049X; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Black, 1990, FESTIVAL SPEECH SYNT; Black A., 2017, 39 ANN M COGNITIVE S, P124; Boll-Avetisyan N., 2018, EMPIRICAL APPROACHES, P213; Boll-Avetisyan N, 2016, LINGUA, V171, P74, DOI 10.1016/j.lingua.2015.11.008; Boll-Avetisyan N, 2014, LANG SPEECH, V57, P394, DOI 10.1177/0023830913508074; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; Brent MR, 1996, COGNITION, V61, P93, DOI 10.1016/S0010-0277(96)00719-6; Cairns P, 1997, COGNITIVE PSYCHOL, V33, P111, DOI 10.1006/cogp.1997.0649; CASSIDY KW, 1991, J MEM LANG, V30, P348, DOI 10.1016/0749-596X(91)90041-H; Christiansen MH, 1998, LANG COGNITIVE PROC, V13, P221, DOI 10.1080/016909698386528; Christiansen MH, 2009, DEVELOPMENTAL SCI, V12, P388, DOI 10.1111/j.1467-7687.2009.00824.x; Christophe A, 1997, LANG COGNITIVE PROC, V12, P585, DOI 10.1080/016909697386637; Cohen L.B., 2004, HABIT X NEW PROGRAM; Conway CM, 2010, COGNITION, V114, P356, DOI 10.1016/j.cognition.2009.10.009; Cunillera T, 2016, NEUROPSYCHOLOGIA, V82, P189, DOI 10.1016/j.neuropsychologia.2016.01.011; Cunillera T, 2010, EXP PSYCHOL, V57, P134, DOI 10.1027/1618-3169/a000017; Curtin S, 2005, COGNITION, V96, P233, DOI 10.1016/j.cognition.2004.08.005; CUTLER A, 1993, J PSYCHOLINGUIST RES, V22, P109; DURIEUX G, 2001, APPROACHES BOOTSTRAP, V0001, P00189; Emberson LL, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12847; Estes KG, 2016, J EXP CHILD PSYCHOL, V146, P34, DOI 10.1016/j.jecp.2016.01.012; Frost R. L. A., 2019, P 41 ANN M COGN SCI; Frost R. L. A., 2020, CURRENT PERSPECTIVES; Frost RLA, 2020, COGNITIVE PSYCHOL, V120, DOI 10.1016/j.cogpsych.2020.101291; Frost RLA, 2019, J EXP PSYCHOL LEARN, V45, P1883, DOI 10.1037/xlm0000683; Frost RLA, 2017, J EXP PSYCHOL HUMAN, V43, P466, DOI 10.1037/xhp0000325; Frost RLA, 2016, P 38 ANN M COGN SCI, P81; Gerken L, 2006, COGNITION, V98, pB67, DOI 10.1016/j.cognition.2005.03.003; Gerken L, 2005, J CHILD LANG, V32, P249, DOI 10.1017/S0305000904006786; Gerken L, 2010, COGNITION, V115, P362, DOI 10.1016/j.cognition.2010.01.006; Gleitman L., 1982, LANG ACQUIS, P3; Gomez R, 2005, INFANCY, V7, P183, DOI 10.1207/s15327078in0702_4; Gomez RL, 2004, DEVELOPMENTAL SCI, V7, P567, DOI 10.1111/j.1467-7687.2004.00381.x; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Gonzales K, 2018, COGNITIVE PSYCHOL, V106, P1, DOI 10.1016/j.cogpsych.2018.04.003; Gonzales K, 2015, COGNITION, V140, P60, DOI 10.1016/j.cognition.2015.03.015; Gonzalez-Gomez N, 2019, J EXP CHILD PSYCHOL, V178, P170, DOI 10.1016/j.jecp.2018.08.014; Gonzalez-Gomez N, 2013, J SPEECH LANG HEAR R, V56, P840, DOI 10.1044/1092-4388(2012/12-0138); Hohenberger A., 2017, P 41 ANN BOSTON U C, P309; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Johnson EK, 2010, DEVELOPMENTAL SCI, V13, P339, DOI 10.1111/j.1467-7687.2009.00886.x; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Kabak B., 2010, LAB PHONOLOGY, V1, P207, DOI [10.1515/labphon.2010.010, DOI 10.1515/LABPHON.2010.010]; KELLY MH, 1992, PSYCHOL REV, V99, P349, DOI 10.1037/0033-295X.99.2.349; Kurumada C, 2013, COGNITION, V127, P439, DOI 10.1016/j.cognition.2013.02.002; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lany J, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: NEURAL CIRCUIT DEVELOPMENT AND FUNCTION IN THE HEALTHY AND DISEASED BRAIN, P231, DOI 10.1016/B978-0-12-397267-5.00034-0; Lany J., 2019, J CHILD LANG, V13, P1; Lany J, 2007, COGNITIVE SCI, V31, P481, DOI 10.1080/15326900701326584; Lany J, 2014, CHILD DEV, V85, P1727, DOI 10.1111/cdev.12199; Lany J, 2011, DEVELOPMENTAL SCI, V14, P1207, DOI 10.1111/j.1467-7687.2011.01073.x; Lany J, 2010, PSYCHOL SCI, V21, P284, DOI 10.1177/0956797609358570; Lany J, 2008, PSYCHOL SCI, V19, P1247, DOI 10.1111/j.1467-9280.2008.02233.x; Lew-Williams C, 2012, COGNITION, V122, P241, DOI 10.1016/j.cognition.2011.10.007; Lew-Williams C, 2011, DEVELOPMENTAL SCI, V14, P1323, DOI 10.1111/j.1467-7687.2011.01079.x; Li P., 2000, ACQUISITION LEXICAL, DOI [10.1515/9783110800715, DOI 10.1515/9783110800715]; Lieven E, 2010, LINGUA, V120, P2546, DOI 10.1016/j.lingua.2010.06.005; Marchetto E, 2015, J CHILD LANG, V42, P873, DOI 10.1017/S0305000914000452; Marchetto E, 2013, COGNITIVE PSYCHOL, V67, P130, DOI 10.1016/j.cogpsych.2013.08.001; Marcus GF, 2007, PSYCHOL SCI, V18, P387, DOI 10.1111/j.1467-9280.2007.01910.x; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Mattys SL, 2005, J EXP PSYCHOL GEN, V134, P477, DOI 10.1037/0096-3445.134.4.477; McQueen JM, 1998, J MEM LANG, V39, P21, DOI 10.1006/jmla.1998.2568; Mersad K, 2012, LANG LEARN DEV, V8, P303, DOI 10.1080/15475441.2011.609106; Mintz TH, 2003, COGNITION, V90, P91, DOI 10.1016/S0010-0277(03)00140-9; Mintz TH, 2002, MEM COGNITION, V30, P678, DOI 10.3758/BF03196424; Mintz TH, 2002, COGNITIVE SCI, V26, P393, DOI 10.1207/s15516709cog2604_1; Mintz TH, 2018, COGNITION, V171, P95, DOI 10.1016/j.cognition.2017.10.020; Monaghan P, 2005, COGNITION, V96, P143, DOI 10.1016/j.cognition.2004.09.001; Monaghan P, 2007, COGNITIVE PSYCHOL, V55, P259, DOI 10.1016/j.cogpsych.2006.12.001; Monaghan P, 2017, TOP COGN SCI, V9, P21, DOI 10.1111/tops.12239; Monaghan P, 2013, J ACOUST SOC AM, V134, pEL45, DOI 10.1121/1.4809775; Monaghan P, 2010, J CHILD LANG, V37, P545, DOI 10.1017/S0305000909990511; Morgan JL, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P263; MORGAN JL, 1996, SIGNAL SYNTAX BOOTST; NELSON DGK, 1995, INFANT BEHAV DEV, V18, P111; Onnis L, 2005, J MEM LANG, V53, P225, DOI 10.1016/j.jml.2005.02.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Perruchet P, 1998, J MEM LANG, V39, P246, DOI 10.1006/jmla.1998.2576; R Core Team, 2020, R LANG ENV STAT COMP; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1997, PSYCHOL SCI, V8, P101, DOI 10.1111/j.1467-9280.1997.tb00690.x; Sandoval M, 2016, LANG LEARN DEV, V12, P398, DOI 10.1080/15475441.2016.1162722; SERENO JA, 1990, J PSYCHOLINGUIST RES, V19, P387, DOI 10.1007/BF01068886; Shi RS, 1998, J CHILD LANG, V25, P169, DOI 10.1017/S0305000997003395; Shi R, 2008, DEVELOPMENTAL SCI, V11, P407, DOI 10.1111/j.1467-7687.2008.00685.x; St Clair MC, 2010, COGNITION, V116, P341, DOI 10.1016/j.cognition.2010.05.012; Suomi K, 1997, J MEM LANG, V36, P422, DOI 10.1006/jmla.1996.2495; Swingley D, 2005, COGNITIVE PSYCHOL, V50, P86, DOI 10.1016/j.cogpsych.2004.06.001; Tagliapietra L, 2009, Q J EXP PSYCHOL, V62, P392, DOI 10.1080/17470210801907379; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Trecca F, 2019, LANG LEARN, V69, P143, DOI 10.1111/lang.12325; Turk AE, 2000, J PHONETICS, V28, P397, DOI 10.1006/jpho.2000.0123; VALIAN V, 1988, J MEM LANG, V27, P71, DOI 10.1016/0749-596X(88)90049-6; Van de Weijer J., 2001, EARLY LEXICON ACQUIS; Van Kampen A., 2008, LANG ACQUIS, P313; Vroomen J, 1998, J MEM LANG, V38, P133, DOI 10.1006/jmla.1997.2548; Wang FH, 2019, COGNITIVE PSYCHOL, V113, DOI 10.1016/j.cogpsych.2019.101223; White J, 2014, COGNITION, V133, P85, DOI 10.1016/j.cognition.2014.05.020; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	111	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243436	10.1371/journal.pone.0243436	http://dx.doi.org/10.1371/journal.pone.0243436			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332419	Green Published, gold			2022-12-26	WOS:000601310900025
J	Kay, AW; Thivalapill, N; Skinner, D; Dube, GS; Dlamini, N; Mzileni, B; Fuentes, P; Ustero, P; Adams, LV; Mandalakas, AM				Kay, Alexander W.; Thivalapill, Neil; Skinner, Donald; Dube, Gloria Sisi; Dlamini, Nomathemba; Mzileni, Bulisile; Fuentes, Patricia; Ustero, Pilar; Adams, Lisa V.; Mandalakas, Anna M.			Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV	PLOS ONE			English	Article							TUBERCULOSIS; RIFAMPIN; REGIMEN	This study identified factors associated with adherence to a 6-month isoniazid preventive therapy (IPT) course among adolescents and children living with HIV. Forty adolescents living with HIV and 48 primary caregivers of children living with HIV completed a Likert-based survey to measure respondent opinions regarding access to care, quality of care, preferred regimens, perceived stigma, and confidence in self-efficacy. Sociodemographic data were collected and adherence measured as the average of pill counts obtained while on IPT. The rates of suboptimal adherence (< 95% adherent) were 22.5% among adolescents and 37.5% among the children of primary caregivers. Univariate logistic regression was used to model the change in the odds of suboptimal adherence. Independent factors associated with suboptimal adherence among adolescents included age, education level, the cost of coming to clinic, stigma from community members, and two variables relating to self-efficacy. Among primary caregivers, child age, concerns about stigma, and location preference for meeting a community-health worker were associated with suboptimal adherence. To determine whether these combined factors contributed different information to the prediction of suboptimal adherence, a risk score containing these predictors was constructed for each group. The risk score had an AUC of 0.87 (95% CI: 0.76, 0.99) among adolescents and an AUC of 0.76 (95% CI: 0.62, 0.90), among primary caregivers suggesting that these variables may have complementary predictive utility. The heterogeneous scope and associations of these variables in different populations suggests that interventions aiming to increase optimal adherence will need to be tailored to specific populations and multifaceted in nature. Ideally interventions should address both long-established barriers to adherence such as cost of transportation to attend clinic and more nuanced psychosocial barriers such as perceived community stigma and confidence in self-efficacy.	[Kay, Alexander W.; Fuentes, Patricia; Ustero, Pilar; Mandalakas, Anna M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Kay, Alexander W.; Fuentes, Patricia; Ustero, Pilar; Mandalakas, Anna M.] Texas Childrens Hosp, Global TB Program, Sect Global & Immigrant Hlth, Houston, TX 77030 USA; [Kay, Alexander W.; Thivalapill, Neil; Dlamini, Nomathemba; Mzileni, Bulisile; Fuentes, Patricia; Ustero, Pilar; Mandalakas, Anna M.] Baylor Coll Med Childrens Fdn, Mbabane, South Africa; [Thivalapill, Neil] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Skinner, Donald] Human Sci Res Council, HIV AIDS STDs & TB, Cape Town, South Africa; [Dube, Gloria Sisi] Minist Hlth, Natl TB Control Program, Mbabane, South Africa; [Adams, Lisa V.] Dartmouth Coll, Geisel Sch Med, Sect Infect Dis & Int Hlth, Hanover, NH 03755 USA	Baylor College of Medicine; Baylor College of Medicine; Columbia University; Human Sciences Research Council-South Africa; Dartmouth College	Kay, AW (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Kay, AW (corresponding author), Texas Childrens Hosp, Global TB Program, Sect Global & Immigrant Hlth, Houston, TX 77030 USA.; Kay, AW (corresponding author), Baylor Coll Med Childrens Fdn, Mbabane, South Africa.	alexander.kay@bcm.edu		Thivalapill, Neil/0000-0003-3398-6710; Adams, Lisa V./0000-0002-1303-2154	Texas Children's Hospital; National Institutes of Health [1K01TW011482-01A1]	Texas Children's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded through an institutional grant from Texas Children's Hospital and the National Institutes of Health (grant number 1K01TW011482-01A1 to AWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91; Boffa J, 2019, PUBLIC HEALTH ACTION, V9, P24, DOI 10.5588/pha.18.0040; Briggs MA, 2015, JAIDS-J ACQ IMM DEF, V68, pS297, DOI 10.1097/QAI.0000000000000497; Cluver L, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25176; Diallo T, 2018, NEW ENGL J MED, V379, P454, DOI 10.1056/NEJMoa1714284; Hill PC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001105; Hunter OF, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05471-z; Imperial MZ, 2018, NAT MED, V24, P1708, DOI 10.1038/s41591-018-0224-2; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mavhu W, 2020, LANCET GLOB HEALTH, V8, pE264, DOI 10.1016/S2214-109X(19)30526-1; Ngugi SK, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05011-9; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; Rutherford ME, 2012, TROP MED INT HEALTH, V17, P1264, DOI 10.1111/j.1365-3156.2012.03053.x; Skinner D, 2013, PUBLIC HEALTH ACTION, V3, P191, DOI 10.5588/pha.13.0010; Skinner D, 2013, INT J TUBERC LUNG D, V17, P175, DOI 10.5588/ijtld.12.0230; Spyridis NP, 2007, CLIN INFECT DIS, V45, P715, DOI 10.1086/520983; van Soelen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080803; Van Wyk SS, 2010, INT J TUBERC LUNG D, V14, P650; Vernon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002884; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2012, REC INV CONT PERS IN; World Health Organization, 2018, LAT TUB INF UPD CONS; Yotebieng M, 2015, AIDS, V29, P2055, DOI 10.1097/QAD.0000000000000791	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243713	10.1371/journal.pone.0243713	http://dx.doi.org/10.1371/journal.pone.0243713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332462	Green Published, gold			2022-12-26	WOS:000601310900026
J	Vornholt, E; Drake, J; Mamdani, M; McMichael, G; Taylor, ZN; Bacanu, SA; Miles, MF; Vladimirov, VI				Vornholt, Eric; Drake, John; Mamdani, Mohammed; McMichael, Gowon; Taylor, Zachary N.; Bacanu, Silviu-Alin; Miles, Michael F.; Vladimirov, Vladimir I.			Network preservation reveals shared and unique biological processes associated with chronic alcohol abuse in NAc and PFC	PLOS ONE			English	Article							GENE-EXPRESSION; FRONTAL-CORTEX; USE DISORDERS; TISSUE; NEUROCIRCUITRY; NEUROBIOLOGY; MECHANISMS; PLASTICITY; ADDICTION; DRINKING	Chronic alcohol abuse has been linked to the disruption of executive function and allostatic conditioning of reward response dysregulation in the mesocorticolimbic pathway (MCL). Here, we analyzed genome-wide mRNA and miRNA expression from matched cases with alcohol dependence (AD) and controls (n = 35) via gene network analysis to identify unique and shared biological processes dysregulated in the prefrontal cortex (PFC) and nucleus accumbens (NAc). We further investigated potential mRNA/miRNA interactions at the network and individual gene expression levels to identify the neurobiological mechanisms underlying AD in the brain. By using genotyped and imputed SNP data, we identified expression quantitative trait loci (eQTL) uncovering potential genetic regulatory elements for gene networks associated with AD. At a Bonferroni corrected p <= 0.05, we identified significant mRNA (NAc = 6; PFC = 3) and miRNA (NAc = 3; PFC = 2) AD modules. The gene-set enrichment analyses revealed modules preserved between PFC and NAc to be enriched for immune response processes, whereas genes involved in cellular morphogenesis/localization and cilia-based cell projection were enriched in NAc modules only. At a Bonferroni corrected p <= 0.05, we identified significant mRNA/miRNA network module correlations (NAc = 6; PFC = 4), which at an individual transcript level implicated miR-449a/b as potential regulators for cellular morphogenesis/localization in NAc. Finally, we identified eQTLs (NAc: mRNA = 37, miRNA = 9; PFC: mRNA = 17, miRNA = 16) which potentially mediate alcohol's effect in a brain region-specific manner. Our study highlights the neurotoxic effects of chronic alcohol abuse as well as brain region specific molecular changes that may impact the development of alcohol addiction.	[Vornholt, Eric; Mamdani, Mohammed; McMichael, Gowon; Taylor, Zachary N.; Bacanu, Silviu-Alin; Miles, Michael F.; Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Vornholt, Eric] Virginia Commonwealth Univ, Integrat Life Sci Doctoral Program, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Drake, John; Vladimirov, Vladimir I.] Texas A&M Univ, Dept Psychiat & Behav Sci, Bryan, TX 77842 USA; [Bacanu, Silviu-Alin] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, VCU Alcohol Res Ctr, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Ctr Biomarker Res & Precis Med, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Sch Pharm, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Vladimirov, Vladimir I.] Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD 21218 USA	Virginia Commonwealth University; Virginia Commonwealth University; Texas A&M University System; Texas A&M University College Station; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Johns Hopkins University	Vornholt, E; Vladimirov, VI (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vornholt, E (corresponding author), Virginia Commonwealth Univ, Integrat Life Sci Doctoral Program, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vladimirov, VI (corresponding author), Texas A&M Univ, Dept Psychiat & Behav Sci, Bryan, TX 77842 USA.; Vladimirov, VI (corresponding author), Virginia Commonwealth Univ, Ctr Biomarker Res & Precis Med, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vladimirov, VI (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vladimirov, VI (corresponding author), Virginia Commonwealth Univ, Sch Pharm, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vladimirov, VI (corresponding author), Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD 21218 USA.	vornholtes@vcu.edu; vivladimirov@tamu.edu	Drake, John/HGA-1355-2022	Drake, John/0000-0002-0420-3740; Bacanu, Silviu-Alin/0000-0002-4364-1583; Vornholt, Eric/0000-0001-8406-1158	National Institute on Alcohol Abuse and Alcoholism; National Institute of Mental Health [F31AA028180, R21AA022749/R01MH118239, P50AA022537]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute on Alcohol Abuse and Alcoholism (https://www.niaaa.nih.gov) and National Institute of Mental Health (https://www.nimh.nih.gov).Grant numbers: F31AA028180 (Eric Vornholt), R21AA022749/R01MH118239 (Dr. Vladimir I. Vladimirov), and P50AA022537 (Dr. Michael F. Miles). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy K, 2010, INT REV NEUROBIOL, V91, P289, DOI 10.1016/S0074-7742(10)91009-X; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alasmari F, 2018, PROG NEUROBIOL, V171, P32, DOI 10.1016/j.pneurobio.2018.10.001; Ben Hamida S, 2018, BIOL PSYCHIAT, V84, P202, DOI 10.1016/j.biopsych.2018.01.026; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Bryant CD, 2016, GENES BRAIN BEHAV, V15, P169, DOI 10.1111/gbb.12273; Bundesarztekammer, 2014, DTSCH ARZTEBL, V111, pA1583; Chang LH, 2019, DRUG ALCOHOL DEPEN, V197, P271, DOI 10.1016/j.drugalcdep.2019.01.015; Choi MR, 2020, BASIC CLIN PHARMACOL, V126, P389, DOI 10.1111/bcpt.13342; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Edenberg HJ, 2002, ALCOHOL RES HEALTH, V26, P214; Ehrlich AT, 2018, BRAIN STRUCT FUNCT, V223, P1275, DOI 10.1007/s00429-017-1547-3; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Evangelou E, 2019, NAT HUM BEHAV, V3, P950, DOI 10.1038/s41562-019-0653-z; Fang YT, 2013, ONCOL REP, V30, P399, DOI 10.3892/or.2013.2465; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Farris SP, 2015, MOL PSYCHIATR, V20, P1438, DOI 10.1038/mp.2014.159; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Garcia-Gonzalez D, 2021, MOL PSYCHIATR, V26, P4616, DOI 10.1038/s41380-020-0823-4; Ge SX, 2018, BIORXIV, DOI [10.1101/315150, DOI 10.1101/315150]; Gilpin NW, 2008, ALCOHOL RES HEALTH, V31, P185; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Hoffman GE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1323-z; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kamarajan C, 2017, INT J PSYCHOPHYSIOL, V115, P13, DOI 10.1016/j.ijpsycho.2016.12.007; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kranzler HR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09480-8; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lehrmann E, 2003, PHARMACOGENOMICS J, V3, P27, DOI 10.1038/sj.tpj.6500146; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luo J, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00102; Mahaweni NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34258-1; Mamdani M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137671; McBride WJ, 2013, ALCOHOL, V47, P367, DOI 10.1016/j.alcohol.2013.04.002; McMichael GO, 2019, ASSESSING ROLE LONG; Montesinos J, 2016, ALCOHOL CLIN EXP RES, V40, P2260, DOI 10.1111/acer.13208; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Quintero GC, 2013, NEUROPSYCH DIS TREAT, V9, P1499, DOI 10.2147/NDT.S45963; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ron D, 2016, NAT REV NEUROSCI, V17, P576, DOI 10.1038/nrn.2016.85; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Simmler LD, 2017, BRIT J PHARMACOL, V174, P2716, DOI 10.1111/bph.13899; Skalny AV, 2018, EUR J NUTR, V57, P2313, DOI 10.1007/s00394-017-1584-y; Smith ACW, 2015, BRAIN RES, V1628, P29, DOI 10.1016/j.brainres.2015.03.027; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Sutherland GT, 2014, ALCOHOL CLIN EXP RES, V38, P1, DOI 10.1111/acer.12243; Teffer K, PROGR BRAIN RES, P191; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; Verhulst B, 2015, PSYCHOL MED, V45, P1061, DOI 10.1017/S0033291714002165; Warden AS, 2017, NEUROPHARMACOLOGY, V122, P161, DOI 10.1016/j.neuropharm.2017.02.017; Weis S, 2007, J NEUROSCI METH, V165, P198, DOI 10.1016/j.jneumeth.2007.06.001; Whitfield JF, 2004, CELL SIGNAL, V16, P763, DOI 10.1016/j.cellsig.2003.12.002; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	66	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243857	10.1371/journal.pone.0243857	http://dx.doi.org/10.1371/journal.pone.0243857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332381	gold, Green Published, Green Submitted			2022-12-26	WOS:000601310900112
J	Bajcar, EA; Wiercioch-Kuzianik, K; Farley, D; Adamczyk, WM; Buglewicz, E; Babel, P				Bajcar, Elzbieta A.; Wiercioch-Kuzianik, Karolina; Farley, Dominika; Adamczyk, Waclaw M.; Buglewicz, Ewa; Babel, Przemyslaw			One of us or one of them? The effects of the model's and observer's characteristics on placebo analgesia induced by observational learning	PLOS ONE			English	Article							PEER MODELS; PAIN; CONFORMITY; SEX; POWER; RACE; FEAR; IMITATION; PRESSURE; GENDER	Previous studies have proved that observational learning can induce placebo analgesia, but the factors that influence observationally induced placebo analgesia have not yet been extensively examined. The primary goal of this study was to investigate the effect of information about the role that the observed person (model) plays in the experiment on the magnitude of the observationally induced placebo effect. This study also examined the contribution of the observer's empathy, conformity and fear of pain to the placebo analgesia induced by observational learning. The effects induced in two experimental groups and one control group were compared. Participants in the experimental groups observed a model introduced as either another participant taking part in the study or a coworker of the experimenter. The model rated the intensity of pain induced by electrocutaneous stimuli preceded by color stimuli. One-half of all participants watched a model rating pain stimuli preceded by the color orange as higher than stimuli preceded by the color blue; for the other half, the ratings were the opposite. There was no observation in the control group. Subsequently, all participants received pain stimuli of the same intensity preceded by orange and blue stimuli and rated the intensity of the experienced pain. Placebo analgesia was found in both experimental groups. However, the way the observed model was introduced to participants did not affect the magnitude of placebo analgesia. Thus, the study showed that the role played by the model is not crucial for observationally induced placebo analgesia. The examined observer's individual characteristics did not predict the magnitude of placebo effect.	[Bajcar, Elzbieta A.; Wiercioch-Kuzianik, Karolina; Farley, Dominika; Buglewicz, Ewa; Babel, Przemyslaw] Jagiellonian Univ, Inst Psychol, Pain Res Grp, Krakow, Poland; [Adamczyk, Waclaw M.] Jerzy Kukuczka Acad Phys Educ, Dept Kinesiotherapy & Special Methods Physiothera, Katowice, Poland	Jagiellonian University; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Bajcar, EA (corresponding author), Jagiellonian Univ, Inst Psychol, Pain Res Grp, Krakow, Poland.	elzbieta.bajcar@uj.edu.pl	Adamczyk, Waclaw M./X-5590-2018	Adamczyk, Waclaw M./0000-0001-8941-8355; Wiercioch-Kuzianik, Karolina/0000-0003-1480-6569; Farley, Dominika/0000-0001-9173-324X	National Science Centre in Poland [2016/23/B/HS6/03890]	National Science Centre in Poland(National Science Centre, Poland)	The study was funded by the National Science Centre in Poland (www.ncn.gov.pl) under the grant no. 2016/23/B/HS6/03890 obtained by PB.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Bajcar EA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02041; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura Albert, 1977, SOCIAL LEARNING THEO; Berger S. M., 1977, SOCIAL COMP PROCESSE, P209; Bobier DM, 2002, EASURE SUSCEPTIBILIT; BREYER NL, 1970, PSYCHOL REP, V27, P639, DOI 10.2466/pr0.1970.27.2.639; BRODY GH, 1985, J GENET PSYCHOL, V146, P161, DOI 10.1080/00221325.1985.9914443; BUSSEY K, 1984, J PERS SOC PSYCHOL, V47, P1292, DOI 10.1037/0022-3514.47.6.1292; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; Egorova N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16809; Epley N, 1999, J EXP SOC PSYCHOL, V35, P578, DOI 10.1006/jesp.1999.1390; Faasse K, 2016, CURR DIR PSYCHOL SCI, V25, P438, DOI 10.1177/0963721416657316; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gibson SJ, 2001, CLIN GERIATR MED, V17, P433, DOI 10.1016/S0749-0690(05)70079-3; Gierthmuhlen J, 2015, PAIN, V156, P2203, DOI 10.1097/j.pain.0000000000000227; GUDJONSSON GH, 1989, PERS INDIV DIFFER, V10, P535, DOI 10.1016/0191-8869(89)90035-4; Haun DBM, 2011, CHILD DEV, V82, P1759, DOI 10.1111/j.1467-8624.2011.01666.x; Hunter T, 2014, EUR J PAIN, V18, P914, DOI 10.1002/j.1532-2149.2013.00436.x; Kamierczak Maria., 2007, PRZEGLAD PSYCHOLOGIC, V50, P9; Karunanayake D, 2004, CAREER DEV Q, V52, P225, DOI 10.1002/j.2161-0045.2004.tb00644.x; Koban L, 2016, EMOTION, V16, P24, DOI 10.1037/emo0000087; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lautenbacher S, 2005, PAIN, V115, P410, DOI 10.1016/j.pain.2005.03.025; LIRGG CD, 1991, RES Q EXERCISE SPORT, V62, P217, DOI 10.1080/02701367.1991.10608713; Lyby PS, 2011, PAIN, V152, P2405, DOI 10.1016/j.pain.2011.07.010; Lyby PS, 2010, J PSYCHOSOM RES, V68, P369, DOI 10.1016/j.jpsychores.2009.10.009; MCCULLAGH P, 1986, J SPORT PSYCHOL, V8, P319, DOI 10.1123/jsp.8.4.319; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Miller FG, 2008, J ROY SOC MED, V101, P222, DOI 10.1258/jrsm.2008.070466; MISCHEL W, 1966, J PERS SOC PSYCHOL, V3, P197, DOI 10.1037/h0022883; Mitsikostas DD, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01178-3; Morrison I, 2013, HUM BRAIN MAPP, V34, P1982, DOI 10.1002/hbm.22040; Osborn Jody, 2010, Pain, V148, P268, DOI 10.1016/j.pain.2009.11.007; PARADISE LV, 1986, J COUNS PSYCHOL, V33, P16; Peirce J, 2019, BEHAV RES METHODS, V51, P195, DOI 10.3758/s13428-018-01193-y; PERRY DG, 1975, J PERS SOC PSYCHOL, V31, P1083, DOI 10.1037/h0076944; Polczyk R, 2007, MECH EFEKTU DEZINFOR, DOI [10.1080/02770900701209772, DOI 10.1080/02770900701209772]; SCHUNK DH, 1987, REV EDUC RES, V57, P149, DOI 10.3102/00346543057002149; SIMON B, 1990, EUR J SOC PSYCHOL, V20, P269; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Swider K, 2013, PAIN, V154, P1312, DOI 10.1016/j.pain.2013.04.001; THELEN MH, 1971, CHILD DEV, V42, P972, DOI 10.1111/j.1467-8624.1971.tb03717.x; Turner J.C., 1991, MAPPING SOCIAL PSYCH; Vandenbroucke S, 2014, FRONT HUM NEUROSCI, P8, DOI [10.3389/fnhum.2014.00008, DOI 10.3389/FNHUM.2014.00008]; Vogtle E, 2016, J PAIN RES, V9, P241, DOI 10.2147/JPR.S96228; Vogtle E, 2013, PAIN, V154, P1427, DOI 10.1016/j.pain.2013.04.041; Wheeler L, 2005, HDB COMPETENCE MOTIV, P566; Wiercioch-Kuzianik K, 2019, PAIN MED, V20, P1955, DOI 10.1093/pm/pny285; WOODROW KM, 1972, PSYCHOSOM MED, V34, P548, DOI 10.1097/00006842-197211000-00007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243996	10.1371/journal.pone.0243996	http://dx.doi.org/10.1371/journal.pone.0243996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326481	Green Published, gold			2022-12-26	WOS:000600176400059
J	Beani, L; Lippi, MM; Mulinacci, N; Manfredini, F; Cecchi, L; Giuliani, C; Tani, C; Meriggi, N; Cavalieri, D; Cappa, F				Beani, Laura; Lippi, Marta Mariotti; Mulinacci, Nadia; Manfredini, Fabio; Cecchi, Lorenzo; Giuliani, Claudia; Tani, Corrado; Meriggi, Niccolo; Cavalieri, Duccio; Cappa, Federico			Altered feeding behavior and immune competence in paper wasps: A case of parasite manipulation?	PLOS ONE			English	Article							HOST MANIPULATION; SELF-MEDICATION; PROTEIN COSTS; INSECTS; BIOLOGY; NECTAR; STREPSIPTERA; VERBASCOSIDE; RESISTANCE; ECOLOGY	Paper wasps (Polistes dominula), parasitized by the strepsipteran Xenos vesparum, are castrated and desert the colony to gather on plants where the parasite mates and releases primary larvae, thus completing its lifecycle. One of these plants is the trumpet creeper Campsis radicans: in a previous study the majority of all wasps collected from this plant were parasitized and focused their foraging activity on C. radicans buds. The unexpected prevalence and unusual feeding strategy prompted us to investigate the influence of this plant on wasp behavior and physiology through a multidisciplinary approach. First, in a series of laboratory bioassays, we observed that parasitized wasps spent more time than non-parasitized ones on fresh C. radicans buds, rich of extra-floral nectaries (EFNs), while the same wasps ignored treated buds that lacked nectar drops. Then, we described the structure and ultra-structure of EFNs secreting cells, compatible with the synthesis of phenolic compounds. Subsequently, we analysed extracts from different bud tissues by HPLC-DAD-MS and found that verbascoside was the most abundant bioactive molecule in those tissues rich in EFNs. Finally, we tested the immune-stimulant properties of verbascoside, as the biochemical nature of this compound indicates it might function as an antibacterial and antioxidant. We measured bacterial clearance in wasps, as a proxy for overall immune competence, and observed that it was enhanced after administration of verbascoside-even more so if the wasp was parasitized. We hypothesize that the parasite manipulates wasp behavior to preferentially feed on C. radicans EFNs, since the bioactive properties of verbascoside likely increase host survival and thus the parasite own fitness.	[Beani, Laura; Lippi, Marta Mariotti; Meriggi, Niccolo; Cavalieri, Duccio; Cappa, Federico] Univ Firenze, Dipartimento Biol, Florence, Italy; [Mulinacci, Nadia; Cecchi, Lorenzo; Tani, Corrado] Univ Firenze, Dipartimento NEUROFARBA, Florence, Italy; [Manfredini, Fabio] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Manfredini, Fabio] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Giuliani, Claudia] Univ Studi Milano, Dipartimento Sci Farmaceut, Milan, Italy	University of Florence; University of Florence; University of London; Royal Holloway University London; University of Aberdeen; University of Milan	Beani, L; Cavalieri, D (corresponding author), Univ Firenze, Dipartimento Biol, Florence, Italy.	laura.beani@unifi.it; duccio.cavalieri@unifi.it	Cecchi, Lorenzo/X-5457-2018	Cecchi, Lorenzo/0000-0002-9332-704X	University of Florence	University of Florence	Financial support to LB was provided by the University of Florence.	Abbott J, 2014, ECOL ENTOMOL, V39, P273, DOI 10.1111/een.12110; Adamo SA, 2002, BRAIN BEHAV EVOLUT, V60, P370, DOI 10.1159/000067790; Adamo SA, 2013, J EXP BIOL, V216, P1, DOI 10.1242/jeb.082511; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Alipieva K, 2014, BIOTECHNOL ADV, V32, P1065, DOI 10.1016/j.biotechadv.2014.07.001; Baracchi D, 2011, TOXICON, V58, P550, DOI 10.1016/j.toxicon.2011.08.017; Beani L, 2005, J MORPHOL, V265, P291, DOI 10.1002/jmor.10359; Beani L, 2006, ANN ZOOL FENN, V43, P564; Beani L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205201; Beani L, 2011, ANIM BEHAV, V82, P1305, DOI 10.1016/j.anbehav.2011.09.012; Bernardo MA, 2017, J EXP BIOL, V220, P2848, DOI 10.1242/jeb.143800; BERTIN RI, 1982, AM J BOT, V69, P122, DOI 10.2307/2442837; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Cappa F, 2020, ETHOL ECOL EVOL, V32, P289, DOI 10.1080/03949370.2019.1695228; Cappa F, 2020, INSECT SCI, V27, P1031, DOI 10.1111/1744-7917.12732; Cappa F, 2015, BIOL J LINN SOC, V114, P274, DOI 10.1111/bij.12427; Cappa F, 2014, PARASITOLOGY, V141, P1080, DOI 10.1017/S003118201400047X; Cervo R, 1996, BEHAV PROCESS, V36, P213, DOI 10.1016/0376-6357(95)00030-5; Chambers J.M., 1992, LINEAR MODELS; Charles HM, 2015, J INSECT PHYSIOL, V81, P97, DOI 10.1016/j.jinsphys.2015.07.005; Cini A, 2018, ECOL ENTOMOL, V43, P351, DOI 10.1111/een.12507; Cook JL, 2014, COMP PARASITOL, V81, P134, DOI 10.1654/4723.1; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Cuautle M, 2003, FUNCT ECOL, V17, P417, DOI 10.1046/j.1365-2435.2003.00732.x; Dapporto L, 2007, PARASITOLOGY, V134, P545, DOI 10.1017/S0031182006001739; Dawkins R., 1982, pi; Dawkins R., 2016, THE EXTENDED PHENOTY; de Roode JC, 2019, CURR OPIN INSECT SCI, V33, P1, DOI 10.1016/j.cois.2018.12.001; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Dohse L, 2009, CUTIS, V83, P177; EICKWORT K, 1969, INSECT SOC, V16, P67, DOI 10.1007/BF02224464; ELIAS TS, 1975, SCIENCE, V189, P289, DOI 10.1126/science.189.4199.289; ELIAS TS, 1976, AM J BOT, V63, P1349, DOI 10.2307/2441843; Fox J., 2018, R COMPANION APPL REG, VThird; Funes L, 2009, FOOD CHEM, V117, P589, DOI 10.1016/j.foodchem.2009.04.059; GALETTO L, 1995, PLANT SYST EVOL, V196, P99, DOI 10.1007/BF00985338; GALETTO L, 2009, J PLANT REPROD BIOL, V1, P1; Geffre AC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0029; Giusti F, 2007, ARTHROPOD STRUCT DEV, V36, P183, DOI 10.1016/j.asd.2007.01.001; Grasso DA, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv002; Hafer N, 2015, EVOLUTION, V69, P611, DOI 10.1111/evo.12612; Hashem F. A., 2007, Journal of Medical Sciences (Pakistan), V7, P1027; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; Hoover K, 2019, CURR OPIN INSECT SCI, V33, pVI, DOI 10.1016/j.cois.2019.06.012; Hughes D, 2013, J EXP BIOL, V216, P142, DOI 10.1242/jeb.077461; Hughes DP, 2019, CURR BIOL, V29, pR45, DOI 10.1016/j.cub.2018.12.001; Hughes DP, 2018, ANNU REV ENTOMOL, V63, P471, DOI 10.1146/annurev-ento-020117-043234; Hughes DP, 2004, BEHAV ECOL, V15, P1037, DOI 10.1093/beheco/arh111; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Kolodziejska-Degorska I, 2006, ACTA SOC BOT POL, V75, P79; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Manfredini F, 2010, MICROBES INFECT, V12, P727, DOI 10.1016/j.micinf.2010.05.001; Manfredini F, 2010, J INSECT PHYSIOL, V56, P253, DOI 10.1016/j.jinsphys.2009.10.009; Meriggi N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02320; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Nepi M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01063; Ogle DH, 2020, FSA FISHERIES STOCK; Ponton F, 2011, INT J PARASITOL, V41, P43, DOI 10.1016/j.ijpara.2010.06.007; Poulin R, 2015, TRENDS PARASITOL, V31, P563, DOI 10.1016/j.pt.2015.07.002; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Povey S, 2009, J ANIM ECOL, V78, P437, DOI 10.1111/j.1365-2656.2008.01499.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rahmatullah M, 2019, ADV NAT APPL SCI, V4, P52; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Spivak M, 2019, CURR OPIN INSECT SCI, V33, P49, DOI 10.1016/j.cois.2019.02.009; Thomas F, 2010, OIKOS, V119, P1217, DOI 10.1111/j.1600-0706.2009.18077.x; Whitehill JGA, 2014, OECOLOGIA, V176, P1047, DOI 10.1007/s00442-014-3082-8; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; WILKINSON GN, 1973, ROY STAT SOC C-APP, V22, P392; 2012, DRUG DISCOV TODAY-TE, V9	73	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242486	10.1371/journal.pone.0242486	http://dx.doi.org/10.1371/journal.pone.0242486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326432	Green Published, gold			2022-12-26	WOS:000600176400035
J	Kolte, IV; Pereira, L; Benites, A; de Sousa, IMC; Basta, PC				Kolte, Ida Viktoria; Pereira, Lucia; Benites, Aparecida; Carvalho de Sousa, Islandia Maria; Basta, Paulo Cesar			The contribution of stigma to the transmission and treatment of tuberculosis in a hyperendemic indigenous population in Brazil	PLOS ONE			English	Article							PEOPLES; PREJUDICE	Background The Guarani-Kaiowa are Brazil's second-largest indigenous group. Average annual tuberculosis (TB) incidence rates among the Guarani-Kaiowa are nearly 400/100,000 in Mato Grosso do Sul state, ten times the national average. Although stigma is considered crucial for TB control in indigenous communities, few studies have investigated TB stigma among indigenous populations. This study sought to understand the role of TB-related stigma and perceptions of TB in maintaining hyperendemic TB transmission in the Guarani-Kaiowa communities. Methods Various forms of stigma were explored through semi-structured interviews with 19 patients, 11 relatives, and 23 community members. Patients were identified from the registry of the healthcare service. Community members, selected by snowball sampling, were matched by gender and village of residence. Interviews were conducted in Guarani and Portuguese and later translated into English. Framework analysis was performed using NVivo. Results Traditional beliefs of a weakening of the body allowing the disease to enter were common, but the exact mechanism of transmission was unknown. Strong community/public stigma associated TB with uncleanliness, abuse, and irresponsibility. Anticipated stigma led to significant treatment delays for fear of exclusion and losing employment. While most patients felt supported by their families, nearly all patients related experienced/enacted stigma in the community such as gossip, avoidance, and social exclusion, leading to long-lasting internalized/self-stigma. Secondary stigmatization of relatives was widespread, and blanket latent TB infection (LTBI) treatment of patients' households was a contributing factor in treatment delay. The healthcare service unnecessarily added to stigmatization by enforcing separate utensils and sleeping arrangements for patients. Conclusions Our findings suggest that stigma is a driver for treatment delay and continued transmission of TB in the community. The stigmatization of TB was rooted in a poor understanding of TB transmission, partly because of incorrect orientation by the healthcare service. Interventions to reduce TB-associated stigma are urgently needed.	[Kolte, Ida Viktoria; Basta, Paulo Cesar] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Pereira, Lucia] Fundacao Univ Fed Grande Dourados, Dept Ciencias Sociais, Dourados, MS, Brazil; [Benites, Aparecida] Univ Estadual Mato Grosso Sul, Dept Hist, Amambai, Brazil; [Carvalho de Sousa, Islandia Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Fundacao Oswaldo Cruz	Kolte, IV (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.	idakolte@hotmail.com	Basta, Paulo Cesar/AAP-5358-2021; de Sousa, Islandia Maria Carvalho/AAY-4209-2020	de Sousa, Islandia Maria Carvalho/0000-0001-9324-4896; Basta, Paulo/0000-0003-0804-0413	Programa de Apoio a Pesquisa, Desenvolvimento e Inovacao em Saude of the Escola Nacional de Saude Publica at the Oswaldo Cruz Foundation/Fundacao Oswaldo Cruz (FIOCRUZ) [ENSP-046-FIO-13]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under the Science without Borders program [88887.091631/2014-00]	Programa de Apoio a Pesquisa, Desenvolvimento e Inovacao em Saude of the Escola Nacional de Saude Publica at the Oswaldo Cruz Foundation/Fundacao Oswaldo Cruz (FIOCRUZ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under the Science without Borders program	PCB received support by the Programa de Apoio a Pesquisa, Desenvolvimento e Inovacao em Saude (ENSP-046-FIO-13) of the Escola Nacional de Saude Publica at the Oswaldo Cruz Foundation/Fundacao Oswaldo Cruz (FIOCRUZ). IVK received support from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under the Science without Borders program (88887.091631/2014-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ASIAN J HUMANITIES S, V2, P219; Basta PC, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004628; Bloss E, 2011, PUBLIC HEALTH REP, V126, P677, DOI 10.1177/003335491112600510; Brasil FIAN, 2016, FIAN BRASIL; Brazil Ministry of Health, 2019, MANUAL RECOMENDACOES; Challenge TB, 2018, TB STIGM MEAS GUID; Cormier M, 2019, LANCET GLOB HEALTH, V7, pE68, DOI 10.1016/S2214-109X(18)30435-2; Sacchi FPC, 2018, AM J TROP MED HYG, V98, P372, DOI 10.4269/ajtmh.17-0480; Sacchi FPC, 2013, T ROY SOC TROP MED H, V107, P152, DOI 10.1093/trstmh/trs089; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Cunha EA, 2014, MEM I OSWALDO CRUZ, V109, P108, DOI 10.1590/0074-0276130082; Daftary A, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000515; Viana PVD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154658; Durham Community Research Team, 2011, COMMUNITY BASED PART; Ferreira R, 2018, POVOS INDIGENAS BRAS; Frick M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1479; Fusch PI, 2015, QUAL REP, V20, P1408; Gibson N, 2005, SOC SCI MED, V61, P931, DOI 10.1016/j.socscimed.2004.10.026; Holkup PA, 2004, ADV NURS SCI, V27, P162, DOI 10.1097/00012272-200407000-00002; Indigenist Missionary Council (Conselho Indigenista Missionario-CIMI), 2020, REP VIOL IND PEOPL B; Instituto Brasileiro de Geografia e Estatistica, 2012, CENS BRAS 2010, P2012; Instituto Socioambiental, 2020, PLATF MON IND SIT PA; International Labour Organization, 2019, QUAL STUD STIGM DISC; Lemos EF, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-237; Long R, 2013, CAN RESPIR J, V20, P223, DOI 10.1155/2013/429496; Macq J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-154; Malacarne J, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860063, 10.1590/s1678-9946201860063]; Malacarne J, 2016, REV SOC BRAS MED TRO, V49, P456, DOI 10.1590/0037-8682-0220-2016; Oliveira R.P, 2015, THESIS; Onyeneho NG, 2011, INT Q COMMUNITY HEAL, V31, P187, DOI 10.2190/IQ.31.2.f; Parker R, 2012, CAD SAUDE PUBLICA, V28, P164, DOI 10.1590/S0102-311X2012000100017; Pescosolido BA, 2008, SOC SCI MED, V67, P431, DOI 10.1016/j.socscimed.2008.03.018; Phelan JC, 2008, SOC SCI MED, V67, P358, DOI 10.1016/j.socscimed.2008.03.022; Smieja M, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363; Sommerland N, 2017, INT J TUBERC LUNG D, V21, pS81, DOI 10.5588/ijtld.16.0788; Sotgiu G, 2020, EUROPEAN RESP J; The Stop TB Partnership UNOPS, 2015, GLOB PLAN END TB 201; Tollefson D, 2013, INT J TUBERC LUNG D, V17, P1139, DOI 10.5588/ijtld.12.0385; Toms C, 2017, CDI, V2017, P41; United Nations, 2016, REP SPEC RAPP RIGHTS; Viney KA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-467; World Health Organization, 2020, GLOB TUB REP 2020; Yuhara LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071201; Zwerling A, 2020, LANCET INFECT DIS, V20, P879, DOI 10.1016/S1473-3099(20)30316-9	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243988	10.1371/journal.pone.0243988	http://dx.doi.org/10.1371/journal.pone.0243988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326453	gold, Green Published			2022-12-26	WOS:000600176400054
J	Smith, M; Mitchell, AS; Townsend, ML; Herbert, JS				Smith, Melissa; Mitchell, Annaleise S.; Townsend, Michelle L.; Herbert, Jane S.			The relationship between digital media use during pregnancy, maternal psychological wellbeing, and maternal-fetal attachment	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIAL MEDIA; SELF-CRITICISM; INTERNET USE; ANTENATAL ATTACHMENT; DECISION-MAKING; DEPRESSION; SUPPORT; ANXIETY; ASSOCIATIONS	The widespread accessibility and use of the internet provides numerous opportunities for women to independently seek out pregnancy-related information and social and emotional support during the antenatal period. Given the heightened psychological vulnerability of the pregnancy period there is a critical need to examine digital media use within the context of the feelings that women have about themselves and towards their fetus. The current study examined the relationship between digital media use during pregnancy, psychological wellbeing and their maternal-fetal attachment using an online survey. Forty-eight pregnant women completed a self-report questionnaire on their reasons for using digital media, and standardised measures of self-criticism, negative affect, social quality of life (QOL), and maternal-fetal attachment. The mean age of participants was 29.4 years (SD = 5.26), with a mean of 24.3 weeks gestation (SD = 9.95). Information seeking, emotional support and social support were highly endorsed reasons for digital media use (85.42%, 66.67%, 62.5% respectively). However, digital media use was positively correlated with negative affect (p = .003) and self-criticism (p < .001). Digital media use was also negatively correlated with QOL (p = .007). There was no evidence of a relationship between digital media use and maternal-fetal attachment (p = .330). Digital environments may be an important social context within which a pregnant woman develops her own maternal identity and knowledge. There are a number of benefits and limitations of this medium for providing information and support for women during pregnancy. Enhancing the opportunities to promote pregnant women's wellbeing in this context is an important avenue for further research and practice.	[Smith, Melissa; Mitchell, Annaleise S.; Townsend, Michelle L.; Herbert, Jane S.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Mitchell, Annaleise S.; Herbert, Jane S.] Univ Wollongong, Early Start, Wollongong, NSW, Australia; [Townsend, Michelle L.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong	Herbert, JS (corresponding author), Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia.; Herbert, JS (corresponding author), Univ Wollongong, Early Start, Wollongong, NSW, Australia.	herbertj@uow.edu.au	Herbert, Jane/GNP-3396-2022; Townsend, Michelle L/M-9667-2017	Herbert, Jane/0000-0002-8762-4531; Townsend, Michelle L/0000-0001-8921-781X	Australian Research Council [DP180101286]	Australian Research Council(Australian Research Council)	Data analysis and the preparation of this manuscript was supported by Discovery Project funding (DP180101286) from the Australian Research Council (arc.gov.au) awarded to JSH.	AINSWORTH MDS, 1979, AM PSYCHOL, V34, P932, DOI 10.1037/0003-066X.34.10.932; Akiki S, 2016, J AFFECT DISORDERS, V196, P260, DOI 10.1016/j.jad.2016.02.016; Alhusen JL, 2008, JOGNN-J OBST GYN NEO, V37, P315, DOI 10.1111/j.1552-6909.2008.00241.x; Alhusen JL, 2013, ARCH WOMEN MENT HLTH, V16, P521, DOI 10.1007/s00737-013-0357-8; Australian Psychological Association, 2017, DIG ME SURV EXPL EFF; BLATT SJ, 1976, J ABNORM PSYCHOL, V85, P383, DOI 10.1037/0021-843X.85.4.383; BOWLBY J, 1982, AM J ORTHOPSYCHIAT, V52, P664, DOI 10.1111/j.1939-0025.1982.tb01456.x; Branjerdporn G, 2017, MATERN CHILD HLTH J, V21, P540, DOI 10.1007/s10995-016-2138-2; Brassel A, 2020, INFANT MENT HEALTH J, V41, P69, DOI 10.1002/imhj.21827; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CACCIA N, 1991, AM J OBSTET GYNECOL, V165, P1122, DOI 10.1016/0002-9378(91)90484-9; Cannon S, 2020, WOMEN BIRTH, V33, P35, DOI 10.1016/j.wombi.2018.12.007; Carr CT, 2015, ATL J COMMUN, V23, P46, DOI 10.1080/15456870.2015.972282; Condon JT, 1997, BRIT J MED PSYCHOL, V70, P359, DOI 10.1111/j.2044-8341.1997.tb01912.x; CRANLEY MS, 1981, NURS RES, V30, P281, DOI 10.1097/00006199-198109000-00008; Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x; Delavari M, 2018, ARCH PSYCHIAT NURS, V32, P263, DOI 10.1016/j.apnu.2017.11.013; Della Vedova AM, 2011, J REPROD INFANT PSYC, V29, P208, DOI 10.1080/02646838.2011.592973; Denton LK, 2020, WOMEN BIRTH, V33, pE48, DOI 10.1016/j.wombi.2018.12.003; Downe Soo, 2018, PLoS One, V13, pe0194906, DOI 10.1371/journal.pone.0194906; Drentea P, 2005, SOCIOL HEALTH ILL, V27, P920, DOI 10.1111/j.1467-9566.2005.00464.x; Ehret AM, 2015, COGNITION EMOTION, V29, P1496, DOI 10.1080/02699931.2014.992394; Emmanuel EN, 2014, J CLIN NURS, V23, P1611, DOI 10.1111/jocn.12265; Felder JN, 2016, ARCH WOMEN MENT HLTH, V19, P687, DOI 10.1007/s00737-016-0628-2; Gavin NI, 2015, IDENTIFYING PERINATAL DEPRESSION AND ANXIETY: EVIDENCE-BASED PRACTICE IN SCREENING, PSYCHOSOCIAL ASSESSMENT, AND MANAGEMENT, P11; Ginja S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2049-x; Haslam DM, 2017, J CHILD FAM STUD, V26, P2026, DOI 10.1007/s10826-017-0716-6; Hopkins J, 2018, J REPROD INFANT PSYC, V36, P381, DOI 10.1080/02646838.2018.1466385; Johnson SA, 2015, CULT HEALTH SEX, V17, P237, DOI 10.1080/13691058.2014.968807; King DB, 2014, CAN PSYCHOL, V55, P240, DOI 10.1037/a0038087; Lagan BM, 2011, BIRTH-ISS PERINAT C, V38, P336, DOI 10.1111/j.1523-536X.2011.00488.x; Lagan BM, 2010, BIRTH-ISS PERINAT C, V37, P106, DOI 10.1111/j.1523-536X.2010.00390.x; Larkin F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220948; Lin LY, 2016, DEPRESS ANXIETY, V33, P323, DOI 10.1002/da.22466; Lobo S, 2020, NUTR DIET, V77, P382, DOI 10.1111/1747-0080.12589; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lupton D, 2017, SOCIETIES, V7, DOI 10.3390/soc7030025; Lupton D, 2016, WOMEN BIRTH, V29, P368, DOI 10.1016/j.wombi.2016.01.008; Lupton D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0971-3; McDaniel BT, 2012, MATERN CHILD HLTH J, V16, P1509, DOI 10.1007/s10995-011-0918-2; Mcnamara J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220032; Mitchell L, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8080074; Pew Research Center, 2015, SOCIAL MEDIA UPDATE; Prescott J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6302; Priel B, 2000, J SOC CLIN PSYCHOL, V19, P437, DOI 10.1521/jscp.2000.19.4.437; Reck C, 2008, ACTA PSYCHIAT SCAND, V118, P459, DOI 10.1111/j.1600-0447.2008.01264.x; Righetti PL, 2005, BRIT J PSYCHOL, V96, P129, DOI 10.1348/000712604X15518; Ross E., 2012, BRIT J MIDWIFERY, V20, P566, DOI [DOI 10.12968/BJOM.2012.20.8.566, 10.12968/bjom.2012.20.8.566]; Rudich Z, 2008, J PAIN, V9, P210, DOI 10.1016/j.jpain.2007.10.013; Scherr S, 2017, SOC MEDIA SOC, V3, DOI 10.1177/2056305117698495; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Staneva AA, 2017, HEALTH CARE WOMEN IN, V38, P658, DOI 10.1080/07399332.2017.1297448; Taipale S, 2016, NEW MEDIA SOC, V18, P44, DOI 10.1177/1461444814536574; Teixeira Maria Inês Félix, 2016, Rev. Enf. Ref., VserIV, P85, DOI 10.12707/RIV15025; University of New South Wales (UNSW), 2018, DASS FAQ FREQ ASK QU; Vachkova E, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-214; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM	57	6	7	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243898	10.1371/journal.pone.0243898	http://dx.doi.org/10.1371/journal.pone.0243898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326465	gold, Green Published			2022-12-26	WOS:000600176400016
J	Ye, JW; Li, J				Ye, Jingwen; Li, Jun			First proteomic analysis of the role of lysine acetylation in extensive functions in Solenopsis invicta	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; WIDE ANALYSIS; ACETYLOME; PROTEINS; VENOM; WIDESPREAD; COMPLEXES; ALLERGENS; SILKWORM; SUGGESTS	Lysine acetylation (Kac) plays a critical role in the regulation of many important cellular processes. However, little is known about Kac in Solenopsis invicta, which is among the 100 most dangerous invasive species in the world. Kac in S. invicta was evaluated for the first time in this study. Altogether, 2387 Kac sites were tested in 992 proteins. The prediction of subcellular localization indicated that most identified proteins were located in the cytoplasm, mitochondria, and nucleus. Venom allergen Sol i 2, Sol i 3, and Sol i 4 were found to be located in the extracellular. The enriched Kac site motifs included Kac H, Kac Y, Kac G, Kac F, Kac T, and Kac W. H, Y, F, and W frequently occurred at the +1 position, whereas G, Y, and T frequently occurred at the -1 position. In the cellular component, acetylated proteins were enriched in the cytoplasmic part, mitochondrial matrix, and cytosolic ribosome. Furthermore, 25 pathways were detected to have significant enrichment. Interestingly, arginine and proline metabolism, as well as phagosome, which are related to immunity, involved several Kac proteins. Sequence alignment analyses demonstrated that V-type proton ATPase subunit G, tubulin alpha chain, and arginine kinase, the acetylated lysine residues, were evolutionarily conserved among different ant species. In the investigation of the interaction network, diverse interactions were adjusted by Kac. The results indicated that Kac may play an important role in the sensitization, cellular energy metabolism, immune response, nerve signal transduction, and response to biotic and abiotic stress of S. invicta. It may be useful to confirm the functions of Kac target proteins for the design of specific and effective drugs to prevent and control this dangerous invasive species.	[Ye, Jingwen; Li, Jun] Guangdong Acad Sci, Inst Zool, Guangdong Key Lab Anim Conservat & Resource Utili, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Li, J (corresponding author), Guangdong Acad Sci, Inst Zool, Guangdong Key Lab Anim Conservat & Resource Utili, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.	junl@giabr.gd.cn			GDAS' Project of Science and Technology Development [2019GDASYL-0103064, 2020GDASYL-20200301003]; Guangdong Basic and Applied Basic Research Foundation [2019A1515110795]; China Postdoctoral Science Foundation [2018M643032]; Graduate and Postdoctoral Fund of Guangdong Institute of Applied Biological Resources [GIABR-pyjj201804]; Science and Technology Planning Project of Guangdong [2018B030324003]; GDAS Special Project of Science and Technology Development [2018GDASCX-0107]	GDAS' Project of Science and Technology Development; Guangdong Basic and Applied Basic Research Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Graduate and Postdoctoral Fund of Guangdong Institute of Applied Biological Resources; Science and Technology Planning Project of Guangdong; GDAS Special Project of Science and Technology Development	The study was supported by GDAS' Project of Science and Technology Development (2019GDASYL-0103064) (JWY) and (2020GDASYL-20200301003) (XKY), Guangdong Basic and Applied Basic Research Foundation (2019A1515110795) (JWY), Project Funded by China Postdoctoral Science Foundation (2018M643032)(JWY), Graduate and Postdoctoral Fund of Guangdong Institute of Applied Biological Resources (GIABR-pyjj201804)(JWY), Science and Technology Planning Project of Guangdong (2018B030324003) (JL), and GDAS Special Project of Science and Technology Development (2018GDASCX-0107) (FSZ).	[Anonymous], 2006, MARITIME STUDIES, V4, P47; Chen J, 2018, J PROTEOMICS, V174, P61, DOI 10.1016/j.jprot.2017.12.019; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dutcher SK, 2001, CURR OPIN CELL BIOL, V13, P49, DOI 10.1016/S0955-0674(00)00173-3; GARCIADELPORTILLO F, 1995, TRENDS MICROBIOL, V3, P373, DOI 10.1016/S0966-842X(00)88982-9; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V91, P71, DOI 10.1016/0091-6749(93)90298-T; Hong Y, 2016, J PROTEOMICS, V148, P202, DOI 10.1016/j.jprot.2016.08.008; Huang Y, 2010, MOL BIOSYST, V6, P683, DOI 10.1039/b920120c; Hui M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4745-3; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Jeon J, 2014, PLANT PATHOLOGY J, V30, P1, DOI 10.5423/PPJ.RW.01.2014.0003; Kang LQ, 2011, COMP BIOCHEM PHYS B, V158, P230, DOI 10.1016/j.cbpb.2010.12.001; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; [李军 LI Jun], 2007, [广东农业科学, Guangdong Agricultural Sciences], P54; Menzies NA, 2018, LANCET INFECT DIS, V18, pE228, DOI 10.1016/S1473-3099(18)30134-8; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Nie ZM, 2015, PROTEOMICS, V15, P3253, DOI 10.1002/pmic.201500001; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Nugent JS, 2004, J ALLERGY CLIN IMMUN, V114, P383, DOI 10.1016/j.jaci.2004.04.016; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; Pruett PS, 2003, J BIOL CHEM, V278, P26952, DOI 10.1074/jbc.M212931200; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Schmidt M, 2003, ALLERGY, V58, P342, DOI 10.1034/j.1398-9995.2003.00085.x; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Wang HC, 2009, GENE, V430, P38, DOI 10.1016/j.gene.2008.10.021; Wang H, 2013, J COMPUT BIOL, V20, P344, DOI 10.1089/cmb.2012.0273; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; Yang Y, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02674; Zeng L., 2005, CHINESE B ENTOMOLOGY, V42, P44; Zheng Ya-Nan, 2018, Acta Entomologica Sinica, V61, P385, DOI 10.16380/j.kcxb.2018.03.013; Zhou XW, 2016, J PROTEOME RES, V15, P2525, DOI 10.1021/acs.jproteome.6b00052	38	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243787	10.1371/journal.pone.0243787	http://dx.doi.org/10.1371/journal.pone.0243787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326466	Green Published, gold			2022-12-26	WOS:000600176400002
J	Melkie, G; Azage, M; Gedamu, G				Melkie, Gashaw; Azage, Muluken; Gedamu, Genet			Prevalence and associated factors of active trachoma among children aged 1-9 years old in mass drug administration graduated and non-graduated districts in Northwest Amhara region, Ethiopia: A comparative cross-sectional study	PLOS ONE			English	Article							FACIAL CLEANLINESS; WATER; ZONE; RISK	Background Mass drug administration has implemented to reduce trachoma since 2001, however, trachoma is still the major public health problem in Amhara Region, Ethiopia. However, credible evidence on the prevalence of trachoma and its associated factors after the implementation of mass drug administration is limited. Objective To assess the prevalence and associated factors of active trachoma among children aged 1-9 years old in mass drug administration graduated and non-graduated districts in the Northwest Amhara Region. Methods A comparative cross-sectional study was conducted from October to November, 2019. A stratified multistage random sampling was used to select 690 households having children aged 1-9 years. Data were collected using a pretested structured questionnaire. Data were entered into Epi-data version 3.1 and exported to SPSS version 20.0 for analysis. Bivariate and multivariable logistic regressions were employed to identify factors associated with active trachoma. Crude and adjusted odds ratios with 95% confidence interval were computed to assess the degree of association between the independent variables and active trachoma. Results The overall prevalence of active trachoma was 8.3% (95% CI: 6.2% -10.5%) and showed a significant variation between graduated [3.5% (95% CI: 1.8% -5.6%)] and non-graduated [13% (95% CI: 9.7%-16.8%)] districts. Living in graduated districts (AOR = 7.39, 95% CI: 3.19, 17.09), fly presence in the house (AOR = 3.14, 95% CI: 1.43, 6.89), presence of more than two children in the family (AOR = 3.78, 95%CI: 1.79, 7.98), did not wash face daily (AOR = 6.31, 95% CI: 1.81, 21.98), did not use soap during face washing (AOR = 3.34, 95% CI: 1.37, 8.15), presence of sleep in eyes (AOR = 3.16, 95% CI: 1.42, 7.02) and presence of dirt on child face (AOR = 2.44, 95% CI: 1.08, 5.50) increased the odds of having active trachoma. Conclusion The prevalence of active trachoma was high in the study area and showed a significant variation between graduated and non-graduated districts with mass drug administration. Living in non-graduated districts, fly presence in the house, more than two children in a household, did not wash the face daily, did not use soap during face washing, presence of sleep in eyes, and dirt on the child's face were the significant predictors of active trachoma. Therefore, the identified modifiable factors are the area of intervention to reduce the burden of active trachoma.	[Melkie, Gashaw; Gedamu, Genet] Teda Hlth Sci Coll, Sch Publ Hlth, Dept Environm Hlth, Gondar, Ethiopia; [Azage, Muluken; Gedamu, Genet] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Environm Hlth, Bahir Dar, Ethiopia	Bahir Dar University	Gedamu, G (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Environm Hlth, Bahir Dar, Ethiopia.	geni_31280@yahoo.com	Azage, Muluken/AAF-6515-2020	Azage, Muluken/0000-0003-3222-0158	Bahir Dar University; Amhara Regional Health Bureau	Bahir Dar University; Amhara Regional Health Bureau	This research work is funded by Bahir Dar University and Amhara Regional Health Bureau.	Alemayehu M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/570898; Miller HA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229297; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P421; [Anonymous], 2007, J ORTHOP TRAUMA, V21, pS39; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; Anteneh Zelalem Alamrew, 2016, Trop Dis Travel Med Vaccines, V2, P5, DOI 10.1186/s40794-016-0022-0; Asres M, 2016, PREV MED, V1, P5; Astale T, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006270; BAILEY R, 1991, T ROY SOC TROP MED H, V85, P824, DOI 10.1016/0035-9203(91)90470-J; Bamani S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000734; BRECHNER RJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P687, DOI 10.1001/archopht.1992.01080170109035; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; Central Gondar Zonal Health Department, 2018, CENTR GOND ZON DISTR; Delea MG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006178; Frick KD, 2003, OPHTHAL EPIDEMIOL, V10, P121, DOI 10.1076/opep.10.2.121.13899; Golovaty I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006702; Kalua K., 2014, Health, V6, P57, DOI 10.4236/health.2014.61009; Kassim K, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3992-5; Ketema K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1105; Lakew T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000507; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mengistu K, 2016, CLIN OPHTHALMOL, V10, P1663, DOI 10.2147/OPTH.S107619; Missamou F, 2018, OPHTHAL EPIDEMIOL, V25, P155, DOI 10.1080/09286586.2018.1546878; Mpyet C, 2018, OPHTHAL EPIDEMIOL, V25, P79, DOI 10.1080/09286586.2018.1467466; Mpyet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040421; Nigusie Adane, 2015, BMC Res Notes, V8, P641, DOI 10.1186/s13104-015-1529-6; Oswald .WE, 2017, B WORLD HEALTH ORGAN, V95, P250, DOI [10.2471/BLT.16.177758, 10.2471/blt.16.177758]; Roba AA, 2011, J EPIDEMIOL COMMUN H, V65, P626, DOI 10.1136/jech.2009.094763; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; Stewart AEP, 2019, AM J TROP MED HYG, V101, P1286, DOI 10.4269/ajtmh.19-0450; Tadesse B, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0358-3; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; WEST SK, 1991, ARCH OPHTHALMOL-CHIC, V109, P855, DOI 10.1001/archopht.1991.01080060119038; WHO, TRACHOMA; WHO, 2016, VAL EL TRACH PUBL HL; WoldeKidan E, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4495-0; World Health Organization, 1998, WHA51 11 GLOB EL BLI; World Health Organization, 2015, PROGR SAN DRINK WAT; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P204; Zack R, 2008, T ROY SOC TROP MED H, V102, P426, DOI 10.1016/j.trstmh.2008.02.001	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243863	10.1371/journal.pone.0243863	http://dx.doi.org/10.1371/journal.pone.0243863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320864	Green Published, gold			2022-12-26	WOS:000600339800039
J	Carlsson, ER; Fenger, M; Henriksen, T; Kjaer, LK; Worm, D; Hansen, DL; Madsbad, S; Poulsen, HE				Carlsson, Elin Rebecka; Fenger, Mogens; Henriksen, Trine; Kjaer, Laura Kofoed; Worm, Dorte; Hansen, Dorte Lindqvist; Madsbad, Sten; Poulsen, Henrik Enghusen			Reduction of oxidative stress on DNA and RNA in obese patients after Roux-en-Y gastric bypass surgery-An observational cohort study of changes in urinary markers	PLOS ONE			English	Article							BARIATRIC SURGERY; WEIGHT; DAMAGE; DETERMINANTS; PROFILE; HUMANS; PLASMA; MASS	Increased oxidative stress in obesity and diabetes is associated with morbidity and mortality risks. Levels of oxidative damage to DNA and RNA can be estimated through measurement of 8-oxo-7,8-dihydro-2 ' -deoxyguanosine (8-oxodG) and 8-oxo-7,8-dihydroguanosine (8-oxoGuo) in urine. Both markers have been associated with type 2 diabetes, where especially 8-oxoGuo is prognostic for mortality risk. We hypothesized that Roux-en-Y gastric bypass (RYGB) surgery that has considerable effects on bodyweight, hyperglycemia and mortality, might be working through mechanisms that reduce oxidative stress, thereby reducing levels of the urinary markers. We used liquid chromatography coupled with tandem mass spectrometry to analyze the content of 8-oxodG and 8-oxoGuo in urinary samples from 356 obese patients treated with the RYGB-procedure. Mean age (SD) was 44.2 (9.6) years, BMI was 42.1 (5.6) kg/m(2). Ninety-six (27%) of the patients had type 2 diabetes. Excretion levels of each marker before and after surgery were compared as estimates of the total 24-hour excretion, using a model based on glomerular filtration rate (calculated from cystatin C, age, height and weight), plasma- and urinary creatinine. The excretion of 8-oxodG increased in the first months after RYGB. For 8-oxoGuo, a gradual decrease was seen. Two years after RYGB and a mean weight loss of 35 kg, decreased hyperglycemia and insulin resistance, excretion levels of both markers were reduced by approximately 12% (P < 0.001). For both markers, mean excretion levels were about 30% lower in the female subgroup (P < 0.0001). Also, in this subgroup, excretion of 8-oxodG was significantly lower in patients with than without diabetes. We conclude, that oxidative damage to nucleic acids, reflected in the excretion of 8-oxodG and 8-oxoGuo, had decreased significantly two years after RYGB-indicating that reduced oxidative stress could be contributing to the many long-term benefits of RYGB-surgery in obesity and type 2 diabetes.	[Carlsson, Elin Rebecka; Fenger, Mogens] Copenhagen Univ Hosp Hvidovre, Dept Clin Biochem, Hvidovre, Denmark; [Carlsson, Elin Rebecka] Univ Copenhagen, Nordsjaellands Hosp, Dept Clin Biochem, Hillerod, Denmark; [Henriksen, Trine; Kjaer, Laura Kofoed; Poulsen, Henrik Enghusen] Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark; [Worm, Dorte] Amager Hosp, Dept Med, Copenhagen, Denmark; [Hansen, Dorte Lindqvist] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Madsbad, Sten] Copenhagen Univ Hosp Hvidovre, Dept Endocrinol, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Steno Diabetes Center; University of Copenhagen	Carlsson, ER (corresponding author), Copenhagen Univ Hosp Hvidovre, Dept Clin Biochem, Hvidovre, Denmark.; Carlsson, ER (corresponding author), Univ Copenhagen, Nordsjaellands Hosp, Dept Clin Biochem, Hillerod, Denmark.; Poulsen, HE (corresponding author), Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark.	elin.rebecka.carlsson@regionh.dk; henrik.enghusen.poulsen.01@regionh.dk			Ministry of Higher Education and Science (the UNIK project)	Ministry of Higher Education and Science (the UNIK project)	The collection of samples to the biobank used in this study was partially funded by The Ministry of Higher Education and Science (the UNIK project). The authors received no specific funding for their work related to this study.	Adams TD, 2017, NEW ENGL J MED, V377, P1143, DOI 10.1056/NEJMoa1700459; [Anonymous], 2005, BUSINESS CHINA  0228, V31, P5; Bankoglu EE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29581-6; Bankoglu EE, 2018, MUTAGENESIS, V33, P61, DOI 10.1093/mutage/gex040; Bankoglu EE, 2016, FREE RADICAL BIO MED, V94, P208, DOI 10.1016/j.freeradbiomed.2016.02.033; Bojsen-Moller KN, 2014, DIABETES, V63, P1725, DOI 10.2337/db13-1307; Broedbaek K, 2011, DIABETES CARE, V34, P2594, DOI 10.2337/dc11-1620; Broedbaek K, 2011, FREE RADICAL BIO MED, V51, P1473, DOI 10.1016/j.freeradbiomed.2011.07.007; Cabrera EJ, 2010, OBES SURG, V20, P42, DOI 10.1007/s11695-009-9988-2; Carlsson ER, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00172; Cejvanovic V, 2018, FREE RADICAL BIO MED, V129, P532, DOI 10.1016/j.freeradbiomed.2018.10.420; Cejvanovic V, 2016, SCAND J CLIN LAB INV, V76, P620, DOI 10.1080/00365513.2016.1230776; Ceriello Antonio, 2006, Endocr Pract, V12 Suppl 1, P60; Cui Hai-Feng, 2012, J Anal Methods Chem, V2012, P793468, DOI 10.1155/2012/793468; da Silva VRG, 2012, EUR J CLIN NUTR, V66, P891, DOI 10.1038/ejcn.2012.17; Dadalt C, 2013, EUR J GASTROEN HEPAT, V25, P580, DOI 10.1097/MEG.0b013e32835d0ae0; Dagan SS, 2017, ADV NUTR, V8, P382, DOI 10.3945/an.116.014258; Fenger M, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0140-8; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326; Jaffe M., 1886, J PHYS CHEM-US, V10, P391, DOI [DOI 10.1515/BCHM1.1886.10.5.391, 10.1515/bchm1.1886.10.5.391]; Jorgensen NB, 2012, AM J PHYSIOL-ENDOC M, V303, pE122, DOI 10.1152/ajpendo.00073.2012; Kelly AS, 2016, INT J OBESITY, V40, P275, DOI 10.1038/ijo.2015.174; Kjaer LK, 2018, FREE RADICAL BIO MED, V129, P247, DOI 10.1016/j.freeradbiomed.2018.09.030; Larsen EL, 2019, FREE RADICAL BIO MED, V145, P256, DOI 10.1016/j.freeradbiomed.2019.09.030; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Liakopoulos V, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000386; Lieske JC, 2014, AM J KIDNEY DIS, V64, P663, DOI 10.1053/j.ajkd.2014.06.016; LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241; Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378; Matter B, 2018, FREE RADICAL BIO MED, V121, P180, DOI 10.1016/j.freeradbiomed.2018.04.561; Monzo-Beltran L, 2017, REDOX BIOL, V12, P389, DOI 10.1016/j.redox.2017.02.003; Nosso G, 2017, NUTR METAB CARDIOVAS, V27, P949, DOI 10.1016/j.numecd.2017.07.004; Park AM, 2009, J UROLOGY, V182, P2334, DOI 10.1016/j.juro.2009.07.044; Poulsen HE, 2019, FREE RADICAL BIO MED, V145, P336, DOI 10.1016/j.freeradbiomed.2019.10.001; Poulsen HE, 2014, BBA-GEN SUBJECTS, V1840, P801, DOI 10.1016/j.bbagen.2013.06.009; Poulsen HE, 2012, FREE RADICAL BIO MED, V52, P1353, DOI 10.1016/j.freeradbiomed.2012.01.009; Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002; Rasmussen ST, 2016, REDOX BIOL, V9, P32, DOI 10.1016/j.redox.2016.05.007; Schmatz R, 2017, CLIN CHIM ACTA, V465, P72, DOI 10.1016/j.cca.2016.12.012; Setayesh T, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900045; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Spahis S, 2017, ANTIOXID REDOX SIGN, V26, P445, DOI 10.1089/ars.2016.6756; Thomas MC, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008226; Tudor MJ, 2006, MEASUREMENT SCI TECH, V17, pR175; Tumova E, 2013, J OBES, V2013, DOI 10.1155/2013/729515; Vaurs C, 2015, DIABETES METAB, V41, P416, DOI 10.1016/j.diabet.2015.04.003; Von Scholten BJ, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0474-0; Xu XJ, 2015, DIABETES, V64, P3155, DOI 10.2337/db14-1765; 2019, ART COLL SOC CIRC, P1	50	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243918	10.1371/journal.pone.0243918	http://dx.doi.org/10.1371/journal.pone.0243918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315915	Green Published, gold			2022-12-26	WOS:000600186100049
J	Chen, HM; Kuo, FC; Chen, CC; Wu, CF; Sun, CW; Chen, ML; Hsieh, CJ; Wang, SL; Wu, MT				Chen, Hui-Ming; Kuo, Fu-Chen; Chen, Chou-Cheng; Wu, Chia-Fang; Sun, Chien-Wen; Chen, Mei-Lien; Hsieh, Chia-Jung; Wang, Shu-Li; Wu, Ming-Tsang			New trimester-specific reference intervals for clinical biochemical tests in Taiwanese pregnant women-cohort of TMICS	PLOS ONE			English	Article							THYROID-HORMONES; REFERENCE VALUES; ESTABLISHMENT; PLATELET; INSULIN	Background Because there are no published biochemical reference intervals (RI) for pregnant Taiwanese women, we used an established islandwide birth cohort, the Taiwan Maternal and Infant Cohort Study, to establish RIs for important biochemical parameters in women during their 3rd trimester in Taiwan. Additionally, we compared the differences in these biochemical parameters between early third trimester (weeks 28 to 31) and late third trimester (weeks 37 to 40) of pregnant women as well as the differences in them between the third trimester and after delivery. Methods Between 2012 and 2015, we recruited a total of 2,136 pregnant women from nine hospitals located in northern (n = 3), central (n = 3), southern (n = 2), and eastern Taiwan (n = 1) to receive regular prenatal health examinations during their third trimester (weeks 28 to 40). After exclusion, samples obtained from 993 eligible pregnant women were analyzed. Results There were increases in both lower and upper normal limits for blood neutrophil, thyroid profile (triiodothyronine (T3) and thyroxine (T4)), testosterone, estradiol, and progesterone and decreases for RBC, hemoglobin (Hb), alanine aminotransferase (ALT) and creatinine (Cr) during their third trimesters. Women in their late third trimester (n = 378) had higher median RBC, Hb, aspartate aminotransferase (AST), Cr, thyroid-stimulating hormone (TSH), testosterone, estradiol, and progesterone and lower median platelet and insulin, compared with those in their early third trimester (n = 490). Twenty-three of the women had both third trimester and post-pregnancy data. After delivery, the women had lower median AST, ALT, insulin, T3, T4, testosterone, estradiol, and progesterone and higher median Cr, free T4, FSH, and luteinizing hormone (LH), compared to their third trimesters. Conclusions Gestation-related changes in important biochemical parameters should be considered when evaluating clinical laboratory values in pregnant women.	[Chen, Hui-Ming; Chen, Chou-Cheng; Wu, Chia-Fang; Wu, Ming-Tsang] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Chen, Hui-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Family Med & Occupat Med, Kaohsiung, Taiwan; [Kuo, Fu-Chen] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Kuo, Fu-Chen] E Da Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Wu, Chia-Fang; Wu, Ming-Tsang] Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan; [Sun, Chien-Wen; Wang, Shu-Li] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Natl Environm Hlth Res Ctr, Miaoli, Taiwan; [Chen, Mei-Lien] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Coll Med, Taipei, Taiwan; [Hsieh, Chia-Jung] Tzu Chi Univ, Dept Publ Hlth, Hualien, Taiwan; [Wang, Shu-Li] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Wang, Shu-Li] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wang, Shu-Li; Wu, Ming-Tsang] Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Chang Gung Memorial Hospital; I Shou University; E-Da Hospital; Kaohsiung Medical University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Tzu Chi University; National Defense Medical Center; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Wu, MT (corresponding author), Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan.; Wu, MT (corresponding author), Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan.; Wang, SL (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Natl Environm Hlth Res Ctr, Miaoli, Taiwan.; Wang, SL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Wang, SL (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Wang, SL; Wu, MT (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan.; Wu, MT (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan.; Wu, MT (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.	slwang@nhri.org.tw; 960021@ms.kmuh.org.tw	Hsieh, Chia-Jung/AAX-3086-2020; Wu, Ming-Tsang/G-5637-2012	Hsieh, Chia-Jung/0000-0002-0381-7783; Wang, Shu-Li/0000-0002-0686-4729; Wu, Chia-Fang/0000-0002-6803-2389; Wu, Ming-Tsang/0000-0001-7307-7816	Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program of the Ministry of Education (MOE) in Taiwan; Kaohsiung Medical University Research Center Grant in Taiwan [KMU-TC108A01]; Ministry of Science and Technology in Taiwan [MOST105-2632-B-037-002, MOST106 -2314-B-214-007, MOST106-2314-B037-030-MY3]; National Health Research Institutes in Taiwan [NHRI EH-102SP-02, EH-103-SP-02, NHRI-EX107-10703PI]; E-Da Hospital in Taiwan [EDAHP106046]	Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program of the Ministry of Education (MOE) in Taiwan; Kaohsiung Medical University Research Center Grant in Taiwan; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); E-Da Hospital in Taiwan	This work was financially supported by the Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE), Kaohsiung Medical University Research Center Grant (KMU-TC108A01), Ministry of Science and Technology (MOST105-2632-B-037-002; MOST106 -2314-B-214-007; and MOST106-2314-B037-030-MY3), grants from National Health Research Institutes (grant numbers NHRI EH-102SP-02; EH-103-SP-02; NHRI-EX107-10703PI), and E-Da Hospital (EDAHP106046), all in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2012, NORDIC J AESTHETICS, V44-45, P68; Bernstein IM, 2001, OBSTET GYNECOL, V97, P669, DOI 10.1016/S0029-7844(00)01222-9; Chandra S, 2012, INDIAN J HEMATOL BLO, V28, P144, DOI 10.1007/s12288-012-0175-6; Ciampelli M, 1998, HUM REPROD UPDATE, V4, P904, DOI 10.1093/humupd/4.6.904; Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065; Dai YP, 2018, ANN CLIN BIOCHEM, V55, P446, DOI 10.1177/0004563217738801; Davison AC, 1997, BOOTSTRAP METHODS TH, Vx, P582; DAVISON JM, 1984, SEMIN NEPHROL, V4, P198; GATTI L, 1994, INT J CLIN LAB RES, V24, P217, DOI 10.1007/BF02592466; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; Gohel MG, 2013, INT J REPROD CONTRAC, V2, P616, DOI DOI 10.5455/2320-1770.IJRCOG20131225; Harel Z, 2019, JAMA-J AM MED ASSOC, V321, P205, DOI 10.1001/jama.2018.17948; Horn PS, 2001, CLIN CHEM, V47, P2137; Jin Y, 2018, CLIN CHEM LAB MED, V56, P973, DOI 10.1515/cclm-2017-0804; Kampmann U, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/5320156; Klajnbard A, 2010, CLIN CHEM LAB MED, V48, P237, DOI 10.1515/CCLM.2010.033; KRUTZEN E, 1992, SCAND J CLIN LAB INV, V52, P387, DOI 10.3109/00365519209088374; Larsson A, 2008, BJOG-INT J OBSTET GY, V115, P874, DOI 10.1111/j.1471-0528.2008.01709.x; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li AW, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22150; McDonald CJ, 2003, CLIN CHEM, V49, P624, DOI 10.1373/49.4.624; Milman N, 1999, ACTA OBSTET GYN SCAN, V78, P749, DOI 10.1034/j.1600-0412.1999.780902.x; Moon HW, 2015, ANN LAB MED, V35, P198, DOI 10.3343/alm.2015.35.2.198; Nazarpour S, 2018, CLIN BIOCHEM, V53, P49, DOI 10.1016/j.clinbiochem.2018.01.006; OLEARY P, 1991, CLIN CHEM, V37, P667; Petersen JF, 2019, CLIN CHEM LAB MED, V57, P1956, DOI 10.1515/cclm-2019-0495; Picciano MF, 2003, J NUTR, V133, p1997S, DOI 10.1093/jn/133.6.1997S; PITKIN RM, 1979, JAMA-J AM MED ASSOC, V242, P2696, DOI 10.1001/jama.242.24.2696; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Sharma K, 2018, J OBSTET GYN INDIA, V68, P27, DOI 10.1007/s13224-017-0988-1; Shehata N, 1999, CLIN OBSTET GYNECOL, V42, P327, DOI 10.1097/00003081-199906000-00017; Solberg HE, 2004, CLIN CHEM LAB MED, V42, P710, DOI 10.1515/CCLM.2004.121; SPELLACY WN, 1963, NEW ENGL J MED, V268, P988, DOI 10.1056/NEJM196305022681805; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Wickstrom K, 2004, SCAND J CLIN LAB INV, V64, P31, DOI 10.1080/00365510410003859; Wu CF, 2018, INT J EPIDEMIOL, V47, P1047, DOI 10.1093/ije/dyy067	38	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243761	10.1371/journal.pone.0243761	http://dx.doi.org/10.1371/journal.pone.0243761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315949	gold, Green Published			2022-12-26	WOS:000600186100019
J	Wu, VCC; Wang, CL; Gan, ST; Wu, M; Chen, SW; Kuo, CF; Huang, YT; Wen, MS; Chang, SH				Wu, Victor Chien-Chia; Wang, Chun-Li; Gan, Shu-Ting; Wu, Michael; Chen, Shao-Wei; Kuo, Chang-Fu; Huang, Yu-Tung; Wen, Ming-Shien; Chang, Shang-Hung			Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement	PLOS ONE			English	Article							FIBRILLATION; STROKE; RISK; DEATH	Background Little is known about the effects of anticoagulation in patients with atrial fibrillation (AF) and left atrial enlargement (LAE). Methods Data of patients with AF were retrieved from Chang Gung Research Database during 2007-2016. We excluded patients who were not using oral anticoagulants, used anticoagulants for <30 days, used <greater than or equal to>2 agents concomitantly or switched anticoagulants, had left atrial diameter missing from their data, were aged <65, had received valve surgeries, had mitral stenosis, or had a history of cancer. The primary outcomes were ischemic stroke (IS)/systemic embolism (SE), major bleeding, and death from any cause. Results We identified 40,777 patients who received a diagnosis of AF. After the exclusion criteria were applied, 6,445 patients remained, 4,922 with LAE, and they were followed up for 2.4 1.9 years. The mean age of the patients was 77.32 <plus/minus> 0.18 in the NOAC group and 76.58 +/- 6.91 in the warfarin group (p < 0.0001); 48.24% of patients in the NOAC group and 46.98% of patients in the warfarin group were men (p > 0.05). The mean CHA(2)DS(2)-VASc score was 3.26 +/- 1.05 in the NOAC group and 3.07 +/- 1.12 in the warfarin group (p < 0.0001). The mean HAS-BLED score was 3.87 <plus/minus> 3.81 in the NOAC group and 3.86 +/- 3.80 in the warfarin group (p > 0.05). Furthermore, the mean LA diameter was 4.75 +/- 0.63 cm in the warfarin group and 4.79 +/- 0.69 cm in the warfarin group (p > 0.05). Among patients with LAE, NOAC was associated with significantly reduced IS/SE events (CRR = 0.63, 95% CI = 0.52-0.77), no difference in major bleeding (CRR = 0.91, 95% CI = 0.78-1.05), and significantly reduced death from any cause (aHR = 0.65, 95% CI = 0.52-0.80) compared with warfarin. Conclusions In elderly patients with AF and LAE, NOAC was associated with reduced IS/SE and death from any cause compared with warfarin, whereas no difference in major bleeding was observed between these treatments.	[Wu, Victor Chien-Chia; Wang, Chun-Li; Wen, Ming-Shien; Chang, Shang-Hung] Chang Gung Mem Hosp, Div Cardiol, Linkou Med Ctr, Taoyuan, Taiwan; [Wu, Victor Chien-Chia; Wang, Chun-Li; Kuo, Chang-Fu; Wen, Ming-Shien; Chang, Shang-Hung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Gan, Shu-Ting; Huang, Yu-Tung; Chang, Shang-Hung] Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Linkou Med Ctr, Taoyuan, Taiwan; [Wu, Michael] Brown Univ, Rhode Isl Hosp, Warren Alpert Sch Med, Div Cardiovasc Med,Arrhythmia Serv Sect, Providence, RI 02903 USA; [Chen, Shao-Wei] Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Linkou Med Ctr, Taoyuan, Taiwan; [Kuo, Chang-Fu] Chang Gung Mem Hosp, Dept Internal Med, Linkou Med Ctr, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Kuo, Chang-Fu] Univ Nottingham, Sch Med, Div Rheumatol Orthopaed & Dermatol, Nottingham, England; [Chang, Shang-Hung] Chang Gung Univ Sci & Technol, Grad Inst Nursing, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; University of Nottingham; Chang Gung University of Science & Technology	Chang, SH (corresponding author), Chang Gung Mem Hosp, Div Cardiol, Linkou Med Ctr, Taoyuan, Taiwan.; Chang, SH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Chang, SH (corresponding author), Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Linkou Med Ctr, Taoyuan, Taiwan.; Chang, SH (corresponding author), Chang Gung Univ Sci & Technol, Grad Inst Nursing, Taoyuan, Taiwan.	afen.chang@gmail.com	Wu, Victor Chien-Chia/GXF-4623-2022; Wu, Michael/ABL-0760-2022; Huang, Yu-Tung/S-4026-2018; Wu, Victor Chien-Chia/ABB-6872-2021	Wu, Victor Chien-Chia/0000-0002-9918-4369; Huang, Yu-Tung/0000-0003-3224-7238; Wu, Victor Chien-Chia/0000-0002-9918-4369	Center for Big Data Analytics and Statistics Grants at Chang Gung Memorial Hospital [CORPG3G0271, CLRPG3D0045]	Center for Big Data Analytics and Statistics Grants at Chang Gung Memorial Hospital	Funded by Center for Big Data Analytics and Statistics Grants, CORPG3G0271 and CLRPG3D0045, at Chang Gung Memorial Hospital, for Dr. Shang-Hung Chang. The funder plays role in the study design and monitor, data analysis and interpretation.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dakay K, 2018, J STROKE CEREBROVASC, V27, P192, DOI 10.1016/j.jstrokecerebrovasdis.2017.08.025; Freedman B, 2016, JAMA CARDIOL, V1, P366, DOI 10.1001/jamacardio.2016.0393; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Gupta DK, 2014, EUR HEART J, V35, P1457, DOI 10.1093/eurheartj/eht500; Hamatani Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31042; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; KEREN G, 1987, AM HEART J, V114, P1146, DOI 10.1016/0002-8703(87)90190-6; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Li Y, 2007, BASIC RES CARDIOL, V102, P245, DOI 10.1007/s00395-007-0641-8; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Maheshwari A, 2019, CIRCULATION, V139, P180, DOI 10.1161/CIRCULATIONAHA.118.035411; Ogata T, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006402; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Psaty BM, 1997, CIRCULATION, V96, P2455; Rapacciuolo A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44214-2; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Steffel J, 2018, EUROPACE, V20, P1231, DOI 10.1093/europace/euy054; Tiwari S, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000439; Tsai MS, 2017, BIOMED J, V40, P263, DOI 10.1016/j.bj.2017.08.002; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Wang CL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009263; Wang CL, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012029; Wang CL, 2019, J THROMB THROMBOLYS, V47, P512, DOI 10.1007/s11239-018-1792-1; Yoshida C, 2009, EUR J ECHOCARDIOGR, V10, P278, DOI 10.1093/ejechocard/jen234	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243866	10.1371/journal.pone.0243866	http://dx.doi.org/10.1371/journal.pone.0243866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315930	gold, Green Published			2022-12-26	WOS:000600186100057
J	Edin, ML; Yamanashi, H; Boeglin, WE; Graves, JP; DeGraff, LM; Lih, FB; Zeldin, DC; Brash, AR				Edin, Matthew L.; Yamanashi, Haruto; Boeglin, William E.; Graves, Joan P.; DeGraff, Laura M.; Lih, Fred B.; Zeldin, Darryl C.; Brash, Alan R.			Epoxide hydrolase 3 (Ephx3) gene disruption reduces ceramide linoleate epoxide hydrolysis and impairs skin barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID; TARGETED DISRUPTION; PERMEABILITY; 12R-LIPOXYGENASE; LIPOXYGENASES; ACYLCERAMIDE; REVEALS; LIPIDS	The mammalian epoxide hydrolase (EPHX)3 is known from in vitro experiments to efficiently hydrolyze the linoleate epoxides 9,10-epoxyoctadecamonoenoic acid (EpOME) and epoxyalcohol 9R,10R-trans-epoxy-11E-13R-hydroxy-octadecenoate to corresponding diols and triols, respectively. Herein we examined the physiological relevance of EPHX3 to hydrolysis of both substrates in vivo. Ephx3(-/-) mice show no deficiency in EpOME-derived plasma diols, discounting a role for EPHX3 in their formation, whereas epoxyalcohol-derived triols esterified in acylceramides of the epidermal 12R-lipoxygenase pathway are reduced. Although the Ephx3(-/-) pups appear normal, measurements of transepidermal water loss detected a modest and statistically significant increase compared with the wildtype or heterozygote mice, reflecting a skin barrier impairment that was not evident in the knockouts of mouse microsomal (EPHX1/microsomal epoxide hydrolase) or soluble (EPHX2/sEH). This barrier phenotype in the Ephx3(-/-) pups was associated with a significant decrease in the covalently bound ceramides in the epidermis (40% reduction, p < 0.05), indicating a corresponding structural impairment in the integrity of the water barrier. Quantitative LC-MS analysis of the esterified linoleate-derived triols in the murine epidermis revealed a marked and isomer-specific reduction (similar to 85%) in the Ephx3(-/-) epidermis of the major trihydroxy isomer 9R,10S,13R-trihydroxy-11E-octadecenoate. We conclude that EPHX3 (and not EPHX1 or EPHX2) catalyzes hydrolysis of the 12R-LOX/eLOX3-derived epoxyalcohol esterified in acylceramide and may function to control flux through the alternative and crucial route of metabolism via the dehydrogenation pathway of SDR9C7. Importantly, our findings also identify a functional role for EPHX3 in transformation of a naturally esterified epoxide substrate, pointing to its potential contribution in other tissues.	[Edin, Matthew L.; Graves, Joan P.; DeGraff, Laura M.; Lih, Fred B.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Yamanashi, Haruto; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Yamanashi, Haruto; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Yamanashi, Haruto] Juntendo Univ, Dept Dermatol & Allergol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Vanderbilt University; Vanderbilt University; Juntendo University	Zeldin, DC (corresponding author), NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.; Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.; Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA.	zeldin@niehs.nih.gov; alan.brash@vanderbilt.edu	; Zeldin, Darryl/Y-7091-2018	Edin, Matthew/0000-0002-7042-500X; Zeldin, Darryl/0000-0002-2087-7307	Division of Intramural Research, National Institute of Environmental Health Sciences, NIH [Z01 ES025034]; NIH [GM134548]	Division of Intramural Research, National Institute of Environmental Health Sciences, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by the Division of Intramural Research, National Institute of Environmental Health Sciences, NIH (Z01 ES025034 to D. C. Z.) and by the NIH grant GM134548 to A. R. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Bai GH, 2019, J CELL PHYSIOL, V234, P22687, DOI 10.1002/jcp.28835; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHANG F, 1993, BIOCHIM BIOPHYS ACTA, V1150, P98, DOI 10.1016/0005-2736(93)90126-K; Chiba T, 2016, J BIOL CHEM, V291, P14540, DOI 10.1074/jbc.M115.711267; Decker M, 2012, J LIPID RES, V53, P2038, DOI 10.1194/jlr.M024448; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; Edin ML, 2018, J BIOL CHEM, V293, P3281, DOI 10.1074/jbc.RA117.000298; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; ELIAS PM, 1991, ADV LIPID RES, V24, P1; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Fischer J, 2020, ACTA DERM-VENEREOL, V100, P186, DOI 10.2340/00015555-3432; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6; Hirabayashi T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14609; Honda Y, 2018, J INVEST DERMATOL, V138, P741, DOI 10.1016/j.jid.2017.11.008; Hoopes SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175348; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Kendall AC, 2013, PROG LIPID RES, V52, P141, DOI 10.1016/j.plipres.2012.10.003; Krieg P, 2014, BBA-MOL CELL BIOL L, V1841, P390, DOI 10.1016/j.bbalip.2013.08.005; Krieg P, 2013, J INVEST DERMATOL, V133, P172, DOI 10.1038/jid.2012.250; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Munoz-Garcia A, 2014, BBA-MOL CELL BIOL L, V1841, P401, DOI 10.1016/j.bbalip.2013.08.020; Schneider C, 2001, ARCH BIOCHEM BIOPHYS, V386, P268, DOI 10.1006/abbi.2000.2217; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Sorokin AV, 2018, J INVEST DERMATOL, V138, P1518, DOI 10.1016/j.jid.2018.02.003; SQUIER CA, 1991, J INVEST DERMATOL, V96, P123, DOI 10.1111/1523-1747.ep12515931; Stott-Miller M, 2014, CANCER EPIDEM BIOMAR, V23, P1331, DOI 10.1158/1055-9965.EPI-13-1000; Takeichi T, 2020, J CLIN INVEST, V130, P890, DOI 10.1172/JCI130675; Takeichi T, 2016, J DERMATOL, V43, P242, DOI 10.1111/1346-8138.13243; Thomas CP, 2013, CHEM PHYS LIPIDS, V167, P21, DOI 10.1016/j.chemphyslip.2013.01.002; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Wagner KM, 2017, PHARMACOL THERAPEUT, V180, P62, DOI 10.1016/j.pharmthera.2017.06.006; Wang WC, 2019, CANCER RES, V79, P1822, DOI 10.1158/0008-5472.CAN-18-3221; WERTZ PW, 1992, J INVEST DERMATOL, V98, P375, DOI 10.1111/1523-1747.ep12499809; Yamamoto H, 2020, P NATL ACAD SCI USA, V117, P2914, DOI 10.1073/pnas.1917525117; Yamanashi H, 2018, J LIPID RES, V59, P684, DOI 10.1194/jlr.M082701; Zheng YX, 2011, J BIOL CHEM, V286, P24046, DOI 10.1074/jbc.M111.251496	41	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100198	10.1074/jbc.RA120.016570	http://dx.doi.org/10.1074/jbc.RA120.016570			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334892	gold, Green Published			2022-12-26	WOS:000672866400176
J	He, XY; Kim, JS; Diaz-Martinez, LA; Han, C; Lane, WS; Budnik, B; Waldman, T				He, Xiaoyuan; Kim, Jung-Sik; Diaz-Martinez, Laura A.; Han, Cecil; Lane, William S.; Budnik, Bogdan; Waldman, Todd			USP13 interacts with cohesin and regulates its ubiquitination in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA; TRANSCRIPTION; PROTEINS	Cohesin is a multiprotein ring complex that regulates 3D genome organization, sister chromatid cohesion, gene expression, and DNA repair. Cohesin is known to be ubiquitinated, although the mechanism, regulation, and effects of cohesin ubiquitination remain poorly defined. We previously used gene editing to introduce a dual epitope tag into the endogenous allele of each of 11 known components of cohesin in human HCT116 cells. Here we report that mass spectrometry analysis of dual-affinity purifications identified the USP13 deubiquitinase as a novel cohesin-interacting protein. Subsequent immunoprecipitation/Western blots confirmed the endogenous interaction in HCT116, 293T, HeLa, and RPE-hTERT cells; demonstrated that the interaction occurs specifically in the soluble nuclear fraction (not in the chromatin); requires the ubiquitin-binding domains (UBA1/2) of USP13; and occurs preferentially during DNA replication. Reciprocal dual-affinity purification of endogenous USP13 followed by mass spectrometry demonstrated that cohesin is its primary interactor in the nucleus. Ectopic expression and CRISPR knockout of USP13 showed that USP13 is paradoxically required for both deubiquitination and ubiquitination of cohesin subunits in human cells. USP13 was dispensable for sister chromatid cohesion in HCT116 and HeLa cells, whereas it was required for the dissociation of cohesin from chromatin as cells transit through mitosis. Together these results identify USP13 as a new cohesin-interacting protein that regulates the ubiquitination of cohesin and its cell cycle regulated interaction with chromatin.	[He, Xiaoyuan; Kim, Jung-Sik; Han, Cecil; Waldman, Todd] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [He, Xiaoyuan; Kim, Jung-Sik; Han, Cecil; Waldman, Todd] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Dept Biochem & Mol Biol, Washington, DC 20057 USA; [Diaz-Martinez, Laura A.] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Lane, William S.; Budnik, Bogdan] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA	Georgetown University; Georgetown University; Gonzaga University; Harvard University	Waldman, T (corresponding author), Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.; Waldman, T (corresponding author), Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Dept Biochem & Mol Biol, Washington, DC 20057 USA.	waldmant@georgetown.edu	Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003	National Institutes of Health [R01CA169345]; Alex's Lemonade Stand; Hyundai Hope on Wheels Foundation [P30CA51008]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand; Hyundai Hope on Wheels Foundation	This research was supported by the National Institutes of Health (R01CA169345 to T. W.), Alex's Lemonade Stand (T. W.), and the Hyundai Hope on Wheels Foundation (T. W.). The Lombardi Comprehensive Cancer Center is supported by P30CA51008. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Frattini C, 2017, MOL CELL, V68, P758, DOI 10.1016/j.molcel.2017.10.012; Gaj T, 2016, MOL THER, V24, P458, DOI 10.1038/mt.2015.151; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Han C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13525; Holzmann J, 2019, ELIFE, V8, DOI 10.7554/eLife.46269; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim JS, 2019, J BIOL CHEM, V294, P8760, DOI 10.1074/jbc.RA119.007832; Kim JS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn566; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Li L, 2019, EBIOMEDICINE, V45, P553, DOI 10.1016/j.ebiom.2019.06.011; Liu YF, 2014, ELIFE, V3, DOI 10.7554/eLife.01369; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Paulo Joao A, 2016, J Biol Methods, V3; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Waldman T, 2020, NAT REV CANCER, V20, P504, DOI 10.1038/s41568-020-0270-1; Xie WH, 2020, CELL REP, V30, P2807, DOI 10.1016/j.celrep.2020.01.088; Xie X, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210856; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Yeh C, 2015, CURR BIOL, V25, P2290, DOI 10.1016/j.cub.2015.07.025; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Zakari M, 2015, WIRES DEV BIOL, V4, P489, DOI 10.1002/wdev.190; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874; Zhang SZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02693-9	34	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100194	10.1074/jbc.RA120.015762	http://dx.doi.org/10.1074/jbc.RA120.015762			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334891	gold, Green Published			2022-12-26	WOS:000672866400172
J	Huang, ZX; Lu, XH; Huang, LL; Zhang, CH; Veldhuis, JD; Cowley, MA; Chen, C				Huang, Zhengxiang; Lu, Xuehan; Huang, Lili; Zhang, Chunhong; Veldhuis, Johannes D.; Cowley, Michael A.; Chen, Chen			Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice	FASEB JOURNAL			English	Article						GH; GHSR; hexarelin; MC4R; obesity	DE-NOVO LIPOGENESIS; GHRELIN RECEPTOR; VISCERAL FAT; PPAR-GAMMA; GH; BASAL; TESAMORELIN; EXPRESSION; ADIPOSITY; PITUITARY	Obese individuals often show low growth hormone (GH) secretion, which leads to reduced lipid mobilization and further fat accumulation. Pharmacological approaches to increase GH levels in obese individuals by GH injection or GH-releasing hormone receptor agonist showed promising effects on fat reduction. However, side effects on glucose metabolism and the heavy costs on making large peptides hindered their clinical application. Here, we tested whether stimulation of endogenous GH secretion by a synthetic GH secretagogue receptor (GHSR) agonist, hexarelin, improved the metabolism in a hyperphagic obese mouse model. Male melanocortin 4 receptor knockout mice (MC4RKO) were pair-fed and received continuous hexarelin (10.56 mu g/day) or vehicle infusion by an osmotic pump for 3-4 weeks. Hexarelin treatment significantly increased the pulsatile GH secretion without detectable alteration on basal GH secretion in MC4RKO mice. The treated mice showed increased lipolysis and lipid oxidation in the adipose tissue, and reduced de novo lipogenesis in the liver, leading to reduced visceral fat mass, reduced triglyceride content in liver, and unchanged circulating free fatty acid levels. Importantly, hexarelin treatment improved the whole-body insulin sensitivity but did not alter glucose tolerance, insulin levels, or insulin-like growth factor 1 (IGF-1) levels. The metabolic effects of hexarelin were likely through the direct action of GH, as indicated by the increased expression level of genes involved in GH signaling pathways in visceral adipose tissues and liver. In conclusion, hexarelin treatment stimulated the pulsatile GH secretion and reduced the fat accumulation in visceral depots and liver in obese MC4RKO mice with improved insulin sensitivity without altered levels of insulin or IGF-1. It provides evidence for managing obesity by enhancing pulsatile GH secretion through activation of GHSR in the pituitary gland.	[Huang, Zhengxiang; Lu, Xuehan; Huang, Lili; Zhang, Chunhong; Chen, Chen] Univ Queensland, Sch Biomed Sci, Bldg 64, St Lucia, Qld, Australia; [Veldhuis, Johannes D.] Mayo Clin, Clin Translat Sci Ctr, Mayo Sch Grad Med Educ, Dept Med,Endocrine Res Unit, Rochester, MN USA; [Cowley, Michael A.] Monash Univ, Dept Physiol, Melbourne, Vic, Australia	University of Queensland; Mayo Clinic; Monash University	Chen, C (corresponding author), Univ Queensland, Sch Biomed Sci, Bldg 64, St Lucia, Qld, Australia.	zhengxiang.huang@uq.net.au; chen.chen@uq.edu.au	chen, chen/GRY-7085-2022; Chen, Chen/B-4284-2010; Huang, Zhengxiang/AAA-8535-2022; CHEN, CHEN/HDM-6657-2022	Chen, Chen/0000-0003-2104-534X; Huang, Zhengxiang/0000-0002-1194-2701; Lu, Xuehan/0000-0002-1248-3180				Berryman DE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081621; Berryman DE, 2013, NAT REV ENDOCRINOL, V9, P346, DOI 10.1038/nrendo.2013.64; Cersosimo E, 1996, AM J PHYSIOL-ENDOC M, V271, pE123, DOI 10.1152/ajpendo.1996.271.1.E123; Cordoba-Chacon J, 2015, DIABETES, V64, P3093, DOI 10.2337/db15-0370; Dhillon S, 2011, DRUGS, V71, P1071, DOI 10.2165/11202240-000000000-00000; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Faje AT, 2010, J CLIN ENDOCR METAB, V95, P2486, DOI 10.1210/jc.2009-2634; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fourman LT, 2017, AIDS, V31, P2253, DOI [10.1097/QAD.0000000000001614, 10.1097/qad.0000000000001614]; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gravholt CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE848, DOI 10.1152/ajpendo.1999.277.5.E848; Hataya Y, 2001, J CLIN ENDOCR METAB, V86, P4552, DOI 10.1210/jc.86.9.4552; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Huang L, 2012, ENDOCRINOLOGY, V153, P4380, DOI 10.1210/en.2012-1178; Huang ZX, 2020, TRENDS ENDOCRIN MET, V31, P642, DOI 10.1016/j.tem.2020.04.005; Huang ZX, 2020, J ENDOCRINOL, V245, P1, DOI 10.1530/JOE-19-0385; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Hwang DL, 2008, GROWTH HORM IGF RES, V18, P65, DOI 10.1016/j.ghir.2007.07.007; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; Karastergiou K, 2016, OBESITY, V24, P1090, DOI 10.1002/oby.21460; Kurashina T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14041; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Li ZR, 2014, P NATL ACAD SCI USA, V111, P13163, DOI 10.1073/pnas.1411571111; Lin LG, 2016, AGING-US, V8, P178, DOI 10.18632/aging.100888; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Ma XJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE422, DOI 10.1152/ajpendo.00576.2011; Marechal L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051529; Mekala KC, 2009, J CLIN ENDOCR METAB, V94, P130, DOI 10.1210/jc.2008-1357; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Roumi M, 2000, DRUG METAB DISPOS, V28, P44; Stanley TL, 2015, GROWTH HORM IGF RES, V25, P59, DOI 10.1016/j.ghir.2014.12.005; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, P150, DOI 10.1210/jc.2010-1587; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Surya S, 2009, J CLIN ENDOCR METAB, V94, P2828, DOI 10.1210/jc.2009-0638; Tan HY, 2016, J PHYSIOL-LONDON, V594, P7309, DOI 10.1113/JP272770; Tsai YS, 2005, TRENDS CARDIOVAS MED, V15, P81, DOI 10.1016/j.tcm.2005.04.002; VANDERSCHUERENLODEWEYCKX M, 1993, HORM RES, V40, P23, DOI 10.1159/000183763; VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; WINER LM, 1990, J CLIN ENDOCR METAB, V70, P1678, DOI 10.1210/jcem-70-6-1678; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002; Zuo LY, 2019, CURR PHARM DESIGN, V25, P3590, DOI 10.2174/1381612825666190920123129	48	4	4	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21269	10.1096/fj.202001924RR	http://dx.doi.org/10.1096/fj.202001924RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368660				2022-12-26	WOS:000605626600037
J	Townsend, LK; Weber, AJ; Day, EA; Shamshoum, H; Shaw, SJ; Perry, CGR; Kemp, BE; Steinberg, GR; Wright, DC				Townsend, Logan K.; Weber, Alyssa J.; Day, Emily A.; Shamshoum, Hesham; Shaw, Simon J.; Perry, Christopher G. R.; Kemp, Bruce E.; Steinberg, Gregory R.; Wright, David C.			AMPK mediates energetic stress-induced liver GDF15	FASEB JOURNAL			English	Article						AMPK; CHOP; energetic stress; ER stress; GDF15; liver	ENDOPLASMIC-RETICULUM STRESS; DIFFERENTIATION FACTOR 15; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; OXIDATIVE-PHOSPHORYLATION; HEPATIC STEATOSIS; HOMEOSTASIS; ACTIVATOR; RECEPTOR; PATHWAY	Growth differentiating factor-15 (GDF15) is an emerging target for the treatment of obesity and metabolic disease partly due to its ability to suppress food intake. GDF15 expression and secretion are thought to be regulated by a cellular integrated stress response, which involves endoplasmic reticulum (ER) stress. AMPK is another cellular stress sensor, but the relationship between AMPK, ER stress, and GDF15 has not been assessed in vivo. Wildtype (WT), AMPK beta 1 deficient (AMPK beta 1(-/-)), and CHOP-/- mice were treated with three distinct AMPK activators; AICAR, which is converted to ZMP mimicking the effects of AMP on the AMPK gamma isoform, R419, which indirectly activates AMPK through inhibition of mitochondrial respiration, or A769662, a direct AMPK activator which binds the AMPK beta 1 isoform ADaM site causing allosteric activation. Following treatments, liver Gdf15, markers of ER-stress, AMPK activity, adenine nucleotides, circulating GDF15, and food intake were assessed. AICAR and R419 caused ER and energetic stress, increased GDF15 expression and secretion, and suppressed food intake. Direct activation of AMPK beta 1 containing complexes by A769662 increased hepatic Gdf15 expression, circulating GDF15, and suppressed food intake, independent of ER stress. The effects of AICAR, R419, and A769662 on GDF15 were attenuated in AMPK beta 1(-/-) mice. AICAR and A769662 increased GDF15 to a similar extent in WT and CHOP-/- mice. Herein, we provide evidence that AMPK plays a role in mediating the induction of GDF15 under conditions of energetic stress in mouse liver in vivo.	[Townsend, Logan K.; Weber, Alyssa J.; Shamshoum, Hesham; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada; [Townsend, Logan K.; Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada; [Townsend, Logan K.; Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Div Endocrinol & Metab, Dept Med, Hamilton, ON, Canada; [Shaw, Simon J.] Rigel Pharmaceut Inc, San Francisco, CA USA; [Perry, Christopher G. R.] York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Kemp, Bruce E.] Univ Melbourne, St Vincents Inst, Dept Med, Melbourne, Vic, Australia; [Kemp, Bruce E.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Fitzroy, Vic, Australia	University of Guelph; McMaster University; McMaster University; York University - Canada; St. Vincent's Institute of Medical Research; University of Melbourne; Australian Catholic University	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca		Wright, David/0000-0003-3867-8901				Banfi S, 2018, P NATL ACAD SCI USA, V115, pE1249, DOI 10.1073/pnas.1717420115; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Bush ND, 2018, J PHARMACOL EXP THER, V365, P526, DOI 10.1124/jpet.118.248393; Campderrs L, 2019, OBESITY, V27, P1606, DOI 10.1002/oby.22584; Choi MJ, 2020, DIABETOLOGIA, V63, P837, DOI 10.1007/s00125-019-05082-7; Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Coll AP, 2020, NATURE, V578, P444, DOI 10.1038/s41586-019-1911-y; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Fiedler M, 2001, DIABETOLOGIA, V44, P2180, DOI 10.1007/s001250100027; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Galic S, 2018, ELIFE, V7, DOI 10.7554/eLife.32656; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gerstein HC, 2017, DIABETES CARE, V40, P280, DOI 10.2337/dc16-1682; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hetz C, 2020, NAT REV MOL CELL BIO, V21, P421, DOI 10.1038/s41580-020-0250-z; Hou WL, 2018, J CELL MOL MED, V22, P1316, DOI 10.1111/jcmm.13432; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Jenkins Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081870; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jung TW, 2018, J BIOL CHEM, V293, P3981, DOI 10.1074/jbc.RA117.000885; Klein MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06003-9; Lee J, 2017, CELL REP, V20, P655, DOI 10.1016/j.celrep.2017.06.080; Li HL, 2014, BBA-MOL BASIS DIS, V1842, P1844, DOI 10.1016/j.bbadis.2014.07.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart SM, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa007; Morris EM, 2017, J PHYSIOL-LONDON, V595, P4909, DOI 10.1113/JP274281; Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114; Mottillo EP, 2016, CELL METAB, V24, P118, DOI 10.1016/j.cmet.2016.06.006; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016; Perry CGR, 2008, APPL PHYSIOL NUTR ME, V33, P1112, DOI 10.1139/H08-097; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Shamshoum H, 2019, FASEB J, V33, P14010, DOI 10.1096/fj.201901820R; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Steneberg P, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99114; Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063; Townsend LK, 2020, AM J PHYSIOL-ENDOC M, V319, pE1053, DOI 10.1152/ajpendo.00271.2020; Townsend LK, 2019, J LIPID RES, V60, P1236, DOI 10.1194/jlr.M092510; Townsend LK, 2019, FASEB J, V33, P4824, DOI 10.1096/fj.201802048RR; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Whitfield J, 2017, J BIOL CHEM, V292, P16653, DOI 10.1074/jbc.M117.806786; Xiong YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8732; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394; Yong J, 2019, ELIFE, V8, DOI 10.7554/eLife.49682; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9	65	9	11	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21218	10.1096/fj.202000954R	http://dx.doi.org/10.1096/fj.202000954R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337559				2022-12-26	WOS:000605626600030
J	Melo-Nascimento, AOD; Sant'Anna, BMM; Goncalves, CC; Santos, G; Noronha, E; Parachin, N; Roque, MRD; Bruce, T				dos Santos Melo-Nascimento, Amanda Oliveira; Sant'Anna, Brena Mota Moitinho; Goncalves, Carolyne Caetano; Santos, Giovanna; Noronha, Eliane; Parachin, Nadia; de Abreu Roque, Milton Ricardo; Bruce, Thiago			Complete genome reveals genetic repertoire and potential metabolic strategies involved in lignin degradation by environmental ligninolytic Klebsiella variicola P1CD1	PLOS ONE			English	Article							BACILLUS-SUBTILIS; KRAFT-LIGNIN; PULP; LACCASE; STREPTOMYCES; CLEAVAGE; SEQUENCE; ENZYMES; DECOLORIZATION; IDENTIFICATION	Lignin is a recalcitrant macromolecule formed by three alcohols (monolignols) predominantly connected by beta-aryl ether linkages and is one of the most abundant organic macromolecules in the biosphere. However, the role played by environmental bacteria in lignin degradation is still not entirely understood. In this study, we identified an environmental Klebsiella strain isolated from sediment collected from an altitudinal region in a unique Brazilian biome called Caatinga. This organism can also grow in the presence of kraft lignin as a sole source of carbon and aromatic compounds. We performed whole-genome sequencing and conducted an extensive genome-based metabolic reconstruction to reveal the potential mechanisms used by the bacterium Klebsiella variicola P1CD1 for lignin utilization as a carbon source. We identified 262 genes associated with lignin-modifying enzymes (LMEs) and lignin-degrading auxiliary enzymes (LDAs) required for lignin and aromatic compound degradation. The presence of one DyP (Dye-decolorizing Peroxidase) gene suggests the ability of P1CD1 strain to access phenolic and nonphenolic structures of lignin molecules, resulting in the production of catechol and protocatechuate (via vanillin or syringate) along the peripheral pathways of lignin degradation. K. variicola P1CD1 uses aldehyde-alcohol dehydrogenase to perform direct conversion of vanillin to protocatechol. The upper funneling pathways are linked to the central pathways of the protocatechuate/catechol catabolic branches via beta-ketoadipate pathways, connecting the more abundant catabolized aromatic compounds with essential cellular functions, such as energy cellular and biomass production (i.e., via acetyl-CoA formation). The combination of phenotypic and genomic approaches revealed the potential dissimilatory and assimilatory ability of K. variicola P1CD1 to perform base-catalyzed lignin degradation, acting on high- and low-molecular-weight lignin fragments. These findings will be relevant for developing metabolic models to predict the ligninolytic mechanism used by environmental bacteria and shedding light on the flux of carbon in the soil.	[dos Santos Melo-Nascimento, Amanda Oliveira; de Abreu Roque, Milton Ricardo; Bruce, Thiago] Univ Fed Bahia, Dept Microbiol, Inst Biol, Grp Biotecnol Ambiental, Salvador, BA, Brazil; [Sant'Anna, Brena Mota Moitinho; de Abreu Roque, Milton Ricardo] Univ Fed Bahia, Inst Ciencias Saude, Lab Bioprospeccao, Salvador, BA, Brazil; [Goncalves, Carolyne Caetano; Santos, Giovanna; Noronha, Eliane] Univ Brasilia, Dept Biol Celular, Inst Biol, Lab Engn Biocatalizadores, Brasilia, DF, Brazil; [Parachin, Nadia; Bruce, Thiago] Univ Brasilia, Dept Biol Celular, Inst Biol, Brasilia, DF, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade de Brasilia; Universidade de Brasilia	Bruce, T (corresponding author), Univ Fed Bahia, Dept Microbiol, Inst Biol, Grp Biotecnol Ambiental, Salvador, BA, Brazil.; Bruce, T (corresponding author), Univ Brasilia, Dept Biol Celular, Inst Biol, Brasilia, DF, Brazil.	thbruce@gmail.com	Rodrigues, Thiago Bruce B/G-8264-2012; Noronha, Eliane F./D-4812-2016	Mota Moitinho SantAnna, Brena/0000-0002-5678-0750; Noronha, Eliane Ferreira/0000-0002-4081-4979	CAPES/PROEX program; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [408778/2018-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [408778/2018-0]	CAPES/PROEX program; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	TB acknowledge funds from CAPES/PROEX program and grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (408778/2018-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (408778/2018-0).	Abdelaziz OY, 2016, BIOTECHNOL ADV, V34, P1318, DOI 10.1016/j.biotechadv.2016.10.001; Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Andrade AC, 2017, MICROB ECOL, V74, P89, DOI 10.1007/s00248-016-0911-9; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandounas L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-94; Barapatre A, 2017, BIOCATAL BIOTRANSFOR, V35, P269, DOI 10.1080/10242422.2017.1327953; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bourbonnais R, 1997, APPL ENVIRON MICROB, V63, P4627, DOI 10.1128/AEM.63.12.4627-4632.1997; Brander S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099402; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; Bugg TDH, 1998, NAT PROD REP, V15, P513; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chandra R, 2011, BIORESOURCE TECHNOL, V102, P6429, DOI 10.1016/j.biortech.2011.03.048; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Davis JR, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00416-13; Davis JR, 2012, J BACTERIOL, V194, P2396, DOI 10.1128/JB.00186-12; de Gonzalo G, 2016, J BIOTECHNOL, V236, P110, DOI 10.1016/j.jbiotec.2016.08.011; DeAngelis KM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00280; Dube E, 2008, APPL MICROBIOL BIOT, V79, P597, DOI 10.1007/s00253-008-1475-5; Galardini M, 2015, METHODS MOL BIOL, V1231, P163, DOI 10.1007/978-1-4939-1720-4_11; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Gao JF, 2010, NUCLEIC ACIDS RES, V38, pD488, DOI 10.1093/nar/gkp771; Grumaz C, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01562-16; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Kamimura N, 2017, ENV MICROBIOL REP, V9, P679, DOI 10.1111/1758-2229.12597; Kamimura N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44422; Kerepesi C, 2014, GENE, V533, P538, DOI 10.1016/j.gene.2013.10.015; Kontur WS, 2019, J BIOL CHEM, V294, P1877, DOI 10.1074/jbc.RA118.006548; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li X, 2007, BIOCHEM BIOPH RES CO, V354, P21, DOI 10.1016/j.bbrc.2006.12.116; Louren?o A., 2018, LIGNIN TRENDS APPL; Majumdar S, 2014, BIOCHEMISTRY-US, V53, P4047, DOI 10.1021/bi500285t; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; MASAI E, 1989, FEBS LETT, V249, P348, DOI 10.1016/0014-5793(89)80656-8; Masai E, 1999, J IND MICROBIOL BIOT, V23, P364, DOI 10.1038/sj.jim.2900747; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Melo-Nascimento AOD, 2018, ARCH MICROBIOL, V200, P1267, DOI 10.1007/s00203-018-1532-0; Naseem A, 2016, INT J BIOL MACROMOL, V93, P296, DOI 10.1016/j.ijbiomac.2016.08.030; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Picart P, 2014, CHEMSUSCHEM, V7, P3164, DOI 10.1002/cssc.201402465; Pokhrel D, 2004, SCI TOTAL ENVIRON, V333, P37, DOI 10.1016/j.scitotenv.2004.05.017; POMETTO AL, 1983, APPL ENVIRON MICROB, V45, P1582, DOI 10.1128/AEM.45.5.1582-1585.1983; Prabhakaran M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00019-15; Raj A, 2007, BIODEGRADATION, V18, P783, DOI 10.1007/s10532-007-9107-9; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Shimizu S, 2001, APPL ENVIRON MICROB, V67, P2021, DOI 10.1128/AEM.67.5.2021-2028.2001; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Teylaert B, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-1; Tian JH, 2014, APPL MICROBIOL BIOT, V98, P9527, DOI 10.1007/s00253-014-6142-4; Woo HL, 2014, STAND GENOMIC SCI, V9, DOI 10.1186/1944-3277-9-19; Xu ZX, 2018, ENVIRON SCI POLLUT R, V25, P14171, DOI 10.1007/s11356-018-1633-y; Yadav S, 2015, J ENVIRON SCI-CHINA, V33, P229, DOI 10.1016/j.jes.2015.01.018	64	5	5	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243739	10.1371/journal.pone.0243739	http://dx.doi.org/10.1371/journal.pone.0243739			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351813	Green Published, gold			2022-12-26	WOS:000603071400015
J	Torres-Cristiani, L; Machkour-M'Rabet, S; Calme, S; Weissenberger, H; Escalona-Segura, G				Torres-Cristiani, Leopoldo; Machkour-M'Rabet, Salima; Calme, Sophie; Weissenberger, Holger; Escalona-Segura, Griselda			Assessment of the American Flamingo distribution, trends, and important breeding areas	PLOS ONE			English	Article							PHOENICOPTERUS-RUBER; CITIZEN SCIENCE; YUCATAN; ARUBA	The American Flamingo, Phoenicopterus ruber, is a charismatic bird distributed throughout the Caribbean, North and South America. Its wide distribution, the complexity of international monitoring due to its capacity for long-distance flying, and a focus mostly on local populations, make it difficult to understand the dynamics between sites. Here, we took advantage of the citizen eBird science project to present a global perspective on the distribution of the American Flamingo, and identify the potentially most important countries for breeding. We obtained 16,930 records for the Americas from the 1960s until October 2018, of which 9,283 could be used for our objectives. The eBird database indicated a considerable increase in the total number of records over the last decade (2010s), probably reflecting an increase in tourism facilities, research investment, technological advancement, interest in conservation, and the worldwide availability of eBird. We also observed a range extension in the Gulf of Mexico in the United States and a significant recolonization in the Florida Peninsula. The apparent range extension to the South is more likely to be linked to biases in the data; for example, in any given country the number of records might reflect either reporting efforts or actual numbers. eBird data confirmed that six countries host the main breeding colonies (Bahamas, Bonaire, Cuba, Ecuador, Mexico, and Venezuela). We suggest three additional countries as potential breeding areas for the species (Colombia, Curacao, Turks and Caicos Islands) for which more field observations are necessary to support this possibility. This global appraisal of the distribution of the American Flamingo using citizen science data provides valuable information for national and international management and conservation programs such as the need to verify the species breeding status in areas where it appears to be expanding its distribution.	[Torres-Cristiani, Leopoldo; Machkour-M'Rabet, Salima] El Colegio Frontera Sur, Dept Conservac Biodivers, Chetmal, Quintana Roo, Mexico; [Calme, Sophie; Weissenberger, Holger] El Colegio Frontera, Dept Observac & Estudio Tierra, Atmosfera & Oceano TAQ, Chetmal, Quintana Roo, Mexico; [Calme, Sophie] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada; [Escalona-Segura, Griselda] El Colegio Frontera, Dept Conservac Biodivers, Campeche, Mexico	El Colegio de la Frontera Sur (ECOSUR); University of Sherbrooke	Machkour-M'Rabet, S (corresponding author), El Colegio Frontera Sur, Dept Conservac Biodivers, Chetmal, Quintana Roo, Mexico.; Calme, S (corresponding author), El Colegio Frontera, Dept Observac & Estudio Tierra, Atmosfera & Oceano TAQ, Chetmal, Quintana Roo, Mexico.; Calme, S (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada.	smachkou@ecosur.mx; scalme@ecosur.mx	Calmé, Sophie/ABC-9684-2021	Calmé, Sophie/0000-0003-0818-3932; Torres Cristiani, Leopoldo/0000-0003-3017-029X; Escalona-Segura, Griselda/0000-0002-6735-7878	CONACYT [213403, 21467, 217950]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT provided financial support in the form of a scholarship for LTC (#213403) and a fellowship for GES (#21467) and SMM (#217950).	Acosta Martin, 2004, Journal of Caribbean Ornithology, V17, P52; Allen R.P, 1956, FLAMINGOS THEIR LIFE; [Anonymous], 2002, PROF ENG, V15, P31; [Anonymous], 2014, APPL GEOMATICS; [Anonymous], 2010, ORF, V18, P62; Arengo F, 2002, CONDOR, V104, P452, DOI 10.1650/0010-5422(2002)104[0452:PCAFBO]2.0.CO;2; Arengo F, 2017, FLAMINGOS BEHAV BIOL, P227; Baldassarre Guy A., 2000, Waterbirds, V23, P70, DOI 10.2307/1522149; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; Baltz ME, 2006, W ANDROS REA REPORT; Bernardon B, 2014, REV BRAS ORNITOL, V22, P285; Bildstein Keith L., 2000, Waterbirds, V23, P206, DOI 10.2307/1522167; BirdLife International, 2018, IUCN RED LIST THREAT; Braun M.J., 2000, FIELD CHECKLIST BIRD; Casler Clark L., 2000, Waterbirds, V23, P95, DOI 10.2307/1522152; Comite Brasileiro de Registros Ornitologicos, 2015, LIST AV BRAS; Coxen CL, 2017, GLOB ECOL CONSERV, V11, P298, DOI 10.1016/j.gecco.2017.08.001; Debrot A, 2008, IMPORTANT BIRD AREAS, P143; ESPINOBARROS R, 1989, CONDOR, V91, P592, DOI 10.2307/1368109; Espinoza Frank, 2000, Waterbirds, V23, P80, DOI 10.2307/1522150; Franke-Ante R, 2013, PROGRAMA CONSERVACIO; Frias-Soler R, 2014, WATERBIRDS, V37, P349, DOI 10.1675/063.037.0402; Galvez X., 2014, REV CUB CIENS BIOL, V3, P52; Galvez X., 2016, REV CUB CIENC BIOL, V4, P93; Plasencia-Vazquez AH, 2017, REV BIOL TROP, V65, P1483, DOI 10.15517/rbt.v65i4.26550; Hilton Geoff M., 2000, Wildfowl, V51, P127; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Izurieta J. C., 2017, GALAPAGOS REPORT 201, P83; Lazell James, 2001, Pitirre, V14, P113; Luksenburg Jolanda A., 2013, Marine Ornithology, V41, P183; Maldonado JH, 2018, WORLD DEV, V106, P78, DOI 10.1016/j.worlddev.2018.01.015; Martínez-Valencia A.B., 2008, Superf. vacío, V21, P18; Mawhinney J., 2008, PHYSIS, V19, P1; Mendoza Luis F., 2013, Huitzil, V14, P84; Morales RA, 2006, MONITOREO AVES MIGRA; Murillo-Pacheco JI, 2013, ORINOQUIA, V18, P105; NORTON R L, 1989, Florida Field Naturalist, V17, P32; PICKERING S, 1992, ZOO BIOL, V11, P229, DOI 10.1002/zoo.1430110402; Porto Tapiquen C.E., 2020, GEOGRAFIA SIG CARTOG; Prins TG, 2009, ARDEA, V97, P137, DOI 10.5253/078.097.0201; Raffaele H., 2021, BIRDS PUERTO RICO VI, V3rd ed.; Sainz-Borgo C., 2018, REV VENEZOLANA ORNIT, V8, P19; Schulz J.P, 1977, Oryx, V14, P133, DOI 10.1017/S0030605300015180; Stephens JL, 1993, VIAJES YUCATAN, VI; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Vargas FH, 2008, J ZOOL, V276, P252, DOI 10.1111/j.1469-7998.2008.00485.x; Walsh-McGehee Martha, 1998, Bahamas Journal of Science, V5, P28; Wells J, 2008, IMPORTANT BIRD AREAS, P95; Whitfield SM, 2018, PETITION EVALUATE SP; Whitfield SM, 2018, CONDOR, V120, P291, DOI 10.1650/CONDOR-17-187.1; Wilson S., 2014, ECOTOURISM IND CARIB	53	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244117	10.1371/journal.pone.0244117	http://dx.doi.org/10.1371/journal.pone.0244117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351836	gold, Green Published			2022-12-26	WOS:000603071400004
J	Xiao, C; Fu, X; Wang, YT; Liu, H; Jiang, YF; Zhao, ZY; You, FM				Xiao, Chong; Fu, Xi; Wang, Yuting; Liu, Hong; Jiang, Yifang; Zhao, Ziyi; You, Fengming			Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation	PLOS ONE			English	Article							PANCREATIC-CANCER; GROWTH; POPULATION; TUMORS; ROS	Background Iron metabolism is essential because it plays regulatory roles in various physiological and pathological processes. Disorders of iron metabolism balance are related to various cancers, including hepatocellular carcinoma. Cancer stem-like cells (CSCs) exert critical effects on chemotherapy failure, cancer metastasis, and subsequent disease recurrence and relapse. However, little is known about how iron metabolism affects liver CSCs. Here, we investigated the expression of transferrin receptor 1 (TFR1) and ferroportin (FPN), two iron importers, and an upstream regulator, iron regulatory protein 2 (IRP2), in liver hepatocellular carcinoma (LIHC) and related CSCs. Methods The expression levels of TFR1, FPN and IRP2 were analysed using the GEPIA database. CSCs were derived from parental LIHC cells cultured in serum-free medium. After TFR1 knockdown, ROS accumulation and malignant behaviours were measured. The CCK-8 assay was performed to detect cell viability after TFR1 knockdown and erastin treatment. Results TFR1 expression was upregulated in LIHC tissue and CSCs derived from LIHC cell lines, prompting us to investigate the roles of TFR1 in regulating CSCs. Knockdown of TFR1 expression decreased iron accumulation and inhibited malignant behaviour. Knockdown of TFR1 expression decreased reactive oxygen species (ROS) accumulation induced by erastin treatment and maintained mitochondrial function, indicating that TFR1 is critical in regulating erastin-induced cell death in CSCs. Additionally, knockdown of TFR1 expression decreased sphere formation by decreasing iron accumulation in CSCs, indicating a potential role for TFR1 in maintaining stemness. Conclusion These findings, which revealed TFR1 as a critical regulator of LIHC CSCs in malignant behaviour and stemness that functions by regulating iron accumulation, may have implications to improve therapeutic approaches.	[Xiao, Chong] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China; [Fu, Xi; Wang, Yuting; Liu, Hong; Jiang, Yifang; Zhao, Ziyi; You, Fengming] Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China	Chengdu University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine	Zhao, ZY; You, FM (corresponding author), Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China.	zhaoziyi925@163.com; youfengming@cdutcm.edu.cn			Young Scientists Fund of the National Natural Science Foundation of China [81803994]; General Program of National Natural Science Foundation of China [81774284]; International Cooperation Project of Sichuan Science and Technology Department [2019YFH0152]; Science and Technology Developmental Foundation of Chengdu University of TCM [QNXZ2019022]	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Sichuan Science and Technology Department; Science and Technology Developmental Foundation of Chengdu University of TCM	This work was supported by Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 81803994), General Program of National Natural Science Foundation of China (Grant No. 81774284), International Cooperation Project of Sichuan Science and Technology Department (Grant No. 2019YFH0152) and Science and Technology Developmental Foundation of Chengdu University of TCM (Grant No. QNXZ2019022) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Buas MF, 2015, BREAST CANCER RES TR, V153, P445, DOI 10.1007/s10549-015-3554-5; Camp ER, 2013, CANCER GENE THER, V20, P222, DOI 10.1038/cgt.2013.9; Chanvorachote P, 2016, AM J PHYSIOL-CELL PH, V310, pC728, DOI 10.1152/ajpcell.00322.2015; Chen Y, 2015, CELL SIGNAL, V27, P168, DOI 10.1016/j.cellsig.2014.11.002; Dhar D, 2018, CANCER CELL, V33, P1061, DOI 10.1016/j.ccell.2018.05.003; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Heath JL, 2013, NUTRIENTS, V5, P2836, DOI 10.3390/nu5082836; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Ho JCM, 2001, CANCER RES, V61, P8578; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jeong SM, 2016, BIOCHEM BIOPH RES CO, V471, P373, DOI 10.1016/j.bbrc.2016.02.023; Kindrat I, 2016, ONCOTARGET, V7, P1276, DOI 10.18632/oncotarget.6004; Kukulj S, 2010, MED ONCOL, V27, P268, DOI 10.1007/s12032-009-9203-2; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Liu P, 2016, J INORG BIOCHEM, V160, P40, DOI 10.1016/j.jinorgbio.2016.04.014; Lobello N, 2016, ONCOTARGET, V7, P62019, DOI 10.18632/oncotarget.11495; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Paul BT, 2017, EXPERT REV HEMATOL, V10, P65, DOI 10.1080/17474086.2016.1268047; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raggi C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17804-1; Respiratory and Meningeal Pathogens Reference Unit National Institute for Communicable Diseases, 2011, COMM DIS SURV B, V9, P50; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tesfay L, 2015, CANCER RES, V75, P2254, DOI 10.1158/0008-5472.CAN-14-2465; Tirnitz-Parker Janina E. E., 2013, Critical Reviews in Oncogenesis, V18, P391; Tominaga K, 2017, ONCOGENE, V36, P1276, DOI 10.1038/onc.2016.293; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Weston C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166593; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yoon SK, 2012, GUT LIVER, V6, P29, DOI 10.5009/gnl.2012.6.1.29; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	39	8	8	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243812	10.1371/journal.pone.0243812	http://dx.doi.org/10.1371/journal.pone.0243812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351833	Green Published, gold			2022-12-26	WOS:000603071400048
J	Heffer, AM; Wang, V; Libby, RT; Feldon, SE; Woeller, CF; Kuriyan, AE				Heffer, Alison M.; Wang, Victor; Libby, Richard T.; Feldon, Steven E.; Woeller, Collynn F.; Kuriyan, Ajay E.			Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RANDOMIZED CONTROLLED-TRIAL; MOLECULAR-WEIGHT HEPARIN; GROWTH-FACTORS; COMBINED 5-FLUOROURACIL; RISK-FACTORS; FIBRONECTIN; ACTIN; CELLS; EYES	Proliferative vitreoretinopathy (PVR) is a progressive disease that develops in a subset of patients who undergo surgery for retinal detachment repair, and results in significant vision loss. PVR is characterized by the migration of retinal pigment epithelial (RPE) cells into the vitreous cavity, where they undergo epithelial-to-mesenchymal transition and form contractile membranes within the vitreous and along the retina, resulting in recurrent retinal detachments. Currently, surgical intervention is the only treatment for PVR and there are no pharmacological agents that effectively inhibit or prevent PVR formation. Here, we show that a single intravitreal injection of the polyether ionophore salinomycin (SNC) effectively inhibits the formation of PVR in a mouse model with no evidence of retinal toxicity. After 4 weeks, fundus photography and optical coherence tomography (OCT) demonstrated development of mean PVR grade of 3.5 (SD: 1.3) in mouse eyes injected with RPE cells/DMSO (vehicle), compared to mean PVR grade of 1.6 (SD: 1.3) in eyes injected with RPE cells/SNC (p = 0.001). Additionally, immunohistochemistry analysis showed RPE cells/SNC treatment reduced both fibrotic (alpha SMA, FN1, Vim) and inflammatory (GFAP, CD3, CD20) markers compared to control RPE cells/DMSO treatment. Finally, qPCR analysis confirmed that Tgf beta, Tnf alpha, Mcp1 (inflammatory/cytokine markers), and Fn1, Col1a1 and Acta2 (fibrotic markers) were significantly attenuated in the RPE cells/SNC group compared to RPE/DMSO control. These results suggest that SNC is a potential pharmacologic agent for the prevention of PVR in humans and warrants further investigation.	[Heffer, Alison M.; Wang, Victor; Libby, Richard T.; Feldon, Steven E.; Woeller, Collynn F.; Kuriyan, Ajay E.] Univ Rochester, Flaum Eye Inst, Rochester, NY 14642 USA; [Libby, Richard T.; Feldon, Steven E.; Kuriyan, Ajay E.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Kuriyan, Ajay E.] Thomas Jefferson Univ, Wills Eye Hosp, Retina Serv, Philadelphia, PA 19107 USA	University of Rochester; University of Rochester; Jefferson University	Heffer, AM; Kuriyan, AE (corresponding author), Univ Rochester, Flaum Eye Inst, Rochester, NY 14642 USA.; Kuriyan, AE (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.; Kuriyan, AE (corresponding author), Thomas Jefferson Univ, Wills Eye Hosp, Retina Serv, Philadelphia, PA 19107 USA.	alison_heffer@urmc.rochester.edu; ajay_kuriyan@gmail.com		Wang, Victor/0000-0002-9649-2411	Research to Prevent Blindness Unrestricted Grant [NIHP30EY001319]	Research to Prevent Blindness Unrestricted Grant(Research to Prevent Blindness (RPB))	Research to Prevent Blindness Unrestricted Grant (to the Flaum Eye Institute) and NIHP30EY001319 (David Williams, Center for Visual Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GW, 1997, ARCH OPHTHALMOL-CHIC, V115, P335, DOI 10.1001/archopht.1997.01100150337005; Ahmadieh H, 2008, OPHTHALMOLOGY, V115, P1938, DOI 10.1016/j.ophtha.2008.05.016; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Antoszczak M, 2015, ANTI-CANCER AGENT ME, V15, P575, DOI 10.2174/1871520615666150101130209; Asaria RHY, 2001, OPHTHALMOLOGY, V108, P1179, DOI 10.1016/S0161-6420(01)00589-9; Asato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054191; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Charteris DG, 2004, OPHTHALMOLOGY, V111, P2240, DOI 10.1016/j.ophtha.2004.05.036; Chen Zhenna, 2015, Mol Vis, V21, P706; Garcia CM, 2006, EXP EYE RES, V83, P999, DOI 10.1016/j.exer.2006.04.009; Grierson I, 1987, SEMINARS OPHTHALMOLO, V2, P99, DOI [10.3109/08820538709062514, DOI 10.3109/08820538709062514]; Hansen TC, 2017, PLAST RECONSTR SURG, V140, P316, DOI 10.1097/PRS.0000000000003542; Hayden JK, 2014, J NURS REGUL, V5, pS3; Heffer A, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.7.9; Heffer AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222596; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P708, DOI 10.1136/bjo.68.10.708; Idrees Sana, 2019, Int Ophthalmol Clin, V59, P221, DOI 10.1097/IIO.0000000000000258; JHHW, 2017, EJIL, V28, P989; Koeck S, 2016, ONCOL LETT, V11, P2946, DOI 10.3892/ol.2016.4323; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; LIMB G A, 1991, Eye (London), V5, P686; Limb GA, 1996, GRAEF ARCH CLIN EXP, V234, P213, DOI 10.1007/BF00430412; Liu L, 2018, CHEM-BIOL INTERACT, V296, P145, DOI 10.1016/j.cbi.2018.09.018; London NJS, 2019, BRIT J OPHTHALMOL, V103, P1306, DOI 10.1136/bjophthalmol-2018-312839; Mao ZL, 2019, ANTI-CANCER DRUG, V30, P892, DOI 10.1097/CAD.0000000000000786; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miller CG, 2017, EXP BIOL MED, V242, P1, DOI 10.1177/1535370216675245; Mitamura Y, 2002, JPN J OPHTHALMOL, V46, P218, DOI 10.1016/S0021-5155(01)00497-X; MIYAZAKI Y, 1974, J ANTIBIOT, V27, P814, DOI 10.7164/antibiotics.27.814; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Pennock S, 2014, AM J PATHOL, V184, P3052, DOI 10.1016/j.ajpath.2014.07.026; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Rai G, 2017, BIOMED PHARMACOTHER, V89, P1142, DOI 10.1016/j.biopha.2017.02.110; s NA, 2018, LANCET INFECT DIS, V18, pe228; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SRAMEK SJ, 1989, OPHTHALMOLOGY, V96, P835; Suguitan Jr AL, 2011, PLOS ONE, V6; Sun JH, 2017, TOXICOLOGY, V384, P1, DOI 10.1016/j.tox.2017.04.006; Tseng W, 2004, AM J OPHTHALMOL, V137, P1105, DOI 10.1016/j.ajo.2004.02.008; Wang ZY, 2019, BRIT J PHARMACOL, V176, P3390, DOI 10.1111/bph.14770; Wickham L, 2007, OPHTHALMOLOGY, V114, P698, DOI 10.1016/j.ophtha.2006.08.042; Wiedemann P, 1998, AM J OPHTHALMOL, V126, P550, DOI 10.1016/S0002-9394(98)00115-9; Williams RG, 1996, GRAEF ARCH CLIN EXP, V234, P496, DOI 10.1007/BF00184858; Woeller CF, 2015, J BIOL CHEM, V290, P3563, DOI 10.1074/jbc.M114.601872; Zhang C, 2018, INT J OPHTHALMOL-CHI, V11, P1120, DOI 10.18240/ijo.2018.07.08; Zhang CY, 2016, CHEM-BIOL INTERACT, V248, P74, DOI 10.1016/j.cbi.2016.02.004; Zhou S, 2013, CURR MED CHEM, V20, P4095	51	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243626	10.1371/journal.pone.0243626	http://dx.doi.org/10.1371/journal.pone.0243626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347461	Green Published, gold			2022-12-26	WOS:000603071100008
J	Zhang, J; Zhang, M; Huang, SY; Zha, X				Zhang, Jing; Zhang, Miao; Huang, Shaoyan; Zha, Xuan			Assessing spatial variability of soil organic carbon and total nitrogen in eroded hilly region of subtropical China	PLOS ONE			English	Article							LOESS PLATEAU; LAND-USE; ELEVATION GRADIENT; SLOPE ASPECT; FOREST; STOCKS; RESTORATION; MATTER; TOPOGRAPHY; VEGETATION	The hilly red soil region of southern China suffers from severe soil erosion that has led to soil degradation and loss of soil nutrients. Estimating the content and spatial variability of soil organic carbon (SOC) and soil total nitrogen (STN) and assessing the influence of topography and land-use type on SOC and STN after years of soil erosion control are important for vegetation restoration and ecological reconstruction. A total of 375 topsoil samples were collected from Changting County, and their SOC and STN distributions were studied by using descriptive statistics and geostatistical methods. Elevation, slope, aspect and land-use type were selected to investigate the impacts of natural and human factors on the spatial heterogeneity of SOC and STN. The mean SOC and STN concentrations were 15.85 and 0.98 g kg(-1) with moderate spatial variations, respectively. SOC and STN exhibited relatively uniform distributions that decreased gradually from the outside parts to the center of the study area. The SOC and STN contents in the study area were still at moderate and low levels after years of erosion control, which suggests that soil nutrient improvement is a slow process. The lowest SOC and STN values were at lower elevations in the center of Changting County. The results indicated that the SOC and STN contents increased most significantly with elevation and slope due to the influence of topography on the regional natural environment and soil erosion in the eroded hilly region. No significant variations were observed among different slope directions and land-use types.	[Zhang, Jing; Huang, Shaoyan; Zha, Xuan] Fujian Normal Univ, Coll Geog Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Jing; Huang, Shaoyan; Zha, Xuan] Minist Sci & Technol & Fujian Prov Funded, Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China; [Zhang, Miao] Fujian Prov Invest Design & Res Inst Water Conser, Dept Ecol Environm, Fuzhou, Fujian, Peoples R China	Fujian Normal University	Zha, X (corresponding author), Fujian Normal Univ, Coll Geog Sci, Fuzhou, Fujian, Peoples R China.; Zha, X (corresponding author), Minist Sci & Technol & Fujian Prov Funded, Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China.	xzha@fjnu.edu.cn			National Key Research and Development Program of "Typical fragile ecology restoration and protection": Soil conservation in the hilly red soil region of southern China [2017YFC05054]; National Key Basic Research Development Plan Project 973, China [2007CB407207]	National Key Research and Development Program of "Typical fragile ecology restoration and protection": Soil conservation in the hilly red soil region of southern China; National Key Basic Research Development Plan Project 973, China(National Basic Research Program of China)	The study was funded by the National Key Research and Development Program of "Typical fragile ecology restoration and protection": Soil conservation in the hilly red soil region of southern China (No. 2017YFC05054) and the National Key Basic Research Development Plan Project 973, China (No. 2007CB407207).	Ai ZM, 2017, CATENA, V152, P9, DOI 10.1016/j.catena.2016.12.024; Al-Kaisi MM, 2005, AGR ECOSYST ENVIRON, V105, P635, DOI 10.1016/j.agee.2004.08.002; [Anonymous], 2003, INT J HYDROPOWER DAM, V10, P79; ARMSTRONG M, 1988, MATH GEOL, V20, P447, DOI 10.1007/BF00892988; Asif R, 2012, IEEE INT CONF NETWOR, P109, DOI 10.1109/ICON.2012.6506543; Bai LY, 2014, J MT SCI-ENGL, V11, P1231, DOI 10.1007/s11629-014-3056-7; Bai YH, 2020, J FORESTRY RES, V31, P1295, DOI 10.1007/s11676-019-00879-z; BALE CL, 1994, FOREST ECOL MANAG, V67, P305, DOI 10.1016/0378-1127(94)90025-6; Barnett V., 1994, OUTLIERS STAT DATA; Berhe AA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000751; Bogunovic I, 2014, SOIL TILL RES, V144, P174, DOI 10.1016/j.still.2014.07.020; Brady N.C, 2000, NATURE PROPERTIES SO; Bringmark E, 1998, AMBIO, V27, P45; Ferreira ACC, 2016, LAND DEGRAD DEV, V27, P171, DOI 10.1002/ldr.2282; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Chen CP, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0147-5; Chen H, 2018, CATENA, V170, P141, DOI 10.1016/j.catena.2018.06.006; Cheng XF, 2004, PEDOSPHERE, V14, P425; China Financial 40 People Forum Project Group, 2013, FINAN RES, V5, P114; Cooke J. A., 2002, Environmental Reviews, V10, P41, DOI 10.1139/a01-014; Cordova C, 2012, AGR ECOSYST ENVIRON, V147, P66, DOI 10.1016/j.agee.2011.06.016; Das B, 2018, MODEL EARTH SYST ENV, V4, P373, DOI 10.1007/s40808-018-0435-z; Dessalegn D, 2014, CATENA, V115, P47, DOI 10.1016/j.catena.2013.11.007; Djukic I, 2010, J PLANT NUTR SOIL SC, V173, P30, DOI 10.1002/jpln.200900027; Du BM, 2014, ECOL RES, V29, P433, DOI 10.1007/s11284-014-1135-4; Egli M, 2012, GEODERMA, V183, P109, DOI 10.1016/j.geoderma.2012.03.017; El Kateb H, 2013, CATENA, V105, P1, DOI 10.1016/j.catena.2012.12.012; Elbasiouny H, 2014, CATENA, V113, P70, DOI 10.1016/j.catena.2013.09.008; Franzluebbers AJ, 2009, AGR ECOSYST ENVIRON, V129, P28, DOI 10.1016/j.agee.2008.06.013; Gao Y, 2011, J APPL ECOL, V48, P1145, DOI 10.1111/j.1365-2664.2011.02011.x; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Gessler PE, 2000, SOIL SCI SOC AM J, V64, P2046, DOI 10.2136/sssaj2000.6462046x; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Guo PT, 2011, SOIL RES, V49, P606, DOI 10.1071/SR11134; Guo YY, 2006, SOIL SCI SOC AM J, V70, P601, DOI 10.2136/sssaj2005.0163; Hu KL, 2014, GEODERMA, V226, P54, DOI 10.1016/j.geoderma.2014.03.001; Kravchenko AN, 2003, SOIL SCI SOC AM J, V67, P1564, DOI 10.2136/sssaj2003.1564; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Lacoste M, 2014, GEODERMA, V213, P296, DOI 10.1016/j.geoderma.2013.07.002; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li QK, 1983, RED EARTHS CHINA, P15; Li SQ, 2013, ENVIRON EARTH SCI, V70, P3323, DOI 10.1007/s12665-013-2397-9; Li ZW, 2015, GEOMORPHOLOGY, V248, P264, DOI 10.1016/j.geomorph.2015.07.036; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu X, 2006, PLANT SOIL ENVIRON, V52, P531, DOI 10.17221/3544-PSE; Liu ZJ, 2014, GEODERMA, V235, P39, DOI 10.1016/j.geoderma.2014.06.027; Lourenco RW, 2010, ENVIRON EARTH SCI, V60, P495, DOI 10.1007/s12665-009-0190-6; Lu R K., 1999, SOIL AGR CHEM ANAL, P106; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; Nielsen D.R., 1985, SOIL SPATIAL VARIABI, P1; Office of the Leading Group of the State Council for the First National Water Resources Census, 2010, GEN SURV SOIL WAT CO, P202; Ou Y, 2017, AGR ECOSYST ENVIRON, V245, P22, DOI 10.1016/j.agee.2017.05.003; Phachomphon K, 2010, GEODERMA, V155, P372, DOI 10.1016/j.geoderma.2009.12.020; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Prietzel J, 2014, GEODERMA, V221, P28, DOI 10.1016/j.geoderma.2014.01.021; Qin YY, 2016, CATENA, V147, P308, DOI 10.1016/j.catena.2016.07.025; Rabbi SMF, 2014, GEODERMA, V216, P10, DOI 10.1016/j.geoderma.2013.10.023; Ritchie JC, 2007, GEOMORPHOLOGY, V89, P163, DOI 10.1016/j.geomorph.2006.07.021; Rosemary F, 2017, CATENA, V150, P53, DOI 10.1016/j.catena.2016.10.017; Rossi JP, 1995, EUR J SOIL BIOL, V31, P173; Schillaci C, 2018, REND ONLINE SOC GEOL, V46, P161, DOI 10.3301/ROL.2018.68; Schillaci C, 2017, SCI TOTAL ENVIRON, V601, P821, DOI 10.1016/j.scitotenv.2017.05.239; SCHMIDT MG, 1993, J SOIL SCI, V44, P417, DOI 10.1111/j.1365-2389.1993.tb00464.x; Selim HM, 2016, SOIL TILL RES, V155, P401, DOI 10.1016/j.still.2015.09.010; Sheikh M. A., 2009, Carbon Balance and Management, V4; Smith JL, 2002, SOIL BIOL BIOCHEM, V34, P1749, DOI 10.1016/S0038-0717(02)00162-1; Sun WY, 2015, ECOL ENG, V83, P249, DOI 10.1016/j.ecoleng.2015.06.030; Tang K., 2004, SOIL WATER CONSERVAT; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Tu CL, 2018, CATENA, V163, P204, DOI 10.1016/j.catena.2017.12.028; Veronesi F, 2019, ECOL INDIC, V101, P1032, DOI 10.1016/j.ecolind.2019.02.026; Wang CC, 2016, LAND DEGRAD DEV, V27, P387, DOI 10.1002/ldr.2397; Wang HJ, 2009, SOIL TILL RES, V105, P300, DOI 10.1016/j.still.2008.08.010; Wang JM, 2015, ECOL ENG, V82, P159, DOI 10.1016/j.ecoleng.2015.04.103; Wang LY, 2019, J SOIL SEDIMENT, V19, P275, DOI 10.1007/s11368-018-2044-x; Wang S, 2018, CATENA, V166, P134, DOI 10.1016/j.catena.2018.03.023; Wang T, 2017, CATENA, V155, P41, DOI 10.1016/j.catena.2017.03.004; [王维明 Wang Weiming], 2005, [水土保持通报, Bulletin of Soil and Water Conservation], V25, P73; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang ZQ, 1999, GEOSTATISTICS ITS AP, P97; Watson RT, 2000, LAND USE LAND USE CH; Webster R., 1985, Advances in Soil Science, V3, P1; Webster R, 2011, STAT EARTH ENV SCI, P526; Wei ZQ, 2014, PEDOSPHERE, V24, P56, DOI 10.1016/S1002-0160(13)60080-6; Wong VNL, 2008, AUST J SOIL RES, V46, P378, DOI 10.1071/SR07160; Yang L, 2007, J ENVIRON MANAGE, V85, P690, DOI 10.1016/j.jenvman.2006.09.011; Yang RM, 2016, ECOL INDIC, V60, P870, DOI 10.1016/j.ecolind.2015.08.036; Yao X, 2019, J FOR RES, V31, P2385; Yao X, 2019, CATENA, V178, P189, DOI 10.1016/j.catena.2019.03.004; Yimer F, 2006, GEODERMA, V135, P335, DOI 10.1016/j.geoderma.2006.01.005; Yuan XY, 2007, NEW ZEAL J AGR RES, V50, P1157, DOI 10.1080/00288230709510398; Yuan XF, 2019, J GEOGR SCI, V29, P779, DOI 10.1007/s11442-019-1627-9; Zhang SR, 2016, SCI TOTAL ENVIRON, V563, P10, DOI 10.1016/j.scitotenv.2016.04.111; Zhong BL, 2013, LAND USE POLICY, V32, P119, DOI 10.1016/j.landusepol.2012.10.005	94	7	8	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244322	10.1371/journal.pone.0244322	http://dx.doi.org/10.1371/journal.pone.0244322			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347496	gold, Green Published			2022-12-26	WOS:000603071100026
J	Bouffard, J; Weber, Z; Pearsall, L; Emery, K; Cote, JN				Bouffard, Jason; Weber, Zachary; Pearsall, Lyndsey; Emery, Kim; Cote, Julie N.			Similar effects of fatigue induced by a repetitive pointing task on local and remote light touch and pain perception in men and women	PLOS ONE			English	Article							EXERCISE-INDUCED HYPOALGESIA; ISOMETRIC-EXERCISE; MUSCLE FATIGUE; NECK/SHOULDER PAIN; GENDER-DIFFERENCES; SEX-DIFFERENCES; BLOOD-PRESSURE; DOSE-RESPONSE; HEALTHY-MEN; MECHANISMS	Background Women involved in repetitive, fatiguing, jobs develop more neck and/or shoulder musculoskeletal disorders than men. Sex differences in the pain response to exercise could contribute to the higher prevalence of neck/shoulder musculoskeletal disorders in women. The objective of this study was to assess sex differences in pain sensitivity following a fatiguing upper limb task. Relationships between measures of fatigue and of the sensitivity to nociceptive and to non-nociceptive stimulations were also explored. Methods Thirty healthy adults (15 women) performed a fatiguing repetitive pointing task with their dominant arm. Upper limb electromyography was recorded from the dominant upper trapezius, anterior deltoid and bicep brachii and from the contralateral tibialis anterior. Before and immediately after the repetitive pointing task, pressure pain and light touch sensitivity thresholds were measured over the same muscles. Results Electromyographic signs of fatigue were observed only in the anterior deltoid and biceps brachii muscles. Pressure pain thresholds over both muscles increased slightly (effect size <= 0.34), but no changes occurred over the upper trapezius and the tibialis anterior. Light touch thresholds increased moderately to importantly after the repetitive pointing task over all four muscles (effect sizes = 0.58 to 0.87). No sex differences were observed in any sensory variable. Moreover, no or weak correlations (r = -0.27 to 0.39) were observed between electromyographical signs of fatigue, light touch threshold and pressure pain threshold variables. Conclusions We observed sex-independent effects of a repetitive upper limb task on the sensitivity to painful and to nonpainful stimuli. Moreover, the hypoalgesia induced by the repetitive pointing task was weak and localized, and did not directly correlate with the induced muscle fatigue. Results suggest that fatigue-related changes in the sensitivity to noxious and innocuous stimuli could not explain women's greater prevalence of neck/shoulder musculoskeletal disorders.	[Bouffard, Jason; Weber, Zachary; Pearsall, Lyndsey; Emery, Kim; Cote, Julie N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Bouffard, Jason; Weber, Zachary; Pearsall, Lyndsey; Emery, Kim; Cote, Julie N.] Jewish Rehabil Hosp, Michael Feil & Ted Oberfeld CRIR Res Ctr, Occupat Biomech & Ergon Lab, Laval, PQ, Canada; [Bouffard, Jason] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Bouffard, Jason] Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada	McGill University; McGill University; Laval University; Laval University	Bouffard, J (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.; Bouffard, J (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.; Bouffard, J (corresponding author), Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada.	Jason.bouffard@kin.ulaval.ca	Bouffard, Jason/AFM-1347-2022	Bouffard, Jason/0000-0003-1083-5899	Natural Sciences and Engineering Research Council [RGPIN-2015-0511]; Canadian Institutes for Health Research [MFE-146666]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The project is funded by a Natural Sciences and Engineering Research Council grant (JNC, #RGPIN-2015-0511, https://www.nserccrsng.gc.ca/index_eng.asp). JB was funded by the Canadian Institutes for Health Research (#MFE-146666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2004, J ELECTROMYOGR KINES, V14, P699, DOI 10.1016/j.jelekin.2004.04.003; [Anonymous], 1999, SENIAM DELIV; ARMSTRONG TJ, 1993, SCAND J WORK ENV HEA, V19, P73, DOI 10.5271/sjweh.1494; BELLKROTOSKI J, 1987, J HAND SURG-AM, V12A, P155, DOI 10.1016/S0363-5023(87)80189-2; Bement MH, 2014, J MOTOR BEHAV, V46, P107, DOI 10.1080/00222895.2013.872078; Bement MKH, 2008, MED SCI SPORT EXER, V40, P1880, DOI 10.1249/MSS.0b013e31817eeecc; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bouffard J, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0175-9; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cote JN, 2008, MOTOR CONTROL, V12, P79, DOI 10.1123/mcj.12.2.79; Cote JN, 2014, ADV EXP MED BIOL, V826, P205, DOI 10.1007/978-1-4939-1338-1_13; Dannecker EA, 2014, SPORTS MED, V44, P921, DOI 10.1007/s40279-014-0172-z; Dimitrova NA, 2003, J ELECTROMYOGR KINES, V13, P13, DOI 10.1016/S1050-6411(02)00083-4; Emery K, 2010, CLIN BIOMECH, V25, P124, DOI 10.1016/j.clinbiomech.2009.10.003; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Focht BC, 2009, J STRENGTH COND RES, V23, P891, DOI 10.1519/JSC.0b013e3181a05564; Fuller JR, 2009, J ELECTROMYOGR KINES, V19, P1043, DOI 10.1016/j.jelekin.2008.10.009; Gajsar H, 2017, PAIN MED, V18, P917, DOI 10.1093/pm/pnw176; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Han J, 2015, J PHYS THER SCI, V27, P551, DOI 10.1589/jpts.27.551; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Hunter SK, 2004, J APPL PHYSIOL, V96, P2125, DOI 10.1152/japplphysiol.01342.2003; Kami K, 2017, ANAT SCI INT, V92, P79, DOI 10.1007/s12565-016-0360-z; Koltyn KF, 2014, J PAIN, V15, P1294, DOI 10.1016/j.jpain.2014.09.006; Koltyn KF, 1998, BRIT J SPORT MED, V32, P20, DOI 10.1136/bjsm.32.1.20; Koltyn KF, 2001, MED SCI SPORT EXER, V33, P282; Koltyn KF, 2000, SPORTS MED, V29, P85, DOI 10.2165/00007256-200029020-00002; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lemley KJ, 2016, EUR J APPL PHYSIOL, V116, P1379, DOI 10.1007/s00421-016-3389-8; Lemley KJ, 2014, MED SCI SPORT EXER, V46, P185, DOI 10.1249/MSS.0b013e3182a05de8; Lima LV, 2017, J PHYSIOL-LONDON, V595, P4141, DOI 10.1113/JP273355; Lomond KV, 2011, WORK, V38, P169, DOI 10.3233/WOR-2011-1119; Mayer J, 2012, INT ARCH OCC ENV HEA, V85, P587, DOI 10.1007/s00420-011-0701-0; Naugle KM, 2014, PAIN MED, V15, P692, DOI 10.1111/pme.12312; Naugle KM, 2012, J PAIN, V13, P1139, DOI 10.1016/j.jpain.2012.09.006; Nordander C, 2008, INT ARCH OCC ENV HEA, V81, P939, DOI 10.1007/s00420-007-0286-9; Otto A, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0253-7; Pereira HM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00517; Peternel L, 2019, ROBOT CIM-INT MANUF, V58, P69, DOI 10.1016/j.rcim.2019.01.013; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Rice D, 2019, J PAIN, V20, P1249, DOI 10.1016/j.jpain.2019.03.005; Rivest K, 2010, MANUAL THER, V15, P154, DOI 10.1016/j.math.2009.10.001; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Saradjian AH, 2015, NEUROPHYSIOL CLIN, V45, P255, DOI 10.1016/j.neucli.2015.09.004; Sarquis LMM, 2016, PAIN, V157, P1028, DOI 10.1097/j.pain.0000000000000477; Sjogaard G, 1998, CLIN ORTHOP RELAT R, P21; Srinivasan D, 2016, EUR J APPL PHYSIOL, V116, P2357, DOI 10.1007/s00421-016-3487-7; Statistics Canada, 2015, ANTHR MEAS HOUS POP; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Travers M, 2018, SCAND J PAIN, V18, P303, DOI 10.1515/sjpain-2018-0020; Tsai NT, 2003, ARCH PHYS MED REHAB, V84, P1000, DOI 10.1016/S0003-9993(03)00127-8; Tse CTF, 2016, J ELECTROMYOGR KINES, V29, P34, DOI 10.1016/j.jelekin.2015.07.003; Umeda M, 2010, BIOL PSYCHOL, V85, P90, DOI 10.1016/j.biopsycho.2010.05.008; Virta L, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-17; Yung M, 2017, ERGONOMICS, V60, P923, DOI 10.1080/00140139.2016.1243734	58	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244321	10.1371/journal.pone.0244321	http://dx.doi.org/10.1371/journal.pone.0244321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338075	Green Published, gold			2022-12-26	WOS:000601313500037
J	Goetz, CM; Arnetz, JE; Sudan, S; Arnetz, BB				Goetz, Courtney M.; Arnetz, Judith E.; Sudan, Sukhesh; Arnetz, Bengt B.			Perceptions of virtual primary care physicians: A focus group study of medical and data science graduate students	PLOS ONE			English	Article							HEALTH-CARE; RACIAL BIAS; AI; PROFESSIONALS; PERFORMANCE; DISEASES; ETHICS	Background Artificial and virtual technologies in healthcare have advanced rapidly, and healthcare systems have been adapting care accordingly. An intriguing new development is the virtual physician, which can diagnose and treat patients independently. Methods and findings This qualitative study of advanced degree students aimed to assess their perceptions of using a virtual primary care physician as a patient. Four focus groups were held: first year medical students, fourth year medical students, first year engineering/data science graduate students, and fourth year engineering/data science graduate students. The focus groups were audiotaped, transcribed verbatim, and content analyses of the transcripts was performed using a data-driven inductive approach. Themes identified concerned advantages, disadvantages, and the future of virtual primary care physicians. Within those main categories, 13 themes emerged and 31 sub-themes. Discussion While participants appreciated that a virtual primary care physician would be convenient, efficient, and cost-effective, they also expressed concern about data privacy and the potential for misdiagnosis. To garner trust from its potential users, future virtual primary physicians should be programmed with a sufficient amount of trustworthy data and have a high level of transparency and accountability for patients.	[Goetz, Courtney M.; Arnetz, Judith E.; Sudan, Sukhesh; Arnetz, Bengt B.] Michigan State Univ, Coll Human Med, Dept Family Med, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine	Goetz, CM (corresponding author), Michigan State Univ, Coll Human Med, Dept Family Med, E Lansing, MI 48824 USA.	goetzcou@msu.edu	Goetz, Courtney/AAD-1270-2022; Arnetz, Bengt/G-1685-2011	Arnetz, Bengt/0000-0001-7173-4333; Goetz, Courtney/0000-0002-2960-0128	Dr. Bengt Arnetz's Michigan State University start-up funds	Dr. Bengt Arnetz's Michigan State University start-up funds	This study was funded by Dr. Bengt Arnetz's Michigan State University start-up funds.	[Anonymous], 2016, LANCET, V387, P506, DOI 10.1016/S0140-6736(16)00267-1; Berchick ER, 2019, HLTH INSURANCE COVER; Blue Cross Blue Shield Association, 2019, HLTH MILL; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Boyatzis RE, 1998, TRANSFORMING QUALITA, DOI [10.1080/00221329809596155, DOI 10.1080/00221329809596155]; Centers for Disease Control and Prevention, TEST COVID 19; Davenport Thomas, 2019, Future Healthc J, V6, P94, DOI 10.7861/futurehosp.6-2-94; Dorsey ER, 2016, NEW ENGL J MED, V375, P154, DOI 10.1056/NEJMra1601705; Efimenko M, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03615-1; Fagherazzi G, 2019, DIABETES METAB, V45, P322, DOI 10.1016/j.diabet.2018.08.012; Gold J, 2020, KAISER HLTH NEWS; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182; Guba E., 1989, 4 GENERATION EVALUAT; Haenssle HA, 2020, ANN ONCOL, V31, P137, DOI 10.1016/j.annonc.2019.10.013; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Israni ST, 2019, JAMA-J AM MED ASSOC, V321, P29, DOI 10.1001/jama.2018.19398; Jacewicz N., 2016, ATLANTIC; Johnson SLJ, 2019, J LEGAL MED, V39, P427, DOI 10.1080/01947648.2019.1690604; Kennedy B., 2016, 28 AM ARE STRONG EAR; Ladika S., 2020, MANAGED CARE; Lagasse J., 2019, ARTIFICIAL INTELLIGE; Lau Annie Y S, 2019, Yearb Med Inform, V28, P174, DOI 10.1055/s-0039-1677935; Lee K., 2020, WIRED; Lewis KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132690; Lin SY, 2019, J GEN INTERN MED, V34, P1626, DOI 10.1007/s11606-019-05035-1; Liu XX, 2019, LANCET DIGIT HEALTH, V1, pE271, DOI 10.1016/S2589-7500(19)30123-2; Liyanage Harshana, 2019, Yearb Med Inform, V28, P41, DOI 10.1055/s-0039-1677901; Lysaght T, 2019, ASIAN BIOETHICS REV, V11, P299, DOI 10.1007/s41649-019-00096-0; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; National Institutes of Health, 2020, NIH HARN AI COVID 19; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Office of Minority Health, 2018, ASTHM AFR AM; Polinski JM, 2016, J GEN INTERN MED, V31, P269, DOI 10.1007/s11606-015-3489-x; Razzaki S, 2018, ARXIV180610698; Resnick B, 2020, VOX             0317; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Roosli E, 2020, J AM MED INFORM ASSN, DOI [10.1093/jamia/ocaa210, DOI 10.1093/JAMIA/0CAA210]; Shanafelt TD, 2019, MAYO CLIN PROC, V94, P1681, DOI 10.1016/j.mayocp.2018.10.023; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Uscher-Pines L, 2014, HEALTH AFFAIR, V33, P258, DOI 10.1377/hlthaff.2013.0989; Vogels E., 2019, MILLENIALS STAND OUT; Walker RC, 2019, INT J MED INFORM, V124, P78, DOI 10.1016/j.ijmedinf.2019.01.013; White MJ, 2016, IMMUNOGENETICS, V68, P391, DOI 10.1007/s00251-016-0914-1; Whitehead PB, 2015, J NURS SCHOLARSHIP, V47, P117, DOI 10.1111/jnu.12115; Winn AN, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.18561; Wosik J, 2020, J AM MED INFORM ASSN, V27, P957, DOI 10.1093/jamia/ocaa067; Yu KH, 2018, NAT BIOMED ENG, V2, P719, DOI 10.1038/s41551-018-0305-z; Zou J, 2018, NATURE, V559, P324, DOI 10.1038/d41586-018-05707-8	48	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243641	10.1371/journal.pone.0243641	http://dx.doi.org/10.1371/journal.pone.0243641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332409	gold, Green Published			2022-12-26	WOS:000601310900036
J	Hirano, H; Koga, K; Takemoto, K				Hirano, Hokuto; Koga, Kazuki; Takemoto, Kazuhiro			Vulnerability of deep neural networks for detecting COVID-19 cases from chest X-ray images to universal adversarial attacks	PLOS ONE			English	Article							PNEUMONIA; DISEASES	Owing the epidemic of the novel coronavirus disease 2019 (COVID-19), chest X-ray computed tomography imaging is being used for effectively screening COVID-19 patients. The development of computer-aided systems based on deep neural networks (DNNs) has become an advanced open source to rapidly and accurately detect COVID-19 cases because the need for expert radiologists, who are limited in number, forms a bottleneck for screening. However, thus far, the vulnerability of DNN-based systems has been poorly evaluated, although realistic and high-risk attacks using universal adversarial perturbation (UAP), a single (input image agnostic) perturbation that can induce DNN failure in most classification tasks, are available. Thus, we focus on representative DNN models for detecting COVID-19 cases from chest X-ray images and evaluate their vulnerability to UAPs. We consider non-targeted UAPs, which cause a task failure, resulting in an input being assigned an incorrect label, and targeted UAPs, which cause the DNN to classify an input into a specific class. The results demonstrate that the models are vulnerable to non-targeted and targeted UAPs, even in the case of small UAPs. In particular, the 2% norm of the UAPs to the average norm of an image in the image dataset achieves >85% and >90% success rates for the non-targeted and targeted attacks, respectively. Owing to the non-targeted UAPs, the DNN models judge most chest X-ray images as COVID-19 cases. The targeted UAPs allow the DNN models to classify most chest X-ray images into a specified target class. The results indicate that careful consideration is required in practical applications of DNNs to COVID-19 diagnosis; in particular, they emphasize the need for strategies to address security concerns. As an example, we show that iterative fine-tuning of DNN models using UAPs improves the robustness of DNN models against UAPs.	[Hirano, Hokuto; Koga, Kazuki; Takemoto, Kazuhiro] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan	Kyushu Institute of Technology	Takemoto, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	takemoto@bio.kyutech.ac.jp	Takemoto, Kazuhiro/H-2915-2019	Takemoto, Kazuhiro/0000-0002-6355-1366				Afshar P., 2020, COVID CAPS CAPSULE N; Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; Carlini N., 2017, P 10 ACM WORKSHOP AR, P3, DOI [10.1145/3128572.3140444, DOI 10.1145/3128572.3140444]; Chen JY, 2019, COMPUT SECUR, V85, P89, DOI 10.1016/j.cose.2019.04.014; Co KT, 2019, PROCEEDINGS OF THE 2019 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (CCS'19), P275, DOI 10.1145/3319535.3345660; Cohen J.P., 2020, COVID 19 IMAGE DATA; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Farooq M., 2020, ARXIV; Finlayson SG, 2019, SCIENCE, V363, P1287, DOI 10.1126/science.aaw4399; Goodfellow Ian J, 2015, P 3 INT C LEARNING R; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hirano H, 2020, P 25 INT S ART LIF R, P426; Hirano H, 2020, ALGORITHMS, V13, DOI 10.3390/a13110268; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hwang U, 2019, IEEE ACCESS, V7, P126582, DOI 10.1109/ACCESS.2019.2939352; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Krizhevsky A, 2009, THESIS U TORONTO TOR; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu XX, 2019, LANCET DIGIT HEALTH, V1, pE271, DOI 10.1016/S2589-7500(19)30123-2; Lv D., 2020, CASCADE NETWORK DETE; Matyasko A, 2018, IMPROVED NETWORK ROB; Moosavi-Dezfooli SM, 2017, PROC CVPR IEEE, P86, DOI 10.1109/CVPR.2017.17; Moosavi-Dezfooli SM, 2016, PROC CVPR IEEE, P2574, DOI 10.1109/CVPR.2016.282; Nicolae M.-I., 2018, 180701069 CORR, V1807.01069; Rahimzadeh M, 2020, NEW MODIFIED DEEP CO; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Simon-Gabriel CJ, 2019, PR MACH LEARN RES, V97; Tartaglione E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186933; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang L., 2020, ARXIV200309871, DOI 10.1038/s41598-020-76550-z; Wang LJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61138-4; Xiao C., 2020, P ICLR; Yang X., 2020, ARXIV PREPRINT ARXIV, V2003, P13865; Yu T, 2019, ADV NEUR IN, V32; Yu XY, 2019, IEEE T NEUR NET LEAR, V30, P2805, DOI 10.1109/TNNLS.2018.2886017; Zhang JQ, 2020, KDD '20: PROCEEDINGS OF THE 26TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2831, DOI 10.1145/3394486.3403334; Zhang K, 2020, CELL, V181, P1423, DOI 10.1016/j.cell.2020.04.045; Zhao H, 2019, CHIN CONT DECIS CONF, P2483, DOI 10.1109/CCDC.2019.8832713	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243963	10.1371/journal.pone.0243963	http://dx.doi.org/10.1371/journal.pone.0243963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332412	Green Published, Green Submitted, gold			2022-12-26	WOS:000601310900090
J	Sasaki, K; Harada, M				Sasaki, Ken; Harada, Mariko			Dopamine production in the brain is associated with caste-specific morphology and behavior in an artificial intermediate honey bee caste	PLOS ONE			English	Article							PRIMITIVELY EUSOCIAL WASP; APIS-MELLIFERA; JUVENILE-HORMONE; REPRODUCTIVE WORKERS; AMINO-ACIDS; DIFFERENTIATION; QUEENS; IMMUNOREACTIVITY; MECHANISMS; DOMINANCE	Caste polymorphism in eusocial insects is based on morphological plasticity and linked to physiological and behavioral characteristics. To test the possibility that dopamine production in the brain is associated with the caste-specific morphology and behavior in female honey bees, an intermediate caste was produced via artificial rearing using different amounts of diet, before quantifying the dopamine levels and conducting behavioral tests. In field colonies, individual traits such as mandibular shape, number of ovarioles, diameter of spermatheca, and dopamine levels in the brain differed significantly between workers and queens. Females given 1.5 times the amount of artificial diet that control worker receives during the larval stage in the laboratory had characteristics intermediate between castes. The dopamine levels in the brain were positively correlated with the mandibular shape indexes, number of ovarioles, and spermatheca diameter among artificially reared females. The dopamine levels were significantly higher in females with mandibular notches than those without. In fighting experiments with the intermediate caste females, the winners had significantly higher dopamine levels in the brain than the losers. Brain levels of tyrosine were positively correlated with those of catecholamines but not phenolamines, thereby suggesting a strong metabolic relationship between tyrosine and dopamine. Thus, the caste-specific characteristics of the honey bee are potentially continuous in the same manner as those in primitively eusocial species. Dopamine production in the brain is associated with the continuous caste-specific morphology, as well as being linked to the amount of tyrosine taken from food, and it supports the aggressive behavior of queen-type females.	[Sasaki, Ken; Harada, Mariko] Tamagawa Univ, Dept Bioresource Sci, Machida, Tokyo, Japan; [Sasaki, Ken] Tamagawa Univ, Honeybee Sci Res Ctr, Machida, Tokyo, Japan; [Harada, Mariko] Res Inst Anim Sci Biochem & Technol, Midori Ku, Sagamihara, Kanagawa, Japan		Sasaki, K (corresponding author), Tamagawa Univ, Dept Bioresource Sci, Machida, Tokyo, Japan.; Sasaki, K (corresponding author), Tamagawa Univ, Honeybee Sci Res Ctr, Machida, Tokyo, Japan.	sasakik@agr.tamagawa.ac.jp		Sasaki, Ken/0000-0003-3515-2170	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP17K07491, JP20K06077]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers JP17K07491 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17K07491/) and JP20K06077 (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20K06077/) to KS.	Alekseyenko OV, 2013, P NATL ACAD SCI USA, V110, P6151, DOI 10.1073/pnas.1303446110; Ali DW, 1997, J EXP BIOL, V200, P1941; [Anonymous], 1971, INSECT SOC; ASENCOT M, 1976, LIFE SCI, V18, P693, DOI 10.1016/0024-3205(76)90180-6; BAILEY L, 1952, J EXP BIOL, V29, P310; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Bloch G, 2000, J COMP PHYSIOL A, V186, P261, DOI 10.1007/s003590050426; Boulay R, 2001, PHYSIOL ENTOMOL, V26, P294, DOI 10.1046/j.0307-6962.2001.00250.x; BRANDES C, 1990, COMP BIOCHEM PHYS C, V97, P53, DOI 10.1016/0742-8413(90)90171-5; Burrows M., 1996, NEUROBIOLOGY INSECT; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Corona M, 2016, CURR OPIN INSECT SCI, V13, P55, DOI 10.1016/j.cois.2015.12.003; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; Dallacqua RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098088; De Souza DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123663; DEWILDE J, 1982, ADV INSECT PHYSIOL, V16, P167; DOGRA GS, 1977, Z NATURFORSCH C, V32, P637; Dombroski TCD, 2003, APIDOLOGIE, V34, P281, DOI 10.1051/apido:2003024; Farkhary SI, 2019, J INSECT BEHAV, V32, P218, DOI 10.1007/s10905-019-09728-7; Farkhary S, 2017, J INSECT BEHAV, V30, P717, DOI 10.1007/s10905-017-9650-0; Gotoh A, 2013, APIDOLOGIE, V44, P133, DOI 10.1007/s13592-012-0165-6; Harano K, 2008, PHYSIOL ENTOMOL, V33, P395, DOI 10.1111/j.1365-3032.2008.00644.x; HARRIS JW, 1995, COMP BIOCHEM PHYS C, V111, P271, DOI 10.1016/0742-8413(95)00048-S; Hartfelder K., 2005, P651; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hoffmann I, 1960, BEE WORLD, V41, P10, DOI [10.1080/0005772X.1960.11096760, DOI 10.1080/0005772X.1960.11096760]; Hrassnigg N, 2003, AMINO ACIDS, V24, P205, DOI 10.1007/s00726-002-0311-y; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kokay IC, 1997, J COMP PHYSIOL A, V181, P415, DOI 10.1007/s003590050125; Laidlaw HH., 1997, QUEEN REARING BEE BR; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; LIVINGSTONE MS, 1983, NATURE, V303, P67, DOI 10.1038/303067a0; Matsuyama S, 2015, GEN COMP ENDOCR, V211, P1, DOI 10.1016/j.ygcen.2014.11.005; MICHENER CD, 1974, SOCIAL BEHAV BEES; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Okada Y, 2015, J EXP BIOL, V218, P1091, DOI 10.1242/jeb.118414; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Penick CA, 2014, J EXP BIOL, V217, P1496, DOI 10.1242/jeb.098301; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P1193, DOI 10.1016/0022-1910(74)90225-X; Sasaki K, 2001, J INSECT PHYSIOL, V47, P1205, DOI 10.1016/S0022-1910(01)00105-6; Sasaki K, 2007, J INSECT PHYSIOL, V53, P940, DOI 10.1016/j.jinsphys.2007.03.006; Sasaki K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206624; Sasaki K, 2017, J INSECT PHYSIOL, V103, P107, DOI 10.1016/j.jinsphys.2017.10.013; Sasaki K, 2016, J INSECT PHYSIOL, V87, P45, DOI 10.1016/j.jinsphys.2016.02.003; Sasaki K, 2012, GEN COMP ENDOCR, V178, P46, DOI 10.1016/j.ygcen.2012.04.006; Sasaki K, 2009, NATURWISSENSCHAFTEN, V96, P625, DOI 10.1007/s00114-009-0510-4; SCHAFER S, 1989, J COMP NEUROL, V280, P43, DOI 10.1002/cne.902800105; SCHURMANN FW, 1989, CELL TISSUE RES, V256, P399, DOI 10.1007/BF00218898; Shimoji H, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-016-2263-3; SHUEL RW, 1978, J APICULT RES, V17, P57, DOI 10.1080/00218839.1978.11099904; Snodgrass R.E., 1956, ANATOMY HONEY BEE; TAYLOR DJ, 1992, J COMP PHYSIOL A, V170, P715, DOI 10.1007/BF00198982; Tedjakumala SR, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00047; Townsend GF, 1940, BIOCHEM J, V34, P1155, DOI 10.1042/bj0341155; VANDENBERG JD, 1987, J APICULT RES, V26, P90, DOI 10.1080/00218839.1987.11100743; Vaughan P.F.T., 1988, P124; Vergoz V, 2012, INSECT MOL BIOL, V21, P21, DOI 10.1111/j.1365-2583.2011.01106.x; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Weaver N., 1974, Journal apic Res, V13, P3; Winston M.L., 1991, BIOL HONEY BEE; Wu LM, 2009, J FOOD COMPOS ANAL, V22, P242, DOI 10.1016/j.jfca.2008.10.022	62	5	5	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244140	10.1371/journal.pone.0244140	http://dx.doi.org/10.1371/journal.pone.0244140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332426	Green Published, gold			2022-12-26	WOS:000601310900114
J	Xue, JX; Thomas, L; Rieg, JDA; Fenton, RA; Rieg, T				Xue, Jianxiang; Thomas, Linto; Dominguez Rieg, Jessica A.; Fenton, Robert A.; Rieg, Timo			Genetic deletion of connexin 37 causes polyuria and polydipsia	PLOS ONE			English	Article							SODIUM-CHLORIDE COTRANSPORTER; GAP-JUNCTION PROTEIN; PLASMA-MEMBRANE; COLLECTING DUCT; RENIN SECRETION; DIETARY SALT; VASOPRESSIN; EXPRESSION; KIDNEY; WATER	The connexin 37 (Cx37) channel is clustered at gap junctions between cells in the renal vasculature or the renal tubule where it is abundant in basolateral cell interdigitations and infoldings of epithelial cells in the proximal tubule, thick ascending limb, distal convoluted tubule and collecting duct; however, physiological data regarding its role are limited. In this study, we investigated the role of Cx37 in fluid homeostasis using mice with a global deletion of Cx37 (Cx37(-/-) mice). Under baseline conditions, Cx37(-/-) had similar to 40% higher fluid intake associated with similar to 40% lower urine osmolality compared to wild-type (WT) mice. No differences were observed between genotypes in urinary adenosine triphosphate or prostaglandin E2, paracrine factors that alter renal water handling. After 18-hours of water deprivation, plasma aldosterone and urine osmolality increased significantly in Cx37(-/-) and WT mice; however, the latter remained similar to 375 mmol/kg lower in Cx37(-/-) mice, an effect associated with a more pronounced body weight loss despite higher urinary AVP/creatinine ratios compared to WT mice. Consistent with this, fluid intake in the first 3 hours after water deprivation was 37% greater in Cx37(-/-) vs WT mice. Cx37(-/-) mice showed significantly lower renal AQP2 abundance and AQP2 phosphorylation at serine 256 than WT mice in response to vehicle or dDAVP, suggesting a partial contribution of the kidney to the lower urine osmolality. The abundance and responses of the vasopressin V-2 receptor, AQP3, NHE3, NKCC2, NCC, H+-ATPase, alpha ENaC, gamma ENaC or Na+/K+-ATPase were not significantly different between genotypes. In summary, these results demonstrate that Cx37 is important for body water handling.	[Xue, Jianxiang; Thomas, Linto; Dominguez Rieg, Jessica A.; Rieg, Timo] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Fenton, Robert A.] Aarhus Univ, Dept Biomed, Aarhus, Denmark	State University System of Florida; University of South Florida; Aarhus University	Rieg, T (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	trieg@usf.edu	Fenton, Robert A/ABD-9824-2021; Fenton, Robert/AFR-6983-2022	Fenton, Robert/0000-0003-1623-199X; Rieg, Timo/0000-0001-6082-662X; Thomas, Linto/0000-0003-3344-1307	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK110621]; American Heart Association Transformational Research Award [19TPA34850116]; LeDucq Foundation; Danish Medical Research Council; Novo Nordisk Foundation; American Heart Association predoctoral fellowship [18PRE33990236];  [19POST34400026]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Transformational Research Award(American Heart Association); LeDucq Foundation(Leducq Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); American Heart Association predoctoral fellowship(American Heart Association); 	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases grant 1R01DK110621 (to Dr. Rieg) and American Heart Association Transformational Research Award 19TPA34850116 (to Dr. Rieg). Funding (to Dr. Fenton) was provided by the LeDucq Foundation, the Danish Medical Research Council, and the Novo Nordisk Foundation. Mr. Xue was supported by an American Heart Association predoctoral fellowship (18PRE33990236) and Dr. Thomas by a postdoctoral fellowship (19POST34400026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed A, 2014, KIDNEY INT, V86, P768, DOI 10.1038/ki.2014.108; Alikhani M., 2007, AM J PHYSIOL, V292, pC850, DOI 10.1152/ajpce11.00356.2006; BARAJAS L, 1994, KIDNEY INT, V46, P621, DOI 10.1038/ki.1994.314; BARLOW ED, 1959, Q J MED, V28, P235; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Cadnapaphornchai MA, 2003, AM J PHYSIOL-RENAL, V285, pF965, DOI 10.1152/ajprenal.00085.2003; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Collings A, 2008, CLIN CHEM LAB MED, V46, P1102, DOI 10.1515/CCLM.2008.216; Condorelli DF, 2003, EUR J NEUROSCI, V18, P1807, DOI 10.1046/j.1460-9568.2003.02910.x; COSTALES M, 1984, J PHYSIOL-LONDON, V352, P467, DOI 10.1113/jphysiol.1984.sp015303; Fang JS, 2011, AM J PHYSIOL-HEART C, V301, pH1872, DOI 10.1152/ajpheart.00683.2011; Fenton RA, 2008, CURR OPIN NEPHROL HY, V17, P513, DOI 10.1097/MNH.0b013e3283050969; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Fenton RA, 2020, AM J PHYSIOL-CELL PH, V319, pC1, DOI 10.1152/ajpcell.00150.2020; Fenton RA, 2017, KIDNEY INT, V92, P397, DOI 10.1016/j.kint.2017.02.001; Fenton RA, 2015, AM J PHYSIOL-RENAL, V308, pF1409, DOI 10.1152/ajprenal.00129.2015; Fenton RA, 2014, J AM SOC NEPHROL, V25, P2822, DOI 10.1681/ASN.2013101102; Gooch JL, 2006, J CELL SCI, V119, P2468, DOI 10.1242/jcs.02971; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gu Y, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1493-8; Haefliger JA, 2006, J CLIN INVEST, V116, P405, DOI 10.1172/JCI23327; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; Hanner F, 2008, CELL COMMUN ADHES, V15, P219, DOI 10.1080/15419060802013836; Hanner F, 2008, AM J PHYSIOL-REG I, V295, pR371, DOI 10.1152/ajpregu.00468.2007; Hanner F, 2010, AM J PHYSIOL-REG I, V298, pR1143, DOI 10.1152/ajpregu.00808.2009; Hills CE, 2006, AM J PHYSIOL-RENAL, V291, pF1045, DOI 10.1152/ajprenal.00344.2005; Hisaki H, 2012, AM J PHYSIOL-RENAL, V303, pF1049, DOI 10.1152/ajprenal.00047.2012; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Jr1 HRF, 1995, AM J PHYSL 1, V269, pL318; Just A, 2009, J AM SOC NEPHROL, V20, P1577, DOI 10.1681/ASN.2008090943; Just AW C, 2010, ACTA PHYSL OXF, V198; Kavvadas P, 2017, J AM SOC NEPHROL, V28, P2915, DOI 10.1681/ASN.2016111211; Kennedy CRJ, 2007, AM J PHYSIOL-RENAL, V292, pF868, DOI 10.1152/ajprenal.00183.2005; Kong J, 2008, J AM SOC NEPHROL, V19, P2396, DOI 10.1681/ASN.2008010011; KUHN K, 1975, CELL TISSUE RES, V160, P193; Kurtz L, 2009, J AM SOC NEPHROL, V20, P506, DOI 10.1681/ASN.2008030252; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; McCulloch F, 2005, AM J PHYSIOL-RENAL, V289, pF1304, DOI 10.1152/ajprenal.00203.2005; Moeller HB, 2013, ENDOCR REV, V34, P278, DOI 10.1210/er.2012-1044; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Olesen ETB, 2017, AM J PHYSIOL-RENAL, V312, pF744, DOI 10.1152/ajprenal.00010.2017; Olesen ETB, 2013, J AM SOC NEPHROL, V24, P169, DOI 10.1681/ASN.2012020217; Olesen ETB, 2011, P NATL ACAD SCI USA, V108, P12949, DOI 10.1073/pnas.1104691108; Oppermann M, 2013, AM J PHYSIOL-RENAL, V304, pF1181, DOI 10.1152/ajprenal.00721.2012; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Poulsen SB, 2018, CLIN SCI, V132, P1779, DOI 10.1042/CS20180060; Poulsen SB, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91042; PRICAM C, 1974, LAB INVEST, V30, P286; Rao R, 2010, J AM SOC NEPHROL, V21, P428, DOI 10.1681/ASN.2009060672; Rieg JAD, 2015, ACTA PHYSIOL, V213, P628, DOI 10.1111/apha.12446; Rieg JAD, 2016, LAB INVEST, V96, P98, DOI 10.1038/labinvest.2015.129; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Rieg T, 2013, AM J PATHOL, V182, P96, DOI 10.1016/j.ajpath.2012.09.014; Rieg T, 2010, J AM SOC NEPHROL, V21, P2059, DOI 10.1681/ASN.2010040409; SABOLIC I, 1995, J MEMBRANE BIOL, V143, P165, DOI 10.1007/BF00233445; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SAINIO K, 1992, DEVELOPMENT, V115, P827; Seul KH, 2000, MICROVASC RES, V59, P140, DOI 10.1006/mvre.1999.2216; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sorensen CM, 2012, AM J PHYSIOL-RENAL, V303, pF855, DOI 10.1152/ajprenal.00026.2012; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Srinivas M, 2018, BBA-BIOMEMBRANES, V1860, P192, DOI 10.1016/j.bbamem.2017.04.024; Stoessel A, 2010, AM J PHYSIOL-RENAL, V298, pF216, DOI 10.1152/ajprenal.00295.2009; Thomas L, 2019, J AM SOC NEPHROL, V30, P2128, DOI 10.1681/ASN.2018121250; Tsumura K, 2006, AM J PHYSIOL-RENAL, V290, pF478, DOI 10.1152/ajprenal.00029.2005; TUCKER MA, 1994, EXP CELL RES, V213, P224, DOI 10.1006/excr.1994.1194; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Wagner C, 2008, KIDNEY INT, V73, P547, DOI 10.1038/sj.ki.5002720; Wagner C, 2009, PFLUG ARCH EUR J PHY, V459, P151, DOI 10.1007/s00424-009-0707-6; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Xue JX, 2020, CLIN SCI, V134, P941, DOI 10.1042/CS20200065; YAMAMOTO T, 1995, AM J PHYSIOL-CELL PH, V268, pC1546, DOI 10.1152/ajpcell.1995.268.6.C1546; Yang BX, 2001, J BIOL CHEM, V276, P2775, DOI 10.1074/jbc.M008216200; Zhang JH, 2005, KIDNEY INT, V68, P1171, DOI 10.1111/j.1523-1755.2005.00509.x; ZHANG JT, 1989, J CELL BIOL, V109, P3391, DOI 10.1083/jcb.109.6.3391; Zheng-Fischhofer Q, 2007, EUR J CELL BIOL, V86, P683, DOI 10.1016/j.ejcb.2007.01.005	81	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244251	10.1371/journal.pone.0244251	http://dx.doi.org/10.1371/journal.pone.0244251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332450	Green Published, gold			2022-12-26	WOS:000601310900094
J	Province, HS; Xiao, CY; Mogul, AS; Sahoo, A; Jacobson, KA; Pinol, RA; Gavrilova, O; Reitman, ML				Province, Haley S.; Xiao, Cuiying; Mogul, Allison S.; Sahoo, Ankita; Jacobson, Kenneth A.; Pinol, Ramon A.; Gavrilova, Oksana; Reitman, Marc L.			Activation of neuronal adenosine A(1) receptors causes hypothermia through central and peripheral mechanisms	PLOS ONE			English	Article							BODY-TEMPERATURE; MICE LACKING; AGONISTS; TORPOR; SLEEP	Extracellular adenosine, a danger signal, can cause hypothermia. We generated mice lacking neuronal adenosine A(1) receptors (A(1)AR, encoded by the Adora1 gene) to examine the contribution of these receptors to hypothermia. Intracerebroventricular injection of the selective A(1)AR agonist (Cl-ENBA, 5'-chloro-5'-deoxy-N-6-endo-norbornyladenosine) produced hypothermia, which was reduced in mice with deletion of A(1)AR in neurons. A non-brain penetrant A(1)AR agonist [SPA, N-6-(p-sulfophenyl) adenosine] also caused hypothermia, in wild type but not mice lacking neuronal A(1)AR, suggesting that peripheral neuronal A(1)AR can also cause hypothermia. Mice expressing Cre recombinase from the Adora1 locus were generated to investigate the role of specific cell populations in body temperature regulation. Chemogenetic activation of Adora1-Cre-expressing cells in the preoptic area did not change body temperature. In contrast, activation of Adora1-Cre-expressing dorsomedial hypothalamus cells increased core body temperature, concordant with agonism at the endogenous inhibitory A(1)AR causing hypothermia. These results suggest that A(1)AR agonism causes hypothermia via two distinct mechanisms: brain neuronal A(1)AR and A(1)AR on neurons outside the blood-brain barrier. The variety of mechanisms that adenosine can use to induce hypothermia underscores the importance of hypothermia in the mouse response to major metabolic stress or injury.	[Province, Haley S.; Xiao, Cuiying; Mogul, Allison S.; Pinol, Ramon A.; Reitman, Marc L.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Sahoo, Ankita; Gavrilova, Oksana] NIDDK, Mouse Metab Core, NIH, Bethesda, MD 20892 USA; [Jacobson, Kenneth A.] NIDDK, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Reitman, ML (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	marc.reitman@nih.gov	Jacobson, Kenneth Alan/A-1530-2009; Reitman, Marc/B-4448-2013	Jacobson, Kenneth Alan/0000-0001-8104-1493; Reitman, Marc/0000-0002-0426-9475; Pinol, Ramon/0000-0002-8877-8444	Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [ZIA DK075062, ZIA DK075063, ZIA DK070002]	Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (ZIA DK075062 and ZIA DK075063 to MLR and ZIA DK070002 to OG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R, 1994, BRIT J PHARMACOL, V113, P1386, DOI 10.1111/j.1476-5381.1994.tb17151.x; [Anonymous], 2010, SCRIBES J LEGAL WRIT, V13, P133; [Anonymous], 2011, PERSPECTIVES SCI CHR, V63, P1; [Anonymous], 2020, J GYNECOL ONCOL, V31, pe69; Arrich J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub4; Bennet DW, 1931, J PHYSIOL-LONDON, V72, P288, DOI 10.1113/jphysiol.1931.sp002775; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Carlin JL, 2018, NEUROPHARMACOLOGY, V139, P268, DOI 10.1016/j.neuropharm.2018.02.035; Carlin JL, 2017, NEUROPHARMACOLOGY, V114, P101, DOI 10.1016/j.neuropharm.2016.11.026; Carlin JL, 2016, J PHARMACOL EXP THER, V356, P474, DOI 10.1124/jpet.115.229872; CLARK WG, 1987, NEUROSCI BIOBEHAV R, V11, P35, DOI 10.1016/S0149-7634(87)80003-9; Drew Kelly L, 2015, Temperature (Austin), V2, P168, DOI 10.4161/23328940.2014.976512; Eisner C, 2017, PFLUG ARCH EUR J PHY, V469, P339, DOI 10.1007/s00424-016-1925-3; FASTBOM J, 1987, NEUROSCIENCE, V22, P813, DOI 10.1016/0306-4522(87)92961-7; Frare C, 2019, J NEUROCHEM, V151, P316, DOI 10.1111/jnc.14814; Fredholm BB, 2014, J MOL MED, V92, P201, DOI 10.1007/s00109-013-1101-6; Glukhova A, 2017, CELL, V168, P867, DOI 10.1016/j.cell.2017.01.042; Hackett TA, 2018, ANAT REC, V301, P1882, DOI 10.1002/ar.23907; Hrvatin S, 2020, NATURE, V583, P115, DOI 10.1038/s41586-020-2387-5; Iliff BW, 2012, AM J PHYSIOL-REG I, V303, pR477, DOI 10.1152/ajpregu.00081.2012; JACOBSON KA, 1992, J MED CHEM, V35, P4143, DOI 10.1021/jm00100a020; Jain S, 2018, AM J PHYSIOL-ENDOC M, V315, pE357, DOI 10.1152/ajpendo.00024.2018; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lima FO, 2010, PAIN, V151, P506, DOI 10.1016/j.pain.2010.08.014; Lute B, 2014, CELL METAB, V20, P333, DOI 10.1016/j.cmet.2014.05.021; Machado NLS, 2020, J NEUROSCI, V40, P2573, DOI 10.1523/JNEUROSCI.2887-19.2020; Morrison SF, 2019, ANNU REV PHYSIOL, V81, P285, DOI 10.1146/annurev-physiol-020518-114546; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Pinol RA, 2018, NAT NEUROSCI, V21, P1530, DOI 10.1038/s41593-018-0249-3; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Sangsiri S, 2013, J PHARMACOL EXP THER, V345, P32, DOI 10.1124/jpet.112.199612; Scammell TE, 2003, J NEUROSCI, V23, P5762; Searl TJ, 2016, J PHARMACOL EXP THER, V356, P116, DOI 10.1124/jpet.115.228882; SEBASTIAO AM, 1990, BRIT J PHARMACOL, V101, P453, DOI 10.1111/j.1476-5381.1990.tb12729.x; Shintani M, 2005, J PHARMACOL SCI, V97, P451, DOI 10.1254/jphs.SC0040178; Silvani A, 2018, PHYSIOLOGY, V33, P182, DOI 10.1152/physiol.00007.2018; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takahashi TM, 2020, NATURE, V583, P109, DOI 10.1038/s41586-020-2163-6; Tan CL, 2018, NEURON, V98, P31, DOI 10.1016/j.neuron.2018.02.022; Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028; TICHO SR, 1991, PHARMACOL BIOCHEM BE, V40, P33, DOI 10.1016/0091-3057(91)90317-U; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; Varani K, 2017, ADV EXP MED BIOL, V1051, P193, DOI 10.1007/5584_2017_61; Xiao CY, 2020, MOL METAB, V36, DOI 10.1016/j.molmet.2020.02.012; Xiao CY, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000161; Zaretskaia MV, 2002, BRAIN RES, V928, P113, DOI 10.1016/S0006-8993(01)03369-8; Zhang KX, 2020, NATURE, V585, P420, DOI 10.1038/s41586-020-2683-0; Zhao ZD, 2017, P NATL ACAD SCI USA, V114, P2042, DOI 10.1073/pnas.1616255114; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	52	2	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243986	10.1371/journal.pone.0243986	http://dx.doi.org/10.1371/journal.pone.0243986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326493	Green Published, gold			2022-12-26	WOS:000600176400053
J	Hanami, T; Tanabe, T; Hanashi, T; Yamaguchi, M; Nakata, H; Mitani, Y; Kimura, Y; Soma, T; Usui, K; Isobe, M; Ogawa, T; Itoh, M; Hayashizaki, Y; Kondo, S				Hanami, Takeshi; Tanabe, Tetsuya; Hanashi, Takuya; Yamaguchi, Mitsushiro; Nakata, Hidetaka; Mitani, Yasumasa; Kimura, Yasumasa; Soma, Takahiro; Usui, Kengo; Isobe, Michiko; Ogawa, Takashi; Itoh, Masayoshi; Hayashizaki, Yoshihide; Kondo, Seiji			Scanning single-molecule counting system for Eprobe with highly simple and effective approach	PLOS ONE			English	Article							INTENSITY DISTRIBUTION ANALYSIS; FLUORESCENCE DETECTION; DIAGNOSTICS	Here, we report a rapid and ultra-sensitive detection technique for fluorescent molecules called scanning single molecular counting (SSMC). The method uses a fluorescence-based digital measurement system to count single molecules in a solution. In this technique, noise is reduced by conforming the signal shape to the intensity distribution of the excitation light via a circular scan of the confocal region. This simple technique allows the fluorescent molecules to freely diffuse into the solution through the confocal region and be counted one by one and does not require statistical analysis. Using this technique, 28 to 62 aM fluorescent dye was detected through measurement for 600 s. Furthermore, we achieved a good signal-to-noise ratio (S/N = 2326) under the condition of 100 pM target nucleic acid by only mixing a hybridization-sensitive fluorescent probe, called Eprobe, into the target oligonucleotide solution. Combination of SSMC and Eprobe provides a simple, rapid, amplification-free, and high-sensitive target nucleic acid detection system. This method is promising for future applications to detect particularly difficult to design primers for amplification as miRNAs and other short oligo nucleotide biomarkers by only hybridization with high sensitivity.	[Hanami, Takeshi; Tanabe, Tetsuya; Hanashi, Takuya; Yamaguchi, Mitsushiro; Soma, Takahiro; Usui, Kengo; Itoh, Masayoshi] RIKEN Ctr Integrat Med Sci, Genet Diag Technol Unit, Yokohama, Kanagawa, Japan; [Hanami, Takeshi; Tanabe, Tetsuya; Hanashi, Takuya; Yamaguchi, Mitsushiro; Nakata, Hidetaka; Isobe, Michiko; Ogawa, Takashi; Itoh, Masayoshi; Kondo, Seiji] RIKEN Innovat Ctr, Wako, Saitama, Japan; [Tanabe, Tetsuya; Hanashi, Takuya; Yamaguchi, Mitsushiro; Nakata, Hidetaka; Kondo, Seiji] Olympus Corp, Med Technol R&D Div, Adv Anal Technol Dept, Hachioji, Tokyo, Japan; [Mitani, Yasumasa; Kimura, Yasumasa] KK DNAFORM, Yokohama, Kanagawa, Japan; [Itoh, Masayoshi; Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan	RIKEN; RIKEN; Olympus Corporation; RIKEN	Hanami, T; Tanabe, T (corresponding author), RIKEN Ctr Integrat Med Sci, Genet Diag Technol Unit, Yokohama, Kanagawa, Japan.; Hanami, T; Tanabe, T (corresponding author), RIKEN Innovat Ctr, Wako, Saitama, Japan.; Tanabe, T (corresponding author), Olympus Corp, Med Technol R&D Div, Adv Anal Technol Dept, Hachioji, Tokyo, Japan.	thanami@riken.jp; te_tanabe@ot.olympus.co.jp	Itoh, Masayoshi/N-5363-2015	Itoh, Masayoshi/0000-0002-1772-318X	RIKEN; Olympus Corporation under RIKEN Integrated Collaborative Research Program with Industry; MEXT; Olympus Corporation; K.K. DNAFORM	RIKEN; Olympus Corporation under RIKEN Integrated Collaborative Research Program with Industry; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Olympus Corporation; K.K. DNAFORM	This work was supported by a research grant from RIKEN and Olympus Corporation under RIKEN Integrated Collaborative Research Program with Industry to SK, a research grant from MEXT to the RIKEN Center for Integrative Medical Science to KU, MEXT to RIKEN Preventive Medicine and Diagnosis Innovation Program to YH. Olympus Corporation also provided funding for the study in the form of salaries for authors TT, T. Hanashi, MY, HN, and SK. Funding was also provided by K.K. DNAFORM, a company holding commercial rights to Eprobe technology, in the form of salaries for authors YM and YK. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Altamore I, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/6/065702; Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Borst A, 2004, EUR J CLIN MICROBIOL, V23, P289, DOI 10.1007/s10096-004-1100-1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Fister JC, 1998, ANAL CHEM, V70, P431, DOI 10.1021/ac9707242; GOODWIN PM, 1993, NUCLEIC ACIDS RES, V21, P803, DOI 10.1093/nar/21.4.803; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Itoh M, 2007, KAGAKU TO SEIBUTSU, V47, P823; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kask P, 2000, BIOPHYS J, V78, P1703, DOI 10.1016/S0006-3495(00)76722-1; Keller RA, 1996, APPL SPECTROSC, V50, pA12, DOI 10.1366/0003702963905600; Kimura Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146950; Li HT, 2003, ANAL CHEM, V75, P1664, DOI 10.1021/ac026367z; Liao PY, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8080231; Ma F, 2016, ACCOUNTS CHEM RES, V49, P1722, DOI 10.1021/acs.accounts.6b00237; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Okamoto A, 2011, CHEM SOC REV, V40, P5815, DOI 10.1039/c1cs15025a; Pei XJ, 2018, ANAL CHEM, V90, P1376, DOI 10.1021/acs.analchem.7b04551; Quan PL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041271; Rigler R., 2001, FLUORESCENCE CORRELA; Sapkota K, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19163495; Satsoura D, 2007, CHEMPHYSCHEM, V8, P834, DOI 10.1002/cphc.200600589; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SOPER SA, 1992, J OPT SOC AM B, V9, P1761, DOI 10.1364/JOSAB.9.001761; Tatulli G, 2020, NANOSCALE, V12, P15604, DOI 10.1039/d0nr03517c; Wabuyele MB, 2003, J AM CHEM SOC, V125, P6937, DOI 10.1021/ja034716g; Walt DR, 2013, ANAL CHEM, V85, P1258, DOI 10.1021/ac3027178; Wu AHB, 2006, CLIN CHEM, V52, P2157, DOI 10.1373/clinchem.2006.073163; Yamaguchi M, 2014, PROC SPIE, V8948, DOI 10.1117/12.2037645	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243319	10.1371/journal.pone.0243319	http://dx.doi.org/10.1371/journal.pone.0243319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320908	Green Published, gold			2022-12-26	WOS:000600339800019
J	Li, CZ; Shen, YT; Huang, LW; Liu, CB; Wang, J				Li, Caizhen; Shen, Yanting; Huang, Liuwei; Liu, Chongbin; Wang, Jun			Senolytic therapy ameliorates renal fibrosis postacute kidney injury by alleviating renal senescence	FASEB JOURNAL			English	Article						acute kidney injury; chronic kidney disease; dasatinib; senescence; senolytics; quercetin	TUBULAR EPITHELIAL-CELLS; DISEASE; PATHOPHYSIOLOGY; STRATEGIES	Acute kidney injury (AKI) is a common clinical problem, and patients who survive AKI have a high risk of chronic kidney disease (CKD). The mechanism of CKD post-AKI, characterized by progressive renal fibrosis, is still unclear. Maladaptive tubular epithelial cells (TECs) after AKI are considered a leading cause of renal fibrosis post-AKI. TECs under maladaptive repair manifest characteristics of senescence. Removing senescent TECs by genetic ablation has been proven effective in reducing renal fibrosis. Senolytics, which eliminate senescent cells by pharmacological intervention, have been studied in a series of degenerative diseases. To our knowledge, the effects of senolytics on renal fibrosis post-AKI have not been verified before. Here, we confirmed renal senescence in the unilateral ischemia/reperfusion injury murine model. Senescent TECs could activate fibroblasts and senolytics specifically induced apoptosis of senescent TECs. Next, we demonstrated that senolytics could reduce renal senescence and ameliorate renal fibrosis in both unilateral renal ischemia/reperfusion injury and multiple-cisplatin-treatment murine models. Our results indicate senescent TECs as a vital factor in renal fibrosis progression, and senolytic therapy might be promising for treating CKD post-AKI.	[Li, Caizhen; Shen, Yanting; Huang, Liuwei; Liu, Chongbin; Wang, Jun] Southern Med Univ, Guangdong Prov Inst Nephrol, State Key Lab Organ Failure Res,Div Nephrol, Natl Clin Res Ctr Kidney Dis,Nanfang Hosp, Guangzhou, Peoples R China	Southern Medical University - China	Wang, J (corresponding author), Nanfang Hosp, Div Nephrol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.	wangjun1975@smu.edu.cn						Andrade L, 2018, CELL TRANSPLANT, V27, P739, DOI 10.1177/0963689717743512; Baisantry A, 2015, J AM SOC NEPHROL, V27, P1; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Cruz FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147005; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DiRocco DP, 2014, AM J PHYSIOL-RENAL, V306, pF379, DOI 10.1152/ajprenal.00475.2013; Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Goligorsky MS, 2020, AM J PATHOL, V190, P1164, DOI 10.1016/j.ajpath.2020.01.016; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Graefe EU, 2001, J CLIN PHARMACOL, V41, P492, DOI 10.1177/00912700122010366; Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069; Hoste EAJ, 2018, NAT REV NEPHROL, V14, P607, DOI 10.1038/s41581-018-0052-0; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jin H, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125490; Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052; Katagiri D, 2016, KIDNEY INT, V89, P374, DOI 10.1038/ki.2015.327; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim SR, 2020, AM J PHYSIOL-RENAL, V318, pF1167, DOI 10.1152/ajprenal.00535.2019; Kim SR, 2019, TRANSL RES, V213, P112, DOI 10.1016/j.trsl.2019.07.005; Kirkland JL, 2015, EXP GERONTOL, V68, P19, DOI 10.1016/j.exger.2014.10.012; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Le Clef N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152153; Leveque D, 2020, CLIN PHARMACOKINET, V59, P849, DOI 10.1007/s40262-020-00872-4; Li CZ, 2019, FREE RADICAL BIO MED, V130, P512, DOI 10.1016/j.freeradbiomed.2018.11.006; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu J, 2012, TRANSL RES, V159, P454, DOI 10.1016/j.trsl.2011.11.008; Liu T, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118116; Megyesi J, 2001, KIDNEY INT, V60, P2164, DOI 10.1046/j.1523-1755.2001.00044.x; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Ovadya Y, 2018, J CLIN INVEST, V128, P1247, DOI 10.1172/JCI95149; Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950; Qi RC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1157-x; Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Sharp CN, 2018, AM J PHYSIOL-RENAL, V315, pF161, DOI 10.1152/ajprenal.00636.2017; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	48	27	28	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21229	10.1096/fj.202001855RR	http://dx.doi.org/10.1096/fj.202001855RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368613				2022-12-26	WOS:000605626600013
J	Hernandez, SE; Dorta, R; Suero, J; Barros-Loscertales, A; Gonzalez-Mora, JL; Rubia, K				Hernandez, Sergio Elias; Dorta, Roberto; Suero, Jose; Barros-Loscertales, Alfonso; Gonzalez-Mora, Jose Luis; Rubia, Katya			Larger whole brain grey matter associated with long-term Sahaja Yoga Meditation: A detailed area by area comparison	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER; MENTAL SILENCE; CORTEX; PARCELLATION; VOLUME; CONNECTIVITY; HIPPOCAMPAL; EXTENT	Objectives Our previous study showed that long-term practitioners of Sahaja Yoga Meditation (SYM) had around 7% larger grey matter volume (GMV) in the whole brain compared with healthy controls; however, when testing individual regions, only 5 small brain areas were statistically different between groups. Under the hypothesis that those results were statistically conservative, with the same dataset, we investigated in more detail the regional differences in GMV associated with the practice of SYM, with a different statistical approach. Design Twenty-three experienced practitioners of SYM and 23 healthy non-meditators matched on age, sex and education level, were scanned using structural magnetic resonance imaging (MRI). Their GMV were extracted and compared using Voxel-Based Morphometry (VBM). Using a novel ad-hoc general linear model, statistical comparisons were made to observe if the GMV differences between meditators and controls were statistically significant. Results In the 16 lobe area subdivisions, GMV was statistically significantly different in 4 out of 16 areas: in right hemispheric temporal and frontal lobes, left frontal lobe and brainstem. In the 116 AAL area subdivisions, GMV difference was statistically significant in 11 areas. The GMV differences were statistically more significant in right hemispheric brain areas. Conclusions The study shows that long-term practice of SYM is associated with larger GMV overall, and with significant differences mainly in temporal and frontal areas of the right hemisphere and the brainstem. These neuroplastic changes may reflect emotional and attentional control mechanisms developed with SYM. On the other hand, our statistical ad-hoc method shows that there were more brain areas with statistical significance compared to the traditional methodology which we think is susceptible to conservative Type II errors.	[Hernandez, Sergio Elias] Univ La Laguna, Dept Ingn Ind, Tenerife, Spain; [Dorta, Roberto] Univ La Laguna, Dept Matemat, Estad Invest Operat, Tenerife, Spain; [Suero, Jose] Sermas, Ctr Salud Jazmin, Madrid, Spain; [Barros-Loscertales, Alfonso] Univ Jaume 1, Dept Psicol Bas Clin & Psicobiol, Castellon de La Plana, Spain; [Gonzalez-Mora, Jose Luis] Univ La Laguna, Dept Fisiol, Tenerife, Spain; [Rubia, Katya] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England	Universidad de la Laguna; Universidad de la Laguna; Universitat Jaume I; Universidad de la Laguna; University of London; King's College London	Hernandez, SE (corresponding author), Univ La Laguna, Dept Ingn Ind, Tenerife, Spain.	sehdez@ull.edu.es	Rubia, Katya/H-7497-2012; Dorta-Guerra, Roberto/F-8947-2016	Rubia, Katya/0000-0002-1410-7701; Dorta-Guerra, Roberto/0000-0002-7269-1889; Hernandez Alonso, Sergio Elias/0000-0001-5043-1341				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2010, VBM TUTORIAL; [Anonymous], 1988, J PERCEPT MOTOR SKIL; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2018, TRENDS COGN SCI, V22, P170, DOI 10.1016/j.tics.2017.11.005; Beauregard M, 2006, NEUROSCI LETT, V405, P186, DOI 10.1016/j.neulet.2006.06.060; Bellato A, 2020, NEUROSCI BIOBEHAV R, V108, P182, DOI 10.1016/j.neubiorev.2019.11.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boccia M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/419808; Brod G, 2016, J NEUROSCI, V36, P8103, DOI 10.1523/JNEUROSCI.0045-16.2016; Chung SC, 2012, J ALTERN COMPLEM MED, V18, P589, DOI 10.1089/acm.2011.0038; COWARD HG, 1985, J ANAL PSYCHOL, V30, P379, DOI 10.1111/j.1465-5922.1985.t01-1-00379.x; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dixon ML, 2017, PSYCHOL BULL, V143, P1033, DOI 10.1037/bul0000096; Dodich A, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1159; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Hernandez SE, 2018, NEUROSCIENCE, V371, P395, DOI 10.1016/j.neuroscience.2017.12.017; Hernandez SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150757; Fox KCR, 2014, NEUROSCI BIOBEHAV R, V43, P48, DOI 10.1016/j.neubiorev.2014.03.016; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Gonoi W, 2010, NEURORADIOLOGY, V52, P865, DOI 10.1007/s00234-009-0641-5; Harrison L.J., 2004, CLIN, V9, P479, DOI [10.1177/1359104504046155, DOI 10.1177/1359104504046155]; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hernandez SE, 2015, J ALTERN COMPLEM MED, V21, P175, DOI 10.1089/acm.2013.0450; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hung YW, 2018, HUM BRAIN MAPP, V39, P4065, DOI 10.1002/hbm.24232; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Kapogiannis D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007180; Kokodoko A, 2014, LIBR J, V139, P96; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lorenz R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03657-3; Luders E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00034; Luders E, 2011, NEUROIMAGE, V57, P1308, DOI 10.1016/j.neuroimage.2011.05.075; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Manocha R, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/960583; Manocha R, 2002, THORAX, V57, P110, DOI 10.1136/thorax.57.2.110; Manocha R, 2007, J CLIN PSYCHOL MED S, V14, P266, DOI 10.1007/s10880-007-9076-5; Manocha R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/350674; Marciniak R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00017; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Morgan A., 2001, TRANSPERSONAL PSYCHO; Nakata H, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01489; Panjwani U, 1996, INDIAN J MED RES, V103, P165; Panjwani U, 2000, APPL PSYCHOPHYS BIOF, V25, P1, DOI 10.1023/A:1009523904786; Panjwani Usha, 1995, Indian Journal of Physiology and Pharmacology, V39, P111; Pavlov SV, 2015, INT J PSYCHOPHYSIOL, V95, P363, DOI 10.1016/j.ijpsycho.2015.01.002; Peelle JE, 2012, NEUROIMAGE, V60, P1503, DOI 10.1016/j.neuroimage.2011.12.086; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; RAININKO R, 1994, NEURORADIOLOGY, V36, P364, DOI 10.1007/BF00612119; Rolls ET, 2015, NEUROIMAGE, V122, P1, DOI 10.1016/j.neuroimage.2015.07.075; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2007, CHILD NEUROPSYCHOL, V13, P276, DOI 10.1080/09297040600770761; Rubia K, 2009, BIOL PSYCHOL, V82, P1, DOI 10.1016/j.biopsycho.2009.04.003; Ryman SG, 2019, HUM BRAIN MAPP, V40, P955, DOI 10.1002/hbm.24424; Sampaio-Baptista C, 2014, NEUROIMAGE, V96, P158, DOI 10.1016/j.neuroimage.2014.03.056; Sedlmeier P, 2012, PSYCHOL BULL, V138, P1139, DOI 10.1037/a0028168; Shao YH, 2015, MOL PHYS, V113, P184, DOI 10.1080/00268976.2014.952696; Singleton O, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00033; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takeda Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00241; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Venkatraman A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00015; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yang CC, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9504642	76	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0237552	10.1371/journal.pone.0237552	http://dx.doi.org/10.1371/journal.pone.0237552			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370272	Green Published, gold, Green Submitted			2022-12-26	WOS:000603611900039
J	Berry, DA; Berry, S; Hale, P; Isakov, L; Lo, AW; Siah, KW; Wong, CH				Berry, Donald A.; Berry, Scott; Hale, Peter; Isakov, Leah; Lo, Andrew W.; Siah, Kien Wei; Wong, Chi Heem			A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates	PLOS ONE			English	Article								We compare and contrast the expected duration and number of infections and deaths averted among several designs for clinical trials of COVID-19 vaccine candidates, including traditional and adaptive randomized clinical trials and human challenge trials. Using epidemiological models calibrated to the current pandemic, we simulate the time course of each clinical trial design for 756 unique combinations of parameters, allowing us to determine which trial design is most effective for a given scenario. A human challenge trial provides maximal net benefits-averting an additional 1.1M infections and 8,000 deaths in the U.S. compared to the next best clinical trial design-if its set-up time is short or the pandemic spreads slowly. In most of the other cases, an adaptive trial provides greater net benefits.	[Berry, Donald A.] Univ Texas Houston, Dept Biostat, Houston, TX USA; [Berry, Donald A.; Berry, Scott] Berry Consultants, Austin, TX USA; [Hale, Peter] Fdn Vaccine Res, Washington, DC USA; [Isakov, Leah] Seqirus, Cambridge, MA USA; [Lo, Andrew W.] MIT Sloan Sch Management, Cambridge, MA 02142 USA; [Lo, Andrew W.; Siah, Kien Wei; Wong, Chi Heem] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	University of Texas System; University of Texas Health Science Center Houston; CSL; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lo, AW (corresponding author), MIT Sloan Sch Management, Cambridge, MA 02142 USA.; Lo, AW (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	alo-admin@mit.edu	Siah, Kien Wei/AAD-9134-2022	/0000-0002-7837-7030; /0000-0003-2944-7773; /0000-0002-4899-5022	MIT Laboratory for Financial Engineering	MIT Laboratory for Financial Engineering	L.I. is an employee of the biotech company Seqirus, and D.A.B. and S.B are employees of Berry Consultants. These companies did not have any role in study design, data collection and analysis, decision to publish, or preparation of this manuscript. The specific roles of these authors are specified in the 'author contributions' section. Funding support from the MIT Laboratory for Financial Engineering is gratefully acknowledged, but no direct funding was received for this study.	Abutaleb Y., 2020, WASH POST; [Anonymous], 2020, BUSINESS WIRE; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bambery B, 2016, PUBLIC HEALTH ETH-UK, V9, P92, DOI 10.1093/phe/phv026; Bentham Jeremy, 2001, FRAGMENT GOVT; Burton TM, 2020, WALL STREET J; Center for Systems Science and Engineering (CSSE), 2020, COVID 19 DAT RESP CT; Chaudhuri SE, 2018, DRUG DISCOV TODAY, V23, P395, DOI 10.1016/j.drudis.2017.09.016; Cochrane J, 2020, SIR MODEL BEHAV; COVID-19 Provisional Counts, 2020, COVID 19 PROV COUNTS; Deming ME, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2020076; Deutsch J., 2020, POLITICO; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Eyal N, 2020, J INFECT DIS, V221, P1752, DOI 10.1093/infdis/jiaa152; Fernandez-Villaverde J, 2020, ESTIMATING SIMULATIN; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta S, 2020, SAUDI J MED MED SCI, V8, P146, DOI 10.4103/sjmms.sjmms_38_19; Hopkins JS, 2020, CORONAVIRUS RES COMP; Isakov L, 2019, J ECONOMETRICS, V211, P117, DOI 10.1016/j.jeconom.2018.12.009; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jamrozik E, 2020, LANCET INFECT DIS, V20, pE198, DOI 10.1016/S1473-3099(20)30438-2; Jennison C, 1997, J AM STAT ASSOC, V92, P1330; Keown A, 2020, OPERATION WARP SPEED; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Miller FG, 2001, CLIN INFECT DIS, V33, P1028, DOI 10.1086/322664; Moderna, 2020, COVE STUD PART MAK W; Montazerhodjat V, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.0123; Nauta J., 2020, STAT CLIN OBSERVATIO, V2nd; Newall AT, 2018, INFLUENZA OTHER RESP, V12, P211, DOI 10.1111/irv.12510; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pfizer, 2020, 2 CIT BRAZ HOST LAT; Plotkin SA, 2020, VACCINE, V38, P3987, DOI 10.1016/j.vaccine.2020.04.039; Ray D., 2020, DATA SCI REV, V2020, P1, DOI [DOI 10.1162/99608F92.60E08ED5, 10.1162/99608f92.60e08ed5, DOI 10.1101/2020.04.15.20067256]; Raymond M, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3844-z; Sarah O, 2020, WHITE HOUSE PRESSURE; Shah SK, 2020, SCIENCE, V368, P832, DOI 10.1126/science.abc1076; Sherman AC, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00107; Shirley Debbie-Ann T, 2011, Vaccine (Auckl), V2011, P3; Stanisic DI, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00479-17; Steenhuysen J, 2020, US MAKE CORONAVIRUS; Taylor NP, 2020, ASTRAZENECAS COVID 1; WHO, 2021, INT RAND TRIAL CAND; Wong C.H., 2020, HARVARD DATA SCI REV; World Health Organization, 2020, KEY CRIT ETH ACC COV, P1; World Health Organization, 2020, FEAS POT VAL LIM EST; Yan W, 2015, CHALLENGE ACCEPTED H	48	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244418	10.1371/journal.pone.0244418	http://dx.doi.org/10.1371/journal.pone.0244418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362278	Green Published, gold, Green Submitted			2022-12-26	WOS:000603071600040
J	Kobayashi, H; Whitehead, H; Amano, M				Kobayashi, Hayao; Whitehead, Hal; Amano, Masao			Long-term associations among male sperm whales (Physeter macrocephalus)	PLOS ONE			English	Article							SOCIAL-STRUCTURE; BEHAVIOR; AGGREGATIONS; COOPERATION; SELECTION; UNITS	Little is known about the social structure of male sperm whales (Physeter macrocephalus) after they leave their natal units. While previous studies found no evidence for preferred associations among males, the observation of mass-strandings consisting exclusively of males, suggest that they have strong social bonds. To investigate the social associations among male sperm whales, we used half weight index of association, permutation tests and standardized lagged association rate models on a large photo-identification database collected between 2006 and 2017 in Nemuro Strait, Japan. Our results suggest that while male sperm whales are not as social as females, they do form long term associations, have preferred companionship, and forage in social proximity to each other. The best-fitting model to the standardized lagged association rate showed that associations among males last for at least 2.7 years and as most males leave the area after 2 years, associations may last for longer. Twenty dyads were observed associating over more than 2 years, for a maximum 5 years. One dyad was observed associating on 19 different days and clustered on 7 different days. Male associations may function to enhance foraging or to fend off predators. Such relationships seem to be adapted to a pelagic habitat with uncertain resource availability and predation pressure.	[Kobayashi, Hayao; Amano, Masao] Nagasaki Univ, Grad Sch Fisheries & Environm Sci, Nagasaki, Japan; [Whitehead, Hal] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Nagasaki University; Dalhousie University	Kobayashi, H (corresponding author), Nagasaki Univ, Grad Sch Fisheries & Environm Sci, Nagasaki, Japan.	physeter0809@gmail.com		Kobayashi, Hayao/0000-0002-2201-7669; Amano, Masao/0000-0001-9495-5315	JSPS KAKENHI [JP18570010, JP21540020, JP24370012]; Inter College Nemuro Scholarship 2017 (Hokkaido Government Nemuro Sub-prefectural Bureau)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Inter College Nemuro Scholarship 2017 (Hokkaido Government Nemuro Sub-prefectural Bureau)	This study was supported by JSPS KAKENHI Grant Numbers JP18570010, JP21540020, and JP24370012 (MA from Japan Society for the Promotion of Science), and Inter College Nemuro Scholarship 2017 (MA from Hokkaido Government Nemuro Sub-prefectural Bureau). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnbom T., 1987, International Whaling Commission Report of the Commission, P201; Autenrieth M, 2018, MAMM BIOL, V88, P156, DOI 10.1016/j.mambio.2017.09.003; Best P.B., 1979, Behavior of Marine Animals, V3, P227; Best P.B., 1984, Reports of the International Whaling Commission Special Issue, P51; Best P. B., 1983, REPORTS IWC, V5, P41; Bond J, 1999, THESIS; Caldwell KD, 1966, WHALES DOLPHINS PORP, P677; Cantor M, 2015, MAR MAMMAL SCI, V31, P1275, DOI 10.1111/mms.12218; CARO TM, 1987, ETHOLOGY, V74, P52; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; Christal J, 1998, CAN J ZOOL, V76, P1431, DOI 10.1139/cjz-76-8-1431; Christal J, 2001, ETHOLOGY, V107, P323, DOI 10.1046/j.1439-0310.2001.00666.x; Christal J, 1997, MAR MAMMAL SCI, V13, P59, DOI 10.1111/j.1748-7692.1997.tb00612.x; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Cure C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01579; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; GASKIN D E, 1970, New Zealand Journal of Marine and Freshwater Research, V4, P456; Gero S, 2015, ANIM BEHAV, V102, P15, DOI 10.1016/j.anbehav.2015.01.008; Gero S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1113; Gillespie Douglas, 1997, Report of the International Whaling Commission, V47, P897; Gordon J.C.D., 1987, International Whaling Commission Report of the Commission, P205; Hammond PS, REP INT WHAL COMM, V12, P440; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Jaquet N, 2000, CAN J ZOOL, V78, P407, DOI 10.1139/cjz-78-3-407; Kasuya Toshio, 1999, Journal of Cetacean Research and Management, V1, P109; Kobayashi H, 2020, MAR MAMMAL SCI, V36, P612, DOI 10.1111/mms.12662; Konrad CM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180914; Leaper Russell, 1998, Report of the International Whaling Commission, V48, P431; Lettevall E, 2002, CAN J ZOOL, V80, P1189, DOI 10.1139/Z02-102; Madsen PT, 2002, J EXP BIOL, V205, P1899; Madsen PT, 2000, J ACOUST SOC AM, V107, P668, DOI 10.1121/1.428568; Madsen PT, 2002, THESIS; Mitani JC, 2000, ANIM BEHAV, V59, P885, DOI 10.1006/anbe.1999.1389; Ohsumi S, 1971, SCI REPORTS WHALE RE, V23, P1; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Rice D.W., 1989, P177; Schnitzler JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29186-z; SERGEANT D E, 1982, Scientific Reports of the Whales Research Institute Tokyo, P1; VANHOOFF JARAM, 1994, BEHAVIOUR, V130, P309, DOI 10.1163/156853994X00587; Wahlberg M, 2002, J EXP MAR BIOL ECOL, V281, P53, DOI 10.1016/S0022-0981(02)00411-2; Weilgart L, 1996, AM SCI, V84, P278; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, P409, DOI 10.1002/2013EO450001; Whitehead H, 2000, CETACEAN SOCIETIES, P154; WHITEHEAD H, 1991, BEHAVIOUR, V118, P275, DOI 10.1163/156853991X00328; WHITEHEAD H, 1992, CAN J ZOOL, V70, P912, DOI 10.1139/z92-130; Whitehead H, 2001, ECOLOGY, V82, P1417, DOI 10.1890/0012-9658(2001)082[1417:AOAMUO]2.0.CO;2; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H., 2003, SPERM WHALES SOCIAL; Whitehead H., 1986, REPORTS INT WHALING, V8, P149; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2012, INT J PRIMATOL, V33, P1142, DOI 10.1007/s10764-012-9598-z; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	55	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244204	10.1371/journal.pone.0244204	http://dx.doi.org/10.1371/journal.pone.0244204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362216	gold, Green Published			2022-12-26	WOS:000603071600024
J	Wang, MM; Zhang, HF; Chen, MGS; Yang, LY; Yang, YC				Wang, Mengmeng; Zhang, Huifen; Chen, Menggaoshan; Yang, Liuyan; Yang, Yichen			Dark accelerates dissolved inorganic phosphorus release of high-density cyanobacteria	PLOS ONE			English	Article							LAKE TAIHU; NUTRIENT RELEASE; EUTROPHIC LAKE; WATER; MICROCYSTIS; DECOMPOSITION; SEDIMENTS; COMMUNITY; BLOOMS; PHYTOPLANKTON	Bloom-forming cyanobacteria dramatically influence nutrient cycling in eutrophic freshwater lakes. The phosphorus (P) assimilation and release of bloom-forming cyanobacteria significantly may also affect the phosphorus source and amounts in water. To understand the phosphorus release process of bloom-forming cyanobacteria below the accumulated surface and sedimentary bloom-forming cyanobacteria, the degradation of bloom-forming cyanobacteria dominated by Microcystis spp. at different cell density in the dark was investigated over a 25-day microcosm experiment. The dissolved inorganic phosphorus (DIP) and dissolved total phosphorus (DTP) contents increased with the increment of cyanobacterial density, and the dark status markedly increased the proportion of DIP in water during the decline period of bloom-forming cyanobacteria. Meanwhile, the process of cyanobacterial apoptosis accompanied by the changes of malondialdehyde (MDA) and phosphatase (AKP) contents, and the increases of superoxide dismutase (SOD) and catalase (CAT) activities of cyanobacteria in the dark, especially in low-density groups (5.23x10(8) cells L-1), which further affect the physicochemical water parameters. Moreover, the DIP release from high-density cyanobacteria (7.86x10(7) cells L-1 similar to 5.23x10(8) cells L-1) resulted from the relative abundance of organophosphorus degrading bacteria in the dark. Therefore, the fast decay of cyanobacteria in the dark could accelerate DIP release, the high DIP release amount from accumulated bloom-cyanobacteria provide adequate P quickly for the sustained growth of cyanobacteria.	[Wang, Mengmeng; Zhang, Huifen; Chen, Menggaoshan; Yang, Liuyan] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Res Reuse, Nanjing, Peoples R China; [Yang, Yichen] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Nanjing University; State University System of Florida; University of Florida	Yang, LY (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Res Reuse, Nanjing, Peoples R China.	yangly@nju.edu.cn	yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022		National Natural Science Foundation of China [41871082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41871082). The funders played role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XL, 2009, ENVIRON POLLUT, V157, P2507, DOI 10.1016/j.envpol.2009.03.018; Balasubramanian D, 2012, ECOL ENG, V44, P111, DOI 10.1016/j.ecoleng.2012.03.002; Cao X, 2016, ENVIRON POLLUT, V219, P580, DOI 10.1016/j.envpol.2016.06.017; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chen W.M., 1996, J LAKE SCI, V3, P248; Chuai XM, 2011, ECOL ENG, V37, P842, DOI 10.1016/j.ecoleng.2011.01.001; Collen J., 2010, J PHYCOL, V35, P54; Dai Ji-cui, 2006, Huanjing Kexue, V27, P1953; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Feng WY, 2016, ENVIRON SCI POLLUT R, V23, P7288, DOI 10.1007/s11356-015-5913-5; Gao G., 2000, J LAKE SCI, V12, P353; Gao L, 2013, ECOL ENG, V60, P19, DOI 10.1016/j.ecoleng.2013.07.055; He XB, 2009, ECOL ENG, V35, P570, DOI 10.1016/j.ecoleng.2008.05.010; JEWELL WJ, 1971, ENVIRON SCI TECHNOL, V5, P1023, DOI 10.1021/es60057a005; Jonna Engstrom-ost<bullet>Riitta, 2013, HYDROBIOLOGIA, V701, P25; Liu H.L., 1987, SPECIFICATION INVEST; [马喆 MA Zhe], 2007, [农业环境科学学报, Journal of Agro-environment Science], V26, P1894; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Niu Y, 2011, WATER RES, V45, P4169, DOI 10.1016/j.watres.2011.05.022; Peng Yu-Ke, 2018, Huan Jing Ke Xue, V39, P4938, DOI 10.13227/j.hjkx.201801195; Perkins RG, 2002, HYDROBIOLOGIA, V481, P75, DOI 10.1023/A:1021281019865; Qian HF, 2012, ENVIRON TOXICOL, V27, P229, DOI 10.1002/tox.20636; Qin BQ, 2007, HYDROBIOLOGIA, V581, P1, DOI 10.1007/s10750-006-0522-4; SEITZINGER SP, 1991, ESTUAR COAST SHELF S, V33, P409, DOI 10.1016/0272-7714(91)90065-J; Shi LM, 2011, ANN LIMNOL-INT J LIM, V47, P355, DOI 10.1051/limn/2011047; Strickland JDH, 1968, PRACTICAL HDB SEAWAT; Sun XiaoJing, 2007, China Environmental Science, V27, P341; Tessarolli LP, 2018, BRAZ J BIOL, V78, P108, DOI 10.1590/1519-6984.07616; Toothman BR, 2009, HYDROBIOLOGIA, V636, P401, DOI 10.1007/s10750-009-9969-4; Voros L, 2003, AQUAT BOT, V77, P99, DOI 10.1016/S0304-3770(03)00090-1; Wang HJ, 2009, PROG NAT SCI, V19, P1445, DOI 10.1016/j.pnsc.2009.03.009; Wang WJ, 2015, BIOCHEM SYST ECOL, V61, P62, DOI 10.1016/j.bse.2015.04.016; WEICH RG, 1989, J EXP MAR BIOL ECOL, V129, P33, DOI 10.1016/0022-0981(89)90061-0; Wu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101837; Wu W., 2015, EXOPOLYSACCHARIDES C; [吴馨婷 Wu Xinting], 2017, [环境科学学报, Acta Scientiae Circumstantiae], V37, P2846; Wu ZX, 2007, ENVIRON POLLUT, V147, P324, DOI 10.1016/j.envpol.2006.05.022; Xie P, 2008, HIST DEV CYANOBACTER; Yamamoto Yoko, 1993, Japanese Journal of Phycology, V41, P215; Yuanyuan W, 2008, J ENVIRON SCI-CHINA, V20, P891, DOI 10.1016/S1001-0742(08)62143-9; Zamyadi A, 2014, ENVIRON SCI-PROC IMP, V16, P313, DOI 10.1039/c3em00603d; Zhang J L, 2016, PHOSPHORUS MINERALIZ; Zhang SH, 2018, ENVIRON SCI POLLUT R, V25, P13579, DOI 10.1007/s11356-018-1517-1; Zhu GW, 2007, HYDROBIOLOGIA, V581, P53, DOI 10.1007/s10750-006-0519-z; Zhu Guangwei, 2020, Hupo Kexue, V32, P21, DOI 10.18307/2020.0103; Zhu MY, 2013, ENVIRON SCI POLLUT R, V20, P1803, DOI 10.1007/s11356-012-1084-9; Zhu YR, 2013, ENVIRON SCI TECHNOL, V47, P7679, DOI 10.1021/es305277g	49	0	1	13	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243582	10.1371/journal.pone.0243582	http://dx.doi.org/10.1371/journal.pone.0243582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351804	gold, Green Published			2022-12-26	WOS:000603071400010
J	Detering, T; Mundry, K; Berger, RG				Detering, Thorben; Mundry, Katharina; Berger, Ralf G.			Generation of 4-vinylguaiacol through a novel high-affinity ferulic acid decarboxylase to obtain smoke flavours without carcinogenic contaminants	PLOS ONE			English	Article							MECHANISM; LACCASE	Traditional smoke flavours bear the risk of containing a multitude of contaminating carcinogenic side-products. Enzymatic decarboxylation of ferulic acid released from agro-industrial side-streams by ferulic acid esterases (FAE) enables the sustainable generation of pure, food grade 4-vinylguaiacol (4-VG), the impact compound of smoke flavour. The first basidiomycetous ferulic acid decarboxylase (FAD) was isolated from Schizophyllum commune (ScoFAD) and heterologously produced by Komagataella phaffii. It showed a molecular mass of 21 kDa, catalytic optima at pH 5.5 and 35 degrees C, and a sequence identity of 63.6% to its next relative, a FAD from the ascomycete Cordyceps farinosa. The ScoFAD exhibited a high affinity to its only known substrate ferulic acid (FA) of 0.16 mmol L-1 and a turnover number of 750 s(-1). The resulting catalytic efficiency k(cat) K-M(-1) of 4,779 L s(-1) mmol(-1) exceeded the next best known enzyme by more than a factor of 50. Immobilised on AminoLink Plus Agarose, ScoFAD maintained its activity for several days. The combination with FAEs and agro-industrial side-streams paves the way for a new generation of sustainable, clean, and safe smoke flavours.	[Detering, Thorben; Mundry, Katharina; Berger, Ralf G.] Leibniz Univ Hannover, Inst Food Chem, Hannover, Lower Saxony, Germany	Leibniz University Hannover	Detering, T (corresponding author), Leibniz Univ Hannover, Inst Food Chem, Hannover, Lower Saxony, Germany.	thorben.detering@lci.uni-hannover.de			BMBF cluster Rauchenzym [031B0586]; Open Access fund of the Gottfried Wilhelm Leibniz Universitat Hannover	BMBF cluster Rauchenzym(Federal Ministry of Education & Research (BMBF)); Open Access fund of the Gottfried Wilhelm Leibniz Universitat Hannover	This research was funded the BMBF cluster Rauchenzym, grant number 031B0586. The APC was funded by the Open Access fund of the Gottfried Wilhelm Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeboye PT, 2017, SCI REP-UK, V7, DOI 10.1038/srep42635; Behrens CJ, 2017, PROTEIN EXPRES PURIF, V137, P34, DOI 10.1016/j.pep.2017.06.014; Bhuiya MW, 2015, APPL ENVIRON MICROB, V81, P4216, DOI 10.1128/AEM.00762-15; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Ciofalo V, 2006, REGUL TOXICOL PHARM, V45, P1, DOI 10.1016/j.yrtph.2006.02.001; Ferguson KL, 2016, BIOCHEMISTRY-US, V55, P2857, DOI 10.1021/acs.biochem.6b00170; Grosse M, 2020, J AGR FOOD CHEM, V68, P10329, DOI 10.1021/acs.jafc.9b06105; Hokkanen M., 2018, J CHEM, V2018, P1; Huang HK, 2012, J IND MICROBIOL BIOT, V39, P55, DOI 10.1007/s10295-011-0998-4; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1; Kolwek J, 2018, J IND MICROBIOL BIOT, V45, P89, DOI 10.1007/s10295-017-1998-9; Li LL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01798; Lin FM, 2015, ACS CHEM BIOL, V10, P1137, DOI 10.1021/cb5008103; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Linke D, 2017, FUNGAL BIOL-UK, V121, P763, DOI 10.1016/j.funbio.2017.05.006; Maeda M, 2018, J BIOSCI BIOENG, V126, P162, DOI 10.1016/j.jbiosc.2018.02.009; Matte A, 2010, ACTA CRYSTALLOGR F, V66, P1407, DOI 10.1107/S174430911003246X; Mittmann E, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10120795; Nagy EZA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36977-x; Nieter A, 2017, NEW BIOTECHNOL, V37, P153, DOI 10.1016/j.nbt.2017.01.002; Nieter A, 2016, BIORESOURCE TECHNOL, V220, P38, DOI 10.1016/j.biortech.2016.08.045; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Payer SE, 2019, ADV SYNTH CATAL, V361, P2402, DOI 10.1002/adsc.201900275; Schwarz KJ, 2012, J I BREWING, V118, P280, DOI 10.1002/jib.41; Siebert M, 2019, LWT-FOOD SCI TECHNOL, V115, DOI 10.1016/j.lwt.2019.108426; Suguitan Jr AL, 2011, PLOS ONE, V6; Thompson CA, 2010, AM J HEALTH-SYST PH, V67, P93, DOI 10.2146/news100005; Woods L., 2003, ENCY FOOD SCI NUTR, P5296, DOI [10.1016/B0-12-227055-X/01093-2, DOI 10.1016/B0-12-227055-X/01093-2]; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	30	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244290	10.1371/journal.pone.0244290	http://dx.doi.org/10.1371/journal.pone.0244290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347481	Green Published, gold			2022-12-26	WOS:000603071100040
J	Noree, C; Sirinonthanawech, N				Noree, Chalongrat; Sirinonthanawech, Naraporn			Nuclear targeted Saccharomyces cerevisiae asparagine synthetases associate with the mitotic spindle regardless of their enzymatic activity	PLOS ONE			English	Article							METABOLIC ENZYMES; CTP SYNTHASE; ASSEMBLIES; PROTEINS	Recently, human asparagine synthetase has been found to be associated with the mitotic spindle. However, this event cannot be seen in yeast because yeast takes a different cell division process via closed mitosis (there is no nuclear envelope breakdown to allow the association between any cytosolic enzyme and mitotic spindle). To find out if yeast asparagine synthetase can also (but hiddenly) have this feature, the coding sequences of green fluorescent protein (GFP) and nuclear localization signal (NLS) were introduced downstream of ASN1 and ASN2, encoding asparagine synthetases Asn1p and Asn2p, respectively, in the yeast genome having mCherrry coding sequence downstream of TUB1 encoding alpha-tubulin, a building block of the mitotic spindle. The genomically engineered yeast strains showed co-localization of Asn1p-GFP-NLS (or Asn2p-GFP-NLS) and Tub1p-mCherry in dividing nuclei. In addition, an activity-disrupted mutation was introduced to ASN1 (or ASN2). The yeast mutants still exhibited co-localization between defective asparagine synthetase and mitotic spindle, indicating that the biochemical activity of asparagine synthetase is not required for its association with the mitotic spindle. Furthermore, nocodazole treatment was used to depolymerize the mitotic spindle, resulting in lack of association between the enzyme and the mitotic spindle. Although yeast cell division undergoes closed mitosis, preventing the association of its asparagine synthetase with the mitotic spindle, however, by using yeast constructs with re-localized Asn1/2p have suggested the moonlighting role of asparagine synthetase in cell division of higher eukaryotes.	[Noree, Chalongrat; Sirinonthanawech, Naraporn] Mahidol Univ, Inst Mol Biosci, Phuttamonthon, Nakhon Pathom, Thailand	Mahidol University	Noree, C (corresponding author), Mahidol Univ, Inst Mol Biosci, Phuttamonthon, Nakhon Pathom, Thailand.	chalongrat.nor@mahidol.edu	Noree, Chalongrat/AAU-3371-2020	Noree, Chalongrat/0000-0002-7774-4281	Coordinating Center for Thai Government Science and Technology Scholarship Students (CSTS) - National Science and Technology Development Agency (NSTDA); National Research Council of Thailand (NRCT) in association with Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (MHESI); Development and Promotion of Science and Technology Talents Project (DPST); Mahidol University (MU)	Coordinating Center for Thai Government Science and Technology Scholarship Students (CSTS) - National Science and Technology Development Agency (NSTDA); National Research Council of Thailand (NRCT) in association with Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (MHESI); Development and Promotion of Science and Technology Talents Project (DPST); Mahidol University (MU)	This project was supported by (1) the Coordinating Center for Thai Government Science and Technology Scholarship Students (CSTS) -the National Science and Technology Development Agency (NSTDA), (2) the National Research Council of Thailand (NRCT) in association with Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (MHESI), (3) the Development and Promotion of Science and Technology Talents Project (DPST), and (4) Mahidol University (MU).	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; [Anonymous], 2020, CANC DISCOV, V10, pOF8; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; ARONOW B, 1987, J BIOL CHEM, V262, P5106; Aughey GN, 2016, CRIT REV BIOCHEM MOL, V51, P282, DOI 10.3109/10409238.2016.1172555; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Boettcher B, 2013, NUCLEUS-PHILA, V4, P160, DOI 10.4161/nucl.24676; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; Espinosa-Cantu A, 2018, GENETICS, V208, P419, DOI 10.1534/genetics.117.300377; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Jeffery CJ, 2017, SCI PROGRESS-UK, V100, P363, DOI 10.3184/003685017X15063357842574; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KLEINSCH.AK, 1969, SCIENCE, V166, P1276, DOI 10.1126/science.166.3910.1276; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Lynch EM, 2020, CURR OPIN CELL BIOL, V66, P28, DOI 10.1016/j.ceb.2020.04.006; Lynch EM, 2020, NAT STRUCT MOL BIOL, V27, P42, DOI 10.1038/s41594-019-0352-5; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2020, BIOL OPEN, V9, DOI 10.1242/bio.051110; Noree C, 2019, MOL BIOL CELL, V30, P2721, DOI 10.1091/mbc.E19-04-0224; Noree C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36719-z; Noree C, 2018, BIOL OPEN, V7, DOI 10.1242/bio.038307; Noree C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24586-7; Noree C, 2014, MOL BIOL CELL, V25, P2282, DOI 10.1091/mbc.E14-04-0912; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Park CK, 2020, NAT REV MOL CELL BIO, V21, P1, DOI 10.1038/s41580-019-0188-1; Park Chad K, 2019, Biophys Rev, V11, P927, DOI 10.1007/s12551-019-00602-6; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; Richards NGJ, 1998, ADV ENZYMOL RAMB, V72, P145; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Sun JG, 2020, J SUPERCOMPUT, V76, P4041, DOI 10.1007/s11227-017-2179-3; Webb BA, 2017, J CELL BIOL, V216, P2305, DOI 10.1083/jcb.201701084; Wilson MZ, 2013, CURR OPIN MICROBIOL, V16, P177, DOI 10.1016/j.mib.2013.03.008; Zhang SS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007737; Zhu W, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0587-z	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243742	10.1371/journal.pone.0243742	http://dx.doi.org/10.1371/journal.pone.0243742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347445	Green Published, gold			2022-12-26	WOS:000603071100005
J	Black, WD				Black, Wesley D.			A comparison of several media types and basic techniques used to assess outdoor airborne fungi in Melbourne, Australia	PLOS ONE			English	Article							VIABLE MOLD PROPAGULES; INDOOR AIR; ENUMERATION; ASSOCIATIONS; TEMPERATURE; SPECTRUM; SURFACE; HOUSES	Despite the recent increase in interest in indoor air quality regarding mould, there is no universally accepted standard media for the detection of airborne fungi, nor verification of many commonly used techniques. Commonly used media including malt-extract agar (MEA), Sabouraud dextrose agar (Sab), potato dextrose agar (PDA) with and without antibiotics chloramphenicol & gentamycin (CG) were compared for their suitability in detecting a range of airborne fungi by collecting 150 L outdoor air on a number of different days and seasons via an Anderson 400-hole sampler in suburban Melbourne, Australia. There was relatively little variation in mean numbers of colony forming units (CFU) and types of fungi recovered between MEA, PDA, Sab media groups relative to variation within each group. There was a significant difference between Sab, Dichloran-18% glycerol (DG18) and V8 (R) Original juice agar media, however. Antibiotics reliably prevented the growth of bacteria that typically interfered with the growth and appearance of fungal colonies. There was no significant evidence for a growth enhancing factor from potato, mineral supplements or various vegetable juices. Differing glucose concentrations had modest effects, showing a vague ideal at 2%-4% with peptone. Sanitisation of the aluminium Andersen 400-hole sampler top-plate by flame is possible, but not strictly required nor advisable. The use of SabCG as a standard medium was generally supported.	[Black, Wesley D.] Biotopia Environm Assessment, Melbourne, Vic, Australia		Black, WD (corresponding author), Biotopia Environm Assessment, Melbourne, Vic, Australia.	wesblack@biotopia.net.au		Black, Wesley/0000-0001-6611-4404	Biotopia Environmental Assessment Pty Ltd	Biotopia Environmental Assessment Pty Ltd	Biotopia Environmental Assessment Pty Ltd provided support in the form of salary and materials to author WDB. The specific roles of this author is articulated in the 'author contributions' section. The funder had no commercial or vested interests in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aktas YD, 2018, SCI TOTAL ENVIRON, V643, P1631, DOI 10.1016/j.scitotenv.2018.06.311; ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; [Anonymous], 2019, ATLAS CLIN FUNGI; [Anonymous], 2009, REV DIREITO SANITARI, V10, P264; [Anonymous], 2008, GUID ASS REM FUNG IN; [Anonymous], 2006, ASS CLEAN REST HVAC; [Anonymous], 2017, D22 ASTM INT, DOI [10.1520/D7658-17, DOI 10.1520/D7658-17]; [Anonymous], 2020, D22 ASTM INT, DOI [10.1520/D7391-20, DOI 10.1520/D7391-20]; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Aryal S, 2019, POTATO DEXTROSE AGAR; Bakke M, 2019, J Prev Med Hyg, V60, pE140, DOI 10.15167/2421-4248/jpmh2019.60.2.1122; Barnett HL., 1987, ILLUSTRATED GENERA I, V4; Baudisch C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-247; Biango-Daniels MN, 2018, FOOD MICROBIOL, V69, P89, DOI 10.1016/j.fm.2017.07.020; Borrego Sofia, 2012, ISRN Microbiol, V2012, P680598, DOI 10.5402/2012/680598; Broadwater D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51593-z; BRUCH MK, 1968, APPL MICROBIOL, V16, P1427, DOI 10.1128/AEM.16.9.1427-1428.1968; Chain E, 1940, LANCET, V2, P226; Chang PK, 2007, LETT APPL MICROBIOL, V44, P131, DOI 10.1111/j.1472-765X.2006.02056.x; Chew GL, 2003, ALLERGY, V58, P13, DOI 10.1034/j.1398-9995.2003.00013.x; de Hoog DS., 2000, ATLAS CLIN FUNGI; Deak T, 2001, INT J FOOD MICROBIOL, V67, P49, DOI 10.1016/S0168-1605(01)00449-4; EHRLICH J, 1947, SCIENCE, V106, P417, DOI 10.1126/science.106.2757.417; Environmental Health Division, 2014, REC BEST PRACT MOLD; Evans S, 2017, ISME J, V11, P176, DOI 10.1038/ismej.2016.96; Fekadu S, 2015, ETHIOP J HEALTH SCI, V25, P117, DOI 10.4314/ejhs.v25i2.3; George D., 2010, SPSS WINDOWS STEP ST, V10; Haig CW, 2016, J HOSP INFECT, V93, P242, DOI 10.1016/j.jhin.2016.03.017; Hargreaves M, 2003, SCI TOTAL ENVIRON, V312, P89, DOI 10.1016/S0048-9697(03)00169-4; Hayleeyesus SF, 2015, INT J HEALTH SCI-IJH, V9, P249; Hayleeyesus Samuel Fekadu, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS312, DOI 10.12980/APJTB.4.2014C807; HEATLEY NG, 1946, BRIT J EXP PATHOL, V27, P378; HENDRICKS CW, 1995, APPL ENVIRON MICROB, V61, P2016, DOI 10.1128/AEM.61.5.2016-2019.1995; Heseltine E., 2009, WHO GUID IND AIR QUA; Hesseltine C. W., 1973, Pure and Applied Chemistry, V35, P259, DOI 10.1351/pac197335030259; HOCKING AD, 1980, APPL ENVIRON MICROB, V39, P488, DOI 10.1128/AEM.39.3.488-492.1980; House of Representatives Standing Committee on Health Aged Care and Sport, 2018, AG CAR SPORT REP INQ; Hungin APS, 2013, ALIMENT PHARM THER, V38, P864, DOI 10.1111/apt.12460; IICRC, 2015, ANSI IICRC STAND REF; ISO, 2015, 1464412015 ISO; Jansen MLA, 2004, APPL ENVIRON MICROB, V70, P1956, DOI 10.1128/AEM.70.4.1956-1963.2004; Kazemian N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220556; Kleinheinz GT, 2006, MICROBIOL RES, V161, P367, DOI 10.1016/j.micres.2006.01.002; Labs Himedia, 2020, DICHL ROS BENG CHLOR; Lee YC, 1996, CORNEA, V15, P376, DOI 10.1097/00003226-199607000-00008; Lo VC, 2014, NANOMATERIALS-BASEL, V4, P827, DOI 10.3390/nano4030827; Lobanovska M, 2017, YALE J BIOL MED, V90, P135; Lonon M K, 1998, BIOAEROSOL SAMPLING; Macindoe I, 2012, P NATL ACAD SCI USA, V109, pE804, DOI 10.1073/pnas.1114052109; Mann EE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-28; Met One Instruments Inc, 2012, 804 PART COUNT FIN D; Met One Instruments Inc, 2012, 831 AER MASS MON DAT; Multon J.L., 1985, PROPERTIES WATER FOO, P273, DOI DOI 10.1007/978-94-009-5103-7_17; Najotra Dipender Kaur, 2017, Int J Appl Basic Med Res, V7, P165, DOI 10.4103/ijabmr.IJABMR_281_16; Neumeister-Kemp H, 2010, AUSTR MOULD GUIDELIN; Nieguitsila A, 2011, ENVIRON RES, V111, P248, DOI 10.1016/j.envres.2010.12.005; Pinto F, 2009, LETT APPL MICROBIOL, V48, P379, DOI 10.1111/j.1472-765X.2008.02534.x; PromptCare, 2014, PROBL FOGG US BIOC M; Rao CY, 1996, J AIR WASTE MANAGE, V46, P899, DOI 10.1080/10473289.1996.10467526; Rieux A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103225; Salas ML, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030037; Scott Jane Margaret, 2001, THESIS; Segers FJJ, 2016, APPL ENVIRON MICROB, V82, P5089, DOI 10.1128/AEM.00510-16; Shama G, 2013, INT J HYG ENVIR HEAL, V216, P115, DOI 10.1016/j.ijheh.2012.03.009; Shannon MW, 2006, PEDIATRICS, V118, P2582, DOI 10.1542/peds.2006-2828; Stetzenbach L, 2004, MICR MOLD IND AIR QU; Sylvain IA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213355; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Uppala SS, 2019, PLANT DIS, V103, P504, DOI [10.1094/PDIS-05-18-0814-RE, 10.1094/pdis-05-18-0814-re]; Urbez-Torres JR, 2010, PLANT DIS, V94, P1476, DOI 10.1094/PDIS-06-10-0423; US EPA I, 2008, MOLD REM SCH COMM BU; VERHOEFF AP, 1990, ALLERGY, V45, P275, DOI 10.1111/j.1398-9995.1990.tb00496.x; VERHOEFF AP, 1992, ALLERGY, V47, P83, DOI 10.1111/j.1398-9995.1992.tb05093.x; WEI CI, 1985, J FOOD PROTECT, V48, P316, DOI 10.4315/0362-028X-48.4.316; Wirth Fernanda, 2012, Interdiscip Perspect Infect Dis, V2012, P465717, DOI 10.1155/2012/465717; Woo Koan Sik, 2015, Prev Nutr Food Sci, V20, P102, DOI 10.3746/pnf.2015.20.2.102; Wu SM, 2019, MAR DRUGS, V17, DOI 10.3390/md17040199; 2019, MICROBIOME, V7, P1	79	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0238901	10.1371/journal.pone.0238901	http://dx.doi.org/10.1371/journal.pone.0238901			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338037	Green Submitted, gold, Green Published			2022-12-26	WOS:000601313500021
J	Jittikoon, J; Sangroongruangsri, S; Thavorncharoensap, M; Chitpim, N; Chaikledkaew, U				Jittikoon, Jiraphun; Sangroongruangsri, Sermsiri; Thavorncharoensap, Montarat; Chitpim, Natthakan; Chaikledkaew, Usa			Economic impact of medical genetic testing on clinical applications in Thailand	PLOS ONE			English	Article							HEALTH	Background Although the clinical benefits of medical genetic testing have been proven, there has been limited evidence on its economic impact in Thai setting. Thus, this study aimed to evaluate the economic impact of genetic testing services provided by the Center for Medical Genomics (CMG) in Thailand. Methods Cost-benefit analysis was conducted from provider and societal perspectives. Cost and output data of genetic testing services provided by the CMG during 2014 to 2018 and published literature reviews were applied to estimate the costs and benefits. Monetary benefits related to genetic testing services were derived through human capital approach. Results The total operation cost was 126 million baht over five years with an average annual cost of 21 million baht per year. The net benefit, benefit-to-cost ratio, and return on investment were 5,477 million baht, 43 times, and 42 times, respectively. Productivity gain was the highest proportion (50.57%) of the total benefit. Conclusions The provision of genetic testing services at the CMG gained much more benefits than the cost. This study highlighted a good value for money in the establishment of medical genomics settings in Thailand and other developing countries.	[Jittikoon, Jiraphun] Mahidol Univ, Dept Biochem, Fac Pharm, Bangkok, Thailand; [Sangroongruangsri, Sermsiri; Thavorncharoensap, Montarat; Chaikledkaew, Usa] Mahidol Univ, Social Adm Pharm Div, Dept Pharm, Fac Pharm, Bangkok, Thailand; [Thavorncharoensap, Montarat; Chaikledkaew, Usa] Mahidol Univ, Mahidol Univ Hlth Technol Assessment MUHTA Grad P, Bangkok, Thailand; [Chitpim, Natthakan] Mahidol Univ, Dept Pharm, Social Econ & Adm Pharm SEAP Grad Program, Fac Pharm, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Chaikledkaew, U (corresponding author), Mahidol Univ, Social Adm Pharm Div, Dept Pharm, Fac Pharm, Bangkok, Thailand.; Chaikledkaew, U (corresponding author), Mahidol Univ, Mahidol Univ Hlth Technol Assessment MUHTA Grad P, Bangkok, Thailand.	usa.chi@mahidol.ac.th		Sangroongruangsri, Sermsiri/0000-0002-5222-8694	Thailand Center of Excellence for Life Sciences (TCELS); International Research Network of the Thailand Research Fund [IRN60W003]	Thailand Center of Excellence for Life Sciences (TCELS); International Research Network of the Thailand Research Fund	This work was supported by the Thailand Center of Excellence for Life Sciences (TCELS) and the International Research Network of the Thailand Research Fund (grant no. IRN60W003). The findings, interpretations, and conclusions expressed in this article do not necessarily reflect the views of the funding agency.	[Anonymous], 2013, NAT REV MICROBIOL, V11, P1, DOI 10.1038/nrmicro2948; Becker F, 2011, EUR J HUM GENET, V19, pS6, DOI 10.1038/ejhg.2010.249; Bureau of AIDS TB and STIs, 2013, HLTH BEN PACK PAT HI; Forero DA, 2016, J MED GENET, V53, P438, DOI 10.1136/jmedgenet-2015-103631; Human Genetics Chronic Diseases and Health Promotion World Health Organization., 2006, CHRON DIS HLTH PROM; McElreavey K, 2005, Community Genet, V8, P130, DOI 10.1159/000084784; OECD, 2013, OECD SCI TECHNOLOGY, V8, DOI 10.1787/5k424rdzj3bx-en; Seguin B, 2008, NAT REV GENET, V9, pS14, DOI 10.1038/nrg2443; Shao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082446; Teeraananchai S, 2017, ANTIVIR THER, V22, P393, DOI 10.3851/IMP3121; Vogenberg F Randy, 2010, P T, V35, P560; Working Group on the Guidelines for Health Technology Assessment in Thailand, 2013, GUID HLTH TECHN ASS GUID HLTH TECHN ASS, V2; Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010508	13	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243934	10.1371/journal.pone.0243934	http://dx.doi.org/10.1371/journal.pone.0243934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338033	Green Published, gold			2022-12-26	WOS:000601313500020
J	Alex, CE; Fahsbender, E; Altan, E; Bildfell, R; Wolff, P; Jin, L; Black, W; Jackson, K; Woods, L; Munk, B; Tse, T; Delwart, E; Pesavento, PA				Alex, Charles E.; Fahsbender, Elizabeth; Altan, Eda; Bildfell, Robert; Wolff, Peregrine; Jin, Ling; Black, Wendy; Jackson, Kenneth; Woods, Leslie; Munk, Brandon; Tse, Tiffany; Delwart, Eric; Pesavento, Patricia A.			Viruses in unexplained encephalitis cases in American black bears (Ursus americanus)	PLOS ONE			English	Article							TORQUE TENO VIRUS; TT VIRUS; CIRCOVIRUS; INFECTION; PIGS; PREVALENCE; VASCULITIS; HEPATITIS; TISSUES; ARCTOS	Viral infections were investigated in American black bears (Ursus americanus) from Nevada and northern California with and without idiopathic encephalitis. Metagenomics analyses of tissue pools revealed novel viruses in the genera Circoviridae, Parvoviridae, Anelloviridae, Polyomaviridae, and Papillomaviridae. The circovirus and parvovirus were of particular interest due to their potential importance as pathogens. We characterized the genomes of these viruses and subsequently screened bears by PCR to determine their prevalence. The circovirus (Ursus americanus circovirus, UaCV) was detected at a high prevalence (10/16, 67%), and the chaphamaparvovirus (Ursus americanus parvovirus, UaPV) was found in a single bear. We showed that UaCV is present in liver, spleen/lymph node, and brain tissue of selected cases by in situ hybridization (ISH) and PCR. Infections were detected in cases of idiopathic encephalitis and in cases without inflammatory brain lesions. Infection status was not clearly correlated with disease, and the significance of these infections remains unclear. Given the known pathogenicity of a closely related mammalian circovirus, and the complex manifestations of circovirus-associated diseases, we suggest that UaCV warrants further study as a possible cause or contributor to disease in American black bears.	[Alex, Charles E.; Jackson, Kenneth; Tse, Tiffany; Pesavento, Patricia A.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Fahsbender, Elizabeth; Altan, Eda; Delwart, Eric] Vitalant Res Inst, San Francisco, CA USA; [Fahsbender, Elizabeth; Altan, Eda; Delwart, Eric] Univ Calif San Diego, Dept Lab Med, San Francisco, CA USA; [Bildfell, Robert; Jin, Ling] Oregon State Univ, Carlson Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Bildfell, Robert; Jin, Ling; Black, Wendy] Oregon State Univ, Carlson Coll Vet Med, Oregon Vet Diagnost Lab, Corvallis, OR USA; [Wolff, Peregrine] Nevada Dept Wildlife, Reno, NV USA; [Woods, Leslie] Calif Anim Hlth & Food Safety Lab, Davis, CA USA; [Munk, Brandon] Calif Dept Fish & Wildlife, Rancho Cordova, CA USA	University of California System; University of California Davis; Vitalant; Vitalant Research Institute; University of California System; University of California San Diego; Oregon State University; Oregon State University	Pesavento, PA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	papesavento@ucdavis.edu	Altan, Eda/W-4368-2017; Altan, Eda/AAK-3420-2021	Altan, Eda/0000-0001-7903-6986; Altan, Eda/0000-0001-7903-6986				Bard SM, 2019, J WILDLIFE DIS, V55, P745, DOI 10.7589/2018-12-286; Black W, 2019, VIRUS RES, V259, P46, DOI 10.1016/j.virusres.2018.10.016; Breitbart M, 2017, J GEN VIROL, V98, P1997, DOI 10.1099/jgv.0.000871; Bronson E, 2014, J WILDLIFE DIS, V50, P829, DOI 10.7589/2013-07-155; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Christensen JK, 2000, J INFECT DIS, V181, P1796, DOI 10.1086/315440; Cottrell WO, 2013, J WILDLIFE DIS, V49, P1024, DOI 10.7589/2013-02-027; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002; Devalle S, 2009, ARCH VIROL, V154, P1285, DOI 10.1007/s00705-009-0440-7; FAHSBENDER E, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11050398; Garshelis D.L., 2016, IUCN RED LIST THREAT, DOI [DOI 10.2305/IUCN.UK.2016-3.RLTS.T41687A45034604.EN, 10.2305/IUCN.UK.2016-3.RLTS.T41687A45034604]; Kekarainen T, 2012, TRANSBOUND EMERG DIS, V59, P103, DOI 10.1111/j.1865-1682.2011.01289.x; Knowles S, 2018, J WILDLIFE DIS, V54, P642, DOI 10.7589/2017-10-245; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Li LL, 2013, EMERG INFECT DIS, V19, P534, DOI 10.3201/eid1904.121390; Madsen Chris D, 2002, HIV Clin Trials, V3, P287; Manzin A, 2015, J INFECT DEV COUNTR, V9, P562, DOI 10.3855/jidc.6912; Meng XJ, 2013, ANNU REV ANIM BIOSCI, V1, P43, DOI 10.1146/annurev-animal-031412-103720; Niedringhaus KD, 2019, VET SCI, V6, DOI 10.3390/vetsci6040075; PENZES JJ, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11060525; Penzes JJ, 2020, ARCH VIROL, V165, P2133, DOI 10.1007/s00705-020-04632-4; Ramey AM, 2019, J WILDLIFE DIS, V55, P576, DOI 10.7589/2018-07-173; Resendes AR, 2015, VET PATHOL, V52, P497, DOI 10.1177/0300985814540542; Roediger B, 2018, CELL, V175, P530, DOI 10.1016/j.cell.2018.08.013; Rosell C, 2000, VET PATHOL, V37, P687, DOI 10.1354/vp.37-6-687; Schaffer AA, 2018, BIOINFORMATICS, V34, P755, DOI 10.1093/bioinformatics/btx669; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Seeliger FA, 2007, VET PATHOL, V44, P621, DOI 10.1354/vp.44-5-621; Shibayama T, 2001, AIDS, V15, P563, DOI 10.1097/00002030-200103300-00004; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Stephenson N, 2015, VECTOR-BORNE ZOONOT, V15, P116, DOI 10.1089/vbz.2014.1671; Thom K, 2007, J MED VIROL, V79, P1, DOI 10.1002/jmv.20756; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Watanabe Toru, 2015, World J Clin Pediatr, V4, P126, DOI 10.5409/wjcp.v4.i4.126; Wohlsein P, 2011, VET MICROBIOL, V149, P456, DOI 10.1016/j.vetmic.2010.11.024	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244056	10.1371/journal.pone.0244056	http://dx.doi.org/10.1371/journal.pone.0244056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332429	Green Published, gold			2022-12-26	WOS:000601310900042
J	Smaoui, MR; Rabasa-Lhoret, R; Haidar, A				Smaoui, Mohamed Raef; Rabasa-Lhoret, Remi; Haidar, Ahmad			Development platform for artificial pancreas algorithms	PLOS ONE			English	Article							GLYCEMIC CONTROL; CARDIOVASCULAR-DISEASE; SEVERE HYPOGLYCEMIA; INSULIN DELIVERY; GLUCOSE; THERAPY	Background and aims Assessing algorithms of artificial pancreas systems is critical in developing automated and fault-tolerant solutions that work outside clinical settings. The development and evaluation of algorithms can be facilitated with a platform that conducts virtual clinical trials. We present in this paper a clinically validated cloud-based distributed platform that supports the development and comprehensive testing of single and dual-hormone algorithms for type 1 diabetes mellitus (T1DM). Methods The platform is built on principles of object-oriented design and runs user algorithms in real-time virtual clinical trials utilizing a multi-threaded environment enabled by concurrent execution over a cloud infrastructure. The platform architecture isolates user algorithms located on personal machines from proprietary patient data running on the cloud. Users import a plugin into their algorithms (Matlab, Python, or Java) to connect to the platform. Once connected, users interact with a graphical interface to design experimental protocols for their trials. Protocols include trial duration in days, mealtimes and amounts, variability in mealtimes and amounts, carbohydrate counting errors, snacks, and onboard insulin levels. Results The platform facilitates development by solving the ODE model in the cloud on large CPU-optimized machines, providing a 62% improvement in memory, speed and CPU utilization. Users can easily debug & modify code, test multiple strategies, and generate detailed clinical performance reports. We validated and integrated into the platform a glucoregulatory system of ordinary differential equations (ODEs) parameterized with clinical data to mimic the inter and intra-day variability of glucose responses of 15 T1DM patients. Conclusion The platform utilizes the validated patient model to conduct virtual clinical trials for the rapid development and testing of closed-loop algorithms for T1DM.	[Smaoui, Mohamed Raef] Kuwait Univ, Fac Sci, Dept Comp Sci, Kuwait, Kuwait; [Rabasa-Lhoret, Remi] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ, Canada; [Rabasa-Lhoret, Remi] Inst Rech Clin Montreal, Montreal, PQ, Canada; [Haidar, Ahmad] McGill Univ, Fac Med, Dept Biomed Engn, Montreal, PQ, Canada	Kuwait University; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University	Smaoui, MR (corresponding author), Kuwait Univ, Fac Sci, Dept Comp Sci, Kuwait, Kuwait.	msmaoui@cs.ku.edu.kw	Smaoui, Mohamed Raef/GQZ-4457-2022	Smaoui, Mohamed Raef/0000-0002-8891-7926				American Diabetes Association, 2001, Diabetes Care, V24, P775; [Anonymous], 1999, IZV VYSSH ZAVED MAT, V1, P41; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Brown Sue A, 2015, J Diabetes Sci Technol, V9, P1192, DOI 10.1177/1932296815608400; Chase HP, 2001, DIABETES CARE, V24, P430, DOI 10.2337/diacare.24.3.430; Cobelli Claudio, 2009, IEEE Rev Biomed Eng, V2, P54, DOI 10.1109/RBME.2009.2036073; El Fathi A, 2018, IEEE CONTR SYST MAG, V38, P67, DOI 10.1109/MCS.2017.2766323; El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619; Elleri D, 2013, DIABETOLOGIA, V56, P1108, DOI 10.1007/s00125-013-2852-x; Elleri D, 2013, DIABETES CARE, V36, P838, DOI 10.2337/dc12-0816; Ellingsen Christian, 2009, J Diabetes Sci Technol, V3, P536; Emami A, 2017, IEEE J BIOMED HEALTH, V21, P1163, DOI 10.1109/JBHI.2016.2593630; George P, 2013, DIABETIC MED, V30, P179, DOI 10.1111/j.1464-5491.2012.03744.x; Goudie RJB, 2014, DIABETES CARE, V37, pE121, DOI 10.2337/dc13-2535; Gruden G, 2012, DIABETES CARE, V35, P1598, DOI 10.2337/dc11-1531; Haidar A, 2016, LANCET DIABETES ENDO, V4, P476, DOI 10.1016/S2213-8587(16)30006-7; Haidar A, 2015, LANCET DIABETES ENDO, V3, P17, DOI 10.1016/S2213-8587(14)70226-8; Haidar Ahmad, 2013, J Diabetes Sci Technol, V7, P1507; Haidar A, 2013, IEEE T BIO-MED ENG, V60, P3524, DOI 10.1109/TBME.2013.2272736; Haidar A, 2013, CAN MED ASSOC J, V185, P297, DOI 10.1503/cmaj.121265; Hovorka R, 2002, AM J PHYSIOL-ENDOC M, V282, pE992, DOI 10.1152/ajpendo.00304.2001; Hovorka R, 2008, PHYSIOL MEAS, V29, P959, DOI 10.1088/0967-3334/29/8/008; Hovorka R, 2006, DIABETES RES CLIN PR, V74, pS178, DOI 10.1016/S0168-8227(06)70027-4; Hovorka R, 2011, NAT REV ENDOCRINOL, V7, P385, DOI 10.1038/nrendo.2011.32; KADISH AH, 1963, T AM SOC ART INT ORG, V9, P363; Kanderian Sami S, 2009, J Diabetes Sci Technol, V3, P1047; Kielgast U, 2011, DIABETES CARE, V34, P1463, DOI 10.2337/dc11-0096; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; Kropff J, 2015, LANCET DIABETES ENDO, V3, P939, DOI 10.1016/S2213-8587(15)00335-6; Leelarathna L, 2013, DIABETES TECHNOL THE, V15, P143, DOI 10.1089/dia.2012.0245; Lehmann Eldon D, 2003, Diabetes Technol Ther, V5, P425, DOI 10.1089/152091503765691938; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Man Chiara Dalla, 2014, J Diabetes Sci Technol, V8, P26; Miller S, 2011, DIABETES TECHNOL THE, V13, P983, DOI 10.1089/dia.2010.0216; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nimri R, 2014, DIABETES CARE, V37, P3025, DOI 10.2337/dc14-0835; Nisly SA, 2013, AM J HEALTH-SYST PH, V70, P311, DOI 10.2146/ajhp110514; Oviedo S, 2019, INT J MED INFORM, V126, P1, DOI 10.1016/j.ijmedinf.2019.03.008; Riddell Michael C, 2015, J Diabetes Sci Technol, V9, P1217, DOI 10.1177/1932296815609370; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Scavone G, 2010, DIABETIC MED, V27, P477, DOI 10.1111/j.1464-5491.2010.02963.x; Sharan K., 2015, MODEL VIEW CONTROLLE; Steil GM, 2011, J CLIN ENDOCR METAB, V96, P1402, DOI 10.1210/jc.2010-2578; Tansey MJ, 2006, DIABETES CARE, V29, P20; Thabit H, 2015, NEW ENGL J MED, V373, P2129, DOI 10.1056/NEJMoa1509351; Toffanin Chiara, 2013, J Diabetes Sci Technol, V7, P1470; Van Herpe T, 2006, PHYSIOL MEAS, V27, P1057, DOI [10.1088/0967-3334/37/11/001, 10.1088/0967-3334/27/11/001]; Visentin R, 2014, DIABETES TECHNOL THE, V16, P428, DOI 10.1089/dia.2013.0377; Weaver J., 2007, JAVAFX SCRIPT DYNAMI; Wilinska Malgorzata E, 2010, J Diabetes Sci Technol, V4, P132	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243139	10.1371/journal.pone.0243139	http://dx.doi.org/10.1371/journal.pone.0243139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332411	Green Published, gold			2022-12-26	WOS:000601310900050
J	Webb, SJN; Schapiro, SJ; Sherwood, CC; Raghanti, MA; Hopkins, WD				Webb, Sarah J. Neal; Schapiro, Steven J.; Sherwood, Chet C.; Raghanti, Mary Ann; Hopkins, William D.			Neutrophil to Lymphocyte Ratio (NLR) in captive chimpanzees (Pan troglodytes): The effects of sex, age, and rearing	PLOS ONE			English	Article							ALLOSTATIC LOAD; DISEASE; STRESS; PLATELET; OUTCOMES; HUMANS; MARKER; CANCER	In humans, neutrophil to lymphocyte ratio (NLR) has been used as a clinical tool in diagnosis and/or prognosis of a variety of cancers and medical conditions, as well as in measuring physiological stress over time. Given the close phylogenetic relationship and physical similarities between humans and apes, NLR may similarly be a useful diagnostic tool in assessing chimpanzee health. Only one study has examined NLR in apes, reporting that NLR increased with age and was affected by body-mass index and sex. In the current study, we examined changes in NLR data from longitudinal health records for 443 chimpanzees in two captive chimpanzee populations. Using these data, we analyzed intra-individual changes and inter-individual differences in NLR as a function of age, rearing history, and sex. Contrary to previous studies in humans and the one previous study in chimpanzees, NLR values did not change over a 10-year timespan within individual chimpanzees. However, cross-sectional comparisons revealed a significant quadratic relationship between age and NLR, with the highest values during mid-life (20-30 years of age) and the lowest values in younger and older individuals. Additionally, males and mother-reared individuals had higher NLR than females and nursery-reared chimpanzees, respectively. Lastly, males and those with higher NLR values died at younger ages. These findings suggest that NLR may be useful as a predictor of longevity in chimpanzees. However, given the complexities of these relationships, more research is needed to determine the utility of NLR as a diagnostic health tool for chimpanzees.	[Webb, Sarah J. Neal; Schapiro, Steven J.; Hopkins, William D.] Univ Texas MD Anderson Canc Ctr, Michale Keeling Ctr Comparat Med & Res, Natl Ctr Chimpanzee Care, Bastrop, TX 78602 USA; [Schapiro, Steven J.] Univ Copenhagen, Dept Expt Med, Copenhagen, Denmark; [Sherwood, Chet C.] George Washington Univ, Dept Anthropol, Washington, DC USA; [Sherwood, Chet C.] George Washington Univ, Ctr Adv Study Human Paleobiol, Washington, DC USA; [Raghanti, Mary Ann] Kent State Univ, Dept Anthropol, Sch Biomed Sci, Kent, OH 44242 USA; [Raghanti, Mary Ann] Kent State Univ, Brain Hlth Res Inst, Kent, OH 44242 USA	University of Texas System; UTMD Anderson Cancer Center; University of Copenhagen; George Washington University; George Washington University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Webb, SJN (corresponding author), Univ Texas MD Anderson Canc Ctr, Michale Keeling Ctr Comparat Med & Res, Natl Ctr Chimpanzee Care, Bastrop, TX 78602 USA.	sjneal@mdanderson.org		Neal Webb, Sarah/0000-0001-9393-3528	Office of Research Infrastructure Programs (ORIP) and Office of the Director (OD) [ORIP/OD P51OD011132];  [U42-OD011197]	Office of Research Infrastructure Programs (ORIP) and Office of the Director (OD); 	The National Center for Chimpanzee Care chimpanzees are supported by Cooperative Agreement U42-OD011197. The Yerkes chimpanzees are supported by the Office of Research Infrastructure Programs (ORIP) and Office of the Director (OD) ORIP/OD P51OD011132.	[Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2016, CANC DISCOV; [Anonymous], 2017, INADEQUATE HAND OFF, V58, P1; Association AVM, 2020, AVMA GUIDELINES EUTH; Azab B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112361; Baldessari A, 2013, PATHOBIOL AGING AGE, V3, DOI 10.3402/pba.v3i0.21073; BARD KA, 1992, INFANT BEHAV DEV, V15, P43, DOI 10.1016/0163-6383(92)90005-Q; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Capitanio J.P., 2006, NURSERY REARING NONH, P191, DOI [10.1007/978-0-387-25640-5_11, DOI 10.1007/978-0-387-25640-5_11]; Chmielewski PP, 2016, ANN ANAT, V204, P1, DOI 10.1016/j.aanat.2015.09.002; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Council NR, 1997, CHIMPANZEES RES STRA, P38; Davis JL, 2016, BIOMARK MED, V10, P953, DOI 10.2217/bmm-2016-0103; Doane CJ, 2006, COMPARATIVE MED, V56, P512; DYKE B, 1995, AM J PRIMATOL, V37, P25, DOI 10.1002/ajp.1350370104; Edes AN, 2017, AM J PHYS ANTHROPOL, V162, P44, DOI 10.1002/ajpa.23146; Edler MK, 2017, NEUROBIOL AGING, V59, P107, DOI 10.1016/j.neurobiolaging.2017.07.006; Ely JJ, 2013, ZOO BIOL, V32, P79, DOI 10.1002/zoo.21044; Ethier JL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0794-1; Forget Patrice, 2017, BMC Res Notes, V10, P12, DOI 10.1186/s13104-016-2335-5; Guevara EE, PHILOS T ROYAL SOC B; Hajibandeh S, 2020, AM J SURG, V219, P154, DOI 10.1016/j.amjsurg.2019.04.018; Han CQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10516-6; Howell S, 2003, COMPARATIVE MED, V53, P413; Hwang SY, 2017, AM J EMERG MED, V35, P234, DOI 10.1016/j.ajem.2016.10.055; Jeon TJ, 2017, WORLD J GASTROENTERO, V23, P3883, DOI 10.3748/wjg.v23.i21.3883; Jiang JW, 2019, AM J EMERG MED, V37, P1482, DOI [10.1016/j.ajem.2018.10.057, 10.1016/ajem.2018.10.057]; Karatas MB, 2016, ACTA CARDIOL SIN, V32, P313, DOI 10.6515/ACS20151013A; Kos Fahriye Tugba, 2015, Asian Pac J Cancer Prev, V16, P3997; Kuyumcu ME, 2012, DEMENT GERIATR COGN, V34, P69, DOI 10.1159/000341583; Lambeth SP, 2013, ANIM WELFARE, V22, P429, DOI 10.7120/09627286.22.4.429; Lammey ML, 2008, COMPARATIVE MED, V58, P389; Lammey ML, 2008, J MED PRIMATOL, V37, P39, DOI 10.1111/j.1600-0684.2007.00260.x; Li J, 2015, J CLIN LAB ANAL, V29, P437, DOI 10.1002/jcla.21791; Lin BD, 2016, BIOMARK MED, V10, P1061, DOI 10.2217/bmm-2016-0147; Lowenstine LJ, 2016, VET PATHOL, V53, P250, DOI 10.1177/0300985815612154; Lubach GR, 2006, NURSERY REARING NONH, P135; Madgen E, 2017, HDB PRIMATE BEHAV MA, P201; Maestripieri D, 2011, DEV PSYCHOPATHOL, V23, P1187, DOI 10.1017/S0954579411000551; Malietzis G, 2014, ANN SURG ONCOL, V21, P3938, DOI 10.1245/s10434-014-3815-2; Nunamaker EA, 2012, COMPARATIVE MED, V62, P131; Obanda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104602; Peng B, 2015, INT J CLIN EXP MED, V8, P3098; Proctor MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116206; Rembach A, 2014, J NEUROIMMUNOL, V273, P65, DOI 10.1016/j.jneuroim.2014.05.005; Sackett GP, 2006, DEV PRIMATOL; Sholl J, 2020, BIOGERONTOLOGY, V21, P399, DOI 10.1007/s10522-020-09872-0; Spinelli S, 2009, ARCH GEN PSYCHIAT, V66, P658, DOI 10.1001/archgenpsychiatry.2009.52; Strong VJ, 2016, J ZOO WILDLIFE MED, V47, P697; Varki N, 2009, EVOL APPL, V2, P101, DOI 10.1111/j.1752-4571.2008.00064.x; Videan EN, 2009, COMPARATIVE MED, V59, P287; Wang F, 2019, CNS NEUROSCI THER, V25, P30, DOI 10.1111/cns.12977; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	53	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244092	10.1371/journal.pone.0244092	http://dx.doi.org/10.1371/journal.pone.0244092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326497	Green Published, gold, Green Submitted			2022-12-26	WOS:000600176400034
J	Teh, K; Armitage, P; Tesfaye, S; Selvarajah, D; Wilkinson, ID				Teh, Kevin; Armitage, Paul; Tesfaye, Solomon; Selvarajah, Dinesh; Wilkinson, Iain D.			Imbalanced learning: Improving classification of diabetic neuropathy from magnetic resonance imaging	PLOS ONE			English	Article							MACHINE; SMOTE; SEGMENTATION; ACCURATE	One of the fundamental challenges when dealing with medical imaging datasets is class imbalance. Class imbalance happens where an instance in the class of interest is relatively low, when compared to the rest of the data. This study aims to apply oversampling strategies in an attempt to balance the classes and improve classification performance. We evaluated four different classifiers from k-nearest neighbors (k-NN), support vector machine (SVM), multilayer perceptron (MLP) and decision trees (DT) with 73 oversampling strategies. In this work, we used imbalanced learning oversampling techniques to improve classification in datasets that are distinctively sparser and clustered. This work reports the best oversampling and classifier combinations and concludes that the usage of oversampling methods always outperforms no oversampling strategies hence improving the classification results.	[Teh, Kevin; Armitage, Paul; Wilkinson, Iain D.] Univ Sheffield, Acad Unit Radiol, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Tesfaye, Solomon; Selvarajah, Dinesh] Sheffield Teaching Hosp NHS Fdn Trust, Diabet Res Dept, Sheffield, S Yorkshire, England; [Selvarajah, Dinesh] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Teh, K (corresponding author), Univ Sheffield, Acad Unit Radiol, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England.	k.teh@sheffield.ac.uk		Selvarajah, Dinesh/0000-0001-7426-1105; Tesfaye, Solomon/0000-0003-1190-1472; Teh, Kevin/0000-0003-2538-5157				Akbani R., 2004, EUR C MACH LEARN; Albers JW, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0473-5; Barua Sukarna, 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference (PAKDD 2013). Proceedings, P317, DOI 10.1007/978-3-642-37456-2_27; Bastyr EJ, 2005, CLIN THER, V27, P1278, DOI 10.1016/j.clinthera.2005.08.002; Batuwita R, 2010, IEEE T FUZZY SYST, V18, P558, DOI 10.1109/TFUZZ.2010.2042721; Bunkhumpornpat C, 2013, 2013 13 INT S COMM I; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen S, 2010, 2010 IEEE 24 INT C A; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Darasay B., 1991, NEAREST NEIGHBOR PAT; Fernandez A, 2018, J ARTIF INTELL RES, V61, P863, DOI 10.1613/jair.1.11192; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fotouhi S, 2019, J BIOMED INFORM, V90, DOI 10.1016/j.jbi.2018.12.003; Gazzah S, 2008, PROCEEDINGS OF THE 8TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS, P677, DOI 10.1109/DAS.2008.74; Gu Q, 2009, INT S INT COMP APPL; Guo HX, 2017, EXPERT SYST APPL, V73, P220, DOI 10.1016/j.eswa.2016.12.035; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han H., 2005, INT C INT COMP; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Jeni LA, 2013, INT CONF AFFECT, P245, DOI 10.1109/ACII.2013.47; Jurgovsky J, 2018, EXPERT SYST APPL, V100, P234, DOI 10.1016/j.eswa.2018.01.037; KNOWLER WC, 1981, AM J EPIDEMIOL, V113, P144, DOI 10.1093/oxfordjournals.aje.a113079; Koto F, 2014, INT C ADV COMP SCI I, P280, DOI 10.1109/ICACSIS.2014.7065849; Kovacs G., 2019, NEUROCOMPUTING; Kovacs G, 2019, APPL SOFT COMPUT, V83, DOI 10.1016/j.asoc.2019.105662; Krawczyk B, 2016, APPL SOFT COMPUT, V38, P714, DOI 10.1016/j.asoc.2015.08.060; Kukar M, 1998, COST SENSITIVE LEARN; Lee J, 2015, P 9 INT C UB INF MAN; Lomax S, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431215; Lopez V, 2014, INFORM SCIENCES, V257, P1, DOI 10.1016/j.ins.2013.09.038; Moro R, 2008, SUPPORT VECTOR MACHI; Nekooeimehr I, 2016, EXPERT SYST APPL, V46, P405, DOI 10.1016/j.eswa.2015.10.031; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qi ZQ, 2013, PROCEDIA COMPUT SCI, V18, P1684, DOI 10.1016/j.procs.2013.05.336; Raeder T, 2012, INTEL SYST REF LIBR, V23, P315; Ramentol E, 2016, ENG APPL ARTIF INTEL, V48, P134, DOI 10.1016/j.engappai.2015.10.009; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Saez JA, 2015, INFORM SCIENCES, V291, P184, DOI 10.1016/j.ins.2014.08.051; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Selvarajah D, 2011, CURR DIABETES REP, V11, P310, DOI 10.1007/s11892-011-0205-z; Sun YM, 2007, PATTERN RECOGN, V40, P3358, DOI 10.1016/j.patcog.2007.04.009; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilkinson ID, 2013, CURR DIABETES REP, V13, P509, DOI 10.1007/s11892-013-0394-8; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147; Zheng Z., 2004, ACM SIGKDD EXPLOR NE, V6, P80, DOI [10.1145/1007730.1007741, DOI 10.1145/1007730.1007741]; Zhou B, 2013, IEEE IJCNN, DOI 10.1109/CLEOE-IQEC.2013.6801089	55	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243907	10.1371/journal.pone.0243907	http://dx.doi.org/10.1371/journal.pone.0243907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320890	Green Accepted, Green Published, gold			2022-12-26	WOS:000600339800016
J	Altonen, BL; Arreglado, TM; Leroux, O; Murray-Ramcharan, M; Engdahl, R				Altonen, Brian L.; Arreglado, Tatiana M.; Leroux, Ofelia; Murray-Ramcharan, Max; Engdahl, Ryan			Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City	PLOS ONE			English	Article							INTERRATER RELIABILITY; OUTCOMES; CHILDREN; PREDICT; DISEASE; INDEX; SCORE	This study reviewed 395 young adults, 18-35 year-old, admitted for COVID-19 to one of the eleven hospitals in New York City public health system. Demographics, comorbidities, clinical course, outcomes and characteristics linked to hospitalization were analyzed including temporal survival analysis. Fifty-seven percent of patients had a least one major comorbidity. Mortality without comorbidity was in 3.8% patients. Further investigation of admission features and medical history was conducted. Comorbidities associated with mortality were diabetes (n = 54 deceased/73 diagnosed,74% tested POS;98.2% with diabetic history deceased; Wilcoxon p (Wp) = .044), hypertension (14/44,32% POS, 25.5%; Wp = 0.030), renal (6/16, 37.5% POS,11%; Wp = 0.000), and cardiac (6/21, 28.6% POS,11%; Wp = 0.015). Kaplan survival plots were statistically significant for these four indicators. Data suggested glucose >215 or hemoglobin A1c >9.5 for young adults on admission was associated with increased mortality. Clinically documented respiratory distress on admission was statistically significant outcome related to mortality (X-2 = 236.6842, df = 1, p < .0001). Overall, 28.9% required supportive oxygen beyond nasal cannula. Nasal cannula oxygen alone was required for 71.1%, who all lived. Non-invasive ventilation was required for 7.8%, and invasive mechanical ventilation 21.0% (in which 7.3% lived, 13.7% died). Temporal survival analysis demonstrated statistically significant response for Time to Death <10 days (X-2 = 18.508, df = 1, p = .000); risk lessened considerably for 21 day cut off (X-2 = 3.464, df = 1, p = .063), followed by 31 or more days of hospitalization (X-2 = 2.212, df = 1, p = .137).	[Altonen, Brian L.] NYC Hlth Hosp, Div Populat Hlth & Res Adm, New York, NY USA; [Arreglado, Tatiana M.] NYC Hlth Hosp, Harlem Hosp, Div Clin Informat, New York, NY USA; [Leroux, Ofelia; Murray-Ramcharan, Max; Engdahl, Ryan] NYC Hlth Hosp, Harlem Hosp, Dept Surg, New York, NY 10013 USA; [Engdahl, Ryan] NYC Hlth Hosp, Woodhull Hosp, Dept Surg, New York, NY 10013 USA		Engdahl, R (corresponding author), NYC Hlth Hosp, Harlem Hosp, Dept Surg, New York, NY 10013 USA.; Engdahl, R (corresponding author), NYC Hlth Hosp, Woodhull Hosp, Dept Surg, New York, NY 10013 USA.	ryan.engdahl@nychhc.org		Murray-Ramcharan, Max/0000-0001-7954-0621; Altonen, Brian/0000-0003-4511-3183				Adams SH, 2020, J ADOLESCENT HEALTH, V67, P362, DOI 10.1016/j.jadohealth.2020.06.025; Argenziano Michael G, 2020, medRxiv, DOI 10.1101/2020.04.20.20072116; Atri D, 2020, JACC-BASIC TRANSL SC, V5, P518, DOI 10.1016/j.jacbts.2020.04.002; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Bajwah S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00815-2020; Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Boehmer TK, 2020, MMWR MORB MORTAL WKL, V23; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Choi Soo-Han, 2020, Clin Exp Pediatr, V63, P125, DOI 10.3345/cep.2020.00535; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Davenne E, 2020, Rev Med Liege, V75, P218; Ghosal S, 2020, DIABETES METAB SYND, V14, P311, DOI 10.1016/j.dsx.2020.03.017; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Haeck G, 2020, Rev Med Liege, V75, P226; Hussain A, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108142; Imam Z, 2020, J INTERN MED, V288, P469, DOI 10.1111/joim.13119; Khendi White Solaru MD, 2020, EXPERT ANAL; Ladha KS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008990; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Messerli FH, 2020, CIRCULATION, V141, P2042, DOI 10.1161/CIRCULATIONAHA.120.047022; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; PICHI B, 2020, ORAL ONCOL, V105, DOI [10.1016/j.oraloncology.2020.104682, DOI 10.1016/J.ORALONCOLOGY.2020.104682]; Richardson S, 2020, JAMA; Sanyaolu A., 2020, CLIN MED, DOI [10.1007/s42399-020-00363-4, DOI 10.1007/S42399-020-00363-4]; Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005; Siedlecki SL, 2017, CLIN NURSE SPEC, V31, P23, DOI 10.1097/NUR.0000000000000260; Simard M, 2018, MED CARE, V56, P441, DOI 10.1097/MLR.0000000000000905; Singh AK, 2020, DIABETES METAB SYND, V14, P283, DOI 10.1016/j.dsx.2020.03.016; Su L, 2020, EMERG MICROBES INFEC, V9, P707, DOI 10.1080/22221751.2020.1744483; Su YJ, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101625; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tang X, 2020, CHEST, V158, P195, DOI 10.1016/j.chest.2020.03.032; Viitasalo A, 2014, DIABETOLOGIA, V57, P940, DOI 10.1007/s00125-014-3172-5; Wang LS, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.20; Yang X, 2020, LANCET RESP MED, V8, pE26; Yawn BP, 2005, AM J EPIDEMIOL, V161, P974, DOI 10.1093/aje/kwi122; Zhao F, 2020, CLIN RES CARDIOL, V382, P1861	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243343	10.1371/journal.pone.0243343	http://dx.doi.org/10.1371/journal.pone.0243343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315929	gold, Green Published			2022-12-26	WOS:000600186100031
J	Kerth, CM; Hautvast, P; Korner, J; Lampert, A; Meents, JE				Kerth, Clara M.; Hautvast, Petra; Koerner, Jannis; Lampert, Angelika; Meents, Jannis E.			Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA(V)1.7; GENES; SCN9A	Mutations in voltage-gated sodium channels (Navs) can cause alterations in pain sensation, such as chronic pain diseases like inherited erythromelalgia. The mutation causing inherited erythromelalgia, Nav1.7 p.I848T, is known to induce a hyperpolarized shift in the voltage dependence of activation in Nav1.7. So far, however, the mechanism to explain this increase in voltage sensitivity remains unknown. In the present study, we show that phosphorylation of the newly introduced Thr residue explains the functional change. We expressed wildtype human Nav1.7, the I848T mutant, or other mutations in HEK293T cells and performed whole-cell patch-clamp electrophysiology. As the insertion of a Thr residue potentially creates a novel phosphorylation site for Ser/Thr kinases and because Nav1.7 had been shown in Xenopus oocytes to be affected by protein kinases C and A, we used different nonselective and selective kinase inhibitors and activators to test the effect of phosphorylation on Nav1.7 in a human system. We identify protein kinase C, but not protein kinase A, to be responsible for the phosphorylation of T848 and thereby for the shift in voltage sensitivity. Introducing a negatively charged amino acid instead of the putative phosphorylation site mimics the effect on voltage gating to a lesser extent. 3D modeling using the published cryo-EM structure of human Nav1.7 showed that introduction of this negatively charged site seems to alter the interaction of this residue with the surrounding amino acids and thus to influence channel function. These results could provide new opportunities for the development of novel treatment options for patients with chronic pain.	[Kerth, Clara M.; Hautvast, Petra; Koerner, Jannis; Lampert, Angelika; Meents, Jannis E.] Rhein Westfal TH Aachen, Inst Physiol, Uniklin, Aachen, Germany; [Koerner, Jannis] Rhein Westfal TH Aachen, Dept Anesthesiol, Uniklin, Aachen, Germany; [Meents, Jannis E.] Multi Channel Syst, Reutlingen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Meents, JE (corresponding author), Rhein Westfal TH Aachen, Inst Physiol, Uniklin, Aachen, Germany.; Meents, JE (corresponding author), Multi Channel Syst, Reutlingen, Germany.	jmeents@multichannelsystems.com	Lampert, Angelika/F-7198-2010	Lampert, Angelika/0000-0001-6319-6272	DFG [LA 2740/3-1, 363055819/GRK2415, 368482240/GRK2416]; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University [IZKF TN1-1/IA 532001]	DFG(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University	This work was supported in part by the DFG LA 2740/3-1 and the DFG-funded research training groups 363055819/GRK2415 and 368482240/GRK2416 (to A. L.). Supported by a grant from the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University (IZKF TN1-1/IA 532001).	Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Ahn HS, 2010, EUR J PAIN, V14, P944, DOI 10.1016/j.ejpain.2010.03.007; Anjana R, 2012, BIOINFORMATION, V8, P1220, DOI 10.6026/97320630081220; Brouwer BA, 2014, J PERIPHER NERV SYST, V19, P53, DOI 10.1111/jns5.12071; Burel S, 2017, J BIOL CHEM, V292, P17431, DOI 10.1074/jbc.M117.787788; Cao LS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7653; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chatelier A, 2008, J NEUROPHYSIOL, V99, P2241, DOI 10.1152/jn.01350.2007; Cheng XY, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-24; Cheng XY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-1; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Davis Mark D P, 2006, Curr Treat Options Cardiovasc Med, V8, P153, DOI 10.1007/s11936-006-0008-8; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Dib-Hajj SD, 2017, PAIN, V158, pS97, DOI 10.1097/j.pain.0000000000000854; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Eberhardt M, 2014, J BIOL CHEM, V289, P1971, DOI 10.1074/jbc.M113.502211; Han CY, 2009, BRAIN, V132, P1711, DOI 10.1093/brain/awp078; Hoeijmakers JGJ, 2012, BRAIN, V135, P345, DOI 10.1093/brain/awr349; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Korner J., 2020, SENSES COMPREHENSIVE, P120, DOI DOI 10.1016/B978-0-12-809324-5.24208-9; Laedermann CJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00263; Laedermann CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00137; Lampert A, 2008, J BIOL CHEM, V283, P24118, DOI 10.1074/jbc.M802900200; Lampert A, 2006, J BIOL CHEM, V281, P36029, DOI 10.1074/jbc.M607637200; Lenaeus MJ, 2017, P NATL ACAD SCI USA, V114, pE3051, DOI 10.1073/pnas.1700761114; Lorenzini M., 2020, PROTEOMIC FUNCTIONAL; Meents JE, 2019, PAIN, V160, P1327, DOI 10.1097/j.pain.0000000000001511; Meents JE, 2016, NEUROMETHODS, V113, P37, DOI 10.1007/978-1-4939-3411-9_3; Neel AJ, 2017, NATURE, V543, P637, DOI 10.1038/nature21701; Novella SP, 2007, NAT CLIN PRACT NEURO, V3, P229, DOI 10.1038/ncpneuro0425; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Schwarz N, 2016, J NEUROL, V263, P334, DOI 10.1007/s00415-015-7984-0; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Tang ZL, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0347-1; Vijayaragavan K, 2004, J NEUROPHYSIOL, V91, P1556, DOI 10.1152/jn.00676.2003; Wang J, 2017, CHANNELS, V11, P534, DOI 10.1080/19336950.2017.1380758; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waxman SG, 2014, LANCET NEUROL, V13, P1152, DOI 10.1016/S1474-4422(14)70150-4; Wisedchaisri G, 2019, CELL, V178, P993, DOI 10.1016/j.cell.2019.06.031; Wu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055212; Zhang LL, 2007, BRIT J DERMATOL, V156, P767, DOI 10.1111/j.1365-2133.2006.07727.x	47	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100227	10.1074/jbc.RA120.014288	http://dx.doi.org/10.1074/jbc.RA120.014288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361158	Green Published, gold			2022-12-26	WOS:000672866400205
J	You, H; Mayer, JU; Johnston, RL; Sivakumaran, H; Ranasinghe, S; Rivera, V; Kondrashova, O; Koufariotis, LT; Du, XF; Driguez, P; French, JD; Waddell, N; Duke, MG; Ittiprasert, W; Mann, VH; Brindley, PJ; Jones, MK; McManus, DP				You, Hong; Mayer, Johannes U.; Johnston, Rebecca L.; Sivakumaran, Haran; Ranasinghe, Shiwanthi; Rivera, Vanessa; Kondrashova, Olga; Koufariotis, Lambros T.; Du, Xiaofeng; Driguez, Patrick; French, Juliet D.; Waddell, Nicola; Duke, Mary G.; Ittiprasert, Wannaporn; Mann, Victoria H.; Brindley, Paul J.; Jones, Malcolm K.; McManus, Donald P.			CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase	FASEB JOURNAL			English	Article						acetylcholinesterase; CRISPR; Cas9; eggs; genome editing; Schistosoma mansoni	END-JOINING PATHWAYS; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; CAENORHABDITIS-ELEGANS; GRANULOMA-FORMATION; CRISPR; GENES; CELLS; ROLES; EGGS	CRISPR/Cas9-mediated genome editing shows cogent potential for the genetic modification of helminth parasites. We report successful gene knock-in (KI) into the genome of the egg of Schistosoma mansoni by combining CRISPR/Cas9 with single-stranded oligodeoxynucleotides (ssODNs). We edited the acetylcholinesterase (AChE) gene of S. mansoni targeting two guide RNAs (gRNAs), X5 and X7, located on exon 5 and exon 7 of Smp_154600, respectively. Eggs recovered from livers of experimentally infected mice were transfected by electroporation with a CRISPR/Cas9-vector encoding gRNA X5 or X7 combining with/ without a ssODN donor. Next generation sequencing analysis of reads of amplicon libraries spanning targeted regions revealed that the major modifications induced by CRISPR/Cas9 in the eggs were generated by homology directed repair (HDR). Furthermore, soluble egg antigen from AChE-edited eggs exhibited markedly reduced AChE activity, indicative that programed Cas9 cleavage mutated the AChE gene. Following injection of AChE-edited schistosome eggs into the tail veins of mice, an significantly enhanced Th2 response involving IL-4, -5, -10, and-13 was detected in lung cells and splenocytes in mice injected with X5-KI eggs in comparison to control mice injected with unmutated eggs. A Th2-predominant response, with increased levels of IL-4, -13, and GATA3, also was induced by X5 KI eggs in small intestine-draining mesenteric lymph node cells when the gene-edited eggs were introduced into the subserosa of the ileum of the mice. These findings confirmed the potential and the utility of CRISPR/Cas9-mediated genome editing for functional genomics in schistosomes.	[You, Hong; Ranasinghe, Shiwanthi; Rivera, Vanessa; Du, Xiaofeng; Duke, Mary G.; Jones, Malcolm K.; McManus, Donald P.] QIMR Berghofer Med Res Inst, Immunol Dept, 300 Herston Rd, Brisbane, Qld 4006, Australia; [Mayer, Johannes U.] Malaghan Inst Med Res, Wellington, New Zealand; [Johnston, Rebecca L.; Sivakumaran, Haran; Kondrashova, Olga; Koufariotis, Lambros T.; French, Juliet D.; Waddell, Nicola] QIMR Berghofer Med Res Inst, Genet & Computat Biol Dept, Brisbane, Qld, Australia; [Rivera, Vanessa] Deakin Univ, Sch Med, Geelong, Vic, Australia; [Driguez, Patrick] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Ittiprasert, Wannaporn; Mann, Victoria H.; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Ittiprasert, Wannaporn; Mann, Victoria H.; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Res Ctr Neglected Dis Poverty, Washington, DC 20052 USA; [Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	QIMR Berghofer Medical Research Institute; Malaghan Institute; Victoria University Wellington; QIMR Berghofer Medical Research Institute; Deakin University; King Abdullah University of Science & Technology; George Washington University; George Washington University; University of Queensland	You, H; McManus, DP (corresponding author), QIMR Berghofer Med Res Inst, Immunol Dept, 300 Herston Rd, Brisbane, Qld 4006, Australia.	Hong.You@qimrberghofer.edu.au; Don.McManus@qimrberghofer.edu.au	Jones, Malcolm K/A-1097-2009; Johnston, Rebecca L./AAX-7868-2021; You, Hong/AAB-4649-2020; Johnston, Rebecca L./C-7683-2011	Jones, Malcolm K/0000-0002-0035-6141; You, Hong/0000-0002-8790-7793; Johnston, Rebecca L./0000-0001-7503-9514; Kondrashova, Olga/0000-0003-0022-5149; Koufariotis, Lambros/0000-0002-4917-1375; McManus, Donald/0000-0001-6443-1449; Driguez, Patrick/0000-0001-8104-677X; Brindley, Paul J./0000-0003-1765-0002; Sivakumaran, Haran/0000-0002-4691-4989; French, Juliet/0000-0002-9770-0198; Mayer, Johannes U/0000-0001-6225-7803	Wellcome Trust [107475/Z/15/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Almadi MA, 2011, NAT REV GASTRO HEPAT, V8, P455, DOI 10.1038/nrgastro.2011.115; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Anthony BJ, 2012, TRENDS PARASITOL, V28, P572, DOI 10.1016/j.pt.2012.09.005; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Ariyaratne A, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00127-19; Arunsan P, 2019, ELIFE, V8, DOI 10.7554/eLife.41463; Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; BUEDING E, 1972, BRIT J PHARMACOL, V46, P480, DOI 10.1111/j.1476-5381.1972.tb08145.x; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Carson JP, 2018, TRENDS PARASITOL, V34, P524, DOI 10.1016/j.pt.2018.02.005; Chatterjee S, 2004, ACTA TROP, V90, P191, DOI 10.1016/j.actatropica.2003.12.002; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Chu D, 2007, PARASITOLOGY, V134, P1611, DOI 10.1017/S0031182007002946; Chuah C, 2016, INT J PARASITOL, V46, P239, DOI 10.1016/j.ijpara.2015.12.004; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Chuah C, 2013, J LEUKOCYTE BIOL, V94, P353, DOI 10.1189/jlb.1212653; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Costain AH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03042; CRABTREE JE, 1980, PARASITOLOGY, V81, P553, DOI 10.1017/S003118200006193X; Craver MPJ, 2007, MOL BIOCHEM PARASIT, V153, P149, DOI 10.1016/j.molbiopara.2007.02.013; Dalton JP, 1997, PARASITOLOGY, V115, P29, DOI 10.1017/S0031182097001091; DONALD RGK, 1994, MOL BIOCHEM PARASIT, V63, P243, DOI 10.1016/0166-6851(94)90060-4; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; EDUNGBOLA LD, 1979, J PARASITOL, V65, P253, DOI 10.2307/3280158; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gang SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006675; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hagan P, 2004, TRENDS PARASITOL, V20, P92, DOI 10.1016/j.pt.2003.11.010; Hagen J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6375; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Hoffmann KF, 2014, SCIENCE, V346, P168, DOI 10.1126/science.1261139; Hoffmann KF, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-8-research0041; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ittiprasert W, 2019, ELIFE, V8, DOI 10.7554/eLife.41337; Janssen BD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18442-3; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jones AK, 2002, FASEB J, V16, P441, DOI 10.1096/fj.01-0683fje; Jurberg AD, 2009, DEV GENES EVOL, V219, P219, DOI 10.1007/s00427-009-0285-9; Kaminsky R, 2008, PARASITOL RES, V103, P931, DOI 10.1007/s00436-008-1080-7; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Koslowski N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005595; Lan Z, 2013, BRAIN RES, V1498, P9, DOI 10.1016/j.brainres.2012.12.040; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; LEVISCHAFFER F, 1984, MOL BIOCHEM PARASIT, V13, P283, DOI 10.1016/0166-6851(84)90120-8; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lino CA, 2018, DRUG DELIV, V25, P1234, DOI 10.1080/10717544.2018.1474964; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Mayer JU, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15820; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; McVeigh P, 2019, ELIFE, V8, DOI 10.7554/eLife.44382; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; NEILL PJG, 1988, AM J TROP MED HYG, V39, P52, DOI 10.4269/ajtmh.1988.39.52; Oliveros JC, 2016, NUCLEIC ACIDS RES, V44, pW267, DOI 10.1093/nar/gkw407; Pearson MS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00213; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Pu Zhang FM, 2006, ELECT J BIOL, V2, P11; Ranasinghe SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200433; Ricciardi A, 2015, VACCINE, V33, P346, DOI 10.1016/j.vaccine.2014.11.016; Rinaldi G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002820; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Robertson Alan P., 2007, Invertebrate Neuroscience, V7, P209, DOI 10.1007/s10158-007-0059-x; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Sankaranarayanan G, 2020, BIORXIV; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Team T. A., 2017, CRISPR 101 DESKT RES; Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9; Vaux R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005998; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30227-w; You H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082426; You H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1615-1; You H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003254; You H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009868; You H, 2009, INT J PARASITOL, V39, P1551, DOI 10.1016/j.ijpara.2009.06.006; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065; Zhang WW, 2015, MBIO, V6, DOI 10.1128/mBio.00861-15; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	88	10	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21205	10.1096/fj.202001745RR	http://dx.doi.org/10.1096/fj.202001745RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337558	Green Published, Green Submitted			2022-12-26	WOS:000605626600007
J	Zhang, L; Gui, T; Console, L; Scalise, M; Indiveri, C; Hausler, S; Kullak-Ublick, GA; Gai, ZB; Visentin, M				Zhang, Lu; Gui, Ting; Console, Lara; Scalise, Mariafrancesca; Indiveri, Cesare; Hausler, Stephanie; Kullak-Ublick, Gerd A.; Gai, Zhibo; Visentin, Michele			Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE CHOLESTEROL; AGE-RELATED-CHANGES; INTRACELLULAR CHLORIDE ACTIVITY; ATPASE ACTIVITY; CONDENSED COMPLEXES; LIPID-COMPOSITION; UP-REGULATION; STEADY-STATE; SODIUM-PUMP; RAT-LIVER	The carnitine/organic cation transporter novel 2 (OCTN2) is responsible for the cellular uptake of carnitine in most tissues. Being a transmembrane protein OCTN2 must interact with the surrounding lipid microenvironment to function. Among the main lipid species that constitute eukaryotic cells, cholesterol has highly dynamic levels under a number of physiopathological conditions. This work describes how plasma membrane cholesterol modulates OCTN2 transport of L-carnitine in human embryonic kidney 293 cells overexpressing OCTN2 (OCTN2-HEK293) and in proteoliposomes harboring human OCTN2. We manipulated the cholesterol content of intact cells, assessed by thin layer chromatography, through short exposures to empty and/or cholesterol-saturated methyl-beta-cyclodextrin (m beta cd), whereas free cholesterol was used to enrich reconstituted proteoliposomes. We measured OCTN2 transport using [H-3]L-carnitine, and expression levels and localization by surface biotinylation and Western blotting. A 20-min preincubation with m beta cd reduced the cellular cholesterol content and inhibited L-carnitine influx by 50% in comparison with controls. Analogously, the insertion of cholesterol in OCTN2-proteoliposomes stimulated L-carnitine uptake in a dose-dependent manner. Carnitine uptake in cells incubated with empty m beta cd and cholesterol-saturated m beta cd to preserve the cholesterol content was comparable with controls, suggesting that the m beta cd effect on OCTN2 was cholesterol dependent. Cholesterol stimulated L-carnitine influx in cells by markedly increasing the affinity for L-carnitine and in proteoliposomes by significantly enhancing the affinity for Na+ and, in turn, the L-carnitine maximal transport capacity. Because of the antilipogenic and antioxidant features of L-carnitine, the stimulatory effect of cholesterol on L-carnitine uptake might represent a novel protective effect against lipid-induced toxicity and oxidative stress.	[Zhang, Lu; Gui, Ting; Gai, Zhibo] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Jinan, Peoples R China; [Zhang, Lu; Hausler, Stephanie; Kullak-Ublick, Gerd A.; Gai, Zhibo; Visentin, Michele] Univ Zurich, Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland; [Console, Lara; Scalise, Mariafrancesca; Indiveri, Cesare] Univ Calabria, Dept DiBEST Biol Ecol Sci Terra, Unit Biochem & Mol Biotechnol, Arcavacata Di Rende, Italy; [Kullak-Ublick, Gerd A.] Novartis Pharmaceut, Mechanist Safety, CMO, Basel, Switzerland; [Kullak-Ublick, Gerd A.] Novartis Pharmaceut, Patient Safety, Global Drug Dev, Basel, Switzerland	Shandong University of Traditional Chinese Medicine; University of Zurich; University Zurich Hospital; University of Calabria; Novartis; Novartis	Gai, ZB (corresponding author), Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Jinan, Peoples R China.; Gai, ZB; Visentin, M (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland.	zhibo.gai@usz.ch; michele.visentin@usz.ch	Console, Lara/S-9677-2019	Gai, Zhibo/0000-0003-1673-6541; Indiveri, Cesare/0000-0001-9818-6621; Visentin, Michele/0000-0002-0209-5600; console, lara/0000-0002-0238-0946	Shandong University of Traditional Chinese Medicine [2020_026]; Swiss National Science Foundation [310030_175639]; University of Calabria	Shandong University of Traditional Chinese Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Calabria	This work was supported by Innovation Research Grant to L. Z. [2020_026] from Shandong University of Traditional Chinese Medicine, Swiss National Science Foundation to G. A. K. -U. [310030_175639], and by "Fondi di Ateneo" from the University of Calabria to C. I. and M. S.	Alvarez E, 2001, CLIN EXP IMMUNOL, V124, P95, DOI 10.1046/j.1365-2249.2001.01490.x; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; BLUME A, 1980, BIOCHEMISTRY-US, V19, P4908, DOI 10.1021/bi00562a032; BOHMER T, 1977, BIOCHIM BIOPHYS ACTA, V465, P627, DOI 10.1016/0005-2736(77)90278-4; BOROCHOV N, 1995, CHEM PHYS LIPIDS, V76, P85, DOI 10.1016/0009-3084(94)02411-W; Caliceti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041246; CHONG PLG, 1994, P NATL ACAD SCI USA, V91, P10069, DOI 10.1073/pnas.91.21.10069; CLARET M, 1972, J PHYSIOL-LONDON, V223, P279, DOI 10.1113/jphysiol.1972.sp009847; CLARET M, 1978, J PHYSIOL-LONDON, V274, P247, DOI 10.1113/jphysiol.1978.sp012145; Console L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22170-7; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cuevas FJ, 2006, BIOCHEMISTRY-US, V45, P13855, DOI 10.1021/bi061351e; Czeredys M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082105; DEMEL RA, 1977, BIOCHIM BIOPHYS ACTA, V465, P1, DOI 10.1016/0005-2736(77)90350-9; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dickens D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43580; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; FITZ JG, 1987, AM J PHYSIOL, V252, pG699, DOI 10.1152/ajpgi.1987.252.5.G699; FOLCH J, 1951, J BIOL CHEM, V191, P833; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Fujita M, 2009, AM J PHYSIOL-GASTR L, V297, pG681, DOI 10.1152/ajpgi.00238.2009; Ganapathy ME, 2000, J BIOL CHEM, V275, P1699, DOI 10.1074/jbc.275.3.1699; Garcia A, 2019, J BIOL CHEM, V294, P5956, DOI 10.1074/jbc.RA118.006223; GRINNA LS, 1977, MECH AGEING DEV, V6, P197, DOI 10.1016/0047-6374(77)90021-5; Habeck M, 2017, P NATL ACAD SCI USA, V114, P2904, DOI 10.1073/pnas.1620799114; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Hashimoto N, 1998, BIOCHEM PHARMACOL, V55, P1729, DOI 10.1016/S0006-2952(97)00670-9; HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8; Hirai T, 2007, BIOL PHARM BULL, V30, P2185, DOI 10.1248/bpb.30.2185; Hormann S, 2020, J PHARMACOL EXP THER, V372, P46, DOI 10.1124/jpet.119.260877; HORIUCHI M, 1993, FEBS LETT, V326, P267, DOI 10.1016/0014-5793(93)81805-A; Huang JY, 2002, BIOPHYS J, V83, P1014, DOI 10.1016/S0006-3495(02)75227-2; Kano T, 2009, DRUG METAB DISPOS, V37, P1009, DOI 10.1124/dmd.108.025015; Kato Y, 2006, MOL PHARMACOL, V70, P829, DOI 10.1124/mol.106.024158; Keller T, 2019, MOL PHARMACOL, V95, P169, DOI 10.1124/mol.118.113498; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; KOIZUMI T, 1988, LAB ANIM, V22, P83, DOI 10.1258/002367788780746511; Li SB, 2015, HEPATOLOGY, V61, P1730, DOI 10.1002/hep.27712; Llanos P, 2015, AM J PHYSIOL-ENDOC M, V308, pE294, DOI 10.1152/ajpendo.00189.2014; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; LUCIO FJ, 1991, EXP PHYSIOL, V76, P437, DOI 10.1113/expphysiol.1991.sp003510; LYALL V, 1987, BIOCHIM BIOPHYS ACTA, V903, P56, DOI 10.1016/0005-2736(87)90155-6; Maeda T, 2008, BIOL PHARM BULL, V31, P1230, DOI 10.1248/bpb.31.1230; MARIN R, 1985, BIOCHEM PHARMACOL, V34, P4197, DOI 10.1016/0006-2952(85)90274-6; NOBES CD, 1989, BIOCHIM BIOPHYS ACTA, V987, P115, DOI 10.1016/0005-2736(89)90462-8; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; PASTORINO JG, 1993, J BIOL CHEM, V268, P13791; Pochini L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031091; PRATZ J, 1985, BIOCHIM BIOPHYS ACTA, V814, P265, DOI 10.1016/0005-2736(85)90444-4; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Radhakrishnan A, 1999, BIOPHYS J, V77, P1507, DOI 10.1016/S0006-3495(99)76998-5; Raffy S, 1999, BIOPHYS J, V76, P2072, DOI 10.1016/S0006-3495(99)77363-7; Ringerike T, 2002, J CELL SCI, V115, P1331; Ringseis R, 2008, EUR J PHARMACOL, V583, P11, DOI 10.1016/j.ejphar.2008.01.008; Ringseis R, 2007, PHARMACOL RES, V56, P175, DOI 10.1016/j.phrs.2007.06.001; Scalise M, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00110; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; SCHREIBMAN PH, 1975, J CLIN INVEST, V55, P986, DOI 10.1172/JCI108028; SCHROEDER F, 1984, NEUROBIOL AGING, V5, P323, DOI 10.1016/0197-4580(84)90010-1; SCHULLER A, 1986, HEPATOLOGY, V6, P714, DOI 10.1002/hep.1840060429; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; Stephens FB, 2006, FASEB J, V20, P377, DOI 10.1096/fj.05-4985fje; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 2001, BBA-BIOMEMBRANES, V1512, P273, DOI 10.1016/S0005-2736(01)00328-5; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tamai I, 2013, BIOPHARM DRUG DISPOS, V34, P29, DOI 10.1002/bdd.1816; Unruh D, 2015, CIRCULATION, V132, P1898, DOI 10.1161/CIRCULATIONAHA.115.017313; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Verstraeten SL, 2018, TOXICOL APPL PHARM, V352, P59, DOI 10.1016/j.taap.2018.05.014; Visentin M, 2017, DRUG METAB DISPOS, V45, P1240, DOI 10.1124/dmd.117.077248; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; YEAGLE PL, 1988, BIOCHEMISTRY-US, V27, P6449, DOI 10.1021/bi00417a037; Yokogawa K, 1999, HEPATOLOGY, V30, P997, DOI 10.1002/hep.510300423; Yokogawa K, 1999, J PHARMACOL EXP THER, V289, P224; Zager RA, 2000, KIDNEY INT, V58, P193, DOI 10.1046/j.1523-1755.2000.00154.x; Zager RA, 1999, KIDNEY INT, V56, P1788, DOI 10.1046/j.1523-1755.1999.00745.x; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	84	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100204	10.1074/jbc.RA120.015175	http://dx.doi.org/10.1074/jbc.RA120.015175			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334877	Green Accepted, gold, Green Published			2022-12-26	WOS:000672866400182
J	Ghareghozloo, ER; Mahdavimehr, M; Meratan, AA; Nikfarjam, N; Ghasemi, A; Katebi, B; Nemat-Gorgani, M				Rostampour Ghareghozloo, Ebrahim; Mahdavimehr, Mohsen; Meratan, Ali Akbar; Nikfarjam, Nasser; Ghasemi, Atiyeh; Katebi, Bentolhoda; Nemat-Gorgani, Mohsen			Role of surface oxygen-containing functional groups of graphene oxide quantum dots on amyloid fibrillation of two model proteins	PLOS ONE			English	Article							NANOPARTICLE INTERACTIONS OPPORTUNITIES; ALZHEIMERS-DISEASE; COLLOIDAL STABILITY; CHEMICAL-REDUCTION; PEPTIDE; INHIBITION; FIBRILS; AGGREGATION; LYSOZYME; INSULIN	There are many reports demonstrating that various derivatives of carbon nanoparticles are effective inhibitors of protein aggregation. As surface structural features of nanoparticles play a key role on modulating amyloid fibrillation process, in the present in vitro study, bovine insulin and hen egg white lysozyme (HEWL) were selected as two model proteins to investigate the reducing effect of graphene oxide quantum dots (GOQDs) on their assembly under amyloidogenic conditions. GOQDs were prepared through direct pyrolysis of citric acid, and the reduction step was carried out using ascorbic acid. The prepared nanoparticles were characterized by UV-Vis, X-ray photoelectron, and FT-IR spectroscopies, transmission electron and atomic force microscopies, zeta potential measurement, and Nile red fluorescence assay. They showed the tendencies to modulate the assembly of the proteins through different mechanisms. While GOQDs appeared to have the capacity to inhibit fibrillation, the presence of reduced GOQDs (rGOQDs) was found to promote protein assembly via shortening the nucleation phase, as suggested by ThT fluorescence data. Moreover, the structures produced in the presence of GOQDs or rGOQDs were totally nontoxic. We suggest that surface properties of these particles may be part of the differences in their mechanism(s) of action.	[Rostampour Ghareghozloo, Ebrahim; Mahdavimehr, Mohsen; Meratan, Ali Akbar; Katebi, Bentolhoda] Inst Adv Studies Basic Sci IASBS, Dept Biol Sci, Zanjan, Iran; [Nikfarjam, Nasser] Inst Adv Studies Basic Sci IASBS, Dept Chem, Zanjan, Iran; [Ghasemi, Atiyeh] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Nemat-Gorgani, Mohsen] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Institute for Advanced Studies in Basic Sciences (IASBS); Institute for Advanced Studies in Basic Sciences (IASBS); University of Tehran; Stanford University	Meratan, AA (corresponding author), Inst Adv Studies Basic Sci IASBS, Dept Biol Sci, Zanjan, Iran.	a.meratan@iasbs.ac.ir		Meratan, Ali Akbar/0000-0002-1428-3254	Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran	Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran	This work was supported by grants from the Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Amiri H, 2013, ACS CHEM NEUROSCI, V4, P1417, DOI 10.1021/cn4001582; Andreev I, 2008, FULLER NANOTUB CAR N, V16, P89, DOI 10.1080/15363830701885831; Azami-Movahed M, 2013, INT J BIOCHEM CELL B, V45, P299, DOI 10.1016/j.biocel.2012.10.004; Ban DK, 2018, LANGMUIR, V34, P15283, DOI 10.1021/acs.langmuir.8b02674; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chen HB, 2011, DRUG DISCOV TODAY, V16, P354, DOI 10.1016/j.drudis.2010.02.009; Chua CK, 2014, CHEM SOC REV, V43, P291, DOI 10.1039/c3cs60303b; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dong YQ, 2012, CARBON, V50, P4738, DOI 10.1016/j.carbon.2012.06.002; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h; Gilead S, 2004, ANGEW CHEM INT EDIT, V43, P4041, DOI 10.1002/anie.200353565; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Gudarzi MM, 2016, LANGMUIR, V32, P5058, DOI 10.1021/acs.langmuir.6b01012; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Javed I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11762-0; Katebi B, 2018, ARCH BIOCHEM BIOPHYS, V659, P22, DOI 10.1016/j.abb.2018.09.024; Ke PC, 2020, ADV MATER, V32, DOI 10.1002/adma.201901690; Kim D, 2018, NAT NANOTECHNOL, V13, P812, DOI 10.1038/s41565-018-0179-y; Kim JE, 2003, BIOCHEM BIOPH RES CO, V303, P576, DOI 10.1016/S0006-291X(03)00393-0; Konkena B, 2012, LANGMUIR, V28, P12432, DOI 10.1021/la3020783; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Laurent S, 2012, RSC ADV, V2, P5008, DOI 10.1039/c2ra01374f; Lee CC, 2016, J BIOL CHEM, V291, P2858, DOI 10.1074/jbc.M115.682336; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Li HY, 2011, BIOPHYS J, V101, P2267, DOI 10.1016/j.bpj.2011.09.046; Li Q, 2014, CHEM-EUR J, V20, P7236, DOI 10.1002/chem.201402022; Li SH, 2015, CHEM MATER, V27, P1764, DOI 10.1021/cm504572b; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Liu YB, 2015, NANOSCALE, V7, P19060, DOI 10.1039/c5nr06282a; Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mahdavimehr M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187841; Mahmoudi M, 2013, NANOSCALE, V5, P2570, DOI 10.1039/c3nr33193h; Mahmoudi M, 2012, NANOSCALE, V4, P7322, DOI 10.1039/c2nr31657a; Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g; Mao XB, 2009, LANGMUIR, V25, P8849, DOI 10.1021/la901342r; Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045; Nedumpully-Govindan P, 2016, PHYS CHEM CHEM PHYS, V18, P94, DOI 10.1039/c5cp05924k; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Ou LC, 2011, J PHYS CHEM B, V115, P9813, DOI 10.1021/jp201474m; Palmal S, 2014, CHEM-EUR J, V20, P6184, DOI 10.1002/chem.201400079; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Qi Y, 2016, ENVIRON SCI-NANO, V3, P1062, DOI 10.1039/c6en00174b; Ren XM, 2018, ENVIRON SCI-NANO, V5, P1298, DOI 10.1039/c7en01258f; Rezaeian N, 2017, ARCH BIOCHEM BIOPHYS, V634, P96, DOI 10.1016/j.abb.2017.09.015; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Szabo T, 2006, CARBON, V44, P537, DOI 10.1016/j.carbon.2005.08.005; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang XY, 2015, NANOSCALE, V7, P2034, DOI 10.1039/c4nr04136d; Xie LG, 2014, BIOPHYS J, V107, P1930, DOI 10.1016/j.bpj.2014.08.034; Yang ZX, 2015, NANOSCALE, V7, P18725, DOI 10.1039/c5nr01172h; Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a; Zhang JN, 2014, ACS APPL MATER INTER, V6, P8475, DOI [10.1021/am501341u, 10.1021/am506435u]; Zhao J, 2015, ENVIRON SCI TECHNOL, V49, P2849, DOI 10.1021/es505605w; Zheng HZ, 2011, CHEM COMMUN, V47, P10650, DOI 10.1039/c1cc14741b; Zheng P, 2017, CHEM-ASIAN J, V12, P2343, DOI 10.1002/asia.201700814; Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068	68	4	4	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244296	10.1371/journal.pone.0244296	http://dx.doi.org/10.1371/journal.pone.0244296			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362209	Green Published, gold			2022-12-26	WOS:000603071600046
J	Shen, MP; Xu, HZ; Fu, JF; Wang, TL; Fu, ZZ; Zhao, XM; Zhou, GD; Jin, Q; Tong, GX				Shen, Meiping; Xu, Hongzhen; Fu, Junfen; Wang, Tianlin; Fu, Zangzang; Zhao, Xiaomei; Zhou, Gendi; Jin, Qi; Tong, Guixiu			Investigation of anxiety levels of 1637 healthcare workers during the epidemic of COVID-19	PLOS ONE			English	Article								Objective This study aimed to investigate the anxiety levels of healthcare workers and to provide guidance on potential accurate social and psychological interventions for healthcare workers during the epidemic of COVID-19 in Zhejiang Province, China. Methods Healthcare workers from five hospitals in Zhejiang Province were randomly selected into this study. Zung Self-Assessment Scale for Anxiety (SAS) was used to evaluate the anxiety status of the included 1637 healthcare workers. Results The total anxiety score of healthcare workers in Zhejiang Province was 30.85 +/- 6.89. The univariate analysis showed that the anxiety level of healthcare workers was related to gender, education, occupation, physical condition, job risk coefficient, and with family members on the first-line combating COVID-19 (P <0.05). The multivariate analysis showed that physical condition and job risk coefficient were predictors of anxiety levels of healthcare workers. Conclusions During the epidemic of COVID-19, 1637 healthcare workers generally had an increased tendency to have anxiety. Individualized assessment of the anxiety level of healthcare workers should be provided, and different interventions should be given based on the evaluation results.	[Shen, Meiping; Xu, Hongzhen; Fu, Junfen; Wang, Tianlin; Fu, Zangzang] Zhejiang Univ, Childrens Hosp, Sch Med, Natl Clin Res Ctr Child Hlth, Hangzhou, Peoples R China; [Zhao, Xiaomei] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China; [Zhou, Gendi] Hangzhou Hosp Tradit Chinese Med, Hangzhou, Peoples R China; [Jin, Qi] Xiaoshan First Peoples Hosp, Hangzhou, Peoples R China; [Tong, Guixiu] Zhejiang Univ, Chunan Hosp Tradit Chinese Med, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Fu, JF (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, Natl Clin Res Ctr Child Hlth, Hangzhou, Peoples R China.	fjf68@zju.edu.cn			Zhejiang University special research scientific research fund for COVID-19 prevention and control	Zhejiang University special research scientific research fund for COVID-19 prevention and control	This work was supported by Zhejiang University special research scientific research fund for COVID-19 prevention and control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, SPACE RAD BIOL BIOL, V18, P200; Tran BX, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010354; Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049; Feng Jie, 2006, ACTA ACAD MED MILTAR, V28, P1111; Hao FY, 2020, BRAIN BEHAV IMMUN, V87, P100, DOI 10.1016/j.bbi.2020.04.069; Ji D, 2017, ONCOTARGET, V8, P12784, DOI 10.18632/oncotarget.14498; Li L, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0341-2; Mak WWS, 2009, PSYCHOL HEALTH, V24, P161, DOI 10.1080/08870440701447649; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Tan W., 2020, BRAIN BEHAV IMMUN; Tang Haibo, 2009, CHINESE J CLIN PSYCH, V17, P199; Tang Haibo, 2009, CHINESE J CLIN PSYCH, V17, P176; Wang C., 2020, BRAIN BEHAV IMMUN, VS0889-1591, P30511; Zhou CY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010113	14	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243890	10.1371/journal.pone.0243890	http://dx.doi.org/10.1371/journal.pone.0243890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351814	gold, Green Published			2022-12-26	WOS:000603071400049
J	Belachew, SA; Muluneh, NY; Erku, DA; Netere, AK				Belachew, Sewunet Admasu; Muluneh, Niguse Yigzaw; Erku, Daniel Asfaw; Netere, Adeladlew Kassie			A cross sectional study on beliefs and roles of community pharmacy professionals in preventing and managing metabolic syndrome in an Ethiopian setting	PLOS ONE			English	Article							MANAGEMENT; PROGRAM; HEALTH; RISK	Introduction Metabolic syndrome (MetS) is a group of cardiovascular risk factors, and its prevalence is becoming alarmingly high in Ethiopia. Studies uncovered as community pharmacy professionals (CPPs) have not yet well integrated into public health programs and priorities. In low income setting like Ethiopia, evidence regarding the roles CPPs in preventing and management of MetS is dearth. Objective The study was aimed to assess community pharmacy professionals'(CPPs) opinions about metabolic syndrome, describe their perception level towards the effectiveness of the main interventions and explore their extent of involvement in counseling patients with the metabolic syndrome in Gondar town, Northwestern Ethiopia. Method A descriptive, cross-sectional study was conducted among pharmacists and druggists working in community medication retail outlets (CMROs) in Gondar town, northwestern Ethiopia from April 1 to May 31, 2019. Data were collected using a self-administered pre-tested questionnaire. Descriptive statistics was used to summarize different variables, and presented in tables and figure. An independent t-test and one way ANOVA (Analysis of Variance) were used to compare mean scores. A 5% level of significance was used. Result Out of the 75 CPPs approached, 65(40 pharmacists and 25 druggists) completed the survey giving a response rate of 86.7%. Smoking cessation practice was identified to be low. There were a statistically significant difference (t = 2.144, P = 0.036) in the involvement towards counseling patients between CPPs who claimed to work in pharmacy (mean = 3.96 out of 5 points Likert scale) and drug stores (mean = 3.80 out of 5 points Likert scale). Conclusion The study concluded that the overall involvement of professionals in counseling patients, opinion about metabolic syndrome, and perception towards the effectiveness of the intervention was found to be more or less positive. However, the provision of services, such as monitoring therapy, selling equipment for home blood pressure and glucose monitoring and documenting patient care services needs to be encouraged. Given proper education and training, the current study hope that community pharmacists could be an important front-line contributors to contain this emerging epidemic in Gondar town as well as in the entire nation.	[Belachew, Sewunet Admasu; Netere, Adeladlew Kassie] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia; [Muluneh, Niguse Yigzaw] Univ Gondar, Dept Psychiat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Erku, Daniel Asfaw] Griffith Univ, Sch Med, Ctr Appl Hlth Econ, Nathan, Qld, Australia; [Erku, Daniel Asfaw] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia	University of Gondar; University of Gondar; Griffith University; Griffith University	Belachew, SA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia.	sewunet.admasu@gmail.com	Erku, Daniel/AAC-1508-2020	Erku, Daniel/0000-0002-8878-0317; Admasu Belachew, Sewunet/0000-0002-1050-8188				Via-Sosa MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-487; Awad A, 2010, PHARM WORLD SCI, V32, P146, DOI 10.1007/s11096-009-9360-6; Benavides S, 2011, J RURAL HEALTH, V27, P184, DOI 10.1111/j.1748-0361.2010.00329.x; Dastani HB, 2004, ANN PHARMACOTHER, V38, P1800, DOI 10.1345/aph.1E205; Eades CE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-582; Erku DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180943; Fornos JA, 2006, PHARM WORLD SCI, V28, P65, DOI 10.1007/s11096-006-9003-0; Hammad EA, 2011, J MANAGE CARE PHARM, V17, P295, DOI 10.18553/jmcp.2011.17.4.295; Hijazi MA, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05258-7; Katoue MG, 2013, INT J CLIN PHARM-NET, V35, P57, DOI 10.1007/s11096-012-9705-4; Kelliny C, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-27; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krass I, 2007, DIABETIC MED, V24, P677, DOI 10.1111/j.1464-5491.2007.02143.x; Laliberte MC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-192; Lau R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-34; Lu B, 2006, METABOLISM, V55, P1088, DOI 10.1016/j.metabol.2006.04.003; Maguire T. A., 2001, Addiction, V96, P325, DOI 10.1046/j.1360-0443.2001.96232516.x; Malone M, 2004, ANN PHARMACOTHER, V38, P1961, DOI 10.1345/aph.1E378; Matowe L, 2003, AM J HEALTH-SYST PH, V60, P1591, DOI 10.1093/ajhp/60.15.1591; McKenney James M, 2004, J Am Pharm Assoc (2003), V44, P562, DOI 10.1331/1544-3191.44.5.562.McKenney; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Mutimura Eugene, 2008, J Cardiometab Syndr, V3, P106, DOI 10.1111/j.1559-4572.2008.07584.x; Olenak JL, 2010, J AM PHARM ASSOC, V50, P32, DOI 10.1331/JAPhA.2010.08104; PALUCK EC, 1994, CAN J PUBLIC HEALTH, V85, P389; Robinson JD, 2010, ANN PHARMACOTHER, V44, P88, DOI 10.1345/aph.1L289; Scott David M., 2016, Pharmacy Pract (Granada), V14, P836, DOI [10.18549/PharmPract.2016.04.836, 10.18549/pharmpract.2016.04.836]; Snella KA, 2006, J AM PHARM ASSOC, V46, P370, DOI 10.1331/154434506777069598; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; Trinca C E, 1995, Am Pharm, VSuppl, P13; WHO, 2008, WORLD HLTH REP PREV; World Health Organization, 2004, GLOB STRAT DIET PHYS	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244211	10.1371/journal.pone.0244211	http://dx.doi.org/10.1371/journal.pone.0244211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347490	Green Published, gold			2022-12-26	WOS:000603071100037
J	House, NCM; Parasuram, R; Layer, JV; Price, BD				House, Nealia C. M.; Parasuram, Ramya; Layer, Jacob V.; Price, Brendan D.			Site-specific targeting of a light activated dCas9-KillerRed fusion protein generates transient, localized regions of oxidative DNA damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; BASE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; BIOLOGICAL CONSEQUENCES; STRUCTURAL BASIS; CHROMATIN; MECHANISMS; INDUCTION; GENOME; H2A.Z	DNA repair requires reorganization of the local chromatin structure to facilitate access to and repair of the DNA. Studying DNA double-strand break (DSB) repair in specific chromatin domains has been aided by the use of sequence-specific endonucleases to generate targeted breaks. Here, we describe a new approach that combines KillerRed, a photosensitizer that generates reactive oxygen species (ROS) when exposed to light, and the genome-targeting properties of the CRISPR/Cas9 system. Fusing KillerRed to catalytically inactive Cas9 (dCas9) generates dCas9-KR, which can then be targeted to any desired genomic region with an appropriate guide RNA. Activation of dCas9-KR with green light generates a local increase in reactive oxygen species, resulting in "clustered" oxidative damage, including both DNA breaks and base damage. Activation of dCas9-KR rapidly (within minutes) increases both gamma H2AX and recruitment of the KU70/80 complex. Importantly, this damage is repaired within 10 minutes of termination of light exposure, indicating that the DNA damage generated by dCas9-KR is both rapid and transient. Further, repair is carried out exclusively through NHEJ, with no detectable contribution from HR-based mechanisms. Surprisingly, sequencing of repaired DNA damage regions did not reveal any increase in either mutations or INDELs in the targeted region, implying that NHEJ has high fidelity under the conditions of low level, limited damage. The dCas9-KR approach for creating targeted damage has significant advantages over the use of endonucleases, since the duration and intensity of DNA damage can be controlled in "real time" by controlling light exposure. In addition, unlike endonucleases that carry out multiple cut-repair cycles, dCas9-KR produces a single burst of damage, more closely resembling the type of damage experienced during acute exposure to reactive oxygen species or environmental toxins. dCas9-KR is a promising system to induce DNA damage and measure site-specific repair kinetics at clustered DNA lesions.	[House, Nealia C. M.; Parasuram, Ramya; Price, Brendan D.] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Layer, Jacob V.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Layer, Jacob V.] eGenesis, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Price, BD (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.	Brendan_price@dfci.harvard.edu		House, Nealia/0000-0003-1264-7699	NIH [CA177804, CA93602]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants CA177804 (BDP) and CA93602 (BDP). One of us (JVL) is currently employed by eGenesis, Cambridge, MA. However, JVL's contribution to the current work was solely carried out while he was an employee of the Dana-Farber Cancer Institute and was completed prior to JVL's departure from the DFCI. "eGenesis did not provide support in the form of salaries to either JVL or other workers, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alatwi HE, 2015, EMBO REP, V16, P986, DOI 10.15252/embr.201540330; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Brinkman EK, 2018, MOL CELL, V70, P801, DOI 10.1016/j.molcel.2018.04.016; Brown AJ, 2018, METHOD ENZYMOL, V601, P111, DOI 10.1016/bs.mie.2017.11.028; Budworth H, 2005, J MOL BIOL, V351, P1020, DOI 10.1016/j.jmb.2005.06.069; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Cannan WJ, 2016, J CELL PHYSIOL, V231, P3, DOI 10.1002/jcp.25048; Cannan WJ, 2014, J BIOL CHEM, V289, P19881, DOI 10.1074/jbc.M114.571588; Carpentier P, 2009, FEBS LETT, V583, P2839, DOI 10.1016/j.febslet.2009.07.041; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chan KKL, 2006, MUTAGENESIS, V21, P173, DOI 10.1093/mutage/gel020; Chen SH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4340; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Clouaire T, 2019, TRENDS GENET, V35, P330, DOI 10.1016/j.tig.2019.02.003; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dhar S, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0284; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Eccles LJ, 2011, MUTAT RES-FUND MOL M, V711, P134, DOI 10.1016/j.mrfmmm.2010.11.003; Fajrial AK, 2020, THERANOSTICS, V10, P5532, DOI 10.7150/thno.43465; Forkink M, 2010, BBA-BIOENERGETICS, V1797, P1034, DOI 10.1016/j.bbabio.2010.01.022; Gangopadhyay SA, 2019, BIOCHEMISTRY-US, V58, P234, DOI 10.1021/acs.biochem.8b01202; Georgakilas AG, 2013, RADIAT RES, V180, P100, DOI 10.1667/RR3041.1; Glaser A, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.48; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gursoy-Yuzugullu O, 2015, P NATL ACAD SCI USA, V112, P7507, DOI 10.1073/pnas.1504868112; Hauer MH, 2017, GENE DEV, V31, P2204, DOI 10.1101/gad.307702.117; Hegde ML, 2016, ONCOTARGET, V7, P54430, DOI 10.18632/oncotarget.9914; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lan L, 2014, NUCLEIC ACIDS RES, V42, P2330, DOI 10.1093/nar/gkt1233; Layer JV, 2018, P NATL ACAD SCI USA, V115, P10076, DOI 10.1073/pnas.1801591115; Lemaitre C, 2014, GENE DEV, V28, P2450, DOI 10.1101/gad.248369.114; Liu Y, 2020, SCIENCE, V368, P1265, DOI 10.1126/science.aay8204; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; Magnander K, 2012, CANCER LETT, V327, P90, DOI 10.1016/j.canlet.2012.02.013; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Mitrentsi I, 2020, CURR OPIN CELL BIOL, V64, P58, DOI 10.1016/j.ceb.2020.02.014; Moore S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08111-y; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nickoloff JA, 2020, GENES-BASEL, V11, DOI 10.3390/genes11010099; Nishibuchi I, 2014, INT J RADIAT ONCOL, V89, P736, DOI 10.1016/j.ijrobp.2014.03.031; Ochs F, 2019, NATURE, V574, P571, DOI 10.1038/s41586-019-1659-4; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Petrova NV, 2016, AGING-US, V8, P2449, DOI 10.18632/aging.101065; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; Sedelnikova OA, 2010, MUTAT RES-REV MUTAT, V704, P152, DOI 10.1016/j.mrrev.2009.12.005; Sharma V, 2016, ONCOTARGET, V7, P25377, DOI 10.18632/oncotarget.8298; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Singleton BK, 2002, CANCER RES, V62, P6263; Strom CE, 2011, NUCLEIC ACIDS RES, V39, P3166, DOI 10.1093/nar/gkq1241; Sun LX, 2015, NUCLEIC ACIDS RES, V43, P6334, DOI 10.1093/nar/gkv598; Tan R, 2017, METHODS MOL BIOL, V1587, P139, DOI 10.1007/978-1-4939-6892-3_14; Tan R, 2016, ACTA BIOCH BIOPH SIN, V48, P617, DOI 10.1093/abbs/gmw040; Tsouroula K, 2016, MOL CELL, V63, P293, DOI 10.1016/j.molcel.2016.06.002; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Vitor AC, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00024; Watts FZ, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6040047; Wei LZ, 2015, P NATL ACAD SCI USA, V112, pE3495, DOI 10.1073/pnas.1507105112; Whitefield DB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36343-x; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Wu YJ, 2020, MOL THER-NUCL ACIDS, V19, P922, DOI 10.1016/j.omtn.2019.12.026; Xu Y, 2012, MOL CELL, V48, P723, DOI 10.1016/j.molcel.2012.09.026; Yang C, 2017, J AGR FOOD CHEM, V65, P818, DOI 10.1021/acs.jafc.6b04962; Yang JL, 2020, NEUROPATH APPL NEURO, V46, P375, DOI 10.1111/nan.12584; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199	79	3	3	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237759	10.1371/journal.pone.0237759	http://dx.doi.org/10.1371/journal.pone.0237759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332350	Green Published, gold, Green Submitted			2022-12-26	WOS:000601310900086
J	Naroda, Y; Endo, Y; Yoshimura, K; Ishii, H; Ei, SI; Miura, T				Naroda, Yuto; Endo, Yoshie; Yoshimura, Kenji; Ishii, Hiroshi; Ei, Shin-Ichiro; Miura, Takashi			Noise-induced scaling in skull suture interdigitation	PLOS ONE			English	Article							MECHANICAL-BEHAVIOR; FRACTAL DIMENSIONS; CRANIAL SUTURES; MODEL	Sutures, the thin, soft tissue between skull bones, serve as the major craniofacial growth centers during postnatal development. In a newborn skull, the sutures are straight; however, as the skull develops, the sutures wind dynamically to form an interdigitation pattern. Moreover, the final winding pattern had been shown to have fractal characteristics. Although various molecules involved in suture development have been identified, the mechanism underlying the pattern formation remains unknown. In a previous study, we reproduced the formation of the interdigitation pattern in a mathematical model combining an interface equation and a convolution kernel. However, the generated pattern had a specific characteristic length, and the model was unable to produce a fractal structure with the model. In the present study, we focused on the anterior part of the sagittal suture and formulated a new mathematical model with time-space-dependent noise that was able to generate the fractal structure. We reduced our previous model to represent the linear dynamics of the centerline of the suture tissue and included a time-space-dependent noise term. We showed theoretically that the final pattern from the model follows a scaling law due to the scaling of the dispersion relation in the full model, which we confirmed numerically. Furthermore, we observed experimentally that stochastic fluctuation of the osteogenic signal exists in the developing skull, and found that actual suture patterns followed a scaling law similar to that of the theoretical prediction.	[Naroda, Yuto] Kyushu Univ, Sch Med, Fukuoka, Fukuoka, Japan; [Endo, Yoshie; Miura, Takashi] Kyushu Univ, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan; [Yoshimura, Kenji] Osaka City Gen Hosp, Dept Neurol, Osaka, Japan; [Ishii, Hiroshi; Ei, Shin-Ichiro] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido, Japan; [Naroda, Yuto] Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan	Kyushu University; Kyushu University; Osaka City General Hospital; Hokkaido University; Matsuyama Red Cross Hospital	Miura, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan.	miura_t@anat1.med.kyushu-u.ac.jp	Miura, Takashi/AAF-3003-2021	Miura, Takashi/0000-0002-9465-275X; Yoshimura, Kenji/0000-0001-5033-3346; Ishii, Hiroshi/0000-0002-6834-6644	JSPS KAKENHI [15KT0018]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TM: JSPS KAKENHI Grant Number 15KT0018.	Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Cohen M.M., 2000, DIAGNOSIS EVALUATION; Di Ieva A, 2013, CHILD NERV SYST, V29, P893, DOI 10.1007/s00381-013-2061-4; Eden M., 1961, P 4 BERK S MATH STAT, V4, P223; Falconer K., 2003, FRACTAL GEOMETRY; GIBERT J, 1995, J HUM EVOL, V28, P561, DOI 10.1006/jhev.1995.1042; Gorski AZ, 2006, J ANAT, V208, P353, DOI 10.1111/j.1469-7580.2006.00529.x; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Kamioka Y, 2012, CELL STRUCT FUNCT, V37, P65, DOI 10.1247/csf.11045; Khoshhesab MM, 2018, EXTREME MECH LETT, V24, P58, DOI 10.1016/j.eml.2018.09.003; Krug J, 1997, ADV PHYS, V46, P139, DOI 10.1080/00018739700101498; Lin E, 2014, J MATER RES, V29, P1867, DOI 10.1557/jmr.2014.175; LONG CA, 1985, J MORPHOL, V185, P285, DOI 10.1002/jmor.1051850303; LONG CA, 1992, ACTA ANAT, V145, P201; Lynnerup N, 2003, AM J PHYS ANTHROPOL, V121, P332, DOI 10.1002/ajpa.10260; MASUDA Y, 1987, Okajimas Folia Anatomica Japonica, V64, P39; Miura T, 2009, J ANAT, V215, P642, DOI 10.1111/j.1469-7580.2009.01148.x; Monteiro L. R., 2000, Revista Brasileira de Biologia, V60, P689, DOI 10.1590/S0034-71082000000400021; Oota Y, 2006, PHYSICA A, V359, P538, DOI 10.1016/j.physa.2005.05.095; OOTA Y, 2004, FORMA, V19, P197; Opreanu C, 1994, EPHEMERIS NAPOCENSIS, V4, P193; Pozzi F, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20697-x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Takayasu H, 1986, FRACTALS; Torimitsu S, 2015, FORENSIC SCI INT, V249, P101, DOI 10.1016/j.forsciint.2015.01.030; Ungari C, 2012, EUR REV MED PHARMACO, V16, P1559; Yoshimura K, 2016, J THEOR BIOL, V408, P66, DOI 10.1016/j.jtbi.2016.08.003; Yu JC, 2003, CLEFT PALATE-CRAN J, V40, P409, DOI 10.1597/1545-1569(2003)040<0409:AFAOHC>2.0.CO;2; Zollikofer CPE, 2011, J ANAT, V219, P100, DOI 10.1111/j.1469-7580.2011.01386.x	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0235802	10.1371/journal.pone.0235802	http://dx.doi.org/10.1371/journal.pone.0235802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332349	Green Submitted, Green Published, gold			2022-12-26	WOS:000601310900014
J	Joshi, A; Thaploo, D; Yan, XG; Herrmann, T; Khabour, HA; Hummel, T				Joshi, Akshita; Thaploo, Divesh; Yan, Xiaoguang; Herrmann, Theresa; Khabour, Hudaa Alrahman; Hummel, Thomas			A novel technique for olfactory bulb measurements	PLOS ONE			English	Article							VOLUME; NEUROGENESIS; NEURONS	Background To introduce new ways to calculate OB volumes, checking their validity and comparing them to already established technique i.e. OB volumetric based on manual segmentation of OB boundaries. Methods Two approaches were used to calculate OB volumes (1) Manual Segmentation using planimetric manual contouring; (2) Box-frame method, calculating the parameters based on a box placed around the OB. Results We calculated OB volumes using both techniques and found comparable outcomes. High inter-observer reliability was found for volumes calculated by both observers. For manual segmentation, Cronbach's alpha (alpha) was 0.91 and 0.93 for right and left OB volume, respectively, whereas for the box-frame method alpha was 0.94 and 0.90 for right and left OB, respectively. Conclusions The simple box-frame method of OB volume calculation appears reliable. Its results are comparable to an established technique.	[Joshi, Akshita; Thaploo, Divesh; Yan, Xiaoguang; Herrmann, Theresa; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Khabour, Hudaa Alrahman] Jordan Univ Sci & Technol, Irbid, Jordan	Technische Universitat Dresden; Jordan University of Science & Technology	Joshi, A (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.	joshiakshita93@gmail.com		Joshi, Akshita/0000-0002-1861-4698				Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; [Anonymous], 2020, J CLIN ENDOCRINOL ME, V105, pe32; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Breton-Provencher V, 2012, BEHAV BRAIN RES, V227, P480, DOI 10.1016/j.bbr.2011.08.001; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Gudziol V, 2009, J NEUROLOGY; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; Han P, 2019, NEURAL PROCESSING OD, DOI [10.1007/s11682-019-00062-2, DOI 10.1007/S11682-019-00062-2]; HINDS JW, 1981, J COMP NEUROL, V203, P441, DOI 10.1002/cne.902030308; Hummel T, 2013, NEUROSCIENCE, V237, P51, DOI [10.1016/J.neuroscience.2013.01.044, 10.1016/j.neuroscience.2013.01.044]; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Lledo PM, 2004, NEUROSCIENTIST, V10, P292, DOI 10.1177/1073858404263460; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; Lotsch J, 2014, BRAIN STRUCT FUNCT, V219, P1991, DOI 10.1007/s00429-013-0618-3; Mazal PP, 2016, EUR ARCH OTO-RHINO-L, V273, P1, DOI 10.1007/s00405-014-3325-7; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Oleszkiewicz A, 2019, EUR ARCH OTO-RHINO-L, V276, P719, DOI 10.1007/s00405-018-5248-1; Patterson A, 2015, EUR ARCH OTO-RHINO-L, V272, P3593, DOI 10.1007/s00405-015-3524-x; Rombaux P, 2007, AM J RHINOL, V21, P548, DOI 10.2500/ajr.2007.21.3067; Rombaux P, 2012, OTOLARYNG HEAD NECK, V147, P1136, DOI 10.1177/0194599812459704; Slotnick B, 2004, J NEUROSCI, V24, P9195, DOI 10.1523/JNEUROSCI.1936-04.2004; Yousem DM, 1997, ACAD RADIOL, V4, P264, DOI 10.1016/S1076-6332(97)80027-X; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243941	10.1371/journal.pone.0243941	http://dx.doi.org/10.1371/journal.pone.0243941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326498	Green Published, gold			2022-12-26	WOS:000600176400037
J	Umeki, M; Yamashita, H; Suzuki, G; Sato, T; Ohara, S; Koike, K				Umeki, Masami; Yamashita, Hiroshi; Suzuki, Go; Sato, Taiki; Ohara, Shizuka; Koike, Kazuhiko			Fecal pellets of giant clams as a route for transporting Symbiodiniaceae to corals	PLOS ONE			English	Article							FREE-LIVING SYMBIODINIUM; ZOOXANTHELLAE; DIVERSITY; SYMBIOSIS; MICROADRIATICUM; FLEXIBILITY; DINOPHYCEAE; TEMPERATURE; MECHANISM; SEDIMENT	Because more than 80% of species of gamete-spawning corals, including most Acroporidae species, do not inherit Symbiodiniaceae from their parents, they must acquire symbiont cells from sources in their environment. To determine whether photosynthetically competent Symbiodiniaceae expelled as fecal pellets from giant clams are capable of colonizing corals, we conducted laboratory experiments in which planula larvae of Acropora tenuis were inoculated with the cells in fecal pellets obtained from Tridacna crocea. T. crocea fecal pellets were administered once a day, and three days later, cells of Symbiodiniaceae from the fecal pellets had been taken up by the coral larvae. T. crocea fecal pellets were not supplied from the 4th day until the 8th day, and the cell densities in the larvae increased until the 8th day, which indicated the successful colonization by Symbiodiniaceae. The control group exhibited the highest mean percentage of larvae (100%) that were successfully colonized by culture strains of Symbiodiniaceae, and larvae inoculated with fecal pellets reached a colonization percentage of 66.7 similar to 96.7% on the 8th day. The highest colonization rate was achieved with the fecal pellets containing cells with high photosynthetic competency (Fv/Fm). Interestingly, the genetic composition of Symbiodiniaceae in the larvae retrieved on the 8th day differed from that in the fecal pellets and showed exclusive domination of the genus Symbiodinium. A minor but significant population of the genus Cladocopium in the fecal pellets was not inherited by the larvae. These experiments provided the first demonstration that the Symbiodiniaceae from tridacnine clams provided via fecal pellets can colonize and even proliferate in coral larvae.	[Umeki, Masami; Sato, Taiki; Ohara, Shizuka; Koike, Kazuhiko] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan; [Yamashita, Hiroshi; Suzuki, Go] Japan Fisheries Res & Educ Agcy, Fisheries Technol Inst, Onna, Okinawa, Japan	Hiroshima University; Japan Fisheries Research & Education Agency (FRA)	Koike, K (corresponding author), Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan.	kazkoike@hiroshima-u.ac.jp		Kazuhiko, Koike/0000-0001-5380-5839; Ohara, Shizuka/0000-0002-1207-6921	MEXT/JSPS KAKENHI [18K19232]; Japan Science Society	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society	This work was supported by MEXT/JSPS KAKENHI Grant Number 18K19232 to KK and Sasakawa Scientific Research Grant fDrom The Japan Science Society to MU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2009, MAR ECOL PROG SER, V377, P149, DOI 10.3354/meps07834; Baghdasarian G, 2000, BIOL BULL-US, V199, P278, DOI 10.2307/1543184; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Bay Line Kolind, 2011, Diversity, V3, P356; Bhagooli R, 2004, MAR BIOL, V145, P329, DOI 10.1007/s00227-004-1309-7; BLANK RJ, 1986, TAXON, V35, P286, DOI 10.2307/1221270; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Cumbo VR, 2013, CORAL REEFS, V32, P111, DOI 10.1007/s00338-012-0951-7; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; FITT WK, 1986, AQUACULTURE, V55, P5, DOI 10.1016/0044-8486(86)90051-7; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Fujise L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114321; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Gabay Y, 2019, ISME J, V13, P2489, DOI 10.1038/s41396-019-0429-5; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; Ikeda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172285; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; Lee SY, 2015, EUR J PHYCOL, V50, P155, DOI 10.1080/09670262.2015.1018336; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Maruyama T, 1997, MAR BIOL, V127, P473, DOI 10.1007/s002270050035; Mies M, 2019, CORAL REEFS, V38, P1067, DOI 10.1007/s00338-019-01857-x; Morishima SY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220141; Nitschke MR, 2015, CORAL REEFS, V34, P161, DOI 10.1007/s00338-014-1220-8; NORTON JH, 1992, BIOL BULL, V183, P503, DOI 10.2307/1542028; Oh-Uchi, 2007, GALAXEA, V9, P1, DOI DOI 10.3755/JCRS.9.1; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; Quigley KM, 2018, HEREDITY, V121, P524, DOI 10.1038/s41437-018-0059-0; Quigley KM, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00401; R Core Team, 2020, R LANG ENV STAT COMP; Ralph PJ, 2001, MAR ECOL PROG SER, V220, P163, DOI 10.3354/meps220163; Reaka-Kudla ML, 1997, GLOBAL BIODIVERSITY, P83; Reaka-Kudla ML, 2005, CARIBBEAN MARINE BIO, P259; Reimer James Davis, 2010, Marine Biodiversity, V40, P237, DOI 10.1007/s12526-010-0044-1; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Suzuki G, 2020, FISHERIES SCI, V86, P665, DOI 10.1007/s12562-020-01425-1; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; TRENCH RK, 1981, BIOL BULL-US, V161, P180, DOI 10.2307/1541117; Yamashita H, 2013, CORAL REEFS, V32, P355, DOI 10.1007/s00338-012-0980-2; Yamashita H, 2018, MAR ECOL PROG SER, V592, P119, DOI 10.3354/meps12474; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097003; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z; Yuyama I, 2005, BIOCHEM BIOPH RES CO, V336, P793, DOI 10.1016/j.bbrc.2005.08.174	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243087	10.1371/journal.pone.0243087	http://dx.doi.org/10.1371/journal.pone.0243087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326418	gold, Green Published			2022-12-26	WOS:000600176400013
J	Zhu, KX; Jiang, S; Han, L; Wang, MM; Wang, XY				Zhu, Ke-Xin; Jiang, Shan; Han, Lei; Wang, Ming-Ming; Wang, Xing-Ya			Fine-scale genetic structure of the overwintering Chilo suppressalis in the typical bivoltine areas of northern China	PLOS ONE			English	Article							RICE STEM BORER; SPATIAL AUTOCORRELATION ANALYSIS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; WALKER LEPIDOPTERA; SOFTWARE; DISPERSAL; DISTANCE	The rice stem borer (RSB), Chilo suppressalis (Lepidoptera: Pyralidae), is an important agricultural pest that has caused serious economic losses in the major rice-producing areas of China. To effectively control this pest, we investigated the genetic diversity, genetic differentiation and genetic structure of 16 overwintering populations in the typical bivoltine areas of northern China based on 12 nuclear microsatellite loci. Moderate levels of genetic diversity and genetic differentiation among the studied populations were detected. Neighbour-joining dendrograms, Bayesian clustering and principal coordinate analysis (PCoA) consistently divided these populations into three genetic clades: western, eastern and northern/central. Isolation by distance (IBD) and spatial autocorrelation analyses demonstrated no correlation between genetic distance and geographic distance. Bottleneck analysis illustrated that RSB populations had not undergone severe bottleneck effects in these regions. Accordingly, our results provide new insights into the genetic relationships of overwintering RSB populations and thus contribute to developing effective management strategies for this pest.	[Zhu, Ke-Xin; Jiang, Shan; Han, Lei; Wang, Ming-Ming; Wang, Xing-Ya] Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Wang, XY (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China.	wangxingya20081@163.com		Jiang, Shan/0000-0002-1976-1278	Scientific Research Project of Education Department of Liaoning Province (Basic Research Program of Natural Science) [LSNJC202008]; National Key Research and Development Program of China [2018YFD0200200]; National Natural Science Foundation of China [31871950]; Science and Technology Plan of Liaoning Province [2019JH2/10200012]	Scientific Research Project of Education Department of Liaoning Province (Basic Research Program of Natural Science); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Liaoning Province	This work was supported by the Scientific Research Project of Education Department of Liaoning Province (Basic Research Program of Natural Science) (LSNJC202008); The National Key Research and Development Program of China (2018YFD0200200); The National Natural Science Foundation of China (Grant No. 31871950); The Science and Technology Plan of Liaoning Province 2019JH2/10200012).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aggarwal RAK, 2007, CURR SCI INDIA, V92, P1133; Andras JP, 2018, MOL ECOL, V27, P1371, DOI 10.1111/mec.14545; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2018, J EARLY REPUBLIC, V38, P61; Avise JC, 2000, PHYLOGEOGRAPHY HIST, V447; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen WenMing, 2009, Scientia Agricultura Sinica, V42, P1100; Cornuet JM, 1996, GENETICS, V144, P2001; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epperson BK, 1997, EVOLUTION, V51, P672, DOI 10.1111/j.1558-5646.1997.tb03651.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fairley TL, 2000, J MED ENTOMOL, V37, P754, DOI 10.1603/0022-2585-37.5.754; Falush D, 2003, GENETICS, V164, P1567; Farahpour Haghani A, 2014, PLANT PROTECT SCI, V50, P26, DOI 10.17221/5/2013-PPS; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Ishiguro N, 2006, APPL ENTOMOL ZOOL, V41, P565, DOI 10.1303/aez.2006.565; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Ju MM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00965; Khan ZR, 1991, WORLD BIBLIO RICE ST; Kim KS, 2013, J ASIA-PAC ENTOMOL, V16, P87, DOI 10.1016/j.aspen.2012.11.004; KIRITANI K, 1979, ANNU REV ENTOMOL, V24, P279, DOI 10.1146/annurev.en.24.010179.001431; Li AX, 1996, CHILO SUPPRESSALIS I; Li GL, 1999, J SHENYANG AGR U, P93; Liu YD, 2013, J INTEGR AGR, V12, P1033, DOI 10.1016/S2095-3119(13)60481-5; Liu YD, 2009, MOL ECOL RESOUR, V9, P180, DOI 10.1111/j.1755-0998.2008.02432.x; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; PATHAK MD, 1968, ANNU REV ENTOMOL, V13, P257, DOI 10.1146/annurev.en.13.010168.001353; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK., 2010, DOCUMENTATION STRUCT; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rashed R, 2014, ARAB SCI PHILOS, V24, P1, DOI 10.1017/S0957423913000088; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Shayanmehr M., 2016, Journal of Entomological and Acarological Research, V48, P360, DOI 10.4081/jear.2016.5507; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Su JW, 2003, ENTOMOLOGICAL KNOWLE, P323; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tang XT, 2016, MITOCHONDRIAL DNA A, V27, P1567, DOI 10.3109/19401736.2014.958670; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yin LA, 2001, LIAONING AGR SCI, P52, DOI DOI 10.3969/J.ISSN.1002-1728.2001.05.020	54	0	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243999	10.1371/journal.pone.0243999	http://dx.doi.org/10.1371/journal.pone.0243999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326485	gold, Green Published			2022-12-26	WOS:000600176400062
J	Schweiss, VR; Rakocinski, CF				Schweiss, Virginia R.; Rakocinski, Chet F.			Destabilizing effects on a classic tri-trophic oyster-reef cascade	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; PREDATOR-PREY INTERACTIONS; COMPLEXITY; INTERFERENCE; COMMUNITY; OMNIVORY; FISH; FACILITATION; SURVIVAL; CRABS	How interactions among multiple predators affect the stability of trophic cascades is a topic of special ecological interest. To examine factors affecting the stability of the classic tri-trophic oyster reef cascade within a different context, configurations of three predators, including the Gulf toadfish, Gulf stone crab, and oystershell mud crab, were manipulated together with either oyster shell or limestone gravel substrate within a multiple predator effects (MPE) experiment. Additionally, a complimentary set of trait-mediated-indirect interaction (TMII) experiments examined the inhibition of oyster consumption relative to mud-crab size and top predator identity in the absence of other cues and factors. The classic tri-trophic cascade formed by the toadfish-mud crab-oyster configuration was potentially weakened by several interactions within the MPE experiment. Consumption of oysters and mud crabs by the intraguild stone crab was undeterred by the presence of toadfish. Although mud crab feeding was inhibited in the presence of both toadfish and stone crabs, estimated non-consumptive effects (NCEs) were weaker for stone crabs in the MPE experiment. Consequently, the total effect was destabilizing when all three predator species were together. Inhibition of mud crab feeding was inversely related to direct predation on mud crabs within the MPE experiment. Complimentary TMII experiments revealed greater inhibition of mud crab feeding in response to stone crabs under sparse conditions. TMII experiments also implied that inhibition of mud crab feeding could have largely accounted for NCEs relative to oysters within the MPE experiment, as opposed to interference by other mud crabs or top predators. An inverse relationship between mud crab size and NCE strength in the TMII experiment disclosed another potentially destabilizing influence on the tri-trophic-cascade. Finally, although habitat complexity generally dampened the consumption of oysters across MPE treatments, complex habitat promoted mud crab feeding in the presence of toadfish alone. This study underscores how ecological interactions can mediate trophic cascades and provides some additional insights into the trophic dynamics of oyster reefs for further testing under natural conditions.	[Schweiss, Virginia R.; Rakocinski, Chet F.] Univ Southern Mississippi, Gulf Coast Res Lab, Sch Ocean Sci & Engn, Div Coastal Sci, Ocean Springs, MS 39564 USA	University of Southern Mississippi	Rakocinski, CF (corresponding author), Univ Southern Mississippi, Gulf Coast Res Lab, Sch Ocean Sci & Engn, Div Coastal Sci, Ocean Springs, MS 39564 USA.	chet.rakocinski@usm.edu						ABBE GR, 1992, AQUACULTURE, V107, P21, DOI 10.1016/0044-8486(92)90047-O; ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; BISKER R, 1989, Journal of Shellfish Research, V8, P25; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Crowder LB, 1997, ECOLOGY, V78, P1796; DIEHL S, 1992, ECOLOGY, V73, P1646, DOI 10.2307/1940017; Fleer VR, 2017, THESIS; Fodrie FJ, 2008, ECOLOGY, V89, P3268, DOI 10.1890/07-1679.1; Freeman A, 2006, BEHAV ECOL, V17, P182, DOI 10.1093/beheco/arj014; Geraldi NR, 2015, ECOLOGY, V96, P2533, DOI 10.1890/14-1026.1; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Grason EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051322; Griffen BD, 2006, OECOLOGIA, V146, P608, DOI 10.1007/s00442-005-0211-4; Hermann SL, 2017, CURR OPIN INSECT SCI, V20, P54, DOI 10.1016/j.cois.2017.03.010; HIDU H, 1974, Proceedings National Shellfisheries Association, V65, P13; Hill JM, 2013, MAR ECOL PROG SER, V488, P209, DOI 10.3354/meps10386; Hill JM, 2013, OECOLOGIA, V172, P79, DOI 10.1007/s00442-012-2488-4; HOLM S, 1979, SCAND J STAT, V6, P65; Hughes AR, 2006, OECOLOGIA, V149, P256, DOI 10.1007/s00442-006-0439-7; Hughes AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044839; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Johnson KD, 2014, MAR ECOL PROG SER, V507, P197, DOI 10.3354/meps10815; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Kuykendall KM, 2015, J SHELLFISH RES, V34, P217, DOI 10.2983/035.034.0203; La Peyre M, 2014, OCEAN COAST MANAGE, V89, P20, DOI 10.1016/j.ocecoaman.2013.12.002; LITTLER MM, 1989, OECOLOGIA, V80, P331, DOI 10.1007/BF00379034; Macreadie PI, 2012, MAR ECOL PROG SER, V466, P145, DOI 10.3354/meps09986; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; MURDOCH W W, 1975, P1; O'Connor NE, 2008, ECOLOGY, V89, P428, DOI 10.1890/06-2029.1; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Raffaelli D, 2007, ENERGETICS ECOSYSTEM; Rindone RR, 2011, J EXP MAR BIOL ECOL, V407, P216, DOI 10.1016/j.jembe.2011.06.018; SCHMITT RJ, 1987, ECOLOGY, V68, P1887, DOI 10.2307/1939880; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Schneider FD, 2012, ECOL LETT, V15, P436, DOI 10.1111/j.1461-0248.2012.01750.x; SCHRIVER P, 1995, FRESHWATER BIOL, V33, P255, DOI 10.1111/j.1365-2427.1995.tb01166.x; Shervette VR, 2004, J CRUSTACEAN BIOL, V24, P652, DOI 10.1651/C-2453; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; SONIAT T M, 1991, Journal of Shellfish Research, V10, P405; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Swisher BJ, 1998, OIKOS, V81, P30, DOI 10.2307/3546464; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wong MC, 2010, MAR ECOL PROG SER, V409, P143, DOI 10.3354/meps08621; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461	55	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242965	10.1371/journal.pone.0242965	http://dx.doi.org/10.1371/journal.pone.0242965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320866	gold, Green Published			2022-12-26	WOS:000600339800034
J	Yu, ZY; Jiang, XY; Qin, L; Deng, HX; Wang, JL; Ren, W; Li, HB; Zhao, L; Liu, HX; Yan, H; Shi, WG; Wang, Q; Luo, CJ; Long, B; Zhou, HN; Sun, H; Jiao, ZY				Yu, Zeyuan; Jiang, Xiangyan; Qin, Long; Deng, Haixiao; Wang, Jianli; Ren, Wen; Li, Hongbin; Zhao, Lei; Liu, Huanxiang; Yan, Hong; Shi, Wengui; Wang, Qi; Luo, Changjiang; Long, Bo; Zhou, Huinian; Sun, Hui; Jiao, Zuoyi			A novel UBE2T inhibitor suppresses Wnt/beta-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination	ONCOGENE			English	Article							CONJUGATING ENZYME UBE2T; E2; WNT; METHYLATION; PROMOTER; PATHWAY; FANCD2; BINDS; DNA	Dysregulation of the Wnt/beta-catenin signaling pathway is critically involved in gastric cancer (GC) progression. However, current Wnt pathway inhibitors being studied in preclinical or clinical settings for other cancers such as colorectal and pancreatic cancers are either too cytotoxic or insufficiently efficacious for GC. Thus, we screened new potent targets from beta-catenin destruction complex associated with GC progression from clinical samples, and found that scaffolding protein RACK1 deficiency plays a significant role in GC progression, but not APC, AXIN, and GSK3 beta. Then, we identified its upstream regulator UBE2T which promotes GC progression via hyperactivating the Wnt/beta-catenin signaling pathway through the ubiquitination and degradation of RACK1 at the lysine K172, K225, and K257 residues independent of an E3 ligase. Indeed, UBE2T protein level is negatively associated with prognosis in GC patients, suggesting that UBE2T is a promising target for GC therapy. Furthermore, we identified a novel UBE2T inhibitor, M435-1279, and suggested that M435-1279 acts inhibit the Wnt/beta-catenin signaling pathway hyperactivation through blocking UBE2T-mediated degradation of RACK1, resulting in suppression of GC progression with lower cytotoxicity in the meantime. Overall, we found that increased UBE2T levels promote GC progression via the ubiquitination of RACK1 and identified a novel potent inhibitor providing a balance between growth inhibition and cytotoxicity as well, which offer a new opportunity for the specific GC patients with aberrant Wnt/beta-catenin signaling.	[Yu, Zeyuan; Jiang, Xiangyan; Deng, Haixiao; Luo, Changjiang; Long, Bo; Zhou, Huinian; Jiao, Zuoyi] Lanzhou Univ, Hosp 2, Dept Gen Surg, Lanzhou 730000, Gansu, Peoples R China; [Qin, Long; Wang, Jianli; Ren, Wen; Li, Hongbin; Zhao, Lei; Shi, Wengui; Sun, Hui; Jiao, Zuoyi] Lanzhou Univ, Hosp 2, Cuiying Expt Ctr, Lanzhou 730000, Gansu, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Gansu, Peoples R China; [Yan, Hong] Lanzhou Univ, Hosp 2, Dept Pathol, Lanzhou 730000, Gansu, Peoples R China; [Wang, Qi] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Ctr, Boston, MA 02215 USA	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Jiao, ZY (corresponding author), Lanzhou Univ, Hosp 2, Dept Gen Surg, Lanzhou 730000, Gansu, Peoples R China.; Sun, H; Jiao, ZY (corresponding author), Lanzhou Univ, Hosp 2, Cuiying Expt Ctr, Lanzhou 730000, Gansu, Peoples R China.	yaohy04@126.com; jiaozy@lzu.edu.cn	ZHOU, Huinian/AAD-9279-2022	Jiang, Xiangyan/0000-0002-2685-2899; Liu, Huanxiang/0000-0002-9284-3667; Jiao, Zuoyi/0000-0003-1942-0905	National Natural Science Foundation of China [31670847]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31670847).	Abdi E, 2019, CANCER MED-US, V8, P6114, DOI 10.1002/cam4.2497; Ajani JA, 2016, J NATL COMPR CANC NE, V14, P1286, DOI 10.6004/jnccn.2016.0137; Al-Batran SE, 2019, LANCET, V393, P1948, DOI 10.1016/S0140-6736(18)32557-1; Alagpulinsa DA, 2019, BLOOD ADV, V3, P3968, DOI 10.1182/bloodadvances.2019000181; Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bang YJ, 2010, LANCET, V376, P1302; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cats A, 2018, LANCET ONCOL, V19, P616, DOI 10.1016/S1470-2045(18)30132-3; Chiurillo MA, 2015, WORLD J EXP MED, V5, P84, DOI [10.5493/wjem.v5.i2.84, DOI 10.5493/wjem.v5.i2.84, DOI 10.5493/WJEM.V5.I2.84]; Clement G, 2004, CANCER RES, V64, P6867, DOI 10.1158/0008-5472.CAN-03-2503; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Day JP, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2018-0022; Deng YZ, 2012, GASTROENTEROLOGY, V142, P812, DOI 10.1053/j.gastro.2011.12.046; Dzobo K, 2019, OMICS, V23, P517, DOI 10.1089/omi.2019.0147; Fischer AS, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7020044; Flanagan DJ, 2019, CANCER RES, V79, P5901, DOI 10.1158/0008-5472.CAN-19-1362; Fomenkov A, 2004, CELL CYCLE, V3, P1285, DOI 10.4161/cc.3.10.1155; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gomez-Martin C, 2012, J CLIN PATHOL, V65, P751, DOI 10.1136/jclinpath-2012-200774; Jung YS, 2020, EXP MOL MED, V52, P183, DOI 10.1038/s12276-020-0380-6; Lee DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5423; Liu LL, 2019, CANCER MANAG RES, V11, P8359, DOI 10.2147/CMAR.S202631; Liu NN, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2351-9; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; Luo CJ, 2017, ONCOTARGET, V8, P32639, DOI 10.18632/oncotarget.15947; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Mao J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.515; Mazzoni SM, 2014, CANCER LETT, V355, P1, DOI 10.1016/j.canlet.2014.09.018; Morreale FE, 2017, J MED CHEM, V60, P8183, DOI 10.1021/acs.jmedchem.7b01071; Morreale FE, 2017, J MED CHEM, V60, P4093, DOI 10.1021/acs.jmedchem.7b00147; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Palle J, 2020, DRUGS, V80, P401, DOI 10.1007/s40265-020-01272-5; Pan KF, 2008, WORLD J GASTROENTERO, V14, P1570, DOI 10.3748/wjg.14.1570; Perez-Pena J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17836-7; Rickman KA, 2015, CELL REP, V12, P35, DOI 10.1016/j.celrep.2015.06.014; Sadowski M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-19; Tan CQ, 2014, PHARMACOECONOMICS, V32, P235, DOI 10.1007/s40273-013-0065-2; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809; van Kappel EC, 2017, BRIT J PHARMACOL, V174, P4575, DOI 10.1111/bph.13922; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Yang HJ, 2018, GASTRIC CANCER, V21, P237, DOI 10.1007/s10120-017-0741-6; Yin J, 2020, J ENVIRON SCI, V89, P65, DOI 10.1016/j.jes.2019.09.025	47	22	24	2	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					1027	1042		10.1038/s41388-020-01572-w	http://dx.doi.org/10.1038/s41388-020-01572-w		DEC 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33323973	Green Published, hybrid			2022-12-26	WOS:000599126500004
J	Shih, KT; Huang, YY; Yang, CY; Cheng, MF; Tien, YW; Shiue, CY; Yen, RF; Hsin, LW				Shih, Kai-Ting; Huang, Ya-Yao; Yang, Chia-Ying; Cheng, Mei-Fang; Tien, Yu-Wen; Shiue, Chyng-Yann; Yen, Rouh-Fang; Hsin, Ling-Wei			Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[F-18]fluoropropyl)-L-glutamic acid ([F-18]FSPG) for clinical use	PLOS ONE			English	Article							X(C)(-) TRANSPORTER ACTIVITY; SYSTEM XC(-); PET; (4S)-4-(3-F-18-FLUOROPROPYL)-L-GLUTAMATE	(4S)-4-(3-[F-18]Fluoropropyl)-L-glutamic acid ([F-18]FSPG) is a positron emission tomography (PET) imaging agent for measuring the system x(C)(-) transporter activity. It has been used for the detection of various cancers and metastasis in clinical trials. [F-18]FSPG is also a promising diagnostic tool for evaluation of multiple sclerosis, drug resistance in chemotherapy, inflammatory brain diseases, and infectious lesions. Due to the very short half-life (110 min) of F-18 nuclide, [F-18]FSPG needs to be produced on a daily basis; therefore, fast and efficient synthesis and analytical methods for quality control must be established to assure the quality and safety of [F-18]FSPG for clinical use. To manufacture cGMP-compliant [F-18]FSPG, all four nonradioactive stereoisomers of FSPG were prepared as reference standards for analysis. (2S,4S)-1 and (2R,4R)-1 were synthesized starting from protected L- and D-glutamate derivatives in three steps, whereas (2S,4R)-1 and (2R,4S)-1 were prepared in three steps from protected (S)- and (R)-pyroglutamates. A chiral HPLC method for simultaneous determination of four FSPG stereoisomers was developed by using a 3-cm Chirex 3126 column and a MeCN/CuSO4(aq) mobile phase. In this method, (2R,4S)-1, (2S,4S)-1, (2R,4R)-1, and (2S,4R)-1 were eluted in sequence with sufficient resolution in less than 25 min without derivatization. Scale-up synthesis of intermediates for the production of [F-18]FSPG in high optical purity was achieved via stereo-selective synthesis or resolution by recrystallization. The enantiomeric excess of intermediates was determined by HPLC using a Chiralcel OD column and monitored at 220 nm. The nonradioactive precursor with >98% ee can be readily distributed to other facilities for the production of [F-18]FSPG. Based on the above accomplishments, cGMP-compliant [F-18]FSPG met the acceptance criteria in specifications and was successfully manufactured for human use. It has been routinely prepared and used in several pancreatic ductal adenocarcinoma metastasis-related clinical trials.	[Shih, Kai-Ting; Yang, Chia-Ying; Hsin, Ling-Wei] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Huang, Ya-Yao; Cheng, Mei-Fang; Shiue, Chyng-Yann; Yen, Rouh-Fang; Hsin, Ling-Wei] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Huang, Ya-Yao; Shiue, Chyng-Yann; Yen, Rouh-Fang; Hsin, Ling-Wei] Natl Taiwan Univ, Mol Imaging Ctr, Mol Probes Dev Core, Taipei, Taiwan; [Huang, Ya-Yao] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan; [Tien, Yu-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Hsin, Ling-Wei] Natl Taiwan Univ, Ctr Innovat Therapeut Discovery, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Hsin, LW (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ, Mol Imaging Ctr, Mol Probes Dev Core, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ, Ctr Innovat Therapeut Discovery, Taipei, Taiwan.	lwhsin@ntu.edu.tw	CHENG, MEIFANG/AAV-8665-2021	CHENG, MEIFANG/0000-0002-9359-0606; HSIN, LING-WEI/0000-0001-5018-4491; YEN, RUOH-FANG/0000-0003-1648-6482; TIEN, YU-WEN/0000-0002-9126-2705	Ministry of Science and Technology of the Republic of China [MOST 103-2320-B002-012-MY3, 105-2321-B-002-040]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was financially supported by the Ministry of Science and Technology of the Republic of China (Grant No. MOST 103-2320-B002-012-MY3 and 105-2321-B-002-040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek S, 2013, J NUCL MED, V54, P117, DOI 10.2967/jnumed.112.108704; Baek S, 2012, CLIN CANCER RES, V18, P5427, DOI 10.1158/1078-0432.CCR-12-0214; Berndt M, 2013, Method for production of f-18 labeled glutamic acid derivatives patent, Patent No. [US20130149243A1, 20130149243]; Chae SY, 2016, J NUCL MED, V57, P67, DOI 10.2967/jnumed.115.164020; Cheng MF, 2019, EUR J NUCL MED MOL I, V46, P810, DOI 10.1007/s00259-018-4251-5; Domercq M, 2016, THERANOSTICS, V6, P1753, DOI 10.7150/thno.15616; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; EZQUERRA J, 1992, TETRAHEDRON LETT, V33, P5589, DOI 10.1016/S0040-4039(00)61153-X; EZQUERRA J, 1993, TETRAHEDRON, V49, P8665, DOI 10.1016/S0040-4020(01)96272-6; Greenwood HE, 2019, CLIN CANCER RES, V25, P2471, DOI 10.1158/1078-0432.CCR-18-3423; Hoehne A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1080-1; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Kavanaugh G, 2016, MOL IMAGING BIOL, V18, P924, DOI 10.1007/s11307-016-1007-0; Koglin N, 2011, CLIN CANCER RES, V17, P6000, DOI 10.1158/1078-0432.CCR-11-0687; Lee HS, 2019, CANCER RES, V79, P701, DOI 10.1158/0008-5472.CAN-18-4034; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Magarik MA, 2018, CLIN NUCL MED, V43, P28, DOI 10.1097/RLU.0000000000001883; Martin A, 2016, EUR J NUCL MED MOL I, V43, P1124, DOI 10.1007/s00259-015-3275-3; McCormick PN, 2019, CANCER RES, V79, P853, DOI 10.1158/0008-5472.CAN-18-2634; Mittra ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148628; Mosci C, 2016, RADIOLOGY, V279, P898, DOI 10.1148/radiol.2015142000; Qu WC, 2011, J AM CHEM SOC, V133, P1122, DOI 10.1021/ja109203d; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shooli H, 2019, QUANT IMAG MED SURG, V9, P1597, DOI 10.21037/qims.2019.08.16	24	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243831	10.1371/journal.pone.0243831	http://dx.doi.org/10.1371/journal.pone.0243831			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315962	gold, Green Published			2022-12-26	WOS:000600186100041
J	Xu, XQ; Zhu, TT; Shi, TT; Chen, J; Jin, L				Xu, Xiaoqiong; Zhu, Tiantian; Shi, Tingting; Chen, Juan; Jin, Ling			Quality suitability regionalization analysis of Angelica sinensis in Gansu, China	PLOS ONE			English	Article							ROOT	The genus Angelica encompasses 80 species worldwide. Among them, only Angelica sinensis is widely used in China and Japan. To explore the quality and geographical distribution of A. sinensis, we collected 1,530 plants from Gansu Province and analyzed them for their contents of chlorogenic acid (CA), ferulic acid (FA), senkyunolide I(SI), senkyunolide A(SA), senkyunolide H (SH), coniferyl ferulate (CF), ligustilide (LI), and butenyl phthalide (BP) using UPLC. We also assessed the relationship between the ecological environment and quality of A. sinensis through maximum entropy modeling and a geographical information system. The habitat suitability distribution demonstrated that the most influential ecological factors for the growth of A. sinensis were altitude, precipitation during March, May, and December, precipitation during the wettest month, and the soil pH. The most suitable areas for cultivation are concentrated to the south of Gansu Province, including Linxia Hui Autonomous Prefecture, Dingxi City, Tianshui City, south of Wuwei City, east of Gannan Tibetan Autonomous Prefecture, north of Longnan City, and northwest of Pingliang City. The quality suitability regionalization analysis divulged that the most influential ecological factors for the index components of A. sinensis were the altitude, sunshine, rainfall, temperature, and soil pH. The highest quality A. sinensis grow in Dingxi City, Tangchang, Lixian, and Wen counties in Longnan City, Wushan County in Tianshui City, Lintan, Zhouqu, and Zhuoni counties in Gannan Tibetan Autonomous Prefecture, Kangle and Linxia counties in Linxia Hui Autonomous Prefecture. The experiment yielded highly accurate results (accuracy of 0.955), suggesting that the results were consistent with the actual distribution of A. sinensis in Gansu. The inferences of this research will naturally draw the attention of the authorities in the fields of natural resources and agriculture departments and provide a scientific basis for the rational selection of A. sinensis cultivation areas.	[Xu, Xiaoqiong; Zhu, Tiantian; Jin, Ling] Gansu Univ Chinese Med, Sch Pharm, Lanzhou, Gansu, Peoples R China; [Xu, Xiaoqiong] Gansu Med Coll, Pingliang, Gansu, Peoples R China; [Shi, Tingting] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat, State Key Lab Breeding Base Dao Di Herbs, Beijing, Peoples R China; [Chen, Juan] Lanzhou Univ, Sch Pharm, Lanzhou, Gansu, Peoples R China; [Jin, Ling] Res Inst Chinese Tibetan Med Resources, Lanzhou, Gansu, Peoples R China	Gansu University of Chinese Medicine; Gansu Medical College; China Academy of Chinese Medical Sciences; Lanzhou University	Jin, L (corresponding author), Gansu Univ Chinese Med, Sch Pharm, Lanzhou, Gansu, Peoples R China.; Jin, L (corresponding author), Res Inst Chinese Tibetan Med Resources, Lanzhou, Gansu, Peoples R China.	xxq198498@163.com		xu, xiaoqiong/0000-0002-7624-2976	National Natural Science Foundation of China [81360615];  [Y520000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	Initials of the author who received each award: L J Grant number awarded to the author: 81360615 The full name of each funder: National Natural Science Foundation of China URL of each funder website: http://www.nsfc.gov.cn/Specific grant numbers: Y520000.	Chinese Academy of Sciences China vegetation map editor commttee, 2007, VEG MAP PEOPL REP CH; Computer network information center Chinese academy of sciences., 2015, GEOSPATIAL DATA CLOU; de Oliveira JB, 2019, FOOD RES INT, V121, P870, DOI 10.1016/j.foodres.2019.01.011; Hook ILI, 2014, J ETHNOPHARMACOL, V152, P1, DOI 10.1016/j.jep.2013.12.018; Jeong SY, 2015, CHEM PHARM BULL, V63, P504, DOI 10.1248/cpb.c15-00081; Kan WLT, 2008, J ETHNOPHARMACOL, V120, P36, DOI 10.1016/j.jep.2008.07.027; Katoh A, 2011, AM J CHINESE MED, V39, P757, DOI 10.1142/S0192415X11009172; Li ZY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48397-6; Lima VA, 2017, AN ACAD BRAS CIENC, V89, P1167, DOI 10.1590/0001-3765201720150770; National Meteorological Information Center China Meteorological Administration., 2015, CHIN MET DAT NETW; Shang Zhong-hui, 2015, Zhong Yao Cai, V38, P1370; Shao M, 2011, PLANTA MED, V77, P809, DOI 10.1055/s-0030-1250573; Tang SN, 2015, CANCER PREV RES, V8, P835, DOI 10.1158/1940-6207.CAPR-15-0051; The Lancet Global Health, 2016, LANCET GLOB HEALTH, V4, pe427; The Office for the second National Soil Survey of China, 1996, SOIL SER CHIN; Walden-Schreiner C, 2017, J ENVIRON MANAGE, V193, P52, DOI 10.1016/j.jenvman.2017.01.076; Wei WL, 2016, J ETHNOPHARMACOL, V190, P116, DOI 10.1016/j.jep.2016.05.023; Yan Hui, 2016, Zhongguo Zhong Yao Za Zhi, V41, P3139, DOI 10.4268/cjcmm20161705; Yan JJ, 2013, BIOL PHARM BULL, V36, P140, DOI 10.1248/bpb.b12-00798; Ojeda-Perez ZZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186540; Zhao L, 2012, FITOTERAPIA, V83, P1712, DOI 10.1016/j.fitote.2012.09.029; Zhu SD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42417	22	4	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243750	10.1371/journal.pone.0243750	http://dx.doi.org/10.1371/journal.pone.0243750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315941	Green Published, gold			2022-12-26	WOS:000600186100068
J	Rocha, JC; Schill, C; Saavedra-Diaz, LM; Moreno, RD; Maldonado, JH				Rocha, Juan C.; Schill, Caroline; Saavedra-Diaz, Lina M.; Moreno, Rocio del Pilar; Maldonado, Jorge Higinio			Cooperation in the face of thresholds, risk, and uncertainty: Experimental evidence in fisher communities from Colombia	PLOS ONE			English	Article							REGIME SHIFTS; CLIMATE; RESOURCES; INSIGHTS	Cooperation is thought to be a necessary condition to solve collective action dilemmas such as climate change or the sustainable use of common pool resources. Yet, it is poorly understood how situations pervaded by thresholds shape the behaviour of people facing collective dilemmas. Here we provide empirical evidence that resource users facing thresholds maintain on average cooperative behaviours in the sense of maximising their individual earnings while ensuring future group opportunities. A framed field experiment in the form of a dynamic game with 256 Colombian fishers helped us investigate individual behavioural responses to the existence of thresholds, risk and uncertainty. Thresholds made fishers extract less fish compared to situation without thresholds, but risk had a stronger effect on reducing individual fishing effort. Contrary to previous expectations, cooperation did not break down. If cooperation can be maintained in the face of thresholds, then communicating uncertainty is more policy-relevant than estimating precisely where tipping points lay in social-ecological systems.	[Rocha, Juan C.; Schill, Caroline] Swedish Royal Acad Sci, Beijer Inst, Stockholm, Sweden; [Rocha, Juan C.; Schill, Caroline] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Rocha, Juan C.] Future Earth, Stockholm, Sweden; [Rocha, Juan C.] South Amer Inst Resilience & Sustainabil Studies, Maldonado, Uruguay; [Saavedra-Diaz, Lina M.] Univ Magdalena, Programa Biol, Santa Marta, Colombia; [Moreno, Rocio del Pilar; Maldonado, Jorge Higinio] Univ Los Andes, Fac Econ, Bogota, Cundinamarca, Colombia	Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; Stockholm University; Universidad del Magdalena; Universidad de los Andes (Colombia)	Rocha, JC (corresponding author), Swedish Royal Acad Sci, Beijer Inst, Stockholm, Sweden.; Rocha, JC (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.; Rocha, JC (corresponding author), Future Earth, Stockholm, Sweden.; Rocha, JC (corresponding author), South Amer Inst Resilience & Sustainabil Studies, Maldonado, Uruguay.	juan.rocha@su.se	Rocha, Juan Carlos/T-8188-2017; Díaz, Lina María Saavedra/AAS-2056-2021	Rocha, Juan Carlos/0000-0003-2322-5459; Saavedra-Diaz, Lina Maria/0000-0003-0511-3437	Formas [211-2013-1120, 942-2015-731]	Formas(Swedish Research Council Formas)	The research was supported by Formas (https://formas.se) grant 211-2013-1120 and 942-2015-731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the fishing communities that participated in our experiments. This work received valuable feedback on early stages of its design by Anne-Sophie Crepin, Therese Lindahl, Juan Camilo Cardenas, Maria Alejandra Velez, and Sandra Vilardy. The field work would have not been possible without the support of Nidia Vanegas, Alisson Soche, Darlin Botto, Maria de losAngeles Gonzalez, Cristhian Marrugo, Gloria de Leon, Jaime Gonzalez, and Jesus Jimenez. JCR benefit from technical advise by Joshua Abbott. The research was supported by Formas grant 211-2013-1120 and 942-2015-731.	Anderies JM, 2011, ECOL ECON, V70, P1571, DOI 10.1016/j.ecolecon.2011.01.011; Axelrod R., 2006, EVOLUTION COOPERATIO; Barrett S, 2014, NAT CLIM CHANGE, V4, P36, DOI [10.1038/nclimate2059, 10.1038/NCLIMATE2059]; Barrett S, 2012, P NATL ACAD SCI USA, V109, P17372, DOI 10.1073/pnas.1208417109; Biggs R, 2018, ECOL SOC, V23, DOI [10.5751/ES-10264-230309, 10.5751/ES-]; Breitburg D, 2018, SCIENCE, V359, P46, DOI 10.1126/science.aam7240; Cardenas JC, 2013, J DEV ECON, V103, P52, DOI 10.1016/j.jdeveco.2013.01.008; Crepin AS, 2012, ECOL ECON, V84, P15, DOI 10.1016/j.ecolecon.2012.09.003; Crepin AS, 2009, ENVIRON RESOUR ECON, V44, P29, DOI 10.1007/s10640-008-9258-0; Dannenberg A, 2014, ENV RESOUR EC DORDR, V61, P365; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; FAO, 2017, FUT FOOD AGR TRENDS; Finkbeiner EM, 2018, GLOBAL ENVIRON CHANG, V48, P151, DOI 10.1016/j.gloenvcha.2017.11.010; Gustafsson M, 1999, ACTA PSYCHOL, V103, P47, DOI 10.1016/S0001-6918(99)00024-4; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Maldonado JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148403; Hoff K, 2016, J ECON BEHAV ORGAN, V126, P25, DOI 10.1016/j.jebo.2016.01.005; Lenton TM, 2019, NATURE, V575, P592, DOI 10.1038/d41586-019-03595-0; Lindahl T, 2016, ENVIRON RESOUR ECON, V65, P657, DOI 10.1007/s10640-016-0043-1; McBride M, 2006, J PUBLIC ECON, V90, P1181, DOI 10.1016/j.jpubeco.2005.09.012; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Nowak Martin, 2013, EVOLUTION GAMES GOD; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Osborne M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225903; Ostrom, 1990, GOVERNING COMMONS; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Polasky S, 2011, J ENVIRON ECON MANAG, V62, P229, DOI 10.1016/j.jeem.2010.09.004; Poncela-Casasnovas J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600451; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rocha JC, 2018, SCIENCE, V362, P1379, DOI 10.1126/science.aat7850; Saavedra-Diaz LM, 2016, MARIT STUD, V15, DOI 10.1186/s40152-016-0047-z; Saavedra-Diaz LM, 2015, MAR POLICY, V56, P61, DOI 10.1016/j.marpol.2014.11.026; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Schill C, 2019, UNCERTAINTY CAN HELP; Schiller CE, 2015, CNS SPECTRUMS, V20, P48, DOI 10.1017/S1092852914000480; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Vasconcelos VV, 2014, P NATL ACAD SCI USA, V111, P2212, DOI 10.1073/pnas.1323479111; Vilardy SP, 2011, HYDROLOG SCI J, V56, P1423, DOI 10.1080/02626667.2011.631497; Witt CM, 2015, SCIENCE, V347, pS50	42	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242363	10.1371/journal.pone.0242363	http://dx.doi.org/10.1371/journal.pone.0242363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370255	Green Published, gold			2022-12-26	WOS:000603611900110
J	Suarez, ET; Granados-Falla, DS; Robledo, SM; Murillo, J; Upegui, Y; Delgado, G				Torres Suarez, Elaine; Granados-Falla, Diana Susana; Robledo, Sara Maria; Murillo, Javier; Upegui, Yulieth; Delgado, Gabriela			Antileishmanial activity of synthetic analogs of the naturally occurring quinolone alkaloid N-methyl-8-methoxyflindersin	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; IN-VITRO; CUTANEOUS LEISHMANIASIS; RESPIRATORY BURST; APOPTOSIS; INFECTION; DRUG; MACROPHAGES; DERIVATIVES; SURVIVAL	Leishmaniasis is a neglected, parasitic tropical disease caused by an intracellular protozoan from the genus Leishmania. Quinoline alkaloids, secondary metabolites found in plants from the Rutaceae family, have antiparasitic activity against Leishmania sp. N-methyl-8-methoxyflindersin (1), isolated from the leaves of Raputia heptaphylla and also known as 7-methoxy-2,2-dimethyl-2H,5H,6H-pyran[3,2-c]quinolin-5-one, shows antiparasitic activity against Leishmania promastigotes and amastigotes. This study used in silico tools to identify synthetic quinoline alkaloids having structure similar to that of compound 1 and then tested these quinoline alkaloids for their in vitro antiparasitic activity against Leishmania (Viannia) panamensis, in vivo therapeutic response in hamsters suffering from experimental cutaneous leishmaniasis (CL), and ex vivo immunomodulatory potential in healthy donors' human peripheral blood (monocyte)-derived macrophages (hMDMs). Compounds 1 (natural), 2 (synthetic), and 8 (synthetic) were effective against intracellular promastigotes (9.9, 3.4, and 1.6 mu g/mL medial effective concentration [EC50], respectively) and amastigotes (5.07, 7.94, and 1.91 mu g/mL EC50, respectively). Compound 1 increased nitric oxide production in infected hMDMs and triggered necrosis-related ultrastructural alterations in intracellular amastigotes, while compound 2 stimulated oxidative breakdown in hMDMs and caused ultrastructural alterations in the parasite 4 h posttreatment, and compound 8 failed to induce macrophage modulation but selectively induced apoptosis of infected hMDMs and alterations in the intracellular parasite ultrastructure. In addition, synthetic compounds 2 and 8 improved the health of hamsters suffering from experimental CL, without evidence of treatment-associated adverse toxic effects. Therefore, synthetic compounds 2 and 8 are potential therapeutic candidates for topical treatment of CL.	[Torres Suarez, Elaine; Granados-Falla, Diana Susana; Delgado, Gabriela] Univ Nacl Colombia, Dept Farm, Grp Invest Inmunotoxicol, Bogota, Colombia; [Granados-Falla, Diana Susana] Univ El Bosque, Vicerrectoria Invest, Bogota, Colombia; [Robledo, Sara Maria; Murillo, Javier; Upegui, Yulieth] Univ Antioquia, Fac Med, PECET, Medellin, Colombia; [Robledo, Sara Maria] Univ Antioquia, Sede Invest Univ, Programa Estudio & Control Enfermedades Trop, Medellin, Colombia; [Delgado, Gabriela] Univ Nacl Colombia, Fac Ciencias, Dept Farm, Bogota, Colombia	Universidad Nacional de Colombia; Universidad El Bosque; Universidad de Antioquia; Universidad de Antioquia; Universidad Nacional de Colombia	Delgado, G (corresponding author), Univ Nacl Colombia, Dept Farm, Grp Invest Inmunotoxicol, Bogota, Colombia.	lgdelgadom@unal.edu.co		Upegui Zapata, Yulieth Alexandra/0000-0002-9348-6227; Torres, Elaine/0000-0002-8547-2132	Colombian Ministry of Science Technology and Innovation; Colciencias-Colfuturo grant [727-2015]; Colombian Ministry of Science and Technology (MinCiencias) grant [777-2017, 110177758192]	Colombian Ministry of Science Technology and Innovation; Colciencias-Colfuturo grant; Colombian Ministry of Science and Technology (MinCiencias) grant	This study was financed by Colombian Ministry of Science Technology and Innovation, E. T: Colciencias-Colfuturo grant 727-2015 for national PhD students and Colombian Ministry of Science and Technology (MinCiencias) grant 777-2017 (project 110177758192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; Aniszewski T., 2015, ALKALOIDS, DOI [10.1016/b978-0-444-59433-4.00002-x, DOI 10.1016/B978-0-444-59433-4.00002-X]; Antinarelli LMR, 2015, CHEM BIOL DRUG DES, V86, P704, DOI 10.1111/cbdd.12540; de Menezes JPB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/815023; Black AT, 2018, SIDE EFFECT, V40, P337, DOI 10.1016/bs.seda.2018.08.004; Bosque F, 2000, SCAND J IMMUNOL, V51, P533; Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; Calixto SL, 2018, CHEM-BIOL INTERACT, V293, P141, DOI 10.1016/j.cbi.2018.08.003; Calla-Magarinos J, 2013, SCAND J IMMUNOL, V77, P30, DOI 10.1111/sji.12010; Calla-Magarinos J, 2009, SCAND J IMMUNOL, V69, P251, DOI 10.1111/j.1365-3083.2008.02219.x; Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480; Coimbra ES, 2016, CHEM-BIOL INTERACT, V260, P50, DOI 10.1016/j.cbi.2016.10.017; Barrera CAC, 2011, CHEM PHARM BULL, V59, P855, DOI 10.1248/cpb.59.855; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; de Almeida MC, 2003, MEM I OSWALDO CRUZ, V98, P861, DOI 10.1590/S0074-02762003000700001; Deschacht M, 2012, PARASITOLOGY, V139, P1429, DOI 10.1017/S003118201200073X; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Forman HJ, 2001, IUBMB LIFE, V51, P365; Getti GT, 2008, PARASITOLOGY, V135, P1391, DOI 10.1017/S0031182008004915; Ghorbani M, 2018, DRUG DES DEV THER, V12, P25, DOI 10.2147/DDDT.S146521; Guo Y, 2009, OPTIMIZATION DRUG DI, DOI 10.1385/1-59259-800-5; Holzmuller P, 2006, PARASITOLOGY, V132, pS19, DOI 10.1017/S0031182006000837; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7; Lombardo M, 2014, EUR J ORG CHEM, V2014, P1607, DOI 10.1002/ejoc.201301394; Maggiora G, 2014, J MED CHEM, V57, P3186, DOI 10.1021/jm401411z; Michael JP, 2008, NAT PROD REP, V25, P166, DOI 10.1039/b612168n; Mishra BB, 2009, MINI-REV MED CHEM, V9, P107, DOI 10.2174/138955709787001758; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Natesan S, 2014, MOL PHARMACEUT, V11, P3577, DOI 10.1021/mp5003366; Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007; Pan American Health Organization, 2019, LEISHM EP REP AM DEC; Perez-Cordero JJ, 2011, EXP PARASITOL, V129, P31, DOI 10.1016/j.exppara.2011.05.022; Perrotta I, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/282739; Podinovskaia M, 2015, FUTURE MICROBIOL, V10, P111, DOI 10.2217/fmb.14.103; Ponte-Sucre A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006052; Pulido SA, 2012, ACTA TROP, V122, P36, DOI 10.1016/j.actatropica.2011.11.015; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Silva GL, 1998, SPECIAL PROBLEMS EXT, DOI DOI 10.1007/978-1-59259-256-2_12; Singh N, 2014, BIOORGAN MED CHEM, V22, P18, DOI 10.1016/j.bmc.2013.11.048; Sousa-Franco J, 2006, MICROBES INFECT, V8, P390, DOI 10.1016/j.micinf.2005.07.007; Sundar S, 2007, THER CLIN RISK MANAG; Tempone AG, 2005, ANTIMICROB AGENTS CH, V49, P1076, DOI 10.1128/AAC.49.3.1076-1080.2005; Torres-Guerrero Edoardo, 2017, F1000Res, V6, P750, DOI 10.12688/f1000research.11120.1; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; Vannier-Santos MA, 2008, MICROBIOL-SGM, V154, P3104, DOI 10.1099/mic.0.2007/013896-0; Vraka C, 2018, NUCL MED BIOL, V58, P20, DOI 10.1016/j.nucmedbio.2017.11.007; Wanderley JLM, 2010, CELL MOL LIFE SCI, V67, P1653, DOI 10.1007/s00018-010-0291-0	51	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243392	10.1371/journal.pone.0243392	http://dx.doi.org/10.1371/journal.pone.0243392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370295	Green Published, gold			2022-12-26	WOS:000603611900023
J	Claude, SJ; Park, SJ				Jean Claude, Sivagami; Park, Seon Joo			Aster spathulifolius Maxim. a leaf transcriptome provides an overall functional characterization, discovery of SSR marker and phylogeny analysis	PLOS ONE			English	Article							SEQUENCE; PROTEIN; PLANTS; FAMILY	Aster spathulifolius Maxim. is belongs to the Asteraceae family, which is distributed only in Korea and Japan. The species is traditionally a medicinal plant and is economically valuable in the ornamental field. On the other hand, the Aster genus, among the Asteraceae family, lacks genomic resources and its molecular functions. Therefore, in our study the high-throughput RNA-sequencing transcriptome data of A. spathulifolius were obtained to identify the molecular functions and its characterization. The de novo assembly produced 98660 uniqueness with an N50 value of 1126bp. Total unigenes were procure to analyze the functional annotation against databases like non-redundant protein, Pfam, Uniprot, KEGG and Gene ontology. The overall percentage of functional annotation to the nr database (43.71%), uniprotein database (49.97%), Pfam (39.94%), KEGG (42.3%) and to GO (30.34%) were observed. Besides, 377 unigenes were found to be involved in the terpenoids pathway and 666 unigenes were actively engaged in other secondary metabolites synthesis, given that 261 unigenes were within phenylpropanoid pathway and 81 unigenes to flavonoid pathway. A further prediction of stress resistance (9,513) unigenes and transcriptional factor (3,027) unigenes in 53 types were vastly regulated in abiotic stress respectively in salt, heat, MAPK and hormone signal transduction pathway. This study discovered 29,692 SSR markers that assist the genotyping approaches and the genetic diversity perspectives. In addition, eight Asteraceae species as in-group together with one out-group were used to construct the phylogenetic relationship by employing their plastid genome and single-copy orthologs genes. Among 50 plastid protein-coding regions, A. spathulifolius is been closely related to A. annua and by 118 single copy orthologs genes, O. taihangensis is more neighboring species to A. spathulifolius. Apart from this, A. spathulifolius and O. taihangensis, genera have recently diverged from other species. Overall, this research gains new insights into transcriptome data by revealing and exposing the secondary metabolite compounds for drug development, the stress-related genes for producing resilient crops and an ortholog gene of A. spathulifolius for the robustness of phylogeny reconstruction among Asteraceae genera.	[Jean Claude, Sivagami; Park, Seon Joo] Yeungnam Univ, Dept Life Sci, Gyongsan, Gyeongbuk, South Korea	Yeungnam University	Park, SJ (corresponding author), Yeungnam Univ, Dept Life Sci, Gyongsan, Gyeongbuk, South Korea.	sjpark01@ynu.ac.kr		park, seonjoo/0000-0001-6494-3460	Yeungnam University Grant 2018 commission, South Korea [217A061011]	Yeungnam University Grant 2018 commission, South Korea	This study was supported by Yeungnam University Grant 2018 commission, South Korea, in the form of a grant awarded to SJP (217A061011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, AM J TRANSPLANT, V19, P291, DOI 10.1111/ajt.15211; Baillo EH, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100771; Beier S, 2017, BIOINFORMATICS, V33, P2583, DOI 10.1093/bioinformatics/btx198; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Breitler JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep38368; Cho IJ, 2016, NUTR RES, V36, P671, DOI 10.1016/j.nutres.2016.03.001; Choi KS, 2015, GENE, V572, P214, DOI 10.1016/j.gene.2015.07.020; Debbarma J, 2019, MOL BIOTECHNOL, V61, P153, DOI 10.1007/s12033-018-0144-x; Diamantopoulos MA, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.06.10; Emms DM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1832-y; FAAIR Scientific Advisory Panel, 2002, CLIN INFECT DIS S3, V34, pS76; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Ito-Inaba Y, 2008, J EXP BOT, V59, P995, DOI 10.1093/jxb/ern024; Jang Y. D., 2008, NATURE OF DOKDO, P10; Jiang AL, 2014, PLANT MOL BIOL REP, V32, P1241, DOI 10.1007/s11105-014-0719-z; Jung SY, 2014, J ASIA-PAC BIODIVERS, V7, P197, DOI DOI 10.1016/j.japb.2014.03.011; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SJ, 2016, J PHARM PHARMACOL, V68, P107, DOI 10.1111/jphp.12485; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee C. B., 1979, ILLUSTRATED FLORA KO, P740; Lee Je-Hyuk, 2013, RES J MED PLANTS, V8, P41; Lee SO, 2005, J NAT PROD, V68, P1471, DOI 10.1021/np058044e; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu PL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-214; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; NESOM G.L., 2000, SIDA BOT MISC, V20, P1; Park JH, 2008, NATURE DOKDO, P166; Pereira A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01123; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Tribble MdC, 2016, HEART SURG FORUM, V19, pE286; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang PF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207344; Wang YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200850; Xie CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-107; Yin XF, 2015, FOOD SCI BIOTECHNOL, V24, P301, DOI 10.1007/s10068-015-0040-0; Yin X, 2015, J MED FOOD, V18, P987, DOI 10.1089/jmf.2014.3416	38	3	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244132	10.1371/journal.pone.0244132	http://dx.doi.org/10.1371/journal.pone.0244132			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362220	Green Published, gold			2022-12-26	WOS:000603071600048
J	Frank, K; Abeynaike, S; Nikzad, R; Patel, RR; Roberts, AJ; Roberto, M; Paust, S				Frank, Kayla; Abeynaike, Shawn; Nikzad, Rana; Patel, Reesha R.; Roberts, Amanda J.; Roberto, Marisa; Paust, Silke			Alcohol dependence promotes systemic IFN-gamma and IL-17 responses in mice	PLOS ONE			English	Article							CHRONIC ETHANOL-CONSUMPTION; TUMOR-NECROSIS-FACTOR; PERIPHERAL-BLOOD; INTERFERON-GAMMA; T-CELLS; ALVEOLAR MACROPHAGES; KUPFFER CELLS; LIVER-DISEASE; B-LYMPHOCYTE; EXPRESSION	Alcohol use disorder (AUD) is a chronic relapsing disorder characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. AUD is associated with a variety of physiological changes and is a substantial risk factor for numerous diseases. We aimed to characterize systemic alterations in immune responses using a well-established mouse model of chronic intermittent alcohol exposure to induce alcohol dependence. We exposed mice to chronic intermittent ethanol vapor for 4 weeks and analyzed the expression of cytokines IFN-gamma, IL-4, IL-10, IL-12 and IL-17 by different immune cells in the blood, spleen and liver of alcohol dependent and non-dependent control mice through multiparametric flow cytometry. We found increases in IFN-gamma and IL-17 expression in a cell type- and organ-specific manner. Often, B cells and neutrophils were primary contributors to increased IFN-gamma and IL-17 levels while other cell types played a secondary role. We conclude that chronic alcohol exposure promotes systemic pro-inflammatory IFN-gamma and IL-17 responses in mice. These responses are likely important in the development of alcohol-related diseases, but further characterization is necessary to understand the initiation and effects of systemic inflammatory responses to chronic alcohol exposure.	[Frank, Kayla; Abeynaike, Shawn; Nikzad, Rana; Paust, Silke] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Patel, Reesha R.; Roberto, Marisa] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Roberts, Amanda J.] Scripps Res Inst, Anim Models Core, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Paust, S (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	paust@scripps.edu	Abeynaike, Shawn/AGR-8674-2022	Frank, Kayla/0000-0002-8150-6657	National Institute on Alcohol Abuse and Alcoholism [AA021491, AA013498, P60 AA006420, AA017447, AA015566, AA027700, F32 AA026765, T32 AA007456]; Pearson Center for Alcoholism and Addiction Research; Scripps Research Institute	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Pearson Center for Alcoholism and Addiction Research; Scripps Research Institute	t Support for this study was provided by the National Institute on Alcohol Abuse and Alcoholism grants AA021491, AA013498, P60 AA006420, AA017447, AA015566, AA027700, F32 AA026765, T32 AA007456, as well as the Pearson Center for Alcoholism and Addiction Research (all to MR) and The Scripps Research Institute's unrestricted funds (SP). The manuscript is The Scripps Research Institute's MS# 30018.	Agoglia AE, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0420-19.2020; Ballester-Lopez C, 2019, EBIOMEDICINE, V43, P562, DOI 10.1016/j.ebiom.2019.03.054; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becker HC, 2004, ALCOHOL CLIN EXP RES, V28, P1829, DOI 10.1097/01.ALC.0000149977.95306.3A; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; BLANK SE, 1993, ALCOHOL CLIN EXP RES, V17, P561, DOI 10.1111/j.1530-0277.1993.tb00800.x; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Brandon-Warner E, 2012, ALCOHOL, V46, P715, DOI 10.1016/j.alcohol.2012.08.004; Chan C, 2016, CLIN LIVER DIS, V20, P595, DOI 10.1016/j.cld.2016.02.014; Cook RT, 1996, CLIN EXP IMMUNOL, V103, P304, DOI 10.1046/j.1365-2249.1996.d01-621.x; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Dominguez-Santalla MJ, 2001, ALCOHOL CLIN EXP RES, V25, P1198, DOI 10.1111/j.1530-0277.2001.tb02336.x; Ellis TN, 2002, J LEUKOCYTE BIOL, V72, P373; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; FUKUI H, 1993, ALCOHOL ALCOHOLISM, V28, P53, DOI 10.1093/alcalc/28.Supplement_1B.53; FULTZ MJ, 1993, INT IMMUNOL, V5, P1383, DOI 10.1093/intimm/5.11.1383; Ganapamo F, 2001, EUR J IMMUNOL, V31, P3460, DOI 10.1002/1521-4141(200112)31:12<3460::AID-IMMU3460>3.0.CO;2-X; Gjertsson I, 2003, MICROB PATHOGENESIS, V35, P119, DOI 10.1016/S0882-4010(03)00114-1; GONZALEZQUINTELA A, 1995, CLIN EXP ALLERGY, V25, P756, DOI 10.1111/j.1365-2222.1995.tb00014.x; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Herman MA, 2016, J NEUROSCI, V36, P10729, DOI 10.1523/JNEUROSCI.1267-16.2016; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86; Laso FJ, 2007, CYTOM PART B-CLIN CY, V72B, P408, DOI 10.1002/cyto.b.20169; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kaufmann U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049008; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Kishore R, 2002, AM J PHYSIOL-GASTR L, V282, pG6, DOI 10.1152/ajpgi.00328.2001; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kono H, 2001, AM J PHYSIOL-GASTR L, V280, pG1289, DOI 10.1152/ajpgi.2001.280.6.G1289; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Laso FJ, 1999, ALCOHOL CLIN EXP RES, V23, P1306, DOI 10.1097/00000374-199908000-00003; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Loxton AG, 2012, CLIN VACCINE IMMUNOL, V19, P746, DOI 10.1128/CVI.00047-12; Ma Hsiao-Yen, 2016, Curr Pathobiol Rep, V4, P27; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mellinger Jessica L, 2019, Clin Liver Dis (Hoboken), V13, P136, DOI 10.1002/cld.806; Pan HN, 2006, ALCOHOL CLIN EXP RES, V30, P1615, DOI 10.1111/j.1530-0277.2006.00194.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Passos ST, 2010, J IMMUNOL, V184, P1776, DOI 10.4049/jimmunol.0901843; Patel RR, 2019, BRAIN BEHAV IMMUN, V75, P208, DOI 10.1016/j.bbi.2018.10.009; Puddu P, 1997, J IMMUNOL, V159, P3490; Ratna A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030061; Roberts AJ, 2019, BRAIN BEHAV IMMUN, V82, P188, DOI 10.1016/j.bbi.2019.08.185; ROBINSON BWS, 1985, J CLIN INVEST, V75, P1488, DOI 10.1172/JCI111852; Rocco A, 2014, WORLD J GASTROENTERO, V20, P14652, DOI 10.3748/wjg.v20.i40.14652; Schlegel PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082580; Schweitzer P, 2016, NEUROPHARMACOLOGY, V107, P1, DOI 10.1016/j.neuropharm.2016.03.003; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Song KJ, 2002, J LEUKOCYTE BIOL, V72, P1109; Starkenburg S, 2001, ALCOHOL CLIN EXP RES, V25, P1221, DOI 10.1097/00000374-200108000-00019; Sturge CR, 2013, P NATL ACAD SCI USA, V110, P10711, DOI 10.1073/pnas.1307868110; Taieb J, 2000, J HEPATOL, V32, P579, DOI 10.1016/S0168-8278(00)80219-6; Varodayan FP, 2018, NEUROPHARMACOLOGY, V133, P470, DOI 10.1016/j.neuropharm.2018.02.014; Viitala K, 1997, HEPATOLOGY, V25, P1418, DOI 10.1002/hep.510250619; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Warden AS, 2020, BIOL PSYCHIAT, V88, P910, DOI 10.1016/j.biopsych.2020.05.011; Yin JY, 2009, J IMMUNOL, V182, P7069, DOI 10.4049/jimmunol.0802410; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Zhang H, 2005, J LEUKOCYTE BIOL, V78, P1070, DOI 10.1189/jlb0605-317; Zhang H, 2015, TOXICOL APPL PHARM, V282, P139, DOI 10.1016/j.taap.2014.11.013; Zhang H, 2009, ALCOHOL CLIN EXP RES, V33, P419, DOI 10.1111/j.1530-0277.2008.00852.x	63	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0239246	10.1371/journal.pone.0239246	http://dx.doi.org/10.1371/journal.pone.0239246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347446	Green Published, gold, Green Submitted			2022-12-26	WOS:000603071100017
J	Chen, Y; Lin, BH; Mancino, L; Ploeg, MV; Zhen, C				Chen, Yu; Lin, Biing-Hwan; Mancino, Lisa; Ploeg, Michele Ver; Zhen, Chen			Nutritional quality of retail food purchases is not associated with participation in the Supplemental Nutrition Assistance Program for nutrition-oriented households	PLOS ONE			English	Article							DIETARY QUALITY; OBESITY; ADULTS; SNAP; INSECURITY; CHOICES; IMPACT	The Supplemental Nutrition Assistance Program (SNAP) provides millions of low-income Americans food benefits and other forms of nutrition assistance. Evidence indicates that SNAP reduces food insecurity. However, there is a concern that the food benefit may increase the demand for less healthy foods more than healthier foods, thereby reducing the overall nutritional quality of the participant's food basket. This paper aims to examine the association of SNAP participation with the nutritional quality of food-at-home purchases of low-income households and to investigate the potential heterogeneity among consumers with different levels of nutrition attitude. This analysis used food purchase data from the USDA National Household Food Acquisition and Purchase Survey (FoodAPS). Our study sample included 2,218 low-income households, of which 1,184 are SNAP participants, and 1,034 are income-eligible nonparticipants. Multivariate regressions were performed to explore the SNAP-nutritional quality association. A household's nutrition attitude was measured using its response to a question on whether the household searched for nutrition information online in the last 2 months. Households that affirmed they had an online nutrition search were treated as nutrition-oriented households (21.2% of the low-income sample), and households that did not were considered less nutrition-oriented households (78.8%). For robustness, we also created an alternative nutrition attitude measure based on reported use of the nutrition facts label. We found that among less nutrition-oriented households, SNAP participants had a statistically significant 0.097 points (p = 0.018) lower Guiding Stars rating than low-income nonparticipants. However, there was no significant SNAP-nutritional quality association among nutrition-oriented households. In conclusion, SNAP participation was associated with lower nutritional quality of food purchases among less nutrition-oriented households, but not among nutrition-oriented households. The results suggest that the intended nutritional benefits of restrictions on purchases of healthy foods may not reach the subgroup of nutrition-oriented SNAP participants.	[Chen, Yu; Zhen, Chen] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA; [Lin, Biing-Hwan; Mancino, Lisa] Econ Res Serv, USDA, Washington, DC USA; [Ploeg, Michele Ver] George Washington Univ, Milken Inst Sch Publ Hlth, Food & Hlth Policy Inst, Washington, DC USA; [Zhen, Chen] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); George Washington University; University System of Georgia; University of Georgia	Zhen, C (corresponding author), Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA.	czhen@uga.edu		Zhen, Chen/0000-0002-6087-7387	U.S. Department of Agriculture, Economic Research Service [58-4000-6-0052]	U.S. Department of Agriculture, Economic Research Service(United States Department of Agriculture (USDA))	CZ is the author who received the award. This research was supported by the intramural research program of the U.S. Department of Agriculture, Economic Research Service and cooperative agreement 58-4000-6-0052. The findings and conclusions in this publication are those of the author(s) and should not be construed to represent any official USDA or U.S. Government determination or policy. The funder website is https://www.ers.usda.gov/.The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Aggarwal A, 2014, J ACAD NUTR DIET, V114, P266, DOI 10.1016/j.jand.2013.06.006; Andreyeva T, 2015, AM J PREV MED, V49, P594, DOI 10.1016/j.amepre.2015.04.035; Andreyeva T, 2012, AM J PREV MED, V43, P411, DOI 10.1016/j.amepre.2012.06.015; [Anonymous], 2013, SAS 94 COMP SOFTW; [Anonymous], 2018, NUTR QUALITY FOODS A; [Anonymous], 2016, NUTR COD OV; Beydoun MA, 2008, EUR J CLIN NUTR, V62, P303, DOI 10.1038/sj.ejcn.1602700; Brownell KD, 2011, JAMA-J AM MED ASSOC, V306, P1370, DOI 10.1001/jama.2011.1382; Cates S, 2014, J NUTR EDUC BEHAV, V46, pS103; Chalak K, 2011, CAN J ECON, V44, P1, DOI 10.1111/j.1540-5982.2010.01622.x; Cole N., 2008, DIET QUALITY AM FOOD; Cuffey J, 2016, PUBLIC HEALTH NUTR, V19, P3216, DOI 10.1017/S1368980015003511; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Dinour LM, 2007, J AM DIET ASSOC, V107, P1952, DOI 10.1016/j.jada.2007.08.006; Fey-Yensan N, 2003, J AM DIET ASSOC, V103, P103, DOI 10.1053/jada.2003.50010; Fischer LM, 2011, AM J HLTH PROMOT, V26, pe55, DOI DOI 10.4278/AJHP.100709-QUAL-238; Fox M, 2004, 040141 EFAN USDA EC; Gregory C., 2013, Supplemental Nutrition Assistance Program (SNAP) participation leads to modest changes in diet quality; Guenther PM, 2014, J NUTR, V144, P399, DOI 10.3945/jn.113.183079; Gundersen C, 2017, AM J AGR ECON, V99, P875, DOI 10.1093/ajae/aax026; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; Harnack L, 2016, JAMA INTERN MED, V176, P1610, DOI 10.1001/jamainternmed.2016.5633; Hearty AP, 2007, APPETITE, V48, P1, DOI 10.1016/j.appet.2006.03.329; Hilmers A, 2014, PREV MED, V62, P44, DOI 10.1016/j.ypmed.2014.01.016; Leung CW, 2014, J NUTR EDUC BEHAV, V46, P68, DOI 10.1016/j.jneb.2013.10.001; Leung CW, 2013, PEDIATRICS, V131, P463, DOI 10.1542/peds.2012-0889; Leung CW, 2012, AM J CLIN NUTR, V96, P977, DOI 10.3945/ajcn.112.040014; Leung CW, 2011, PUBLIC HEALTH NUTR, V14, P645, DOI 10.1017/S1368980010002090; Levin SM, 2017, AM J PREV MED, V52, pS186, DOI 10.1016/j.amepre.2016.07.016; Mankiw N.G., 2020, PRINCIPLES MICROECON, DOI 10.1016/j.neuroimage.2019.116122; Mozaffarian D, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002661; Nguyen BT, 2014, MAYO CLIN PROC, V89, P1211, DOI 10.1016/j.mayocp.2014.05.010; Pinard CA, 2017, J HUNGER ENVIRON NUT, V12, P151, DOI 10.1080/19320248.2016.1146194; Rahkovsky I, 2013, FOOD POLICY, V43, P100, DOI 10.1016/j.foodpol.2013.08.013; Ratcliffe C, 2011, AM J AGR ECON, V93, P1082, DOI 10.1093/ajae/aar026; Rosenbaum D, 2018, FACTORS AFFECTING SN; Savoie MR, 2015, J NUTR EDUC BEHAV, V47, P81, DOI 10.1016/j.jneb.2014.08.009; Schwartz MB, 2017, AM J PREV MED, V52, pS199, DOI 10.1016/j.amepre.2016.09.022; Steele-Adjognon M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4942-z; Taylor R, 2016, AM J AGR ECON, V98, P513, DOI 10.1093/ajae/aaw009; The Lancet HIV, 2017, LANCET HIV, V4, pe51; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Ver Ploeg M., 2015, DO AM USUALLY SHOP F; Vericker TC, 2019, J SCHOOL HEALTH, V89, P907, DOI 10.1111/josh.12828; Williams PA, 2014, J ACAD NUTR DIET, V114, P1001, DOI 10.1016/j.jand.2014.01.015	46	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0240263	10.1371/journal.pone.0240263	http://dx.doi.org/10.1371/journal.pone.0240263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338058	gold, Green Published			2022-12-26	WOS:000601313500016
J	Fidalgo-Herrera, AJ; Martinez-Beltran, MJ; de la Torre-montero, JC; Moreno-Ruiz, JA; Barton, G				Fidalgo-Herrera, Alberto Javier; Martinez-Beltran, Maria Jesus; de la Torre-montero, Julio Cesar; Moreno-Ruiz, Jose Andres; Barton, Gabor			Artificial intelligence prediction of the effect of rehabilitation in whiplash associated disorder	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; MODERATE/SEVERE DISABILITY; CERVICAL RANGE; FULL RECOVERY; INJURY; MOTION; VALIDATION; RELIABILITY; GONIOMETER; EXTENSION	The active cervical range of motion (aROM) is assessed by clinicians to inform their decision-making. Even with the ability of neck motion to discriminate injured from non-injured subjects, the mechanisms to explain recovery or persistence of WAD remain unclear. There are few studies of ROM examinations with precision tools using kinematics as predictive factors of recovery rate. The present paper will evaluate the performance of an artificial neural network (ANN) using kinematic variables to predict the overall change of aROM after a period of rehabilitation in WAD patients. To achieve this goal the neck kinematics of a cohort of 1082 WAD patients (55.1% females), with mean age 37.68 (SD 12.88) years old, from across Spain were used. Prediction variables were the kinematics recorded by the EBI(R) 5 in routine biomechanical assessments of these patients. These include normalized ROM, speed to peak and ROM coefficient of variation. The improvement of aROM was represented by the Neck Functional Holistic Analysis Score (NFHAS). A supervised multi-layer feed-forward ANN was created to predict the change in NFHAS. The selected architecture of the ANN showed a mean squared error of 308.07-272.75 confidence interval for a 95% in the Monte Carlo cross validation. The performance of the ANN was tested with a subsample of patients not used in the training. This comparison resulted in a medium correlation with R = 0.5. The trained neural network to predict the expected difference in NFHAS between baseline and follow up showed modest results. While the overall performance is moderately correlated, the error of this prediction is still too large to use the method in clinical practice. The addition of other clinically relevant factors could further improve prediction performance.	[Fidalgo-Herrera, Alberto Javier] RetiaTech, Biomech Dept, FisiON Hlth Grp, Las Rozas, Spain; [Martinez-Beltran, Maria Jesus; de la Torre-montero, Julio Cesar] Comillas Pontifical Univ, San Juan de Dios Sch Nursing & Phys Therapy, Madrid, Spain; [Moreno-Ruiz, Jose Andres] Univ Almeria, Dept Comp, Almeria, Spain; [Barton, Gabor] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England	Comillas Pontifical University; Universidad de Almeria; Liverpool John Moores University	Fidalgo-Herrera, AJ (corresponding author), RetiaTech, Biomech Dept, FisiON Hlth Grp, Las Rozas, Spain.	afidalgo@fisi-on.com	de la Torre-Montero, Julio C./I-6095-2019	de la Torre-Montero, Julio C./0000-0001-6843-8234; Fidalgo Herrera, Alberto Javier/0000-0002-8202-2670; Martinez Beltran, Maria Jesus/0000-0003-3869-3626	RetiaTech	RetiaTech	RetiaTech provided support in the form of salaries for the author AFH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. The author(s) received no further specific funding for this work.	Asha SE, 2013, J MANIP PHYSIOL THER, V36, P538, DOI 10.1016/j.jmpt.2013.07.005; Boggenpoel B, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025076; Bohman T, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-264; Bussieres AE, 2016, J MANIP PHYSIOL THER, V39, P523, DOI 10.1016/j.jmpt.2016.08.007; Connelly LB, 2017, J ORTHOP SPORT PHYS, V47, P503, DOI 10.2519/jospt.2017.7533; Duc C, 2014, MED ENG PHYS, V36, P49, DOI 10.1016/j.medengphy.2013.09.002; Dvir Zeevi, 2004, Pain Res Manag, V9, P131; Farooq MN, 2016, PAK J MED SCI, V32, P457, DOI 10.12669/pjms.322.8747; Fidalgo-Herrera A, 2019, CALGARY; Fidalgo-Herrera AJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238424; Ganesan N, 2010, INT J COMPUT APPL, V1, P76, DOI [10.5120/476-783, DOI 10.5120/476-783]; Grip H, 2003, IEEE T INF TECHNOL B, V7, P412, DOI 10.1109/TITB.2003.821322; Hendriks EJM, 2005, PAIN, V114, P408, DOI 10.1016/j.pain.2005.01.006; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Krogh S, 2018, J REHABIL MED, V50, P548, DOI 10.2340/16501977-2348; La Delfa NJ, 2016, J BIOMECH, V49, P602, DOI 10.1016/j.jbiomech.2016.01.008; Lemeunier N, 2018, MUSCULOSKEL SCI PRAC, V38, P128, DOI 10.1016/j.msksp.2018.09.013; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Ludvigsson ML, 2019, QUAL LIFE RES, V28, P357, DOI 10.1007/s11136-018-2004-3; Mourcou Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/328142; Ng TS, 2015, PHYSIOTHER RES INT, V20, P77, DOI 10.1002/pri.1598; Niederer D, 2015, EUR SPINE J, V24, P493, DOI 10.1007/s00586-014-3715-y; Ogundimu EO, 2016, J CLIN EPIDEMIOL, V76, P175, DOI 10.1016/j.jclinepi.2016.02.031; Ohberg F, 2003, IEEE T INF TECHNOL B, V7, P274, DOI 10.1109/TITB.2003.821328; Osborne JW, 2001, PRACT ASSESSMENT RES, V7, P2000; Pare C, 2019, CLIN J PAIN, V35, P880, DOI 10.1097/AJP.0000000000000749; Quek J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-65; Ritchie C, 2016, J ORTHOP SPORT PHYS, V46, P851, DOI 10.2519/jospt.2016.6918; Ritchie C, 2015, J ORTHOP SPORT PHYS, V45, P242, DOI 10.2519/jospt.2015.5642; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Rydman E, 2018, EUR SPINE J, V27, P1255, DOI 10.1007/s00586-018-5507-2; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Shechtman Orit, 2006, Work, V26, P335; Stenneberg MS, 2017, ARCH PHYS MED REHAB, V98, P1407, DOI 10.1016/j.apmr.2016.10.003; Sterling M, 2012, PAIN, V153, P1727, DOI 10.1016/j.pain.2012.05.004; Sterling M, 2011, SPINE, V36, pS330, DOI 10.1097/BRS.0b013e3182388523; Stove MP, 2018, KNEE, V25, P66, DOI 10.1016/j.knee.2017.11.001; Tousignant M, 2001, MANUAL THER, V6, P235, DOI 10.1054/math.2001.0419; Tousignant M, 2000, SPINE, V25, P324, DOI 10.1097/00007632-200002010-00011; Walton DM, 2017, J ORTHOP SPORT PHYS, V47, P462, DOI 10.2519/jospt.2017.7455; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Wilamowski BM, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT)	42	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243816	10.1371/journal.pone.0243816	http://dx.doi.org/10.1371/journal.pone.0243816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332408	Green Accepted, Green Published, gold			2022-12-26	WOS:000601310900018
J	Robinson, NM; Blanchard, W; MacGregor, C; Brewster, R; Dexter, N; Lindenmayer, DB				Robinson, Natasha M.; Blanchard, Wade; MacGregor, Christopher; Brewster, Rob; Dexter, Nick; Lindenmayer, David B.			Finding food in a novel environment: The diet of a reintroduced endangered meso-predator to mainland Australia, with notes on foraging behaviour	PLOS ONE			English	Article							CONSERVATION; EXPERIENCE; SURVIVAL; ANIMALS; CARNIVORES; SKILLS; QUOLL	Translocated captive-bred predators are less skilled at hunting than wild-born predators and more prone to starvation post-release. Foraging in an unfamiliar environment presents many further risks to translocated animals. Knowledge of the diet and foraging behaviour of translocated animals is therefore an important consideration of reintroductions. We investigated the diet of the endangered meso-predator, the eastern quoll Dasyurus viverrinus. We also opportunistically observed foraging behaviour, enabling us to examine risks associated with foraging. Sixty captive-bred eastern quolls were reintroduced to an unfenced reserve on mainland Australia (where introduced predators are managed) over a two year period (2018, 2019). Quolls were supplementary fed macropod meat but were also able to forage freely. Dietary analysis of scats (n = 56) revealed that quolls ate macropods, small mammals, birds, invertebrates, fish, reptiles and frogs, with some between-year differences in the frequency of different diet categories. We also observed quolls hunting live prey. Quolls utilised supplementary feeding stations, indicating that this may be an important strategy during the establishment phase. Our study demonstrated that, in a novel environment, captive-bred quolls were able to locate food and hunt live prey. However, foraging was not without risks; with the ingestion of toxic substances and foraging in dangerous environments found to be potentially harmful. Knowledge of the diet of reintroduced fauna in natural landscapes is important for understanding foraging behaviour and evaluating habitat suitability for future translocations and management.	[Robinson, Natasha M.; Blanchard, Wade; MacGregor, Christopher; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Robinson, Natasha M.; MacGregor, Christopher; Lindenmayer, David B.] Australian Natl Univ, Natl Environm Sci Program, Threatened Species Recovery Hub, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Brewster, Rob] Rewilding Australia, Sydney, NSW, Australia; [Dexter, Nick] Booderee Natl Pk, Jervis Bay, Jervis Bay Terr, Australia	Australian National University; Australian National University	Robinson, NM (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.; Robinson, NM (corresponding author), Australian Natl Univ, Natl Environm Sci Program, Threatened Species Recovery Hub, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	natasha.robinson@anu.edu.au	MacGregor, Christopher/AFQ-6785-2022	MacGregor, Christopher/0000-0002-7908-204X; Brewster, Rob/0000-0001-5068-8614; Robinson, Natasha/0000-0003-0421-8683	Australian Government's National Environmental Science Program through the Threatened Species Recovery Hub	Australian Government's National Environmental Science Program through the Threatened Species Recovery Hub(Australian Government)	This research is funded by the Australian Government's National Environmental Science Program through the Threatened Species Recovery Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Atlas of Living Australia. Dasyurus viverrinus, DAS VIV; Baker CM, 2019, ECOL APPL, V29, DOI 10.1002/eap.1811; Baker Jack, 2009, Ecological Management & Restoration, V10, pS136, DOI 10.1111/j.1442-8903.2009.00448.x; BLACKHALL S, 1980, AUST WILDLIFE RES, V7, P191, DOI 10.1071/WR9800191; BOM, 2020, SUMM STAT 2018 2019; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burbidge A. A., 2016, DASYURUS VIVERRINUS, DOI [10.2305/IUCN.UK.2016-1.RLTS.T6296A21947190.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T6296A21947190.EN]; CHRISTIAN JJ, 1970, SCIENCE, V168, P84, DOI 10.1126/science.168.3927.84; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Dickman Christopher R., 2001, Pacific Conservation Biology, V7, P124; DNP, 2015, BOOD NAT PARK MAN PL; DoEE, 2019, OP REP FOX CONTR MON; Fancourt BA, 2018, WILDLIFE RES, V45, P737, DOI 10.1071/WR18063; Fancourt BA, 2016, WILDLIFE RES, V43, P197, DOI 10.1071/WR15188; Fancourt BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129420; Gelman A., 2020, PRIOR CHOICE RECOMME; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Godsell J., 1983, ECOLOGY E QUOLL DASY; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; HARPER DGC, 1982, ANIM BEHAV, V30, P575, DOI 10.1016/S0003-3472(82)80071-7; Jones ME, 1998, ANIM BEHAV, V56, P1279, DOI 10.1006/anbe.1998.0893; Jones ME, 2000, J MAMMAL, V81, P434, DOI 10.1644/1545-1542(2000)081<0434:NDASAD>2.0.CO;2; Jule KR, 2008, BIOL CONSERV, V141, P355, DOI 10.1016/j.biocon.2007.11.007; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Lindenmayer DB, 2018, BIOL CONSERV, V221, P279, DOI 10.1016/j.biocon.2018.03.007; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; MCILROY JC, 1981, AUST WILDLIFE RES, V8, P385, DOI 10.1071/WR9810385; National Health and Medical Research Council (NHMRC) Nh, 2013, AUSTR COD CAR US AN; O'Donnell S, 2010, J APPL ECOL, V47, P558, DOI 10.1111/j.1365-2664.2010.01802.x; Owen-Smith N, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P93; Peacock D, 2014, AUST J ZOOL, V62, P294, DOI 10.1071/ZO14029; Peacock D, 2013, AUST J ZOOL, V61, P206, DOI 10.1071/ZO12129; PELLIS S M, 1984, Australian Mammalogy, V7, P5; R Core Team, 2020, R LANG ENV STAT COMP; Robinson NM, 2018, WILDLIFE RES, V45, P132, DOI 10.1071/WR17040; Robinson NM, 2020, RESTOR ECOL, V28, P29, DOI 10.1111/rec.13028; Robinson NH, 1988, THESIS; Rogers T, 2016, WILDLIFE RES, V43, P544, DOI 10.1071/WR15221; Short Jeff, 2001, Australian Zoologist, V31, P533; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Stephens D. W., 2008, FORAGING BEHAV ECOLO; Swaisgood RR, 2018, ANIM CONSERV, V21, P474, DOI 10.1111/acv.12418; Taws N., 1997, VEGETATION SURVEY MA; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Triggs B., 2004, TRACKS SCATS OTHER T; Vargas A, 1999, J MAMMAL, V80, P263, DOI 10.2307/1383226; West RS, 2020, AUST MAMMAL, V42, P257, DOI 10.1071/AM19041; Whiteside MA, 2015, J ANIM ECOL, V84, P1480, DOI 10.1111/1365-2656.12401	52	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243937	10.1371/journal.pone.0243937	http://dx.doi.org/10.1371/journal.pone.0243937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332425	Green Published, gold			2022-12-26	WOS:000601310900017
J	Smith, SL; Golden, AS; Ramenzoni, V; Zemeckis, DR; Jensen, OP				Smith, Sarah Lindley; Golden, Abigail S.; Ramenzoni, Victoria; Zemeckis, Douglas R.; Jensen, Olaf P.			Adaptation and resilience of commercial fishers in the Northeast United States during the early stages of the COVID-19 pandemic	PLOS ONE			English	Article							FISHING COMMUNITIES; ADAPTIVE CAPACITY; VULNERABILITY; UNCERTAINTY; GROUNDFISH; MANAGEMENT; LESSONS	Commercial fisheries globally experienced numerous and significant perturbations during the early months of the COVID-19 pandemic, affecting the livelihoods of millions of fishers worldwide. In the Northeast United States, fishers grappled with low prices and disruptions to export and domestic markets, leaving many tied to the dock, while others found ways to adapt to the changing circumstances brought about by the pandemic. This paper investigates the short-term impacts of the early months of the COVID-19 pandemic (March-June 2020) on commercial fishers in the Northeast U.S. to understand the effects of the pandemic on participation in the fishery and fishers' economic outcomes, using data collected from an online survey of 258 Northeast U.S. commercial fishers. This research also assesses characteristics of those fishers who continued fishing and their adaptive strategies to the changing circumstances. Analysis of survey responses found the majority of fishers continued fishing during the early months of the pandemic, while a significant number had stopped fishing. Nearly all reported a loss of income, largely driven by disruptions of export markets, the loss of restaurant sales, and a resulting decline in seafood prices. Landings data demonstrate that while fishing pressure in 2020 was reduced for some species, it remained on track with previous years for others. Fishers reported engaging in a number of adaptation strategies, including direct sales of seafood, switching species, and supplementing their income with government payments or other sources of income. Many fishers who had stopped fishing indicated plans to return, suggesting refraining from fishing as a short-term adaptation strategy, rather than a plan to permanently stop fishing. Despite economic losses, fishers in the Northeast U.S. demonstrated resilience in the face of the pandemic by continuing to fish and implementing other adaptation strategies rather than switching to other livelihoods.	[Smith, Sarah Lindley; Ramenzoni, Victoria] Rutgers State Univ, Dept Human Ecol, New Brunswick, NJ 08901 USA; [Golden, Abigail S.; Jensen, Olaf P.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ USA; [Golden, Abigail S.] Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ USA; [Zemeckis, Douglas R.] Rutgers State Univ, Dept Agr & Nat Resources, Toms River, NJ USA; [Jensen, Olaf P.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Wisconsin System; University of Wisconsin Madison	Smith, SL (corresponding author), Rutgers State Univ, Dept Human Ecol, New Brunswick, NJ 08901 USA.	sarah.l.smith@rutgers.edu		Zemeckis, Douglas/0000-0003-2857-9723	National Oceanic and Atmospheric Administration (NOAA) Coastal and Oceanic Climate Adaptations (COCA) program [2019002753]; National Socio-Environmental Synthesis Center (SESYNC) under National Science Foundation [DBI-1639145]; National Science Foundation Graduate Research Fellowship Program [NSF DGE-1842213]	National Oceanic and Atmospheric Administration (NOAA) Coastal and Oceanic Climate Adaptations (COCA) program; National Socio-Environmental Synthesis Center (SESYNC) under National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	SLS and VR were funded by the National Oceanic and Atmospheric Administration (NOAA) Coastal and Oceanic Climate Adaptations (COCA) program (Project number 2019002753). OPJ was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation (DBI-1639145). ASG is supported by the National Science Foundation Graduate Research Fellowship Program (Grant No. NSF DGE-1842213). DRZ received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson J, 2014, MARIT STUD, V13, DOI 10.1186/2212-9790-13-8; Aguilera SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118992; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2020, CHESAPEAKE BAY  0413; [Anonymous], 2012, REGEN MED S3, V7, pS14; Belarmino E.H., 2020, COLL AGR LIFE SCI FA; Belhabib D, 2018, FISH FISH, V19, P1092, DOI 10.1111/faf.12314; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Bene C, 2020, FOOD SECUR, V12, P805, DOI 10.1007/s12571-020-01076-1; Bennett NJ, 2020, COAST MANAGE, V48, P336, DOI 10.1080/08920753.2020.1766937; Berkes F, 2007, NAT HAZARDS, V41, P283, DOI 10.1007/s11069-006-9036-7; Bittenbender S., 2020, SEAFOOD SOURCE  0626; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Clay PM, 2008, HUM ECOL REV, V15, P143; Clay PM, 2016, MAR POLICY, V74, P334, DOI 10.1016/j.marpol.2016.04.049; Clay PM, 2014, MAR POLICY, V44, P27, DOI 10.1016/j.marpol.2013.08.009; Colburn L. L., 2012, J ECOLOGICAL ANTHR, V15, P74, DOI DOI 10.5038/2162-4593.15.1.6; Colburn LL, 2015, NMFSFSPO157 NOAA, P68; Coulthard S, 2012, ECOL SOC, V17, DOI 10.5751/ES-04483-170104; Crona BI, 2016, MAR POLICY, V65, P1, DOI 10.1016/j.marpol.2015.11.016; Cumming G, 2020, J ENVIRON STUD SCI, V10, P68, DOI 10.1007/s13412-019-00577-6; Dandurant K., 2020, FOSTERS         0427; Drummond C., 2020, WESTERLY SUN    0406; FAO, 2020, FOOD OUTL BIANN REP; Ferro-Azcona H, 2019, OCEAN COAST MANAGE, V173, P36, DOI 10.1016/j.ocecoaman.2019.01.005; Fisheries NOAA, 2020, COMM LAND 2015 2020; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Gephart JA, 2017, GLOBAL ENVIRON CHANG, V42, P24, DOI 10.1016/j.gloenvcha.2016.11.003; Goldthwait J., 2020, STATE MAINE LOBSTERM, DOI 10.1097/BPO.0000000000001610; Henry A, 2014, NMFSNE230 NOAA; Herz N., 2020, NATL PUBLIC RADIO; Himes-Cornell A, 2015, ECOL SOC, V20, DOI 10.5751/ES-07074-200209; Johnson TR, 2018, B MAR SCI, V94, P1185, DOI 10.5343/bms.2017.1108; Johnson TR, 2014, HUM ECOL REV, V20, P97; Kleisner KM, 2017, PROG OCEANOGR, V153, P24, DOI 10.1016/j.pocean.2017.04.001; Kuschner E., 2020, BOSTON GLOBE; Love DC, 2020, EMERGING COVID 19 IM, DOI [10.31235/osf.io/x8aew, DOI 10.31235/0SF.I0/X8AEW]; Marshall NA, 2007, ECOL SOC, V12, DOI 10.5751/es-01940-120101; McClenachan L, 2020, AMBIO, V49, P144, DOI 10.1007/s13280-019-01156-3; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Myers HJ, 2020, MAR POLICY, V118, DOI 10.1016/j.marpol.2020.104017; National Marine Fisheries Service, 2018, NMFSFSPO187 NOAA; National Marine Fisheries Service, 2009, NAT GUID MAN HIV AID; National Marine Fisheries Service (NMFS), 2018, FISH US 2017 REP; NOAA Fisheries, FISH DIS DET; Parry ML, 2007, CLIMATE CHANGE 2007; Perry RI, 2011, FISH FISH, V12, P427, DOI 10.1111/j.1467-2979.2010.00402.x; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pollnac RB, 2008, HUM ECOL REV, V15, P194; Pollnac RB, 2015, ENVIRON IMPACT ASSES, V55, P136, DOI 10.1016/j.eiar.2015.08.006; R Core Team, 2021, R LANGUAGE ENV STAT; Ramenzoni V.C., 2015, CLIM CHANGE CULT EC, P177, DOI [10.1108/S0190-128120150000035008, DOI 10.1108/S0190-128120150000035008]; Schoon ML, 2012, SOC NATUR RESOUR, V25, P141, DOI 10.1080/08941920.2010.549933; Scyphers SB, 2019, P NATL ACAD SCI USA, V116, P22912, DOI 10.1073/pnas.1913914116; Seara T, 2020, COAST MANAGE, V48, P418, DOI 10.1080/08920753.2020.1795969; Seara T, 2017, OCEAN COAST MANAGE, V141, P1, DOI 10.1016/j.ocecoaman.2017.02.016; Seara T, 2016, GLOBAL ENVIRON CHANG, V38, P49, DOI 10.1016/j.gloenvcha.2016.01.006; Smith CL, 2010, HUM ORGAN, V69, P158, DOI 10.17730/humo.69.2.b83x6t44878u4782; Smith Q., 2020, YACHATS COMMUNI 0607; Smith T. D., 1994, SCALING FISHERIES SC; Stoll J. S., 2020, ALTERNATIVE SEAFOOD, DOI 10.32942/osf.io/kuzwq; Stoll JS, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00239; Stoll JS, 2015, OCEAN COAST MANAGE, V116, P185, DOI 10.1016/j.ocecoaman.2015.07.019; Teh LCL, 2013, FISH FISH, V14, P77, DOI 10.1111/j.1467-2979.2011.00450.x; Thompson C, 2016, J RURAL STUD, V45, P165, DOI 10.1016/j.jrurstud.2016.03.008; U.S. Department of Agriculture (USDA), 2020, USDA ANN ADD FOOD PU; van Densen W.L.T., 2001, PERCEPTION TIME TREN; van Oostenbrugge JAE, 2004, AGR SYST, V82, P57, DOI 10.1016/j.agsy.2004.01.002; van Oostenbrugge JAE, 2003, UNCERTAINTY DAILY CA; Wells P., 2020, NEW YORK TIMES  0505; White C., 2020, SEAFOOD SOURCE  0612; White ER, 2020, EARLY EFFECTS COVID, DOI [10.31219/osf.io/9bxnh, DOI 10.31219/0SF.I0/9BXNH]; Wiedenmann J, 2018, CAN J FISH AQUAT SCI, V75, P342, DOI 10.1139/cjfas-2016-0484; Witter A, 2017, MAR POLICY, V80, P130, DOI 10.1016/j.marpol.2016.09.023	74	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243886	10.1371/journal.pone.0243886	http://dx.doi.org/10.1371/journal.pone.0243886			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332383	gold, Green Published			2022-12-26	WOS:000601310900039
J	Andreu-Ballester, JC; Galindo-Regal, L; Hidalgo-Coloma, J; Cuellar, C; Garcia-Ballesteros, C; Hurtado, C; Uribe, N; Martin, MD; Jimenez, AI; Lopez-Chulia, F; Llombart-Cussac, A				Carlos Andreu-Ballester, Juan; Galindo-Regal, Lorena; Hidalgo-Coloma, Julia; Cuellar, Carmen; Garcia-Ballesteros, Carlos; Hurtado, Carolina; Uribe, Natalia; del Carmen Martin, Maria; Isabel Jimenez, Ana; Lopez-Chulia, Francisca; Llombart-Cussac, Antonio			Differences in circulating gamma delta T cells in patients with primary colon cancer and relation with prognostic factors	PLOS ONE			English	Article							PERIPHERAL-BLOOD; INTERFERON-GAMMA; MICROVASCULAR INVASION; INDUCE APOPTOSIS; LYMPHOCYTES; PROLIFERATION; EXPRESSION; INDICATOR; ANTIGEN; DEFICIT	Downregulation of the T cell system has been proposed as a mechanism to block immunity in colonic cancer (CC). However, little has been studied about circulating alpha beta and gamma delta T cells and their immunological status in newly diagnosed patients. The aim of this study was to characterize the alpha beta and gamma delta T cell subsets in peripheral blood of patients with CC matched with healthy volunteers. In this prospective case-control study, blood samples were obtained from 96 patients with newly diagnosed treatment-naive infiltrating colonic adenocarcinoma and 48 healthy volunteers. Pathological report at surgery was obtained from all CC patients. A significant decrease in CD3+ gamma delta T cells and CD3+CD8+ gamma delta T cells (p<0.001) were observed in CC patients. Apoptosis was significantly increased in all conventional and both <alpha>beta and gamma delta T cell subsets in patients with CC vs healthy subjects. gamma delta T cells were decreased in peripheral blood of patients with microscopic infiltration in tissues, history of cancer and synchronous colon cancer (p < 0.05). IFN-<gamma> was significantly reduced in CC patients compared to controls. Cytotoxic effector gamma delta T cells TEMRA (CD8 and CD56) are the proportionally most abundant T cells in peripheral blood of CC patients. Patients with CC present a deep downregulation in the systemic T-cell immunity. These variations are evident through all tumor stages and suggest that a deficiency in gamma delta T cell populations could be preventing control of tumor progression. This fact prove the role of immunomodulation on CC carcinogenesis.	[Carlos Andreu-Ballester, Juan] Arnau de Vilanova Univ Hosp, Res Dept, Valencia, Spain; [Galindo-Regal, Lorena; Garcia-Ballesteros, Carlos; Lopez-Chulia, Francisca] Arnau de Vilanova Univ Hosp, Dept Hematol, Valencia, Spain; [Hidalgo-Coloma, Julia; Llombart-Cussac, Antonio] Arnau de Vilanova Univ Hosp, Dept Med Oncol, Valencia, Spain; [Cuellar, Carmen] Univ Complutense, Dept Microbiol & Parasitol, Fac Pharm, Madrid, Spain; [Hurtado, Carolina] Univ San Pablo CEU, Parasitol Lab, Fac Pharm, Madrid, Spain; [Uribe, Natalia; del Carmen Martin, Maria] Arnau de Vilanova Univ Hosp, Dept Gen & Digest Surg, Valencia, Spain; [Isabel Jimenez, Ana] Arnau de Vilanova Univ Hosp, Dept Pathol, Valencia, Spain	Complutense University of Madrid; San Pablo CEU University	Andreu-Ballester, JC (corresponding author), Arnau de Vilanova Univ Hosp, Res Dept, Valencia, Spain.	jcandreuballester@outlook.com	Andreu-Ballester, Juan Carlos/GPF-7094-2022; García, Carlos/GNM-5627-2022; Hurtado-Marcos, Carolina/AAH-3586-2020	Andreu-Ballester, Juan Carlos/0000-0003-3790-3054; Hurtado-Marcos, Carolina/0000-0003-0364-7742	Town Council of Lliria, Valencia, Spain	Town Council of Lliria, Valencia, Spain	"Town Council of Lliria, Valencia, Spain". "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; [Anonymous], 2014, J RETAIL CONSUM SERV, V21, P61; Caccamo N, 2005, EUR J IMMUNOL, V35, P1764, DOI 10.1002/eji.200525983; Andreu-Ballester JC, 2011, DIGEST DIS SCI, V56, P2613, DOI 10.1007/s10620-011-1636-8; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Chen SH, 2011, HEMATOLOGY, V16, P31, DOI 10.1179/102453311X12902908411832; Clark E J, 2007, HPB (Oxford), V9, P456, DOI 10.1080/13651820701774891; Contreras TN, 2000, J IMMUNOTHER, V23, P67, DOI 10.1097/00002371-200001000-00009; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Feng JF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000257; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreira LMR, 2013, INT REV IMMUNOL, V32, P223, DOI 10.3109/08830185.2013.783831; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Fleming C, 2017, TRENDS CANCER, V3, P561, DOI 10.1016/j.trecan.2017.06.003; Gaafar A, 2009, EXP HEMATOL, V37, P838, DOI 10.1016/j.exphem.2009.04.003; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Grimm M, 2012, CLIN TRANSL ONCOL, V14, P870, DOI 10.1007/s12094-012-0867-2; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Heinzelbecker J, 2014, J UROLOGY, V192, P593, DOI 10.1016/j.juro.2014.02.2569; Hoffmann TK, 2002, CLIN CANCER RES, V8, P2553; Huang H, 2015, INT J CLIN EXP MED, V8, P10779; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Katz SG, 2020, METHODS MOL BIOL, V2097, P3, DOI 10.1007/978-1-0716-0203-4_1; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Kobayashi H, 2011, ANTICANCER RES, V31, P1027; Lafont V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00622; Lam AKY, 2014, WORLD J GASTROENTERO, V20, P6815, DOI 10.3748/wjg.v20.i22.6815; Marks DJB, 2011, CURR OPIN GASTROEN, V27, P328, DOI 10.1097/MOG.0b013e3283463b45; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Maser EA, 2013, INFLAMM BOWEL DIS, V19, P1827, DOI 10.1097/MIB.0b013e318289c166; Mirzaei HR, 2016, CANCER LETT, V380, P413, DOI 10.1016/j.canlet.2016.07.001; Mollberg NM, 2014, ANN THORAC SURG, V97, P965, DOI 10.1016/j.athoracsur.2013.11.002; Pajares JA, 2015, WORLD J GASTRO ONCOL, V7, P434, DOI 10.4251/wjgo.v7.i12.434; Ramutton T, 2014, IMMUNOTHERAPY-UK, V6, P989, DOI 10.2217/imt.14.59; Raverdeau M, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1080; Reichert TE, 2002, CLIN CANCER RES, V8, P3137; Richards CH, 2014, EUR J CANCER, V50, P309, DOI 10.1016/j.ejca.2013.09.008; Rodriguez-Peralvarez M, 2013, ANN SURG ONCOL, V20, P325, DOI 10.1245/s10434-012-2513-1; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Saroha S, 2013, J UROLOGY, V189, P454, DOI 10.1016/j.juro.2012.09.166; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Soares TF, 2007, CLIN MICROBIOL INFEC, V13, P1083, DOI 10.1111/j.1469-0691.2007.01814.x; Takahashi A, 2001, CLIN CANCER RES, V7, P74; Testa Ugo, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6020031; Thiels CA, 2016, J SURG ONCOL, V114, P80, DOI 10.1002/jso.24258; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Xiao YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070345; Yamamoto M, 2019, DIGEST SURG, V36, P487, DOI 10.1159/000492340; Youssef Manal M S, 2015, Egypt J Immunol, V22, P19; 2014, REG ANESTH PAIN MED, V9	54	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243545	10.1371/journal.pone.0243545	http://dx.doi.org/10.1371/journal.pone.0243545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326443	Green Published, gold			2022-12-26	WOS:000600176400001
J	Dahl, HC; Kanchwala, M; Thomas-Jardin, SE; Sandhu, A; Kanumuri, P; Nawas, AF; Xing, C; Lin, CC; Frigo, DE; Delk, NA				Dahl, Haley C.; Kanchwala, Mohammed; Thomas-Jardin, Shayna E.; Sandhu, Amrit; Kanumuri, Preethi; Nawas, Afshan F.; Xing, Chao; Lin, Chenchu; Frigo, Daniel E.; Delk, Nikki A.			Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TUMOR-NECROSIS-FACTOR; NEUROENDOCRINE DIFFERENTIATION; CHRONIC INFLAMMATION; RECEPTOR EXPRESSION; KAPPA-B; PROMOTES; INTERLEUKIN-1; ANTIANDROGEN; PROGRESSION	Chronic inflammation promotes prostate cancer (PCa) initiation and progression. We previously reported that acute intereluekin-1 (IL-1) exposure represses androgen receptor (AR) accumulation and activity, providing a possible mechanism for IL-1-mediated development of androgen- and AR-independent PCa. Given that acute inflammation is quickly resolved, and chronic inflammation is, instead, co-opted by cancer cells to promote tumorigenicity, we set out to determine if chronic IL-1 exposure leads to similar repression of AR and AR activity observed for acute IL-1 exposure and to determine if chronic IL-1 exposure selects for androgen- and AR-independent PCa cells. We generated isogenic sublines from LNCaP cells chronically exposed to IL-1 alpha or IL-1 beta. Cells were treated with IL-1 alpha, IL-1 beta, TNF alpha or HS-5 bone marrow stromal cells conditioned medium to assess cell viability in the presence of cytotoxic inflammatory cytokines. Cell viability was also assessed following serum starvation, AR siRNA silencing and enzalutamide treatment. Finally, RNA sequencing was performed for the IL-1 sublines. MTT, RT-qPCR and western blot analysis show that the sublines evolved resistance to inflammation-induced cytotoxicity and intracellular signaling and evolved reduced sensitivity to siRNA-mediated loss of AR, serum deprivation and enzalutamide. Differential gene expression reveals that canonical AR signaling is aberrant in the IL-1 sublines, where the cells show constitutive PSA repression and basally high KLK2 and NKX3.1 mRNA levels and bioinformatics analysis predicts that pro-survival and pro-tumorigenic pathways are activated in the sublines. Our data provide evidence that chronic IL-1 exposure promotes PCa cell androgen and AR independence and, thus, supports CRPCa development.	[Dahl, Haley C.; Thomas-Jardin, Shayna E.; Sandhu, Amrit; Kanumuri, Preethi; Nawas, Afshan F.; Delk, Nikki A.] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA; [Kanchwala, Mohammed; Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Lin, Chenchu; Frigo, Daniel E.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Lin, Chenchu] Univ Texas MD Anderson Canc Ctr, UTHealth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Frigo, Daniel E.] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Frigo, Daniel E.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Frigo, Daniel E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Frigo, Daniel E.] Houston Methodist Res Inst, Houston, TX USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston	Delk, NA (corresponding author), Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA.	nikki.delk@utdallas.edu		Thomas-Jardin, Shayna/0000-0002-2412-7562; Xing, Chao/0000-0002-1838-0502; Frigo, Daniel/0000-0002-0713-471X; Nawas, Afshan Fathima/0000-0001-5606-9603; Kanchwala, Mohammed/0000-0001-6035-2970; Delk, Nikki/0000-0001-9482-3830	University of Texas at Dallas; NIH [R01CA184208]; Prostate Cancer SPORE [P50CA140388]; Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship; Robert Hazelwood Graduate Fellowship for Cancer Research;  [UL1TR001105]	University of Texas at Dallas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer SPORE; Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship; Robert Hazelwood Graduate Fellowship for Cancer Research; 	ND, University of Texas at Dallas, utdallas.edu, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CX, UL1TR001105, NIH.gov, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DF, NIH R01CA184208, Prostate Cancer SPORE P50CA140388, NIH.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CL, Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship, Robert Hazelwood Graduate Fellowship for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Blaser H, 2016, TRENDS CELL BIOL, V26, P249, DOI 10.1016/j.tcb.2015.12.002; Bluemn EG, 2017, CANCER CELL, V32, P474, DOI 10.1016/j.ccell.2017.09.003; Cai T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153833; Chang MA, 2014, J CELL BIOCHEM, V115, P2188, DOI 10.1002/jcb.24897; Cheng I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008736; Chiao JW, 1999, INT J ONCOL, V15, P1033; Culig Z, 1998, BRIT J CANCER, V78, P1004, DOI 10.1038/bjc.1998.619; Debes JD, 2005, CANCER RES, V65, P5965, DOI 10.1158/0008-5472.CAN-04-2837; Di Donato M, 2019, CANCERS, V11, DOI 10.3390/cancers11060784; Diaz M, 1998, PROSTATE, P32; Gurel B, 2014, CANCER EPIDEM BIOMAR, V23, P847, DOI 10.1158/1055-9965.EPI-13-1126; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HIROSE K, 1993, FASEB J, V7, P361, DOI 10.1096/fasebj.7.2.8440412; Jeong JH, 2017, MOL CELL, V65, P154, DOI 10.1016/j.molcel.2016.11.034; Kawada M, 2006, CANCER LETT, V242, P46, DOI 10.1016/j.canlet.2005.10.040; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; Li QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06067-7; Li YJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-87; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu QX, 2013, CANCER RES, V73, P3297, DOI 10.1158/0008-5472.CAN-12-3970; Liu YH, 2017, ONCOTARGET, V8, P17027, DOI 10.18632/oncotarget.15224; Mahal BA, 2018, EUR UROL, V74, P146, DOI 10.1016/j.eururo.2018.01.043; Mandel A, 2018, MOL MED, V24, P1, DOI 10.1186/s10020-018-0035-4; Moreira DM, 2014, CANCER-AM CANCER SOC, V120, P190, DOI 10.1002/cncr.28349; Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098; Nawas AF, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6529-9; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Perrier S, 2009, FEBS LETT, V583, P259, DOI 10.1016/j.febslet.2008.12.030; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Platz EA, 2017, CANCER EPIDEM BIOMAR, V26, P1549, DOI 10.1158/1055-9965.EPI-17-0503; Poluri RTK, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104372; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Santer FR, 2015, SEMIN CANCER BIOL, V35, P133, DOI 10.1016/j.semcancer.2015.08.005; Semenas J, 2013, DRUG DES DEV THER, V7, P875, DOI 10.2147/DDDT.S45703; Shahriari K, 2017, ONCOGENE, V36, P2846, DOI 10.1038/onc.2016.436; Shen YC, 2018, PROSTATE CANCER P D, V21, P113, DOI 10.1038/s41391-017-0013-x; Staverosky JA, 2013, AM J CLIN EXP UROL, V1, P53; Tafuri A, 2020, ARAB J UROL, V18, P148, DOI 10.1080/2090598X.2020.1757335; Tazaki E, 2011, EXP THER MED, V2, P887, DOI 10.3892/etm.2011.286; THALMANN GN, 1994, CANCER RES, V54, P2577; Thomas-Jardin SE, 2020, PROSTATE, V80, P133, DOI 10.1002/pros.23925; Thomas-Jardin SE, 2018, PROSTATE, V78, P595, DOI 10.1002/pros.23504; Vander Ark A, 2018, FRONT ONCOL, P8, DOI [10.3389/fonc.2018.00008, DOI 10.3389/FONC.2018.00008]; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Wang DP, 2009, CANCER RES, V69, P9448, DOI 10.1158/0008-5472.CAN-09-1903; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Wingett S, 2011, FASTQ SCREEN QUALITY, DOI [10.3109/17435390.2011.587031, DOI 10.3109/17435390.2011.587031]; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yin H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-158; Zhang BY, 2016, MOL CELL, V63, P976, DOI 10.1016/j.molcel.2016.07.025; Zhang C, 2011, PROSTATE, V71, P157, DOI 10.1002/pros.21231	62	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242970	10.1371/journal.pone.0242970	http://dx.doi.org/10.1371/journal.pone.0242970			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326447	Green Submitted, Green Published, gold			2022-12-26	WOS:000600176400036
J	Arega, B; Mersha, A; Minda, A; Getachew, Y; Sitotaw, A; Gebeyehu, T; Agunie, A				Arega, Balew; Mersha, Amdemeskel; Minda, Abraham; Getachew, Yitagesu; Sitotaw, Alazar; Gebeyehu, Tefera; Agunie, Asnake			Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; LYMPHADENITIS	Background Ethiopia reported a high rate of extra-pulmonary tuberculosis (EPTB) and the cases are increasing since the last three decades. However, diagnostic evidence to initiate TB treatment among EPTB cases is not well known. Therefore, we described the epidemiology and assessed how EPTB is diagnosed in a teaching hospital in Ethiopia. Methods We conducted a retrospective review among all adult EPTB cases diagnosed in Yekatit 12 Hospital Medical College from 2015 to 2019. Using a standardized data abstraction sheet, we collected data from patients' medical records on sociodemographic, sites, and laboratory diagnosis of EPTB cases. Results Of the 965 total TB cases, 49.8%(481) had a recorded diagnosis of EPTB during the study period. The mean age of EPTB patients was 32.9 years (SD13.9) and 50.7% were males. Tubercular lymphadenitis (40.3%), abdominal (23.4%), and pleural TB(13.5%) were the most common sites of EPTB involvement, followed in descending order by the genitourinary, skeletal, central nervous system, abscess, breast, and laryngeal TB. We found a histopathology finding consistent with EPTB in 59.1% of cases, Acid-fast bacilli positive in 1.5%, and the rest diagnosed on radiological grounds. In the majority of cases, more than one diagnostic method was used to diagnose EPTB cases. Conclusions Nearly half of TB patients had a recorded diagnosis of EPTB that comprise heterogeneous anatomical sites. All EPTB patients were started anti-TB therapy without definitive microbiology results. This indicates the diagnostic challenge of EPTB faced in our setting and proves to be significant for TB control in Ethiopia.	[Arega, Balew; Mersha, Amdemeskel; Minda, Abraham; Getachew, Yitagesu; Sitotaw, Alazar; Gebeyehu, Tefera; Agunie, Asnake] Yekatit 12 Hosp Med Coll, Addis Ababa, Ethiopia		Arega, B (corresponding author), Yekatit 12 Hosp Med Coll, Addis Ababa, Ethiopia.	balewmlt@gmail.com		Negatie, Balew Arega/0000-0002-4222-8420; Yirga, Asnake/0000-0002-9790-430X				A YX, 2011, J MODERN ONCOLOGY, V19, P111; Abdallah Taj Eldin Mohammedein, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P505, DOI 10.1016/j.apjtb.2015.02.004; Abdissa K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0720-z; Abebe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-504; Adada H, 2014, INT J TUBERC LUNG D, V18, P1516, DOI 10.5588/ijtld.14.0319; Adrian O, 2004, CLININFE DIS, V38, P25; Alemu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232426; [Anonymous], 2017, BRIDGES, V21, P36; [Anonymous], 2013, KOVETZ HITZEI GIBORI, V6, P21; [Anonymous], REP TUB US 1999; Arega B, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09117-2; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Bekele S, 2018, TROP DIS TRAVEL MED, V4, DOI 10.1186/s40794-018-0075-3; Berg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0846-7; Biadglegne F, 2014, TUBERCULOSIS, V94, P502, DOI 10.1016/j.tube.2014.05.002; Biadglegne F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081918; Biadglegne F, 2013, INT J MED SCI, V10, P1589, DOI 10.7150/ijms.6806; Biadglegne F, 2013, JPN J INFECT DIS, V66, P263, DOI 10.7883/yoken.66.263; CABIE A, 1995, PRESSE MED, V24, P601; Chander V, 2012, PUBLIC HLTH RES, V2, P185; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Fain, 2000, Eur J Intern Med, V11, P145, DOI 10.1016/S0953-6205(00)00076-5; Fantahun M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222402; Federal Ministry of Health (Ethiopia), 2013, GUID CLIN PROGR MAN, V5th; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Kandola P, 2014, ADV MAT REV, V1, P13; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; Korma W, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1177-4; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Licastro Federico, 2005, Immun Ageing, V2, P8; Makhloufa Nahed A., 2016, AL AZHAR ASSIUT MED, V14, P132; Mesfin MM, 2005, ETH J HLTH DEV; Metaferia Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8207098; Modi S, 2018, J DATTA MEGHE I MED, V13, P163; Muluye D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-435; Noertjojo K, 2002, INT J TUBERC LUNG D, V6, P879; Ozvaran Mustafa Kursat, 2007, Ann Thorac Med, V2, P118, DOI 10.4103/1817-1737.33700; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Prakasha SR, 2013, J GLOB INFECT DIS, V5, P54, DOI 10.4103/0974-777X.112277; Purohit M, 2015, J CLIN DIAGN RES, V9, pEE1, DOI 10.7860/JCDR/2015/12422.5792; Solovic I, 2013, EUROSURVEILLANCE, V18, P34; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Srinidhi R, 2020, IP INDIAN J IMMUNOL, V5, P152; Suguitan Jr AL, 2011, PLOS ONE, V6; Tadesse M, 2019, CLIN MICROBIOL INFEC, V25, P1000, DOI 10.1016/j.cmi.2018.12.018; Tadesse M, 2017, INFECT GENET EVOL, V55, P251, DOI 10.1016/j.meegid.2017.09.016; Tadesse M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137471; Tahseen S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232134; Wani R. L. S., 2013, South Sudan Medical Journal, V6, P52; WHO, 2017, GLOB TUB REP; WHO W, 2012, GLOB TUB REP 2012; World Health Organization, 2011, RAP IMPL XPERT MTB R; Zewdie O, 2016, INT J TUBERC LUNG D, V20, P1529, DOI 10.5588/ijtld.15.1023; Zewdie O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2194-2	55	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243945	10.1371/journal.pone.0243945	http://dx.doi.org/10.1371/journal.pone.0243945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320897	gold, Green Published			2022-12-26	WOS:000600339800023
J	Barycka, K; Szarpak, L; Filipiak, KJ; Jaguszewski, M; Smereka, J; Ladny, JR; Turan, O				Barycka, Katarzyna; Szarpak, Lukasz; Filipiak, Krzysztof Jerzy; Jaguszewski, Milosz; Smereka, Jacek; Ladny, Jerzy Robert; Turan, Oguz			Comparative effectiveness of N95 respirators and surgical/face masks in preventing airborne infections in the era of SARS-CoV2 pandemic: A meta-analysis of randomized trials	PLOS ONE			English	Article							MEDICAL MASKS; CLINICAL-TRIAL; FACE MASK; INFLUENZA; TRANSMISSION	Background Recently, several randomized controlled trials (RCTs) have evaluated the effect of N95 respirators compared with medical masks to protect against acute respiratory infections. However, these studies are limited by modest sample sizes and inconclusive results. Therefore, the goal of the present study was to review the relevant and available published RCTs with the aid of the increased power of meta-analytic methods in order to assess the effectiveness of medical masks and N95 respirators in reducing the risk of respiratory infections. Methods This meta-analysis follows the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for conducting and reporting results. We searched PubMed, Web of Science, Embase, and Cochrane databases from inception through April 1, 2020 to identify potentially relevant studies. Two authors (LS and JS) independently searched the titles and abstracts of the potentially eligible articles. They independently retrieved required data from the eligible trials; the data were initially tabulated for statistical analysis. Two authors (JRL and LS) independently assessed the methodological quality of the included RCTs using the Cochrane Collaboration's tool for assessing risk of bias. Results Six articles met the inclusion criteria. The pooled analysis showed that N95 respirators did not reduce the risk of infection with respiratory viruses compared with medical/surgical masks (5.7% vs. 7.9%; RR = 1.12; 95% CI: 0.88-1.41; p = 0.36); however, there was no statistically significant difference in laboratory-confirmed influenza between N95 and medical masks (RR = 0.91; 95% CI: 0.77-1.07; p = 0.26). Medical masks provided similar protection against other viruses, including coronavirus (RR = 0.74; 95% CI: 0.32-1.73; p = 0.49). Respiratory illness, as well as influenza-like illness were less frequently observed with N95 respirators. Conclusions Our meta-analysis suggests that there are insufficient data to definitively determine whether N95 respirators are superior to medical masks in protection against transmissible acute respiratory infections. Further randomized trials are necessary to compare the above methods of respiratory protection in the context of COVID-19 incidence.	[Barycka, Katarzyna] Polish Soc Disaster Med, Warsaw, Poland; [Szarpak, Lukasz] Maria Sklodowska Curie Med Acad Warsaw, Warsaw, Poland; [Filipiak, Krzysztof Jerzy] Med Univ Warsaw, Chair & Dept Cardiol 1, Warsaw, Poland; [Jaguszewski, Milosz] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland; [Smereka, Jacek] Wroclaw Med Univ, Dept Emergency Med Serv, Wroclaw, Poland; [Ladny, Jerzy Robert] Med Univ Bialystok, Clin Emergency Med, Bialystok, Poland; [Turan, Oguz] Cleveland Clin, Anesthesiol Inst, Dept Outcomes Res, Cleveland, OH 44106 USA	Medical University of Warsaw; Fahrenheit Universities; Medical University Gdansk; Wroclaw Medical University; Medical University of Bialystok; Cleveland Clinic Foundation	Szarpak, L (corresponding author), Maria Sklodowska Curie Med Acad Warsaw, Warsaw, Poland.	lukasz.szarpak@gmail.com	Jaguszewski, Milosz/AAL-3169-2020; Ladny, Jerzy/S-4769-2018	Szarpak, Lukasz/0000-0002-0973-5455; Ladny, Jerzy/0000-0003-4167-1962				[Anonymous], 2020, CORONAVIRUS COVID 19; Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072; Christian MD, 2004, EMERG INFECT DIS, V10, P287, DOI 10.3201/eid1002.030700; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kim H, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014250; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MacIntyre CR, 2014, PREV MED, V62, P1, DOI 10.1016/j.ypmed.2014.01.015; MacIntyre CR, 2013, AM J RESP CRIT CARE, V187, P960, DOI 10.1164/rccm.201207-1164OC; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Radonovich LJ, 2019, JAMA-J AM MED ASSOC, V322, P824, DOI 10.1001/jama.2019.11645; Radonovich LJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1494-2; Ruetzler K, 2020, DISASTER EMERG MED J, V5, P106; Sandaradura I, 2020, J HOSP INFECT, V104, P529, DOI 10.1016/j.jhin.2020.01.006; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Smereka J, 2020, AM J EMERG MED, V38, P2232, DOI 10.1016/j.ajem.2020.03.038; Stower H, 2020, NAT MED, V26, P465, DOI 10.1038/s41591-020-0850-3; Suen LKP, 2020, J HOSP INFECT, V104, P336, DOI 10.1016/j.jhin.2019.09.014; Szarpak L, 2020, CARDIOL J, V27, P218, DOI 10.5603/CJ.a2020.0054; Vuma CD, 2019, ANN WORK EXPOS HEAL, V63, P930, DOI 10.1093/annweh/wxz060; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707; Zhou SS, 2018, J THORAC DIS, V10, P2059, DOI 10.21037/jtd.2018.03.103	24	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242901	10.1371/journal.pone.0242901	http://dx.doi.org/10.1371/journal.pone.0242901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320847	gold, Green Published			2022-12-26	WOS:000600339800018
J	Sharma, S; Pei, XH; Xing, F; Wu, SY; Wu, KR; Tyagi, A; Zhao, D; Deshpande, R; Ruiz, MG; Singh, R; Lyu, F; Watabe, K				Sharma, Sambad; Pei, Xinhong; Xing, Fei; Wu, Shih-Ying; Wu, Kerui; Tyagi, Abhishek; Zhao, Dan; Deshpande, Ravindra; Ruiz, Marco Gabriel; Singh, Ravi; Lyu, Feng; Watabe, Kounosuke			Regucalcin promotes dormancy of prostate cancer	ONCOGENE			English	Article							SMOOTH-MUSCLE; RADICAL PROSTATECTOMY; MAMMARY-GLAND; HUMAN BREAST; PROTEIN; CELLS; GENE; EXPRESSION; PROLIFERATION; REVEALS	Prostate cancer is one of the leading causes of mortality in men. The major cause of death in prostate cancer patients can be attributed to metastatic spread of disease or tumor recurrence after initial treatment. Prostate tumors are known to remain undetected or dormant for a long period of time before they progress locoregionally or at distant sites as overt tumors. However, the molecular mechanism of dormancy is yet poorly understood. In this study, we performed a differential gene expression analysis and identified a gene, Regucalcin (RGN), which promotes dormancy of prostate cancer. We found that cancer patients expressing higher level of RGN showed significantly longer recurrence-free and overall- survival. Using a doxycycline-inducible RGN expression system, we showed that ectopic expression of RGN in prostate tumor cells induced dormancy in vivo, while following suppression of RGN triggered recurrence of tumor growth. On the other hand, silencing RGN in LNCap cells promoted its outgrowth in the tibia of mice. Importantly, RGN promoted multiple known hallmarks of tumor dormancy including activation of p38 MAPK, decrease in Erk signaling and inhibition of FOXM1 expression. Furthermore, we found that RGN significantly suppressed angiogenesis by increasing secretory miR-23c level in the exosomes. Intriguingly, FOXM1 was found to negatively regulate miR-23c expression in prostate cancer. In addition, we identified 11 RGN downstream target genes that independently predicted longer recurrence-free survival in patients. We found that expression of these genes was regulated by FOXM1 and/or p38 MAPK. These findings suggest a critical role of RGN in prostate cancer dormancy, and the utility of RGN signaling and exosomal miR-23c as biomarkers for predicting recurrence.	[Sharma, Sambad; Xing, Fei; Wu, Shih-Ying; Wu, Kerui; Tyagi, Abhishek; Zhao, Dan; Deshpande, Ravindra; Ruiz, Marco Gabriel; Lyu, Feng; Watabe, Kounosuke] Wake Forest Baptist Med Ctr, Dept Canc Biol, Winston Salem, NC 27157 USA; [Pei, Xinhong] Zhengzhou Univ, Affiliated Hosp 1, Dept Breast Surg, Zhengzhou 450052, Henan, Peoples R China	Wake Forest University; Wake Forest Baptist Medical Center; Zhengzhou University	Watabe, K (corresponding author), Wake Forest Baptist Med Ctr, Dept Canc Biol, Winston Salem, NC 27157 USA.	kwatabe@wakehealth.edu	Tyagi, Abhishek/AFZ-6213-2022; Tyagi, Abhishek/CAF-1274-2022; Zhao, Dan/Y-8065-2019; Deshpande, Ravindra/AAE-6392-2021; Singh, Ravi N/A-5740-2011	Tyagi, Abhishek/0000-0002-0155-2099; Tyagi, Abhishek/0000-0002-0155-2099; Zhao, Dan/0000-0002-5120-6725; Singh, Ravi N/0000-0003-0750-1804	NIH [RO1CA173499, RO1CA185650, RO1CA205067]; China Scholarship Council [2014084100701, 2018093]; National Institutes of Health [P30CA012197]; comprehensive cancer center of Wake Forest University	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); comprehensive cancer center of Wake Forest University	This work was supported by NIH grant RO1CA173499, RO1CA185650, and RO1CA205067 to KW. XP was supported by State Scholarship fund (2014084100701) by China Scholarship Council. FL was supported by State Scholarship fund 2018093 by China Scholarship Council. The tumor tissue and pathology shared resources, biostatistics/bioinformatics shared resources, flow cytometry, and cell engineering shared resources are supported by comprehensive cancer center of Wake Forest University and, National Institutes of Health Grant (P30CA012197). The funding agency had no role in study design, data collection, data analysis, interpretation, and writing of the report. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Amin KN, 2020, MICROVASC RES, V127, DOI 10.1016/j.mvr.2019.103924; Aslan C, 2019, J CELL PHYSIOL, V234, P16885, DOI 10.1002/jcp.28374; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Boorjian SA, 2011, EUR UROL, V59, P893, DOI 10.1016/j.eururo.2011.02.026; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cackowski FC, 2019, PROSTATE, V79, P1715, DOI 10.1002/pros.23896; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chand V, 2019, MOL CANCER RES, V17, P1063, DOI 10.1158/1541-7786.MCR-18-0968; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chery L, 2014, ONCOTARGET, V5, P9939, DOI 10.18632/oncotarget.2480; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Crumbaker M, 2017, CANCERS, V9, DOI 10.3390/cancers9040034; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Eckers JC, 2014, RADIAT RES, V182, P420, DOI 10.1667/RR13726.1; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Henderson JR, 1999, DEV DYNAM, V214, P229, DOI 10.1002/(SICI)1097-0177(199903)214:3<229::AID-AJA6>3.3.CO;2-J; Huang W, 2012, ONCOGENE, V31, P4527, DOI 10.1038/onc.2011.573; Huang YQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0820-4; Ishigami A, 2015, GERIATR GERONTOL INT, V15, P804, DOI 10.1111/ggi.12347; Jones CU, 2011, NEW ENGL J MED, V365, P107, DOI 10.1056/NEJMoa1012348; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Kupelian P, 1996, UROLOGY, V48, P249, DOI 10.1016/S0090-4295(96)00167-7; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Lyu TJ, 2013, EPIGENETICS-US, V8, P1330, DOI 10.4161/epi.26675; Maia C, 2009, J CELL BIOCHEM, V107, P667, DOI 10.1002/jcb.22158; Maia CJB, 2008, MOL CELL BIOCHEM, V311, P81, DOI 10.1007/s11010-007-9697-x; Marques R, 2015, EXP CELL RES, V330, P325, DOI 10.1016/j.yexcr.2014.08.007; Marques R, 2014, CELL MOL LIFE SCI, V71, P93, DOI 10.1007/s00018-013-1323-3; MIWA T, 1991, MOL CELL BIOL, V11, P3296, DOI 10.1128/MCB.11.6.3296; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Nakagawa T, 2008, INT J MOL MED, V21, P605; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Ribeiro Mara Fernandes, 2013, Curr Angiogenes, V2, P54; Shaked Y, 2014, CURR PHARM DESIGN, V20, P4920; Sharma S, 2019, EBIOMEDICINE, V44, P194, DOI 10.1016/j.ebiom.2019.05.038; Sharma S, 2016, J BIOL CHEM, V291, P19351, DOI 10.1074/jbc.M116.737379; Sharma S, 2014, FRONT BIOSCI-LANDMRK, V19, P339, DOI 10.2741/4211; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Tanjore H, 2006, AM J PATHOL, V168, P715, DOI 10.2353/ajpath.2006.051321; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varisli L, 2013, GENET TEST MOL BIOMA, V17, P562, DOI 10.1089/gtmb.2012.0524; Vaz CV, 2016, CURR MOL MED, V16, P607, DOI 10.2174/156652401666616; Vaz CV, 2015, TRANSL RES, V166, P693, DOI 10.1016/j.trsl.2015.08.009; Vaz CV, 2015, BBA-MOL CELL RES, V1853, P2621, DOI 10.1016/j.bbamcr.2015.07.006; Wang J, 2017, ONCOL LETT, V13, P4979, DOI 10.3892/ol.2017.6050; Wu KR, 2017, BBA-REV CANCER, V1868, P538, DOI 10.1016/j.bbcan.2017.10.001; Xing F, 2018, CANCER RES, V78, P4316, DOI 10.1158/0008-5472.CAN-18-1102; Yamaguchi M, 2005, INT J MOL MED, V15, P371; YAMAGUCHI M, 1990, BIOCHEM MED METAB B, V43, P140, DOI 10.1016/0885-4505(90)90019-W; Yamaguchi M, 2018, INT J ONCOL, V53, P1313, DOI 10.3892/ijo.2018.4458; Yamaguchi M, 2017, MOL CELL BIOCHEM, V430, P37, DOI 10.1007/s11010-017-2952-x; Yamaguchi M, 2016, INT J ONCOL, V49, P812, DOI 10.3892/ijo.2016.3538; Yamaguchi M, 2016, INT J ONCOL, V48, P1955, DOI 10.3892/ijo.2016.3409; Yamaguchi M, 2015, J CANCER RES CLIN, V141, P1333, DOI 10.1007/s00432-014-1831-z; Yamaguchi M, 2013, APOPTOSIS, V18, P1145, DOI 10.1007/s10495-013-0859-x; Yang ZH, 2017, DIS MODEL MECH, V10, P39, DOI 10.1242/dmm.027417	62	3	3	3	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					1012	1026		10.1038/s41388-020-01565-9	http://dx.doi.org/10.1038/s41388-020-01565-9		DEC 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33323968	Green Accepted			2022-12-26	WOS:000599126500010
J	Christoforou, AN; Armstrong, MJ; Bergin, MJG; Robbins, A; Merillat, SA; Erwin, P; Getchius, TSD; McCrea, M; Markowitz, AJ; Manley, GT; Giacino, JT				Christoforou, Andrea N.; Armstrong, Melissa J.; Bergin, Michael J. G.; Robbins, Ann; Merillat, Shannon A.; Erwin, Patricia; Getchius, Thomas S. D.; McCrea, Michael; Markowitz, Amy J.; Manley, Geoffrey T.; Giacino, Joseph T.			An evidence-based methodology for systematic evaluation of clinical outcome assessment measures for traumatic brain injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; HEALTH-STATUS; COSMIN; RECOMMENDATIONS; PROGRESS; QUALITY; DISORDERS; CHECKLIST; REVIEWS; SCALES	Introduction The high failure rate of clinical trials in traumatic brain injury (TBI) may be attributable, in part, to the use of untested or insensitive measurement instruments. Of more than 1,000 clinical outcome assessment measures (COAs) for TBI, few have been systematically vetted to determine their performance within specific "contexts of use (COU)." As described in guidance issued by the U.S. Food and Drug Administration (FDA), the COU specifies the population of interest and the purpose for which the COA will be employed. COAs are commonly used for screening, diagnostic categorization, outcome prediction, and establishing treatment effectiveness. COA selection typically relies on expert consensus; there is no established methodology to match the appropriateness of a particular COA to a specific COU. We developed and pilot-tested the Evidence-Based Clinical Outcome assessment Platform (EB-COP) to systematically and transparently evaluate the suitability of TBI COAs for specific purposes. Methods and findings Following a review of existing literature and published guidelines on psychometric standards for COAs, we developed a 6-step, semi-automated, evidence-based assessment platform to grade COA performance for six specific purposes: diagnosis, symptom detection, prognosis, natural history, subgroup stratification and treatment effectiveness. Mandatory quality indicators (QIs) were identified for each purpose using a modified Delphi consensus-building process. The EB-COP framework was incorporated into a Qualtrics software platform and pilot-tested on the Glasgow Outcome Scale-Extended (GOSE), the most widely-used COA in TBI clinical studies. Conclusion The EB-COP provides a systematic methodology for conducting more precise, evidence-based assessment of COAs by evaluating performance within specific COUs. The EB-COP platform was shown to be feasible when applied to a TBI COA frequently used to detect treatment effects and can be modified to address other populations and COUs. Additional testing and validation of the EB-COP are warranted.	[Christoforou, Andrea N.; Bergin, Michael J. G.; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Christoforou, Andrea N.; Bergin, Michael J. G.; Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Armstrong, Melissa J.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Robbins, Ann] Ann Robbins LLC, Bradenton, FL USA; [Merillat, Shannon A.; Getchius, Thomas S. D.] Amer Acad Neurol, Minneapolis, MN USA; [Erwin, Patricia] Mayo Clin, Rochester, MN USA; [Getchius, Thomas S. D.] Amer Heart Assoc, Amer Coll Cardiol, Dallas, TX USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Markowitz, Amy J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA	Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Mayo Clinic; Medical College of Wisconsin; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Giacino, JT (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA.; Giacino, JT (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.	amymarkowitz@gmail.com; jgiacino@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Armstrong, Melissa/0000-0002-2163-1907	University of California at San Francisco (UCSF) (TBI Endpoint Development Initiative) [W81XWH-14-2-0176]; DoD grant	University of California at San Francisco (UCSF) (TBI Endpoint Development Initiative); DoD grant	This study was supported by a seed grant awarded to JTG by the University of California at San Francisco (UCSF) as part of a prime award (TBI Endpoint Development Initiative; URL: https://tbiendpoints.ucsf.edu/) issued to UCSF by the U.S. Department of Defense (DoD) Army Medical Research and Materiel Command (W81XWH-14-2-0176; URL: https://mrdc.amedd.army.mil/).GM served as the PI on the primary DoD grant. The funder provided support in the form of salaries [JTG, AC, MJB, GM, AM] and consulting fees [MJA, AR, SM, PE, TSG, MM] for authors. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One author [AR] has a commercial interest as the President of Ann Robbins, LLC, a regulatory affairs consulting company that provides regulatory consulting services to drug development and non-profit research organizations. Dr. Robbins' commercial affiliation did not play any role in this study and she was not compensated for her participation.	[Anonymous], 2011, CLIN PRACTICE GUIDEL, DOI DOI 10.17226/13058; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; FDA, 2017, FDA CDRH QUALIFICATI; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Friedman JH, 2010, MOVEMENT DISORD, V25, P805, DOI 10.1002/mds.22989; Gronseth GS., 2017, CLIN PRACTICE GUIDEL, V2nd; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; Institute of Medicine, 2011, FIND WHAT WORKS HLTH, DOI [10.17226/13059., DOI 10.17226/13059, 10.17226/13059]; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkham JJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002447; Kirkham JJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002148; Kucukdeveci AA, 2011, J REHABIL MED, V43, P661, DOI 10.2340/16501977-0844; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Meeuws S, 2020, J NEUROTRAUM, V37, P1283, DOI 10.1089/neu.2019.6867; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Menon DK, 2009, CRIT CARE MED, P37; Mokkink LB., 2012, COSMIN CHECKLIST MAN; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Moore JL, 2014, ARCH PHYS MED REHAB, V95, P197, DOI 10.1016/j.apmr.2013.09.010; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, P18; Prinsen CAC, 2018, QUAL LIFE RES, V27, P1147, DOI 10.1007/s11136-018-1798-3; Salter K, 2017, EVIDENCE BASED REV M, P1; Schmidt M., 1996, W PSYCHOL SERVICES; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; U.S. Food and Drug Administration, 2016, DRUG DEV TOOLS QUAL; U.S. Food and Drug Administration, 2016, CLIN OUTC ASS COMP; U.S. Food and Drug Administration, 2016, PIL CLIN OUTC ASS CO; Venderbos LDF, 2015, PSYCHO-ONCOLOGY, V24, P348, DOI 10.1002/pon.3657; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	46	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242811	10.1371/journal.pone.0242811	http://dx.doi.org/10.1371/journal.pone.0242811			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315925	Green Published, gold			2022-12-26	WOS:000600186100030
J	Miao, R; Xiang, XH; Wu, Q; Jiang, ZB				Miao, Rui; Xiang, Xiaohao; Wu, Qi; Jiang, Zhibin			Evaluation method of medical service system based on DEMATEL and the information entropy: A case study of hypertension diagnosis and treatment in China	PLOS ONE			English	Article							HEALTH-CARE; PAIN; ALLOCATION; ANXIETY; COST	Precise and reasonable evaluation of the multi-attribute value of medical system is the basis for hospitals to implement total quality management. Excellent medical system is necessary as a part of modern urban governance. However, most of medical value evaluation work relies on scale and artificial scoring at present, lacking in objectivity. Therefore, a scientific and comprehensive medical value evaluation system is needed urgently to give full play to the guiding role of value evaluation and promote the improvement of the medical service system. In this study, DEMATEL and information entropy are used to quantify the degree of mutual influence between system indicators and the differences in medical market performance respectively, so as to obtain the objective index weight. Hypertension has the highest incidence in the whole chronic disease system, which seriously affects people's daily life. Based on the existing hypertension diagnosis and treatment index system, a comprehensive and objective evaluation model is established to evaluate the hypertension diagnosis and treatment behaviors of different medical institutions, which achieves good result. This method has effectively improved the relative deficiency of one-sided subjective evaluation and has a great guiding significance for the comparison of treatment in departments and the economical use of medical resources.	[Miao, Rui] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai, Peoples R China; [Miao, Rui] Shanghai Jiao Tong Univ, China Inst Urban Governance, Shanghai, Peoples R China; [Xiang, Xiaohao; Wu, Qi] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai, Peoples R China; [Jiang, Zhibin] Shanghai Jiao Tong Univ, Antai Coll Econ & Management, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Miao, R (corresponding author), Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai, Peoples R China.; Miao, R (corresponding author), Shanghai Jiao Tong Univ, China Inst Urban Governance, Shanghai, Peoples R China.	miaorui@sjtu.edu.cn			National Natural Science Foundation, China [71971139,71432006]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation, China (No. 71971139,71432006).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar V, 2015, PHYSICA A, V423, P72, DOI 10.1016/j.physa.2014.12.031; Albasan H, 2013, ANKARA UNIV VET FAK, V60, P297, DOI 10.1501/Vetfak_0000002594; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA1, DOI 10.1089/dia.2020.2525.abstracts; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Berwick D, 2016, MILBANK Q, V94, P237, DOI 10.1111/1468-0009.12189; BioCentury, 2010, BIOCENTURY, V18, pB16; Brugnoli MP, 2018, ANN PALLIAT MED, V7, P17, DOI 10.21037/apm.2017.10.03; Cai HF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00463; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Du T, 2014, EC GEOGRAPHY, V34, P40; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; GILLON R, 1985, BRIT MED J, V291, P266, DOI 10.1136/bmj.291.6490.266; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Gu Qian, 2019, MODERN HOSP MANAGEME, V17, P20; Hauser D, 2018, HEALTH AFFAIR, V37, P793, DOI 10.1377/hlthaff.2017.1548; Hsu CW, 2013, J CLEAN PROD, V56, P164, DOI 10.1016/j.jclepro.2011.09.012; Jiang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064589; Lakdawalla DN, 2018, VALUE HEALTH, V21, P131, DOI 10.1016/j.jval.2017.12.007; Lesne A, 2014, MATH STRUCT COMP SCI, V24, DOI 10.1017/S0960129512000783; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Liu CM, 2021, J HEALTH PSYCHOL, V26, P2822, DOI 10.1177/1359105320934158; Liu Y, 2013, IEEE T SOFTWARE ENG, V39, P1018, DOI 10.1109/TSE.2012.82; Mantzorou M, 2018, PHYTOTHER RES, V32, P957, DOI 10.1002/ptr.6037; Michael E, 2006, REDEFINING HLTH CARE; Morton A, 2016, J HEALTH ECON, V49, P97, DOI 10.1016/j.jhealeco.2016.06.001; Osamy W, 2020, WIREL NETW, V26, P1869, DOI 10.1007/s11276-018-1877-y; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Shahidi F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061573; Shu C, 2018, MODERN MED HLTH, V20, P166; Song WC, 2011, CHINESE HLTH EC, V30, P57; Su W, 2014, CHINESE HLTH INSURAN; Taylor M, 2017, VALUE HEALTH, V20, P224, DOI 10.1016/j.jval.2016.12.009; Tian C, 2014, CHINESE HOSP, V18, P28; Tian CJ, 2014, CHIN HOSP, V18, P28; Tzeng GH, 2010, SOFT COMPUT, V14, P1141, DOI 10.1007/s00500-009-0507-0; Verguet S, 2016, PHARMACOECONOMICS, V34, P913, DOI 10.1007/s40273-016-0414-z; Wang J, 2018, MODERN MED HLTH, V19, P138; Williams SE, 2009, PAIN, V146, P283, DOI 10.1016/j.pain.2009.07.039; Wu WW, 2008, EXPERT SYST APPL, V35, P828, DOI 10.1016/j.eswa.2007.07.025; Xia Feng, 2019, CHINESE HOSP MANAGEM, V39, P13; Zhou XB, 2011, J ECON STUD, V38, P17, DOI 10.1108/01443581111096123; 王舟强, 2017, [中国卫生统计, Chinese Journal of Health Statistics], V34, P604	42	2	2	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243832	10.1371/journal.pone.0243832	http://dx.doi.org/10.1371/journal.pone.0243832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33318708	Green Published, gold			2022-12-26	WOS:000600186100042
J	Nosyreva, ED; Thompson, D; Syeda, R				Nosyreva, Elena D.; Thompson, David; Syeda, Ruhma			Identification and functional characterization of the Piezo1 channel pore domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM; MODULE; CELL	Mechanotransduction is the process by which cells convert physical forces into electrochemical responses. On a molecular scale, these forces are detected by mechanically activated ion channels, which constitute the basis for hearing, touch, pain, cold, and heat sensation, among other physiological processes. Exciting high-resolution structural details of these channels are currently emerging that will eventually allow us to delineate the molecular determinants of gating and ion permeation. However, our structural-functional understanding across the family remains limited. Piezo1 is one of the largest and least understood of these channels, with various structurally identified features within its trimeric assembly. This study seeks to determine the modularity and function of Piezo1 channels by constructing deletion proteins guided by cryo EM structural knowledge. Our comprehensive functional study identified, for the first time, the minimal amino acid sequence of the full-length Piezo1 that can fold and function as the channel's pore domain between E2172 and the last residue E2547. While the addition of an anchor region has no effect on permeation properties. The Piezo1 pore domain is not pressure-sensitive and the appending of Piezo Repeat-A did not restore pressure-dependent gating, hence the sensing module must exist between residues 1 to 1952. Our efforts delineating the permeation and gating regions within this complex ion channel have implications in identifying small molecules that exclusively regulate the activity of the channel's pore module to influence mechanotransduction and downstream processes.	[Nosyreva, Elena D.; Thompson, David; Syeda, Ruhma] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Syeda, R (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	Ruhma.syeda@utsouthwestern.edu		Nosyreva, Elena D/0000-0002-6624-7415	UT Southwestern Medical Center Endowed Scholar Program; Welch Foundation [I-1965-20180324]; American Heart Association scientist development grant [17SDG33410184]	UT Southwestern Medical Center Endowed Scholar Program; Welch Foundation(The Welch Foundation); American Heart Association scientist development grant(American Heart Association)	This study was supported by the UT Southwestern Medical Center Endowed Scholar Program, Welch Foundation Award (I-1965-20180324), and American Heart Association scientist development grant (17SDG33410184) to R.S.	Alper SL, 2017, CURR TOP MEMBR, V79, P97, DOI 10.1016/bs.ctm.2017.01.001; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Erdogmus S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13722-0; Geng J, 2020, NEURON, V106, P438, DOI 10.1016/j.neuron.2020.02.010; Gottlieb PA, 2017, CURR TOP MEMBR, V79, P1, DOI 10.1016/bs.ctm.2016.11.007; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660; Hyman AJ, 2017, CURR TOP MEMBR, V79, P37, DOI 10.1016/bs.ctm.2016.11.001; Kovacsova G, 2015, PROTEIN EXPRES PURIF, V111, P42, DOI 10.1016/j.pep.2015.03.002; Lewis AH, 2020, CELL REP, V30, P870, DOI 10.1016/j.celrep.2019.12.040; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Maneshi MM, 2017, CURR TOP MEMBR, V79, P309, DOI 10.1016/bs.ctm.2016.11.005; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; MONTAL M, 1990, FASEB J, V4, P2623, DOI 10.1096/fasebj.4.9.1693348; Moroni M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03502-7; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Patten CD, 1999, FEBS LETT, V463, P375, DOI 10.1016/S0014-5793(99)01659-2; Penny CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38426; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Saotome K, 2018, NATURE, V554, P481, DOI 10.1038/nature25453; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Spasic Milos, 2017, Semin Cell Dev Biol, V71, P42, DOI 10.1016/j.semcdb.2017.08.036; Suchyna TM, 2017, PROG BIOPHYS MOL BIO, V130, P244, DOI 10.1016/j.pbiomolbio.2017.07.011; Syeda R, 2016, CELL REP, V17, P1739, DOI 10.1016/j.celrep.2016.10.033; Syeda R, 2016, J BIOL CHEM, V291, P2931, DOI 10.1074/jbc.M115.683185; Syeda R, 2012, P NATL ACAD SCI USA, V109, P16917, DOI 10.1073/pnas.1205592109; Szczot M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9892; Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Xu J, 2018, CELL, V173, P762, DOI 10.1016/j.cell.2018.03.076; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zeng WZ, 2018, SCIENCE, V362, P464, DOI 10.1126/science.aau6324; Zeng Y, 2018, ADV EXP MED BIOL, V1097, P1, DOI 10.1007/978-3-319-96445-4_1; Zhao J, 2016, ELIFE, V5, DOI 10.7554/eLife.18130; Zhao QC, 2018, NATURE, V554, P487, DOI 10.1038/nature25743; Zhao QC, 2016, NEURON, V89, P1248, DOI 10.1016/j.neuron.2016.01.046; Zheng W, 2019, ELIFE, V8, DOI 10.7554/eLife.44003	44	7	8	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100225	10.1074/jbc.RA120.015905	http://dx.doi.org/10.1074/jbc.RA120.015905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361157	gold, Green Published			2022-12-26	WOS:000672866400203
J	Sticco, MJ; Palomino, PAP; Lukacsovich, D; Thompson, BL; Foldy, C; Ressl, S; Martinelli, DC				Sticco, Matthew J.; Pena Palomino, Perla A.; Lukacsovich, David; Thompson, Brianna L.; Foeldy, Csaba; Ressl, Susanne; Martinelli, David C.			C1QL3 promotes cell-cell adhesion by mediating complex formation between ADGRB3/BAI3 and neuronal pentraxins	FASEB JOURNAL			English	Article						CTRP13; NPTXR; NPTX1; synapse; trans&#8208; synaptic	SYNAPSE FORMATION; SECRETED PROTEIN; RECEPTOR BAI3; EXPRESSION; NEUREXIN; NP1; INTEGRATION; TAIPOXIN; DOMAIN; BRAIN	Synapses are the fundamental structural unit by which neurons communicate. An orchestra of proteins regulates diverse synaptic functions, including synapse formation, maintenance, and elimination-synapse homeostasis. Some proteins of the larger C1q super-family are synaptic organizers involved in crucial neuronal processes in various brain regions. C1Q-like (C1QL) proteins bind to the adhesion G protein-coupled receptor B3 (ADGRB3) and act at synapses in a subset of circuits. To investigate the hypothesis that the secreted C1QL proteins mediate tripartite trans-synaptic adhesion complexes, we conducted an in vivo interactome study and identified new binding candidates. We demonstrate that C1QL3 mediates a novel cell-cell adhesion complex involving ADGRB3 and two neuronal pentraxins, NPTX1 and NPTXR. Analysis of single-cell RNA-Seq data from the cerebral cortex shows that C1ql3, Nptx1, and Nptxr are highly co-expressed in the same excitatory neurons. Thus, our results suggest the possibility that in vivo the three co-expressed proteins are presynaptically secreted and form a complex capable of binding to postsynaptically localized ADGRB3, thereby creating a novel trans-synaptic adhesion complex. Identifying new binding partners for C1QL proteins and deciphering their underlying molecular principles will accelerate our understanding of their role in synapse organization.	[Sticco, Matthew J.; Thompson, Brianna L.; Martinelli, David C.] Univ Connecticut Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA; [Pena Palomino, Perla A.; Ressl, Susanne] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN USA; [Lukacsovich, David; Foeldy, Csaba] Univ Zurich, Fac Med, Brain Res Inst, Lab Neural Connect, Zurich, Switzerland; [Lukacsovich, David; Foeldy, Csaba] Univ Zurich, Fac Sci, Brain Res Inst, Lab Neural Connect, Zurich, Switzerland; [Ressl, Susanne; Martinelli, David C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ressl, Susanne] Univ Texas Austin, Dept Neurosci, 100 E 24TH ST,NHB 4-336, Austin, TX 78712 USA; [Martinelli, David C.] Connecticut Inst Brain & Cognit Sci IBACS, Storrs, CT USA	University of Connecticut; Indiana University System; Indiana University Bloomington; University of Geneva; University of Zurich; University of Zurich; Stanford University; University of Texas System; University of Texas Austin	Martinelli, DC (corresponding author), Univ Connecticut Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.; Ressl, S (corresponding author), Univ Texas Austin, Dept Neurosci, 100 E 24TH ST,NHB 4-336, Austin, TX 78712 USA.	suressl@utexas.edu; martinelli.uchc@gmail.com	Ressl, Susanne/AAT-2517-2021	Foldy, Csaba/0000-0001-8709-8490; Martinelli, David/0000-0002-8318-3986	NIDA NIH HHS [F32 DA031654] Funding Source: Medline; NIH HHS [#UL1TR001108] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aydin H, 2012, JOVE-J VIS EXP, DOI 10.3791/4041; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chew KS, 2017, J BIOL RHYTHM, V32, P222, DOI 10.1177/0748730417704766; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; de Wit J, 2016, NAT REV NEUROSCI, V17, P22, DOI 10.1038/nrn.2015.3; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Elegheert J, 2016, SCIENCE, V353, P295, DOI 10.1126/science.aae0104; Farhy-Tselnicker I, 2017, NEURON, V96, P428, DOI 10.1016/j.neuron.2017.09.053; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Gupta R, 2018, J BIOL CHEM, V293, P18086, DOI 10.1074/jbc.RA118.005403; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Honig B, 2020, CELL, V181, P520, DOI 10.1016/j.cell.2020.04.010; Huang LL, 2021, J NEUROL, V268, P4023, DOI 10.1007/s00415-020-10094-0; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; Inforzato A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00407; Jean AHW, 2012, METHODS MOL BIOL, V803, P231, DOI 10.1007/978-1-61779-364-6_16; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; Koch SM, 2010, J NEUROSCI, V30, P5404, DOI 10.1523/JNEUROSCI.4893-09.2010; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Koltes JE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46219-3; Lukacsovich D, 2019, CELL REP, V27, P3752, DOI 10.1016/j.celrep.2019.05.090; Martinelli DC, 2016, NEURON, V91, P1034, DOI 10.1016/j.neuron.2016.07.002; Matsuda K, 2016, NEURON, V90, P752, DOI 10.1016/j.neuron.2016.04.001; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Pacchioni AM, 2009, J PHARMACOL EXP THER, V328, P183, DOI 10.1124/jpet.108.143115; Paxinos G, 2004, COMPACT; Pelkey KA, 2015, NEURON, V85, P1257, DOI 10.1016/j.neuron.2015.02.020; Ressl S, 2015, STRUCTURE, V23, P688, DOI 10.1016/j.str.2015.01.019; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Schaukowitch K, 2017, CELL REP, V18, P1512, DOI 10.1016/j.celrep.2017.01.033; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sigoillot SM, 2015, CELL REP, V10, P820, DOI 10.1016/j.celrep.2015.01.034; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Ye JJ, 2020, P NATL ACAD SCI USA, V117, P17381, DOI 10.1073/pnas.1922270117; Yuzaki M, 2017, TRENDS NEUROSCI, V40, P138, DOI 10.1016/j.tins.2016.12.004; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	52	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21194	10.1096/fj.202000351RR	http://dx.doi.org/10.1096/fj.202000351RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337553				2022-12-26	WOS:000605626600022
J	Fisher, NL; Campbell, DA; Hughes, DJ; Kuzhiumparambil, U; Halsey, KH; Ralph, PJ; Suggett, DJ				Fisher, Nerissa L.; Campbell, Douglas A.; Hughes, David J.; Kuzhiumparambil, Unnikrishnan; Halsey, Kimberly H.; Ralph, Peter J.; Suggett, David J.			Divergence of photosynthetic strategies amongst marine diatoms	PLOS ONE			English	Article							FAST REPETITION RATE; PHOTOSYSTEM-II PHOTOINACTIVATION; ALTERNATIVE ELECTRON-TRANSPORT; XANTHOPHYLL-CYCLE ACTIVITY; PHAEODACTYLUM-TRICORNUTUM; HIGH-LIGHT; CHLOROPHYLL FLUORESCENCE; DIADINOXANTHIN CYCLE; ENERGY-DISSIPATION; DYNAMIC LIGHT	Marine phytoplankton, and in particular diatoms, are responsible for almost half of all primary production on Earth. Diatom species thrive from polar to tropical waters and across light environments that are highly complex to relatively benign, and so have evolved highly divergent strategies for regulating light capture and utilization. It is increasingly well established that diatoms have achieved such successful ecosystem dominance by regulating excitation energy available for generating photosynthetic energy via highly flexible light harvesting strategies. However, how different light harvesting strategies and downstream pathways for oxygen production and consumption interact to balance excitation pressure remains unknown. We therefore examined the responses of three diatom taxa adapted to inherently different light climates (estuarine Thalassioisira weissflogii, coastal Thalassiosira pseudonana and oceanic Thalassiosira oceanica) during transient shifts from a moderate to high growth irradiance (85 to 1200 mu mol photons m(-2) s(-1)). Transient high light exposure caused T. weissflogii to rapidly downregulate PSII with substantial nonphotochemical quenching, protecting PSII from inactivation or damage, and obviating the need for induction of O-2 consuming (light-dependent respiration, LDR) pathways. In contrast, T. oceanica retained high excitation pressure on PSII, but with little change in RCII photochemical turnover, thereby requiring moderate repair activity and greater reliance on LDR. T. pseudonana exhibited an intermediate response compared to the other two diatom species, exhibiting some downregulation and inactivation of PSII, but high repair of PSII and induction of reversible PSII nonphotochemical quenching, with some LDR. Together, these data demonstrate a range of strategies for balancing light harvesting and utilization across diatom species, which reflect their adaptation to sustain photosynthesis under environments with inherently different light regimes.	[Fisher, Nerissa L.; Hughes, David J.; Kuzhiumparambil, Unnikrishnan; Ralph, Peter J.; Suggett, David J.] Univ Technol Sydney, Climate Change Cluster, Ultimo, NSW, Australia; [Campbell, Douglas A.] Mt Allison Univ, Dept Biol, Sackville, NB, Canada; [Halsey, Kimberly H.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	University of Technology Sydney; Mount Allison University; Oregon State University	Fisher, NL (corresponding author), Univ Technol Sydney, Climate Change Cluster, Ultimo, NSW, Australia.	nerissa.fisher@uts.edu.au	Hughes, David/K-8960-2019; Campbell, Douglas/B-3768-2010; Kuzhiumparambil, Unnikrishnan/B-4842-2013; Ralph, Peter/C-5029-2009	Hughes, David/0000-0003-3778-7460; Campbell, Douglas/0000-0001-8996-5463; Kuzhiumparambil, Unnikrishnan/0000-0003-0582-6779; Ralph, Peter/0000-0002-3103-7346; Fisher, Nerissa/0000-0001-7996-8310				Allahverdiyeva Y, 2015, J EXP BOT, V66, P2427, DOI 10.1093/jxb/eru463; Alric J, 2017, CURR OPIN PLANT BIOL, V37, P78, DOI 10.1016/j.pbi.2017.03.014; Ananda MMA, 1997, STAT SINICA, V7, P631; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2016, LANCET ONCOL, V17, P1, DOI 10.1016/S1470-2045(15)00568-9; [Anonymous], 2001, NAT CELL BIOL, V3, pE199; [Anonymous], 2009, DOCUMENTATION BIBLIO, V56, P147; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Barnett A, 2015, ISME J, V9, P32, DOI 10.1038/ismej.2014.105; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Blommaert L, 2017, LIMNOL OCEANOGR, V62, P1466, DOI 10.1002/lno.10511; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Bucciarelli E, 2013, LIMNOL OCEANOGR, V58, P1667, DOI 10.4319/lo.2013.58.5.1667; Buck JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12043-6; Campbell DA., 2020, PHOTOSYNTHESIS ALGAE, P329, DOI DOI 10.1007/978-3-030-33397-3_13; Campbell DA, 2013, PHOTOSYNTH RES, V115, P43, DOI 10.1007/s11120-013-9809-2; Campbell DA, 2012, BBA-BIOENERGETICS, V1817, P258, DOI 10.1016/j.bbabio.2011.04.010; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P912, DOI 10.1016/j.bbabio.2010.12.004; Claquin P, 2004, EUR J PHYCOL, V39, P33, DOI 10.1080/0967026032000157165; Croteau D, 2021, LIMNOL OCEANOGR, V66, pS231, DOI 10.1002/lno.11587; Derks AK, 2018, PHOTOSYNTH RES, V138, P149, DOI 10.1007/s11120-018-0558-0; Dimier C, 2007, J PHYCOL, V43, P937, DOI 10.1111/j.1529-8817.2007.00381.x; Du N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199125; Edwards KF, 2015, LIMNOL OCEANOGR, V60, P540, DOI 10.1002/lno.10033; Feikema WO, 2006, BBA-BIOENERGETICS, V1757, P829, DOI 10.1016/j.bbabio.2006.06.003; Ferron S, 2016, LIMNOL OCEANOGR-METH, V14, P610, DOI 10.1002/lom3.10116; Fisher NL, 2016, PHOTOSYNTH RES, V129, P183, DOI 10.1007/s11120-016-0282-6; Gao G, 2018, ENVIRON EXP BOT, V147, P95, DOI 10.1016/j.envexpbot.2017.11.014; Genty B, 1996, PHOTOSYNTHESIS ENV, P67, DOI DOI 10.1073/pnas.1110189108; Giordano M, 2005, NEW PHYTOL, V166, P371, DOI 10.1111/j.1469-8137.2005.01335.x; Giovagnetti V, 2017, BBA-BIOENERGETICS, V1858, P218, DOI 10.1016/j.bbabio.2016.12.005; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Grouneva I, 2006, PHYSIOL PLANTARUM, V126, P205, DOI 10.1111/j.1399-3054.2006.00613.x; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; Halsey KH, 2010, PHOTOSYNTH RES, V103, P125, DOI 10.1007/s11120-009-9526-z; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; HORTON P, 1992, PHOTOSYNTH RES, V34, P375, DOI 10.1007/BF00029812; Hughes DJ, 2018, LIMNOL OCEANOGR, V63, P1891, DOI 10.1002/lno.10814; Hughes DJ, 2018, ENVIRON SCI TECHNOL, V52, P12039, DOI 10.1021/acs.est.8b03488; Joly D, 2007, BIOCHEMISTRY-US, V46, P5534, DOI 10.1021/bi602627d; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Klughammer C, 2008, PAM APPL NOTES, V1, P27; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; Kuzminov FI, 2016, PHOTOSYNTH RES, V127, P219, DOI 10.1007/s11120-015-0180-3; Lacour T, 2020, J PHYCOL, V56, P245, DOI 10.1111/jpy.12944; Lacour T, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00354; Larkum AWD, 2003, ADV PHOTO RESPIRAT, V14, P277; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lavaud J, 2016, PHOTOSYNTH RES, V127, P189, DOI 10.1007/s11120-015-0172-3; Lavaud J, 2014, ADV PHOTOSYNTH RESP, V40, P421, DOI 10.1007/978-94-017-9032-1_20; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; Laws EA, LIMNOLOGY OCEANOGRAP, V25, P457, DOI [10.4319/lo.2004.49.6.2316, DOI 10.4319/LO.2004.49.6.2316]; Lepetit B, 2017, NEW PHYTOL, V214, P205, DOI 10.1111/nph.14337; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Li G, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00218; Li G, 2015, NEW PHYTOL, V205, P533, DOI 10.1111/nph.13037; Litchman E, 2004, LIMNOL OCEANOGR, V49, P1457, DOI 10.4319/lo.2004.49.4_part_2.1457; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lomas MW, 2004, MAR BIOL, V144, P37, DOI 10.1007/s00227-003-1181-x; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Malviya S, 2016, P NATL ACAD SCI USA, V113, pE1516, DOI 10.1073/pnas.1509523113; McKew BA, 2013, NEW PHYTOL, V200, P74, DOI 10.1111/nph.12373; Milligan AJ, 2012, MAR ECOL PROG SER, V448, P67, DOI 10.3354/meps09544; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Miyake C, 2012, SOIL SCI PLANT NUTR, V58, P718, DOI 10.1080/00380768.2012.736078; Murik O, 2019, NEW PHYTOL, V221, P1303, DOI 10.1111/nph.15479; Nawrocki WJ, 2015, ANNU REV PLANT BIOL, V66, P49, DOI 10.1146/annurev-arplant-043014-114744; Oliver RL, 2013, J PLANKTON RES, V35, P927, DOI 10.1093/plankt/fbt043; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Perkins R, 2018, PHOTOSYNTH RES, V137, P377, DOI 10.1007/s11120-018-0508-x; Prihoda J, 2012, J EXP BOT, V63, P1543, DOI 10.1093/jxb/err441; R Core Team, R LANG ENV STAT COMP; Raven JA, 2000, J MAR BIOL ASSOC UK, V80, P1, DOI 10.1017/S0025315499001526; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; RStudio Team, RSTUDIO INT DEV R; Rusch Douglas B, 2010, Proc Natl Acad Sci U S A, V107, P16184, DOI 10.1073/pnas.1009513107; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Serodio J, 2005, J EXP MAR BIOL ECOL, V326, P157, DOI 10.1016/j.jembe.2005.05.011; STRANSKY H, 1970, ARCH MIKROBIOL, V72, P84, DOI 10.1007/BF00411017; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett DJ, 2015, NEW PHYTOL, V208, P370, DOI 10.1111/nph.13483; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Suggett DJ, 2003, EUR J PHYCOL, V38, P371, DOI 10.1080/09670260310001612655; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Taddei L, 2018, PLANT PHYSIOL, V177, P953, DOI 10.1104/pp.18.00448; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; Wagner H, 2016, PHOTOSYNTH RES, V128, P151, DOI 10.1007/s11120-015-0209-7; Walter B, 2015, ICES J MAR SCI, V72, P2061, DOI 10.1093/icesjms/fsu218; Waring J, 2010, J PHYCOL, V46, P1206, DOI 10.1111/j.1529-8817.2010.00919.x; WEGER HG, 1989, LIMNOL OCEANOGR, V34, P1153, DOI 10.4319/lo.1989.34.7.1153; Westberry T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003078; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wilhelm C, 2014, MAR GENOM, V16, P5, DOI 10.1016/j.margen.2013.12.003; Wu HY, 2012, PLANT PHYSIOL, V160, P464, DOI 10.1104/pp.112.203067; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	117	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244252	10.1371/journal.pone.0244252	http://dx.doi.org/10.1371/journal.pone.0244252			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370327	Green Published, gold			2022-12-26	WOS:000603611900102
J	Karuppusami, R; Antonisami, B; Vasan, SK; Gowri, M; Selliah, HY; Arulappan, G; Jebasingh, F; Thomas, N; Paul, TV				Karuppusami, Reka; Antonisami, Belavendra; Vasan, Senthil K.; Gowri, Mahasampath; Selliah, Hepsy Y.; Arulappan, Geethanjali; Jebasingh, Felix; Thomas, Nihal; Paul, Thomas V.			Association of serum 25-Hydroxy vitamin D with total and regional adiposity and cardiometabolic traits	PLOS ONE			English	Article							D DEFICIENCY; HYPOVITAMINOSIS-D; D SUPPLEMENTATION; INSULIN-RESISTANCE; DIETARY CALCIUM; HIGH PREVALENCE; ASIAN INDIANS; HEALTHY; OBESITY; METAANALYSIS	Background Lower serum 25-hydroxyvitamin D [25(OH)D] is associated with greater adiposity and adverse cardiometabolic risk profile. The evidence is inconsistent among South Asian Indians. We aimed to examine associations between 25(OH)D and cardiovascular (CVD) risk markers in a rural and urban cohort from South India. Subjects/Methods In this cross sectional study, 373 individuals (men, n = 205) underwent detailed CVD risk marker assessment including anthropometry [body mass index (BMI), waist, (WC) and hip circumferences (HC)], body composition analysis using dual energy x-ray absorptiometry (DXA), blood pressure and biochemical analysis (glucose, insulin and lipids). The distribution of CVD risk factors were compared across serum 25(OH)D levels, stratified as deficiency (<20 ng/ml), insufficiency (20 to 29 ng/ml) and normal (>= 30 ng/ml) levels. Multiple regression analysis, adjusting for potential confounders, was used to study associations of 25(OH)D with adiposity and cardiometabolic traits. Results The mean and standard deviation (SD) of age, BMI and 25(OH)D levels were 41.4 (1.1) years, 25.5 (4.8) kg/m(2) and 23.4 (10.4) ng/ml respectively. The prevalence of 25(OH)D deficiency was 39.9% in this cohort. Individuals in the 25(OH)D deficiency category had significantly higher mean (SD) BMI [26.6 (5.1) kg/m(2)], waist circumference [89.9 (12.5) cm] and total fat mass [20.6 (7.9) kg] compared with the Vitamin D sufficient group [BMI: 24.0 (4.4); WC 84.7 (12.0); total fat mass: 15.2 (6.8)]. Significantly inverse associations were observed with DXA measured total and regional fat depots with 25(OH)D levels, while anthropometric indices of adiposity showed significant inverse association only in women. After adjusting for total fat mass, no significant associations were observed between 25(OH)D and the cardiometabolic traits. Conclusions Our results confirm that lower 25(OH)D is independently associated with both total and regional adiposity, but not with cardiometabolic traits, in this population.	[Karuppusami, Reka; Antonisami, Belavendra; Gowri, Mahasampath; Selliah, Hepsy Y.] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Vasan, Senthil K.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Arulappan, Geethanjali] Christian Med Coll & Hosp, Dept Clin Biochem, Vellore, Tamil Nadu, India; [Jebasingh, Felix; Thomas, Nihal; Paul, Thomas V.] Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; University of Oxford; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Paul, TV (corresponding author), Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India.	thomasvpaul@yahoo.com		jebasingh, felix/0000-0001-5903-6110; PAUL, THOMAS/0000-0003-3315-341X	Indian Institute of Public Health, Hyderabad [09-2012]; Christian Medical College, Vellore	Indian Institute of Public Health, Hyderabad; Christian Medical College, Vellore	The study was jointly funded by the Indian Institute of Public Health, Hyderabad (WTP Project grant/09-2012) and internal research funds from Christian Medical College, Vellore.	Antonisamy B, 2009, INT J EPIDEMIOL, V38, P663, DOI 10.1093/ije/dyn159; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Baker CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129468; Beloyartseva Maria, 2012, Arch Osteoporos, V7, P187, DOI 10.1007/s11657-012-0096-x; Chandler PD, 2015, NUTR REV, V73, P577, DOI 10.1093/nutrit/nuv012; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285; Gangloff A, 2015, INT J OBESITY, V39, P1638, DOI 10.1038/ijo.2015.118; Geleijnse JM, 2011, AM J HYPERTENS, V24, P253, DOI 10.1038/ajh.2010.199; Gepner AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036617; Harinarayan CV, 2007, AM J CLIN NUTR, V85, P1062, DOI 10.1093/ajcn/85.4.1062; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kelly TLWK, 2011, US patent application, Patent No. [US2011-02358812011, 201102358812011]; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Majumdar V, 2011, INT J OBESITY, V35, P1131, DOI 10.1038/ijo.2010.232; Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991; Misra A, 2009, J Assoc Physicians India, V57, P163; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Ock SY, 2016, DIABETES METAB J, V40, P367, DOI 10.4093/dmj.2016.40.5.367; Pelczynska M, 2016, ANN AGR ENV MED, V23, P403, DOI 10.5604/12321966.1219177; Ponda MP, 2012, CIRCULATION, V126, P270, DOI 10.1161/CIRCULATIONAHA.111.077875; Saneei P, 2013, OBES REV, V14, P393, DOI 10.1111/obr.12016; Savastano S, 2017, REV ENDOCR METAB DIS, V18, P215, DOI 10.1007/s11154-017-9410-7; Shivane VK, 2011, POSTGRAD MED J, V87, P514, DOI 10.1136/pgmj.2010.113092; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Sulistyoningrum DC, 2013, METABOLISM, V62, P1795, DOI 10.1016/j.metabol.2013.07.009; Sulistyoningrum DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043159; Vasan SK, 2018, INT J OBESITY, V42, P850, DOI 10.1038/ijo.2017.289; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wamberg L, 2013, INT J OBESITY, V37, P651, DOI 10.1038/ijo.2012.112; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wright CS, 2015, J NUTR, V145, P2683, DOI 10.3945/jn.115.220541; Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212; Zhang J, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1794894	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243850	10.1371/journal.pone.0243850	http://dx.doi.org/10.1371/journal.pone.0243850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370344	Green Published, gold			2022-12-26	WOS:000603611900109
J	Afaa, TJ; Amegan-Aho, KH; Dono, MT; Odei, E; Awuku, YA				Afaa, Taiba Jibril; Amegan-Aho, Kokou Hefoume; Dono, Matilda Tierenye; Odei, Eric; Awuku, Yaw Asante			Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa	PLOS ONE			English	Article							LIVER-DISEASE; MANAGEMENT; DIAGNOSIS	Background Autoimmune hepatitis (AIH) is a progressive inflammatory liver disease of unknown aetiology. The number of reported AIH cases is increasing in the developed countries but the same cannot be said about sub Saharan Africa (SSA). Paediatric AIH diagnosis is usually missed and patients present with decompensated liver disease. Our study highlights the clinical profile of paediatric AIH cases at a referral hospital in Ghana. Methods This is a retrospective review of all cases of children diagnosed with autoimmune hepatitis at the gastroenterology clinic in Korle Bu Teaching Hospital, Accra, Ghana. Data was extracted from the patients' records from April 2016 to October 2019. These children were diagnosed based on the presence of autoantibodies, elevated immunoglobulin G and histologic presence of interphase hepatitis with the exclusion of hepatitis A, B, C and E depending on their clinical presentation, Wilson's disease, HIV, Schistosomiasis and sickle cell disease. Results Thirteen patients aged between 5 years to 13 years with a mean age of 10 years were diagnosed with AIH. All the patients had type 1 AIH with majority 8 (61.5%) being females. Most of the children presented with advanced liver disease with complications. Three patients had other associated autoimmune diseases. The patients were treated with prednisolone with or without azathioprine depending on the severity of the liver disease. Conclusion Majority of paediatric AIH presents with advanced liver disease. There is the need for early detection to change the natural history of AIH in SSA.	[Afaa, Taiba Jibril] Univ Ghana, Med Sch, Dept Child Hlth, Coll Hlth Sci, Accra, Ghana; [Amegan-Aho, Kokou Hefoume] Univ Hlth & Allied Sci, Dept Paediat & Child Hlth, Ho, Ghana; [Dono, Matilda Tierenye] Korle Bu Teaching Hosp, Dept Child Hlth, Accra, Ghana; [Odei, Eric] Korle Bu Teaching Hosp, Dept Publ Hlth, Accra, Ghana; [Awuku, Yaw Asante] Univ Hlth & Allied Sci, Dept Med & Therapeut, Ho, Ghana	University of Ghana	Afaa, TJ (corresponding author), Univ Ghana, Med Sch, Dept Child Hlth, Coll Hlth Sci, Accra, Ghana.	taibaafaa@yahoo.com		Amegan-Aho, Kokou/0000-0001-7982-9222				Behairy OGA, 2017, EGYPT PEDIATR ASSO, V65, P108, DOI 10.1016/j.epag.2017.11.002; Bjornsson E, 2011, CLIN GASTROENTEROL H, V9, P57, DOI 10.1016/j.cgh.2010.07.016; Czaja AJ, 2019, WORLD J GASTROENTERO, V25, P6579, DOI 10.3748/wjg.v25.i45.6579; Czaja AJ, 2016, GUT LIVER, V10, P177, DOI 10.5009/gnl15352; El-Koofy N, 2010, MED J CAIRO U, V78, P107; Ferri PM, 2012, WORLD J GASTROENTERO, V18, P4470, DOI 10.3748/wjg.v18.i33.4470; Gregorio GV, 1997, HEPATOLOGY, V25, P541, DOI 10.1002/hep.510250308; Guo LP, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/2376231; Jimenez-Rivera C, 2015, PEDIATRICS, V136, pE1237, DOI 10.1542/peds.2015-0578; Kerkar N, 2015, ANN PEDIAT CHILD HLT, V3, P1045; Liberal R, 2013, J AUTOIMMUN, V41, P126, DOI 10.1016/j.jaut.2012.11.002; Lim KN, 2001, AM J GASTROENTEROL, V96, P3390, DOI 10.1111/j.1572-0241.2001.05272.x; Lohse AW, 2015, J HEPATOL, V63, P971, DOI 10.1016/j.jhep.2015.06.030; Maggiore G, 2014, WORLD J HEPATOL, V6, P464, DOI 10.4254/wjh.v6.i7.464; MCFARLANE IG, 1990, LANCET, V335, P754, DOI 10.1016/0140-6736(90)90870-B; Mieli-Vergani G, 2018, J PEDIATR GASTR NUTR, V66, P345, DOI 10.1097/MPG.0000000000001801; Mieli-Vergani G, 2013, ARCH DIS CHILD, V98, P1012, DOI 10.1136/archdischild-2013-303848; Muratori P, 2015, EUR J GASTROEN HEPAT, V27, P1175, DOI 10.1097/MEG.0000000000000424; Pathak S, 2018, PEDIATR ANN, V47, pE81, DOI 10.3928/19382359-20180126-01; Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024; Sebode M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00609; Shah Rushikesh, 2017, World J Gastrointest Pathophysiol, V8, P108, DOI 10.4291/wjgp.v8.i3.108; Shaker Y, 2014, J CLIN TRANSL HEPATO, V2, P212, DOI 10.14218/JCTH.2014.00018; Wong GW, 2015, DIGEST DIS, V33, P25, DOI 10.1159/000440707	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0239964	10.1371/journal.pone.0239964	http://dx.doi.org/10.1371/journal.pone.0239964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362271	Green Published, gold			2022-12-26	WOS:000603071600021
J	Stevens, CR; Berenson, J; Sledziona, M; Moore, TP; Dong, L; Cheetham, J				Stevens, Courtney R.; Berenson, Josh; Sledziona, Michael; Moore, Timothy P.; Dong, Lynn; Cheetham, Jonathan			Approach for semi-automated measurement of fiber diameter in murine and canine skeletal muscle	PLOS ONE			English	Article							SEGMENTATION; HYPERTROPHY	Currently available software tools for automated segmentation and analysis of muscle cross-section images often perform poorly in cases of weak or non-uniform staining conditions. To address these issues, our group has developed the MyoSAT (Myofiber Segmentation and Analysis Tool) image-processing pipeline. MyoSAT combines several unconventional approaches including advanced background leveling, Perona-Malik anisotropic diffusion filtering, and Steger's line detection algorithm to aid in pre-processing and enhancement of the muscle image. Final segmentation is based upon marker-based watershed segmentation. Validation tests using collagen V labeled murine and canine muscle tissue demonstrate that MyoSAT can determine mean muscle fiber diameter with an average accuracy of similar to 92.4%. The software has been tested to work on full muscle cross-sections and works well even under non-optimal staining conditions. The MyoSAT software tool has been implemented as a macro for the freely available ImageJ software platform. This new segmentation tool allows scientists to efficiently analyze large muscle cross-sections for use in research studies and diagnostics.	[Stevens, Courtney R.; Berenson, Josh; Sledziona, Michael; Moore, Timothy P.; Dong, Lynn; Cheetham, Jonathan] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Cornell University	Cheetham, J (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.	jc485@cornell.edu		Cheetham, Jonathan/0000-0001-9309-5261	National Institute of Deafness and Communication Disorders [1R01DC017171]	National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an award from the National Institute of Deafness and Communication Disorders (received award 1R01DC017171).	[Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; Bergmeister KD, 2016, MUSCLE NERVE, V54, P292, DOI 10.1002/mus.25033; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Brox T, 2006, FULLY AUTOMATED ANAL, P86; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Klemencic A, 1998, CYTOMETRY, V32, P317, DOI 10.1002/(SICI)1097-0320(19980801)32:4<317::AID-CYTO9>3.0.CO;2-E; Legland D, 2016, BIOINFORMATICS, V32, P3532, DOI 10.1093/bioinformatics/btw413; Liu F, 2013, J MICROSC-OXFORD, V252, P275, DOI 10.1111/jmi.12090; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Meunier B, 2010, HISTOCHEM CELL BIOL, V134, P307, DOI 10.1007/s00418-010-0733-7; Miazaki M, 2015, COMPUT BIOL MED, V63, P28, DOI 10.1016/j.compbiomed.2015.04.020; Mula J, 2013, J APPL PHYSIOL, V114, P148, DOI 10.1152/japplphysiol.01022.2012; NICKS DK, 1989, J ANAT, V163, P1; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Roorda BD, 2005, J LIPID RES, V46, P230, DOI 10.1194/jlr.M400416-JLR200; Sacha J, 2017, IJ PLUGINS TOOLKIT V; Saez A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-77; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Soille P, 1990, DETERMINING WATERSHE, P240, DOI [10.1117/12.24211, DOI 10.1117/12.24211]; Spiegel, 1984, SPIEGEL, V9, P101; Steger C, 1996, UNBIASED DETECTOR CU; TAYLOR NAS, 1986, SPORTS MED, V3, P190, DOI 10.2165/00007256-198603030-00003; Wagner T, 2017, RIDGE DETECTION V1 4; Wen Y, 2018, J APPL PHYSIOL, V124, P40, DOI 10.1152/japplphysiol.00762.2017; Zuravin S.J., 1986, J FAM VIOLENCE, V1, P307, DOI DOI 10.1007/BF00978275; Zygelyte E, 2016, J NEUROSCI METH, V271, P34, DOI 10.1016/j.jneumeth.2016.05.017	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243163	10.1371/journal.pone.0243163	http://dx.doi.org/10.1371/journal.pone.0243163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362264	gold, Green Published, Green Submitted			2022-12-26	WOS:000603071600047
J	Goyal, N; Rongsen-Chandola, T; Sood, M; Sinha, B; Kumar, A; Qazi, SA; Aboubaker, S; Nisar, YB; Bahl, R; Bhan, MK; Bhandari, N				Goyal, Nidhi; Rongsen-Chandola, Temsunaro; Sood, Mangla; Sinha, Bireshwar; Kumar, Amit; Qazi, Shamim Ahmad; Aboubaker, Samira; Nisar, Yasir Bin; Bahl, Rajiv; Bhan, Maharaj Kishan; Bhandari, Nita			Management of possible serious bacterial infection in young infants closer to home when referral is not feasible: Lessons from implementation research in Himachal Pradesh, India	PLOS ONE			English	Article							INJECTABLE PROCAINE BENZYLPENICILLIN; COMMUNITY-HEALTH WORKERS; CLINICAL SIGNS; OPEN-LABEL; GENTAMICIN; MORTALITY; NEWBORNS; CARE	Background Government of India and the World Health Organization have guidelines for outpatient management of young infants 0-59 days with signs of Possible Serious Bacterial Infection (PSBI), when referral is not feasible. Implementation research was conducted to identify facilitators and barriers to operationalizing these guidelines. Methods Himachal Pradesh government implemented the guidelines in program settings supported by Centre for Health Research and Development, Society for Applied Studies. The strategy included community sensitization, skill enhancement of Accredited Social Health Activists (ASHA), Auxiliary Nurse Midwives (ANMs) and Medical Officers (MOs) to identify PSBI and treat when referral was not feasible. The research team collected information on facilitators and barriers. A technical support unit provided training and oversight. Findings Among 1997 live births from June 2017 to January 2019, we identified 160 cases of PSBI in young infants resulting in a coverage of 80%, assuming an incidence of 10%. Of these,29(18.1%) had signs of critical illness (CI), 92 (57.5%) had clinical severe infection (CSI), 5 (3.1%)had severe pneumonia (only fast breathing in young infants 0-6 days), while 34 (21%) had pneumonia (only fast breathing in young infants 7-59 days). Hospital referral was accepted by 48/160 (30%), whereas 112/160 (70%) were treated with the simplified treatment regimens at primary level facilities. Of the 29 infants with CI, 18 (62%) accepted referral; 26 (90%) recovered while 3 (10%) who had accepted referral, died. Of the 92 infants who had CSI, 86 (93%) recovered, 65 (71%) received simplified treatment and one infant who had accepted referral, died. All the five infants who had severe pneumonia, recovered; 3 (60%) had received simplified treatment. Of the 34 pneumonia cases, 33 received simplified treatment of which 5 (15%) failed treatment; two out of these 5 died. Overall, 6/160 infants died (case-fatality-rate 3.4%); 2 in the simplified treatment (case-fatality-rate 1.8%) and 4 in the hospital group (case-fatality-rate 8.3%). Delayed identification and care-seeking by families and health system weaknesses like manpower gaps and interrupted supplies were challenges in implementation. Conclusions Implementation of the guidelines in program settings is possible and acceptable. Scaling up would require creating community awareness, early identification and appropriate care-seeking, strengthening ASHA home-visitation program, building skills and confidence of MOs and ANMs, uninterrupted supplies and a dependable referral system.	[Goyal, Nidhi; Rongsen-Chandola, Temsunaro; Sinha, Bireshwar; Kumar, Amit; Bhandari, Nita] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India; [Sood, Mangla] Indira Gandhi Med Coll, Dept Pediat, Shimla, Himachal Prades, India; [Sood, Mangla] Natl Hlth Mission, Child Hlth, Shimla, Himachal Prades, India; [Qazi, Shamim Ahmad; Aboubaker, Samira; Nisar, Yasir Bin; Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth & A, Geneva, Switzerland; [Bhan, Maharaj Kishan] Indian Inst Technol Delhi, New Delhi, India; [Bhan, Maharaj Kishan] Biotechnol Ind Res Assistance Council BIRAC, Knowledge Integrat & Translat Platform KnIT, New Delhi, India	Indira Gandhi Medical College & Hospital Shimla; World Health Organization; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Biotechnology Industry Research Assistance Council (BIRAC)	Rongsen-Chandola, T (corresponding author), Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India.	naro@sas.org.in	Sood, Mangla/AAO-2493-2020; Sinha, Bireshwar/AEA-9974-2022; Nisar, Yasir Bin/AFO-2407-2022	Sood, Mangla/0000-0002-9616-5410; Sinha, Bireshwar/0000-0002-7408-7474; 	Bill and Melinda Gates Foundation (BMGF) through the Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland [OPP1114815]; Technical Service Agreement with WHO [2016/640408-0]	Bill and Melinda Gates Foundation (BMGF) through the Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland; Technical Service Agreement with WHO	The study was supported by a grant from the Bill and Melinda Gates Foundation (BMGF Grant No. OPP1114815) through the Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland. TRC received funds through a Technical Service Agreement with WHO, (WHO Reference 2016/640408-0). URL of funder website: www.gatesfoundation.org.The funder, BMGF had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. SAQ, SA, YBN and RB from WHO were involved in study design, decision to publish and preparation of the manuscript.	[Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; Applegate JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229988; Applegate JA, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001643; Awasthi S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234212; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Bhandari N, 1996, LANCET, V347, P1774, DOI 10.1016/S0140-6736(96)90856-9; Bhura M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240688; Fadel SA, 2017, LANCET, V390, P1972, DOI 10.1016/S0140-6736(17)32162-1; [GOI MOHFW], 2014, OP GUID US GENT ANMS; [GOI MoHFW], 2017, ADD OP GUID US GENT; [GOI MoHFW], 2011, HOM BAS NEWB CAR OP; Government of India, 2018, NAVJ SHISH SUR KAR B; Guenther T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229248; Harden SM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00071; Khanal S, 2011, J HEALTH POPUL NUTR, V29, P255, DOI 10.3329/jhpn.v29i3.7873; Kozuki N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2330-0; Kumar Pratyush, 2018, J Family Med Prim Care, V7, P1157, DOI 10.4103/jfmpc.jfmpc_254_18; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; National Health Authority, 2018, AYS BHAR PRADH MANTR; NFHS4-Telangana, 2015, NATL FAMILY HLTH SUR; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Rahman AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232675; Roy S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236355; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Taneja S, 2018, ACTA PAEDIATR, V107, P80, DOI 10.1111/apa.14428; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; Wammanda RD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228718; World Health Organization, 2015, GUID MAN POSS SER BA; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zaidi AKM, 2012, PEDIATR INFECT DIS J, V31, P667, DOI 10.1097/INF.0b013e318256f86c	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243724	10.1371/journal.pone.0243724	http://dx.doi.org/10.1371/journal.pone.0243724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351810	Green Published, gold			2022-12-26	WOS:000603071400033
J	Deren, K; Wyszynska, J; Nyankovskyy, S; Nyankovska, O; Yatsula, M; Luszczki, E; Sobolewski, M; Mazur, A				Deren, Katarzyna; Wyszynska, Justyna; Nyankovskyy, Serhiy; Nyankovska, Olena; Yatsula, Marta; Luszczki, Edyta; Sobolewski, Marek; Mazur, Artur			Assessment of body mass index in a pediatric population aged 7-17 from Ukraine according to various international criteria-A cross-sectional study	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; OBESITY TASK-FORCE; CLASSIFICATION SYSTEMS; PRESCHOOL-CHILDREN; CHILDHOOD OBESITY; OVERWEIGHT; PREVALENCE; REFERENCES; REGION	Childhood obesity is one of the most serious public health problems. The prevalence of obesity among children is increasing and may negatively affect their immediate health, but it can also lead to obesity in adulthood. The aim of the study was to compare BMI cut-off points by examining three main international references: the World Health Organization (WHO), the International Task Force Obesity (IOTF) and the US Center for Disease Control and Prevention (CDC). Ultimately, the study group consisted of 18,144 children and adolescents aged 6.5-17.5 years. Body mass was measured on medical scales with an accuracy of +/- 100 g and height measurement was taken using a height meter with an accuracy of +/- 0.1 cm three times. Underweight, overweight and obesity were calculated according to WHO, IOTF and CDC BMI international references. There were differences in the incidence of underweight between the classifications: 16.8% according to IATF, 5.3% according to WHO and 9.9% according to CDC. There were also differences in the incidence of overweight and obesity between the classifications: 13% according to IOTF, 19.7% according to WHO and 14.1% according to CDC. In the CDC and WHO studies, a significantly higher prevalence of childhood obesity (4.0% and 4.7%, respectively) was observed compared with IOTF (2.1%). The prevalence of overweight and obesity in this study was higher among boys compared to girls. However, estimates of prevalence of overweight and obesity differ in methods and reference cut-off points. Higher prevalence was obtained in IOTF classification, followed by the WHO and CDC classification.	[Deren, Katarzyna; Wyszynska, Justyna; Nyankovskyy, Serhiy; Luszczki, Edyta] Rzeszow Univ, Med Coll, Inst Hlth Sci, Rzeszow, Poland; [Deren, Katarzyna; Wyszynska, Justyna; Nyankovskyy, Serhiy; Yatsula, Marta] Danylo Halytsky Lviv Natl Med Univ, Pediat Dept 1, Lvov, Ukraine; [Nyankovska, Olena] Danylo Halytsky Lviv Natl Med Univ, Dept Pediat & Neonatol, Lvov, Ukraine; [Sobolewski, Marek] Rzeszow Univ Technol, Fac Management, Rzeszow, Poland; [Mazur, Artur] Rzeszow Univ, Inst Med Sci, Med Coll, Rzeszow, Poland	University of Rzeszow; Danylo Halytsky Lviv National Medical University; Danylo Halytsky Lviv National Medical University; Rzeszow University of Technology; University of Rzeszow	Deren, K (corresponding author), Rzeszow Univ, Med Coll, Inst Hlth Sci, Rzeszow, Poland.; Deren, K (corresponding author), Danylo Halytsky Lviv Natl Med Univ, Pediat Dept 1, Lvov, Ukraine.	kderen@ur.edu.pl	Łuszczki, Edyta/AAP-1883-2020; Wyszynska, Justyna/L-5315-2016	Łuszczki, Edyta/0000-0002-4619-7705; Sobolewski, Marek/0000-0001-6564-8877; Wyszynska, Justyna/0000-0002-5786-6214; Deren, Katarzyna/0000-0002-0977-5844; Mazur, Artur/0000-0001-5393-3515				[Anonymous], 2000, EUR J INT LAW, V11, P1; Center for Disease Control and Prevention, DEF CHILDH OV OB; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Deren K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21773-4; Rios MIE, 2013, AN PEDIATR, V78, P374, DOI 10.1016/j.anpedi.2012.09.007; Lopez-Sanchez GF, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00130; Goldfield GS, 2006, J SPORT MED PHYS FIT, V46, P447; Haq I, 2017, ANN TROP MED PUBLIC, V10, P1814, DOI [10.4103/ATMPH.ATMPH_98_17, 10.4103/atmph.atmph_98_17]; Hassapidou M, 2015, HORM-INT J ENDOCRINO, V14, P615, DOI 10.14310/horm.2002.1601; Keke LM, 2015, REV EPIDEMIOL SANTE, V63, P173, DOI 10.1016/j.respe.2014.11.003; Kim S, 2017, CHILD YOUTH SERV REV, V79, P309, DOI 10.1016/j.childyouth.2017.06.028; Lemelin L, 2013, SANTE PUBLIQUE, V25, P571, DOI 10.3917/spub.135.0571; Medehouenou TCM, 2015, J ADOLESCENT HEALTH, V57, P31, DOI 10.1016/j.jadohealth.2015.03.022; Moreno LA, 2003, NUTRITION, V19, P481, DOI 10.1016/S0899-9007(03)00040-6; MPhil UP, 2017, J PEDIAT, V190; Partap U, 2017, J PEDIAT, V190; Pattinson CL, 2017, OBES REV, V18, P1, DOI 10.1111/obr.12581; Pelegrini A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-5; Ramirez E, 2006, ARCH LATINOAM NUTR, V56, P251; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; Twells LK, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-21; World Health Organisation, 2020, OV OB; World Health Organization, GROWTH REF 5 19 YEAR	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244300	10.1371/journal.pone.0244300	http://dx.doi.org/10.1371/journal.pone.0244300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338085	Green Published, gold			2022-12-26	WOS:000601313500045
J	Lopez-Incera, A; Ried, K; Muller, T; Briegel, HJ				Lopez-Incera, Andrea; Ried, Katja; Mueller, Thomas; Briegel, Hans J.			Development of swarm behavior in artificial learning agents that adapt to different foraging environments	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; COLLECTIVE MOTION; MULTIMODEL INFERENCE; PHASE-TRANSITION; LEVY WALKS; PREY; STOCHASTICITY; SELECTION; MOVEMENT; ECOLOGY	Collective behavior, and swarm formation in particular, has been studied from several perspectives within a large variety of fields, ranging from biology to physics. In this work, we apply Projective Simulation to model each individual as an artificial learning agent that interacts with its neighbors and surroundings in order to make decisions and learn from them. Within a reinforcement learning framework, we discuss one-dimensional learning scenarios where agents need to get to food resources to be rewarded. We observe how different types of collective motion emerge depending on the distance the agents need to travel to reach the resources. For instance, strongly aligned swarms emerge when the food source is placed far away from the region where agents are situated initially. In addition, we study the properties of the individual trajectories that occur within the different types of emergent collective dynamics. Agents trained to find distant resources exhibit individual trajectories that are in most cases best fit by composite correlated random walks with features that resemble Levy walks. This composite motion emerges from the collective behavior developed under the specific foraging selection pressures. On the other hand, agents trained to reach nearby resources predominantly exhibit Brownian trajectories.	[Lopez-Incera, Andrea; Ried, Katja; Briegel, Hans J.] Univ Innsbruck, Inst Theoret Phys, Innsbruck, Austria; [Mueller, Thomas; Briegel, Hans J.] Univ Konstanz, Fachbereich Philosophie, Constance, Germany	University of Innsbruck; University of Konstanz	Lopez-Incera, A (corresponding author), Univ Innsbruck, Inst Theoret Phys, Innsbruck, Austria.	andrea.lopez-incera@uibk.ac.at		Muller, Thomas/0000-0003-1225-1483	Austrian Science Fund (FWF) [SFB BeyondC F7102]; Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg [AZ:33-7533-30-10/41/1]; Volkswagen Foundation [Az:97721]; BlueSky project of the University of Konstanz	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg; Volkswagen Foundation(Volkswagen); BlueSky project of the University of Konstanz	AL, KR and HJB were supported by the Austrian Science Fund (FWF) through grant SFB BeyondC F7102. HJB was supported by the Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg (AZ:33-7533-30-10/41/1). HJB and TM were supported by Volkswagen Foundation (Az:97721) and a BlueSky project of the University of Konstanz.	Ariel G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004522; Auger-Methe M, 2015, METHODS ECOL EVOL, V6, P1179, DOI 10.1111/2041-210X.12412; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Bilecenoglu Murat, 2005, Zoology in the Middle East, V35, P29; Bode NWF, 2010, J THEOR BIOL, V267, P292, DOI 10.1016/j.jtbi.2010.08.034; Briegel HJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00400; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Czirok A, 1999, PHYSICA A, V264, P299, DOI 10.1016/S0378-4371(98)00468-3; Czirok A, 1999, PHYS REV LETT, V82, P209, DOI 10.1103/PhysRevLett.82.209; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Durve M, 2019, ARXIV191101697; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Edwards AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045174; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Eifler D, 2014, AMPHIBIA-REPTILIA, V35, P383, DOI 10.1163/15685381-00002963; Gautestad AO, 2012, J R SOC INTERFACE, V9, P2332, DOI 10.1098/rsif.2012.0059; Holland J.H., 1975, ADAPTATION NATURAL A; HUMPHRIE.DA, 1970, OECOLOGIA, V5, P285, DOI 10.1007/BF00815496; Humphries NE, 2013, METHODS ECOL EVOL, V4, P930, DOI 10.1111/2041-210X.12096; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Jansen VAA, 2012, SCIENCE, V335, DOI 10.1126/science.1215747; Jones KA, 2011, BEHAV ECOL, V22, P831, DOI 10.1093/beheco/arr062; Kolpas A, 2007, P NATL ACAD SCI USA, V104, P5931, DOI 10.1073/pnas.0608270104; Levy P, 1954, THEORIE ADDITION VAR, V1; Makmal A, 2016, IEEE ACCESS, V4, P2110, DOI 10.1109/ACCESS.2016.2556579; Martinez-Gil F, 2017, SIMUL MODEL PRACT TH, V74, P117, DOI 10.1016/j.simpat.2017.03.003; Mautner J, 2015, NEW GENERAT COMPUT, V33, P69, DOI 10.1007/s00354-015-0102-0; Melnikov AA, 2018, IEEE ACCESS, V6, P64639, DOI 10.1109/ACCESS.2018.2876494; Melnikov AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14740-y; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Mueller T, 2011, THEOR ECOL-NETH, V4, P341, DOI 10.1007/s12080-010-0081-1; O'Loan OJ, 1999, J PHYS A-MATH GEN, V32, pL99, DOI 10.1088/0305-4470/32/8/002; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Plank MJ, 2008, J R SOC INTERFACE, V5, P1077, DOI 10.1098/rsif.2008.0006; Plank MJ, 2009, ECOLOGY, V90, P3546, DOI 10.1890/09-0079.1; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Pyke GH, 2015, METHODS ECOL EVOL, V6, P1, DOI 10.1111/2041-210X.12298; Raposo EP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434003; Reynolds AM, 2013, J THEOR BIOL, V332, P117, DOI 10.1016/j.jtbi.2013.04.035; Reynolds AM, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/18001; Reynolds AM, 2012, ECOLOGY, V93, P1228, DOI 10.1890/11-1815.1; Reynolds AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30515; Richardson G, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1112; Ried K, 2019, ARXIV191006985V1; Ried K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212044; Santos MC, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434017; Shimada K, 2018, P GEN EV COMP C COMP, P169, DOI [10.1145/3205651.3205770, DOI 10.1145/3205651.3205770]; Shlesinger MF, 1986, GROWTH AND FORM; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sinervo B., 1997, OPTIMAL FORAGING THE; Stephens D., 2007, FORAGING BEHAV ECOLO; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wosniack ME, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005774; YAGER DD, 1990, J EXP BIOL, V152, P17; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	65	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243628	10.1371/journal.pone.0243628	http://dx.doi.org/10.1371/journal.pone.0243628			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338066	Green Published, Green Submitted, gold			2022-12-26	WOS:000601313500038
J	Espersen, J; Weber, U; Romer-Franz, A; Lenarz, T; Stolle, SRO; Warnecke, A				Espersen, Julia; Weber, Ursula; Romer-Franz, Ariane; Lenarz, Thomas; Stolle, Stefan R. O.; Warnecke, Athanasia			Level of sex hormones and their association with acetylsalicylic acid intolerance and nasal polyposis	PLOS ONE			English	Article							EXACERBATED RESPIRATORY-DISEASE; DIAGNOSIS	Background Chronic rhinosinusitis may be associated with nasal polyposis. Recurrence of disease is often observed and may be due to an intolerance of acetylsalicylic acid. Sex hormones are known to modulate allergic reactions and inflammation. Whether they may be involved in the development and progression of nasal polyposis has not been investigated yet. Aim Examine the relationship between levels of sex hormones and nasal polyposis. Methods Hormonal levels (estradiol, testosterone and progesterone) in patients with nasal polyposis (n = 26) with or without acetylsalicylic acid-intolerance were determined and compared to hormonal levels in patients with septal deviation (n = 35). Cone-beam computed tomography scans were analysed by using scores as defined by Lund and Mackay and by Kennedy. Results Our results show a 5 times greater odds (p = 0.01) for developing nasal polyposis in the presence of lowered estradiol plasma levels than in the presence of normal / elevated levels. When analyzing females and males separately, a 6 times greater odds for females to develop nasal polyposis in the presence of lowered estradiol plasma levels was calculated (p = 0.02). Thus, females are more likely to develop nasal polyposis when they have lowered estradiol levels than males. In addition, female patients showed an increased risk for developing ASA intolerance (p = 0.01). Conclusion Variation of sex hormones may be involved in nasal polyposis. Further studies including more patients to validate the presented results are required. Significance Retrospective clinical investigation suggesting a correlation between varying sex hormones and nasal polyposis.	[Espersen, Julia; Weber, Ursula; Romer-Franz, Ariane; Lenarz, Thomas; Stolle, Stefan R. O.; Warnecke, Athanasia] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Espersen, Julia] Clin Reg Hannover, Hannover, Germany; [Romer-Franz, Ariane] Private Phoniatr Off Hanover, Hannover, Germany; [Stolle, Stefan R. O.] Private ENT Off Hanover, Hannover, Germany	Hannover Medical School	Warnecke, A (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Warnecke.Athanasia@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022					Almeida-Pereira G, 2019, J ENDOCRINOL, V240, P345, DOI 10.1530/JOE-18-0095; [Anonymous], 2019, NAT METHODS, V16, P1, DOI 10.1038/s41592-018-0292-8; [Anonymous], 2019, FRONTIERS PLANT SCI; Ashraf N, 2001, OTOLARYNG HEAD NECK, V125, P483, DOI 10.1067/mhn.2001.119324; Bankova LG, 2020, ANN ALLERGY ASTHMA I; Blesson CS, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-3; Bonfils P, 2008, ACTA OTO-LARYNGOL, V128, P318, DOI 10.1080/00016480701551760; Bonfils P, 2008, ACTA OTO-LARYNGOL, V128, P186, DOI 10.1080/00016480701387165; Case Allison M., 2001, Comprehensive Therapy, V27, P65, DOI 10.1007/s12019-001-0010-8; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Baldacara RPD, 2017, SAO PAULO MED J, V135, P4, DOI 10.1590/1516-3180.2016.011827016; Frump AL, 2016, RESPIR MED SER, P27, DOI 10.1007/978-3-319-23998-9_2; Fuseini H, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0686-1; Kennedy JL, 2016, AM J RHINOL ALLERGY, V30, P407, DOI 10.2500/ajra.2016.30.4370; Keselman A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00568; Kirsche H, 2015, HNO, V63, P357, DOI 10.1007/s00106-015-0008-7; Koper I, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0177-9; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Laidlaw TM, 2016, NEW ENGL J MED, V374, P484, DOI 10.1056/NEJMcibr1514013; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Machado-Carvalho L, 2016, RHINOLOGY, V54, P254, DOI 10.4193/Rhino15.207; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082373; Mitts KB, 2020, J ALLERGY CLIN IMMUN, V145, P777, DOI 10.1016/j.jaci.2020.01.029; Mudo G, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1417-4; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA486, DOI 10.1016/j.autrev.2011.11.023; Park SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181806; PATRIARCA G, 1986, ARCH OTO-RHINO-LARYN, V243, P16, DOI 10.1007/BF00457900; Sakalar EG, 2017, EUR ARCH OTO-RHINO-L, V274, P1291, DOI 10.1007/s00405-016-4273-1; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Simsek E, 2016, ACTA OTO-LARYNGOL, V136, P1180, DOI 10.1080/00016489.2016.1186833; Song WJ, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0880-4; Stubner UP, 1999, ALLERGY, V54, P865, DOI 10.1034/j.1398-9995.1999.00961.x; Yoo F, 2019, INT FORUM ALLERGY RH, V9, P1135, DOI 10.1002/alr.22406; Zhang H, 2011, MENOPAUSE, V18, P1001, DOI 10.1097/gme.0b013e3182127c9b; 2019, BRAIN STIMUL MAR, V12	36	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243732	10.1371/journal.pone.0243732	http://dx.doi.org/10.1371/journal.pone.0243732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332460	gold, Green Published			2022-12-26	WOS:000601310900109
J	Maharaj, AD; Evans, SM; Zalcberg, JR; Ioannou, LJ; Graco, M; Croagh, D; Pilgrim, CHC; Dodson, T; Goldstein, D; Philip, J; Kench, JG; Merrett, ND; Neale, RE; White, K; Evans, P; Leong, T; Green, SE				Maharaj, Ashika D.; Evans, Sue M.; Zalcberg, John R.; Ioannou, Liane J.; Graco, Marnie; Croagh, Daniel; Pilgrim, Charles H. C.; Dodson, Theresa; Goldstein, David; Philip, Jennifer; Kench, James G.; Merrett, Neil D.; Neale, Rachel E.; White, Kate; Evans, Peter; Leong, Trevor; Green, Sally E.			Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework	PLOS ONE			English	Article							AMERICAN SOCIETY; DIAGNOSIS; PANCREATICODUODENECTOMY; MULTIDISCIPLINARY; MANAGEMENT; CARE; CT	Background Accurate pre-operative imaging plays a vital role in patient selection for surgery and in allocating stage-appropriate therapies to patients diagnosed with pancreatic cancer (PC). This study aims to: (1) understand the current diagnosis and staging practices for PC; and (2) explore the factors (barriers and enablers) that influence the use of a pancreatic protocol computed tomography (PPCT) or magnetic resonance imaging (MRI) to confirm diagnosis and/or accurately stage PC. Methods Semi-structured interviews were conducted with radiologists, surgeons, gastroenterologists, medical and radiation oncologists from the states of New South Wales (NSW) and Victoria, Australia. Interviews were conducted either in person or via video conferencing. All interviews were recorded, transcribed verbatim, de-identified and data were thematically coded according to the 12 domains explored within the Theoretical Domains Framework (TDF). Common belief statements were generated to compare the variation between participant responses. Findings In total, 21 clinicians (5 radiologists, 10 surgeons, 2 gastroenterologists, 4 medical and radiation oncologists) were interviewed over a four-month-period. Belief statements relevant to the TDF domains were generated. Across the 11 relevant domains, 20 themes and 30 specific beliefs were identified. All TDF domains, with the exception of social influences were identified by participants as relevant to protocol-based imaging using either a PPCT or MRI, with the domains of knowledge, skills and environmental context and resources being offered by most participants as being relevant in influencing their decisions. Conclusions To maximise outcomes and personalise therapy it is imperative that diagnosis and staging investigations using the most appropriate imaging modalities are conducted in a timely, efficient and effective manner. The results provide an understanding of specialists' opinion and behaviour in relation to a PPCT or MRI and should be used to inform the design of future interventions to improve compliance with this practice.	[Maharaj, Ashika D.; Evans, Sue M.; Zalcberg, John R.; Ioannou, Liane J.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Evans, Sue M.] Canc Council Victoria, Melbourne, Vic, Australia; [Zalcberg, John R.; Graco, Marnie; Pilgrim, Charles H. C.] Alfred Hlth, Melbourne, Vic, Australia; [Croagh, Daniel; Dodson, Theresa] Monash Hlth, Clayton, Vic, Australia; [Goldstein, David] Univ New South Wales, Prince Wales Clin Sch, Randwick, NSW, Australia; [Philip, Jennifer] St Vincents Hosp Melbourne, Melbourne, Vic, Australia; [Philip, Jennifer; Leong, Trevor] Univ Melbourne, Melbourne, Vic, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Merrett, Neil D.] Univ Western Sydney, Sch Med, Penrith, NSW, Australia; [Neale, Rachel E.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [White, Kate] Univ Sydney, Sydney Nursing Sch, Sydney, NSW, Australia; [Evans, Peter] Peninsula Hlth, Frankston, Vic, Australia; [Leong, Trevor] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Monash University; Cancer Council Victoria; University of New South Wales Sydney; St Vincent's Hospital Melbourne; University of Melbourne; University of Sydney; Western Sydney University; QIMR Berghofer Medical Research Institute; University of Sydney; Peter Maccallum Cancer Center	Green, SE (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	sally.green@monash.edu	Merrett, Neil/ABB-4342-2021; Graco, Marnie/AAA-1334-2020; Maharaj, Ashika/ABD-7648-2021; Merrett, Neil/H-8033-2019; goldstein, david/J-6711-2012	Merrett, Neil/0000-0002-8370-0293; Graco, Marnie/0000-0001-6048-0147; Merrett, Neil/0000-0002-8370-0293; Maharaj, Ashika/0000-0002-4725-613X; Philip, Jennifer/0000-0002-3312-0645; Evans, Sue/0000-0003-2962-8400; Zalcberg, John/0000-0002-6624-0782	Australian National Health and Medical Research Council (NHMRC) [PCR4QI, APP1125395]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The authors of this study would like to acknowledge the Australian National Health and Medical Research Council (NHMRC) for the Pancreatic Cancer Registry for Quality Improvement (PCR4QI) grant [grant number APP1125395].	Al-Hawary MM, 2014, GASTROENTEROLOGY, V146, P291, DOI 10.1053/j.gastro.2013.11.004; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0589-5; Australian Gastro-Intestinal Trials Group (AGITG), 2015, CONS STAT DEF SURG S; Balaban EP, 2016, J CLIN ONCOL, V34, P2654, DOI 10.1200/JCO.2016.67.5561; Brook OR, 2015, RADIOLOGY, V274, P464, DOI 10.1148/radiol.14140206; Burge ME, 2015, HPB, V17, P624, DOI 10.1111/hpb.12418; Feldman MK, 2016, SURG CLIN N AM, V96, P1235, DOI 10.1016/j.suc.2016.07.007; Francis JJ, 2009, BRIT J HEALTH PSYCH, V14, P625, DOI 10.1348/135910708X397025; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gagliardi AR, 2016, PANCREAS, V45, P161, DOI 10.1097/MPA.0000000000000484; Gandy RC, 2016, MED J AUSTRALIA, V204, P419, DOI 10.5694/mja16.00061; Graco M, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4197-8; Hata T, 2016, ANN SURG, V263, P664, DOI 10.1097/SLA.0000000000001437; Horlait M, 2019, J MULTIDISCIP HEALTH, V12, P159, DOI 10.2147/JMDH.S196660; Jeong SA, 2019, EXPERT OPIN BIOL TH, V19, P1085, DOI 10.1080/14712598.2019.1554052; Johnson MJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008592; Kartalis N, 2018, EUR RADIOL, V28, P3482, DOI 10.1007/s00330-018-5486-z; Khorana AA, 2017, J CLIN ONCOL, V35, P2324, DOI 10.1200/JCO.2017.72.4948; Kim FJ, 2015, PATIENT SAF SURG, V9, DOI 10.1186/s13037-015-0067-4; Lacey K, 2016, MED J AUSTRALIA, V205, P66, DOI 10.5694/mja15.01169; Lee ES, 2014, WORLD J GASTROENTERO, V20, P7864, DOI 10.3748/wjg.v20.i24.7864; Liles JS, 2014, EXPERT REV ANTICANC, V14, P919, DOI 10.1586/14737140.2014.919860; Maharaj AD, 2021, BMJ QUAL SAF, V30, P792, DOI 10.1136/bmjqs-2020-011793; Maharaj AD, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031434; Maharaj AD, 2019, HPB, V21, P444, DOI 10.1016/j.hpb.2018.08.016; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Slavova-Azmanova NS, 2015, MED J AUSTRALIA, V202, P144, DOI 10.5694/mja14.00768; Sohal DPS, 2018, J CLIN ONCOL, V36, P2545, DOI 10.1200/JCO.2018.78.9636; Torgeson A, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2017-000282; Tummers WS, 2018, PANCREAS, V47, P675, DOI 10.1097/MPA.0000000000001075; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Zhang LL, 2018, WORLD J GASTROENTERO, V24, P2047, DOI 10.3748/wjg.v24.i19.2047; Zins M, 2018, RADIOLOGY, V287, P374, DOI 10.1148/radiol.2018171670	35	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243312	10.1371/journal.pone.0243312	http://dx.doi.org/10.1371/journal.pone.0243312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332372	Green Published, gold			2022-12-26	WOS:000601310900023
J	Jaffey, JA; Matheson, J; Shumway, K; Pacholec, C; Ullal, T; Van den Bossche, L; Fieten, H; Ringold, R; Lee, KJ; DeClue, AE				Jaffey, Jared A.; Matheson, Jodi; Shumway, Kate; Pacholec, Christina; Ullal, Tarini; Van den Bossche, Lindsay; Fieten, Hille; Ringold, Randy; Lee, Keun Jung; DeClue, Amy E.			Serum 25-hydroxyvitamin D concentrations in dogs with gallbladder mucocele	PLOS ONE			English	Article							VITAMIN-D CONCENTRATIONS; GALL-BLADDER MUCOCELES; RECEPTOR 4 EXPRESSION; CLINICAL FINDINGS; CYTOKINE PRODUCTION; BILIARY SLUDGE; D DEFICIENCY; BILE-SALTS; ASSOCIATION; DISEASE	Gallbladder mucocele (GBM) is a common biliary disorder in dogs. Gallbladder hypokinesia has been proposed to contribute to its formation and progression. The specific cause of gallbladder stasis in dogs with GBM as well as viable treatment options to resolve dysmotility remains unknown. Vitamin D deficiency is one of the many potential causes of gallbladder hypokinesia in humans and repletion results in complete resolution of stasis. Improving our understanding of the relationship between serum vitamin D and GBM could help identify dogs as a model for humans with gallbladder hypokinesia. Furthermore, this relationship could provide insight into the pathogenesis of GBM and support the need for future studies to investigate vitamin D as a novel treatment target. Therefore, goals of this study were i) to determine if serum 25-hydroxyvitamin(OH)D concentrations were decreased in dogs with GBM, ii) if serum 25(OH)D concentrations were different in clinical versus dogs subclinical for GBM, and iii) to determine if serum 25(OH)D concentrations could predict the ultrasonographic type of GBM. Sixty-two dogs (clinical, n = 26; subclinical, n = 36) with GBM and 20 healthy control dogs were included in this prospective observational study. Serum 25(OH)D concentrations were measured with a competitive chemiluminescence immunoassay. Overall, dogs with GBM had lower serum 25(OH)D concentrations than control dogs (P = 0.004). Subsequent subgroup analysis indicated that this difference was only significant in the subclinical group compared to the control dogs (P = 0.008), and serum 25(OH)D concentrations did not significantly differ between dogs clinical for GBM versus subclinical or control dogs, indicating that inflammatory state in clinical dogs was not the major constituent of the observed findings. Decreasing serum 25(OH)D concentrations, but not clinical status, was associated with a more advanced developmental stage of GBM type determined by ultrasonography. Our results indicate that vitamin D has a role in dogs with GBM. Additional studies are needed to assess if reduced vitamin D in dogs with GBM is a cause or effect of their biliary disease and to investigate if vitamin D supplementation could be beneficial for dogs with GBM.	[Jaffey, Jared A.] Midwestern Univ, Coll Vet Med, Dept Specialty Med, Glendale, AZ 85308 USA; [Matheson, Jodi; Shumway, Kate; Pacholec, Christina; DeClue, Amy E.] Univ Missouri, Dept Vet Med & Surg, Vet Hlth Ctr, Columbia, MO USA; [Ullal, Tarini] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Van den Bossche, Lindsay; Fieten, Hille] Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Yalelaan, Utrecht, Netherlands; [Ringold, Randy] VDI Lab LLC, Simi Valley, CA USA; [Lee, Keun Jung] Midwestern Univ, Coll Vet Med, Dept Pathol & Populat Med, Glendale, AZ USA	Midwestern University; University of Missouri System; University of Missouri Columbia; Colorado State University; Utrecht University; Midwestern University	Jaffey, JA (corresponding author), Midwestern Univ, Coll Vet Med, Dept Specialty Med, Glendale, AZ 85308 USA.	jjaffe@midwestern.edu		Ullal, Tarini/0000-0002-8728-3706; Jaffey, Jared/0000-0002-0270-4728	VDI Laboratory, LLC	VDI Laboratory, LLC	VDI Laboratory, LLC provided funding for this study in the form of salary for author RR. This study was not supported by a grant or any other source of external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Aguirre AL, 2007, JAVMA-J AM VET MED A, V231, P79, DOI 10.2460/javma.231.1.79; Allerton F, 2018, J VET INTERN MED, V32, P1618, DOI 10.1111/jvim.15249; Anwar E, 2017, NUTR CLIN PRACT, V32, P378, DOI 10.1177/0884533616671741; Barko PC, 2018, J VET INTERN MED, V32, P1600, DOI 10.1111/jvim.15292; Behar J, 2013, NEUROGASTROENT MOTIL, V25, P283, DOI 10.1111/nmo.12094; Besso JG, 2000, VET RADIOL ULTRASOUN, V41, P261, DOI 10.1111/j.1740-8261.2000.tb01489.x; Bhattacharya, 2013, INDIAN J GASTROENTER, V32, pA1; Bolukbas FF, 2006, J GASTROEN HEPATOL, V21, P1150, DOI 10.1111/j.1440-1746.2006.04444.x; Boyan BD, 2003, CONNECT TISSUE RES, V44, P130, DOI 10.1080/03008200390152214; Ceglia L, 2009, CURR OPIN CLIN NUTR, V12, P628, DOI 10.1097/MCO.0b013e328331c707; Ceglia L, 2008, MOL ASPECTS MED, V29, P407, DOI 10.1016/j.mam.2008.07.002; Center SA, 2009, VET CLIN N AM-SMALL, V39, P543, DOI 10.1016/j.cvsm.2009.01.004; Choi J, 2014, VET RADIOL ULTRASOUN, V55, P202, DOI 10.1111/vru.12120; Crews LJ, 2009, JAVMA-J AM VET MED A, V234, P359, DOI 10.2460/javma.234.3.359; DEBOER SY, 1994, DIABETOLOGIA, V37, P75, DOI 10.1007/s001250050075; Edwards MA, 2014, DIGEST DIS SCI, V59, P2773, DOI 10.1007/s10620-014-3213-4; Grobman M, 2017, J VET INTERN MED, V31, P1430, DOI 10.1111/jvim.14787; Hookey TJ, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2018.7; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Hurst EA, 2020, VET CLIN PATH, V49, P279, DOI 10.1111/vcp.12859; Jacobs ET, 2016, CANCER PREV RES, V9, P589, DOI 10.1158/1940-6207.CAPR-16-0033; Jaffey JA, 2019, VET J, V251, DOI 10.1016/j.tvjl.2019.105350; Jaffey JA, 2018, VET REC, V183, P26, DOI 10.1016/j.tvjl.2018.04.010; Jaffey JA, 2018, J VET INTERN MED, V32, P195, DOI 10.1111/jvim.14898; Jaffey JA, 2018, AM J VET RES, V79, P1071, DOI 10.2460/ajvr.79.10.1071; Jaffey JA, 2018, AM J VET RES, V79, P1064, DOI 10.2460/ajvr.79.10.1064; Jaffey JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194062; Jonkers IJAM, 2003, GUT, V52, P109, DOI 10.1136/gut.52.1.109; Kesimer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138988; Klenk J, 2013, AGE AGEING, V42, P404, DOI 10.1093/ageing/aft042; Kutsunai M, 2014, VET J, V199, P76, DOI 10.1016/j.tvjl.2013.10.019; LAMORTE WW, 1985, SURGERY, V98, P445; Laukkarinen J, 2003, SURGERY, V133, P288, DOI 10.1067/msy.2003.77; Leary PF, 2017, J AM OSTEOPATH ASSOC, V117, P433, DOI 10.7556/jaoa.2017.089; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Malek S, 2013, VET SURG, V42, P418, DOI 10.1111/j.1532-950X.2012.01072.x; Merg AR, 2002, J GASTROINTEST SURG, V6, P432, DOI 10.1016/S1091-255X(01)00061-0; Mesich MLL, 2009, J SMALL ANIM PRACT, V50, P630, DOI 10.1111/j.1748-5827.2009.00811.x; Nishida S, 2009, DRUG METAB DISPOS, V37, P2037, DOI 10.1124/dmd.109.027334; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Parkanzky M, 2019, J VET INTERN MED, V33, P2057, DOI 10.1111/jvim.15611; Pike FS, 2004, JAVMA-J AM VET MED A, V224, P1615, DOI 10.2460/javma.2004.224.1615; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Selting KA, 2016, VET COMP ONCOL, V14, P295, DOI 10.1111/vco.12101; Singla R, 2015, DIGEST DIS SCI, V60, P2793, DOI 10.1007/s10620-015-3678-9; SVANVIK J, 1986, J SURG RES, V41, P425, DOI 10.1016/0022-4804(86)90057-0; Thompson PD, 2002, BIOCHEM BIOPH RES CO, V299, P730, DOI 10.1016/S0006-291X(02)02742-0; Tsukagoshi T, 2012, VET RADIOL ULTRASOUN, V53, P84, DOI 10.1111/j.1740-8261.2011.01868.x; van Erpecum KJ, 2006, J LIPID RES, V47, P32, DOI 10.1194/jlr.M500180-JLR200; Walsh JS, 2017, CURR OPIN ENDOCRINOL, V24, P389, DOI 10.1097/MED.0000000000000371; Weidner N, 2017, J VET INTERN MED, V31, P1796, DOI 10.1111/jvim.14834; Worley DR, 2004, JAVMA-J AM VET MED A, V225, P1418, DOI 10.2460/javma.2004.225.1418; Xiao ZL, 2003, HEPATOLOGY, V37, P1442, DOI 10.1053/jhep.2003.50243; Xiao ZL, 2001, AM J PHYSIOL-GASTR L, V281, pG490, DOI 10.1152/ajpgi.2001.281.2.G490; Yoshida T, 2001, BBA-MOL CELL BIOL L, V1530, P199, DOI 10.1016/S1388-1981(00)00183-9	56	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244102	10.1371/journal.pone.0244102	http://dx.doi.org/10.1371/journal.pone.0244102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326487	Green Published, gold			2022-12-26	WOS:000600176400051
J	Zhang, RF; Cheng, G; Chen, XL				Zhang, Ruofei; Cheng, Gary; Chen, Xieling			Game-based self-regulated language learning: Theoretical analysis and bibliometrics	PLOS ONE			English	Article							EFFICACY; ENGLISH; TECHNOLOGY; STRATEGIES	Game-based learning and self-regulated learning have long been valued as effective approaches to language education. However, little research has been conducted to investigate their integration, namely, game-based self-regulated language learning (GBSRLL). This study aims to conceptualise GBSRLL based on the combination of theoretical analysis, thematic evolution analysis, and social network analysis on the research articles in the fields of game-based language learning and self-regulated language learning. The results show that GBSRLL is a new interdisciplinary field emerging since the period from 2018 to 2019. Self-regulated learning strategies that can be performed in GBSRLL, the effects of GBSRLL on learners' affective states, and the features in GBSRLL were the prominent research topics in this field. Its theoretical foundation centres on the positive correlations between learner motivation, self-efficacy, and autonomy and the implementation of game-based learning and self-regulated learning. It is feasible to conduct GBSRLL due to the strong supportiveness of game mechanics for various phases and strategies of self-regulated learning. More contributions to this new interdisciplinary field are called for, especially from the aspects of the long-term effects of GBSRLL on academic performance and the useful tools and technologies for implementing GBSRLL.	[Zhang, Ruofei] Educ Univ Hong Kong, Dept English Language Educ, Hong Kong, Peoples R China; [Cheng, Gary; Chen, Xieling] Educ Univ Hong Kong, Dept Math & Informat Technol, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK)	Cheng, G (corresponding author), Educ Univ Hong Kong, Dept Math & Informat Technol, Hong Kong, Peoples R China.	chengks@eduhk.hk		Cheng, Gary/0000-0002-5614-3348	One-off Special Fund from Central and Faculty Fund [MIT02/19-20]; Research Cluster Fund of The Education University of Hong Kong [RG 78/2019-2020R]	One-off Special Fund from Central and Faculty Fund; Research Cluster Fund of The Education University of Hong Kong	This study was supported by One-off Special Fund from Central and Faculty Fund in Support of Research from 2019/20 to 2021/22 (MIT02/19-20) and Research Cluster Fund (RG 78/2019-2020R) of The Education University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annetta LA, 2010, REV GEN PSYCHOL, V14, P105, DOI 10.1037/a0018985; [Anonymous], 2019, INT WORKSH HUM BRAIN; Bai B, 2020, LANG TEACH RES, DOI 10.1177/1362168820933190; Bai B, 2018, READ WRIT Q, V34, P523, DOI 10.1080/10573569.2018.1499058; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Braghirolli LF, 2016, COMPUT HUM BEHAV, V58, P315, DOI 10.1016/j.chb.2015.12.063; Broadbent J, 2015, INTERNET HIGH EDUC, V27, P1, DOI 10.1016/j.iheduc.2015.04.007; Chen X, 2020, COMPUT EDUC, V151, DOI 10.1016/j.compedu.2020.103855; Chen XL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231192; Chen XL, 2020, BRIT J EDUC TECHNOL, V51, P692, DOI 10.1111/bjet.12907; Chen YL, 2020, COMPUT EDUC, V154, DOI 10.1016/j.compedu.2020.103910; Chik A, 2014, LANG LEARN TECHNOL, V18, P85; Dent AL, 2016, EDUC PSYCHOL REV, V28, P425, DOI 10.1007/s10648-015-9320-8; Fu QK, 2018, COMPUT EDUC, V119, P129, DOI 10.1016/j.compedu.2018.01.004; Garcia R, 2018, COMPUT EDUC, V123, P150, DOI 10.1016/j.compedu.2018.05.006; Godwin-Jones R, 2011, LANG LEARN TECHNOL, V15, P4; Goudarzi E, 2014, PRAGMAT COGN, V22, P325, DOI 10.1075/pc.22.3.03gou; Guo YR, 2017, ASLIB J INFORM MANAG, V69, P46, DOI 10.1108/AJIM-08-2016-0131; Hromalik CD, 2018, DISTANCE EDUC, V39, P528, DOI 10.1080/01587919.2018.1520044; Hsu TC, 2017, COMPUT EDUC, V106, P137, DOI 10.1016/j.compedu.2016.12.007; Hung HT, 2018, COMPUT EDUC, V126, P89, DOI 10.1016/j.compedu.2018.07.001; Khodarahmi E, 2016, CURR PSYCHOL, V35, P700, DOI 10.1007/s12144-015-9340-z; Lai C, 2017, ADV DIGIT LANG LEARN, P1; Lin V, 2020, COMPUT ASSIST LANG L, V2020, P1; Liu YC, 2021, J EDUC COMPUT RES, V59, P3, DOI 10.1177/0735633120952044; Mahayanti NWS, 2020, ASIAN ESP J, V5, P5; Malone T.W., 1987, APTITUDE LEARNING IN, V1st ed., P223, DOI [10.4324/9781003163244, DOI 10.4324/9781003163244]; Mizumoto A, 2013, INNOV LANG LEARN TEA, V7, P253, DOI 10.1080/17501229.2013.836206; Panadero E, 2017, EDUC RES REV-NETH, V22, P74, DOI 10.1016/j.edurev.2017.08.004; Park J, 2019, COMPUT EDUC, V139, P1, DOI 10.1016/j.compedu.2019.04.016; Perttula A, 2017, INT J SERIOUS GAMES, V4, P57, DOI 10.17083/ijsg.v4i1.151; Prell C, 2009, SOC NATUR RESOUR, V22, P501, DOI 10.1080/08941920802199202; Schunk DH, 2016, EDUC PSYCHOL HANDB, P34; Serrat O., 2017, KNOWLEDGE SOLUTIONS, DOI [10.1007/978-981-10-0983-9_9, DOI 10.1007/978-981-10-0983-9_9]; Teng LS, 2016, MOD LANG J, V100, DOI 10.1111/modl.12339; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tseng WT, 2006, APPL LINGUIST, V27, P78, DOI 10.1093/applin/ami046; Vandercruysse S, 2013, ETR&D-EDUC TECH RES, V61, P927, DOI 10.1007/s11423-013-9314-5; Warschauer M, 2011, STUD SELF-ACCESS LEA, V2, P107; Yang JC, 2016, J EDUC COMPUT RES, V54, P371, DOI 10.1177/0735633115620433; Yang QF, 2020, COMPUT EDUC, V148, DOI 10.1016/j.compedu.2020.103808; Yukselturk E, 2018, EDUC TECHNOL SOC, V21, P159; Zhang LJ, 2008, BRIT J EDUC PSYCHOL, V78, P245, DOI 10.1348/000709907X218179; Zhang R, 2020, COMPUT ASSIST LANG L, V2020, P1; Zimmerman B., 2000, HDB SELF REGULATION, P13, DOI [DOI 10.1016/B978-012109890-2/50031-7, 10.1016/B978-012109890-2/50031-7]; Zimmerman BJ, 2002, THEOR PRACT, V41, P64, DOI 10.1207/s15430421tip4102_2; ZIMMERMAN BJ, 1986, AM EDUC RES J, V23, P614, DOI 10.3102/00028312023004614; Zou D, 2019, CRIT REV MICROBIOL, V45, P239, DOI 10.1080/1040841X.2019.1575793	49	3	3	12	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243827	10.1371/journal.pone.0243827	http://dx.doi.org/10.1371/journal.pone.0243827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326464	Green Published, gold			2022-12-26	WOS:000600176400044
J	Bergin, CJ; Zouggar, A; Haebe, JR; Masibag, AN; Desrochers, FM; Reilley, SY; Agrawal, G; Benoit, YD				Bergin, Christopher J.; Zouggar, Aicha; Haebe, Joshua R.; Masibag, Angelique N.; Desrochers, Francois M.; Reilley, Simon Y.; Agrawal, Gautam; Benoit, Yannick D.			G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer	ONCOGENE			English	Article							STEM-CELLS; HISTONE H3; IDENTIFICATION; METHYLATION; METASTASIS; FEATURES	Colorectal tumors are hierarchically organized and governed by populations of self-renewing cancer stem cells, representing one of the deadliest types of cancers worldwide. Emergence of cancer stemness phenotype depends on epigenetic reprogramming, associated with profound transcriptional changes. As described for pluripotent reprogramming, epigenetic modifiers play a key role in cancer stem cells by establishing embryonic stem-like transcriptional programs, thus impacting the balance between self-renewal and differentiation. We identified overexpression of histone methyltransferase G9a as a risk factor for colorectal cancer, associated with shorter relapse-free survival. Moreover, using human transformed pluripotent cells as a surrogate model for cancer stem cells, we observed that G9a activity is essential for the maintenance of embryonic-like transcriptional signature promoting self-renewal, tumorigenicity, and undifferentiated state. Such a role was also applicable to colorectal cancer, where inhibitors of G9a histone methyltransferase function induced intestinal differentiation while restricting tumor-initiating activity in patient-derived colorectal tumor samples. Finally, by integrating transcriptome profiling with G9a/H3K9me2 loci co-occupancy, we identified the canonical Wnt pathway, epithelial-to-mesenchyme transition, and extracellular matrix organization as potential targets of such a chromatin regulation mechanism in colorectal cancer stem cells. Overall, our findings provide novel insights on the role of G9a as a driver of cancer stem cell phenotype, promoting self-renewal, tumorigenicity, and undifferentiated state.	[Bergin, Christopher J.; Zouggar, Aicha; Haebe, Joshua R.; Masibag, Angelique N.; Desrochers, Francois M.; Reilley, Simon Y.; Agrawal, Gautam; Benoit, Yannick D.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Benoit, YD (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.	ybenoit@uottawa.ca		Bergin, Chris/0000-0003-3610-6184; Benoit, Yannick/0000-0002-6677-4020	Cancer Research Society [22778, 24039]; Ontario Ministry of Research, Innovation and Science [ER17-13-012]; CIHR [PJT-173541]; National Science and Engineering Research Council [RGPIN-2018-06521, DGECR-2018-00029]	Cancer Research Society; Ontario Ministry of Research, Innovation and Science; CIHR(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Cancer Research Society (#22778 and #24039), the Ontario Ministry of Research, Innovation and Science (ER17-13-012), the CIHR (PJT-173541), and the National Science and Engineering Research Council (RGPIN-2018-06521 and DGECR-2018-00029).	Ardeljan D, 2017, CLIN CHEM, V63, P816, DOI 10.1373/clinchem.2016.257444; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benoit YD, 2017, CELL CHEM BIOL, V24, P833, DOI 10.1016/j.chembiol.2017.05.026; Benoit YD, 2014, CLIN CANCER RES, V20, P5372, DOI 10.1158/1078-0432.CCR-13-2491; Bergin CJ, 2020, GENES-BASEL, V11, DOI 10.3390/genes11060616; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Melo FDE, 2017, NATURE, V543, P676, DOI 10.1038/nature21713; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Jung G, 2020, NAT REV GASTRO HEPAT, V17, P111, DOI 10.1038/s41575-019-0230-y; Kato S, 2020, CANCER DISCOV, V10, P980, DOI 10.1158/2159-8290.CD-19-0532; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Lenstra DC, 2018, BIOORG MED CHEM LETT, V28, P1234, DOI 10.1016/j.bmcl.2018.02.043; Lima-Fernandes E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09309-4; Liu SL, 2015, ONCOTARGET, V6, P6887, DOI 10.18632/oncotarget.3159; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Luo CW, 2017, RADIOTHER ONCOL, V124, P395, DOI 10.1016/j.radonc.2017.03.002; Malta TM, 2018, CELL, V173, P338, DOI 10.1016/j.cell.2018.03.034; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Nakazawa T, 2012, HUM PATHOL, V43, P834, DOI 10.1016/j.humpath.2011.07.009; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pangeni RP, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00879-5; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wainwright EN, 2017, TRENDS CANCER, V3, P372, DOI 10.1016/j.trecan.2017.04.004; Wang HJ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0147-5; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Werbowetski-Ogilvie TE, 2012, STEM CELLS, V30, P392, DOI 10.1002/stem.1017; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Zhang T, 2016, CELL REP, V15, P77, DOI 10.1016/j.celrep.2016.03.007	43	13	13	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1191	1202		10.1038/s41388-020-01591-7	http://dx.doi.org/10.1038/s41388-020-01591-7		DEC 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33323965	Green Published, hybrid			2022-12-26	WOS:000599126500012
J	Correa, TD; Cordioli, RL; Guerra, JCC; da Silva, BC; Rodrigues, RD; de Souza, GM; Midega, TD; Campos, NS; Carneiro, BV; Campos, FND; Guimaraes, HP; de Matos, GFJ; de Aranda, VF; Ferraz, LJR				Correa, Thiago Domingos; Cordioli, Ricardo Luiz; Campos Guerra, Joao Carlos; da Silva, Bruno Caldin; Rodrigues, Roseny dos Reis; de Souza, Guilherme Martins; Midega, Thais Dias; Campos, Niklas Soderberg; Carneiro, Barbara Vieira; Dias Campos, Flavia Nunes; Guimaraes, Helio Penna; Janot de Matos, Gustavo Faissol; de Aranda, Valdir Fernandes; Rolim Ferraz, Leonardo Jose			Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study	PLOS ONE			English	Article							PROTEIN-C CONCENTRATIONS; INTENSIVE-CARE; DISEASE; SCORE	Background Coagulation abnormalities in COVID-19 patients have not been addressed in depth. Objective To perform a longitudinal evaluation of coagulation profile of patients admitted to the ICU with COVID-19. Methods Conventional coagulation tests, rotational thromboelastometry (ROTEM), platelet function, fibrinolysis, antithrombin, protein C and S were measured at days 0, 1, 3, 7 and 14. Based on median total maximum SOFA score, patients were divided in two groups: SOFA <= 10 and SOFA > 10. Results Thirty patients were studied. Some conventional coagulation tests, as aPTT, PT and INR remained unchanged during the study period, while alterations on others coagulation laboratory tests were detected. Fibrinogen levels were increased in both groups. ROTEM maximum clot firmness increased in both groups from Day 0 to Day 14. Moreover, ROTEM-FIBTEM maximum clot firmness was high in both groups, with a slight decrease from day 0 to day 14 in group SOFA <= 10 and a slight increase during the same period in group SOFA > 10. Fibrinolysis was low and decreased over time in all groups, with the most pronounced decrease observed in INTEM maximum lysis in group SOFA > 10. Also, D-dimer plasma levels were higher than normal reference range in both groups and free protein S plasma levels were low in both groups at baseline and increased over time, Finally, patients in group SOFA > 10 had lower plasminogen levels and Protein C than patients with SOFA <10, which may represent less fibrinolysis activity during a state of hypercoagulability. Conclusion COVID-19 patients have a pronounced hypercoagulability state, characterized by impaired endogenous anticoagulation and decreased fibrinolysis. The magnitude of coagulation abnormalities seems to correlate with the severity of organ dysfunction. The hypercoagulability state of COVID-19 patients was not only detected by ROTEM but it much more complex, where changes were observed on the fibrinolytic and endogenous anticoagulation system.	[Correa, Thiago Domingos; Cordioli, Ricardo Luiz; da Silva, Bruno Caldin; Rodrigues, Roseny dos Reis; de Souza, Guilherme Martins; Midega, Thais Dias; Campos, Niklas Soderberg; Carneiro, Barbara Vieira; Dias Campos, Flavia Nunes; Guimaraes, Helio Penna; Janot de Matos, Gustavo Faissol; Rolim Ferraz, Leonardo Jose] Hosp Israelita Albert Einstein, Dept Crit Care Med, Sao Paulo, Brazil; [Campos Guerra, Joao Carlos; de Aranda, Valdir Fernandes] Hosp Israelita Albert Einstein, Dept Lab Ctr, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Cordioli, RL (corresponding author), Hosp Israelita Albert Einstein, Dept Crit Care Med, Sao Paulo, Brazil.	ricardo.cordioli@einstein.br	Midega, Thais/HGB-9347-2022; Silva, Bruno C/AAE-6350-2020	Silva, Bruno C/0000-0001-9568-0974; Martins de Souza, Guilherme/0000-0002-0643-2723				Barrett CD, 2020, J THROMB HAEMOST, V18, P2060, DOI 10.1111/jth.14860; Berlin DA, 2020, N ENGL J MED; BERTOZZI P, 1990, NEW ENGL J MED, V322, P890, DOI 10.1056/NEJM199003293221304; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Brunkhorst F, 2007, ANESTHESIOLOGY, V107, P15, DOI 10.1097/01.anes.0000267531.39410.d3; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Collett LW, 2020, AUST CRIT CARE; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Creel-Bulos C, 2021, SHOCK, V55, P316, DOI 10.1097/SHK.0000000000001635; Crochemore T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192965; Crochemore T, 2017, EINSTEIN-SAO PAULO, V15, P380, DOI [10.1590/S1679-45082017MD3130, 10.1590/s1679-45082017md3130]; Dolhnikoff M, 2020, J THROMB HAEMOST, V18, P1517, DOI 10.1111/jth.14844; Escher R, 2020, THROMB RES, V190, P62, DOI 10.1016/j.thromres.2020.04.014; Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188; Hardy M, 2020, J THROMB HAEMOST, V18, P3121, DOI 10.1111/jth.15061; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Ibanez C, 2021, J THROMB THROMBOLYS, V51, P308, DOI 10.1007/s11239-020-02226-0; Joly BS, 2020, INTENS CARE MED, V46, P1603, DOI 10.1007/s00134-020-06088-1; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Lier H, 2013, HAMOSTASEOLOGIE, V33, P51, DOI 10.5482/HAMO-12-05-0011; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Medcalf RL, 2020, J THROMB HAEMOST, V18, P2118, DOI 10.1111/jth.14960; Mesters RM, 2000, CRIT CARE MED, V28, P2209, DOI 10.1097/00003246-200007000-00005; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Mortus JR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11192; Nougier C, 2020, J THROMB HAEMOST, V18, P2215, DOI 10.1111/jth.15016; Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850; Pavoni V, 2020, J THROMB THROMBOLYS, V50, P281, DOI 10.1007/s11239-020-02130-7; Petricevic M, 2016, ANAESTHESIA, V71, P636, DOI 10.1111/anae.13303; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Sarangi PP, 2010, BRIT J HAEMATOL, V148, P817, DOI 10.1111/j.1365-2141.2009.08020.x; Semeraro F, 2018, CRIT CARE MED, V46, pe221, DOI 10.1097/CCM.0000000000002919; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Whiting D, 2014, AM J HEMATOL, V89, P228, DOI 10.1002/ajh.23599; Wool GD, 2021, PATHOBIOLOGY, V88, P15, DOI 10.1159/000512007; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yan SB, 2001, CHEST, V120, P915, DOI 10.1378/chest.120.3.915; Zampieri Fernando Godinho, 2017, Rev. bras. ter. intensiva, V29, P418, DOI [10.5935/0103-507X.20170062, 10.5935/0103-507x.20170062]; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	47	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243604	10.1371/journal.pone.0243604	http://dx.doi.org/10.1371/journal.pone.0243604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320874	Green Published, gold			2022-12-26	WOS:000600339800051
J	Olakunde, BO; Pharr, JR; Chien, LC; Benfield, RD; Sy, FS				Olakunde, Babayemi O.; Pharr, Jennifer R.; Chien, Lung-Chang; Benfield, Rebecca D.; Sy, Francisco S.			Individual- and country-level correlates of female permanent contraception use in sub-Saharan Africa	PLOS ONE			English	Article							MULTILEVEL LOGISTIC-REGRESSION; BRIEF CONCEPTUAL TUTORIAL; TUBAL-LIGATION; SOCIAL EPIDEMIOLOGY; FERTILITY DESIRES; BEHAVIORAL-MODEL; STERILIZATION; WOMEN; ACCESS; HEALTH	Background Female permanent contraception is a cost-effective contraceptive method that can help clients with the desire to limit childbearing achieve their reproductive intention. However, despite its benefits, the use of FPC remains low in sub-Saharan Africa (SSA), and limited studies have examined the correlates of its uptake. In this study, we assessed the individual- and country-level factors associated with the use of FPC among married or in-union women using modern contraceptive methods to limit childbearing in SSA. Methods This study was a secondary data analysis of individual- and country-level data obtained from the Demographic and Health Surveys (DHS) Program and three open data repositories. The study included 29,777 married or in-union women aged 15-49 years using modern contraceptive methods to limit childbearing from DHS conducted in 33 sub-Sahara African countries between 2010 and 2018. We performed descriptive statistics and fitted multilevel logistic regression models to determine the predisposing, enabling, and need factors associated with the use of FPC. Results Approximately 13% of the women used FPC. About 20% of the variance in the odds of using FPC was attributable to between-country differences. In the full model, the significant individual-level factors associated with the use of FPC compared with other modern contraceptive methods were: age (odds ratio [OR] = 1.10; 95%CI = 1.08-1.12), living children (OR = 1.11, 95%CI = 1.04-1.16), high household wealth (OR = 1.39, 95%CI = 1.18-1.64), rural residence (OR = 0.83, 95% CI = 0.71-0.97), joint contraceptive decision with partner (OR = 1.68, 95% = 1.43-1.99), contraceptive decision by partner and others (OR = 2.46, 95% = 1.97-3.07), and the number of living children less than the ideal number of children (OR = 1.40, 95%CI = 1.21-1.62). The significantly associated country-level factors were births attended by skilled health providers (OR = 1.03, 95%CI = 1.00-1.05) and density of medical doctors (OR = 1.37, 95%CI = 1.01-1.85). Conclusions Our results suggest that both individual- and country-level factors affect uptake of FPC in SSA. Increasing geographic, economic, and psychosocial access to FPC may improve its uptake in SSA.	[Olakunde, Babayemi O.; Pharr, Jennifer R.; Sy, Francisco S.] Univ Nevada, Sch Publ Hlth, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA; [Olakunde, Babayemi O.] Natl Agcy Control AIDS, Dept Community Prevent & Care Serv, Abuja, Nigeria; [Chien, Lung-Chang] Univ Nevada, Sch Publ Hlth, Dept Epidemiol & Biostat, Las Vegas, NV 89154 USA; [Benfield, Rebecca D.] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Olakunde, BO (corresponding author), Univ Nevada, Sch Publ Hlth, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA.; Olakunde, BO (corresponding author), Natl Agcy Control AIDS, Dept Community Prevent & Care Serv, Abuja, Nigeria.	olakunde@unlv.nevada.edu		Pharr, Jennifer/0000-0002-0383-2641				Adegoke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040220; Alemayehu M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-6; Andersen R, 1968, BEHAV MODEL FAMILIES BEHAV MODEL FAMILIES; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andersen RM, 2008, MED CARE, V46, P647, DOI [10.1097/MLR.0b013e31817a835d, 10.1097/MLR.0b013e31817f4d48]; Anderson JE, 2012, CONTRACEPTION, V85, P552, DOI 10.1016/j.contraception.2011.10.009; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Baatiema L, 2019, ADV PUBLIC HEAL, V2019, P1; Balogun OR, 2017, J MED BIOMED SCI, V6, P1, DOI 10.4314/jmbs.v6i3.1; Bass LE, 2013, SOCIOL FOCUS, V46, P47; Blackstone SR, 2017, INT Q COMMUNITY HEAL, V37, P79, DOI 10.1177/0272684X16685254; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Borrero S, 2007, OBSTET GYNECOL, V109, P94, DOI 10.1097/01.AOG.0000249604.78234.d3; Bradley SEK, 2011, DHS ANAL STUDIES; Casterline JB, 2017, DEMOGR RES, V36, P427, DOI 10.4054/DemRes.2017.36.14; Channon MD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219736; CHIBALONZA K, 1989, STUD FAMILY PLANN, V20, P273, DOI 10.2307/1966764; Choi Y, 2019, CONTRACEPTION, V99, P131, DOI 10.1016/j.contraception.2018.10.006; Croft TN, 2018, GUIDE DHS STAT; Daniele MAS, 2018, B WORLD HEALTH ORGAN, V96, P450, DOI [10.2471/BLT.17.206466, 10.2471/blt.17.206466]; Darroch J.E., 2017, ADDING IT INVESTING; de Oliveira IT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086654; Dereuddre R, 2016, SOC SCI MED, V161, P1, DOI [10.10161/j.socscimed.2016.05.030, 10.1016/j.socscimed.2016.05.030]; EASTERLIN RA, 1988, STUD FAMILY PLANN, V19, P257, DOI 10.2307/1966791; EASTERLIN RA, 1975, STUD FAMILY PLANN, V6, P54, DOI 10.2307/1964934; Edmeades J, 2011, GLOB PUBLIC HEALTH, V6, P407, DOI 10.1080/17441692.2010.533686; EngenderHealth, 2002, CONTR STER GLOB ISS; Fabic MS, 2019, GLOB HEALTH-SCI PRAC, V7, P564, DOI 10.9745/GHSP-D-19-00298; Festin MPR, 2016, CONTRACEPTION, V94, P289, DOI 10.1016/j.contraception.2016.05.015; Ghosh S, 2017, J BIOSOC SCI, V49, P48, DOI 10.1017/S0021932016000080; Gordon-Maclean C, 2014, INT J GYNECOL OBSTET, V124, P34, DOI 10.1016/j.ijgo.2013.07.016; Guttmacher Institute, 2017, ADD IT INV CONTR MAT; Jacobs C, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00011; Jacobstein R, 2013, STUD FAMILY PLANN, V44, P85, DOI 10.1111/j.1728-4465.2013.00345.x; Kriel Y, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0749-y; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lunde B, 2013, OBSTET GYNECOL, V122, P304, DOI 10.1097/AOG.0b013e31829b5a11; Lutala PM, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-38; Marie Stopes International EngenderHealth  International IntraHealth  International Planned Parenthood Federation Population Council Jhpiego, 2014, INCR ACC HIGH QUAL V; Mengesha ZB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0598-9; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Micks EA, 2015, WOMENS HEALTH, V11, P769, DOI 10.2217/whe.15.69; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Mohanty SK, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-0884-1; Musalia JM, 2005, SEX ROLES, V53, P835, DOI 10.1007/s11199-005-8296-0; Nuccio O, 2017, HEALTH POLICY PLANN, V32, P163, DOI 10.1093/heapol/czw105; Nyongesa C, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1727-z; Olakunde BO, 2019, CONTRACEPTION, V99, P205, DOI 10.1016/j.contraception.2018.12.007; Perpetuo HIO, 2003, POVERTY FERTILITY FA, P311; Ren R., NOTE DHS STANDARD WE; RODRIGUES J, 1995, J BIOSOC SCI, V27, P339, DOI 10.1017/S0021932000022860; Rutaremwa G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1611-y; Seiber EE, 2007, INT FAM PLAN PERSPEC, V33, P117, DOI 10.1363/3311707; Sennott C, 2012, INT PERSPECT SEX R H, V38, P34, DOI 10.1363/3803412; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Sonfield A, 2013, SOCIAL EC BENEFITS W; Speizer IS, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0729-3; Speizer IS, 2000, INT FAM PLAN PERSPEC, V26, P13, DOI 10.2307/2648285; Stephenson R, 2006, J HEALTH POPUL NUTR, V24, P100; The RESPOND Project, 2014, MATT FACT MATT CHOIC; Thind A, 2005, J FAM PLAN REPROD H, V31, P34, DOI 10.1783/0000000052972762; Tumlinson K, 2015, CONTRACEPTION, V92, P143, DOI 10.1016/j.contraception.2015.04.002; United Nations Department of Economic and Social Affairs Population Division., 2019, CONTR US METH 2019 D; United Nations Department of Economic and Social Affairs Population Division, 2015, TRENDS CONTR US WORL; Van Lith LM, 2013, GLOB HEALTH-SCI PRAC, V1, P97, DOI 10.9745/GHSP-D-12-00036; von Lengerke T., 2014, HLTH CARE UTILIZATIO, DOI DOI 10.1007/978-1-4614-9191-0_2; Westoff CF, 2000, INT FAM PLAN PERSPEC, V26, P56, DOI 10.2307/2648268; Westoff CF, 2012, UNMET NEED MODERN CO; White K, 2015, WOMEN HEALTH ISS, V25, P628, DOI 10.1016/j.whi.2015.06.011; World Health Organization, 2012, WHO REC OPT HLTH WOR	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243316	10.1371/journal.pone.0243316	http://dx.doi.org/10.1371/journal.pone.0243316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320877	gold, Green Published			2022-12-26	WOS:000600339800005
J	Zhang, Y; Yan, Q; Gong, LQ; Xu, H; Liu, BL; Fang, XN; Yu, DD; Li, L; Wei, T; Wang, Y; Wong, CN; Lyu, Z; Tang, Y; Sham, PC; Guan, XY				Zhang, Yu; Yan, Qian; Gong, Lanqi; Xu, Hang; Liu, Beilei; Fang, Xiaona; Yu, Dandan; Li, Lei; Wei, Ting; Wang, Ying; Wong, Ching Ngar; Lyu, Zhaojie; Tang, Ying; Sham, Pak Chung; Guan, Xin-Yuan			C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism	ONCOGENE			English	Article							VIRUS X PROTEIN; HEPATOCELLULAR-CARCINOMA; AEROBIC GLYCOLYSIS; TUMOR-SUPPRESSOR; LIVER-CANCER; METASTASIS; ACTIVATION; INTEGRATION; EXPRESSION; PATHWAY	Chronic hepatitis B virus (HBV) infection is strongly associated with the initiation and development of hepatocellular carcinoma (HCC). However, the genetic alterations and pathogenesis mechanisms remain significantly unexplored, especially for HBV-induced metabolic reprogramming. Analysis of integration breakpoints in HBV-positive HCC samples revealed the preferential clustering pattern within the 3 '-end of X gene in the HBV genome, leading to the production of C-terminal truncated X protein (Ct-HBx). In this study, we not only characterized the oncogenic role of two Ct-HBx (HBx-120 and HBx-134) via in vitro and in vivo functional assays but also deciphered their underlying molecular mechanisms. Gene expression profiling by transcriptome sequencing identified potential targets of Ct-HBx and novel malignant hallmarks such as glycolysis, cell cycle, and m-TORC1 signaling in Ct-HBx-expressing cells. TXNIP, a well-established regulator of glucose metabolism, was shown to be downregulated by Ct-HBx and play a pivotal role in Ct-HBx-mediated HCC progression. Suppression of TXNIP is frequently observed in HCC patients with Ct-HBx expression and significantly (P = 0.015) correlated to a poorer prognosis. Re-introduction of TXNIP attenuated the metabolic reprogramming induced by the Ct-HBx and inhibited the tumor growth in the mice model. Further study suggested that Ct-HBx could downregulate TXNIP via a transcriptional repressor nuclear factor of activated T cells 2 (NFACT2). Collectively, our findings indicate that TXNIP plays a critical role in Ct-HBx-mediated hepatocarcinogenesis, serving as a novel therapeutic strategy in HCC treatment.	[Zhang, Yu; Gong, Lanqi; Liu, Beilei; Fang, Xiaona; Yu, Dandan; Li, Lei; Wang, Ying; Wong, Ching Ngar; Lyu, Zhaojie; Tang, Ying; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Peoples R China; [Zhang, Yu; Gong, Lanqi; Liu, Beilei; Fang, Xiaona; Yu, Dandan; Li, Lei; Wang, Ying; Wong, Ching Ngar; Lyu, Zhaojie; Tang, Ying; Guan, Xin-Yuan] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China; [Yan, Qian] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Res Ctr Med Sci, Guangzhou 510030, Peoples R China; [Yan, Qian; Guan, Xin-Yuan] Univ Hong Kong, Shenzhen Hosp, Dept Clin Oncol, Shenzhen 518053, Peoples R China; [Xu, Hang; Sham, Pak Chung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Peoples R China; [Yu, Dandan] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China; [Wei, Ting] Southern Med Univ, Zhujiang Hosp, Dept Oncol, Guangzhou 510282, Peoples R China; [Guan, Xin-Yuan] Sun Yat Sen Univ, State Key Lab Oncol Southern China, Canc Ctr, Guangzhou 510060, Peoples R China	University of Hong Kong; University of Hong Kong; Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Hong Kong; University of Hong Kong; Southern University of Science & Technology; Southern Medical University - China; State Key Lab Oncology South China; Sun Yat Sen University	Guan, XY (corresponding author), Univ Hong Kong, Dept Clin Oncol, Hong Kong, Peoples R China.; Guan, XY (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China.; Guan, XY (corresponding author), Univ Hong Kong, Shenzhen Hosp, Dept Clin Oncol, Shenzhen 518053, Peoples R China.; Guan, XY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol Southern China, Canc Ctr, Guangzhou 510060, Peoples R China.	xyguan@hku.hk			Hong Kong Research Grant Council (RGC) [C7065-18GF, C7026-18GF, T12-704/16-R]; Research Grant Council (RGC) [17143716]; National Key R&D Program of China [2017YFC1309000]; National Natural Science Foundation of China [81903049, 81772554]; Shenzhen Peacock Team Project [KQTD201533117210153, KQTD2018041118502879]	Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); Research Grant Council (RGC)(Hong Kong Research Grants Council); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Team Project	This project was supported by grants from the Hong Kong Research Grant Council (RGC) grants including Collaborative Research Funds (C7065-18GF and C7026-18GF), Theme-based Research Scheme (T12-704/16-R), Research Grant Council (RGC) grants including GRF (17143716), the National Key R&D Program of China (2017YFC1309000), National Natural Science Foundation of China (81903049, 81772554), and The Shenzhen Peacock Team Project (KQTD201533117210153, KQTD2018041118502879). Professor Xin-Yuan Guan is Sophie YM Chan Professor in Cancer Research.	Arzumanyan A, 2011, CANCER RES, V71, P3701, DOI 10.1158/0008-5472.CAN-10-3951; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chambers JW, 2010, J VIROL, V84, P1867, DOI 10.1128/JVI.02123-09; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Delgado T, 2010, P NATL ACAD SCI USA, V107, P10696, DOI 10.1073/pnas.1004882107; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hardie DG, 2015, CLIN CANCER RES, V21, P3836, DOI 10.1158/1078-0432.CCR-14-3300; He L, 2018, MOL CELL, V70, P949, DOI 10.1016/j.molcel.2018.04.024; He ZL, 2017, ONCOL LETT, V14, P1323, DOI 10.3892/ol.2017.6296; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Ishikawa T, 2010, WORLD J GASTROENTERO, V16, P2463, DOI 10.3748/wjg.v16.i20.2463; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Ji SR, 2016, CLIN CANCER RES, V22, P3950, DOI 10.1158/1078-0432.CCR-15-2380; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Keng VW, 2011, HEPATOLOGY, V53, P781, DOI 10.1002/hep.24091; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Lara-Pezzi E, 1998, EMBO J, V17, P7066, DOI 10.1093/emboj/17.23.7066; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Li XJ, 2014, J HEPATOL, V60, P975, DOI 10.1016/j.jhep.2013.12.014; Liu XW, 2016, MOL MED REP, V14, P2311, DOI 10.3892/mmr.2016.5472; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14813-y; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lo AKF, 2015, J PATHOL, V237, P238, DOI 10.1002/path.4575; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; Ma T, 2015, ANGIOGENESIS, V18, P477, DOI 10.1007/s10456-015-9475-4; Malone CF, 2017, CANCER DISCOV, V7, P1450, DOI 10.1158/2159-8290.CD-17-0177; Noch E, 2012, MOL CANCER THER, V11, P14, DOI 10.1158/1535-7163.MCT-11-0517; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pusapati RV, 2016, CANCER CELL, V29, P548, DOI 10.1016/j.ccell.2016.02.018; Quetier I, 2015, J GEN VIROL, V96, P614, DOI 10.1099/vir.0.070680-0; Schoder H, 2007, J NUCL MED, V48, p4S; Shen LL, 2015, P NATL ACAD SCI USA, V112, P5425, DOI 10.1073/pnas.1501555112; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Suzuki J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05854-6; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; Wang Y, 2002, J PATHOL, V197, P610, DOI 10.1002/path.1150; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; Yang WJ, 2009, HEPATOLOGY, V49, P1515, DOI 10.1002/hep.22833; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Yu DY, 1999, J HEPATOL, V31, P123, DOI 10.1016/S0168-8278(99)80172-X; Zhang R, 2016, AM J CANCER RES, V6, P312; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]	50	24	25	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1147	1161		10.1038/s41388-020-01593-5	http://dx.doi.org/10.1038/s41388-020-01593-5		DEC 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33323975	hybrid, Green Published			2022-12-26	WOS:000599126500007
J	Kim, W; Choi, D; Jang, Y; Nam, CM; Hur, SH; Hong, MK				Kim, Wonho; Choi, Donghoon; Jang, Yangsoo; Nam, Chung Mo; Hur, Seung-Ho; Hong, Myeong-Ki			Effect of intentional restriction of venous return on tissue oxygenation in a porcine model of acute limb ischemia	PLOS ONE			English	Article							CORONARY-SINUS; ARTERY; OCCLUSION; DISEASE; INJURY; LOCUS; SWINE; FLOW	Introduction A sufficient oxygen supply to ischemic limb tissue is the most important requirement for wound healing and limb salvage. We investigated whether partial venous occlusion in the common iliac vein (CIV) causes a further increase of venous oxygenation in a porcine model of acute hindlimb ischemia. Materials and methods In 7 pigs, the model of acute hindlimb ischemia was created with intra-vascular embolization of the common iliac artery (CIA). The arterial and venous oxygen saturation was evaluated at different moments. Oxygen saturation was evaluated at baseline (T0), just after the arterial embolization (T1), at 10 minutes (T2), at 20 minutes (T3), and at 40 minutes (T4). Next, an intentional partial venous occlusion was achieved by inflating the vascular balloon at the level of the right CIV. Then, blood sampling was repeated at 5 minutes (T5), at 15 minutes (T6), and at 25 minutes (T7). Results The arterial oxygen saturation in the right SFA was similar during all phases. In contrast, after arterial embolization, an immediate reduction of venous oxygen saturation was observed (from 85.57 1.72 at T0 to 71.86 +/- 7.58 at T4). After the partial venous occlusion, interestingly, the venous oxygen saturations (T5-T7) were significantly increased, again. The venous oxygen saturations evaluated in the hindlimb ischemia with partial venous occlusion and in the control limb (without partial venous occlusion) were significantly over time. Venous oxygen saturations in the experimental limbs were higher than those in the control limbs (79.28 +/- 4.82 vs 59.00 +/- 2.82, p-value <0.001, 79.71 <plus/minus> 4.78 vs 60.00 +/- 4.24 at T7, p-value <0.001). Conclusions Partial venous occlusion results in an increase of venous oxygen saturation in the ischemic limb, while significant changes in venous oxygen saturation are not observed in the control limb. An explanation for this may be that the oxygen consumption in the limb tissue is increased because it gets congested with the partial venous occlusion in the right CIV.	[Kim, Wonho] Yonsei Univ, Coll Med, Grad Sch, Dept Internal Med, Seoul, South Korea; [Kim, Wonho] Eulji Univ, Eulji Univ Hosp, Sch Med, Div Cardiol, Daejeon, South Korea; [Choi, Donghoon; Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Nam, Chung Mo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hur, Seung-Ho] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea	Yonsei University; Yonsei University Health System; Eulji University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Keimyung University	Kim, W (corresponding author), Yonsei Univ, Coll Med, Grad Sch, Dept Internal Med, Seoul, South Korea.; Kim, W (corresponding author), Eulji Univ, Eulji Univ Hosp, Sch Med, Div Cardiol, Daejeon, South Korea.; Hong, MK (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.	cardiokwh@gmail.com; mkhong61@yuhs.ac		Choi, Donghoon/0000-0002-2009-9760; Jang, Yangsoo/0000-0002-2169-3112; Nam, Chung Mo/0000-0003-0985-0928; Hong, Myeong-Ki/0000-0002-2090-2031				Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; BECK CS, 1955, JAMA-J AM MED ASSOC, V159, P1264, DOI 10.1001/jama.1955.02960300008003; Beckert S, 2004, DIABETES CARE, V27, P2863, DOI 10.2337/diacare.27.12.2863; Chen M, 2017, MICROVASC RES, V110, P48, DOI 10.1016/j.mvr.2016.12.006; Diaz JA, 2012, ARTERIOSCL THROM VAS, V32, P556, DOI 10.1161/ATVBAHA.111.244608; Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gao Y, 2020, J SURG RES, V249, P168, DOI 10.1016/j.jss.2019.12.005; Institute for Laboratory Animal Resources (US), 1996, GUIDE CARE USE LAB A; Kapanadze T, 2019, THERANOSTICS, V9, P152, DOI 10.7150/thno.27175; Lelasi A, 2016, INT J CARDIOL, V209, P122, DOI 10.1016/j.ijcard.2016.02.018; Long CA, 2017, J VASC SURG, V66, P891, DOI 10.1016/j.jvs.2016.07.127; McClung JM, 2016, J VASC SURG, V64, P1101, DOI 10.1016/j.jvs.2015.06.139; Md AOD, 2008, CIRCULATION, V117, P1207, DOI 10.1161/CIRCULATIONAHA.107.736447; Naehle CP, 2015, J VASC SURG, V61, P1312, DOI 10.1016/j.jvs.2013.11.094; Nakamura H, 2020, INT J LOW EXTR WOUND, V19, P57, DOI 10.1177/1534734619868925; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Romiti M, 2008, J VASC SURG, V47, P975, DOI 10.1016/j.jvs.2008.01.005; Rushing AM, 2019, J VASC SURG, V69, P1924, DOI 10.1016/j.jvs.2018.08.172; Sealock R, 2014, CIRC RES, V114, P660, DOI 10.1161/CIRCRESAHA.114.302931; Shi WY, 2015, THROMB RES, V135, P1172, DOI 10.1016/j.thromres.2015.03.006; Tang GL, 2005, J VASC SURG, V41, P312, DOI 10.1016/j.jvs.2004.11.012; Verheye S, 2015, NEW ENGL J MED, V372, P519, DOI 10.1056/NEJMoa1402556; Ziegler MA, 2010, MICROCIRCULATION, V17, P3, DOI 10.1111/j.1549-8719.2010.00008.x	24	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243033	10.1371/journal.pone.0243033	http://dx.doi.org/10.1371/journal.pone.0243033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33318709	gold, Green Published			2022-12-26	WOS:000600186100043
J	Wagner, DR; Teramoto, M				Wagner, Dale R.; Teramoto, Masaru			Interrater reliability of novice examiners using A-mode ultrasound and skinfolds to measure subcutaneous body fat	PLOS ONE			English	Article							GENERALIZED EQUATIONS; DENSITY	Examiners with minimal training and skill are often called upon to make body composition assessments using field methods. This study compared the interrater reliability of novice examiners for the skinfold (SKF) and A-mode ultrasound (US) methods of body composition assessment. Undergraduate Kinesiology majors (48 males, 32 females) with minimal training took both SKF and US measurements at three sites (males: chest, abdomen, thigh; females: triceps, suprailiac, thigh). Interrater reliability was significantly better for US compared to SKF at the thigh (ICCUS = 0.975, ICCSKF = 0.912) and abdomen (ICCUS = 0.984, ICCSKF = 0.693) for men and suprailiac (ICCUS = 0.978, ICCSKF = 0.883) for women. Additionally, interrater reliability of the US method was superior to the SKF method for the estimate of male body fat percentage (ICCUS = 0.990, ICCSKF = 0.862). The 95% CI was generally narrower for the US method than the SKF method at each site. The interrater reliability of the US method was superior to or equal to the SKF method for measuring subcutaneous body fat when novice examiners took the measurements.	[Wagner, Dale R.] Utah State Univ, Kinesiol & Hlth Sci Dept, Logan, UT 84322 USA; [Teramoto, Masaru] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; University of Utah	Wagner, DR (corresponding author), Utah State Univ, Kinesiol & Hlth Sci Dept, Logan, UT 84322 USA.	dale.wagner@usu.edu		Wagner, Dale/0000-0003-1575-1555				American College of Sports Medicine, 2018, ACSMS GUIDELINES EXE, V10th; Beaton DE, 2001, J RHEUMATOL, V28, P400; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; de Vet HW, 2011, MEASUREMENT MED PRAC; Gibson AL., 2019, ADV FITNESS ASSESSME, V8; Hendrickson N, 2019, J ORTHOP TRAUMA, V33, P472, DOI 10.1097/BOT.0000000000001498; Heyward V.H., 2004, APPL BODY COMPOSITIO, V2nd ed.; Hume P.A., 2018, BEST PRACTICE PROTOC, P61; Hume P, 2008, J SPORT SCI, V26, P1333, DOI 10.1080/02640410802165707; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; JACKSON AS, 1978, RES QUART, V49, P546, DOI 10.1080/10671315.1978.10615569; KERR L, 1994, ISOKINET EXERC SCI, V4, P137, DOI 10.3233/IES-1994-4402; KISPERT CP, 1987, PHYS THER, V67, P917, DOI 10.1093/ptj/67.6.917; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; LOHMAN TG, 1981, HUM BIOL, V53, P181; Lohman TG, 2020, ACSMS BODY COMPOSITI; Meyer NL, 2013, BRIT J SPORT MED, V47, P1044, DOI 10.1136/bjsports-2013-092561; Milliken L.A., 2020, ACSMS BODY COMPOSITI, P59; Muller W, 2013, BRIT J SPORT MED, V47, P1028, DOI 10.1136/bjsports-2013-092232; Buxade CPC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205226; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; RUIZ L, 1971, BRIT J PREV SOC MED, V25, P165; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siri W., 1961, TECHNIQUES MEASURING, P223; Stewart A., 2011, INT STANDARDS ANTHRO, V137; Wagner DR, 2020, ULTRASOUND MED BIOL, V46, P944, DOI 10.1016/j.ultrasmedbio.2019.11.018; Wagner DR, 2019, EUR J CLIN NUTR, V73, P518, DOI 10.1038/s41430-018-0085-2; Wagner DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153146; Wagner DR, 2013, J OBES, V2013, DOI 10.1155/2013/280713; Wagner DR, 1999, RES Q EXERCISE SPORT, V70, P135, DOI 10.1080/02701367.1999.10608031	32	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0244019	10.1371/journal.pone.0244019	http://dx.doi.org/10.1371/journal.pone.0244019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315956	gold, Green Published			2022-12-26	WOS:000600186100070
J	Abergel, Z; Shaked, M; Shukla, V; Wu, ZX; Gross, E				Abergel, Zohar; Shaked, Maayan; Shukla, Virendra; Wu, Zheng-Xing; Gross, Einav			The phosphatidylinositol transfer protein PITP-1 facilitates fast recovery of eating behavior after hypoxia in the nematode Caenorhabditis elegans	FASEB JOURNAL			English	Article						C elegans; GLOBIN 5; hypoxia; oxygen sensing neurons; PITP&#8208; 1; PKC&#8208; 1	SOLUBLE GUANYLATE CYCLASES; C-ELEGANS; SYNAPTIC-TRANSMISSION; PHOSPHATIDIC-ACID; NATURAL VARIATION; NERVOUS-SYSTEM; O-2 RESPONSES; OXYGEN; KINASE; NEURONS	Among the fascinating adaptations to limiting oxygen conditions (hypoxia) is the suppression of food intake and weight loss. In humans, this phenomenon is called high-altitude anorexia and is observed in people suffering from acute mountain syndrome. The high-altitude anorexia appears to be conserved in evolution and has been seen in species across the animal kingdom. However, the mechanism underlying the recovery of eating behavior after hypoxia is still not known. Here, we show that the phosphatidylinositol transfer protein PITP-1 is essential for the fast recovery of eating behavior after hypoxia in the nematode Caenorhabditis elegans. Unlike the neuroglobin GLB-5 that accelerates the recovery of eating behavior through its function in the oxygen (O-2)-sensing neurons, PITP-1 appears to act downstream, in neurons that express the mod-1 serotonin receptor. Indeed, pitp-1 mutants display wild-type-like O-2-evoked-calcium responses in the URX O-2-sensing neuron. Intriguingly, loss-of-function of protein kinase C 1 (PKC-1) rescues pitp-1 mutants' recovery after hypoxia. Increased diacylglycerol (DAG), which activates PKC-1, attenuates the recovery of wild-type worms. Together, these data suggest that PITP-1 enables rapid recovery of eating behavior after hypoxia by limiting DAG's availability, thereby limiting PKC activity in mod-1-expressing neurons.	[Abergel, Zohar; Shaked, Maayan; Shukla, Virendra; Gross, Einav] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Fac Med, IMRIC, POB 12271, IL-9112102 Jerusalem, Israel; [Wu, Zheng-Xing] Huazhong Univ Sci & Technol, Dept Biophys & Mol Physiol, Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ,Inst Biophys & Bi, Wuhan, Peoples R China	Hebrew University of Jerusalem; Huazhong University of Science & Technology	Gross, E (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Fac Med, IMRIC, POB 12271, IL-9112102 Jerusalem, Israel.; Wu, ZX (corresponding author), Huazhong Univ Sci & Technol, Dept Biophys & Mol Physiol, Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ,Inst Biophys & Bi, Wuhan, Peoples R China.	ibbwuzx@mail.hust.edu.cn; einavg@ekmd.huji.ac.il	Gross, Einav/AAS-7417-2021		European Research Council [281844] Funding Source: Medline; NIH HHS [P40 OD010440] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abergel Z, 2016, J NEUROSCI, V36, P963, DOI 10.1523/JNEUROSCI.3170-15.2016; Alam T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10388; Alberts B, 2008, MOL BIOL CELL; [Anonymous], 2018, WORMATLAS; BRENNER S, 1974, GENETICS, V77, P71; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Cai HH, 2019, J GERONTOL A-BIOL, V74, P1198, DOI 10.1093/gerona/glx206; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; De Henau S, 2016, WORM, V5, DOI DOI 10.1080/21624054.2016.1184390; De Henau S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9782; Farzin M, 2014, J INSECT PHYSIOL, V68, P23, DOI 10.1016/j.jinsphys.2014.06.017; Fenk LA, 2017, P NATL ACAD SCI USA, V114, P4195, DOI 10.1073/pnas.1618934114; Frokjaer-Jensen C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002467; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grabon A, 2019, J LIPID RES, V60, P242, DOI 10.1194/jlr.R089730; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Green MR, 2012, MOL CLONING LAB MANU, V1; Grimm ER, 2011, NUTR REV, V69, P52, DOI 10.1111/j.1753-4887.2010.00361.x; Gross E, 2014, J NEUROSCI, V34, P16726, DOI 10.1523/JNEUROSCI.5368-13.2014; Gurel G, 2012, GENETICS, V192, P1359, DOI 10.1534/genetics.112.142125; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Hsieh YS, 2005, EUR J NEUROSCI, V22, P715, DOI 10.1111/j.1460-9568.2005.04245.x; Hyde R, 2011, GENES BRAIN BEHAV, V10, P286, DOI 10.1111/j.1601-183X.2010.00667.x; Iwata R, 2011, P NATL ACAD SCI USA, V108, P7589, DOI 10.1073/pnas.1016232108; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kim S, 2013, EMBO REP, V14, P891, DOI 10.1038/embor.2013.113; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; KONNO Y, 1989, J BIOCHEM-TOKYO, V106, P673, DOI 10.1093/oxfordjournals.jbchem.a122915; Kurland M, 2020, J DEV BIOL, V8, DOI 10.3390/jdb8010005; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Milward K, 2011, P NATL ACAD SCI USA, V108, P20672, DOI 10.1073/pnas.1106134109; Nagashima T, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008297; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; Park D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07313-6; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Sun CL, 2014, CELL DEATH DIFFER, V21, P557, DOI 10.1038/cdd.2013.176; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Takeishi A, 2016, NEURON, V90, P235, DOI 10.1016/j.neuron.2016.03.002; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Tilleman L, 2011, IUBMB LIFE, V63, P166, DOI 10.1002/iub.443; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Tran A, 2017, ELIFE, V6, DOI [10.7554/eLife.23770, 10.7554/elife.23770]; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Vats P, 2004, HIGH ALT MED BIOL, V5, P90, DOI 10.1089/152702904322963753; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wojtyniak M, 2013, J CELL SCI, V126, P4381, DOI 10.1242/jcs.127274; Zhao YH, 2018, ELIFE, V7, DOI 10.7554/eLife.38675; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	67	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21202	10.1096/fj.202000704R	http://dx.doi.org/10.1096/fj.202000704R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368638	Green Published, hybrid			2022-12-26	WOS:000605626600010
J	Ikeuchi, M; Yuki, R; Saito, Y; Nakayama, Y				Ikeuchi, Masayoshi; Yuki, Ryuzaburo; Saito, Youhei; Nakayama, Yuji			The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner	FASEB JOURNAL			English	Article						bleb; Hippo pathway; LATS2; Merlin; v&#8208; Src	C-SRC; TYROSINE PHOSPHORYLATION; FAMILY KINASES; CELL-MIGRATION; IN-VITRO; F-ACTIN; EXPRESSION; PATHWAY; CANCER; ACTIVATION	When cells with excess DNA, such as tetraploid cells, undergo cell division, it can contribute to cellular transformation via asymmetrical chromosome segregation-generated genetic diversity. Cell cycle progression of tetraploid cells is suppressed by large tumor suppressor 2 (LATS2) kinase-induced inhibitory phosphorylation of the transcriptional coactivator Yes-associated protein (YAP). We recently reported that the oncogene v-Src induces tetraploidy and promotes cell cycle progression of tetraploid cells by suppressing LATS2 activity. We explore here the mechanism by which v-Src suppresses LATS2 activity and the role of LATS2 in v-Src-expressing cells. LATS2 was directly phosphorylated by v-Src and the proto-oncogene c-Src, resulting in decreased LATS2 kinase activity. This kinase-deficient LATS2 accumulated in a YAP transcriptional activity-dependent manner, and knockdown of either LATS2 or the LATS2-binding partner moesin-ezrin-radixin-like protein (Merlin) accelerated v-Src-induced membrane bleb formation. Upon v-Src expression, the interaction of Merlin with LATS2 was increased possibly due to a decrease in Merlin phosphorylation at Ser518, the dephosphorylation of which is required for the open conformation of Merlin and interaction with LATS2. LATS2 was colocalized with Merlin at the plasma membrane in a manner that depends on the Merlin-binding region of LATS2. The bleb formation in v-Src-expressing and LATS2-knockdown cells was rescued by the reexpression of wild-type or kinase-dead LATS2 but not the LATS2 mutant lacking the Merlin-binding region. These results suggest that the kinase-deficient LATS2 plays a role with Merlin at the plasma membrane in the maintenance of cortical rigidity in v-Src-expressing cells, which may cause tumor suppression.	[Ikeuchi, Masayoshi; Yuki, Ryuzaburo; Saito, Youhei; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto, Japan; [Ikeuchi, Masayoshi] Japan Soc Promot Sci, DC1, Tokyo, Japan	Kyoto Pharmaceutical University; Japan Society for the Promotion of Science	Nakayama, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Yamashina Ku, 5 Misasagi Nakauchi Cho, Kyoto 6078414, Japan.	nakayama@mb.kyoto-phu.ac.jp		Saito, Youhei/0000-0002-8545-6925				Aoki K, 2016, P NATL ACAD SCI USA, V113, pE1863, DOI 10.1073/pnas.1600968113; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Brault E, 2001, J CELL SCI, V114, P1901; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Dehm S, 2001, FEBS LETT, V487, P367, DOI 10.1016/S0014-5793(00)02354-1; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fincham VJ, 1999, J CELL SCI, V112, P947; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Guo Feng, 2008, Biotechnol J, V3, P370, DOI 10.1002/biot.200700170; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; Honda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38751; Horiuchi M, 2018, J BIOL CHEM, V293, P15524, DOI 10.1074/jbc.RA118.002784; Ikeuchi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060871; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; James MF, 2001, BIOCHEM J, V356, P377, DOI 10.1042/0264-6021:3560377; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kakae K, 2017, CELL SIGNAL, V30, P19, DOI 10.1016/j.cellsig.2016.11.014; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim HB, 2018, BMB REP, V51, P119, DOI 10.5483/BMBRep.2018.51.3.018; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Nakayama Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040811; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Park GS, 2016, ONCOTARGET, V7, P24063, DOI 10.18632/oncotarget.8211; Penuel E, 1999, MOL BIOL CELL, V10, P1693, DOI 10.1091/mbc.10.6.1693; Rusnak L, 2018, J MOL CELL BIOL, V10, P549, DOI 10.1093/jmcb/mjy061; Sabra H, 2017, J BIOL CHEM, V292, P19179, DOI 10.1074/jbc.M117.808063; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sun CX, 2002, J CELL SCI, V115, P3991, DOI 10.1242/jcs.00094; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Wang TT, 2019, CURR DRUG TARGETS, V20, P1, DOI 10.2174/1389450119666180405094046; Warren JSA, 2018, CANCERS, V10, DOI 10.3390/cancers10040115; Webb BL, 2000, MOL CELL BIOL, V20, P9271, DOI 10.1128/MCB.20.24.9271-9280.2000; Welman A, 2006, NEOPLASIA, V8, P905, DOI 10.1593/neo.06475; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu T, 2015, PROTEIN CELL, V6, P6, DOI 10.1007/s13238-014-0122-4	64	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21242	10.1096/fj.202001909R	http://dx.doi.org/10.1096/fj.202001909R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368671				2022-12-26	WOS:000605626600001
J	Myllykoski, M; Sutinen, A; Koski, MK; Kallio, JP; Raasakka, A; Myllyharju, J; Wierenga, RK; Koivunen, P				Myllykoski, Matti; Sutinen, Aleksi; Koski, M. Kristian; Kallio, Juha P.; Raasakka, Arne; Myllyharju, Johanna; Wierenga, Rik K.; Koivunen, Peppi			Structure of transmembrane prolyl 4-hydroxylase reveals unique organization of EF and dioxygenase domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; SMALL-ANGLE SCATTERING; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; PETRA III; BINDING; PROTEIN; MODEL; VALIDATION; BEAMLINE	Prolyl 4-hydroxylases (P4Hs) catalyze post-translational hydroxylation of peptidyl proline residues. In addition to collagen P4Hs and hypoxia-inducible factor P4Hs, a third P4H-the poorly characterized endoplasmic reticulum-localized transmembrane prolyl 4-hydroxylase (P4H-TM)-is found in animals. P4H-TM variants are associated with the familiar neurological HIDEA syndrome, but how these variants might contribute to disease is unknown. Here, we explored this question in a structural and functional analysis of soluble human P4H-TM. The crystal structure revealed an EF domain with two Ca2+-binding motifs inserted within the catalytic domain. A substrate-binding groove was formed between the EF domain and the conserved core of the catalytic domain. The proximity of the EF domain to the active site suggests that Ca2+ binding is relevant to the catalytic activity. Functional analysis demonstrated that Ca2+-binding affinity of P4H-TM is within the range of physiological Ca2+ concentration in the endoplasmic reticulum. P4H-TM was found both as a monomer and a dimer in the solution, but the monomer-dimer equilibrium was not regulated by Ca2+. The catalytic site contained bound Fe2+ and N-oxalylglycine, which is an analogue of the cosubstrate 2-oxoglutarate. Comparison with homologous P4H structures complexed with peptide substrates showed that the substrate-interacting residues and the lid structure that folds over the substrate are conserved in P4H-TM, whereas the extensive loop structures that surround the substrate-binding groove, generating a negative surface potential, are different. Analysis of the structure suggests that the HIDEA variants cause loss of P4H-TM function. In conclusion, P4H-TM shares key structural elements with other P4Hs while having a unique EF domain.	[Myllykoski, Matti; Sutinen, Aleksi; Koski, M. Kristian; Myllyharju, Johanna; Wierenga, Rik K.; Koivunen, Peppi] Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Myllykoski, Matti; Myllyharju, Johanna; Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland; [Kallio, Juha P.; Raasakka, Arne] Univ Bergen, Dept Biomed, Bergen, Norway	University of Oulu; University of Oulu; University of Bergen	Koivunen, P (corresponding author), Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, Oulu, Finland.; Koivunen, P (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland.	peppi.koivunen@oulu.fi	Raasakka, Arne/AAA-5251-2020	Raasakka, Arne/0000-0002-9443-9959; Kallio, Juha Pekka/0000-0003-3092-4012; wierenga, rik/0000-0001-6554-471X; Myllykoski, Matti/0000-0001-6641-5856; Sutinen, Aleksi/0000-0001-6704-1702	Academy of Finland [266719, 308009, 296498]; Academy of Finland Center of Excellence 2012-2017 grant [251314, 284605]; S. Juselius Foundation; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence 2012-2017 grant(Academy of Finland); S. Juselius Foundation; Jane and Aatos Erkko Foundation	This work was supported by Academy of Finland grants 266719 and 308009 (P. K.), and 296498 (J. M.), the Academy of Finland Center of Excellence 2012-2017 grant 251314 and 284605 (J. M.), and grants from the S. Juselius Foundation (P. K. and J. M.) and the Jane and Aatos Erkko Foundation (P. K. and J. M.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ahmed S, 2017, J MED CHEM, V60, P5663, DOI 10.1021/acs.jmedchem.7b00352; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12673; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Deutsch EW, 2015, J PROTEOME RES, V14, P3461, DOI 10.1021/acs.jproteome.5b00500; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gore S, 2017, STRUCTURE, V25, P1916, DOI 10.1016/j.str.2017.10.009; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hyvarinen J, 2010, J BIOL CHEM, V285, P42023, DOI 10.1074/jbc.M110.145904; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kaasinen E, 2014, EUR J MED GENET, V57, P543, DOI 10.1016/j.ejmg.2014.07.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kawasaki H, 2017, PROTEIN SCI, V26, P1898, DOI 10.1002/pro.3233; Kiema TR, 2019, BIOCHEM J, V476, P307, DOI 10.1042/BCJ20180788; Koivunen P, 2007, J BIOL CHEM, V282, P30544, DOI 10.1074/jbc.M704988200; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Koski MK, 2017, BIOCHEM J, V474, P751, DOI 10.1042/BCJ20161000; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Leinonen H, 2019, NEUROPHARMACOLOGY, V153, P63, DOI 10.1016/j.neuropharm.2019.04.023; Leinonen H, 2016, HUM MOL GENET, V25, P3810, DOI 10.1093/hmg/ddw228; Li WZ, 2012, BIOINFORMATICS, V28, P1650, DOI 10.1093/bioinformatics/bts240; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Miles AJ, 2018, PROTEIN SCI, V27, P1717, DOI 10.1002/pro.3474; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2013, BIOL CHEM, V394, P435, DOI 10.1515/hsz-2012-0328; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rahikkala E, 2019, GENET MED, V21, P2355, DOI 10.1038/s41436-019-0503-4; Rappu P, 2019, ESSAYS BIOCHEM, V63, P325, DOI 10.1042/EBC20180053; Schnicker NJ, 2016, ACTA CRYSTALLOGR D, V72, P675, DOI 10.1107/S2059798316004198; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	66	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100197	10.1074/jbc.RA120.016542	http://dx.doi.org/10.1074/jbc.RA120.016542			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334883	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400175
J	Bell, S; Clarke, R; Paterson, P; Mounier-Jack, S				Bell, Sadie; Clarke, Richard; Paterson, Pauline; Mounier-Jack, Sandra			Parents' and guardians' views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed methods study in England	PLOS ONE			English	Article							COVERAGE	Objective To explore parents' and guardians' views and experiences of accessing National Health Service (NHS) general practices for routine childhood vaccinations during the coronavirus (COVID-19) pandemic in England. Design Mixed methods approach involving an online cross-sectional survey (conducted between 19(th) April and 11(th) May 2020) and semi-structured telephone interviews (conducted between 27(th) April and 27(th) May 2020). Participants 1252 parents and guardians (aged 16+ years) who reported living in England with a child aged 18 months or under completed the survey. Nineteen survey respondents took part in follow-up interviews. Results The majority of survey respondents (85.7%) considered it important for their children to receive routine vaccinations on schedule during the COVID-19 pandemic; however, several barriers to vaccination were identified. These included a lack of clarity around whether vaccination services were operating as usual, particularly amongst respondents from lower income households and those self-reporting as Black, Asian, Chinese, Mixed or Other ethnicity; difficulties in organising vaccination appointments; and fears around contracting COVID-19 while attending general practice. Concerns about catching COVID-19 while accessing general practice were weighed against concerns about children acquiring a vaccine-preventable disease if they did not receive scheduled routine childhood vaccinations. Many parents and guardians felt their child's risk of acquiring a vaccine-preventable disease was low as the implementation of stringent physical distancing measures (from March 23(rd) 2020) meant they were not mixing with others. Conclusion To promote routine childhood vaccination uptake during the current COVID-19 outbreak, further waves of COVID-19 infection, and future pandemics, prompt and sustained national and general practice level communication is needed to raise awareness of vaccination service continuation and the importance of timely vaccination, and invitation-reminder systems for vaccination need to be maintained. To allay concerns about the safety of accessing general practice, practices should communicate the measures being implemented to prevent COVID-19 transmission.	[Bell, Sadie; Mounier-Jack, Sandra] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London, England; [Clarke, Richard] Newcastle Univ London, Newcastle Univ Business Sch, London, England; [Paterson, Pauline] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bell, S (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London, England.	sadie.bell@lshtm.ac.uk		Bell, Sadie/0000-0003-4381-0030	National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation at the London School of Hygiene & Tropical Medicine; Public Health England	National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation at the London School of Hygiene & Tropical Medicine; Public Health England	The research was funded by the National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation at the London School of Hygiene & Tropical Medicine in partnership with Public Health England. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.	Bramer CA, 2020, MMWR-MORBID MORTAL W, V69, P630, DOI 10.15585/mmwr.mm6920e1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Dann L, 2020, ARCH DIS CHILD, V105, P810, DOI 10.1136/archdischild-2020-319654; Habersaat KB, 2020, BUNDESGESUNDHEITSBLA, V63, P32, DOI 10.1007/s00103-019-03063-0; Joint Committee on Vaccination and Immunisation, 2020, STAT JCVI IMM PRIOR; Kleinman Z, 2020, BBC NEWS; McDonald HI, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.19.2000848; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Nelson R, 2020, LANCET INFECT DIS, V20, P546, DOI 10.1016/S1473-3099(20)30304-2; NHS England, 2020, NHS URG PUBL GET ESS; Public Health England, 2020, NFDA NEWS 0401; Public Health England, 2020, EM DEP SYNDR SURV SY; Royal College of General Practitioners (RCGP), 2020, RCGP GUID WORKL PRIO; Royal Society for Public Health, 2020, MOV NEEDL PROM VACC; Santoli JM, 2020, MMWR-MORBID MORTAL W, V69, P591, DOI 10.15585/mmwr.mm6919e2; SAXENA S, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2392; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; The Rt Hon Boris Johnson MP, 2020, PRIME MINISTERS STAT; THORNTON J, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1401; Tiley KS, 2018, VACCINE, V36, P6726, DOI 10.1016/j.vaccine.2018.09.032; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; Wagner KS, 2014, ARCH DIS CHILD, V99, P348, DOI 10.1136/archdischild-2013-304388; WHO, 2020, WHO UNICEF WARN DECL; Williams Nia, 2011, JRSM Short Rep, V2, P81, DOI 10.1258/shorts.2011.011112; World Health Organisation, 2020, LEAST 8000000 CHILDR; World Health Organization, 2020, GUID PRINC IMM ACT C	26	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244049	10.1371/journal.pone.0244049	http://dx.doi.org/10.1371/journal.pone.0244049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370323	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000603611900080
J	Chekol, D; Bedimo, M; Mulugeta, Y; Bantie, GM				Chekol, Dessalegn; Bedimo, Melkamu; Mulugeta, Yihun; Bantie, Getasew Mulat			Determinants of non-Hodgkin's lymphoma at Felegehiwot specialized hospital, North West Ethiopia: A case-control study	PLOS ONE			English	Article							RISK-FACTORS; OBESITY	Background The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors. Hence, the purpose of this study was to identify determinants of Non-Hodgkin lymphoma cancer among individuals who diagnosed at the Felegehiwot specialized hospital, North West Ethiopia, 2019. Methods An institution-based unmatched case-control study was conducted at the Felegehiwot Specialized hospital from December 2018 up to June 2019. The sample size calculated using the two-population proportion formula. The final sample size was 486, (162 cases and 324 controls). The simple random sampling method was employed to catch up with the estimated samples. The collected data entered into the Epi-data version 3.1 software and analyzed using SPSS version 21 software. Descriptive statistics computed. Simple logistic analysis was run (at 95% CI and p-value < 0.05) to identify the determinants of non-Hodgkin's lymphoma. Result A total of 486 patients participated. Nearly one-third of the cases and controls were in the age group of 46-60 years. About 90% of cases and 91% of controls were orthodox Christian. Monthly income of <= 28 dollars (AOR = 2. 73, 95%CI: 1. 8, 4.2), male sex (AOR = 1. 8, 95%CI: 1.2, 2.8), ever had chemical exposure, (AOR = 11. 9, 95%CI: 7.6, 18.8), no regular physical exercise (AOR = 15. 5, 95%CI: 5.7, 42.3), and having hypertension [AOR = 0. 03; 95%CI:0.005, 0.2), lung disease (AOR = 0. 2; 95%CI: 0.06, 0.7), and chronic kidney and cardiac diseases (AOR = 0. 06; 95%CI: 0.01, 0.2) were the determinants of non-Hodgkin's lymphoma. Conclusions The findings in this study suggest that having a low monthly income, being male sex, ever had chemical exposure, not engaged in regular physical exercise, and being diabetic were the determinants of non-Hodgkin's lymphoma.	[Chekol, Dessalegn] Felegehiwot Comprehens Specialized Hosp, Dept Nursing, Bahir Dar, Ethiopia; [Bedimo, Melkamu; Mulugeta, Yihun] Bahir Dar Univ, Dept Biostat & Epidemiol, Bahir Dar, Ethiopia; [Bantie, Getasew Mulat] Alkan Hlth Sci Business & Technol Coll, Fac Community Hlth, Dept Publ Hlth, Bahir Dar, Ethiopia	Bahir Dar University	Bantie, GM (corresponding author), Alkan Hlth Sci Business & Technol Coll, Fac Community Hlth, Dept Publ Hlth, Bahir Dar, Ethiopia.	getasewmulat@gmail.com	Bantie, Getasew/ABZ-4323-2022; Fazli, Ghazal/AAE-8320-2022	Bantie, Getasew/0000-0002-5073-6767; Beyene, Melkamu Bedimo/0000-0003-4349-9887				[Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Balasubramaniam G, 2013, ASIAN PAC J CANCER P, V14, P775, DOI 10.7314/APJCP.2013.14.2.775; Cerhan JR, 1997, J NATL CANCER I, V89, P314, DOI 10.1093/jnci/89.4.314; Fabbro-Peray P, 2001, CANCER CAUSE CONTROL, V12, P201, DOI 10.1023/A:1011274922701; Frederiksen BL, 2012, BRIT J CANCER, V106, P988, DOI 10.1038/bjc.2012.3; GLOBOCAN, 2018, GLOBOCAN 2018; Hardell L, 1999, CANCER, V85, P1353, DOI 10.1002/(SICI)1097-0142(19990315)85:6&lt;1353::AID-CNCR19&gt;3.0.CO;2-1; Luo D, 2016, SCI REP-UK, V6, DOI 10.1038/srep25768; Mitri J, 2008, DIABETES CARE, V31, P2391, DOI 10.2337/dc08-1034; Naresh KN, 2011, BRIT J HAEMATOL, V154, P696, DOI 10.1111/j.1365-2141.2011.08772.x; Pan SY, 2005, AM J EPIDEMIOL, V162, P1162, DOI 10.1093/aje/kwi342; Skibola CF, 2007, CANCER EPIDEM BIOMAR, V16, P392, DOI 10.1158/1055-9965.EPI-06-1081; Zebrack BJ, 2002, PEDIATRICS, V110, P42, DOI 10.1542/peds.110.1.42; Zhang Yawei, 2011, Expert Opin Med Diagn, V5, P539	15	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243561	10.1371/journal.pone.0243561	http://dx.doi.org/10.1371/journal.pone.0243561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370329	Green Submitted, Green Published, gold			2022-12-26	WOS:000603611900104
J	Bezerra, CRF; Borges, KRA; Alves, RDS; Teles, AM; Rodrigues, IVP; da Silva, MACN; Nascimento, MDSB; Bezerra, GFD				Bezerra, Carolina Rabelo Falcao; Assuncao Borges, Katia Regina; Alves, Rita de Nazare Silva; Teles, Amanda Mara; Pimentel Rodrigues, Igor Vinicius; da Silva, Marcos Antonio Custodio Neto; Nascimento, Maria do Desterro Soares Brandao; Bezerra, Geusa Felipa de Barros			Highly efficient antibiofilm and antifungal activity of green propolis against Candida species in dentistry materials	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; CHEMICAL-COMPOSITION; NATURAL-PRODUCTS; EXTRACT; COLONIZATION	This study evaluated the effect of green propolis extract on the adhesion and biofilm formation of Candida species in dentistry materials. Phytochemical analysis of green propolis extract was performed by high-performance liquid chromatography. Adhesion was quantified by counting the number of yeast cells adherent to dental material fragments in a Neubauer chamber. Biofilm formation was determined by counting colony-forming units recovered from dental material fragments. The intensity of biofilm adhesion was classified as negative, weak, moderate, strong, or very strong. Fifteen compounds, mainly flavonoids, were identified in green propolis extract. All strains adhered to and formed biofilms on the surfaces of the orthodontic materials studied. On steel and resin, yeast cell adhesion intensities were weak at all incubation times, except for those of Candida parapsilosis and C. tropicalis, which were moderate at 12 h. At 24 and 48 h, C. albicans formed biofilms on steel with moderate adhesion affinities; at 24 and 48 h, C. parapsilosis formed biofilms with very strong affinities. C. tropicalis formed biofilms with strong and very strong affinities at 24 and 48 h, respectively. On resin, all species displayed strong affinity for biofilm formation at 24 and 48 h, except for C. tropicalis, which displayed very strong affinity at only 48 h. Green propolis extract displayed antifungal activity and inhibited both adhesion and biofilm formation at 2.5 mu g/mL. This study reinforces the idea that green propolis has antifungal activity and interferes with the virulence of Candida species.	[Bezerra, Carolina Rabelo Falcao] Fed Univ Maranhao UFMA, Postgrad Program Adult Hlth, Sao Luis, Maranhao, Brazil; [Assuncao Borges, Katia Regina; Alves, Rita de Nazare Silva; Pimentel Rodrigues, Igor Vinicius; Nascimento, Maria do Desterro Soares Brandao; Bezerra, Geusa Felipa de Barros] Fed Univ Maranhao UFMA, Postgrad Program Adult Hlth Basic & Appl Immunol, Sao Luis, Maranhao, Brazil; [Teles, Amanda Mara] Fed Univ Maranhao UFMA, Postgrad Program Biotechnol, Sao Luis, Maranhao, Brazil; [da Silva, Marcos Antonio Custodio Neto] State Univ Campinas UNICAMP, Postgrad Program Internal Med, Campinas, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Estadual de Campinas	Bezerra, GFD (corresponding author), Fed Univ Maranhao UFMA, Postgrad Program Adult Hlth Basic & Appl Immunol, Sao Luis, Maranhao, Brazil.	geusabezerra@gmail.com	Teles, Amanda Mara/AAE-4264-2021; Nascimento, Maria do Desterro/S-7024-2019	Custodio Neto da Silva, Marcos Antonio/0000-0003-2748-1564; Nascimento, Maria do Desterro/0000-0003-2783-362X	Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Estado do Maranhao (FAPEMA)	Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Estado do Maranhao (FAPEMA)(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA))	GFBB receveid financial support by Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Estado do Maranhao (FAPEMA). Notice 31/2016 for accquiring equipments and reagents.	Afrouzan Houshang, 2018, Iranian Biomedical Journal, V22, P50, DOI 10.22034/ibj.22.1.50; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; [Anonymous], 2017, FUEL CELLS B, V2017, P7, DOI [10.1016/S1464-2859(17)30385-1, DOI 10.1016/S1464-2859(17)30385-1]; [Anonymous], 2016, FUEL CELLS B, V2016, P11; [Anonymous], 2017, PEDIAT RADIOL S2, V47, pS303; Borges KRA, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860059, 10.1590/S1678-9946201860059]; Bankova V, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-28; Bhargava P, 2018, INT J ONCOL, V52, P925, DOI 10.3892/ijo.2018.4249; CANNON RD, 1995, J DENT RES, V74, P1152, DOI 10.1177/00220345950740050301; CLSI, 2010, METHOD ANTIFUNGAL DI; D'Auria FD, 2003, J CHEMOTHERAPY, V15, P454, DOI 10.1179/joc.2003.15.5.454; de A Matos FJ, 2009, INTRO FITOQUIMICA EX, V3rd; de Moura RS, 2011, FOOD CHEM TOXICOL, V49, P855, DOI 10.1016/j.fct.2010.12.007; De-Carli AD, 2011, REV ODONTOL BRAS CEN, V9, P310; Devequi-Nunes D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207676; Ferreira JM, 2017, J SCI FOOD AGR, V97, P3552, DOI 10.1002/jsfa.8210; Franchin M, 2018, EUR J MED CHEM, V153, P49, DOI 10.1016/j.ejmech.2017.06.050; Galletti J, 2017, FUTURE MICROBIOL, V12, P1311, DOI 10.2217/fmb-2017-0052; Ghazal ARA, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0765-x; Capoci IRG, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/287693; Herrera CL, 2010, CIENC INVESTIG AGRAR, V37, P75; Khurshid Zohaib, 2017, J Dent Res Dent Clin Dent Prospects, V11, P265, DOI 10.15171/joddd.2017.046; Koo H, 2000, CURR MICROBIOL, V41, P192, DOI 10.1007/s0028400101170; Koya-Miyata S, 2009, BIOL PHARM BULL, V32, P2022, DOI 10.1248/bpb.32.2022; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Maruyama H, 2009, BIOL PHARM BULL, V32, P1244, DOI 10.1248/bpb.32.1244; Maureira Natalia, 2017, Int. J. Odontostomat., V11, P295; Miguel MG, 2010, FOOD CHEM TOXICOL, V48, P3418, DOI 10.1016/j.fct.2010.09.014; Morawiec T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/869575; Mystkowska J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030743; Okada H, 2019, CLIN EXP NEPHROL, V23, P1, DOI 10.1007/s10157-018-1648-1; Oliveira-Junior JK, 2018, REV UNINGA REV, V30, P45; Ota C, 2001, MYCOSES, V44, P375, DOI 10.1046/j.1439-0507.2001.00671.x; Packer Janaina F., 2007, Rev. bras. farmacogn., V17, P102, DOI 10.1590/S0102-695X2007000100019; Paulino N, 2006, PLANTA MED, V72, P899, DOI 10.1055/s-2006-947185; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pina GDS, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8971746; Oliveira ACP, 2006, MEM I OSWALDO CRUZ, V101, P493, DOI 10.1590/S0074-02762006000500002; Andrade JKS, 2017, FOOD RES INT, V101, P129, DOI 10.1016/j.foodres.2017.08.066; Sayyadi F, 2020, CASP J INTERN MED, V11, P62, DOI 10.22088/cjim.11.1.62; Sforcin J. M., 2001, Journal of Venomous Animals and Toxins, V7, P139, DOI 10.1590/S0104-79302001000100009; Silici S, 2006, LETT APPL MICROBIOL, V43, P318, DOI 10.1111/j.1472-765X.2006.01949.x; Silva S, 2010, J MED MICROBIOL, V59, P747, DOI 10.1099/jmm.0.017517-0; Silva-Carvalho R, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/206439; Singla RK, 2019, CURR TOP MED CHEM, V19, P2567, DOI 10.2174/1568026619666191025154834; Siqueira ABS, 2015, BRAZ ORAL RES, V29, DOI 10.1590/1807-3107BOR-2015.vol29.0083; Machado BAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145954; Stefanakis, 2015, INT J GEOGRAPHICAL I, V29, P1; Tobaldini-Valerio FK, 2016, FUTURE MICROBIOL, V11, P1035, DOI 10.2217/fmb-2015-0016; Waterhouse A., 2012, AM J ECOL VITIC, P357; Yen GC, 1999, FOOD CHEM, V65, P375, DOI 10.1016/S0308-8146(98)00239-8	51	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0228828	10.1371/journal.pone.0228828	http://dx.doi.org/10.1371/journal.pone.0228828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362254	Green Published, gold			2022-12-26	WOS:000603071600003
J	Kim, D; Lee, JH; Kim, HY; Shin, J; Kim, K; Lee, S; Park, J; Kim, J; Kim, Y				Kim, DaWon; Lee, Jeong Hwa; Kim, Hye Yun; Shin, Jisu; Kim, Kyeonghwan; Lee, Sejin; Park, Jinwoo; Kim, JinIkyon; Kim, YoungSoo			Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; PROTEIN-PRECURSOR; DISEASE; OLIGOMERS; NEURODEGENERATION; MICE; PET	Alzheimer disease (AD) is a neurodegenerative disorder characterized by the aberrant production and accumulation of amyloid-beta (A beta) peptides in the brain. Accumulated A beta in soluble oligomer and insoluble plaque forms are considered to be a pathological culprit and biomarker of the disorder. Here, we report a fluorescent universal A beta-indicator YI-13, 5-(4-fluorobenzoyl)-7,8-dihydropyrrolo[1,2-b]isoquinolin-9(6H)-one, which detects A beta monomers, dimers, and plaques. We synthesized a library of 26 fluorescence chemicals with the indolizine core and screen them through a series of in vitro tests utilizing A beta as a target and YI-13 was selected as the final imaging candidate. YI-13 was found to stain and visualize insoluble A beta plaques in the brain tissue, of a transgenic mouse model with five familial AD mutations (5XFAD), by a histochemical approach and to label soluble A beta oligomers within brain lysates of the mouse model under a fluorescence plate reader. Among oligomers aggregated from monomers and synthetic dimers from chemically conjugated monomers, YI-13 preferred the dimeric A beta.	Yonsei Univ, Dept Pharm, Coll Pharm, Incheon, South Korea; [Kim, DaWon; Lee, Jeong Hwa; Kim, Hye Yun; Shin, Jisu; Kim, Kyeonghwan; Lee, Sejin; Kim, JinIkyon; Kim, YoungSoo] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea; [Park, Jinwoo] BioActs, Incheon, South Korea	Yonsei University; Yonsei University	Kim, J; Kim, Y (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea.	ikyonkim@yonsei.ac.kr; y.kim@yonsei.ac.kr	Kim, YoungSoo/AAO-1970-2020	Kim, YoungSoo/0000-0001-5029-7082; Kim, Hye Yun/0000-0003-3757-5652	Korea Health Industry Development Institute [HI18C0836]; National Research Foundation of Korea (Basic Science Research Program) [NRF-2018R1A6A1A03023718, NRF-2018M3C7A1021858]; National Research Foundation of Korea [NRF-2020R1A2C2005961]; POSCO TJ Park Foundation (POSCO Science Fellowship)	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (Basic Science Research Program); National Research Foundation of Korea(National Research Foundation of Korea); POSCO TJ Park Foundation (POSCO Science Fellowship)	Korea Health Industry Development Institute (HI18C0836)(URL:https://www.khidi.or.kr) awarded to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Research Foundation of Korea (Basic Science Research Program NRF-2018R1A6A1A03023718, Original Technology Research Program for Brain Science NRF-2018M3C7A1021858)(URL:http://www.nrf.re.kr) awarded to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Research Foundation of Korea (NRF-2020R1A2C2005961)(URL:http://www.nrf.re.kr) awarded to IK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. -POSCO TJ Park Foundation (POSCO Science Fellowship) (URL:https://www.postf.org) awarded to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. -The funder, BioActs, provided support in the form of salaries for author J. Park, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aho L, 2010, J ALZHEIMERS DIS, V20, P1015, DOI 10.3233/JAD-2010-091681; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Geerts H, 2020, ALZHEIMERS DEMENT, V16, P862, DOI 10.1002/alz.12082; Gorman AM, 2008, J CELL MOL MED, V12, P2263, DOI 10.1111/j.1582-4934.2008.00402.x; Herzog B, 2018, PHOTOCHEM PHOTOBIOL, V94, P384, DOI 10.1111/php.12861; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KARSTENS T, 1980, J PHYS CHEM-US, V84, P1871, DOI 10.1021/j100451a030; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim M, 2013, J ORG CHEM, V78, P10395, DOI 10.1021/jo401801j; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lee D, 2019, ACS CHEM NEUROSCI, V10, P2647, DOI 10.1021/acschemneuro.9b00199; Lee JC, 2020, ANGEW CHEM INT EDIT, V59, P11491, DOI 10.1002/anie.202002574; Lee S, 2015, B KOREAN CHEM SOC, V36, P2147, DOI 10.1002/bkcs.10391; Liu X, 2019, SYNLETT, V30, P1026, DOI 10.1055/s-0037-1611476; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Moon SH, 2016, BIOORG MED CHEM LETT, V26, P110, DOI 10.1016/j.bmcl.2015.11.021; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Ng S, 2007, J NUCL MED, V48, P547, DOI 10.2967/jnumed.106.037762; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Park S, 2018, EUR J MED CHEM, V144, P435, DOI 10.1016/j.ejmech.2017.12.056; Rahimi Farid, 2009, J Vis Exp, DOI 10.3791/1071; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Sharma V, 2014, MED CHEM RES, V23, P3593, DOI 10.1007/s00044-014-0940-1; Shin NN, 2019, ACS CHEM NEUROSCI, V10, P3031, DOI 10.1021/acschemneuro.9b00093; Storey E, 1999, NEUROPATH APPL NEURO, V25, P81; Vemula V, 2011, INT J PHARM SCI REV, V11, P159; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107	37	4	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243041	10.1371/journal.pone.0243041	http://dx.doi.org/10.1371/journal.pone.0243041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362250	Green Published, gold			2022-12-26	WOS:000603071600043
J	Lu, YF; Xu, P; Li, QW; Wang, YK; Wu, C				Lu, Yafeng; Xu, Pei; Li, Qinwen; Wang, Yukuan; Wu, Cheng			Planning priority conservation areas for biodiversity under climate change in topographically complex areas: A case study in Sichuan province, China	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LAND-USE; PHENOLOGY; RANGE	Identifying priority conservation areas plays a significant role in conserving biodiversity under climate change, but uncertainties create challenges for conservation planning. To reduce uncertainties in the conservation planning framework, we developed an adaptation index to assess the effect of topographic complexity on species adaptation to climate change, which was incorporated into the conservation framework as conservation costs. Meanwhile, the species distributions were predicted by the Maxent model, and the priority conservation areas were optimized during different periods in Sichuan province by the Marxan model. Our results showed that the effect of topographic complexity was critical for species adaptation, but the adaptation index decreased with the temperature increase. Based on the conservation targets and costs, the distributions of priority conservation areas were mainly concentrated in mountainous areas around the Sichuan Basin where may be robust to the adaptation to climate change. In the future, the distributions of priority conservation areas had no evident changes, accounting for about 26% and 28% of the study areas. Moreover, most species habitats could be conserved in terms of conservation targets in these priority conservation areas. Therefore, our approach could achieve biodiversity conservation goals and be highly practical. More importantly, quantifying the effect of topography also is critical for options for planning conservation areas in response to climate change.	[Lu, Yafeng; Xu, Pei; Li, Qinwen; Wang, Yukuan] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Lu, Yafeng; Xu, Pei; Li, Qinwen; Wang, Yukuan] Minist Water Resources, Chengdu, Peoples R China; [Wu, Cheng] Power China Kunming Engn Corp Ltd, Kuming, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS	Xu, P (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China.; Xu, P (corresponding author), Minist Water Resources, Chengdu, Peoples R China.	xupei@imde.ac.cn			Youth Program of National Natural Science Foundation of China [41701114]; West Light Foundation of The Chinese Academy of Sciences [Y7R280080]; General Program of Beijing Natural Science Foundation [8182018]	Youth Program of National Natural Science Foundation of China; West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences); General Program of Beijing Natural Science Foundation	This work was supported by a Youth Program of National Natural Science Foundation of China (http://www.nsfc.gov.cn/) Project Grant (41701114) and by the West Light Foundation of The Chinese Academy of Sciences (http://www.cas.cn) Project Grant (Y7R280080) to Yafeng Lu, Pei Xu, Yukuan Wang. Additionally, the General Program of Beijing Natural Science Foundation (http://kw.beijing.gov.cn/) Project Grant (8182018) provided support in the form of salary for authors [Qinwen Li and Cheng Wu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Baker B, 2010, CLIMATIC CHANGE, V98, P113, DOI 10.1007/s10584-009-9622-2; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bertolino S, 2020, MAMMAL REV, V50, P187, DOI 10.1111/mam.12185; Brown CJ, 2016, GLOBAL CHANGE BIOL, V22, P1548, DOI 10.1111/gcb.13184; Chaudhary A, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082764; Crossman ND, 2007, BIODIVERS CONSERV, V16, P3781, DOI 10.1007/s10531-007-9180-8; Desmet P, 2004, ECOL SOC, V9; Di Pasquale G, 2020, FORESTS, V11, DOI 10.3390/f11060673; Dobson AP, 1996, CONSERVATION BIODIVE; Geiger R., 2003, CLIMATE NEAR GROUND; Hallfors MH, 2016, ECOL APPL, V26, P1154, DOI 10.1890/15-0926; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho SP, 2020, B AM METEOR SOC, V101, pE1107, DOI 10.1175/BAMS-D-18-0290.1; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hui Y, 2015, ENVIRON EARTH SCI, V74, P4335, DOI 10.1007/s12665-015-4443-2; Jones KR, 2016, BIOL CONSERV, V194, P121, DOI 10.1016/j.biocon.2015.12.008; Kareiva P, 2017, SCIENCE; Li J, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/706713; Mathevet R, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10114171; Miller KM, 2018, GLOBAL ECOL BIOGEOGR, V27, P57, DOI 10.1111/geb.12671; Moradi S, 2019, ECOL INDIC, V97, P159, DOI 10.1016/j.ecolind.2018.10.003; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Newman TP, 2017, PUBLIC UNDERST SCI, V26, P815, DOI 10.1177/0963662516628477; Nunez TA, 2013, CONSERV BIOL, V27, P407, DOI 10.1111/cobi.12014; Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qu H, 2018, NAT CONSERV-BULGARIA, P89, DOI 10.3897/natureconservation.25.20063; Raffini F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114508; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Sarkar S., 2005, BIODIVERSITY ENV PHI, DOI DOI 10.1017/CBO9780511498558; Sittaro F, 2017, GLOBAL CHANGE BIOL, V23, P3292, DOI 10.1111/gcb.13622; Andrade-Diaz MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221901; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Tang CC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00440; Tang CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43822; Trigas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059425; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Wang JJ, 2018, CONSERV BIOL, V32, P1266, DOI 10.1111/cobi.13147; Wang WJ, 2018, J BIOGEOGR, V45, P2766, DOI 10.1111/jbi.13467; Wang WJ, 2017, LANDSCAPE ECOL, V32, P1399, DOI 10.1007/s10980-016-0429-z; Weiss A., 2001, ESR INT USER C; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Yang J, 2020, BIOL CONSERV, V244, DOI 10.1016/j.biocon.2020.108535; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Zhang MG, 2012, BIOL CONSERV, V153, P257, DOI 10.1016/j.biocon.2012.04.023; Zhang WJ, 2008, SCI CHINA SER D, V51, P748, DOI 10.1007/s11430-008-0037-0	55	1	1	10	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243425	10.1371/journal.pone.0243425	http://dx.doi.org/10.1371/journal.pone.0243425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362279	Green Published, gold			2022-12-26	WOS:000603071600004
J	Jalenques, I; Cyrille, D; Derost, P; Hartmann, A; Lauron, S; Jameux, C; Tauveron-Jalenques, U; Guiguet-Auclair, C; Rondepierre, F				Jalenques, Isabelle; Cyrille, Diane; Derost, Philippe; Hartmann, Andreas; Lauron, Sophie; Jameux, Clara; Tauveron-Jalenques, Urbain; Guiguet-Auclair, Candy; Rondepierre, Fabien		Syndrome de Gilles de La Tourette	Cross-cultural adaptation and psychometric evaluation of the French version of the Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL)	PLOS ONE			English	Article							HEALTH-STATUS QUESTIONNAIRES; IMPACT; ADULTS; ADOLESCENTS; POPULATION; PREVALENCE; GUIDELINES; MOVES; TICS	Introduction The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL) is a self-rated disease-specific questionnaire to assess health-related quality of life of subjects with GTS. Our aim was to perform the cross-cultural adaptation of the GTS-QOL into French and to assess its psychometric properties. Methods The GTS-QOL was cross-culturally adapted by conducting forward and backward translations, following international guidelines. The psychometric properties of the GTS-QOL-French were assessed in 109 participants aged 16 years and above with regard to factor structure, internal consistency, reliability and convergent validity with the MOVES (Motor tic, Obsessions and compulsions, Vocal tic Evaluation Survey) and the WHOQOL-BREF (World Health Organization Quality of Life Brief). Results Exploratory factor analysis of the GTS-QOL-French resulted in a 6-factor solution and did not replicate the original structure in four subscales. The results showed good acceptability (missing values per subscale ranging from 0% to 0.9%), good internal consistency (Cronbach's alpha ranging from 0.68 to 0.94) and good test-retest reliability (intraclass correlation coefficients ranging from 0.70 to 0.81). Convergent validity with the MOVES and WHOQOL-BREF scales showed high correlations. Discussion Our study provides evidence of the good psychometric properties of the GTS-QOL-French. The cross-cultural adaptation and validation of this specific instrument will make it possible to assess health-related quality of life in French-speaking subjects with GTS. The GTS-QOL-French could be recommended for use in future research.	[Jalenques, Isabelle; Cyrille, Diane; Lauron, Sophie; Jameux, Clara; Tauveron-Jalenques, Urbain; Rondepierre, Fabien] Univ Clermont Auvergne, CHU Clermont Ferrand, Ctr Competence Gilles Tourette, Serv Psychiat Adulte & Psychol Med A, Clermont Ferrand, France; [Derost, Philippe] CHU Clermont Ferrand, Serv Neurol, Clermont Ferrand, France; [Hartmann, Andreas] Hop La Pitie Salpetriere, AP HP, Natl Reference Ctr Tourette Syndrome, Paris, France; [Guiguet-Auclair, Candy] Univ Clermont Auvergne, CHU Clermont Ferrand, CNRS, Inst Pascal,SIGMA Clermont, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA)	Jalenques, I (corresponding author), Univ Clermont Auvergne, CHU Clermont Ferrand, Ctr Competence Gilles Tourette, Serv Psychiat Adulte & Psychol Med A, Clermont Ferrand, France.	ijalenques@chu-clermontferrand.fr		Rondepierre, Fabien/0000-0002-8998-1559; Guiguet-Auclair, Candy/0000-0002-0782-2889	University Hospital of Clermont-Ferrand (AOI); Association Francaise Syndrome Gilles de la Tourette (AO AFSGT)	University Hospital of Clermont-Ferrand (AOI); Association Francaise Syndrome Gilles de la Tourette (AO AFSGT)	IJ received a grant from the University Hospital of Clermont-Ferrand (AOI 2012) and the Association Francaise Syndrome Gilles de la Tourette (AO AFSGT 2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2005, NEPHROL CARLT, V10, pS157; [Anonymous], COSMIN IMPR SEL OUTC; [Anonymous], 2011, PRESCRIRE INT, V20, P173; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Blazquez A, 2019, COMPR PSYCHIAT, V89, P33, DOI 10.1016/j.comppsych.2018.11.011; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Cath DC, 2011, EUR CHILD ADOLES PSY, V20, P155, DOI 10.1007/s00787-011-0164-6; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cavanna AE, 2008, NEUROLOGY, V71, P1410, DOI 10.1212/01.wnl.0000327890.02893.61; Cavanna AE, 2018, REV NEUROL-FRANCE, V174, P621, DOI 10.1016/j.neurol.2018.06.006; Cavanna AE, 2012, EUR J PAEDIATR NEURO, V16, P605, DOI 10.1016/j.ejpn.2012.02.004; Cavanna AE, 2009, J NEUROPSYCH CLIN N, V21, P13, DOI 10.1176/appi.neuropsych.21.1.13; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conelea CA, 2013, COMMUNITY MENT HLT J, V49, P110, DOI 10.1007/s10597-011-9465-y; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crossley E, 2013, PSYCHIAT RES, V209, P705, DOI 10.1016/j.psychres.2013.04.019; Eapen V, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00097; Eddy CM, 2014, BEHAV MODIF, V38, P264, DOI 10.1177/0145445513504432; Eddy CM, 2013, J PSYCHIATR RES, V47, P1259, DOI 10.1016/j.jpsychires.2013.05.019; Elstner K, 2001, ACTA PSYCHIAT SCAND, V103, P52, DOI 10.1034/j.1600-0447.2001.00147.x; Evans J, 2016, EUR CHILD ADOLES PSY, V25, P939, DOI 10.1007/s00787-016-0823-8; Freeman RD, 2009, DEV MED CHILD NEUROL, V51, P218, DOI 10.1111/j.1469-8749.2008.03135.x; GAFFNEY GR, 1994, J CHILD ADOL PSYCHOP, V4, P269, DOI 10.1089/cap.1994.4.269; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P953, DOI 10.1016/S0895-4356(98)00086-9; Guyatt GH, 1997, CANADIAN RESP J HIND, V4, pe271269; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Hinkle DEJS, 2002, APPL STAT BEHAV SCI; Huisman-van Dijk HM, 2019, ACTA NEUROL SCAND, V140, P390, DOI 10.1111/ane.13155; Jalenques I, 2020, MENDELEY DATA V3; Jalenques I, 2018, J NEUROL, V265, P678, DOI 10.1007/s00415-018-8769-z; Jalenques I, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-109; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; Kobierska M, 2014, NEUROL NEUROCHIR POL, V48, P1, DOI 10.1016/j.pjnns.2013.03.001; Leplege A, 2000, ENCEPHALE, V26, P13; Martino D, 2017, MOVEMENT DISORD, V32, P467, DOI 10.1002/mds.26891; McHorney CA, 1998, MED CARE, V36, P445, DOI 10.1097/00005650-199804000-00001; Muller-Vahl K, 2010, MOVEMENT DISORD, V25, P309, DOI 10.1002/mds.22900; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pringsheim T, 2019, NEUROLOGY, V92, P896, DOI 10.1212/WNL.0000000000007466; Puett M, 2013, CRIT RES RELIG, V1, P95, DOI 10.1177/2050303213476115; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Robertson MM, 2008, J PSYCHOSOM RES, V65, P461, DOI 10.1016/j.jpsychores.2008.03.006; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Su MT, 2017, J CHILD NEUROL, V32, P76, DOI 10.1177/0883073816670083; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Trillini MO, 2015, PSYCHIAT RES, V228, P765, DOI 10.1016/j.psychres.2015.04.043; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7; Ware JE, 1980, MODEL HLTH METHODOLO, VI; Worbe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012959; Yang J, 2016, MOVEMENT DISORD, V31, P1658, DOI 10.1002/mds.26766	52	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243912	10.1371/journal.pone.0243912	http://dx.doi.org/10.1371/journal.pone.0243912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351837	Green Published, gold			2022-12-26	WOS:000603071400021
J	Wei, YL; Silke, JR; Aris, P; Xia, XH				Wei, Yulong; Silke, Jordan R.; Aris, Parisa; Xia, Xuhua			Coronavirus genomes carry the signatures of their habitats	PLOS ONE			English	Article							INHIBITS HIV-1 INFECTION; APOBEC3 PROTEINS; ANTIRETROVIRAL FACTOR; DEAMINATION HOTSPOTS; CYTOSINE DEAMINATION; CYTIDINE DEAMINASES; RESTRICTION FACTOR; VIRUS-REPLICATION; SEQUENCE CONTEXT; FAMILY-MEMBERS	Coronaviruses such as SARS-CoV-2 regularly infect host tissues that express antiviral proteins (AVPs) in abundance. Understanding how they evolve to adapt or evade host immune responses is important in the effort to control the spread of infection. Two AVPs that may shape viral genomes are the zinc finger antiviral protein (ZAP) and the apolipoprotein B mRNA editing enzyme-catalytic polypeptide-like 3 (APOBEC3). The former binds to CpG dinucleotides to facilitate the degradation of viral transcripts while the latter frequently deaminates C into U residues which could generate notable viral sequence variations. We tested the hypothesis that both APOBEC3 and ZAP impose selective pressures that shape the genome of an infecting coronavirus. Our investigation considered a comprehensive number of publicly available genomes for seven coronaviruses (SARS-CoV-2, SARS-CoV, and MERS infecting Homo sapiens, Bovine CoV infecting Bos taurus, MHV infecting Mus musculus, HEV infecting Sus scrofa, and CRCoV infecting Canis lupus familiaris). We show that coronaviruses that regularly infect tissues with abundant AVPs have CpG-deficient and U-rich genomes; whereas those that do not infect tissues with abundant AVPs do not share these sequence hallmarks. Among the coronaviruses surveyed herein, CpG is most deficient in SARS-CoV-2 and a temporal analysis showed a marked increase in C to U mutations over four months of SARS-CoV-2 genome evolution. Furthermore, the preferred motifs in which these C to U mutations occur are the same as those subjected to APOBEC3 editing in HIV-1. These results suggest that both ZAP and APOBEC3 shape the SARS-CoV-2 genome: ZAP imposes a strong CpG avoidance, and APOBEC3 constantly edits C to U. Evolutionary pressures exerted by host immune systems onto viral genomes may motivate novel strategies for SARS-CoV-2 vaccine development.	[Wei, Yulong; Silke, Jordan R.; Aris, Parisa; Xia, Xuhua] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Xia, XH (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.; Xia, XH (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada.	Xuhua.Xia@uottawa.ca	Xia, Xuhua/E-5264-2010	Xia, Xuhua/0000-0002-3092-7566; Wei, Yulong/0000-0003-1218-2086; Aris, Parisa/0000-0003-2774-7035; Silke, Jordan/0000-0002-1578-1933	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/2018-03878]; NSERC Doctoral Scholarship [CGSD/2019-535291]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Doctoral Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, https://www.nserc-crsng.gc.ca/) Discovery Grant to X.X. [RGPIN/2018-03878], and NSERC Doctoral Scholarship to Y.W. [CGSD/2019-535291]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph MB, 2018, ACS INFECT DIS, V4, P224, DOI 10.1021/acsinfecdis.7b00221; Adolph MB, 2017, NUCLEIC ACIDS RES, V45, P3378, DOI 10.1093/nar/gkx066; Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; [Anonymous], 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1494; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Antzin-Anduetza I, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0374-1; Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Briggs J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017107; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chen J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005471; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Desimmie BA, 2016, NUCLEIC ACIDS RES, V44, P7848, DOI 10.1093/nar/gkw653; Di Gioacchino Andrea, 2020, bioRxiv, DOI 10.1101/2020.05.06.074039; Di Giorgio S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5813; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Duff MO, 2015, NATURE, V521, P376, DOI 10.1038/nature14475; Ebrahimi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087679; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Eisenberg E, 2018, NAT REV GENET, V19, P473, DOI 10.1038/s41576-018-0006-1; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Ficarelli M, 2020, J VIROL, V94, DOI 10.1128/JVI.01337-19; Fros JJ, 2017, ELIFE, V6, DOI 10.7554/eLife.29112; Gillick K, 2013, J VIROL, V87, P1508, DOI 10.1128/JVI.02587-12; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hayward JA, 2018, MOL BIOL EVOL, V35, P1626, DOI 10.1093/molbev/msy048; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Holtz CM, 2013, NUCLEIC ACIDS RES, V41, P6139, DOI 10.1093/nar/gkt246; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jiang W, 2020, 2020040335 PREPR; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI 10.1053/S0016-5085(03)01215-0; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu P, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008421; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luo X, 2020, CELL REP, V30, P46, DOI 10.1016/j.celrep.2019.11.116; Martinez T, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vey040; McDaniel YZ, 2020, NUCLEIC ACIDS RES, V48, P1353, DOI 10.1093/nar/gkz1164; Meagher JL, 2019, P NATL ACAD SCI USA, V116, P24303, DOI 10.1073/pnas.1913232116; Milewska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24448-2; Mitra M, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0130-8; Nabel CS, 2013, P NATL ACAD SCI USA, V110, P14225, DOI 10.1073/pnas.1306345110; Nchioua R, 2020, MBIO, V11, DOI 10.1128/mBio.01930-20; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; O'Connell MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005687; Odon V, 2019, NUCLEIC ACIDS RES, V47, P8061, DOI 10.1093/nar/gkz581; Okeoma CM, 2010, CELL HOST MICROBE, V8, P534, DOI 10.1016/j.chom.2010.11.003; Ooms M, 2013, CELL HOST MICROBE, V14, P411, DOI 10.1016/j.chom.2013.09.006; Palasca O, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay003; Pauli EK, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-38; Pimentel H, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1357-2; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rodriguez-Frias F, 2013, WORLD J GASTROENTERO, V19, P6995, DOI 10.3748/wjg.v19.i41.6995; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Saraconi G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0417-z; Shamimuzzaman M, 2020, NUCLEIC ACIDS RES, V48, pD676, DOI 10.1093/nar/gkz944; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Sharma S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1651-1; Sharma S, 2017, PEERJ, V5, DOI 10.7717/peerj.4136; Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39100; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Silvas TV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25881-z; Simmonds P., 2020, RAMPANT C U HYPERMUT, DOI [10.1101/2020.05.01.072330, DOI 10.1101/2020.05.01.072330]; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Suspene R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063461; Suspene R, 2011, J VIROL, V85, P2458, DOI 10.1128/JVI.02138-10; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Theys K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007420; Trus I, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03077; Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Victorovich KV, 2020, TRANSLATION ASS MUTA, DOI [10.1101/2020.05.05.078238, DOI 10.1101/2020.05.05.078238]; Wan L, 2018, PHYS CHEM CHEM PHYS, V20, P3109, DOI 10.1039/c7cp04477a; Wang SM, 2009, VIROLOGY, V388, P112, DOI 10.1016/j.virol.2009.03.010; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wasson MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08716-1; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xia XH, 2020, MOL BIOL EVOL, V37, P2699, DOI 10.1093/molbev/msaa094; Xia XH, 2018, MOL BIOL EVOL, V35, P1550, DOI 10.1093/molbev/msy073; Yao XH, 2020, CELL RES, V30, P541, DOI 10.1038/s41422-020-0318-5; Yap YL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-43; Yi L, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1419-z; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhao ZM, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-21; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	112	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244025	10.1371/journal.pone.0244025	http://dx.doi.org/10.1371/journal.pone.0244025			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351847	gold, Green Published, Green Submitted			2022-12-26	WOS:000603071400053
J	Meng, GY; Zheng, RQ; Chen, HP; Ma, GH; Wei, ZW; Xiang, GH; Zhou, J				Meng, Guiyuan; Zheng, Rongqian; Chen, Haiping; Ma, Guohui; Wei, Zhongwei; Xiang, Guohong; Zhou, Jing			Plant-atmosphere and soil-atmosphere temperature differences and their impact on grain yield of super hybrid rice under different irrigation conditions	PLOS ONE			English	Article							RADIATION USE EFFICIENCY; WATER-USE; LODGING RESISTANCE; CANOPY TEMPERATURE; DROUGHT; STRESS; ACHIEVEMENTS; AGRICULTURE; PERFORMANCE; CULTIVARS	Continued drought during the late growth stage of super hybrid rice (SHR) markedly reduces yield, and management practices that use water more efficiently can contribute greatly to high and stable yields from SHR. The absolute temperature differences (ATDs) between the rice plant and the atmosphere and between the soil and the atmosphere are believed to be important determinants of grain yield. However, it has not previously been determined whether these ATDs have any effect on SHR yields under water-saving cultivation. A two-year field experiment involving two SHR varieties, Liangyoupeijiu (LYPJ) and Y-Liangyou 9000 (YLY900), evaluated the effects of reducing water supply from mid-booting to maturity on grain yield, canopy relative humidity (CRH), leaf area index (LAI), and ATDs between the ambient temperature and the leaf surface, panicles, canopy, and soil. Grain yield increased significantly under shallow water irrigation (SW), by 8.84% (YLY900) and 12.26% (LYPJ), but decreased significantly under mild water stress (MS, -20 to -30 kPa), by 14.36% (YLY900) and 9.47% (LYPJ), as well as severe water stress (SS, -40 to -50 kPa), by 35.06% (YLY900) and 28.74% (LYPJ). As water supply decreased, so did the CRH and the ATDs, with significant decreases under MS and SS. The temperature differences were significantly and positively correlated with grain yield (P < 0.01) in both cultivars. LAI was increased under SW conditions, but was significantly decreased under MS and SS. Our study suggests that the dual goal of saving water while maintaining high yield can be achieved by applying SW irrigation from mid-booting to maturity and by adopting cultivation measures that maintain high CRH and high plant-atmosphere and soil-atmosphere ATDs in order to alleviate water stress. YLY900 has a higher yield potential than LYPJ under SW conditions, suggesting that its wide cultivation may help achieve this dual goal.	[Meng, Guiyuan; Zheng, Rongqian; Chen, Haiping; Xiang, Guohong; Zhou, Jing] Hunan Univ Humanities Sci & Technol, Coll Agr & Biotechnol, Loudi, Hunan, Peoples R China; [Meng, Guiyuan; Ma, Guohui; Wei, Zhongwei; Zhou, Jing] State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China; [Ma, Guohui; Wei, Zhongwei] Hunan Hybrid Rice Res Ctr, Changsha, Hunan, Peoples R China	Hunan University Of Humanities, Science & Technology; Hunan Academy of Agricultural Sciences	Zhou, J (corresponding author), Hunan Univ Humanities Sci & Technol, Coll Agr & Biotechnol, Loudi, Hunan, Peoples R China.; Zhou, J (corresponding author), State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China.	kiki010206@163.com			National Natural Science Foundation of China [31701375]; National Key R&D Plan: Focus on Science and Technology Innovation for High Grain Efficiency [2018YFD0301002, 2018YFD0301004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Plan: Focus on Science and Technology Innovation for High Grain Efficiency	This work was funded by funded by the National Natural Science Foundation of China (Grant no. 31701375), A National Key R&D Plan: Focus on Science and Technology Innovation for High Grain Efficiency (2018YFD0301002, 2018YFD0301004).	[Anonymous], 2012, Z DIALEKTISCHE THEOL, V28, P86; Areum Chun, 2015, Journal of Agricultural and Food Chemistry, V63, P3085; Barnaby JY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081846; Belder P, 2004, AGR WATER MANAGE, V65, P193, DOI 10.1016/j.agwat.2003.09.002; Bouman BAM, 2007, AGR SYST, V93, P43, DOI 10.1016/j.agsy.2006.04.004; Bouman BAM, 2005, AGR WATER MANAGE, V74, P87, DOI 10.1016/j.agwat.2004.11.007; Cabuslay GS, 2002, PLANT SCI, V163, P815, DOI 10.1016/S0168-9452(02)00217-0; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Cheng SH, 2007, J INTEGR PLANT BIOL, V49, P805, DOI [10.1111/j.1744-7909.2007.00514.x, 10.1111/j.1672-9072.2007.00514.x]; Duan Hua, 2012, Acta Agronomica Sinica, V38, P107, DOI 10.3724/SP.J.1006.2012.00107; Experimental drug may change the treatment of osteoporosis, 2014, DUKEMEDICINE HEALTHN, V20, P7; Fu CX, 2010, RURAL WATER CONSERVA, V12, P31; [高继平 Gao Jiping], 2016, [核农学报, Journal of Nuclear Agricultural Sciences], V30, P596; Gao JiPing, 2011, Journal of Shenyang Agricultural University, V42, P399; GARRITY DP, 1995, AGRON J, V87, P773, DOI 10.2134/agronj1995.00021962008700040027x; Haefele SM, 2016, FIELD CROP RES, V190, P60, DOI 10.1016/j.fcr.2016.02.001; Han Y., 2006, CHINESE AGR SCI B, V22, P214; He C. X, 1998, HYBRID RICE, V13, P29; Huang M, 2017, J INTEGR AGR, V16, P1009, DOI 10.1016/S2095-3119(16)61535-6; Huang M, 2016, FIELD CROP RES, V193, P87, DOI 10.1016/j.fcr.2016.03.009; Lal R, 2012, J SOIL WATER CONSERV, V67, p162A, DOI 10.2489/jswc.67.6.162A; LEE B., 2007, PATTERN RECOGN, V4, P327; [刘斐 Liu Fei], 2013, [干旱地区农业研究, Agricultural Research in the Arid Areas], V31, P95; Liu K, 2020, FIELD CROP RES, V253, DOI 10.1016/j.fcr.2020.107804; Liu K, 2019, AGRON J, V111, P1788, DOI 10.2134/agronj2018.10.0662; Ma GH, 2015, J INTEGR AGR, V14, P197, DOI 10.1016/S2095-3119(14)60922-9; Marcaida M, 2014, FIELD CROP RES, V162, P30, DOI 10.1016/j.fcr.2014.03.013; Peng S., 1994, BREAKING YIELD BARRI; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Pimentel D, 1997, BIOSCIENCE, V47, P97, DOI 10.2307/1313020; Singh N, 2005, FOOD CHEM, V89, P253, DOI 10.1016/j.foodchem.2004.02.032; TURNER NC, 1986, FIELD CROP RES, V13, P257, DOI 10.1016/0378-4290(86)90027-4; Wang JL, 2005, CHINESE J RICE SCI, V46, P1046, DOI [10.1360/aps040074, DOI 10.1360/APS040074]; [王泽杰 WANG Zejie], 2008, [干旱地区农业研究, Agricultural Research in the Arid Areas], V26, P138; Weerakoon WMW, 2008, J AGRON CROP SCI, V194, P135, DOI 10.1111/j.1439-037X.2008.00293.x; Yan Chuan, 2008, Agricultural Sciences in China, V7, P678, DOI 10.1016/S1671-2927(08)60102-9; Yan C, 2012, PLANT PROD SCI, V15, P92, DOI 10.1626/pps.15.92; Yang JC, 2007, J EXP BOT, V58, P1545, DOI 10.1093/jxb/erm032; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Yao FX, 2012, FIELD CROP RES, V126, P16, DOI 10.1016/j.fcr.2011.09.018; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Yuan L.P., 2018, J AGRONOMY, V8, P71, DOI 10.1016/s1672-6308(07)60011-0; Yuan LP, 2015, ENGINEERING, V1, P13, DOI 10.15302/J-ENG-2015021; Zhang H, 2009, FIELD CROP RES, V113, P31, DOI 10.1016/j.fcr.2009.04.004; Zhang J, 2014, FIELD CROP RES, V161, P64, DOI 10.1016/j.fcr.2014.01.012; Zhang WZ, 2007, RICE SCI, V14, P67, DOI 10.1016/S1672-6308(07)60010-9; Zhang WJ, 2014, J INTEGR AGR, V13, P63, DOI 10.1016/S2095-3119(13)60388-3; Zhou Q, 2017, J INTEGR AGR, V16, P1028, DOI 10.1016/S2095-3119(16)61506-X; 陈健晓, 2016, [杂交水稻, Hybrid Rice], V31, P40; 2014, N PLUS ONE, V20, P1	50	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243580	10.1371/journal.pone.0243580	http://dx.doi.org/10.1371/journal.pone.0243580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332448	gold, Green Published			2022-12-26	WOS:000601310900070
J	Min, JW				Min, Jungwon			Does social trust slow down or speed up the transmission of COVID-19?	PLOS ONE			English	Article							GENERALIZED TRUST; UNITED-STATES; COHESION	Social trust has been an important mechanism in overcoming crises throughout history. Several societies are now emphasizing its role in combating the COVID-19 pandemic. This study aims to investigate how variations in social trust across 68 countries are related to the transmission speed of COVID-19. Specifically, using cross-national index data from the World Value Survey, the study tests how variations in social trust across countries generate different time durations at which each country reaches the peak in terms of increases in new infections of COVID-19. Using data drawn between December 31, 2019 and July 31, 2020, this study found that in countries with a high level of social trust, particularly trust among ingroup members, or with a narrower or wider range than the intermediate range of trustees, the number of new infections tended to reach the first peak within a shorter time duration than in other countries. These results imply that in such societies, on the one hand, high cooperation among people to achieve common goals and strong compliance to social norms may allow them to begin neutralizing COVID-19 faster. On the other hand, however, the low risk perception and prevalence of cohesive relationships among people may lead to speedier transmission of COVID-19 before neutralization takes place.	[Min, Jungwon] Sophia Univ, Fac Econ & Management, Tokyo, Japan	Sophia University	Min, JW (corresponding author), Sophia Univ, Fac Econ & Management, Tokyo, Japan.	j-min-2k4@sophia.ac.jp		Min, Jungwon/0000-0002-7420-2807	JSPS; JSPS KAKENHI [19H01507]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study is supported by JSPS Grant-inAid for Young Scientists-KAKENHI and JSPS KAKENHI Grant Number 19H01507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MODERN PRACTICAL MED, V21, P814; [Anonymous], 2000, BOWLING ALONE; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2018, OXFORD HDB SOCIAL PO; [Anonymous], 1991, CREDIBILITY TRUST RI; Bjornskov C, 2007, PUBLIC CHOICE, V130, P1, DOI 10.1007/s11127-006-9069-1; Bjornskov C, 2012, SOUTH ECON J, V78, P1346, DOI 10.4284/0038-4038-78.4.1346; Chen XY, 2020, CORP SOC RESP ENV MA, V27, P485, DOI 10.1002/csr.1814; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Cox D., 1972, REGRESSION MODELS LI, V34, P187; Delhey J, 2005, EUR SOCIOL REV, V21, P311, DOI 10.1093/esr/jci022; Delhey J, 2016, INT J PSYCHOL, V51, P163, DOI 10.1002/ijop.12149; Delhey J, 2011, AM SOCIOL REV, V76, P786, DOI 10.1177/0003122411420817; Fan Y, 2020, 27211 NBER; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Galasso V., 2020, 27359 NBER; Gheorghiu MA, 2009, SOC PSYCHOL QUART, V72, P365, DOI 10.1177/019027250907200408; Google LLC, GOOGL COVID 19 COMM; Gundelach B, 2016, POLITICAL STUDIES, V65, P413; Helliwell JF, 2014, J HAPPINESS STUD, V15, P145, DOI 10.1007/s10902-013-9441-z; Islam MK, 2006, INT J EQUITY HLTH, DOI 10.1186%2F1475-9276-5-3; Kanagaretnam K, 2019, J FINANC QUANT ANAL, V54, P275, DOI 10.1017/S0022109018000455; Kennedy BP, 1998, WORLD DEV, V26, P2029, DOI 10.1016/S0305-750X(98)00094-1; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Kye B, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100523; Langfred CW, 2004, ACAD MANAGE J, V47, P385, DOI 10.2307/20159588; Lind JT, 2010, OXFORD B ECON STAT, V72, P109, DOI 10.1111/j.1468-0084.2009.00569.x; Messner SF, 2004, AM SOCIOL REV, V69, P882, DOI 10.1177/000312240406900607; Newton K, 2011, EUR POLIT SCI REV, V3, P169, DOI 10.1017/S1755773910000330; Paxton P, 2002, AM SOCIOL REV, V67, P254, DOI 10.2307/3088895; Paxton P, 2007, SOC FORCES, V86, P47, DOI 10.1353/sof.2007.0107; Persson T, 2017, PUBLIC ADMIN, V95, P97, DOI 10.1111/padm.12295; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Schiefer D, 2017, SOC INDIC RES, V132, P579, DOI 10.1007/s11205-016-1314-5; Schrad ML., 2020, FOREIGNPOLICY; Siegrist M, 2005, J RISK RES, V8, P145, DOI 10.1080/1366987032000105315; Su K, 2019, MANAG DECIS ECON, V40, P596, DOI 10.1002/mde.3030; The Economist Intelligence Unit, DEM IND 2019; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Bavel JJ, 2020, NATL IDENTITY PREDIC, DOI [10.31234/osf.io/ydt95, DOI 10.31234/OSF.IO/YDT95.2020]; World Bank, WORLD DEV IND; Molina-Morales FX, 2011, LONG RANGE PLANN, V44, P118, DOI 10.1016/j.lrp.2011.01.001; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397	45	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244273	10.1371/journal.pone.0244273	http://dx.doi.org/10.1371/journal.pone.0244273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332467	gold, Green Published			2022-12-26	WOS:000601310900069
J	Pham, TA; Tran, VQ; Vu, HLT; Ly, HB				Pham, Tuan Anh; Tran, Van Quan; Vu, Huong-Lan Thi; Ly, Hai-Bang			Design deep neural network architecture using a genetic algorithm for estimation of pile bearing capacity	PLOS ONE			English	Article							COMPRESSIVE STRENGTH; DRIVEN PILES; PREDICTION; SIMULATION	Determination of pile bearing capacity is essential in pile foundation design. This study focused on the use of evolutionary algorithms to optimize Deep Learning Neural Network (DLNN) algorithm to predict the bearing capacity of driven pile. For this purpose, a Genetic Algorithm (GA) was developed to select the most significant features in the raw dataset. After that, a GA-DLNN hybrid model was developed to select optimal parameters for the DLNN model, including: network algorithm, activation function for hidden neurons, number of hidden layers, and the number of neurons in each hidden layer. A database containing 472 driven pile static load test reports was used. The dataset was divided into three parts, namely the training set (60%), validation (20%) and testing set (20%) for the construction, validation and testing phases of the proposed model, respectively. Various quality assessment criteria, namely the coefficient of determination (R-2), Index of Agreement (IA), mean absolute error (MAE) and root mean squared error (RMSE), were used to evaluate the performance of the machine learning (ML) algorithms. The GA-DLNN hybrid model was shown to exhibit the ability to find the most optimal set of parameters for the prediction process.The results showed that the performance of the hybrid model using only the most critical features gave the highest accuracy, compared with those obtained by the hybrid model using all input variables.	[Pham, Tuan Anh; Tran, Van Quan; Vu, Huong-Lan Thi; Ly, Hai-Bang] Univ Transport Technol, Hanoi, Vietnam		Pham, TA (corresponding author), Univ Transport Technol, Hanoi, Vietnam.	anhpt@utt.edu.vn	Pham, Tuan Anh/AAH-3985-2020	Tran, Van Quan/0000-0002-4157-7717; Anh, Pham Tuan/0000-0001-9484-1916				Abusamra H, 2013, PROCEDIA COMPUT SCI, V23, P5, DOI 10.1016/j.procs.2013.10.003; [Anonymous], IEEE J MAGAZINE; [Anonymous], 2018, BIZNES, V16-17, P6; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 1995, NCSUIE TR; Architectural Institute of Japan (AIJ), 2004, REC DES BUILD FDN; Ardalan H, 2009, COMPUT GEOTECH, V36, P616, DOI 10.1016/j.compgeo.2008.09.003; Ardalan H., 2008, 12 INT C INT ASS COM, P1850; Armaghani DJ, 2017, NEURAL COMPUT APPL, V28, P391, DOI 10.1007/s00521-015-2072-z; Asteris PG, 2020, NEURAL COMPUT APPL, V32, P11807, DOI 10.1007/s00521-019-04663-2; Asteris PG, 2019, COMPUT CONCRETE, V24, P469, DOI 10.12989/cac.2019.24.5.469; Asteris PG, 2019, COMPUT CONCRETE, V24, P329, DOI 10.12989/cac.2019.24.4.329; Asteris PG, 2019, COMPUT CONCRETE, V24, P137, DOI 10.12989/cac.2019.24.2.137; Asteris PG, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9020243; Asteris PG, 2019, MECH ADV MATER STRUC, V26, P1146, DOI 10.1080/15376494.2018.1430874; Asteris PG, 2019, NEURAL COMPUT APPL, V31, P409, DOI 10.1007/s00521-017-3007-7; Baginska M, 2019, KSCE J CIV ENG, V23, P130, DOI 10.1007/s12205-018-2636-4; Bazaraa AR, 1986, N VALUES USED PREDIC, P462; Pham BT, 2019, SCI TOTAL ENVIRON, V679, P172, DOI 10.1016/j.scitotenv.2019.05.061; Birid KC, 2018, SUSTAIN CIV INFRASTR, P1, DOI 10.1007/978-3-319-61642-1_1; Bond A.J., 2013, EUROCODE 7 GEOTECHNI, DOI DOI 10.2788/3398; Bouafia A, 2002, ASSESSMENT SPT BASED, P369; CFA Institute CFA Program Curriculum, 2020, CFA PROGR CURR 2020; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Chen H, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9061042; Decourt L., 1985, CICLO CONFERENCIAS I, P85; Dimiduk DM, 2018, INTEGR MATER MANUF I, V7, P157, DOI 10.1007/s40192-018-0117-8; Dao DV, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9061113; Dao DV, 2019, MATERIALS, V12, DOI 10.3390/ma12060983; Drusa M, 2016, CIV ENVIRON ENG, V12, P128, DOI 10.1515/cee-2016-0018; Ezzat D., 2020, ARXIV200405084; Goh ATC, 2005, J GEOTECH GEOENVIRON, V131, P84, DOI 10.1061/(ASCE)1090-0241(2005)131:1(84); GOH ATC, 1995, ARTIF INTELL ENG, V9, P143, DOI 10.1016/0954-1810(94)00011-S; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245458; Ly HB, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19224941; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183841; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112258; Hajihassani M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9214650; Hastie T., INFERENCE PREDICTION; Hegazy T, 2003, J CONSTR ENG M, V129, P698, DOI 10.1061/(ASCE)0733-9364(2003)129:6(698); Nguyen HL, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9214715; Nguyen HL, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9153172; Holland J. H., 1992, ADAPTATION NATURAL A; Hopgood AA, 2012, INTELLIGENT SYSTEMS FOR ENGINEERS AND SCIENTISTS, 3RD EDITION, P1; Huang L, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245372; Kozlowski W, 2016, PROCEDIA ENGINEER, V161, P1001, DOI [10.1016/j.proeng.2016.08.839, 10.1016/j.procng.2016.08.839]; LE LM, 2019, MATERIALS, V12, DOI DOI 10.3390/MA1210167031121948; Liang X., 2020, ARXIV200407700PHYSIC; Liptak B.G., 1995, PROCESS CONTROL INST; Liu LQ, 2020, ENG COMPUT-GERMANY, V36, P421, DOI 10.1007/s00366-019-00767-4; Lopes F.R., 1988, P INT GEOT SEM DEEP, P537; Marto A, 2014, APPL MECH MATER, V567, P681, DOI 10.4028/www.scientific.net/AMM.567.681; Meyerhof GG, 1976, ASCE J GEOTECH ENG D, V102; Moayedi H, 2020, ENG COMPUT-GERMANY, V36, P227, DOI 10.1007/s00366-018-00694-w; Momeni E, 2014, MEASUREMENT, V57, P122, DOI 10.1016/j.measurement.2014.08.007; Momeni E, 2020, ARAB J SCI ENG, V45, P8255, DOI 10.1007/s13369-020-04683-4; Momeni E, 2018, ENG COMPUT-GERMANY, V34, P319, DOI 10.1007/s00366-017-0542-x; Momeni E, 2015, EARTH SCI RES J, V19, P85, DOI 10.15446/esrj.v19n1.38712; Nawari N, 1999, ELECTRON J GEOTECH E, V4, P1; Nejad FP, 2009, COMPUT GEOTECH, V36, P1125, DOI 10.1016/j.compgeo.2009.04.003; Nhu VH, 2020, ENG COMPUT-GERMANY, V36, P603, DOI 10.1007/s00366-019-00718-z; PHAM BT, 2020, SUSTAINABILITY-BASEL, V12, DOI DOI 10.3390/SU12062218; Qi CC, 2020, CHEMOSPHERE, V244, DOI 10.1016/j.chemosphere.2019.125450; Robert Y, 1997, CAN GEOTECH J, V34, P560, DOI 10.1139/t97-024; Rojas F, 2020, MON NOT R ASTRON SOC, V494, P3741, DOI 10.1093/mnras/staa1009; Shahin MA, 2005, COMPUT GEOTECH, V32, P153, DOI 10.1016/j.compgeo.2005.02.003; Shahin MA, 2016, GEOSCI FRONT, V7, P33, DOI 10.1016/j.gsf.2014.10.002; Shahin MA, 2010, CAN GEOTECH J, V47, P230, DOI 10.1139/T09-094; Shahinn MA, 2014, SOILS FOUND, V54, P515, DOI 10.1016/j.sandf.2014.04.015; Shariatmadari N, 2008, IRAN J SCI TECHNOL B, V32, P125; Shioi Y, 1982, P 2 EUROPEAN S PENET, P159; Shooshpasha I, 2013, INT J GEOMATE, V4, P560; Sommers GM, 2020, PHYS CHEM CHEM PHYS, V22, P10592, DOI 10.1039/d0cp01893g; Teh CI, 1997, J COMPUT CIVIL ENG, V11, P129, DOI 10.1061/(ASCE)0887-3801(1997)11:2(129); Ting CK, 2005, LECT NOTES ARTIF INT, V3630, P403, DOI 10.1007/11553090_41; Pham TA, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10051871; Van Der Malsburg C., 1986, BRAIN THEORY, P245, DOI [10.1007/978-3-642-70911-1_20, DOI 10.1007/978-3-642-70911-1_20]; Willmott C.J., 1980, PHYS GEOGR, V1, P59, DOI DOI 10.1080/02723646.1980.10642189; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Xu H, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183715; Zemouri R, 2020, NEURAL COMPUT APPL, V32, P18143, DOI 10.1007/s00521-019-04196-8; Zhou YJ, 2019, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1939-6	82	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243030	10.1371/journal.pone.0243030	http://dx.doi.org/10.1371/journal.pone.0243030			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332377	gold, Green Published			2022-12-26	WOS:000601310900027
J	Hernandez-Rubio, JC; Abad, MSC; Leon, AY; Higuera, GD; Rodriguez, LG; Torrejon, CG; Cacho, AM; Rodriguez, AJ; Martin, MGS				Carrillo Hernandez-Rubio, Javier; Sanchez-Carpintero Abad, Maria; Yordi Leon, Andrea; Doblare Higuera, Guillermo; Garcia Rodriguez, Leticia; Garcia Torrejon, Carmen; Mayor Cacho, Alejandro; Jimenez Rodriguez, Angel; Garcia-Salmones Martin, Mercedes			Outcomes of an intermediate respiratory care unit in the COVID-19 pandemic	PLOS ONE			English	Article							NONINVASIVE VENTILATION	Background 15% of COVID-19 patients develop severe pneumonia. Non-invasive mechanical ventilation and high-flow nasal cannula can reduce the rate of endotracheal intubation in adult respiratory distress syndrome, although failure rate is high. Objective To describe the rate of endotracheal intubation, the effectiveness of treatment, complications and mortality in patients with severe respiratory failure due to COVID-19. Methods Prospective cohort study in a first-level hospital in Madrid. Patients with a positive polymerase chain reaction for SARS-CoV-2 and admitted to the Intermediate Respiratory Care Unit with tachypnea, use of accessory musculature or Sp(O2) <92% despite Fi(O2)> 0.5 were included. Intubation rate, medical complications, and 28-day mortality were recorded. Statistical analysis through association studies, logistic and Cox regression models and survival analysis was performed. Results Seventy patients were included. 37.1% required endotracheal intubation, 58.6% suffered medical complications and 24.3% died. Prone positioning was independently associated with lower need for endotracheal intubation (OR 0.05; 95% CI 0.005 to 0.54, p = 0.001). The adjusted HR for death at 28 days in the group of patients requiring endotracheal intubation was 5.4 (95% CI 1.51 to 19.5; p = 0.009). Conclusions The rate of endotracheal intubation in patients with severe respiratory failure from COVID-19 was 37.1%. Complications and mortality were lower in patients in whom endotracheal intubation could be avoided. Prone positioning could reduce the need for endotracheal intubation.	[Carrillo Hernandez-Rubio, Javier] Rey Juan Carlos Univ Hosp, Dept Pulmonol & Resp Med, Madrid, Spain; [Sanchez-Carpintero Abad, Maria; Yordi Leon, Andrea; Doblare Higuera, Guillermo; Garcia Rodriguez, Leticia; Garcia-Salmones Martin, Mercedes] Infanta Elena Univ Hosp, Dept Pulmonol & Resp Med, Madrid, Spain; [Garcia Torrejon, Carmen] Infanta Elena Univ Hosp, Dept Intens Care Med, Madrid, Spain; [Mayor Cacho, Alejandro] Infanta Elena Univ Hosp, Dept Anesthesiol, Madrid, Spain; [Jimenez Rodriguez, Angel] Infanta Elena Univ Hosp, Dept Internal Med, Madrid, Spain		Hernandez-Rubio, JC (corresponding author), Rey Juan Carlos Univ Hosp, Dept Pulmonol & Resp Med, Madrid, Spain.	jcarrillohr@gmail.com		Carrillo Hernandez-Rubio, Javier/0000-0001-5083-9902				[Anonymous], 2020, LANCET, V395, P1054; [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961; [Anonymous], JAMA J AM MED ASSOC, DOI [10.3760/cma.j.issn.1009-9921.2017.11.016, DOI 10.3760/CMA.J.ISSN.1009-9921.2017.11.016]; [Anonymous], 2016, REV ESP ANESTESIOL R, V63, pe23; [Anonymous], 2019, AM J RESP CRIT CARE, V200, pe70, DOI 10.1164/rccm.201908-1590ST; [Anonymous], 2020, ACTUALIZACION N 109; [Anonymous], 2020, JAMA-J AM MED ASSOC, V323, P1574; Brochard L, 2014, SEMIN RESP CRIT CARE, V35, P492, DOI 10.1055/s-0034-1383863; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carteaux G, 2016, CRIT CARE MED, V44, P282, DOI 10.1097/CCM.0000000000001379; Gomez CC, 2020, REV ESP ANEST REANIM, V67, P261, DOI 10.1016/j.redar.2020.03.006; Coudroy R, 2020, RESP CARE, V65, P525, DOI 10.4187/respcare.07104; Ding L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2738-5; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hui DS, 2015, CHEST, V147, P1336, DOI 10.1378/chest.14-1934; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; Patel BK, 2016, JAMA-J AM MED ASSOC, V315, P2435, DOI 10.1001/jama.2016.6338; Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016; Satou T, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.465; Slutsky AS, 2014, NEW ENGL J MED, V370, P1668; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Wan SX, 2020, BRIT J HAEMATOL, V189, P428, DOI 10.1111/bjh.16659; Wang Y, 2020, NPJ SCHIZOPHR, V6, DOI 10.1038/s41537-020-0095-7; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Zhang JJY, 2020, CLIN INFECT DIS, V71, P2199, DOI 10.1093/cid/ciaa576	30	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243968	10.1371/journal.pone.0243968	http://dx.doi.org/10.1371/journal.pone.0243968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326484	gold, Green Published			2022-12-26	WOS:000600176400078
J	Belay, A; Ashagrie, M; Seyoum, B; Alemu, M; Tsegaye, A				Belay, Assefa; Ashagrie, Melaku; Seyoum, Berhanu; Alemu, Mekuanent; Tsegaye, Aster			Prevalence of enteric pathogens, intestinal parasites and resistance profile of bacterial isolates among HIV infected and non-infected diarrheic patients in Dessie Town, Northeast Ethiopia	PLOS ONE			English	Article							HIV/AIDS PATIENTS; GLOBAL BURDEN; ETIOLOGIES; SHIGELLA; CHILDREN; DISEASE	Background Enteric pathogens like Salmonella and Shigella species as well as intestinal parasites (IPs) are among the main causative agents of diarrhea in people with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), particularly in low income countries like Ethiopia. Antimicrobial resistance against commonly prescribed drugs has become a major global threat. This study, therefore, aimed at determining the magnitude of Salmonella, Shigella and IPs infections, their predicting factors, and antimicrobial susceptibility pattern among HIV infected and non-infected diarrheic patients in Dessie town, Northeast Ethiopia. Methods A cross sectional study was conducted at three health facilities in Northeast Ethiopia between January 2018 and March 2018. Data on socio-demographic and associated risk factors were collected using structured questionnaire from 354 HIV infected and non-infected diarrheic outpatients. Fresh stool specimen was processed according to standard operating procedures. Data were entered and analyzed using SPSS version 22. Descriptive statistics was used to determine frequency, Bivariate and multivariate logistic regression analyses were performed to identify predicting factors associated with the outcome variable. P-value <0.05 were used to declare statistical significance. Results Among 354 diarrheic patients, 112 were HIV infected and 242 were HIV non-infected. The overall prevalence of intestinal parasite and bacterial infection among HIV infected versus non-infected, respectively, was 26 (23.2%) and 8 (7.1%) versus 50 (20.7) and 16 (6.6%). Salmonella was the highest in both groups, 6 (5.4%) vs 11 (4.5%). Most prevalent parasite was C. parvum, 9 (8%) among HIV+ while E. histolytica/dispar 39 (16.1%) among HIV-. Having bloody plus mucoid diarrhea, not utilizing latrine and drinking river or spring water were factors significantly associated with bacterial infection. Whereas, being illiterate or having primary level education, diarrhea lasting for 6-10 days, CD4 level between 200-500 cells/<mu>l, not washing hand with soap showed significant association with IPs. The bacterial isolates were 100% susceptible to Ceftriaxone and 95.4% to Ciprofloxacin, while 100% resistant to Ampicillin and Amoxicillin. MDR was observed among 19 (79.2%) isolates. Conclusion Preventing and controlling infection by enteric pathogens as well as IPs require strengthening intervention measures. The 100% resistance of isolates to commonly prescribed antibiotics calls for expanding antimicrobial susceptibility testing so as to select appropriate antimicrobial agent and prevent emergence of drug resistant bacteria.	[Belay, Assefa; Alemu, Mekuanent] Dessie Hlth Sci Coll, Dept Med Lab Sci, Dessie, Ethiopia; [Ashagrie, Melaku] Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie, Ethiopia; [Seyoum, Berhanu] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Tsegaye, Aster] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia	Addis Ababa University	Tsegaye, A (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia.	tsegayeaster@yahoo.com	Belete, Melaku Ashagrie/ABA-4783-2020	Belete, Melaku Ashagrie/0000-0002-0706-9903; Tsegaye, Aster/0000-0002-9026-4629				Adamu H, 2009, ETHIOP J HEALTH DEV, V23, P133; Adekunle O. T., 2015, International Journal of Biomedical and Advance Research, V6, P413; AIDS info, 2017, GUID PREV TREATM OPP, P1; Alemu A, 2011, ASIAN PAC J TROP MED, V4, P661, DOI 10.1016/S1995-7645(11)60168-5; ANDUALEM B, 2006, ETHIOP J HEALTH DEV, V20, P100; [Anonymous], 2008, PHARMACOLOGYONLINE; [Anonymous], 2019, CDC TRAV REL INF DIS; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Awole M., 2003, ETHIOP J HEALTH DEV, V17, P71; Beyene G, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-10; Carcamo C, 2005, J INFECT DIS, V191, P11, DOI 10.1086/426508; Cheesbrough M, 2006, MED LAB MAN TROPICAL, P179; Clinical & Laboratory Standards Institute (CLSI), 2017, PERFORMANCE STANDARD; Dikman AE, 2015, DIGEST DIS SCI, V60, P2236, DOI 10.1007/s10620-015-3615-y; Ethiopia Food Medicine and Health Care Administration and Control Authority, 2014, STAND TREATM GUID GE; Fisseha B, 1999, ETHIOP J HEALTH DEV, V13, P163; Gebrekidan Atsebaha, 2015, BMC Res Notes, V8, P611, DOI 10.1186/s13104-015-1606-x; Gosa Girma, 2015, Research Journal of Microbiology, V10, P288; Ketema T, 2017, AFRICAN J BASIC APPL, V9, P118; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; MENGISTU G, 2014, J MICROBIAL BIOCH S, V2, P1, DOI DOI 10.4172/1948-5948.S2-006; Missaye A, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-7; Mulatu Getamesay, 2014, Ethiop J Health Sci, V24, P101, DOI 10.4314/ejhs.v24i2.1; Musiime Victor, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P185, DOI 10.1177/1545109709333082; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nkenfou CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057914; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Reda A.A., 2011, J INFECT DIS IMMUN, V3, P134; Saeed A, 2015, J MED MICROBIOL, V64, P432, DOI 10.1099/jmm.0.000043; Samiel A, 2014, SE ASIAN J TROP MED, V45, P783; Shah S, 2016, CUREUS, V8, DOI 10.7759/cureus.807; Tambe AB., 2015, CHALLENGES, V6, P229, DOI [DOI 10.3390/CHALLE6020229, 10.3390/challe6020229]; Troeger C, 2018, LANCET INFECT DIS, V18, P1211, DOI 10.1016/S1473-3099(18)30362-1; UNICEF/WHO, 2009, WHY CHILDR STILL DYI; Urio EM, 2001, TROP MED INT HEALTH, V6, P55, DOI 10.1046/j.1365-3156.2001.00668.x; Vouking MZ, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.136.3052; WHO (World Health Organization), 2003, BASIC LAB PROCEDURES, V2nd; world health organization, DIARRH DIS FACT SHEE; World Health Organization, 2005, WHO GUID CONTR SHIG; World Health Organization, 2013, POCK BOOK HOSP CAR C	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243479	10.1371/journal.pone.0243479	http://dx.doi.org/10.1371/journal.pone.0243479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320909	gold, Green Published			2022-12-26	WOS:000600339800014
J	Hobbs, RS; Hall, JR; Graham, LA; Davies, PL; Fletcher, GL				Hobbs, Rod S.; Hall, Jennifer R.; Graham, Laurie A.; Davies, Peter L.; Fletcher, Garth L.			Antifreeze protein dispersion in eelpouts and related fishes reveals migration and climate alteration within the last 20 Ma	PLOS ONE			English	Article							ANTARCTIC EEL POUT; ICE-BINDING; PEPTIDE HETEROGENEITY; CONVERGENT EVOLUTION; FREEZING RESISTANCE; THERMAL HYSTERESIS; CRYSTAL-STRUCTURE; GENE; SEA; DIVERSIFICATION	Antifreeze proteins inhibit ice growth and are crucial for the survival of supercooled fish living in icy seawater. Of the four antifreeze protein types found in fishes, the globular type III from eelpouts is the one restricted to a single infraorder (Zoarcales), which is the only clade know to have antifreeze protein-producing species at both poles. Our analysis of over 60 unique antifreeze protein gene sequences from several Zoarcales species indicates this gene family arose around 18 Ma ago, in the Northern Hemisphere, supporting recent data suggesting that the Arctic Seas were ice-laden earlier than originally thought. The Antarctic was subject to widespread glaciation over 30 Ma and the Notothenioid fishes that produce an unrelated antifreeze glycoprotein extensively exploited the adjoining seas. We show that species from one Zoarcales family only encroached on this niche in the last few Ma, entering an environment already dominated by ice-resistant fishes, long after the onset of glaciation. As eelpouts are one of the dominant benthic fish groups of the deep ocean, they likely migrated from the north to Antarctica via the cold depths, losing all but the fully active isoform gene along the way. In contrast, northern species have retained both the fully active (QAE) and partially active (SP) isoforms for at least 15 Ma, which suggests that the combination of isoforms is functionally advantageous.	[Hobbs, Rod S.; Fletcher, Garth L.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Hall, Jennifer R.] Mem Univ Newfoundland, Aquat Res Cluster, CREAIT Network, St John, NF, Canada; [Graham, Laurie A.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Queens University - Canada	Graham, LA (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	grahamla@queensu.ca		Davies, Peter/0000-0002-8026-7818	Canadian Institutes of Health Research [FRN 148422]; Natural Sciences and Engineering Research Council [6836-06]; Canada Research Chair in Protein Engineering	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Protein Engineering(Canada Research Chairs)	This research was supported by the Canadian Institutes of Health Research (https://cihr-irsc.gc.ca/e/193.html)(Foundation Grant FRN 148422 to P.L.D.) and the Natural Sciences and Engineering Research Council (https://www.nserccrsng.gc.ca/index_eng.asp) (Discovery Grant 6836-06 to G.L.F.). P.L.D. holds the Canada Research Chair in Protein Engineering (https://www.chairs-chaires.gc.ca/home-accueil-eng.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, EBIOMEDICINE, V14, P1, DOI DOI 10.2903/J.EFSA.2016.4418; Antson AA, 2001, J MOL BIOL, V305, P875, DOI 10.1006/jmbi.2000.4336; Baalsrud HT, 2018, MOL BIOL EVOL, V35, P593, DOI 10.1093/molbev/msx311; Baardsnes J, 2002, BBA-PROTEINS PROTEOM, V1601, P49, DOI 10.1016/S1570-9639(02)00431-4; Baardsnes J, 2001, TRENDS BIOCHEM SCI, V26, P468, DOI 10.1016/S0968-0004(01)01879-5; Bar Dolev M, 2016, ANNU REV BIOCHEM, V85, P515, DOI 10.1146/annurev-biochem-060815-014546; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Biscoito M, 2004, COPEIA, P562, DOI 10.1643/CI-03-031R2; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; CHAO H, 1994, PROTEIN SCI, V3, P1760, DOI 10.1002/pro.5560031016; Charmantier Guy, 2009, P165; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; CHENG CHC, 1989, BIOCHIM BIOPHYS ACTA, V997, P55, DOI 10.1016/0167-4838(89)90135-0; Cheng CHC, 2006, P NATL ACAD SCI USA, V103, P10491, DOI 10.1073/pnas.0603796103; Corbella C, 2015, MAR BIOL RES, V11, P180, DOI 10.1080/17451000.2014.894245; Davies PL, 2018, SYST BIOL REPROD MED, V64, P403, DOI 10.1080/19396368.2018.1511764; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DAVIES PL, 1988, CAN J ZOOL, V66, P2611, DOI 10.1139/z88-385; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Deng C, 2010, P NATL ACAD SCI USA, V107, P21593, DOI 10.1073/pnas.1007883107; Desjardins M, 2012, FEBS J, V279, P2215, DOI 10.1111/j.1742-4658.2012.08605.x; Donnelly J, 2004, POLAR BIOL, V27, P637, DOI 10.1007/s00300-004-0632-2; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; Ewart KV, 1999, CELL MOL LIFE SCI, V55, P271, DOI 10.1007/s000180050289; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; FLETCHER GL, 1986, CAN J ZOOL, V64, P1897, DOI 10.1139/z86-284; Froese R, FISHBASE; Garnham CP, 2012, FEBS LETT, V586, P3876, DOI 10.1016/j.febslet.2012.09.017; Garnham CP, 2010, BIOCHEMISTRY-US, V49, P9063, DOI 10.1021/bi100516e; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; GONG ZY, 1992, CAN J ZOOL, V70, P810, DOI 10.1139/z92-114; Graham LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081285; Graham LA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-190; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; Hagemans D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00056; Hamada T, 2006, PROTEIN SCI, V15, P1010, DOI 10.1110/ps.051700406; Hansen J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0294; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; HEW CL, 1988, J BIOL CHEM, V263, P12049; Hobbs RS, 2013, COMP BIOCHEM PHYS A, V164, P111, DOI 10.1016/j.cbpa.2012.10.017; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kelley JL, 2010, J MOL EVOL, V71, P111, DOI 10.1007/s00239-010-9367-6; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Ko TP, 2003, BIOPHYS J, V84, P1228, DOI 10.1016/S0006-3495(03)74938-8; Kristiansson E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-345; Kumar D, 2016, J MOL ENDOCRINOL, V56, pT63, DOI 10.1530/JME-15-0266; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI XM, 1985, J BIOL CHEM, V260, P2904; Marincovich L, 2001, QUATERNARY SCI REV, V20, P329, DOI 10.1016/S0277-3791(00)00113-X; Marincovich L, 1999, NATURE, V397, P149, DOI 10.1038/16446; Matschiner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018911; McCusker MR, 2010, J HERED, V101, P591, DOI 10.1093/jhered/esq062; Miller GH, 2010, QUATERNARY SCI REV, V29, P1679, DOI 10.1016/j.quascirev.2010.03.001; Moller PR, 2003, MOL PHYLOGENET EVOL, V26, P369, DOI 10.1016/S1055-7903(02)00362-7; Nazarkin M. V., 2002, J ICHTHYOL+, V42, P279; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Nishimiya Y, 2005, FEBS J, V272, P482, DOI 10.1111/j.1742-4658.2004.04490.x; OSUGA DT, 1978, J BIOL CHEM, V253, P5338; Pross J, 2012, NATURE, V488, P73, DOI 10.1038/nature11300; Radchenko OA, 2015, RUSS J GENET+, V51, P1096, DOI 10.1134/S1022795415100130; Radchenko OA, 2014, RUSS J MAR BIOL+, V40, P473, DOI 10.1134/S1063074014060194; Radchenko O.A., 2016, J ICHTHYOL+, V56, P556, DOI [10.1134/S0032945216040123, DOI 10.1134/S0032945216040123]; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Salim D, 2019, CHROMOSOME RES, V27, P73, DOI 10.1007/s10577-018-9599-7; SCHOLANDER PF, 1957, J CELL COMPAR PHYSL, V49, P5, DOI 10.1002/jcp.1030490103; SCHRAG JD, 1983, COMP BIOCHEM PHYS A, V74, P381, DOI 10.1016/0300-9629(83)90619-9; SCHRAG JD, 1987, BIOCHIM BIOPHYS ACTA, V915, P357, DOI 10.1016/0167-4838(87)90021-5; SCOTT GK, 1988, MOL CELL BIOL, V8, P3670, DOI 10.1128/MCB.8.9.3670; SCOTT GK, 1986, CAN J FISH AQUAT SCI, V43, P1028, DOI 10.1139/f86-128; Scott W.B., 1988, CAN B FISH AQUAT SCI, V219, P1; Shears Margaret A., 1993, Molecular Marine Biology and Biotechnology, V2, P104; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Stickley CE, 2009, NATURE, V460, P376, DOI 10.1038/nature08163; Takamichi M, 2009, FEBS J, V276, P1471, DOI 10.1111/j.1742-4658.2009.06887.x; Trend-Staid M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000506; Tripati A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03180-5; Wang L, 2005, BIOCHEMISTRY-US, V44, P10305, DOI 10.1021/bi050728y; WANG X, 1995, BBA-PROTEIN STRUCT M, V1247, P163, DOI 10.1016/0167-4838(94)00205-U; WANG X, 1995, MOL MAR BIOL BIOTECH, V4, P135; Wilkens C, 2014, CRYOBIOLOGY, V69, P163, DOI 10.1016/j.cryobiol.2014.07.003; WILSON PW, 1993, CRYO-LETT, V14, P31; Windisch HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-549; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang JF, 2009, POLAR BIOL, V32, P35, DOI 10.1007/s00300-008-0499-8; Zhuang X, 2019, P NATL ACAD SCI USA, V116, P4400, DOI 10.1073/pnas.1817138116	92	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243273	10.1371/journal.pone.0243273	http://dx.doi.org/10.1371/journal.pone.0243273			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320906	Green Published, gold			2022-12-26	WOS:000600339800027
J	Saito, E; Tang, XH; Abe, SK; Sawada, N; Ishihara, J; Takachi, R; Iso, H; Shimazu, T; Yamaji, T; Iwasaki, M; Inoue, M; Tsugane, S				Saito, Eiko; Tang, Xiaohe; Abe, Sarah Krull; Sawada, Norie; Ishihara, Junko; Takachi, Ribeka; Iso, Hiroyasu; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Inoue, Manami; Tsugane, Shoichiro		JPHC Study Grp	Association between meat intake and mortality due to all-cause and major causes of death in a Japanese population	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; HETEROCYCLIC AMINE CONTENT; CORONARY-HEART-DISEASE; N-NITROSO COMPOUNDS; FOLLOW-UP SURVEY; RED MEAT; CARDIOVASCULAR-DISEASE; VARYING DEGREES; PROTEIN-INTAKE; COHORT-I	Purpose We examined the association between meat intake and mortality due to all-cause and major causes of death using a population-based cohort study in Japan. Methods 87,507 Japanese aged between 45 and 74 years old at 5-year follow-up study were followed for 14.0 years on average. Associations between meat intake and mortality risk were assessed using a Cox proportional hazards model. Results A heavy intake of total meat was associated with a higher risk of all-cause mortality relative to the lowest quartile intake in men (Q4: HR,1.18; 95%CIs, 1.06-1.31). A higher intake of total meat was associated with a lower risk of stroke mortality in women (Q2: HR, 0.70; 95%CIs, 0.51-0.94, Q3: HR, 0.68; 95%CIs, 0.50-0.95, Q4: HR, 0.66; 95%CIs, 0.44-0.99). A heavy intake of red meat was also associated with all-cause mortality (Q4: HR, 1.13; 95%CIs, 1.02-1.26) and heart disease mortality (Q4: HR, 1.51; 95%CIs, 1.11-2.06) in men but not in women. Heavy intake of chicken was inversely associated with cancer mortality in men. Conclusions Heavy intakes of total and red meat were associated with an increase in all-cause and heart disease mortality in men, while total meat intake was associated with a lower risk of stroke mortality in women.	[Saito, Eiko] Natl Canc Ctr, Div Canc Stat Integrat, Ctr Canc Control & Informat Serv, Chuo Ku, Tokyo, Japan; [Saito, Eiko; Abe, Sarah Krull; Sawada, Norie; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Grp, Ctr Publ Hlth Sci, Chuo Ku, Tokyo, Japan; [Tang, Xiaohe] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo, Japan; [Ishihara, Junko] Azabu Univ, Sch Life & Environm Sci, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan; [Takachi, Ribeka] Nara Womens Univ, Fac Human Life & Environm, Dept Food Sci & Nutr, Nara, Nara, Japan; [Iso, Hiroyasu] Osaka Univ, Dept Social & Environm Med, Publ Hlth, Grad Sch Med, Suita, Osaka, Japan	National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; Azabu University; Nara Womens University; Osaka University	Inoue, M (corresponding author), Natl Canc Ctr, Epidemiol & Prevent Grp, Ctr Publ Hlth Sci, Chuo Ku, Tokyo, Japan.	mnminoue@ncc.go.jp	Shimazu, Taichi/A-4470-2015	Shimazu, Taichi/0000-0001-6000-9830; Saito, Eiko/0000-0002-4550-9631	National Cancer Center Research and Development Fund [23-A-31, 26-A-2, 29-A-4]; Ministry of Health, Labour and Welfare of Japan	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by National Cancer Center Research and Development Fund (23-A-31[toku], 26-A-2 and 29-A-4) (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2014, BRIT J NUTR, V112, P762, DOI 10.1017/S000711451400124X; [Anonymous], 2003, DIET NUTR PREV CHRON; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Budhathoki S, 2019, JAMA INTERN MED, V179, P1509, DOI 10.1001/jamainternmed.2019.2806; Center for Cancer Control and Information Services National Cancer Center, 2016, MON CANC INC JAP SUR; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Daniel CR, 2011, CANCER PREV RES, V4, P1903, DOI 10.1158/1940-6207.CAPR-11-0241; Fung TT, 2004, STROKE, V35, P2014, DOI 10.1161/01.STR.0000135762.89154.92; Hebels DGAJ, 2009, TOXICOL SCI, V108, P290, DOI 10.1093/toxsci/kfp035; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2018, IARC MONOGRAPHS EVAL; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Ishihara J, 2003, J EPIDEMIOL, V13, pS134; Iso H, 2001, CIRCULATION, V103, P856, DOI 10.1161/01.CIR.103.6.856; Iso H, 2011, J ATHEROSCLER THROMB, V18, P83, DOI 10.5551/jat.6866; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; Khan M M H, 2004, Asian Pac J Cancer Prev, V5, P58; Larsson SC, 2014, AM J EPIDEMIOL, V179, P282, DOI 10.1093/aje/kwt261; Lee JE, 2013, AM J CLIN NUTR, V98, P1032, DOI 10.3945/ajcn.113.062638; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P40, DOI 10.1093/jjco/hyq167; McCord JM, 1998, SEMIN HEMATOL, V35, P5; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Ministry of Health Labour and Welfare of Japan, 2005, NAT HLTH NUTR SURV; MIRVISH SS, 1977, J TOXICOL ENV HEALTH, V2, P1267, DOI 10.1080/15287397709529529; Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6; Nanri A, 2012, J EPIDEMIOL, V22, P205, DOI 10.2188/jea.JE20110087; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Sasaki S, 2003, J EPIDEMIOL, V13, pS115; Sasaki S, 2003, J EPIDEMIOL, V13, pS57; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Sinha R, 1998, FOOD CHEM TOXICOL, V36, P279, DOI 10.1016/S0278-6915(97)00162-2; Sinha R, 1998, FOOD CHEM TOXICOL, V36, P289, DOI 10.1016/S0278-6915(97)00159-2; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; SKOG K, 1995, CARCINOGENESIS, V16, P861, DOI 10.1093/carcin/16.4.861; Takachi R, 2011, ASIA PAC J CLIN NUTR, V20, P603; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Umesawa M, 2009, AM J CLIN NUTR, V90, P377, DOI 10.3945/ajcn.2008.27109; Watanabe S, 2001, J Epidemiol, V11, pS3; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2009, INT STAT CLASS DIS R; Yamagishi K, 2013, EUR HEART J, V34, P1225, DOI 10.1093/eurheartj/eht043; Zheng W, 2009, NUTR CANCER, V61, P437, DOI 10.1080/01635580802710741; Zheng Y, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2110	47	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244007	10.1371/journal.pone.0244007	http://dx.doi.org/10.1371/journal.pone.0244007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320898	Green Published, gold			2022-12-26	WOS:000600339800025
J	Zaugg, TL; Thielman, EJ; Carlson, KF; Tuepker, A; Elnitsky, C; Drummond, KL; Schmidt, CJ; Newell, S; Kaelin, C; Choma, C; Henry, JA				Zaugg, Tara L.; Thielman, Emily J.; Carlson, Kathleen F.; Tuepker, Anais; Elnitsky, Christine; Drummond, Karen L.; Schmidt, Caroline J.; Newell, Summer; Kaelin, Christine; Choma, Christie; Henry, James A.			Factors affecting the implementation of evidence-based Progressive Tinnitus Management in Department of Veterans Affairs Medical Centers	PLOS ONE			English	Article							AUDIOLOGICAL TINNITUS; SUPPORTED EMPLOYMENT; COLLABORATIVE CARE; SKILLS EDUCATION; HEALTH; PROGRAM; SYSTEM	Purpose Progressive Tinnitus Management (PTM) is an evidence-based interdisciplinary stepped-care approach to improving quality of life for patients with tinnitus. PTM was endorsed by Department of Veterans Affairs (VA) Audiology leadership in 2009. Factors affecting implementation of PTM are unknown. We conducted a study to: 1) estimate levels of PTM program implementation in VA Audiology and Mental Health clinics across the country; and 2) identify barriers and facilitators to PTM implementation based on the experiences of VA audiologists and mental health providers. Method We conducted an anonymous, web-based survey targeting Audiology and Mental Health leaders at 144 major VA facilities. Quantitative analyses summarized respondents' facility characteristics and levels of program implementation (full PTM, partial PTM, or no PTM). Qualitative analyses identified themes in factors influencing the implementation of PTM across VA sites. Results Surveys from 87 audiologists and 66 mental health clinicians revealed that few facilities offered full PTM; the majority offered partial or no PTM. Inductive analysis of the open-ended survey responses identified seven factors influencing implementation of PTM: 1) available resources, 2) service collaboration, 3) prioritization, 4) Veterans' preferences and needs, 5) clinician training, 6) awareness of (evidence-based) options, and 7) perceptions of scope of practice. Conclusion Results suggest wide variation in services provided, a need for greater engagement of mental health providers in tinnitus care, and an interest among both audiologists and mental health providers in receiving tinnitus-related training. Future research should address barriers to PTM implementation, including methods to: 1) improve understanding among mental health providers of their potential role in tinnitus management; 2) enhance coordination of tinnitus-related care between health care disciplines; and 3) collect empirical data on Veterans' need for and interest in PTM, including delivery by telehealth modalities.	[Zaugg, Tara L.; Thielman, Emily J.; Carlson, Kathleen F.; Kaelin, Christine; Choma, Christie; Henry, James A.] VA Portland Hlth Care Syst, VA RR&D Natl Ctr Rehabil Auditory Res NCRAR, Portland, OR 97239 USA; [Carlson, Kathleen F.; Tuepker, Anais; Newell, Summer; Choma, Christie] VA Portland Hlth Care Syst, VA HSR&D Ctr Improve Veteran Involvement Care CIV, Portland, OR USA; [Carlson, Kathleen F.] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Tuepker, Anais] Oregon Hlth & Sci Univ OHSU, Div Gen Internal Med & Geriatr, Portland, OR USA; [Elnitsky, Christine] Univ N Carolina, Coll Hlth & Human Serv, Charlotte, NC USA; [Drummond, Karen L.] Cent Arkansas Vet Healthcare Syst, VA Ctr Mental Healthcare & Outcomes Res, North Little Rock, AR USA; [Drummond, Karen L.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA; [Schmidt, Caroline J.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Henry, James A.] Oregon Hlth & Sci Univ OHSU, Dept Otolaryngol Head & Neck Surg, Portland, OR USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Portland State University; Oregon Health & Science University; University of North Carolina; University of North Carolina Charlotte; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; Yale University; Oregon Health & Science University	Zaugg, TL (corresponding author), VA Portland Hlth Care Syst, VA RR&D Natl Ctr Rehabil Auditory Res NCRAR, Portland, OR 97239 USA.	tara.zaugg@va.gov			Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI) [RRP 13-440/IRB3295]	Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI)(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI) through a Rapid Response Project mechanism (RRP 13-440/IRB3295) (JAH). https://www.queri.research.va.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, CANC DISCOV, V10, pOF8; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Bach-Mortensen AM, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0789-7; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Beck JE, 2019, AM J AUDIOL, V28, P162, DOI 10.1044/2018_AJA-TTR17-18-0040; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Carlson KF, 2019, AM J AUDIOL, V28, P181, DOI 10.1044/2018_AJA-TTR17-18-0042; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; EC, 2000, OFF J EUR UNION; Edmonds CM, 2017, AM J AUDIOL, V26, P242, DOI 10.1044/2017_AJA-16-0085; Fuller TE, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00206; Gaudet T, 2019, J ALTERN COMPLEM MED, V25, pS7, DOI 10.1089/acm.2018.29061.gau; Henry JA, 2020, HEAR J, V73, P32; Henry JA, 2019, EAR HEARING, V40, P227, DOI 10.1097/AUD.0000000000000609; Henry JA, 2017, J SPEECH LANG HEAR R, V60, P1378, DOI 10.1044/2016_JSLHR-H-16-0126; Henry JA, 2016, OTOL NEUROTOL, V37, pE276, DOI 10.1097/MAO.0000000000001070; Henry JA, 2009, NOISE HEALTH, V11, P33, DOI 10.4103/1463-1741.45311; Martin WH, 2017, AM J PREV MED, V52, pS268, DOI 10.1016/j.amepre.2016.10.031; Martinez-Devesa P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub3; McIntosh N, 2014, HEALTH CARE MANAGE R, V39, P279, DOI 10.1097/HMR.0000000000000004; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Myers PJ, 2014, J REHABIL RES DEV, V51, P609, DOI 10.1682/JRRD.2013.08.0189; Pearce J, 2012, J CONTIN EDUC HEALTH, V32, P215, DOI 10.1002/chp.21148; Peker S, 2016, MED HYPOTHESES, V91, P95, DOI 10.1016/j.mehy.2016.04.023; Pogoda TK, 2018, ARCH PHYS MED REHAB, V99, pS14, DOI 10.1016/j.apmr.2017.06.029; Pugh MJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-44; Pyne JM, 2011, ARCH INTERN MED, V171, P23, DOI 10.1001/archinternmed.2010.395; Pyne JM, 2010, ARCH GEN PSYCHIAT, V67, P812, DOI 10.1001/archgenpsychiatry.2010.82; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Schmidt Caroline J, 2017, Fed Pract, V34, P6; Sharma U, 2014, INDIAN J CLIN BIOCHE, V29, P269, DOI 10.1007/s12291-013-0408-y; Sherlock LP, 2019, MIL MED; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Taylor SL, 2019, J ALTERN COMPLEM MED, V25, pS52, DOI 10.1089/acm.2018.0445; Tuepker A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196105; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Ubbink DT, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001881; Westin VZ, 2011, BEHAV RES THER, V49, P737, DOI 10.1016/j.brat.2011.08.001; Williams KM, 2017, TELEMED E-HEALTH, V23, P577, DOI 10.1089/tmj.2016.0166; Wyse JJ, 2018, SUBST ABUS, V39, P139, DOI 10.1080/08897077.2018.1452327	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242007	10.1371/journal.pone.0242007	http://dx.doi.org/10.1371/journal.pone.0242007			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370307	gold, Green Published			2022-12-26	WOS:000603611900123
J	Jones, LK; Sturm, AC; Seaton, TL; Gregor, C; Gidding, SS; Williams, MS; Rahm, AK				Jones, Laney K.; Sturm, Amy C.; Seaton, Terry L.; Gregor, Christina; Gidding, Samuel S.; Williams, Marc S.; Rahm, Alanna Kulchak			Barriers, facilitators, and solutions to familial hypercholesterolemia treatment	PLOS ONE			English	Article							PREVALENCE; STATINS; DISEASE	Background Familial hypercholesterolemia (FH) is an inherited lipid disorder that confers high risk for premature cardiovascular disease but remains undertreated. Causes are multifactorial and multilevel, ranging from underprescribing (at the clinician-level) to medication nonadherence (at the patient-level). We evaluated patient and clinician stakeholder barriers and facilitators for treatment of FH to explore possible solutions to the problem. Methods and results Semi-structured interviews and focus groups guided by the Practical, Robust, Implementation and Sustainability Model (PRISM), were conducted with 33 patients and 17 clinician stakeholders across three healthcare systems. A total of14 patients and 9 clinician stakeholders participated in on-site focus groups and the remainder were individual interviews. Transcripts were coded using an iterative process to create a static codebook. We characterized patient and clinician stakeholder barriers into three categories: medical care-, medication-, and life-related. Feasibility of brainstormed solutions varied and was not always representative of the needs of all stakeholders. Patients suggested a need for childhood screening for FH and doctors being persistent about the importance of treating FH, creation of a patient peer group, data transparency, advocacy, and policy changes that would enable patients to receive better treatment. Clinician stakeholders suggested the need for clinical champions. Both groups of stakeholders discussed the need for education about FH. Conclusions Proposed solutions to improve treatment of FH proffered by participants in this study included resources for both patients and clinician stakeholders that clarify cardiovascular disease risks from FH, develop programs to screen for and identify FH at younger ages, and foster open conversations between patients and clinicians about treatment.	[Jones, Laney K.; Sturm, Amy C.; Gidding, Samuel S.; Williams, Marc S.; Rahm, Alanna Kulchak] Geisinger, Genom Med Inst, Danville, PA 17822 USA; [Jones, Laney K.; Gregor, Christina] Geisinger, Ctr Pharm Innovat & Outcomes, Danville, PA 17822 USA; [Seaton, Terry L.] Univ Hlth Sci & Pharm St Louis, St Louis, MO USA; [Seaton, Terry L.] Mercy Clin East Communities, St Louis, MO USA		Jones, LK (corresponding author), Geisinger, Genom Med Inst, Danville, PA 17822 USA.; Jones, LK (corresponding author), Geisinger, Ctr Pharm Innovat & Outcomes, Danville, PA 17822 USA.	ljones14@geisinger.edu	Rahm, Alanna Kulchak/AAG-1967-2021	Rahm, Alanna Kulchak/0000-0003-2513-9298; Jones, Laney/0000-0002-6182-5634	National Heart, Lung, and Blood Institute of the National Institutes of Health [K12HL137942]	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number K12HL137942 (LKJ, MSW).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2019, CIRCULATION, V139, pe42; Banerjee A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000438; Barkas F., 2016, HELLENIC J ATHEROSCL, V7, P120; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Clough JD, 2019, J AM HEART ASSOC, V8, DOI [10.1161/jaha.118.010241, 10.1161/JAHA.118.010241]; deGoma EM, 2016, CIRC-CARDIOVASC GENE, V9, P240, DOI 10.1161/CIRCGENETICS.116.001381; Glasgow RE, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00064; Hope HF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0201196; Jones LK, 2020, RES SOC ADMIN PHARM, V16, P390, DOI 10.1016/j.sapharm.2019.06.006; Kedward J, 2003, BRIT J GEN PRACT, V53, P684; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Khoury M, 2019, CTR DIS CONTR PREV; Kinnear FJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030290; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Martin-Ruiz E, 2018, J CARDIOVASC PHARM T, V23, P200, DOI 10.1177/1074248417745357; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Patton M. Q., 1990, QUALITATIVE EVALUATI; Powell BJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0209-1; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-105; Shi ZM, 2014, INT J CARDIOL, V174, P834, DOI 10.1016/j.ijcard.2014.04.165; Strauss A., 1998, BASICS QUALITATIVE R	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244193	10.1371/journal.pone.0244193	http://dx.doi.org/10.1371/journal.pone.0244193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362269	gold, Green Published			2022-12-26	WOS:000603071600019
J	Georges, JL; Gilles, F; Cochet, H; Bertrand, A; De Tournemire, M; Monguillon, V; Pasqualini, M; Prevot, A; Roger, G; Saba, J; Soltani, J; Koukabi-Fradelizi, M; Beressi, JP; Laureana, C; Prost, JF; Livarek, B				Georges, Jean-Louis; Gilles, Floriane; Cochet, Helene; Bertrand, Alisson; De Tournemire, Marie; Monguillon, Victorien; Pasqualini, Maeva; Prevot, Alix; Roger, Guillaume; Saba, Joseph; Soltani, Josephine; Koukabi-Fradelizi, Mehrsa; Beressi, Jean-Paul; Laureana, Cecile; Prost, Jean-Francois; Livarek, Bernard			Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ACE2; HYPERTENSION; PROTECTS	Background Angiotensin-converting enzyme 2 is the receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses for entry into lung cells. Because ACE-2 may be modulated by angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), there is concern that patients treated with ACEIs and ARBs are at higher risk of coronavirus disease 2019 (COVID-19) pneumonia. Aim This study sought to analyze the association of COVID-19 pneumonia with previous treatment with ACEIs and ARBs. Materials and methods We retrospectively reviewed 684 consecutive patients hospitalized for suspected COVID-19 pneumonia and tested by polymerase chain reaction assay. Patients were split into two groups, according to whether (group 1, n = 484) or not (group 2, n = 250) COVID-19 was confirmed. Multivariable adjusted comparisons included a propensity score analysis. Results The mean age was 63.6 +/- 18.7 years, and 302 patients (44%) were female. Hypertension was present in 42.6% and 38.4% of patients in groups 1 and 2, respectively (P = 0.28). Treatment with ARBs was more frequent in group 1 than group 2 (20.7% vs. 12.0%, respectively; odds ratio [OR] 1.92, 95% confidence interval [CI] 1.23-2.98; P = 0.004). No difference was found for treatment with ACEIs (12.7% vs. 15.7%, respectively; OR 0.81, 95% CI 0.52-1.26; P = 0.35). Propensity score-matched multivariable logistic regression confirmed a significant association between COVID-19 and previous treatment with ARBs (adjusted OR 2.36, 95% CI 1.38-4.04; P = 0.002). Significant interaction between ARBs and ACEIs for the risk of COVID-19 was observed in patients aged > 60 years, women, and hypertensive patients. Conclusions This study suggests that ACEIs and ARBs are not similarly associated with COVID-19. In this retrospective series, patients with COVID-19 pneumonia more frequently had previous treatment with ARBs compared with patients without COVID-19.	[Georges, Jean-Louis; Gilles, Floriane; Cochet, Helene; Bertrand, Alisson; De Tournemire, Marie; Monguillon, Victorien; Pasqualini, Maeva; Prevot, Alix; Roger, Guillaume; Saba, Joseph; Soltani, Josephine; Prost, Jean-Francois; Livarek, Bernard] Ctr Hosp Versailles, Dept Cardiol, Le Chesnay, France; [Koukabi-Fradelizi, Mehrsa] Ctr Hosp Versailles, Emergency Dept, Le Chesnay, France; [Beressi, Jean-Paul] Ctr Hosp Versailles, Dept Diabetol, Le Chesnay, France; [Laureana, Cecile] Ctr Hosp Versailles, Dept Med Informat, Le Chesnay, France	Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay	Georges, JL (corresponding author), Ctr Hosp Versailles, Dept Cardiol, Le Chesnay, France.	jgeorges@ch-versailles.fr		Georges, Jean-Louis/0000-0003-4728-2220; ROGER, Guillaume/0000-0001-8310-7919				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, CELL, V181, DOI DOI 10.1016/j.cell.2020.02.052; [Anonymous], 2020, EUR HEART J, DOI DOI 10.1093/eurheartj/ehaa373; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Caldeira D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4260; De Simone G, POSITION STATEMENT E; Deborde T, 2018, J HYPERTENS, V36, P939, DOI 10.1097/HJH.0000000000001607; Ferrario CM, 2011, CURR OPIN NEPHROL HY, V20, P1, DOI 10.1097/MNH.0b013e3283406f57; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a; Kaparianos A, 2011, CURR MED CHEM, V18, P3506, DOI 10.2174/092986711796642562; Kreutz R, 2020, CARDIOVASC RES, V116, P1688, DOI 10.1093/cvr/cvaa097; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mackey K, 2020, ANN INTERN MED, V173, P195, DOI 10.7326/M20-1515; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Mehta N, 2020, JAMA CARDIOL, V5, P1020, DOI 10.1001/jamacardio.2020.1855; Meng J, 2020, EMERG MICROBES INFEC, V9, P757, DOI 10.1080/22221751.2020.1746200; Meng Y, 2014, AM J RESP CELL MOL, V50, P723, DOI 10.1165/rcmb.2012-0451OC; Murray E, 2020, CARDIOVASC RES, V116, pE87, DOI 10.1093/cvr/cvaa096; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Rossi GP, 2020, ELIFE, V9, DOI 10.7554/eLife.57278; Wosten-van Asperen RM, 2011, J PATHOL, V225, P618, DOI 10.1002/path.2987	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244349	10.1371/journal.pone.0244349	http://dx.doi.org/10.1371/journal.pone.0244349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347477	gold, Green Published, Green Submitted			2022-12-26	WOS:000603071100047
J	Issimov, A; Taylor, DB; Zhugunissov, K; Kutumbetov, L; Zhanabayev, A; Kazhgaliyev, N; Akhmetaliyeva, A; Nurgaliyev, B; Shalmenov, M; Absatirov, G; Dushayeva, L; White, PJ				Issimov, Arman; Taylor, David B.; Zhugunissov, Kuandyk; Kutumbetov, Lespek; Zhanabayev, Assylbek; Kazhgaliyev, Nurlybay; Akhmetaliyeva, Aliya; Nurgaliyev, Birzhan; Shalmenov, Malik; Absatirov, Gaisa; Dushayeva, Laura; White, Peter J.			The combined effects of temperature and relative humidity parameters on the reproduction of Stomoxys species in a laboratory setting	PLOS ONE			English	Article							STABLE FLIES DIPTERA; NIGER-NIGER DIPTERA; MECHANICAL TRANSMISSION; FLY DIPTERA; CALCITRANS DIPTERA; FEVER VIRUS; MUSCIDAE; ABUNDANCE; MOSQUITOS; AEGYPTI	In this study, Stomoxys species (S. calcitrans, S. sitiens and S. indica) were examined to improve on the current technique for mass rearing using a method of combined incubation parameters. Moreover, the reproductive potential of immature forms at various stages of development was defined. Immature forms of stable flies were incubated according to species. There was no significant difference in the number of immature forms obtained among species incubated under the same conditions. Six incubation parameters were used in combination, at temperatures (T) of 32 degrees C, 27 degrees C and 22 degrees C and relative humidity (RH) of 90% and 70% RH. The combined method resulted in a higher number of eggs hatching at 32 degrees C and 90% humidity as well as an increase in the number of larva pupated and emergence of imago at 27 degrees C and 70% humidity.	[Issimov, Arman; White, Peter J.] Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Sydney, NSW, Australia; [Taylor, David B.] ARS, Agroecosyst Management Res Unit, USDA, Lincoln, NE USA; [Zhugunissov, Kuandyk; Kutumbetov, Lespek] Minist Educ & Sci Republ Kazakhstan, RGE Res Inst Biol Safety Problems, Comm Sci, Nur Sultan, Kazakhstan; [Zhanabayev, Assylbek; Kazhgaliyev, Nurlybay] Saken Seifullin Kazakh Agrotech Univ, Dept Vet Med, Nur Sultan, Kazakhstan; [Akhmetaliyeva, Aliya; Nurgaliyev, Birzhan; Shalmenov, Malik; Absatirov, Gaisa; Dushayeva, Laura] Zhangir Khan West Kazakhstan Agr Tech Univ, Dept Vet Med, Uralsk, Kazakhstan	University of Sydney; United States Department of Agriculture (USDA); Saken Seifullin Kazakh Agrotechnical University; Zhangir Khan West Kazakhstan Agrarian Technical University	Issimov, A (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Sydney, NSW, Australia.	issimovarman@gmail.com	Жанабаев, Асылбек/AAE-1050-2021; Zhugunissov, Kuandyk/G-2087-2015; Issimov, Arman/HCI-0729-2022; Zhugunissov, Kuandyk/N-9990-2019; Nurgaliyev, Birzhan/AAI-9982-2021	Жанабаев, Асылбек/0000-0002-1267-3814; Nurgaliyev, Birzhan/0000-0001-5998-8250; White, Peter/0000-0002-9742-4939; Zhugunissov, Kuandyk/0000-0003-4238-5116; Issimov, Arman/0000-0002-0486-0054	Science Committee/Ministry of Education and Science/Republic of Kazakhstan [AP05135323]	Science Committee/Ministry of Education and Science/Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	Issimov, A. This study was funded by research project #AP05135323 of the Science Committee/Ministry of Education and Science/Republic of Kazakhstan.	Baldacchino F, 2013, PARASITE, V20, DOI 10.1051/parasite/2013026; BERKEBILE DR, 1994, J ECON ENTOMOL, V87, P1555, DOI 10.1093/jee/87.6.1555; BRUCE WN, 1958, J ECON ENTOMOL, V51, P269, DOI 10.1093/jee/51.3.269; CAMPBELL JB, 1987, J ECON ENTOMOL, V80, P117, DOI 10.1093/jee/80.1.117; Campbell JB, 2001, J ECON ENTOMOL, V94, P780, DOI 10.1603/0022-0493-94.3.780; Chihota CM, 2001, EPIDEMIOL INFECT, V126, P317, DOI 10.1017/S0950268801005179; Cruz-Vazquez Carlos, 2004, Parasitologia Latinoamericana, V59, P99; Desquesnes M, 2004, VET PARASITOL, V119, P9, DOI 10.1016/j.vetpar.2003.10.015; Florez-Cuadros M, 2019, INSECTS, V10, DOI 10.3390/insects10070207; FOIL LD, 1983, AM J VET RES, V44, P155; Friesen K, 2018, JOVE-J VIS EXP, DOI 10.3791/57341; Gilles J, 2005, J MED ENTOMOL, V42, P959, DOI 10.1603/0022-2585(2005)042[0959:EOTOTR]2.0.CO;2; Gilles J, 2005, J MED ENTOMOL, V42, P260, DOI 10.1603/0022-2585(2005)042[0260:TEODAS]2.0.CO;2; Issimov A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030477; KUNZ SE, 1977, ANN ENTOMOL SOC AM, V70, P169, DOI 10.1093/aesa/70.2.169; Lysyk TJ, 1999, J MED ENTOMOL, V36, P382, DOI 10.1093/jmedent/36.3.382; Lysyk TJ, 1998, J MED ENTOMOL, V35, P107, DOI 10.1093/jmedent/35.2.107; LYSYK TJ, 1993, J MED ENTOMOL, V30, P888, DOI 10.1093/jmedent/30.5.888; Masmeatathip Roungthip, 2006, Kasetsart Journal Natural Sciences, V40, P872; McPheron LJ, 1996, ENVIRON ENTOMOL, V25, P665, DOI 10.1093/ee/25.3.665; MELLOR PS, 1987, RES VET SCI, V43, P109, DOI 10.1016/S0034-5288(18)30753-7; Mohamed Z., 2014, JURNAL TEKNOLOGI DYN, V5, P9; PARR H. C. M., 1959, BULL ENT RES, V50, P165, DOI 10.1017/S0007485300054481; RAMSAMY M, 1979, B ENTOMOL RES, V69, P477, DOI 10.1017/S0007485300018988; RASMUSSEN RL, 1981, ENVIRON ENTOMOL, V10, P798, DOI 10.1093/ee/10.5.798; Romero A, 2006, MED VET ENTOMOL, V20, P115, DOI 10.1111/j.1365-2915.2006.00602.x; Sohier C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56605-6; SUTHERLAND B, 1979, ONDERSTEPOORT J VET, V46, P223; Talley J, 2009, J MED ENTOMOL, V46, P1310, DOI 10.1603/033.046.0609; TURELL MJ, 1987, INFECT IMMUN, V55, P1859, DOI 10.1128/IAI.55.8.1859-1861.1987; TURELL MJ, 1990, AM J TROP MED HYG, V43, P677, DOI 10.4269/ajtmh.1990.43.677; WANG YHE, 1970, J ECON ENTOMOL, V63, P1666, DOI 10.1093/jee/63.5.1666; Zumpt F., 1973, TAXONOMY BIOL EC IMP	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0242794	10.1371/journal.pone.0242794	http://dx.doi.org/10.1371/journal.pone.0242794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347453	Green Published, gold			2022-12-26	WOS:000603071100039
J	Beck, MA; Liu, CY; Bidinosti, CP; Henry, CJ; Godee, CM; Ajmani, M				Beck, Michael A.; Liu, Chen-Yi; Bidinosti, Christopher P.; Henry, Christopher J.; Godee, Cara M.; Ajmani, Manisha			An embedded system for the automated generation of labeled plant images to enable machine learning applications in agriculture	PLOS ONE			English	Article							PRECISION AGRICULTURE; ARABIDOPSIS-THALIANA; COMPUTER VISION; FIELD; PLATFORM; CROP; CLASSIFICATION; OPERATIONS; ROBOTS	A lack of sufficient training data, both in terms of variety and quantity, is often the bottleneck in the development of machine learning (ML) applications in any domain. For agricultural applications, ML-based models designed to perform tasks such as autonomous plant classification will typically be coupled to just one or perhaps a few plant species. As a consequence, each crop-specific task is very likely to require its own specialized training data, and the question of how to serve this need for data now often overshadows the more routine exercise of actually training such models. To tackle this problem, we have developed an embedded robotic system to automatically generate and label large datasets of plant images for ML applications in agriculture. The system can image plants from virtually any angle, thereby ensuring a wide variety of data; and with an imaging rate of up to one image per second, it can produce lableled datasets on the scale of thousands to tens of thousands of images per day. As such, this system offers an important alternative to time- and cost-intensive methods of manual generation and labeling. Furthermore, the use of a uniform background made of blue keying fabric enables additional image processing techniques such as background replacement and image segementation. It also helps in the training process, essentially forcing the model to focus on the plant features and eliminating random correlations. To demonstrate the capabilities of our system, we generated a dataset of over 34,000 labeled images, with which we trained an ML-model to distinguish grasses from non-grasses in test data from a variety of sources. We now plan to generate much larger datasets of Canadian crop plants and weeds that will be made publicly available in the hope of further enabling ML applications in the agriculture sector.	[Beck, Michael A.; Bidinosti, Christopher P.; Ajmani, Manisha] Univ Winnipeg, Dept Phys, Winnipeg, MB, Canada; [Beck, Michael A.; Bidinosti, Christopher P.; Henry, Christopher J.; Ajmani, Manisha] Univ Winnipeg, Dept Appl Comp Sci, Winnipeg, MB, Canada; [Liu, Chen-Yi; Bidinosti, Christopher P.] Univ Manitoba, Dept Elect & Comp Engn, Winnipeg, MB, Canada; [Godee, Cara M.] Univ Winnipeg, Dept Biol, Winnipeg, MB, Canada	University of Winnipeg; University of Winnipeg; University of Manitoba; University of Winnipeg	Beck, MA (corresponding author), Univ Winnipeg, Dept Phys, Winnipeg, MB, Canada.; Beck, MA (corresponding author), Univ Winnipeg, Dept Appl Comp Sci, Winnipeg, MB, Canada.	m.beck@uwinnipeg.ca		Henry, Christopher/0000-0002-2624-1502	George Weston Limited -Seeding Food Innovation [SFI18-0276]; Western Economic Diversification Canada -Regional Innovation Ecosystems Program [15453]; Mitacs -Accelerate [IT14120]	George Weston Limited -Seeding Food Innovation; Western Economic Diversification Canada -Regional Innovation Ecosystems Program; Mitacs -Accelerate	M.B., C.B., C.H., C.-Y., and C.G. received funding from: George Weston Limited -Seeding Food Innovation SFI18-0276, https://www.weston.ca; Mitacs -Accelerate IT14120, https://www.mitacs.ca; and Western Economic Diversification Canada -Regional Innovation Ecosystems Program 15453, https://www.wd-deo.gc.ca/eng/19775.asp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; [Anonymous], 2019, NAT ELECTRON, V2, P1, DOI 10.1038/s41928-019-0203-8; [Anonymous], 2015, Prescrire Int, V24, P93; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; Antonacci A, 2018, TRAC-TREND ANAL CHEM, V98, P95, DOI 10.1016/j.trac.2017.10.022; Antoniou A, 2018, 171104340 ARXIV; Barbedo JGA, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-660; Bacco Manlio., 2019, ARRAY, V3-4, P100009, DOI [DOI 10.1016/J.ARRAY.2019.100009, 10.1016/j.array.2019.100009]; Bah MD, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10111690; Bai G, 2016, COMPUT ELECTRON AGR, V128, P181, DOI 10.1016/j.compag.2016.08.021; Barker J, 2016, COMPUT ELECTRON AGR, V122, P74, DOI 10.1016/j.compag.2016.01.017; Bechar A, 2017, BIOSYST ENG, V153, P110, DOI 10.1016/j.biosystemseng.2016.11.004; Bechar A, 2016, BIOSYST ENG, V149, P94, DOI 10.1016/j.biosystemseng.2016.06.014; Beck MB, 2020, EAGL 1; Binch A, 2017, COMPUT ELECTRON AGR, V140, P123, DOI 10.1016/j.compag.2017.05.018; Bojarski Mariusz, 2016, arXiv; Bosilj P, 2018, IEEE ROBOT AUTOM LET, V3, P2950, DOI 10.1109/LRA.2018.2848305; Bradski G, 2008, LEARNING OPENCV COMP; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chene Y, 2012, COMPUT ELECTRON AGR, V82, P122, DOI 10.1016/j.compag.2011.12.007; Crimmins MA, 2008, ENVIRON MANAGE, V41, P949, DOI 10.1007/s00267-008-9086-6; Cubuk ED, 2019, 180509501 ARXIV; Dobrescu A, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0247-6; Duckett T, 2020, 2018 INT ROB SHOWC U; Dutta Abhishek, 2019, MM '19: Proceedings of the 27th ACM International Conference on Multimedia, P2276, DOI 10.1145/3343031.3350535; Gehan MA, 2017, PEERJ, V5, DOI 10.7717/peerj.4088; Gehan MA, 2017, AM J BOT, V104, P505, DOI 10.3732/ajb.1700044; Giselsson T. M., 2017, PUBLIC IMAGE DATABAS; Giuffrida MV, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0278-7; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; Han DM, 2018, EXPERT SYST APPL, V95, P43, DOI 10.1016/j.eswa.2017.11.028; Haug S, 2015, LECT NOTES COMPUT SC, V8928, P105, DOI [10.1007/978-3-319-16220-1-8, 10.1007/978-3-319-16220-1_8]; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Henry CJ, 2019, INT J REMOTE SENS, V40, P4416, DOI 10.1080/01431161.2018.1563840; Iandola FN, 160207360 ARXIV; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; Jiang Y, 2016, COMPUT ELECTRON AGR, V130, P57, DOI 10.1016/j.compag.2016.09.017; Jimenez-Berni JA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00237; Kamilaris A, 2018, COMPUT ELECTRON AGR, V147, P70, DOI 10.1016/j.compag.2018.02.016; Khanna A, 2019, COMPUT ELECTRON AGR, V157, P218, DOI 10.1016/j.compag.2018.12.039; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lemley J, 2017, IEEE ACCESS, V5, P5858, DOI 10.1109/ACCESS.2017.2696121; Liakos KG, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082674; Lobet G, 2017, TRENDS PLANT SCI, V22, P559, DOI 10.1016/j.tplants.2017.05.002; Lottes P, 2016, IEEE INT CONF ROBOT, P5157, DOI 10.1109/ICRA.2016.7487720; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mikolajczyk A., 2018, 2018 INT INTERDISCIP, P117, DOI DOI 10.1109/IIPHDW.2018.8388338; Minervini M, 2017, PLANT J, V90, P204, DOI 10.1111/tpj.13472; Mingxing T, 190511946 ARXIV; Oberti R, 2016, BIOSYST ENG, V146, P1, DOI 10.1016/j.biosystemseng.2016.05.010; Patricio DI, 2018, COMPUT ELECTRON AGR, V153, P69, DOI 10.1016/j.compag.2018.08.001; Rapson, 2018, P 2018 11 INT C MOB, P1, DOI [10.1109/IVCNZ.2018.8634750, DOI 10.1109/IVCNZ.2018.8634750]; Relf-Eckstein JE, 2019, NJAS-WAGEN J LIFE SC, V90-91, DOI 10.1016/j.njas.2019.100307; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Russell BC, 2008, INT J COMPUT VISION, V77, P157, DOI 10.1007/s11263-007-0090-8; Schenk E., 2009, WORKSH OP SOURC INN, V72, P3; Shakoor N, 2017, CURR OPIN PLANT BIOL, V38, P184, DOI 10.1016/j.pbi.2017.05.006; Shamshiri RR, 2018, INT J AGR BIOL ENG, V11, P1, DOI 10.25165/j.ijabe.20181104.4278; Singh A, 2016, TRENDS PLANT SCI, V21, P110, DOI 10.1016/j.tplants.2015.10.015; Sixt L, 2017, 161101331 ARXIV; Story D, 2015, MACH VISION APPL, V26, P495, DOI 10.1007/s00138-015-0670-5; Taigman Y., 2014, P IEEE COMP SOC C CO; Tardieu F, 2017, CURR BIOL, V27, pR770, DOI 10.1016/j.cub.2017.05.055; Tisne S, 2013, PLANT J, V74, P534, DOI 10.1111/tpj.12131; Ubbens J, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0273-z; Unal I, 2015, INT J ADV ROBOT SYST, V12, DOI 10.5772/62059; Vazquez-Arellano M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16050618; Vinyals O, 2015, P IEEE COMP SOC C CO; Waldchen J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005993; Xie S, 161105431 ARXIV; Narvaez FY, 2017, IEEE-ASME T MECH, V22, P2428, DOI 10.1109/TMECH.2017.2760866	75	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243923	10.1371/journal.pone.0243923	http://dx.doi.org/10.1371/journal.pone.0243923			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332382	gold, Green Submitted, Green Published			2022-12-26	WOS:000601310900040
J	Kazmi, SZH; Habib, N; Riaz, R; Rizvi, SS; Abbas, SA; Chung, TS				Kazmi, Syed Zaki Hassan; Habib, Nazneen; Riaz, Rabia; Rizvi, Sanam Shahla; Abbas, Syed Ali; Chung, Tae-Sun			Multiscale based nonlinear dynamics analysis of heart rate variability signals	PLOS ONE			English	Article							TIME-SERIES; ENTROPY; HEALTHY; INDEX	Acceleration change index (ACI) is a fast and easy to understand heart rate variability (HRV) analysis approach used for assessing cardiac autonomic control of the nervous systems. The cardiac autonomic control of the nervous system is an example of highly integrated systems operating at multiple time scales. Traditional single scale based ACI did not take into account multiple time scales and has limited capability to classify normal and pathological subjects. In this study, a novel approach multiscale ACI (MACI) is proposed by incorporating multiple time scales for improving the classification ability of ACI. We evaluated the performance of MACI for classifying, normal sinus rhythm (NSR), congestive heart failure (CHF) and atrial fibrillation subjects. The findings reveal that MACI provided better classification between healthy and pathological subjects compared to ACI. We also compared MACI with other scale-based techniques such as multiscale entropy, multiscale permutation entropy (MPE), multiscale normalized corrected Shannon entropy (MNCSE) and multiscale permutation entropy (IMPE). The preliminary results show that MACI values are more stable and reliable than IMPE and MNCSE. The results show that MACI based features lead to higher classification accuracy.	[Kazmi, Syed Zaki Hassan; Riaz, Rabia; Abbas, Syed Ali] Univ Azad Jammu & Kashmir, Dept Comp Sci & Informat Technol, Muzaffarabad, Pakistan; [Habib, Nazneen] Univ Azad Jammu & Kashmir, Dept Sociol & Rural Dev, Muzaffarabad, Pakistan; [Rizvi, Sanam Shahla] Raptor Interact Pty Ltd, Centurion, South Africa; [Chung, Tae-Sun] Ajou Univ, Dept Software, Suwon, South Korea	University of Azad Jammu & Kashmir; University of Azad Jammu & Kashmir; Ajou University	Chung, TS (corresponding author), Ajou Univ, Dept Software, Suwon, South Korea.	tschung@ajou.ac.kr	Rizvi, Sanam Shahla/GQQ-8390-2022	Rizvi, Sanam Shahla/0000-0003-4694-3250	National Research Foundation of Korea (NRF) - Ministry of Education [2019R1F1A1058548]; Raptor Interactive (Pty) Ltd.	National Research Foundation of Korea (NRF) - Ministry of Education; Raptor Interactive (Pty) Ltd.	Basic Science Research provided support for this study through the National Research Foundation of Korea (NRF) funded by the Ministry of Education in the form of a grant awarded to TSC (2019R1F1A1058548). This funder played a role in study design, decision to publish, and preparation of the manuscript, but did not play a role in data collection or analysis. Raptor Interactive (Pty) Ltd. provided support in the form of a salary for SSR. The specific roles of this author are articulated in the `author contributions' section. This funder played a major role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SA, 2018, IEEE ACCESS, V6, P67555, DOI 10.1109/ACCESS.2018.2879115; Arif M, 2005, PHYSIOL MEAS, V26, P653, DOI 10.1088/0967-3334/26/5/007; Ashkenazy Y, 2000, COMPUT CARDIOL, V27, P139, DOI 10.1109/CIC.2000.898475; Awan I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196823; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; de Geus EJC, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13287; Valencia JF, 2009, IEEE T BIO-MED ENG, V56, P2202, DOI 10.1109/TBME.2009.2021986; Garcia-Gonzalez MA, 2003, PHYSIOL MEAS, V24, P819, DOI 10.1088/0967-3334/24/4/301; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Guzman-Vargas L, 2008, NAT HAZARD EARTH SYS, V8, P855, DOI 10.5194/nhess-8-855-2008; Humeau-Heurtier A, 2014, ENTROPY-SWITZ, V16, P5777, DOI 10.3390/e16115777; Hussain L, 2018, BIOMED ENG-BIOMED TE, V63, P481, DOI 10.1515/bmt-2017-0041; Kazmi SZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157557; Massaro S., 2016, ORGAN RES METHODS, V22, P354, DOI DOI 10.1177/1094428116681072; Nikulin VV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.089803; Niu H, 2015, COMMUN NONLINEAR SCI, V22, P375, DOI 10.1016/j.cnsns.2014.08.038; Pan YH, 2011, J MAR SCI TECH-TAIW, V19, P107; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Salmoirago-Blotcher E., 2019, PSYCHOSOMATIC MED; Shah SAA, 2020, TRAIT SIGNAL, V37, P355, DOI 10.18280/ts.370302; Wu SD, 2013, PHYSICA A, V392, P5865, DOI 10.1016/j.physa.2013.07.075; Wu SD, 2013, ENTROPY-SWITZ, V15, P1069, DOI 10.3390/e15031069	22	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243441	10.1371/journal.pone.0243441	http://dx.doi.org/10.1371/journal.pone.0243441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332361	Green Published, gold			2022-12-26	WOS:000601310900097
J	de Castro, ACV; Fuchs, D; Morello, GM; Pastur, S; de Sousa, L; Olsson, IAS				de Castro, Ana Catarina Vieira; Fuchs, Danielle; Morello, Gabriela Munhoz; Pastur, Stefania; de Sousa, Liliana; Olsson, I. Anna S.			Does training method matter? Evidence for the negative impact of aversive-based methods on companion dog welfare	PLOS ONE			English	Article							CANIS-FAMILIARIS; SALIVA CORTISOL; PLASMA-CORTISOL; COGNITIVE BIAS; BEHAVIOR; STRESS; RESPONSES; BENEFITS; COLLAR	Dog training methods range broadly from those using mostly positive punishment and negative reinforcement (aversive-based) to those using primarily positive reinforcement (reward-based). Although aversive-based training has been strongly criticized for negatively affecting dog welfare, there is no comprehensive research focusing on companion dogs and mainstream techniques, and most studies rely on owner-reported assessment of training methods and dog behavior. The aim of the present study was to evaluate the effects of aversive- and reward-based training methods on companion dog welfare within and outside the training context. Ninety-two companion dogs were recruited from three reward-based schools (Group Reward, n = 42), and from four aversive-based schools, two using low proportions of aversive-based methods (Group Mixed, n = 22) and two using high proportions of aversive-based methods (Group Aversive, n = 28). For evaluating welfare during training, dogs were video recorded for three sessions and six saliva samples were collected, three at home (baseline levels) and three after training (post-training levels). Video recordings were used to examine the frequency of stress-related behaviors (e.g., lip lick, yawn) and the overall behavioral state of the dog (e.g., tense, relaxed), and saliva samples were analyzed for cortisol concentration. For evaluating welfare outside the training context, dogs participated in a cognitive bias task. Results showed that dogs from Group Aversive displayed more stress-related behaviors, were more frequently in tense and low behavioral states and panted more during training, and exhibited higher post-training increases in cortisol levels than dogs from Group Reward. Additionally, dogs from Group Aversive were more 'pessimistic' in the cognitive bias task than dogs from Group Reward. Dogs from Group Mixed displayed more stress-related behaviors, were more frequently in tense states and panted more during training than dogs from Group Reward. Finally, although Groups Mixed and Aversive did not differ in their performance in the cognitive bias task nor in cortisol levels, the former displayed more stress-related behaviors and was more frequently in tense and low behavioral states. These findings indicate that aversive-based training methods, especially if used in high proportions, compromise the welfare of companion dogs both within and outside the training context.	[de Castro, Ana Catarina Vieira; Fuchs, Danielle; Morello, Gabriela Munhoz; Pastur, Stefania; Olsson, I. Anna S.] Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; [de Castro, Ana Catarina Vieira; Fuchs, Danielle; Morello, Gabriela Munhoz; Pastur, Stefania; Olsson, I. Anna S.] Univ Porto, I3S, Porto, Portugal; [de Castro, Ana Catarina Vieira; de Sousa, Liliana] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal; [Fuchs, Danielle] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Pastur, Stefania] Univ Trieste, Trieste, Italy	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Edinburgh; University of Trieste	de Castro, ACV (corresponding author), Univ Porto, Inst Biol Mol & Celular, Porto, Portugal.; de Castro, ACV (corresponding author), Univ Porto, I3S, Porto, Portugal.; de Castro, ACV (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal.	ana.castro@ibmc.up.pt	Morello, Gabriela/P-1005-2017	Morello, Gabriela/0000-0002-5439-969X; Olsson, Anna/0000-0002-4369-8723; Vieira de Castro, Ana/0000-0002-3357-7282	FCT -Fundacao Portuguesa para a Ciencia e Tecnologia; UFAW -Universities Federation for Animal Welfare [14-16/17]; PIPOL Regione Friuli Venezia Giulia	FCT -Fundacao Portuguesa para a Ciencia e Tecnologia; UFAW -Universities Federation for Animal Welfare; PIPOL Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia)	The current research study was supported by FCT -Fundacao Portuguesa para a Ciencia e Tecnologia (Fellowship SFRH/BPD/111509/2015) and UFAW -Universities Federation for Animal Welfare (Grant 14-16/17), with grants awarded to ACVC. SP was supported by PIPOL Regione Friuli Venezia Giulia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. FCT -Fundacao Portuguesa para a Ciencia e Tecnologia: https://www.fct.pt/index.phtml.pt UFAW - Universities Federation for Animal Welfare: https://www.ufaw.org.uk/.	Arhant C, 2010, APPL ANIM BEHAV SCI, V123, P131, DOI 10.1016/j.applanim.2010.01.003; Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Beerda B, 1997, APPL ANIM BEHAV SCI, V52, P307, DOI 10.1016/S0168-1591(96)01131-8; Blackwell EJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-93; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; Boissy A, 2014, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, 2ND EDITION, P81, DOI 10.1016/B978-0-12-394586-0.00003-2; Buttner AP, 2015, PHYSIOL BEHAV, V147, P54, DOI 10.1016/j.physbeh.2015.04.010; China L, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00508; Christiansen FO, 2001, APPL ANIM BEHAV SCI, V72, P131, DOI 10.1016/S0168-1591(00)00203-3; Companion Animal Welfare Council , 2012, US EL PULS TRAIN AID; Cooper JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102722; Crawford EK, 2006, ANTHROZOOS, V19, P98, DOI 10.2752/089279306785593757; Deakin A, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0779; Deldalle S, 2014, J VET BEHAV, V9, P58, DOI 10.1016/j.jveb.2013.11.004; Dreschel NA, 2009, HORM BEHAV, V55, P163, DOI 10.1016/j.yhbeh.2008.09.010; Fernandes JG, 2017, APPL ANIM BEHAV SCI, V196, P1, DOI 10.1016/j.applanim.2017.07.001; Feuerbacher EN, 2012, J EXP ANAL BEHAV, V98, P105, DOI 10.1901/jeab.2012.98-105; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Haverbeke A, 2008, APPL ANIM BEHAV SCI, V113, P110, DOI 10.1016/j.applanim.2007.11.010; Haverbeke A, 2010, J VET BEHAV, V5, P112, DOI 10.1016/j.jveb.2009.08.008; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Herron ME, 2009, APPL ANIM BEHAV SCI, V117, P47, DOI 10.1016/j.applanim.2008.12.011; Hiby EF, 2004, ANIM WELFARE, V13, P63; Horvath M, 2016, APPL ANIM BEHAV SCI, V185, P121, DOI 10.1016/j.applanim.2016.09.007; Iigaya K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165840; Jokinen I, 2017, APPL ANIM BEHAV SCI, V195, P87, DOI 10.1016/j.applanim.2017.06.003; Kobelt AJ, 2003, RES VET SCI, V75, P157, DOI 10.1016/S0034-5288(03)00080-8; Lattal K. A., 2013, APA HDB BEHAV ANAL, V1, P483, DOI [10.1037/13937-021, DOI 10.1037/13937-021]; Marshall-Pescini S, 2008, BEHAV PROCESS, V78, P449, DOI 10.1016/j.beproc.2008.02.022; Mendl M, 2020, NEUROSCI BIOBEHAV R, V112, P144, DOI 10.1016/j.neubiorev.2020.01.025; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Mills DS, 2020, J VET BEHAV CLIN AP, V5, P60; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Neville V, 2020, NEUROSCI BIOBEHAV R, V108, P269, DOI 10.1016/j.neubiorev.2019.11.008; Piotti P, 2018, LEARN BEHAV, V46, P537, DOI 10.3758/s13420-018-0357-7; Reid P, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P120, DOI 10.1079/9781845931872.0120; Reisner I, 2017, DOMESTIC DOG: ITS EVOLUTION, BEHAVIOR AND INTERACTIONS WITH PEOPLE, 2ND EDITION, P210; REUL JMHM, 1991, J STEROID BIOCHEM, V40, P63, DOI 10.1016/0960-0760(91)90168-5; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Salgirli Y, 2012, REV MED VET-TOULOUSE, V163, P530; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Schalke E, 2007, APPL ANIM BEHAV SCI, V105, P369, DOI 10.1016/j.applanim.2006.11.002; Schilder MBH, 2004, APPL ANIM BEHAV SCI, V85, P319, DOI 10.1016/j.applanim.2003.10.004; Schoberl I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170707; Skinner B. F., 1953, SCI HUMAN BEHAV; Steiss JE, 2007, APPL ANIM BEHAV SCI, V106, P96, DOI 10.1016/j.applanim.2006.06.018; Tiira K, 2014, APPL ANIM BEHAV SCI, V155, P82, DOI 10.1016/j.applanim.2014.03.007; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Visser EK, 2009, VET J, V181, P48, DOI 10.1016/j.tvjl.2009.03.009; Voith VL, 1996, READINGS COMPANION A, P140; Zidar J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23545-6	55	12	12	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0225023	10.1371/journal.pone.0225023	http://dx.doi.org/10.1371/journal.pone.0225023			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326450	gold, Green Published, Green Submitted			2022-12-26	WOS:000600176400043
J	Li, CS; Yao, H; Wang, HB; Fang, JY; Xu, J				Li, Chushu; Yao, Han; Wang, Huanbin; Fang, Jing-Yuan; Xu, Jie			Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity	ONCOGENE			English	Article							SELECTIVE AUTOPHAGY; SIGNALING PATHWAYS; MEDIATED CLEAVAGE; CANCER; EXPRESSION; CALPAIN; REVEALS; COMPLEX; CA2+; MEK	Cancer cell expression of PD-L1 leads to T cells exhaustion by transducing co-inhibitory signal, and further understanding the regulation of PD-L1 in cancer cells may provide additional therapeutic strategies. Here by drug repurposing screen, we identified amlodipine as a potent inhibitor of PD-L1 expression in cancer cells. Further survey of calcium-associated pathways revealed calpain-dependent stabilization of the PD-L1 protein. Intracellular calcium delivered an operational signal to calpain-dependent Beclin-1 cleavage, blocking autophagic degradation of PD-L1 accumulated on recycling endosome (RE). Blocking calcium flux by amlodipine depleted PD-L1 expression and increased CD8+ T-cell infiltration in tumor tissues but not in myocardium, causing dose-dependent tumor suppression in vivo. Rescuing PD-L1 expression eliminated the effects of amlodipine, suggesting the PD-L1-dependent effect of amlodipine. These results reveal a calcium-dependent mechanism controlling PD-L1 degradation, and highlight calcium flux blockade as a potential strategy for combinatorial immunotherapy.	[Li, Chushu; Yao, Han; Wang, Huanbin; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Renji Hosp,Sch Med,Minist Hlth, Div Gastroenterol & Hepatol,Key Lab Gastroenterol, State Key Lab Oncogenes & Related Genes,Shanghai, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China; [Xu, Jie] Fudan Univ, Zhongshan Xuhui Hosp, Inst Biomed Sci, Shanghai, Peoples R China; [Xu, Jie] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Div Gastroenterol & Hepatol, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Xu, J (corresponding author), Fudan Univ, Zhongshan Xuhui Hosp, Inst Biomed Sci, Shanghai, Peoples R China.; Xu, J (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Div Gastroenterol & Hepatol, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.	jie_xu@fudan.edu.cn	li, chu/GPS-7224-2022; Xu, Jie/K-3712-2019	Xu, Jie/0000-0001-9163-3898; Li, Chushu/0000-0001-6658-2208	National Natural Science Foundation of China [82030104, 81874050, 81572326]; Basic Research Projects of Shanghai Science and Technology Innovation Action Plan [20JC1410700]; National Key R & D Program of China [2016YFC0906002]; Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Projects of Shanghai Science and Technology Innovation Action Plan; National Key R & D Program of China; Fudan University	This work was supported by National Natural Science Foundation of China (No: 82030104, 81874050, 81572326), Basic Research Projects of Shanghai Science and Technology Innovation Action Plan (20JC1410700); National Key R & D Program of China (2016YFC0906002, 2016YFC0906002), Tang Scholar (JX), and Startup Research Funding of Fudan University.	Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Barcelo C, 2020, CANCERS, V12, DOI 10.3390/cancers12020391; Beese CJ, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00373; Blander JM, 2018, ANNU REV IMMUNOL, V36, P717, DOI 10.1146/annurev-immunol-041015-055523; Bong AHL, 2018, BBA-MOL CELL RES, V1865, P1786, DOI 10.1016/j.bbamcr.2018.05.015; Bootman MD, 2018, CELL CALCIUM, V70, P32, DOI 10.1016/j.ceca.2017.08.005; Bulsara K.G., 2020, STATPEARLS; Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Cao DL, 2019, CANCER RES, V79, P2604, DOI 10.1158/0008-5472.CAN-18-3842; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cha JH, 2018, MOL CELL, V71, P606, DOI 10.1016/j.molcel.2018.07.030; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Geng Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125326; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guo YJ, 2012, J CELL SCI, V125, P1706, DOI 10.1242/jcs.093203; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hong SD, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1094598; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kang SH, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1515057; Kaplon H, 2019, MABS-AUSTIN, V11, P219, DOI 10.1080/19420862.2018.1556465; Kayamori H, 2018, INT HEART J, V59, P607, DOI 10.1536/ihj.17-265; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Knaevelsrud H, 2013, AUTOPHAGY, V9, P1639, DOI 10.4161/auto.26124; KOIDE Y, 1988, P NATL ACAD SCI USA, V85, P3120, DOI 10.1073/pnas.85.9.3120; Kon E, 2019, DRUG RESIST UPDATE, V45, P13, DOI 10.1016/j.drup.2019.07.004; Li CW, 2018, CANCER CELL, V33, P187, DOI 10.1016/j.ccell.2018.01.009; Li CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12632; Li J, 2019, EXP CELL RES, V374, P304, DOI 10.1016/j.yexcr.2018.12.001; Liu L, 2015, CLIN CANCER RES, V21, P1639, DOI 10.1158/1078-0432.CCR-14-2339; Loi S, 2016, CLIN CANCER RES, V22, P1499, DOI 10.1158/1078-0432.CCR-15-1125; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Ma L, 2019, INTERDISCIP SCI, V11, P266, DOI 10.1007/s12539-019-00331-0; Maher CM, 2018, MOL CANCER RES, V16, P243, DOI 10.1158/1541-7786.MCR-17-0166; Marie N, 2005, BIOCHEM J, V389, P223, DOI 10.1042/BJ20042116; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohan N, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1624128; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Pan MR, 2020, CANCERS, V12, DOI 10.3390/cancers12010094; Pavel M, 2017, FEBS J, V284, P672, DOI 10.1111/febs.13931; Pimentel-Muinos FX, 2014, AUTOPHAGY, V10, P397, DOI 10.4161/auto.27244; Puri C, 2018, DEV CELL, V45, P114, DOI 10.1016/j.devcel.2018.03.008; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; Shaughnessy M, 2019, INT J ONCOL, V55, P1090, DOI 10.3892/ijo.2019.4873; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Sun F, 2016, TUMOR BIOL, V37, P15467, DOI 10.1007/s13277-016-5353-y; Syn NL, 2017, LANCET ONCOL, V18, pE731, DOI 10.1016/S1470-2045(17)30607-1; Wang HB, 2019, NAT CHEM BIOL, V15, P42, DOI 10.1038/s41589-018-0161-x; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wang XJ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1148-5; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xia HG, 2010, AUTOPHAGY, V6, P61, DOI 10.4161/auto.6.1.10326; Yamashita S, 2017, AUTOPHAGY, V13, P980, DOI 10.1080/15548627.2017.1291113; Yao H, 2019, NAT BIOMED ENG, V3, P306, DOI 10.1038/s41551-019-0375-6; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang Z, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00213-8; Zhao Q, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.66; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	66	10	11	6	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1128	1146		10.1038/s41388-020-01592-6	http://dx.doi.org/10.1038/s41388-020-01592-6		DEC 2020	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33323966	Green Submitted			2022-12-26	WOS:000599126500011
J	Mallia, V; Verhaegen, S; Styrishave, B; Eriksen, GS; Johannsen, ML; Ropstad, E; Uhlig, S				Mallia, Vittoria; Verhaegen, Steven; Styrishave, Bjarne; Eriksen, Gunnar Sundstol; Johannsen, Malene Louise; Ropstad, Erik; Uhlig, Silvio			Microcystins and Microcystis aeruginosa PCC7806 extracts modulate steroidogenesis differentially in the human H295R adrenal model	PLOS ONE			English	Article							BLUE-GREEN-ALGA; IN-VITRO; CYANOBACTERIAL BLOOMS; PROTEIN PHOSPHATASES; HORMONE SYNTHESIS; CELL-LINE; PCC 7806; ENDOCRINE; TOXICITY; LR	The aim of this study was to investigate the potential interference of cyanobacterial metabolites, in particular microcystins (MCs), with steroid hormone biosynthesis. Steroid hormones control many fundamental processes in an organism, thus alteration of their tissue concentrations may affect normal homeostasis. We used liquid chromatography-tandem mass spectrometry (LC-MS/MS) to investigate the modulation of 14 hormones involved in the adrenal steroid biosynthesis pathway using forskolin-treated H295R cells, following exposure with either microcystin-LR (MC-LR) alone, a mixture made up of MC-LR together with eight other MCs and nodularin-R (NOD-R), or extracts from the MC-LR-producing Microcystis aeruginosa PCC7806 strain or its MC-deficient mutant PCC7806mcyB-. Production of 17-hydroxypregnenolone and dehydroepiandrosterone (DHEA) was increased in the presence of MC-LR in a dose-dependent manner, indicating an inhibitory effect on 3 beta -hydroxysteroid dehydrogenase (3 beta -HSD). This effect was not observed following exposure with a MCs/NOD-R mixture, and thus the effect of MC-LR on 3 beta -HSD appears to be stronger than for other congeners. Exposure to extracts from both M. aeruginosa PCC7806 and M. aeruginosa PCC7806mcyB- had an opposite effect on 3 beta -HSD, i.e. concentrations of pregnenolone, 17-hydroxypregnenolone and DHEA were significantly decreased, showing that there are other cyanobacterial metabolites that outcompete the effect of MC-LR, and possibly result instead in net-induction. Another finding was a possible concentration-dependent inhibition of CYP21A2 or CYP11 beta 1, which catalyse oxidation reactions leading to cortisol and cortisone, by MC-LR and the MCs/NOD-R mixture. However, both M. aeruginosa PCC7806 and M. aeruginosa PCC7806mcyB- extracts had an opposite effect resulting in a substantial increase in cortisol levels. Our results suggest that MCs can modulate steroidogenesis, but the net effect of the M. aeruginosa metabolome on steroidogenesis is different from that of pure MC-LR and independent of MC production.	[Mallia, Vittoria; Eriksen, Gunnar Sundstol; Uhlig, Silvio] Norwegian Vet Inst, Toxinol Res Grp, Oslo, Norway; [Mallia, Vittoria] Univ Oslo, Dept Chem, Oslo, Norway; [Verhaegen, Steven; Ropstad, Erik] Norwegian Univ Life Sci, Dept Prod Anim Clin Sci, Fac Vet Med, Oslo, Norway; [Styrishave, Bjarne; Johannsen, Malene Louise] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Toxicol & Drug Metab Grp, Copenhagen, Denmark	Norwegian Veterinary Institute; University of Oslo; Norwegian University of Life Sciences; University of Copenhagen	Uhlig, S (corresponding author), Norwegian Vet Inst, Toxinol Res Grp, Oslo, Norway.	silvio.uhlig@vetinst.no	Eriksen, Gunnar/GOP-0440-2022	Styrishave, Bjarne/0000-0003-1619-2468; Eriksen, Gunnar Sundstol/0000-0002-4944-3393	European Union [722634]	European Union(European Commission)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 722634.	Ahmed KEM, 2018, TOXICOL IN VITRO, V52, P332, DOI 10.1016/j.tiv.2018.07.002; Asif AR, 2005, PFLUG ARCH EUR J PHY, V450, P88, DOI 10.1007/s00424-004-1373-3; Bernard C., 2017, HDB CYANOBACTERIAL M; Blasco H, 2015, J BIOMED INFORM, V53, P291, DOI 10.1016/j.jbi.2014.12.001; BOTES DP, 1982, TOXICON, V20, P945, DOI 10.1016/0041-0101(82)90097-6; BOTES DP, 1982, TOXICON, V20, P1037, DOI 10.1016/0041-0101(82)90105-2; Bouaicha N, 2019, TOXINS, V11, DOI 10.3390/toxins11120714; Briand E, 2016, ENVIRON MICROBIOL, V18, P384, DOI 10.1111/1462-2920.12904; Buratti FM, 2017, ARCH TOXICOL, V91, P1049, DOI 10.1007/s00204-016-1913-6; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; Chen L, 2016, J HAZARD MATER, V301, P381, DOI 10.1016/j.jhazmat.2015.08.041; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; (EMA) EMA, ICH Q2 R1 VAL AN PRO; Fontanillo M, 2018, BIOORGAN MED CHEM, V26, P1118, DOI 10.1016/j.bmc.2017.08.040; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; GAZDAR AF, 1990, CANCER RES, V50, P5488; Gracia T, 2006, ECOTOX ENVIRON SAFE, V65, P293, DOI 10.1016/j.ecoenv.2006.06.012; Hecker M, 2008, ANAL BIOANAL CHEM, V390, P287, DOI 10.1007/s00216-007-1657-5; Hecker M, 2006, TOXICOL APPL PHARM, V217, P114, DOI 10.1016/j.taap.2006.07.007; Hinson JP, 2006, BEST PRACT RES CL EN, V20, P111, DOI 10.1016/j.beem.2005.09.006; Hou J, 2016, ENVIRON POLLUT, V208, P477, DOI 10.1016/j.envpol.2015.10.018; Huisman J, 2018, NAT REV MICROBIOL, V16, P471, DOI 10.1038/s41579-018-0040-1; IPCS, 2002, GLOBAL ASSESSMENT ST; Janssen EML, 2019, WATER RES, V151, P488, DOI 10.1016/j.watres.2018.12.048; Jia XY, 2018, ENVIRON POLLUT, V236, P12, DOI 10.1016/j.envpol.2018.01.057; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jonas A, 2015, CHEMOSPHERE, V120, P321, DOI 10.1016/j.chemosphere.2014.07.074; Kellogg JJ, 2016, J NAT PROD, V79, P376, DOI 10.1021/acs.jnatprod.5b01014; Kotai J., 1972, PUBLICATION B, VB-11/69; La Merrill MA, 2020, NAT REV ENDOCRINOL, V16, P45, DOI 10.1038/s41574-019-0273-8; Lee JW, 2018, MOLECULES, V23, DOI 10.3390/molecules23082062; Lee TC, 1999, J CLIN ENDOCR METAB, V84, P2104, DOI 10.1210/jc.84.6.2104; Li L, 2005, TOXICON, V46, P533, DOI 10.1016/j.toxicon.2005.06.025; Liu WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22819; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mallia V, 2020, TOXINS, V12, DOI 10.3390/toxins12040228; Mallia V, 2019, MAR DRUGS, V17, DOI 10.3390/md17110643; Merel S, 2013, ENVIRON INT, V59, P303, DOI 10.1016/j.envint.2013.06.013; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Niedermeyer THJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091476; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Organisation for Economic Co-operation and Development (OECD), 2018, REV GUID DOC 150 STA; Oziol L, 2010, J HAZARD MATER, V174, P610, DOI 10.1016/j.jhazmat.2009.09.095; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Portmann C, 2008, J NAT PROD, V71, P1891, DOI 10.1021/np800409z; Portmann C, 2008, J NAT PROD, V71, P1193, DOI 10.1021/np800118g; RAINEY WE, 1994, MOL CELL ENDOCRINOL, V100, P45, DOI 10.1016/0303-7207(94)90277-1; RAINEY WE, 1993, J CLIN ENDOCR METAB, V77, P731, DOI 10.1210/jc.77.3.731; Rogers ED, 2011, ENVIRON SCI TECHNOL, V45, P1962, DOI 10.1021/es103538b; Sanderson JT, 2002, TOXICOL APPL PHARM, V182, P44, DOI 10.1006/taap.2002.9420; Stefanelli M, 2014, CHEM-BIOL INTERACT, V215, P54, DOI 10.1016/j.cbi.2014.03.006; Stepankova T, 2011, AQUAT TOXICOL, V105, P497, DOI 10.1016/j.aquatox.2011.08.002; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Sychrova E, 2012, ENVIRON INT, V39, P134, DOI 10.1016/j.envint.2011.10.004; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Tonk L, 2009, HARMFUL ALGAE, V8, P219, DOI 10.1016/j.hal.2008.05.005; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; Wang LH, 2013, ECOTOXICOLOGY, V22, P1555, DOI 10.1007/s10646-013-1141-2; Wang LK, 2020, TOXINS, V12, DOI 10.3390/toxins12050282; Weisser JJ, 2016, ANAL BIOANAL CHEM, V408, P4883, DOI 10.1007/s00216-016-9575-z; World Health Organization, 2017, DEPR OTH COMM MENT D; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; YOSHIZAWA S, 1990, J CANCER RES CLIN, V116, P609, DOI 10.1007/BF01637082; Zhao YY, 2015, CHEMOSPHERE, V120, P115, DOI 10.1016/j.chemosphere.2014.06.028; 2011, PLACENTA S2, V32, P81	69	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244000	10.1371/journal.pone.0244000	http://dx.doi.org/10.1371/journal.pone.0244000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320886	Green Published, gold			2022-12-26	WOS:000600339800028
J	Bassis, S; Fischer, S; Kohler, H; Reinhold, P				Bassis, Stefanie; Fischer, Sina; Koehler, Heike; Reinhold, Petra			Acid-base variables in acute and chronic form of nontuberculous mycobacterial infection in growing goats experimentally inoculated with Mycobacterium avium subsp. hominissuis or Mycobacterium avium subsp. paratuberculosis	PLOS ONE			English	Article							ANION GAP; PATHOLOGICAL-CHANGES; BLOOD-CHEMISTRY; CARBON-DIOXIDE; SEPTIC SHOCK; ANIMALS BODY; SERUM; PROTEIN; PH; MODEL	In current literature, data assessing the acid-base equilibrium in animals and humans during bacterial infection are rare. This study aimed to evaluate acid-base deteriorations in growing goats with experimentally induced NTM (nontuberculous mycobacteria) infections by application of the traditional Henderson-Hasselbalch approach and the strong ion model. NTM-challenged animals were orally inoculated with either Mycobacterium avium subsp. hominissuis (MAH; n = 18) or Mycobacterium avium subsp. paratuberculosis (MAP; n = 48). Twenty-five goats served as non-infected controls. Until 51(st) week post-inoculation (wpi), blood gas analysis, serum biochemical analysis, and serum electrophoresis were performed on venous blood. Fifty percent (9/18) of goats inoculated with MAH developed acute clinical signs like apathy, fever, and diarrhea. Those animals died or had to be euthanized within 11 weeks post-inoculation. This acute form of NTM-infection was characterized by significantly lower concentrations of sodium, calcium, albumin, and total protein, as well as significantly higher concentrations of gamma globulin, associated with reduced albumin/globulin ratio. Acid-base status indicated alkalosis, but normal base excess and HCO3- concentrations, besides significantly reduced levels of SID (strong ion difference), A(tot Alb) (total plasma concentration of weak non-volatile acids, based on albumin), A(tot TP) (A(tot) based on total protein) and markedly lower SIG (strong ion gap). The remaining fifty percent (9/18) of MAH-infected goats and all goats challenged with MAP survived and presented a more sub-clinical, chronic form of infection mainly characterized by changes in serum protein profiles. With the progression of the disease, concentrations of gamma globulin, and total protein increased while albumin remained lower compared to controls. Consequently, significantly reduced albumin/globulin ratio and lower A(tot Alb) as well as higher A(tot TP) were observed. Changes were fully compensated with no effect on blood pH. Only the strong ion variables differentiated alterations in acid-base equilibrium during acute and chronic NTM-infection.	[Bassis, Stefanie; Fischer, Sina; Koehler, Heike; Reinhold, Petra] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Koehler, Heike] Natl Reference Lab ParaTB, Jena, Germany; [Bassis, Stefanie] Univ Vet Med Vienna, Clin Unit Anesthesiol & Perioperat Intens Care Me, Emergency Clin Small Anim, Vienna, Austria; [Fischer, Sina] Chem & Vet Invest Off CVUA Karlsruhe, Karlsruhe, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; University of Veterinary Medicine Vienna	Reinhold, P (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany.	petra.reinhold@fli.de						Agdestein A, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-46; Agdestein A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-63; [Anonymous], 2002, ACHAEMENID HIST, V12, P113; AUSTIN WH, 1963, J APPL PHYSIOL, V18, P301, DOI 10.1152/jappl.1963.18.2.301; Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086; Bidani A, 1998, LUNG, V176, P111, DOI 10.1007/PL00007593; Borrmann E, 2011, VET MICROBIOL, V152, P101, DOI 10.1016/j.vetmic.2011.04.002; CAMERON JN, 1989, PHYSIOL ZOOL, V62, P845, DOI 10.1086/physzool.62.4.30157933; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Constable P.D., 2000, VET CLIN PATHOL, V29, P1; Constable PD, 2005, J VET INTERN MED, V19, P581, DOI 10.1892/0891-6640(2005)19[581:UOAQSI]2.0.CO;2; Constable PD, 1997, J APPL PHYSIOL, V83, P297, DOI 10.1152/jappl.1997.83.1.297; Constable PD, 1997, J VET INTERN MED, V11, P71, DOI 10.1111/j.1939-1676.1997.tb00076.x; Constable PD, 1998, AM J VET RES, V59, P881; Cullen GE, 1925, J BIOL CHEM, V66, P301; Day TK, 2002, VET CLIN N AM-SMALL, V32, P1031, DOI 10.1016/S0195-5616(02)00035-9; Elisaf M, 1993, Eur J Med, V2, P404; Feldman M, 2005, J LAB CLIN MED, V146, P317, DOI 10.1016/j.lab.2005.07.008; Fencl V, 2000, AM J RESP CRIT CARE, V162, P2246, DOI 10.1164/ajrccm.162.6.9904099; FENCL V, 1993, RESP PHYSIOL, V91, P1, DOI 10.1016/0034-5687(93)90085-O; Figge J, 1998, CRIT CARE MED, V26, P1807, DOI 10.1097/00003246-199811000-00019; Funk GC, 2007, WIEN KLIN WOCHENSCHR, V119, P390, DOI 10.1007/s00508-007-0811-6; Haist V, 2008, EMERG INFECT DIS, V14, P988, DOI 10.3201/eid1406.071463; Heming TA, 2001, CLIN SCI, V101, P267, DOI 10.1042/CS20010139; Herdt TH, 2013, CUNNINGHAMS TXB VET, P297; HERRMANN FR, 1992, ARCH INTERN MED, V152, P125, DOI 10.1001/archinte.152.1.125; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Johansen TB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189649; Kellum JA, 2005, CRIT CARE, V9, P500, DOI 10.1186/cc3789; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; KELLUM JA, 1995, J APPL PHYSIOL, V78, P2212, DOI 10.1152/jappl.1995.78.6.2212; Klang A, 2014, WIEN TIERARZTL MONAT, V101, P74; Kriz P, 2010, EMERG INFECT DIS, V16, P1328, DOI 10.3201/eid1608.100097; Kruger C, 2015, VET PATHOL, V52, P276, DOI 10.1177/0300985814533804; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; LOKEN HF, 1960, J BIOL CHEM, V235, P3654; MCAULIFFE JJ, 1986, AM J MED, V81, P86, DOI 10.1016/0002-9343(86)90187-7; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; Noritomi DT, 2009, CRIT CARE MED, V37, P2733, DOI 10.1097/CCM.0b013e3181a59165; Ostermann C, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-10; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Putnam RW, 1991, WHICH VALUE 1 DISSOC; Raphael KL, 2016, CLIN J AM SOC NEPHRO, V11, P308, DOI 10.2215/CJN.06200615; Redlberger S, 2017, VET J, V229, P45, DOI 10.1016/j.tvjl.2017.10.017; Reinhold P, 2010, VET J, V184, P212, DOI 10.1016/j.tvjl.2009.02.005; Robinson NE, 2013, CUNNINGHAMS TXB VET, P549; ROSSING TH, 1986, J APPL PHYSIOL, V61, P2260, DOI 10.1152/jappl.1986.61.6.2260; Schinkothe J, 2016, J COMP PATHOL, V155, P218, DOI 10.1016/j.jcpa.2016.06.008; Schinkothe J, 2016, COMP IMMUNOL MICROB, V47, P41, DOI 10.1016/j.cimid.2016.05.006; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith I, 2001, INTENS CARE MED, V27, P74, DOI 10.1007/s001340051352; Stampfli HR, 2014, VET CLIN PATH, V43, P547, DOI 10.1111/vcp.12200; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; STOGDALE L, 1981, J S AFR VET ASSOC, V52, P155; STOGDALE L, 1981, J S AFR VET ASSOC, V52, P57; van Coppenraet LESB, 2008, EUR J CLIN MICROBIOL, V27, P293, DOI 10.1007/s10096-007-0440-z; Van Slyke DD, 1928, J BIOL CHEM, V78, P765; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Wilkes P, 1998, J APPL PHYSIOL, V84, P1740, DOI 10.1152/jappl.1998.84.5.1740; Willard MD, 2006, LABORDIAGNOSTIK KLEI, P305; Wohl JS, 1997, AM J VET RES, V58, P910; Zampieri FG, 2014, CRIT CARE, V18, DOI 10.1186/cc13993; 2014, INT J RES PHARM SCI, V4, P40	65	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243892	10.1371/journal.pone.0243892	http://dx.doi.org/10.1371/journal.pone.0243892			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315933	gold, Green Published			2022-12-26	WOS:000600186100026
J	McKechnie, S; Fletcher, D; Newman, J; Bragg, C; Dillingham, PW; Clucas, R; Scott, D; Uhlmann, S; Lyver, P; Gormley, A; Moller, H				McKechnie, Sam; Fletcher, David; Newman, Jamie; Bragg, Corey; Dillingham, Peter W.; Clucas, Rosemary; Scott, Darren; Uhlmann, Sebastian; Lyver, Phil; Gormley, Andrew; Moller, Henrik		Rakiura Titi Islands Administering	Separating the effects of climate, bycatch, predation and harvesting on tt (Ardenna grisea) population dynamics in New Zealand: A model-based assessment	PLOS ONE			English	Article							SHEARWATER PUFFINUS-GRISEUS; STATE-SPACE MODELS; SOOTY SHEARWATER; INTRODUCED PREDATORS; RAKIURA-MAORI; FISHERIES; ISLAND; CONSERVATION; SEABIRD; ALBATROSSES	A suite of factors may have contributed to declines in the tt (sooty shearwater; Ardenna grisea) population in the New Zealand region since at least the 1960s. Recent estimation of the magnitude of most sources of non-natural mortality has presented the opportunity to quantitatively assess the relative importance of these factors. We fit a range of population dynamics models to a time-series of relative abundance data from 1976 until 2005, with the various sources of mortality being modelled at the appropriate part of the life-cycle. We present estimates of effects obtained from the best-fitting model and using model averaging. The best-fitting models explained much of the variation in the abundance index when survival and fecundity were linked to the Southern Oscillation Index, with strong decreases in adult survival, juvenile survival and fecundity being related to El Nino-Southern Oscillation (ENSO) events. Predation by introduced animals, harvesting by humans, and bycatch in fisheries also appear to have contributed to the population decline. It is envisioned that the best-fitting models will form the basis for quantitative assessments of competing management strategies. Our analysis suggests that sustainability of the New Zealand tt population will be most influenced by climate, in particular by how climate change will affect the frequency and intensity of ENSO events in the future. Removal of the effects of both depredation by introduced predators and harvesting by humans is likely to have fewer benefits for the population than alleviating climate effects.	[McKechnie, Sam] Pacific Community, Noumea, New Caledonia; [Fletcher, David] David Fletcher Consulting Ltd, Karitane, Aotearoa, New Caledonia; [Newman, Jamie] Parliamentary Commissioner Environm, Wellington, Aotearoa, New Zealand; [Bragg, Corey] Tokona Ao Tribal Econ, Dunedin, Aotearoa, New Zealand; [Dillingham, Peter W.] Univ Otago, Dept Math & Stat, Dunedin, Aotearoa, New Zealand; [Uhlmann, Sebastian] Flanders Res Inst Agr Fisheries & Food, Fisheries & Aquat Prod, Oostende, Belgium; [Lyver, Phil; Gormley, Andrew] Manaaki Whenua Landcare Res, Lincoln, Aotearoa, New Zealand; [Moller, Henrik] Univ Otago, Ctr Sustainabil, Dunedin, Aotearoa, New Zealand	University of Otago; Institute For Agricultural & Fisheries Research; Landcare Research - New Zealand; University of Otago	Fletcher, D (corresponding author), David Fletcher Consulting Ltd, Karitane, Aotearoa, New Caledonia.	david@davidfletcher.consulting	Dillingham, Peter/AAC-6856-2022	Dillingham, Peter/0000-0001-6302-3275; Fletcher, David/0000-0003-1988-5796; Uhlmann, Sven Sebastian/0000-0003-2830-5845	New Zealand Ministry of Business, Innovation and Employment: Strategic Science Investment Fund [MWLR-2019/20]	New Zealand Ministry of Business, Innovation and Employment: Strategic Science Investment Fund	The New Zealand Ministry of Business, Innovation and Employment: Strategic Science Investment Fund (www.mbie.govt.nz) provided support for this study in the form of a grant awarded to PL (MWLR-2019/20). David Fletcher Consulting Limited provided support in the form of a salary to DF. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ER, 2019, 226 NZ MIN PRIM IND; Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; [Anonymous], 2000, MILL PULP PAP WEEK, V22, P5; Artukhin YB, 2010, ACCIDENTAL CATCH MAR; Baker GB, 2002, EMU, V102, P71, DOI 10.1071/MU01036; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Besbeas P, 2012, J R STAT SOC C-APPL, V61, P151, DOI 10.1111/j.1467-9876.2011.01012.x; Bragg C, 2007, 210 U OT WILDL MAN; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buckland ST, 2004, ECOL MODEL, V171, P157, DOI 10.1016/j.ecolmodel.2003.08.002; Caswell, 2000, MATRIX POPULATION MO; Clucas RJ, 2008, EMU, V108, P237, DOI 10.1071/MU07069; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Devney CA, 2009, ECOLOGY, V90, P1175, DOI 10.1890/08-0634.1; Dillingham P, 2007, 206 U OT WILDL; Dillingham PW, 2016, ECOL APPL, V26, P322, DOI 10.1890/14-1990; Dillingham PW, 2011, BIOL CONSERV, V144, P1885, DOI 10.1016/j.biocon.2011.04.014; Fasiolo M, 2016, STAT SCI, V31, P96, DOI 10.1214/15-STS534; Fletcher D, 2018, SPRINGERBRIEF STAT, P1, DOI 10.1007/978-3-662-58541-2; Fletcher D, 2013, CONDOR, V115, P465, DOI 10.1525/cond.2013.110151; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Gelman A, 2013, BAYESIAN DATA ANAL, V3rd; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Harper GA, 2007, WILDLIFE RES, V34, P443, DOI 10.1071/WR07037; Hawke D, 2003, J ROY SOC NEW ZEAL, V33, P497, DOI 10.1080/03014223.2003.9517740; Humphries GR, 2018, MACHINE LEARNING ECO, P263; Humphries GRW, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3182-1; Hunter CM, 2000, ECOL MODEL, V134, P299, DOI 10.1016/S0304-3800(00)00344-6; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jones C, 2000, NEW ZEAL J ZOOL, V27, P327, DOI 10.1080/03014223.2000.9518242; King R, 2010, INTERD STAT, P1; Linden A, 2009, OIKOS, V118, P675, DOI 10.1111/j.1600-0706.2008.17250.x; Ludwig SC, 2012, IBIS, V154, P74, DOI 10.1111/j.1474-919X.2011.01199.x; Lyver P. O'B., 2000, Pacific Conservation Biology, V5, P347; Lyver PO, 1999, MAR ECOL PROG SER, V188, P237, DOI 10.3354/meps188237; Lyver POB, 2002, WILDLIFE SOC B, V30, P29; Magnusson A, 2007, FISH FISH, V8, P337, DOI 10.1111/j.1467-2979.2007.00258.x; Mckechnie S, 2007, J WILDLIFE MANAGE, V71, P1325, DOI 10.2193/2006-018; McKechnie S, 2006, NEW ZEAL J ZOOL, V33, P259, DOI 10.1080/03014223.2006.9518455; Mckechnie S, 2010, J WILDLIFE MANAGE, V74, P828, DOI 10.2193/2007-530; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Millar RB, 2000, CAN J FISH AQUAT SCI, V57, P43, DOI 10.1139/f99-169; Moller H, 2006, DONG WU XUE BAO, V52, P649; Nevins HM, 2009, J ROY SOC NEW ZEAL, V39, P183, DOI 10.1080/03014220909510576; Newman J, 2009, NEW ZEAL J ZOOL, V36, P307, DOI 10.1080/03014220909510157; Newman J, 2009, WILDLIFE RES, V36, P159, DOI 10.1071/WR06074; Newman KB, 2006, ECOL APPL, V16, P74, DOI 10.1890/04-0592; Orwin KH, 2016, OECOLOGIA, V180, P217, DOI 10.1007/s00442-015-3437-9; Owen-Smith N, 2006, ECOL MONOGR, V76, P93, DOI 10.1890/05-0765; Pedersen MW, 2011, ECOL MODEL, V222, P1394, DOI 10.1016/j.ecolmodel.2011.01.007; POLACHECK T, 1993, CAN J FISH AQUAT SCI, V50, P2597, DOI 10.1139/f93-284; Polansky L, 2008, THEOR ECOL-NETH, V1, P221, DOI 10.1007/s12080-008-0022-4; Polansky L, 2009, ECOLOGY, V90, P2313, DOI 10.1890/08-1461.1; PRINCE PA, 1994, IBIS, V136, P50, DOI 10.1111/j.1474-919X.1994.tb08131.x; R Core Team, 2021, R LANGUAGE ENV STAT; RICHDALE L. E., 1963, PROC ZOOL SOC LONDON, V141, P1; Robertson G, 2006, BIOL CONSERV, V132, P458, DOI 10.1016/j.biocon.2006.05.003; SCHNUTE JT, 1994, CAN J FISH AQUAT SCI, V51, P1676, DOI 10.1139/f94-168; Scofield R. Paul, 2002, Notornis, V49, P158; Scott Darren, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P185; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Snover ML, 2008, ECOL MODEL, V212, P545, DOI 10.1016/j.ecolmodel.2007.11.002; Spiridonov VA, 2004, DRIFTNET FISHERY SAL; Starfield A. M., 1986, BUILDING MODELS CONS; Thompson DR, 2015, MAR ECOL PROG SER, V521, P277, DOI 10.3354/meps11128; TROUP AJ, 1965, Q J ROY METEOR SOC, V91, P490, DOI 10.1002/qj.49709139009; Uhlmann S, 2005, BIOL CONSERV, V123, P151, DOI 10.1016/j.biocon.2004.11.003; Uhlmann SS, 2011, BIOL CONSERV, V144, P1859, DOI 10.1016/j.biocon.2011.02.025; Veit RR, 1997, GLOB CHANGE BIOL, V3, P23, DOI 10.1046/j.1365-2486.1997.d01-130.x; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Yao YL, 2018, BAYESIAN ANAL, V13, P917, DOI 10.1214/17-BA1091; Zydelis R, 2009, CONSERV BIOL, V23, P608, DOI 10.1111/j.1523-1739.2009.01172.x	74	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243794	10.1371/journal.pone.0243794	http://dx.doi.org/10.1371/journal.pone.0243794			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315952	gold, Green Published			2022-12-26	WOS:000600186100012
J	von Lassberg, C; Campos, JL; Beykirch, KA				von Lassberg, Christoph; Campos, Jennifer L.; Beykirch, Karl A.			Long term measures of vestibulo-ocular reflex function in high level male gymnasts and its possible role during context specific rotational tasks	PLOS ONE			English	Article							OCULAR REFLEX; EYE-MOVEMENTS; ADAPTATION; HABITUATION; SOMERSAULT; MOTION	In a prior publication, we described a previously unknown eye movement phenomenon during the execution of actively performed multiaxial rotations in high level gymnasts. This phenomenon was consistently observed during the phase of fast free flight rotations and was marked by a prolonged and complete suppression of nystagmus and gaze stabilizing "environment referenced eye movements" (EREM; such as the vestibulo-ocular reflex, optokinetic reflex, smooth pursuit and others). Instead, these eye movements were coupled with intersegmental body movements. We have therefore called it "spinal motor-coupled eye movements" (SCEM) and have interpreted the phenomenon to likely be caused by anti-compensatory functions of more proprioceptive mediated reflexes and perhaps other mechanisms (e.g., top-down regulation as part of a motor plan) to effectively cope with a new-orientation in space, undisturbed by EREM functions. In the phase before landing, the phenomenon was replaced again by the known gaze-stabilizing EREM functions. The present study specifically evaluated long-term measures of vestibulo-ocular reflex functions (VOR) in high level gymnasts and controls during both passively driven monoaxial rotations and context-specific multiaxial somersault simulations in a vestibular lab. This approach provided further insights into the possible roles of adaptive or mental influences concerning the VOR function and how they are associated with the described phenomenon of SCEM. Results showed high inter-individual variability of VOR function in both gymnasts and controls, but no systematic adaptation of the VOR in gymnasts, neither compared to controls nor over a period of three years. This might generally support the hypothesis that the phenomenon of SCEM might indeed be driven more by proprioceptively mediated and situationally dominant eye movement functions than by adaptative processes of the VOR.	[von Lassberg, Christoph] Univ Tubingen, Dept Sports Med, Med Clin, Tubingen, Germany; [Campos, Jennifer L.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Campos, Jennifer L.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Beykirch, Karl A.] Max Planck Inst Biol Cybernet, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Max Planck Society	von Lassberg, C (corresponding author), Univ Tubingen, Dept Sports Med, Med Clin, Tubingen, Germany.	cvl-lassberg@t-online.de			Bundesinstitut fur Sportwissenschaft, Bonn, Germany (Federal Institute of Sport Science) [AZ: VF0407/06/51/03-04, IIA1-070603/11]; University of Tubingen, Germany	Bundesinstitut fur Sportwissenschaft, Bonn, Germany (Federal Institute of Sport Science); University of Tubingen, Germany	This work was supported by the Bundesinstitut fur Sportwissenschaft, Bonn, Germany (Federal Institute of Sport Science; AZ: VF0407/06/51/03-04 and IIA1-070603/11). We further acknowledge support by Open Access Publishing Fund of University of Tubingen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SC, 2000, J VESTIBUL RES-EQUIL, V10, P17; Ahn SC, 2003, AVIAT SPACE ENVIR MD, V74, P285; Alpini D, 2009, SPORT SCI HLTH, V5, P129, DOI DOI 10.1007/S1S1332-009-00888-4; BALOH RW, 1982, AM J OTOLARYNG, V3, P235, DOI 10.1016/S0196-0709(82)80061-6; BALOH RW, 1980, AVIAT SPACE ENVIR MD, V51, P563; Bechert K, 1996, NEURO-OPHTHALMOLOGY, V16, P163, DOI 10.3109/01658109609009677; Beykirch K, 2006, 20032005 M PLANCK I, P43; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; COLLEWIJN H, 1989, PROG BRAIN RES, V80, P197; Curtis CE, 2003, J COGNITIVE NEUROSCI, V15, P409, DOI 10.1162/089892903321593126; Davlin CD, 2001, MOTOR CONTROL, V5, P337, DOI 10.1123/mcj.5.4.337; Eggers SDZ, 2003, ANN NY ACAD SCI, V1004, P94, DOI 10.1196/annals.1303.010; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Hartmann M, 2014, EXP BRAIN RES, V232, P1249, DOI 10.1007/s00221-014-3841-0; Heinen T, 2011, MOTOR CONTROL, V15, P267, DOI 10.1123/mcj.15.2.267; Hondzinski JM, 2001, MOTOR CONTROL, V5, P281, DOI 10.1123/mcj.5.3.281; JONES GM, 1984, EXP BRAIN RES, V56, P149; Koenig E, 1996, NEURO-OPHTHALMOLOGY, V16, P157, DOI 10.3109/01658109609009676; LEE DN, 1992, J EXP PSYCHOL HUMAN, V18, P1195, DOI 10.1037/0096-1523.18.4.1195; Lee MY, 2004, LARYNGOSCOPE, V114, P897, DOI 10.1097/00005537-200405000-00021; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lewis RF, 2003, CEREBELLUM, V2, P123, DOI 10.1080/14734220309407; Luis M, 2008, MOTOR CONTROL, V12, P210, DOI 10.1123/mcj.12.3.210; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Natrup J, 2020, HUM MOVEMENT SCI, V70, DOI 10.1016/j.humov.2020.102589; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; ORNITZ EM, 1985, ACTA OTO-LARYNGOL, V100, P180, DOI 10.3109/00016488509104780; Osterhammel P, 1968, Acta Otolaryngol, V66, P221, DOI 10.3109/00016486809126289; Osterhammel P, 1968, Acta Otolaryngol, V66, P145, DOI 10.3109/00016486809126282; Quarck G, 2015, SCI MOTRICITE, V55, P101; Sakaguchi M, 1997, ACTA OTO-LARYNGOL, P70; Sato Y, 2017, PERCEPT MOTOR SKILL, V124, P248, DOI 10.1177/0031512516676148; SCHWARZ U, 1989, AVIAT SPACE ENVIR MD, V60, P755; Shelhamer M, 1992, J Vestib Res, V2, P89; Stangl W., 2000, LEISTUNGSSPORT, V30, P58; Tanguy S, 2008, EUR J APPL PHYSIOL, V104, P1031, DOI 10.1007/s00421-008-0859-7; von Lassberg C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095450; von Lassberg C, 2012, MOTOR CONTROL, V16, P176, DOI 10.1123/mcj.16.2.176; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243752	10.1371/journal.pone.0243752	http://dx.doi.org/10.1371/journal.pone.0243752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315913	gold, Green Published			2022-12-26	WOS:000600186100064
J	Chen, C; Chen, JM; Wang, Y; Liu, ZG; Wu, YL				Chen, Chao; Chen, Jingmeng; Wang, Yan; Liu, Zuguo; Wu, Yalin			Ferroptosis drives photoreceptor degeneration in mice with defects in all-trans-retinal clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-PEROXIDASE 4; CELL-DEATH; LIPID-PEROXIDATION; MECHANISM; DISEASE; PROTEIN; DAMAGE; METABOLISM; IDENTIFICATION; RETINOPATHY	The death of photoreceptor cells in dry age-related macular degeneration (AMD) and autosomal recessive Stargardt disease (STGD1) is closely associated with disruption in all-transretinal (atRAL) clearance in neural retina. In this study, we reveal that the overload of atRAL leads to photoreceptor degeneration through activating ferroptosis, a nonapoptotic form of cell death. Ferroptosis of photoreceptor cells induced by atRAL resulted from increased ferrous ion (Fe2+), elevated ACSL4 expression, system Xc(-) inhibition, and mitochondrial destruction. Fe2+ overload, tripeptide glutathione (GSH) depletion, and damaged mitochondria in photoreceptor cells exposed to atRAL provoked reactive oxygen species (ROS) production, which, together with ACSL4 activation, promoted lipid peroxidation and thereby evoked ferroptotic cell death. Moreover, exposure of photoreceptor cells to atRAL activated COX2, a well-accepted biomarker for ferroptosis onset. In addition to GSH supplement, inhibiting either Fe2+ by deferoxamine mesylate salt (DFO) or lipid peroxidation with ferrostatin-1 (Fer-1) protected photoreceptor cells from ferroptosis caused by atRAL. Abca4(-/-)Rdh8(-/-) mice exhibiting defects in atRAL clearance is an animal model for dry AMD and STGD1. We observed that ferroptosis was indeed present in neural retina of Abca4(-/-)Rdh8(-/-) mice after light exposure. More importantly, photoreceptor atrophy and ferroptosis in light-exposed Abca4(-/-)Rdh8(-/-) mice were effectively alleviated by intraperitoneally injected Fer-1, a selective inhibitor of ferroptosis. Our study suggests that ferroptosis is one of the important pathways of photoreceptor cell death in retinopathies arising from excess atRAL accumulation and should be pursued as a novel target for protection against dry AMD and STGD1.	[Chen, Chao; Liu, Zuguo; Wu, Yalin] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Dept Ophthalmol, Xiangan Hosp,Eye Inst, Xiamen, Peoples R China; [Chen, Jingmeng] Xiamen Univ, Sch Med, Xiamen, Fujian, Peoples R China; [Wang, Yan] Southern Med Univ, Shenzhen Hosp, Dept Ophthalmol, Shenzhen, Guangdong, Peoples R China; [Wu, Yalin] Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Wu, Yalin] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Xiamen University; Xiamen University; Southern Medical University - China; Xiamen University; Xiamen University	Wu, YL (corresponding author), Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Dept Ophthalmol, Xiangan Hosp,Eye Inst, Xiamen, Peoples R China.; Wu, YL (corresponding author), Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China.; Wu, YL (corresponding author), Xiamen Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China.	yalinw@xmu.edu.cn		Chao, Chen/0000-0002-3191-0838	National Natural Science Foundation of China [81870671, 81570857]; Natural Science Foundation of Guangdong Province, China; Basic Research Program of Shenzhen [JCYJ20180306173025004]; XMU Training Program of Innovation and Enterpreneurship for Undergraduates	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Basic Research Program of Shenzhen; XMU Training Program of Innovation and Enterpreneurship for Undergraduates	This work was supported in part by grants from National Natural Science Foundation of China (Nos. 81870671 and 81570857, to Y. Wu), the Natural Science Foundation of Guangdong Province, China (to Y. Wu), the Basic Research Program of Shenzhen (No. JCYJ20180306173025004, to Y. Wu), and XMU Training Program of Innovation and Enterpreneurship for Undergraduates.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Ashraf A, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101494; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Carlson BA, 2016, REDOX BIOL, V9, P22, DOI 10.1016/j.redox.2016.05.003; Chang LC, 2018, CANCER LETT, V416, P124, DOI 10.1016/j.canlet.2017.12.025; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Cong L, 2019, EUR J MED CHEM, V166, P11, DOI 10.1016/j.ejmech.2019.01.039; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Coon KD, 2006, J ALZHEIMERS DIS, V9, P225; Daruwalla A, 2018, BIOCHEM J, V475, P3171, DOI 10.1042/BCJ20180193; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hassannia B, 2019, CANCER CELL, V35, P830, DOI 10.1016/j.ccell.2019.04.002; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; ISHII T, 1987, J CELL PHYSIOL, V133, P330, DOI 10.1002/jcp.1041330217; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Li HL, 2017, EXPERT OPIN INV DRUG, V26, P1103, DOI 10.1080/13543784.2017.1369042; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Liao CY, 2020, J BIOL CHEM, V295, P6958, DOI 10.1074/jbc.RA120.013189; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Liu X, 2016, INVEST OPHTH VIS SCI, V57, P1017, DOI 10.1167/iovs.15-18429; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2014, P NATL ACAD SCI USA, V111, pE1428, DOI 10.1073/pnas.1317986111; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Masutomi K, 2012, PHOTOCHEM PHOTOBIOL, V88, P1356, DOI 10.1111/j.1751-1097.2012.01129.x; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Miotto G, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101328; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Proneth B, 2019, CELL DEATH DIFFER, V26, P14, DOI 10.1038/s41418-018-0173-9; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Rando RR, 1996, CHEM BIOL, V3, P255, DOI 10.1016/S1074-5521(96)90105-2; Ren XY, 2017, ANTIOXID REDOX SIGN, V27, P989, DOI 10.1089/ars.2016.6925; Riveiro-Alvarez R, 2009, BRIT J OPHTHALMOL, V93, P1359, DOI 10.1136/bjo.2008.148155; Sawada O, 2014, EXP EYE RES, V123, P27, DOI 10.1016/j.exer.2014.04.003; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shu WT, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040112; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tang HX, 2019, INT J PHARMACEUT, V572, DOI 10.1016/j.ijpharm.2019.118782; Tsin A, 2018, J BIOL CHEM, V293, P13016, DOI 10.1074/jbc.AW118.003228; Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Xia CL, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01627-6; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Yanatori I, 2019, FREE RADICAL BIO MED, V133, P55, DOI 10.1016/j.freeradbiomed.2018.07.020; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yang YF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14324-x; Ye FH, 2019, AM J CANCER RES, V9, P730; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P1338, DOI 10.1016/j.bbrc.2016.08.124; Zhang CP, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2384-5; Zhang P, 2020, FREE RADICAL BIO MED, V152, P227, DOI 10.1016/j.freeradbiomed.2020.03.015	75	22	22	9	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100187	10.1074/jbc.RA120.015779	http://dx.doi.org/10.1074/jbc.RA120.015779			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334878	gold, Green Published			2022-12-26	WOS:000672866400165
J	Tiffner, A; Schober, R; Hoglinger, C; Bonhenry, D; Pandey, S; Lunz, V; Sallinger, M; Frischauf, I; Fahrner, M; Lindinger, S; Maltan, L; Berlansky, S; Stadlbauer, M; Schindl, R; Ettrich, R; Romanin, C; Derler, I				Tiffner, Adela; Schober, Romana; Hoeglinger, Carmen; Bonhenry, Daniel; Pandey, Saurabh; Lunz, Victoria; Sallinger, Matthias; Frischauf, Irene; Fahrner, Marc; Lindinger, Sonja; Maltan, Lena; Berlansky, Sascha; Stadlbauer, Michael; Schindl, Rainer; Ettrich, Rudiger; Romanin, Christoph; Derler, Isabella			CRAC channel opening is determined by a series of Orai1 gating checkpoints in the transmembrane and cytosolic regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTION MOLECULE-1 STIM1; STORE-OPERATED CHANNELS; ION SELECTIVITY; CALCIUM SENSOR; SOFTWARE NEWS; FORCE-FIELD; CA2+ SENSOR; ACTIVATION; BINDING; PROTEIN	The initial activation step in the gating of ubiquitously expressed Orai1 calcium (Ca2+) ion channels represents the activation of the Ca2+-sensor protein STIM1 upon Ca2+ store depletion of the endoplasmic reticulum. Previous studies using constitutively active Orai1 mutants gave rise to, but did not directly test, the hypothesis that STIM1-mediated Orai1 pore opening is accompanied by a global conformational change of all Orai transmembrane domain (TM) helices within the channel complex. We prove that a local conformational change spreads omnidirectionally within the Orai1 complex. Our results demonstrate that these locally induced global, opening-permissive TM motions are indispensable for pore opening and require clearance of a series of Orai1 gating checkpoints. We discovered these gating checkpoints in the middle and cytosolic extended TM domain regions. Our findings are based on a library of double point mutants that contain each one loss-of-function with one gain-of-function point mutation in a series of possible combinations. We demonstrated that an array of loss-of-function mutations are dominant over most gain-of-function mutations within the same as well as of an adjacent Orai subunit. We further identified inter- and intramolecular salt-bridge interactions of Orai subunits as a core element of an opening-permissive Orai channel architecture. Collectively, clearance and synergistic action of all these gating checkpoints are required to allow STIM1 coupling and Orai1 pore opening. Our results unravel novel insights in the preconditions of the unique fingerprint of CRAC channel activation, provide a valuable source for future structural resolutions, and help to understand the molecular basis of disease-causing mutations.	[Tiffner, Adela; Schober, Romana; Hoeglinger, Carmen; Lunz, Victoria; Sallinger, Matthias; Frischauf, Irene; Fahrner, Marc; Lindinger, Sonja; Maltan, Lena; Berlansky, Sascha; Stadlbauer, Michael; Romanin, Christoph; Derler, Isabella] Johannes Kepler Univ Linz, Inst Biophys, JKU Life Sci Ctr, Linz, Austria; [Bonhenry, Daniel; Pandey, Saurabh] Czech Acad Sci, Inst Microbiol, Ctr Nanobiol & Struct Biol, Nove Hrady, Czech Republic; [Schindl, Rainer] Med Univ Graz, Gottfried Schatz Res Ctr, Graz, Austria; [Ettrich, Rudiger] Larkin Univ, Coll Biomed Sci, Miami, FL USA; [Ettrich, Rudiger] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic; [Ettrich, Rudiger] Florida Int Univ, Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA	Johannes Kepler University Linz; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Medical University of Graz; Charles University Prague; State University System of Florida; Florida International University	Derler, I (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, JKU Life Sci Ctr, Linz, Austria.	Isabella.derler@jku.at	Ettrich, Rudi H/C-1463-2011; Pandey, Saurabh Kumar/H-8148-2014; Hoeglinger, Carmen/AAF-9364-2021; Derler, Isabella/B-7871-2019	Ettrich, Rudi H/0000-0001-8624-7706; Pandey, Saurabh Kumar/0000-0002-5923-5045; Lunz, Victoria/0000-0003-2272-9655; Derler, Isabella/0000-0002-4768-146X; Hoglinger, Carmen/0000-0002-2754-592X; Lindinger, Sonja/0000-0002-4199-0376; Fahrner, Marc/0000-0002-2689-0158; Frischauf, Irene/0000-0003-0661-2932; Tiffner, Adela/0000-0002-7529-4504	Linz Institute of Technology project [LIT-2018-05-SEE-111]; Austrian Science Fund (FWF) [P27641, P30567, P32851, P32947, P28701, P27263, P33283, P32075-B]; Czech Science Foundation [19-20728Y]; PhD program "NanoCell" [W1250]	Linz Institute of Technology project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Czech Science Foundation(Grant Agency of the Czech Republic); PhD program "NanoCell"	This work was supported in part by the Linz Institute of Technology project LIT-2018-05-SEE-111 and the Austrian Science Fund (FWF) projects P27641, P30567, and P32851 (to I. D.), P32947 (to M. F.), P32075-B (to I. F.), P28701 (to R. Schindl), P27263, P33283, and PhD program W1250 "NanoCell" (to C. R.). D. B. was supported by the Czech Science Foundation (19-20728Y).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bohm J, 2017, HUM MUTAT, V38, P426, DOI 10.1002/humu.23172; Bulla M, 2019, J PHYSIOL-LONDON, V597, P561, DOI 10.1113/JP277079; Butorac C, 2020, ADV EXP MED BIOL, V1131, P547, DOI 10.1007/978-3-030-12457-1_23; Butorac C, 2019, CELL CALCIUM, V79, P57, DOI 10.1016/j.ceca.2019.02.009; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Cai XY, 2018, J BIOL CHEM, V293, P12962, DOI 10.1074/jbc.RA118.003424; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Derler I, 2018, J BIOL CHEM, V293, P1259, DOI 10.1074/jbc.M117.812206; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Dong H, 2019, ISCIENCE, V16, P356, DOI 10.1016/j.isci.2019.05.041; Duboue-Dijon E, 2018, J PHYS CHEM B, V122, P3296, DOI 10.1021/acs.jpcb.7b09612; Endo Y, 2015, HUM MOL GENET, V24, P637, DOI 10.1093/hmg/ddu477; Fahrner M, 2018, J BIOL CHEM, V293, P1271, DOI 10.1074/jbc.M117.812693; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Frischauf I, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao0358; Frischauf I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1901; Fujiwara K, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-18; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; Hoth M, 2013, CURR TOP MEMBR, V71, P237, DOI 10.1016/B978-0-12-407870-3.00010-X; Hou XW, 2020, ELIFE, V9, DOI 10.7554/eLife.62772; Hou XW, 2018, ELIFE, V7, DOI 10.7554/eLife.36758; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kann ZR, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4894500; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kohagen M, 2014, J PHYS CHEM B, V118, P7902, DOI 10.1021/jp5005693; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krizova A, 2019, EUR BIOPHYS J BIOPHY, V48, P425, DOI 10.1007/s00249-019-01355-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Leontyev I, 2011, PHYS CHEM CHEM PHYS, V13, P2613, DOI 10.1039/c0cp01971b; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Liu XF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000096; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Palty R, 2017, CELL REP, V19, P1929, DOI 10.1016/j.celrep.2017.05.025; Palty R, 2016, J BIOL CHEM, V291, P334, DOI 10.1074/jbc.M115.685289; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3033, DOI 10.1113/jphysiol.2008.156885; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Pluharova E, 2013, J PHYS CHEM A, V117, P11766, DOI 10.1021/jp402532e; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sallinger M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124410; Schober R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax3194; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Srikanth S, 2013, CURR TOP MEMBR, V71, P181, DOI 10.1016/B978-0-12-407870-3.00008-1; Srikanth S, 2011, J BIOL CHEM, V286, P35318, DOI 10.1074/jbc.M111.265884; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.201912397; Yamashita M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14512; Yen M, 2018, J GEN PHYSIOL, V150, P1373, DOI 10.1085/jgp.201711985; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeung PSW, 2018, P NATL ACAD SCI USA, V115, pE5193, DOI 10.1073/pnas.1718373115; Yeung PSW, 2020, ELIFE, V9, DOI 10.7554/eLife.60751; Yeung PSW, 2020, J PHYSIOL-LONDON, V598, P1707, DOI 10.1113/JP276550; Yeung PSW, 2018, J GEN PHYSIOL, V150, P1352, DOI 10.1085/jgp.201812172; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YD, 2017, CELL CALCIUM, V63, P8, DOI 10.1016/j.ceca.2017.01.001; Zhou YD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13725; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625	89	13	13	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100224	10.1074/jbc.RA120.015548	http://dx.doi.org/10.1074/jbc.RA120.015548			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361160	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400202
J	van de Louw, A; Cohrs, A; Leslie, D				van de Louw, Andry; Cohrs, Austin; Leslie, Douglas			Incidence of sepsis and associated mortality within the first year after cancer diagnosis in middle aged adults: A US population based study	PLOS ONE			English	Article							SEPTIC SHOCK; EPIDEMIOLOGY; BACTEREMIA	Background The incidence of sepsis has been rising overall but updated data in cancer patients are lacking. After a cancer diagnosis, incidence of sepsis and overall mortality peak within the first year. However, how much sepsis contributes to mortality remains unclear. We used a multistate model approach to analyze the incidence, risk factors and associated mortality of sepsis within 1 year of cancer diagnosis in middle aged adults. Methods Analysis of a large US health insurance claims database (Marketscan) between 2005 and 2014. Patients with a new diagnosis of cancer who received chemotherapy were included. Within a year of diagnosis, we assessed inpatient admissions for sepsis based on ICD-9 codes and survival using hospitalizations, outpatient visits and prescriptions filled. Competing risk and multistate models were used to assess the incidence of sepsis and transition probabilities between cancer, sepsis and death. Results 119,379 patients (38.9% males), aged 55 (50-60) years, were included; 2,560 developed isolated sepsis, 477 severe sepsis and 1331 septic shock within 1 year, with associated hospital mortality of 14.8%, 30% and 46% respectively. The probability of sepsis increased between 2005 and 2014; at 1 year, its cumulative incidence was 3.7% with a probability of mortality after sepsis of 35.5% (95% CI 21.6%-50.9%). Age, male gender, Charlson comorbidity index, hematological malignancies and metastases at diagnosis were associated with sepsis and mortality. Conclusions Incidence and mortality of sepsis were 3.7% and 35.5% at 1 year after cancer diagnosis and were both associated with baseline patient and cancer characteristics.	[van de Louw, Andry] Penn State Hlth Milton S Hershey Med Ctr, Div Pulm & Crit Care Med, Hershey, PA 17033 USA; [Cohrs, Austin; Leslie, Douglas] Penn State Hlth Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	van de Louw, A (corresponding author), Penn State Hlth Milton S Hershey Med Ctr, Div Pulm & Crit Care Med, Hershey, PA 17033 USA.	avandelouw@pennstatehealth.psu.edu		Cohrs, Austin/0000-0002-4952-0045	Department of Medicine of the Penn State Health Milton S Hershey Medical Center	Department of Medicine of the Penn State Health Milton S Hershey Medical Center	AV and DL received an internal grant from the Department of Medicine of the Penn State Health Milton S Hershey Medical Center to fund this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Heron Melonie, 2015, Natl Vital Stat Rep, V64, P1; Lemiale V, 2020, CRIT CARE MED, V48, P822, DOI 10.1097/CCM.0000000000004322; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Meira-Machado L, 2009, STAT METHODS MED RES, V18, P195, DOI 10.1177/0962280208092301; Montassier E, 2013, EUR J CLIN MICROBIOL, V32, P841, DOI 10.1007/s10096-013-1819-7; Ngoma T, 2006, ANN ONCOL, V17, P9, DOI [10.1093/annonc.mdl983, 10.1093/annonc/mdl982]; Rhee C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7571; Roberts SCM, 2018, JAMA-J AM MED ASSOC, V319, P2497, DOI 10.1001/jama.2018.7675; Schelenz S, 2013, J ANTIMICROB CHEMOTH, V68, P1431, DOI 10.1093/jac/dkt002; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; De La Rica AS, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.59; te Marvelde L, 2020, AUST NZ J PUBL HEAL, V44, P53, DOI 10.1111/1753-6405.12935; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Wren AA, 2018, INFLAMM BOWEL DIS, V24, P2093, DOI 10.1093/ibd/izy222; Yadegarynia D, 2003, CLIN INFECT DIS, V37, P1144, DOI 10.1086/378305; Zaorsky NG, 2017, ANN ONCOL, V28, P400, DOI 10.1093/annonc/mdw604	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243449	10.1371/journal.pone.0243449	http://dx.doi.org/10.1371/journal.pone.0243449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370330	Green Published, gold			2022-12-26	WOS:000603611900100
J	Ibrahim, R; Gleich, DF				Ibrahim, Rania; Gleich, David F.			Local hypergraph clustering using capacity releasing diffusion	PLOS ONE			English	Article								Local graph clustering is an important machine learning task that aims to find a well-connected cluster near a set of seed nodes. Recent results have revealed that incorporating higher order information significantly enhances the results of graph clustering techniques. The majority of existing research in this area focuses on spectral graph theory-based techniques. However, an alternative perspective on local graph clustering arises from using max-flow and min-cut on the objectives, which offer distinctly different guarantees. For instance, a new method called capacity releasing diffusion (CRD) was recently proposed and shown to preserve local structure around the seeds better than spectral methods. The method was also the first local clustering technique that is not subject to the quadratic Cheeger inequality by assuming a good cluster near the seed nodes. In this paper, we propose a local hypergraph clustering technique called hypergraph CRD (HG-CRD) by extending the CRD process to cluster based on higher order patterns, encoded as hyperedges of a hypergraph. Moreover, we theoretically show that HG-CRD gives results about a quantity called motif conductance, rather than a biased version used in previous experiments. Experimental results on synthetic datasets and real world graphs show that HG-CRD enhances the clustering quality.	[Ibrahim, Rania; Gleich, David F.] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ibrahim, R (corresponding author), Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA.	ibrahimr@purdue.edu			NSF [IIS-1546488, CCF-1909528]; NASA; Sloan Foundation; NSF Center for Science of Information STC [CCF-0939370, DE-SC0014543]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Sloan Foundation(Alfred P. Sloan Foundation); NSF Center for Science of Information STC	This work is supported by NSF awards IIS-1546488, CCF-1909528 NSF Center for Science of Information STC, CCF-0939370, DE-SC0014543, NASA, and the Sloan Foundation.	Agarwal S., 2006, P 23 INT C MACH LEAR, P17, DOI DOI 10.1145/1143844.1143847; Andersen R, 2006, ANN IEEE SYMP FOUND, P475; Andersen R, 2008, PROCEEDINGS OF THE NINETEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P651; [Anonymous], 2020, ZENODO, V21, P1; Benson AR, 2018, P NATL ACAD SCI USA, V115, pE11221, DOI 10.1073/pnas.1800683115; Chung F, 2007, LINEAR ALGEBRA APPL, V423, P22, DOI 10.1016/j.laa.2006.07.018; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Fountoulakis K, 2017, P IEEE, V105, P256, DOI 10.1109/JPROC.2016.2637349; Ghahramani Z., 2003, INT C MACH LEARN, P912, DOI DOI 10.1/1/14/4312; Gleich D. F., 2016, HDB MODERN STAT METH, P191, DOI [10.1201/b19567-17, DOI 10.1201/B19567-17]; Gleich DF, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P359, DOI 10.1145/2783258.2783376; GOLDBERG AV, 1988, J ACM, V35, P921, DOI 10.1145/48014.61051; Guo XD, 2018, DESTECH TRANS ENVIR, P223; Hein M., 2013, ADV NEURAL INFORM PR, P2427, DOI DOI 10.5555/2999792.2999883; Kloumann IM, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1366, DOI 10.1145/2623330.2623621; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lang K, 2004, LECT NOTES COMPUT SC, V3064, P325; Lang K., 2005, ADV NEURAL INFORM PR, P715; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Li P, 2017, ADV NEUR IN, V30; Mahoney MW, 2012, J MACH LEARN RES, V13, P2339; Orecchia L., 2014, PROC 25 ANN ACM SIAM, P1267; Pan J-Y, 2004, P 10 ACM SIGKDD INT, P653, DOI 10.1145/1014052.1014135; Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001; Spielman DA, 2013, SIAM J COMPUT, V42, P1, DOI 10.1137/080744888; Tsourkakis CE, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1451, DOI 10.1145/3038912.3052653; Veldt N, 2020, HYPERGRAPH CUTS GEN; Veldt N, 2018, ARXIV181112280; Veldt N, 2020, ARXIV200209441; Veldt N, 2016, PR MACH LEARN RES, V48; Wang D, 2017, PR MACH LEARN RES, V70; Yin H, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P555, DOI 10.1145/3097983.3098069; Zhou D, 2007, 2007 IEEE NORTH-EAST WORKSHOP ON CIRCUITS AND SYSTEMS, P167, DOI 10.1109/CADCG.2007.4407875; Zhu Z. A., 2013, PROC INT C MACH LEAR, P396	35	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243485	10.1371/journal.pone.0243485	http://dx.doi.org/10.1371/journal.pone.0243485			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362247	Green Published, gold, Green Submitted			2022-12-26	WOS:000603071600051
J	Bitew, MS; Zewde, MF; Wubetu, M; Alemu, AA				Bitew, Mezinew Sintayehu; Zewde, Maereg Fekade; Wubetu, Muluken; Alemu, Addisu Alehegn			Consumption of alcohol and binge drinking among pregnant women in Addis Ababa, Ethiopia: Prevalence and determinant factors	PLOS ONE			English	Article							SPECTRUM DISORDERS; CHILDBEARING AGE; SOCIAL SUPPORT; SUBSTANCE USE; RISK; EXPOSURE; HEALTH; OUTCOMES; SMOKING; 1ST	Introduction People in Ethiopia, including pregnant women, highly consume both home-made and manufactured alcohol beverages due to lack of awareness about the harmful effect of risky alcohol use, and cultural acceptance of alcohol consumption. Alcohol consumption and other hazardous patterns of use like binge drinking have tremendous adverse effects on fetus and mothers. Therefore, this study aimed to assess the magnitude of alcohol consumption, binge drinking and its determinants among pregnant women residing in Kolfe sub-city, Addis Ababa, Ethiopia. Methods Institutional based cross-sectional study was conducted among a total of 367 pregnant women. The participants were selected using a systematic random sampling method. Data were collected through a structured questionnaire. A binary logistic regression was conducted using SPSS version 20 software to identify determinants of alcohol consumption and binge drinking. A p-value < 0.05 was used to declare a statistical significance in multiple logistic regression. The results were described using adjusted odds ratio with a 95% confidence interval. Results This study revealed that the prevalence of alcohol consumption, binge drinking, and weekly alcohol consumption of four or more units among pregnant women was 39.78%, 3.54% and 4.9%, respectively. Not having formal education [AOR 95% CI = 8.47 (2.42, 29.62), having primary education [AOR 95% CI = 4.26 (1.23, 14.74), being a housewife [AOR 95% CI = 4.18 (2.13, 8.22), having an unplanned pregnancy [AOR 95% CI = 2.47(1.33, 4.60), having a history of abortion [AOR 95% CI = 3.33 (1.33, 6.05)], not having awareness about the harmful effect of alcohol consumption [AOR 95% CI = 4.66 (2.53, 8.61)], and not having family social support [AOR 95% CI = 2(1.14,3.53) were determinants of alcohol consumption among pregnant women. Conclusions This study found a high level of alcohol consumption among pregnant women. Interventions to create awareness on the harmful effects of alcohol are needed. Moreover, strengthening social support during pregnancy and family planning services to reduce unplanned pregnancy and abortion should be considered.	[Bitew, Mezinew Sintayehu] Debre Markos Univ, Dept Mental Hlth, Debre Markos, Amhara, Ethiopia; [Zewde, Maereg Fekade] Addis Ababa City Adm Hlth Bur, Dept Maternal & Child Hlth, Addis Ababa, Ethiopia; [Wubetu, Muluken] Debre Markos Univ, Dept Pharm, Debre Markos, Amhara, Ethiopia; [Alemu, Addisu Alehegn] Debre Markos Univ, Dept Midwifery, Debre Markos, Amhara, Ethiopia		Bitew, MS (corresponding author), Debre Markos Univ, Dept Mental Hlth, Debre Markos, Amhara, Ethiopia.	sintayehume@gmail.com	Alemu, Addisu Alehegn/AFP-1663-2022	Alemu, Addisu Alehegn/0000-0001-6415-6635; Sintayehu Bitew, Mezinew/0000-0002-4134-8543				Abebe H, 2011, ISOLATION CHARACTERI; Adusi-Poku Y, 2012, AFR J REPROD HEALTH, V16, P1; Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; [Anonymous], 2009, AM J TRANSPLANTAT S3, V9, pS1; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Anteab K, 2014, ASSESSMENT PREVALENC, V2014; Bailey BN, 2004, AM J OBSTET GYNECOL, V191, P1037, DOI 10.1016/j.ajog.2004.05.048; BARNET B, 1995, PEDIATRICS, V96, P659; Barthelemy T-U, 2011, OPEN J OBSTET GYNECO, V1, P208, DOI DOI 10.4236/ojog.2011.14040; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Butt P., 2011, ALCOHOL HLTH CANADA; Coleman PK, 2005, BRIT J HEALTH PSYCH, V10, P255, DOI 10.1348/135910705X25499; Coles CD, 2006, J PEDIATR PSYCHOL, V31, P1, DOI 10.1093/jpepsy/jsj036; Demographic N, 2012, HLTH SURV 2011; Dupraz J, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13795; English L, 2015, J OBSTET GYNAECOL CA, V37, P901, DOI 10.1016/S1701-2163(16)30027-5; Goldschmidt L, 2004, NEUROTOXICOL TERATOL, V26, P521, DOI 10.1016/j.ntt.2004.04.003; HARLAP S, 1980, LANCET, V2, P173, DOI 10.1016/S0140-6736(80)90061-6; Haynes G, 2003, NEUROTOXICOL TERATOL, V25, P659, DOI 10.1016/j.ntt.2003.07.003; Isaksen AB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0630-0; Jr IW, 2009, AM J MED S, V122, pS3; Kalberg WO, 2006, ALCOHOL CLIN EXP RES, V30, P2037, DOI 10.1111/j.1530-0277.2006.00250.x; Kesmodel U, 2002, AM J EPIDEMIOL, V155, P305, DOI 10.1093/aje/155.4.305; Kesmodel U, 2002, ALCOHOL ALCOHOLISM, V37, P87, DOI 10.1093/alcalc/37.1.87; Kesmodel U, 2001, AM J EPIDEMIOL, V154, P777, DOI 10.1093/aje/154.8.777; Lekettey JD, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0384-4; Linell A, 2013, SCAND J PUBLIC HEALT, V41, P3, DOI 10.1177/1403494812466989; Manning MA, 2007, NEUROSCI BIOBEHAV R, V31, P230, DOI 10.1016/j.neubiorev.2006.06.016; Mardby AC, 2017, WOMEN BIRTH, V30, pE207, DOI 10.1016/j.wombi.2017.01.003; McGee CL, 2009, NEUROTOXICOL TERATOL, V31, P71, DOI 10.1016/j.ntt.2008.09.004; McNamara TK, 2006, J WOMENS HEALTH, V15, P70, DOI 10.1089/jwh.2006.15.70; MOHAMMED MA, 2013, J APP PHARM SCI, V3, P116, DOI DOI 10.7324/JAPS.2013.3421; Muckle G, 2011, ALCOHOL CLIN EXP RES, V35, P1081, DOI 10.1111/j.1530-0277.2011.01441.x; Namagembe I, 2010, MATERN CHILD HLTH J, V14, P492, DOI 10.1007/s10995-009-0500-3; Nykjaer C, 2014, J EPIDEMIOL COMMUN H, V68, P542, DOI 10.1136/jech-2013-202934; Odejide AO, 2006, INT J MENT HEALTH AD, V4, P87, DOI DOI 10.1007/S11469-006-9015-Y; Onah MN, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0070-x; Onwuka CI, 2016, J CLIN DIAGN RES, V10, pQC10, DOI 10.7860/JCDR/2016/21036.8449; Ordinioha B, 2015, NIGER J CLIN PRACT, V18, P13, DOI 10.4103/1119-3077.146966; Popova S, 2017, EUR J MED GENET, V60, P32, DOI 10.1016/j.ejmg.2016.09.010; Popova S, 2016, TROP MED INT HEALTH, V21, P1209, DOI 10.1111/tmi.12755; Poznyak V, 2015, TACKLING HARMFUL ALC, V81; Rasch V, 2003, ACTA OBSTET GYN SCAN, V82, P182, DOI 10.1034/j.1600-0412.2003.00078.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Seiler NK, 2016, PUBLIC HEALTH REP, V131, P623, DOI 10.1177/0033354916662222; Seyoum G, 1995, RAPID ASSESSMENT SIT, P9; Skeen S, 2010, INT REV PSYCHIATR, V22, P624, DOI 10.3109/09540261.2010.535509; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Statistical Agency C International I. Ethiopia, 2011, ETHIOPIA; Sudhinaraset M, 2016, ALCOHOL RES CURR REV; Tan CH, 2015, MMWR-MORBID MORTAL W, V64, P1042, DOI 10.15585/mmwr.mm6437a3; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; White H.R., 2016, OXFORD HDB SUBSTANCE, V2; Williams AD, 2013, BIRTH DEFECTS RES A, V97, P489, DOI 10.1002/bdra.23127; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243784	10.1371/journal.pone.0243784	http://dx.doi.org/10.1371/journal.pone.0243784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351815	Green Published, gold			2022-12-26	WOS:000603071400001
J	Ehrenfeld, V; Heusel, JR; Fulda, S; van Wijk, SJL				Ehrenfeld, Vanessa; Heusel, Jan R.; Fulda, Simone; van Wijk, Sjoerd J. L.			ATM inhibition enhances Auranofin-induced oxidative stress and cell death in lung cell lines	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; DNA-DAMAGE; THIOREDOXIN; ACTIVATION; GLUTAREDOXIN; PROGRESSION; DISEASE; SYSTEM	Ataxia-Telangiectasia (A-T), a pleiotropic chromosomal breakage syndrome, is caused by the loss of the kinase Ataxia-telangiectasia mutated (ATM). ATM is not only involved in the response to DNA damage, but also in sensing and counteracting oxidative stress. Since a disturbed redox balance has been implicated in the pathophysiology of A-T lung disease, we aimed to further explore the interplay between ATM and oxidative stress in lung cells. Using a kinetic trapping approach, we could demonstrate an interaction between the trapping mutant TRX1-CS and ATM upon oxidative stress. We could further show that combined inhibition of thioredoxin reductase (TrxR) and ATM kinase activity, using Auranofin and KU55933 respectively, induced an increase in cellular reactive oxygen species (ROS) levels and protein oxidation in lung cells. Furthermore, ATM inhibition sensitized lung cells to Auranofin-induced cell death that could be rescued by ROS scavengers. As a consequence, targeted reduction of ATM by TRX1 could serve as a regulator of oxidative ATM activation and contribute to the maintenance of the cellular redox homeostasis. These results highlight the importance of the redox-active function of ATM in preventing ROS accumulation and cell death in lung cells.	[Ehrenfeld, Vanessa; Heusel, Jan R.; Fulda, Simone; van Wijk, Sjoerd J. L.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Frankfurt, Germany; [Fulda, Simone] Partner Site Frankfurt, German Canc Consortium DKTK, Frankfurt, Germany; [Fulda, Simone] German Canc Res Ctr, Heidelberg, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	van Wijk, SJL (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Frankfurt, Germany.	s.wijk@kinderkrebsstiftung-frankfurt.de	van Wijk, Sjoerd/AAL-6680-2021	van Wijk, Sjoerd/0000-0001-6532-7651; Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft [SFB 815, FU 436/21-1]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work has been supported by grants from the Deutsche Forschungsgemeinschaft (https://www.dfg.de), grant numbers SFB 815 (to S.F and to V.E.) and FU 436/21-1 (to S.F. and S.J.L. v.W.) Bundesministerium fur Bildung und Forschung (https://www.bmbf.de), no grant number available (to S.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; Arodin L, 2014, FREE RADICAL BIO MED, V73, P328, DOI 10.1016/j.freeradbiomed.2014.05.011; Arodin L, 2014, J ALZHEIMERS DIS, V39, P787, DOI 10.3233/JAD-131814; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Duecker R, 2018, REDOX BIOL, V14, P645, DOI 10.1016/j.redox.2017.11.006; Fulda S, 1997, CANCER RES, V57, P3823; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hampton MB, 2018, ANTIOXID REDOX SIGN, V28, P591, DOI 10.1089/ars.2017.7422; Hastings TG, 2009, J BIOENERG BIOMEMBR, V41, P469, DOI 10.1007/s10863-009-9257-z; Haydn T, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.239; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kamsler A, 2001, CANCER RES, V61, P1849; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Maciejczyk M, 2017, REDOX BIOL, V11, P375, DOI 10.1016/j.redox.2016.12.030; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MCFARLIN DE, 1972, MEDICINE, V51, P281, DOI 10.1097/00005792-197207000-00002; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; Reliene R, 2004, CANCER RES, V64, P5148, DOI 10.1158/0008-5472.CAN-04-0442; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Rotman G, 1997, BIOESSAYS, V19, P911, DOI 10.1002/bies.950191011; Schroeder SA, 2005, PEDIATR PULM, V39, P537, DOI 10.1002/ppul.20209; Schroeder SA, 2014, PEDIATR PULM, V49, P389, DOI 10.1002/ppul.22817; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Taylor AMR, 2015, CLIN GENET, V87, P199, DOI 10.1111/cge.12453; Yin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024080; Zhang YC, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaq0702	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244060	10.1371/journal.pone.0244060	http://dx.doi.org/10.1371/journal.pone.0244060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338048	Green Published, gold			2022-12-26	WOS:000601313500022
J	Paz, S; Mauer, C; Ritchie, A; Robishaw, JD; Caputi, M				Paz, Sean; Mauer, Christopher; Ritchie, Anastasia; Robishaw, Janet D.; Caputi, Massimo			A simplified SARS-CoV-2 detection protocol for research laboratories	PLOS ONE			English	Article								Widespread testing is required to limit the current public health crisis caused by the COVID-19 pandemic. Multiple tests protocols have been authorized by the food and drugs administration (FDA) under an emergency use authorization (EUA). The majority of these protocols are based on the gold-standard RT-qPCR test pioneered by the U.S. Centers for Disease Control and Prevention (CDC). However, there is still a widespread lack of testing in the US and many of the clinical diagnostics protocols require extensive human labor and materials that could face supply shortages and present biosafety concerns. Given the need to develop alternative reagents and approaches to provide nucleic-acid testing in the face of heightened demand and potential shortages, we have developed a simplified SARS-CoV-2 testing protocol adapted for its use in research laboratories with minimal molecular biology equipment and expertise. The protocol utilizes TRIzol to purify the viral RNA from different types of clinical specimens, requires minimal BSL-1 precautions and, given its high sensitivity, can be easily adapted to pooling samples strategies.	[Paz, Sean; Mauer, Christopher; Ritchie, Anastasia; Robishaw, Janet D.; Caputi, Massimo] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Caputi, M (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.	mcaputi@health.fau.edu		Caputi, Massimo/0000-0002-4926-9700; Mauer, Christopher/0000-0001-6092-4385; Ritchie, Anastasia/0000-0001-5761-2663	Florida Blue foundation	Florida Blue foundation	This work was supported by the Florida Blue foundation grant "Developing Predictive Algorithms for COVID-19 Infection in FAU Health Care Workers". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2020, 1POINT3ACRES; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Basu A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01136-20; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Jones T.C., 2020, ANAL SARS COV 2 VIRA, DOI [10.1101/2020.06.08.20125484, DOI 10.1101/2020.06.08.20125484]; Ketchum K, 2020, SARS COV 2 TESTING P; Klebe RJ, 1996, BIOTECHNIQUES, V21, P1094; Noriega R., 2020, INCREASING TESTING T, DOI [10.1101/2020.04.03.024216v1.full.pdf, DOI 10.1101/2020.04.03.024216V1.FULL.PDF]; Pere H, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00721-20; Sinnott-Armstrong N, 2020, EVALUATION GROUP TES, DOI [DOI 10.1101/2020.03.27.20043968, 10.1101/2020.03.27.20043968]; To KKW, 2019, CLIN MICROBIOL INFEC, V25, P372, DOI 10.1016/j.cmi.2018.06.009; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wyllie A.L., 2020, SALIVA IS MORE SENSI, V8, P12, DOI [10.1101/2020.04.16.20067835, DOI 10.1101/2020.04.16.20067835]; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Xu RB, 2020, IEEE PHOTONICS J, V12, DOI [10.1109/JPHOT.2020.2979564, 10.1038/s41368-020-0080-z]	19	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244271	10.1371/journal.pone.0244271	http://dx.doi.org/10.1371/journal.pone.0244271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338082	Green Published, Green Submitted, gold			2022-12-26	WOS:000601313500029
J	Islam, MS; Chughtai, AA; Nazneen, A; Chowdhury, KIA; Islam, MT; Tarannum, S; Islam, SMH; Banu, S; Seale, H				Islam, Md Saiful; Chughtai, Abrar Ahmad; Nazneen, Arifa; Chowdhury, Kamal Ibne Amin; Islam, Muhammad Tauhidul; Tarannum, Sayeeda; Islam, S. M. Hasibul; Banu, Sayera; Seale, Holly			A tuberculin skin test survey among healthcare workers in two public tertiary care hospitals in Bangladesh	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RESISTANT TUBERCULOSIS; INFECTION; RISK; PRACTITIONERS; POPULATION; PREVENTION; PREVALENCE; GUIDELINES; CONVERSION	In Bangladesh, there is currently no data on the burden of latent TB infection (LTBI) amongst hospital healthcare workers (HCWs). This study aimed to determine the prevalence of LTBI and compare the prevalence among HCWs in two public tertiary care hospitals. Between September 2018 and August 2019, we conducted a cross-sectional study in two public tertiary care general hospitals. Using a survey and tuberculin skin test (TST), we assessed risk factors for LTBI, adjusting for known and plausible confounders. In addition, a facility assessment was undertaken to understand the implementation of relevant IPC measures. The prevalence of LTBI among HCWs was 42%. HCWs spent a median of 6 hours (SD = 1.76, IQR 2.00) per day and attended an average of 1.87 pulmonary TB patients per week. HCWs did not receive any TB IPC training, the wards lacked a symptom checklist to screen patients for TB, and no masks were available for coughing patients. Seventy-seven percent reportedly did not use any facial protection (masks or respirators) while caring for patients. In the multivariable model adjusting for hospital level clustering effect, TST positivity was significantly higher among HCWs aged 35-45 years (aOR1.36, 95% CI: 1.06-1.73) and with >3 years of service (aOR 1.67, 95% CI: 1.62-1.72). HCWs working in the medicine ward had 3.65 (95% CI: 2.20-6.05) times, and HCWs in the gynecology and obstetrics ward had 2.46 (95% CI: 1.42-4.27) times higher odds of TST positivity compared to HCWs working in administrative areas. This study identified high prevalence of LTBI among HCWs. This may be due to the level of exposure to pulmonary TB patients, and/or limited use of personal protective equipment along with poor implementation of TB IPC in the hospitals. Considering the high prevalence of LTBI, we recommend the national TB program consider providing preventative therapy to the HCWs as the high-risk group, and implement TB IPC in the hospitals.	[Islam, Md Saiful; Nazneen, Arifa; Chowdhury, Kamal Ibne Amin; Islam, Muhammad Tauhidul; Tarannum, Sayeeda; Islam, S. M. Hasibul; Banu, Sayera] Icddr B, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh; [Islam, Md Saiful; Chughtai, Abrar Ahmad; Seale, Holly] Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of New South Wales Sydney	Islam, MS (corresponding author), Icddr B, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh.; Islam, MS (corresponding author), Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia.	saiful@icddrb.org	Islam, Saiful/GOH-2641-2022	Islam, Md Saiful/0000-0002-5690-5971	United States Centers for Disease Control and Prevention (CDC) [5U01GH1207]; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This research protocol was funded by the United States Centers for Disease Control and Prevention (CDC), through the cooperative agreement grant number 5U01GH1207. icddr,b acknowledges with gratitude the commitment of CDC to its research efforts. icddr,b is also grateful to the Governments of Bangladesh, Canada, Sweden, and the UK for providing core/unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Andalib A, 2020, INT J PERCEPTIONS PU, V1, P9; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; CDC, 1994, GUID PREV TRANSM MYC; Centers for Disease Control and Prevention, 2016, TB RISK FACT ATL; Chae Y.K., 2009, PLOS ONE, V4, pe6523; Chen B, 2019, INT J INFECT DIS, V79, P26, DOI 10.1016/j.ijid.2018.11.010; Clark TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083012; Dagnew Alemnew F, 2012, BMC Res Notes, V5, P415, DOI 10.1186/1756-0500-5-415; Donald PR, 2009, NEW ENGL J MED, V360, P2393, DOI 10.1056/NEJMp0903806; EFSA FEEDAP, 2014, EFSA J, V12, P1, DOI DOI 10.2903/j.efsa.2014.3547; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Franchi A, 2007, INT ARCH OCC ENV HEA, V80, P533, DOI 10.1007/s00420-006-0160-1; Franchi A, 2009, AM J IND MED, V52, P297, DOI 10.1002/ajim.20680; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Gopinath KG, 2004, J HOSP INFECT, V57, P339, DOI 10.1016/j.jhin.2004.03.029; Gruen R, 2002, SOC SCI MED, V54, P267, DOI 10.1016/S0277-9536(01)00026-0; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Islam MS, 2020, PREVALENCE INC UNPUB; Jo KW, 2017, TUBERC RESPIR DIS, V80, P21, DOI 10.4046/trd.2017.80.1.21; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kizza FN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0904-1; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Knight GM, 2019, LANCET INFECT DIS, V19, P903, DOI 10.1016/S1473-3099(19)30307-X; Kumar MG, 2019, INDIAN J OCCUP ENVIR, V23, P83, DOI 10.4103/ijoem.IJOEM_269_18; Kwon YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129792; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, P111, DOI 10.1093/cid/ciw778; Lillebaek T, 2002, J INFECT DIS, V185, P401, DOI 10.1086/338342; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Nasreen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164034; Nathavitharana RR, 2017, PRESSE MED, V46, pE53, DOI 10.1016/j.lpm.2017.01.014; National Institute of Population Research and Training Associates for Community and Population Research ICF International, 2016, BANGL HLTH FAC SURV; Nazneen A, 2020, ASSESSING IMPLEMENTA; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; Rimi NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089085; Rutanga C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124485; Sabri A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221081; Sadaf R, 2020, PAK J MED SCI, V36, P198, DOI 10.12669/pjms.36.2.936; Sarkar PK., 2017, BANGLADESH J CHILD H, V39, P93, DOI DOI 10.3329/BJCH.V39I2.31540; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Uden L, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx137; Ullah AZ, 2010, WORLD MED HEALTH POL, V2, P217, DOI 10.2202/1948-4682.1029; Vinton P, 2009, INFECT CONT HOSP EP, V30, P215, DOI 10.1086/595695; Weber AM, 2008, INFECT CONT HOSP EP, V29, P648, DOI 10.1086/588684; WHO, 2020, GLOB TUB REP; WHO, 2010, REP NAT TUB DIS CUM; World Health Organization, 2019, WHOCDSTB20191; World Health Organization, 2015, CHECKL PER EV TB INF; World Health Organization, 2018, WHOCDSTB20184; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	56	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243951	10.1371/journal.pone.0243951	http://dx.doi.org/10.1371/journal.pone.0243951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332458	Green Published, gold			2022-12-26	WOS:000601310900024
J	Merz, EC; Monk, C; Bansal, R; Sawardekar, S; Lee, SJ; Feng, TS; Spann, M; Foss, S; McDonough, L; Werner, E; Peterson, BS				Merz, Emily C.; Monk, Catherine; Bansal, Ravi; Sawardekar, Siddhant; Lee, Seonjoo; Feng, Tianshu; Spann, Marisa; Foss, Sophie; McDonough, Laraine; Werner, Elizabeth; Peterson, Bradley S.			Neonatal brain metabolite concentrations: Associations with age, sex, and developmental outcomes	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; FALSE DISCOVERY RATE; WHITE-MATTER; N-ACETYLASPARTATE; INTELLECTUAL ABILITY; MR SPECTROSCOPY; PRETERM INFANTS; IN-VIVO; TERM; IMPACT	Age and sex differences in brain metabolite concentrations in early life are not well understood. We examined the associations of age and sex with brain metabolite levels in healthy neonates, and investigated the associations between neonatal brain metabolite concentrations and developmental outcomes. Forty-one infants (36-42 gestational weeks at birth; 39% female) of predominantly Hispanic/Latina mothers (mean 18 years of age) underwent MRI scanning approximately two weeks after birth. Multiplanar chemical shift imaging was used to obtain voxel-wise maps of N-acetylaspartate (NAA), creatine, and choline concentrations across the brain. The Bayley Scales of Infant and Toddler Development, a measure of cognitive, language, and motor skills, and mobile conjugate reinforcement paradigm, a measure of learning and memory, were administered at 4 months of age. Findings indicated that postmenstrual age correlated positively with NAA concentrations in multiple subcortical and white matter regions. Creatine and choline concentrations showed similar but less pronounced age related increases. Females compared with males had higher metabolite levels in white matter and subcortical gray matter. Neonatal NAA concentrations were positively associated with learning and negatively associated with memory at 4 months. Age-related increases in NAA, creatine, and choline suggest rapid development of neuronal viability, cellular energy metabolism, and cell membrane turnover, respectively, during early life. Females may undergo earlier and more rapid regional developmental increases in the density of viable neurons compared to males.	[Merz, Emily C.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Monk, Catherine; Lee, Seonjoo; Spann, Marisa; Foss, Sophie; Werner, Elizabeth] Columbia Univ, Dept Psychiat, Irving Med Ctr, New York, NY USA; [Monk, Catherine; Werner, Elizabeth] Columbia Univ, Dept Obstet & Gynecol, Irving Med Ctr, New York, NY USA; [Monk, Catherine; Feng, Tianshu; Spann, Marisa] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Bansal, Ravi; Sawardekar, Siddhant; Peterson, Bradley S.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Bansal, Ravi; Sawardekar, Siddhant; Peterson, Bradley S.] Univ Southern Calif, Los Angeles, CA 90007 USA; [Bansal, Ravi; Peterson, Bradley S.] Childrens Hosp Los Angeles, Inst Dev Mind, Los Angeles, CA 90027 USA; [McDonough, Laraine] CUNY Brooklyn Coll, Dept Psychol, New York, NY USA; [McDonough, Laraine] CUNY, Grad Ctr, New York, NY USA; [Peterson, Bradley S.] Univ Southern Calif, Keck Sch Med, Dept Psychiat, Div Child & Adolescent Psychiat, Los Angeles, CA 90007 USA	Colorado State University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; New York State Psychiatry Institute; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; City University of New York (CUNY) System; City University of New York (CUNY) System; University of Southern California	Merz, EC (corresponding author), Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA.	emily.merz@colostate.edu	Monk, Catherine/X-2277-2019	Monk, Catherine/0000-0001-7827-2602; Merz, Emily/0000-0003-1950-2345; lee, seonjoo/0000-0003-3177-6357; Foss, Sophie/0000-0001-8918-2899	National Institute of Health (NIH) [R01MH093677-01]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this research was provided by a National Institute of Health (NIH) grant (R01MH093677-01) awarded to C. Monk and B. Peterson. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Alexander B, 2019, NEUROIMAGE, V185, P654, DOI 10.1016/j.neuroimage.2018.07.021; Allen PJ, 2012, NEUROSCI BIOBEHAV R, V36, P1442, DOI 10.1016/j.neubiorev.2012.03.005; Amaral AI, 2017, NEUROCHEM RES, V42, P827, DOI 10.1007/s11064-016-1985-y; Anderson PJ, 2017, CLIN NEUROPSYCHOL, V31, P371, DOI 10.1080/13854046.2016.1216518; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; [Anonymous], 2014, CINEASTE, V39, P1; [Anonymous], 2019, BIOL PSYCHIAT; Augustine EM, 2008, J PERINATOL, V28, P611, DOI 10.1038/jp.2008.66; Bapat R, 2014, PEDIATR NEUROL, V51, P53, DOI 10.1016/j.pediatrneurol.2014.03.011; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Bayley N, 1993, BAYLEY SCALES INFANT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Bjartmar C, 2002, ANN NEUROL, V51, P51, DOI 10.1002/ana.10052; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Bluml S, 2013, CEREB CORTEX, V23, P2944, DOI 10.1093/cercor/bhs283; Chau V, 2013, NEUROLOGY, V81, P2082, DOI 10.1212/01.wnl.0000437298.43688.b9; Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Cohen-Gilbert JE, 2014, DEV PSYCHOPATHOL, V26, P405, DOI 10.1017/S0954579414000030; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Dipietro JA, 2017, NEUROSCIENCE, V342, P4, DOI 10.1016/j.neuroscience.2015.07.068; Dong ZC, 2007, MAGN RESON IMAGING, V25, P1148, DOI 10.1016/j.mri.2007.01.005; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Durazzo TC, 2016, BIOL PSYCHIAT, V79, P481, DOI 10.1016/j.biopsych.2015.03.029; Else-Quest NM, 2006, PSYCHOL BULL, V132, P33, DOI 10.1037/0033-2909.132.1.33; Eriksson M, 2012, BRIT J DEV PSYCHOL, V30, P326, DOI 10.1111/j.2044-835X.2011.02042.x; Gadin E, 2012, PEDIATR PHYS THER, V24, P38, DOI 10.1097/PEP.0b013e31823e069d; Galsworthy MJ, 2000, DEVELOPMENTAL SCI, V3, P206, DOI 10.1111/1467-7687.00114; Gilmore JH, 2018, NAT REV NEUROSCI, V19, P123, DOI 10.1038/nrn.2018.1; Goh S, 2014, JAMA PSYCHIAT, V71, P665, DOI 10.1001/jamapsychiatry.2014.179; Goh S, 2011, DEV COGN NEUROS-NETH, V1, P305, DOI 10.1016/j.dcn.2011.03.001; Hao XJ, 2013, HUM BRAIN MAPP, V34, P253, DOI 10.1002/hbm.21440; Karl A, 2010, NEUROSCI BIOBEHAV R, V34, P7, DOI 10.1016/j.neubiorev.2009.06.008; Kelly CE, 2016, BRAIN IMAGING BEHAV, V10, P41, DOI 10.1007/s11682-015-9361-0; Kendall GS, 2014, RADIOLOGY, V271, P230, DOI 10.1148/radiol.13122679; Knickmeyer RC, 2017, CEREB CORTEX, V27, P5616, DOI 10.1093/cercor/bhw331; Knickmeyer RC, 2014, CEREB CORTEX, V24, P2721, DOI 10.1093/cercor/bht125; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; Lally PJ, 2019, LANCET NEUROL, V18, P35, DOI 10.1016/S1474-4422(18)30325-9; Lebel C, 2018, NEUROIMAGE, V182, P207, DOI 10.1016/j.neuroimage.2017.12.097; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; McCarthy MM, 2019, CURR OPIN BEHAV SCI, V25, P83, DOI 10.1016/j.cobeha.2018.10.005; McCarthy MM, 2017, NAT REV NEUROSCI, V18, P471, DOI 10.1038/nrn.2017.61; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; Merz EC, 2017, DEV PSYCHOBIOL, V59, DOI 10.1002/dev.21520; Meyerhoff DJ, 2013, CURR TOP BEHAV NEURO, V13, P511, DOI 10.1007/7854_2011_131; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Nelson MB, 2019, J NEUROSCI, V39, P8362, DOI 10.1523/JNEUROSCI.2422-18.2019; O'Neill J, 2020, BIOL PSYCHIAT, V87, P174, DOI 10.1016/j.biopsych.2019.06.010; Ozcaliskan S, 2010, DEVELOPMENTAL SCI, V13, P752, DOI 10.1111/j.1467-7687.2009.00933.x; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Pouwels PJW, 1997, NMR BIOMED, V10, P73, DOI 10.1002/(SICI)1099-1492(199704)10:2<73::AID-NBM448>3.0.CO;2-4; Qiu AQ, 2013, NEUROIMAGE, V65, P315, DOI 10.1016/j.neuroimage.2012.09.032; Rovee-Collier C, 1999, DEV PSYCHOBIOL, V35, P91, DOI 10.1002/(SICI)1098-2302(199909)35:2<91::AID-DEV2>3.0.CO;2-U; Rubinow DR, 2019, NEUROPSYCHOPHARMACOL, V44, P111, DOI 10.1038/s41386-018-0148-z; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Tanifuji S, 2017, BRAIN DEV-JPN, V39, P196, DOI 10.1016/j.braindev.2016.10.006; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Taylor MJ, 2018, NEURORADIOLOGY, V60, P1063, DOI 10.1007/s00234-018-2064-7; Tomiyasu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082746; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; Wheelock MD, 2019, DEV COGN NEUROS-NETH, V36, DOI 10.1016/j.dcn.2019.100632; Wijtenburg SA, 2013, NEUROIMAGE, V66, P161, DOI 10.1016/j.neuroimage.2012.10.014; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5; Zhao Q, 2007, 3D INTERACTIVE CHEM; Zhu H, 2011, METHODS MOL BIOL, V711, P203, DOI 10.1007/978-1-61737-992-5_9	71	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243255	10.1371/journal.pone.0243255	http://dx.doi.org/10.1371/journal.pone.0243255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332379	Green Published, gold			2022-12-26	WOS:000601310900059
J	Pinchoff, J; Santhya, KG; White, C; Rampal, S; Acharya, R; Ngo, TD				Pinchoff, Jessie; Santhya, K. G.; White, Corinne; Rampal, Shilpi; Acharya, Rajib; Ngo, Thoai D.			Gender specific differences in COVID-19 knowledge, behavior and health effects among adolescents and young adults in Uttar Pradesh and Bihar, India	PLOS ONE			English	Article								On March 24, 2020 India implemented a national lockdown to prevent spread of the novel Coronavirus disease (COVID-19) among its 1.3 billion people. As the pandemic may disproportionately impact women and girls, this study examines gender differences in knowledge of COVID-19 symptoms and preventive behaviors, as well as the adverse effects of the lockdown among adolescents and young adults. A mobile phone-based survey was implemented from April 3-22, 2020 in Uttar Pradesh and Bihar among respondents randomly selected from an existing cohort study. Respondents answered questions related to demographics, COVID-19 knowledge, attitudes, and preventive behaviors practiced, and impacts on social, economic and health outcomes. Descriptive analyses and linear probability regression models were performed for all participants and separately for men and women. A total of 1,666 adolescents and young adults (18-24 years old) were surveyed; 70% were women. While most participants had high awareness of disease symptoms and preventive behaviors, there was variation by gender. Compared to men, women were seven percentage points (pp) less likely to know the main symptoms of COVID-19 (coeff = -0.071; 95% confidence interval: -0.122 - -0.021). Among women, there was variation in knowledge by education level, urban residence, and household wealth. Women were 22 pp less likely to practice key preventive behaviors compared to men (coeff = -0.222; 95% CIL -0.263, -0.181). Women were also more likely to report recent depressive symptoms than men (coeff = 0.057; 95% CI: 0.004, 0.109). Our findings underscore that COVID-19 is already disproportionately impacting adolescent girls and young women and that they may require additional targeted, gender-sensitive messaging to foster behavior change. Gender-sensitive information campaigns and provision of health services must be accessible and provide women and girls with needed resources and support during the pandemic to ensure gains in public health and gender equity are not lost.	[Pinchoff, Jessie; White, Corinne; Ngo, Thoai D.] Populat Council, One Dag Hammarskjold Plaza, New York, NY 10017 USA; [Santhya, K. G.; Rampal, Shilpi; Acharya, Rajib] Populat Council, India Habitat Ctr, Delhi, India	Population Council	Pinchoff, J (corresponding author), Populat Council, One Dag Hammarskjold Plaza, New York, NY 10017 USA.	jpinchoff@popcouncil.org		Pinchoff, Jessie/0000-0003-3155-595X	Bill and Melinda Gates Foundation; Packard Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Packard Foundation(The David & Lucile Packard Foundation)	The initial UDAYA cohort was funded by the Bill and Melinda Gates Foundation and Packard Foundation. No additional funds were received for the COVID-19 survey.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akseer N, 2020, AM J CLIN NUTR, V112, P251, DOI 10.1093/ajcn/nqaa171; [Anonymous], 2020, LANCET, V395, P1315, DOI 10.1016/S0140-6736(20)30938-7; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; Cash R, 2020, LANCET, V395, P1687, DOI 10.1016/S0140-6736(20)31089-8; Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704; GSM Association, 2020, CONN WOM MOB GEND GA; John N, 2020, DEV WORLD BIOETH, V20, P65, DOI 10.1111/dewb.12261; Johns Hopkins Coronavirus Resource Center, COVID 19 MAP; Kamate SK, 2010, J INFECT DEV COUNTR, V4, P7, DOI 10.3855/jidc.501; Kapoor M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026850; Kelley M, 2020, LANCET GLOB HEALTH, V8, pE888, DOI 10.1016/S2214-109X(20)30249-7; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Ministry of Housing Communities and Local Government, 2020, GUID INF PREV CONTR, P1; Mobarak AM, FOREIGN POLICY; Parker W, RETHINKING CONCEPTUA, V7; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; Saikarthik J, 2020, MED RXIV, DOI [10.1101/2020.06.13.20130153., DOI 10.1101/2020.06.13.20130153, 10.1101/2020.06.13.20130153]; Santhya KG, 2017, J BIOSOC SCI, V49, pS74, DOI 10.1017/S0021932017000360; Undie C-C, 2020, SEXUAL VIOLENCE RES; UNICEF, 2017, CHILDR DIG WORLD; Wanqing Zhang, 2020, DOMESTIC VIOLENCE CA; World Health Organization, 2019, MENT HLTH EM; World Health Organization, 2020, COVID 19 VIOL WOM WH	25	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244053	10.1371/journal.pone.0244053	http://dx.doi.org/10.1371/journal.pone.0244053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332461	Green Published, gold			2022-12-26	WOS:000601310900041
J	Rieg, T; Frick, J; Baumgartl, H; Buettner, R				Rieg, Thilo; Frick, Janek; Baumgartl, Hermann; Buettner, Ricardo			Demonstration of the potential of white-box machine learning approaches to gain insights from cardiovascular disease electrocardiograms	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ATRIAL-FIBRILLATION; DIABETIC-RETINOPATHY; P-WAVE; CLASSIFICATION; MANAGEMENT; VALIDATION; FEATURES; MODELS; CARE	We present the results from a white-box machine learning approach to detect cardiac arrhythmias using electrocardiographic data. A C5.0 is trained to recognize four classes using common features. The four classes are (i) atrial fibrillation and atrial flutter, (ii) tachycardias (iii), sinus bradycardia and (iv) sinus rhythm. Data from 10,646 subjects, 83% of whom have at least one arrhythmia and 17% of whom exhibit a normal sinus rhythm, are used. The C5.0 is trained using 10-fold cross-validation and is able to achieve a balanced accuracy of 95.35%. By using the white-box machine learning approach, a clear and comprehensible tree structure can be revealed, which has selected the 5 most important features from a total of 24 features. These 5 features are ventricular rate, RR-Interval variation, atrial rate, age and difference between longest and shortest RR-Interval. The combination of ventricular rate, RR-Interval variation and atrial rate is especially relevant to achieve classification accuracy, which can be disclosed through the tree. The tree assigns unique values to distinguish the classes. These findings could be applied in medicine in the future. It can be shown that a white-box machine learning approach can reveal granular structures, thus confirming known linear relationships and also revealing nonlinear relationships. To highlight the strength of the C5.0 with respect to this structural revelation, the results of further white-box machine learning and black-box machine learning algorithms are presented.	[Rieg, Thilo; Frick, Janek; Baumgartl, Hermann; Buettner, Ricardo] Aalen Univ, Machine Learning Res Grp, Aalen, Germany	Hochschule Aalen	Rieg, T (corresponding author), Aalen Univ, Machine Learning Res Grp, Aalen, Germany.	thilo.rieg@gmx.de		Rieg, Thilo/0000-0001-5295-7021; Baumgartl, Hermann/0000-0001-8918-3197	Carl Zeiss Foundation; German Federal Ministry of Education and Research [13FH4E05IA]	Carl Zeiss Foundation; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This research is funded by the Carl Zeiss Foundation and the German Federal Ministry of Education and Research (13FH4E05IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami RG, 2016, PATTERN RECOGN LETT, V70, P45, DOI 10.1016/j.patrec.2015.11.018; Alcaraz R, 2010, BIOMED SIGNAL PROCES, V5, P1, DOI 10.1016/j.bspc.2009.11.001; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Banerjee S, 2012, MEASUREMENT, V45, P474, DOI 10.1016/j.measurement.2011.10.025; Barrett TW, 2012, AM J CARDIOL, V110, P1315, DOI 10.1016/j.amjcard.2012.06.037; Ben-Tal A, 2012, J PHYSIOL-LONDON, V590, P1989, DOI 10.1113/jphysiol.2011.222422; BOINEAU JP, 1989, J ELECTROCARDIOL, V22, P189; Castellanos A, 1998, AM J CARDIOL, V82, P531, DOI 10.1016/S0002-9149(98)00373-7; Celin S, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1083-6; Chen B, 2016, LECT NOTES COMPUT SC, V9728, P239, DOI 10.1007/978-3-319-41561-1_18; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Christov I, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aad9f0; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Elola A, 2019, MED BIOL ENG COMPUT, V57, P453, DOI 10.1007/s11517-018-1892-2; FRIEDMAN HS, 1974, CHEST, V66, P172, DOI 10.1378/chest.66.2.172; Goodacre S, 2002, BRIT MED J, V324, P594, DOI 10.1136/bmj.324.7337.594; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Haque A, 2020, NATURE, V585, P193, DOI 10.1038/s41586-020-2669-y; Hennig T, 2006, J BIOL PHYS, V32, P383, DOI 10.1007/s10867-006-9022-z; James AF, 2007, PROG BIOPHYS MOL BIO, V94, P265, DOI 10.1016/j.pbiomolbio.2005.05.010; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kerr AJ, 2001, AM J CARDIOL, V87, P1116, DOI 10.1016/S0002-9149(01)01475-8; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lee H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25835; Loyola-Gonzalez O, 2019, IEEE ACCESS, V7, P154096, DOI 10.1109/ACCESS.2019.2949286; Luz EJD, 2013, EXPERT SYST APPL, V40, P3561, DOI 10.1016/j.eswa.2012.12.063; Lyon A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0821; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; McLachlan Craig S, 2010, Proc (Bayl Univ Med Cent), V23, P368; McManus DD, 2013, HEART RHYTHM, V10, P315, DOI 10.1016/j.hrthm.2012.12.001; MORILLO CA, 1994, CIRCULATION, V90, P873, DOI 10.1161/01.CIR.90.2.873; Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Olshansky B, 2013, J AM COLL CARDIOL, V61, P793, DOI 10.1016/j.jacc.2012.07.074; Page RL, 2016, CIRCULATION, V133, pE506, DOI 10.1161/CIR.0000000000000311; Pandya R., 2015, INT J COMPUT APPL, V117, P18, DOI DOI 10.5120/20639-3318; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Popper K. R., 1963, CONJECTURES REFUTAT; Popper K.R., 1959, LOGIC SCI DISCOVERY; Price WN, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5333; Rajesh KNVPS, 2017, COMPUT BIOL MED, V87, P271, DOI 10.1016/j.compbiomed.2017.06.006; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Salles GF, 2004, AM J CARDIOL, V93, P1136, DOI 10.1016/j.amjcard.2004.01.040; Schlapfer J, 2017, J AM COLL CARDIOL, V70, P1183, DOI 10.1016/j.jacc.2017.07.723; Shah AP, 2007, J ELECTROCARDIOL, V40, P385, DOI 10.1016/j.jelectrocard.2007.03.008; Shi HT, 2019, COMPUT METH PROG BIO, V171, P1, DOI 10.1016/j.cmpb.2019.02.005; Srinivasan NT, 2019, HEART RHYTHM, V16, P943, DOI 10.1016/j.hrthm.2018.12.006; Tateno K, 2001, MED BIOL ENG COMPUT, V39, P664, DOI 10.1007/BF02345439; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Valdes G, 2016, SCI REP-UK, V6, DOI 10.1038/srep37854; vandenBerg MP, 1997, CIRCULATION, V96, P1209, DOI 10.1161/01.CIR.96.4.1209; Yan D, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015536; Zhang J, 2007, J MANIP PHYSIOL THER, V30, P374, DOI 10.1016/j.jmpt.2007.04.001; Zheng JW, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0386-x; Zimmer K, 2016, INT J CARDIOL, V212, P59, DOI 10.1016/j.ijcard.2016.03.031	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243615	10.1371/journal.pone.0243615	http://dx.doi.org/10.1371/journal.pone.0243615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332440	gold, Green Published			2022-12-26	WOS:000601310900111
J	Thakwalakwa, C; Flax, VL; Phuka, JC; Garcia, H; Jaacks, LM				Thakwalakwa, Chrissie; Flax, Valerie L.; Phuka, John C.; Garcia, Harrison; Jaacks, Lindsay M.			Drivers of food consumption among overweight mother-child dyads in Malawi	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; NUTRITION; OBESITY; WOMEN; HIV; PATTERNS; FRUIT; MALNUTRITION; PREFERENCES; PERCEPTIONS	To address the increase in overweight and obesity among mothers and children in sub-Saharan Africa, an understanding of the factors that drive their food consumption is needed. We hypothesized food consumption in Malawi is driven by a combination of factors, including season, food accessibility (area of residence, convenience of purchasing food, female autonomy), food affordability (household resources, food expenditures, household food insecurity), food desirability (taste preferences, body size preferences), demographics, and morbidity. Participants in Lilongwe and Kasungu Districts were enrolled across three types of mother-child dyads: either the mother (n = 120), child (n = 80), or both (n = 74) were overweight. Seven-day dietary intake was assessed using a quantitative food frequency questionnaire during the dry and rainy seasons. Drivers associated with intake of calories, macronutrients, and 11 food groups at p<0.1 in univariate models were entered into separate multivariate linear regression models for each dietary intake outcome. Mother-child dyads with an overweight child had a higher percent of calories from carbohydrates and lower percent of calories from fat compared to dyads with a normal weight child (both p<0.01). These mothers also had the highest intake of grains (p<0.01) and their children had the lowest intake of oil/fat (p = 0.01). Household food insecurity, maternal taste preferences, and maternal body size preferences were the most consistent predictors of food group consumption. Household food insecurity was associated with lower intake of grains, fruits, meat and eggs, oil/fat, and snacks. Maternal taste preferences predicted increased consumption of grains, legumes/nuts, vegetables, fish, and oil/fat. Maternal body size preferences for herself and her child were associated with consumption of grains, legumes/nuts, dairy, and sweets. Predictors of food consumption varied by season, across food groups, and for mothers and children. In conclusion, indicators of food affordability and desirability were the most common predictors of food consumption among overweight mother-child dyads in Malawi.	[Thakwalakwa, Chrissie] Univ Malawi, Chancellor Coll, Ctr Social Res, Zomba, Malawi; [Flax, Valerie L.] RTI Int, Res Triangle Pk, NC 27709 USA; [Phuka, John C.] Univ Malawi, Coll Med, Blantyre, Malawi; [Garcia, Harrison; Jaacks, Lindsay M.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	University of Malawi; Research Triangle Institute; University of Malawi; Harvard University; Harvard T.H. Chan School of Public Health	Flax, VL (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	vflax@rti.org		Phuka, John/0000-0003-4951-8145; Jaacks, Lindsay/0000-0002-7791-5167; Flax, Valerie/0000-0003-0200-3355	Drivers of Food Choice (DFC) Competitive Grants Programs; Bill & Melinda Gates Foundation; UK Government's Department for International Development	Drivers of Food Choice (DFC) Competitive Grants Programs; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK Government's Department for International Development	This research was funded by the Drivers of Food Choice (DFC) Competitive Grants Programs, which is funded by the UK Government's Department for International Development and the Bill & Melinda Gates Foundation, and managed by the University of South Carolina, Arnold School of Public Health, USA; however, the views expressed do not necessarily reflect the UK Government's official policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2006, SOC FORCES, V84, P2077, DOI 10.1353/sof.2006.0079; Amo-Adjei J, 2015, J BIOSOC SCI, V47, P613, DOI 10.1017/S002193201400025X; Angeles G, 2015, BASELINE REPORT IMPA; [Anonymous], 2019, TR2195 3GPP; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2007, EUR J NUCL MED MOL I; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; Azupogo F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5845-3; Bentley ME, 2005, J NUTR, V135, P945; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; Brown C, 2015, APPETITE, V95, P29, DOI 10.1016/j.appet.2015.06.018; Chakona G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112668; Croffut SE, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12446; Drewnowski A, 2000, J AM DIET ASSOC, V100, P1325, DOI 10.1016/S0002-8223(00)00375-8; Farris AR, 2019, J HUNGER ENV NUTR, P1, DOI DOI 10.1080/19320248.2019; FERGUSON EL, 1995, EUR J CLIN NUTR, V49, P565; FERGUSON EL, 1993, ECOL FOOD NUTR, V29, P219, DOI 10.1080/03670244.1993.9991307; Flax V, 2020, MATERNAL CHILD NUTR; Flax VL, 2015, MATERN CHILD NUTR, V11, P104, DOI 10.1111/mcn.12073; Gissing SC, 2017, PUBLIC HEALTH NUTR, V20, P2104, DOI 10.1017/S1368980017000970; Hager ER, 2010, OBESITY, V18, P397, DOI 10.1038/oby.2009.293; Heim A, 2020, APPETITE, V151, DOI 10.1016/j.appet.2020.104709; Heim A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4408-8; Hemsworth J, 2016, J NUTR, V146, P326, DOI 10.3945/jn.115.215327; Hotz C, 2001, EUR J CLIN NUTR, V55, P841, DOI 10.1038/sj.ejcn.1601239; Hunter-Adams J, 2019, APPETITE, V137, P244, DOI 10.1016/j.appet.2019.03.012; Independent Expert Group of the Global Nutrition Report, 2020, GLOB NUTR REP ACT EQ; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kodish SR, 2016, MATERN CHI NUTR 0119; Lukmanji Z., 2008, TANZANIA FOOD COMPOS; Maleta K, 2003, ACTA PAEDIATR, V92, P491, DOI 10.1111/j.1651-2227.2003.tb00584.x; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; Miller V, 2016, LANCET GLOB HEALTH, V4, pE695, DOI 10.1016/S2214-109X(16)30186-3; Mndala L, 2019, EPIDEMIOL HEALTH, V41, DOI 10.4178/epih.e2019039; Msambichaka B, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020222; Nago ES, 2012, J NUTR EDUC BEHAV, V44, P548, DOI 10.1016/j.jneb.2011.06.006; National Statistical Office (NSO) [Malawi] and ICF, 2017, MALAWI DEMOGRAPHIC H; Office MNS Demographic MIIfRD Surveys H, 2010, DEM MIIFRD SURV H; Okop KJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7254-7; Okoro CS, 2017, AM J MENS HEALTH, V11, P1713, DOI 10.1177/1557988315625775; Peltzer K, 2015, INT J PUBLIC HEALTH, V60, P79, DOI 10.1007/s00038-014-0631-1; Peltzer K, 2012, GLOBAL HEALTH ACTION, V5, DOI [10.3402/gha.v5i0.18545, 10.3402/gha.v5i0.18668]; PERYAM DR, 1957, FOOD TECHNOL-CHICAGO, V11, P32; Pisa PT, 2017, EUR J PUBLIC HEALTH, V27, P404, DOI 10.1093/eurpub/ckw119; Pisa PT, 2015, NUTRIENTS, V7, P3464, DOI 10.3390/nu7053464; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; Prynn JE, 2018, AM J CLIN NUTR, V108, P587, DOI 10.1093/ajcn/nqy125; Ramlal RT, 2015, NUTRIENTS, V7, P584, DOI 10.3390/nu7010584; Rodas-Moya S, 2016, PUBLIC HEALTH NUTR, V19, P693, DOI 10.1017/S1368980015001822; Ruel M.T., 2005, PATTERNS DETERMINANT; Steyn N.P., 2005, GUIDE USE DIETARY AS; Steyn NP, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-104; Thakwalakwa CM, 2015, MATERN CHI NUTR, V11, P326; Turner C, 2018, GLOB FOOD SECUR-AGR, V18, P93, DOI 10.1016/j.gfs.2018.08.003; Voorend CGN, 2013, PUBLIC HEALTH NUTR, V16, P559, DOI 10.1017/S1368980012003254; Wojcicki JM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1124; Wrottesley SV, 2014, PUBLIC HEALTH NUTR, V17, P1603, DOI 10.1017/S1368980013001808; Zingoni C, 2009, ECOL FOOD NUTR, V48, P178, DOI 10.1080/03670240902794713; 2018, INT J COMMUN SYST, V31	61	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243721	10.1371/journal.pone.0243721	http://dx.doi.org/10.1371/journal.pone.0243721			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332387	gold, Green Published			2022-12-26	WOS:000601310900089
J	Torti, M; Fossati, C; Casali, M; De Pandis, MF; Grassini, P; Radicati, FG; Stirpe, P; Vacca, L; Iavicoli, I; Leso, V; Ceppi, M; Bruzzone, M; Bonassi, S; Stocchi, F				Torti, Margherita; Fossati, Chiara; Casali, Miriam; De Pandis, Maria Francesca; Grassini, Paola; Radicati, Fabiana Giada; Stirpe, Paola; Vacca, Laura; Iavicoli, Ivo; Leso, Veruscka; Ceppi, Marcello; Bruzzone, Marco; Bonassi, Stefano; Stocchi, Fabrizio			Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study	PLOS ONE			English	Article							PESTICIDE EXPOSURE; INFLAMMATION; METAANALYSIS; SOLVENTS; METALS; COPPER; IRON	Background The aetiology of Parkinson's disease (PD) is still very controversial, with a peculiar lack of established risk factors or protective behavior. Methods We carried out a case-control study of 634 idiopathic PD patients admitted from 2011 to 2015 to two hospitals located in central Italy and 532 controls matched by hospital, gender and age (+/- 5 years). The study questionnaire included questions on host factors, family history, residence, occupation and lifestyle. Odds ratios (ORs) for PD and 95% confidence intervals (CIs) were estimated with logistic regression, adjusting for actual and potential confounders. Results A lower OR was observed in females (0.74; 95%CI:0.58-0.96), while older age classes showed a constantly increased risk for PD (p<0.005) starting from the class 65-69 years. Subjects who reported a first degree relative affected by PD showed a borderline increase which was more evident in those enrolled in the urban center of Rome (OR = 1.65; 95%CI: 1.09-2.50). Significant reduction of the risk was associated to current smoking (OR = 0.48; 95%CI: 0.24-0.54), and to vegetables consumption (p<0.03), while borderline increases were associated to meat and cold cut consumption. Occupational activities classified according to ISCO-08 categories did not show increased risk, while higher ORs' were found for pilots and physicians. Conclusions The results from this study confirmed the higher risk of PD in males and in elderly, and the inverse association with smoking habit. The possible etiological role of familial clustering, dietary habit, and some job tasks is suggested.	[Torti, Margherita; Casali, Miriam; Grassini, Paola; Radicati, Fabiana Giada; Stirpe, Paola; Vacca, Laura; Stocchi, Fabrizio] San Raffaele Pisana Inst Res & Med Care, Clin Trial Ctr, Rome, Italy; [Fossati, Chiara] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [De Pandis, Maria Francesca] San Raffaele Cassino, Cassino, Italy; [Iavicoli, Ivo; Leso, Veruscka] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Ceppi, Marcello; Bruzzone, Marco] Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy; [Bonassi, Stefano] San Raffaele Pisana, Inst Res & Med Care, Unit Clin & Mol Epidemiol, Rome, Italy; [Bonassi, Stefano; Stocchi, Fabrizio] San Raffaele Univ, Dept Human Sci & Qual Life Promot, Rome, Italy	Foro Italico University of Rome; University of Naples Federico II; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University	Torti, M (corresponding author), San Raffaele Pisana Inst Res & Med Care, Clin Trial Ctr, Rome, Italy.	margherita.torti@sanraffaele.it	De Pandis, Maria Francesca/GPC-8167-2022; Iavicoli, Ivo/K-9062-2016; stocchi, fabrizio/K-5089-2016; Casali, Massimiliano/AAK-3309-2021	Iavicoli, Ivo/0000-0003-0444-3792; stocchi, fabrizio/0000-0002-5763-0033; Casali, Massimiliano/0000-0003-3832-8696; bonassi, stefano/0000-0003-3833-6717; Vacca, Laura/0000-0002-6634-4119; Bruzzone, Marco/0000-0002-8821-4542; Radicati, Fabiana Giada/0000-0001-9930-6656	INAIL (Istituto Nazionale Assicurazione Infortuni sul Lavoro)	INAIL (Istituto Nazionale Assicurazione Infortuni sul Lavoro)	Funding: The study has been supported with grants funded by INAIL (Istituto Nazionale Assicurazione Infortuni sul Lavoro).	[Anonymous], 2017, NAT REV NEUROL, V13, P707, DOI 10.1038/nrneurol.2017.155; [Anonymous], 2012, ISCO08, V1; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Beard JD, 2017, MMWR-MORBID MORTAL W, V66, P718, DOI 10.15585/mmwr.mm6627a2; Breckenridge CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151841; Brouwer M, 2017, ENVIRON INT, V107, P100, DOI 10.1016/j.envint.2017.07.001; Caudle WM, 2012, NEUROTOXICOLOGY, V33, P585, DOI 10.1016/j.neuro.2012.04.011; Caudle WM, 2012, NEUROTOXICOLOGY, V33, P178, DOI 10.1016/j.neuro.2012.01.010; Cote ML, 2012, EUR J CANCER, V48, P1957, DOI 10.1016/j.ejca.2012.01.038; Erro R, 2018, J NEUROL, V265, P12, DOI 10.1007/s00415-017-8639-0; Fenech M, 2005, CARCINOGENESIS, V26, P991, DOI 10.1093/carcin/bgi042; Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788; Frigerio R, 2006, MOVEMENT DISORD, V21, P1688, DOI 10.1002/mds.21009; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JL Fleiss B, 2003, PAIK STAT METHODS RA; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Lai BCL, 2002, PARKINSONISM RELAT D, V8, P297, DOI 10.1016/S1353-8020(01)00054-2; Lan AP, 2016, BIOMETALS, V29, P665, DOI 10.1007/s10534-016-9942-4; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; McDonnell L, 2003, NEUROLOGY, V61, P716, DOI 10.1212/WNL.61.5.716; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Moisan F, 2015, ENVIRON HEALTH PERSP, V123, P1123, DOI 10.1289/ehp.1307970; Nandipati S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090881; Nielsen LA, 2015, OBESITY FACTS, V8, P319, DOI 10.1159/000441375; Park J, 2005, NEUROTOXICOLOGY, V26, P99, DOI 10.1016/j.neuro.2004.07.001; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435; Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123; Santangelo G, 2017, J NEUROL SCI, V374, P17, DOI 10.1016/j.jns.2017.01.013; StataCorp, 2015, STAT STAT SOFTW REL; Thacker EL, 2008, MOVEMENT DISORD, V23, P1174, DOI 10.1002/mds.22067; Tsui JKC, 1999, CAN J PUBLIC HEALTH, V90, P334, DOI 10.1007/BF03404523; Valdes EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106676; van der Mark M, 2015, PARKINSONISM RELAT D, V21, P635, DOI 10.1016/j.parkreldis.2015.03.025; van der Mark M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095297; Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Zhang DF, 2014, MOVEMENT DISORD, V29, P819, DOI 10.1002/mds.25863	39	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243612	10.1371/journal.pone.0243612	http://dx.doi.org/10.1371/journal.pone.0243612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332388	Green Published, gold			2022-12-26	WOS:000601310900110
J	Burleigh, MC; Sculthorpe, N; Henriquez, FL; Easton, C				Burleigh, Mia C.; Sculthorpe, Nicholas; Henriquez, Fiona L.; Easton, Chris			Nitrate-rich beetroot juice offsets salivary acidity following carbohydrate ingestion before and after endurance exercise in healthy male runners	PLOS ONE			English	Article							DIETARY NITRATE; INORGANIC NITRATE; PLASMA NITRITE; ORAL-HEALTH; BLOOD-PRESSURE; DENTAL PLAQUE; DOUBLE-BLIND; SUPPLEMENTATION; PERFORMANCE; FLOW	There have been recent calls for strategies to improve oral health in athletes. High carbohydrate diets, exercise induced dehydration and transient perturbations to immune function combine to increase oral disease risk in this group. We tested whether a single dose of nitrate (NO3-) would offset the reduction in salivary pH following carbohydrate ingestion before and after an exercise bout designed to cause mild dehydration. Eleven trained male runners ((V)over dotO(2max) 53 +/- 9 ml.kg(-1).min(-1), age 30 +/- 7 years) completed a randomised placebo-controlled study comprising four experimental trials. Participants ingested the following fluids one hour before each trial: (a) 140 ml of water (negative-control), (b) 140 ml of water (positive-control), (c) 140 ml of NO3- rich beetroot juice (similar to 12.4 mmol NO3-) (NO3- trial) or (d) 140 ml NO3- depleted beetroot juice (placebo-trial). During the negative-control trial, participants ingested 795 ml of water in three equal aliquots: before, during, and after 90 min of submaximal running. In the other trials they received 795 ml of carbohydrate supplements in the same fashion. Venous blood was collected before and after the exercise bout and saliva was sampled before and repeatedly over the 20 min following carbohydrate or water ingestion. As expected, nitrite (NO2-) and NO3- were higher in plasma and saliva during the NO3- trial than all other trials (all P<0.001). Compared to the negative-control, salivary-pH was significantly reduced following the ingestion of carbohydrate in the positive-control and placebo trials (both P < 0.05). Salivary-pH was similar between the negative-control and NO3- trials before and after exercise despite ingestion of carbohydrate in the NO3- trial (both P >= 0.221). Ingesting NO3- attenuates the expected reduction in salivary-pH following carbohydrate supplements and exercise-induced dehydration. NO3- should be considered by athletes as a novel nutritional strategy to reduce the risk of developing acidity related oral health conditions.	[Burleigh, Mia C.; Sculthorpe, Nicholas; Easton, Chris] Univ West Scotland, Inst Clin Hlth & Exercise Sci, Blantyre, Scotland; [Henriquez, Fiona L.] Univ West Scotland, Inst Biomed & Environm Hlth Res, Blantyre, Scotland		Easton, C (corresponding author), Univ West Scotland, Inst Clin Hlth & Exercise Sci, Blantyre, Scotland.	chris.easton@uws.ac.uk		Sculthorpe, Nicholas/0000-0001-8235-8580; Henriquez, Fiona/0000-0002-5534-1019; Burleigh, Mia Cousins/0000-0002-0569-4895; Easton, Chris/0000-0003-4808-1287	Hannah Dairy Research Foundation	Hannah Dairy Research Foundation	This project was funded by a grant from the Hannah Dairy Research Foundation (https://www.hannahdairyresearch.org.uk/) awarded to CE, MB, NS, FH. The funder had no involvement in study design, data collection, or the writing of this report.	Abbate G M, 2014, J Clin Dent, V25, P71; [Anonymous], 2009, J ATHL TRAINING, V44, P538; Ashley P, 2015, BRIT J SPORT MED, V49, P14, DOI 10.1136/bjsports-2014-093617; Bahadoran Z, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0013-6; Bailey SJ, 2010, J APPL PHYSIOL, V109, P135, DOI 10.1152/japplphysiol.00046.2010; Bailey SJ, 2009, J APPL PHYSIOL, V107, P1144, DOI 10.1152/japplphysiol.00722.2009; Bayindir YZ, 2005, CARIES RES, V39, P130, DOI 10.1159/000083158; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BERGSTROM J, 1967, SCAND J CLIN LAB INV, V19, P218, DOI 10.3109/00365516709090629; Berry MJ, 2015, NITRIC OXIDE-BIOL CH, V48, P22, DOI 10.1016/j.niox.2014.10.007; Bowen WH, 2013, ODONTOLOGY, V101, P2, DOI 10.1007/s10266-012-0092-z; Bryant S, 2011, INT J SPORTS MED, V32, P720, DOI 10.1055/s-0031-1277192; Burleigh M, 2019, NITRIC OXIDE-BIOL CH, V89, P54, DOI 10.1016/j.niox.2019.04.010; Burleigh MC, 2018, FREE RADICAL BIO MED, V120, P80, DOI 10.1016/j.freeradbiomed.2018.03.023; Cochrane NJ, 2012, AUST DENT J, V57, P359, DOI 10.1111/j.1834-7819.2012.01708.x; COYLE EF, 1984, SPORTS MED, V1, P446, DOI 10.2165/00007256-198401060-00004; de Melo Mary Anne Sampaio, 2016, Restor Dent Endod, V41, P246; Doel JJ, 2004, EUR J ORAL SCI, V112, P424, DOI 10.1111/j.1600-0722.2004.00153.x; Ehlen LA, 2008, NUTR RES, V28, P299, DOI 10.1016/j.nutres.2008.03.001; Erdemir U, 2016, WORLD J STOMATOL, V5, P1, DOI DOI 10.5321/WJS.V5.I1.1; Ferguson SK, 2013, J PHYSIOL-LONDON, V591, P547, DOI 10.1113/jphysiol.2012.243121; Gallagher J, 2017, BRIT J SPORT MED, V51, P3203, DOI [10.1136/bjsports-2016-097372.94, DOI 10.1136/BJSP0RTS-2016-097372.94]; Gallagher J, 2018, COMMUNITY DENT ORAL, V46, P563, DOI 10.1111/cdoe.12392; Gilchrist M, 2011, CARDIOVASC RES, V89, P492, DOI 10.1093/cvr/cvq309; Hans R, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/5027283; HASE JC, 1988, ARCH ORAL BIOL, V33, P875, DOI 10.1016/0003-9969(88)90016-7; Hernandez A, 2012, J PHYSIOL-LONDON, V590, P3575, DOI 10.1113/jphysiol.2012.232777; Hohensinn B, 2016, NITRIC OXIDE-BIOL CH, V60, P10, DOI 10.1016/j.niox.2016.08.006; Jarvinen VK, 2016, RISK FACTORS DENT ER, DOI [10.1177/00220345910700060601, DOI 10.1177/00220345910700060601]; Jeukendrup AE, 2004, NUTRITION, V20, P669, DOI 10.1016/j.nut.2004.04.017; Jeukendrup AE, 2008, EUR J SPORT SCI, V8, P77, DOI 10.1080/17461390801918971; Kapil V, 2014, NITRIC OXIDE-BIOL CH, V38, P45, DOI 10.1016/j.niox.2014.03.162; Kelly J, 2014, AM J PHYSIOL-REG I, V307, pR920, DOI 10.1152/ajpregu.00068.2014; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Koch CD, 2017, FREE RADICAL BIO MED, V105, P48, DOI 10.1016/j.freeradbiomed.2016.12.015; Koopman JE, 2016, MICROB ECOL, V72, P479, DOI 10.1007/s00248-016-0775-z; Kragt L, 2019, PHYSICIAN SPORTSMED, V47, P182, DOI 10.1080/00913847.2018.1546105; Larsen FJ, 2007, ACTA PHYSIOL, V191, P59, DOI 10.1111/j.1748-1716.2007.01713.x; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Li H, 2007, ORAL MICROBIOL IMMUN, V22, P67, DOI 10.1111/j.1399-302X.2007.00313.x; Liddle L, 2018, NITRIC OXIDE-BIOL CH, V72, P59, DOI 10.1016/j.niox.2017.11.008; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; Lussi A, 2008, CLIN ORAL INVEST, V12, pS5, DOI 10.1007/s00784-007-0179-z; Lutovac Mitar, 2017, Open Access Maced J Med Sci, V5, P987, DOI 10.3889/oamjms.2017.180; Mcllvenna LC, 2017, NITRIC OXIDE-BIOL CH, V64, P61, DOI 10.1016/j.niox.2016.12.006; McMahon NF, 2017, SPORTS MED, V47, P735, DOI 10.1007/s40279-016-0617-7; Milosevic A, 1997, BRIT J SPORT MED, V31, P28, DOI 10.1136/bjsm.31.1.28; Muggeridge DJ, 2017, J SCI MED SPORT, V20, P92, DOI 10.1016/j.jsams.2016.04.014; Mulic A, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-8; Murtaza N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030614; Navazesh M, 2008, J AM DENT ASSOC, V139, p35S, DOI 10.14219/jada.archive.2008.0353; NAVIA JM, 1994, AM J CLIN NUTR, V59, p719S, DOI 10.1093/ajcn/59.3.719S; Needleman I, 2014, BRIT DENT J, V217, DOI 10.1038/sj.bdj.2014.1000; Needleman I, 2013, BRIT J SPORT MED, V47, P1054, DOI 10.1136/bjsports-2013-092891; Petersson J, 2007, AM J PHYSIOL-GASTR L, V292, pG718, DOI 10.1152/ajpgi.00435.2006; Rees Jeremy, 2005, Eur J Prosthodont Restor Dent, V13, P186; Rosier BT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69931-x; Rosier BT, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.555465; Saluja Pulin, 2014, J Clin Diagn Res, V8, pZC81, DOI 10.7860/JCDR/2014/9935.5071; Scardina GA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/720692; Senthil Eagappan A R, 2016, Dent Res J (Isfahan), V13, P338; Staff report, 2007, MODERN POWER SYSTEMS, V27, P33; Tanabe M, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-49; Tiso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119712; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Touger-Decker R, 2003, J AM DIET ASSOC, V103, P615, DOI 10.1053/jada.2003.50130; Tungare S, 2019, DIET NUTR PREVENT DE, DOI [10.1177/2380084419892550, DOI 10.1177/2380084419892550]; URBANIAK GC, 2013, RES RANDOMIZER; Vanhatalo A, 2018, FREE RADICAL BIO MED, V124, P21, DOI 10.1016/j.freeradbiomed.2018.05.078; Velmurugan S, 2016, AM J CLIN NUTR, V103, P25, DOI 10.3945/ajcn.115.116244; Wadhwani S, 2015, MENSTRUAL CYCLE RELA; Wang YL, 2014, J FORMOS MED ASSOC, V113, P850, DOI 10.1016/j.jfma.2014.06.002; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Wightman EL, 2015, PHYSIOL BEHAV, V149, P149, DOI 10.1016/j.physbeh.2015.05.035; Williamson S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/246178; Wylie LJ, 2013, J APPL PHYSIOL, V115, P325, DOI 10.1152/japplphysiol.00372.2013	76	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243755	10.1371/journal.pone.0243755	http://dx.doi.org/10.1371/journal.pone.0243755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320868	gold, Green Published			2022-12-26	WOS:000600339800045
J	Toparslan, E; Karabag, K; Bilge, U				Toparslan, Emine; Karabag, Kemal; Bilge, Ugur			A workflow with R: Phylogenetic analyses and visualizations using mitochondrial cytochrome b gene sequences	PLOS ONE			English	Article							POPULATION-GENETICS; PACKAGE	Phylogenetic analyses can provide a wealth of information about the past demography of a population and the level of genetic diversity within and between species. By using special computer programs developed in recent years, large amounts of data have been produced in the molecular genetics area. To analyze these data, powerful new methods based on large computations have been applied in various software packages and programs. But these programs have their own specific input and output formats, and users need to create different input formats for almost every program. R is an open source software environment, and it supports open contribution and modification to its libraries. Furthermore, it is also possible to perform several analyses using a single input file format. In this article, by using the multiple sequences FASTA format file (.fas extension) we demonstrate and share a workflow of how to extract haplotypes and perform phylogenetic analyses and visualizations in R. As an example dataset, we used 120 Bombus terrestris dalmatinus mitochondrial cytochrome b gene (cyt b) sequences (373 bp) collected from eight different beehives in Antalya. This article presents a short guide on how to perform phylogenetic analyses using R and RStudio.	[Toparslan, Emine; Bilge, Ugur] Akdeniz Univ, Inst Nat & Appl Sci, Antalya, Turkey; [Toparslan, Emine; Karabag, Kemal] Akdeniz Univ, Dept Agr Biotechnol, Fac Agr, Antalya, Turkey; [Bilge, Ugur] Akdeniz Univ, Dept Biostat & Med Informat, Fac Med, Antalya, Turkey	Akdeniz University; Akdeniz University; Akdeniz University	Bilge, U (corresponding author), Akdeniz Univ, Dept Biostat & Med Informat, Fac Med, Antalya, Turkey.	ubilge@akdeniz.edu.tr	Bilge, Ugur/C-1044-2016	Bilge, Ugur/0000-0002-5186-1092; TOPARSLAN, Emine/0000-0001-8194-7842	Scientific Research Projects Coordination Unit of Akdeniz University [FYL-2016-1502]	Scientific Research Projects Coordination Unit of Akdeniz University(Akdeniz University)	The data used in this project were provided by the project numbered FYL-2016-1502, supported by the Scientific Research Projects Coordination Unit of Akdeniz University. We would like to thank Philippa Price for proofreading this article.	Aktas C., 2020, HAPLOTYPES MANIPULAT; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Gentleman R., 2020, BIOSTRINGS STRING OB; Gupta A, 2015, J BIODIVERS ENDANGER, VS1, P6; Heibl C, 2019, PACKAGEIPSVERSION 0; Jombart T, 2020, ADEGENET EXPLORATORY; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Kress WJ, 2002, AM J BOT, V89, P1682, DOI 10.3732/ajb.89.10.1682; Morandat F, 2012, LECT NOTES COMPUT SC, V7313, P104, DOI 10.1007/978-3-642-31057-7_6; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pele J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-133; Pinheiro HP, 2005, J STAT PLAN INFER, V130, P325, DOI 10.1016/j.jspi.2003.03.002; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; R Core Team, 2021, R LANGUAGE ENV STAT; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Wang LG, 2020, MOL BIOL EVOL, V37, P599, DOI 10.1093/molbev/msz240; Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147; Xie Y, 2020, KNITR GEN PURPOSE PA; Xie Y., 2018, R MARKDOWN DEFINITIV; Yu Guangchuang, 2020, Curr Protoc Bioinformatics, V69, pe96, DOI 10.1002/cpbi.96; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	25	6	6	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243927	10.1371/journal.pone.0243927	http://dx.doi.org/10.1371/journal.pone.0243927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320915	Green Published, gold			2022-12-26	WOS:000600339800037
J	Koponen, M; Marjamaa, A; Tuiskula, AM; Viitasalo, M; Nallinmaa-Luoto, T; Leinonen, JT; Widen, E; Toivonen, L; Kontula, K; Swan, H				Koponen, Mikael; Marjamaa, Annukka; Tuiskula, Annukka M.; Viitasalo, Matti; Nallinmaa-Luoto, Terhi; Leinonen, Jaakko T.; Widen, Elisabeth; Toivonen, Lauri; Kontula, Kimmo; Swan, Heikki			Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; MOLECULAR CHARACTERIZATION; BETA-BLOCKERS; ARRHYTHMIAS; GENE; ASSOCIATION; FLECAINIDE; CHILDREN; THERAPY; EVENTS	Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe inherited arrhythmic disease associated with a risk of syncope and sudden cardiac death (SCD). Aims We aimed at identifying RYR2 P2328S founder mutation carriers and describing the clinical course associated with the mutation. Methods The study population was drawn from the Finnish Inherited Cardiac Disorder Research Registry, and from the present genealogical study. Kaplan-Meier graphs, log-rank test and Cox regression model were used to evaluate the clinical course. Results Genealogical study revealed a common ancestor couple living in the late 17(th) century. A total of 1837 living descendants were tested for RYR2 P2328S mutation unveiling 62 mutation carriers aged mean 3923 years old. No arrhythmic deaths were documented among genotyped subjects, but 11 SCDs were detected in non-genotyped family members since 1970. Three genotyped patients (5%) suffered an aborted cardiac arrest (ACA), and 15 (25%) had a syncope triggered by exercise or stress. Rate of cardiac events was higher among patients who in exercise stress test showed a maximum rate of premature ventricular contractions >30/min (68% vs 17%, p<0.01; hazard ratio = 7.1, p = 0.02), in comparison to patients without the respective finding. A cardioverter-defibrillator (ICD) was implanted to 13 (22%) patients, with an appropriate ICD shock in four (31%) subjects. All ICD shocks, one ACA, and one syncope occurred during <beta>-blocker medication. Conclusions Previously undiagnosed CPVT patients may be identified by well-conducted genealogical studies. The RYR2 P2328S mutation causes a potentially severe phenotype, but its expression is variable, thus calling for additional studies on modifying factors.	[Koponen, Mikael; Marjamaa, Annukka; Viitasalo, Matti; Toivonen, Lauri] Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland; [Koponen, Mikael; Tuiskula, Annukka M.; Kontula, Kimmo; Swan, Heikki] Univ Helsinki, Helsinki, Finland; [Tuiskula, Annukka M.; Kontula, Kimmo] Helsinki Univ Hosp, Dept Med, Helsinki, Finland; [Tuiskula, Annukka M.] Helsinki Univ Hosp, Genet Lab, HUSLAB, Helsinki, Finland; [Nallinmaa-Luoto, Terhi] Univ Turku, Turku, Finland; [Leinonen, Jaakko T.; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland, FIMM, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Helsinki	Koponen, M (corresponding author), Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland.; Koponen, M (corresponding author), Univ Helsinki, Helsinki, Finland.	mikael.koponen@helsinki.fi		Tuiskula, Annukka/0000-0002-6538-635X				Ackerman MJ, 2017, HEART RHYTHM, V14, pE41, DOI 10.1016/j.hrthm.2016.09.012; Coumel P., 1978, BRIT HEART J, V40, P28; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; Hayashi M, 2012, EUROPACE, V14, P1344, DOI 10.1093/europace/eus031; Kannankeril PJ, 2017, JAMA CARDIOL, V2, P759, DOI 10.1001/jamacardio.2017.1320; Kujala K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044660; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; Lehnart SE, 2004, CIRCULATION, V109, P3208, DOI 10.1161/01.CIR.0000132472.98675.EC; Leren IS, 2016, HEART RHYTHM, V13, P433, DOI 10.1016/j.hrthm.2015.09.029; Lieve KV, 2016, CIRC J, V80, P1285, DOI 10.1253/circj.CJ-16-0326; Mohamed U, 2006, HEART RHYTHM, V3, P1486, DOI 10.1016/j.hrthm.2006.08.018; Paavola J, 2007, EUR HEART J, V28, P1135, DOI 10.1093/eurheartj/ehl543; Paavola J, 2016, EUROPACE, V18, P1599, DOI 10.1093/europace/euv380; Penttinen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125366; Perez-Riera AR, 2018, ANN NONINVAS ELECTRO, V23, DOI 10.1111/anec.12512; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REID DS, 1975, BRIT HEART J, V37, P339; Roston TM, 2018, HEART RHYTHM, V15, P1791, DOI 10.1016/j.hrthm.2018.06.046; Roston TM, 2015, CIRC-ARRHYTHMIA ELEC, V8, P633, DOI 10.1161/CIRCEP.114.002217; Swan H, 1999, J AM COLL CARDIOL, V34, P2035, DOI 10.1016/S0735-1097(99)00461-1; van der Werf C, 2019, EUR HEART J, V40, P2953, DOI 10.1093/eurheartj/ehz309; van der Werf C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P748, DOI 10.1161/CIRCEP.112.970517; van der Werf C, 2012, EUROPACE, V14, P175, DOI 10.1093/europace/eur277; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Viitasalo M, 2008, HEART RHYTHM, V5, P1382, DOI 10.1016/j.hrthm.2008.06.011; Wanguemert F, 2015, HEART RHYTHM, V12, P1636, DOI 10.1016/j.hrthm.2015.03.033; Zhang YM, 2011, CARDIOVASC RES, V89, P794, DOI 10.1093/cvr/cvq229	33	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243649	10.1371/journal.pone.0243649	http://dx.doi.org/10.1371/journal.pone.0243649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315912	gold, Green Published			2022-12-26	WOS:000600186100027
J	Glance, LG; Thirukumaran, CP; Shippey, E; Lustik, SJ; Dick, AW				Glance, Laurent G.; Thirukumaran, Caroline P.; Shippey, Ernie; Lustik, Stewart J.; Dick, Andrew W.			Impact of medicaid expansion on disparities in revascularization in patients hospitalized with acute myocardial infarction	PLOS ONE			English	Article							ASSOCIATION TASK-FORCE; HEART-DISEASE; CARDIOVASCULAR HEALTH; AMERICAN-COLLEGE; MANAGEMENT; GUIDELINE; INSURANCE; UPDATE; CARE; MORTALITY	Introduction Blacks are more likely to live in poverty and be uninsured, and are less likely to undergo revascularization after am acute myocardial infarction compared to whites. The objective of this study was to determine whether Medicaid expansion was associated with a reduction in revascularization disparities in patients admitted with an acute myocardial infarction. Methods Retrospective analysis study using data (2010-2018) from hospitals participating in the University Health Systems Consortium, now renamed the Vizient Clinical Database. Comparative interrupted time series analysis was used to compare changes in the use of revascularization therapies (PCI and CABG) in white versus non-Hispanic black patients hospitalized with either ST-segment elevation (STEMI) or non-ST-segment elevation acute myocardial infarctions (NSTEMI) after Medicaid expansion. Results The analytic cohort included 68,610 STEMI and 127,378 NSTEMI patients. The percentage point decrease in the uninsured rate for STEMIs and NSTEMIs was greater for blacks in expansion states compared to whites in expansion states. For patients with STEMIs, differences in black versus white revascularization rates decreased by 2.09 percentage points per year (95% CI, 0.29-3.88, P = 0.023) in expansion versus non-expansion states after adjusting for patient and hospital characteristics. Black patients hospitalized with STEMI in non-expansion states experienced a 7.24 percentage point increase in revascularization rate in 2014 (95% CI, 2.83-11.7, P < 0.001) but did not experience significant annual percentage point increases in the rate of revascularization in subsequent years (1.52; 95% CI, -0.51-3.55, P = 0.14) compared to whites in non-expansion states. Medicaid expansion was not associated with changes in the revascularization rate for either blacks or whites hospitalized with NSTEMIs. Conclusion Medicaid expansion was associated with greater reductions in the number of uninsured blacks compared to uninsured whites. Medicaid expansion was not associated, however, with a reduction in revascularization disparities between black and white patients admitted with acute myocardial infarctions.	[Glance, Laurent G.; Lustik, Stewart J.] Univ Rochester, Sch Med, Dept Anesthesiol & Perioperat Med, Rochester, NY 14627 USA; [Glance, Laurent G.] Univ Rochester, Sch Med, Dept Publ Hlth Sci, Rochester, NY 14627 USA; [Glance, Laurent G.; Dick, Andrew W.] RAND, RAND Hlth, Boston, MA 02116 USA; [Thirukumaran, Caroline P.] Univ Rochester, Dept Orthoped, Sch Med, Rochester, NY 14642 USA; [Shippey, Ernie] Vizient, Irving, TX USA	University of Rochester; University of Rochester; RAND Corporation; University of Rochester	Glance, LG (corresponding author), Univ Rochester, Sch Med, Dept Anesthesiol & Perioperat Med, Rochester, NY 14627 USA.; Glance, LG (corresponding author), Univ Rochester, Sch Med, Dept Publ Hlth Sci, Rochester, NY 14627 USA.; Glance, LG (corresponding author), RAND, RAND Hlth, Boston, MA 02116 USA.	Laurent_Glance@urmc.rochester.edu		Thirukumaran, Caroline/0000-0003-3316-0951; Glance, Laurent/0000-0003-3381-699X	NIH [R01 MD012422]; Department of Anesthesiology and Perioperative Medicine at the University of Rochester School of Medicine and Dentistry, RAND Health	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesiology and Perioperative Medicine at the University of Rochester School of Medicine and Dentistry, RAND Health	This work was supported by NIH grant R01 MD012422, and by the Department of Anesthesiology and Perioperative Medicine at the University of Rochester School of Medicine and Dentistry, RAND Health, and Vizient. The funder provided support in the form of salaries for authors [LGG, ES, SJL, AWD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akhabue E, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1296; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], 2018, POVERTY RATE RACE ET; Baicker K, 2004, HEALTH AFFAIR, V23, pVAR33, DOI 10.1377/hlthaff.var.33; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Buchmueller TC, 2016, AM J PUBLIC HEALTH, V106, P1416, DOI 10.2105/AJPH.2016.303155; Bureau USC,, 2018, ICONCOME POVERTYU US; Bydon M, 2020, CLIN NEUROL NEUROSUR, V188, DOI 10.1016/j.clineuro.2019.105585; Carnethon MR, 2017, CIRCULATION, V136, pE393, DOI 10.1161/CIR.0000000000000534; Cromwell J, 2005, MED CARE, V43, P330, DOI 10.1097/01.mlr.0000156864.80880.aa; Damico A, 2020, CHANGES HLTH COVERAG; Eagle Kim A, 2004, Circulation, V110, pe340; Eguia E, 2018, ANN SURG, V268, P584, DOI 10.1097/SLA.0000000000002952; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Eltorai AEM, 2017, JAMA-J AM MED ASSOC, V317, P1407, DOI 10.1001/jama.2017.2042; Etzioni DA, 2015, JAMA-J AM MED ASSOC, V313, P505, DOI 10.1001/jama.2015.90; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Kahn JM, 2019, JAMA-J AM MED ASSOC, V322, P240, DOI 10.1001/jama.2019.9021; Khatana SAM, 2019, JAMA CARDIOL, V4, P671, DOI 10.1001/jamacardio.2019.1651; Li SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069855; Loehrer AP, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2017.5568; McWilliams JM, 2018, NEW ENGL J MED, V379, P1139, DOI 10.1056/NEJMsa1803388; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Qian F, 2012, ANN SURG; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Simorov A, 2012, ANN SURG, V256, P462, DOI 10.1097/SLA.0b013e3182657ec5; Sommers BD, 2017, AM J HEALTH ECON, V3, P392, DOI 10.1162/ajhe_a_00080; Soni A, 2020, HEALTH AFFAIR, V39, P371, DOI 10.1377/hlthaff.2019.01436; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wadhera RK, 2019, JAMA CARDIOL, V4, P120, DOI 10.1001/jamacardio.2018.4577; Wadhera RK, 2017, CIRCULATION, V135, P1988, DOI 10.1161/CIRCULATIONAHA.117.028618; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Xu J, DEATHS FINAL DATA 20; Yong CM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001029	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243385	10.1371/journal.pone.0243385	http://dx.doi.org/10.1371/journal.pone.0243385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362198	Green Published, gold			2022-12-26	WOS:000603071600013
J	Wu, ZH; Hai, EH; Di, ZY; Ma, R; Shang, FZ; Wang, Y; Wang, M; Liang, LL; Rong, YJ; Pan, JF; Wu, WB; Su, R; Wang, ZY; Wang, RJ; Zhang, YJ; Li, JQ				Wu, Zhihong; Hai, Erhan; Di, Zhengyang; Ma, Rong; Shang, Fangzheng; Wang, Yu; Wang, Min; Liang, Lili; Rong, Youjun; Pan, Jianfeng; Wu, Wenbin; Su, Rui; Wang, Zhiying; Wang, Ruijun; Zhang, Yanjun; Li, Jinquan			Using WGCNA (weighted gene co-expression network analysis) to identify the hub genes of skin hair follicle development in fetus stage of Inner Mongolia cashmere goat	PLOS ONE			English	Article							CELL POLARITY; WNT; ACTIVATION; GASTRULATION; SUPPRESSION; MECHANISMS; BUD	Objective Mature hair follicles represent an important stage of hair follicle development, which determines the stability of hair follicle structure and its ability to enter the hair cycle. Here, we used weighted gene co-expression network analysis (WGCNA) to identify hub genes of mature skin and hair follicles in Inner Mongolian cashmere goats. Methods We used transcriptome sequencing data for the skin of Inner Mongolian cashmere goats from fetal days 45-135 days, and divided the co expressed genes into different modules by WGCNA. Characteristic values were used to screen out modules that were highly expressed in mature skin follicles. Module hub genes were then selected based on the correlation coefficients between the gene and module eigenvalue, gene connectivity, and Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The results were confirmed by quantitative polymerase chain reaction (qPCR). Results Ten modules were successfully defined, of which one, with a total of 3166 genes, was selected as a specific module through sample and gene expression pattern analyses. A total of 584 candidate hub genes in the module were screened by the correlation coefficients between the genes and module eigenvalue and gene connectivity. Finally, GO/KEGG functional enrichment analyses detected WNT10A as a key gene in the development and maturation of skin hair follicles in fetal Inner Mongolian cashmere goats. qPCR showed that the expression trends of 13 genes from seven fetal skin samples were consistent with the sequencing results, indicating that the sequencing results were reliable.n	[Wu, Zhihong; Hai, Erhan; Di, Zhengyang; Ma, Rong; Shang, Fangzheng; Wang, Min; Liang, Lili; Rong, Youjun; Pan, Jianfeng; Su, Rui; Wang, Zhiying; Wang, Ruijun; Zhang, Yanjun; Li, Jinquan] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China; [Li, Jinquan] Key Lab Anim Genet Breeding & Reprod, Hohhot, Inner Mongolia, Peoples R China; [Li, Jinquan] Minist Agr, Key Lab Mutton Sheep Genet & Breeding, Hohhot, Peoples R China; [Zhang, Yanjun; Li, Jinquan] Engn Res Ctr Goat Genet & Breeding, Hohhot, Inner Mongolia, Peoples R China; [Wang, Yu] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Inner Mongolia, Peoples R China; [Wu, Wenbin] Zhenlai Hehe Anim Husb Dev Co Ltd, Baicheng, Peoples R China	Inner Mongolia Agricultural University; Ministry of Agriculture & Rural Affairs; Inner Mongolia Agricultural University	Zhang, YJ; Li, JQ (corresponding author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China.; Li, JQ (corresponding author), Key Lab Anim Genet Breeding & Reprod, Hohhot, Inner Mongolia, Peoples R China.; Li, JQ (corresponding author), Minist Agr, Key Lab Mutton Sheep Genet & Breeding, Hohhot, Peoples R China.; Zhang, YJ; Li, JQ (corresponding author), Engn Res Ctr Goat Genet & Breeding, Hohhot, Inner Mongolia, Peoples R China.	imauzyj@163.com; lijinquan_nd@126.com	wu, zhi/GXH-3041-2022		National Natural Science Foundation of China [31860627]; Plan Project of Science and Technology in Inner Mongolia [2019GG243]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan Project of Science and Technology in Inner Mongolia	This work was supported by National Natural Science Foundation of China in the form of a grant awarded to YZ (31860627) and Plan Project of Science and Technology in Inner Mongolia in the form of a grant awarded to YZ (2019GG243).	Ahn S, 2020, BIOMATERIALS, V255, DOI 10.1016/j.biomaterials.2020.120149; An JA, 2015, BIOCHEM BIOPH RES CO, V461, P142, DOI 10.1016/j.bbrc.2015.03.182; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; [Anonymous], 2020, CANC DISCOV, V10, pOF8; Anyabolu Ernest Ndukaife, 2017, CLIN MED DIAGN, V7, P8, DOI DOI 10.5923/J.CMD.20170701.02; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Basler K, 2016, J CONTROL RELEASE, V242, P105, DOI 10.1016/j.jconrel.2016.08.007; Bai JY, 2006, ASIAN AUSTRAL J ANIM, V19, P13; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Bray MA, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw014; Chamcheu JC, 2011, ARCH BIOCHEM BIOPHYS, V508, P123, DOI 10.1016/j.abb.2010.12.019; Deng ZL, 2015, J MOL CELL BIOL, V7, P62, DOI 10.1093/jmcb/mjv005; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Feltrin AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210431; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Han WJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60351-5; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hoefert JE, 2018, J CELL BIOL, V217, P2185, DOI 10.1083/jcb.201708173; Kim HS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225511; Klufa J, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax2693; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee J, 2018, CELL REP, V22, P242, DOI 10.1016/j.celrep.2017.12.007; Lefever T, 2010, J CELL SCI, V123, P128, DOI 10.1242/jcs.053835; Li J, 2019, ONCOL LETT, V17; Liu X, 2020, GENE, V733, DOI 10.1016/j.gene.2019.144242; Manli Yang, 2020, J COSMET DERMATOL; Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x; Mikkola ML, 2006, J MAMMARY GLAND BIOL, V11, P187, DOI 10.1007/s10911-006-9029-x; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Noramly S, 1999, DEVELOPMENT, V126, P3509; Petridis C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07459-5; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reyes CC, 2014, CURR BIOL, V24, P1263, DOI 10.1016/j.cub.2014.04.021; Roy E, 2016, EMBO J, V35, P2658, DOI 10.15252/embj.201693806; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sennett R, 2015, DEV CELL, V34, P577, DOI 10.1016/j.devcel.2015.06.023; Shin W, 2020, DEV CELL, V53, P185, DOI 10.1016/j.devcel.2020.03.019; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Suen WJ, 2020, STEM CELLS, V38, P301, DOI 10.1002/stem.3117; Tiskinformation, 2006, TISKINFORMATION, V25, P2; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Xiong Y, 2019, J DENT RES, V98, P580, DOI 10.1177/0022034519835194; Xu XG, 2018, ACTA DERM-VENEREOL, V98, P318, DOI 10.2340/00015555-2843; Yang L, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27266; Yu M, 2020, J DENT RES, V99, P311, DOI 10.1177/0022034519897607; Yu Miao, 2019, AM J MED GENETICS A, V179; Zhang Yanjun, 2007, INNER MONGOLIA CASHM; Zhou T, 2016, CELL PHYSIOL BIOCHEM, V38, P959, DOI 10.1159/000443048; Zorn-Kruppa M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30341-9; 2018, CURR OPIN TOXICOL, V10; 2019, J CROHNS COLITIS S1, V13	59	5	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243507	10.1371/journal.pone.0243507	http://dx.doi.org/10.1371/journal.pone.0243507			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351808	gold, Green Published			2022-12-26	WOS:000603071400028
J	Barakat, M; Al-Qudah, R; Akour, A; Al-Qudah, N; Bashi, YDH				Barakat, Muna; Al-Qudah, Raja'a; Akour, Amal; Al-Qudah, Najem; Dallal Bashi, Yahya H.			Unforeseen uses of oral contraceptive pills: Exploratory study in Jordanian community pharmacies	PLOS ONE			English	Article							KNOWLEDGE; MISUSE; WOMEN; PRESCRIPTION; ATTITUDE; IMPACT; ABUSE	Background The use of oral contraceptive pills (OCPs) as a birth control method is very common worldwide. OCPs have many other labeled non-contraceptive indications, and as a result there is an associated risk of improper use, as with any other medications. This study was designed to assess the unforeseen improper uses of OCPs observed by community pharmacists in Jordan. Method A cross-sectional study design was conducted using a self-administered survey. A convenience sample (n = 380) of Jordanian community pharmacists, were recruited through social media resources. The survey included multiple-choice and open-ended questions. Descriptive statistics and correlation analyses were completed using SPSS. Results More than half of the recruited pharmacists (55.3%) were female, and the mean age of the participants was 32.58 +/- 9.94. The majority of the pharmacists (85%) had good knowledge about the non-contraceptive indications of OCPs. About 53% of them confirmed their exposure to cases of the improper use of OCPs. About 67.5% of the pharmacists who confirmed exposure to such cases, reported the topical use of OCPs for the enhancement of hair growth. Around 15% of those pharmacists stated that OCPs were used to give negative results for addictive drug screening tests. In the event that the pharmacists suspected improper use, more than 90% suggested they would refrain from dispensing the pills. Conclusion This study has spotlighted many unforeseen uses of OCPs in Jordan and highlighted the need for restricted national regulations on the monitoring of OCP prescription/selling patterns in Jordan by policymakers. Moreover, there is a need for the establishment of national educational programs for the Jordanian community regarding the safe proper use of OCPs.	[Barakat, Muna; Al-Qudah, Raja'a] Appl Sci Private Univ, Fac Pharm, Amman, Jordan; [Akour, Amal] Al Zaytoonah Univ Jordan, Dept Pharm, Fac Pharm, Amman, Jordan; [Akour, Amal] Univ Jordan, Dept Biopharmaceut & Clin Pharm, Sch Pharm, Amman, Jordan; [Al-Qudah, Najem] Al Balqa Appl Univ, Fac Med, Al Salt, Jordan; [Dallal Bashi, Yahya H.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland	Al-Zaytoonah University of Jordan; University of Jordan; Al-Balqa Applied University; Queens University Belfast	Barakat, M (corresponding author), Appl Sci Private Univ, Fac Pharm, Amman, Jordan.	m_barakat@asu.edu.jo	Barakat, Muna/AAN-8778-2020	Barakat, Muna/0000-0002-7966-1172; Dallal Bashi, Yahya H/0000-0002-8480-9776				Akour A, 2017, EUR J CONTRACEP REPR, V22, P459, DOI 10.1080/13625187.2017.1412425; Albsoul-Younes A, 2010, SUBST USE MISUSE, V45, P1319, DOI 10.3109/10826080802490683; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; [Anonymous], 2018, GLOBAL NEWS; [Anonymous], 2007, DIABETES CARE S1, V30, pS4; Bardaweel SK, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0770-x; Bardaweel SK, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0275-1; Boynton PM, 2004, BRIT MED J, V328, P1312, DOI 10.1136/bmj.328.7451.1312; Cundill Pauline, 2020, Aust J Gen Pract, V49, P385, DOI 10.31128/AJGP-01-20-5197; Daniels Kimberly, 2014, NCHS Data Brief, P1; El-Mowafi IM, 2020, CONTRACEPTION, V101, P261, DOI 10.1016/j.contraception.2019.10.002; Foroutan Nazanin, 2016, Pharmacy Pract (Granada), V14, P745, DOI [10.18549/PharmPract.2016.04.745, 10.18549/pharmpract.2016.04.745]; Francis A, 2018, Womens Midlife Health, V4, P12, DOI 10.1186/s40695-018-0042-1; Fu S, 2016, ADV CLIN CHEM, V76, P123, DOI 10.1016/bs.acc.2016.05.003; Gardner JS, 2008, J AM PHARM ASSOC, V48, P212, DOI 10.1331/JAPhA.2008.07138; GOLDSTUCK N D, 1987, Advances in Contraception, V3, P335, DOI 10.1007/BF01849291; Hajhashemi V, 2007, PHYSIOL PHARMACOL, V11, P68; Health WHOR, 2018, FAM PLANN GLOB HDB P; Huang QL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016440; Ibrahim OM, 2017, TROP J PHARM RES, V16, P947, DOI 10.4314/tjpr.v16i4.29; Ilardo ML, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020536; Irwin AN, 2019, RES SOC ADMIN PHARM, V15, P650, DOI 10.1016/j.sapharm.2018.08.003; Jager J, 2017, MONOGR SOC RES CHILD, V82, P13, DOI 10.1111/mono.12296; Jordan Food and Drug Administration (JFDA)., 2018, LIST NONPR MED; Jordanian pharmacist's association (JPA), 2019, JPA STAT NUMB PHARM; Kennedy CE, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001402; Kirkpatrick K., 2015, WHAT MAN TAKES BIRTH; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Mahmoud MA, 2018, COMMUNITY PHARM PERS; McIntosh J, 2011, PHARMACOTHERAPY, V31, P424, DOI 10.1592/phco.31.4.424; Mobark DM, 2019, PHARM PRACT-GRANADA, V17, DOI [10.18549/pharmpract.2019.2.1465, 10.18549/PharmPract.2019.2.1465]; Obreli-Neto PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079875; Pazol K, 2018, AM J PREV MED, V55, P703, DOI 10.1016/j.amepre.2018.07.012; Rafie S, 2019, PHARMACY-BASEL, V7, DOI 10.3390/pharmacy7030096; Ratanajamit C, 2001, PHARMACOEPIDEM DR S, V10, P149, DOI 10.1002/pds.573; ROSENBERG MJ, 1995, CONTRACEPTION, V51, P283, DOI 10.1016/0010-7824(95)00074-K; Saadatnia M, 2012, J RES MED SCI, V17, P344; Sattari M, 2013, E MEDITERR HEALTH J, V19, P547, DOI 10.26719/2013.19.6.547; Schindler AE, 2013, INT J ENDOCRINOL MET, V11, P41, DOI 10.5812/ijem.4158; Skouby SO, 2004, EUR J CONTRACEP REPR, V9, P57, DOI 10.1080/13625180410001715681; Smith SM, 2013, PAIN, V154, P2287, DOI 10.1016/j.pain.2013.05.053; Spooner C., 2005, SOCIAL DETERMINANTS; Tahaineh L, 2020, J PHARM HEALTH SERV, V11, P33, DOI 10.1111/jphs.12337; Taherdoost H., 2017, INT J EC MANAGEMENT, V2, P237, DOI DOI 10.1016/J.JTH.2017.07.005; The United States Agency for International Development (USAID), 2015, JORD PROGR PROF; Weerasinghe M, 2017, J FAM PLAN REPROD H, V43, P147, DOI 10.1136/jfprhc-2015-101171	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244373	10.1371/journal.pone.0244373	http://dx.doi.org/10.1371/journal.pone.0244373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347511	Green Published, gold			2022-12-26	WOS:000603071100032
J	de Lemos, APS; Sacchi, CT; Goncalves, CR; Camargo, CH; Andrade, AL				de Lemos, Ana Paula Silva; Sacchi, Claudio Tavares; Goncalves, Claudia Regina; Camargo, Carlos Henrique; Andrade, Ana Lucia			Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; MOLECULAR EPIDEMIOLOGY; MULTICOMPONENT VACCINE; 4CMENB VACCINE; RESISTANCE; CANDIDATE; VARIANTS; COVERAGE; PREVALENCE; CIPROFLOXACIN	Background Neisseria meningitidis serogroup B remains a prominent cause of invasive meningococcal disease (IMD) in Brazil. Because two novel protein-based vaccines against serogroup B are available, the main purpose of this study was to provide data on the diversity and distribution of meningococcal vaccine antigen types circulating in Brazil. Methodology Genetic lineages, vaccine antigen types, and allele types of antimicrobial-associated resistance genes based on whole-genome sequencing of a collection of 145 Neisseria meningitidis serogroup B invasive strains recovered in Brazil from 2016 to 2018 were collected. Results A total of 11 clonal complexes (ccs) were identified among the 145 isolates, four of which were predominant, namely, cc461, cc35, cc32, and cc213, accounting for 72.0% of isolates. The most prevalent fHbp peptides were 24 (subfamily A/variant 2), 47 (subfamily A/variant 3), 1 (subfamily B/variant 1) and 45 (subfamily A/variant 3), which were predominantly associated with cc35, cc461, cc32, and cc213, respectively. The NadA peptide was detected in only 26.2% of the isolates. The most frequent NadA peptide 1 was found almost exclusively in cc32. We found seven NHBA peptides that accounted for 74.5% of isolates, and the newly described peptide 1390 was the most prevalent peptide exclusively associated with cc461. Mutated penA alleles were detected in 56.5% of the isolates, whereas no rpoB and gyrA mutant alleles were found. Conclusion During the study period, changes in the clonal structure of circulating strains were observed, without a predominance of a single hyperinvasive lineage, indicating that an epidemiologic shift has occurred that led to a diversity of vaccine antigen types in recent years in Brazil.	[de Lemos, Ana Paula Silva; Camargo, Carlos Henrique] Inst Adolfo Lutz IAL, Ctr Bacteriol, Sao Paulo, Brazil; [Sacchi, Claudio Tavares; Goncalves, Claudia Regina] Inst Adolfo Lutz IAL, Strateg Lab, Sao Paulo, Brazil; [Andrade, Ana Lucia] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil	Universidade Federal de Goias	de Lemos, APS (corresponding author), Inst Adolfo Lutz IAL, Ctr Bacteriol, Sao Paulo, Brazil.	ana.lemos@ial.sp.gov.br			Pfizer	Pfizer(Pfizer)	This research was supported by an Investigator-Initiated Research award from Pfizer. The authors were responsible for the content of the manuscript and the decision to submit for publication. Pfizer had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150721; Andrade AL, 2017, VACCINE, V35, P2025, DOI 10.1016/j.vaccine.2017.03.010; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 1983, HIST EC SOC, V2, P355; Argimon S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093; Bambini S, 2014, CLIN VACCINE IMMUNOL, V21, P966, DOI 10.1128/CVI.00825-13; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Bennett DE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228629; Brehony C, 2016, VACCINE, V34, P4690, DOI 10.1016/j.vaccine.2016.08.015; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Brik A, 2020, INT J INFECT DIS, V91, P73, DOI 10.1016/j.ijid.2019.11.013; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Ceyhan M, 2020, VACCINE, V38, P3545, DOI 10.1016/j.vaccine.2020.03.024; Chang HY, 2019, J INFECTION, V79, P426, DOI 10.1016/j.jinf.2019.09.001; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Christodoulides M, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx033; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Deceuninck G, 2019, VACCINE, V37, P4243, DOI 10.1016/j.vaccine.2019.06.021; Chicuto LAD, 2020, HUM VACC IMMUNOTHER, V16, P1945, DOI 10.1080/21645515.2019.1700710; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Enriquez R, 2008, J ANTIMICROB CHEMOTH, V61, P286, DOI 10.1093/jac/dkm452; Leon ME, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.10; European Centre for Disease Prevention and Control (ECDC), EXP OP INTR MEN B 4C; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Gorla Maria Cecilia, 2020, Access Microbiol, V2, pacmi000079, DOI 10.1099/acmi.0.000079; Gorla MC, 2018, J MED MICROBIOL, V67, P286, DOI 10.1099/jmm.0.000685; Government of South Australia South Australian Meningococcal B expert working group, 2018, S AUSTR MEN B EXP WO; Green UR, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00204-18, 10.1128/jcm.00204-18]; Harcourt BH, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv117; Hoiseth SK, 2013, PEDIATR INFECT DIS J, V32, P1096, DOI 10.1097/INF.0b013e31829aa63b; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Lemos A., 2012, 18 INT PATH NEISS C; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P194, DOI 10.1128/CVI.00401-10; MacNeil JR, 2015, MMWR-MORBID MORTAL W, V64, P1171, DOI 10.15585/mmwr.mm6441a3; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McNeil LK, 2018, MBIO, V9, DOI 10.1128/mBio.00036-18; Ministerio da Saude, DAT; Moreno J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234475; Mothibeli KM, 2011, VACCINE, V29, P2187, DOI 10.1016/j.vaccine.2010.11.072; Mowlaboccus S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158315; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Muzzi A, 2019, VACCINE, V37, P991, DOI 10.1016/j.vaccine.2018.12.061; Ohyama Yoshiaki, 2013, J Cardiol Cases, V8, pe13, DOI 10.1016/j.jccase.2013.02.015; Orus P, 2001, INT J ANTIMICROB AG, V18, P113, DOI 10.1016/S0924-8579(01)00362-4; Parikh SR, 2017, LANCET INFECT DIS, V17, P754, DOI 10.1016/S1473-3099(17)30170-6; Parikh SR, 2016, LANCET, V388, P2775, DOI 10.1016/S0140-6736(16)31921-3; Perez-Trallero E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116024; Rodrigues CMC, 2018, EMERG INFECT DIS, V24, P673, DOI 10.3201/eid2404.171480; Rodrigues CMS, MENINGOCOCCAL DEDUCE, DOI 10.1101/2020.08.18.256834v1; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; SACCHI CT, 1992, J CLIN MICROBIOL, V30, P1734, DOI 10.1128/JCM.30.7.1734-1738.1992; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Shi FL, 2017, VACCINE, V35, P2343, DOI 10.1016/j.vaccine.2017.03.057; Shultz TR, 2000, ANTIMICROB AGENTS CH, V44, P1116, DOI 10.1128/AAC.44.4.1116-1116.2000; Silva LA, 2018, INFECT DIS-NOR, V50, P697, DOI 10.1080/23744235.2018.1459829; SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626; Taha MK, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05241-9; Taha MK, 2010, ANTIMICROB AGENTS CH, V54, P3651, DOI 10.1128/AAC.00315-10; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Tsang RSW, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00883-19; Tsang RSW, 2017, CAN J MICROBIOL, V63, P265, DOI 10.1139/cjm-2016-0716; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Vacca P, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00207-18; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wang X, 2011, VACCINE, V29, P4739, DOI 10.1016/j.vaccine.2011.04.092; Wasko I, 2020, VACCINE, V38, P1943, DOI 10.1016/j.vaccine.2020.01.021; Zlotnick GW, 2015, HUM VACC IMMUNOTHER, V11, P5, DOI 10.4161/hv.34293	72	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243375	10.1371/journal.pone.0243375	http://dx.doi.org/10.1371/journal.pone.0243375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347452	Green Published, gold			2022-12-26	WOS:000603071100057
J	Hatabu, A; Mao, XH; Zhou, Y; Kawashita, N; Wen, Z; Ueda, M; Takagi, T; Tian, YS				Hatabu, Asuka; Mao, Xinhua; Zhou, Yi; Kawashita, Norihito; Wen, Zheng; Ueda, Mikiko; Takagi, Tatsuya; Tian, Yu-Shi			Knowledge, attitudes, and practices toward COVID-19 among university students in Japan and associated factors: An online cross-sectional survey	PLOS ONE			English	Article							SELF-CONSCIOUSNESS; OUTBREAK	The coronavirus disease (COVID-19) pandemic has greatly altered peoples' daily lives, and it continues spreading as a crucial concern globally. Knowledge, attitudes, and practices (KAP) toward COVID-19 are related to individuals' adherence to government measures. This study evaluated KAP toward COVID-19 among university students in Japan between May 22 and July 16, 2020, via an online questionnaire, and it further investigated the associated determining KAP factors. Among the eligible respondents (n = 362), 52.8% were female, 79.0% were undergraduate students, 32.9% were students whose major university subjects were biology-related, 35.4% were from the capital region, and 83.7% were Japanese. The overall KAP of university students in Japan was high. All respondents (100%) showed they possessed knowledge on avoiding enclosed spaces, crowded areas, and close situations. Most respondents showed a moderate or higher frequency of washing their hands or wearing masks (both at 96.4%). In addition, 68.5% of respondents showed a positive attitude toward early drug administration. In the logistic regressions, gender, major subjects, education level, nationality, residence, and psychological factors (private self-consciousness and extroversion) were associated with knowledge or attitudes toward COVD-19 (p < 0.05). In the logistic and multiple linear regressions, capital regions, high basic knowledge, high information acquisition, correct information explanations contributed positively to preventative action (p < 0.05). Non-capital regions, male gender, non-bio-backgrounds, high public self-consciousness, high advanced knowledge, incorrect information explanations, and high extroversion contributed negatively to self-restraint (p < 0.05). Moreover, self-restraint was decreasing over time. These findings clarify the Japanese university students' KAP and the related factors in the early period of the COVID-19 pandemic, and they may help university managers, experts, and policymakers control the future spread of COVID-19 and other emerging infections.	[Hatabu, Asuka; Zhou, Yi; Ueda, Mikiko; Takagi, Tatsuya; Tian, Yu-Shi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Mao, Xinhua] Kobe Gakuin Univ, Fac Psychol, Kobe, Hyogo, Japan; [Kawashita, Norihito] Kindai Univ, Grad Sch Sci & Engn Res, Higashiosaka, Osaka, Japan; [Wen, Zheng] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan	Osaka University; Kobe Gakuin University; Kindai University (Kinki University); Waseda University	Tian, YS (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan.	yushi-tian@phs.osaka-u.ac.jp	wen, zheng/AGG-3620-2022; wen, zheng/HII-3705-2022; Zhou, Yi/GQQ-3081-2022; Tian, Yu-Shi/AAM-2780-2021	wen, zheng/0000-0002-9942-8431; Zhou, Yi/0000-0001-9254-3245; Tian, Yu-Shi/0000-0002-8988-9453; TAKAGI, Tatsuya/0000-0002-0044-0722				Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969; Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04; Amazaki Mitsuhiro, 2008, Nihon Koshu Eisei Zasshi, V55, P306; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Babalola S., 2020, KAP COVID DASHBOARD; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Bhatti JS, 2020, MOL NEUROBIOL, V57, P4856, DOI 10.1007/s12035-020-02074-2; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; CSSE. Center For Systems Science and Engineering at JHU, 2020, COVID 19 MAP J HOPK; Erikson E., 1963, YOUTH CHANGE CHALLEN; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Fetzer T. R., 2020, 27082 NBER, DOI DOI 10.31234/OSF; Fujimoto J, NOTICE URGENT SURVEY; Gupta S, 2020, JAMA INTERN MED, V15, P2020, DOI [10.1001/jamainternmed.2020.3596, DOI 10.1001/JAMAINTERNMED.2020.359632667668]; Iwasaki A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012481; Jung C.G., 1921, PSYCHOL TYPEN; Katz MH, 2021, JAMA INTERN MED, V181, P381, DOI 10.1001/jamainternmed.2020.5415; Kooka A, RELATIONSHIP U STUDE; Liu C, 2020, ACS CENTRAL SCI, V6, P315, DOI 10.1021/acscentsci.0c00272; Machida M, 2020, INT J INFECT DIS, V94, P139, DOI 10.1016/j.ijid.2020.04.014; Ministry of Education Culture Sports Science and Technology of Japan, SCH BAS SURV; Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2; Muto K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234292; Namikawa Tsutomu, 2012, Shinrigaku Kenkyu, V83, P91; Ningthoujam R, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109896; Odriozola-Gonzalez P, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113108; Olaimat AN, 2020, AM J TROP MED HYG, V103, P1177, DOI 10.4269/ajtmh.20-0418; Pagnini F, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.15821; Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z; Saefi M, 2020, DATA BRIEF, V31, DOI 10.1016/j.dib.2020.105855; Sakakibara R, 2020, PSYCHOL BEHAV SURVEY, DOI [10.31234/osf.io/635zk, DOI 10.31234/OSF.I0/635ZK]; SUGAWARA K, 1984, JPN J PSYCHOL, V55, P184, DOI 10.4992/jjpsy.55.184; Sugawara K., 2004, SELF OTHER PERSONS E; Sutin AR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237056; Takahashi R., 2020, JAPAN TIMES; World Health Organization, COR DIS COVID 19; Zhao B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186671; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhou Y, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3494-x	39	42	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244350	10.1371/journal.pone.0244350	http://dx.doi.org/10.1371/journal.pone.0244350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347488	gold, Green Published			2022-12-26	WOS:000603071100009
J	Machado-Alba, JE; Jimenez-Morales, AL; Moran-Yela, YC; Parrado-Fajardo, IY; Valladales-Restrepo, LF				Enrique Machado-Alba, Jorge; Liliana Jimenez-Morales, Anyi; Carolina Moran-Yela, Yulieth; Yadira Parrado-Fajardo, Ilsa; Fernando Valladales-Restrepo, Luis			Adverse drug reactions associated with the use of biological agents	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; EVENTS; SAFETY; SURVEILLANCE	Introduction Biological drugs open new possibilities to treat diseases for which drug therapy is limited, but they may be associated with adverse drug reactions (ADRs). Objective To identify the ADRs associated with the use of biological drugs in Colombia. Methods This was a retrospective study of ADR reports from 2014 to 2019, contained in the database of Audifarma SA pharmacovigilance program. The ADRs, groups of associated drugs, and affected organs were classified. Results In total, 5,415 reports of ADRs associated with biological drugs were identified in 78 Colombian cities. A total of 76.1% of the cases corresponded to women. The majority were classified as type A (55.0%) and B (28.9%), and 16.7% were serious cases. The respiratory tract was the most affected organ system (16.8%), followed by the skin and appendages (15.6%). Antineoplastic and immunomodulatory drugs accounted for 70.6% of the reports, and the drugs related to the greatest number of ADRs were adalimumab (12.2%) and etanercept (11.6%). Conclusions The reporting of ADRs has increased in recent years and these reactions are mostly classified as tyoe A or B, categorized as serious in almost one-fifth of the reported cases and associated mainly with immunomodulators and antineoplastic agents. This type of study can support decision makers in ways that benefit patient safety and interaction with health systems.	[Enrique Machado-Alba, Jorge; Fernando Valladales-Restrepo, Luis] Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Risaralda, Colombia; [Enrique Machado-Alba, Jorge; Liliana Jimenez-Morales, Anyi; Carolina Moran-Yela, Yulieth] Univ Tecnol Pereira Audifarma SA, Pereira, Risaralda, Colombia; [Yadira Parrado-Fajardo, Ilsa] Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Bogota, Colombia; [Fernando Valladales-Restrepo, Luis] Fundac Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Colombia	Universidad Tecnologica de Pereira; Universidad Tecnologica de Pereira; Universidad Tecnologica de Pereira	Machado-Alba, JE (corresponding author), Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Risaralda, Colombia.	machado@utp.edu.co		Valladales Restrepo, Luis Fernando/0000-0002-4245-0101; Machado-Alba, Jorge Enrique/0000-0002-8455-0936				Abasolo L, 2015, SEMIN ARTHRITIS RHEU, V44, P506, DOI 10.1016/j.semarthrit.2014.11.003; Al-Ahmad Mona, 2018, Open Access Maced J Med Sci, V6, P1839, DOI 10.3889/oamjms.2018.394; [Anonymous], 2008, J EARTHQUAKE ENG ENG, V5, P119; Aspden P, 2004, PATIENT SAFETY ACHIE, P200; Barbieri MA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041227; Cutroneo PM, 2014, DRUG SAFETY, V37, P961, DOI 10.1007/s40264-014-0224-1; de Camargo MC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00965; Durand Z, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7222; Machado-Alba JE, 2014, REV PANAM SALUD PUBL, V36, P396; Food US  Administration D, 2020, GUIDELINE IND CLIN S, P1995; Gabay Michael, 2013, Hosp Pharm, V48, P473, DOI 10.1310/hpj4806-473; Giezen TJ, 2009, DRUG SAFETY, V32, P811, DOI 10.2165/11316550-000000000-00000; Ha D, 2020, CLIN RHEUMATOL, V39, P347, DOI 10.1007/s10067-019-04802-z; Heather EM, 2014, PHARMACOECONOMICS, V32, P109, DOI 10.1007/s40273-013-0120-z; Klein K, 2016, DRUG SAFETY, V39, P185, DOI 10.1007/s40264-015-0383-8; Koike T, 2009, J RHEUMATOL, V36, P898, DOI 10.3899/jrheum.080791; Leon L, 2018, CLIN EXP RHEUMATOL, V36, P29; Machado-Alba Jorge E, 2006, Rev. salud pública, V8, P200, DOI 10.1590/S0124-00642006000200008; Mendoza-Sassi R, 2001, Cad Saude Publica, V17, P819, DOI 10.1590/S0102-311X2001000400016; Narongroeknawin P, 2018, INT J RHEUM DIS, V21, P169, DOI 10.1111/1756-185X.12937; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; O'Callaghan J, 2018, BIODRUGS, V32, P267, DOI 10.1007/s40259-018-0281-6; Ortona Elena, 2016, Ann Ist Super Sanita, V52, P205, DOI 10.4415/ANN_16_02_12; Palleria C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205134; Pryymachenko Y, 2020, J ARTHROPLASTY, V35, P3099, DOI 10.1016/j.arth.2020.06.040; Ringold S, 2015, ARTHRIT CARE RES, V67, P529, DOI 10.1002/acr.22487; Roberti R, 2020, CURR MED RES OPIN, V36, P1457, DOI 10.1080/03007995.2020.1786681; Rojas K, 2016, CLIN OBSTET GYNECOL, V59, P651, DOI 10.1097/GRF.0000000000000239; Sim DW, 2016, PHARMACOEPIDEM DR S, V25, P1279, DOI 10.1002/pds.4049; Sousa J, 2020, EXPERT OPIN DRUG SAF, V19, P99, DOI 10.1080/14740338.2020.1686481; Sultana J, 2013, J PHARMACOL PHARMACO, V4, pS73, DOI 10.4103/0976-500X.120957; Vermeer NS, 2019, CLIN PHARMACOL THER, V105, P962, DOI 10.1002/cpt.1310; Yamanaka H, 2019, MOD RHEUMATOL, V29, P737, DOI 10.1080/14397595.2018.1510759	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0240276	10.1371/journal.pone.0240276	http://dx.doi.org/10.1371/journal.pone.0240276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338057	Green Published, Green Submitted, gold			2022-12-26	WOS:000601313500005
J	Barberi, T; Cui, C; Friedman, AD				Barberi, Theresa; Cui, Cheng; Friedman, Alan D.			C/EBP alpha induces Ebf1 gene expression in common lymphoid progenitors	PLOS ONE			English	Article							BINDING PROTEIN-ALPHA; B-CELL FACTOR; REGULATORY NETWORK; DISTAL ENHANCER; TRANSCRIPTION; SPECIFICATION; INTERLEUKIN-7; COMMITMENT; ABSENCE; DIFFERENTIATION	C/EBP alpha is required for formation of granulocyte-monocyte progenitors (GMP) and also participates in B lymphopoiesis. The common lymphoid progenitor (CLP) and preproB populations but not proB cells express Cebpa, and pan-hematopoietic deletion of the +37 kb Cebpa enhancer using Mx1-Cre leads not only to reduced GMP but also to 2-fold reduced marrow preproB and >15-fold reduced proB and preB cells. We now show that IL7R alpha-Cre-mediated deletion of the +37 kb Cebpa enhancer, which occurs in 89% of Ly6D(+) and 65% of upstream Ly6D(-) CLP, leads to a 2-fold reduction of both preproB and proB cells, and a 3-fold reduction in preB cells, with no impact on GMP numbers. These data support a direct role for C/EBP alpha during B lineage development, with reduced enhancer deletion in Ly6D(-) CLP mediated by IL7R alpha-Cre diminishing the effect on B lymphopoiesis compared to that seen with Mx1-Cre. Amongst mRNAs encoding key transcriptional regulators that initiate B lymphoid specification (PU.1, E2A, IKAROS, EBF1, FOXO1, and BACH2), only Ebf1 levels are altered in CLP upon Mx1-Cre-mediated Cebpa enhancer deletion, with Ebf1 reduced similar to 40-fold in Flt3(+)Sca-1(int)c-kit(int)IL7R alpha(+) CLP. In addition, Cebpa and Ebf1 RNAs were 4- and 14-fold higher in hCD4(+) versus hCD4(-) CLP from Cebpa-hCD4 transgenic mice. Histone modification ChIP-Seq data for CLP indicate the presence of active, intronic Ebf1 enhancers located 270 and 280 kb upstream of the transcription start sites. We identified a cis element in this region that strongly binds C/EBP alpha using the electrophoretic mobility shift assay. Mutation of this C/EBP alpha-binding site in an Ebf1 enhancer-TK-luciferase reporter leads to a 4-fold reduction in C/EBP alpha-mediated trans-activation. These findings support a model of B lymphopoiesis in which induction of Ebf1 by C/EBP alpha in a subset of CLP contributes to initiation of B lymphopoiesis.	[Barberi, Theresa; Cui, Cheng; Friedman, Alan D.] Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21218 USA; [Cui, Cheng] China Med Univ, Dept Physiol, Shenyang, Peoples R China	Johns Hopkins University; China Medical University	Friedman, AD (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21218 USA.	afriedm2@jhmi.edu			National Institutes of Health [R01 HL130034, P30 CA006973]; Giant Food Children's Cancer Research Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giant Food Children's Cancer Research Fund	This work was support by National Institutes of Health grants R01 HL130034 to ADF and P30 CA006973 (www.nih.gov) and the Giant Food Children's Cancer Research Fund (www.giantfood.com).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Avellino R, 2016, BLOOD, V127, P2991, DOI 10.1182/blood-2016-01-695759; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Guo H, 2018, J IMMUNOL, V201, P1692, DOI 10.4049/jimmunol.1800244; Guo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150809; Guo H, 2014, J LEUKOCYTE BIOL, V96, P419, DOI 10.1189/jlb.2AB0314-145R; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hagman J, 2012, CURR TOP MICROBIOL, V356, P17, DOI 10.1007/82_2011_139; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Itoh-Nakadai A, 2017, CELL REP, V18, P2401, DOI 10.1016/j.celrep.2017.02.029; Jack GD, 2009, BLOOD, V114, P2172, DOI 10.1182/blood-2008-11-191536; Jensen CT, 2018, J EXP MED, V215, P1947, DOI 10.1084/jem.20171384; Karamitros D, 2018, NAT IMMUNOL, V19, P85, DOI 10.1038/s41590-017-0001-2; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Medina KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078408; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Pang SHM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01264; Paz-Priel I, 2009, LEUKEMIA, V23, P365, DOI 10.1038/leu.2008.297; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; SCOTT LM, 1992, BLOOD, V80, P1725; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; von Muenchow L, 2016, P NATL ACAD SCI USA, V113, pE8122, DOI 10.1073/pnas.1613316113; Welner RS, 2013, BLOOD, V121, P4073, DOI 10.1182/blood-2012-10-463448; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464	48	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244161	10.1371/journal.pone.0244161	http://dx.doi.org/10.1371/journal.pone.0244161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332417	Green Published, gold			2022-12-26	WOS:000601310900083
J	Boukthir, S; Moullec, S; Cariou, ME; Meygret, A; Morcet, J; Faili, A; Kayal, S				Boukthir, Sarrah; Moullec, Severine; Cariou, Marie-Estelle; Meygret, Alexandra; Morcet, Jeff; Faili, Ahmad; Kayal, Samer			A prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Comprehensive dynamic of new emergent emm genotypes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; CLUSTER TYPING SYSTEM; MOLECULAR EPIDEMIOLOGY; DISEASE; SEQUENCE; SEPSIS; SKIN	Streptococcus pyogenes or group A Streptococcus (GAS) causes diseases ranging from uncomplicated pharyngitis to life-threatening infections. It has complex epidemiology driven by the diversity, the temporal and geographical fluctuations of the circulating strains. Despite the global burden of GAS diseases, there is currently no available vaccination strategy against GAS infections. This study, based on a longitudinal population survey, aimed to understand the dynamic of GAS emm types and to give leads to better recognition of underlying mechanisms for the emergence of successful clones. From 2009 to 2017, we conducted a systematic culture-based diagnosis of GAS infections in a French Brittany population with a prospective recovery of clinical data. The epidemiological analysis was performed using emm typing combined with the structural and functional cluster-typing system for all the recovered strains. Risk factors for the invasiveness, identified by univariate analysis, were computed in a multiple logistic regression analysis, and the only independent risk factor remaining in the model was the age (OR for the entire range [CI95%] = 6.35 [3.63, 11.10]; p<0.0001). Among the 61 different emm types identified, the most prevalent were emm28 (16%), emm89 (15%), emm1 (14%), and emm4 (8%), which accounted for more than 50% of circulating strains. During the study period, five genotypes identified as emm44, 66, 75, 83, 87 emerged successively and belonged to clusters D4, E2, E3, and E6 that were different from those gathering "Prevalent" emm types (clusters A-C3 to 5, E1 and E4). We previously reported significant genetic modifications for emm44, 66, 83 and 75 types resulting possibly from a short adaptive evolution. Herein we additionally observed that the emergence of a new genotype could occur in a susceptible population having specific risk factors or probably lacking a naturally-acquired cluster-specific immune cross-protection. Among emergent emm types, emm75 and emm87 tend to become prevalent with a stable annual incidence and the risk of a clonal expansion have to be considered.	[Boukthir, Sarrah; Meygret, Alexandra; Morcet, Jeff; Kayal, Samer] CHU Rennes, Serv Bacteriol Hyg Hosp, Rennes, France; [Boukthir, Sarrah; Moullec, Severine; Morcet, Jeff; Faili, Ahmad; Kayal, Samer] Inserm, CIC 1414, Rennes, France; [Boukthir, Sarrah; Moullec, Severine; Meygret, Alexandra; Kayal, Samer] Univ Rennes 1, Fac Med, Rennes, France; [Cariou, Marie-Estelle] Ctr Hosp Bretagne Sud, Lab Biol, Lorient, France; [Faili, Ahmad] Univ Rennes 1, Fac Pharm, Rennes, France; [Meygret, Alexandra] Ctr Hosp Basse Terre, Serv Bacteriol, Basse Terre, Guadeloupe, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes	Kayal, S (corresponding author), CHU Rennes, Serv Bacteriol Hyg Hosp, Rennes, France.; Kayal, S (corresponding author), Inserm, CIC 1414, Rennes, France.; Kayal, S (corresponding author), Univ Rennes 1, Fac Med, Rennes, France.	samer.kayal@univ-rennes1.fr			University Rennes-1 Medical School; University Hospital Center of Rennes-France	University Rennes-1 Medical School; University Hospital Center of Rennes-France	This work was supported by the University Rennes-1 Medical School, and by University Hospital Center of Rennes-France and did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors.	Baroux N, 2014, CLIN INFECT DIS, V59, pE84, DOI 10.1093/cid/ciu490; BEACHEY EH, 1981, NATURE, V292, P457, DOI 10.1038/292457a0; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bessen DE, 2015, INFECT GENET EVOL, V33, P393, DOI 10.1016/j.meegid.2014.10.011; Bessen DE, 2010, FUTURE MICROBIOL, V5, P623, DOI [10.2217/fmb.10.28, 10.2217/FMB.10.28]; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Cady A, 2011, EMERG INFECT DIS, V17, P315, DOI 10.3201/eid1702.101022; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cohen R, 2015, CLIN INFECT DIS, V60, P267, DOI 10.1093/cid/ciu794; Dale JB, 2017, VACCINE, V35, P19, DOI 10.1016/j.vaccine.2016.11.065; Darenberg J, 2007, CLIN INFECT DIS, V45, P450, DOI 10.1086/519936; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Friaes A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12057; Frost HR, 2017, CLIN INFECT DIS, V65, P1523, DOI 10.1093/cid/cix599; Gallo V, 2012, EUR J CLIN INVEST, V42, P1, DOI 10.1111/j.1365-2362.2011.02561.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Koutouzi F, 2015, J CLIN MICROBIOL, V53, P2015, DOI 10.1128/JCM.00301-15; Lamagni T L, 2005, Euro Surveill, V10, P179; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; LANCEFIELD RC, 1959, J EXP MED, V110, P271, DOI 10.1084/jem.110.2.271; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Mason KL, 2012, AM J REPROD IMMUNOL, V67, P91, DOI 10.1111/j.1600-0897.2011.01083.x; Meisal R, 2010, J CLIN MICROBIOL, V48, P842, DOI 10.1128/JCM.01312-09; Meygret A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00689-16; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Plainvert C, 2014, ARCH PEDIATRIE, V21, pS62, DOI 10.1016/S0929-693X(14)72262-6; Rattanavong S, 2016, EPIDEMIOL INFECT, V144, P1770, DOI 10.1017/S0950268815002927; Rochefort A, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00957-17, 10.1128/genomea.00957-17]; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Sheel M, 2016, EXPERT REV VACCINES, V15, P227, DOI 10.1586/14760584.2016.1116946; Shulman ST, 2014, CLIN INFECT DIS, V59, P1651, DOI 10.1093/cid/ciu649; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037; Smit PW, 2015, EUR J CLIN MICROBIOL, V34, P2131, DOI 10.1007/s10096-015-2462-2; Soriano N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01174-14; Soriano N, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01459-14; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Turner CE, 2015, MBIO, V6, DOI 10.1128/mBio.00622-15; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244063	10.1371/journal.pone.0244063	http://dx.doi.org/10.1371/journal.pone.0244063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332468	Green Published, gold			2022-12-26	WOS:000601310900052
J	Burlando, B; Milanese, M; Giordano, G; Bonifacino, T; Ravera, S; Blanchini, F; Bonanno, G				Burlando, Bruno; Milanese, Marco; Giordano, Giulia; Bonifacino, Tiziana; Ravera, Silvia; Blanchini, Franco; Bonanno, Giambattista			A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; MOTOR-NEURONS; DYSFUNCTION; DISEASE; SOD1; PHOSPHORYLATION; EXCITOTOXICITY; STIMULATION	Amyotrophic lateral sclerosis (ALS) is a poor-prognosis disease with puzzling pathogenesis and inconclusive treatments. We develop a mathematical model of ALS based on a system of interactive feedback loops, focusing on the mutant SOD1(G93A) mouse. Misfolded mutant SOD1 aggregates in motor neuron (MN) mitochondria and triggers a first loop characterized by oxidative phosphorylation impairment, AMP kinase over-activation, 6-phosphofructo-2-kinase (PFK3) rise, glucose metabolism shift from pentose phosphate pathway (PPP) to glycolysis, cell redox unbalance, and further worsening of mitochondrial dysfunction. Oxidative stress then triggers a second loop, involving the excitotoxic glutamatergic cascade, with cytosolic Ca2+ overload, increase of PFK3 expression, and further metabolic shift from PPP to glycolysis. Finally, cytosolic Ca2+ rise is also detrimental to mitochondria and oxidative phosphorylation, thus closing a third loop. These three loops are overlapped and positive (including an even number of inhibitory steps), hence they form a candidate multistationary (bistable) system. To describe the system dynamics, we model the interactions among the functional agents with differential equations. The system turns out to admit two stable equilibria: the healthy state, with high oxidative phosphorylation and preferential PPP, and the pathological state, with AMP kinase activation, PFK3 over expression, oxidative stress, excitotoxicity and MN degeneration. We demonstrate that the loop system is monotone: all functional agents consistently act toward the healthy or pathological condition, depending on low or high mutant SOD1 input. We also highlight that molecular interactions involving PFK3 are crucial, as their deletion disrupts the system's bistability leading to a single healthy equilibrium point. Hence, our mathematical model unveils that promising ALS management strategies should be targeted to mechanisms that keep low PFK3 expression and activity within MNs.	[Burlando, Bruno; Milanese, Marco; Bonifacino, Tiziana; Bonanno, Giambattista] Univ Genoa, Dept Pharm, Genoa, Italy; [Giordano, Giulia] Univ Trento, Dept Ind Engn, Trento, Italy; [Giordano, Giulia] Delft Univ Technol, Delft Ctr Syst & Control, Delft, Netherlands; [Ravera, Silvia] Univ Genoa, Dept Expt Med, Genoa, Italy; [Blanchini, Franco] Univ Udine, Dipartimento Sci Matemat Informat & Fis, Udine, Italy; [Bonanno, Giambattista] IRCCS Osped Policlin San Martino, Genoa, Italy	University of Genoa; University of Trento; Delft University of Technology; University of Genoa; University of Udine	Giordano, G (corresponding author), Univ Trento, Dept Ind Engn, Trento, Italy.; Giordano, G (corresponding author), Delft Univ Technol, Delft Ctr Syst & Control, Delft, Netherlands.	g.giordano@tudelft.nl	Giordano, Giulia/L-5209-2015; Bonifacino, Tiziana/AAA-5471-2019; Milanese, Marco/AAB-2238-2021; Ravera, Silvia/AAA-7982-2019; Blanchini, Franco/A-6513-2008	Giordano, Giulia/0000-0002-8600-1738; Bonifacino, Tiziana/0000-0002-3966-9874; Milanese, Marco/0000-0003-3384-0666; Ravera, Silvia/0000-0002-0803-1042; Blanchini, Franco/0000-0002-4109-5531; Burlando, Bruno/0000-0001-7545-0311	Italian Ministry of Education, University and Research (SIR project) [RBSI14B1Z1]; Fondazione Compagnia di San Paolo [2018.AAI629. U730/SD/pv]; Motor Neurone Disease Association [April16/848-791]	Italian Ministry of Education, University and Research (SIR project); Fondazione Compagnia di San Paolo(Compagnia di San Paolo); Motor Neurone Disease Association	Study financially supported by the Italian Ministry of Education, University and Research (SIR project n.RBSI14B1Z1) (MM), the Fondazione Compagnia di San Paolo (project n.2018.AAI629. U730/SD/pv) (GB), and the Motor Neurone Disease Association (project n. April16/848-791) (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, INT LEGAL MAT, V43, P5; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Bhattacharya S, 2010, TOXICOL SCI, V115, P51, DOI 10.1093/toxsci/kfq035; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Blanchini F, 2014, B MATH BIOL, V76, P2542, DOI 10.1007/s11538-014-0023-y; Bonifacino T, 2016, NEUROBIOL DIS, V95, P122, DOI 10.1016/j.nbd.2016.07.011; Bozzo F, 2017, NEUROSCI LETT, V636, P3, DOI 10.1016/j.neulet.2016.04.065; Carriedo SG, 2000, J NEUROSCI, V20, P240, DOI 10.1523/JNEUROSCI.20-01-00240.2000; Choi SY, 2019, NAT NEUROSCI, V22, P851, DOI 10.1038/s41593-019-0397-0; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; Deng JW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005357; Dervishi I, 2018, DRUG DISCOV TODAY, V23, P696, DOI 10.1016/j.drudis.2018.01.027; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Doig AJ, 2018, J ALZHEIMERS DIS, V66, P25, DOI 10.3233/JAD-180583; Geloso MC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00242; Gesztelyi R, 2012, ARCH HIST EXACT SCI, V66, P427, DOI 10.1007/s00407-012-0098-5; Giordano G, 2016, J MATH BIOL, V72, P1927, DOI 10.1007/s00285-015-0933-9; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Holecek V, 2017, NEUROENDOCRINOL LETT, V38, P528; Hounoum BM, 2017, GLIA, V65, P592, DOI 10.1002/glia.23114; Hoye ML, 2018, BRAIN, V141, P2561, DOI 10.1093/brain/awy182; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Le Masson G, 2014, NEURON, V83, P975, DOI 10.1016/j.neuron.2014.07.001; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Maestre C, 2008, EMBO J, V27, P2736, DOI 10.1038/emboj.2008.195; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Medinas DB, 2018, P NATL ACAD SCI USA, V115, P8209, DOI 10.1073/pnas.1801109115; Mejzini R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01310; Muyderman H, 2014, BRIT J PHARMACOL, V171, P2191, DOI 10.1111/bph.12476; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Perera ND, 2016, NEUROCHEM RES, V41, P544, DOI 10.1007/s11064-015-1665-3; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rao SD, 2003, J NEUROSCI, V23, P2627; Ravera S, 2019, J NEUROCHEM, V151, P336, DOI 10.1111/jnc.14819; Ravera S, 2018, MOL NEUROBIOL, V55, P9220, DOI 10.1007/s12035-018-1059-z; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2; Stifanese R, 2014, ARCH BIOCHEM BIOPHYS, V562, P1, DOI 10.1016/j.abb.2014.08.006; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184; Taylor AA, 2016, ANN CLIN TRANSL NEUR, V3, P866, DOI 10.1002/acn3.348; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; Vandoorne T, 2018, ACTA NEUROPATHOL, V135, P489, DOI 10.1007/s00401-018-1835-x; Voit EO, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1391; Wang P, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007947; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2018, NEUROSCI RES, V126, P31, DOI 10.1016/j.neures.2017.09.011; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561	61	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244234	10.1371/journal.pone.0244234	http://dx.doi.org/10.1371/journal.pone.0244234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332476	Green Published, gold			2022-12-26	WOS:000601310900013
J	de Almeida-Neto, PF; da Silva, LF; de Matos, DG; Jeffreys, I; Cesario, TD; Neto, RB; Barbosa, WD; Aidar, FJ; Dantas, PMS; Cabral, BGDT				de Almeida-Neto, Paulo Francisco; da Silva, Luiz Felipe; de Matos, Dihogo Gama; Jeffreys, Ian; Cesario, Tatianny de Macedo; Neto, Rui Barboza; Barbosa, Wagner de Almeida; Aidar, Felipe J.; Dantas, Paulo Moreira Silva; Cabral, Breno Guilherme de Araujo Tinoco			Equation for analyzing the peak power in aquatic environment: An alternative for olympic rowing athletes	PLOS ONE			English	Article							ERGOMETER PERFORMANCE	Purpose To develop an equation to provide the peak power (PP) through a specific stimulus performed in an aquatic environment, as well as to correlate morphological, anthropometric and strength variables with rowing performance. Methods The sample consisted of 16 elite young rowing athletes of both sexes (15.7 +/- 1.21 years). The strength of upper limbs and lower limbs was verified. To analyze the PP, a 100-m Sprint test was performed on an indoor rowing type ergometer, and after a 72-hour wash-out, the test was repeated in an aquatic environment on a vessel equipped with a global position system. Body composition was analyzed by examining bone densitometry with an X-ray source and maturation was verified by anthropometry. Results The tests for water sprint and indoor rowing showed significant reliability (ICC = 0.695; p = 0.0007). The PP aquatic showed reliability with that acquired in indoor rowing (ICC = 0.897; p<0.0001) and was related to maturation (p<0.05). The morphology, anthropometry and strength of the upper limbs were related to the sprint and peak strength in both tests (p<0.05). Conclusion The equation for the PP in aquatic environment presented by the present study is highly reliable with an indoor ergometer digital ergometer.	[de Almeida-Neto, Paulo Francisco; da Silva, Luiz Felipe; Cesario, Tatianny de Macedo; Neto, Rui Barboza; Dantas, Paulo Moreira Silva; Cabral, Breno Guilherme de Araujo Tinoco] Univ Fed Rio Grande do Norte, Dept Phys Educ, Natal, RN, Brazil; [de Matos, Dihogo Gama] Tras dos Montes & Alto Douro Univ, Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, Vila Real, Portugal; [de Matos, Dihogo Gama; Aidar, Felipe J.] Fed Univ Sergipe UFS, Grp Studies & Res Performance Sport Healt & Paral, Sao Cristovao, Sergipe, Brazil; [Jeffreys, Ian] Univ South Wales, Fac Life Sci & Educ, Pontypridd, M Glam, Wales; [Barbosa, Wagner de Almeida] Univ Fed Rio Grande do Norte, Dept Theoret & Expt Phys, UFRN, Natal, RN, Brazil; [Aidar, Felipe J.] Fed Univ Sergipe UFS, Dept Phys Educ, Sao Cristovao, Sergipe, Brazil; [Aidar, Felipe J.] Fed Univ Sergipe UFS, Grad Program Masters Level, Dept Phys Educ, Sao Cristovao, Sergipe, Brazil; [Aidar, Felipe J.] Fed Univ Sergipe UFS, Program Physiol Sci, Sao Cristovao, Sergipe, Brazil	Universidade Federal do Rio Grande do Norte; University of Tras-os-Montes & Alto Douro; University of South Wales; Universidade Federal do Rio Grande do Norte	de Almeida-Neto, PF (corresponding author), Univ Fed Rio Grande do Norte, Dept Phys Educ, Natal, RN, Brazil.	paulojitte@ufrn.edu.br	Almeida-Neto, Paulo Francisco de/AAZ-4182-2020; cao, xiaoxiang/AAR-9291-2021; Aidar, Felipe J./AAO-2744-2020; de Matos, Dihogo/D-3273-2013	Almeida-Neto, Paulo Francisco de/0000-0002-2860-2260; Aidar, Felipe J./0000-0001-7378-4529; de Matos, Dihogo/0000-0002-7394-8527; Silva, Luiz Felipe/0000-0002-1825-8443	Federal University of Rio Grande do Norte (UFRN); Physical Activity and Health (AFISA) research base; Higher Education Personnel Improvement Coordination (CAPES); Remo Sport club, Natal-Brazil; Child and Adolescent Maturation Research Group (GEPMAC); National Council for Scientific Development (CNPQ)	Federal University of Rio Grande do Norte (UFRN); Physical Activity and Health (AFISA) research base; Higher Education Personnel Improvement Coordination (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Remo Sport club, Natal-Brazil; Child and Adolescent Maturation Research Group (GEPMAC); National Council for Scientific Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	For your support and encouragement for the development of this academic article, we thank the Federal University of Rio Grande do Norte (UFRN), the Physical Activity and Health (AFISA) research base, the Child and Adolescent Maturation Research Group (GEPMAC). The National Council for Scientific Development (CNPQ). The Higher Education Personnel Improvement Coordination (CAPES) and the Remo Sport club, Natal-Brazil for their support and encouragement for the development of research.	de Almeida-Neto PF, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176696; [Anonymous], 2018, DIABETES CARE, V41, pS4, DOI [10.2337/dc18-SREV01, 10.2337/dc18-Srev01]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bourdin M, 2017, INT J SPORTS MED, V38, P1023, DOI 10.1055/s-0043-118849; Caporaso T, 2018, INT J INTERACT DES M, V12, P1211, DOI 10.1007/s12008-018-0483-7; Cataldo A, 2015, J SPORT MED PHYS FIT, V55, P872; Cuijpers LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133527; Da Silva FM, 2015, MOTRICIDADE, V11, P190; Dantas MP., 2018, MOTRICIDADE, V14, P4; de Almeida-Neto PF, 2021, J SPORT MED PHYS FIT, V61, P829, DOI 10.23736/S0022-4707.20.11497-X; de Almeida-Neto PF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165637; de Almeida-Neto PF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093277; Cesario TD, 2021, AM J HUM BIOL, V33, DOI 10.1002/ajhb.23503; Durkalec-Michalski K, 2019, J SPORT MED PHYS FIT, V59, P1526, DOI 10.23736/S0022-4707.19.08951-5; Forza J, 2019, J MULT ENG SCI TECH, V6, P9982; Freeze J, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P913; Hatchett A, 2019, J SPORTS RES, V6, P29, DOI [10.18488/journal.90.2019.61.29.32, DOI 10.18488/J0URNAL.90.2019.61.29.32]; Karupaiah T., 2018, J RENAL NUTR METABOL, V3, P11, DOI DOI 10.4103/2395-1540.232541; Keenan KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191504; Lee PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06085; Maciejewski H, 2019, J STRENGTH COND RES, V33, P3000, DOI 10.1519/JSC.0000000000002406; Maia S, 2017, REV BRASILEIRA MED E, V23, P1806, DOI [10.1590/1517-869220172306165108, DOI 10.1590/1517-869220172306165108]; Majumdar P., 2017, J PHYS ED SPORT, V17, P2502, DOI 10.7752/jpes.2017.04281; Mello FD, 2009, EUR J APPL PHYSIOL, V107, P615, DOI 10.1007/s00421-009-1172-9; Mello Júlio Brugnara, 2016, Rev. bras. cineantropom. desempenho hum., V18, P658, DOI 10.5007/1980-0037.2016v18n6p658; Metikos B, 2015, J STRENGTH COND RES, V29, P2919, DOI 10.1519/JSC.0000000000000944; Miot Hélio Amante, 2016, J. vasc. bras., V15, P89, DOI 10.1590/1677-5449.004216; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Penichet-Tomas A, 2019, J SPORT MED PHYS FIT, V59, P767, DOI 10.23736/S0022-4707.18.08524-9; Perini Talita Adão, 2005, Rev Bras Med Esporte, V11, P81, DOI 10.1590/S1517-86922005000100009; Raymond-Pope CJ, 2020, J STRENGTH COND RES, V34, P1690, DOI 10.1519/JSC.0000000000002688; Reed KE, 2017, SCAND J MED SCI SPOR, V27, P2070, DOI 10.1111/sms.12815; Reijnierse EM, 2017, J CACHEXIA SARCOPENI, V8, P466, DOI 10.1002/jcsm.12181; Riechman SE, 2002, J SPORT SCI, V20, P681, DOI 10.1080/026404102320219383; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Siahkouhian M, 2016, S AFR J RES SPORT PH, V38, P179; Strobe, 2014, STROBE CHECKLIST STR; Warmenhoven J, 2018, SPORTS MED, V48, P2703, DOI 10.1007/s40279-018-0992-3; Wasserman H, 2017, BONE, V104, P84, DOI 10.1016/j.bone.2016.12.008; Wolf A., 2016, STRENGTH CONDITIONIN, P589; Worsey MTO, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8111304	42	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243157	10.1371/journal.pone.0243157	http://dx.doi.org/10.1371/journal.pone.0243157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332449	Green Published, gold			2022-12-26	WOS:000601310900020
J	Hirabayashi, A; Yahara, K; Kajihara, T; Sugai, M; Shibayama, K				Hirabayashi, Aki; Yahara, Koji; Kajihara, Toshiki; Sugai, Motoyuki; Shibayama, Keigo			Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance	PLOS ONE			English	Article							ESCHERICHIA-COLI; DISSEMINATION; EMERGENCE; SEQUENCE; JAPAN	Enterobacterales resistant to carbapenems, a class of last-resort antimicrobials, are ranked as an "urgent" and "critical" public health hazard by CDC and WHO. IMP-type carbapenemase-containing Enterobacterales are endemic in Japan, and bla(IMP-6) is one of the notable carbapenemase genes responsible for the resistance. The gene is plasmid-encoded and confers resistance to meropenem, but not to imipenem. Therefore, IMP-6-producing Enterobacterales isolates are occasionally overlooked in clinical laboratories and are referred to as 'stealth-type'. Since previous reports in Japan were confined only to some geographical regions, their distribution across prefectures and the factors affecting the distribution remain unclear. Here, we revealed the dynamics of the geographical distribution of Enterobacterales with IMP-6 phenotype associated with antimicrobial use in Japan. We utilized comprehensive national surveillance data of all routine bacteriological test results from more than 1,400 hospitals in 2015 and 2016 to enumerate Escherichia coli and Klebsiella pneumoniae isolates with the antimicrobial susceptibility pattern (phenotype) characteristic of IMP-6 (imipenem susceptible, meropenem resistant), and to tabulate the frequency of isolates with the phenotype for each prefecture. Isolates were detected in approximately half of all prefectures, and combined analysis with the national data of antimicrobial usage revealed a statistically significant association between the frequency and usage of not carbapenems but third-generation cephalosporins (p = 0.006, logistic mixed-effect regression) and a weaker association between the frequency and usage of fluoroquinolones (p = 0.043). The usage of third-generation cephalosporins and fluoroquinolones may select the strains with the IMP-6 phenotype, and contribute to their occasional spread. We expect the findings will promote antimicrobial stewardship to reduce the spread of the notable carbapenemase gene.	[Hirabayashi, Aki; Yahara, Koji; Kajihara, Toshiki; Sugai, Motoyuki; Shibayama, Keigo] Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Tokyo, Japan; [Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Hirabayashi, A; Yahara, K (corresponding author), Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Tokyo, Japan.	akihira@nih.go.jp; k-yahara@nih.go.jp		Kajihara, Toshiki/0000-0002-7576-2654	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) [JP19fk0108061]	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This study was supported by Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) under grant number JP19fk0108061.	Abe R, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4779-x; Albiger B, 2015, EUROSURVEILLANCE, V20, P17, DOI 10.2807/1560-7917.ES.2015.20.45.30062; Aldred KJ, 2014, BIOCHEMISTRY-US, V53, P1565, DOI 10.1021/bi5000564; [Anonymous], 2015, Arthritis Rheumatol, V67 Suppl 10, P1, DOI 10.1002/art.39448; [Anonymous], 2007, REV CUB ALIMENT NU S, V17, pS20; [Anonymous], 2005, LANCET, V365, P579; [Anonymous], 2019, INFECT AGENTS SURVEI, V40, P157; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Chen Y, 2014, EUR J CLIN MICROBIOL, V33, P1181, DOI 10.1007/s10096-014-2063-5; Clinical and Laboratory Standards Institute, 2016, M100S26 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; FRANKO M, 1994, TDR-DRAMA REV-J PERF, V38, P71, DOI 10.2307/1146425; Gbaguidi-Haore H, 2009, J MED MICROBIOL, V58, P1337, DOI 10.1099/jmm.0.010116-0; Hagiya H, 2018, J INFECT CHEMOTHER, V24, P769, DOI 10.1016/j.jiac.2018.03.009; Hosaka Y, 2019, THESIS, P2; Kajihara T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228234; Kanazawa S, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00576-17; Kayama S, 2015, ANTIMICROB AGENTS CH, V59, P1356, DOI 10.1128/AAC.04759-14; Komatsu Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202276; Matsumura Y, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02729-16; Matsumura Y, 2013, ANTIMICROB AGENTS CH, V57, P4736, DOI 10.1128/AAC.00641-13; McDonnell L, 2017, J ANTIMICROB CHEMOTH, V72, P3199, DOI 10.1093/jac/dkx248; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Ohno Y, 2017, J INFECT CHEMOTHER, V23, P224, DOI 10.1016/j.jiac.2016.12.013; Poirel L, 2008, CLIN MICROBIOL INFEC, V14, P295, DOI 10.1111/j.1469-0691.2007.01930.x; Shigemoto N, 2012, DIAGN MICR INFEC DIS, V72, P109, DOI 10.1016/j.diagmicrobio.2011.09.019; Teramae M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205162; Uchida Y, 2010, INT J ANTIMICROB AG, V35, P444, DOI 10.1016/j.ijantimicag.2009.12.012; Yano H, 2001, ANTIMICROB AGENTS CH, V45, P1343, DOI 10.1128/AAC.45.5.1343-1348.2001; Yano H, 2012, ANTIMICROB AGENTS CH, V56, P4554, DOI 10.1128/AAC.00617-12; Yoo JS, 2012, INT J ANTIMICROB AG, V39, P300, DOI 10.1016/j.ijantimicag.2011.11.018	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243630	10.1371/journal.pone.0243630	http://dx.doi.org/10.1371/journal.pone.0243630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332370	Green Published, gold			2022-12-26	WOS:000601310900080
J	Tawab, F; Munir, I; Nasim, Z; Khan, MS; Tawab, S; Nasim, A; Iqbal, A; Ahmad, MA; Ali, W; Munir, R; Munir, M; Asim, N				Tawab, Faiza; Munir, Iqbal; Nasim, Zeeshan; Khan, Mohammad Sayyar; Tawab, Saleha; Nasim, Adnan; Iqbal, Aqib; Ahmad, Mian Afaq; Ali, Waqar; Munir, Raheel; Munir, Maria; Asim, Noreen			Identification and characterization of a novel multi-stress responsive gene in Arabidopsis	PLOS ONE			English	Article							SALT STRESS; DROUGHT STRESS; OSMOTIC-STRESS; ORYZA-SATIVA; SALINITY; EXPRESSION; ACID; GERMINATION; TOLERANCE; PROLINE	Abiotic stresses especially salinity, drought and high temperature result in considerable reduction of crop productivity. In this study, we identified AT4G18280 annotated as a glycine-rich cell wall protein-like (hereafter refer to as GRPL1) protein as a potential multistress-responsive gene. Analysis of public transcriptome data and GUS assay of pGRPL1::GUS showed a strong induction of GRPL1 under drought, salinity and heat stresses. Transgenic plants overexpressing GRPL1-3HA showed significantly higher germination, root elongation and survival rate under salt stress. Moreover, the 35S::GRPL1-3HA transgenic lines also showed higher survival rates under drought and heat stresses. GRPL1 showed similar expression patterns with Abscisic acid (ABA)-pathway genes under different growth and stress conditions, suggesting a possibility that GRPL1 might act in the ABA pathway that is further supported by the inability of ABA-deficient mutant (aba2-1) to induce GRPL1 under drought stress. Taken together, our data presents GRPL1 as a potential multi-stress responsive gene working downstream of ABA.	[Tawab, Faiza; Munir, Iqbal; Nasim, Zeeshan; Iqbal, Aqib; Ahmad, Mian Afaq; Munir, Raheel; Munir, Maria] Univ Agr, Inst Biotechnol & Genet Engn IBGE, Div Biochem, Peshawar, Khyber Pakhtunk, Pakistan; [Khan, Mohammad Sayyar; Asim, Noreen] Univ Agr, Inst Biotechnol & Genet Engn IBGE, Genom & Bioinformat Div, Peshawar, Khyber Pakhtunk, Pakistan; [Tawab, Saleha; Nasim, Adnan] Agr Res Syst, Peshawar, Khyber Pakhtunk, Pakistan; [Ali, Waqar] Univ Malakand, Dept Biotechnol, Lower Dir, Khyber Pakhtunk, Pakistan	Agricultural University Peshawar; University of Agriculture Faisalabad; Agricultural University Peshawar; University of Agriculture Faisalabad	Munir, I (corresponding author), Univ Agr, Inst Biotechnol & Genet Engn IBGE, Div Biochem, Peshawar, Khyber Pakhtunk, Pakistan.	iqmunir@aup.edu.pk	Iqbal, Aqib/GVU-1049-2022	Munir, Iqbal/0000-0002-5359-6333; , Noreen/0000-0001-9233-5681				Abraham E, 2010, METHODS MOL BIOL, V639, P317, DOI 10.1007/978-1-60761-702-0_20; Adams E., 2014, ISRN BOT, V2014, P490252, DOI [10.1155/2014/490252, DOI 10.1155/2014/490252]; [Anonymous], 2011, CANC DISCOV; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bayuelo-Jimenez JS, 2002, CROP SCI, V42, P1584, DOI 10.2135/cropsci2002.1584; Burssens S, 2000, PLANTA, V211, P632, DOI 10.1007/s004250000334; Bustos D, 2008, ANN BOT-LONDON, V102, P551, DOI 10.1093/aob/mcn141; Czolpinska M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00302; Dar M.I., 2016, OSMOLYTES PLANTS ACC, P155, DOI DOI 10.1007/978-81-322-2616-1_9; De Leonardis AM, 2007, PLANT SCI, V172, P1005, DOI 10.1016/j.plantsci.2007.02.002; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gulzar S, 2001, SEED SCI TECHNOL, V29, P21; Hazman M, 2015, J EXP BOT, V66, P3339, DOI 10.1093/jxb/erv142; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Huang J, 1995, CAN J PLANT SCI, V75, P815, DOI 10.4141/cjps95-137; Jiang KN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00081; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; Kim SG, 2008, PLANT SIGNAL BEHAV, V3, P877, DOI 10.4161/psb.3.10.6247; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Lee S, 2010, NEW PHYTOL, V188, P626, DOI 10.1111/j.1469-8137.2010.03378.x; Liu WW, 2014, NEW PHYTOL, V201, P1192, DOI 10.1111/nph.12607; Liu ZY, 2020, MOL BIOL REP, V47, P497, DOI 10.1007/s11033-019-05156-0; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; NEUMANN PM, 1995, CROP SCI, V35, P1258, DOI 10.2135/cropsci1995.0011183X003500050002x; Newton AC, 2011, EUPHYTICA, V179, P3, DOI 10.1007/s10681-011-0359-4; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Park HJ, 2016, MOL CELLS, V39, P447, DOI 10.14348/molcells.2016.0083; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Sharma P, 2016, BMC COMPLEM ALTERN M, DOI [10.1186/s12906-016-1240-8, DOI 10.1186/S12906-016-1240-8]; Shen Y, 2013, PHYSIOL PLANTARUM, V147, P270, DOI 10.1111/j.1399-3054.2012.01670.x; Shinde S, 2016, PLANT PHYSIOL, V172, P1074, DOI 10.1104/pp.16.01097; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Su ZX, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43026; Suzuki N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147625; Taffouo V. D., 2010, International Journal of Botany, V6, P53; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turan M. A., 2007, Journal of Agronomy, V6, P378; Ullah A, 2018, PHYSIOL PLANTARUM, V162, P439, DOI 10.1111/ppl.12651; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; Vishwakarma K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00161; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang XS, 2012, MOL BIOL REP, V39, P8147, DOI 10.1007/s11033-012-1662-4; WERNER JE, 1995, PHYSIOL PLANTARUM, V93, P659, DOI 10.1111/j.1399-3054.1995.tb05114.x; Yang DH, 2014, PLANT SCI, V214, P106, DOI 10.1016/j.plantsci.2013.10.006; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang SW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01405; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	61	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244030	10.1371/journal.pone.0244030	http://dx.doi.org/10.1371/journal.pone.0244030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332435	gold, Green Published			2022-12-26	WOS:000601310900068
J	Ambel, AA; Mugera, HK; Bain, RES				Ambel, Alemayehu Azeze; Mugera, Harriet Kasidi; Bain, Robert E. S.			Accounting for drinking water quality in measuring multidimensional poverty in Ethiopia	PLOS ONE			English	Article							DEVELOPING-COUNTRIES	The Multidimensional Poverty Index is used increasingly to measure poverty in developing countries. The index is constructed using selected indicators that cover health, education, and living standards dimensions. The accuracy of this tool, however, depends on how each indicator is measured. This study explores the effect of accounting for water quality in multidimensional poverty measurement. Access to drinking water is traditionally measured by water source types. The study uses a more comprehensive measure, access to safely managed drinking water services, which are free from E. coli contamination, available when needed and accessible on premises in line with Sustainable Development Goal target 6.1. The study finds that the new measure increases national multidimensional headcount poverty by 5-13 percentage points, which would mean that 5-13 million more people are multidimensionally poor. It also increases the poverty level in urban areas to a greater extent than in rural areas. The finding is robust to changes in water contamination risk levels and Multidimensional Poverty Index aggregation approaches and weighting structures.	[Ambel, Alemayehu Azeze] World Bank, Dev Data Grp, 1818 H St NW, Washington, DC 20433 USA; [Mugera, Harriet Kasidi] World Bank, Dev Data Grp, Copenhagen, Denmark; [Bain, Robert E. S.] United Nations Childrens Fund UNICEF, Div Data Anal Planning & Monitoring, New York, NY USA	The World Bank; UNICEF	Ambel, AA (corresponding author), World Bank, Dev Data Grp, 1818 H St NW, Washington, DC 20433 USA.	aambel@worldbank.org		Ambel, Alemayehu/0000-0002-0990-4466; Bain, Robert/0000-0001-6577-2923				Alkire S., 2019, OPHI MPI METHODOLOGI, P47; Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; Alkire S, 2011, J PUBLIC ECON, V95, P476, DOI 10.1016/j.jpubeco.2010.11.006; Alkire S, 2007, OXF DEV STUD, V35, P347, DOI 10.1080/13600810701701863; Ambel A, 2015, WORLD BANK POLICY RE, P7417; [Anonymous], 2017, DRINKING WATER QUALI; Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bruck T., 2013, 7364 IZA; Carranza E, POVERTY REDUCTION EC; Carranza E., 2013, ETHIOPIA TRENDS WELL; Central Statistical Agency, 2017, DRINK WAT QUAL ETH R; Dotter C, 2017, DISCUSSION PAPERS, V233; Glewwe P, 2016, HBK ECON, V5, P653, DOI 10.1016/B978-0-444-63459-7.00010-5; IEA, 2011, WORLD EN OUTL; Kostyla C, 2015, SCI TOTAL ENVIRON, V514, P333, DOI 10.1016/j.scitotenv.2015.01.018; Landrine H, 2016, TOB CONTROL, V25, pe142; Oxford Poverty and Human Development Initiative (OPHI), 2019, GLOB MPI COUNTR BRIE; RAVALLION M, 1991, REV INCOME WEALTH, P345; Ronoh P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176355; Santos M., 2019, STAT SERIES; Sen A.K., 1981, POVERTY FAMINES; WHO/UNICEF, 2018, COR QUEST DRINK WAT; World Bank,, 2015, ETH POV ASS; World Health Organization, 2012, RAP ASS DRINK WAT QU; World Health Organization, 2017, DEPR OTH COMM MENT D; Wright JA, 2012, POPUL SPACE PLACE, V18, P116, DOI 10.1002/psp.681	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243921	10.1371/journal.pone.0243921	http://dx.doi.org/10.1371/journal.pone.0243921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320919	Green Published, gold			2022-12-26	WOS:000600339800031
J	Getie, A; Baylie, A; Bante, A; Geda, B; Mesfin, F				Getie, Asmare; Baylie, Amsalu; Bante, Agegnehu; Geda, Biftu; Mesfin, Firehiwot			Pressure ulcer prevention practices and associated factors among nurses in public hospitals of Harari regional state and Dire Dawa city administration, Eastern Ethiopia	PLOS ONE			English	Article							KNOWLEDGE; CARE	Introduction Pressure ulcer is one of the major challenges in hospitals; which endanger patient safety, prolonging hospital stay and contributed to disability and death. Data regarding to pressure ulcer prevention practice are very important to take action. However in Ethiopia, there are limited researches that have been conducted and there is clearly paucity of information on this regard. Hence, this study aimed to assess pressure ulcer prevention practice and associated factors among nurses in public hospitals of Eastern Ethiopia. Methods A cross-sectional study was conducted among randomly selected 422 nurses who were working in the public hospitals of Eastern Ethiopia. Data were collected from the 1(st) February to the 1(st) March 2018 using pretested structured self-administered questionnaire and observational checklist. The collected data were entered into EpiData version 3.1 and exported to SPSS version 22.0 for analysis. Bivariable and multivariable logistic regression with crude and adjusted odds ratios along with the 95% confidence interval was computed and interpreted accordingly. Pressure ulcer prevention was determined based on mean calculation; a result above the mean value was categorized as good pressure ulcer prevention practice, and a P-value of <0.05 was considered to declare a result as statistically significant. Results In this study 51.9% (95% CI: 47.1%, 56.4%) of nurses were reported that they have good pressure ulcer prevention practice. On observation 45.2% of nurses were practicing proper pressure ulcer prevention activities. Pressure ulcer prevention practice were statistically associated with nurses with bachelor degree and above qualification level (AOR = 1.7, 95% CI: 1.02, 2.83), availability of pressure-relieving devices (AOR = 2.2, 95% CI: 1.34, 3.63), being satisfied with their job (AOR = 1.65, 95% CI: 1.09, 2.52) and good knowledge (AOR = 2.3, 95% CI: 1.48, 3.55). Conclusions In this study the self-reported practice and results from observation was substantially low. Continuing education and training should be considered for nurses to enhance their practice regarding pressure ulcer prevention practice.	[Getie, Asmare; Bante, Agegnehu] Arba Minch Univ, Sch Nursing, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Baylie, Amsalu] Bahir Dar Univ, Sch Nursing, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Geda, Biftu; Mesfin, Firehiwot] Haramaya Univ, Sch Publ Hlth, Coll Hlth & Med Sci, Harar, Ethiopia	Arba Minch University; Bahir Dar University; Haramaya University	Getie, A (corresponding author), Arba Minch Univ, Sch Nursing, Coll Med & Hlth Sci, Arba Minch, Ethiopia.	asmaregetie2017@gmail.com		Bante, Agegnehu/0000-0003-0583-6635; Getie, Asmare/0000-0002-4078-0078				Al-Ghamdi A, 2017, AM J NURSING SCI, V6, P387; Albuquerque M A., 2014, J NURSING, V8, P229; [Anonymous], 2013, PANCREATOLOGY, V13, pe1; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; Baghaei R, 2016, INT J MED RES HEALTH, V5, P215; Bains Puneet, 2011, Indian J Community Med, V36, P114, DOI 10.4103/0970-0218.84129; Central Statistical Agency (Ethiopia), 2007, POPULATION HOUSING C; Cho I, 2011, INT J MED INFORM, V80, P47, DOI 10.1016/j.ijmedinf.2010.10.019; Edsberg LE, 2016, J WOUND OSTOMY CONT, V43, P585, DOI 10.1097/WON.0000000000000281; Fuel Cells Bulletin, 2015, FUEL CELLS B, V2015, P1, DOI DOI 10.1155/2015/528103; Gunningberg L, 2015, BMJ OPEN; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Johansen E, 2015, HEALTHCARE-BASEL, V3, P417, DOI 10.3390/healthcare3020417; Kallman U, 2009, SCAND J CARING SCI, V23, P334, DOI 10.1111/j.1471-6712.2008.00627.x; Kose I, 2016, INT J CARING SCI, V9, P677; Lupear SK, 2015, NURS CLIN N AM, V50, P411, DOI 10.1016/j.cnur.2015.03.006; Mwebaza I, 2014, NURS RES PRACT, V2014, DOI 10.1155/2014/973602; NPUAP/EPUAP, 2014, EUR PRESS ULC ADV PA; Nurhusien N, 2015, BMC NURS, V14, P34; Ozyurek P, 2016, E J MED, V21, P1; Pancorbo-Hidalgo PL, 2007, J ADV NURS, V58, P327, DOI 10.1111/j.1365-2648.2007.04236.x; Saleh MYN, 2013, J TISSUE VIABILITY, V22, P1, DOI 10.1016/j.jtv.2013.01.003; Sawant N, 2017, INT J SCI REIJSR, V6, P739; Shrestha N, 2016, J- GMC- N., V9, P47; Spector P. E., 2011, JOB SATISFACTION SUR; Strand Tillan, 2010, Intensive Crit Care Nurs, V26, P335, DOI 10.1016/j.iccn.2010.08.006; Taha A S., 2014, NURSES KNOWLEDGE PRA, V2, P247; Tayyib N, 2016, INT WOUND J, V13, P912, DOI 10.1111/iwj.12406; Uba M.N., 2015, INERNATIONAL J NURS, V7, P54, DOI [DOI 10.5897/IJNM2014.0155, 10.5897/ijnm2014.0155, DOI 10.5897/IJNM2014]; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; 2017, AM SOC TEST MAT, V3, P520	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243875	10.1371/journal.pone.0243875	http://dx.doi.org/10.1371/journal.pone.0243875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320888	Green Published, gold			2022-12-26	WOS:000600339800044
J	Zhang, MC; He, SY; Qin, B; Jin, XJ; Wang, MX; Ren, CY; Cao, L; Zhang, YX				Zhang, Mingcong; He, Songyu; Qin, Bin; Jin, Xijun; Wang, Mengxue; Ren, Chunyuan; Cao, Liang; Zhang, Yuxian			Exogenous melatonin reduces the inhibitory effect of osmotic stress on antioxidant properties and cell ultrastructure at germination stage of soybean	PLOS ONE			English	Article							LIPID-PEROXIDATION; DROUGHT STRESS; SEED-GERMINATION; HYDROGEN-PEROXIDE; ENZYME-ACTIVITIES; WATER-DEFICIT; TOLERANCE; PROLINE; GROWTH; ELONGATION	Understanding the relationship between exogenous melatonin and water deficit stress is crucial for alleviating the effects of water deficit stress at germination stage of soybean (Glycine max (L.) Merrill) in agriculture. This study investigated the effects of exogenous melatonin on soybean antioxidant properties and cell ultrastructure under water deficit stress induced by polyethylene glycol (PEG) 6000. The drought-sensitive soybean variety Suinong 26 was used as the material to study the effects of different concentrations of melatonin (0, 300, 500 mu mol.L-1) soaking soybean seeds under drought stress (PEG-6000: 3% and 6%). The results showed that the germination rate (GR), germination potential (GP), germination index (GI) and radicle shape of soybean were affected negatively to different degrees under PEG stress. Moreover, stress induced by different PEG concentrations overproduced the content of reactive oxygen species (H2O2, O-2.(-)) in cells, leading to increased lipid membrane peroxidation as electrolyte leakage (EL) and malondialdehyde (MDA) content, which resulted in impaired cell integrity. However, after seeds soaking with melatonin, the lipid peroxidation of the cell membrane was reduced, and the activities of antioxidant enzymes such as superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and ascorbate peroxidase (APX) further increased to minimize the excessive generation of ROS. Similar results were obtained for soluble protein and proline, that may help in regulating the osmotic pressure and maintain cellular integrity. With the interaction of these enzymes, compared with 300 mu mol.L-1 melatonin, 500 mu mol.L-1 melatonin could more effective to remove the ROS and reduce cell peroxidation. Overall, 500 mu mol.L-1 melatonin performed better than 300 mu mol.L-1. In conclusion, the seed soaking with melatonin promoted the germination of soybean seeds under water stress.	[Zhang, Mingcong; He, Songyu; Qin, Bin; Jin, Xijun; Wang, Mengxue; Ren, Chunyuan; Cao, Liang; Zhang, Yuxian] Heilongjiang Bayi Agr Univ, Coll Agron, Daqing, Peoples R China	Heilongjiang Bayi Agricultural University	Zhang, YX (corresponding author), Heilongjiang Bayi Agr Univ, Coll Agron, Daqing, Peoples R China.	zyx_lxy@126.com			National Natural Science Foundation of China [31801303]; China Postdoctoral Science Foundation [2016M591561]; Natural Science Foundation of Heilongjiang Province of China [C2016042]; Doctoral Scientific Research Start-up Foundation of Heilongjiang Bayi Agricultural University of China [XYB2014-04]; Key Scientific Research Projects of Heilongjiang Farms and Land Reclamation administration [HKKY190206-1]; Applied Technology Research and Development Project of Heilongjiang Province [GA19B101-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Doctoral Scientific Research Start-up Foundation of Heilongjiang Bayi Agricultural University of China; Key Scientific Research Projects of Heilongjiang Farms and Land Reclamation administration; Applied Technology Research and Development Project of Heilongjiang Province	The sequencing and analysis were financially supported by the National Natural Science Foundation of China (No. 31801303), the China Postdoctoral Science Foundation (No. 2016M591561), the Natural Science Foundation of Heilongjiang Province of China (No. C2016042), the Doctoral Scientific Research Start-up Foundation of Heilongjiang Bayi Agricultural University of China (No. XYB2014-04), the Key Scientific Research Projects of Heilongjiang Farms and Land Reclamation administration (No. HKKY190206-1), and Applied Technology Research and Development Project of Heilongjiang Province (No. GA19B101-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi T, 2010, CZECH J GENET PLANT, V46, P27, DOI 10.17221/67/2009-CJGPB; Ahmad P, 2008, J PLANT BIOL, V51, P167, DOI 10.1007/BF03030694; AKINCI S, 2014, APPROACHES PLANT STR, DOI DOI 10.1007/978-81-322-1620-9_8; Anjum SA, 2012, SCI HORTIC-AMSTERDAM, V140, P66, DOI 10.1016/j.scienta.2012.03.028; Arnao MB, 2007, J PINEAL RES, V42, P147, DOI 10.1111/j.1600-079X.2006.00396.x; Arnao MB, 2009, J PINEAL RES, V46, P295, DOI 10.1111/j.1600-079X.2008.00660.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEERS RF, 1952, J BIOL CHEM, V195, P133; CHAITANYA KSK, 1994, NEW PHYTOL, V126, P623, DOI 10.1111/j.1469-8137.1994.tb02957.x; Chaoui A, 1997, PLANT SCI, V127, P139, DOI 10.1016/S0168-9452(97)00115-5; Cui GB, 2017, PLANT PHYSIOL BIOCH, V118, P138, DOI 10.1016/j.plaphy.2017.06.014; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Devi M. K. Akitha, 2015, Proceedings of the Indian National Science Academy Part B Biological Sciences, V85, P35, DOI 10.1007/s40011-013-0244-0; Ding F, 2017, MECH MELATONIN ALLEV, P15; EGLEY GH, 1983, PLANTA, V157, P224, DOI 10.1007/BF00405186; EMMERICH WE, 1990, AGRON J, V82, P1103, DOI 10.2134/agronj1990.00021962008200060015x; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Gao WY, 2018, MOLECULES, V23, DOI 10.3390/molecules23071580; Gong Biao, 2017, Scientia Agricultura Sinica, V50, P2326; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; Guo YY, 2018, RUSS J PLANT PHYSL+, V65, P244, DOI 10.1134/S1021443718020127; Hameed A, 2013, BIOL PLANTARUM, V57, P370, DOI 10.1007/s10535-012-0286-9; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hernandez-Ruiz J, 2008, J AGR FOOD CHEM, V56, P10567, DOI 10.1021/jf8022063; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Kala S., 2011, J SCI RES, V55, P65, DOI DOI 10.1080/02827581.2011.517949; Kaya MD, 2006, EUR J AGRON, V24, P291, DOI 10.1016/j.eja.2005.08.001; Khalid KA, 2010, SCI HORTIC-AMSTERDAM, V125, P159, DOI 10.1016/j.scienta.2010.03.009; Khan MN, 2019, IND CROP PROD, V140, DOI 10.1016/j.indcrop.2019.111597; Kumar S., 2014, SABRAO Journal of Breeding and Genetics, V46, P217; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Li L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05859; Lum MS, 2014, J ANIM PLANT SCI, V24, P1487; Man D, 2011, HORTSCIENCE, V46, P1027, DOI 10.21273/HORTSCI.46.7.1027; Meher, 2018, SAUDI J BIOL SCI, V25, P285, DOI 10.1016/j.sjbs.2017.04.008; Meng JF, 2014, J PINEAL RES, V57, P200, DOI 10.1111/jpi.12159; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MUKHERJEE SP, 1983, PHYSIOL PLANTARUM, V58, P166, DOI 10.1111/j.1399-3054.1983.tb04162.x; Muscolo A, 2014, J PLANT INTERACT, V9, P354, DOI 10.1080/17429145.2013.835880; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Okcu Gamze, 2005, Turkish Journal of Agriculture and Forestry, V29, P237; Park S, 2012, J PINEAL RES, V53, P385, DOI 10.1111/j.1600-079X.2012.01008.x; Patane C, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2135-5; Posmyk MM, 2009, J PINEAL RES, V46, P214, DOI 10.1111/j.1600-079X.2008.00652.x; Qayyum A, 2011, AFR J BIOTECHNOL, V10, P14038, DOI 10.5897/AJB11.2220; Reiter RJ, 2007, ACTA BIOCHIM POL, V54, P1; Rezayian M, 2018, SOIL SCI PLANT NUTR, V64, P360, DOI 10.1080/00380768.2018.1436407; Sandalio LM, 2008, METHOD ENZYMOL, V440, P397, DOI 10.1016/S0076-6879(07)00825-7; Sethy Sunil Kumar, 2013, J Nat Sci Biol Med, V4, P272, DOI 10.4103/0976-9668.116964; SHIDA CS, 1994, J PINEAL RES, V16, P198, DOI 10.1111/j.1600-079X.1994.tb00102.x; Silva EN, 2010, J PLANT PHYSIOL, V167, P1157, DOI 10.1016/j.jplph.2010.03.005; Sofo A, 2015, INT J MOL SCI, V16, P13561, DOI 10.3390/ijms160613561; Stajner D, 2011, AFR J BIOTECHNOL, V10, P1609; SUTINEN ML, 1992, TREE PHYSIOL, V11, P241, DOI 10.1093/treephys/11.3.241; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Velazquez-Marquez S, 2015, PLANT PHYSIOL BIOCH, V96, P29, DOI 10.1016/j.plaphy.2015.07.006; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Wu CH, 2011, AFR J BIOTECHNOL, V10, P17954, DOI 10.5897/AJB11.2018; [邢国芳 Xing Guofang], 2015, [植物生理学报, Plant Physiology Journal], V51, P2101; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yang W, 2020, TRENDS MICROBIOL, V28, P68, DOI 10.1016/j.tim.2019.08.002; Yang Y, 2008, ACTA PHYSIOL PLANT, V30, P433, DOI 10.1007/s11738-008-0140-z; Zhang HJ, 2014, J PINEAL RES, V57, P269, DOI 10.1111/jpi.12167; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhang JT, 2009, SOIL SCI PLANT NUTR, V55, P685, DOI 10.1111/j.1747-0765.2009.00411.x; Zhang MC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226542; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zou JN, 2019, PHOTOSYNTHETICA, V57, P512, DOI 10.32615/ps.2019.066; Zou JingNan, 2020, Acta Agronomica Sinica, V46, P745, DOI 10.3724/SP.J.1006.2020.94111	76	12	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243537	10.1371/journal.pone.0243537	http://dx.doi.org/10.1371/journal.pone.0243537			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320882	Green Published, gold			2022-12-26	WOS:000600339800012
J	Almomani, BA; Khasawneh, RA; Saqan, R; Alnajjar, MS; Al-Natour, L				Almomani, Basima A.; Khasawneh, Rawand A.; Saqan, Rola; Alnajjar, Munther S.; Al-Natour, Lara			Predictive utility of prior positive urine culture of extended- spectrum beta -lactamase producing strains	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRACT-INFECTION; RISK-FACTORS; ENTEROBACTERIACEAE; EPIDEMIOLOGY; SUSCEPTIBILITY; COLONIZATION; BACTEREMIA; OUTCOMES; IMPACT	Rising incidence of extended- spectrum beta-lactamase (ESBL) induced urinary tract infections (UTIs) is an increasing concern worldwide. Thus, it is of paramount importance to investigate novel approaches that can facilitate the identification and guide empiric antibiotic therapy in such episodes. The study aimed to evaluate the usability of antecedent ESBL-positive urine culture to predict the pathogenic identity of future ones. Moreover, the study evaluated the accuracy of selected empiric therapy in index episodes. This was a retrospective study that included 693 cases with paired UTI episodes, linked to two separate hospital admissions within 12 month-period, and a conditional previous ESBL positive episode. Pertinent information was obtained by reviewing patients' medical records and computerized laboratory results. Multivariate analysis showed that shorter interval between index and previous episodes was significantly associated with increased chance of ESBL-positive results in current culture (OR = 0.912, 95CI% = 0.863-0.963, p = 0.001). Additionally, cases with ESBL-positive results in current culture were more likely to have underlying urological/surgical condition (OR = 1.416, 95CI% = 1.018-1.969, p = 0.039). Investigations of the accuracy of current empirical therapy revealed that male patients were less accurately treated compared to female patients (OR = 0.528, 95CI% = 0.289-0.963, p = 0.037). Furthermore, surgical patients were treated less accurately compared to those treated in internal ward (OR = 0.451, 95CI% = 0.234-0.870, p = 0.018). Selecting an agent concordant with previous microbiologic data significantly increased the accuracy of ESBL-UTIs therapy (p<0.001). A quick survey of the previous ESBL urine culture results can guide practitioners in the selection of empiric therapy for the pending current culture and thus improve treatment accuracy.	[Almomani, Basima A.; Khasawneh, Rawand A.; Al-Natour, Lara] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan; [Saqan, Rola] Jordan Univ Sci & Technol, Fac Med, Dept Pediat & Neonatol, Irbid, Jordan; [Alnajjar, Munther S.] Al Ahliyya Amman Univ, Coll Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan	Jordan University of Science & Technology; Jordan University of Science & Technology; Al-Ahliyya Amman University	Almomani, BA (corresponding author), Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan.	baalmomani1@just.edu.jo		Almomani, Basima/0000-0002-2229-5837; Alnajjar, Munther/0000-0002-8472-0173	Jordan University of Science and Technology, Irbid, Jordan [379/2019]	Jordan University of Science and Technology, Irbid, Jordan	Basima Almomani (BA) received a grant (reference number 379/2019) from Deanship of Research at Jordan University of Science and Technology, Irbid, Jordan. http://www.just.edu.jo/Pages/Default.aspx.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The funder provided support in the form of salaries for authors [BA, RK, RS and LA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section".	Akram Mohammed, 2007, Ann Clin Microbiol Antimicrob, V6, P4, DOI 10.1186/1476-0711-6-4; Almomani BA, 2018, INFECTION, V46, P495, DOI 10.1007/s15010-018-1148-y; Alnajjar MS, 2019, INFECTION, V47, P781, DOI 10.1007/s15010-019-01305-6; Amin O, 2020, PEDIATR INFECT DIS J, V39, P211, DOI 10.1097/INF.0000000000002531; Anesi JA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3804-y; [Anonymous], 2019, MEDICINA LITHUANIA, DOI DOI 10.3390/MEDICINA55070356; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; Batchoun Raymond G, 2009, Int J Microbiol, V2009, P513874, DOI 10.1155/2009/513874; Behzadi P, 2021, ADV EXP MED BIOL, V1323, P35, DOI 10.1007/5584_2020_566; Briongos-Figuero LS, 2012, INT J CLIN PRACT, V66, P891, DOI 10.1111/j.1742-1241.2012.02991.x; Christiaens G, 2006, J HOSP INFECT, V62, P386, DOI 10.1016/j.jhin.2005.09.014; Chu CM, 2018, AM J OBSTET GYNECOL, V219, P40, DOI 10.1016/j.ajog.2017.12.231; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI S; Dason S, 2011, CUAJ-CAN UROL ASSOC, V5, P316, DOI 10.5489/cuaj.11214; Dickstein Y, 2016, ANTIMICROB AGENTS CH, V60, P4717, DOI 10.1128/AAC.00202-16; Eisenbeiss W, 2012, INT J BURNS TRAUMA, V2, P71; Fan NC, 2014, J MICROBIOL IMMUNOL, V47, P399, DOI 10.1016/j.jmii.2013.05.006; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Gajdacs M, 2020, LIFE-BASEL, V10, DOI 10.3390/life10020016; Garcia-Tello A, 2018, SCAND J UROL, V52, P70, DOI 10.1080/21681805.2017.1373698; Goulenok T, 2013, J HOSP INFECT, V84, P294, DOI 10.1016/j.jhin.2013.04.018; Goyal D, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy357; Hoban DJ, 2011, DIAGN MICR INFEC DIS, V70, P507, DOI 10.1016/j.diagmicrobio.2011.03.021; Lee DS, 2010, KOREAN J UROL, V51, P492, DOI 10.4111/kju.2010.51.7.492; Leekha S, 2011, MAYO CLIN PROC, V86, P156, DOI 10.4065/mcp.2010.0639; Linsenmeyer K, 2015, ANTIMICROB AGENTS CH, V59, P7593, DOI 10.1128/AAC.01638-15; MacFadden DR, 2014, CLIN INFECT DIS, V59, P1265, DOI 10.1093/cid/ciu588; Marchaim D, 2010, ANTIMICROB AGENTS CH, V54, P5099, DOI 10.1128/AAC.00565-10; Ortega M, 2009, J ANTIMICROB CHEMOTH, V63, P568, DOI 10.1093/jac/dkn514; Peeters P, 2019, INFECT DRUG RESIST, V12, P329, DOI 10.2147/IDR.S184116; Picozzi SCM, 2014, UROL ANNALS, V6, P107, DOI 10.4103/0974-7796.130536; Schulz LT, 2012, PHARMACOTHERAPY, V32, P668, DOI 10.1002/j.1875-9114.2012.01163.x; Schweizer ML, 2008, INFECT CONT HOSP EP, V29, P972, DOI 10.1086/590665; Taneja N, 2008, INDIAN J MED RES, V127, P85; van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009; Zilberberg MD, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2383-z	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243741	10.1371/journal.pone.0243741	http://dx.doi.org/10.1371/journal.pone.0243741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315921	gold, Green Published			2022-12-26	WOS:000600186100054
J	Faruqu, FN; Liam-Or, R; Zhou, S; Nip, R; Al-Jamal, KT				Faruqu, Farid N.; Liam-Or, Revadee; Zhou, Shuai; Nip, Rebecca; Al-Jamal, Khuloud T.			Defined serum-free three-dimensional culture of umbilical cord-derived mesenchymal stem cells yields exosomes that promote fibroblast proliferation and migration in vitro	FASEB JOURNAL			English	Article						Aggrewell plates; fibroblasts; platelet lysate; proliferation; wound healing	FETAL BOVINE SERUM; HEPATOCYTE GROWTH-FACTOR; EXTRACELLULAR VESICLES; OSTEOGENIC DIFFERENTIATION; DERMAL FIBROBLASTS; CONDITIONED MEDIUM; SPHEROID CULTURE; STROMAL CELLS; ALTERNATIVES; ANGIOGENESIS	Stem cell-derived exosomes are emerging as novel and clinically relevant cell-free therapeutics for regenerative therapy. This work focused on investigating the stimulation of fibroblasts by exosomes derived from umbilical cord-derived mesenchymal stem cells (ucMSC) in a defined serum-free three-dimensional (3D) culture. 3D culture of ucMSC was carried out in medium supplemented with KnockOut serum replacement (KO-medium) using the Aggrewell system. ucMSC in KO-medium formed spheroids with maintained size and integrity throughout culture. This enabled the isolation of vesicles from ucMSC spheroids in KO-medium with sizes that fall within the exosomal size range and were positive for the expression of canonical exosomal markers CD63, CD9, CD81, Alix, and TSG101. The ucMSC-derived exosomes (Exo(ucMSC)) were shown to significantly increase the migration and proliferation of murine fibroblasts in vitro. To conclude, 3D culture of ucMSC in defined serum-free KO-medium formed viable spheroids which enabled the isolation of Exo(ucMSC) with the potential of accelerating wound healing.	[Faruqu, Farid N.; Liam-Or, Revadee; Zhou, Shuai; Nip, Rebecca; Al-Jamal, Khuloud T.] Kings Coll London, Inst Pharmaceut Sci, Room 5-67,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England	University of London; King's College London	Al-Jamal, KT (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Room 5-67,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	khuloud.al-jamal@kcl.ac.uk	Al-Jamal, Khuloud/ABD-5668-2021; Faruqu, Farid Nazer/AAO-4364-2020	Faruqu, Farid Nazer/0000-0001-5718-0039; AL-JAMAL, KHULOUD/0000-0001-5165-2699	Wellcome Trust [WT103913] Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Bainbridge P, 2013, J WOUND CARE, V22, P407; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Blackford SJI, 2019, STEM CELL TRANSL MED, V8, P124, DOI 10.1002/sctm.18-0084; Blak AA, 2011, MOL THER, V19, pS330; Borger V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071450; Casado-Diaz A, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00146; Cesarz Z, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9176357; Chang YH, 2018, TZU CHI MED J, V30, P71, DOI 10.4103/tcmj.tcmj_23_18; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cooper DR, 2018, ADV WOUND CARE, V7, P299, DOI 10.1089/wound.2017.0775; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Deng MW, 2020, PHOTOCH PHOTOBIO SCI, V19, P406, DOI 10.1039/c9pp00421a; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang S, 2016, STEM CELL TRANSL MED, V5, P1425, DOI 10.5966/sctm.2015-0367; Faruqu FN, 2020, FASEB BIOADV, V2, P419, DOI 10.1096/fba.2020-00025; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haraszti RA, 2018, MOL THER, V26, P2838, DOI 10.1016/j.ymthe.2018.09.015; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; Jarmalaviciute A, 2015, CYTOTHERAPY, V17, P932, DOI 10.1016/j.jcyt.2014.07.013; Kim MS, 2016, NANOMED-NANOTECHNOL, V12, P655, DOI 10.1016/j.nano.2015.10.012; Kusuma GD, 2017, STEM CELLS DEV, V26, P617, DOI 10.1089/scd.2016.0349; Lai RC, 2011, METHODS MOL BIOL, V698, P141, DOI 10.1007/978-1-60761-999-4_11; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lee JH, 2016, BIOMOL THER, V24, P260, DOI 10.4062/biomolther.2015.146; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; Li X, 2016, EBIOMEDICINE, V8, P72, DOI 10.1016/j.ebiom.2016.04.030; Li Y, 2015, CELL TISSUE RES, V360, P297, DOI 10.1007/s00441-014-2055-x; Ma J, 2017, STEM CELL TRANSL MED, V6, P51, DOI 10.5966/sctm.2016-0038; Mahaweni NM, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22492; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Marote A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00231; Masamune A, 2018, BIOCHEM BIOPH RES CO, V495, P71, DOI 10.1016/j.bbrc.2017.10.141; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Monguio-Tortajada M, 2017, THERANOSTICS, V7, P270, DOI 10.7150/thno.16154; Mou S, 2009, KAOHSIUNG J MED SCI, V25, P577, DOI 10.1016/S1607-551X(09)70560-1; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Pal R, 2009, J TISSUE ENG REGEN M, V3, P163, DOI 10.1002/term.143; Petrova A, 2020, J INVEST DERMATOL, V140, P121, DOI 10.1016/j.jid.2019.05.031; Pires AO, 2016, STEM CELLS DEV, V25, P1073, DOI 10.1089/scd.2016.0048; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Price P, 1998, EMBRYONIC STEM CELL, Patent No. WO98/30679; Randle WL, 2007, TISSUE ENG, V13, P2957, DOI 10.1089/ten.2007.0072; Ranzato E, 2009, J CELL MOL MED, V13, P2030, DOI 10.1111/j.1582-4934.2008.00467.x; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rauch C, 2011, ALTEX-ALTERN ANIM EX, V28, P305, DOI 10.14573/altex.2011.4.305; Razian G, 2013, JOVE-J VIS EXP, DOI 10.3791/50665; Schievenbusch S, 2009, BIOCHEM BIOPH RES CO, V385, P55, DOI 10.1016/j.bbrc.2009.05.010; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Sherman AB, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0577-3; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; Torreggiani E, 2014, EUR CELLS MATER, V28, P137, DOI 10.22203/eCM.v028a11; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Wang JY, 2020, STEM CELLS INT, V2020, DOI 10.1155/2020/6091269; Wang L, 2017, MICROCHIM ACTA, V7, P1; Wang LX, 2019, ACS OMEGA, V4, P22638, DOI 10.1021/acsomega.9b03561; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Witzeneder K, 2013, TRANSFUS MED HEMOTH, V40, P417, DOI 10.1159/000356236; Yan LT, 2020, CELL BIOL TOXICOL, V36, P165, DOI 10.1007/s10565-019-09504-5; Yan YM, 2017, MOL THER, V25, P465, DOI 10.1016/j.ymthe.2016.11.019; Yin F, 2019, WORLD J STEM CELLS, V11, P548, DOI 10.4252/wjsc.v11.i8.548; Yin SQ, 2019, AM J TRANSL RES, V11, P1230; Yu A, 2012, J BIOMAT SCI-POLYM E, V23, P1315, DOI 10.1163/092050611X580463; Zhang B, 2015, STEM CELLS, V33, P2158, DOI 10.1002/stem.1771; Zhang J, 2009, J TISSUE ENG REGEN M, V3, P63, DOI 10.1002/term.135; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhao YY, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/761643; Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o; Zhou PP, 2017, BIOCHEM BIOPH RES CO, V491, P323, DOI 10.1016/j.bbrc.2017.07.102; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194	73	9	9	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21206	10.1096/fj.202001768RR	http://dx.doi.org/10.1096/fj.202001768RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368666	Green Published			2022-12-26	WOS:000605626600006
J	Belovsky, GE; Slade, JB				Belovsky, Gary E.; Slade, Jennifer B.			Climate change and primary production: Forty years in a bunchgrass prairie	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; UNITED-STATES; GRASSLAND; TERRESTRIAL; PRECIPITATION; RESPONSES; FORESTS; VARIABILITY; PERSPECTIVE; INCREASES	Over the past 109 years, a Montana intermountain bunchgrass prairie annually became warmer (0.7 degrees C) and drier (27%). The temperature and precipitation trends continued since 1978, as we studied nitrogen availability, annual aboveground primary production (ANPP), plant phenology and species composition. Given the annual increase in temperature and decrease in precipitation, ANPP might be expected to decline; however, it increased by 110%, as the period of greatest production (late-May-June) became wetter and cooler, counter to the annual pattern, and this was strongest at lower elevations. Grass production increased by 251%, while dicot production declined by 65%, which increased grass relative abundance by 54%. Summer temperatures increased 12.5% which increased plant senescence by 119% and decreased fall plant regrowth by 68%. More intense summer senescence changed plant species composition in favor of more drought tolerant species. The greater ANPP and summer senescence may increase susceptibility for fire, but fire tolerance of the plant species composition did not change. Invasive plant species increased 108% over the study with annual grasses accounting for >50% of this increase, which further increased summer plant senescence. Therefore, seasonal climate changes at a smaller geographical scale (local), rather than average annual climate changes over a larger geographical scale (regional), may better reflect plant community responses, and this makes ecological forecasting of climate change more difficult.	[Belovsky, Gary E.] Univ Notre Dame, Environm Res Ctr, Notre Dame, IN 46556 USA; [Belovsky, Gary E.; Slade, Jennifer B.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Belovsky, GE (corresponding author), Univ Notre Dame, Environm Res Ctr, Notre Dame, IN 46556 USA.; Belovsky, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	belovsky.1@nd.edu			National Science Foundation: NSF [NSF DEB78-02069, NSF BSR-83-07352, NSF DEB-9317984, NSF DEB-97-07564, NSF DEB-04-15390, NSF DEB-09-18306, NSF DEB-1456511]; National Geographic Society [FY79]; University of Michigan Rackham Graduate School; University of Michigan Vice-President of Research Grant; USDA/GHIPM (1989-1994); Utah State University Agricultural Experiment Station; USDA/ARS; USDA-CSREES/NRICGP [00-35101-9267]	National Science Foundation: NSF(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); University of Michigan Rackham Graduate School(University of Michigan System); University of Michigan Vice-President of Research Grant(University of Michigan System); USDA/GHIPM (1989-1994); Utah State University Agricultural Experiment Station; USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-CSREES/NRICGP(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	Funding to 1st author GEB: National Science Foundation: NSF -www.nsf.gov NSF DEB78-02069, NSF BSR-83-07352, NSF DEB-9317984, NSF DEB-97-07564, NSF DEB-04-15390, NSF DEB-09-18306, NSF DEB-1456511 National Geographic Society Grant FY79 -https://www.nationalgeographic.org; University of Michigan Rackham Graduate School -https://rackham.umich.edu/; University of Michigan Vice-President of Research Grant -https://www.research.umich.edu; USDA/GHIPM (1989-1994) -www.ars.usda.gov (GHIPM program ended in 1994); Utah State University Agricultural Experiment Station (1992-1996) -https://uaes.usu.edu/; USDA/ARS and USDA-CSREES/NRICGP (00-35101-9267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; ANTOS JA, 1983, AM MIDL NAT, V110, P354, DOI 10.2307/2425275; Baer SG, 2008, ECOLOGY, V89, P1859, DOI 10.1890/07-0417.1; Belovsky Gary E., 2002, Journal of Orthoptera Research, V11, P29, DOI 10.1665/1082-6467(2002)011[0029:AEPOGC]2.0.CO;2; BELOVSKY GE, 1995, OECOLOGIA, V101, P383, DOI 10.1007/BF00328826; Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Belovsky GE, 2000, NATO ASI 2, V73, P7; Binkley D., 1989, Advances in Soil Science, V10, P57; Blair J. M., 1998, GRASSLAND DYNAMICS L, P222; Booth ELJ, 2012, INT J CLIMATOL, V32, P2283, DOI 10.1002/joc.3401; Bragg Thomas B., 1995, P49; Branson DH, 2001, THESIS; Briske DD, 2015, FRONT ECOL ENVIRON, V13, P249, DOI 10.1890/140266; Burke IC, 1997, ECOLOGY, V78, P1330, DOI 10.1890/0012-9658(1997)078[1330:RATVIN]2.0.CO;2; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Cleland EE, 2013, ECOLOGY, V94, P1687, DOI 10.1890/12-1006.1; Collins Scott L., 1995, P128; Conroy JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039558; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; Craine JM, 2011, OECOLOGIA, V165, P1109, DOI 10.1007/s00442-011-1938-8; Craine JM, 2010, ECOLOGY, V91, P2132, DOI 10.1890/09-1242.1; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; DAUBENMIRE R, 1956, ECOL MONOGR, V26, P131, DOI 10.2307/1943287; DAUBENMIRE R. F., 1942, ECOL MONOGR, V12, P53, DOI 10.2307/1948422; Daubenmire RF, 1947, PANTS ENV TXB PLANT; Daubenmire RF, 1970, WASH AGR STA TECH B, P62; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; Dice LR, 1962, NATURAL COMMUNITIES; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dorn R. D., 1984, VASCULAR PLANTS MONT; Everard K, 2010, AM NAT, V175, P85, DOI 10.1086/648557; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finch DM, RMRSGTR285, DOI 10.2737/RMRS-GTR-285; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garcia A, 1976, TOUGH TRIP PARADISE; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Harte J, 2015, GLOBAL CHANGE BIOL, V21, P2349, DOI 10.1111/gcb.12831; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; Heyerdahl EK, 2008, ECOLOGY, V89, P705, DOI 10.1890/06-2047.1; Hitchcock A. S., 1971, MANUAL GRASSES US; Hitchcock C.L., 1973, FLORA PACIFIC NW; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; JOERN A, 1995, CHANGING PRAIRIE N A; Johnson D., 2001, WILDLIFE HABITAT REL; Johnson SE, 1930, U MONTANA BULLETIN, V237; Kennedy PL, 2009, RESTOR ECOL, V17, P515, DOI 10.1111/j.1526-100X.2008.00402.x; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Knapp A.K., 1998, GRASSLAND DYNAMICS L, V1st; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Knapp AK, 2015, OECOLOGIA, V177, P949, DOI 10.1007/s00442-015-3233-6; Lackschewitz K, 1991, INT277 USDA FOR SERV; Lauenroth WK, 2006, ECOSYSTEMS, V9, P843, DOI 10.1007/s10021-005-0072-z; Lauenroth W. K., 1979, Perspectives in grassland ecology., P3; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Lavin M, 2011, GRASSES MONTANA; Lesica P, 2010, J ARID ENVIRON, V74, P1013, DOI 10.1016/j.jaridenv.2010.02.002; LONG SP, 1991, ECOL APPL, V1, P139, DOI 10.2307/1941807; Manske LL, 2001, N DAKOTA STATE U 200; McDougall W. B., 1956, PLANTS YELLOWSTONE N; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; MILTON EJ, 1987, INT J REMOTE SENS, V8, P1807, DOI 10.1080/01431168708954818; Moran MS, 2014, ECOLOGY, V95, P2121, DOI 10.1890/13-1687.1; MORRIS MELVIN S., 1957, JOUR WILDLIFE MANAGEMENT, V21, P189, DOI 10.2307/3797584; MOULTON G, 1988, J LEWIS CLARK EXPEDI; National Atmospheric Deposition Program (NADP), 2009, NADP C OCT 6 8; Nelson R. A., 1992, HDB ROCKY MOUNTAIN P; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Ortiz R. D. C., AM J BOT, V94, P1425, DOI [10.3732/ajb.94.8.1425, DOI 10.3732/AJB.94.8.1425, DOI 10.3732/AJB.94.4.55121636425]; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; PEARSON LC, 1965, ECOLOGY, V46, P278, DOI 10.2307/1936331; PEARSON RL, 1976, APPL OPTICS, V15, P416, DOI 10.1364/AO.15.000416; Pederson GT, 2011, SCIENCE, V333, P332, DOI 10.1126/science.1201570; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Peng J, 2012, ADV ATMOS SCI, V29, P1063, DOI 10.1007/s00376-012-1172-2; Pohl RW, 1976, KNOW GRASSES; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Price C., 2009, LIGHTNING PRINCIPLES, P521, DOI [10.1007/978-1-4020-9079-0_24, DOI 10.1007/978-1-4020-9079-0_24]; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; RICKARD WH, 1985, NORTHWEST SCI, V59, P126; Robertson G.P, 1999, LONG TERM ECOLOGICAL; Romps DM, 2014, SCIENCE, V346, P851, DOI 10.1126/science.1259100; Sala OE, 2012, PHILOS T R SOC B, V367, P3135, DOI 10.1098/rstb.2011.0347; SCHMITZ OJ, 1993, OECOLOGIA, V93, P327, DOI 10.1007/BF00317874; Seager R, 2009, J CLIMATE, V22, P5021, DOI 10.1175/2009JCLI2683.1; Seastedt Timothy R., 1995, P157; Seastedt TR, 1998, GRASSLAND DYNAMICS L, P283; SHELFORD VE, 1963, ECOLOGY N AM; SMOLIAK S, 1986, J RANGE MANAGE, V39, P100, DOI 10.2307/3899276; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856; Stuart G, 2004, 40 YEARS FRONTIER; Volenec ZM, 2018, OECOLOGIA, V188, P913, DOI 10.1007/s00442-018-4247-7; West N.E., 1983, P351; Western Regional Climate Center (WRCC), DIV ATM SCI; WHITE KL, 1967, ECOLOGY, V48, P949, DOI 10.2307/1934539; Wu ZT, 2017, GLOBAL CHANGE BIOL, V17, P927; Ye JS, 2014, ECOLOGY, V95, P2109, DOI 10.1890/13-1014.1; Zhang YH, 2018, OECOLOGIA, V188, P183, DOI 10.1007/s00442-018-4208-1	98	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243496	10.1371/journal.pone.0243496	http://dx.doi.org/10.1371/journal.pone.0243496			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362217	Green Published, gold			2022-12-26	WOS:000603071600069
J	Lee, Y; Oh, D; Han, JH; Gong, HS; Lee, WW				Lee, Yohan; Oh, Dongkyu; Han, Jeong Hee; Gong, Hyun Sik; Lee, Won Woo			Semiquantitative single-photon-emission computed tomography /computed tomography study to evaluate concomitant ulnar impaction syndrome in patients presenting with triangular fibrocartilage complex tears	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; WRIST; SPECT/CT; REPAIR; OSTEOARTHRITIS	Introduction Patients presenting with tears of the triangular fibrocartilage complex (TFCC) can have ulnar positive variance, for which the clinical relevance to concomitant ulnar impaction syndrome (UIS) may be unclear. We hypothesized that maximum standardized uptake value (SUVmax), a semiquantitative single-photon-emission computed tomography/computed tomography (SPECT/CT) value, would distinguish between the traumatic TFCC tear and degenerative TFCC tear associated with the UIS. This study aimed to compare SUVmax between patients with TFCC tear only and patients with TFCC tear and UIS. Methods A total of 26 patients presenting with TFCC tears on magnetic resonance imaging (MRI) underwent semiquantitative SPECT/CT examinations. The diagnosis of concomitant UIS was made based on positive ulnar impaction tests and MRI findings. We compared the SUVmax between patients with and without concomitant UIS. We also calculated the cutoff value for the diagnosis of UIS using receiver operating characteristic curve analysis. Results Of 26 patients, 14 had concomitant UIS, and 12 had TFCC tears only. The SUVmax was significantly higher in patients with concomitant UIS than in those without UIS (p = 0.048). With a SUVmax cutoff value of 4.09 for UIS, sensitivity of 67% and specificity of 82% were obtained. Conclusions In the semiquantitative SPECT/CT examinations of patients with TFCC tears, those with concomitant UIS had a higher SUVmax than those without UIS. Semiquantitative SPECT/CT can be helpful in confirming concomitant UIS in patients with TFCC tears.	[Lee, Yohan] Seoul Natl Univ, Boramae Hosp, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Oh, Dongkyu; Han, Jeong Hee; Lee, Won Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Nucl Med, Seoul, South Korea; [Gong, Hyun Sik] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Orthopaed Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Lee, WW (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Nucl Med, Seoul, South Korea.; Gong, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Orthopaed Surg, Seoul, South Korea.	hsgong@snu.ac.kr; wwlee@snu.ac.kr			National Research Foundation of Korea - Ministry of Education [2018R1D1A1A09081961]; Korean Society of Nuclear Medicine Clinical Trial Network (KSNM CTN) working group - Korean Society of Nuclear Medicine [KSNM-CTN-2017-0101]	National Research Foundation of Korea - Ministry of Education; Korean Society of Nuclear Medicine Clinical Trial Network (KSNM CTN) working group - Korean Society of Nuclear Medicine	This study was supported in part by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2018R1D1A1A09081961) and by the Korean Society of Nuclear Medicine Clinical Trial Network (KSNM CTN) working group funded by the Korean Society of Nuclear Medicine (KSNM-CTN-2017-0101).	[Anonymous], 2016, MEDICINE BALTIMORE, V95, pe3187; Bae S, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014022; COLEMAN DA, 1987, J BONE JOINT SURG AM, V69A, P385; DaSilva MF, 2017, J AM ACAD ORTHOP SUR, V25, pE150, DOI 10.5435/JAAOS-D-16-00407; FRIEDMAN SL, 1991, HAND CLIN, V7, P295; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Huellner MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085359; Iordache SD, 2012, J HAND SURG-AM, V37A, P98, DOI 10.1016/j.jhsa.2011.10.006; Kim J, 2017, CLIN RADIOL, V72, P580, DOI 10.1016/j.crad.2017.03.009; Meier R, 2005, Handchir Mikrochir Plast Chir, V37, P85, DOI 10.1055/s-2004-830376; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; PALMER AK, 1989, J HAND SURG-AM, V14A, P594, DOI 10.1016/0363-5023(89)90174-3; Porteous R, 2012, CAN ASSOC RADIOL J, V63, P18, DOI 10.1016/j.carj.2010.07.007; Reiter A, 2008, ARTHROSCOPY, V24, P1244, DOI 10.1016/j.arthro.2008.06.022; Ruch DS, 2005, ARTHROSCOPY, V21, P1126, DOI 10.1016/j.arthro.2005.05.024; Saha S, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120519; Schleich FS, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-53; Schmauss D, 2016, ARCH ORTHOP TRAUM SU, V136, P873, DOI 10.1007/s00402-016-2441-9; Shirley RA, 2016, J PLAST RECONSTR AES, V69, P1424, DOI 10.1016/j.bjps.2016.04.011; Strobel K, 2014, EUR J NUCL MED MOL I, V41, P548, DOI 10.1007/s00259-013-2584-7; Strzelczyk Jadwiga Jodi, 2007, J Am Coll Radiol, V4, P32, DOI 10.1016/j.jacr.2006.07.010; Suh MS, 2016, RADIOLOGY, V280, P890, DOI 10.1148/radiol.2016152294; Tatebe M, 2007, J HAND SURG-AM, V32A, P445, DOI 10.1016/j.jhsa.2007.01.013	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244256	10.1371/journal.pone.0244256	http://dx.doi.org/10.1371/journal.pone.0244256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362280	Green Published, gold			2022-12-26	WOS:000603071600053
J	Paramita, RI; Nelwan, EJ; Fadilah, F; Renesteen, E; Puspandari, N; Erlina, L				Paramita, Rafika Indah; Nelwan, Erni Juwita; Fadilah, Fadilah; Renesteen, Editha; Puspandari, Nelly; Erlina, Linda			Genome-based characterization of Escherichia coli causing bloodstream infection through next-generation sequencing	PLOS ONE			English	Article							VIRULENCE FACTORS; SPECTRUM; ST131; ENTEROBACTERIACEAE; PREVALENCE; RESISTANCE; GENE; EPIDEMIOLOGY; SURVEILLANCE; DIVERSITY	Escherichia coli are one of the commonest bacteria causing bloodstream infection (BSI). The aim of the research was to identify the serotypes, MLST (Multi Locus Sequence Type), virulence genes, and antimicrobial resistance of E. coli isolated from bloodstream infection hospitalized patients in Cipto Mangunkusumo National Hospital Jakarta. We used whole genome sequencing methods rather than the conventional one, to characterized the serotypes, MLST (Multi Locus Sequence Type), virulence genes, and antimicrobial resistance (AMR) of E. coli. The composition of E. coli sequence types (ST) was as follows: ST131 (n = 5), ST38 (n = 3), ST405 (n = 3), ST69 (n = 3), and other STs (ST1057, ST127, ST167, ST3033, ST349, ST40, ST58, ST6630). Enteroaggregative E. coli (EAEC) and Extra-intestinal pathogenic E. coli (ExPEC) groups were found dominant in our samples. Twenty isolates carried virulence genes for host cells adherence and 15 for genes that encourage E. coli immune evasion by enhancing survival in serum. ESBL-genes were present in 17 E. coli isolates. Other AMR genes also encoded resistance against aminoglycosides, quinolones, chloramphenicol, macrolides and trimethoprim. The phylogeny analysis showed that phylogroup D is dominated and followed by phylogroup B2. The E. coli isolated from 22 patients in Cipto Mangunkusumo National Hospital Jakarta showed high diversity in serotypes, sequence types, virulence genes, and AMR genes. Based on this finding, routinely screening all bacterial isolates in health care facilities can improve clinical significance. By using Whole Genome Sequencing for laboratory-based surveillance can be a valuable early warning system for emerging pathogens and resistance mechanisms.	[Paramita, Rafika Indah; Fadilah, Fadilah; Erlina, Linda] Univ Indonesia, Fac Med, Dept Med Chem, Dki Jakarta, Indonesia; [Paramita, Rafika Indah; Fadilah, Fadilah; Erlina, Linda] Univ Indonesia, Fac Med, Bioinformat Core Facil IMERI, Dki Jakarta, Indonesia; [Paramita, Rafika Indah; Fadilah, Fadilah; Erlina, Linda] Univ Indonesia, Fac Med, Masters Programme Biomed Sci, Dki Jakarta, Indonesia; [Nelwan, Erni Juwita] Univ Indonesia, Fac Med, Dept Internal Med, Dki Jakarta, Indonesia; [Nelwan, Erni Juwita; Renesteen, Editha] Univ Indonesia, Fac Med, Infect Dis & Immunol Res Ctr IMERI, Dki Jakarta, Indonesia; [Puspandari, Nelly] Minist Hlth, Natl Inst Hlth Res & Dev, Ctr Res & Dev Biomed & Basic Hlth Technol, Dki Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia; University of Indonesia; University of Indonesia; National Institute of Health Research & Development - Indonesia	Erlina, L (corresponding author), Univ Indonesia, Fac Med, Dept Med Chem, Dki Jakarta, Indonesia.; Erlina, L (corresponding author), Univ Indonesia, Fac Med, Bioinformat Core Facil IMERI, Dki Jakarta, Indonesia.; Erlina, L (corresponding author), Univ Indonesia, Fac Med, Masters Programme Biomed Sci, Dki Jakarta, Indonesia.	linda.erlina22@ui.ac.id		Renesteen, Editha/0000-0003-1635-528X; Erlina, Linda/0000-0003-1108-0600	Universitas Indonesia (Q1Q2 Grant) [NBK-0220/UN2.R3.1/HKP.05.00/2019]	Universitas Indonesia (Q1Q2 Grant)	This research was funded by Universitas Indonesia (Q1Q2 Grant; grant number NBK-0220/UN2.R3.1/HKP.05.00/2019).	Aibinu I, 2012, CLIN MICROBIOL INFEC, V18, pE49, DOI 10.1111/j.1469-0691.2011.03730.x; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Boisen N, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008613; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boll EJ, 2013, INFECT IMMUN, V81, P1164, DOI 10.1128/IAI.01376-12; Cha MK, 2016, DIAGN MICR INFEC DIS, V84, P102, DOI 10.1016/j.diagmicrobio.2015.10.015; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Frieri M, 2017, J INFECT PUBLIC HEAL, V10, P369, DOI 10.1016/j.jiph.2016.08.007; Habouria H, 2019, VIRULENCE, V10, P568, DOI 10.1080/21505594.2019.1624102; Havt A, 2017, DIAGN MICR INFEC DIS, V89, P98, DOI 10.1016/j.diagmicrobio.2017.06.024; Herzog K, 2014, INFECTION, V42, P441, DOI 10.1007/s15010-013-0569-x; Huang WC, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00677-4; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson JR, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx089; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Kaye KS, 2015, PHARMACOTHERAPY, V35, P949, DOI 10.1002/phar.1636; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Mandomando I, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008274; Manyahi J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2395-8; Nelwan EJ, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105631; Nguyen MCP, 2009, EMERG INFECT DIS, V15, P1648, DOI 10.3201/eid1510.090696; Noguchi N, 2000, J BACTERIOL, V182, P5052, DOI 10.1128/JB.182.18.5052-5058.2000; Olesen B, 2012, J CLIN MICROBIOL, V50, P3703, DOI 10.1128/JCM.01909-12; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Peirano G, 2010, INT J ANTIMICROB AG, V36, P19, DOI 10.1016/j.ijantimicag.2010.02.016; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2012, INFECT GENET EVOL, V12, P883, DOI 10.1016/j.meegid.2012.02.008; Roer L, 2017, J ANTIMICROB CHEMOTH, V72, P1922, DOI 10.1093/jac/dkx092; Sarowska J, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0290-0; Seki LM, 2013, BRAZ J INFECT DIS, V17, P640, DOI 10.1016/j.bjid.2013.03.012; Shakya M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58356-1; Sonda T, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0361-x; Storberg Viktor, 2014, Infection Ecology & Epidemiology, V4, P20342, DOI 10.3402/iee.v4.20342; Torres AG, 2009, J CLIN MICROBIOL, V47, P2442, DOI 10.1128/JCM.00566-09; Trecarichi EM, 2016, AM J HEMATOL, V91, P1076, DOI 10.1002/ajh.24489; Valenza G, 2017, VET MICROBIOL, V200, P138, DOI 10.1016/j.vetmic.2015.10.008; Xiong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036144; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	44	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244358	10.1371/journal.pone.0244358	http://dx.doi.org/10.1371/journal.pone.0244358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362261	Green Published, gold			2022-12-26	WOS:000603071600002
J	Ishiyama, Y; Shimbo, M; Iizuka, J; Deshpande, G; Tanabe, K; Hattori, K				Ishiyama, Yudai; Shimbo, Masaki; Iizuka, Junpei; Deshpande, Gautam; Tanabe, Kazunari; Hattori, Kazunori			Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort	PLOS ONE			English	Article							BREAST-CANCER; RISK; SURVIVAL; OBESITY; BRCA1	In addition to breast, ovarian, and pancreatic cancers, BRCA1/2 genes have been associated with prostate cancer (PC). However, the role of BRCA1/2-associated family cancer history (FCH) has remained unexplored in treating these four cancer types as a homogenous pathophysiological group. We aimed to clarify the relationship between BRCA1/2-associated FCH and PC, and to assess its relationship with cancer aggressiveness. Patient characteristics, positive family history of BRCA1/2-associated cancer, and cancer characteristics (Gleason score, prostate specific antigen level at diagnosis, and clinical tumor stage) were analyzed. Among the 1,985 eligible candidates, 473 (23.83%) patients had adequately detailed FCH, obtained via questionnaire, and were thus included in the study. BRCA1/2-associated FCH was observed in 135 (28.54%) patients with PC (68, 14.38%), breast (44, 9.30%), pancreatic (31, 6.55%), or ovarian (8, 1.69%) cancers. BRCA1/2-associated FCH was not significantly associated with high Gleason score (>= 8). Patients with BRCA-associated FCH were less likely to present with high clinical tumor stage, and no difference was observed in prostate-specific antigen level, presence of metastatic lesions at diagnosis, or likelihood of high-risk classification between patients with and without BRCA-associated FCH. This is the first report of BRCA1/2-associated FCH in Japanese men, indicating that family history did not affect the severity or aggressiveness of PC.	[Ishiyama, Yudai; Shimbo, Masaki; Hattori, Kazunori] St Lukes Int Hosp, Dept Urol, Tokyo, Japan; [Ishiyama, Yudai; Iizuka, Junpei; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan; [Deshpande, Gautam] St Lukes Int Univ, Support Unit Conducting Clinically Essential Stud, Tokyo, Japan; [Deshpande, Gautam] St Lukes Int Hosp, Dept Gen Internal Med, Tokyo, Japan	St. Luke's International Hospital; Tokyo Women's Medical University; St. Luke's International Hospital; St. Luke's International Hospital	Ishiyama, Y (corresponding author), St Lukes Int Hosp, Dept Urol, Tokyo, Japan.; Ishiyama, Y (corresponding author), Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan.	yuishi0831@gmail.com	Ishiyama, Yudai/AAM-7002-2021; Shimbo, Masaki/AAQ-9862-2021	Ishiyama, Yudai/0000-0002-8440-6264; 				Allott EH, 2013, EUR UROL, V63, P800, DOI 10.1016/j.eururo.2012.11.013; BASTACKY SI, 1995, J UROLOGY, V153, P987, DOI 10.1016/S0022-5347(01)67619-5; Beger C, 2004, CLIN CANCER RES, V10, P3780, DOI 10.1158/1078-0432.CCR-0992-3; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Calvocoressi L, 2018, J INVEST MED, V66, P1142, DOI 10.1136/jim-2018-000804; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Castro E, 2015, EUR UROL, V68, P186, DOI 10.1016/j.eururo.2014.10.022; Castro E, 2013, J CLIN ONCOL, V31, P1748, DOI 10.1200/JCO.2012.43.1882; Chen YC, 2008, PROSTATE, V68, P1582, DOI 10.1002/pros.20825; de Bono J, 2020, NEW ENGL J MED, V382, P2091, DOI 10.1056/NEJMoa1911440; Epstein JI, 2014 INT SOC UR PATH; Hemminki K, 2008, J CLIN ONCOL, V26, P1705, DOI 10.1200/JCO.2007.13.3355; Hemminki K, 2012, WORLD J UROL, V30, P143, DOI 10.1007/s00345-011-0801-1; Imamoto T, 2010, UROLOGY, V76, P404, DOI 10.1016/j.urology.2009.05.084; Jeong IG, 2017, J UROLOGY, V198, P71, DOI 10.1016/j.juro.2017.01.073; Kimura T, 2018, INT J UROL, V25, P524, DOI 10.1111/iju.13593; Maier C, 2014, PROSTATE, V74, P1444, DOI 10.1002/pros.22860; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mori M, 2011, ASIAN PAC J CANCER P, V12, P743; Network N. C. C, GEN FAM HIGH RISK AS; Network NCC, 2020, PROST CANC VERS 2 20; Rodriguez C, 1998, EPIDEMIOLOGY, V9, P525, DOI 10.1097/00001648-199809000-00009; Services NCCJCfCCaI, SERV NCCJCFCCAI; Shiga Y, 2003, JPN J UROL SURG, V16, P867; Thomas JA, 2012, J INTERN MED, V272, P85, DOI 10.1111/j.1365-2796.2011.02504.x; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Yadav SS, 2018, UROL ONCOL-SEMIN ORI, V36, P349, DOI 10.1016/j.urolonc.2018.05.008	27	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244149	10.1371/journal.pone.0244149	http://dx.doi.org/10.1371/journal.pone.0244149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351846	gold, Green Published			2022-12-26	WOS:000603071400044
J	Tuot, S; Teo, AKJ; Chhoun, P; Mun, P; Prem, K; Yi, SY				Tuot, Sovannary; Teo, Alvin Kuo Jing; Chhoun, Pheak; Mun, Phalkun; Prem, Kiesha; Yi, Siyan			Risk factors of HIV infection among female entertainment workers in Cambodia: Findings of a national survey	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SEX WORKERS; PHNOM-PENH; STIMULANT USE; BEHAVIORS	Background Cambodia has been well recognized for its success in the fight against the HIV epidemic. However, challenges remain in eliminating HIV infections in key populations, including women working in entertainment establishments, such as massage parlors, karaoke bars, or beer gardens. This study explored the prevalence of HIV and identified factors associated with HIV infection among female entertainment workers (FEWs) in Cambodia. Methods This national biological and behavioral survey was conducted in 2016 in Phnom Penh and 17 provinces. We used a two-stage cluster sampling method to recruit FEWs for HIV testing performed on-site and face-to-face interviews using a structured questionnaire. We investigated factors associated with HIV infection using multiple logistic regression. Results This study included 3149 FEWs with a mean age of 26.2 years (SD 5.7). The adjusted prevalence of HIV was 3.2% (95% CI 1.76-5.75). In the multiple logistic regression model, the odds of HIV infection were significantly higher among FEWs in the age group of 31 to 35 (AOR 2.72, 95% CI 1.36-8.25) and 36 or older (AOR 3.62, 95% CI 1.89-10.55); FEWs who were not married but living with a sexual partner (AOR 3.00, 95% CI 1.16-7.79); FEWs who had at least ten years of formal education (AOR 0.32, 95% CI 0.17-0.83); FEWs who reported having abnormal vaginal discharge (AOR 3.51, 95% CI 1.12-9.01), genital ulcers or sores (AOR 2.06, 95% CI 1.09-3.17), and genital warts (AOR 2.89, 95% CI 1.44-6.33) in the past three months; and FEWs who reported using illicit drugs (AOR 3.28, 95% CI 1.20-4.27) than their respective reference group. The odds of HIV infection were significantly lower among FEWs working in karaoke bars (AOR 0.26, 95% CI 0.14-0.50) and beer gardens (AOR 0.17, 95% CI 0.09-0.54) than among freelance FEWs. Conclusions The prevalence of HIV among FEWs in Cambodia remains much higher than that in the general population. These findings indicate that differentiated strategies to address HIV and other sexually transmitted infections should be geared towards FEWs working as freelancers or in veiled entertainment venues such as massage parlors and freelance sex workers. Prevention efforts among venue-based FEWs should be sustained.	[Tuot, Sovannary; Chhoun, Pheak; Yi, Siyan] KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia; [Teo, Alvin Kuo Jing; Prem, Kiesha; Yi, Siyan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Teo, Alvin Kuo Jing; Prem, Kiesha; Yi, Siyan] Natl Univ Hlth Syst, Singapore, Singapore; [Mun, Phalkun] Natl Ctr HIV AIDS Dermatol & STD, Phnom Penh, Cambodia; [Prem, Kiesha] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England; [Yi, Siyan] Touro Univ Calif, Ctr Global Hlth Res, Vallejo, CA 94592 USA	National University of Singapore; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; Touro University California	Yi, SY (corresponding author), KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia.; Yi, SY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Yi, SY (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.; Yi, SY (corresponding author), Touro Univ Calif, Ctr Global Hlth Res, Vallejo, CA 94592 USA.	ephsyi@nus.edu.sg	Chhoun, Pheak/AAR-3361-2021; Teo, Alvin/AAH-4516-2020	Chhoun, Pheak/0000-0001-6369-0190; Teo, Alvin/0000-0002-0569-3518	Global Fund to Fight AIDS, Tuberculosis, and Malaria through the National Center for HIV/AIDS, Dermatology, and STD; GF-New Funding Model grant (GF-NFM)	Global Fund to Fight AIDS, Tuberculosis, and Malaria through the National Center for HIV/AIDS, Dermatology, and STD; GF-New Funding Model grant (GF-NFM)	This study was funded by the Global Fund to Fight AIDS, Tuberculosis, and Malaria through the National Center for HIV/AIDS, Dermatology, and STD. The funding was part of the GF-New Funding Model grant (GF-NFM 2015-2017). KHANA Center for Population Health Research provided technical support to the study design, data collection, data analyses, and report writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received a salary from the funder.	[Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2016, J IMMUNOTHERAPY CA S, V4, P91; [Anonymous], 2014, JURNAL ILMIAH PEURAD, V2, P211; [Anonymous], 2017, B DE LIAISON, V17, P20; Bell BA, 2012, AM J PUBLIC HEALTH, V102, P1399, DOI 10.2105/AJPH.2011.300398; Brody C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2814-6; Couture MC, 2012, DRUG ALCOHOL DEPEN, V120, P119, DOI 10.1016/j.drugalcdep.2011.07.005; Couture MC, 2011, SEX TRANSM DIS, V38, P33, DOI 10.1097/OLQ.0b013e3182000e47; Dean AG, OPENEPI OPEN SOURCE; Kim AA, 2005, SEX TRANSM DIS, V32, P745, DOI 10.1097/01.olq.0000175384.44106.be; Maher L, 2011, INT J DRUG POLICY, V22, P203, DOI 10.1016/j.drugpo.2011.01.003; Maher L, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-30; Ministry of Health, 2012, STAND OP PROC HIV TE; Ministry of Justice, 2011, LAW SUPPR HUM TRAFF; Moret JED, 2016, DRUG ALCOHOL DEPEN, V161, P171, DOI 10.1016/j.drugalcdep.2016.01.028; Mun P, 2016, NATL HIV SENTINEL SU; National Center for HIV/AIDS, 2013, ANN REP 2012; National Center for HIV/AIDS Dermatology and STD, 2014, ANN REP 2013; National Center for HIV/AIDS Dermatology and STD, 2016, ANN REP 2015; National Center for HIV/AIDS Dermatology and STD., 2011, DERM STD EST HIV PRE; National Center for HIV/AIDS Dermatology and STD (NCHADS), 2013, BEH SENT SURV BSS 20; Needle R, 2008, SOC SCI MED, V67, P1447, DOI 10.1016/j.socscimed.2008.06.031; Parcesepe AM, 2016, SEX TRANSM INFECT, V92, P593, DOI 10.1136/sextrans-2016-052549; Remple VP, 2007, SEX TRANSM DIS, V34, P754, DOI 10.1097/01.olq.0000261327.78674.cb; Sopheab H, 2003, SEX TRANSM INFECT, V79, DOI 10.1136/sti.79.4.e2; Sopheab H, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0075-y; UNAIDS and World Health Organization, 2010, GUID EST SIZ POP MOS; Vun MC, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18905; World Bank Group, 2016, NEW COUNTR CLASS INC; Yi SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198095; Yi SY, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0122-6; Yi SY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007947; Yi SY, 2015, BMC INFECT DIS, V15, DOI [10.1186/s12879-015-0954-4, 10.1186/s12889-015-2096-4]	33	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244357	10.1371/journal.pone.0244357	http://dx.doi.org/10.1371/journal.pone.0244357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347494	gold, Green Published			2022-12-26	WOS:000603071100002
J	Werner, A; Molling, P; Fagerstrom, A; Dyrkell, F; Arnellos, D; Johansson, K; Sundqvist, M; Noren, T				Werner, Anders; Molling, Paula; Fagerstrom, Anna; Dyrkell, Fredrik; Arnellos, Dimitrios; Johansson, Karin; Sundqvist, Martin; Noren, Torbjorn			Whole genome sequencing of Clostridioides difficile PCR ribotype 046 suggests transmission between pigs and humans	PLOS ONE			English	Article							INFECTION; EVOLUTION; BURDEN	Background A zoonotic association has been suggested for several PCR ribotypes (RTs) of Clostridioides difficile. In central parts of Sweden, RT046 was found dominant in neonatal pigs at the same time as a RT046 hospital C. difficile infection (CDI) outbreak occurred in the southern parts of the country. Objective To detect possible transmission of RT046 between pig farms and human CDI cases in Sweden and investigate the diversity of RT046 in the pig population using whole genome sequencing (WGS). Methods WGS was performed on 47 C. difficile isolates from pigs (n = 22), the farm environment (n = 7) and human cases of CDI (n = 18). Two different core genome multilocus sequencing typing (cgMLST) schemes were used together with a single nucleotide polymorphisms (SNP) analysis and the results were related to time and location of isolation of the isolates. Results The pig isolates were closely related (<= 6 cgMLST alleles differing in both cgMLST schemes) and conserved over time and were clearly separated from isolates from the human hospital outbreak (>= 76 and >= 90 cgMLST alleles differing in the two cgMLST schemes). However, two human isolates were closely related to the pig isolates, suggesting possible transmission. The SNP analysis was not more discriminate than cgMLST. Conclusion No general pattern suggesting zoonotic transmission was apparent between pigs and humans, although contrasting results from two isolates still make transmission possible. Our results support the need for high resolution WGS typing when investigating hospital and environmental transmission of C. difficile.	[Werner, Anders] Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Region Vastra G, Sweden; [Molling, Paula; Fagerstrom, Anna; Johansson, Karin; Sundqvist, Martin; Noren, Torbjorn] Orebro Univ, Fac Med & Hlth, Natl Reference Lab Clostridioides Difficile, Dept Lab Med,Clin Microbiol, Orebro, Sweden; [Dyrkell, Fredrik; Arnellos, Dimitrios] 1928 Diagnost, Gothenburg, Sweden	Sahlgrenska University Hospital; Orebro University	Werner, A (corresponding author), Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Region Vastra G, Sweden.	anders.e.werner@gmail.com			Research Committee of Region Orebro County [OLL-674241]	Research Committee of Region Orebro County	K.J., P.M., T.N. and M.S. has received funding for this study from the Research Committee of Region Orebro County (grant OLL-674241). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. D.A. and F.D. employees of 1928 Diagnostics. 1928 Diagnostics provided support in the form of salaries for D.A. and F.D. and made the analysis available for free, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balsells E, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010407; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bletz S, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01987-17, 10.1128/jcm.01987-17]; Cairns MD, 2017, J CLIN MICROBIOL, V55, P865, DOI 10.1128/JCM.01296-16; de Been M, 2015, J CLIN MICROBIOL, V53, P3788, DOI 10.1128/JCM.01946-15; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Dominguez SR, 2016, J PEDIAT INF DIS SOC, V5, P329, DOI 10.1093/jpids/piv020; Eyre DW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01037-19; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Garrison E, 2012, HAPLOTYPE BASED VARI; Knetsch CW, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01384-17; Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954; Knetsch CW, 2013, EUROSURVEILLANCE, V18, P57; Knight DR, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02138; Knight DR, 2015, CLIN MICROBIOL REV, V28, P721, DOI 10.1128/CMR.00127-14; Koene MGJ, 2012, CLIN MICROBIOL INFEC, V18, P778, DOI 10.1111/j.1469-0691.2011.03651.x; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linkevicius M, 2019, EUROSURVEILLANCE, V24, P7, DOI 10.2807/1560-7917.ES.2019.24.49.1900681; Munoz M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47688-2; Noren T, 2014, CLIN MICROBIOL INFEC, V20, pO2, DOI 10.1111/1469-0691.12296; Obuch-Woszczatynski P, 2013, EUR J CLIN MICROBIOL, V32, P1027, DOI 10.1007/s10096-013-1845-5; Pearce ME, 2018, INT J FOOD MICROBIOL, V274, P1, DOI 10.1016/j.ijfoodmicro.2018.02.023; Plaza-Garrido A, 2016, EPIDEMIOL INFECT, V144, P976, DOI 10.1017/S0950268815002459; Rizzardi K, 2018, EMERG INFECT DIS, V24, P1617, DOI 10.3201/eid2409.171658; Schurch AC, 2018, CLIN MICROBIOL INFEC, V24, P350, DOI 10.1016/j.cmi.2017.12.016; Tian TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151964; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Yaeger M, 2002, J VET DIAGN INVEST, V14, P281, DOI 10.1177/104063870201400402; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244227	10.1371/journal.pone.0244227	http://dx.doi.org/10.1371/journal.pone.0244227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347506	Green Published, gold			2022-12-26	WOS:000603071100046
J	Duorui, N; Shi, B; Zhang, T; Chen, CY; Fang, CK; Yue, ZJ; Wu, P; Wu, ZM; Huang, XW; Li, M				Duorui, Nie; Shi, Bin; Zhang, Tao; Chen, Chuyao; Fang, Chongkai; Yue, Zhijun; Wu, Peng; Wu, Zhiming; Huang, Xuewu; Li, Meng			The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study	PLOS ONE			English	Article							MARITAL-STATUS; INSTITUTIONAL SERIES; SURVIVAL; CANCER; OUTCOMES; PATIENT	Background Primary acinar cell carcinoma (ACC) is a rare exocrine tumor of the pancreas with unclear clinical characteristics. Our goal was to determine the incidence and update the clinical characteristics and outcomes of ACC. Methods Through the Surveillance, Epidemiology, and End Results (SEER) database, we identified 252 patients with the latest diagnosis of ACC (2004-2016). The age-adjusted incidence (AAI) was calculated using the SEER*Stat Software version 8.3.6. The Kaplan-Meier method was used to draw survival curves and differences among them were compared by the log-rank test. Cox proportional hazards models were used to evaluate factors that had independent predictive effects on the overall survival. Results The AAI of pancreatic ACC was on the rise with the mean age at diagnosis of 63.79 +/- 14.79 years. Most patients (15.9%) had poorer differentiated tumors. The patients presented with distant stage were 54.4% compared with 53.1% between 1988 and 2003. The 1-, 2-, and 5-years survival rates for pancreatic ACC patients were 53.5%, 34.6%,17.5%, respectively (compared with 78.5%, 67.0%, and 42.8%, between 1988 and 2003). The multivariate COX analysis showed that the patient's age, surgery, chemotherapy, and summary stage, but not marital status were independent prognosis factors for ACC. Conclusions Pancreatic ACC is a highly malignant tumor with an increasing incidence in recent years. The rate of distant metastasis is increasing and the survival rate is worse than in the past, suggesting that it may require more aggressive treatment and follow-up. Surgery, radiotherapy, and chemotherapy are all effective treatments, but prospective studies are still needed to verify them.	[Duorui, Nie; Shi, Bin; Zhang, Tao; Chen, Chuyao; Fang, Chongkai; Yue, Zhijun; Wu, Peng; Wu, Zhiming] Guangzhou Univ Chinese Med, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China; [Huang, Xuewu] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Li, Meng] Guangzhou Univ Chinese Med, Shenzhen Hosp Futian, Dept Oncol, Shenzhen, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Huang, XW (corresponding author), Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Ctr Canc, Guangzhou, Guangdong, Peoples R China.; Li, M (corresponding author), Guangzhou Univ Chinese Med, Shenzhen Hosp Futian, Dept Oncol, Shenzhen, Guangdong, Peoples R China.	drhuangxw@163.com; lemondxx@outlook.com	Nie, Duorui/CAH-8713-2022; fang, chongkai/GLV-2993-2022; Nie, Duorui/CAF-2721-2022	fang, chongkai/0000-0001-8319-5189; Nie, Duorui/0000-0003-3412-1196				Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Al-Hader A, 2017, WORLD J GASTROENTERO, V23, P7945, DOI 10.3748/wjg.v23.i45.7945; Baine M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021052; Brunetti O, 2018, PANCREAS, V47, P759, DOI 10.1097/MPA.0000000000001063; Butturini G, 2011, LANGENBECK ARCH SURG, V396, P363, DOI 10.1007/s00423-010-0706-2; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2003, CAN J DIABETES S2, V27, pS37; Du LJ, 2017, ONCOTARGET, V8, P95965, DOI 10.18632/oncotarget.21609; Egal A, 2019, PANCREAS, V48, P1393, DOI 10.1097/MPA.0000000000001440; Fang W, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02308-w; Furukawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08829; Glazer ES, 2016, CANCER CONTROL, V23, P446, DOI 10.1177/107327481602300417; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; He CB, 2018, J CANCER, V9, P4117, DOI 10.7150/jca.26936; Holen KD, 2002, J CLIN ONCOL, V20, P4673, DOI 10.1200/JCO.2002.02.005; Jauch SF, 2016, PANCREATOLOGY, V16, P153, DOI 10.1016/j.pan.2015.09.006; Jin JJ, 2016, CANCER MED-US, V5, P1821, DOI 10.1002/cam4.758; Kryklyva V, 2019, CANCER BIOL THER, V20, P949, DOI 10.1080/15384047.2019.1595274; Landa K, 2019, HPB, V21, P687, DOI 10.1016/j.hpb.2018.10.014; Lowery MA, 2011, ONCOLOGIST, V16, P1714, DOI 10.1634/theoncologist.2011-0231; Mohammed S, 2017, Mymensingh Med J, V26, P684; Schmidt CM, 2008, J GASTROINTEST SURG, V12, P2078, DOI 10.1007/s11605-008-0705-6; Seo S, 2017, J DIGEST DIS, V18, P480, DOI 10.1111/1751-2980.12505; Seth AK, 2008, J GASTROINTEST SURG, V12, P1061, DOI 10.1007/s11605-007-0338-1; Thompson ED, 2019, ARCH PATHOL LAB MED, DOI 10.5858/arpa.2019-0472-RA; Toll AD, 2013, KOREAN J PATHOL, V47, P93, DOI 10.4132/KoreanJPathol.2013.47.2.93; Virlos I T, 2002, HPB (Oxford), V4, P87, DOI 10.1080/136518202760378452; Wasif N, 2010, ANN SURG ONCOL, V17, P2312, DOI 10.1245/s10434-010-1071-7; Wisnoski NC, 2008, SURGERY, V144, P141, DOI 10.1016/j.surg.2008.03.006; Yoo C, 2017, CANCER RES TREAT, V49, P759, DOI 10.4143/crt.2016.371; Yoshihiro T, 2017, MOL CLIN ONCOL, V6, P866, DOI 10.3892/mco.2017.1240; Zhang SL, 2019, CANCER MED-US, V8, P465, DOI 10.1002/cam4.1802; Zhang XM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5008-z; Zhou HQ, 2017, CLIN RES HEPATOL GAS, V41, P476, DOI 10.1016/j.clinre.2017.02.008	33	6	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243164	10.1371/journal.pone.0243164	http://dx.doi.org/10.1371/journal.pone.0243164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332471	Green Published, gold			2022-12-26	WOS:000601310900096
J	Kardos, J; Rose, TL; Manocha, U; Wobker, SE; Damrauer, JS; Bivalaqua, TJ; Kates, M; Moore, KJ; Parker, JS; Kim, WY				Kardos, Jordan; Rose, Tracy L.; Manocha, Ujjawal; Wobker, Sara E.; Damrauer, Jeffrey S.; Bivalaqua, Trinity J.; Kates, Max; Moore, Kristin J.; Parker, Joel S.; Kim, William Y.			Development and validation of a NanoString BASE47 bladder cancer gene classifier	PLOS ONE			English	Article							SUBTYPES; SURVIVAL	Background Recent molecular characterization of urothelial cancer (UC) has suggested potential pathways in which to direct treatment, leading to a host of targeted therapies in development for UC. In parallel, gene expression profiling has demonstrated that high-grade UC is a heterogeneous disease. Prognostic basal-like and luminal-like subtypes have been identified and an accurate transcriptome BASE47 classifier has been developed. However, these phenotypes cannot be broadly investigated due to the lack of a clinically viable diagnostic assay. We sought to develop and evaluate a diagnostic classifier of UC subtype with the goal of accurate classification from clinically available specimens. Methods Tumor samples from 52 patients with high-grade UC were profiled for BASE47 genes concurrently by RNAseq as well as NanoString. After design and technical validation of a BASE47 NanoString probeset, results from the RNAseq and NanoString were used to translate diagnostic criteria to the Nanostring platform. Evaluation of repeatability and accuracy was performed to derive a final Nanostring based classifier. Diagnostic classification resulting from the NanoString BASE47 classifier was validated on an independent dataset (n = 30). The training and validation datasets accurately classified 87% and 93% of samples, respectively. Results Here we have derived a NanoString-platform BASE47 classifier that accurately predicts basal-like and luminal-like subtypes in high grade urothelial cancer. We have further validated our new NanoString BASE47 classifier on an independent dataset and confirmed high accuracy when compared with our original Transcriptome BASE47 classifier. Conclusions The NanoString BASE47 classifier provides a faster turnaround time, a lower cost per sample to process, and maintains the accuracy of the original subtype classifier for better clinical implementation.	[Kardos, Jordan; Rose, Tracy L.; Manocha, Ujjawal; Wobker, Sara E.; Damrauer, Jeffrey S.; Parker, Joel S.; Kim, William Y.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Rose, Tracy L.; Kim, William Y.] Univ North Carolina Chapel Hill, Div Oncol, Dept Med, Chapel Hill, NC 27515 USA; [Rose, Tracy L.; Kim, William Y.] Univ North Carolina Chapel Hill, Dept Urol, Chapel Hill, NC 27515 USA; [Wobker, Sara E.] Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Bivalaqua, Trinity J.; Kates, Max] Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Moore, Kristin J.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Kardos, Jordan] Gilead Sci, Foster City, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Gilead Sciences	Parker, JS; Kim, WY (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Kim, WY (corresponding author), Univ North Carolina Chapel Hill, Div Oncol, Dept Med, Chapel Hill, NC 27515 USA.; Kim, WY (corresponding author), Univ North Carolina Chapel Hill, Dept Urol, Chapel Hill, NC 27515 USA.	wykim@med.unc.edu; parkerjs@email.unc.edu	, Pathology Services Core/CEZ-2246-2022	Rose, Tracy/0000-0003-1411-2487	University Cancer Research Fund (UCRF); American Cancer Society [RSG-14-219-01-TBG]; National Cancer Institute at the National Institutes of Health K08 Mentored Clinical Scientist Research Career Development Award [1K08CA248967-01]; Doris Duke Charitable Foundation [2015213]; NCI [P30-CA016086, R01-CA241810]	University Cancer Research Fund (UCRF); American Cancer Society(American Cancer Society); National Cancer Institute at the National Institutes of Health K08 Mentored Clinical Scientist Research Career Development Award; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University Cancer Research Fund (UCRF) [WYK and JSP], the NCI P30-CA016086 (JSP), the American Cancer Society grant RSG-14-219-01TBG [WYK]. TLR is supported by the National Cancer Institute at the National Institutes of Health K08 Mentored Clinical Scientist Research Career Development Award (1K08CA248967-01) and Grant 2015213 from the Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the entire Kim Lab for their continued help throughout the project. This work was supported by the University Cancer Research Fund (UCRF) [WYK and JSP], the NCI P30-CA016086 (JSP), R01-CA241810 (WYK), the American Cancer Society grant RSG-14-219-01-TBG [WYK]. TLR is supported by the National Cancer Institute at the National Institutes of Health K08 Mentored Clinical Scientist Research Career Development Award (1K08CA248967-01) and Grant 2015213 from the Doris Duke Charitable Foundation. JK is an employee of Gilead Sciences, although the work done within this study was completed while he was a student at University of North Carolina and Gilead Sciences had no role in funding, study design, data collection and analysis, decision to publish, or preparation of the manuscript. The above funders also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guo CC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66747-7; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Kamoun A, 2020, EUR UROL, V77, P420, DOI 10.1016/j.eururo.2019.09.006; Kardos J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85902; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Seiler Roland, 2017, Eur Urol, V72, P544, DOI 10.1016/j.eururo.2017.03.030; Sharma P, 2017, LANCET ONCOL, V18, P312, DOI 10.1016/S1470-2045(17)30065-7; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622	18	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243935	10.1371/journal.pone.0243935	http://dx.doi.org/10.1371/journal.pone.0243935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332422	Green Published, gold			2022-12-26	WOS:000601310900015
J	Yu, B; Liu, ZY; Zhang, CY; Wu, Y; Han, JS; Li, HJ; Xu, B; Guo, HY; Zhang, K				Yu, Bo; Liu, Zhongyu; Zhang, Chunyu; Wu, Yu; Han, Jinsong; Li, Huajun; Xu, Bing; Guo, Hongyan; Zhang, Kun			Allogeneic uterus transplantation in a rhesus model: A short-term graft viability study	PLOS ONE			English	Article							UTERINE TRANSPLANTATION; PREGNANCY; PRIMATES	Objective This study examined the feasibility and safety of allogeneic uterus transplantation (UTx) from a living donor and assessed short-term graft viability in a rhesus model. This research is an important step towards further clinical application of UTx in humans. Materials and methods Four female rhesus monkeys with regular menstrual cycles were used in this study, the animals were either donors or recipients depending on ABO blood type compatibility. Retrieval surgery was performed to connect the uterus and uterine arteries together with the ovarian uterine vein from the living donor, and the vagina of the recipient was excised. After the back table had been prepared, bilateral uterine arteries were anastomosed end-to-side with the iliac externa arteries, and bilateral ovarian uterine veins were anastomosed end-to-side with the iliac externa vena. The transplanted uterus was evaluated based on the conditions of arterial blood, and flow was evaluated by transabdominal ultrasonography one month post operation. The conditions of the transplanted uterus were examined by secondary laparotomy. The reproductive function of rhesus monkeys was evaluated on the basis of the menstrual cycle. Results All 4 rhesus monkeys received the transplantation surgery without any surgical complications. No injury occurred in the other organs, and no vascular injury was observed in the allogeneic uterus. All recipients survived after the surgery with a 100% short-term survival rate. All recipients resumed normal menstruation within two months after surgery. Conclusions Our short follow-up shows that allogeneic UTx surgery is a safe and feasible technology in the rhesus model. The arterial conditions and blood flow of the grafted uterus can be monitored by ultrasonography examination.	[Yu, Bo; Liu, Zhongyu; Zhang, Chunyu; Wu, Yu; Han, Jinsong; Li, Huajun; Xu, Bing; Guo, Hongyan; Zhang, Kun] Peking Univ Third Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China		Guo, HY; Zhang, K (corresponding author), Peking Univ Third Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China.	bysyghy@163.com; bysyzk@163.com	Zhang, Chun-yu/HDP-5776-2022		Peking University Third hospital	Peking University Third hospital	This study is supported by Peking University Third hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Fertil Steril, V81 Suppl 4, pS9; [Anonymous], 2013, FERTIL STERIL, V100, pS51; Brannstrom M, 2019, FERTIL STERIL, V112, P3, DOI 10.1016/j.fertnstert.2019.05.030; Brannstrom M, 2018, FERTIL STERIL, V109, P256, DOI 10.1016/j.fertnstert.2017.12.007; Brannstrom M, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5872-0; Brannstrom M, 2014, FERTIL STERIL, V101, P1228, DOI 10.1016/j.fertnstert.2014.02.024; Brinsden PR, 2003, HUM REPROD UPDATE, V9, P483, DOI 10.1093/humupd/dmg033; Chmel R, 2019, AM J TRANSPLANT, V19, P855, DOI 10.1111/ajt.15096; Diaz-Garcia C, 2014, FERTIL STERIL, V102, P1545, DOI 10.1016/j.fertnstert.2014.09.010; Ejzenberg D, 2018, LANCET, V392, P2697, DOI 10.1016/S0140-6736(18)31766-5; El-Akouri RR, 2003, HUM REPROD, V18, P2018, DOI 10.1093/humrep/deg396; Hanafy A, 2011, AUST NZ J OBSTET GYN, V51, P199, DOI 10.1111/j.1479-828X.2010.01283.x; Jones BP, 2019, BJOG-INT J OBSTET GY, V126, P1310, DOI 10.1111/1471-0528.15863; Jones BP, 2016, BJOG-INT J OBSTET GY, V123, P1434, DOI 10.1111/1471-0528.13963; Kisu I, 2018, BJOG-INT J OBSTET GY, V125, P1352, DOI 10.1111/1471-0528.15230; Kisu I, 2013, FERTIL STERIL, V100, P280, DOI 10.1016/j.fertnstert.2013.03.004; Perez-Aytes A, 2017, EUR J MED GENET, V60, P16, DOI 10.1016/j.ejmg.2016.09.014; Puntambekar S, 2019, J MINIM INVAS GYN, V26, P628, DOI 10.1016/j.jmig.2018.11.021; Puntambekar S, 2018, J MINIM INVAS GYN, V25, P622, DOI 10.1016/j.jmig.2018.01.009; Ramirez ER, 2011, J MINIM INVAS GYN, V18, P238, DOI 10.1016/j.jmig.2010.11.006; Semba Y, 2010, BIOETHICS, V24, P348, DOI 10.1111/j.1467-8519.2009.01780.x; Testa G, 2017, AM J TRANSPLANT, V17, P2901, DOI 10.1111/ajt.14326; Tocci LJ, 2009, J VET EMERG CRIT CAR, V19, P66, DOI 10.1111/j.1476-4431.2009.00387.x; Tzakis AG, 2013, FERTIL STERIL, V100, P61, DOI 10.1016/j.fertnstert.2013.03.041; Westhoff CM, 2019, BLOOD, V133, P1814, DOI 10.1182/blood-2018-11-833954	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243140	10.1371/journal.pone.0243140	http://dx.doi.org/10.1371/journal.pone.0243140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332374	Green Published, gold			2022-12-26	WOS:000601310900008
J	Zhang, Y; Zhao, MC; Cheng, J; Liu, S; Yuan, HB				Zhang, Ying; Zhao, Min-chi; Cheng, Jia; Liu, Shuo; Yuan, Hai-bin			Population dynamics and species composition of maize field parasitoids attacking aphids in northeastern China	PLOS ONE			English	Article								Maize, Zea mays L., is the most abundant field crop in China. Aphids are the most economically damaging pest on maize, particularly in the maize agri-ecosystems of Jilin Province, northeastern China. Parasitic wasps are important natural enemies of aphids, but limited information exists about their species composition, richness and seasonal dynamics in northeastern China. In this study, the population dynamics of maize aphids and parasitoid wasps were assessed in relation to each other during the summer seasons of two consecutive years, 2018 and 2019. We selected maize fields in the Changchun, Songyuan, Huinan and Gongzhuling areas of Jilin Province. Four species of aphids were recorded from these maize fields: Rhopalosiphum padi (L), Rhopalosiphum maidis (Fitch), Aphis gossypii Glover and Macrosiphum miscanthi (Takahashi). The dominant species in each of the four areas were R. maids (Filch) and R. padi in Changchun, R. padi in Songyuan, A. gossypii and R. padi in Huinan, and A.gossypii and R. padi in Gongzhuling. We delineated a species complex made up of primary parasitoids and hyperparasitoids associated with maize aphids. The primary parasitoids Lysiphlebus testaceipes, Binodoxys communis and Aphelinus albipodus together formed approximately 85.3% of the parasitoid complex. Pachyneuron aphidis, Phaenoglyphis villosa, Syrphophagus taeniatus and Asaphes suspensus made up the hyperparasitoids. Of the primary parasitoids, L. testaceipes was the dominant species (81.31%). Of the hyperparasitoid group, P. villosa was the dominant species (68.42%). Parasitism rates followed the fluctuation of the aphid population. The highest parasitic rate was observed during the peak period of cotton aphids. In this paper, the occurrence dynamics and dominant species of aphids and the dynamics of parasitic natural enemies of aphids in maize fields in Jilin Province are, for the first time, systematically reported. This study provides important information for the establishment and promotion of aphid biological control in maize fields.	[Zhang, Ying; Zhao, Min-chi; Cheng, Jia; Liu, Shuo; Yuan, Hai-bin] Jilin Agr Univ, Dept Plant Protect, Changchun, Peoples R China	Jilin Agricultural University	Yuan, HB (corresponding author), Jilin Agr Univ, Dept Plant Protect, Changchun, Peoples R China.	yhb-74@163.com			National Science and Technology major project of China [2019ZX08012004-009]; National Key Research and Development Program of China [2017YFD0300606]	National Science and Technology major project of China; National Key Research and Development Program of China	This research was funded by the The National Science and Technology major project of China (Grant No.2019ZX08012004-009), and the National Key Research and Development Program of China (Grant No.2017YFD0300606).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid A, 2018, KEY APHID NATURAL EN, V266, P1; Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24273; Alichi M., 2008, Journal of Science and Technology of Agriculture and Natural Resources, V12, P287; [Anonymous], 2012, THESIS; [Anonymous], 2003, GUYANA MUSLIM J, V6, P10; Ansell-Pearson Keith., 1991, NIETZSCHE STUDIEN, V20, P267, DOI DOI 10.1515/9783110244397; ARCHER TL, 1974, ANN ENTOMOL SOC AM, V67, P11, DOI 10.1093/aesa/67.1.11; Asin L, 2001, ENVIRON ENTOMOL, V30, P1127, DOI 10.1603/0046-225X-30.6.1127; BING JW, 1991, J ECON ENTOMOL, V84, P625, DOI 10.1093/jee/84.2.625; Blum B, 2003, BIOCONTROL, V48, P477; Chen CY, 2009, SYMBIOSIS, V49, P53, DOI 10.1007/s13199-009-0011-4; Ding Wei, 2003, Yingyong Shengtai Xuebao, V14, P1481; El-Muadhidi M. A., 2001, Phytopathologia Mediterranea, V40, P224; Gagic V, 2012, OECOLOGIA, V170, P1099, DOI 10.1007/s00442-012-2366-0; Han BY, 2000, ACTA ENTOMOL SINICA, V1, P143; Hopkinson J, 2010, COTTON, V130, P325; Huang W L, 1997, B AGR SCI TECHNOLOGY, V7, P31; Judenko E, 1973, ANAL METHOD ASSESSIN, P24; Kamenova S, 2018, MOL ECOLOGY RESOURCE; Klimenta D, 2018, IET GENER TRANSM DIS, V12, P2968, DOI 10.1049/iet-gtd.2017.1298; Kraaijeveld D, 2006, VIDA RURAL; Li HP, 2018, HEILONGJIANG AGR SCI, V285, P49; Patil V. P., 2012, POPULATION DYNAMICS, V7, P107; PONS JM, 1994, ETHOL ECOL EVOL, V6, P1, DOI 10.1080/08927014.1994.9523003; Pons X, 2011, J PEST SCI, V84, P437, DOI 10.1007/s10340-011-0383-0; Rusk R, 2010, MANAGEMENT CORN APHI; Sahaza JH, 2014, COMP IMMUNOL MICROB, V37, P143, DOI 10.1016/j.cimid.2014.03.002; Shelby T., 2012, LAW ETHICS HUMAN RIG, V6, P70, DOI [DOI 10.1515/1938-2545.1068, https://doi.org/10.1515/1938-2545.1068]; Shiyomi M., 1964, RES POPUL ECOL, V6, P79; Sigsgaard L, 2010, J APPL ENTOMOL, V126, P101; Stary DP, 2010, J APPL ENTOMOL, V105, P74; [王永宏 Wang Yonghong], 2002, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V30, P55; Watson R.T., 2000, IMPL DIFF DEF GEN IS, P375; Yan Zhimiao, 2011, THESIS; Yang F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10345-7; Yang J., 2013, THESIS; ZHANG YS, 2009, CHINA TROP AGR, V4, P15; Zhu T, 2019, WATER RESOUR RES, V55, P28; Zou Yunding, 2005, Yingyong Shengtai Xuebao, V16, P631	39	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0241530	10.1371/journal.pone.0241530	http://dx.doi.org/10.1371/journal.pone.0241530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332420	Green Published, gold			2022-12-26	WOS:000601310900030
J	Ma, Y; Song, Z; Li, SQ; Jiang, TY				Ma, Yan; Song, Zhe; Li, Shuangqi; Jiang, Tangyang			Dynamic evolution analysis of the factors driving the growth of energy-related CO2 emissions in China: An input-output analysis	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; RENEWABLE ENERGY; ECONOMIC-GROWTH; DECOMPOSITION ANALYSIS; NONRENEWABLE ENERGY; CONSUMPTION STRUCTURE; REDUCTION; PANEL; COUNTRIES; INDUSTRY	In recent years, the global greenhouse effect caused by excessive energy-related carbon emissions has attracted more and more attention. In this paper, we studied the dynamic evolution of factors driving China's energy-related CO2 emissions growth from 2007 to 2015 by using energy consumption method and input-output analysis and used the IO-SDA model to decompose the energy carbon emissions. Within the research interval, the results showed that (1) on the energy supply-side, the high carbon energy represented by raw coal was still the main factor to promote the growth of energy-related CO2 emissions. However, the optimization of energy consumption structure is conducive to reducing emissions. Specifically, the high carbon energy represented by raw coal exhibited a downward trend in promoting the increment of energy-related CO2 emissions, while the clean energy represented by natural gas showed an upward trend in promoting the increment of CO2 emissions. It is worth noting that there is still a lot of room for optimization of China's energy consumption structure to reduce emissions. (2) On the energy demand-side, the final demand effect is the main driving force of the growth of carbon emissions from fossil energy. Among them, the secondary industry plays a major role in the final demand effect. The "high carbonization" of the final product reflects the characteristics of China's high energy input in the process of industrialization. At the same time, since the carbon emission efficiency of the tertiary industry and the primary industry is better than that of the secondary industry, actively optimizing the industrial structure is conducive to slowing down the growth of carbon emission brought by the demand effect. (3) The input structure effect is the main restraining factor for the growth of energy carbon emissions, while the energy intensity effect has a slight driving effect on the growth of energy carbon emissions. The results show that China's "extensive" economic growth model has been effectively reversed, but the optimization of fossil energy utilization efficiency is still not obvious, and there is still a large space to curb carbon emissions by improving fossil energy utilization efficiency in the future.	[Ma, Yan; Li, Shuangqi; Jiang, Tangyang] Zhongnan Univ Econ & Law, Postdoctoral Res Stn Appl Econ, Wuhan, Peoples R China; [Ma, Yan] Zhongnan Univ Econ & Law, Sch Business Adm, Wuhan, Peoples R China; [Song, Zhe] Chongqing Univ, Sch Econ & Business Adm, Chongqing, Peoples R China; [Li, Shuangqi] Chongqing Technol & Business Univ, Sch Accounting, Chongqing, Peoples R China; [Jiang, Tangyang] Anhui Univ, Sch Internet, Hefei, Anhui, Peoples R China	Zhongnan University of Economics & Law; Zhongnan University of Economics & Law; Chongqing University; Chongqing Technology & Business University; Anhui University	Li, SQ (corresponding author), Chongqing Technol & Business Univ, Sch Accounting, Chongqing, Peoples R China.; Jiang, TY (corresponding author), Anhui Univ, Sch Internet, Hefei, Anhui, Peoples R China.	lsqwuhan@163.com; jiang_tangyang@163.com		Li, Shuangqi/0000-0002-1705-1256	China Postdoctoral Science Foundation [2020M672459]; Fundamental Research Funds for the Central Universities of China [2722020PY056]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	The authors are grateful to the financial support provided by China Postdoctoral Science Foundation (2020M672459) and by the Fundamental Research Funds for the Central Universities of China (Grant No. 2722020PY056).	An RY, 2018, APPL ENERG, V226, P862, DOI 10.1016/j.apenergy.2018.06.044; Bilgili F, 2016, RENEW SUST ENERG REV, V54, P838, DOI 10.1016/j.rser.2015.10.080; Boontome P, 2017, ENRGY PROCED, V138, P925, DOI 10.1016/j.egypro.2017.10.141; Chen YL, 2019, RENEW ENERG, V140, P341, DOI 10.1016/j.renene.2019.03.058; Chen ZF, 2017, ENERG ECON, V68, P89, DOI 10.1016/j.eneco.2017.09.015; Dong KY, 2017, ENERGY, V141, P1466, DOI 10.1016/j.energy.2017.11.092; Du G, 2018, J CLEAN PROD, V184, P1102, DOI 10.1016/j.jclepro.2018.02.304; Du Q, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061220; Du ZL, 2018, J CLEAN PROD, V176, P1177, DOI 10.1016/j.jclepro.2017.11.178; Duan Wen-biao, 2017, Forest Research, V30, P268, DOI 10.13275/j.cnki.lykxyj.2017.02.012; Feng C, 2018, RESOUR POLICY, V59, P487, DOI 10.1016/j.resourpol.2018.09.003; Gao C., 2009, MODERN CHEM IND, V81, P337, DOI [10.2307/3547054, DOI 10.2307/3547054]; Gao ZY, 2019, J CLEAN PROD, V223, P94, DOI 10.1016/j.jclepro.2019.03.092; Henson SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14682; Jia JS, 2018, J CLEAN PROD, V183, P843, DOI 10.1016/j.jclepro.2018.02.116; Jiang TY, 2020, J CLEAN PROD, V264, DOI 10.1016/j.jclepro.2020.121507; Jiang TY, 2019, J CLEAN PROD, V240, DOI 10.1016/j.jclepro.2019.118116; Jiang XM, 2018, CLIM POLICY, V18, P889, DOI 10.1080/14693062.2017.1388211; Nguyen KH, 2019, RENEW ENERG, V132, P1049, DOI 10.1016/j.renene.2018.08.069; Ko L, 2013, ENERG POLICY, V61, P551, DOI 10.1016/j.enpol.2013.05.120; Li JL, 2018, CHINA ECON REV, V50, P17, DOI 10.1016/j.chieco.2018.03.006; LIAO M, 2017, STAT RES, V34, P62; Lin BQ, 2015, ENERG POLICY, V86, P483, DOI 10.1016/j.enpol.2015.07.030; [刘宇 Liu Yu], 2015, [中国人口·资源与环境, China Population Resources and Environment], V25, P21; Liu Z, 2015, NATURE, V524, P335, DOI 10.1038/nature14677; Long XL, 2015, RENEW SUST ENERG REV, V52, P680, DOI 10.1016/j.rser.2015.07.176; Moutinho V, 2018, RENEW SUST ENERG REV, V90, P605, DOI 10.1016/j.rser.2018.02.009; Muhammad B, 2019, ENERGY, V179, P232, DOI 10.1016/j.energy.2019.03.126; Pata UK, 2018, J CLEAN PROD, V187, P770, DOI 10.1016/j.jclepro.2018.03.236; Risinger CF., 2009, SOC EDUC, V73, P279; Shafiei S, 2014, ENERG POLICY, V66, P547, DOI 10.1016/j.enpol.2013.10.064; Sharif A, 2019, RENEW ENERG, V133, P685, DOI 10.1016/j.renene.2018.10.052; Sheinbaum C, 2011, ENERGY, V36, P3629, DOI 10.1016/j.energy.2010.07.023; Shi YR, 2012, ENRGY PROCED, V16, P121, DOI 10.1016/j.egypro.2012.01.022; Shrestha RM, 2005, ENERG POLICY, V33, P815, DOI 10.1016/j.enpol.2003.10.007; Su B, 2017, ENERG POLICY, V105, P484, DOI 10.1016/j.enpol.2017.03.027; Tang CC, 2017, ENERG POLICY, V109, P704, DOI 10.1016/j.enpol.2017.07.050; Wang CH, 2017, APPL ENERG, V194, P223, DOI 10.1016/j.apenergy.2017.02.045; Wang XW, 2015, J CLEAN PROD, V103, P705, DOI 10.1016/j.jclepro.2014.10.030; Wang ZX, 2017, J CLEAN PROD, V142, P600, DOI 10.1016/j.jclepro.2016.08.067; Xia FQ, 2020, SCI TOTAL ENVIRON, V708, DOI 10.1016/j.scitotenv.2019.134587; Xie YY, 2017, ENVIRON POLLUT, V225, P338, DOI 10.1016/j.envpol.2017.02.059; Xu SC, 2017, J CLEAN PROD, V142, P3061, DOI 10.1016/j.jclepro.2016.10.161; Xu SC, 2014, APPL ENERG, V127, P182, DOI 10.1016/j.apenergy.2014.03.093; Yang LS, 2016, RENEW SUST ENERG REV, V60, P258, DOI 10.1016/j.rser.2016.01.058; Yu SW, 2018, ENERG ECON, V74, P693, DOI 10.1016/j.eneco.2018.07.017; Zhang YJ, 2015, RENEW SUST ENERG REV, V41, P1255, DOI 10.1016/j.rser.2014.09.021; Zhao X, 2018, ENERGY STRATEG REV, V22, P303, DOI 10.1016/j.esr.2018.10.003	48	6	6	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243557	10.1371/journal.pone.0243557	http://dx.doi.org/10.1371/journal.pone.0243557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326468	Green Published, gold			2022-12-26	WOS:000600176400079
J	Murata, Y; Yoshida, M; Sakamoto, N; Morimoto, S; Watanabe, T; Namba, K				Murata, Yoshiko; Yoshida, Masami; Sakamoto, Naho; Morimoto, Shiho; Watanabe, Takehiro; Namba, Kosuke			Iron uptake mediated by the plant-derived chelator nicotianamine in the small intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2'-DEOXYMUGINEIC ACID; MUGINEIC ACID; TRANSPORTER; RICE; IDENTIFICATION; ACQUISITION; ABSORPTION; PHYTOSIDEROPHORES; BIOSYNTHESIS; ACTIVATION	Iron is an essential metal for all living organisms that is absorbed in the intestinal cells as a heme-chelated or free form. It is unclear how important plant-derived chelators, such as nicotianamine (NA), an organic small molecule that is ubiquitous in crops, vegetables, and various other foods, contribute to iron bioavailability in mammals. We performed electrophysiological assays with Xenopus laevis oocytes and radioactive tracer experiments with Caco-2 cells. The findings revealed that the proton-coupled amino acid transporter SLC36A1 (PAT1) transports iron in the form of NA-Fe (II) complex in vitro. Decreased expression of hPAT1 by RNA interference in Caco-2 cells reduced the uptake of NA-Fe-59 (II) complex. The uptake of inorganic Fe-59 (II) was relatively unaffected. These results imply that PAT1 transports iron as a NA-Fe (II) complex. The rate of Fe-59 absorption in the spleen, liver, and kidney was higher when mice were orally administered NA-Fe-59 (II) compared with free Fe-59 (II). The profile of site-specific PAT1 expression in the mouse intestine coincided with those of NA and iron contents, which were the highest in the proximal jejunum. Orally administered NA-Fe-59 (II) complex in mice was detected in the proximal jejunum by thin layer chromatography. In contrast, much less Fe-59 (or NA) was detected in the duodenum, where the divalent metal transporter SLC11A2 (DMT1) absorbs free Fe (II). The collective results revealed the role of PAT1 in NA-Fe (II) absorption in the intestine and potential implication of NA in iron uptake in mammals.	[Murata, Yoshiko; Yoshida, Masami; Sakamoto, Naho; Morimoto, Shiho; Watanabe, Takehiro] Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto, Japan; [Namba, Kosuke] Tokushima Univ, Grad Sch Pharmaceut Sci, Tokushima, Japan	Suntory Holdings Ltd; Tokushima University	Murata, Y (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto, Japan.	murata@sunbor.or.jp		Namba, Kosuke/0000-0003-1548-5656; Murata, Yoshiko/0000-0003-1891-2609	Japan Society for the Promotion of Science (JSPS) [JP25350973, JP16K01927]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (JSPS), Grants-inAid for Scientific Research (KAKENHI) Grant Nos. JP25350973 and JP16K01927 (to Y. M.).	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Anderson CMH, 2004, GASTROENTEROLOGY, V127, P1410, DOI 10.1053/j.gastro.2004.08.017; Armstrong T, 2007, PANCREATOLOGY, V7, P37, DOI 10.1159/000101876; Broberg ML, 2012, BRIT J PHARMACOL, V167, P654, DOI 10.1111/j.1476-5381.2012.02030.x; Chen Z, 2003, J PHYSIOL-LONDON, V546, P349, DOI 10.1113/jphysiol.2002.026500; Clemens S, 2014, PLANT SCI, V225, P52, DOI 10.1016/j.plantsci.2014.05.014; Conte SS, 2012, CURR TOP MEMBR, V69, P295, DOI 10.1016/B978-0-12-394390-3.00011-2; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Das P, 2016, J BIOCHEM, V160, P163, DOI 10.1093/jb/mvw023; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Eagling T, 2014, J AGR FOOD CHEM, V62, P10320, DOI 10.1021/jf5026295; Fuqua BK, 2012, J TRACE ELEM MED BIO, V26, P115, DOI 10.1016/j.jtemb.2012.03.015; Guan M, 2012, INT J NANOMED, V7, P1921, DOI 10.2147/IJN.S30034; Gunshin H, 2005, BLOOD, V106, P2879, DOI 10.1182/blood-2005-02-0716; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Harada E, 2016, FEBS LETT, V590, P4617, DOI 10.1002/1873-3468.12482; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Jeong J, 2017, CURR OPIN PLANT BIOL, V39, P106, DOI 10.1016/j.pbi.2017.06.014; Kaplan J, 2000, NATURE, V403, P711, DOI 10.1038/35001691; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Lee S, 2012, MOL CELLS, V33, P269, DOI 10.1007/s10059-012-2231-3; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038659; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Lubkowitz Mark, 2006, Genet Eng (N Y), V27, P35, DOI 10.1007/0-387-25856-6_3; MA JF, 1995, J BIOL CHEM, V270, P16549, DOI 10.1074/jbc.270.28.16549; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Metzner L, 2005, FASEB J, V19, P1468, DOI 10.1096/fj.05-3683com; Morrissey J, 2009, CHEM REV, V109, P4553, DOI 10.1021/cr900112r; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Namba K, 2007, ANGEW CHEM INT EDIT, V46, P7060, DOI 10.1002/anie.200702403; Namba K, 2010, ANGEW CHEM INT EDIT, V49, P9956, DOI 10.1002/anie.201004853; Nozoye T, 2014, BIOSCI BIOTECH BIOCH, V78, P1677, DOI 10.1080/09168451.2014.936350; Perland E, 2017, TRENDS PHARMACOL SCI, V38, P305, DOI 10.1016/j.tips.2016.11.008; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Thondorf I, 2011, BIOORGAN MED CHEM, V19, P6409, DOI 10.1016/j.bmc.2011.08.058; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Walker D, 1998, J PHYSIOL-LONDON, V507, P697, DOI 10.1111/j.1469-7793.1998.697bs.x; Wang XY, 2019, MOL THER, V27, P493, DOI 10.1016/j.ymthe.2019.01.003; Wei YY, 2012, J AGR FOOD CHEM, V60, P11433, DOI 10.1021/jf3036462; Welch RM, 2002, PLANT SOIL, V247, P83, DOI 10.1023/A:1021140122921; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Yamaguchi H, 2012, J AGR FOOD CHEM, V60, P10000, DOI 10.1021/jf3035868; Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881; Zheng LQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010190; Zhu L, 2006, J AGR FOOD CHEM, V54, P7924, DOI 10.1021/jf061036z	55	6	6	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100195	10.1074/jbc.RA120.015861	http://dx.doi.org/10.1074/jbc.RA120.015861			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334885	Green Published, gold			2022-12-26	WOS:000672866400173
J	Braun, A; Evdokimov, D; Frank, J; Pauli, P; Uceyler, N; Sommer, C				Braun, Alexandra; Evdokimov, Dimitar; Frank, Johanna; Pauli, Paul; Ueceyler, Nurcan; Sommer, Claudia			Clustering fibromyalgia patients: A combination of psychosocial and somatic factors leads to resilient coping in a subgroup of fibromyalgia patients	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; QUALITY-OF-LIFE; GERMAN VERSION; VITAMIN-D; PAIN; PROFILES; FATIGUE; VALIDATION; STRATEGIES; CYTOKINES	Background Coping strategies and their efficacy vary greatly in patients suffering from fibromyalgia syndrome (FMS). Objective We aimed to identify somatic and psychosocial factors that might contribute to different coping strategies and resilience levels in FMS. Subjects and methods Standardized questionnaires were used to assess coping, pain, and psychological variables in a cohort of 156 FMS patients. Quantitative real-time polymerase chain reaction (qRT-PCR) determined gene expression of selected cytokines in white blood cells of 136 FMS patients and 25 healthy controls. Data of skin innervation, functional and structural sensory profiles of peripheral nociceptive nerve fibers of a previous study were included into the statistics. An exploratory factor analysis was used to define variance explaining factors, which were then included into cluster analysis. Results 54.9% of the variance was explained by four factors which we termed (1) affective load, (2) coping, (3) pain, and (4) pro-inflammatory cytokines (p < 0.05). Considering differences in the emerged factors, coping strategies, cytokine profiles, and disability levels, 118 FMS patients could be categorized into four clusters which we named "maladaptive", "adaptive", "vulnerable", and "resilient" (p < 0.05). The adaptive cluster had low scores in disability and in all symptom categories in contrast to the vulnerable cluster, which was characterized by high scores in catastrophizing and disability (p < 0.05). The resilient vs. the maladaptive cluster was characterized by better coping and a less pro-inflammatory cytokine pattern (p < 0.05). Conclusion Our data suggest that problem- and emotion-focused coping strategies and an anti-inflammatory cytokine pattern are associated with reduced disability and might promote resilience. Additional personal factors such as low anxiety scores, ability of acceptance, and persistence further favor a resilient phenotype. Individualized therapy should take these factors into account.	[Braun, Alexandra; Evdokimov, Dimitar; Frank, Johanna; Ueceyler, Nurcan; Sommer, Claudia] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Pauli, Paul] Univ Wurzburg, Dept Psychol Biol Psychol Clin Psychol & Psychoth, Wurzburg, Germany; [Pauli, Paul] Univ Wurzburg, Ctr Mental Hlth, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Braun, A (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.	Braun_A5@ukw.de			Evangelisches Studienwerk e.V.; Else Kroner-Fresenius-Stiftung; Department of Neurology of the University hospital Wurzburg;  [2014_A129]	Evangelisches Studienwerk e.V.; Else Kroner-Fresenius-Stiftung; Department of Neurology of the University hospital Wurzburg; 	A.B. was funded by Evangelisches Studienwerk e.V. (available from: https://www.evstudienwerk.de/english/doctoral.html) and the study is part of her doctoral thesis in the framework of the German graduate program DoloRes (available from: http://www.dolo-res.de/). The funding only included salary for A.B., a grant number is not available. The study was in part funded by Else Kroner-Fresenius-Stiftung (available from: https://www.ekfs.de/en). N.U. was the recipient of the grant with the grant number 2014_A129. Further funding came from internal research funds of the Department of Neurology of the University hospital Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ablin JN, 2016, PEERJ, V4, DOI 10.7717/peerj.2421; Allen D., 2013, CLUSTER ANAL NEUROPS, DOI [10.1007/978-1-4614-6744-1, DOI 10.1007/978-1-4614-6744-1]; [Anonymous], 1995, SO AFRICAN J CHILD A, DOI DOI 10.1080/16826108.1995.9632442; Ayed N, 2019, PSYCHOL PSYCHOTHER-T, V92, P299, DOI 10.1111/papt.12185; Baastrup S, 2016, SCAND J PSYCHOL, V57, P516, DOI 10.1111/sjop.12325; Bartley EJ, 2018, J PAIN, V19, P372, DOI 10.1016/j.jpain.2017.11.014; Basu N, 2017, PSYCHOSOM MED, V79, P1051, DOI 10.1097/PSY.0000000000000498; Becker LA, EFFECT SIZE CALCULAT; Belcaro G, 2014, PHYTOTHER RES, V28, P444, DOI 10.1002/ptr.5014; Bender D, 1998, PROTEKTIVE FAKTOREN, P117; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Block JH, 1980, ROLE EGO CONTROL EGO, P64; Brown MM, 2010, PSYCHOL REP, V106, P383, DOI 10.2466/PR0.106.2.383-393; Bullinger M., 1995, J PUBLIC HEALTH-UK, V3, P21, DOI [DOI 10.1007/BF02959944, 10.1007/BF02959944]; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Casale R, 2019, CLIN EXP RHEUMATOL, V37, pS105; Cohen J.E., 1988, STAT POWER ANAL BEHA; CORNELIUS SW, 1987, PSYCHOL AGING, V2, P144, DOI 10.1037/0882-7974.2.2.144; da Silva MM, 2018, LASER MED SCI, V33, P343, DOI 10.1007/s10103-017-2388-2; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2018, BRAIN BEHAV IMMUN, V74, P28, DOI 10.1016/j.bbi.2018.08.010; Dorado K, 2018, HEALTH PSYCHOL OPEN, V5, DOI 10.1177/2055102918807406; Ellingson LD, 2018, PAIN MED, V19, P2408, DOI 10.1093/pm/pny008; Estevez-Lopez F, 2017, RHEUMATOLOGY, V56, P2015, DOI 10.1093/rheumatology/kex302; Evdokimov D, 2019, ANN NEUROL, V86, P504, DOI 10.1002/ana.25565; Feder A, 2019, BIOL PSYCHIAT, V86, P443, DOI 10.1016/j.biopsych.2019.07.012; Follick BT, 2016, J AM ASSOC NURSE PRA, V28, P19, DOI 10.1002/2327-6924.12270; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hauser W, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.22; Hauser W, 2011, DTSCH ARZTEBL INT, V108, P287, DOI 10.3238/arztebl.2011.0287; HAITOVSKY Y, 1969, REV ECON STAT, V51, P486, DOI 10.2307/1926450; Hassett AL, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0567-7; Jacobs H, 2019, CLIN RHEUMATOL; Kline P, 1999, HDB PSYCHOL TESTING, P744; Klitsch A, 2020, J PERIPHER NERV SYST, V25, P9, DOI 10.1111/jns.12360; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kumpfer K.L., 2002, RESILIENCE DEV, P179, DOI DOI 10.1007/0-306-47167-1_9; Lami MJ, 2018, J CLIN PSYCHOL MED S, V25, P80, DOI 10.1007/s10880-018-9543-1; Laux L., 1981, STATE TRAIT ANGSTINV; Lee YC, 2014, ARTHRITIS RHEUMATOL, V66, P2006, DOI 10.1002/art.38682; Leppert K, 2005, PSYCHOTHER PSYCH MED, V55, P365, DOI 10.1055/s-2005-866873; Loevinger BL, 2012, CLIN RHEUMATOL, V31, P677, DOI 10.1007/s10067-011-1912-1; Luciano JV, 2016, CLIN J PAIN, V32, P829, DOI 10.1097/AJP.0000000000000336; Lukkahatai N, 2016, ARTHRIT CARE RES, V68, P99, DOI 10.1002/acr.22626; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Meyer TD, 2001, DIAGNOSTICA, V47, P208, DOI 10.1026//0012-1924.47.4.208; Moos RH, 2003, J CLIN PSYCHOL, V59, P1387, DOI 10.1002/jclp.10229; Moyal N, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01019; Musekamp G, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0903-4; Navrady Lauren B, 2018, Wellcome Open Res, V3, P12, DOI 10.12688/wellcomeopenres.13854.1; Offenbaecher M, 2000, J RHEUMATOL, V27, P1984; Park C.L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037/1089-2680.1.2.115, DOI 10.1037/1089-2680.1.2.115, 10.1037//1089-2680.1.2.115, DOI 10.1037//1089-2680.1.2.115]; Perez-Aranda A, 2018, PAIN; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Ramirez-Maestre C, 2008, EUR J PAIN, V12, P749, DOI 10.1016/j.ejpain.2007.11.004; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Rodman AM, 2019, BIOL PSYCHIAT, V86, P464, DOI 10.1016/j.biopsych.2019.04.033; Salaffi F, 2016, J PAIN RES, V9, P279, DOI 10.2147/JPR.S100829; Segura-Jimenez V, 2019, ARCH PHYS MED REHAB, V100, P1234, DOI 10.1016/j.apmr.2018.12.019; Seminowicz DA, 2007, CEREB CORTEX, V17, P1412, DOI 10.1093/cercor/bhl052; Signoret-Genest J, 2019, 3D MODEL ROTATING FM; Singh L, 2019, NEUROCHEM RES, V44, P1517, DOI 10.1007/s11064-019-02805-5; Sommer C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-104; Stainton A, 2019, EARLY INTERV PSYCHIA, V13, P725, DOI 10.1111/eip.12726; Sturgeon JA, 2014, PAIN, V155, P292, DOI 10.1016/j.pain.2013.10.007; Sturgeon JA, 2010, CURR PAIN HEADACHE R, V14, P105, DOI 10.1007/s11916-010-0095-9; Trinanes Y, 2014, RHEUMATOL INT, V34, P1571, DOI 10.1007/s00296-014-3007-1; Tuarp J., 2000, QUINTESSENZ, V51, P721; Turk DC, 1998, ARTHRIT CARE RES, V11, P397, DOI 10.1002/art.1790110511; Turk DC, 1996, J RHEUMATOL, V23, P1255; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Uceyler N, 2015, J NEUROL, V262, P203, DOI 10.1007/s00415-014-7556-8; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Uceyler N, 2006, ARTHRITIS RHEUM-US, V54, P2656, DOI 10.1002/art.22026; van Koulil S, 2010, ARTHRIT CARE RES, V62, P1377, DOI 10.1002/acr.20268; van Leeuwen N, 2015, RHEUMATOLOGY, V54, P776, DOI 10.1093/rheumatology/keu387; Verra ML, 2006, J PAIN, V7, P327, DOI 10.1016/j.jpain.2005.12.005; Vincent A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0463-7; Wirtz MA, 2018, DIAGNOSTICA, V64, P215, DOI 10.1026/0012-1924/a000205; Wittbrodt MT, 2019, J AFFECT DISORDERS, V254, P49, DOI 10.1016/j.jad.2019.05.018; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Yim YR, 2017, EUR J PAIN, V21, P374, DOI 10.1002/ejp.935; Yong WC, 2017, CLIN RHEUMATOL, V36, P2825, DOI 10.1007/s10067-017-3754-y	85	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243806	10.1371/journal.pone.0243806	http://dx.doi.org/10.1371/journal.pone.0243806			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370324	gold, Green Published, Green Submitted			2022-12-26	WOS:000603611900066
J	Armstrong-Hough, M; Sharma, S; Kishore, SP; Akiteng, AR; Schwartz, JI				Armstrong-Hough, Mari; Sharma, Srish; Kishore, Sandeep P.; Akiteng, Ann R.; Schwartz, Jeremy I.			Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis	PLOS ONE			English	Article							ADHERENCE; ACCESS; CARE	Background Availability of essential medicines for non-communicable diseases (NCDs) is poor in low- and middle-income countries. Availability and cost are conventionally assessed using cross-sectional data. However, these characteristics may vary over time. Methods We carried out a prospective, descriptive analysis of the availability and cost of essential medicines in 23 Ugandan health facilities over a five-week period. We surveyed facility pharmacies in-person up to five times, recording availability and cost of 19 essential medicines for NCDs and four essential medicines for communicable diseases. Results Availability of medicines varied substantially over time, especially among public facilities. Among private-for-profit facilities, the cost of the same medicine varied from week to week. Private-not-for-profit facilities experienced less dramatic fluctuations in price. Conclusions We conclude that there is a need for standardized, continuous monitoring to better characterize the availability and cost of essential medicines, understand demand for these medicines, and reduce uncertainty for patients.	[Armstrong-Hough, Mari] NYU, Sch Global Publ Hlth, New York, NY 10012 USA; [Sharma, Srish] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Kishore, Sandeep P.] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA; [Kishore, Sandeep P.] Young Profess Chron Dis Network, New York, NY USA; [Akiteng, Ann R.; Schwartz, Jeremy I.] Uganda Initiat Integrated Management Noncommun, Kampala, Uganda; [Schwartz, Jeremy I.] Yale Sch Med, Dept Internal Med, New Haven, CT USA	New York University; Wake Forest University; Icahn School of Medicine at Mount Sinai; Yale University	Armstrong-Hough, M (corresponding author), NYU, Sch Global Publ Hlth, New York, NY 10012 USA.	mah842@nyu.edu	Armstrong-Hough, Mari/AGF-1466-2022	Schwartz, Jeremy/0000-0003-0139-2600	MacMillan Center of Yale University; Yale Global Health Leadership Institute; Knoema	MacMillan Center of Yale University; Yale Global Health Leadership Institute; Knoema	The MacMillan Center of Yale University and the Yale Global Health Leadership Institute provided funding to support travel for JIS through the Hecht-Albert Pilot Innovation Award for Junior Faculty. Knoema provided funding for data collection and the development of the data collection and management tool. The funders played no further role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Muhammed, 2017, BMC Res Notes, V10, P676, DOI 10.1186/s13104-017-3025-7; [Anonymous], 2014, NONC DIS GLOB MON FR; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Ansah EK, 2016, INT HEALTH, V8, P427, DOI 10.1093/inthealth/ihw041; Armstrong-Hough M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192332; Bahendeka S, 2016, TROP MED INT HEALTH, V21, P405, DOI 10.1111/tmi.12663; Chiwanga FS, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31440; Fung V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191817; Gaziano T, 2015, HEALTH AFFAIR, V34, P1578, DOI 10.1377/hlthaff.2015.0351; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Kishore SP, 2018, J AM COLL CARDIOL, V71, P564, DOI 10.1016/j.jacc.2017.11.056; Kishore SP, 2015, HEALTH AFFAIR, V34, P1569, DOI 10.1377/hlthaff.2015.0375; Ministry of Health ROU, 2012, ESS MED HLTH SUPPL L; National Medical Logistics, FY 2017 18 NAT MED S; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Rash JA, 2016, PREV MED, V90, P155, DOI 10.1016/j.ypmed.2016.07.006; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Schwartz JI, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0077-5; Siddharthan T, 2015, HEALTH AFFAIR, V34, P1506, DOI 10.1377/hlthaff.2015.0382; United Nations, 2018, SUST DEV GOALS REP 2; World Health Organization, 2015, UG WHO STAT PROF; Yadav P., 2010, ALWAYS COLA RARELY E	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0241555	10.1371/journal.pone.0241555	http://dx.doi.org/10.1371/journal.pone.0241555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362249	gold, Green Submitted, Green Published			2022-12-26	WOS:000603071600065
J	Fervers, P; Kottlors, J; Zopfs, D; Bremm, J; Maintz, D; Safarov, O; Tritt, S; Abdullayev, N; Persigehl, T				Fervers, Philipp; Kottlors, Jonathan; Zopfs, David; Bremm, Johannes; Maintz, David; Safarov, Orkhan; Tritt, Stephanie; Abdullayev, Nuran; Persigehl, Thorsten			Calcification of the thoracic aorta on low-dose chest CT predicts severe COVID-19	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RISK-FACTORS; ATHEROSCLEROSIS; DEFINITION; DISEASE	Background Cardiovascular comorbidity anticipates poor prognosis of SARS-CoV-2 disease (COVID-19) and correlates with the systemic atherosclerotic transformation of the arterial vessels. The amount of aortic wall calcification (AWC) can be estimated on low-dose chest CT. We suggest quantification of AWC on the low-dose chest CT, which is initially performed for the diagnosis of COVID-19, to screen for patients at risk of severe COVID-19. Methods Seventy consecutive patients (46 in center 1, 24 in center 2) with parallel low-dose chest CT and positive RT-PCR for SARS-CoV-2 were included in our multi-center, multi-vendor study. The outcome was rated moderate (no hospitalization, hospitalization) and severe (ICU, tracheal intubation, death), the latter implying a requirement for intensive care treatment. The amount of AWC was quantified with the CT vendor's software. Results Of 70 included patients, 38 developed a moderate, and 32 a severe COVID-19. The average volume of AWC was significantly higher throughout the subgroup with severe COVID-19, when compared to moderate cases (771.7 mm(3) (Q1 = 49.8 mm(3), Q3 = 3065.5 mm(3)) vs. 0 mm(3) (Q1 = 0 mm(3), Q3 = 57.3 mm(3))). Within multivariate regression analysis, including AWC, patient age and sex, as well as a cardiovascular comorbidity score, the volume of AWC was the only significant regressor for severe COVID-19 (p = 0.004). For AWC > 3000 mm(3), the logistic regression predicts risk for a severe progression of 0.78. If there are no visually detectable AWC risk for severe progression is 0.13, only. Conclusion AWC seems to be an independent biomarker for the prediction of severe progression and intensive care treatment of COVID-19 already at the time of patient admission to the hospital; verification in a larger multi-center, multi-vendor study is desired.	[Fervers, Philipp; Kottlors, Jonathan; Zopfs, David; Bremm, Johannes; Maintz, David; Abdullayev, Nuran; Persigehl, Thorsten] Univ Cologne, Fac Med, Dept Diagnost & Intervent Radiol, Cologne, Germany; [Fervers, Philipp; Kottlors, Jonathan; Zopfs, David; Bremm, Johannes; Maintz, David; Abdullayev, Nuran; Persigehl, Thorsten] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Safarov, Orkhan; Tritt, Stephanie] Helios Dr Horst Schmidt Kliniken Wiesbaden, Dept Radiol, Wiesbaden, Germany	University of Cologne; University of Cologne	Fervers, P (corresponding author), Univ Cologne, Fac Med, Dept Diagnost & Intervent Radiol, Cologne, Germany.; Fervers, P (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.	philipp.fervers@uk-koeln.de	Abdullayev, Nuran/P-5363-2019	Abdullayev, Nuran/0000-0003-4522-537X; Fervers, Philipp/0000-0003-3663-3486				Basta Giuseppina, 2020, Recenti Prog Med, V111, P238, DOI 10.1701/3347.33187; Berlin I, 2020, NICOTINE TOB RES, V22, P1650, DOI 10.1093/ntr/ntaa059; Berman DS, 2016, JACC-CARDIOVASC IMAG, V9, P1417, DOI 10.1016/j.jcmg.2016.05.020; Bluemke DA, FLEISCHNER STATEMENT; Borsa S, 2020, ACTA NEUROCHIR, V162, P1227, DOI 10.1007/s00701-020-04333-6; Breheny P, 2017, R J, V9, P56, DOI 10.32614/RJ-2017-046; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Djekic D, 2018, EUR J PREV CARDIOL, V25, P1756, DOI 10.1177/2047487318792103; Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Grani C, 2018, EUR HEART J-CARD IMG, V19, P1362, DOI 10.1093/ehjci/jey019; Grundy EJ, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/124788; Hariyanto TI, 2020, DIABETES METAB SYND, V14, P1463, DOI 10.1016/j.dsx.2020.07.054; Isgum I, 2010, MED PHYS, V37, P714, DOI 10.1118/1.3284211; Itani Y, 2004, CIRC J, V68, P538, DOI 10.1253/circj.68.538; JANOWITZ WR, 1991, AM J CARDIOL, V68, P1, DOI 10.1016/0002-9149(91)90700-U; John F., 2019, R COMPANION APPL REG, VThird; Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Lessmann N, 2018, IEEE T MED IMAGING, V37, P615, DOI 10.1109/TMI.2017.2769839; Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549; Mahdjoub E, 2020, INTENS CARE MED, V46, P1648, DOI 10.1007/s00134-020-06118-y; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nikolich-Zugich J, 2020, GEROSCIENCE, V42, P505, DOI 10.1007/s11357-020-00186-0; Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9; Olds JL, 2020, FEBS J, V287, P3651, DOI 10.1111/febs.15303; Ozma MA, INFEZ MED, V28, P153; Rubin GD, 2020, RADIOLOGY, V296, P172, DOI [10.1016/j.chest.2020.04.003, 10.1148/radiol.2020201365]; Rusnak J, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-017-0290-9; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Takasu J, 2008, AM HEART J, V155, P765, DOI 10.1016/j.ahj.2007.11.019; Thomas IC, 2018, ARTERIOSCL THROM VAS, V38, P1926, DOI 10.1161/ATVBAHA.118.310850; van Velzen SGM, 2020, RADIOLOGY, V295, P66, DOI 10.1148/radiol.2020191621; van Zyl-Smit RN, 2020, LANCET RESP MED, V8, P664, DOI 10.1016/S2213-2600(20)30239-3; WITTEMAN JCM, 1986, LANCET, V2, P1120; WITTEMAN JCM, 1990, AM J CARDIOL, V66, P1060, DOI 10.1016/0002-9149(90)90505-U; World Health Organization, 2020, SMOK COVID 19 SCI BR; Zhai Pan, 2020, Int J Antimicrob Agents, V55, P105955, DOI 10.1016/j.ijantimicag.2020.105955; Zhang HF, 2020, ANESTHESIOLOGY, V132, P1333, DOI 10.1097/ALN.0000000000003300; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou M, 2020, 2020 THE 3RD INTERNATIONAL CONFERENCE ON INTELLIGENT AUTONOMOUS SYSTEMS (ICOIAS'2020), P1, DOI 10.1109/ICoIAS49312.2020.9081851	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244267	10.1371/journal.pone.0244267	http://dx.doi.org/10.1371/journal.pone.0244267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362199	Green Published, gold			2022-12-26	WOS:000603071600071
J	Jiang, W; Zhang, K; Wang, N; Yu, M				Jiang, Wei; Zhang, Kai; Wang, Nan; Yu, Miao			MeshCut data augmentation for deep learning in computer vision	PLOS ONE			English	Article								To solve overfitting in machine learning, we propose a novel data augmentation method called MeshCut, which uses a mesh-like mask to segment the whole image to achieve more partial diversified information. In our experiments, this strategy outperformed the existing augmentation strategies and achieved state-of-the-art results in a variety of computer vision tasks. MeshCut is also an easy-to-implement strategy that can efficiently improve the performance of the existing convolutional neural network models by a good margin without careful hand-tuning. The performance of such a strategy can be further improved by incorporating it into other augmentation strategies, which can make MeshCut a promising baseline strategy for future data augmentation algorithms.	[Jiang, Wei; Zhang, Kai; Yu, Miao] Sichuan Univ, Sch Mech Engn, Chengdu, Peoples R China; [Wang, Nan] Southwest Jiaotong Univ, Sch Phys Sci & Technol, Chengdu, Peoples R China	Sichuan University; Southwest Jiaotong University	Yu, M (corresponding author), Sichuan Univ, Sch Mech Engn, Chengdu, Peoples R China.; Wang, N (corresponding author), Southwest Jiaotong Univ, Sch Phys Sci & Technol, Chengdu, Peoples R China.	705679317@qq.com; miaoyu@scu.edu.cn			Sichuan Province Science and Technology Support Program [2019YFG0373]; Major Special Projects of Sichuan Province [2020ZDZX0024]; Department of Science and Technology of Sichuan Province [2019YFG0397]	Sichuan Province Science and Technology Support Program; Major Special Projects of Sichuan Province; Department of Science and Technology of Sichuan Province	The project of Sichuan Province Science and Technology Support Program under Grant 2019YFG0373; The Major Special Projects of Sichuan Province under Grant 2020ZDZX0024; Department of Science and Technology of Sichuan Province, 2019YFG0397.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Cubuk ED, 2019, PROC CVPR IEEE, P113, DOI 10.1109/CVPR.2019.00020; Devries T., 2017, IMPROVED REGULARIZAT; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, 10.1109/TPAMI.2018.2844175]; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Li W., 2013, INT C MACH LEARN; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Poria S, 2016, IEEE DATA MINING, P439, DOI [10.1109/ICDM.2016.178, 10.1109/ICDM.2016.0055]; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Singh K. K., 2018, HIDE AND SEEK DATA A; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Wang SJ, 2019, ENVIRON CHEM LETT, V17, P509, DOI 10.1007/s10311-018-0796-6; Yun Sangdoo, 2019, CUTMIX REGULARIZATIO; Zagoruyko S., 2017, ARXIV160507146; Zhang Hongyi, 2018, INT C LEARN REPR ICL, DOI 10.48550/arXiv.1710.09412; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660; Zhong Z, 2020, AAAI CONF ARTIF INTE, V34, P13001; Zhou Bolei, 2016, IEEE CVF C COMP VIS, DOI DOI 10.1109/CVPR.2016.319; 2018, INT J COMMUN SYST, V31	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243613	10.1371/journal.pone.0243613	http://dx.doi.org/10.1371/journal.pone.0243613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362231	Green Published, gold			2022-12-26	WOS:000603071600060
J	Bassett, IV; Triant, VA; Bunda, BA; Selvaggi, CA; Shinnick, DJ; He, W; Lu, F; Porneala, BC; Cao, TY; Lubitz, SA; Meigs, JB; Hsu, J; Foulkes, AS				Bassett, Ingrid V.; Triant, Virginia A.; Bunda, Bridget A.; Selvaggi, Caitlin A.; Shinnick, Daniel J.; He, Wei; Lu, Frances; Porneala, Bianca C.; Cao, Tingyi; Lubitz, Steven A.; Meigs, James B.; Hsu, John; Foulkes, Andrea S.			Massachusetts general hospital Covid-19 registry reveals two distinct populations of hospitalized patients by race and ethnicity	PLOS ONE			English	Article							ADULT PATIENTS	Objective To evaluate differences by race/ethnicity in clinical characteristics and outcomes among hospitalized patients with Covid-19 at Massachusetts General Hospital (MGH). Methods The MGH Covid-19 Registry includes confirmed SARS-CoV-2-infected patients hospitalized at MGH and is based on manual chart reviews and data extraction from electronic health records (EHRs). We evaluated differences between White/Non-Hispanic and Hispanic patients in demographics, complications and 14-day outcomes among the N = 866 patients hospitalized with Covid-19 from March 11, 2020-May 4, 2020. Results Overall, 43% of patients hospitalized with Covid-19 were women, median age was 60.4 [IQR = (48.2, 75)], 11.3% were Black/non-Hispanic and 35.2% were Hispanic. Hispanic patients, representing 35.2% of patients, were younger than White/non-Hispanic patients [median age 51y; IQR = (40.6, 61.6) versus 72y; (58.0, 81.7) (p<0.001)]. Hispanic patients were symptomatic longer before presenting to care (median 5 vs 3d, p = 0.039) but were more likely to be sent home with self-quarantine than be admitted to hospital (29% vs 16%, p<0.001). Hispanic patients had fewer comorbidities yet comparable rates of ICU or death (34% vs 36%). Nonetheless, a greater proportion of Hispanic patients recovered by 14 days after presentation (62% vs 45%, p<0.001; OR = 1.99, p = 0.011 in multivariable adjusted model) and fewer died (2% versus 18%, p<0.001). Conclusions Hospitalized Hispanic patients were younger and had fewer comorbidities compared to White/non-Hispanic patients; despite comparable rates of ICU care or death, a greater proportion recovered. These results have implications for public health policy and the design and conduct of clinical trials.	[Bassett, Ingrid V.; Triant, Virginia A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bassett, Ingrid V.; Triant, Virginia A.; He, Wei; Porneala, Bianca C.; Meigs, James B.; Hsu, John] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Bassett, Ingrid V.; Bunda, Bridget A.; Hsu, John] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Bassett, Ingrid V.; Triant, Virginia A.; Lubitz, Steven A.; Meigs, James B.; Hsu, John; Foulkes, Andrea S.] Harvard Med Sch, Boston, MA 02115 USA; [Selvaggi, Caitlin A.; Lu, Frances; Foulkes, Andrea S.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Shinnick, Daniel J.; Cao, Tingyi] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Lubitz, Steven A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Bassett, IV (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.; Bassett, IV (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.; Bassett, IV (corresponding author), Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Bassett, IV (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ibassett@mgh.harvard.edu		Cao, Tingyi/0000-0002-4210-7127; Lu, Frances/0000-0003-2031-7884	Weissman Family MGH Research Scholar; MGH Division of Clinical Research; National Institutes of Health [R37AI058736-16S1, R01GM127862, R01HL132786, R01AG062393]	Weissman Family MGH Research Scholar; MGH Division of Clinical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Weissman Family MGH Research Scholar (IVB); MGH Division of Clinical Research (ASF, JBM); The National Institutes of Health: R37AI058736-16S1 (IVB); R01GM127862 (ASF); R01HL132786 (VAT); R01AG062393 (VAT) The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2020, MASS DEP PUBL HLTH C; [Anonymous], MASS DEP PUBL HLTH C; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; CDC, 2020, ED ELEMENTS; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Clark E, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008484; de l I, 2018, J CLIN GASTROENTEROL, V52, pe63; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Gottlieb M, 2020, ACAD EMERG MED, V27, P963, DOI 10.1111/acem.14104; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Hawkins Devan, 2020, J Prev Med Public Health, V53, P220, DOI 10.3961/jpmph.20.256; Haynes N, 2020, CIRCULATION, V142, P105, DOI 10.1161/CIRCULATIONAHA.120.048126; Hsu HE, 2020, MMWR-MORBID MORTAL W, V69, P864, DOI 10.15585/mmwr.mm6927a3; Lewis NM, 2020, MMWR-MORBID MORTAL W, V69, P1369, DOI 10.15585/mmwr.mm6938a4; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775; Schnitzer K, 2020, ACAD EMERG MED, V27, P943, DOI 10.1111/acem.14092; U.S. Census Bureau, 2017, AM COMMUNITY SURVEY; Vahidy FS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039849; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Weber GM, 2017, J AM MED INFORM ASSN, V24, P1134, DOI 10.1093/jamia/ocx071	23	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244270	10.1371/journal.pone.0244270	http://dx.doi.org/10.1371/journal.pone.0244270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351826	gold, Green Published, Green Submitted			2022-12-26	WOS:000603071400014
J	Galea, N; Rosato, E; Gigante, A; Borrazzo, C; Fiorelli, A; Barchetti, G; Trombetta, AC; Digiulio, MA; Francone, M; Catalano, C; Carbone, I				Galea, Nicola; Rosato, Edoardo; Gigante, Antonietta; Borrazzo, Cristian; Fiorelli, Andrea; Barchetti, Giovanni; Trombetta, Amelia Chiara; Digiulio, Maria Anna; Francone, Marco; Catalano, Carlo; Carbone, Iacopo			Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor test	PLOS ONE			English	Article							FOLLOW-UP; QUANTIFICATION; DIAGNOSIS; FIBROSIS; EDEMA; CLASSIFICATION; ENHANCEMENT; INVOLVEMENT; SCLERODERMA; PERFUSION	Purpose Cardiac involvement in Systemic Sclerosis (SSc) is increasingly recognized as a mayor cause of morbidity and mortality. The aim of present study is to investigate the early stages of cardiac involvement in SSc by Cardiovascular magnetic resonance (CMR), combining the non-invasive detection of myocardial inflammation and fibrosis using T2 and T1 mapping techniques and the assessment of microcirculatory impairment through perfusion response to cold pressor test (CPT). Methods 40 SSc patients (30 females, mean age: 42.1 years) without cardiac symptoms and 10 controls underwent CMR at 1.5 T unit. CMR protocol included: native and contrast-enhanced T1 mapping, T2 mapping, T2-weighted, cineMR and late gadolinium enhancement (LGE) imaging. Microvascular function was evaluated by comparing myocardial blood flow (MBF) on perfusion imaging acquired at rest and after CPT. Native myocardial T1 and T2 relaxation times, extracellular volume fraction (ECV), T2 signal intensity ratio, biventricular volumes and LGE were assessed in each patient. Results SSc patients had significantly higher mean myocardial T1 (1029 +/- 32ms vs. 985 +/- 18ms, p<0.01), ECV (30.1 +/- 4.3% vs. 26.7 +/- 2.4%, p<0.05) and T2 (50.1 +/- 2.8ms vs. 47 +/- 1.5ms, p<0.01) values compared with controls. No significant differences were found between absolute MBF values at rest and after CPT; whereas lower MBF variation after CPT was observed in SSc patients (+33 +/- 14% vs. +44 +/- 12%, p<0.01). MBF variation had inverse correlation with native T1 values (r: -0.32, p<0.05), but not with ECV. Conclusions Myocardial involvement in SSc at preclinical stage increases native T1, T2 and ECV values, reflecting inflammation and fibrosis, and reduces vasodilatory response to CPT, as expression of microvascular dysfunction.	[Galea, Nicola; Fiorelli, Andrea; Barchetti, Giovanni; Francone, Marco; Catalano, Carlo; Carbone, Iacopo] Sapienza Univ Rome, Dept Expt Med, Rome, Italy; [Galea, Nicola] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy; [Rosato, Edoardo; Gigante, Antonietta; Trombetta, Amelia Chiara; Digiulio, Maria Anna] Sapienza Univ Rome, Scleroderma Ctr, Clin Immunol Unit, Dept Clin Med, Rome, Italy; [Borrazzo, Cristian] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Stat Unit, Rome, Italy; [Borrazzo, Cristian] Osped San Pietro Fatebenefratelli, Radiotherapy Unit, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Galea, N (corresponding author), Sapienza Univ Rome, Dept Expt Med, Rome, Italy.; Galea, N (corresponding author), Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy.	nicola.galea@uniroma1.it	Trombetta, Amelia Chiara/AAL-1841-2021; Borrazzo, Cristian/AAS-6644-2020; Galea, Nicola/AAQ-6612-2020	Borrazzo, Cristian/0000-0002-2346-898X; Galea, Nicola/0000-0003-4708-5120				Barison A, 2015, EUR HEART J-CARD IMG, V16, P74, DOI 10.1093/ehjci/jeu167; Cannarile F, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.12; Cianci R, 2020, KIDNEY BLOOD PRESS R, V45, P350, DOI 10.1159/000505659; Cutolo M, 2006, RHEUMATOLOGY, V45, P43, DOI 10.1093/rheumatology/kel310; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Di Cesare E, 2013, EUR J RADIOL, V82, pE268, DOI 10.1016/j.ejrad.2013.02.014; Faccini A, 2016, EUR HEART J, V37, P1799, DOI 10.1093/eurheartj/ehw018; Faccini A, 2015, CIRC J, V79, P825, DOI 10.1253/circj.CJ-14-1114; Fairbairn TA, 2014, RADIOLOGY, V270, P82, DOI 10.1148/radiol.13122345; Ferreira VM, 2013, JACC-CARDIOVASC IMAG, V6, P1048, DOI 10.1016/j.jcmg.2013.03.008; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; FOLLANSBEE WP, 1984, NEW ENGL J MED, V310, P142, DOI 10.1056/NEJM198401193100302; FOLLANSBEE WP, 1990, J RHEUMATOL, V17, P656; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Galea N, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8437927; GUSTAFSSON R, 1989, LANCET, V2, P475; Gyllenhammar T, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0756-x; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; Hromadka M, 2017, INT J CARDIOL, V249, P448, DOI 10.1016/j.ijcard.2017.08.072; Jerosch-Herold M, 1998, MED PHYS, V25, P73, DOI 10.1118/1.598163; Kahaleh B, 2008, RHEUMATOLOGY, V47, pV14, DOI 10.1093/rheumatology/ken279; Kellman P, 2007, MAGN RESON MED, V57, P891, DOI 10.1002/mrm.21215; Komocsi A, 2012, RHEUMATOLOGY, V51, P1027, DOI 10.1093/rheumatology/ker357; Krumm P, 2020, ROFO-FORTSCHR RONTG, V192, P669, DOI 10.1055/a-1088-3478; Krumm P, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0289-3; LEROY EC, 1988, J RHEUMATOL, V15, P202; Mavrogeni S, 2017, INT J CARDIOL, V228, P444, DOI 10.1016/j.ijcard.2016.11.242; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Miller CA, 2013, CIRC-CARDIOVASC IMAG, V6, P373, DOI 10.1161/CIRCIMAGING.112.000192; Mizuno R, 2010, EUR J HEART FAIL, V12, P268, DOI 10.1093/eurjhf/hfp198; Mueller KAL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126707; Ntusi NAB, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-21; Pingitore A, 2013, RHEUMATOLOGY, V52, P1920, DOI 10.1093/rheumatology/ket002; Poindron V, 2020, SEMIN ARTHRITIS RHEU, V50, P128, DOI 10.1016/j.semarthrit.2019.06.013; Quarta S, 2016, EXPERT REV CLIN IMMU, V12, P251, DOI 10.1586/1744666X.2016.1134320; Sano M, 2015, HEART VESSELS, V30, P779, DOI 10.1007/s00380-014-0539-y; Thuny F, 2014, RADIOLOGY, V271, P373, DOI 10.1148/radiol.13131280; Tzelepis GE, 2007, ARTHRITIS RHEUM-US, V56, P3827, DOI 10.1002/art.22971; Valentini G, 2001, ANN RHEUM DIS, V60, P592, DOI 10.1136/ard.60.6.592; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Wong TC, 2012, CIRCULATION, V126, P1206, DOI 10.1161/CIRCULATIONAHA.111.089409; Zhang Y, 2015, INT J CARDIOVAS IMAG, V31, P389, DOI 10.1007/s10554-014-0560-3	42	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244282	10.1371/journal.pone.0244282	http://dx.doi.org/10.1371/journal.pone.0244282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351821	Green Published, gold			2022-12-26	WOS:000603071400023
J	Hahnel, V; Peterhoff, D; Bauerlein, V; Brosig, AM; Pamler, I; Johnson, C; Bica, A; Totir, M; Ossner, T; Stemmer, B; Toelge, M; Schutz, A; Niller, HH; Schmidt, B; Wagner, R; Gessner, A; Burkhard, R; Offner, R				Hahnel, Viola; Peterhoff, David; Bauerlein, Veronika; Brosig, Andreas-Michael; Pamler, Irene; Johnson, Christian; Bica, Adelina; Totir, Monica; Ossner, Thomas; Stemmer, Barbara; Toelge, Martina; Schutz, Anja; Niller, Hans-Helmut; Schmidt, Barbara; Wagner, Ralf; Gessner, Andre; Burkhard, Ralph; Offner, Robert			Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality	PLOS ONE			English	Article							CORONAVIRUS; PNEUMONIA; THERAPY; COV	The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019. Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the manufacturing of a plasma-based product containing antibodies specific to SARS-CoV-2 obtained from recently recovered COVID-19 patients. Convalescent plasma donors were screened as follows: 1) previously confirmed SARS-CoV-2 infection (by real-time PCR (RT-PCR)); 2) a subsequent negative PCR test followed by a 2-week waiting period; 3) an additional negative PCR test prior to plasmapheresis; and 4) confirmation of the presence of SARS-CoV-2 specific antibodies. Convalescent plasma was stored fresh (2-6 degrees C) for up to 5 days or frozen (-30 degrees C) for long-term storage. Donor peripheral blood and final plasma product were assayed for binding antibodies targeting the SARS-CoV-2 S-protein receptor-binding domain (RBD) and their titers measured by an enzyme-linked immunosorbent assay (ELISA). We performed 72 plasmaphereses resulting in 248 final products. Convalescent plasma contained an RBD-specific antibody titer (IgG) ranging from 1:100 to 1:3200 (median 1:800). The titer was congruent to the titer of the blood (n = 34) before collection (1:100-1:6400, median 1:800). Levels of IL-8 and LBP of donors were slightly increased. Therapeutic products derived from a human origin must undergo rigorous testing to ensure uniform quality and patient safety. Whilst previous publications recommended RBD-specific binding antibody titers of >= 1:320, we selected a minimum titer of 1:800 in order to maximize antibody delivery. Production of highly standardized convalescent plasma was safe, feasible and was readily implemented in the treatment of severely ill COVID-19 patients.	[Hahnel, Viola; Bauerlein, Veronika; Brosig, Andreas-Michael; Pamler, Irene; Johnson, Christian; Bica, Adelina; Totir, Monica; Ossner, Thomas; Stemmer, Barbara; Burkhard, Ralph; Offner, Robert] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Transfus Med, Regensburg, Germany; [Peterhoff, David; Toelge, Martina; Schutz, Anja; Niller, Hans-Helmut; Schmidt, Barbara; Wagner, Ralf; Gessner, Andre] Univ Hosp Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany; [Niller, Hans-Helmut; Schmidt, Barbara; Wagner, Ralf; Gessner, Andre] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Hahnel, V (corresponding author), Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Transfus Med, Regensburg, Germany.	viola.haehnel@ukr.de	Wagner, Ralf/D-1389-2010; Schmidt, Barbara/AEZ-2050-2022; Peterhoff, David/ABD-6746-2020	Wagner, Ralf/0000-0002-0220-2154; Johnson, Christian/0000-0001-9942-672X	Bavarian Ministry of Science and Art; project EHVA (H2020) [681032]	Bavarian Ministry of Science and Art; project EHVA (H2020)	The authors acknowledge financial support through the pandemic responsiveness of The Bavarian Ministry of Science and Art. DP, AS were funded by project EHVA (H2020, Grant 681032 to RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, Cancer Discov, V10, pOF8, DOI 10.1158/2159-8290.CD-ND2020-008; [Anonymous], 2017, RICHTL GEW BLUT BLUT; [Anonymous], 2020, EU PROGRAMME COVID 1; Arabi YM, 2016, EMERG INFECT DIS, V22, P1554, DOI 10.3201/eid2209.151164; Bica AF, 2020, TRANFUS MED HEMOT S1, V47, P1; Brown BL, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102790; Bulow S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02768; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Garraud O, 2016, TRANSFUS CLIN BIOL, V23, P39, DOI 10.1016/j.tracli.2015.12.003; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta R, 2021, MOL CELL BIOCHEM, V476, P633, DOI 10.1007/s11010-020-03932-2; Gupta R, 2020, DIABETES METAB SYND, V14, P251, DOI 10.1016/j.dsx.2020.03.012; Henss L, 2021, J INFECT DIS, V223, P56, DOI 10.1093/infdis/jiaa680; Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020; Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P152, DOI 10.2450/2015.0131-15; Meftahi GH, 2020, INFLAMM RES, V69, P825, DOI 10.1007/s00011-020-01372-8; Ossner T SB, 2020, TRANFUS MED HEMOT S1, V47, P1; Pamler I, 2020, TRANSFUSION, V60, P1260, DOI 10.1111/trf.15801; Peterhoff D, 2021, INFECTION, V49, P75, DOI 10.1007/s15010-020-01503-7; Roback JD, 2020, JAMA-J AM MED ASSOC, V323, P1561, DOI 10.1001/jama.2020.4940; Rojas M, 2020, J TRANSL AUTOIMMUN, V3, DOI 10.1016/j.jtauto.2020.100069; Rojas M, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102554; Rychter AM, 2020, OBES REV, V21, DOI 10.1111/obr.13083; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Tamara A, 2020, DIABETES METAB SYND, V14, P655, DOI 10.1016/j.dsx.2020.05.020; Tarrant JM, 2010, TOXICOL SCI, V117, P4, DOI 10.1093/toxsci/kfq134; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Valk SJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013600; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Xie MX, 2020, INT J INFECT DIS, V94, P119, DOI 10.1016/j.ijid.2020.03.071; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346; Zeng QL, 2020, J INFECT DIS, V222, P38, DOI 10.1093/infdis/jiaa228; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu H, 2020, CURR CARDIOL REP, V22, DOI [10.1007/s11886-020-01292-3, 10.1007/s11886-020-01302-4]	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243967	10.1371/journal.pone.0243967	http://dx.doi.org/10.1371/journal.pone.0243967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351831	gold, Green Published			2022-12-26	WOS:000603071400034
J	Kang, H; Lee, SJ; Shin, HJ; Lee, AG				Kang, Hyunkyoo; Lee, Sang Jae; Shin, Hyun Jin; Lee, Andrew G.			Measuring ocular torsion and its variations using different nonmydriatic fundus photographic methods	PLOS ONE			English	Article							CYCLODEVIATION; SIGN	Purpose To compare the variations in ocular torsion measurements made using different fundus photographic methods. Methods We enrolled subjects with three conditions: (1) patients with intermittent exotropia (IXT) (n = 44), (2) patients with unilateral superior oblique palsy (SOP) (n = 10), and (3) normal subjects as controls (n = 85). Ocular torsion was measured by disc-center-fovea angle (DFA) using three different imaging modalities: (1) conventional fundus photography (CFP) with a 45 degrees field of view (FV), (2) wide-field fundus photography (WFP) with a 200 degrees FV, and (3) optical coherence tomography (OCT) with a 55 degrees FV. Results In the IXT group, the DFAs in the right and left eyes were 5.70 +/- 3.35 degrees and 6.37 +/- 3.36 degrees, respectively, for CFP, 8.39 +/- 5.24 degrees and 8.61 +/- 3.67 degrees for WFP, and 5.73 +/- 3.61 degrees for 6.16 +/- 3.50 degrees for OCT. In the SOP group, the DFAs in paretic and nonparetic eyes were 12.19 +/- 1.69 degrees and 6.71 +/- 1.09 degrees, respectively, for CFP, 14.29 +/- 2.36 degrees and 8.23 +/- 3.31 degrees for WFP, and 12.12 +/- 1.73 degrees and 6.91 +/- 1.12 degrees for OCT. In the control group, the DFAs in the right and left eyes were 5.39 +/- 2.65 degrees and 5.71 +/- 3.16 degrees, respectively, for CFP, 8.77 +/- 5.56 degrees and 8.90 +/- 6.24 degrees for WFP, and 5.27 +/- 2.67 degrees and 5.72 +/- 3.20 degrees for OCT. There was no difference between the results from CFP and OCT among the three groups. However, the torsional angle was larger when measured using WFP than the other two photographic methods (CFP and OCT) in all three groups (all p<0.05). Conclusion The ocular torsion measurement varies with the fundus photographic method used to measure it. Clinicians should be careful to avoid overestimating ocular extorsion when it is evaluated using WFP.	[Kang, Hyunkyoo] Konkuk Univ, Dept Mechatron & Elect Engn, Glocal Campus, Chungcheongbuk Do, South Korea; [Lee, Sang Jae] Konkuk Univ, Sch Med, Seoul, South Korea; [Shin, Hyun Jin] Konkuk Univ, Med Ctr, Res Inst Med Sci, Sch Med,Dept Ophthalmol, Seoul, South Korea; [Lee, Andrew G.] Houston Methodist Hosp, Blanton Eye Inst, Dept Ophthalmol, Houston, TX USA; [Lee, Andrew G.] Weill Cornell Med, Dept Ophthalmol, Neurol, Neurosurg, New York, NY USA; [Lee, Andrew G.] Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX USA; [Lee, Andrew G.] UT MD Anderson Canc Ctr, Dept Ophthalmol, Houston, TX USA; [Lee, Andrew G.] Texas A & M Coll Med, Dept Ophthalmol, College Stn, TX USA; [Lee, Andrew G.] Univ Iowa Hosp & Clin, Dept Ophthalmol, Iowa City, IA USA; [Lee, Andrew G.] Baylor Coll Med, Ctr Space Med, Dept Ophthalmol, Houston, TX USA; [Lee, Andrew G.] Univ Buffalo, Dept Ophthalmol, Buffalo, NY USA	Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Iowa; Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shin, HJ (corresponding author), Konkuk Univ, Med Ctr, Res Inst Med Sci, Sch Med,Dept Ophthalmol, Seoul, South Korea.	shineye@kuh.ac.kr	Shin, Hyunjin/ABF-6057-2021; Lee, Andrew/GVU-2817-2022	Shin, Hyun Jin/0000-0002-3563-8042; Kang, Hyunkyoo/0000-0001-9664-1563	National Research Foundation of Korea(NRF) by Ministry of Education;  [2020R1I1A3075301]	National Research Foundation of Korea(NRF) by Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); 	Initials of the authors who received each award: H Kang center dot Grant numbers awarded to each author: 2020R1I1A3075301 center dot The full name of each funder: Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education center dot URL of each funder website: www.nrf.re.kr www.moe.go.kr center dot Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET HIV, V2017, pPE475; BIXENMAN WW, 1982, OPHTHALMOLOGY, V89, P58; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRANDT T, 1993, ANN NEUROL, V33, P528, DOI 10.1002/ana.410330518; Brodsky MC, 2014, J AAPOS, V18, P306, DOI 10.1016/j.jaapos.2014.01.009; Ehrt O, 2001, GRAEF ARCH CLIN EXP, V239, P678, DOI 10.1007/s004170100347; GALETTA SL, 1994, AM J OPHTHALMOL, V118, P509; GUYTON DL, 1988, GRAEF ARCH CLIN EXP, V226, P241, DOI 10.1007/BF02181189; Hyung Lee Si, 2013, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V54, P1091; Jethani J, 2010, INDIAN J OPHTHALMOL, V58, P417, DOI 10.4103/0301-4738.67060; Kothari Mihir T., 2005, Indian Journal of Ophthalmology, V53, P43; Kushner BJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P712, DOI 10.1001/archophthalmol.2010.88; Le Jeune C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191007; LEE J, 1985, BRIT J OPHTHALMOL, V69, P508, DOI 10.1136/bjo.69.7.508; LEVINE MH, 1972, AM J OPHTHALMOL, V73, P262, DOI 10.1016/0002-9394(72)90142-0; Ong JKY, 2010, J NEUROSCI METH, V192, P261, DOI 10.1016/j.jneumeth.2010.08.004; Parsa CF, 2013, BRIT J OPHTHALMOL, V97, P126, DOI 10.1136/bjophthalmol-2011-300867; Philips PH, 1999, CLIN STRABISMUS MANA, P52; Piedrahita-Alonso E, 2014, BRIT J OPHTHALMOL, V98, P115, DOI 10.1136/bjophthalmol-2013-303680; Qiu KL, 2019, BRIT J OPHTHALMOL, V103, P821, DOI 10.1136/bjophthalmol-2018-312162; Rohrschneider K, 2004, INVEST OPHTH VIS SCI, V45, P3257, DOI 10.1167/iovs.03-1157; SIMONS K, 1994, OPHTHALMOLOGY, V101, P1897; Toslak D, 2020, BIOMED OPT EXPRESS, V11, P68, DOI 10.1364/BOE.11.000068	23	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244230	10.1371/journal.pone.0244230	http://dx.doi.org/10.1371/journal.pone.0244230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351818	Green Published, gold			2022-12-26	WOS:000603071400008
J	Shin, HK; Park, SH; Kim, KW				Shin, Hye-kyung; Park, Sang Hee; Kim, Kyoung-woo			Inter-floor noise classification using convolutional neural network	PLOS ONE			English	Article							IMPACT; DWELLINGS; COMFORT; SOUNDS	In apartment houses, noise between floors can disturb pleasant living environments and cause disputes between neighbors. As a means of resolving disputes caused by inter-floor noise, noises are recorded for 24 hours in a household to verify whether the inter-floor noise exceeded the legal standards. If the noise exceeds the legal standards, the recorded sound is listened to, and it is checked whether the noise comes from neighboring households. When done manually, this process requires time and is costly, and there is a problem of whether the listener's judgments of the sound source are consistent. This study aims to classify inter-floor noise according to noise sources by using a convolutional neural network model. A total of 1,515 sound sources of data recorded for 24 h from three households were annotated, and 40 4s audio clips of six noise sources, including "Footsteps," "Dragging furniture," "Hammering," "Instant impact (dropping a heavy item)," "Vacuum cleaner," and "Public announcement system" were identified. Moreover, datasets of 16 classes using ESC50's urban sound category audio were used to distinguish the inter-floor noise heard indoors from the external noise. Although DenseNet, ResNet, Inception, and EfficientNet are models that use images as their domains, they showed an accuracy of 91.43-95.27% when classifying the inter-floor noise dataset. Among the reviewed models, ResNet showed an accuracy of 95.27 +/- 2.30% as well as a highest performance level in the F1 score, precision, and recall metrics. Additionally, ResNet showed the shortest inference time. This paper concludes by suggesting that the present findings can be extended in future research for monitoring acoustic elements of indoor soundscape.	[Shin, Hye-kyung; Park, Sang Hee; Kim, Kyoung-woo] Korea Inst Civil Engn & Bldg Technol, Dept Living & Built Environm Res, Goyang Si, Kyeonggi Do, South Korea	Korea Institute of Civil Engineering & Building Technology (KICT)	Kim, KW (corresponding author), Korea Inst Civil Engn & Bldg Technol, Dept Living & Built Environm Res, Goyang Si, Kyeonggi Do, South Korea.	kwmj@kict.re.kr		Park, Sang Hee/0000-0002-1476-2378	Residential Environment Research Program - Ministry of Land, Infrastructure and Transport of the Korean government [20RERP-B082204-07]	Residential Environment Research Program - Ministry of Land, Infrastructure and Transport of the Korean government	This research was supported by a grant (20RERP-B082204-07) from Residential Environment Research Program funded by Ministry of Land, Infrastructure and Transport of the Korean government.	[Anonymous], 2015, NAT BUILD COD CAN; Barbas Carmen Sílvia Valente, 2014, Rev. bras. ter. intensiva, V26, P215, DOI 10.5935/0103-507X.20140034; Choi H, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183735; Frontczak M, 2011, BUILD ENVIRON, V46, P922, DOI 10.1016/j.buildenv.2010.10.021; Guzhov A., 2020, ESRESNET ENV SOUND C; Ha J.W., 2020, ARXIV200608217; He K., 2016, CVPR, P770; Huang G, 2018, ARXIV160806993V5, DOI [10.3969/j.issn.1673-4254.2018.06.04, DOI 10.3969/J.ISSN.1673-4254.2018.06.04]; International Code Council, 2018, INT BUILD COD; ISO, 2003, 156662003E ISOTS; Jakovjevic B, 2009, ENVIRON INT, V35, P552, DOI 10.1016/j.envint.2008.10.001; Jeon JY, 2015, BUILD ENVIRON, V94, P821, DOI 10.1016/j.buildenv.2015.07.021; Kim K, 2015, ELEC DES ADV PACKAG, P12, DOI 10.1109/EDAPS.2015.7383663; Kim KW, 2009, BUILD ENVIRON, V44, P1589, DOI 10.1016/j.buildenv.2008.10.005; Korea Environment Corporation, 2019, INT NOIS NEIGHB CTR; Lee J., 2017, ARXIV PREPRINT ARXIV; Lee PJ, 2009, ACTA ACUST UNITED AC, V95, P707, DOI 10.3813/AAA.918199; Li XY, 2019, INTERSPEECH, P3604, DOI 10.21437/Interspeech.2019-3019; McFee B., 2019, LIBROSA LIBROSA 0 6; Ministry of Environment, 2014, AP NEIGHB NOIS RES S; Mukhopadhyay AK, 2020, ARXIV191210905; Sousa ANE, 2011, APPL ACOUST, V72, P177, DOI 10.1016/j.apacoust.2010.11.006; Nordtest ACOU, 2002, 111 HUM SOUND PERC G; Palanisamy K., 2020, RETHINKING CNN MODEL; Park SH, 2019, APPL ACOUST, V150, P268, DOI 10.1016/j.apacoust.2019.02.021; Piczak KJ, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1015, DOI 10.1145/2733373.2806390; Qawaqneh Z, 2017, KNOWL-BASED SYST, V115, P5, DOI 10.1016/j.knosys.2016.10.008; Rasmussen B., 2019, PROC ICA 2019, P5102; Salamon J, 2017, IEEE SIGNAL PROC LET, V24, P279, DOI 10.1109/LSP.2017.2657381; Schoenwald S, 2010, INFLUENCE RECEIVE RO; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tan M, 2019, ARXIV190511946V5; Vacher M, 2014, P 4 C SPEECH TECHN H, P135, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CB09781107415324.004]; Vardaxis NG, 2018, BUILD ACOUST, V25, P151, DOI 10.1177/1351010X18762687; Wang H, 2020, ARXIV191206808V2, DOI [10.4057/jsr.65.145, DOI 10.4057/JSR.65.145]; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Xue P, 2016, ENERG BUILDINGS, V116, P181, DOI 10.1016/j.enbuild.2016.01.006; Yeon JO, 2017, APPL ACOUST, V125, P20, DOI 10.1016/j.apacoust.2017.03.019; Yu L., 2005, J ACOUST SOC AM, V117, P2591, DOI DOI 10.1121/1.4777296	39	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243758	10.1371/journal.pone.0243758	http://dx.doi.org/10.1371/journal.pone.0243758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351829	Green Published, gold			2022-12-26	WOS:000603071400020
J	Shahidullah, M; Wilson, WS; Rafiq, K; Sikder, MH; Ferdous, J; Delamere, NA				Shahidullah, Mohammad; Wilson, William Stuart; Rafiq, Kazi; Sikder, Mahmudul Hasan; Ferdous, Jannatul; Delamere, Nicholas Anthony			Terbutaline, forskolin and cAMP reduce secretion of aqueous humour in the isolated bovine eye	PLOS ONE			English	Article							CAPACITATIVE CALCIUM-ENTRY; INTRACELLULAR-CALCIUM; CYCLIC-AMP; INOSITOL TRISPHOSPHATE; INTRAOCULAR-PRESSURE; CA2+ MOBILIZATION; EPITHELIAL-CELLS; CILIARY; TIMOLOL; TRANSPORT	In order to elucidate involvement of cyclic AMP and intracellular Ca2+,[Ca2+](i), in the modulation of aqueous humour formation (AHF), we studied the effects of terbutaline, forskolin and 8-Br-cAMP in the isolated bovine eye. We also studied the interaction of cAMP on calcium signaling in cultured ciliary epithelial (CE) cells. Drug effects on AHF were measured by fluorescein dilution. Drug effects on [Ca2+](i) were studied by the fura-2 fluorescence ratio technique. Terbutaline (100 nmol-100 M), forskolin (30 nM-100 M) or 8-Br-cAMP (100 nM- 10 mu M), administered in the arterial perfusate produced significant reductions in AHF. The AH reducing effect of terbutaline was blocked by a selective inhibitor of protein kinase A (KT-5720). ATP (100 M) caused a rapid, transient (peak) increase in [Ca2+](i) followed by a sustained plateau phase lasting more than 5 minutes. Preincubation of the cells (6 min) with terbutaline, forskolin or 8-Br-cAMP significantly reduced the peak calcium response to ATP. The sustained plateau phase of the response, on the other hand, was augmented by each of the agents. KT-5720 partially reversed the inhibitory effect of terbutaline on the peak and totally inhibited its effect on the plateau phase. These data indicate: (a) that AHF in the bovine eye can be manipulated through cyclic AMP, operating via protein kinase A, (b) that protein kinase A can affect [Ca2+](i) homeostasis, (c) that calcium release from the intracellular store, not the entry, affects AHF, and (d) that interaction of [Ca2+](i) with cAMP plays a role in modulating AH secretion.	[Shahidullah, Mohammad; Delamere, Nicholas Anthony] Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA; [Shahidullah, Mohammad; Delamere, Nicholas Anthony] Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA; [Wilson, William Stuart] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Rafiq, Kazi; Sikder, Mahmudul Hasan; Ferdous, Jannatul] Bangladesh Agr Univ, Dept Pharmacol, Mymensing, Bangladesh	University of Arizona; University of Arizona; University of Glasgow; Bangladesh Agricultural University (BAU)	Shahidullah, M (corresponding author), Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA.; Shahidullah, M (corresponding author), Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA.	shahidua@arizona.edu	Rafiq, Kazi/AEU-4834-2022; Shahidullah, Mohammad/AAA-1359-2022	Shahidullah, Mohammad/0000-0002-1142-4242	Fight for Sight, London, through National Lottery Charities Board, UK; USPHS Research Award, USA [R01EY029171]	Fight for Sight, London, through National Lottery Charities Board, UK; USPHS Research Award, USA	This research was generously supported by the charity, Fight for Sight, London, through a grant from the National Lottery Charities Board, UK and by a USPHS Research Award, R01EY029171, USA.	Abdollahi M, 2001, FUND CLIN PHARMACOL, V15, P307, DOI 10.1046/j.1472-8206.2001.00041.x; [Anonymous], 2004, AM J PHYSIOL-ENDOC M, V287, pE955; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BRUBAKER RF, 1984, INVEST OPHTH VIS SCI, V25, P357; BRUNE B, 1992, EUR J BIOCHEM, V207, P607, DOI 10.1111/j.1432-1033.1992.tb17087.x; Civan MM, 2003, J EXP ZOOL PART A, V300A, P5, DOI 10.1002/jez.a.10303; Civan MM, 2008, CURR TOP MEMBR, V62, P1, DOI 10.1016/S1063-5823(08)00401-8; COAKES RL, 1978, ARCH OPHTHALMOL-CHIC, V96, P2045, DOI 10.1001/archopht.1978.03910060433007; CROOK RB, 1991, CURR EYE RES, V10, P593, DOI 10.3109/02713689109013851; CROOK RB, 1992, EXP EYE RES, V55, P785, DOI 10.1016/0014-4835(92)90005-D; DAILEY RA, 1982, AM J OPHTHALMOL, V93, P232, DOI 10.1016/0002-9394(82)90419-6; Farahbakhsh NA, 1997, EXP EYE RES, V64, P173, DOI 10.1006/exer.1996.0194; Fleischhauer JC, 2001, AM J PHYSIOL-CELL PH, V281, pC1614, DOI 10.1152/ajpcell.2001.281.5.C1614; GAMBERUCCI A, 1994, J BIOL CHEM, V269, P23597; Giovanelli A, 1996, BIOCHEM BIOPH RES CO, V220, P472, DOI 10.1006/bbrc.1996.0423; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLAM TJ, 1988, BIOCHEM J, V251, P243, DOI 10.1042/bj2510243; Jackson TS, 1996, AM J PHYSIOL-HEART C, V271, pH924, DOI 10.1152/ajpheart.1996.271.3.H924; Kageyama Kyoko, 2004, J Anesth, V18, P107, DOI 10.1007/s00540-004-0228-6; Leipziger J, 1997, PFLUG ARCH EUR J PHY, V434, P77; LINCOLN TM, 1990, AM J PHYSIOL, V258, pC399, DOI 10.1152/ajpcell.1990.258.3.C399; MITTAG TW, 1993, AM J PHYSIOL, V264, pF1060, DOI 10.1152/ajprenal.1993.264.6.F1060; NATHANSON JA, 1980, P NATL ACAD SCI-BIOL, V77, P7420, DOI 10.1073/pnas.77.12.7420; NEUFELD AH, 1972, EXP EYE RES, V14, P242, DOI 10.1016/0014-4835(72)90009-7; Niisato N, 1997, CAN J PHYSIOL PHARM, V75, P1030, DOI 10.1139/cjpp-75-8-1030; PATERSON GD, 1972, BRIT J OPHTHALMOL, V56, P288, DOI 10.1136/bjo.56.3.288; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Schutte M, 1996, J PHYSIOL-LONDON, V496, P25, DOI 10.1113/jphysiol.1996.sp021662; Shaharuddin M.I., 2011, MED CHEM RES, P1; Shahidullah M, 2003, INVEST OPHTH VIS SCI, V44, P1185, DOI 10.1167/iovs.02-0397; SHAHIDULLAH M, 1995, CURR EYE RES, V14, P519, DOI 10.3109/02713689508998398; Shahidullah M, 1997, CURR EYE RES, V16, P1006, DOI 10.1076/ceyr.16.10.1006.9018; Shahidullah M, 1999, BRIT J PHARMACOL, V127, P1438, DOI 10.1038/sj.bjp.0702681; Song SK, 1998, BIOCHEM PHARMACOL, V56, P561, DOI 10.1016/S0006-2952(97)00660-6; STRAUSS O, 1992, J OCUL PHARMACOL, V8, P359, DOI 10.1089/jop.1992.8.359; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Suzuki Y, 1997, CURR EYE RES, V16, P166, DOI 10.1076/ceyr.16.2.166.5095; TSUNODA Y, 1993, BIOCHIM BIOPHYS ACTA, V1154, P105, DOI 10.1016/0304-4157(93)90008-C; Wang Z, 2010, AM J PHYSIOL-CELL PH, V298, pC798, DOI 10.1152/ajpcell.00406.2009; WETTRELL K, 1977, EXP EYE RES, V24, P613, DOI 10.1016/0014-4835(77)90119-1; WETTRELL K, 1977, ACTA OPHTHALMOL, P7; WILSON WS, 1993, CURR EYE RES, V12, P609, DOI 10.3109/02713689309001840; YABLONSKI ME, 1978, EXP EYE RES, V27, P135, DOI 10.1016/0014-4835(78)90083-0; Yang CM, 1996, PFLUG ARCH EUR J PHY, V432, P708, DOI 10.1007/s004240050189; YOSHIMURA N, 1995, CURR EYE RES, V14, P629, DOI 10.3109/02713689508998489	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244253	10.1371/journal.pone.0244253	http://dx.doi.org/10.1371/journal.pone.0244253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347508	Green Published, gold, Green Accepted			2022-12-26	WOS:000603071100033
J	Viana, MVC; Profeta, R; da Silva, AL; Hurtado, R; Cerqueira, JC; Ribeiro, BFS; Almeida, MO; Morais-Rodrigues, F; Soares, SD; Oliveira, M; Tavares, L; Figueiredo, H; Wattam, AR; Barh, D; Ghosh, P; Silva, A; Azevedo, V				Viana, Marcus Vinicius Canario; Profeta, Rodrigo; da Silva, Alessandra Lima; Hurtado, Raquel; Cerqueira, Janaina Canario; Ribeiro, Bruna Ferreira Sampaio; Almeida, Marcelle Oliveira; Morais-Rodrigues, Francielly; Soares, Siomar de Castro; Oliveira, Manuela; Tavares, Luis; Figueiredo, Henrique; Wattam, Alice Rebecca; Barh, Debmalya; Ghosh, Preetam; Silva, Artur; Azevedo, Vasco			Taxonomic classification of strain PO100/5 shows a broader geographic distribution and genetic markers of the recently described Corynebacterium silvaticum	PLOS ONE			English	Article							PATHOGEN; PROTEIN; DNA	The bacterial strain PO100/5 was isolated from a skin abscess taken from a pig (Sus scrofa domesticus) in the Alentejo region of southern Portugal. It was identified as Corynebacterium pseudotuberculosis using biochemical tests, multiplex PCR and Pulsed Field Gel Electrophoresis. After genome sequencing and rpoB phylogeny, the strain was classified as C. ulcerans. To better understand the taxonomy of this strain and improve identification methods, we compared strain PO100/5 to other publicly available genomes from C. diphtheriae group. Taxonomic analysis reclassified it and three others strains as the recently described C. silvaticum, which have been isolated from wild boar and roe deer in Germany and Austria. The results showed that PO100/5 is the first sequenced genome of a C. silvaticum strain from livestock and a different geographical region, has the unique sequence type ST709, and could be could produce the diphtheriae toxin, along with strain 05-13. Genomic analysis of PO100/5 showed four prophages, and eight conserved genomic islands in comparison to C. ulcerans. Pangenome analysis of 38 C. silvaticum and 76 C. ulcerans genomes suggested that C. silvaticum is a genetically homogeneous species, with 73.6% of its genes conserved and a pangenome near to be closed (alpha > 0.952). There are 172 genes that are unique to C. silvaticum in comparison to C. ulcerans. Most of these conserved genes are related to nutrient uptake and metabolism, prophages or immunity against them, and could be genetic markers for species identification. Strains PO100/5 (livestock) and KL0182(T) (wild boar) were predicted to be potential human pathogens. This information may be useful for identification and surveillance of this pathogen.	[Viana, Marcus Vinicius Canario; Profeta, Rodrigo; da Silva, Alessandra Lima; Hurtado, Raquel; Cerqueira, Janaina Canario; Ribeiro, Bruna Ferreira Sampaio; Almeida, Marcelle Oliveira; Morais-Rodrigues, Francielly; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Biol Sci, Dept Genet Ecol & Evolut, Belo Horizonte, MG, Brazil; [Viana, Marcus Vinicius Canario; Silva, Artur] Fed Univ Para, Inst Biol Sci, Dept Genet, Belem, Para, Brazil; [Soares, Siomar de Castro] Univ Fed Triangulo Mineiro, Inst Biol Sci & Nat Sci, Dept Immunol Microbiol & Parasitol, Uberaba, MG, Brazil; [Oliveira, Manuela; Tavares, Luis] Univ Lisbon, Ctr Interdisciplinary Res Anim Hlth, Fac Vet Med, Lisbon, Portugal; [Figueiredo, Henrique] Univ Fed Minas Gerais, Natl Reference Lab Aquat Anim Dis, Belo Horizonte, MG, Brazil; [Wattam, Alice Rebecca] Univ Virginia, Biocomplex Inst, Charlottesville, VA USA; [Barh, Debmalya] Inst Integrat Omics & Appl Biotechnol, Purba Medinipur, W Bengal, India; [Ghosh, Preetam] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA	Universidade Federal de Minas Gerais; Universidade Federal do Para; Universidade Federal do Triangulo Mineiro; Universidade de Lisboa; Universidade Federal de Minas Gerais; University of Virginia; Virginia Commonwealth University	Azevedo, V (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Genet Ecol & Evolut, Belo Horizonte, MG, Brazil.	vasco@icb.ufmg.br	Barh, Debmalya/O-4246-2015; Azevedo, Vasco/B-1556-2019; de Castro Soares, Siomar/I-2705-2012; Lima da Silva, Alessandra/AGF-3709-2022	Barh, Debmalya/0000-0002-2557-7768; Azevedo, Vasco/0000-0002-4775-2280; de Castro Soares, Siomar/0000-0001-7299-3724; Lima da Silva, Alessandra/0000-0002-2698-6889; Tavares, Luis/0000-0001-8671-6285; Cerqueira, Janaina/0000-0003-3410-1419; Ghosh, Preetam/0000-0003-3880-5886; Ribeiro, Bruna/0000-0001-7068-7539; Oliveira, Manuela/0000-0002-3910-1525; Canario Viana, Marcus Vinicius/0000-0002-7017-6437	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Minas Gerais (UFMG); Pro-Reitoria de Pesquisa da UFMG (PRPQ-UFMG); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400027C]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Minas Gerais (UFMG); Pro-Reitoria de Pesquisa da UFMG (PRPQ-UFMG); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Minas Gerais (UFMG); and Pro-Reitoria de Pesquisa da UFMG (PRPQ-UFMG); A. R. Wattam was supported by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272201400027C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; [Anonymous], 2017, Future Oncol, V13, P1, DOI 10.2217/fon-2017-0071; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Badell E, 2020, RES MICROBIOL, V171, P122, DOI 10.1016/j.resmic.2020.02.003; Badell E, 2019, J MED MICROBIOL, V68, P1455, DOI 10.1099/jmm.0.001070; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berger A, 2013, ZOONOSES PUBLIC HLTH, V60, P539, DOI 10.1111/zph.12031; Berger AA, 2014, WHAT OBJECTS MEAN: AN INTRODUCTION TO MATERIAL CULTURE, 2ND EDITION, P171; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chang CY, 2011, MOL MICROBIOL, V79, P1236, DOI 10.1111/j.1365-2958.2010.07515.x; Contzen M, 2011, ZOONOSES PUBLIC HLTH, V58, P479, DOI 10.1111/j.1863-2378.2011.01396.x; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; Dangel A, 2020, INT J SYST EVOL MICR, V70, P3614, DOI 10.1099/ijsem.0.004195; Dazas M, 2018, INT J SYST EVOL MICR, V68, P3826, DOI 10.1099/ijsem.0.003069; Eisenberg T, 2014, EMERG INFECT DIS, V20, P448, DOI 10.3201/eid2003.130423; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Fimereli Danai K., 2012, Artificial Intelligence: Theories and Applications. Proceedings 7th Hellenic Conference on AI, SETN 2012, P285, DOI 10.1007/978-3-642-30448-4_36; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Jain C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07641-9; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Konig C, 2014, J CLIN MICROBIOL, V52, P4318, DOI 10.1128/JCM.02291-14; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu HH, 2020, COGNITION, V194, DOI 10.1016/j.cognition.2019.104055; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Meier-Kolthoff JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10210-3; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Meinel DM, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0113-3; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; Moller JR, 2020, ANTON LEEUW INT J G, V113, P1225, DOI 10.1007/s10482-020-01430-5; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Oliveira M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0218-3; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Pacheco LGC, 2007, J MED MICROBIOL, V56, P480, DOI 10.1099/jmm.0.46997-0; Page AJ., 2016, J OPEN SOURCE SOFTW, V1, P118, DOI 10.21105/joss.00118; Ramirez NA, 2020, TRENDS MICROBIOL, V28, P999, DOI 10.1016/j.tim.2020.05.008; Rau J, 2019, VET MICROBIOL, V237, DOI 10.1016/j.vetmic.2019.108399; Schaeffer J, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.00946-20; Schuhegger Regina, 2009, Emerg Infect Dis, V15, P1314, DOI 10.3201/eid1508.081568; Seth-Smith HMB, 2019, FRONT PUBLIC HEALTH, P1, DOI [10.3389/fpubh.2019.00001, DOI 10.3389/FPUBH.2019.00001]; Soares SC, 2016, J BIOTECHNOL, V232, P2, DOI 10.1016/j.jbiotec.2015.09.008; Subedi R., 2018, New Microbes and New Infections, V25, P7, DOI 10.1016/j.nmni.2018.05.005; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tauch A, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv185; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Trost E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-383; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017	58	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244210	10.1371/journal.pone.0244210	http://dx.doi.org/10.1371/journal.pone.0244210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347470	Green Published, gold, Green Submitted			2022-12-26	WOS:000603071100035
J	Asefa, F; Cummins, A; Dessie, Y; Foureu, M; Hayen, A				Asefa, Fekede; Cummins, Allison; Dessie, Yadeta; Foureu, Maralyn; Hayen, Andrew			Midwives' and obstetricians' perspectives about pregnancy related weight management in Ethiopia: A qualitative study	PLOS ONE			English	Article							GAIN; HEALTH; OUTCOMES; ASSOCIATIONS; EDUCATION; WOMEN; CARE	Background Midwives and obstetricians are key maternity care providers; they are the most trusted source of information regarding nutrition and gestational weight gain. However, their views, practices and perceived barriers to managing pregnancy related weight gain have not been studied in Ethiopia. The aim of this study was to explore midwives' and obstetricians' observations and perspectives about gestational weight gain and postpartum weight management in Ethiopia. Methods We conducted face-to-face interviews with 11 midwives and 10 obstetricians, from January 2019 to March 2019. All interview data were transcribed verbatim. We analysed the data using thematic analysis with an inductive approach. Results We identified three themes and associated subthemes. Midwives and obstetricians had limited knowledge of the optimal gestational weight gain. Almost all participants were unaware of the presence of the Institute of Medicine recommendations for optimal weight gain in pregnancy. According to the study participants, women in Ethiopia do not want to gain weight during pregnancy, but do want to gain weight after the birth. Counselling about gestational weight gain and postpartum weight management was not routinely provided for pregnant women. This is mostly because gestational weight gain counselling was not considered to be a priority by maternity care providers in Ethiopia. Conclusions The limited knowledge of and low attention to pregnancy related weight management by midwives and obstetricians in this setting needs appropriate intervention. Adapting a guideline for pregnancy weight management and integrating it into antenatal care is essential.	[Asefa, Fekede; Dessie, Yadeta] Haramaya Univ, Coll Hlth & Med Sci, Sch Publ Hlth, Harar, Ethiopia; [Asefa, Fekede; Cummins, Allison; Foureu, Maralyn] Univ Technol Sydney, Fac Hlth, Ctr Midwifery Child & Family Hlth, Sydney, NSW, Australia; [Asefa, Fekede; Hayen, Andrew] Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Sydney, NSW, Australia; [Foureu, Maralyn] Univ Newcastle, Hunter New England Hlth Nursing & Midwifery Res C, Newcastle, NSW, Australia	Haramaya University; University of Technology Sydney; University of Technology Sydney; University of Newcastle	Asefa, F (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Sch Publ Hlth, Harar, Ethiopia.; Asefa, F (corresponding author), Univ Technol Sydney, Fac Hlth, Ctr Midwifery Child & Family Hlth, Sydney, NSW, Australia.; Asefa, F (corresponding author), Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Sydney, NSW, Australia.	sinboona@gmail.com	Bacha, Yadeta/AAF-8849-2021; Cummins, Allison M/G-8614-2015; asefa, fekede/AAE-1700-2020	Cummins, Allison M/0000-0003-0626-3365; asefa, fekede/0000-0002-6700-4810; Hayen, Andrew/0000-0003-4046-8030	Australian Government Research Training Program; Haramaya University [HURG_2018_02_01_30]; Centre for Midwifery, Child and Family Health, University of Technology Sydney	Australian Government Research Training Program(Australian Government); Haramaya University; Centre for Midwifery, Child and Family Health, University of Technology Sydney	An Australian Government Research Training Program provided a full scholarship for the corresponding author. This study was partially funded by the Haramaya University as a part of staff grant [grant number: HURG_2018_02_01_30]. The Centre for Midwifery, Child and Family Health, University of Technology Sydney provided financial support for data transcription purpose. There was no additional external funding received for this study.	Alavi N, 2013, OBES REV, V14, P68, DOI 10.1111/j.1467-789X.2012.01059.x; Anon, 2013, MACQUARIE DISPATCH, V12, P1; [Anonymous], 2018, Obstet Gynecol, V132, pe181, DOI 10.1097/AOG.0000000000002897; [Anonymous], 2017, INT J RES HUMANITIES, V46, P1; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Arrish J, 2014, WOMEN BIRTH, V27, P2, DOI 10.1016/j.wombi.2013.02.003; Asefa F, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0225-x; Ashley-Martin J, 2014, MATERN CHILD HLTH J, V18, P1927, DOI 10.1007/s10995-014-1438-7; Bookari K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4856527; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Campbell F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-491; Central Statistical Agency, 2016, ETHIOPIA DEM HLTH SU ETHIOPIA DEM HLTH SU; Christensen AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166167; Clarke V, 2013, PSYCHOLOGIST, V26, P120; Cole KOW, 2017, J WOMENS HEALTH, V26, P1123, DOI 10.1089/jwh.2016.6115; Committee on Practice Bulletins-Obstetrics, 2018, OBSTET GYNECOL, V131, pe49; Criss S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1118-2; de la Torre L, 2011, AM J PERINAT, V28, P285, DOI 10.1055/s-0030-1271211; Duthie EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-231; Ehrenberg HM, 2003, AM J OBSTET GYNECOL, V189, P1726, DOI 10.1016/S0002-9378(03)00860-3; Gedamu H, 2016, INT J REPROD MED, V2018, P1, DOI [10.1155/2018/5945060, DOI 10.1155/2018/5945060]; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Haugen M, 2015, BMC PREGNANCY CHILDB, V14, P1; Hickey CA, 2000, AM J CLIN NUTR, V71, p1364S, DOI 10.1093/ajcn/71.5.1364s; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Lindsay AC, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111412; Macleod M, 2013, MATERN CHILD NUTR, V9, P467, DOI 10.1111/j.1740-8709.2011.00396.x; Magilvy JK, 2009, J SPEC PEDIATR NURS, V14, P298, DOI 10.1111/j.1744-6155.2009.00212.x; Mamun AA, 2010, AM J CLIN NUTR, V91, P1336, DOI 10.3945/ajcn.2009.28950; Mcphie S, 2015, AUST NZ J OBSTET GYN, V55, P21, DOI 10.1111/ajo.12265; Mitchell LJ, 2017, J ACAD NUTR DIET, V117, P1941, DOI 10.1016/j.jand.2017.06.364; Moos MK, 2008, AM J OBSTET GYNECOL, V199, pS280, DOI 10.1016/j.ajog.2008.08.060; Morris J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018527; Mwape L, 2018, OPEN J PSYCHIAT, V8, P152; Nemomsa D., 2018, E AFR J HLTH BIOMED, V2, P1; Oken E, 2007, AM J PREV MED, V32, P305, DOI 10.1016/j.amepre.2006.11.012; Olander EK, 2011, SEX REPROD HEALTHC, V2, P43, DOI 10.1016/j.srhc.2010.10.004; QSR International, 2012, NVIVO QUAL DAT AN SO; Sandall J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub5; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Schmied VA, 2011, MIDWIFERY, V27, P424, DOI 10.1016/j.midw.2010.02.010; Scott C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-167; Seifu B., 2017, ASSESMENT GESTATIONA; Shub Alexis, 2013, BMC Res Notes, V6, P278, DOI 10.1186/1756-0500-6-278; Tela FG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212424; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; Timmerman GM, 2017, J PERINAT EDUC, V26, P70, DOI 10.1891/1058-1243.26.2.70; Tovar A, 2010, MATERN CHILD HLTH J, V14, P938, DOI 10.1007/s10995-009-0524-8; Tully KP, 2017, AM J OBSTET GYNECOL, V217, P37, DOI 10.1016/j.ajog.2017.03.032; van Nes F, 2010, EUR J AGEING, V7, P313, DOI 10.1007/s10433-010-0168-y; Weeks A, 2018, OBSTET GYNECOL SURV, V73, P486, DOI 10.1097/OGX.0000000000000588; WHO, 2022, WHO RECOMMENDATIONS; Willcox JC, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-102; World Health Organization, 2017, MAN COMPL PREG CHILD; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; Yigzaw T, 2016, INT J WOMENS HEALTH, V8, P181, DOI 10.2147/IJWH.S105046; Zerfu TA, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0059-8; 2015, MEDICC REV, V17, P5	61	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244221	10.1371/journal.pone.0244221	http://dx.doi.org/10.1371/journal.pone.0244221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332406	gold, Green Published			2022-12-26	WOS:000601310900056
J	Hotaling, A; Bagrow, JP				Hotaling, Abigail; Bagrow, James P.			Efficient crowdsourcing of crowd-generated microtasks	PLOS ONE			English	Article								Allowing members of the crowd to propose novel microtasks for one another is an effective way to combine the efficiencies of traditional microtask work with the inventiveness and hypothesis generation potential of human workers. However, microtask proposal leads to a growing set of tasks that may overwhelm limited crowdsourcer resources. Crowdsourcers can employ methods to utilize their resources efficiently, but algorithmic approaches to efficient crowdsourcing generally require a fixed task set of known size. In this paper, we introduce cost forecasting as a means for a crowdsourcer to use efficient crowdsourcing algorithms with a growing set of microtasks. Cost forecasting allows the crowdsourcer to decide between eliciting new tasks from the crowd or receiving responses to existing tasks based on whether or not new tasks will cost less to complete than existing tasks, efficiently balancing resources as crowdsourcing occurs. Experiments with real and synthetic crowdsourcing data show that cost forecasting leads to improved accuracy. Accuracy and efficiency gains for crowd-generated microtasks hold the promise to further leverage the creativity and wisdom of the crowd, with applications such as generating more informative and diverse training data for machine learning applications and improving the performance of user-generated content and question-answering platforms.	[Hotaling, Abigail; Bagrow, James P.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Hotaling, Abigail; Bagrow, James P.] Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Bagrow, JP (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.; Bagrow, JP (corresponding author), Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT 05405 USA.	james.bagrow@uvm.edu	Bagrow, James/E-1701-2016	Bagrow, James/0000-0002-4614-0792	National Science Foundation [IIS-1447634]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. IIS-1447634 (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; [Anonymous], 2018, GIN SURG RES COMMUN, V2, P24; Audibert JY, 2009, THEOR COMPUT SCI, V410, P1876, DOI 10.1016/j.tcs.2009.01.016; Aydin BI, 2021, CONCURR COMP-PRACT E, V33, DOI 10.1002/cpe.4168; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Bernstein M, 2010, S USER INTERFACE SOF, P313, DOI [10.1145/1866029.1866078, DOI 10.1145/1866029.1866078]; Bian J., 2008, P 17 INT C WORLD WID, P467, DOI DOI 10.1145/1367497.1367561; Bongard JC, 2013, IEEE T SYST MAN CY-S, V43, P176, DOI 10.1109/TSMCA.2012.2195168; Brabham D.C., 2008, CONVERGENCE-US, V14, P75, DOI DOI 10.1177/1354856507084420; Chen Xi, 2013, P 30 INT C MACHINE L, P64; Dagan I, 2006, LECT NOTES ARTIF INT, V3944, P177; Dai P, 2013, ARTIF INTELL, V202, P52, DOI 10.1016/j.artint.2013.06.002; Dawid A.P., 1979, J ROYAL STAT SOC C, V28, P20, DOI [10.2307/2346806, DOI 10.2307/2346806]; Franzoni C, 2014, RES POLICY, V43, P1, DOI 10.1016/j.respol.2013.07.005; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Karger DR, 2014, OPER RES, V62, P1, DOI 10.1287/opre.2013.1235; Kittur A, 2013, C COMPUTER SUPPORTED, P1301, DOI [DOI 10.1145/2441776.2441923, 10.1145/2441776.2441923]; Kittur A, 2011, S USER INTERFACE SOF, P43, DOI DOI 10.1145/2047196.2047202; Li Q, 2016, PROCEEDINGS OF THE NINTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING (WSDM'16), P237, DOI 10.1145/2835776.2835797; Liu Y., 2018, 32 AAAI C ART INT; Maurer A, 2009, P 22 ANN C LEARN THE; McAndrew TC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182662; Salganik MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123483; Sheng V. S., 2008, P 14 ACM SIGKDD INT, P614, DOI DOI 10.1145/1401890.1401965; Shtok A., 2012, P 21 INT C WORLD WID, P759, DOI DOI 10.1145/2187836.2187939; Snow R., 2008, P C EMP METH NAT LAN, P254, DOI DOI 10.3115/1613715.1613751; Wagy MD, 2018, IEEE SYST J, V12, P3151, DOI 10.1109/JSYST.2017.2778144; Welinder P., 2010, ADV NEURAL INFORM PR, V23, P2424; Zhang J., 2007, P 16 INT C WORLD WID, P221, DOI DOI 10.1145/1242572.1242603	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244245	10.1371/journal.pone.0244245	http://dx.doi.org/10.1371/journal.pone.0244245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332455	gold, Green Published, Green Submitted			2022-12-26	WOS:000601310900032
J	Nehoya, KN; Hamatui, N; Shilangale, RP; Onywera, H; Kennedy, J; Mwapagha, LM				Nehoya, Kaarina N.; Hamatui, Ndinomholo; Shilangale, Renatus P.; Onywera, Harris; Kennedy, Jeya; Mwapagha, Lamech M.			Characterization of Shiga toxin-producing Escherichia coli in raw beef from informal and commercial abattoirs	PLOS ONE			English	Article							O157-H7 REQUIRES INTIMIN; REAL-TIME PCR; MULTIPLEX PCR; INFECTIONS; CATTLE; PATHOGENICITY; PREVALENCE; EMERGENCE; CARCASSES; GENES	Shiga toxin-producing Escherichia coli are foodborne pathogens that are mostly associated with beef products and have been implicated in human illness. E.coli-associated illness range from asymptomatic conditions of mild diarrhoea to haemorrhagic colitis which can progress into life threatening haemolytic uremic syndrome (HUS). Beef from cattle are regarded as the main reservoir of Shiga toxin-producing E. coli (STEC) pathogen. The aim of this study was to assess the level and sources of contamination of raw beef with STEC, and determine the incidences of STEC strains in raw beef from informal and commercial abattoirs in Windhoek, Namibia. A total of 204 raw beef samples, 37 equipment and 29 hand swabs were collected and tested for STEC. The meat samples were first enriched with pre-warmed buffered peptone water, cultured on Tryptone Bile X-Glucuronide and CHROMagar STEC, and then sub-cultured on nutrient agar. The presence of E.coli in the samples was confirmed by using VITEK 2 E.coli identification cards and PCR. The overall prevalence of STEC in the meat samples from both the abattoirs was 41.66% raw beef samples; 5.40% equipment swabs; and none of the hand swabs was STEC positive. From the STEC positive meat samples 29.41% contained one of the major STEC strains. Moreover, 52% of the 25 samples that contained the major STECs were characterised by eae and stx(1), 8% characterised by eae and stx(2) while 40% were characterised by eae, stx(1) and stx(2) virulence genes. This study has revealed the necessity for proper training on meat safety (for meat handlers) as well as the development, implementation and maintenance of effective sanitary dressing procedures at abattoirs to eliminate beef contamination by STECs thereby ensuring the production of wholesome meat, and to prevent the occurrences of STEC infections.	[Nehoya, Kaarina N.; Hamatui, Ndinomholo] Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Hlth Sci, Windhoek, Namibia; [Nehoya, Kaarina N.] Minist Agr Water & Forestry, Directorate Vet Serv, Windhoek, Namibia; [Shilangale, Renatus P.] Minist Agr Water & Forestry, Cent Vet Lab, Windhoek, Namibia; [Onywera, Harris] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Onywera, Harris] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Kennedy, Jeya; Mwapagha, Lamech M.] Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Nat & Appl Sci, Windhoek, Namibia	Namibia University of Science & Technology; University of Cape Town; University of Cape Town; Namibia University of Science & Technology	Mwapagha, LM (corresponding author), Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Nat & Appl Sci, Windhoek, Namibia.	lmwapa@gmail.com	Onywera, Harris/AAM-6198-2021	Onywera, Harris/0000-0002-7298-4921; Hamatui, Ndinomholo/0000-0002-6397-8597; Mwapagha, Lamech/0000-0003-1048-1787				Arthur TM, 2002, APPL ENVIRON MICROB, V68, P4847, DOI 10.1128/AEM.68.10.4847-4852.2002; Montero DA, 2019, EMERG MICROBES INFEC, V8, P486, DOI 10.1080/22221751.2019.1595985; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003; Baumgartner A, 2016, J VERBRAUCH LEBENSM, V11, P353, DOI 10.1007/s00003-016-1053-1; Bertrand R, 2007, WATER RES, V41, P1280, DOI 10.1016/j.watres.2006.11.027; Bettelheim KA, 2000, J APPL MICROBIOL, V88, p38S, DOI 10.1111/j.1365-2672.2000.tb05331.x; Blanco M, 1997, VET MICROBIOL, V54, P309, DOI 10.1016/S0378-1135(96)01292-8; Bollinger LM, 2004, EFFECTS SEASON ANIMA; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Brusa V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00171; Cook EAJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3923-y; Dean-Nystrom EA, 1998, INFECT IMMUN, V66, P4560; Effler P, 2001, EMERG INFECT DIS, V7, P812; Fleiss J., 1981, STAT METHODS RATES P, P870; Franco MG, 2017, J BLACK PSYCHOL, V43, P435, DOI 10.1177/0095798416657260; Hassanien A, CONTAMINATION BEEF C; Hedican EB, 2009, CLIN INFECT DIS, V49, P358, DOI 10.1086/600302; Hernandez Marta, 2009, P427, DOI 10.1007/978-0-387-89026-5_16; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Islam MA, 2010, FOODBORNE PATHOG DIS, V7, P1381, DOI 10.1089/fpd.2010.0569; Jenkins C, 2020, J MED MICROBIOL, V69, P487, DOI 10.1099/jmm.0.001136; Kothari C.R., 2014, REMETHODOLOGY METH; Koyange L, 2004, EMERG INFECT DIS, V10, P968, DOI 10.3201/eid1005.031034; Llorente P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/795104; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; McEvoy JM, 2000, LETT APPL MICROBIOL, V30, P390, DOI [10.1046/j.1472-765x.2000.00739.x, 10.1046/j.1472-765X.2000.00739.x]; MCKEE ML, 1995, INFECT IMMUN, V63, P3739, DOI 10.1128/IAI.63.9.3739-3744.1995; Montero DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06999-y; Mwai C, 2011, RISK CONTAMINATION B; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Nowicki S., 2010, Morbidity and Mortality Weekly Report, V59, P557; Oloyede A R, 2016, NIGERIAN J BIOTECHNO, V31, P15; Rigobelo E. C., 2012, J MICROBIOLOGY RES, V2, P103; Sarimehmetoglu B, 2009, FOOD CONTROL, V20, P357, DOI 10.1016/j.foodcont.2008.06.002; Svoboda AL, 2013, FOODBORNE PATHOG DIS, V10, P789, DOI 10.1089/fpd.2012.1445; Tau NP, 2012, EMERG INFECT DIS, V18, P1314, DOI 10.3201/eid1808.111616; Woodward MJ, 2003, INT J MED MICROBIOL, V293, P299, DOI 10.1078/1438-4221-00264; Xia XD, 2010, APPL ENVIRON MICROB, V76, P1709, DOI 10.1128/AEM.01968-09	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243828	10.1371/journal.pone.0243828	http://dx.doi.org/10.1371/journal.pone.0243828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332397	Green Published, gold			2022-12-26	WOS:000601310900034
J	Pattabiraman, C; Habib, F; Harsha, PK; Rasheed, R; Prasad, P; Reddy, V; Dinesh, P; Damodar, T; Hosallimath, K; George, AK; Reddy, NVK; John, B; Pattanaik, A; Kumar, N; Mani, RS; Venkataswamy, MM; Hameed, SSK; Kumar, BGP; Desai, A; Vasanthapuram, R				Pattabiraman, Chitra; Habib, Farhat; Harsha, P. K.; Rasheed, Risha; Prasad, Pramada; Reddy, Vijayalakshmi; Dinesh, Prameela; Damodar, Tina; Hosallimath, Kiran; George, Anson K.; Kiran Reddy, Nakka Vijay; John, Banerjee; Pattanaik, Amrita; Kumar, Narendra; Mani, Reeta S.; Venkataswamy, Manjunatha M.; Shahul Hameed, Shafeeq K.; Kumar, Prakash B. G.; Desai, Anita; Vasanthapuram, Ravi			Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka	PLOS ONE			English	Article								Karnataka, a state in south India, reported its first case of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection on March 8, 2020, more than a month after the first case was reported in India. We used a combination of contact tracing and genomic epidemiology to trace the spread of SARS-CoV-2 in the state up until May 21, 2020 (1578 cases). We obtained 91 genomes of SARS-CoV-2 which clustered into seven lineages (Pangolin lineages-A, B, B.1, B.1.80, B.1.1, B.4, and B.6). The lineages in Karnataka were known to be circulating in China, Southeast Asia, Iran, Europe and other parts of India and are likely to have been imported into the state both by international and domestic travel. Our sequences grouped into 17 contact clusters and 24 cases with no known contacts. We found 14 of the 17 contact clusters had a single lineage of the virus, consistent with multiple introductions and most (12/17) were contained within a single district, reflecting local spread. In most of the 17 clusters, the index case (12/17) and spreaders (11/17) were symptomatic. Of the 91 sequences, 47 belonged to the B.6 lineage, including eleven of 24 cases with no known contact, indicating ongoing transmission of this lineage in the state. Genomic epidemiology of SARS-CoV-2 in Karnataka suggests multiple introductions of the virus followed by local transmission in parallel with ongoing viral evolution. This is the first study from India combining genomic data with epidemiological information emphasizing the need for an integrated approach to outbreak response.	[Pattabiraman, Chitra; Harsha, P. K.; Rasheed, Risha; Prasad, Pramada; Reddy, Vijayalakshmi; Damodar, Tina; Hosallimath, Kiran; George, Anson K.; Kiran Reddy, Nakka Vijay; John, Banerjee; Pattanaik, Amrita; Kumar, Narendra; Mani, Reeta S.; Venkataswamy, Manjunatha M.; Shahul Hameed, Shafeeq K.; Desai, Anita; Vasanthapuram, Ravi] Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bengaluru, India; [Habib, Farhat] TruFactor InMobi Grp, Bengaluru, India; [Dinesh, Prameela; Kumar, Prakash B. G.] Govt Karnataka, Directorate Hlth & Family Welf Serv, Bengaluru, India	National Institute of Mental Health & Neurosciences - India	Vasanthapuram, R (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bengaluru, India.	virusravi@gmail.com	P, Dinesh/AFP-6053-2022; Pattanaik, Amrita/AGR-4884-2022; Habib, Farhat/AAP-5421-2021; K Shahul Hameed, Shafeeq/GRX-8518-2022	P, Dinesh/0000-0003-4195-9536; Habib, Farhat/0000-0002-4295-2750; K Shahul Hameed, Shafeeq/0000-0002-3976-1443; Kumar, Narendra/0000-0002-4787-355X; Pattanaik, Amrita/0000-0002-1562-0347; PRASAD, PRAMADA/0000-0003-0933-3728; Pattabiraman, Chitra/0000-0002-9707-3358; Mani, Reeta/0000-0001-6039-1187; Damodar, Tina/0000-0002-7658-3367	NIMHANS; DBT/Wellcome Trust India Alliance Fellowship [IA/E/15/1/502336]; TruFactor-InMobi Group	NIMHANS; DBT/Wellcome Trust India Alliance Fellowship; TruFactor-InMobi Group	This work was supported by core funds of NIMHANS to the Department of Neurovirology and the DBT/Wellcome Trust India Alliance Fellowship IA/E/15/1/502336 awarded to Chitra P. YTruFactor-InMobi Group provided support in the form of salary for author FH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of FH are articulated in the `author contributions' section.	Banu S, 2020, DISTINCT PHYLOGENETI; Bedford T, 2020, CRYPTIC TRANSMISSION; Bell S. M, 2020, GENOMIC ANAL COVID 1; Biswas NK, 2020, INDIAN J MED RES, V151, P450, DOI 10.4103/ijmr.IJMR_1125_20; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbe S, 2017, GLOB CHALLENGES; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hodcroft E., 2020, GENOMIC ANAL COVID 1; ICMR Covid Study Grp, 2020, INDIAN J MED RES, V151, P424, DOI 10.4103/ijmr.IJMR_1896_20; Korber B, 2020, SPIKE MUTATION PIPEL; Lu J, 2020, CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023; MacLean OA, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa034; Mondal M, 2020, CURR SCI; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Potdar V, 2020, INDIAN J MED RES, V151, P255, DOI 10.4103/ijmr.IJMR_1058_20; Quick J, 2020, NCOV 2019 SEQUENCING, DOI [10.17504/protocols.io.bdp7i5rn, DOI 10.17504/PROTOCOLS.IO.BDP7I5RN]; Rambaut A., 2020, PHYLODYNAMIC ANAL; Rambaut A, 2020, DYNAMIC NOMENCLATURE, V5, P1403, DOI 10.1101/2020.04.17.046086; Singer J., 2020, COV GLUE WEB APPL TR, DOI [10.20944/preprints202006.0225.v1, DOI 10.20944/PREPRINTS202006.0225.V1]; WHO, 2020, 5 WHO; Yadav PD, 2020, INDIAN J MED RES, V151, P200, DOI 10.4103/ijmr.IJMR_663_20; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243412	10.1371/journal.pone.0243412	http://dx.doi.org/10.1371/journal.pone.0243412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332472	Green Published, Green Submitted, gold			2022-12-26	WOS:000601310900049
J	Sherman, CS; Heupel, MR; Johnson, M; Kaimuddin, M; Qamar, LMS; Chin, A; Simpfendorfer, CA				Sherman, C. Samantha; Heupel, Michelle R.; Johnson, Mohini; Kaimuddin, Muslimin; Qamar, L. M. Sjamsul; Chin, Andrew; Simpfendorfer, Colin A.			Repeatability of baited remote underwater video station (BRUVS) results within and between seasons	PLOS ONE			English	Article							REEF SHARKS; FISH ASSEMBLAGES; VERTICAL MIGRATION; RHINCODON-TYPUS; WHALE SHARKS; HABITAT USE; RAY; VARIABILITY; STINGRAY; CHONDRICHTHYES	Baited remote underwater video stations (BRUVS) are increasingly being used to evaluate and monitor reef communities. Many BRUVS studies compare multiple sites sampled at single time points that may differ from the sampling time of another site. As BRUVS use grows in its application to provide data relevant to sustainable management, marine protected area success, and overall reef health, understanding repeatability of sampling results is vital. We examined the repeatability of BRUVS results for the elasmobranch community both within and between seasons and years, and explored environmental factors affecting abundances at two sites in Indonesia. On 956 BRUVS, 1139 elasmobranchs (69% rays, 31% sharks) were observed. We found consistent results in species composition and abundances within a season and across years. However, elasmobranch abundances were significantly higher in the wet season. The elasmobranch community was significantly different between the two sites sampled, one site being more coastal and easily accessed by fishermen. Our results demonstrate that while BRUVS are a reliable and repeatable method for surveying elasmobranchs, care must be taken in the timing of sampling between different regions to ensure that any differences observed are due to inherent differences amongst sampling areas as opposed to seasonal dissimilarities.	[Sherman, C. Samantha; Chin, Andrew; Simpfendorfer, Colin A.] James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Sherman, C. Samantha] James Cook Univ, DB17 063, AIMS JCU, Townsville, Qld, Australia; [Sherman, C. Samantha] Simon Fraser Univ, Earth Oceans Res Grp, Dept Biol Sci, Burnaby, BC, Canada; [Heupel, Michelle R.; Chin, Andrew] Australian Inst Marine Sci, Cape Cleveland, Qld, Australia; [Johnson, Mohini] Operat Wallacea, Spilsby, Lincs, England; [Kaimuddin, Muslimin] Wasage Divers, Wakatobi, Southeast Sulaw, Indonesia; [Kaimuddin, Muslimin] Wasage Divers, Buton, Southeast Sulaw, Indonesia; [Qamar, L. M. Sjamsul] Univ Dayanu Ikhsanuddin, Fisheries Dept, Bau Bau, Southeast Sulaw, Indonesia	James Cook University; James Cook University; Simon Fraser University; Australian Institute of Marine Science	Sherman, CS (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia.; Sherman, CS (corresponding author), James Cook Univ, DB17 063, AIMS JCU, Townsville, Qld, Australia.; Sherman, CS (corresponding author), Simon Fraser Univ, Earth Oceans Res Grp, Dept Biol Sci, Burnaby, BC, Canada.	sammsherman27@gmail.com		Sherman, C. Samantha/0000-0002-7150-1035	Paul G. Allen Philanthropies; Global FinPrint project; Operation Wallacea; Wasage Divers	Paul G. Allen Philanthropies; Global FinPrint project; Operation Wallacea; Wasage Divers	This work was funded by Paul G. Allen Philanthropies and the Global FinPrint project (https://www.pgafamilyfoundation.org) awarded to CAS and MRH. Additional project support was provided by Operation Wallacea (https://www.opwall.com) and Wasage Divers (http://wasagedivers.com/en/home/) to CSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the funders (Wasage Divers) provided support in the form of salaries for authors M.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Anderson RC, 1996, MAR FRESHWATER RES, V47, P605, DOI 10.1071/MF9960605; [Anonymous], 1998, CERCETARI ISTORICE, V17, P101; [Anonymous], 2014, ANN FAM MED, V12, piii; [Anonymous], 2012, EUROPEAN J NUCL MED, V39, pS493; Asut H, 2019, WORLD NEWS NATURAL S, V24, P89; Barausse A, 2014, ICES J MAR SCI, V71, P1593, DOI 10.1093/icesjms/fst222; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Baum G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138271; Bernard ATF, 2012, MAR ECOL PROG SER, V471, P235, DOI 10.3354/meps10039; Birt MJ, 2012, J EXP MAR BIOL ECOL, V416, P92, DOI 10.1016/j.jembe.2012.02.011; Bouyoucos IA, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy053; Brinton CP, 2017, MAR FRESHWATER RES, V68, P1716, DOI 10.1071/MF16073; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cartamil DP, 2003, MAR BIOL, V142, P841, DOI 10.1007/s00227-003-1014-y; Cassey P, 2006, BIOSCIENCE, V56, P958, DOI 10.1641/0006-3568(2006)56[958:RARIE]2.0.CO;2; Chin A, 2013, AQUAT CONSERV, V23, P468, DOI 10.1002/aqc.2349; Chin A, 2016, MAR ECOL PROG SER, V544, P197, DOI 10.3354/meps11545; Cinner JE, 2018, P NATL ACAD SCI USA, V115, pE6116, DOI 10.1073/pnas.1708001115; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; Crow G.L., 2004, ELASMOBRANCH HUSBAND, V1st ed., P467; D'Croz L, 2007, ESTUAR COAST SHELF S, V73, P325, DOI 10.1016/j.ecss.2007.01.013; Dabruzzi TF, 2013, HYDROBIOLOGIA, V701, P37, DOI 10.1007/s10750-012-1249-z; Davy LE, 2015, MAR FRESHWATER RES, V66, P481, DOI 10.1071/MF14028; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Ellison AM, 2010, ECOLOGY, V91, P2536, DOI 10.1890/09-0032.1; Elphick CS, 2008, J APPL ECOL, V45, P1313, DOI 10.1111/j.1365-2664.2008.01545.x; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Gill H., 2004, ELASMOBRANCHS FITZRO; Goetze JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200960; Greenwell B, 2018, GEN BOOSTED REGRESSI; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heupel MR, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00012; HOPKINS TE, 1994, COPEIA, P529, DOI 10.2307/1447005; Hunter E, 2005, J MAR BIOL ASSOC UK, V85, P1199, DOI 10.1017/S0025315405012300; Hunter E, 2006, J APPL ECOL, V43, P710, DOI 10.1111/j.1365-2664.2006.01194.x; Janse M, 2010, J MAR BIOL ASSOC UK, V90, P353, DOI 10.1017/S002531540999035X; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Kilfoil JP, 2017, MAR ECOL PROG SER, V585, P113, DOI 10.3354/meps12395; Knip DM, 2011, MAR FRESHWATER RES, V62, P658, DOI 10.1071/MF10136; Last P. R., 2016, P1; MacNeil MA, 2020, NATURE; Merkel A, CLIMATE BAU BAU; Mourier J, 2013, MOL ECOL, V22, P201, DOI 10.1111/mec.12103; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Papastamatiou YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127807; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Parsons GR, 1998, FISH PHYSIOL BIOCHEM, V19, P189, DOI 10.1023/A:1007730308184; Pierce SJ, 2009, J FISH BIOL, V75, P2490, DOI 10.1111/j.1095-8649.2009.02435.x; Pomilla C, 2005, BIOL LETTERS, V1, P476, DOI 10.1098/rsbl.2005.0351; REYES E, 1991, ESTUARIES, V14, P372, DOI 10.2307/1352262; Rokhim R, 2017, J ENTERP COMMUNITIES, V11, P438, DOI 10.1108/JEC-09-2015-0049; Samson, 2015, OPEN J STAT, V5, P754, DOI DOI 10.4236/OJS.2015.57075; Schlaff AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231142; Schlaff AM, 2014, REV FISH BIOL FISHER, V24, P1089, DOI 10.1007/s11160-014-9364-8; Schroeder T, 2012, MAR POLLUT BULL, V65, P210, DOI 10.1016/j.marpolbul.2012.02.022; Sellas AB, 2015, J HERED, V106, P266, DOI 10.1093/jhered/esv011; Sherman CS, 2020, MAR ECOL PROG SER, V641, P145, DOI 10.3354/meps13307; Sherman CS, 2018, J EXP MAR BIOL ECOL, V503, P80, DOI 10.1016/j.jembe.2018.03.002; Simmonds M.P., 2014, J OCEAN TECHNOL, V9, P71; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; SMITH AFM, 1992, AM STAT, V46, P84, DOI 10.2307/2684170; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; Stuber EF, 2013, BEHAV ECOL, V24, P1092, DOI 10.1093/beheco/art035; Taylor MD, 2013, FISH RES, V140, P96, DOI 10.1016/j.fishres.2012.12.013; Tickler DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177374; Tjasyono H.K.B, 2008, INT S EQ MONS SYST Y; Udyawer V, 2013, MAR ECOL PROG SER, V480, P171, DOI 10.3354/meps10244; Barbosa MLV, 2016, MAR POLICY, V73, P210, DOI 10.1016/j.marpol.2016.08.007; Varkey DA, 2010, MAR POLICY, V34, P228, DOI 10.1016/j.marpol.2009.06.009; Vaudo JJ, 2009, MAR BIOL, V156, P2579, DOI 10.1007/s00227-009-1282-2; White J, 2013, J EXP MAR BIOL ECOL, V448, P281, DOI 10.1016/j.jembe.2013.08.004; White W.T., 2006, EC IMPORTANT SHARKS; Whitmarsh SK, 2017, REV FISH BIOL FISHER, V27, P53, DOI 10.1007/s11160-016-9450-1; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Wraith J, 2013, MAR ECOL PROG SER, V477, P189, DOI 10.3354/meps10137	82	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244154	10.1371/journal.pone.0244154	http://dx.doi.org/10.1371/journal.pone.0244154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332427	Green Published, Green Accepted, gold			2022-12-26	WOS:000601310900072
J	Zanetti, M; Barazzoni, R; Kiwanuka, E; Vettore, M; Vedovato, M; Tessari, P				Zanetti, Michela; Barazzoni, Rocco; Kiwanuka, Edward; Vettore, Monica; Vedovato, Monica; Tessari, Paolo			Accelerated whole-body protein catabolism in subjects with type 2 Diabetes Mellitus and albuminuria	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; AMINO-ACID-METABOLISM; STAGE RENAL-DISEASE; PHENYLALANINE HYDROXYLATION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; TYROSINE; KIDNEY; CONVERSION; LEUCINE	Background Albuminuria develops in similar to 40% of subjects with Type 2 Diabetes Mellitus (T2DM), and is often associated with malnutrition, severe comorbidities and decreased life expectancy. The association between albuminuria and altered whole body protein turnover in T2DM is currently unknown. Objective To assess whole body protein degradation and synthesis in type 2 diabetes with and without albuminuria. Methods Fourteen T2DM male subjects, with either increased [AER+] or normal [AER-] urinary albumin excretion rate, and eleven age-matched male healthy controls, were infused with phenylalanine [Phe] and tyrosine [Tyr] tracers. Post-absorptive rates of appearance (Ra) of Phe (= protein degradation) and Tyr, Phe hydroxylation to Tyr (Hy) (catabolic pathway), and Phe disposal to protein synthesis [PS], were determined. Results Phe and Tyr Ra were not different among the groups. However, in T2DM [AER+], the fraction of Phe disposal to hydroxylation was similar to 50% and similar to 25% greater than that of both controls and T2DM [AER-] (p<0.006 and p = 0.17, respectively). Conversely, as compared to controls, the fractional Phe disposal to PS was similar to 10% lower in T2DM [AER+] (p<0.006), and not different from that in T2DM [AER-]. As a consequence, in T2DM [AER+], the ratio between the fractional Phe disposal to hydroxylation and that to PS was similar to 70% greater (p = 0.005) than that in healthy controls, whereas in the T2DM [AER-] this ratio was similar to 30% greater than in controls (p = 0.19). Conclusions On the basis of the kinetics of the essential amino acid phenylalanine, T2DM subjects with increased AER exhibit a catabolic pattern of whole body protein turnover.	[Zanetti, Michela; Barazzoni, Rocco; Kiwanuka, Edward; Vettore, Monica; Vedovato, Monica; Tessari, Paolo] Univ Padua, Dept Med, Metab Div, Padua, Italy; [Zanetti, Michela; Barazzoni, Rocco] Univ Trieste, DSM, Trieste, Italy	University of Padua; University of Trieste	Zanetti, M; Tessari, P (corresponding author), Univ Padua, Dept Med, Metab Div, Padua, Italy.; Zanetti, M (corresponding author), Univ Trieste, DSM, Trieste, Italy.	zanetti@units.it; paolo.tessari@unipd.it		ZANETTI, MICHELA/0000-0002-2634-6363	2002-2003 "FIRB" Grant of the Italian Minister for University and Research Project title "Molecular mechanisms of the pathogenesis and progression of diabetic nephropathy"	2002-2003 "FIRB" Grant of the Italian Minister for University and Research Project title "Molecular mechanisms of the pathogenesis and progression of diabetic nephropathy"	PT - 2002-2003 "FIRB" Grant of the Italian Minister for University and Research Project title "Molecular mechanisms of the pathogenesis and progression of diabetic nephropathy". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAWI J, 1990, DIABETIC MED, V7, P115, DOI 10.1111/j.1464-5491.1990.tb01344.x; Berhane AM, 2011, CLIN J AM SOC NEPHRO, V6, P2444, DOI 10.2215/CJN.00580111; BERKELHAMMER CH, 1987, AM J CLIN NUTR, V46, P778, DOI 10.1093/ajcn/46.5.778; BIOLO G, 1992, AM J PHYSIOL, V263, pE877, DOI 10.1152/ajpendo.1992.263.5.E877; BIOLO G, 1992, AM J PHYSIOL, V262, pE455, DOI 10.1152/ajpendo.1992.262.4.E455; Boirie Y, 2004, KIDNEY INT, V66, P591, DOI 10.1111/j.1523-1755.2004.00778.x; CASTELLINO P, 1992, AM J PHYSIOL, V262, pF168, DOI 10.1152/ajprenal.1992.262.2.F168; CLARKE JTR, 1982, METABOLISM, V31, P999, DOI 10.1016/0026-0495(82)90142-1; de Zeeuw D, 2007, SEMIN NEPHROL, V27, P172, DOI 10.1016/j.semnephrol.2007.01.002; DEFERRARI G, 1988, AM J CLIN NUTR, V48, P72, DOI 10.1093/ajcn/48.1.72; Giordano M, 2008, DIABETOLOGIA, V51, P21, DOI 10.1007/s00125-007-0874-y; GOODSHIP THJ, 1990, J AM SOC NEPHROL, V1, P66; Han E, 2016, METABOLISM, V65, P1531, DOI 10.1016/j.metabol.2016.07.003; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hoffmann MR, 2016, EUR J CLIN NUTR, V70, P743, DOI 10.1038/ejcn.2015.185; HUME R, 1971, J CLIN PATHOL, V24, P234, DOI 10.1136/jcp.24.3.234; JONES MR, 1978, KIDNEY INT, V14, P169, DOI 10.1038/ki.1978.104; Karalliedde J, 2010, J AM SOC NEPHROL, V21, P2020, DOI 10.1681/ASN.2010030250; Khan SM, 2009, J RENAL NUTR, V19, P275, DOI 10.1053/j.jrn.2009.01.026; Kopple JD, 2007, J NUTR, V137, p1586S, DOI 10.1093/jn/137.6.1586S; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LUZI L, 1993, DIABETES, V42, P1868, DOI 10.2337/diabetes.42.12.1868; Mancia G, 2005, ACTA DIABETOL, V42, pS17, DOI 10.1007/s00592-005-0177-z; Maroni BJ, 1997, J CLIN INVEST, V99, P2479, DOI 10.1172/JCI119432; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Moller N, 2000, P NATL ACAD SCI USA, V97, P1242, DOI 10.1073/pnas.97.3.1242; Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887; Pugliese G, 2014, NUTR METAB CARDIOVAS, V24, P815, DOI 10.1016/j.numecd.2014.02.013; REAICH D, 1992, AM J PHYSIOL, V263, pE735, DOI 10.1152/ajpendo.1992.263.4.E735; REAICH D, 1993, AM J PHYSIOL, V265, pE230, DOI 10.1152/ajpendo.1993.265.2.E230; Rosenberg LE, 1980, METABOLIC CONTROL DI, P707; SCHWENK WF, 1984, ANAL BIOCHEM, V141, P101; Sun X, 2015, DIABETES RES CLIN PR, V110, pE22, DOI 10.1016/j.diabres.2015.09.012; Tessari P, 2006, DIABETOLOGIA, V49, P1955, DOI 10.1007/s00125-006-0288-2; Tessari P, 2003, AM J PHYSIOL-ENDOC M, V284, pE1037, DOI 10.1152/ajpendo.00416.2002; Tessari P, 1999, KIDNEY INT, V56, P2168, DOI 10.1038/sj.ki.4491156; Tessari P, 2015, J CLIN ENDOCR METAB, V100, P4098, DOI 10.1210/jc.2015-2172; TIZIANELLO A, 1980, AM J CLIN NUTR, V33, P1354, DOI 10.1093/ajcn/33.7.1354; Wolfe RR, 1992, RADIOACTIVE STABLE I, P62; YOUNG GA, 1973, CLIN SCI MOL MED, V45, P89, DOI 10.1042/cs0450089; Zanetti M, 2001, AM J PHYSIOL-ENDOC M, V280, pE591, DOI 10.1152/ajpendo.2001.280.4.E591	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243638	10.1371/journal.pone.0243638	http://dx.doi.org/10.1371/journal.pone.0243638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332405	gold, Green Published			2022-12-26	WOS:000601310900046
J	Linda, R; Kunes, I; Balas, M				Linda, Rostislav; Kunes, Ivan; Balas, Martin			Genetic and morphometric variability between populations of Betula xoycoviensis from Poland and Czechia: A revised view of the taxonomic treatment of the Ojcow birch	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; PHYLOGENETIC-RELATIONSHIPS; EST-SSRS; INFERENCE; PROGRAM	Birches are generally known for their high genetic and morphological variability, which has resulted in the description of many species. Ojcow birch was described in 1809 by Willibald Suibert Joseph Gottlieb Besser in Poland. Since then, several studies assessing its taxonomy were conducted. Today, various authors present Ojcow birch at different taxonomic ranks. In Czechia, the Ojcow birch is classified a critically endangered taxon and confirmed at one locality consisting of several tens of individuals. However, before a strategy for its conservation can be applied, we consider it necessary to assess the taxonomic position of the endangered Czech population and to evaluate its relationship to the original Polish population. This study aimed to evaluate the morphometric and genetic variability between populations of B. xoycoviensis in Poland and the Czechia and their relationship to regional populations of B. pendula, one of the putative parental species of the Ojcow birch. Altogether, 106 individuals were sampled, including the holotype of B. szaferi, the second putative parental species of B. xoycoviensis, received from the herbarium of W. Szafer, which is deposited at the Institute of Botany in Krakow. Morphological analyses identified differences in leaves between B. xoycoviensis and B. pendula. However, no significant differences were found in genome size between selected taxa/working units except for B. pendula sampled in Czechia. The identified difference of the Czech population of B. pendula is probably caused by population variability. Genetic variability between all the taxa under comparison, regardless of their origin, was also very low; only the benchmark taxa (B. nana and B. humilis) clearly differed from all samples analyzed. The results indicate minute morphological and negligible genetic variability between the Czech and Polish populations of B. xoycoviensis. In light of our results, the classification of B. xoycoviensis as B. pendula var. oycoviensis seems more accurate than all hitherto presented alternatives (e.g. B. xoycoviensis as a separate species).	[Linda, Rostislav; Kunes, Ivan; Balas, Martin] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Silviculture, Prague, Suchdol, Czech Republic	Czech University of Life Sciences Prague	Linda, R (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Silviculture, Prague, Suchdol, Czech Republic.	lindar@fld.czu.cz		Kunes, Ivan/0000-0002-1875-384X	Technology Agency of the Czech Republic [TACR TH03030339]; Internal Grant Agency of Faculty of Forestry and Wood Sciences [A_19_24]	Technology Agency of the Czech Republic; Internal Grant Agency of Faculty of Forestry and Wood Sciences	The research activities were supported by Technology Agency of the Czech Republic: grant project No. TACR TH03030339 (Ivan Kunes.) and by Internal Grant Agency of Faculty of Forestry and Wood Sciences No. A_19_24 (Martin Balas.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Anamthawat-Jonsson K, 2003, PLANT CELL TISS ORG, V75, P99, DOI 10.1023/A:1025063123552; [Anonymous], 2012, J MIDWIFERY WOM HEAL, V57, P112, DOI 10.1111/j.1542-2011.2011.00163.x; Ashburner K, 2013, GENUS BETULA TAXONOM; ATKINSON M D, 1986, Watsonia, V16, P75; Bala M, 2019, VYSKYT JEDINCU S FEN; Balas M, 2016, DENDROBIOLOGY, V76, P117, DOI 10.12657/denbio.076.011; Besser WSJG, 1809, PRIMITIAE FLORAE GAL; Biemont C, 2008, HEREDITY, V101, P297, DOI 10.1038/hdy.2008.80; DOMIN KAREL, 1927, ROZPRAVY CESKI AKAD VED A UMENI, V36, P1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fiek E, 1888, JAHRES BERICHT SCHLE, V65, P310; Franiel I., 2009, Fragmenta Floristica et Geobotanica Polonica, V16, P27; FURLOW JJ, 1990, J ARNOLD ARBORETUM, V71, P1; Gardiner AS, 1962, SILVAE GENET, V11, P125; GILL JA, 1983, NEW PHYTOL, V94, P433, DOI 10.1111/j.1469-8137.1983.tb03457.x; Goudet J, 1996, GENETICS, V144, P1933; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; Grimm GW, 2013, BOT J LINN SOC, V172, P465, DOI 10.1111/boj.12065; Grulich, 2017, PRIRODA, V35, P75; Hejtmanek J., 1956, Preslia, V28, P245; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jarvinen P, 2004, AM J BOT, V91, P1834, DOI 10.3732/ajb.91.11.1834; JENTYS-SZAFEROWA J, 1974, Fragmenta Floristica et Geobotanica, V20, P203; Jentys-Szaferowa J, 1921, FLORA POLSKA 2, P3; Jentys-Szaferowa J, 1967, ROCZ SEKC DENDROL PO, V2, P5; Jentys-Szaferowa J, 1928, ROCZ POL TOW DENDROL, V2, P69; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kaplan Z., 2019, KLI KE KVETENE ESKE; Ki Z, 2003, KVETENA ESKE REPUBLI, P36; Korczyk A., 1967, Ochrona Przyrody, V32, P133; Koutecky P, 2015, PLANT SYST EVOL, V301, P1115, DOI 10.1007/s00606-014-1153-2; Kulju KKM, 2004, MOL ECOL NOTES, V4, P471, DOI 10.1111/j.1471-8286.2004.00704.x; Linda Rostislav, 2017, Journal of Forest Science (Prague), V63, P531, DOI [10.17221/105/2017-jfs, 10.17221/105/2017-JFS]; Mallet J, 2007, ENCY BIODIVERSITY, V5, P1, DOI [10.1016/B0-12-226865-2/00261-3, DOI 10.1016/B0-12-226865-2/00261-3]; Olshanskyi I. G., 2016, Ukrayins'kyi Botanichnyi Zhurnal, V73, P401, DOI 10.15407/ukrbotj73.04.401; Otto F, 1990, Methods Cell Biol, V33, P105; Pawowska L, 1980, ACTA SOC BOT POL, V49, P311; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rivers M.C., 2019, EUROPEAN RED LIST TR, P60, DOI [10.2305/IUCN.CH.2019.ERL.1.en, DOI 10.2305/IUCN.CH.2019.ERL.1.EN]; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rutkowski L, 2018, KLUCZ OZNACZANIA ROL; Schenk MF, 2008, TREE GENET GENOMES, V4, P911, DOI 10.1007/s11295-008-0162-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw K, 2014, BETULACEAE; Siegel S, 1988, NONPARAMETRIC STAT B, V2; STASZKIEWICZ J, 1986, ACTA SOC BOT POL, V55, P361, DOI 10.5586/asbp.1986.033; Staszkiewicz J, 1985, CHROMY PRZYR OJCZYST, V41, P36; Staszkiewicz J, 1992, VEROFFENTLICHUNGEN G, V107, P94; Staszkiewicz J, 2013, BRZOZA OJCOWSKA BETU; Suda J, 2010, PRESLIA, V82, P1; Sykora T, 1983, ZPR CS BOT SPOLEC, V18, P1; SZWABOWICZ A, 1976, Acta Societatis Botanicorum Poloniae, V45, P169, DOI 10.5586/4970; Thorsson AETH, 2007, ANN BOT-LONDON, V99, P1183, DOI 10.1093/aob/mcm060; Tsuda Y, 2009, CONSERV GENET, V10, P1385, DOI 10.1007/s10592-008-9701-3; Tsuda Y, 2009, CONSERV GENET, V10, P661, DOI 10.1007/s10592-008-9608-z; Vaut RJ, 2019, KLI KE KVETENE ESKE, P1172; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Willdenow CL, 1805, CAROLI LINNE SPECIES, P1805, DOI [10.5962/bhl.title.727, DOI 10.5962/BHL.TITLE.727]; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Zachos FE., 2016, SPECIES CONCEPTS BIO	69	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243310	10.1371/journal.pone.0243310	http://dx.doi.org/10.1371/journal.pone.0243310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326473	gold, Green Published			2022-12-26	WOS:000600176400006
J	Ognibene, M; Pezzolo, A				Ognibene, Marzia; Pezzolo, Annalisa			Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma	PLOS ONE			English	Article							ERM PROTEINS; MESENCHYMAL TRANSITION; ACTIVATION; PATTERN; GROWTH; MAP2	In a previous study, we demonstrated that CHL1, the neuronal cell adhesion molecule close homolog of L1, acts as a tumor suppressor in human neuroblastoma (NB), a still highly lethal childhood malignancy, influencing its differentiation and proliferation degree. Here we found that ezrin, one of the ERM (ezrin, radixin, moesin) proteins involved in cytoskeleton organization, strongly interacts with CHL1. The low expression of EZRIN, as well as the low expression of CHL1 and of the neuronal differentiation marker MAP2, correlates with poor outcome in NB patients. Knock-down of ezrin in HTLA-230 cell line induces neurite retraction, enhances cell proliferation and migration, and triggers anchorage-independent growth, with effects very similar to those already obtained by CHL1 silencing. Furthermore, lack of ezrin inhibits the expression of MAP2 and of the oncosuppressor molecule p53, whereas it enhances MAPK activation, all typical features of tumor aggressiveness. As already described, CHL1 overexpression in IMR-32 cell line provokes an opposite trend, but the co-silencing of ezrin reduces these effects, confirming the hypothesis that CHL1 acts in close connection with ezrin. Overall, our data show that ezrin reinforces the differentiating and oncosuppressive functions of CHL1, identifying this ERM protein as a new targetable molecule for NB therapy.	[Ognibene, Marzia] IRCCS Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy; [Pezzolo, Annalisa] IRCCS Ist Giannina Gaslini, Lab Cellule Staminali Post Natali & Terapie Cellu, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Ognibene, M (corresponding author), IRCCS Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy.	marziaognibene@gaslini.org	Ognibene, Marzia/AAA-7275-2020	Ognibene, Marzia/0000-0003-3698-9319	Compagnia San Paolo [ROL 20207]; Italian Ministry of Health [MSALRC18]	Compagnia San Paolo(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy)	This research was funded by Compagnia San Paolo (ID ROL 20207) (AP) and by Finanziamento Ricerca Corrente 2018, Italian Ministry of Health (MSALRC18) (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-36; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brooks CL, 2010, CELL RES, V20, P614, DOI 10.1038/cr.2010.53; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Depuydt P, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djy022; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Guo JC, 2017, J MOL MED, V95, P1355, DOI 10.1007/s00109-017-1595-4; Haas MA, 2007, J NEUROSCI RES, V85, P34, DOI 10.1002/jnr.21102; He J, 2017, MED SCI MONITOR, V23, P1583, DOI 10.12659/MSM.904124; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Katic J, 2014, J NEUROSCI, V34, P14606, DOI 10.1523/JNEUROSCI.3280-13.2014; Lane J, 2012, ENRICH COMMUN, V6; Li JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17903; Liu P, 2018, MED SCI MONITOR, V24, P2098, DOI 10.12659/MSM.906945; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matsumoto Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105435; MATSUSHIMA H, 1992, INT J CANCER, V51, P250, DOI 10.1002/ijc.2910510214; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Ognibene M, 2020, CANCER BIOL THER, V21, P391, DOI 10.1080/15384047.2019.1704122; Ognibene M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194764; Ognibene Marzia, 2018, Oncotarget, V9, P25903, DOI 10.18632/oncotarget.25403; Ognibene M, 2011, J BIOL CHEM, V286, P29973, DOI 10.1074/jbc.M111.270785; Oh JE, 2006, AMINO ACIDS, V31, P289, DOI 10.1007/s00726-005-0256-z; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Riecken LB, 2015, HUM MUTAT, V36, P270, DOI 10.1002/humu.22737; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Tolbert VP, 2018, CELL TISSUE RES, V372, P195, DOI 10.1007/s00441-018-2821-2; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Wachowiak R, 2019, OPEN MED-WARSAW, V14, P920, DOI 10.1515/med-2019-0109; Wennersten C, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0189-5; Zhang WW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0581-9	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244069	10.1371/journal.pone.0244069	http://dx.doi.org/10.1371/journal.pone.0244069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326488	Green Published, gold			2022-12-26	WOS:000600176400020
J	Luo, JH; Liu, S; Tao, JY; Ren, BG; Luo, K; Chen, ZH; Nalesnik, M; Cieply, K; Ma, TZ; Cheng, SY; Chen, Q; Michalopoulos, GK; Nelson, JB; Bhargava, R; Zhang, J; Ma, DQ; Jarrard, D; Pennathur, A; Luketich, JD; DeFranco, DB; Monga, SP; Tseng, G; Yu, YP				Luo, Jian-Hua; Liu, Silvia; Tao, Junyan; Ren, Bao-Guo; Luo, Katherine; Chen, Zhang-Hui; Nalesnik, Michael; Cieply, Kathleen; Ma, Tianzhou; Cheng, Shi-Yuan; Chen, Qi; Michalopoulos, George K.; Nelson, Joel B.; Bhargava, Rohit; Zhang, Jun; Ma, Deqin; Jarrard, David; Pennathur, Arjun; Luketich, James D.; DeFranco, Donald B.; Monga, Satdarshan Paul; Tseng, George; Yu, Yan-Ping			Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; TUMOR-SUPPRESSOR; ONCOGENIC ACTIVITY; PROSTATE-CANCER; PTEN; GENE; MAINTENANCE; NUCLEOLAR; NOPP140	Inactivation of Pten gene through deletions and mutations leading to excessive pro-growth signaling pathway activations frequently occurs in cancers. Here, we report a Pten derived pro-cancer growth gene fusion Pten-NOLC1 originated from a chr10 genome rearrangement and identified through a transcriptome sequencing analysis of human cancers. Pten-NOLC1 fusion is present in primary human cancer samples and cancer cell lines from different organs. The product of Pten-NOLC1 is a nuclear protein that interacts and activates promoters of EGFR, c-MET, and their signaling molecules. Pten-NOLC1 promotes cancer proliferation, growth, invasion, and metastasis, and reduces the survival of animals xenografted with Pten-NOLC1-expressing cancer cells. Genomic disruption of Pten-NOLC1 induces cancer cell death, while genomic integration of this fusion gene into the liver coupled with somatic Pten deletion produces spontaneous liver cancers in mice. Our studies indicate that Pten-NOLC1 gene fusion is a driver for human cancers.	[Luo, Jian-Hua; Liu, Silvia; Tao, Junyan; Ren, Bao-Guo; Chen, Zhang-Hui; Nalesnik, Michael; Cieply, Kathleen; Michalopoulos, George K.; Bhargava, Rohit; Monga, Satdarshan Paul; Yu, Yan-Ping] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Luo, Katherine; Tseng, George] Columbia Univ, Dept Biol, 1212 Amsterdam Ave, New York, NY 10027 USA; [Ma, Tianzhou] Univ Pittsburgh, Sch Med, Dept Biostat, Pittsburgh, PA 15261 USA; [Cheng, Shi-Yuan] Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Chen, Qi] Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Nelson, Joel B.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15261 USA; [Zhang, Jun] Univ Iowa, Dept Med, Iowa City, IA 52242 USA; [Ma, Deqin] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Jarrard, David] Univ Wisconsin, Dept Urol, Madison, WI 53792 USA; [Pennathur, Arjun; Luketich, James D.] Univ Pittsburgh, Sch Med, Dept Thorac Surg, Pittsburgh, PA 15261 USA; [DeFranco, Donald B.] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Ma, Tianzhou] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Zhang, Jun] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66160 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; University of Kansas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland College Park; University of Kansas; University of Kansas Medical Center	Luo, JH; Yu, YP (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA.	luoj@msx.upmc.edu; ypyu@pitt.edu	Luo, jian/HGE-7331-2022; Ma, Tianzhou/AAC-8221-2021; Yu, Yan/GYV-4514-2022	Ma, Tianzhou/0000-0003-3605-0811; Luo, Jianhua/0000-0002-3189-4225; Cheng, Shiyuan/0000-0003-1737-0588; Zhang, Jun/0000-0001-7886-6187	NCI NIH HHS [P30 CA086862, R56 CA229262, R01 CA250227, R01 CA098249, R01 CA251155] Funding Source: Medline; NIDDK NIH HHS [P30 DK120531] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; BENSON ES, 1961, POSTGRAD MED, V30, pA22; Chen HK, 1999, MOL CELL BIOL, V19, P8536; Chen ZH, 2017, GASTROENTEROLOGY, V153, P1120, DOI 10.1053/j.gastro.2016.12.036; Chen ZH, 2017, NAT BIOTECHNOL, V35, P543, DOI 10.1038/nbt.3843; Chen ZH, 2015, J BIOL CHEM, V290, P1404, DOI 10.1074/jbc.M114.622761; Gao XS, 2011, BMB REP, V44, P70, DOI 10.5483/BMBRep.2011.44.1.70; Han YC, 2013, J PATHOL, V230, P184, DOI 10.1002/path.4169; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He DM, 2017, ONCOGENE, V36, P3629, DOI 10.1038/onc.2017.123; Hwang YC, 2009, AM J PATHOL, V175, P342, DOI 10.2353/ajpath.2009.080931; Isaac C, 1998, J CELL BIOL, V142, P319, DOI 10.1083/jcb.142.2.319; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Lee YM, 1996, MOL CELL BIOL, V16, P4257; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Luo JH, 2015, AM J PATHOL, V185, P1834, DOI 10.1016/j.ajpath.2015.03.008; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; PAI CY, 1995, J CELL SCI, V108, P1911; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Renvoise B, 2009, HUM MOL GENET, V18, P1181, DOI 10.1093/hmg/ddp009; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tsai YT, 2008, J BIOMED SCI, V15, P471, DOI 10.1007/s11373-007-9226-7; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Yan-Ping Y., 2019, ONCOTARGET; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Yu GY, 2006, AM J PATHOL, V168, P597, DOI 10.2353/ajpath.2006.050620; Yu YP, 2014, AM J PATHOL, V184, P2840, DOI 10.1016/j.ajpath.2014.06.025; Yu YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092820; Yu Yan-Ping, 2019, Oncotarget, V10, P3352; Yu YP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38550-6; Zuo ZH, 2017, MOL CARCINOGEN, V56, P315, DOI 10.1002/mc.22494	40	4	4	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1064	1076		10.1038/s41388-020-01582-8	http://dx.doi.org/10.1038/s41388-020-01582-8		DEC 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33323972	Green Accepted			2022-12-26	WOS:000599126500006
J	Breslawec, AP; Wang, SC; Li, C; Poulin, MB				Breslawec, Alexandra P.; Wang, Shaochi; Li, Crystal; Poulin, Myles B.			Anionic amino acids support hydrolysis of poly-beta-(1,6)-N-acetylglucosamine exopolysaccharides by the biofilm dispersing glycosidase Dispersin B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLHEXOSAMINIDASE; SUBSTRATE-ASSISTED CATALYSIS; STAPHYLOCOCCUS-EPIDERMIDIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; INTERCELLULAR-ADHESION; STRUCTURAL-ANALYSIS; PROVIDES INSIGHT; MOLECULAR-BASIS; MATRIX; POLYSACCHARIDE	The exopolysaccharide poly-beta-(1 -> 6)-N-acetylglucosamine (PNAG) is a major structural determinant of bacterial biofilms responsible for persistent and nosocomial infections. The enzymatic dispersal of biofilms by PNAG-hydrolyzing glycosidase enzymes, such as Dispersin B (DspB), is a possible approach to treat biofilm-dependent bacterial infections. The cationic charge resulting from partial de-N-acetylation of native PNAG is critical for PNAG-dependent biofilm formation. We recently demonstrated that DspB has increased catalytic activity on de-N-acetylated PNAG oligosaccharides, but the molecular basis for this increased activity is not known. Here, we analyze the role of anionic amino acids surrounding the catalytic pocket of DspB in PNAG substrate recognition and hydrolysis using a combination of site-directed mutagenesis, activity measurements using synthetic PNAG oligosaccharide analogs, and in vitro biofilm dispersal assays. The results of these studies support a model in which bound PNAG is weakly associated with a shallow anionic groove on the DspB protein surface with recognition driven by interactions with the -1 GlcNAc residue in the catalytic pocket. An increased rate of hydrolysis for cationic PNAG was driven, in part, by interaction with D147 on the anionic surface. Moreover, we identified that a DspB mutant with improved hydrolysis of fully acetylated PNAG oligosaccharides correlates with improved in vitro dispersal of PNAG-dependent Staphylococcus epidermidis biofilms. These results provide insight into the mechanism of substrate recognition by DspB and suggest a method to improve DspB biofilm dispersal activity by mutation of the amino acids within the anionic binding surface.	[Breslawec, Alexandra P.; Wang, Shaochi; Li, Crystal; Poulin, Myles B.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Poulin, MB (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	mpoulin@umd.edu			Faculty Student Research Award from the Graduate School at University of Maryland College Park	Faculty Student Research Award from the Graduate School at University of Maryland College Park	This work was funded in part by startup funds and a Faculty Student Research Award from the Graduate School at University of Maryland College Park.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chen KM, 2014, MICROB PATHOGENESIS, V77, P89, DOI 10.1016/j.micpath.2014.11.005; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; CHRISTENSEN GD, 1982, ANN INTERN MED, V96, P1, DOI 10.7326/0003-4819-96-1-1; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Donelli G, 2007, ANTIMICROB AGENTS CH, V51, P2733, DOI 10.1128/AAC.01249-06; Eddenden A, 2020, ACS CHEM BIOL, V15, P1204, DOI 10.1021/acschembio.9b00907; Fazekas E, 2012, CARBOHYD RES, V363, P7, DOI 10.1016/j.carres.2012.09.016; Fekete A, 2011, CARBOHYD RES, V346, P1445, DOI 10.1016/j.carres.2011.03.029; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Forman A, 2019, ORG BIOMOL CHEM, V17, P9456, DOI 10.1039/c9ob02079a; [郭海娜 Guo Haina], 2015, [中华烧伤杂志, Chinese Journal of Burns], V31, P45; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; Ito T, 2013, J BIOL CHEM, V288, P11795, DOI 10.1074/jbc.M112.420109; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Kaplan JB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205526; Kaplan JB, 2014, METHODS MOL BIOL, V1147, P203, DOI 10.1007/978-1-4939-0467-9_14; Koo H, 2016, CURR OPIN CELL BIOL, V42, P102, DOI 10.1016/j.ceb.2016.05.005; Landini P, 2010, APPL MICROBIOL BIOT, V86, P813, DOI 10.1007/s00253-010-2468-8; Little DJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006998; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; Manuel SGA, 2007, FEBS J, V274, P5987, DOI 10.1111/j.1742-4658.2007.06121.x; Mark BL, 1998, J BIOL CHEM, V273, P19618, DOI 10.1074/jbc.273.31.19618; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Nadell CD, 2015, ISME J, V9, P1700, DOI 10.1038/ismej.2014.246; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Ren B, 2005, TETRAHEDRON LETT, V46, P8083, DOI 10.1016/j.tetlet.2005.09.142; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stroberg W, 2016, BIOPHYS CHEM, V219, P17, DOI 10.1016/j.bpc.2016.09.004; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wang SC, 2020, CHEM-EUR J, V26, P10719, DOI 10.1002/chem.202002475; Wang SC, 2019, ACS CHEM BIOL, V14, P1998, DOI 10.1021/acschembio.9b00467; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Woods Group, 2005, GLYCAM WEB; Yan J, 2019, CELL HOST MICROBE, V26, P15, DOI 10.1016/j.chom.2019.06.002	59	4	4	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100203	10.1074/jbc.RA120.015524	http://dx.doi.org/10.1074/jbc.RA120.015524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334876	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400181
J	Lee, JY; Tokumoto, M; Satoh, M				Lee, Jin-Yong; Tokumoto, Maki; Satoh, Masahiko			Cadmium toxicity mediated by the inhibition of SLC2A4 expression in human proximal Tubule cells	FASEB JOURNAL			English	Article						ATP; cadmium; glucose; MEF2A transcription factor; proximal tubule	UBE2D FAMILY GENES; DOWN-REGULATION; DNA MICROARRAY; IN-VITRO; BINDING; EXPOSURE; ACCUMULATION; DISRUPTION; EXERCISE; PATHWAY	Cadmium (Cd) is an environmental contaminant that causes renal toxicity. We have previously demonstrated that Cd induces renal toxicity by altering transcriptional activities. In this study, we show that Cd markedly inhibited the activity of transcription factor MEF2A in HK-2 human proximal tubule cells, which generated significant cytotoxicity in the cells. This reduction in the nuclear levels of MEF2A protein may be involved in the Cd-induced inhibition of MEF2A activity. We also demonstrate that one of the glucose transporters, GLUT4, was downregulated not only by Cd treatment but also by MEF2A knockdown. Knockdown of SLC2A4, encoding GLUT4, eliminated both cell viability and Cd toxicity. Cd treatment or SLC2A4 deficiency reduced the cellular concentration of glucose. Therefore, the suppression of SLC2A4 expression, which mediates the reduction in cellular glucose, is involved in Cd toxicity. The Cd toxicity induced by the reduction in GLUT4 may be associated with a reduction of cellular ATP levels in HK-2 cells. The levels of Slc2a4 mRNA in the kidney of mice exposed to Cd for 6 or 12 months were significantly lower than those in the control group. These results demonstrate that Cd exerts its cytotoxicity through the suppression in SLC2A4 expression and the subsequent inhibition of MEF2A transcriptional activity. Cd-induced suppression of SLC2A4 expression also reduces cellular ATP levels, partly by reducing glucose levels. This study suggests that the glucose transporter plays an important role in the renal toxicity of Cd, and provides a crucial breakthrough in our understanding of the mechanism of Cd toxicity.	[Lee, Jin-Yong; Tokumoto, Maki; Satoh, Masahiko] Aichi Gakuin Univ, Sch Pharm, Lab Pharmaceut Hlth Sci, Nagoya, Aichi, Japan	Aichi Gakuin University	Satoh, M (corresponding author), Aichi Gakuin Univ, Sch Pharm, Lab Pharmaceut Hlth Sci, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	masahiko@dpc.agu.ac.jp						Alsahli M, 2017, DIABETES RES CLIN PR, V133, P1, DOI 10.1016/j.diabres.2017.07.033; Chang WQ, 2011, BBA-GEN SUBJECTS, V1810, P569, DOI 10.1016/j.bbagen.2011.02.001; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; Cui X, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113634; Do DT, 2016, CYTOTECHNOLOGY, V68, P2589, DOI 10.1007/s10616-016-9983-0; Fujiwara Y, 2012, BIOL PHARM BULL, V35, P1892, DOI 10.1248/bpb.b212014; Ghezzi C, 2018, DIABETOLOGIA, V61, P2087, DOI 10.1007/s00125-018-4656-5; Gong HJ, 2011, MED SCI SPORT EXER, V43, P1441, DOI 10.1249/MSS.0b013e31820f6093; Guzman J, 2014, DIABETES, V63, P701, DOI 10.2337/db13-0752; Harjutsalo V, 2014, ADV CHRONIC KIDNEY D, V21, P260, DOI 10.1053/j.ackd.2014.03.009; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Houmard JA, 1995, J APPL PHYSIOL, V79, P1936, DOI 10.1152/jappl.1995.79.6.1936; Huff MO, 2016, TOXICOL SCI, V152, P62, DOI 10.1093/toxsci/kfw064; Jarup L, 1998, SCAND J WORK ENV HEA, V24, P240; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; Kothinti RK, 2010, TOXICOL APPL PHARM, V244, P254, DOI 10.1016/j.taap.2009.12.038; Lee JY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17494-9; Lee JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21968; Lee JY, 2015, J TOXICOL SCI, V40, P901, DOI 10.2131/jts.40.901; Lee JY, 2013, J TOXICOL SCI, V38, P959, DOI 10.2131/jts.38.959; Lee JY, 2019, CADMIUM TOXICITY CUR; Lee WK, 2017, ARCH TOXICOL, V91, P3225, DOI 10.1007/s00204-017-1942-9; Luo TW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04555-2; Madugula Kiran, 2019, Oncotarget, V10, P2755, DOI 10.18632/oncotarget.26763; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z; Nerpin E, 2008, DIABETES CARE, V31, P1550, DOI 10.2337/dc08-0369; Nicotera P, 1998, TOXICOL LETT, V103, P139; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pajares M, 2018, AUTOPHAGY, V14, P1310, DOI 10.1080/15548627.2018.1474992; Richardson Marion, 2006, Nurs Times, V102, P28; Roder PV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089977; Sarma SN, 2018, J TOXICOL SCI, V43, P89, DOI 10.2131/jts.43.89; Shinkai Y, 2016, TOXICOL APPL PHARM, V295, P37, DOI 10.1016/j.taap.2016.01.020; Smith JAH, 2008, AM J PHYSIOL-ENDOC M, V295, pE698, DOI 10.1152/ajpendo.00747.2007; Tabatabai NA, 2005, TOXICOLOGY, V207, P369, DOI 10.1016/j.tox.2004.10.007; Tabatabai NM, 2001, TOXICOL APPL PHARM, V177, P163, DOI 10.1006/taap.2001.9321; Thevenod F, 2013, ARCH TOXICOL, V87, P1743, DOI 10.1007/s00204-013-1110-9; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; Tokumoto M, 2014, J TOXICOL SCI, V39, P735, DOI 10.2131/jts.39.735; Tokumoto M, 2013, J TOXICOL SCI, V38, P799; Tokumoto M, 2011, J TOXICOL SCI, V36, P191, DOI 10.2131/jts.36.191; Tokumoto M, 2011, J TOXICOL SCI, V36, P127, DOI 10.2131/jts.36.127; Wang XY, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22011; Watanuki S, 2019, BIOCHEM BIOPH RES CO, V514, P287, DOI 10.1016/j.bbrc.2019.04.123; Wei W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18427-2; Wilmes A, 2011, TOXICOL IN VITRO, V25, P613, DOI 10.1016/j.tiv.2010.12.009; Yue RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050778; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003; Zhang L, 2014, AUTOPHAGY, V10, P1015, DOI 10.4161/auto.28477	53	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21236	10.1096/fj.202001871R	http://dx.doi.org/10.1096/fj.202001871R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337552				2022-12-26	WOS:000605626600025
J	Kempnich, MW; Sison-Mangus, MP				Kempnich, Michael W.; Sison-Mangus, Marilou P.			Presence and abundance of bacteria with the Type VI secretion system in a coastal environment and in the global oceans	PLOS ONE			English	Article							PREDATION; ANTIBACTERIAL; POPULATIONS; COMPETITION; DIVERSITY; SEQUENCES; SINKING; BIOMASS; DIATOM; SNOW	Marine bacteria employ various strategies to maintain their competitive advantage over others in a mixed community. The use of Type VI Secretion Systems (T6SS), a protein secretion apparatus used as a molecular weapon for interbacterial competition and eukaryotic interactions, is one of the competitive strategies that is least studied among heterotrophic bacteria living in the water column. To get an insight into the temporal and spatial distribution of bacteria with T6SS in this portion of the marine environment, we examine the presence and abundance of T6SS-bearing bacteria at both local and global scales through the use of metagenome data from water samples obtained from the coast of Monterey Bay and the TARA Oceans project. We also track the abundance of T6SS-harboring bacteria through a two-year time series of weekly water samples in the same coastal site to examine the environmental factors that may drive their presence and abundance. Among the twenty-one T6SS-bearing bacterial genera examined, we found several genera assume a particle-attached lifestyle, with only a few genera having a free-living lifestyle. The abundance of T6SS-harboring bacteria in both niches negatively correlates with the abundance of autotrophs. Globally, we found that T6SS genes are much more abundant in areas with low biological productivity. Our data suggest that T6SS-harboring bacteria tend to be abundant spatially and temporally when organic resources are limited. This ecological study agrees with the patterns observed from several in vitro studies; that T6SS could be an adaptive strategy employed by heterotrophic bacteria to obtain nutrients or reduce competition when resources are in limited quantity.	[Kempnich, Michael W.; Sison-Mangus, Marilou P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Kempnich, Michael W.; Sison-Mangus, Marilou P.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Sison-Mangus, MP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	msisonma@ucsc.edu		Sison-Mangus, Marilou/0000-0002-6569-9380; Kempnich, Michael/0000-0002-8884-2194	Myers Trust; TARA Oceans project	Myers Trust; TARA Oceans project	The authors thank Sanjin Mehic and Terrill Yazzie for their contributions to sample collection, and Jiunn Fong for his support throughout the experiments. We also acknowledge the support from Myers Trust to MWK and the TARA Oceans project for its open-source data policies that made worldwide metagenomics comparisons possible.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; ALLDREDGE AL, 1986, LIMNOL OCEANOGR, V31, P68, DOI 10.4319/lo.1986.31.1.0068; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MC, 2017, CELL HOST MICROBE, V21, P769, DOI 10.1016/j.chom.2017.05.004; Martin-Fernandez JA, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P43; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Bruland KW, 2001, LIMNOL OCEANOGR, V46, P1661, DOI 10.4319/lo.2001.46.7.1661; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen LH, 2015, MICROBIOL RES, V172, P19, DOI 10.1016/j.micres.2015.01.004; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Das S, 2006, CURR SCI INDIA, V90, P1325; De La Rocha CL, 2007, DEEP-SEA RES PT II, V54, P639, DOI 10.1016/j.dsr2.2007.01.004; Diniz JA, 2015, CELL MICROBIOL, V17, P1742, DOI 10.1111/cmi.12532; Dorr NCD, 2018, P NATL ACAD SCI USA, V115, P8855, DOI 10.1073/pnas.1812776115; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Guillemette R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227864; Heip C, 2009, MARINE BIODIVERSITY, P100, DOI [10.13140/RG.2.1.2569.4966, DOI 10.13140/RG.2.1.2569.4966]; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Hunter-Cevera J, 2005, AM ACAD MICROBIOLOGY, DOI [10.1128/AAMCol.8Apr.2005, DOI 10.1128/AAMCOL.8APR.2005]; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Jiang F, 2014, CELL HOST MICROBE, V15, P600, DOI 10.1016/j.chom.2014.04.010; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Kudela RM, 2020, HABS DATA; Long E., 1999, NAT RES COUNC US STE; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Marsay CM, 2015, P NATL ACAD SCI USA, V112, P1089, DOI 10.1073/pnas.1415311112; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Oksanen J., 2019, R PACKAGE VERSION; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Perez J, 2016, ENVIRON MICROBIOL, V18, P766, DOI 10.1111/1462-2920.13171; Pokrzywinski KL, 2012, HARMFUL ALGAE, V19, P23, DOI 10.1016/j.hal.2012.05.002; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00384; Quinn TP, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz107; Ray A, 2017, EMBO REP, V18, P1978, DOI 10.15252/embr.201744226; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Sison-Mangus MP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01433; Sison-Mangus MP, 2014, ISME J, V8, P63, DOI 10.1038/ismej.2013.138; Speare L, 2018, P NATL ACAD SCI USA, V115, pE8528, DOI 10.1073/pnas.1808302115; Su JQ, 2011, BIOL CONTROL, V56, P132, DOI 10.1016/j.biocontrol.2010.10.004; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Tian YL, 2017, PHYTOPATHOLOGY, V107, P654, DOI [10.1094/PHYTO-11-16-0393-R, 10.1094/phyto-11-16-0393-r]; Townsley L, 2016, APPL ENVIRON MICROB, V82, P4441, DOI 10.1128/AEM.00807-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WATSON SW, 1977, APPL ENVIRON MICROB, V33, P940, DOI 10.1128/AEM.33.4.940-946.1977; Wexler AG, 2016, P NATL ACAD SCI USA, V113, P3639, DOI 10.1073/pnas.1525637113; Zhao WJ, 2018, SCIENCE, V359, P210, DOI 10.1126/science.aap8775; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	60	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244217	10.1371/journal.pone.0244217	http://dx.doi.org/10.1371/journal.pone.0244217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351849	Green Published, gold			2022-12-26	WOS:000603071400032
J	Hodlmoser, S; Winkelmayer, WC; Zee, J; Pecoits, R; Pisoni, RL; Port, FK; Robinson, BM; Ristl, R; Krenn, S; Kurnikowski, A; Lewandowski, M; Ton, A; Carrero, JJ; Schernhammer, ES; Hecking, M				Hoedlmoser, Sebastian; Winkelmayer, Wolfgang C.; Zee, Jarcy; Pecoits-Filho, Roberto; Pisoni, Ronald L.; Port, Friedrich K.; Robinson, Bruce M.; Ristl, Robin; Krenn, Simon; Kurnikowski, Amelie; Lewandowski, Michal; Ton, Allison; Carrero, Juan Jesus; Schernhammer, Eva S.; Hecking, Manfred			Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018	PLOS ONE			English	Article							UNITED-STATES; DIALYSIS; TRENDS; PREVALENCE; HEALTH; RISK	Background Chronic kidney disease (CKD) is less prevalent among men than women, but more men than women initiate kidney replacement therapy. Differences in CKD awareness may contribute to this gender gap, which may further vary by race/ethnicity. We aimed to investigate trends in CKD awareness and the association between individual characteristics and CKD awareness among US men versus women. Methods and findings We conducted a serial, cross-sectional analysis of 10 cycles (1999-2018) from the National Health and Nutrition Examination Survey (NHANES). Adult participants with CKD stages G3-G5 (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73m(2)) were included, unless they were on dialysis or medical information was missing. Serum creatinine was measured during NHANES medical exams. CKD stage was classified by eGFR, based on the CKD-EPI formula. CKD awareness was assessed with the question: "Have you ever been told by a health care professional you had weak or failing kidneys", asked in standardized NHANES questionnaires on each survey. Using logistic regression models, we evaluated the association between sex and CKD awareness, adjusting for potential confounders including age, race/ethnicity and comorbidities. We stratified CKD awareness by 5 pre-defined calendar-year periods and conducted all analyses for the complete study population as well as the Caucasian and African American subpopulations. We found that among 101871 US persons participating in NHANES, 4411 (2232 women) had CKD in stages G3-G5. These participants were, on average, 7310 years old, 25.3% reported diabetes, 78.0% reported hypertension or had elevated blood pressure during medical examinations and 39.8% were obese (percentages were survey-weighted). CKD awareness was more prevalent among those with higher CKD stage, younger age, diabetes, hypertension and higher body mass index. CKD awareness was generally low (<22.5%), though it increased throughout the study period, remaining consistently higher among men compared to women, with a decreasing gender gap over time (adjusted odds ratio [men-to-women] for CKD awareness = 2.71 [1.31-5.64] in period 1; = 1.32 [0.82-2.12] in period 5). The sex difference in CKD awareness was smaller in African American participants, in whom CKD awareness was generally higher. Using serum creatinine rather than eGFR as the CKD-defining exposure, CKD awareness increased with rising serum creatinine, in a close to identical fashion among both sexes during 1999-2008, while during 2009-2018, CKD awareness among women increased earlier than among men (i.e. with lower serum creatinine levels). Conclusions CKD awareness is lower among US women than men. The narrowing gap between the sexes in more recent years and the results on CKD awareness by serum creatinine indicate that health care professionals have previously been relying on serum creatinine to inform patients about their condition, but in more recent years have been using eGFR, which accounts for women's lower serum creatinine levels due to their lower muscle mass. Additional efforts should be made to increase CKD awareness among both sexes.	[Hoedlmoser, Sebastian; Schernhammer, Eva S.] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria; [Hoedlmoser, Sebastian; Krenn, Simon; Kurnikowski, Amelie; Lewandowski, Michal; Ton, Allison; Hecking, Manfred] Med Univ Vienna, Clin Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria; [Winkelmayer, Wolfgang C.] Baylor Coll Med, Nephrol Sect, Selzman Inst Kidney Hlth, Houston, TX 77030 USA; [Zee, Jarcy; Pecoits-Filho, Roberto; Pisoni, Ronald L.; Port, Friedrich K.; Robinson, Bruce M.] Arbor Res Collaborat Hlth, Ann Arbor, MI USA; [Pecoits-Filho, Roberto] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil; [Ristl, Robin] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Ton, Allison] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Carrero, Juan Jesus] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Schernhammer, Eva S.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schernhammer, Eva S.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Schernhammer, Eva S.] Harvard Med Sch, Boston, MA 02115 USA	Medical University of Vienna; Medical University of Vienna; Baylor College of Medicine; Arbor Research Collaborative for Health; Pontificia Universidade Catolica do Parana; Medical University of Vienna; University of Sydney; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schernhammer, ES (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria.; Schernhammer, ES (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Schernhammer, ES (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Schernhammer, ES (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	eva.schernhammer@meduniwien.ac.at	Hecking/AAK-7399-2021	Robinson, Bruce/0000-0003-0749-1714; Hodlmoser, Sebastian/0000-0003-2441-1210; Krenn, Simon/0000-0003-0899-9085; Zee, Jarcy/0000-0003-0586-1160	Austrian Science Fund	Austrian Science Fund(Austrian Science Fund (FWF))	This study was supported by a grant from the Austrian Science Fund https://m.fwf.ac.at/en/with grant No. KL754-B, received by MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2018, US RENAL DATA SYSTEM; [Anonymous], 2019, CHRON KIDN DIS US; [Anonymous], 2019, US RENAL DATA SYSTEM; [Anonymous], 2006, NATL HLTH NUTR EXAMI; [Anonymous], 2020, NATL HLTH NUTR EXAMI; Antlanger M, 2019, CLIN J AM SOC NEPHRO, V14, P1616, DOI 10.2215/CJN.04400419; Arhuidese IJ, 2020, ANN VASC SURG, V65, P196, DOI 10.1016/j.avsg.2019.08.083; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181; (CDC) CfDCaP, 2020, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2022, NHANES SURV METH AN; Chu CD, 2020, AM J KIDNEY DIS, DOI [10.1053/j.ajkd.2020.01.007, DOI 10.1053/J.AJKD.2020.01.00732305206]; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Crews DC, 2014, J AM SOC NEPHROL, V25, P370, DOI 10.1681/ASN.2013050567; Curtis S, 2020, CURR OPIN NEPHROL HY, V29, P333, DOI 10.1097/MNH.0000000000000597; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Division of the National Health and Nutrition Examination Surveys, 2018, NATL HLTH NUTR EXAMI; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Glassock R, 2015, JAMA-J AM MED ASSOC, V314, P559, DOI 10.1001/jama.2015.6731; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Imai E, 2010, CLIN EXP NEPHROL, V14, P558, DOI 10.1007/s10157-010-0328-6; Kainz A, 2019, NEPHROL DIAL TRANSPL, V34, P1026, DOI 10.1093/ndt/gfy322; Kausz AT, 2000, J AM SOC NEPHROL, V11, P2351, DOI 10.1681/ASN.V11122351; Kidney Disease Improving Global Outcomes (KDIGO), 2013, KDIGO 2012 CLIN PRAC; KJELLSTRAND CM, 1987, NEPHRON, V45, P257, DOI 10.1159/000184160; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Levin A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-121; Lumley T., 2019, SURVEY ANAL COMPLEX; McDonough DP, 2007, CLIN J AM SOC NEPHRO, V2, P1355, DOI 10.2215/CJN.01570407; Muntner P, 2012, CLIN J AM SOC NEPHRO, V7, P101, DOI 10.2215/CJN.06450611; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Plantinga LC, 2008, ARCH INTERN MED, V168, P2268, DOI 10.1001/archinte.168.20.2268; Slinin Y, 2014, CLIN J AM SOC NEPHRO, V9, P310, DOI 10.2215/CJN.04190413; Stengel B, 2019, NEPHROL DIAL TRANSPL, V34, P277, DOI 10.1093/ndt/gfy058; Swedko P, 2003, ARCH INTERN MED, V163, P356, DOI 10.1001/archinte.163.3.356; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; Titze S, 2015, NEPHROL DIAL TRANSPL, V30, P441, DOI 10.1093/ndt/gfu294; Tuot DS, 2019, KIDNEY MED, V1, P43, DOI 10.1016/j.xkme.2019.01.005; Tuot DS, 2016, CLIN J AM SOC NEPHRO, V11, P1566, DOI 10.2215/CJN.00490116; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Wheeler W, 2013, MMWR-MORBID MORTAL W, V62, P245; Xie Y, 2018, KIDNEY INT, V94, P567, DOI 10.1016/j.kint.2018.04.011; Yuan J, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0441-9; 2008, NATL HLTH NUTR EXAMI	48	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243431	10.1371/journal.pone.0243431	http://dx.doi.org/10.1371/journal.pone.0243431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338051	gold, Green Published			2022-12-26	WOS:000601313500010
J	Chuerduangphui, J; Ekalaksananan, T; Heawchaiyaphum, C; Vatanasapt, P; Pientong, C				Chuerduangphui, Jureeporn; Ekalaksananan, Tipaya; Heawchaiyaphum, Chukkris; Vatanasapt, Patravoot; Pientong, Chamsai			Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation	PLOS ONE			English	Article							OXIDATIVE-STRESS; CANCER CELLS; COLORECTAL-CANCER; RISK FACTOR; ARECA NUT; SURVIVAL; PRDX2	Peroxiredoxin 2 (PRDX2) is upregulated in various cancers including oral squamous cell carcinoma (OSCC). It is a known tumor promoter in some cancers, but its role in OSCC is unclear. This study aimed to investigate the effect of arecoline, an alkaloid of the betel nut, and human papillomavirus type 16 (HPV16) E6/E7 oncoproteins on induction of PRDX2 expression, and also the effects of PRDX2 overexpression in oral cell lines. Levels of PRDX2 protein were determined using western blot analysis of samples of exfoliated normal oral cells (n = 75) and oral lesion cells from OSCC cases (n = 75). Some OSCC cases were positive for HPV infection and some patients had a history of betel quid chewing. To explore the level of PRDX2 by western blot, the proteins were extracted from oral cell lines that were treated with arecoline or retroviruses containing HPV16 E6 gene and HPV16 E6/E7 expressing vector. For analysis of PRDX2 functions, cell proliferation, cell-cycle progression, apoptosis and migration was compared between oral cells overexpressing PRDX2 and cells with PRDX2-knockdown. PRDX2 expression levels tended to be higher in OSCC samples that were positive for HPV infection and had history of betel quid chewing. Arecoline treatment in vitro at low concentrations and overexpression of HPV16 E6 or E6/E7 in oral cells induced PRDX2 overexpression. Interestingly, in oral cells, PRDX2 promoted cell proliferation, cell-cycle progression (G2/M phase), cell migration and inhibited apoptosis. Upregulation of PRDX2 in oral cells was induced by arecoline and HPV16 oncoproteins and promoted growth of OSCC cells.	[Chuerduangphui, Jureeporn] Kasetsart Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Chuerduangphui, Jureeporn; Ekalaksananan, Tipaya; Heawchaiyaphum, Chukkris; Vatanasapt, Patravoot; Pientong, Chamsai] Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand; [Ekalaksananan, Tipaya; Heawchaiyaphum, Chukkris; Pientong, Chamsai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Vatanasapt, Patravoot] Khon Kaen Univ, Fac Med, Dept Otorhinolaryngol, Khon Kaen, Thailand	Kasetsart University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Pientong, C (corresponding author), Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand.; Pientong, C (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	chapie@kku.ac.th			Health Systems Research Institute (HSRI), Thailand; Khon Kaen University [I62-00-18-03]	Health Systems Research Institute (HSRI), Thailand; Khon Kaen University	This study was supported by Health Systems Research Institute (HSRI), Thailand, in the form of funding for CP; and Khon Kaen University in the form of a grant (Grant number I62-00-18-03) for TE.	Agrawal-Singh S, 2012, BLOOD, V119, P2346, DOI 10.1182/blood-2011-06-358705; [Anonymous], 2018, PHARMACOTHERAPY, V38, pe29, DOI 10. 1002/phar. 2101; Bara R, 2018, NEOPLASIA, V20, P1106, DOI 10.1016/j.neo.2018.08.013; Chernov IP, 2008, BIOTECHNIQUES, V44, P775, DOI 10.2144/000112732; Chikara S, 2018, CANCER LETT, V413, P122, DOI 10.1016/j.canlet.2017.11.002; Chuerduangphui J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192009; Chuerduangphui J, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0800-6; Cui JD, 2015, INT J CLIN EXP PATHO, V8, P12400; De Franceschi L, 2011, HAEMATOL-HEMATOL J, V96, P1595, DOI 10.3324/haematol.2011.043612; De Marco F, 2013, VIRUSES-BASEL, V5, P708, DOI 10.3390/v5020708; Duan T, 2016, MOL MED REP, V13, P4807, DOI 10.3892/mmr.2016.5147; Durzynska J, 2017, MUTAT RES-REV MUTAT, V772, P36, DOI 10.1016/j.mrrev.2016.09.006; Feng K, 2020, ROUTL FRONT BUS MANA, P1; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hamid S, 2007, INT J MOL MED, V19, P453; Han XL, 2007, CHINESE MED J-PEKING, V120, P405; Heawchaiyaphum C, 2018, J PROTEOMICS, V173, P52, DOI 10.1016/j.jprot.2017.11.022; Kesarwala AH, 2016, ORAL DIS, V22, P9, DOI 10.1111/odi.12300; Kikuta K, 2010, PROTEOM CLIN APPL, V4, P560, DOI 10.1002/prca.200900172; Kim Y, 2019, J CANCER PREV, V24, P65, DOI 10.15430/JCP.2019.24.2.65; Lee SS, 2010, ORAL DIS, V16, P696, DOI 10.1111/j.1601-0825.2010.01680.x; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Lin PC, 2011, J TOXICOL ENV HEAL A, V74, P737, DOI 10.1080/15287394.2011.539123; Lu WD, 2014, MOL CELL BIOCHEM, V387, P261, DOI 10.1007/s11010-013-1891-4; Luo WB, 2016, ONCOTARGET, V7, P6379, DOI 10.18632/oncotarget.7142; Lv ZB, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1357-7; Maliekal TT, 2008, ONCOGENE, V27, P5110, DOI 10.1038/onc.2008.224; Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392; Nicolussi A, 2017, MOL CLIN ONCOL, V6, P139, DOI 10.3892/mco.2017.1129; Park MH, 2016, PHARMACOL THERAPEUT, V163, P1, DOI 10.1016/j.pharmthera.2016.03.018; Peng LL, 2017, ONCOTARGET, V8, P15057, DOI 10.18632/oncotarget.14801; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Shih YT, 2010, FREE RADICAL BIO MED, V49, P1471, DOI 10.1016/j.freeradbiomed.2010.07.017; Sonini Y, 2006, APMIS, V114, P329; Stresing V, 2013, ONCOGENE, V32, P724, DOI 10.1038/onc.2012.93; Tamm I, 2002, CANCER GENE THER, V9, P641, DOI 10.1038/sj.cgt.7700480; Thangjam GS, 2009, J PERIODONTAL RES, V44, P673, DOI 10.1111/j.1600-0765.2008.01176.x; Tomar S, 2016, HEAD NECK-J SCI SPEC, V38, pE694, DOI 10.1002/hed.24072; Wang S, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101319; Warnakulasuriya S, 2002, BMJ-BRIT MED J, V324, P799, DOI 10.1136/bmj.324.7341.799; Williams VM, 2014, J VIROL, V88, P6751, DOI 10.1128/JVI.03355-13; Wu F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.301; Yang Y, 2018, INT J MOL MED, V41, P3366, DOI 10.3892/ijmm.2018.3519; Zhang EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103440; Zhao X, 2018, NAT COMMUN, V9, P1	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0242465	10.1371/journal.pone.0242465	http://dx.doi.org/10.1371/journal.pone.0242465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332365	Green Published, gold			2022-12-26	WOS:000601310900029
J	Biswas, A; Divya, S; Sharmila, P; Pardha-Saradhi, P				Biswas, Abhishek; Divya, Subramaniyan; Sharmila, Peddisetty; Pardha-Saradhi, Peddisetty			Light promoted brown staining of protoplasm by Ag+ is ideal to test wheat pollen viability rapidly	PLOS ONE			English	Article							SILVER; NANOPARTICLES	Pollen viability is crucial for wheat breeding programs. The unique potential of the protoplasm of live cells to turn brown due to the synthesis of silver nanoparticles (AgNPs) through rapid photoreduction of Ag+, was exploited for testing wheat pollen viability. Ag+-viability test medium (consisting of 0.5 mM AgNO3 and 300 mM KNO3) incubated with wheat pollen turned brown within 2 min under intense light (similar to 600 mu mol photon flux density m(-2)s(-1)), but not in dark. The brown medium displayed AgNPs-specific surface plasmon resonance band in its absorption spectrum. Light microscopic studies showed the presence of uniformly stained brown protoplasm in viable pollen incubated with Ag+-viability medium in the presence of light. Investigations with transmission electron microscope coupled with energy dispersive X-ray established the presence of distinct 5-35 nm NPs composed of Ag. Powder X-ray diffraction analysis revealed that AgNPs were crystalline and biphasic composed of Ag-0 and Ag2O. Conversely, non-viable pollen and heat-killed pollen did not turn brown on incubation with Ag(+-)medium in light. We believe that the viable wheat pollen turn brown rapidly by bio-transforming Ag+ to AgNPs through photoreduction. Our findings furnish a novel simplest and rapid method for testing wheat pollen viability.	[Biswas, Abhishek; Divya, Subramaniyan; Sharmila, Peddisetty; Pardha-Saradhi, Peddisetty] Univ Delhi, Dept Environm Studies, Delhi, India	University of Delhi	Pardha-Saradhi, P (corresponding author), Univ Delhi, Dept Environm Studies, Delhi, India.	ppsaradhi@gmail.com		Biswas, Abhishek/0000-0001-8125-1167; Pardha-Saradhi, P./0000-0001-7122-7518				Beattie IR, 2011, METALLOMICS, V3, P628, DOI 10.1039/c1mt00044f; Dafni A, 2000, PLANT SYST EVOL, V222, P113, DOI 10.1007/BF00984098; Firon N, 2012, ANN BOT-LONDON, V109, P1201, DOI 10.1093/aob/mcs070; Guo HY, 2019, ENVIRON SCI-NANO, V6, P1099, DOI [10.1039/C9EN00088G, 10.1039/c9en00088g]; Heidmann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165531; HESLOPHARRISON J, 1984, THEOR APPL GENET, V67, P367, DOI 10.1007/BF00272876; Impe D, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01588; Maillard M, 2003, NANO LETT, V3, P1611, DOI 10.1021/nl034666d; Mesihovic A, 2016, PLANT REPROD, V29, P93, DOI 10.1007/s00497-016-0281-y; Mohan S, 2014, CARBOHYD POLYM, V106, P469, DOI 10.1016/j.carbpol.2014.01.008; Pacini E, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00679; Pardha-Saradhi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106715; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Shabnam N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01052; Shabnam N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167937; Speranza A, 1997, SEX PLANT REPROD, V10, P110, DOI 10.1007/s004970050076; STONE JL, 1995, AM J BOT, V82, P1186, DOI 10.2307/2446073; Yamal G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061750	18	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243856	10.1371/journal.pone.0243856	http://dx.doi.org/10.1371/journal.pone.0243856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326483	gold, Green Published			2022-12-26	WOS:000600176400074
J	Kolewe, EL; Stillman, Z; Woodward, IR; Fromen, CA				Kolewe, Emily L.; Stillman, Zachary; Woodward, Ian R.; Fromen, Catherine A.			Check the gap: Facemask performance and exhaled aerosol distributions around the wearer	PLOS ONE			English	Article							PARTICLE-SIZE; RESPIRATOR; LEAKAGE; FILTER; MASKS; EFFICIENCY	Current facemask research focuses on material characterization and efficiency; however, facemasks are often not tested such that aerosol distributions are evaluated from the gaps in the sides, bottom, and nose areas. Poor evaluation methods could lead to misinformation on optimal facemasks use; a high-throughput, reproducible method which illuminates the issue of fit influencing aerosol transmission is needed. To this end, we have created an in vitro model to quantify particle transmission by mimicking exhalation aerosols in a 3D printed face-nose-mouth replica via a nebulizer and quantifying particle counts using a hand-held particle counter. A sewn, sewn with pipe cleaner nose piece, and sewn with a coffee filter facemask were used to evaluate current common homemade sewn facemask designs, benchmarked against industry standard surgical, N95 respirator tightly fit, and N95 respirator loosely fit facemasks. All facemasks have significantly reduced particle counts in front of the facemask, but the side and top of the facemask showed increases in particle counts over the no facemask condition at that same position, suggesting that some proportion of aerosols are being redirected to these gaps. An altered size distribution of aerosols that escape at the vulnerable positions was observed; escaped particles have larger count median diameters, with a decreased ratio of smaller to larger particles, possibly due to hygroscopic growth or aggregation. Of the homemade sewn facemasks, the facemask with a coffee filter insert performed the best at reducing escaped aerosols, with increased efficiency also observed for sewn masks with a pipe cleaner nose piece. Importantly, there were minimal differences between facemasks at increasing distances, which supports that social distance is a critical element in reducing aerosol transmission. This work brings to light the importance of quantifying particle count in positions other than directly in front of the facemask and identifies areas of research to be explored.	[Kolewe, Emily L.; Stillman, Zachary; Woodward, Ian R.; Fromen, Catherine A.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19711 USA	University of Delaware	Fromen, CA (corresponding author), Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19711 USA.	cfromen@udel.edu		Woodward, Ian/0000-0003-4471-3734	University of Delaware; Delaware INBRE program; National Institute of General Medical Sciences-NIGMS from the National Institutes of Health [P20 GM103446]; NIGMS [T32GM008550]; State of Delaware	University of Delaware; Delaware INBRE program; National Institute of General Medical Sciences-NIGMS from the National Institutes of Health; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); State of Delaware	This work was supported in part by internal University of Delaware (https://www.udel.edu/) funds received by C.A.F. and by the Delaware INBRE program supported by a grant from the National Institute of General Medical SciencesNIGMS (https://www.nigms.nih.gov/) Award Number P20 GM103446 - from the National Institutes of Health and the State of Delaware received by C.A.F.. Z.S.S. was supported by a NIGMS training grant Award Number T32GM008550. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat A, AEROSOL AIR QUALITY, P20; [Anonymous], 1994, ARCHIVUM HIST PONTIF, p254s; Brooks JT, 2020, JAMA-J AM MED ASSOC, V324, P635, DOI 10.1001/jama.2020.13107; Cherrie JW, 2019, J EXPO SCI ENV EPID, V29, P578, DOI 10.1038/s41370-018-0089-y; Cho HW, 2011, ANN OCCUP HYG, V55, P666, DOI 10.1093/annhyg/mer032; Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43; Davies C N, 1953, P I MECH ENG, V167, P185, DOI DOI 10.1177/095440545300100113; Davies J, NEBULIZER PERFORMANC, pA2193; Dbouk T, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0015044; Fabian P, 2011, J AEROSOL MED PULM D, V24, P137, DOI 10.1089/jamp.2010.0815; Feng Yu, 2017, Bioengineering-Basel, V4, P90, DOI 10.3390/bioengineering4040090; Fischer EP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd3083; FURUHASHI M, 1978, Bulletin of Tokyo Medical and Dental University, V25, P7; Gordon CC., 1989, ANTHROPOMETRIC SURVE; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; HOLTON PM, 1987, AM IND HYG ASSOC J, V48, P848, DOI 10.1202/0002-8894(1987)048<0848:PSLALO>2.0.CO;2; Howard JR, 2020, SUNY Series Afr Amer, P1; Jain M, 2020, CUREUS, V12, DOI 10.7759/cureus.10423; Kahler CJ, 2020, J AEROSOL SCI, V148, DOI 10.1016/j.jaerosci.2020.105617; Kim JH, 2015, INT J OCCUP MED ENV, V28, P71, DOI 10.13075/ijomeh.1896.00153; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Leaks Jr CR, COVID 19 AD HOC SUBC; Lei ZP, 2013, ANN OCCUP HYG, V57, P493, DOI 10.1093/annhyg/mes085; Lenth RV., 2021, EMMEANS ESTIMATED MA; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Liloia GJ, 1965, Face mask patent, Patent No. [US3220409, 3220409]; Maurer L, 2021, J AEROSOL MED PULM D, V34, P11, DOI 10.1089/jamp.2020.1635; Mueller AV, 2020, MATTER-US, V3, P950, DOI 10.1016/j.matt.2020.07.006; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; OESTENSTAD RK, 1990, AM IND HYG ASSOC J, V51, P285, DOI 10.1202/0002-8894(1990)051<0285:DOFLSO>2.0.CO;2; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; RCore Team, 2020, R LANG ENV STAT COMP; Rengasamy S, 2012, ANN OCCUP HYG, V56, P568, DOI 10.1093/annhyg/mer122; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; SAWCHUK WS, 1989, ARCH DERMATOL, V125, P1689, DOI 10.1001/archderm.125.12.1689; Scheuch G, 2020, J AEROSOL MED PULM D, V33, P230, DOI 10.1089/jamp.2020.1616; Schwarz K, 2010, J AEROSOL MED PULM D, V23, P371, DOI 10.1089/jamp.2009.0809; Setti L, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109754; Sickbert-Bennett EE, 2020, JAMA INTERN MED, V180, P1607, DOI 10.1001/jamainternmed.2020.4221; Simha PP, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0021666; STAFFORD RG, 1972, ATMOS ENVIRON, V6, P353, DOI 10.1016/0004-6981(72)90201-6; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; TUOMI T, 1985, AM IND HYG ASSOC J, V46, P308, DOI 10.1080/15298668591394879; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0016018; Wagner SL, 1980, PROTECTIVE FACE MASK; Wang DJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240285; White K A, 1985, West Pa Hist Mag, V68, P221; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wilkinson IJ, 2010, INFECT CONT HOSP EP, V31, P918, DOI 10.1086/655460; Wong P, 2020, J ANESTH, V34, P924, DOI 10.1007/s00540-020-02819-2; World Health Organization, 2020, TRANSM SARS COV2 IMP; World Health Organization, 2020, ADVICE USE MASKS CON; World Health Organization (WHO), 2014, GUID VOL ORG VOL PRA; Zemouri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178007; Zhang YP, 2013, NICOTINE TOB RES, V15, P501, DOI 10.1093/ntr/nts165; 2014, REG ANESTH PAIN MED, V9	58	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243885	10.1371/journal.pone.0243885	http://dx.doi.org/10.1371/journal.pone.0243885			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326449	Green Published, gold			2022-12-26	WOS:000600176400008
J	Diani-Moore, S; Marques Pedro, T; Rifkind, AB				Diani-Moore, Silvia; Marques Pedro, Tiago; Rifkind, Arleen B.			Organ-specific effects on glycolysis by the dioxin-activated aryl hydrocarbon receptor	PLOS ONE			English	Article							T-CELL DEVELOPMENT; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; AEROBIC GLYCOLYSIS; GENE-EXPRESSION; THYMIC ATROPHY; AH RECEPTOR; FATTY LIVER; IL-7; METABOLISM; SIRT6	Activation of the aryl hydrocarbon receptor (AHR) by the environmental toxin dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) causes diverse toxicities, including thymus atrophy and hepatosteatosis. The mechanisms by which AHR activation by TCDD leads to these toxicities are not fully understood. Here we studied the effects of TCDD on a major energy pathway, glycolysis, using the chick embryo close to hatching, a well-established model for studying dioxin toxicity. We showed that 24 hr of TCDD treatment causes changes in glycolysis in both thymus and liver. In thymus glands, TCDD decreased mRNAs for glycolytic genes and glucose transporters, glycolytic indices and levels of IL7 mRNA, phosphorylated AKT (pAKT) and HIF1A, stimulators of glycolysis and promoters of survival and proliferation of thymic lymphocytes. In contrast, in liver, TCDD increased mRNA levels for glycolytic genes and glucose transporters, glycolytic endpoints and pAKT levels. Similarly, increases by TCDD in mRNA levels for glycolytic genes and glucose transporters in human primary hepatocytes showed that effects in chick embryo liver pertain also to human cells. Treatment with the glycolytic inhibitor 2-deoxy-d-glucose exacerbated the effects on thymus atrophy by TCDD, supporting a role for decreased glycolysis in thymus atrophy by TCDD, but did not prevent hepatosteatosis. NAD(+) precursors abolished TCDD effects on glycolytic endpoints in both thymus and liver. In summary, we report here that dioxin disrupts glycolysis mediated energy metabolism in both thymus and liver, and that it does so in opposite ways, decreasing it in the thymus and increasing it in the liver. Further, the findings support NAD(+) boosting as a strategy against metabolic effects of environmental pollutants such as dioxins.	[Diani-Moore, Silvia; Marques Pedro, Tiago; Rifkind, Arleen B.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Diani-Moore, Silvia; Marques Pedro, Tiago; Rifkind, Arleen B.] Weill Cornell Med, Pharmacol PhD Program, New York, NY USA	Cornell University; Cornell University	Rifkind, AB (corresponding author), Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.	arifkind@med.cornell.edu		Marques Pedro, Tiago/0000-0002-1767-0321	NIH [ES-027488]; Winston Foundation; Winston Foundation's gift	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winston Foundation; Winston Foundation's gift	This research was supported by NIH grant ES-027488 (A.B.R.) and by funds from The Winston Foundation (A.B.R.). Portions of salaries for AB Rifkind and S Diani-Moore were paid with the NIH grant ES-027488 and The Winston Foundation's gift. A portion of T Marques Pedro's salary was paid with The Winston Foundation's gift. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 2002, EXP GERONTOL, V37, P455, DOI 10.1016/S0531-5565(01)00213-3; Angrish MM, 2013, TOXICOL SCI, V131, P108, DOI 10.1093/toxsci/kfs277; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Beamer CA, 2019, ARCH TOXICOL, V93, P355, DOI 10.1007/s00204-018-2366-x; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Carbo R, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-64; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Diani-Moore S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02332-9; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; ElKassar N, 2010, J IMMUNOTOXICOL, V7, P1, DOI 10.3109/15476910903453296; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Finlay DK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00247; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Hale LP, 2002, AM J PHYSIOL-HEART C, V282, pH1467, DOI 10.1152/ajpheart.00682.2001; Han M, 2017, TOXICOL LETT, V273, P10, DOI 10.1016/j.toxlet.2017.03.013; Hantzidiamantis PJ, 2022, PHYSL GLUCOSE STATPE, P2022; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Humphrey BD, 2008, J NUTR, V138, P1153, DOI 10.1093/jn/138.6.1153; Imai S, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.17; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; KENNEDY SW, 1995, ANAL BIOCHEM, V226, P362, DOI 10.1006/abio.1995.1237; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Laiosa MD, 2003, J IMMUNOL, V171, P4582, DOI 10.4049/jimmunol.171.9.4582; LENGLE EE, 1978, CANCER RES, V38, P1113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Nadtochiy SM, 2018, J MOL CELL CARDIOL, V121, P155, DOI 10.1016/j.yjmcc.2018.06.007; Nagai H, 2006, INT IMMUNOPHARMACOL, V6, P279, DOI 10.1016/j.intimp.2005.08.015; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011; RIFKIND AB, 1994, J BIOL CHEM, V269, P3387; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Viluksela M, 1995, TOXICOL APPL PHARM, V135, P308, DOI 10.1006/taap.1995.1237; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang WQ, 2015, J BIOL CHEM, V290, P26163, DOI 10.1074/jbc.M115.662916; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Zhang L, 2020, P NATL ACAD SCI USA, V117, P13447, DOI 10.1073/pnas.1921815117; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143	53	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243842	10.1371/journal.pone.0243842	http://dx.doi.org/10.1371/journal.pone.0243842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320884	Green Published, gold			2022-12-26	WOS:000600339800048
J	Nagata, JM; Ganson, KT; Cunningham, ML; Mitchison, D; Lavender, JM; Blashill, AJ; Gooding, HC; Murray, SB				Nagata, Jason M.; Ganson, Kyle T.; Cunningham, Mitchell L.; Mitchison, Deborah; Lavender, Jason M.; Blashill, Aaron J.; Gooding, Holly C.; Murray, Stuart B.			Associations between legal performance-enhancing substance use and future cardiovascular disease risk factors in young adults: A prospective cohort study	PLOS ONE			English	Article							ANABOLIC-ANDROGENIC STEROIDS; CREATINE SUPPLEMENTATION; NUTRITIONAL SUPPLEMENTS; HEALTH; TERM; CONSEQUENCES; ADOLESCENTS; PREVALENCE; DRUGS; ADHD	Background Legal performance-enhancing substances (PES), such as creatine, are commonly used by adolescents and young adults. As PES are mostly unregulated by the US Food and Drug Administration, there has been limited empirical attention devoted to examining their long-term safety and health outcomes. Preliminary studies have demonstrated associations between PES use and severe medical events, including hospitalizations and death. PES could be linked to cardiovascular disease (CVD), the most common cause of mortality in the US, by altering the myocardium, vasculature, or metabolism. The objective of this study was to examine prospective associations between the use of legal PES in young adulthood and CVD risk factors at seven-year follow-up. Materials and methods Nationally representative longitudinal cohort data from the National Longitudinal Study of Adolescent to Adult Health, Waves III (2001-2002) and IV (2008), were analyzed. Regression models determined the prospective association between the use of legal PES (e.g. creatine monohydrate) and CVD risk factors (e.g. body mass index, diabetes, hypertension, hyperlipidemia), adjusting for relevant covariates. Results Among the diverse sample of 11,996 male and female participants, no significant differences by PES use in body mass index, diabetes, hypertension, or hyperlipidemia were noted at Wave III. In unadjusted comparisons, legal PES users (versus non-users) were more likely to be White, be male, be college educated, drink alcohol, and engage in weightlifting, exercise, individual sports, team sports, and other strength training. There were no significant prospective associations between legal PES use at Wave III and body mass index, hemoglobin A1c, systolic and diastolic blood pressure, and cholesterol (total, HDL, LDL, triglycerides) deciles at seven-year follow-up (Wave IV), adjusting for demographics, health behaviors, and Wave III CVD risk factors. Similarly, there were no significant prospective associations between legal PES use and diabetes, hypertension, or hyperlipidemia based on objective measures or self-reported medications and diagnoses, adjusting for demographics, health behaviors, and Wave III CVD risk. Conclusions We do not find evidence for a prospective association between legal PES use and CVD risk factors in young adults over seven years of follow-up, including BMI, diabetes, hypertension, or hyperlipidemia. It should be noted that legal PES use was operationalized dichotomously and as one broad category, which did not account for frequency, amount, or duration of use. Given the lack of regulation and clinical trials data, observational studies can provide much needed data to inform the safety and long-term health associations of legal PES use and, in turn, inform clinical guidance and policy.	[Nagata, Jason M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ganson, Kyle T.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Cunningham, Mitchell L.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Mitchison, Deborah] Univ Western Sydney, Sch Med, Translat Hlth Res Inst, Sydney, NSW, Australia; [Mitchison, Deborah] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Lavender, Jason M.] Uniformed Serv Univ Hlth Sci, Mil Cardiovasc Outcomes Res Program MiCOR, Dept Med, Bethesda, MD 20814 USA; [Lavender, Jason M.] Metis Fdn, San Antonio, TX USA; [Blashill, Aaron J.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Blashill, Aaron J.] San Diego State Univ, San Diego Joint Doctoral Program Clin Psychol, San Diego, CA 92182 USA; [Blashill, Aaron J.] Univ Calif San Diego, San Diego Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Gooding, Holly C.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Murray, Stuart B.] Univ Southern Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA	University of California System; University of California San Francisco; University of Toronto; University of Sydney; Western Sydney University; Macquarie University; Uniformed Services University of the Health Sciences - USA; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; Emory University; University of Southern California	Nagata, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	jasonmnagata@gmail.com	Mitchison, Deborah/AAH-4842-2021	Nagata, Jason/0000-0002-6541-0604; MITCHISON, DEBORAH/0000-0002-6736-7937	American Heart Association [CDA34760281]; National Institutes of Health [K23 MH115184, P01-HD31921, K23 HL122361]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	J.M.N was a participant in the Pediatric Scientist Development Program and is supported by the American Heart Association (CDA34760281, https://www.heart.org/).H.C.G.is supported by the National Institutes of Health K23 HL122361 (https://www.nih.gov/).S.B.M.is supported by the National Institutes of Health K23 MH115184. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. No direct support was received from grant P01-HD31921 for this analysis. The opinions and assertions expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Uniformed Services University or the U.S. Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackard DM, 2003, PEDIATRICS, V111, P67, DOI 10.1542/peds.111.1.67; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Angell P, 2012, SPORTS MED, V42, P119, DOI 10.2165/11598060-000000000-00000; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Block G, 2007, NUTR J, P6, DOI [10.1186/1475-2891-6-6, DOI 10.1186/1475-2891-6-6]; Brenu EW, 2011, MINI-REV MED CHEM, V11, P438; Chen P., 2020, GUIDELINES ANAL ADD; Cohen PA, 2009, NEW ENGL J MED, V361, P1523, DOI 10.1056/NEJMp0904768; Eisenberg ME, 2012, PEDIATRICS, V130, P1019, DOI 10.1542/peds.2012-0095; Ganson KT, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-0409; Ganson KT, 2020, LANCET CHILD ADOLESC, V4, P13, DOI 10.1016/S2352-4642(19)30345-1; Geyer H, 2004, INT J SPORTS MED, V25, P124, DOI 10.1055/s-2004-819955; Geyer H, 2008, J MASS SPECTROM, V43, P892, DOI 10.1002/jms.1452; Gooding HC, 2016, J ADOLESCENT HEALTH, V58, P119, DOI 10.1016/j.jadohealth.2015.09.011; Grasser EK, 2016, ADV NUTR, V7, P950, DOI 10.3945/an.116.012526; Green GA, 2001, CLIN J SPORT MED, V11, P254, DOI 10.1097/00042752-200110000-00008; Hamad R, 2020, JAMA CARDIOL, V5, P899, DOI 10.1001/jamacardio.2020.1458; Harris KM, 2017, NATL LONGITUDINAL ST; Harty PS, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0247-6; Hennissen L, 2017, CNS DRUGS, V31, P199, DOI 10.1007/s40263-017-0410-7; Kanayama G, 2008, DRUG ALCOHOL DEPEN, V98, P1, DOI 10.1016/j.drugalcdep.2008.05.004; Kreider RB, 2003, MOL CELL BIOCHEM, V244, P95, DOI 10.1023/A:1022469320296; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; La Gerche A, 2017, CIRCULATION, V135, P89, DOI 10.1161/CIRCULATIONAHA.116.022535; LaBotz M, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1300; Liu JD, 2019, CHINESE MED J-PEKING, V132, P2229, DOI 10.1097/CM9.0000000000000407; Lundholm L, 2010, DRUG ALCOHOL DEPEN, V111, P222, DOI 10.1016/j.drugalcdep.2010.04.020; Mathews NM, 2018, SPORTS HEALTH, V10, P19, DOI 10.1177/1941738117727736; Martinez-Sanz JM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101093; Murray SB, 2017, CLIN PSYCHOL REV, V57, P1, DOI 10.1016/j.cpr.2017.08.001; Nagata Jason M, 2020, Int J Adolesc Med Health, V34, P119, DOI 10.1515/ijamh-2020-0001; Nagata JM, 2020, JAMA PEDIATR, V174, P992, DOI 10.1001/jamapediatrics.2020.0883; Nagata JM, 2021, EAT DISORD, V29, P599, DOI 10.1080/10640266.2020.1712637; Nagata JM, 2019, J GEN INTERN MED, V34, P2756, DOI 10.1007/s11606-019-05317-8; Nagata JM, 2019, LANCET CHILD ADOLESC, V3, P444, DOI 10.1016/S2352-4642(19)30147-6; Nagata JM, 2018, INT J EAT DISORDER, V51, P931, DOI 10.1002/eat.22927; Nikolopoulos DD, 2011, FUND CLIN PHARMACOL, V25, P535, DOI 10.1111/j.1472-8206.2010.00881.x; Or F, 2019, J ADOLESC HEAL PUBL, DOI [10.1016/j.jadohealth.2019.03.005, DOI 10.1016/J.JAD0HEALTH.2019.03.005]; dos Santos MAP, 2014, SUBST USE MISUSE, V49, P1132, DOI 10.3109/10826084.2014.903751; Perry JC, 2020, CUREUS, V12, DOI 10.7759/cureus.9333; Pickering C, 2019, SPORTS MED, V49, P1007, DOI 10.1007/s40279-019-01101-0; Pinto CL, 2016, AMINO ACIDS, V48, P2103, DOI 10.1007/s00726-016-2277-1; Pope HG, 2014, ENDOCR REV, V35, P341, DOI 10.1210/er.2013-1058; Pope HG, 2000, ARCH GEN PSYCHIAT, V57, P133, DOI 10.1001/archpsyc.57.2.133; Qato DM, 2018, JAMA PEDIATR, V172, P780, DOI 10.1001/jamapediatrics.2018.1008; Sachs KV, 2016, INT J EAT DISORDER, V49, P238, DOI 10.1002/eat.22481; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; Torres-Acosta N, 2020, J AM COLL CARDIOL, V76, P858, DOI 10.1016/j.jacc.2020.05.081; Van Poucke C, 2007, ANAL CHIM ACTA, V586, P35, DOI 10.1016/j.aca.2006.09.050; Van Wagoner RM, 2017, JAMA-J AM MED ASSOC, V318, P2004, DOI 10.1001/jama.2017.17069; Vanberg Paul, 2010, Handb Exp Pharmacol, P411, DOI 10.1007/978-3-540-79088-4_18; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]	53	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244018	10.1371/journal.pone.0244018	http://dx.doi.org/10.1371/journal.pone.0244018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320903	Green Published, gold			2022-12-26	WOS:000600339800047
J	Sedghizadeh, MJ; Hojjati, H; Ezzatdoost, K; Aghajan, H; Vahabi, Z; Tarighatnia, H				Sedghizadeh, Mohammad Javad; Hojjati, Hadi; Ezzatdoost, Kiana; Aghajan, Hamid; Vahabi, Zahra; Tarighatnia, Heliya			Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; SMELL IDENTIFICATION TEST; CROSS-MODAL INTERACTIONS; NEURONAL-ACTIVITY; EEG SYNCHRONIZATION; WORKING-MEMORY; DEMENTIA; CIRCUITS; TAU; NEURODEGENERATION	High-frequency oscillations of the frontal cortex are involved in functions of the brain that fuse processed data from different sensory modules or bind them with elements stored in the memory. These oscillations also provide inhibitory connections to neural circuits that perform lower-level processes. Deficit in the performance of these oscillations has been examined as a marker for Alzheimer's disease (AD). Additionally, the neurodegenerative processes associated with AD, such as the deposition of amyloid-beta plaques, do not occur in a spatially homogeneous fashion and progress more prominently in the medial temporal lobe in the early stages of the disease. This region of the brain contains neural circuitry involved in olfactory perception. Several studies have suggested that olfactory deficit can be used as a marker for early diagnosis of AD. A quantitative assessment of the performance of the olfactory system can hence serve as a potential biomarker for Alzheimer's disease, offering a relatively convenient and inexpensive diagnosis method. This study examines the decline in the perception of olfactory stimuli and the deficit in the performance of high-frequency frontal oscillations in response to olfactory stimulation as markers for AD. Two measurement modalities are employed for assessing the olfactory performance: 1) An interactive smell identification test is used to sample the response to a sizable variety of odorants, and 2) Electroencephalography data are collected in an olfactory perception task with a pair of selected odorants in order to assess the connectivity of frontal cortex regions. Statistical analysis methods are used to assess the significance of selected features extracted from the recorded modalities as Alzheimer's biomarkers. Olfactory decline regressed to age in both healthy and mild AD groups are evaluated, and single- and multi-modal classifiers are also developed. The novel aspects of this study include: 1) Combining EEG response to olfactory stimulation with behavioral assessment of olfactory perception as a marker of AD, 2) Identification of odorants most significantly affected in mild AD patients, 3) Identification of odorants which are still adequately perceived by mild AD patients, 4) Analysis of the decline in the spatial coherence of different oscillatory bands in response to olfactory stimulation, and 5) Being the first study to quantitatively assess the performance of olfactory decline due to aging and AD in the Iranian population.	[Sedghizadeh, Mohammad Javad; Hojjati, Hadi; Ezzatdoost, Kiana; Aghajan, Hamid] Sharif Univ Technol, Dept Elect Engn, Tehran, Iran; [Vahabi, Zahra; Tarighatnia, Heliya] Univ Tehran Med Sci, Ziaeian Hosp, Dept Geriatr Med, Tehran, Iran; [Vahabi, Zahra] Univ Tehran Med Sci, Roozbeh Hosp, Memory & Behav Neurol Div, Tehran, Iran	Sharif University of Technology; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Aghajan, H (corresponding author), Sharif Univ Technol, Dept Elect Engn, Tehran, Iran.	aghajan@ee.sharif.edu	Hojjati, Hadi/GQP-2765-2022	Hojjati, Hadi/0000-0001-7271-0587; Sedghizadeh, Mohammad Javad/0000-0003-2888-7240	Cognitive Sciences & Technologies Council of Iran [G970736]; Sharif University of Technology	Cognitive Sciences & Technologies Council of Iran; Sharif University of Technology	This work was partially funded by the Cognitive Sciences & Technologies Council of Iran. This work was also partially supported by grant G970736 from Sharif University of Technology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSJCaWSC T. S. Lorig, B PSYCHONOMIC SOC, V131-134, P131; Adler G, 2003, J NEURAL TRANSM, V110, P1051, DOI 10.1007/s00702-003-0024-8; [Anonymous], 2011, MOL CELLULAR PROTEOM, V10, pR110; [Anonymous], 2011, J CLIN HYPERTENSI S1, V13, pA155; [Anonymous], 2004, J NEUROSCI METH, V134, P9; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; BRUN A, 1976, ARCH PSYCHIAT NERVEN, V223, P15, DOI 10.1007/BF00367450; Buzsaki G., 2006, RHYTHMS BRAIN; Caminiti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103151; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Chen CC, 2015, J FORMOS MED ASSOC, V114, P729, DOI 10.1016/j.jfma.2013.07.008; Chua XY, 2019, INT PSYCHOGERIATR, V31, P147, DOI 10.1017/S1041610218000704; Ciceliene J, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54020013; Cole A, 2018, ALZHEIMERS DEMENT, V14, P1180; Counts SE, 2017, NEUROTHERAPEUTICS, V14, P35, DOI 10.1007/s13311-016-0481-z; Custers, 2019, BIBLIOTHECA ORIENTAL, V76, p422a; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; Doty RL, 1995, SMELL IDENTIFICATION, VThird; Efron B., 2010, LARGE SCALE INFERENC; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gillespie AK, 2016, NEURON, V90, P740, DOI 10.1016/j.neuron.2016.04.009; Hojjati H, 2019, AUSTR INT BIOM ENG C; Hyvarinen E. 0. Aapo, 2000, INDEPENDENT COMPONEN; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Invitto S, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00272; Invitto S, 2019, RESP PHYSIOL NEUROBI, V259, P37, DOI 10.1016/j.resp.2018.07.002; Jack CR, 2019, JAMA-J AM MED ASSOC, V321, P2316, DOI 10.1001/jama.2019.7437; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Kjelvik G, 2007, INT J GERIATR PSYCH, V22, P1020, DOI 10.1002/gps.1783; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; LEUCHTER AF, 1987, ARCH GEN PSYCHIAT, V44, P993; Luck S.J., 2005, INTRO EVENT RELATED; Makowska I, 2011, ARCH CLIN NEUROPSYCH, V26, P270, DOI 10.1093/arclin/acr011; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; Mishra J, 2006, NEURAL NETWORKS, V19, P1329, DOI 10.1016/j.neunet.2006.08.005; Morgan CD, 2002, J INT NEUROPSYCH SOC, V8, P753, DOI 10.1017/S1355617702860039; Musaeus CS, 2019, CLIN NEUROPHYSIOL, V130, P1889, DOI 10.1016/j.clinph.2019.07.016; Musaeus CS, 2018, J ALZHEIMERS DIS, V65, P475, DOI 10.3233/JAD-180384; Musaeus CS, 2018, J ALZHEIMERS DIS, V64, P1359, DOI 10.3233/JAD-180300; Nancy K, 1975, ELECTROENCEPHALOGRAP, P387; Oniz A, 2013, J NEUROL SCI-TURK, V30, P270; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pijnenburg YAL, 2004, CLIN NEUROPHYSIOL, V115, P1332, DOI 10.1016/j.clinph.2003.12.029; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Samper-Gonzalez J, 2018, NEUROIMAGE, V183, P504, DOI 10.1016/j.neuroimage.2018.08.042; Seitz DP, 2018, COCHRANE SYSTEMATIC, P1465; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shaw LM, 2018, ALZHEIMERS DEMENT, V14, P1505, DOI 10.1016/j.jalz.2018.07.220; Silva Maren de Moraes e, 2018, Dement. neuropsychol., V12, P123, DOI 10.1590/1980-57642018dn12-020004; Silveira-Moriyama L, 2010, ARQ NEURO-PSIQUIAT, V68, P700, DOI 10.1590/S0004-282X2010000500005; Tadayon R, 2019, PROCEEDINGS OF THE 4TH INTERNATIONAL WORKSHOP ON MULTIMEDIA FOR PERSONAL HEALTH & HEALTH CARE (HEALTHMEDIA'19), P16, DOI 10.1145/3347444.3356239; Taherkhani S, 2015, CHEMOSENS PERCEPT, V8, P183, DOI 10.1007/s12078-015-9192-9; TALAMO BR, 1989, NATURE, V337, P736, DOI 10.1038/337736a0; Taylor K, 2005, CEREB CORTEX, V15, P1424, DOI 10.1093/cercor/bhi023; Tremblay C, 2018, CHEM SENSES, V43, P611, DOI 10.1093/chemse/bjy049; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Velayudhan L, 2013, INT PSYCHOGERIATR, V25, P1157, DOI 10.1017/S1041610213000446; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang RF, 2014, CHAOS, V24, DOI 10.1063/1.4896095; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Wolk D, 2019, JAMA-J AM MED ASSOC, V321, P2289, DOI 10.1001/jama.2019.7534; Yuval-Greenberg S, 2007, J NEUROSCI, V27, P1090, DOI 10.1523/JNEUROSCI.4828-06.2007; Zou YM, 2016, NEUROPSYCH DIS TREAT, V12, P869, DOI 10.2147/NDT.S104886	73	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243535	10.1371/journal.pone.0243535	http://dx.doi.org/10.1371/journal.pone.0243535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320870	Green Published, gold			2022-12-26	WOS:000600339800011
J	Souris, M; Gonzalez, JP				Souris, Marc; Gonzalez, Jean-Paul			COVID-19: Spatial analysis of hospital case-fatality rate in France	PLOS ONE			English	Article								When the population risk factors and reporting systems are similar, the assessment of the case-fatality (or lethality) rate (ratio of cases to deaths) represents a perfect tool for analyzing, understanding and improving the overall efficiency of the health system. The objective of this article is to estimate the influence of the hospital care system on lethality in metropolitan France during the inception of the COVID-19 epidemic, by analyzing the spatial variability of the hospital case-fatality rate (CFR) between French districts. In theory, the hospital age-standardized CFR should not display significant differences between districts, since hospital lethality depends on the virulence of the pathogen (the SARS-CoV-2 virus), the vulnerability of the population (mainly age-related), the healthcare system quality, and cases and deaths definition and the recording accuracy. We analyzed hospital data on COVID-19 hospitalizations, severity (admission to intensive care units for reanimation or endotracheal intubation) and mortality, from March 19 to May 8 corresponding to the first French lockdown. All rates were age-standardized to eliminate differences in districts age structure. The results show that the higher case-fatality rates observed by districts are mostly related to the level of morbidity. Time analysis shows that the case-fatality rate has decreased over time, globally and in almost all districts, showing an improvement in the management of severe patients during the epidemic. In conclusion, it appears that during the first critical phase of COVID-19 ramping epidemic in metropolitan France, the higher case-fatality rates were generally related to the higher level of hospitalization, then potentially related to the overload of healthcare system. Also, low hospitalization with high case-fatality rates were mostly found in districts with low population density, and could due to some limitation of the local healthcare access. However, the magnitude of this increase of case-fatality rate represents less than 10 per cent of the average case-fatality rate, and this variation is small compared to much greater variation across countries reported in the literature.	[Souris, Marc] UVE Aix Marseille Univ, UMR Unite Virus Emergents, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France; [Gonzalez, Jean-Paul] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC USA; [Gonzalez, Jean-Paul] Commonwealth Trade Partners Inc, Alexandria, VA USA; [Gonzalez, Jean-Paul] Centaurus Biotech LLC, Manassas, VA USA	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Georgetown University	Souris, M (corresponding author), UVE Aix Marseille Univ, UMR Unite Virus Emergents, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.	marc.souris@ird.fr		Gonzalez, Jean-Paul/0000-0003-3063-1770				Allard T, 2020, INSEE ANAL ILE DE FR; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Bouyer J, 1993, EPIDEMIOLOGIE PRINCI; Breslow N E, 1980, IARC Sci Publ, P5; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Collier L, 2016, HUMAN VIROLOGY; Hurraux JM, 2003, TRAITE VIROLOGIE HUM; Khafaie Morteza Abdullatif, 2020, Osong Public Health Res Perspect, V11, P74, DOI 10.24171/j.phrp.2020.11.2.03; Lipsitch M, 2020, LANCET INFECT DIS, V20, P775, DOI [10.1016/S1473-3099(20)30246-2, 10.1016/S1473-3099(20)30245-0]; Miller RG, 1996, SIMULTANEOUS STAT IN; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Porta M, 2008, DICT EPIDEMIOLOGY; Rinaldia G, EMPIRICAL ESTIMATE I; Robert-Bobee, 2020, INSEE FOCUS; Salie H, 2020, SCIENCE         0513, DOI [10.1126/science.abc3517, DOI 10.1126/SCIENCE.ABC3517]; Saluzzo J-F, 2004, VIRUS EMERGENTS; SAMUELS SJ, 1991, AM J EPIDEMIOL, V133, P1191, DOI 10.1093/oxfordjournals.aje.a115831; Souris M, 2019, EPIDEMIOLOGY AND GEOGRAPHY: PRINCIPLES, METHODS AND TOOLS OF SPATIAL ANALYSIS, P1, DOI 10.1002/9781119528203; Temps, TEMPS	19	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243606	10.1371/journal.pone.0243606	http://dx.doi.org/10.1371/journal.pone.0243606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320895	gold, Green Published, Green Submitted			2022-12-26	WOS:000600339800063
J	Hutson, SP; Golden, A; Odoi, A				Hutson, Sadie P.; Golden, Ashley; Odoi, Agricola			Geographic distribution of hospice, homecare, and nursing home facilities and access to end-of-life care among persons living with HIV/AIDS in Appalachia	PLOS ONE			English	Article							HEALTH; DISPARITIES; TENNESSEE; STROKE; GIS	Background Access to healthcare services, from diagnosis through end of life (EOL), is important among persons living with Human Immunodeficiency Syndrome (HIV) and Acquired Immunodeficiency Syndrome (AIDS) (PLWHA). However, little is known about the availability of hospice services in Appalachian areas. Therefore, the objective of this study is to describe the geographic distribution of hospice, homecare and nursing home facilities in order to demonstrate current existence of and access to resources for EOL care among PLWHA in the Appalachian regions of Tennessee and Alabama. Methods This paper reports on the second aim of a larger sequential, mixed methods qualitative-quantitative (qual -> quan) study. Data from advance care planning (ACP) surveys were collected by both electronic (n = 28) and paper copies (n = 201) and, among other things, obtained information on zip codes of residence of PLWHA. This enabled assessment of the geographic distribution of residences of PLWHA in relation to the distribution of healthcare services such as hospice and home healthcare services. Hospice and Home Healthcare data were obtained from the Tennessee and Alabama Departments of Health. The street addresses of these facilities were used to geocode and map the geographic distributions of the facilities using Street Map USA. Travel times to Hospice and Home Healthcare facilities were computed and mapped using ArcGIS 10.3. Results We identified a total of 32 hospice and 69 home healthcare facilities in the Tennessee Appalachian region, while the Alabama Appalachian region had a total of 110 hospice and 86 home healthcare facilities. Most care facilities were located in urban centers. The distribution of care facilities was worse in Tennessee with many counties having no facilities, requiring up to an hour drive time to reach patients. A total of 86% of the PLWHA indicated preference to die at home. Conclusions Persons living with HIV/AIDS in Appalachia face a number of challenges at the end of life that make access to EOL services difficult. Although respondents indicated a preference to die at home, the hospice/homecare infrastructure and resources are overwhelmingly inadequate to meet this need. There is need to improve access to EOL care in the Appalachian regions of both Tennessee and Alabama although the need is greater in Tennessee.	[Hutson, Sadie P.] Univ Tennessee, Coll Nursing, Knoxville, TN 37901 USA; [Golden, Ashley] Oak Ridge Associated Univ, Oak Ridge, TN USA; [Odoi, Agricola] Univ Tennessee, Inst Agr, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Hutson, SP (corresponding author), Univ Tennessee, Coll Nursing, Knoxville, TN 37901 USA.	shutson@utk.edu	Odoi, Agricola/I-9532-2019; Golden, Ashley/AAG-9445-2021	Odoi, Agricola/0000-0001-5050-6737; Golden, Ashley/0000-0002-9430-7702	National Institute of Nursing Research of the National Institutes of Health [R21NR014055]	National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was funded by the National Institute of Nursing Research of the National Institutes of Health under Award Number R21NR014055 to SPH. ninr.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appalachian Regional Commission, 2017, CREAT CULT HLTH APP; Bone AE, 2018, PALLIATIVE MED, V32, P329, DOI 10.1177/0269216317734435; Busingye D, 2011, SPAT SPATIO-TEMPORAL, V2, P247, DOI 10.1016/j.sste.2011.07.010; Campbell CL, 2009, J NURS SCHOLARSHIP, V41, P420, DOI 10.1111/j.1547-5069.2009.01310.x; Carlson MDA, 2010, J PALLIAT MED, V13, P1331, DOI 10.1089/jpm.2010.0209; Casey Michelle M, 2005, Am J Hosp Palliat Care, V22, P363, DOI 10.1177/104990910502200509; Centers for Disease Control and Prevention, 2016, HIV SURV REP, V28; Centers for Disease Control and Prevention (CDC) National HIV Surveillance System, 2012, 2012 HIV PREV RAT PE; Chukwusa E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231666; Chukwusa E, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0172-1; ESRI, 2015, ARCGIS DESKT REL 10; Finucane AM, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0490-x; Gatrell AC, 2012, HEALTH PLACE, V18, P832, DOI 10.1016/j.healthplace.2012.03.009; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Griffith BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-229; Hawley P., 2017, BARRIERS ACCESS PALL, DOI [10.1177/1178224216688887, DOI 10.1177/1178224216688887]; Heckman TG, 1998, AIDS CARE, V10, P365, DOI 10.1080/713612410; Jenkins TM, 2009, PREV CHRONIC DIS, P6; Kohli S, 1995, J Med Syst, V19, P425, DOI 10.1007/BF02260846; Lindley LC, 2015, AM J HOSP PALLIAT ME, V32, P849, DOI 10.1177/1049909114543641; Lyon ME, 2008, J PALLIAT MED, V11, P459, DOI 10.1089/jpm.2007.0148; Madigan Elizabeth A, 2009, Policy Polit Nurs Pract, V10, P71, DOI 10.1177/1527154409333861; McLafferty SL, 2003, ANNU REV PUBL HEALTH, V24, P25, DOI 10.1146/annurev.publhealth.24.012902.141012; Medicare Payment Advisory Commission, 2009, C MED PAYM POL; Pedigo AS, 2010, ANN EPIDEMIOL, V20, P924, DOI 10.1016/j.annepidem.2010.06.013; Rainsford S, 2018, HEALTH SOC CARE COMM, V26, P273, DOI 10.1111/hsc.12385; Rainsford S, 2017, PALLIATIVE MED, V31, P895, DOI 10.1177/0269216316685234; Ray N, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-63; Rhodes RL, 2016, J PAIN SYMPTOM MANAG, V51, P120, DOI 10.1016/j.jpainsymman.2015.08.010; Schuurman Nadine, 2006, Int J Health Geogr, V5, P43, DOI 10.1186/1476-072X-5-43; Tansley G, 2019, CAN J SURG, V62, P123, DOI 10.1503/cjs.004218; Tansley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141113; US Census Bureau Geography Division, 2016, CART BOUNDR FIL DESC; Virnig BA, 2006, J PALLIAT MED, V9, P1292, DOI 10.1089/jpm.2006.9.1292; Walker BB, 2017, RURAL REMOTE HEALTH, V17, DOI 10.22605/RRH4210; World Health Organization, 2020, PALLI8 ENS PALL CAR	36	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243814	10.1371/journal.pone.0243814	http://dx.doi.org/10.1371/journal.pone.0243814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315923	gold, Green Published			2022-12-26	WOS:000600186100038
J	Flynn, DE; Mao, D; Yerkovich, ST; Franz, R; Iswariah, H; Hughes, A; Shaw, IM; Tam, DPL; Chandrasegaram, MD				Flynn, David E.; Mao, Derek; Yerkovich, Stephanie T.; Franz, Robert; Iswariah, Harish; Hughes, Andrew; Shaw, Ian M.; Tam, Diana P. L.; Chandrasegaram, Manju D.			The impact of comorbidities on post-operative complications following colorectal cancer surgery	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; CLASSIFICATION; INDEX; AGE	Background Colorectal cancer surgery is complex and can result in severe post-operative complications. Optimisation of surgical outcomes requires a thorough understanding of the background complexity and comorbid status of patients. Aim The aim of this study is to determine whether certain pre-existing comorbidities are associated with high grade post-operative complications following colorectal cancer surgery. The study also aims to define the prevalence of demographic, comorbid and surgical features in a population undergoing colorectal cancer resection. Method A colorectal cancer database at The Prince Charles Hospital was established to capture detailed information on patient background, comorbidities and clinicopathological features. A single-centre retrospective study was undertaken to assess the effect of comorbidities on post-operative outcomes following colorectal cancer resection. Five hundred and thirty-three patients were reviewed between 2010-2018 to assess if specific comorbidities were associated with higher grade post-operative complications. A Clavien-Dindo grade of three or higher was defined as a high grade complication. Results Fifty-eight percent of all patients had an ASA grade of ASA III or above. The average BMI of patients undergoing resection was 28 +/- 6.0. Sixteen percent of all patients experienced a high grade complications. Patients with high grade complications had a higher mean average age compared to patients with low grade or no post-operative complications (74 years vs 70 years, p = 0.01). Univariate analysis revealed patients with atrial fibrillation, COPD, ischaemic heart disease and heart failure had an increased risk of high grade complications. Multivariate analysis revealed pre-existing atrial fibrillation (OR 2.70, 95% CI 1.53-4.89, p <0.01) and COPD (OR 2.02 1.07-3.80, p = 0.029) were independently associated with an increased risk of high grade complications. Conclusion Pre-existing atrial fibrillation and COPD are independent risk factors for high grade complications. Targeted perioperative management is necessary to optimise outcomes.	[Flynn, David E.; Mao, Derek; Franz, Robert; Iswariah, Harish; Hughes, Andrew; Shaw, Ian M.; Tam, Diana P. L.; Chandrasegaram, Manju D.] Prince Charles Hosp, Dept Gen Surg, Brisbane, Qld, Australia; [Yerkovich, Stephanie T.] Prince Charles Hosp, Common Good Fdn, Brisbane, Qld, Australia	Prince Charles Hospital; Prince Charles Hospital	Flynn, DE (corresponding author), Prince Charles Hosp, Dept Gen Surg, Brisbane, Qld, Australia.	deflynn75@gmail.com	Iswariah, Harish/G-3503-2011	Iswariah, Harish/0000-0001-6272-3755; Mao, Derek/0000-0002-3979-734X				American Diabetes Association, 2005, DIABETES CARE S1, V28, pS37; An Qi, 2016, Zhonghua Wei Chang Wai Ke Za Zhi, V19, P1035; Andre C, 2015, ARQ NEURO-PSIQUIAT, V73, P704, DOI 10.1590/0004-282X20150085; [Anonymous], 2014, DIABETES CARE, V1, pS14; Aquina CT, 2017, BRIT J CANCER, V116, P389, DOI 10.1038/bjc.2016.421; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Australian Institute of Health and Welfare, 2018, CANC DAT AUSTR AUSTR; Australian Institute of Health and Welfare, 2019, AUSTR BURD DIS STUD; Ball J, 2015, MED J AUSTRALIA, V202, P32, DOI 10.5694/mja14.00238; Bokey L, 2015, ANZ J SURG, V85, P128, DOI 10.1111/ans.12685; Capucci A, 1997, PACE, V20, P2684, DOI 10.1111/j.1540-8159.1997.tb06117.x; Cuthbert CA, 2018, J CANCER SURVIV, V12, P733, DOI 10.1007/s11764-018-0710-z; Dasgupta P, 2013, CANCER CAUSE CONTROL, V24, P897, DOI 10.1007/s10552-013-0166-4; Duraes LC, 2018, ANN SURG ONCOL, V25, P188, DOI 10.1245/s10434-017-6142-6; Fitz-Henry J, 2011, ANN ROY COLL SURG, V93, P185, DOI 10.1308/rcsann.2011.93.3.185a; Grosso G, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-S1-S20; Heriot A, 2018, BINATIONAL COLORECTA; Lemmens VEPP, 2007, WORLD J SURG, V31, P192, DOI 10.1007/s00268-005-0711-8; Mann CJ, 2007, HEART, V93, P45, DOI 10.1136/hrt.2006.099929; Pedrazzani C, 2009, WORLD J GASTROENTERO, V15, P5706, DOI 10.3748/wjg.15.5706; Pule ML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44969-8; Sutton C D, 2004, Colorectal Dis, V6, P21, DOI 10.1111/j.1463-1318.2004.00574.x; Tominaga T, 2018, INDIAN J SURG, V80, P54, DOI 10.1007/s12262-016-1544-4; Walsh Stewart R, 2004, World J Surg Oncol, V2, P40; Xu L, 2018, Zhonghua Wai Ke Za Zhi, V56, P900, DOI 10.3760/cma.j.issn.0529-5815.2018.12.005; Yap R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167271	26	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243995	10.1371/journal.pone.0243995	http://dx.doi.org/10.1371/journal.pone.0243995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362234	Green Published, gold			2022-12-26	WOS:000603071600025
J	Lin, WY; Liang, WC; Nguy, T; Maia, M; Tyagi, T; Chiu, C; Hoi, KH; Chen, YM; Wu, Y				Lin, WeiYu; Liang, Wei-Ching; Nguy, Trung; Maia, Mauricio; Tyagi, Tulika; Chiu, Cecilia; Hoi, Kam Hon; Chen, Yongmei; Wu, Yan			Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology	PLOS ONE			English	Article							GENERATION; ANTIBODIES	The proactive generation of anti-idiotypic antibodies (anti-IDs) against therapeutic antibodies with desirable properties is an important step in pre-clinical and clinical assay development supporting their bioanalytical programs. Here, we describe a robust platform to generate anti-IDs using rabbit single B cell sorting-culture and cloning technology by immunizing rabbits with therapeutic drug Fab fragment and sorting complementarity determining regions (CDRs) specific B cells using designed framework control as a negative gate to exclude non-CDRs-specific B cells. The supernatants of cultured B cells were subsequently screened for binding to drug-molecule by enzyme-linked immunosorbent assay and the positive hits of B cell lysates were selected for cloning of their immunoglobulin G (IgG) variable regions. The recombinant monoclonal anti-IDs generated with this method have high affinity and specificity with broad epitope coverage and different types. The recombinant anti-IDs were available for assay development to support pharmacokinetic (PK) and immunogenicity studies within 12 weeks from the start of rabbit immunization. Using this novel rapid and efficient in-house approach we have generated a large panel of anti-IDs against a series of 11 therapeutic antibody drugs and successfully applied them to the clinical assay development.	[Lin, WeiYu; Liang, Wei-Ching; Tyagi, Tulika; Chiu, Cecilia; Hoi, Kam Hon; Chen, Yongmei; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Nguy, Trung; Maia, Mauricio] Genentech Inc, DevSci BioAnalyt Sci, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Wu, Y (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.	yw@gene.com						[Anonymous], 2007, AAPS J, V9, pE336; [Anonymous], 2015, STRED CTR J INTERDIS, V7, P9; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Bos AB, 2015, BIOTECHNOL BIOENG, V112, P1832, DOI 10.1002/bit.25601; Carter PJ, 2018, NAT REV DRUG DISCOV, V17, P197, DOI 10.1038/nrd.2017.227; DeSilva B, 2003, PHARM RES-DORDR, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Iezzi ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00273; Gomes CPC, 2017, MOL THER-NUCL ACIDS, V8, P494, DOI 10.1016/j.omtn.2017.07.014; Harth S, 2019, MABS-AUSTIN, V11, P178, DOI 10.1080/19420862.2018.1538723; Huehls AM, 2015, IMMUNOL CELL BIOL, V93, P290, DOI 10.1038/icb.2014.93; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Liu ZQ, 2003, HYBRIDOMA HYBRIDOM, V22, P219, DOI 10.1089/153685903322328947; Seeber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086184; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Starkie DO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152282; Tiller T, 2011, NEW BIOTECHNOL, V28, P453, DOI 10.1016/j.nbt.2011.03.014; Wranik BJ, 2012, J BIOL CHEM, V287, P43331, DOI 10.1074/jbc.M112.397869; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096697	20	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244158	10.1371/journal.pone.0244158	http://dx.doi.org/10.1371/journal.pone.0244158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347473	Green Published, gold			2022-12-26	WOS:000603071100001
J	Gibeau, P; Bradford, MJ; Palen, WJ				Gibeau, Pascale; Bradford, Michael J.; Palen, Wendy J.			Can the creation of new freshwater habitat demographically offset losses of Pacific salmon from chronic anthropogenic mortality?	PLOS ONE			English	Article							COHO SALMON; ONCORHYNCHUS-KISUTCH; LIFE-HISTORY; BIODIVERSITY OFFSETS; BRITISH-COLUMBIA; FISH POPULATIONS; CARNATION CREEK; CHINOOK SALMON; RIVER; SURVIVAL	Over 1 billion USD are devoted annually to rehabilitating freshwater habitats to improve survival for the recovery of endangered salmon populations. Mitigation often requires the creation of new habitat (e.g. habitat offsetting) to compensate population losses from human activities, however offsetting schemes are rarely evaluated. Anadromous Pacific salmon are ecologically, culturally, and economically important in the US and Canada, and face numerous threats from degradation of freshwater habitats. Here we used a matrix population model of coho salmon (Oncorhynchus kisutch) to determine the amount of habitat offsetting needed to compensate mortality (2-20% per year) caused by a range of development activities. We simulated chronic mortality to three different life stages (egg, parr, smolt/adult), individually and simultaneously, to mimic impacts from development, and evaluated if the number of smolts produced from constructed side-channels demographically offset losses. We show that under ideal conditions, the typical size of a constructed side-channel in the Pacific Northwest (PNW) (3405 m(2)) is sufficient to compensate for only relatively low levels of chronic mortality to either the parr or smolt/adult stages (2-7% per year), but populations do not recover if mortality is >10% per year. When we assumed lower productivity (e.g.; 25(th) percentile), we found that constructed channels would need to be 2.5-4.5 fold larger as compared to the typical size built in the PNW, respectively, to maintain population sizes. Moreover, when we imposed mortality to parr and smolt/adult stages simultaneously, we found that constructed side-channels would need to be between 1.8- and 2.3- fold larger that if the extra chronic mortality was imposed to one life stage only. We conclude that habitat offsetting has the potential to mitigate chronic mortality to early life stages, but that realistic assumptions about productivity of constructed side-channels and cumulative effects of anthropogenic disturbances on multiple life stages need to be considered.	[Gibeau, Pascale; Palen, Wendy J.] Simon Fraser Univ, Earth Ocean Res Grp, Dept Biol Sci, Burnaby, BC, Canada; [Bradford, Michael J.] Fisheries & Ocean Canada, Pacific Sci Enterprise Ctr, W Vancouver, BC, Canada	Simon Fraser University; Fisheries & Oceans Canada	Gibeau, P (corresponding author), Simon Fraser Univ, Earth Ocean Res Grp, Dept Biol Sci, Burnaby, BC, Canada.	pgibeau@sfu.ca		Bradford, Michael/0000-0002-4810-0495	NSERC Discovery Grant; Gordon and Betty Moore Foundation; Wilburforce Foundation	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Wilburforce Foundation	NSERC Discovery Grant, the Gordon and Betty Moore, and Wilburforce Foundations to WJP.	Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; Anderson D, 2015, WATER ENVIRON J, V29, P268, DOI 10.1111/wej.12101; Baisez Aurore, 2011, Endangered Species Research, V15, P265, DOI 10.3354/esr00384; Barnthouse LW, 2019, ENVIRON MANAGE, V64, P593, DOI 10.1007/s00267-019-01214-2; Barnthouse LW, 2013, ENVIRON SCI POLICY, V31, P149, DOI 10.1016/j.envsci.2013.03.001; BECKER CD, 1985, ENVIRON BIOL FISH, V12, P33, DOI 10.1007/BF00007708; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Beverton R.J.H., 1957, FISH INVEST SER, P19; Booth DB, 2016, WATER-SUI, V8, DOI 10.3390/w8050174; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P677, DOI 10.1139/cjfas-57-4-677; BRADFORD MJ, 1995, CAN J FISH AQUAT SCI, V52, P1327, DOI 10.1139/f95-129; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; Bull JW, 2013, ORYX, V47, P369, DOI 10.1017/S003060531200172X; Casas-Mulet R, 2015, RIVER RES APPL, V31, P433, DOI 10.1002/rra.2827; CHAPMAN DW, 1962, J FISH RES BOARD CAN, V19, P1047, DOI 10.1139/f62-069; Chittenden CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010869; CRONE RA, 1976, FISH B-NOAA, V74, P897; Crozier LG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217711; Gibeau P, 2017, CAN J FISH AQUAT SCI, V74, P1135, DOI 10.1139/cjfas-2016-0253; Goodwin NB, 2006, CAN J FISH AQUAT SCI, V63, P494, DOI 10.1139/f05-234; Greene CM, 2004, CAN J FISH AQUAT SCI, V61, P590, DOI 10.1139/F04-024; Groot C., 1995, PHYSL ECOLOGY PACIFI; Hall J.D., 2008, HYDROLOGICAL BIOL RE, P78; Hartman GF, 1996, CAN J FISH AQUAT SCI, V53, P237, DOI 10.1139/cjfas-53-S1-237; Hayes D, 2009, REV FISH BIOL FISHER, V19, P295, DOI 10.1007/s11160-009-9103-8; Hodgson EE, 2017, ECOLOGY, V98, P2673, DOI 10.1002/ecy.1961; HOLTBY LB, 1990, ECOLOGY, V71, P678, DOI 10.2307/1940322; Keeley E. R., 1996, 4 MIN ENV LANDS PARK; Korman J., 2019, 2019001 CAN SCI ADV; Korman J, 2014, 2014089 CAN SCI ADV; Levin PS, 2001, ANIM CONSERV, V4, P291, DOI 10.1017/S1367943001001342; McCay DPF, 2003, MAR ECOL PROG SER, V264, P177; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Milner NJ, 2003, FISH RES, V62, P111, DOI 10.1016/S0165-7836(02)00157-1; Morley SA, 2005, CAN J FISH AQUAT SCI, V62, P2811, DOI 10.1139/F05-185; Morris W. F., 2002, QUANTITATIVE CONSERV; Muir WD, 2001, N AM J FISH MANAGE, V21, P135, DOI 10.1577/1548-8675(2001)021<0135:SOJSPT>2.0.CO;2; Nagrodski A, 2012, J ENVIRON MANAGE, V103, P133, DOI 10.1016/j.jenvman.2012.03.007; Naiman RJ, 2000, BIOSCIENCE, V50, P996, DOI 10.1641/0006-3568(2000)050[0996:REAMIT]2.0.CO;2; Naiman RJ, 2008, CR GEOSCI, V340, P629, DOI 10.1016/j.crte.2008.01.002; Nickelson TE, 1998, CAN J FISH AQUAT SCI, V55, P2383, DOI 10.1139/cjfas-55-11-2383; Nislow KH, 2004, T AM FISH SOC, V133, P79, DOI 10.1577/T02-168; Ogston L, 2015, CAN J FISH AQUAT SCI, V72, P479, DOI 10.1139/cjfas-2014-0189; Pascoe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025762; Quetier F, 2011, BIOL CONSERV, V144, P2991, DOI 10.1016/j.biocon.2011.09.002; Quigley JT, 2006, ENVIRON MANAGE, V37, P351, DOI 10.1007/s00267-004-0263-y; R Core Team, 2021, R LANGUAGE ENV STAT; Roni P, 2006, T AM FISH SOC, V135, P1398, DOI 10.1577/T05-296.1; Roni P, 2010, N AM J FISH MANAGE, V30, P1469, DOI 10.1577/M09-162.1; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rosenfeld JS, 2008, N AM J FISH MANAGE, V28, P1108, DOI 10.1577/M07-027.1; Schreck CB, 2006, T AM FISH SOC, V135, P457, DOI 10.1577/T05-184.1; SCRIVENER JC, 1989, CAN J FISH AQUAT SCI, V46, P681, DOI 10.1139/f89-087; Shapovalov L., 1954, FISH B, V98; Spidle AP, 1998, J FISH BIOL, V52, P907, DOI 10.1111/j.1095-8649.1998.tb00591.x; TANG J, 1987, PROG FISH CULT, V49, P167, DOI 10.1577/1548-8640(1987)49&lt;167:EOTEOT&gt;2.0.CO;2; Tschaplinski PJ, 2017, ECOHYDROLOGY, V10, DOI 10.1002/eco.1812; Walters AW, 2013, ECOL FRESHW FISH, V22, P508, DOI 10.1111/eff.12046; Waples RS, 2009, ECOL SOC, V14; Ward B.R., 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V118, P209; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2	61	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237052	10.1371/journal.pone.0237052	http://dx.doi.org/10.1371/journal.pone.0237052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332352	Green Submitted, gold, Green Published			2022-12-26	WOS:000601310900105
J	Hirabayashi, G; Saito, M; Terayama, S; Akihisa, Y; Maruyama, K; Andoh, T				Hirabayashi, Go; Saito, Minami; Terayama, Sachiko; Akihisa, Yuki; Maruyama, Koichi; Andoh, Tomio			Lung-protective properties of expiratory flow-initiated pressure-controlled inverse ratio ventilation: A randomised controlled trial	PLOS ONE			English	Article							LAPAROSCOPIC RADICAL PROSTATECTOMY; PULMONARY GAS-EXCHANGE; CO2 ELIMINATION; OXYGENATION; PAUSE	Background Expiratory flow-initiated pressure-controlled inverse ratio ventilation (EF-initiated PC-IRV) reduces physiological dead space. We hypothesised that EF-initiated PC-IRV would be lung protective compared with volume-controlled ventilation (VCV). Methods Twenty-eight men undergoing robot-assisted laparoscopic radical prostatectomy were enrolled in this randomised controlled trial. The EF-initiated PC-IRV group (n = 14) used pressure-controlled ventilation with the volume guaranteed mode. The inspiratory to expiratory (I:E) ratio was individually adjusted by observing the expiratory flow-time wave. The VCV group (n = 14) used the volume control mode with a 1:2 I:E ratio. The Mann-Whitney U test was used to compare differences in the serum cytokine levels. Results There were no significant differences in serum IL-6 between the EF-initiated PC-IRV (median 34 pg ml(-1) (IQR 20.5 to 63.5)) and VCV (31 pg ml(-1) (24.5 to 59)) groups (P = 0.84). The physiological dead space rate (physiological dead space/expired tidal volume) was significantly reduced in the EF-initiated PC-IRV group as compared with that in the VCV group (0.31 +/- 0.06 vs 0.4 +/- 0.07; P<0.001). The physiological dead space rate was negatively correlated with the forced vital capacity (% predicted) in the VCV group (r = -0.85, P<0.001), but not in the EF-initiated PC-IRV group (r = 0.15, P = 0.62). Two patients in the VCV group had permissive hypercapnia with low forced vital capacity (% predicted). Conclusions There were no differences in the lung-protective properties between the two ventilatory strategies. However, EF-initiated PC-IRV reduced physiological dead space rate; thus, it may be useful for reducing the ventilatory volume that is necessary to maintain normocapnia in patients with low forced vital capacity (% predicted) during robot-assisted laparoscopic radical prostatectomy.	[Hirabayashi, Go; Saito, Minami; Terayama, Sachiko; Akihisa, Yuki; Maruyama, Koichi; Andoh, Tomio] Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Anaesthesiol, Sagamiko, Kanagawa, Japan	Teikyo University	Hirabayashi, G (corresponding author), Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Anaesthesiol, Sagamiko, Kanagawa, Japan.	goh@med.teikyo-u.ac.jp			Department of Anaesthesiology, Mizonokuchi Hospital Teikyo University School of Medicine, Kanagawa, Japan	Department of Anaesthesiology, Mizonokuchi Hospital Teikyo University School of Medicine, Kanagawa, Japan	This study was financially supported by internal funding from the Department of Anaesthesiology, Mizonokuchi Hospital Teikyo University School of Medicine, Kanagawa, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1990, CHEST, V98, P1445, DOI 10.1378/chest.98.6.1445; Balick-Weber CC, 2007, BRIT J ANAESTH, V99, P429, DOI 10.1093/bja/aem166; Cadi P, 2008, BRIT J ANAESTH, V100, P709, DOI 10.1093/bja/aen067; CHAN K, 1992, CHEST, V102, P1556, DOI 10.1378/chest.102.5.1556; Choi EM, 2011, J CLIN ANESTH, V23, P183, DOI 10.1016/j.jclinane.2010.08.006; Devaquet J, 2008, J APPL PHYSIOL, V105, P1944, DOI 10.1152/japplphysiol.90682.2008; Gainsburg DM, 2012, MINERVA ANESTESIOL, V78, P596; Hirabayashi G, 2018, EUR J ANAESTH, V35, P307, DOI 10.1097/EJA.0000000000000732; Kalmar AF, 2010, BRIT J ANAESTH, V104, P433, DOI 10.1093/bja/aeq018; Kim MS, 2018, INT J MED SCI, V15, P1522, DOI 10.7150/ijms.28442; Lestar M, 2011, ANESTH ANALG, V113, P1069, DOI 10.1213/ANE.0b013e3182075d1f; Markstrom Agneta M., 1996, Upsala Journal of Medical Sciences, V101, P257; MERCAT A, 1993, CHEST, V104, P871, DOI 10.1378/chest.104.3.871; Michelet P, 2006, ANESTHESIOLOGY, V105, P911, DOI 10.1097/00000542-200611000-00011; Ogurlu M, 2010, J MINIM INVAS GYN, V17, P295, DOI 10.1016/j.jmig.2009.10.007; Prella M, 2002, CHEST, V122, P1382, DOI 10.1378/chest.122.4.1382; Sturesson LW, 2016, BRIT J ANAESTH, V117, P243, DOI 10.1093/bja/aew194; THARRATT RS, 1988, CHEST, V94, P755, DOI 10.1378/chest.94.4.755; TWEED WA, 1992, CAN J ANAESTH, V39, P1036, DOI 10.1007/BF03008371; TWEED WA, 1991, CAN J ANAESTH, V38, P311, DOI 10.1007/BF03007620; Uttman L, 2003, CLIN PHYSIOL FUNCT I, V23, P252, DOI 10.1046/j.1475-097X.2003.00498.x; Wang SH, 2002, AM J SURG, V183, P151, DOI 10.1016/S0002-9610(01)00870-4; Zavala E, 1998, ANESTHESIOLOGY, V88, P35, DOI 10.1097/00000542-199801000-00008	23	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243971	10.1371/journal.pone.0243971	http://dx.doi.org/10.1371/journal.pone.0243971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332454	gold, Green Published			2022-12-26	WOS:000601310900104
J	Kinshella, MLW; Salimu, S; Chiwaya, B; Chikoti, F; Chirambo, L; Mwaungulu, E; Banda, M; Newberry, L; Njirammadzi, J; Hiwa, T; Vidler, M; Molyneux, EM; Dube, Q; Mfutso-Bengo, J; Goldfarb, DM; Kawaza, K; Nyondo-Mipando, AL				Kinshella, Mai-Lei Woo; Salimu, Sangwani; Chiwaya, Brandina; Chikoti, Felix; Chirambo, Lusungu; Mwaungulu, Ephrida; Banda, Mwai; Newberry, Laura; Njirammadzi, Jenala; Hiwa, Tamanda; Vidler, Marianne; Molyneux, Elizabeth M.; Dube, Queen; Mfutso-Bengo, Joseph; Goldfarb, David M.; Kawaza, Kondwani; Nyondo-Mipando, Alinane Linda			"So sometimes, it looks like it's a neglected ward": Health worker perspectives on implementing kangaroo mother care in southern Malawi	PLOS ONE			English	Article							DISTRICT	Introduction Kangaroo mother care (KMC) involves continuous skin-to-skin contact of baby on mother's chest to provide warmth, frequent breastfeeding, recognizing danger signs of illness, and early discharge. Though KMC is safe, effective and recommended by the World Health Organization, implementation remains limited in practice. The objective of this study is to understand barriers and facilitators to KMC practice at tertiary and secondary health facilities in southern Malawi from the perspective of health workers. Methods This study is part of the "Integrating a neonatal healthcare package for Malawi" project in the Innovating for Maternal and Child Health in Africa initiative. In-depth interviews were conducted between May-Aug 2019 with a purposively drawn sample of service providers and supervisors working in newborn health at a large tertiary hospital and three district-level hospitals in southern Malawi. Data were analyzed using a thematic approach using NVivo 12 software (QSR International, Melbourne, Australia). Findings A total of 27 nurses, clinical officers, paediatricians and district health management officials were interviewed. Staff attitudes, inadequate resources and reliance on families emerged as key themes. Health workers from Malawi described KMC practice positively as a low-cost, low-technology solution appropriate for resource-constrained health settings. However, staff perceptions that KMC babies were clinically stable was associated with lower prioritization in care and poor monitoring practices. Neglect of the KMC ward by medical staff, inadequate staffing and reliance on caregivers for supplies were associated with women self-discharging early. Conclusion Though routine uptake of KMC was policy for stable low birthweight and preterm infants in the four hospitals, there were gaps in monitoring and maintenance of practice. While conceptualized as a low-cost intervention, sustainable implementation requires investments in technologies, staffing and hospital provisioning of basic supplies such as food, bedding, and KMC wraps. Strengthening hospital capacities to support KMC is needed as part of a continuum of care for premature infants.	[Kinshella, Mai-Lei Woo; Vidler, Marianne] BC Childrens & Womens Hosp, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Kinshella, Mai-Lei Woo; Vidler, Marianne] Univ British Columbia, Vancouver, BC, Canada; [Salimu, Sangwani; Chiwaya, Brandina; Chikoti, Felix; Chirambo, Lusungu; Mwaungulu, Ephrida; Banda, Mwai; Newberry, Laura; Njirammadzi, Jenala; Hiwa, Tamanda; Molyneux, Elizabeth M.; Kawaza, Kondwani] Univ Malawi, Coll Med, Dept Pediat & Child Hlth, Blantyre, Malawi; [Dube, Queen; Kawaza, Kondwani] Queen Elizabeth Cent Hosp, Pediat, Blantyre, Malawi; [Mfutso-Bengo, Joseph; Nyondo-Mipando, Alinane Linda] Univ Malawi, Dept Hlth Syst & Policy, Sch Publ Hlth & Family Med, Coll Med, Blantyre, Malawi; [Mfutso-Bengo, Joseph] Ctr Bioeth Eastern & Southern Africa CEBESA, Blantyre, Malawi; [Goldfarb, David M.] BC Childrens & Womens Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Malawi; University of Malawi; University of Malawi; University of British Columbia	Kinshella, MLW (corresponding author), BC Childrens & Womens Hosp, Dept Obstet & Gynaecol, Vancouver, BC, Canada.; Kinshella, MLW (corresponding author), Univ British Columbia, Vancouver, BC, Canada.	maggie.kinshella@cw.bc.ca	Goldfarb, David/ABD-4623-2021; Nyondo, Alinane/AFN-8844-2022; Kinshella, Mai-Lei Woo/AAA-8117-2022	Nyondo, Alinane/0000-0002-3572-3810; Kinshella, Mai-Lei Woo/0000-0001-5846-3014; Vidler, Marianne/0000-0002-7633-8812; Goldfarb, David/0000-0003-0835-9504	Canadian International Development Research Centre (IDRC); Global Affairs Canada (GAC); Canadian Institutes for Health Research (CIHR) [108030]	Canadian International Development Research Centre (IDRC); Global Affairs Canada (GAC)(CGIAR); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	MWK, ALNM, KK, QD and DG were funded by the Canadian International Development Research Centre (IDRC), Global Affairs Canada (GAC) and the Canadian Institutes for Health Research (CIHR). Project ID is 108030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akseer N, 2015, INT J GYNECOL OBSTET, V131, pS43, DOI 10.1016/j.ijgo.2015.03.017; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2016, WHO REC INT IMPR PRE; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2010, EUR J VASC MED, V39, pS/78; Bergh AM, 2003, ACTA PAEDIATR, V92, P709, DOI 10.1080/08035250310002399; Bergh AM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-75; Bergh AM, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-13; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Boundy EO, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2238; Chan GJ, 2016, B WORLD HEALTH ORGAN, V94, P130, DOI 10.2471/BLT.15.157818; Charpak N, 2020, ACTA PAEDIATR, V109, P2278, DOI 10.1111/apa.15214; Conde-Agudelo A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub4; Department for Maternal NC& AHW, ONG RES PROJ OV IMM; Feucht U, 2016, SAMJ S AFR MED J, V106, P49, DOI [10.7196/SAMJ.2016.v106i1.10149, 10.7196/SAMJ.2016.V106I1.10149]; Gondwe A, 2016, MATERN CHILD HLTH J, V20, P1441, DOI 10.1007/s10995-016-1942-z; Hobart City Council, 2009, HOBART CITY COUNCIL, V5, P48; Hodgins S, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010306; Kambarami R. A., 1999, Central African Journal of Medicine, V45, P56; Kampekete G. S. M., 2018, African Journal of Midwifery and Women's Health, V12, P178, DOI 10.12968/ajmw.2018.12.4.178; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Leonard A, 2008, HEALTH SA GESONDHEID, V13; Lincetto O, 2000, J TROP PEDIATRICS, V46, P293, DOI 10.1093/tropej/46.5.293; Medvedev MM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-4044-6; National Statistical Office Malawi ICF, 2017, MAL DEM HLTH SURV 20; Nyqvist KH, 2016, ACTA PAEDIATR, V105, P341, DOI 10.1111/apa.13236; Okoh BA., 2016, NIGER J PAEDIAT, V43, P252, DOI [DOI 10.4314/NJP.V43I4.4, 10.4314/njp.v43i4.4]; Phaphali Adzitey S, 2017, ANN MED HLTH SCI RES; Reddy J., 2007, EXPERIENCES MOTHERS, DOI DOI 10.4102/CURATIONIS.V30I3.1104; Seidman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125643; Solomons N, 2012, S AFR J CLIN NUTR, V25, P33; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vesel L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S5; Watkins HC, 2018, ACTA PAEDIATR, V107, P1541, DOI 10.1111/apa.14344; Weldearegay HG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225258	35	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243770	10.1371/journal.pone.0243770	http://dx.doi.org/10.1371/journal.pone.0243770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332395	Green Published, gold			2022-12-26	WOS:000601310900055
J	Perry, G; Taylor, NW; Bothwell, PCH; Milbourn, CC; Powell, G; Singh, KD				Perry, Gavin; Taylor, Nathan W.; Bothwell, Philippa C. H.; Milbourn, Colette C.; Powell, Georgina; Singh, Krish D.			The gamma response to colour hue in humans: Evidence from MEG	PLOS ONE			English	Article							VISUAL-CORTEX; OSCILLATIONS; FREQUENCY; POWER; SYNCHRONIZATION; MECHANISMS; LFP; V1	It has recently been demonstrated through invasive electrophysiology that visual stimulation with extended patches of uniform colour generates pronounced gamma oscillations in the visual cortex of both macaques and humans. In this study we sought to discover if this oscillatory response to colour can be measured non-invasively in humans using magnetoencephalography. We were able to demonstrate increased gamma (40-70 Hz) power in response to full-screen stimulation with four different colour hues and found that the gamma response is particularly strong for long wavelength (i.e. red) stimulation, as was found in previous studies. However, we also found that gamma power in response to colour was generally weaker than the response to an identically sized luminance-defined grating. We also observed two additional responses in the gamma frequency: a lower frequency response around 25-35 Hz that showed fewer clear differences between conditions than the gamma response, and a higher frequency response around 70-100 Hz that was present for red stimulation but not for other colours. In a second experiment we sought to test whether differences in the gamma response between colour hues could be explained by their chromatic separation from the preceding display. We presented stimuli that alternated between each of the three pairings of the three primary colours (red, green, blue) at two levels of chromatic separation defined in the CIELUV colour space. We observed that the gamma response was significantly greater to high relative to low chromatic separation, but that at each level of separation the response was greater for both red-blue and red-green than for blue-green stimulation. Our findings suggest that the stronger gamma response to red stimulation cannot be wholly explained by the chromatic separation of the stimuli.	[Perry, Gavin; Taylor, Nathan W.; Bothwell, Philippa C. H.; Milbourn, Colette C.; Powell, Georgina; Singh, Krish D.] Cardiff Univ, Sch Psychol, Cardiff Univ Brain Res Imaging Ctr CUBRIC, Cardiff, Wales	Cardiff University	Perry, G (corresponding author), Cardiff Univ, Sch Psychol, Cardiff Univ Brain Res Imaging Ctr CUBRIC, Cardiff, Wales.	perryg@cardiff.ac.uk	Powell, Georgina/GXM-7788-2022	Milbourn, Colette/0000-0002-1305-8127	Medical Research Council [MR/K005464/1]; MRC [MR/K005464/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded by a Medical Research Council partnership grant (MR/K005464/1) awarded to Krish D Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2004, EUR J NEUROSCI, V20, P587, DOI 10.1111/j.1460-9568.2004.03495.x; Adjamian P, 2008, J VISION, V8, DOI 10.1167/8.7.4; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Bartoli E, 2019, CURR BIOL, V29, P3345, DOI 10.1016/j.cub.2019.08.004; Brunet NM, 2019, NEUROIMAGE, V200, P635, DOI 10.1016/j.neuroimage.2019.06.051; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hadjipapas A, 2015, NEUROIMAGE, V112, P327, DOI 10.1016/j.neuroimage.2015.02.062; Haigh SM, 2018, NEUROPSYCHOLOGIA, V108, P1, DOI 10.1016/j.neuropsychologia.2017.11.020; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hermes D, 2015, CEREB CORTEX, V25, P2951, DOI 10.1093/cercor/bhu091; Hermes D, 2017, CURR BIOL, V27, pR336, DOI 10.1016/j.cub.2017.03.076; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Jia XX, 2011, J NEUROSCI, V31, P9390, DOI 10.1523/JNEUROSCI.0645-11.2011; Johnson EN, 2004, J NEUROPHYSIOL, V91, P2501, DOI 10.1152/jn.01043.2003; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Koelewijn L, 2011, NEUROIMAGE, V54, P2983, DOI 10.1016/j.neuroimage.2010.11.045; LENNIE P, 1990, J NEUROSCI, V10, P649; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Muthukumaraswamy SD, 2008, NEUROIMAGE, V40, P1552, DOI 10.1016/j.neuroimage.2008.01.052; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Orekhova EV, 2019, HUM BRAIN MAPP, V40, P1583, DOI 10.1002/hbm.24469; Parra J, 2007, BRAIN, V130, P1679, DOI 10.1093/brain/awm103; Perry G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124798; Perry G, 2014, EPILEPSY RES, V108, P1076, DOI 10.1016/j.eplepsyres.2014.04.012; Perry G, 2013, NEUROIMAGE, V68, P83, DOI 10.1016/j.neuroimage.2012.11.043; Peter A, 2019, ELIFE, V8, DOI 10.7554/eLife.42101; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Rols G, 2001, VISUAL NEUROSCI, V18, P527, DOI 10.1017/S0952523801184038; Shirakawa S, 2001, EPILEPSIA, V42, P922, DOI 10.1046/j.1528-1157.2001.042007922.x; Shirhatti V, 2018, P NATL ACAD SCI USA, V115, P4489, DOI 10.1073/pnas.1717334115; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Swettenham JB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00076; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; TAKAHASHI T, 1976, ELECTROEN CLIN NEURO, V41, P124, DOI 10.1016/0013-4694(76)90040-7; Takahashi Y, 1999, NEUROLOGY, V53, P926, DOI 10.1212/WNL.53.5.926; Tobimatsu S, 1999, ANN NEUROL, V45, P790, DOI 10.1002/1531-8249(199906)45:6<790::AID-ANA14>3.0.CO;2-7; Veit J, 2017, NAT NEUROSCI, V20, P951, DOI 10.1038/nn.4562; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243237	10.1371/journal.pone.0243237	http://dx.doi.org/10.1371/journal.pone.0243237			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332389	Green Published, gold, Green Accepted			2022-12-26	WOS:000601310900081
J	Gerasimenko, M; Lopatina, O; Shabalova, AA; Cherepanov, SM; Salmina, AB; Yokoyama, S; Goto, H; Okamoto, H; Yamamoto, Y; Ishihara, K; Higashida, H				Gerasimenko, Maria; Lopatina, Olga; Shabalova, Anna A.; Cherepanov, Stanislav M.; Salmina, Alla B.; Yokoyama, Shigeru; Goto, Hisanori; Okamoto, Hiroshi; Yamamoto, Yasuhiko; Ishihara, Katsuhiko; Higashida, Haruhiro			Distinct physical condition and social behavior phenotypes of CD157 and CD38 knockout mice during aging	PLOS ONE			English	Article							OXYTOCIN LEVELS; AGE; MEMORY; DECLINE; ADULTS; DYSFUNCTION; ACTIVATION; DEFICITS; DEFECTS; ANXIETY	The ability of CD38 and CD157 to utilize nicotinamide adenine dinucleotide (NAD) has received much attention because the aging-induced elevation of CD38 expression plays a role in the senescence-related decline in NAD levels. Therefore, it is of interest to examine and compare the effects of age-associated changes on the general health and brain function impairment of Cd157 and Cd38 knockout (CD157 KO and CD38 KO) mice. The body weight and behaviors were measured in 8-week-old (young adult) or 12-month-old (middle-aged) male mice of both KO strains. The locomotor activity, anxiety-like behavior, and social behavior of the mice were measured in the open field and three-chamber tests. The middle-aged CD157 KO male mice gained more body weight than young adult KO mice, while little or no body weight gain was observed in the middle-aged CD38 KO mice. Middle-aged CD157 KO mice displayed increased anxiety-like behavior and decreased sociability and interaction compared with young adult KO mice. Middle-aged CD38 KO mice showed less anxiety and hyperactivity than CD157 KO mice, similar to young adult CD38 KO mice. The results reveal marked age-dependent changes in male CD157 KO mice but not in male CD38 KO mice. We discuss the distinct differences in aging effects from the perspective of inhibition of NAD metabolism in CD157 and CD38 KO mice, which may contribute to differential behavioral changes during aging.	[Gerasimenko, Maria; Lopatina, Olga; Shabalova, Anna A.; Cherepanov, Stanislav M.; Salmina, Alla B.; Yokoyama, Shigeru; Higashida, Haruhiro] Kanazawa Univ, Res Ctr Child Mental Dev, Dept Basic Res Social Recognit & Memory, Kanazawa, Ishikawa, Japan; [Lopatina, Olga; Salmina, Alla B.; Higashida, Haruhiro] Krasnoyarsk State Med Univ, Res Inst Mol Med & Pathobiochem, Lab Social Brain Studies, Krasnoyarsk, Russia; [Lopatina, Olga; Salmina, Alla B.; Higashida, Haruhiro] Krasnoyarsk State Med Univ, Dept Biochem, Krasnoyarsk, Russia; [Goto, Hisanori; Okamoto, Hiroshi; Yamamoto, Yasuhiko] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan; [Ishihara, Katsuhiko] Kawasaki Med Sch, Dept Immunol & Mol Genet, Kurashiki, Okayama, Japan	Kanazawa University; Krasnoyarsk State Medical University; Krasnoyarsk State Medical University; Kanazawa University; Kawasaki Medical School	Higashida, H (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Dept Basic Res Social Recognit & Memory, Kanazawa, Ishikawa, Japan.; Higashida, H (corresponding author), Krasnoyarsk State Med Univ, Res Inst Mol Med & Pathobiochem, Lab Social Brain Studies, Krasnoyarsk, Russia.; Higashida, H (corresponding author), Krasnoyarsk State Med Univ, Dept Biochem, Krasnoyarsk, Russia.	haruhiro@med.kanazawa-u.ac.jp	Salmina, Alla B./L-7977-2013; Ishihara, Katsuhiko/AAL-8175-2021	Cherepanov, Stanislav/0000-0001-5093-3480; Gerasimenko, Maria/0000-0002-6344-9900	Kanazawa University SAKIGAKE project 2018; Takeda Science Foundation, Japan; Japan Society for Promotion of Sciences;  [24590375];  [25461335];  [18K06889]	Kanazawa University SAKIGAKE project 2018; Takeda Science Foundation, Japan(Takeda Science Foundation (TSF)); Japan Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; 	We acknowledge financial supports from the Kanazawa University SAKIGAKE project 2018 and Takeda Science Foundation, Japan. We thank the Grants-in-Aid for Scientific Research (24590375, 25461335 and 18K06889) and Program for Fostering Globally Talented Researchers from the Japan Society for Promotion of Sciences.	[Anonymous], 2014, DAM, V3, P6; Associated Press, 2014, BLOOMINGTON HER 0602, V6, pB5; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Barnard-Brak L, 2019, ADV AUTISM, V5, P293, DOI 10.1108/AIA-11-2018-0045; Boyer F, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00055; Burke LK, 2014, ENDOCRINOLOGY, V155, P3732, DOI 10.1210/en.2014-1223; Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Chiang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134927; Chini C, 2019, BIOCHEM BIOPH RES CO, V513, P486, DOI 10.1016/j.bbrc.2019.03.199; Chini EN, 2018, TRENDS PHARMACOL SCI, V39, P424, DOI 10.1016/j.tips.2018.02.001; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Fahlstrom A, 2011, NEUROBIOL AGING, V32, P1868, DOI 10.1016/j.neurobiolaging.2009.11.003; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; FRICK KM, 1995, NEUROBIOL AGING, V16, P149, DOI 10.1016/0197-4580(94)00155-3; Garaschuk O, 2018, AGEING RES REV, V43, P26, DOI 10.1016/j.arr.2018.02.003; Gargiulo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/253067; Gerasimenko M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57236-7; Gorina YV, 2017, ADV GERONTOL, V7, P137, DOI 10.1134/S2079057017020060; Guerreiro S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020471; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Happe F, 2012, GERONTOLOGY, V58, P70, DOI 10.1159/000329720; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Higashida H, 2019, CELLS, V9, P62; Higashida H, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0350-7; Higashida H, 2011, BIOL PHARM BULL, V34, P1369, DOI 10.1248/bpb.34.1369; Hirvikoski T, 2016, BRIT J PSYCHIAT, V208, P232, DOI 10.1192/bjp.bp.114.160192; Hogan KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01187; Ishihara K, 2000, CHEM IMMUNOL, V75, P235; Ishimori N, 2004, J LIPID RES, V45, P1624, DOI 10.1194/jlr.M400098-JLR200; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kasai S, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00075; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; LAMBERTY Y, 1992, PHYSIOL BEHAV, V51, P81, DOI 10.1016/0031-9384(92)90206-H; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lessard-Beaudoin M, 2015, EXP GERONTOL, V63, P27, DOI 10.1016/j.exger.2015.01.003; Lever AG, 2016, AUTISM RES, V9, P666, DOI 10.1002/aur.1545; Lever AG, 2016, J AUTISM DEV DISORD, V46, P1916, DOI 10.1007/s10803-016-2722-8; Lezak KR, 2017, DIALOGUES CLIN NEURO, V19, P181; Liu HX, 2008, NEUROSCI LETT, V448, P67, DOI 10.1016/j.neulet.2008.09.084; Lopatina O, 2011, J NEUROENDOCRINOL, V23, P1125, DOI 10.1111/j.1365-2826.2011.02136.x; Lopatina O, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00133; Lopatina OL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00266; Magnusson KR, 2003, BEHAV NEUROSCI, V117, P485, DOI 10.1037/0735-7044.117.3.485; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; McQuail JA, 2015, TRENDS MOL MED, V21, P450, DOI 10.1016/j.molmed.2015.05.002; Mizuno A, 2015, BRAIN SCI, V5, P3, DOI 10.3390/brainsci5010003; Oizumi H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222076; Pagni BA, 2020, FRONT INTEGR NEUROSC, V14, DOI 10.3389/fnint.2020.571408; Pappas LE, 2019, EUR J CLIN NUTR, V73, P172, DOI 10.1038/s41430-018-0324-6; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Powell PS, 2017, J AUTISM DEV DISORD, V47, P3204, DOI 10.1007/s10803-017-3238-6; Quarona V, 2013, CYTOM PART B-CLIN CY, V84B, P207, DOI 10.1002/cyto.b.21092; Ring M, 2016, AUTISM RES, V9, P97, DOI 10.1002/aur.1493; Sheth KA, 2018, NEUROBIOL AGING, V67, P128, DOI 10.1016/j.neurobiolaging.2018.03.016; Shoji Hirotaka, 2019, Neuropsychopharmacology Reports, V39, P100, DOI 10.1002/npr2.12052; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Singhal G, 2020, BEHAV BRAIN RES, V383, DOI 10.1016/j.bbr.2020.112501; Sjogren K, 2001, J NUTR, V131, P2963, DOI 10.1093/jn/131.11.2963; Sultana R, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190574; Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016; Wang LF, 2018, J CELL MOL MED, V22, P101, DOI 10.1111/jcmm.13297; Weber M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0047-15.2015; Wise EA, 2017, J AUTISM DEV DISORD, V47, P1708, DOI 10.1007/s10803-017-3095-3; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Zhong J, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00304	65	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244022	10.1371/journal.pone.0244022	http://dx.doi.org/10.1371/journal.pone.0244022			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326496	Green Published, Green Submitted, gold			2022-12-26	WOS:000600176400075
J	Tovar-Sanchez, A; Sparaventi, E; Gaudron, A; Rodriguez-Romero, A				Tovar-Sanchez, Antonio; Sparaventi, Erica; Gaudron, Amandine; Rodriguez-Romero, Araceli			A new approach for the determination of sunscreen levels in seawater by ultraviolet absorption spectrophotometry	PLOS ONE			English	Article							ORGANIC UV FILTERS; MYTILUS-GALLOPROVINCIALIS; ECOTOXICOLOGICAL EVALUATION; ISOCHRYSIS-GALBANA; MARINE ORGANISMS	Sunscreen is released into the marine environment and is considered toxic for marine life. The current analytical methods for the quantification of sunscreen are mostly specific to individual chemical ingredients and based on complex analytical and instrumental techniques. A simple, selective, rapid, reproducible and low-cost spectrophotometric procedure for the quantification of commercial sunscreen in seawater is described here. The method is based on the inherent properties of these cosmetics to absorb in the wavelength of 300-400 nm. The absorption at 303 nm wavelength correlates with the concentration of most commercial sunscreens. This method allows the determination of sunscreens in the range of 2.5-1500 mg L-1, it requires no sample pretreatment and offers a precision of up to 0.2%. The spectrophotometric method was applied to quantify sunscreen concentrations at an Atlantic Beach with values ranging from 10 to 96.7 mg L-1 in the unfiltered fraction and from the undetectable value to 75.7 mg L-1 in the dissolved fraction. This method is suggested as a tool for sunscreen quantifications in environmental investigations and monitoring programs.	[Tovar-Sanchez, Antonio; Sparaventi, Erica; Gaudron, Amandine; Rodriguez-Romero, Araceli] ICMAN CSIC, Inst Marine Sci Andalusia, Dept Ecol & Coastal Management, Cadiz, Spain; [Rodriguez-Romero, Araceli] Univ Cadiz, Fac Marine & Environm Sci, Dept Analyt Chem, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidad de Cadiz	Tovar-Sanchez, A (corresponding author), ICMAN CSIC, Inst Marine Sci Andalusia, Dept Ecol & Coastal Management, Cadiz, Spain.	a.tovar@csic.es	Rodríguez, Araceli/GXM-7707-2022	Rodríguez, Araceli/0000-0002-6718-1040; Sparaventi, Erica/0000-0002-7578-8918; Tovar-Sanchez, Antonio/0000-0003-4375-1982	2014-2020 ERDF Operational Programme; Department of Economy, Knowledge, Business and the University of the Regional Government of Andalusia [FEDER-UCA18106672]; Spanish grant Juan de la Cierva Incorporacion [IJC2018-037545-I]	2014-2020 ERDF Operational Programme; Department of Economy, Knowledge, Business and the University of the Regional Government of Andalusia; Spanish grant Juan de la Cierva Incorporacion	This work has been co-financed by the 2014-2020 ERDF Operational Programme and by the Department of Economy, Knowledge, Business and the University of the Regional Government of Andalusia. Project reference: FEDER-UCA18106672. A. Rodri ' guez-Romero is supported by the Spanish grant Juan de la Cierva Incorporacio ' n referenced as IJC2018-037545-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FK, 2008, WORLDWIDE REGULATION, P65, DOI [10.3109/9781420080858.005, DOI 10.3109/9781420080858.005]; Angrish A, 2020, SPECTROCHIM ACTA A, V242, DOI 10.1016/j.saa.2020.118708; Araujo CVM, 2020, CHEMOSPHERE, V257, DOI 10.1016/j.chemosphere.2020.127190; Benede JL, 2014, ANAL CHIM ACTA, V812, P50, DOI 10.1016/j.aca.2013.12.033; Benede JL, 2018, J CHROMATOGR A, V1564, P25, DOI 10.1016/j.chroma.2018.06.003; Corinaldesi C, 2018, SCI TOTAL ENVIRON, V637, P1279, DOI 10.1016/j.scitotenv.2018.05.108; Downs CA, 2016, ARCH ENVIRON CON TOX, V70, P265, DOI 10.1007/s00244-015-0227-7; Downs CA, 2014, ECOTOXICOLOGY, V23, P175, DOI 10.1007/s10646-013-1161-y; Gago-Ferrero P, 2012, ANAL BIOANAL CHEM, V404, P2597, DOI 10.1007/s00216-012-6067-7; Giokas DL, 2007, TRAC-TREND ANAL CHEM, V26, P360, DOI 10.1016/j.trac.2007.02.012; Giraldo A, 2017, ARCH ENVIRON CON TOX, V72, P606, DOI 10.1007/s00244-017-0399-4; Molins-Delgado D, 2018, SCI TOTAL ENVIRON, V618, P451, DOI 10.1016/j.scitotenv.2017.11.033; Moschino V, 2017, MAR POLLUT BULL, V122, P306, DOI 10.1016/j.marpolbul.2017.06.062; NOAA, 2020, SKINC CHEM COR REEFS; Paredes E, 2014, CHEMOSPHERE, V104, P44, DOI 10.1016/j.chemosphere.2013.10.053; Rodriguez-Romero A, 2019, ENVIRON SCI TECHNOL, V53, P10177, DOI 10.1021/acs.est.9b02739; Sanchez-Brunete C, 2011, J CHROMATOGR A, V1218, P4291, DOI 10.1016/j.chroma.2011.05.030; Sanchez-Quiles D, 2015, ENVIRON INT, V83, P158, DOI 10.1016/j.envint.2015.06.007; Tarazona I, 2014, ANAL METHODS-UK, V6, P7772, DOI 10.1039/c4ay01403k; Tovar-Sanchez A., SUNSCREENS COASTAL E; Tovar-Sanchez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065451; Vidal-Linan L, 2018, CHEMOSPHERE, V190, P267, DOI 10.1016/j.chemosphere.2017.09.144	22	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243591	10.1371/journal.pone.0243591	http://dx.doi.org/10.1371/journal.pone.0243591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326482	Green Published, gold			2022-12-26	WOS:000600176400028
J	Kazibwe, G; Katami, P; Alinaitwe, R; Alafi, S; Nanteza, A; Nakavuma, JL				Kazibwe, George; Katami, Phionah; Alinaitwe, Ruth; Alafi, Stephen; Nanteza, Ann; Nakavuma, Jesca Lukanga			Bacteriophage activity against and characterisation of avian pathogenic Escherichia coli isolated from colibacillosis cases in Uganda	PLOS ONE			English	Article							VIRULENCE-ASSOCIATED GENES; BROILER-CHICKENS; POULTRY; PREVALENCE; EPIDEMIOLOGY; RESISTANCE; PHYLOGENY; GENOTYPES; THERAPY; FOOD	Avian Pathogenic Escherichia coli (APEC) cause colibacillosis leading to significant economic losses in the poultry industry. This laboratory-based study aimed at establishing stocks of avian pathogenic Escherichia coli lytic bacteriophages, for future development of cocktail products for colibacillosis management. The study determined the antibiotic susceptibility; phylogenetic categories, occurrence of selected serotypes and virulence genes among Escherichia coli stock isolates from chicken colibacillosis cases; and evaluated bacteriophage activity against the bacteria. Escherichia coli characterization was done through phenotypic and multiplex PCR methods. Bacteriophage isolation and preliminary characterization was achieved using the spot assay and overlay plating techniques. Fifty-six (56) isolates were phenotypically confirmed as E. coli and all exhibited resistance to at least one antimicrobial agent; while multi-drug resistance (at least three drugs) was encountered in 50 (89.3%) isolates. The APEC isolates mainly belonged to phylogroups A and D, representing 44.6% and 39.3%, respectively; whereas serotypes O1, O2 and O78 were not detected. Of the 56 isolates, 69.6% harbored at least one virulence gene, while 50% had at least four virulence genes; hence confirmed as APEC. Virulence genes, ompT and iutA were the most frequent in 33 (58.9%) and 32 (57.1%) isolates respectively; while iroN least occurred in 23 (41.1%) isolates. Seven lytic bacteriophages were isolated and their host range, at 1x10(8) PFU/ml, varied from 1.8% to 17.9% of the 56 APEC isolates, while the combined lytic spectrum was 25%. Phage stability was negatively affected by increasing temperatures with both UPEC04 and UPEC10 phages being undetectable at 70 degrees C; whereas activity was detected between pH 2 and 12. The high occurrence of APEC isolates resistant against the commonly used antibiotics supports the need for alternative strategies of bacterial infections control in poultry. The low host range exhibited by the phages necessitates search for more candidates before in-depth phage characterization and application.	[Kazibwe, George; Katami, Phionah; Alinaitwe, Ruth; Alafi, Stephen; Nanteza, Ann; Nakavuma, Jesca Lukanga] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Sch Biosecur Biotech & Lab Sci, Kampala, Uganda	Makerere University	Nakavuma, JL (corresponding author), Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Sch Biosecur Biotech & Lab Sci, Kampala, Uganda.	JLNakavuma@covab.mak.ac.ug		Nakavuma, Jesca/0000-0002-4585-5163	Competitive Small Grants of the Makerere-Sweden Bilateral Research Program	Competitive Small Grants of the Makerere-Sweden Bilateral Research Program	The research was financed under the Competitive Small Grants of the Makerere-Sweden Bilateral Research Program Call 2018. The funders had no role in the study design, data collection and analysis; decision to publish or preparation of the manuscript.	Abalaka S. E., 2017, Sokoto Journal of Veterinary Sciences, V15, P95, DOI 10.4314/sokjvs.v15i3.14; Abedon ST, 2009, FOODBORNE PATHOG DIS, V6, P807, DOI 10.1089/fpd.2008.0242; [Anonymous], 2017, NAT MATER, V16, P1, DOI 10.1038/nmat4841; [Anonymous], 2018, ADV CIV ENG, V2018, P1, DOI DOI 10.1017/S1473550418000022; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2016, BRIDGES WEEKLY, V20, P1, DOI DOI 10.1007/s10120-016-0622-4; [Anonymous], 2016, J NANOMED NANOTECHNO, V7, P5, DOI [10.4172/2157-7439.1000407, DOI 10.4172/2157-7439.1000407]; [Anonymous], 2017, JAP CLASS ES CANC, V14, P1, DOI [DOI 10.1007/s10388-016-0551-7, DOI 10.1093/GERONT/GNY014]; [Anonymous], 2014, CANC DISCOV, V4, pOF1; [Anonymous], 2015, CONCURR COMPUT PRACT, V27, pi; Asadi A, 2018, VET RES FORUM, V9, P211, DOI 10.30466/vrf.2018.30827; Azeem T, 2017, WORLD POULTRY SCI J, V73, P29, DOI [10.1017/s0043933916000866, 10.1017/S0043933916000866]; Barnes H.J., 2008, DIS POULTRY, P691; Byaruhanga J, 2017, INT J VET SCI MED, V5, P168, DOI 10.1016/j.ijvsm.2017.07.001; Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x; Casey E, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040163; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; COLLINGWOOD C, 2014, FRONT VET SCI, V1, P1, DOI DOI 10.3389/FVETS.2014.00005; Delicato ER, 2003, VET MICROBIOL, V94, P97, DOI 10.1016/S0378-1135(03)00076-2; Dissanayake DRA, 2008, VET MICROBIOL, V132, P355, DOI 10.1016/j.vetmic.2008.05.024; Doffkay Zsolt, 2015, Acta Biologica Szegediensis, V59, P291; Dou XH, 2016, GENE, V576, P244, DOI 10.1016/j.gene.2015.10.012; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Gill JJ, 2016, J ANIM SCI, V94, P57, DOI 10.2527/ssasas2015-118; Halfaoui Z, 2017, VET WORLD, V10, P830, DOI 10.14202/vetworld.2017.830-835; Hyman P, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010035; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kabir SML, 2010, INT J ENV RES PUB HE, V7, P89, DOI 10.3390/ijerph7010089; Kariyawasam S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-81; Kemmett K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067749; Knobl T, 2012, SCI WORLD J, DOI 10.1100/2012/437342; Kuhnert P, 2000, FEMS MICROBIOL REV, V24, P107, DOI 10.1111/j.1574-6976.2000.tb00535.x; Landman WJM, 2015, AVIAN PATHOL, V44, P370, DOI 10.1080/03079457.2015.1060584; Limbago B., 2001, CLIN MICROBIOL NEWSL, V23, P49, DOI [10.1016/S0196-4399(01)88009-0, DOI 10.1016/S0196-4399(01)88009-0]; Lu Z, 2003, INT J FOOD MICROBIOL, V84, P225, DOI 10.1016/S0168-1605(03)00111-9; Majalija S., 2010, Veterinary Research (Pakistan), V3, P75; Matin MA, 2017, VET WORLD, V10, P29, DOI 10.14202/vetworld.2017.29-33; Mbanga J, 2015, ONDERSTEPOORT J VET, V82, DOI 10.4102/ojvr.v82i1.850; Miller RW, 2010, AVIAN DIS, V54, P33, DOI 10.1637/8953-060509-Reg.1; Mirzaei MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127606; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Naghizadeh M, 2019, POULTRY SCI, V98, P653, DOI 10.3382/ps/pey414; Nhung NT, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00126; Olarinmoye AO, 2013, MALAYS J MICROBIOL, V9, P317, DOI 10.21161/mjm.53013; Oliveira A, 2009, J APPL MICROBIOL, V106, P1919, DOI 10.1111/j.1365-2672.2009.04145.x; Paixao AC, 2016, POULTRY SCI, V95, P1646, DOI 10.3382/ps/pew087; Patey O, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010018; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Rodriguez-Siek KE, 2004, VET RES, V35, P467; Shende RK, 2017, VET WORLD, V10, P973, DOI 10.14202/vetworld.2017.973-978; Sola-Gines M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143191; Stacy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086565; Subedi M, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1442-z; Thapa D.B., 2020, INT J APPL SCI BIOTE, V8, P52, DOI [10.3126/ijasbt.v8i1.28254, DOI 10.3126/IJASBT.V8I1.28254]; Wang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096904; Wang XM, 2010, FOODBORNE PATHOG DIS, V7, P1099, DOI 10.1089/fpd.2010.0542; Yu YP, 2013, FEMS MICROBIOL LETT, V348, P112, DOI 10.1111/1574-6968.12277; Yuvraj Panth, 2019, Journal of Agriculture and Natural Resources, V2, P301, DOI 10.3126/janr.v2i1.26094	62	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0239107	10.1371/journal.pone.0239107	http://dx.doi.org/10.1371/journal.pone.0239107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320859	Green Submitted, Green Published, gold			2022-12-26	WOS:000600339800055
J	Yamamoto, H; Uchida, Y; Chiba, T; Kurimoto, R; Matsushima, T; Inotsume, M; Ishikawa, C; Li, HY; Shiga, T; Muratani, M; Uchida, T; Asahara, H				Yamamoto, Hiroto; Uchida, Yutaro; Chiba, Tomoki; Kurimoto, Ryota; Matsushima, Takahide; Inotsume, Maiko; Ishikawa, Chihiro; Li, Haiyan; Shiga, Takashi; Muratani, Masafumi; Uchida, Tokujiro; Asahara, Hiroshi			Transcriptome analysis of sevoflurane exposure effects at the different brain regions	PLOS ONE			English	Article							POSTOPERATIVE DELIRIUM; ANESTHESIA; EXPRESSION; INDUCTION; PROPOFOL; NEURONS; CELLS	Backgrounds Sevoflurane is a most frequently used volatile anesthetics, but its molecular mechanisms of action remain unclear. We hypothesized that specific genes play regulatory roles in brain exposed to sevoflurane. Thus, we aimed to evaluate the effects of sevoflurane inhalation and identify potential regulatory genes by RNA-seq analysis. Methods Eight-week old mice were exposed to sevoflurane. RNA from medial prefrontal cortex, striatum, hypothalamus, and hippocampus were analysed using RNA-seq. Differently expressed genes were extracted and their gene ontology terms were analysed using Metascape. These our anesthetized mouse data and the transcriptome array data of the cerebral cortex of sleeping mice were compared. Finally, the activities of transcription factors were evaluated using a weighted parametric gene set analysis (wPGSA). JASPAR was used to confirm the existence of binding motifs in the upstream sequences of the differently expressed genes. Results The gene ontology term enrichment analysis result suggests that sevoflurane inhalation upregulated angiogenesis and downregulated neural differentiation in each region of brain. The comparison with the brains of sleeping mice showed that the gene expression changes were specific to anesthetized mice. Focusing on individual genes, sevoflurane induced Klf4 upregulation in all sampled parts of brain. wPGSA supported the function of KLF4 as a transcription factor, and KLF4-binding motifs were present in many regulatory regions of the differentially expressed genes. ConclusionsKlf4 was upregulated by sevoflurane inhalation in the mouse brain. The roles of KLF4 might be key to elucidating the mechanisms of sevoflurane induced functional modification in the brain.	[Yamamoto, Hiroto; Uchida, Yutaro; Chiba, Tomoki; Kurimoto, Ryota; Matsushima, Takahide; Inotsume, Maiko; Asahara, Hiroshi] Tokyo Med & Dent Univ TMDU, Dept Syst BioMed, Tokyo, Japan; [Yamamoto, Hiroto; Uchida, Tokujiro] Tokyo Med & Dent Univ TMDU, Dept Anesthesiol, Tokyo, Japan; [Ishikawa, Chihiro; Li, Haiyan; Shiga, Takashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Shiga, Takashi] Univ Tsukuba, Dept Neurobiol, Fac Med, Tsukuba, Ibaraki, Japan; [Muratani, Masafumi] Univ Tsukuba, Dept Genome Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Asahara, Hiroshi] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tsukuba; University of Tsukuba; University of Tsukuba; Scripps Research Institute	Uchida, T; Asahara, H (corresponding author), Tokyo Med & Dent Univ TMDU, Dept Syst BioMed, Tokyo, Japan.; Uchida, T (corresponding author), Tokyo Med & Dent Univ TMDU, Dept Anesthesiol, Tokyo, Japan.; Asahara, H (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.	uchida.mane@tmd.ac.jp; asahara@scripps.edu		Uchida, Yutaro/0000-0002-2790-6879	Japan Society for the Promotion of Science KAKENHI [20H00547, 19KK0227, 18K19603, 15H02560]; AMED-CREST from AMED [JP20gm0810008]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED-CREST from AMED	This work was supported by Japan Society for the Promotion of Science KAKENHI (URL:https://www.jsps.go.jp/english/index.html, Grant Nos. 20H00547, 19KK0227, 18K19603 and 15H02560 to HA) and AMED-CREST from AMED (URL: https://www.amed.go.jp/en/index.html, Grant No. JP20gm0810008 to HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya NK, 2015, BRAIN RES, V1620, P29, DOI 10.1016/j.brainres.2015.04.054; Ando N, 2014, EUR J NEUROSCI, V40, P3147, DOI 10.1111/ejn.12691; [Anonymous], 2015, INT J COMPUTER APPL, V121, P661; [Anonymous], 2013, FARMERS 1, V29, P15; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Bellesi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0176-7; Chung W, 2017, ANESTHESIOLOGY, V126, P288, DOI 10.1097/ALN.0000000000001470; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fukuda M, 2019, EUR J NEUROSCI, V50, P3520, DOI 10.1111/ejn.14524; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Ghaleb AM, 2017, GENE, V611, P27, DOI 10.1016/j.gene.2017.02.025; Hayase T, 2016, MED GAS RES, V6, P70, DOI 10.4103/2045-9912.184715; Ishikawa C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177833; Jenkins A, 1999, ANESTHESIOLOGY, V90, P484, DOI 10.1097/00000542-199902000-00024; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jiang-Xie LF, 2019, NEURON, V102, P1053, DOI 10.1016/j.neuron.2019.03.033; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kawakami E, 2016, NUCLEIC ACIDS RES, V44, P5010, DOI 10.1093/nar/gkw355; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang P, 2017, BRIT J ANAESTH, V119, P1047, DOI 10.1093/bja/aex043; Mori K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087319; Neufeld KJ, 2013, ANESTH ANALG, V117, P471, DOI 10.1213/ANE.0b013e3182973650; Plourde G, 2003, BRIT J ANAESTH, V91, P583, DOI 10.1093/bja/aeg209; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Rudolph JL, 2011, ANESTH ANALG, V112, P1202, DOI 10.1213/ANE.0b013e3182147f6d; Sebel LE, 2006, ANESTHESIOLOGY, V104, P1176, DOI 10.1097/00000542-200606000-00012; Stucke AG, 2002, ANESTHESIOLOGY, V96, P955, DOI 10.1097/00000542-200204000-00025; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wu J, 1996, BRIT J PHARMACOL, V119, P1013, DOI 10.1111/j.1476-5381.1996.tb15772.x; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	31	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0236771	10.1371/journal.pone.0236771	http://dx.doi.org/10.1371/journal.pone.0236771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320849	Green Published, gold, Green Submitted			2022-12-26	WOS:000600339800043
J	Zylbersztejn, A; Gilbert, R; Hardelid, P				Zylbersztejn, Ania; Gilbert, Ruth; Hardelid, Pia			Developing a national birth cohort for child health research using a hospital admissions database in England: The impact of changes to data collection practices	PLOS ONE			English	Article								Background National birth cohorts derived from administrative health databases constitute unique resources for child health research due to whole country coverage, ongoing follow-up and linkage to other data sources. In England, a national birth cohort can be developed using Hospital Episode Statistics (HES), an administrative database covering details of all publicly funded hospital activity, including 97% of births, with longitudinal follow-up via linkage to hospital and mortality records. We present methods for developing a national birth cohort using HES and assess the impact of changes to data collection over time on coverage and completeness of linked follow-up records for children. Methods We developed a national cohort of singleton live births in 1998-2015, with information on key risk factors at birth (birth weight, gestational age, maternal age, ethnicity, area-level deprivation). We identified three changes to data collection, which could affect linkage of births to follow-up records: (1) the introduction of the "NHS Numbers for Babies (NN4B)", an on-line system which enabled maternity staff to request a unique healthcare patient identifier (NHS number) immediately at birth rather than at civil registration, in Q4 2002; (2) the introduction of additional data quality checks at civil registration in Q3 2009; and (3) correcting a postcode extraction error for births by the data provider in Q2 2013. We evaluated the impact of these changes on trends in two outcomes in infancy: hospital readmissions after birth (using interrupted time series analyses) and mortality rates (compared to published national statistics). Results The cohort covered 10,653,998 babies, accounting for 96% of singleton live births in England in 1998-2015. Overall, 2,077,929 infants (19.5%) had at least one hospital readmission after birth. Readmission rates declined by 0.2% percentage points per annual quarter in Q1 1998 to Q3 2002, shifted up by 6.1% percentage points (compared to the expected value based on the trend before Q4 2002) to 17.7% in Q4 2002 when NN4B was introduced, and increased by 0.1% percentage points per annual quarter thereafter. Infant mortality rates were under-reported by 16% for births in 1998-2002 and similar to published national mortality statistics for births in 2003-2015. The trends in infant readmission were not affected by changes to data collection practices in Q3 2009 and Q2 2013, but the proportion of unlinked mortality records in HES and in ONS further declined after 2009. Discussion HES can be used to develop a national birth cohort for child health research with follow-up via linkage to hospital and mortality records for children born from 2003 onwards. Re-linking births before 2003 to their follow-up records would maximise potential benefits of this rich resource, enabling studies of outcomes in adolescents with over 20 years of follow-up.	[Zylbersztejn, Ania; Gilbert, Ruth; Hardelid, Pia] UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Res & Teaching Dept, London, England; [Zylbersztejn, Ania; Gilbert, Ruth; Hardelid, Pia] UCL Great Ormond St Inst Child Hlth, NIHR Children & Families Policy Res Unit, London, England; [Gilbert, Ruth] UCL, Hlth Data Res UK London, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Zylbersztejn, A (corresponding author), UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Res & Teaching Dept, London, England.; Zylbersztejn, A (corresponding author), UCL Great Ormond St Inst Child Hlth, NIHR Children & Families Policy Res Unit, London, England.	ania.zylbersztejn@ucl.ac.uk		Zylbersztejn, Ania/0000-0003-1035-1448; Gilbert, Ruth/0000-0001-9347-2709	Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; National Institute for Health Research, National Institute for Social Care and Health Research; Wellcome Trust [MR/K006584/1]; National Institute for Health Research (NIHR) Children and Families Policy Research Unit; NIHR Great Ormond Street Hospital Biomedical Research Centre; Health Data Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; National Institute for Health Research, National Institute for Social Care and Health Research; Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Children and Families Policy Research Unit(National Institute for Health Research (NIHR)); NIHR Great Ormond Street Hospital Biomedical Research Centre; Health Data Research UK; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AZ was funded by a PhD studentship funded from awards to the Farr Institute of Health Informatics Research, London, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant no MR/K006584/1). This research benefits from and contributes to the National Institute for Health Research (NIHR) Children and Families Policy Research Unit, but was not commissioned by the NIHR Policy Research Programme. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Research at UCL Great Ormond Street Institute of Child Health is supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre. RG receives funding from Health Data Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CONTINUING ED ANAEST, V13, P200; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Ball SJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4333; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Cromwell DA, 2014, J CLIN EPIDEMIOL, V67, P578, DOI 10.1016/j.jclinepi.2013.10.011; Dattani Nirupa, 2011, Health Stat Q, P53, DOI 10.1057/hsq.2011.3; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Department of Health, 2012, SIMPL GUID PAYM RES; Digital NHS, 2019, MAT SERV DAT SET; Hagger-Johnson G, 2015, HEALTH SERV RES, V50, P1162, DOI 10.1111/1475-6773.12272; Hardelid P, 2013, OVERVIEW CHILD DEATH; Hardelid P, 2019, EUROSURVEILLANCE, V24, P7, DOI 10.2807/1560-7917.ES.2019.24.1.1800046; Hardelid P, 2018, J ANTIMICROB CHEMOTH, V73, P779, DOI 10.1093/jac/dkx463; Hardelid P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005331; Harron K, 2018, BMJ QUAL SAF, V27, P31, DOI 10.1136/bmjqs-2016-006253; Harron K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164667; Health & Social Care Information Centre, 2014, METH CREAT HES PAT I; Health The and Social Care Information Centre (HSCIC), 2015, GUIDE LINKED MORTALI; Herbert A, 2017, INT J EPIDEMIOL, V46, P1093, DOI 10.1093/ije/dyx015; Knight H, 2013, PATTERNS MATERNITY C; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Maret-Ouda J, 2017, SCAND J PUBLIC HEALT, V45, P14, DOI 10.1177/1403494817702336; Marquis S, 2020, RES DEV DISABIL, V96, DOI 10.1016/j.ridd.2019.103516; Moore HC, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028710; Moser K, 2008, HLTH STAT Q; Murray J, 2013, J PUBLIC HEALTH-UK, V35, P298, DOI 10.1093/pubmed/fds077; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Nguyen D., 2011, CELL DEATH DIS, V2, pe240; NHS Digital, 2020, OPCS CLASS INT PROC, VI; Office for National Statistics, 2014, BIRTH STAT MET; Relph S, 2020, NHS MATERNITY CARE W; Swiss Re Report, 2018, SIGMA, V3148, DOI DOI 10.2218/PIHPH.3.2018.2602; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Thygesen LC, 2014, EUR J EPIDEMIOL, V29, P551, DOI 10.1007/s10654-013-9873-0; Verfurden ML, 2018, ARCH DIS CHILD, V103, P1125, DOI 10.1136/archdischild-2017-314098; Wijlaars LPMM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021015; Wood AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1552; Yu YF, 2017, JAMA PEDIATR, V171, P538, DOI 10.1001/jamapediatrics.2017.0197; Zylbersztejn A., 2018, USING ADM LINKED DAT; Zylbersztejn A, 2020, PAEDIATR PERINAT EP, V34, P21, DOI 10.1111/ppe.12627; Zylbersztejn A, 2018, LANCET, V391, P2008, DOI [10.1016/S0140-6736(18)30670-6, 10.1016/s0140-6736(18)30670-6]; 2019, MICROBIOME, V7, P1	44	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243843	10.1371/journal.pone.0243843	http://dx.doi.org/10.1371/journal.pone.0243843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320878	Green Published, gold			2022-12-26	WOS:000600339800050
J	Xu, L; Wu, F; Yang, L; Wang, FF; Zhang, T; Deng, XT; Zhang, XM; Yuan, XL; Yan, Y; Li, YY; Yang, ZP; Yu, DN				Xu, Lei; Wu, Fan; Yang, Lei; Wang, Fangfang; Zhang, Tong; Deng, Xintao; Zhang, Xiumei; Yuan, Xiaoling; Yan, Ying; Li, Yaoyao; Yang, Zhangping; Yu, Duonan			miR-144/451 inhibits c-Myc to promote erythroid differentiation	FASEB JOURNAL			English	Article						anemia; erythropoiesis; enucleation; nuclear condensation	CHROMATIN CONDENSATION; MIR-451 PROTECTS; B-LYMPHOMAS; CELL; EXPRESSION; ERYTHROLEUKEMIA; ENUCLEATION; LOCUS; ERYTHROPOIESIS; CONTRIBUTES	Ablation of miR-144/451 disrupts homeostasis of erythropoiesis. Myc, a protooncogenic protein, is essential for erythroblast proliferation but commits rapid downregulation during erythroid maturation. How erythroblasts orchestrate maturation processes through coding and non-coding genes is largely unknown. In this study, we use miR-144/451 knockout mice as in vivo model, G1E, MEL erythroblast lines and erythroblasts from fresh mouse fetal livers as in vitro systems to demonstrate that targeted depletion of miR-144/451 blocks erythroid nuclear condensation and enucleation. This is due, at least in part, to the continued high expression of Myc in erythroblasts when miR-144/451 is absent. Specifically, miR-144/451 directly inhibits Myc in erythroblasts. Loss of miR-144/451 locus derepresses, and thus, increases the expression of Myc. Sustained high levels of Myc in miR-144/451-depleted erythroblasts blocks erythroid differentiation. Moreover, Myc reversely regulates the expression of miR-144/451, forming a positive miR-144/451-Myc feedback to ensure the complete shutoff of Myc during erythropoiesis. Given that erythroid-specific transcription factor GATA1 activates miR-144/451 and inactivates Myc, our findings indicate that GATA1-miR-144/451-Myc network safeguards normal erythroid differentiation. Our findings also demonstrate that disruption of the miR-144/451-Myc crosstalk causes anemia, suggesting that miR-144/451 might be a potential therapeutic target in red cell diseases.	[Xu, Lei; Wu, Fan; Yang, Lei; Wang, Fangfang; Yan, Ying; Li, Yaoyao; Yu, Duonan] Yangzhou Univ, Inst Translat Med Med Coll, Med Coll, Yangzhou, Jiangsu, Peoples R China; [Xu, Lei; Wu, Fan; Yang, Lei; Wang, Fangfang; Yan, Ying; Li, Yaoyao; Yu, Duonan] Yangzhou Univ, Jiangsu Key Lab Expt & Translat Noncoding RNA Res, Yangzhou, Jiangsu, Peoples R China; [Xu, Lei; Li, Yaoyao; Yu, Duonan] Yangzhou Univ, Cent Lab, Affiliated Hosp, Yangzhou, Jiangsu, Peoples R China; [Zhang, Tong; Deng, Xintao; Zhang, Xiumei; Yu, Duonan] Yangzhou Univ, Xinghua Peoples Hosp, Xinghua, Peoples R China; [Yuan, Xiaoling] Yangzhou Univ, Yangzhou Maternal & Child Care Serv Ctr, Yangzhou, Jiangsu, Peoples R China; [Yang, Zhangping] Yangzhou Univ, Coll Anim Sci & Technol, Dept Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University	Yu, DN (corresponding author), Yangzhou Univ, Med Coll, Jiangsu Key Lab Expt & Translat Noncoding RNA Res, 136 Jiangyang Rd, Yangzhou 225009, Jiangsu, Peoples R China.	dnyu@yzu.edu.cn			National Natural Science Foundation of China (NSFC) [81470277, 81670186, 81870096]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81470277, 81670186 and 81870096	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Ding L, 2018, ONCOGENE, V37, P1293, DOI 10.1038/s41388-017-0055-5; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Fang X, 2018, HAEMATOLOGICA, V103, P406, DOI 10.3324/haematol.2017.177394; Figueroa AA, 2018, HAEMATOLOGICA, V103, pE341, DOI 10.3324/haematol.2017.171785; Frojmark AS, 2010, J MOL MED, V88, P39, DOI 10.1007/s00109-009-0558-9; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Hattangadi SM, 2014, BLOOD, V124, P1931, DOI 10.1182/blood-2013-11-537761; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Jayapal S, 2010, J BIOL CHEM, V285, P40252, DOI 10.1074/jbc.M110.181073; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Ji P, 2015, INT REV CEL MOL BIO, V316, P159, DOI 10.1016/bs.ircmb.2015.01.006; Ji P, 2011, TRENDS CELL BIOL, V21, P409, DOI 10.1016/j.tcb.2011.04.003; Kim M, 2015, BRIT J HAEMATOL, V168, P583, DOI 10.1111/bjh.13164; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mayers S, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-019-0515-9; Ney PA, 2011, CURR OPIN HEMATOL, V18, P152, DOI 10.1097/MOH.0b013e328345213e; Nowak RB, 2017, BLOOD, V130, P1144, DOI 10.1182/blood-2017-05-787051; Pang CJ, 2012, MOL CELL BIOL, V32, P2628, DOI 10.1128/MCB.00104-12; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SKODA RC, 1995, J EXP MED, V181, P1603, DOI 10.1084/jem.181.5.1603; Sui ZH, 2014, BLOOD, V123, P758, DOI 10.1182/blood-2013-03-492710; Wang WC, 2017, ONCOTARGET, V8, P107109, DOI 10.18632/oncotarget.22346; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yu D, 2019, EXRNA, V1, P16, DOI [10.1186/s41544-019-0035-8, DOI 10.1186/S41544-019-0035-8]; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Yu DN, 2005, CANCER RES, V65, P5454, DOI 10.1158/0008-5472.CAN-04-4197; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244; Yu DN, 2007, BLOOD, V109, P4936, DOI 10.1182/blood-2006-10-050294; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218; Zhen R, 2020, BLOOD, V135, P208, DOI 10.1182/blood.2019002165	47	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13194	13210		10.1096/fj.202000941R	http://dx.doi.org/10.1096/fj.202000941R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	33319407	hybrid			2022-12-26	WOS:000562539500001
J	Marquez-Exposito, L; Rodrigues-Diez, RR; Rayego-Mateos, S; Fierro-Fernandez, M; Rodrigues-Diez, R; Orejudo, M; Santos-Sanchez, L; Blanco, EM; Laborda, J; Mezzano, S; Lamas, S; Lavoz, C; Ruiz-Ortega, M				Marquez-Exposito, Laura; Rodrigues-Diez, Raul R.; Rayego-Mateos, Sandra; Fierro-Fernandez, Marta; Rodrigues-Diez, Raquel; Orejudo, Macarena; Santos-Sanchez, Laura; Blanco, Eva Maria; Laborda, Jorge; Mezzano, Sergio; Lamas, Santiago; Lavoz, Carolina; Ruiz-Ortega, Marta			Deletion of delta-like 1 homologue accelerates renal inflammation by modulating the Th17 immune response	FASEB JOURNAL			English	Article						DLK1; inflammation; NOTCH; renal damage; Th17 response	GROWTH-FACTOR; NOTCH LIGAND; CELL-ACTIVATION; KIDNEY; PATHWAY; DLK1; INHIBITOR; INTERLEUKIN-17A; SECUKINUMAB; FIBROSIS	Preclinical studies have demonstrated that activation of the NOTCH pathway plays a key role in the pathogenesis of kidney damage. There is currently no information on the role of the Delta-like homologue 1 (DLK1), a NOTCH inhibitor, in the regulation of renal damage. Here, we investigated the contribution of DLK1 to experimental renal damage and the underlying molecular mechanisms. Using a Dlk1-null mouse model in the experimental renal damage of unilateral ureteral obstruction, we found activation of NOTCH, as shown by increased nuclear translocation of the NOTCH1 intracellular domain, and upregulation of Dlk2/hey-1 expression compared to wild-type (WT) littermates. NOTCH1 over-activation in Dlk1-null injured kidneys was associated with a higher inflammatory response, characterized by infiltration of inflammatory cells, mainly CD4/IL17A + lymphocytes, and activation of the Th17 immune response. Furthermore, pharmacological NOTCH blockade inhibited the transcription factors controlling Th17 differentiation and gene expression of the Th17 effector cytokine IL-17A and other related-inflammatory factors, linked to a diminution of inflammation in the injured kidneys. We propose that the non-canonical NOTCH ligand DLK1 acts as a NOTCH antagonist in renal injury regulating the Th17-mediated inflammatory response.	[Marquez-Exposito, Laura; Rodrigues-Diez, Raul R.; Rayego-Mateos, Sandra; Orejudo, Macarena; Santos-Sanchez, Laura; Ruiz-Ortega, Marta] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Cellular & Mol Biol Renal & Vasc Pathol, Madrid, Spain; [Marquez-Exposito, Laura; Rodrigues-Diez, Raul R.; Orejudo, Macarena; Santos-Sanchez, Laura; Ruiz-Ortega, Marta] Red Invest Renal REDINREN, Madrid, Spain; [Rayego-Mateos, Sandra] Inst Recerca Biomed Lleida IRBLleida, Vasc & Renal Translat Res Grp, Lleida, Spain; [Fierro-Fernandez, Marta; Blanco, Eva Maria; Lamas, Santiago] Ctr Biol Mol Severo Ochoa CSIC UAM, C Nicolas Cabrera 1, Madrid 28049, Spain; [Rodrigues-Diez, Raquel] Univ Autonoma Madrid, Fac Med, Dept Farmacol, Madrid, Spain; [Laborda, Jorge] Univ Castilla La Mancha, Biochem & Mol Biol Branch, Dept Inorgan & Organ Chem & Biochem, Spanish Natl Res Council CSIC, Albacete, Spain; [Mezzano, Sergio; Lavoz, Carolina] Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile	Autonomous University of Madrid; Fundacion Jimenez Diaz; Institut de Recerca Biomedica - IRB Lleida; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Universidad Austral de Chile	Fierro-Fernandez, M (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, C Nicolas Cabrera 1, Madrid 28049, Spain.; Ruiz-Ortega, M (corresponding author), IIS Fdn Jimenez Diaz, Cellular & Mol Biol Renal & Vasc Pathol, Avda Reyes Catolicos 2, Madrid 28040, Spain.	mfierro@cbm.csic.es; mruizo@fjd.es	DEL RÍO, MACARENA OREJUDO/AFU-0330-2022; Laborda, Jorge/L-5726-2014	DEL RÍO, MACARENA OREJUDO/0000-0001-7670-1848; Laborda, Jorge/0000-0002-9210-838X; Marquez-Exposito, Laura/0000-0003-4812-1939; Blanco-Ruiz, Eva/0000-0001-5940-1827				Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bonegio R, 2012, EXP CELL RES, V318, P986, DOI 10.1016/j.yexcr.2012.02.036; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chacon MR, 2008, INT J OBESITY, V32, P1122, DOI 10.1038/ijo.2008.40; Cortvrindt C, 2017, PATHOLOGY, V49, P247, DOI 10.1016/j.pathol.2017.01.003; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Djudjaj S, 2012, J PATHOL, V228, P286, DOI 10.1002/path.4076; Sanchez-Nino MD, 2012, J PATHOL, V228, P266, DOI 10.1002/path.4101; Dong XY, 2008, KIDNEY INT, V74, P1294, DOI 10.1038/ki.2008.394; El Machhour F, 2015, J AM SOC NEPHROL, V26, P1561, DOI 10.1681/ASN.2013090968; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukuda D, 2013, CIRC J, V77, P2462, DOI 10.1253/circj.CJ-13-0873; Huang M, 2018, CELL SIGNAL, V51, P139, DOI 10.1016/j.cellsig.2018.08.002; Huang Q, 2019, KOREAN J PHYSIOL PHA, V23, P251, DOI 10.4196/kjpp.2019.23.4.251; Huang SZ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005233; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jensen CH, 1997, CLIN CHIM ACTA, V268, P1, DOI 10.1016/S0009-8981(97)00152-6; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Kavvadas P, 2018, KIDNEY INT, V94, P126, DOI 10.1016/j.kint.2018.01.031; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kitching AR, 2011, J AM SOC NEPHROL, V22, P235, DOI 10.1681/ASN.2010050536; Kretzler M, 2008, NAT MED, V14, P246, DOI 10.1038/nm0308-246; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; Lasagni L, 2010, STEM CELLS, V28, P1673, DOI 10.1002/stem.492; Lavoz C, 2019, KIDNEY INT, V95, P1418, DOI 10.1016/j.kint.2018.12.031; Lavoz C, 2018, CLIN SCI, V132, P1097, DOI 10.1042/CS20171553; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Ma L, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1442-6; Marquez-Exposito L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01195; Marquez-Exposito L, 2018, NEFROLOGIA, V38, P466, DOI 10.1016/j.nefro.2017.11.027; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Nueda ML, 2007, J MOL BIOL, V367, P1270, DOI 10.1016/j.jmb.2006.10.020; Nueda ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35252-3; Orejudo M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01015; Peng XG, 2015, J PATHOL, V235, P79, DOI 10.1002/path.4430; Pindjakova J, 2012, KIDNEY INT, V81, P379, DOI 10.1038/ki.2011.348; Puertas-Avendano RA, 2011, J NEUROENDOCRINOL, V23, P849, DOI 10.1111/j.1365-2826.2011.02189.x; Puri RV, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.040642; Quillard T, 2013, INT J MOL SCI, V14, P6863, DOI 10.3390/ijms14046863; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Ramani K, 2016, CLIN IMMUNOL, V162, P31, DOI 10.1016/j.clim.2015.10.009; Rodrigues-Diez R, 2013, LAB INVEST, V93, P812, DOI 10.1038/labinvest.2013.67; Rodriguez P, 2012, CARDIOVASC RES, V93, P232, DOI 10.1093/cvr/cvr296; Rodriguez-Cano MM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092032; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Smas CM, 1997, MOL CELL BIOL, V17, P977, DOI 10.1128/MCB.17.2.977; Ucero AC, 2014, INT UROL NEPHROL, V46, P765, DOI 10.1007/s11255-013-0520-1; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Vijayaraghavan J, 2018, ADV EXP MED BIOL, V1066, P339, DOI 10.1007/978-3-319-89512-3_17; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Xue L, 2011, J SURG RES, V171, P266, DOI 10.1016/j.jss.2009.12.031; Yin XW, 2019, INFLAMM RES, V68, P761, DOI 10.1007/s00011-019-01260-w; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC	62	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21213	10.1096/fj.201903131R	http://dx.doi.org/10.1096/fj.201903131R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368614	Green Published			2022-12-26	WOS:000605626600047
J	Zemel, BM; Zhi, LT; Brown, EV; Tymanskyj, SR; Liang, QS; Covarrubias, M				Zemel, Benjamin M.; Zhi, Lianteng; Brown, Eric V.; Tymanskyj, Stephen R.; Liang, Qiansheng; Covarrubias, Manuel			PKC epsilon associates with the Kv3.4 channel to promote its expression in a kinase activity-dependent manner	FASEB JOURNAL			English	Article						dorsal root ganglia; Kv3; 4; PKC&#949	GATED K+ CHANNELS; POTASSIUM CHANNEL; ION CHANNELS; PHOSPHORYLATION; INACTIVATION; MODULATION; SUBUNITS; DYSREGULATION; NEURONS; STATE	The voltage-gated potassium channel Kv3.4 is a crucial regulator of nociceptive signaling in the dorsal root ganglion (DRG) and the dorsal horn of the spinal cord. Moreover, Kv3.4 dysfunction has been linked to neuropathic pain. Although kinases and phosphatases can directly modulate Kv3.4 gating, the signaling mechanisms regulating the expression and stability of the Kv3.4 protein are generally unknown. We explored a potential role of PKC epsilon and found an unexpected interaction that has a positive effect on Kv3.4 expression. Co-immunoprecipitation studies revealed a physical association between PKC epsilon and Kv3.4 in both heterologous cells and rat DRG neurons. Furthermore, in contrast to the wild-type and constitutively active forms of PKC epsilon, expression of a catalytically inactive form of the enzyme inhibits Kv3.4 expression and membrane localization through a dominant negative effect. Co-expression of Kv3.4 with the wild-type, constitutively active, or catalytically inactive forms of PKC epsilon had no significant effects on Kv3.4 gating. These results suggest that a novel physical interaction of the Kv3.4 channel with functional PKC epsilon primarily determines its stability and localization in DRG neurons. This interaction is akin to those of previously identified accessory ion channel proteins, which could be significant in neural tissues where Kv3.4 regulates electrical signaling.	[Zemel, Benjamin M.; Zhi, Lianteng; Brown, Eric V.; Tymanskyj, Stephen R.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Dept Neurosci, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Zemel, Benjamin M.; Zhi, Lianteng; Brown, Eric V.; Tymanskyj, Stephen R.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Vickie & Jack Farber Inst Neurosci, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Zemel, Benjamin M.; Zhi, Lianteng; Brown, Eric V.; Tymanskyj, Stephen R.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Jefferson Coll Life Sci, Philadelphia, PA 19107 USA; [Zemel, Benjamin M.] Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Jefferson University; Jefferson University; Jefferson University; Oregon Health & Science University	Zemel, BM (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zemel@ohsu.edu		Tymanskyj, Stephen/0000-0002-6837-0644; Covarrubias, Manuel/0000-0002-0881-4143	NIH HHS [NS090689, NS079855] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Beck EJ, 1998, J GEN PHYSIOL, V112, P71, DOI 10.1085/jgp.112.1.71; Cai SQ, 2006, CELL BIOCHEM BIOPHYS, V46, P91, DOI 10.1385/CBB:46:1:91; Cartwright TA, 2007, BBA-GEN SUBJECTS, V1770, P666, DOI 10.1016/j.bbagen.2006.11.013; Chen Y, 2006, CELL SIGNAL, V18, P215, DOI 10.1016/j.cellsig.2005.04.007; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; Desai R, 2008, J BIOL CHEM, V283, P22283, DOI 10.1074/jbc.M801663200; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Kaczmarek LK, 2017, PHYSIOL REV, V97, P1431, DOI 10.1152/physrev.00002.2017; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Levitan IB, 1999, ADV SEC MESS PHOSPH, V33, P3; Liu PW, 2017, J NEUROSCI, V37, P9705, DOI 10.1523/JNEUROSCI.1703-17.2017; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MORENO H, 1995, J NEUROSCI, V15, P5486; Muqeem T, 2018, J NEUROSCI, V38, P3729, DOI 10.1523/JNEUROSCI.3212-17.2018; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Ritter DM, 2015, J NEUROSCI, V35, P1260, DOI 10.1523/JNEUROSCI.1594-14.2015; Ritter DM, 2012, J PHYSIOL-LONDON, V590, P145, DOI 10.1113/jphysiol.2011.218560; Rossie S, 1999, ADV SEC MESS PHOSPH, V33, P23; Rowan MJM, 2017, CELL REP, V18, P2018, DOI 10.1016/j.celrep.2017.01.068; Rowan MJM, 2016, NEURON, V91, P370, DOI 10.1016/j.neuron.2016.05.035; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Song P, 2006, J BIOL CHEM, V281, P15582, DOI 10.1074/jbc.M512866200; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Velasco I, 1998, Neurobiology (Bp), V6, P23; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Zemel BM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00253; Zemel BM, 2017, J NEUROSCI, V37, P8256, DOI 10.1523/JNEUROSCI.0434-17.2017	35	0	0	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21241	10.1096/fj.201901877R	http://dx.doi.org/10.1096/fj.201901877R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368632				2022-12-26	WOS:000605626600002
J	Kato, T; Yaku, H; Morimoto, T; Inuzuka, Y; Tamaki, Y; Ozasa, N; Yamamoto, E; Yoshikawa, Y; Kitai, T; Taniguchi, R; Iguchi, M; Kato, M; Takahashi, M; Jinnai, T; Ikeda, T; Nagao, K; Kawai, T; Komasa, A; Nishikawa, R; Kawase, Y; Morinaga, T; Kawato, M; Seko, Y; Shiba, M; Toyofuku, M; Furukawa, Y; Ando, K; Kadota, K; Sato, Y; Kuwahara, K; Kimura, T				Kato, Takao; Yaku, Hidenori; Morimoto, Takeshi; Inuzuka, Yasutaka; Tamaki, Yodo; Ozasa, Neiko; Yamamoto, Erika; Yoshikawa, Yusuke; Kitai, Takeshi; Taniguchi, Ryoji; Iguchi, Moritake; Kato, Masashi; Takahashi, Mamoru; Jinnai, Toshikazu; Ikeda, Tomoyuki; Nagao, Kazuya; Kawai, Takafumi; Komasa, Akihiro; Nishikawa, Ryusuke; Kawase, Yuichi; Morinaga, Takashi; Kawato, Mitsunori; Seko, Yuta; Shiba, Masayuki; Toyofuku, Mamoru; Furukawa, Yutaka; Ando, Kenji; Kadota, Kazushige; Sato, Yukihito; Kuwahara, Koichiro; Kimura, Takeshi			Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HYPOALBUMINEMIA	Background Despite the prognostic importance of hypoalbuminemia, the prognostic implication of a change in albumin levels has not been fully investigated during hospitalization in patients with acute decompensated heart failure (ADHF). Methods Using the data from the Kyoto Congestive Heart Failure registry on 3160 patients who were discharged alive for acute heart failure hospitalization and in whom the change in albumin levels was calculated at discharge, we evaluated the association with an increase in serum albumin levels from admission to discharge and clinical outcomes by a multivariable Cox hazard model. The primary outcome measure was a composite of all-cause death or hospitalization for heart failure. Findings Patients with increased albumin levels (N = 1083, 34.3%) were younger and less often had smaller body mass index and renal dysfunction than those with no increase in albumin levels (N = 2077, 65.7%). Median follow-up was 475 days with a 96% 1-year follow-up rate. Relative to the group with no increase in albumin levels, the lower risk of the increased albumin group remained significant for the primary outcome measure (hazard ratio: 0.78, 95% confidence interval: 0.69-0.90: P = 0.0004) after adjusting for confounders including baseline albumin levels. When stratified by the quartiles of baseline albumin levels, the favorable effect of increased albumin was more pronounced in the lower quartiles of albumin levels, but without a significant interaction effect (interaction P = 0.49). Conclusions Independent of baseline albumin levels, an increase in albumin during index hospitalization was associated with a lower 1-year risk for a composite of all-cause death and hospitalization in patients with acute heart failure.	[Kato, Takao; Yaku, Hidenori; Ozasa, Neiko; Yamamoto, Erika; Yoshikawa, Yusuke; Shiba, Masayuki; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan; [Inuzuka, Yasutaka] Shiga Gen Hosp, Dept Cardiovasc Med, Shiga, Japan; [Tamaki, Yodo] Tenri Hosp, Div Cardiol, Nara, Japan; [Kitai, Takeshi; Furukawa, Yutaka] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Taniguchi, Ryoji; Sato, Yukihito] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Cardiol, Amagasaki, Hyogo, Japan; [Iguchi, Moritake] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Kato, Masashi] Mitsubishi Kyoto Hosp, Dept Cardiol, Kyoto, Japan; [Takahashi, Mamoru] Shimabara Hosp, Dept Cardiol, Kyoto, Japan; [Jinnai, Toshikazu] Japanese Red Cross Otsu Hosp, Dept Cardiol, Shiga, Japan; [Ikeda, Tomoyuki] Hikone Municipal Hosp, Dept Cardiol, Shiga, Japan; [Nagao, Kazuya] Osaka Red Cross Hosp, Dept Cardiol, Osaka, Japan; [Kawai, Takafumi] Kishiwada City Hosp, Dept Cardiol, Osaka, Japan; [Komasa, Akihiro] Kansai Elect Power Hosp, Dept Cardiol, Osaka, Japan; [Nishikawa, Ryusuke] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Shizuoka, Japan; [Kawase, Yuichi; Kadota, Kazushige] Kurashiki Cent Hosp, Dept Cardiol, Okayama, Japan; [Morinaga, Takashi; Ando, Kenji] Kokura Mem Hosp, Dept Cardiol, Fukuoka, Japan; [Kawato, Mitsunori] Kobe City Nishi Kobe Med Ctr, Dept Cardiol, Kobe, Hyogo, Japan; [Seko, Yuta] Kitano Hosp, Osaka, Japan; [Toyofuku, Mamoru] Japanese Red Cross Wakayama Med Ctr, Dept Cardiol, Wakayama, Japan; [Kuwahara, Koichiro] Shinshu Univ, Grad Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano, Japan	Kyoto University; Hyogo College of Medicine; Tenri Hospital; Kobe City Medical Center General Hospital; Osaka Red Cross Hospital; Shizuoka General Hospital; Kurashiki Central Hospital; Kokura Memorial Hospital; Kobe City Medical Center General Hospital; Kitano Hospital; Shinshu University	Kato, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	tkato75@kuhp.kyoto-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022; Yoshikawa, Yusuke/AAV-6436-2021	Kuwahara, Koichiro/0000-0003-2670-7170; Yoshikawa, Yusuke/0000-0001-8082-2036; Kato, Takao/0000-0001-8213-7999; Yaku, Hidenori/0000-0002-1011-1033	Japan Agency for Medical Research and Development [18059186]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Agency for Medical Research and Development [18059186] (Drs T. Kato, T. Kuwahara, and N. Ozasa). The founder had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; [Anonymous], 2008, JAPANS ETHICAL GUIDE; Arques S, 2008, INT J CARDIOL, V125, P265, DOI 10.1016/j.ijcard.2007.07.094; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60404-9; Kawamoto A, 2015, INT J CARDIOL, V187, P27, DOI 10.1016/j.ijcard.2015.03.354; Kitai T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4296; Koyama S, 2013, CIRC-HEART FAIL, V6, P227, DOI 10.1161/CIRCHEARTFAILURE.112.000152; Bonilla-Palomas JL, 2014, J CARD FAIL, V20, P350, DOI 10.1016/j.cardfail.2014.01.016; Nakayama H, 2016, AM J CARDIOL, V117, P1305, DOI 10.1016/j.amjcard.2016.01.030; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Regalbuto R, 2014, J CARD FAIL, V20, P641, DOI 10.1016/j.cardfail.2014.06.358; Su Kanae, 2019, Circ Rep, V1, P517, DOI 10.1253/circrep.CR-19-0054; Tanada Y, 2015, LIFE SCI, V137, P20, DOI 10.1016/j.lfs.2015.06.021; Uchino Y, 2018, AM J CARDIOVASC DRUG, V18, P327, DOI 10.1007/s40256-018-0269-0; Yaku H, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5892; Yaku H, 2018, CIRC J, V82, P2811, DOI 10.1253/circj.CJ-17-1386; Yamamoto E, 2017, ESC HEART FAIL, V4, P216, DOI 10.1002/ehf2.12138; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243818	10.1371/journal.pone.0243818	http://dx.doi.org/10.1371/journal.pone.0243818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370299	Green Published, gold			2022-12-26	WOS:000603611900013
J	Menneson, S; Serrand, Y; Janvier, R; Noirot, V; Etienne, P; Coquery, N; Val-Laillet, D				Menneson, Sophie; Serrand, Yann; Janvier, Regis; Noirot, Virginie; Etienne, Pierre; Coquery, Nicolas; Val-Laillet, David			Regular exposure to a Citrus-based sensory functional food ingredient alleviates the BOLD brain responses to acute pharmacological stress in a pig model of psychosocial chronic stress	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; SWEET ORANGE AROMA; FMRI; PREFERENCES; DEPRESSION; ANHEDONIA; SURVIVAL; NEURONS; ANXIETY; IMPACT	Psychosocial chronic stress is a critical risk factor for the development of mood disorders. However, little is known about the consequences of acute stress in the context of chronic stress, and about the related brain responses. In the present study we examined the physio-behavioural effects of a supplementation with a sensory functional food ingredient (FI) containing Citrus sinensis extract (D11399, Phode, France) in a pig psychosocial chronic stress model. Female pigs underwent a 5- to 6-week stress protocol while receiving daily the FI (FI, n = 10) or a placebo (Sham, n = 10). We performed pharmacological magnetic resonance imaging (phMRI) to study the brain responses to an acute stress (injection of Synacthen(R), a synthetic ACTH-related agonist) and to the FI odour with or without previous chronic supplementation. The olfactory stimulation with the ingredient elicited higher brain responses in FI animals, demonstrating memory retrieval and habituation to the odour. Pharmacological stress with Synacthen injection resulted in an increased activity in several brain regions associated with arousal, associative learning (hippocampus) and cognition (cingulate cortex) in chronically stressed animals. This highlighted the specific impact of acute stress on the brain. These responses were alleviated in animals previously supplemented by the FI during the entire chronic stress exposure. As chronic stress establishes upon the accumulation of acute stress events, any attenuation of the brain responses to acute stress can be interpreted as a beneficial effect, suggesting that FI could be a viable treatment to help individuals coping with repeated stressful events and eventually to reduce chronic stress. This study provides additional evidence on the potential benefits of this FI, of which the long-term consequences in terms of behaviour and physiology need to be further investigated.	[Menneson, Sophie; Serrand, Yann; Janvier, Regis; Coquery, Nicolas; Val-Laillet, David] Univ Rennes, INSERM, Nutr Metabolisms & Canc, INRAE,NuMeCan, Rennes, France; [Menneson, Sophie; Noirot, Virginie; Etienne, Pierre] Phode, Terssac, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Coquery, N (corresponding author), Univ Rennes, INSERM, Nutr Metabolisms & Canc, INRAE,NuMeCan, Rennes, France.	nicolas.coquery@inrae.fr	coquery, nicolas/GQP-5662-2022; coquery, nicolas/N-9206-2019; VAL-LAILLET, David/AAH-6454-2021	coquery, nicolas/0000-0002-4687-5924; coquery, nicolas/0000-0002-4687-5924; Noirot, Virginie/0000-0002-7489-3783	Phode (Terssac, France); Association Nationale de la Recherche et de la Technologie (ANRT); french Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE) [2016/0891]	Phode (Terssac, France); Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); french Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE)	The funder (Phode (Terssac, France; https://www.phode.com/en/) provided the functional ingredient tested and support in the form of salaries for authors SM, VN, and PE but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors affiliated to our private partner are articulated in the 'author contributions' section. Notably, authors PE and VN read and validated the final manuscript but did not decide which results to publish and how to interpret these results. The Association Nationale de la Recherche et de la Technologie (ANRT; http://www.anrt.asso.fr/fr), and the french Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE; https://www.inrae.fr/) (PhD grant CIFRE of SM, No 2016/0891) also provided funding for this study.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; Bali A, 2015, REV NEUROSCIENCE, V26, P555, DOI 10.1515/revneuro-2015-0004; Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077; Campolongo P, 2011, HDB STRESS NEUROPSYC, P179, DOI [10.1002/9781118083222.ch9, DOI 10.1002/9781118083222.CH9]; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen HJ, 2019, AUST NZ J PSYCHIAT, V53, P68, DOI 10.1177/0004867418812674; Cho S, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1431; Clouard C, 2014, J ANIM SCI, V92, P2133, DOI 10.2527/jas.2013-6809; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Coquery N, 2019, J FOOD SCI, V84, P2666, DOI 10.1111/1750-3841.14772; Coquery N, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00151; Costa CARA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-42; Coutens B, 2020, NEUROSCIENCE, V451, P149, DOI 10.1016/j.neuroscience.2020.09.040; Dedovic K, 2005, J PSYCHIATR NEUROSCI, V30, P319; Dedovic K, 2009, BRAIN RES, V1293, P49, DOI 10.1016/j.brainres.2009.06.044; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Faturi CB, 2010, PROG NEURO-PSYCHOPH, V34, P605, DOI 10.1016/j.pnpbp.2010.02.020; Ferrari L, 2012, J NEUROSCI METH, V204, P9, DOI 10.1016/j.jneumeth.2011.10.020; Finsterwald C, 2014, NEUROBIOL LEARN MEM, V112, P17, DOI 10.1016/j.nlm.2013.09.017; Gautier Y, 2018, FASEB J, V32, P6478, DOI 10.1096/fj.201701541; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Goes TC, 2012, J ALTERN COMPLEM MED, V18, P798, DOI 10.1089/acm.2011.0551; Gompf HS, 2010, J NEUROSCI, V30, P14543, DOI 10.1523/JNEUROSCI.3037-10.2010; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Heilbronner SR, 2016, ANNU REV NEUROSCI, V39, P149, DOI 10.1146/annurev-neuro-070815-013952; In MH, 2017, NEUROIMAGE, V158, P26, DOI 10.1016/j.neuroimage.2017.06.069; Ironside M, 2018, CURR OPIN BEHAV SCI, V22, P106, DOI 10.1016/j.cobeha.2018.01.016; Jafarzadeh Mehdi, 2013, Adv Biomed Res, V2, P10, DOI 10.4103/2277-9175.107968; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Lewis AH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00179; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mannucci C, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/3624094; Menneson S, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103599; Menneson S, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00161; Murphy E, 2014, APPL ANIM BEHAV SCI, V159, P9, DOI 10.1016/j.applanim.2014.08.002; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Okuyama S, 2018, BIOSCI BIOTECH BIOCH, V82, P869, DOI 10.1080/09168451.2018.1433993; OP026, 2016, J CROHNS COLITIS, V10, pS21; Page GG, 2016, NEUROBIOL STRESS, V3, P105, DOI 10.1016/j.ynstr.2016.03.002; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rolls ET, 2019, BRAIN STRUCT FUNCT, V224, P3001, DOI 10.1007/s00429-019-01945-2; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sawamoto A, 2016, MOLECULES, V21, DOI 10.3390/molecules21040541; Shenhav A, 2016, NAT NEUROSCI, V19, P1286, DOI 10.1038/nn.4384; Tang CY, 2016, INT ANESTHESIOL CLIN, V54, P129, DOI 10.1097/AIA.0000000000000081; Val-Laillet D, 2019, ANIMAL, V13, P2699, DOI 10.1017/S1751731119001745; Val-Laillet D, 2017, FASEB J, V31, P2037, DOI 10.1096/fj.201601015R; Val-Laillet D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162660; Valle-Leija P, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/975367; Valle-Leija P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035358; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Willner P, 2017, NEUROBIOL STRESS, V6, P78, DOI 10.1016/j.ynstr.2016.08.002; Wolffenbuttel AN, 2018, PHYTOTHER RES, V32, P160, DOI 10.1002/ptr.5964; Zhang LL, 2019, J AGR FOOD CHEM, V67, P13817, DOI 10.1021/acs.jafc.9b00650; 2019, J CROHNS COLITIS S1, V13	63	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243893	10.1371/journal.pone.0243893	http://dx.doi.org/10.1371/journal.pone.0243893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370353	gold, Green Published			2022-12-26	WOS:000603611900064
J	Okello, N; Oloro, J; Kyakwera, C; Kumbakumba, E; Obua, C				Okello, Nelson; Oloro, Joseph; Kyakwera, Catherine; Kumbakumba, Elias; Obua, Celestino			Antibiotic prescription practices among prescribers for children under five at public health centers III and IV in Mbarara district	PLOS ONE			English	Article							MANAGEMENT	Introduction Rational use of medicines requires that patients receive medications appropriate to their clinical needs. Irrational prescription of antibiotics has been reported in many health systems across the world. In Uganda, mainly nurses and assistant medical officers (Clinical officers) prescribe for children at level III and IV primary care facilities (health center II and IV). Nurses are not primarily trained prescribers; their antibiotic prescription maybe associated with errors. There is a need to understand the practices of antibiotic prescription among prescribers in the public primary care facilities. We therefore determined antibiotic prescription practices of prescribers for children under five years at health center III and IV in Mbarara district, South Western Uganda. Methods This was a retrospective descriptive cross-sectional study. We reviewed outpatient records of children <5 years of age retrospectively. Information obtained from the outpatient registers were captured in predesigned data abstraction form. Health care providers working at health centers III and IV were interviewed using a structured questionnaire. They provided information on socio-demographic, health facility, antibiotic prescription practices and availability of reference tools. Data was analyzed using STATA software version 13 center dot 0. Results There were 1218 outpatients records of children under five years reviewed and 35 health care providers interviewed. The most common childhood illness diagnosed was upper respiratory tract infection. It received the most antibiotic prescription (53%). The most commonly prescribed oral antibiotics were cotrimoxazole and amoxicillin, and ceftriaxone and benzyl penicillin were the commonest prescribed injectable antibiotics. Up to 68.4% of the antibiotic prescription was irrational. No prescriber or facility factors were associated with irrational antibiotic prescription practices. Conclusion Upper respiratory tract infection is the most diagnosed condition in children under five years with Cotrimoxazole and Amoxicillin being the most commonly prescribed antibiotics. Antibiotics are being prescribed irrationally at health centers III and IV in Mbarara District. Training and support supervision of prescribers at health centers III and IV in Mbarara district need to be prioritized by the district health team.	[Okello, Nelson; Kyakwera, Catherine; Kumbakumba, Elias] Mbarara Univ Sci & Technol, Dept Paediat & Child Hlth, Fac Med, Mbarara, Uganda; [Okello, Nelson] Lira Univ, Dept Paediat & Child Hlth, Fac Hlth Sci, Lira, Uganda; [Oloro, Joseph; Obua, Celestino] Mbarara Univ Sci & Technol, Dept Pharmacol & Therapeut, Fac Med, Mbarara, Uganda	Mbarara University of Science & Technology; Mbarara University of Science & Technology	Okello, N (corresponding author), Mbarara Univ Sci & Technol, Dept Paediat & Child Hlth, Fac Med, Mbarara, Uganda.; Okello, N (corresponding author), Lira Univ, Dept Paediat & Child Hlth, Fac Hlth Sci, Lira, Uganda.	docnelsons@gmail.com		Neli, Nelson/0000-0002-7791-4068	Makerere University - Swedish International development Agency (SIDA)	Makerere University - Swedish International development Agency (SIDA)	This study was funded by Makerere University - Swedish International development Agency (SIDA) research scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bozic B, 2015, ARCH DIS CHILD, V100, P966, DOI 10.1136/archdischild-2015-308274; Cochran W, 1963, G 1963 SAMPLING TECH; Dekker ARJ, 2017, FAM PRACT, V34, P169, DOI 10.1093/fampra/cmw125; DEMERS P, 1968, CAN MED ASSOC J, V99, P849; Desalegn AA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-170; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; health UMo, 2016, UG CLIN GUID, P335; HOGERZEIL HV, 1995, BRIT J CLIN PHARMACO, V39, P1; Kotwani A, 2012, J CLIN PHARM THER, V37, P308, DOI 10.1111/j.1365-2710.2011.01293.x; Maheshwari A, 2012, INDIAN J PEDIATR, V79, P75, DOI 10.1007/s12098-011-0540-8; Mihani J, 2018, OPEN ACCESS MACED J, DOI [10.3889/oamjms.2018.150, DOI 10.3889/0AMJMS.2018.150]; MoH, 2016, UG CLIN GUID; Nash DR, 2002, ARCH PEDIAT ADOL MED, V156, P1114, DOI 10.1001/archpedi.156.11.1114; Prah J, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.214.13940; Statistics UBo, 2016, NAT POP HOUS CENS 20; van Driel ML, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0470-7; World Health Organization, 2007, INT CLASS DIS REL HL	17	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243868	10.1371/journal.pone.0243868	http://dx.doi.org/10.1371/journal.pone.0243868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370280	Green Published, gold			2022-12-26	WOS:000603611900072
J	Alemu, MH; Grebitus, C				Alemu, Mohammed Hussen; Grebitus, Carola			Towards sustainable urban food systems: Analyzing contextual and intrapsychic drivers of growing food in small-scale urban agriculture	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; COMMUNITY GARDENS; ENVIRONMENTAL SUSTAINABILITY; KNOWLEDGE; BEHAVIOR; DETROIT; DESERT; URBANIZATION; VEGETABLES; ATTITUDES	Small-scale urban agriculture is associated with positive health and environmental outcomes. Previous studies examined factors that drive people to grow foods in urban areas mainly drawing on qualitative data. This research investigates quantitatively what determines consumer preferences for growing foods in community gardens, informing efforts to upscale urban agriculture. We conducted choice experiments in North America and performed latent class analysis of contextual and intrapsychic factors affecting consumers' preferences for growing foods in cities. Results show that providing tools and guidance are the most important contextual factors affecting community garden participation. The preferences of proponents of growing foods are explained by their high subjective knowledge about growing foods and reasons tied to the benefits of participating in community gardening. Opponents of growing foods at community gardens are characterized by low knowledge. The findings can be used to design policies that promote sustainable food systems in urban areas.	[Alemu, Mohammed Hussen] Univ Copenhagen, Dept Food & Resource Econ, Frederiksberg C, Denmark; [Grebitus, Carola] Arizona State Univ, WP Carey Sch Business, Morrison Sch Agribusiness, Mesa, AZ USA	University of Copenhagen; Arizona State University	Alemu, MH (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Frederiksberg C, Denmark.	mha@ifro.ku.dk	Alemu, Mohammed Hussen/O-6772-2017	Alemu, Mohammed Hussen/0000-0002-0404-0232	EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA [201567003-23508]; NSF-MPS-DMS [1419593]	EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA; NSF-MPS-DMS	This work was supported by EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA (Grant Number: 201567003-23508) and NSF-MPS-DMS (Award Number: 1419593). Dr. Carola Grebitus was the grand holder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Andrews RL, 2003, J MARKETING RES, V40, P235, DOI 10.1509/jmkr.40.2.235.19225; Artmann M, 2020, J CLEAN PROD, V255, DOI 10.1016/j.jclepro.2020.120220; Artmann M, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061937; Benis K, 2017, J CLEAN PROD, V140, P784, DOI 10.1016/j.jclepro.2016.05.176; Bethlehem J, 2010, INT STAT REV, V78, P161, DOI 10.1111/j.1751-5823.2010.00112.x; BLACK JS, 1985, J APPL PSYCHOL, V70, P3, DOI 10.1037/0021-9010.70.1.3; Boxall PC, 2002, ENVIRON RESOUR ECON, V23, P421, DOI 10.1023/A:1021351721619; Budzynska K, 2013, PUBLIC HEALTH NUTR, V16, P2114, DOI 10.1017/S1368980013000967; Carley S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204917; Carlson JP, 2009, J CONSUM RES, V35, P864, DOI 10.1086/593688; Carmody D, 2018, GROWING CITY DETROIT; ChoiceMetrics, 2012, NGENE 111 USER MANUA; Cohen N, 2015, RENEW AGR FOOD SYST, V30, P103, DOI 10.1017/S1742170514000210; Colasanti KJA, 2012, URBAN GEOGR, V33, P348, DOI 10.2747/0272-3638.33.3.348; Dancey C., 2004, STAT MATHS PSYCHOL U; de-Magistris T, 2016, J CLEAN PROD, V118, P97, DOI 10.1016/j.jclepro.2016.01.050; Diaz JM, 2018, URBAN FOR URBAN GREE, V31, P197, DOI 10.1016/j.ufug.2018.02.014; Dietrich F, 2013, NOUS, V47, P104, DOI 10.1111/j.1468-0068.2011.00840.x; Drake L, 2015, AGR HUM VALUES, V32, P241, DOI 10.1007/s10460-014-9558-7; DUG. Denver Urban Gardens, 2012, GROW COMM GARD DENV; Ericksen PJ, 2008, GLOBAL ENVIRON CHANG, V18, P234, DOI 10.1016/j.gloenvcha.2007.09.002; Fila SA, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-11; Garnett T, 2016, SCIENCE, V353, P1202, DOI 10.1126/science.aah4765; Gerster-Bentaya M, 2013, FOOD SECUR, V5, P723, DOI 10.1007/s12571-013-0295-3; Global Panel on Agriculture and Food Systems for Nutrition, 2016, FOOD SYSTEMS DIETS F; GLOPAN, 2017, URB DIETS NUTR TREND; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grebitus C, 2017, ECOL ECON, V136, P189, DOI 10.1016/j.ecolecon.2017.02.010; Guitart D, 2012, URBAN FOR URBAN GREE, V11, P364, DOI 10.1016/j.ufug.2012.06.007; Holland L., 2004, Local Environment, V9, P285, DOI 10.1080/1354983042000219388; Joiner C, 1998, ADV CONSUM RES, V25, P311; Keep Growing Detroit, 2019, SOW SEEDS REL 2019 A; Kline P., 1994, EASY GUIDE FACTOR AN; Kulak M, 2013, LANDSCAPE URBAN PLAN, V111, P68, DOI 10.1016/j.landurbplan.2012.11.007; Leiserowitz AA, 2006, ANNU REV ENV RESOUR, V31, P413, DOI 10.1146/annurev.energy.31.102505.133552; Loomis JB, 2014, J AGR RESOUR ECON, V39, P34; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Lusk JL, 2003, AM J AGR ECON, V85, P840, DOI 10.1111/1467-8276.00492; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; McDougall R, 2019, P NATL ACAD SCI USA, V116, P129, DOI 10.1073/pnas.1809707115; McFadden D., 1986, MARKET SCI, V5, p275?297, DOI [10.1287/mksc.5.4.275, DOI 10.1287/MKSC.5.4.275]; McVey D, 2018, REG STUD REG SCI, V5, P40, DOI 10.1080/21681376.2017.1409650; Milburn L.A.S., 2010, LANDSC J, V29, P71, DOI [10.3368/lj.29.1.71, DOI 10.3368/LJ.29.1.71]; National Research Center I, 2006, COMM FOOD PROJ EV TO; Ochoa J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11143978; ONU, 2015, TRANSF OUR WORLD 203; Parfit Derek., 1984, REASONS PERSONS; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; Peschel AO, 2016, APPETITE, V106, P78, DOI 10.1016/j.appet.2016.02.162; Raju P.S., 1995, J CONSUM PSYCHOL, V4, P153, DOI DOI 10.1207/S15327663JCP0402_04; Raz J., 1999, PRACTICAL REASON NOR; Savoie-Roskos MR, 2017, J ACAD NUTR DIET, V117, P240, DOI 10.1016/j.jand.2016.10.014; Schram-Bijkerk D, 2018, SCI TOTAL ENVIRON, V621, P863, DOI 10.1016/j.scitotenv.2017.11.160; Seto KC, 2016, SCIENCE, V352, P943, DOI 10.1126/science.aaf7439; Shrestha MK, 2012, APPL GEOGR, V32, P522, DOI 10.1016/j.apgeog.2011.04.004; Soga Masashi, 2017, Prev Med Rep, V5, P92; Solino M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089603; Somerset S, 2009, PUBLIC HEALTH NUTR, V12, P214, DOI 10.1017/S1368980008003327; Sorqvist P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080719; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Swait J., 1994, J RETAIL CONSUM SERV, V1, P77, DOI [10.1016/0969-6989(94)90002-7, DOI 10.1016/0969-6989(94)90002-7]; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Taylor DE, 2015, ENVIRON PRAC, V17, P102, DOI 10.1017/S1466046614000544; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Twiss J, 2003, AM J PUBLIC HEALTH, V93, P1435, DOI 10.2105/AJPH.93.9.1435; Vallin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152160; Vavra J, 2018, J CLEAN PROD, V185, P1015, DOI 10.1016/j.jclepro.2018.02.261; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; Wallace RJ, 2004, REASON VALUE THEMES; Wang HL, 2014, APPL GEOGR, V55, P127, DOI 10.1016/j.apgeog.2014.09.010; Warren E, 2015, FOOD POLICY, V53, P54, DOI 10.1016/j.foodpol.2015.03.004; Watson DLB, 2011, PERSPECT PUBLIC HEAL, V131, P163, DOI 10.1177/1757913911412475; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Weidner T, 2019, J CLEAN PROD, V209, P1637, DOI 10.1016/j.jclepro.2018.11.004; Weinberger K, 2013, FOOD SECUR, V5, P847, DOI 10.1007/s12571-013-0299-z; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Wils WPJ, 2019, WORLD COMPET, V42, P21; Wooldridge J.M., 2008, INTRO ECONOMETRICS M, VFourth; Zick CD, 2013, AM J PUBLIC HEALTH, V103, P1110, DOI 10.2105/AJPH.2012.301009	84	4	4	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243949	10.1371/journal.pone.0243949	http://dx.doi.org/10.1371/journal.pone.0243949			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362258	Green Published, gold			2022-12-26	WOS:000603071600031
J	Camougrand, N; Vigie, P; Gonzalez, C; Manon, S; Bhatia-Kissova, I				Camougrand, Nadine; Vigie, Pierre; Gonzalez, Cecile; Manon, Stephen; Bhatia-Kissova, Ingrid			The yeast mitophagy receptor Atg32 is ubiquitinated and degraded by the proteasome	PLOS ONE			English	Article							N-TERMINAL ACETYLATION; MITOCHONDRIAL AUTOPHAGY; ATP SYNTHASE; PROTEIN; DEGRADATION; LIGASE; FUNDC1; SYSTEM; ULK1	Mitophagy, the process that degrades mitochondria selectively through autophagy, is involved in the quality control of mitochondria in cells grown under respiratory conditions. In yeast, the presence of the Atg32 protein on the outer mitochondrial membrane allows for the recognition and targeting of superfluous or damaged mitochondria for degradation. Post-translational modifications such as phosphorylation are crucial for the execution of mitophagy. In our study we monitor the stability of Atg32 protein in the yeast S. cerevisiae and show that Atg32 is degraded under normal growth conditions, upon starvation or rapamycin treatment. The Atg32 turnover can be prevented by inhibition of the proteasome activity, suggesting that Atg32 is also ubiquitinated. Mass spectrometry analysis of purified Atg32 protein revealed that at least lysine residue in position 282 is ubiquitinated. Interestingly, the replacement of lysine 282 with alanine impaired Atg32 degradation only partially in the course of cell growth, suggesting that additional lysine residues on Atg32 might also be ubiquitinated. Our results provide the foundation to further elucidate the physiological significance of Atg32 turnover and the interplay between mitophagy and the proteasome.	[Camougrand, Nadine; Vigie, Pierre; Gonzalez, Cecile; Manon, Stephen] CNRS, Bordeaux, France; [Camougrand, Nadine; Vigie, Pierre; Gonzalez, Cecile; Manon, Stephen] Univ Bordeaux, IBGC, UMR5095, Bordeaux, France; [Bhatia-Kissova, Ingrid] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava, Slovakia; [Gonzalez, Cecile] Univ Lyon, IBCP, UMR5086, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Comenius University Bratislava; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Camougrand, N (corresponding author), CNRS, Bordeaux, France.; Camougrand, N (corresponding author), Univ Bordeaux, IBGC, UMR5095, Bordeaux, France.	n.camougrand@ibgc.cnrs.fr			Slovak APVV agency [SK-FR-20150005]; CNRS; University of Bordeaux; Agence Nationale pour la Recherche [ANR-10-IDEX-03-02]; Campus France (Stefanik) [35809VC]	Slovak APVV agency(Slovak Research and Development Agency); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Campus France (Stefanik)	IBK: Slovak APVV agency (SK-FR-20150005) NC and PV: CNRS, the University of Bordeaux and the Doctoral International Program from IDEX of Bordeaux supported by Agence Nationale pour la Recherche (ANR-10-IDEX-03-02) NC and IBK: France/Slovakia collaboration was supported by Campus France (Stefanik no 35809VC) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Belgareh-Touze N, 2017, AUTOPHAGY, V13, P114, DOI 10.1080/15548627.2016.1252889; Braun RJ, 2017, TRENDS CELL BIOL, V27, P441, DOI 10.1016/j.tcb.2017.02.007; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034; Chen ZH, 2017, EMBO REP, V18, P495, DOI 10.15252/embr.201643309; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Deffieu M, 2009, J BIOL CHEM, V284, P14828, DOI 10.1074/jbc.M109.005181; Eiyama A, 2015, J BIOL CHEM, V290, P25034, DOI 10.1074/jbc.M115.677468; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Hu GH, 2020, BIOCHEM BIOPH RES CO, V522, P254, DOI 10.1016/j.bbrc.2019.11.089; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Levchenko M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168518; Liu CC, 2016, MOL CELL, V61, P84, DOI 10.1016/j.molcel.2015.11.001; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Sakakibara K, 2015, EMBO J, V34, P2703, DOI 10.15252/embj.201591440; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Velours J, 2000, BBA-BIOENERGETICS, V1458, P443, DOI 10.1016/S0005-2728(00)00093-1; Vigie P, 2019, J CELL SCI, V132, DOI 10.1242/jcs.221655; Wang K, 2013, AUTOPHAGY, V9, P1828, DOI 10.4161/auto.26281; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang BC, 2008, CELL RES, V18, P900, DOI 10.1038/cr.2008.75	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0241576	10.1371/journal.pone.0241576	http://dx.doi.org/10.1371/journal.pone.0241576			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362225	Green Published, gold			2022-12-26	WOS:000603071600028
J	Peixoto, MA; Alves, RS; Coelho, IF; Evangelista, JSPC; de Resende, MDV; Rocha, JRDSD; Silva, FFE; Laviola, BG; Bhering, LL				Peixoto, Marco Antonio; Alves, Rodrigo Silva; Coelho, Igor Ferreira; Evangelista, Jeniffer Santana Pinto Coelho; de Resende, Marcos Deon Vilela; Rocha, Joao Romero do Amaral Santos de Carvalho; Silva, Fabyano Fonseca; Laviola, Bruno Galveas; Bhering, Leonardo Lopes			Random regression for modeling yield genetic trajectories in Jatropha curcas breeding	PLOS ONE			English	Article							SELECTION; STABILITY; INCREASE; BIOFUEL; OIL; L.	Random regression models (RRM) are a powerful tool to evaluate genotypic plasticity over time. However, to date, RRM remains unexplored for the analysis of repeated measures in Jatropha curcas breeding. Thus, the present work aimed to apply the random regression technique and study its possibilities for the analysis of repeated measures in Jatropha curcas breeding. To this end, the grain yield (GY) trait of 730 individuals of 73 half-sib families was evaluated over six years. Variance components were estimated by restricted maximum likelihood, genetic values were predicted by best linear unbiased prediction and RRM were fitted through Legendre polynomials. The best RRM was selected by Bayesian information criterion. According to the likelihood ratio test, there was genetic variability among the Jatropha curcas progenies; also, the plot and permanent environmental effects were statistically significant. The variance components and heritability estimates increased over time. Non-uniform trajectories were estimated for each progeny throughout the measures, and the area under the trajectories distinguished the progenies with higher performance. High accuracies were found for GY in all harvests, which indicates the high reliability of the results. Moderate to strong genetic correlation was observed across pairs of harvests. The genetic trajectories indicated the existence of genotype x measurement interaction, once the trajectories crossed, which implies a different ranking in each year. Our results suggest that RRM can be efficiently applied for genetic selection in Jatropha curcas breeding programs.	[Peixoto, Marco Antonio; Coelho, Igor Ferreira; Evangelista, Jeniffer Santana Pinto Coelho; Rocha, Joao Romero do Amaral Santos de Carvalho; Silva, Fabyano Fonseca; Bhering, Leonardo Lopes] Univ Fed Vicosa, Vicosa, MG, Brazil; [Alves, Rodrigo Silva] Univ Fed Vicosa, INCT Cafe, Vicosa, MG, Brazil; [de Resende, Marcos Deon Vilela] Univ Fed Vicosa, Embrapa Cafe, Vicosa, MG, Brazil; [Laviola, Bruno Galveas] Embrapa Agroenergia, Brasilia, DF, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Bhering, LL (corresponding author), Univ Fed Vicosa, Vicosa, MG, Brazil.	leonardo.bhering@ufv.br		Bhering, Leonardo/0000-0002-6072-0996; Peixoto, Marco Antonio/0000-0003-0564-7068				Alves RS, 2020, BRAGANTIA, V79, P360, DOI [10.1590/1678-4499.20200125, 10.1590/1678-4499.20200125.]; Alves RS, 2020, TREE GENET GENOMES, V16, DOI 10.1007/s11295-020-01431-5; Alves RS, 2019, IND CROP PROD, V130, P558, DOI 10.1016/j.indcrop.2018.12.019; Alves RS, 2018, IND CROP PROD, V119, P290, DOI 10.1016/j.indcrop.2018.04.029; [Anonymous], 2007, PESQUI AGROPECUARIA, DOI DOI 10.5216/PAT.V37I3.1867; Berchmans HJ, 2008, BIORESOURCE TECHNOL, V99, P1716, DOI 10.1016/j.biortech.2007.03.051; Bhering LL, 2013, IND CROP PROD, V41, P260, DOI 10.1016/j.indcrop.2012.04.026; Carels N., 2013, JATROPHA CHALLENGES, P263, DOI [10.1007/978-1-4614-4915-7_14, DOI 10.1007/978-1-4614-4915-7_14]; Gilmour A. R., 2015, ASREML USER GUIDE RE; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Iglesias Domingo J., 2007, Braz. J. Plant Physiol., V19, P333, DOI 10.1590/S1677-04202007000400006; Junqueira VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157038; KIRKPATRICK M, 1990, GENETICS, V124, P979; Laviola BG, 2019, EMBRAPA AGROENERGIA, V1, P420; Laviola BG, 2018, IND CROP PROD, V117, P216, DOI 10.1016/j.indcrop.2018.03.003; Laviola BG, 2013, IND CROP PROD, V51, P70, DOI 10.1016/j.indcrop.2013.08.016; Marchal A., 2019, PLANT GENOME-US, V13, P281, DOI [10.1017/S0021859605005587, DOI 10.1017/S0021859605005587]; Marchal A, 2019, G3-GENES GENOM GENET, V9, P21, DOI 10.1534/g3.118.200697; Meyer K, 2004, LIVEST PROD SCI, V86, P69, DOI 10.1016/S0301-6226(03)00142-8; Morrissey MB, 2016, EVOLUTION, V70, P1944, DOI 10.1111/evo.13003; Mota RR, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-015-0178-5; Nithiyanantham S, 2012, J AM OIL CHEM SOC, V89, P961, DOI 10.1007/s11746-012-2012-3; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Peixoto LD, 2016, IND CROP PROD, V80, P70, DOI 10.1016/j.indcrop.2015.10.034; Peixoto MA, 2020, AGRON J, DOI [10.1002/agj2.20344, DOI 10.1002/AGJ2.20344]; Pu Y, 2011, BIORESOURCES, V6, P4856; R Development Core Team, 2020, R LANGUAGE ENV STAT; RESENDE M. D. V., 2014, ESTATISTICA MATEMATI; Resende M.D.V, 2015, GENETICA QUANTITATIV, P463; RESENDE M.D.V. de, 2002, GENETICA BIOMETRICA; Resende MDV, 2001, ESTIMATIVAS PARAMETR; Riday H, 2006, CROP SCI, V46, P1058, DOI 10.2135/cropsci2005.0272; Rosado TB, 2010, CROP SCI, V50, P2372, DOI 10.2135/cropsci2010.02.0112; Rocha JRDSD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203818; Schaeffer LR, 2016, RANDOM REGRESSION MO, P171, DOI DOI 10.1016/J.FORSCIINT.2016.12.027; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Wilkins PW, 2003, J AGR SCI-CAMBRIDGE, V140, P129, DOI 10.1017/S0021859603003058; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244021	10.1371/journal.pone.0244021	http://dx.doi.org/10.1371/journal.pone.0244021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362265	Green Published, gold			2022-12-26	WOS:000603071600067
J	Adhyapok, P; Fu, X; Sluka, JP; Clendenon, SG; Sluka, VD; Wang, ZM; Dunn, K; Klaunig, JE; Glazier, JA				Adhyapok, Priyom; Fu, Xiao; Sluka, James P.; Clendenon, Sherry G.; Sluka, Victoria D.; Wang, Zemin; Dunn, Kenneth; Klaunig, James E.; Glazier, James A.			A computational model of liver tissue damage and repair	PLOS ONE			English	Article							INDUCED HEPATIC-NECROSIS; CELLULAR-AUTOMATON MODEL; IMMUNOHISTOCHEMICAL LOCALIZATION; CONTACT INHIBITION; ACETAMINOPHEN; PROTEIN; FAILURE; INJURY; QUANTIFICATION; HEPATOTOXICITY	Drug induced liver injury (DILI) and cell death can result from oxidative stress in hepatocytes. An initial pattern of centrilobular damage in the APAP model of DILI is amplified by communication from stressed cells and immune system activation. While hepatocyte proliferation counters cell loss, high doses are still lethal to the tissue. To understand the progression of disease from the initial damage to tissue recovery or death, we computationally model the competing biological processes of hepatocyte proliferation, necrosis and injury propagation. We parametrize timescales of proliferation (alpha), conversion of healthy to stressed cells (beta) and further sensitization of stressed cells towards necrotic pathways (gamma) and model them on a Cellular Automaton (CA) based grid of lattice sites. 1D simulations show that a small alpha/beta (fast proliferation), combined with a large gamma/beta (slow death) have the lowest probabilities of tissue survival. At large alpha/beta, tissue fate can be described by a critical gamma/beta* ratio alone; this value is dependent on the initial amount of damage and proportional to the tissue size N. Additionally, the 1D model predicts a minimum healthy population size below which damage is irreversible. Finally, we compare 1D and 2D phase spaces and discuss outcomes of bistability where either survival or death is possible, and of coexistence where simulated tissue never completely recovers or dies but persists as a mixture of healthy, stressed and necrotic cells. In conclusion, our model sheds light on the evolution of tissue damage or recovery and predicts potential for divergent fates given different rates of proliferation, necrosis, and injury propagation.	[Adhyapok, Priyom; Sluka, James P.; Clendenon, Sherry G.; Sluka, Victoria D.; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA; [Adhyapok, Priyom] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Fu, Xiao] Francis Crick Inst, London, England; [Sluka, James P.; Clendenon, Sherry G.; Glazier, James A.] Indiana Univ, Dept Intelligent Syst Engn, Bloomington, IN USA; [Wang, Zemin; Klaunig, James E.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA; [Dunn, Kenneth] Indiana Univ, Sch Med, Indianapolis, IN USA; [Sluka, Victoria D.] UCL, Inst Archaeol, London, England; [Wang, Zemin] US FDA, Washington, DC 20204 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Francis Crick Institute; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; University of London; University College London; US Food & Drug Administration (FDA)	Adhyapok, P (corresponding author), Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA.; Adhyapok, P (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	priyom.adhyapok@gmail.com	Sluka, James P/AAL-9294-2021	Sluka, James P/0000-0002-5901-1404; Klaunig, James/0000-0002-4736-2223; Glazier, James Alexander/0000-0003-3634-190X; Wang, Zemin/0000-0003-4189-578X; Fu, Xiao/0000-0002-8611-891X; Adhyapok, Priyom/0000-0003-3067-7058	National Institute of Health; NIH [U01 GM111243, R01 GM122424, U24 EB028887]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health (www.nih.gov) grants; NIH U01 GM111243 Development of a Multiscale Mechanistic Simulation of Acetaminophen Induced Liver Damage funded JPS, SGC, VDS, ZW, KD, JEK, JAG; NIH R01 GM122424 Competitive Renewal of Development, Improvement and Extension of the Tissue Simulation Environment -CompuCell3D funded JPS, JAG; and NIH U24 EB028887 Dissemination of libRoadRunner and CompuCell3D funded JPS, JAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Antoine DJ, 2009, TOXICOL SCI, V112, P521, DOI 10.1093/toxsci/kfp235; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Baratta JL, 2009, HISTOCHEM CELL BIOL, V131, P713, DOI 10.1007/s00418-009-0577-1; BARTOLONE JB, 1989, FUND APPL TOXICOL, V13, P859, DOI 10.1016/0272-0590(89)90339-4; Bartolozzi M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046112; Blackmore L, 2015, CLIN MED, V15, P468, DOI 10.7861/clinmedicine.15-5-468; BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125; Clendenon SG, 2011, MICROSC MICROANAL, V17, P614, DOI 10.1017/S1431927611000535; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Dunn KW, 2020, TOXICOLOGY, V439, DOI 10.1016/j.tox.2020.152464; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Encinas LH, 2007, APPL MATH MODEL, V31, P1213, DOI 10.1016/j.apm.2006.04.001; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Fu GB, 2019, CELL RES, V29, P8, DOI 10.1038/s41422-018-0103-x; Fu X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198060; Gekle S, 2005, EUR PHYS J B, V45, P569, DOI 10.1140/epjb/e2005-00215-3; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Jaeschke H, 2006, HEPATOLOGY, V43, P1191, DOI 10.1002/hep.21246; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jaeschke H, 2015, DIGEST DIS, V33, P464, DOI 10.1159/000374090; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Kamp C, 2002, P ROY SOC B-BIOL SCI, V269, P2035, DOI 10.1098/rspb.2002.2095; Karafyllidis I, 1997, ECOL MODEL, V99, P87, DOI 10.1016/S0304-3800(96)01942-4; Kennedy RC, 2019, TOXICOL SCI, V169, P151, DOI 10.1093/toxsci/kfz029; Kerner BS, 2002, J PHYS A-MATH GEN, V35, P9971, DOI 10.1088/0305-4470/35/47/303; Klotz U, 2012, ARZNEIMITTELFORSCH, V62, P355, DOI 10.1055/s-0032-1321785; Krapivsky PL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238701; Lawson JA, 2000, TOXICOL SCI, V54, P509, DOI 10.1093/toxsci/54.2.509; LEE Y, 1995, BIOPHYS J, V69, P1284, DOI 10.1016/S0006-3495(95)79996-9; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; MEYERS LL, 1988, TOXICOL APPL PHARM, V93, P378, DOI 10.1016/0041-008X(88)90040-3; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8; Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618; Moore RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010794.pub2; Nourjah P, 2006, PHARMACOEPIDEM DR S, V15, P398, DOI 10.1002/pds.1191; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; QI AS, 1993, J THEOR BIOL, V161, P1, DOI 10.1006/jtbi.1993.1035; Qiu YC, 2001, ADV EXP MED BIOL, V500, P663; ROBERTS DW, 1991, AM J PATHOL, V138, P359; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Saito C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05169; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Shoda LKM, 2017, GENE REGUL SYST BIO, V11, DOI 10.1177/1177625017696074; Simpson MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021918; Sipahi R, 2018, J THEOR BIOL, V445, P151, DOI 10.1016/j.jtbi.2018.02.025; Streichan SJ, 2014, P NATL ACAD SCI USA, V111, P5586, DOI 10.1073/pnas.1323016111; TIRMENSTEIN MA, 1989, J BIOL CHEM, V264, P9814; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; van Ballegooijen WM, 2004, P NATL ACAD SCI USA, V101, P18246, DOI 10.1073/pnas.0405682101; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243451	10.1371/journal.pone.0243451	http://dx.doi.org/10.1371/journal.pone.0243451			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347443	Green Published, gold			2022-12-26	WOS:000603071100053
J	Nkhata, W; Shimelis, H; Melis, R; Chirwa, R; Mzengeza, T; Mathew, I; Shayanowako, A				Nkhata, Wilson; Shimelis, Hussein; Melis, Rob; Chirwa, Rowland; Mzengeza, Tenyson; Mathew, Isack; Shayanowako, Admire			Population structure and genetic diversity analyses of common bean germplasm collections of East and Southern Africa using morphological traits and high-density SNP markers	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; GENOTYPES; POLYMORPHISM; IDENTIFICATION; QUALITY; ORIGIN	Knowledge of genetic diversity in plant germplasm and the relationship between genetic factors and phenotypic expression is vital for crop improvement. This study's objectives were to understand the extent of genetic diversity and population structure in 60 common bean genotypes from East and Southern Africa. The common bean genotypes exhibited significant (p<0.05) levels of variability for traits such as days to flowering (DTF), days to maturity (DTM), number of pods per plant (NPP), number of seeds per pod (NSP), and grain yield per hectare in kilograms (GYD). About 47.82 per cent of the variation among the genotypes was explained by seven principal components (PC) associated with the following agronomic traits: NPP, NFF (nodes to first flower), DTF, GH (growth habit) and GYD. The SNP markers revealed mean gene diversity and polymorphic information content values of 0.38 and 0.25, respectively, which suggested the presence of considerable genetic variation among the assessed genotypes. Analysis of molecular variance showed that 51% of the genetic variation were between the gene pools, while 49% of the variation were within the gene pools. The genotypes were delineated into two distinct groups through the population structure, cluster and phylogenetic analyses. Genetically divergent genotypes such as DRK57, MW3915, NUA59, and VTTT924/4-4 with high yield and agronomic potential were identified, which may be useful for common bean improvement.	[Nkhata, Wilson; Shimelis, Hussein; Melis, Rob; Mathew, Isack; Shayanowako, Admire] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, African Ctr Crop Improvement, Pietermaritzburg, South Africa; [Chirwa, Rowland] Int Ctr Trop Agr, Chitedze Agr Res Stn, Lilongwe, Malawi; [Mzengeza, Tenyson] Chitedze Agr Res Stn, Dept Agr Res Serv, Lilongwe, Malawi	University of Kwazulu Natal; Alliance; International Center for Tropical Agriculture - CIAT	Nkhata, W (corresponding author), Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, African Ctr Crop Improvement, Pietermaritzburg, South Africa.	wilsonkhata@gmail.com	Shimelis, Hussein/N-5073-2013	Shimelis, Hussein/0000-0003-2793-8392; Nkhata, Wilson/0000-0003-2698-8398	Alliance for A Green in Africa (AGRA)	Alliance for A Green in Africa (AGRA)	WN received from Alliance for A Green in Africa (AGRA). Grant/Award number. AGRAPASS30.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu H., 2017, INT J ADV RES PUBLIC, V1, P39; [Anonymous], 2014, SCI SIGNAL, V7, pra13; Asfaw A, 2009, THEOR APPL GENET, V120, P1, DOI 10.1007/s00122-009-1154-7; Bhutta WM, 2006, S AFR J BOT, V72, P280, DOI 10.1016/j.sajb.2005.09.005; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Blair MW, 2006, THEOR APPL GENET, V112, P1149, DOI 10.1007/s00122-006-0217-2; Blair MW, 2006, THEOR APPL GENET, V112, P913, DOI 10.1007/s00122-005-0195-9; Cabral PDS, 2011, GENET MOL RES, V10, P140, DOI 10.4238/vol10-1gmr993; Chacon S MI, 2007, PLANT SYST EVOL, V266, P175, DOI 10.1007/s00606-007-0536-z; Chiorato AF, 2006, GENET MOL BIOL, V29, P105, DOI 10.1590/S1415-47572006000100020; Cichy KA, 2015, CROP SCI, V55, P2149, DOI 10.2135/cropsci2014.09.0653; Cichy KA, 2015, THEOR APPL GENET, V128, P1555, DOI 10.1007/s00122-015-2531-z; Coates BS, 2009, J HERED, V100, P556, DOI 10.1093/jhered/esp028; Cooper H, 2001, BROADENING GENETIC B, P1, DOI DOI 10.1079/9780851994116.0001; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Eltaher S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00076; Fisseha Z., 2016, African Journal of Biotechnology, V15, P2824; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gayacharan, 2020, ANN APPL BIOL, V177, P346, DOI 10.1111/aab.12624; GENTRY HS, 1969, ECON BOT, V23, P55, DOI 10.1007/BF02862972; Goncalves-Vidigal MC, 2008, EUPHYTICA, V164, P551, DOI 10.1007/s10681-008-9758-6; Guidoti DT, 2018, ACTA SCI-AGRON, V40, DOI 10.4025/actasciagron.v40i1.33032; Hallauer A.R., 1988, QUANTITATIVE GENETIC; Hegay S., 2012, Scientific Journal of Crop Science, V1, P63; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; IBPGR, 1982, DESCR PHAS VUL L; Katungi E., 2009, INT CTR TROPIC AGR, V61, P1; Katungi E., 2009, COMMON BEAN E SO AFR; Kimani P., 2001, PAN AFR BEAN RES NET, P13; Kumar V, 2008, SCI HORTIC-AMSTERDAM, V116, P138, DOI 10.1016/j.scienta.2007.12.001; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Liu K, 2005, POWERMAKER INTEGRATE; Luo ZN, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00184; McClean PE, 2012, GENET RESOUR CROP EV, V59, P499, DOI 10.1007/s10722-011-9699-0; Mercati F, 2013, GENET RESOUR CROP EV, V60, P839, DOI 10.1007/s10722-012-9879-6; Metais I, 2000, THEOR APPL GENET, V101, P1207, DOI 10.1007/s001220051599; Muturi PW, 2014, INT J TROP INSECT SC, V34, P260, DOI 10.1017/S1742758414000459; Mwadzingeni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171692; Nadeem MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205363; Ojwang PPO, 2011, FIELD CROP RES, V120, P223, DOI 10.1016/j.fcr.2010.10.010; Okii D., 2014, African Crop Science Journal, V22, P59; Payne RW., 2017, GENSTAT WINDOWS, V19th; Silva VMPE, 2013, SCI AGR, V70, P167, DOI 10.1590/S0103-90162013000300005; Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144; Polania J, PLANT PHYSL, V40, P503; Pritchard JK, 2000, GENETICS, V155, P945; Raatz B, 2019, GENET RESOUR CROP EV, V66, P707, DOI 10.1007/s10722-019-00746-0; Radosavljevic I, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv106; Salem KFM, 2016, CR BIOL, V339, P1, DOI 10.1016/j.crvi.2015.11.003; Sartie A, 2012, GENET RESOUR CROP EV, V59, P1753, DOI 10.1007/s10722-012-9797-7; Sharma PN, 2013, PLANT GENET RESOUR-C, V11, P121, DOI 10.1017/S1479262112000469; Sicard D, 2005, PLANT BREEDING, V124, P464, DOI 10.1111/j.1439-0523.2005.01137.x; SINGH SP, 1991, CROP SCI, V31, P19, DOI 10.2135/cropsci1991.0011183X003100010004x; Somta P, 2009, BREEDING SCI, V59, P149, DOI 10.1270/jsbbs.59.149; Sperling L, 2001, BIODIVERS CONSERV, V10, P989, DOI 10.1023/A:1016628310917; Sundaram P, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2464-8; Talukder ZI, 2010, CAN J PLANT SCI, V90, P49, DOI 10.4141/CJPS09096; Tiranti B, 2007, MOL ECOL, V16, P4942, DOI 10.1111/j.1365-294X.2007.03566.x; Vahdati K, 2015, PLANT SYST EVOL, V301, P691, DOI 10.1007/s00606-014-1107-8; Valdisser PAMR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3805-4; Vinu V, 2013, REV BIOL TROP, V61, P1919; Vitorino CA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00159	66	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243238	10.1371/journal.pone.0243238	http://dx.doi.org/10.1371/journal.pone.0243238			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338076	Green Published, gold			2022-12-26	WOS:000601313500035
J	Shongwe, NA; Byaruhanga, C; Dorny, P; Dermauw, V; Qekwana, DN				Shongwe, Nothando Altrecia; Byaruhanga, Charles; Dorny, Pierre; Dermauw, Veronique; Qekwana, Daniel Nenene			Knowledge, practices and seroprevalence of Taenia species in smallholder farms in Gauteng, South Africa	PLOS ONE			English	Article							SOLIUM PORCINE CYSTICERCOSIS; EASTERN CAPE PROVINCE; RISK-FACTORS; HEALTH-EDUCATION; MBULU DISTRICT; PREVALENCE; PIGS; NEUROCYSTICERCOSIS; HYDATIGENA; COMMUNITY	Porcine cysticercosis and associated human infections are endemic in Sub-Saharan Africa, Latin America, and Asia. Poor agricultural practices, sanitary practices, and lack of knowledge increase the burden of the diseases in susceptible populations. This study investigates the seroprevalence of Taenia spp. in township pigs in Gauteng, South Africa and describes knowledge and farming practices of pig farmers regarding T. solium infections. Blood samples were collected from 126 pigs in three Gauteng township areas, and analyzed for active Taenia spp. infection using the B158/B60 Ag-ELISA. Farmer questionnaire surveys were conducted in four township areas to investigate the level of knowledge and practices associated with porcine cysticercosis and neurocysticercosis. Logistic regression models were used to assess the relationship between predictor variables and the outcome variable, knowledge of porcine cysticercosis or knowledge of neurocysticercosis. Overall, 7% of the pigs were seropositive for active Taenia spp. infection. 46% of farmers practiced a free-ranging system, while 25% practiced a semi-intensive system. Latrines were absent on all farms; however, 95% of farmers indicated that they have access to latrines at home. Most farmers had no knowledge of porcine cysticercosis (55%) or neurocysticercosis (79%), and this was not associated with any of the factors investigated. The prevalence of active Taenia spp. infection was reasonably low in this study, yet the knowledge level was also low, thus calling for further educational and training programmes to prevent Taenia spp. transmission in these communities.	[Shongwe, Nothando Altrecia; Byaruhanga, Charles; Qekwana, Daniel Nenene] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Pretoria, South Africa; [Dorny, Pierre; Dermauw, Veronique] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Dorny, Pierre] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Qekwana, Daniel Nenene] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Sect Vet Publ Hlth, Pretoria, South Africa	University of Pretoria; Institute of Tropical Medicine (ITM); Ghent University; University of Pretoria	Qekwana, DN (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Sect Vet Publ Hlth, Pretoria, South Africa.	Nenene.Qekwana@up.ac.za	Dermauw, Veronique/AFO-8354-2022	Dermauw, Veronique/0000-0001-8745-5304; Byaruhanga, Charles/0000-0002-5368-6400	Belgian Directorate-General for Development Co-operation Framework Agreement (FA4 DGDITM 2017-2021)	Belgian Directorate-General for Development Co-operation Framework Agreement (FA4 DGDITM 2017-2021)	NA Shongwe received funding from the Belgian Directorate-General for Development Co-operation Framework Agreement (FA4 DGDITM 2017-2021). URL:https://diplomatie.belgium.be/en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AM, 2012, INT HEALTH, V4, P164, DOI 10.1016/j.inhe.2012.04.003; [Anonymous], 2010, ADV MAT, V22, pE170; Apdia bvba, 2004, AP IN VITR DIAGN KIT, P5; Audige L, 2005, PREV VET MED, DOI [10.1016/j.prevetmed.2004.11.001, DOI 10.1016/J.PREVETMED.2004.11.001]; Braae Uffe Christian, 2016, Parasite Epidemiol Control, V1, P245; Braae UC, 2015, TROP ANIM HEALTH PRO, V47, P1523, DOI 10.1007/s11250-015-0892-6; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bulaya C, 2015, VET PARASITOL, V207, P241, DOI 10.1016/j.vetpar.2014.12.030; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; CHEMBENSOFU M, 2017, PARASITE VECTOR, V10, P1; Dahourou L. D., 2018, Health, V10, P95, DOI 10.4236/health.2018.101008; Del Brutto OH, 2012, SCI WORLD J, DOI 10.1100/2012/159821; Dermauw V, 2016, VET PARASITOL, V230, P9, DOI 10.1016/j.vetpar.2016.10.022; Dinno A, 2009, STATA J, V9, P291, DOI 10.1177/1536867X0900900207; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Dorny P, 2003, ACTA TROP, V87, P79, DOI 10.1016/S0001-706X(03)00058-5; Dyson LL, 2009, WATER SA, V35, P627; Flisser A, 2007, PARASITE IMMUNOL, V29, P637, DOI 10.1111/j.1365-3024.2007.00981.x; Foyaca-Sibat H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000562; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gonzalez AE, 2006, PARASITOL INT, V55, pS131, DOI 10.1016/j.parint.2005.11.021; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kabululu ML, 2020, PERFORMANCE AG ELISA, P1; Komba EVG, 2013, VET PARASITOL, V198, P284, DOI 10.1016/j.vetpar.2013.09.020; Krecek RC, 2008, VET PARASITOL, V154, P38, DOI 10.1016/j.vetpar.2008.03.005; Krecek RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037718; Kungu JM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2122-x; Lightowlers MW, 2010, INT J PARASITOL, V40, P1183, DOI 10.1016/j.ijpara.2010.05.001; Mafojane NA, 2003, ACTA TROP, V87, P25, DOI 10.1016/S0001-706X(03)00052-4; Nguyen MTT, 2016, VET PARASITOL, V226, P97, DOI 10.1016/j.vetpar.2016.06.034; Maridadi A. F., 2011, International Journal of Animal and Veterinary Advances, V3, P196; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Myeni L, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113003; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2004, TROP ANIM HEALTH PRO, V36, P335, DOI 10.1023/B:TROP.0000026663.07862.2a; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Pal DK, 2000, J NEUROL NEUROSUR PS, V68, P137, DOI 10.1136/jnnp.68.2.137; Phiri IK, 2003, ACTA TROP, V87, P13, DOI 10.1016/S0001-706X(03)00051-2; Pondja A, 2015, PREV VET MED, V118, P493, DOI 10.1016/j.prevetmed.2015.01.001; Porphyre V, 2016, VET PARASITOL, V219, P77, DOI 10.1016/j.vetpar.2015.08.027; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004; Shey-Njila O, 2004, J HELMINTHOL, DOI [10.1079/joh2003179, DOI 10.1079/J0H200317914649245]; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; Statistics South Africa, 2016, COMM SURV 2016 AGR H; Statistics South Africa, 2011, 030005 STAT S AFR; StatsSA, 2019, STAT REL P0302 2000; Thomas LF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005371; Thys S, 2016, VET PARASITOL, V225, P33, DOI 10.1016/j.vetpar.2016.05.029; Thys S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003570; Trevisan C, 2017, ACTA TROP, V165, P141, DOI 10.1016/j.actatropica.2015.12.021; Tsotetsi-Khambule AM, 2018, TROP ANIM HEALTH PRO, V50, P1951, DOI 10.1007/s11250-018-1627-2; Tsotetsi-Khambule AM, 2017, ACTA TROP, V172, P91, DOI 10.1016/j.actatropica.2017.04.019; WHO/FAO/OIE, 2005, GUID SURV PREV CONTR; Winkler AS, 2012, PATHOG GLOB HEALTH, V106, P261, DOI 10.1179/2047773212Y.0000000047; Zammarchi L, 2018, EUROSURVEILLANCE, V23, P23, DOI 10.2807/1560-7917.ES.2018.23.40.1700709; Zirintunda G, 2007, OCCURRENCE PORCINE C, P1, DOI [10.4102/ojvr.v82i1.888, DOI 10.4102/0JVR.V82I1.88826244682]	58	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244055	10.1371/journal.pone.0244055	http://dx.doi.org/10.1371/journal.pone.0244055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338060	Green Published, gold			2022-12-26	WOS:000601313500013
J	Ahmad, A; Almsned, F; Ghazal, P; Ahmed, MW; Jafri, MS; Bokhari, H				Ahmad, Aftab; Almsned, Fahad; Ghazal, Pasha; Ahmed, Malik Waqar; Jafri, M. Saleet; Bokhari, Habib			Neuropeptide S receptor gene Asn107 polymorphism in obese male individuals in Pakistan	PLOS ONE			English	Article							ASSOCIATION; STRESS; SYSTEM; VARIANTS; DYNAMICS; PEPTIDE	Neuropeptide S (NPS) is a naturally occurring appetite stimulant, associated with anxiety, stress, and excitement regulation. Neuropeptide S serves as a hypothalamic energy regulator that enhances food intake with a reduced level of satiety. NPS activates fat angiogenesis and the proliferation of new adipocytes in obesity. NPS has an established role in energy regulation by many pre-clinical investigations; however we have limited data available to support this notion in humans. We found significant association of Neuropeptide S receptor (NPSR1) Asn107Ile (rs324981, A>T) polymorphism with obese male participants. The current investigation carried out genotype screening of NPSR1 allele to assess the spectrum of the Asn107Ile polymorphism in obese and healthy Pakistani individuals. We revealed a significant (p = 0.04) difference between AA vs TT + AT genotype distribution of NPSR1 (SNP rs324981,) between obese and healthy individuals (p = 0.04). In this genotype analysis of (SNP rs324981) of the NPSR1 gene, T allele was marked as risk allele with higher frequency in the obese (38%) compared to its frequency in the controls (25%). Single Nucleotide Polymorphism (SNP, rs324981) Asn107Ile of NPSR1gene, that switches an amino acid from Asn to Ile, has been found associated with increased susceptibility to obesity in Pakistani individuals. Furthermore, molecular simulation studies predicted a lower binding affinity of NPSR1 Asn107Ile variant to NPS than the wild-type consistent with the genotype studies. These molecular simulation studies predict a possible molecular mechanism of this interaction by defining the key amino acid residues. However, a significantly (p<0.0001) lower concentration of NPS was recorded independent of genotype frequencies in obese subjects compared to healthy controls. We believe that large scale polymorphism data of population for important gene players including NPSR1 will be more useful to understand obesity and its associated risk factors.	[Ahmad, Aftab; Ghazal, Pasha; Ahmed, Malik Waqar; Bokhari, Habib] COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan; [Almsned, Fahad; Jafri, M. Saleet] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Almsned, Fahad; Jafri, M. Saleet] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Almsned, Fahad] King Fahad Specialist Hosp Dammam, Dammam, Saudi Arabia; [Jafri, M. Saleet; Bokhari, Habib] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	COMSATS University Islamabad (CUI); George Mason University; George Mason University; University System of Maryland; University of Maryland Baltimore	Bokhari, H (corresponding author), COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan.; Bokhari, H (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	habib@comsats.edu.pk		, Malik Waqar Ahmed/0000-0002-2430-7475; bokhari, habib/0000-0002-2171-6062; Jafri, Mohsin/0000-0003-3174-1007	Higher Education Commision, Pakistan [IRSIP36-BMS71]	Higher Education Commision, Pakistan	The study was supported by the Higher Education Commision, Pakistan (Grant #IRSIP36-BMS71) received by Aftab Ahmad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ballantyne GH, 2006, OBES SURG, V16, P651, DOI 10.1381/096089206776944959; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beste C, 2013, NEUROIMAGE, V71, P1, DOI 10.1016/j.neuroimage.2013.01.004; Boughton CK, 2013, BRIT J PHARMACOL, V170, P1333, DOI 10.1111/bph.12037; Camilleri M, 2010, GASTROENTEROLOGY, V138, P98, DOI 10.1053/j.gastro.2009.08.051; Deng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083009; Dimitriadis GK, 2017, CURR OBES REP, V6, P253, DOI 10.1007/s13679-017-0276-5; Domschke K, 2011, MOL PSYCHIATR, V16, P938, DOI 10.1038/mp.2010.81; Domschke K, 2011, BEHAV NEUROGENETICS, P463; Domschke K, 2015, CEREB CORTEX, V27, P554; Donner J, 2010, BIOL PSYCHIAT, V68, P474, DOI 10.1016/j.biopsych.2010.05.039; Feng Y, 2006, J ALLERGY CLIN IMMUN, V117, P612, DOI 10.1016/j.jaci.2005.11.045; Gafarov V, 2017, EUR NEUROPSYCHOPHARM, V27, pS453, DOI 10.1016/j.euroneuro.2016.09.522; Ghazal P, 2016, CURR PROTEIN PEPT SC, V17, P380, DOI 10.2174/1389203717666151218150704; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Helble M, IMMINENT OBESITY CRI; Howe AS, 2016, MOL PSYCHIATR, V21, P665, DOI 10.1038/mp.2015.138; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Josephson CB, 2013, NEUROLOGY, V80, P1669, DOI 10.1212/WNL.0b013e3182904f82; Karvonen MK, 1998, NAT MED, V4, P1434, DOI 10.1038/4027; Klauke B, 2014, WORLD J BIOL PSYCHIA, V15, P17, DOI 10.3109/15622975.2011.646302; Laas K, 2015, J PSYCHOPHARMACOL, V29, P878, DOI 10.1177/0269881115573803; Laas K, 2014, INT J NEUROPSYCHOPH, V17, P541, DOI 10.1017/S1461145713001478; Laas K, 2014, J PSYCHOPHARMACOL, V28, P227, DOI 10.1177/0269881112472562; Lin XJ, 2018, MED SCI MONITOR, V24, P6680, DOI 10.12659/MSM.910432; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Okamura N, 2007, PROG NEURO-PSYCHOPH, V31, P1444, DOI 10.1016/j.pnpbp.2007.06.026; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; R Studio Team, 2016, RSTUDIO INT DEV ENV; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Ruland T, 2015, EUR NEUROPSYCHOPHARM, V25, P1677, DOI 10.1016/j.euroneuro.2015.07.011; Slattery DA, 2015, J NEUROSCI, V35, P4599, DOI 10.1523/JNEUROSCI.4764-13.2015; Streit F, 2017, PSYCHONEUROENDOCRINO, V76, P49, DOI 10.1016/j.psyneuen.2016.10.027; Tupak SV, 2013, NEUROIMAGE, V66, P353, DOI 10.1016/j.neuroimage.2012.10.033; WHO, FACT SHEET; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zankert S, 2015, PSYCHONEUROENDOCRINO, V61, P59, DOI 10.1016/j.psyneuen.2015.07.550; Zhang CX, 2017, NUCLEIC ACIDS RES, V45, pW291, DOI 10.1093/nar/gkx366; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243205	10.1371/journal.pone.0243205	http://dx.doi.org/10.1371/journal.pone.0243205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332443	Green Published, gold			2022-12-26	WOS:000601310900091
J	Walker, MR; Knudsen, AS; Partey, FD; Bassi, MR; Frank, AM; Castberg, FC; Sarbah, EW; Ofori, MF; Hviid, L; Barfod, L				Walker, Melanie R.; Knudsen, Anne S.; Partey, Frederica D.; Bassi, Maria R.; Frank, Asger M.; Castberg, Filip C.; Sarbah, Edem W.; Ofori, Michael F.; Hviid, Lars; Barfod, Lea			Acquisition and decay of IgM and IgG responses to merozoite antigens after Plasmodium falciparum malaria in Ghanaian children	PLOS ONE			English	Article							NATURALLY ACQUIRED ANTIBODIES; MEMBRANE ANTIGEN; IMMUNITY; PROTECTION; VACCINE; VIRUS; RESISTANCE; INVASION; IDENTIFICATION; MAGNITUDE	Developing a vaccine against Plasmodium falciparum malaria has been challenging, primarily due to high levels of antigen polymorphism and a complex parasite lifecycle. Immunization with the P. falciparum merozoite antigens PfMSRP5, PfSERA9, PfRAMA, PfCyRPA and PfRH5 has been shown to give rise to growth inhibitory and synergistic antisera. Therefore, these five merozoite proteins are considered to be promising candidates for a second-generation multivalent malaria vaccine. Nevertheless, little is known about IgG and IgM responses to these antigens in populations that are naturally exposed to P. falciparum. In this study, serum samples from clinically immune adults and malaria exposed children from Ghana were studied to compare levels of IgG and IgM specific for PfMSRP5, PfSERA9, PfRAMA, PfCyRPA and PfRH5. All five antigens were found to be specifically recognized by both IgM and IgG in serum from clinically immune adults and from children with malaria. Longitudinal analysis of the latter group showed an early, transient IgM response that was followed by IgG, which peaked 14 days after the initial diagnosis. IgG levels and parasitemia did not correlate, whereas parasitemia was weakly positively correlated with IgM levels. These findings show that IgG and IgM specific for merozoite antigens PfMSRP5, PfSERA9, PfRAMA, PfCyRPA and PfRH5 are high in children during P. falciparum malaria, but that the IgM induction and decline occurs earlier in infection than that of IgG.	[Walker, Melanie R.; Knudsen, Anne S.; Bassi, Maria R.; Frank, Asger M.; Hviid, Lars; Barfod, Lea] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Partey, Frederica D.; Sarbah, Edem W.; Ofori, Michael F.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Castberg, Filip C.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark	University of Copenhagen; University of Ghana; Rigshospitalet; University of Copenhagen	Barfod, L (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Fac Hlth & Med Sci, Copenhagen, Denmark.	lbarfod@sund.ku.dk	Ofori, Michael F/H-9072-2013; Hviid, Lars/G-3705-2012	Ofori, Michael F/0000-0003-2341-7514; Hviid, Lars/0000-0002-1698-4927; Knudsen, Anne Schlitterlau/0000-0003-3234-9082; Bassi, Maria Rosaria/0000-0001-6736-6152; Walker, Melanie/0000-0002-9731-9880; Barfod, Lea/0000-0001-6510-495X; Castberg, Filip Christian/0000-0002-1140-5527	Novo Nordisk Foundation [NNF170C0026778]; Danida [17-02-KU, 12-081RH]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danida	The work was supported by the Novo Nordisk Foundation (NNF170C0026778) as well as Danida (17-02-KU and 12-081RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adepoju P, 2019, LANCET, V393, P1685, DOI 10.1016/S0140-6736(19)30937-7; Adu B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1146-4; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; [Anonymous], 1991, FRONTIERS, V12, pix; Arama C, 2014, J INTERN MED, V275, P456, DOI 10.1111/joim.12223; Arama C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv118; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Baumgarth N, 2017, J IMMUNOL, V199, P3387, DOI 10.4049/jimmunol.1700943; Boyle MJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax4489; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Bustamante LY, 2017, P NATL ACAD SCI USA, V114, P12045, DOI 10.1073/pnas.1702944114; Castberg FC, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2609-6; Chua CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171989; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Dondorp AM, 2013, TRENDS PARASITOL, V29, P359, DOI 10.1016/j.pt.2013.05.005; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Douglas AD, 2015, CELL HOST MICROBE, V17, P130, DOI 10.1016/j.chom.2014.11.017; Escalante AA, 1998, GENETICS, V149, P189; Finney OC, 2014, MOL CELL PROTEOMICS, V13, P2646, DOI 10.1074/mcp.M113.036632; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Gong S, 2018, AIDS, V32, pF5, DOI [10.1097/qad.0000000000001857, 10.1097/QAD.0000000000001857]; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Gupta S, 1999, P ROY SOC B-BIOL SCI, V266, P33, DOI 10.1098/rspb.1999.0600; Haldar K, 2018, NAT REV MICROBIOL, V16, P156, DOI 10.1038/nrmicro.2017.161; Healer J, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13030; Hjerrild KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30357; Janeway CA Jr TP, 2001, DISTRIBUTION FUNCTIO; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Jin J, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0071-7; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086; Mugyenyi CK, 2017, J INFECT DIS, V216, P887, DOI 10.1093/infdis/jix370; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; Nixon CP, 2005, J INFECT DIS, V192, P861, DOI 10.1086/432550; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Partey FD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198371; Payne RO, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96381; Quach TD, 2016, J IMMUNOL, V196, P1060, DOI 10.4049/jimmunol.1501843; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Siciliano G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00391; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Skountzou I, 2014, CLIN VACCINE IMMUNOL, V21, P1481, DOI 10.1128/CVI.00374-14; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Stanisic DI, 2015, INFECT IMMUN, V83, P646, DOI 10.1128/IAI.02398-14; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Topolska AE, 2004, INFECT IMMUN, V72, P3325, DOI 10.1128/IAI.72.6.3325-3330.2004; Tran TM, 2014, J INFECT DIS, V209, P789, DOI 10.1093/infdis/jit553; Uwimana A, 2020, NAT MED, V26, P1602, DOI 10.1038/s41591-020-1005-2; Walke RMR, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010075; Weaver R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33094; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; WHO, 2019, WORLD MALARIA REPORT; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715; Zenonos ZA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-93	67	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243943	10.1371/journal.pone.0243943	http://dx.doi.org/10.1371/journal.pone.0243943			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332459	Green Published, gold			2022-12-26	WOS:000601310900007
J	Dhongde, S				Dhongde, Shatakshee			Multidimensional economic deprivation during the coronavirus pandemic: Early evidence from the United States	PLOS ONE			English	Article							POVERTY	The coronavirus pandemic led to a severe economic shock in the United States. This paper uses a unique survey data collected early on in the pandemic to measure economic deprivation among individuals. The Federal Reserve Board fielded a Survey of Household Economics and Decision-making (SHED) in April 2020. This survey is used to compile data on four indicators of economic deprivation, namely: i) Overall financial condition, ii) Loss of employment, iii) Reduction in income and iv) Inability to pay bills in full. Data on these indicators is compiled for each individual and is used in a novel way to construct a set of multidimensional deprivation indices. These indices measure the overlap of deprivations experienced by an individual. Results show that almost 25 percent of the respondents faced hardships in at least two of the four indicators. More than 13 percent of adults reported their inability to pay monthly bills and struggled to make ends meet financially. One in four respondents had lower income compared to income from previous month. The economic shock affected Hispanics in a more profound way. More than 37 percent Hispanics reported hardship in two or more indicators and 8 percent reported hardship in all four indicators. Higher proportion of young adults and those without a college degree suffered multiple hardships. The paper highlights the plight of Americans during the early months of the economic crisis set in motion amid the coronavirus pandemic and sheds light on how economic disparities deepened along racial/ethnic lines.	[Dhongde, Shatakshee] Georgia Inst Technol, Sch Econ, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Dhongde, S (corresponding author), Georgia Inst Technol, Sch Econ, Atlanta, GA 30332 USA.	shatakshee.dhongde@econ.gatech.edu		Dhongde, Shatakshee/0000-0003-2587-9528				Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]; Alexander D, 2020, 3583625 SSRN, DOI [10.21033/wp-2020-12, DOI 10.21033/WP-2020-12]; Alkire S., 2015, MULTIDIMENSIONAL POV, DOI [10.1093/acprof:oso/9780199689491.001.0001, DOI 10.1093/ACPROF:OSO/9780199689491.001.0001]; Alkire S., 2011, J PUBLIC EC, V95, P476, DOI [DOI 10.1016/J.JPUBEC0.2010.11.006, 10.1016/j.jpubeco.2010.11.006]; [Anonymous], 2017, GALLUP HEALTHWAYS RE; [Anonymous], 2020, NY TIMES; Bartik A., 2020, BROOKINGS PAPERS EC; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423; Carlsson-Szlezak P., 2020, HARVARD BUS REV, V3, P1; Chetty R., 2020, EC IMPACTS COVID 19; Coibion O., 2020, LABOR MARKETS COVID, DOI 10.3386/w27017; Cox N., 2020, BROOKINGS PAPERS EC; Dhongde S, 2019, REV INCOME WEALTH, V65, pS281, DOI 10.1111/roiw.12411; Dhongde S, 2017, SOC INDIC RES, V133, P477, DOI 10.1007/s11205-016-1379-1; Dotter C., 2017, COURANT RES CTR POVE, V233; Evans D, 2020, EC IMPACT COVID 19 L; Federal Reserve Board (FRB), 2020, REPORT EC WELL BEING; Federal Reserve Board Report, 2020, REP EC WELL BEING US; Ferreira FHG, 2013, WORLD BANK RES OBSER, V28, P220, DOI 10.1093/wbro/lks013; Glassman B., 2019, AM COMMUNITY SURVEY, V-40; Gupta S., 2020, NBER WORKING PAPER; Martin Amory, 2020, Econ Disaster Clim Chang, V4, P453, DOI 10.1007/s41885-020-00070-3; Mitra S, 2019, ECON BULL, V39, P1272; Mitra S, 2017, SOC SCI QUART, V98, P37, DOI 10.1111/ssqu.12291; Moore JT, 2020, MMWR-MORBID MORTAL W, V69, P1122, DOI 10.15585/mmwr.mm6933e1; National Bureau of Economics Research, WORK PAP COVID 19; Pattanaik PK, 2018, J ECON LIT, V56, P657, DOI 10.1257/jel.20161454; Seth S., 2019, 132 OXF POV HUM DEV; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244130	10.1371/journal.pone.0244130	http://dx.doi.org/10.1371/journal.pone.0244130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326495	Green Published, gold			2022-12-26	WOS:000600176400069
J	Ishihara, T; Ohkochi, T; Yamaguchi, A; Kotani, Y; Oura, M				Ishihara, Tomoko; Ohkochi, Takuo; Yamaguchi, Akinobu; Kotani, Yoshinori; Oura, Masaki			Visualization of elemental distributions and local analysis of element-specific chemical states of an Arachnoidiscus sp. frustule using soft X-ray spectromicroscopy	PLOS ONE			English	Article							DIATOMS; TRANSMISSION; ACID; FLUORESCENCE; SPECTROSCOPY; MICROSCOPY; BIOSILICA; SILICA	Using soft X-ray (SX) spectromicroscopy, we show maps of the spatial distribution of constituent elements and local analysis of the density of states (DOS) related to the element-specific chemical states of diatom frustules, which are composed of naturally grown nanostructured hydrogenated amorphous silica. We applied X-ray photoemission electron microscopy (X-PEEM) as well as microprobe X-ray fluorescence (mu XRF) analysis to characterize the surfaces of diatom frustules by means of X-ray absorption spectroscopy (XAS) and X-ray emission spectroscopy (XES). We successfully demonstrated that SX spectromicroscopy is able to participate in potential observation tools as a new method to spectroscopically investigate diatom frustules.	[Ishihara, Tomoko; Ohkochi, Takuo; Yamaguchi, Akinobu; Oura, Masaki] RIKEN, Soft Xray Spect Instrumentat Team, Phys & Chem Res Infrastruct Grp, Adv Photon Technol Div,SPring 8 Ctr, Sayo, Hyogo, Japan; [Ohkochi, Takuo; Kotani, Yoshinori] Japan Synchrotron Radiat Res Inst JASRI, Spect & Imaging Div, Spectroscop Anal Grp 2, Sayo, Hyogo, Japan; [Yamaguchi, Akinobu] Univ Hyogo, Lab Adv Sci & Technol Ind LASTI, Kobe, Hyogo, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Synchrotron Radiation Research Institute; University of Hyogo	Oura, M (corresponding author), RIKEN, Soft Xray Spect Instrumentat Team, Phys & Chem Res Infrastruct Grp, Adv Photon Technol Div,SPring 8 Ctr, Sayo, Hyogo, Japan.	oura@spring8.or.jp	Oura, Masaki/A-2057-2014	Oura, Masaki/0000-0002-9999-5612	JSPS KAKENHI [17H02755]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AY acknowledges JSPS KAKENHI Grants-in-Aid for Scientific Research B (No. 17H02755) for partially supporting the research and development in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alipour L, 2016, APPL SPECTROSC, V70, P427, DOI 10.1177/0003702815626665; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Brun N, 1996, MICROSC MICROANAL M, V7, P161, DOI 10.1051/mmm:1996112; Chaffin JD, 2012, J APPL PHYCOL, V24, P1045, DOI 10.1007/s10811-011-9732-x; Chauton MS, 2015, J APPL PHYCOL, V27, P777, DOI 10.1007/s10811-014-0373-8; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; de Jonge MD, 2010, P NATL ACAD SCI USA, V107, P15676, DOI 10.1073/pnas.1001469107; Ferrara MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103750; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gu B, 2014, BIOGEOSCIENCES, V11, P5259, DOI 10.5194/bg-11-5259-2014; HAMALAINEN K, 1991, PHYS REV LETT, V67, P2850, DOI 10.1103/PhysRevLett.67.2850; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; HIMPSEL FJ, 1991, PHYS REV B, V43, P6899, DOI 10.1103/PhysRevB.43.6899; Hirai A, 1999, JPN J APPL PHYS 1, V38, P274, DOI 10.1143/JJAP.38.274; Hirata A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11591; Hitchcock AP, 2012, ENVIRON SCI TECHNOL, V46, P2821, DOI 10.1021/es202238k; Jiang WK, 2015, J APPL PHYCOL, V27, P243, DOI 10.1007/s10811-014-0324-4; Jiang WK, 2014, J APPL PHYCOL, V26, P1511, DOI 10.1007/s10811-013-0192-3; Kobayashi A., 1998, DIATOM, V14, P25; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P307, DOI 10.1063/1.555594; LI D, 1994, AM MINERAL, V79, P622; Losic D, 2007, J POROUS MAT, V14, P61, DOI 10.1007/s10934-006-9009-y; Losic D, 2007, LANGMUIR, V23, P5014, DOI 10.1021/la062666y; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; Martens I, 2019, J PHYS CHEM C, V123, P16023, DOI 10.1021/acs.jpcc.9b03924; Menzel A, 2010, ULTRAMICROSCOPY, V110, P1143, DOI 10.1016/j.ultramic.2010.04.007; Mishra M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01239; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Ohashi H, 2007, AIP CONF PROC, V879, P523; Ohashi H, 2006, PROC SPIE, V6317, DOI 10.1117/12.682329; Ohkochi T, 2019, JPN J APPL PHYS, V58, DOI 10.7567/1347-4065/ab4b12; Oura M, 2007, J SYNCHROTRON RADIAT, V14, P483, DOI 10.1107/S0909049507040289; Oura M, 2020, JPN J APPL PHYS, V59, DOI 10.35848/1347-4065/ab9461; Oura M, 2020, J SYNCHROTRON RADIAT, V27, P664, DOI 10.1107/S1600577520002258; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; Senba Y, 2007, AIP CONF PROC, V879, P718; Suzuki M, 2019, MOLECULES, V24, DOI 10.3390/molecules24193488; Umemura K, 2008, J BIOL PHYS, V34, P189, DOI 10.1007/s10867-008-9086-z; Wang J, 2009, J ELECTRON SPECTROSC, V170, P25, DOI 10.1016/j.elspec.2008.01.002; Wang J, 2009, J PHYS CHEM B, V113, P1869, DOI 10.1021/jp808289e; Wang Y, 2013, APPL MICROBIOL BIOT, V97, P453, DOI 10.1007/s00253-012-4568-0; Wolfe AP, 2009, AM J BOT, V96, P487, DOI 10.3732/ajb.0800307; Yamane H, 2020, J PHYS CHEM C, V124, P9622, DOI 10.1021/acs.jpcc.0c02838; Yamane H, 2019, J ELECTRON SPECTROSC, V232, P11, DOI 10.1016/j.elspec.2018.12.005; Yogi C, 2014, R1405 SYNCHR RAD CTR	47	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243874	10.1371/journal.pone.0243874	http://dx.doi.org/10.1371/journal.pone.0243874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326474	Green Published, gold			2022-12-26	WOS:000600176400058
J	Manjarin, R; Maj, MA; La Frano, MR; Glanz, H				Manjarin, Rodrigo; Maj, Magdalena A.; La Frano, Michael R.; Glanz, Hunter			%polynova_2way: A SAS macro for implementation of mixed models for metabolomics data	PLOS ONE			English	Article								The generation of large metabolomic data sets has created a high demand for software that can fit statistical models to one-metabolite-at-a-time on hundreds of metabolites. We provide the %polynova_2way macro in SAS to identify metabolites differentially expressed in study designs with a two-way factorial treatment and hierarchical design structure. For each metabolite, the macro calculates the least squares means using a linear mixed model with fixed and random effects, runs a 2-way ANOVA, corrects the P-values for the number of metabolites using the false discovery rate or Bonferroni procedure, and calculate the P-value for the least squares mean differences for each metabolite. Finally, the %polynova_2way macro outputs a table in excel format that combines all the results to facilitate the identification of significant metabolites for each factor. The macro code is freely available in the Supporting Information.	[Manjarin, Rodrigo] Calif Polytech State Univ San Luis Obispo, Dept Anim Sci, San Luis Obispo, CA 93407 USA; [Maj, Magdalena A.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA 93407 USA; [Maj, Magdalena A.] Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA; [La Frano, Michael R.] Calif Polytech State Univ San Luis Obispo, Dept Food Sci & Nutr, San Luis Obispo, CA 93407 USA; [La Frano, Michael R.] Calif Polytech State Univ San Luis Obispo, Ctr Hlth Res, San Luis Obispo, CA 93407 USA; [Glanz, Hunter] Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA	California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo	Glanz, H (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA.	hglanz@calpoly.edu		Glanz, Hunter/0000-0001-6726-8261	California State University Agricultural Research Institute; ARI [58913, 58873]	California State University Agricultural Research Institute; ARI	R.M. ARI#58873, California State University Agricultural Research Institute https://www2.calstate.edu/impact-of-the-csu/research/ari M.M. ARI#58913 California State University Agricultural Research Institute https://www2.calstate.edu/impact-of-the-csu/research/ari The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, AM J PHYSIOL-CELL PH, V318, pC137; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Broadhurst D, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1367-3; Milliken GA, 2009, ANAL MESSY DATA, V1, P43; Pang ZQ, 2020, METABOLITES, V10, DOI 10.3390/metabo10050186; Piepho HP, 2009, AGRON J, V101, P865, DOI 10.2134/agronj2008.0226x; SAS Institute Inc, 2015, SAS STAT 14 1 USERS; Schrimpe-Rutledge AC, 2016, J AM SOC MASS SPECTR, V27, P1897, DOI 10.1007/s13361-016-1469-y; Wanichthanarak K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171046	10	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244013	10.1371/journal.pone.0244013	http://dx.doi.org/10.1371/journal.pone.0244013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320899	Green Published, gold			2022-12-26	WOS:000600339800053
J	Nowak-Kornicka, J; Borkowska, B; Pawlowski, B				Nowak-Kornicka, Judyta; Borkowska, Barbara; Pawlowski, Boguslaw			Masculinity and immune system efficacy in men	PLOS ONE			English	Article							DIGIT RATIO 2D4D; MUSCLE STRENGTH; HANDGRIP STRENGTH; SEXUAL-DIMORPHISM; PRENATAL TESTOSTERONE; REPRODUCTIVE SUCCESS; ANDROGEN TREATMENT; GRIP STRENGTH; T-CELL; BODY	Masculinity-related morphological traits are supposed to be honest indicators of a man's biological quality. While some studies showed that sexually dimorphic traits are related to various aspects of biological condition such as general health, immunity or fertility, still little is known about the relationship between masculine traits and the effectiveness of innate and adaptive immunity in humans. The aim of this study was to see if masculine traits, which are dependent on androgen levels in foetal and pubertal stages of development, are related to the immune quality in healthy men. The immune quality was evaluated for 91 healthy men aged 19-36 years. Immunity measurements included innate and adaptive parameters. General health status, age, testosterone level, BMI, physical activity, and smoking were controlled. The shoulder-to-hip ratio (SHR), 2D:4D digit ratio and hand-grip strength (HGS) were used as markers of masculinization. The regressions showed that when controlling for confounds, masculinity-related traits were in general not related to innate and adaptive immunity. Only a weak association was observed for right 2D:4D ratio and T-lymphocyte counts (but it becomes non-significant after adjustment for multiple comparisons). Our results do not support the premise that masculinity is a cue for immunological quality in men. However, the positive association between right 2D:4D and T lymphocytes might suggest that further studies are needed to verify if androgen stimulation in prenatal development might be related to immunity in adulthood.	[Nowak-Kornicka, Judyta; Borkowska, Barbara; Pawlowski, Boguslaw] Univ Wroclaw, Dept Human Biol, Wroclaw, Poland	University of Wroclaw	Pawlowski, B (corresponding author), Univ Wroclaw, Dept Human Biol, Wroclaw, Poland.	boguslaw.pawlowski@uwr.edu.pl		Nowak-Kornicka, Judyta/0000-0002-3468-8128; Pawlowski, Boguslaw/0000-0002-7418-475X	BP National Science Centre, Poland [OPUS 4 2012/07/B/NZ8/02666]	BP National Science Centre, Poland	BP National Science Centre, Poland. Grant number: OPUS 4 2012/07/B/NZ8/02666. https://ncn.gov.pl/?language=en The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C., 2006, P ROYAL SOC B, V274, P819; Anderson M, 1994, SEXUAL SELECTION; [Anonymous], 2013, TREAT GUIDEL MED LET, V11, pe1; [Anonymous], 2017, ECONOMICS-KIEL, V6, P1, DOI 10.1057/s11369-017-0051-3; Apicella CL, 2014, EVOL HUM BEHAV, V35, P508, DOI 10.1016/j.evolhumbehav.2014.07.001; Arnocky S, 2018, EVOL HUM BEHAV, V39, P602, DOI 10.1016/j.evolhumbehav.2018.06.003; Bhongade MB, 2015, ANDROLOGIA, V47, P336, DOI 10.1111/and.12268; Chiu HT, 2020, AGING MALE, V23, P915, DOI 10.1080/13685538.2019.1632282; Darwin C., 1871, P423; Demirci BG, 2018, EXP CLIN TRANSPLANT, V16, P75, DOI 10.6002/ect.TOND-TDTD2017.O31; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Foo YZ, 2017, BIOL REV, V92, P551, DOI 10.1111/brv.12243; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; Garvin JC, 2008, BEHAV ECOL, V19, P54, DOI 10.1093/beheco/arm099; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; Gettler LT, 2010, AM J PHYS ANTHROPOL, V142, P590, DOI 10.1002/ajpa.21282; Hackney AC, 1998, J SPORT MED PHYS FIT, V38, P138; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hansen L, 1999, J APPL PHYSIOL, V87, P1141, DOI 10.1152/jappl.1999.87.3.1141; Hiort O, 2002, BEST PRACT RES CL EN, V16, P31, DOI 10.1053/beem.2002.0178; Hodges-Simeon CR, 2019, AM J HUM BIOL, V31, DOI 10.1002/ajhb.23284; Hogrel JY, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0612-4; Hone LSE, 2012, EVOL HUM BEHAV, V33, P780, DOI 10.1016/j.evolhumbehav.2012.07.003; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Kilgour AHM, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-33; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; KONSTADOULAKIS MM, 1995, HORM METAB RES, V27, P275, DOI 10.1055/s-2007-979958; Lamason R, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-2; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; LEHMANN D, 1988, CLIN IMMUNOL IMMUNOP, V46, P122, DOI 10.1016/0090-1229(88)90012-8; Mann DR, 1999, AM J REPROD IMMUNOL, V42, P175; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006; Martin JT, 2000, EUR J PHARMACOL, V405, P251, DOI 10.1016/S0014-2999(00)00557-4; McMurray RW, 2001, PATHOBIOLOGY, V69, P44, DOI 10.1159/000048757; Mougeot F, 2004, J AVIAN BIOL, V35, P425, DOI 10.1111/j.0908-8857.2004.03256.x; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Muller MN, 2009, P ROY SOC B-BIOL SCI, V276, P347, DOI 10.1098/rspb.2008.1028; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; Nowak J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25694-0; Oken O, 2008, RHEUMATOL INT, V29, P163, DOI 10.1007/s00296-008-0661-1; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Pawlowski B, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1372; Phalane KG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08015-9; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rantala MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1696; Raso V, 2013, CLINICS, V68, P359, DOI 10.6061/clinics/2013(03)OA12; Ribeiro E, 2016, EARLY HUM DEV, V100, P21, DOI 10.1016/j.earlhumdev.2016.04.003; Richards G, 2019, J DEV ORIG HLTH DIS, V10, P362, DOI 10.1017/S2040174418000752; Richards G, 2017, EARLY HUM DEV, V113, P75, DOI 10.1016/j.earlhumdev.2017.09.004; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Ronay R, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00030; Saino N, 2003, J EVOLUTION BIOL, V16, P1127, DOI 10.1046/j.1420-9101.2003.00616.x; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Sim K., 2013, J SOC EVOL CULT PSYC, V7, P97, DOI [10.1037/h0099207, DOI 10.1037/H0099207]; TANNER JM, 1981, NUTR REV, V39, P43, DOI 10.1111/j.1753-4887.1981.tb06734.x; The Abu Dhabi Declaration, 2010, J NATL COMPR CANC S3, V8, pS1; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Trumble BC, 2016, AM J PHYS ANTHROPOL, V161, P494, DOI 10.1002/ajpa.23054; Ventura T, 2013, EARLY HUM DEV, V89, P107, DOI 10.1016/j.earlhumdev.2012.08.009; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Wind AE, 2010, EUR J PEDIATR, V169, P281, DOI 10.1007/s00431-009-1010-4; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuk M, 1998, P ROY SOC B-BIOL SCI, V265, P1631, DOI 10.1098/rspb.1998.0481	74	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243777	10.1371/journal.pone.0243777	http://dx.doi.org/10.1371/journal.pone.0243777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315964	gold, Green Published			2022-12-26	WOS:000600186100024
J	Xiao, L; Han, L; Li, BF; Zhang, MF; Zhou, HZ; Luo, QS; Zhang, XZ; Huang, YH				Xiao, Le; Han, Long; Li, Bufan; Zhang, Manfeng; Zhou, Haizhen; Luo, Qingshan; Zhang, Xinzheng; Huang, Yihua			Structures of the beta-barrel assembly machine recognizing outer membrane protein substrates	FASEB JOURNAL			English	Article						outer membrane protein biogenesis; the BAM&#8208; substrate complex; X&#8208; ray crystallography; Cryo&#8208; EM; &#946; &#8208; signal hypothesis	CARBOXY-TERMINAL PHENYLALANINE; HIGH-RESOLUTION STRUCTURE; CRYSTAL-STRUCTURE; ESSENTIAL COMPONENT; PERIPLASMIC DOMAIN; BAM COMPLEX; BIOGENESIS; INSERTION; TRANSLOCATION; FLEXIBILITY	beta-barrel outer membrane proteins (beta-OMPs) play critical roles in nutrition acquisition, protein import/export, and other fundamental biological processes. The assembly of beta-OMPs in Gram-negative bacteria is mediated by the beta-barrel assembly machinery (BAM) complex, yet its precise mechanism remains elusive. Here, we report two structures of the BAM complex in detergents and in nanodisks, and two crystal structures of the BAM complex with bound substrates. Structural analysis indicates that the membrane compositions surrounding the BAM complex could modulate its overall conformations, indicating low energy barriers between different conformational states and a highly dynamic nature of the BAM complex. Importantly, structures of the BAM complex with bound substrates and the related functional analysis show that the first beta-strand of the BamA beta-barrel (beta 1(BamA)) in the BAM complex is associated with the last but not the first beta-strand of a beta-OMP substrate via antiparallel beta-strand interactions. These observations are consistent with the beta-signal hypothesis during beta-OMP biogenesis, and suggest that the beta 1(BamA) strand in the BAM complex may interact with the last beta-strand of an incoming beta-OMP substrate upon their release from the chaperone-bound state.	[Xiao, Le; Han, Long; Li, Bufan; Zhou, Haizhen; Zhang, Xinzheng; Huang, Yihua] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xiao, Le; Han, Long; Li, Bufan; Zhou, Haizhen; Zhang, Xinzheng; Huang, Yihua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Manfeng] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Genome Anal Lab, Lingnan Guangdong Lab Modern Agr,Minist Agr, Shenzhen, Peoples R China; [Luo, Qingshan] Jinan Univ, Shenzhen Baoan Womens & Childrens Hosp, Shenzhen, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Ministry of Agriculture & Rural Affairs; Jinan University	Huang, YH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	yihuahuang@sun5.ibp.ac.cn	han, long/AHE-5759-2022	han, long/0000-0001-6142-8412				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Bamert RS, 2017, MOL MICROBIOL, V106, P142, DOI 10.1111/mmi.13757; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; deCock H, 1997, J MOL BIOL, V269, P473, DOI 10.1006/jmbi.1997.1069; DeLano WL, 2009, ABSTR PAP AM CHEM S, V238; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Doyle MT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11230-9; Efremov RG, 2017, METHOD ENZYMOL, V594, P1, DOI 10.1016/bs.mie.2017.05.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frauenfeld J, 2016, NAT METHODS, V13, P345, DOI [10.1038/NMETH.3801, 10.1038/nmeth.3801]; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Ge X, 2014, FEBS J, V281, P1226, DOI 10.1111/febs.12701; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Hohr AIC, 2018, SCIENCE, V359, P289, DOI 10.1126/science.aah6834; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Jansen KB, 2015, J BIOL CHEM, V290, P2126, DOI 10.1074/jbc.M114.584524; Jiang JH, 2012, INT J MOL SCI, V13, P8038, DOI 10.3390/ijms13078038; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lee J, 2019, ELIFE, V8, DOI 10.7554/eLife.49787; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mallarino LE, 2015, BIOCHEMISTRY-US, V54, P844, DOI 10.1021/bi5011305; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; Tomasek D, 2020, NATURE, V583, P473, DOI 10.1038/s41586-020-2370-1; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang H, 2011, ACTA CRYSTALLOGR F, V67, P734, DOI 10.1107/S1744309111014254; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	62	11	11	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21207	10.1096/fj.202001443RR	http://dx.doi.org/10.1096/fj.202001443RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368572				2022-12-26	WOS:000605626600043
J	Cerda, P; Ribas, J; Iriarte, A; Mora-Lujan, JM; Torres, R; del Rio, B; Jofre, HI; Ruiz, Y; Huguet, M; Fuset, MP; Martinez-Yelamos, S; Santos, S; Llecha, N; Corbella, X; Riera-Mestre, A				Cerda, Pau; Ribas, Jesus; Iriarte, Adriana; Mora-Lujan, Jose Maria; Torres, Raquel; del Rio, Belen; Jofre, Hector Ignacio; Ruiz, Yolanda; Huguet, Marta; Fuset, Mari Paz; Martinez-Yelamos, Sergio; Santos, Salud; Llecha, Nuria; Corbella, Xavier; Riera-Mestre, Antoni			Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosis	PLOS ONE			English	Article							MANAGEMENT; COAGULOPATHY	Background A higher incidence of thrombotic events, mainly pulmonary embolism (PE), has been reported in hospitalized patients with COVID-19. The main objective was to assess clinical and laboratory differences in hospitalized COVID-19 patients according to occurrence of PE. Methods This retrospective study included all consecutive patients hospitalized with COVID-19 who underwent a computed tomography (CT) angiography for PE clinical suspicion. Clinical data and median blood test results distributed into weekly periods from COVID-19 symptoms onset, were compared between PE and non-PE patients. Results Ninety-two patients were included, 29 (32%) had PE. PE patients were younger (63.9 (SD 13.7) vs 69.9 (SD 12.5) years). Clinical symptoms and COVID-19 CT features were similar in both groups. PE was diagnosed after a mean of 20.0 (SD 8.6) days from the onset of COVID-19 symptoms. Corticosteroid boluses were more frequently used in PE patients (62% vs. 43%). No patients met ISTH DIC criteria. Any parameter was statistically significant or clinically relevant except for D-Dimer when comparing both groups. Median values [IQR] of D-dimer in PE vs non-PE patients were: week 2 (2010.7 [770.1-11208.9] vs 626.0 [374.0-2382.2]; p = 0.004); week 3 (3893.1 [1388.2-6694.0] vs 1184.4 [461.8-2447.8]; p = 0.003); and week 4 (2736.3 [1202.1-8514.1] vs 1129.1 [542.5-2834.6]; p = 0.01). Median fold-increase of D-dimer between week 1 and 2 differed between groups (6.64 [3.02-23.05] vs 1.57 [0.64-2.71], p = 0.003); ROC curve AUC was 0.879 (p = 0.003) with a sensitivity and specificity for PE of 86% and 80%, respectively. Conclusions Among hospitalized COVID-19 patients, D-dimer levels are higher at weeks 2, 3 and 4 after COVID-19 symptom onset in patients who develop PE. This difference is more pronounced when the fold increase between weeks 1 and 2 is compared.	[Cerda, Pau; Iriarte, Adriana; Mora-Lujan, Jose Maria; Torres, Raquel; Corbella, Xavier; Riera-Mestre, Antoni] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Internal Med, Barcelona, Spain; [Ribas, Jesus; Ruiz, Yolanda; Santos, Salud] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Pneumol, Barcelona, Spain; [del Rio, Belen; Jofre, Hector Ignacio] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Imaging Diagnost, Barcelona, Spain; [Huguet, Marta; Fuset, Mari Paz] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Intens Med, Barcelona, Spain; [Martinez-Yelamos, Sergio] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Neurol, Barcelona, Spain; [Llecha, Nuria] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Clin Lab, Barcelona, Spain; [Corbella, Xavier] Univ Int Catalunya, Sch Med, Barcelona, Spain; [Riera-Mestre, Antoni] Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universitat Internacional de Catalunya (UIC); University of Barcelona	Riera-Mestre, A (corresponding author), Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Internal Med, Barcelona, Spain.; Riera-Mestre, A (corresponding author), Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain.	ariera@bellvitgehospital.cat		Santos, Salud/0000-0002-5835-1028; Cerda, Pau/0000-0003-4368-6260; Ribas Sola, Jesus/0000-0001-7356-4307	Research Committee of the University Hospital of Bellvitge (HUB; Barcelona, Spain)	Research Committee of the University Hospital of Bellvitge (HUB; Barcelona, Spain)	PC receives a salary by an Intensification/Post-Residency Grant from Research Committee of the University Hospital of Bellvitge (HUB; Barcelona, Spain) 2019-2021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Avruscio G, 2020, CTS-CLIN TRANSL SCI, V13, P1108, DOI 10.1111/cts.12907; Barco S, 2020, LANCET RESP MED, V8, P277, DOI 10.1016/S2213-2600(19)30354-6; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Bompard F, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01365-2020; Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Di Nisio M, 2021, EUR J INTERN MED, V83, P34, DOI 10.1016/j.ejim.2020.10.020; Esmon CT, 2005, BIOCHEM SOC T, V33, P401, DOI 10.1042/BST0330401; Fu JH, 2020, THROMB RES, V192, P3, DOI 10.1016/j.thromres.2020.05.006; Grillet F, 2020, RADIOLOGY, V296, pE186, DOI 10.1148/radiol.2020201544; Grimes DA, 2002, LANCET, V359, P145, DOI 10.1016/S0140-6736(02)07373-7; Gustafson D, 2020, ARTERIOSCL THROM VAS, V40, P1818, DOI 10.1161/ATVBAHA.120.314558; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Iba T, 2018, J THROMB HAEMOST, V16, P231, DOI 10.1111/jth.13911; Iba T, 2019, J THROMB HAEMOST, V17, P1989, DOI 10.1111/jth.14578; Jackson SP, 2019, BLOOD, V133, P906, DOI 10.1182/blood-2018-11-882993; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Konstantinides Stavros V, 2020, Eur Heart J, V41, P543, DOI 10.1093/eurheartj/ehz405; Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561; Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650; Marietta M, 2020, BLOOD TRANSFUS-ITALY, V18, P167, DOI 10.2450/2020.0083-20; Marongiu F, 2020, J THROMB HAEMOST, V18, P1511, DOI 10.1111/jth.14818; Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888; Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Prokop M, 2020, RADIOLOGY, V296, pE97, DOI 10.1148/radiol.2020201473; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Whyte MB, 2020, THROMB RES, V195, P95, DOI 10.1016/j.thromres.2020.07.025; World Health Organization (WHO), 2020, COR DIS COVID 19 OUT, DOI DOI 10.1016/S0140-6736(20)30566-3; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Yin JJ, 2014, STAT MED, V33, P985, DOI 10.1002/sim.5992; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	44	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243533	10.1371/journal.pone.0243533	http://dx.doi.org/10.1371/journal.pone.0243533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370304	Green Published, gold			2022-12-26	WOS:000603611900055
J	Heikkinen, T; Bragge, T; Bhattarai, N; Parkkari, T; Puolivali, J; Kontkanen, O; Sweeney, P; Park, LC; Munoz-Sanjuan, I				Heikkinen, Taneli; Bragge, Timo; Bhattarai, Niina; Parkkari, Teija; Puolivali, Jukka; Kontkanen, Outi; Sweeney, Patrick; Park, Larry C.; Munoz-Sanjuan, Ignacio			Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease	PLOS ONE			English	Article							INTERLIMB COORDINATION; GAIT ANALYSIS; MOTOR ABNORMALITIES; TIME-COURSE; SYMPTOMS; DISTURBANCES; IMPAIRMENT; RECOVERY; ROTATION; REPEAT	Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by severe disruption of cognitive and motor functions, including changes in posture and gait. A number of HD mouse models have been engineered that display behavioral and neuropathological features of the disease, but gait alterations in these models are poorly characterized. Sensitive high-throughput tests of fine motor function and gait in mice might be informative in evaluating disease-modifying interventions. Here, we describe a hypothesis-free workflow that determines progressively changing locomotor patterns across 79 parameters in the R6/2 and Q175 mouse models of HD. R6/2 mice (120 CAG repeats) showed motor disturbances as early as at 4 weeks of age. Similar disturbances were observed in homozygous and heterozygous Q175 KI mice at 3 and 6 months of age, respectively. Interestingly, only the R6/2 mice developed forelimb ataxia. The principal components of the behavioral phenotypes produced two phenotypic scores of progressive postural instability based on kinematic parameters and trajectory waveform data, which were shared by both HD models. This approach adds to the available HD mouse model research toolbox and has a potential to facilitate the development of therapeutics for HD and other debilitating movement disorders with high unmet medical need.	[Heikkinen, Taneli; Bragge, Timo; Parkkari, Teija; Puolivali, Jukka; Kontkanen, Outi] Charles River Discovery Serv, Kuopio, Finland; [Bhattarai, Niina] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland; [Sweeney, Patrick; Park, Larry C.] Naason Sci Inc, Chungcheongbuk Do, South Korea; [Park, Larry C.; Munoz-Sanjuan, Ignacio] CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA	University of Eastern Finland	Munoz-Sanjuan, I (corresponding author), CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA.	ignacio.munoz@chdifoundation.org	Harju, Niina/ABA-7085-2020	Harju, Niina/0000-0001-9031-5353; Heikkinen, Taneli/0000-0002-8844-6618; Bragge, Timo/0000-0002-8634-0297	CHDI Foundation	CHDI Foundation	CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. The research described was conducted by Charles River under a fee-for-service agreement for CHDI Foundation in collaboration with and funded by CHDI Foundation. The funder, through CHDI Management, fully participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Abada YSK, 2016, BEHAV PHARMACOL, V27, P403, DOI 10.1097/FBP.0000000000000217; Abd-Elrahman KS, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan6387; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Alexandrov V, 2016, NAT BIOTECHNOL, V34, P838, DOI 10.1038/nbt.3587; Alpaugh M, 2017, EMBO MOL MED, V9, P1537, DOI 10.15252/emmm.201707763; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; BARCLAY OR, 1953, J EXP BIOL, V30, P116; Bellardita C, 2015, CURR BIOL, V25, P1426, DOI 10.1016/j.cub.2015.04.005; Biglan KM, 2009, MOVEMENT DISORD, V24, P1763, DOI 10.1002/mds.22601; Broom L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03336-1; Carlozzi NE, 2014, J HUNTINGTONS DIS, V3, P233, DOI 10.3233/JHD-140115; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen X, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-81; Croft JL, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00716; Dai Y, 2009, J NEUROSCI, V29, P11550, DOI 10.1523/JNEUROSCI.3307-09.2009; Datson NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171127; Defazio Giovanni, 2013, Tremor Other Hyperkinet Mov (N Y), V3, DOI 10.7916/D8QN65GQ; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Delval A, 2006, J NEUROL, V253, P73, DOI 10.1007/s00415-005-0929-2; Delval A, 2008, MOVEMENT DISORD, V23, P684, DOI 10.1002/mds.21896; Deng YP, 2021, J COMP NEUROL, V529, P1327, DOI 10.1002/cne.25023; Dong Y, 2013, CLIN GENET, V83, P380, DOI 10.1111/j.1399-0004.2012.01927.x; Federolf PA, 2013, J BIOMECH, V46, P2173, DOI 10.1016/j.jbiomech.2013.06.032; Ferrara JM, 2012, NEUROL THER, V1, DOI 10.1007/s40120-012-0005-7; Fiander MDJ, 2017, JOVE-J VIS EXP, DOI 10.3791/56032; Garry MI, 2005, HUM MOVEMENT SCI, V24, P849, DOI 10.1016/j.humov.2005.10.005; Gassner H, 2020, J NEUROL, V267, P1594, DOI 10.1007/s00415-020-09725-3; Gloersen O, 2018, J SPORT SCI, V36, P229, DOI 10.1080/02640414.2017.1298826; Grande G, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.05.014; Grimbergen YAM, 2008, MOVEMENT DISORD, V23, P970, DOI 10.1002/mds.22003; Gulinello M, 2019, NEUROBIOL LEARN MEM, V165, DOI 10.1016/j.nlm.2018.01.001; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Heikkinen T, 2016, 31127M10 SOC NEUR; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hetze S, 2012, J NEUROSCI METH, V206, P7, DOI 10.1016/j.jneumeth.2012.02.001; Hsieh TH, 2011, BEHAV BRAIN RES, V222, P1, DOI 10.1016/j.bbr.2011.03.031; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kale A, 2008, HYPERKINETIC RIGID G; Kegelmeyer DA, 2014, J NEUROL SCI, V347, P219, DOI 10.1016/j.jns.2014.09.053; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; LAZARUS JAC, 1992, MOVEMENT DISORD, V7, P159, DOI 10.1002/mds.870070211; Leblond H, 2003, J NEUROSCI, V23, P11411; Lee HY, 2012, MED BIOL ENG COMPUT, V50, P937, DOI 10.1007/s11517-012-0933-5; Li KZH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00913; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mancuso R, 2011, BRAIN RES, V1406, P65, DOI 10.1016/j.brainres.2011.06.033; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McColgan P, 2018, EUR J NEUROL, V25, P24, DOI 10.1111/ene.13413; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mestre TA, 2018, MOV DISORD CLIN PRAC, V5, P111, DOI 10.1002/mdc3.12571; Mirelman A, 2019, LANCET NEUROL, V18, P697, DOI 10.1016/S1474-4422(19)30044-4; Muybridge E., 1881, ATTITUDES ANIMALS MO; Nanhoe-Mahabier W, 2011, NEUROSCIENCE, V182, P217, DOI 10.1016/j.neuroscience.2011.02.061; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Paldino E, 2020, MOL NEUROBIOL, V57, P1889, DOI 10.1007/s12035-019-01847-8; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Pyo SJ, 2017, J MOV DISORD, V10, P140, DOI 10.14802/jmd.17041; Ramaswamy S, 2007, ILAR J, V48, P356, DOI 10.1093/ilar.48.4.356; Reiner A, 2012, NEUROBIOL DIS, V47, P75, DOI 10.1016/j.nbd.2012.03.025; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Rodriguez-Quiroga Sergio Alejandro, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2012-008380; Rostosky CM, 2018, JOVE-J VIS EXP, DOI 10.3791/57752; Schutte LM, 2000, GAIT POSTURE, V11, P25, DOI 10.1016/S0966-6362(99)00047-8; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Shuvaev AN, 2017, J PHYSIOL-LONDON, V595, P141, DOI 10.1113/JP272950; SPARROW WA, 1983, J MOTOR BEHAV, V15, P237; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Takakusaki K, 2017, J MOV DISORD, V10, P1, DOI 10.14802/jmd.16062; Takeuchi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047553; Tanahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084423; Thibaudier Y, 2017, J NEUROTRAUM, V34, P1751, DOI 10.1089/neu.2016.4421; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Vuong K, 2018, HAND CLINIC, V159, P251, DOI 10.1016/B978-0-444-63916-5.00016-1; Wang XH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-142; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; William Yang X, 2011, NEUROBIOLOGY HUNTING; Zimmermann T, 2016, STEM CELL REP, V7, P693, DOI 10.1016/j.stemcr.2016.08.018; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	84	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243052	10.1371/journal.pone.0243052	http://dx.doi.org/10.1371/journal.pone.0243052			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370315	gold, Green Published			2022-12-26	WOS:000603611900122
J	Pan, X; Wang, ZY; Gao, Y; Zhang, ZC; Meng, ZJ; Dang, XH; Lu, LQ; Chen, JH				Pan, Xia; Wang, Zhenyi; Gao, Yong; Zhang, Zhengcai; Meng, Zhongjv; Dang, Xiaohong; Lu, Liqiang; Chen, Jiahuan			Windbreak and airflow performance of different synthetic shrub designs based on wind tunnel experiments	PLOS ONE			English	Article							WATER-USE EFFICIENCY; SHELTERBELT STRUCTURE; SEDIMENT TRANSPORT; ECOSYSTEM SERVICES; EROSION; SPEED; DESERTIFICATION; BIODIVERSITY; RESPONSES; RECOVERY	Wind erosion has gained increasing attention as one of the most serious global ecological and environmental threats. Windbreaks are effective at decreasing wind erosion by reducing wind speed to protect crops, livestock, and farmsteads, while providing wildlife habitats. Synthetic shrubs can act as novel windbreaks; however, there is limited knowledge on how their design affects wind speed. This study determined the protective effects (airflow field and sheltering efficiency) based on the design of synthetic shrubs in a wind tunnel. Broom-shaped synthetic shrubs weakened the wind speeds mainly at the middle and upper parts of the shrubs (5-14 cm), while for hemisphere-shaped shrubs this effect was greatest near their bases (below 4 cm) and least in the middle and upper parts (7-14 cm). Spindle-shaped synthetic shrubs provided the best reduction effect in wind range and strength. Moreover, the wind speed reduction ratio decreased with improved wind speeds and ranged from 26.25 cm (between the second and third rows) to 52.5 cm (after the third row). These results provide strong evidence that synthetic shrubs should be considered to decrease wind speed and prevent wind erosion.	[Pan, Xia; Wang, Zhenyi; Gao, Yong; Meng, Zhongjv; Dang, Xiaohong; Lu, Liqiang; Chen, Jiahuan] Inner Mongolia Agr Univ, Coll Desert Control Sci & Engn, Hohhot, Inner Mongolia, Peoples R China; [Gao, Yong; Meng, Zhongjv] Wind Eros Key Lab Cent & Govt, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Zhengcai] Chinese Acad Sci, Key Lab Desert & Desertificat, Northwest Inst Ecoenvironm & Resources, Lanzhou, Peoples R China; [Dang, Xiaohong] Natl Positioning Observat Res Stn Hangjin Desert, Ordos, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Chinese Academy of Sciences	Gao, Y (corresponding author), Inner Mongolia Agr Univ, Coll Desert Control Sci & Engn, Hohhot, Inner Mongolia, Peoples R China.; Gao, Y (corresponding author), Wind Eros Key Lab Cent & Govt, Hohhot, Inner Mongolia, Peoples R China.	13948815709@163.com		xia, Pan/0000-0001-6618-4162	National Natural Science Foundation of China [41967009]; 10th "Prairie Talents" of Inner Mongolia Autonomous Region [PC201907220608]; China Scholarship Council [201908150155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 10th "Prairie Talents" of Inner Mongolia Autonomous Region; China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China: Action Mechanism Research on Ecology Spatial Configuration of Desert Shrub to the Formation and Development of Fertile Island (41967009), the 10th "Prairie Talents" of Inner Mongolia Autonomous Region (PC201907220608), and the China Scholarship Council (201908150155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANZHAF J, 1992, AGRON J, V84, P1056, DOI 10.2134/agronj1992.00021962008400060028x; Boutraa T, 2010, J TAIBAH UNIV SCI, V3, P39, DOI 10.1016/S1658-3655(12)60019-3; Brandle JR, 2004, AGROFOREST SYST, V61-2, P65, DOI 10.1023/B:AGFO.0000028990.31801.62; Cao JX, 2012, URBAN FOR URBAN GREE, V11, P465, DOI 10.1016/j.ufug.2012.05.003; Chen BY, 2019, AEOLIAN RES, V38, P1, DOI 10.1016/j.aeolia.2019.03.001; Chen XH, 2016, LAND DEGRAD DEV, V27, P561, DOI 10.1002/ldr.2400; Chen YF, 2003, ENVIRON MANAGE, V32, P413, DOI 10.1007/s00267-003-0042-1; Cheng H, 2019, AGR FOREST METEOROL, V266, P29, DOI 10.1016/j.agrformet.2018.11.039; Cheng H, 2018, AGR FOREST METEOROL, V263, P362, DOI 10.1016/j.agrformet.2018.08.025; Cornelis Wim M., 2000, Secheresse (Montrouge), V11, P52; Cornelis WM, 2005, J ARID ENVIRON, V61, P315, DOI 10.1016/j.jaridenv.2004.10.005; Van Thuyet D, 2014, AGROFOREST SYST, V88, P237, DOI 10.1007/s10457-013-9671-4; Dong ZB, 2007, AGR FOREST METEOROL, V146, P82, DOI 10.1016/j.agrformet.2007.05.009; Dupont S, 2014, J GEOPHYS RES-EARTH, V119, P168, DOI 10.1002/2013JF002875; Dupont S, 2009, J FLUID MECH, V630, P93, DOI 10.1017/S0022112009006739; Dupont S, 2011, AGR FOREST METEOROL, V151, P328, DOI 10.1016/j.agrformet.2010.11.007; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; Fu LT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48574-7; GANDEMER J, 1979, J IND AERODYNAM, V4, P371, DOI 10.1016/0167-6105(79)90013-8; Gillies JA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001259; Gillies JA, 2014, AEOLIAN RES, V12, P135, DOI 10.1016/j.aeolia.2013.12.005; Hesp PA, 2019, GEOMORPHOLOGY, V337, P165, DOI 10.1016/j.geomorph.2019.03.020; Hong Y, 2016, J EARTH SYST SCI, V125, P499, DOI 10.1007/s12040-016-0684-z; Hua FY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12717; Leenders JK, 2007, EARTH SURF PROC LAND, V32, P1454, DOI 10.1002/esp.1452; Leenders JK, 2011, EARTH SURF PROC LAND, V36, P1218, DOI 10.1002/esp.2147; Li GS, 2013, ECOL ENG, V57, P293, DOI 10.1016/j.ecoleng.2013.04.042; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; [李雪琳 Li Xuelin], 2018, [中国沙漠, Journal of Desert Research], V38, P936; Liu BL, 2019, CATENA, V172, P266, DOI 10.1016/j.catena.2018.08.037; Liu CC, 2011, TREES-STRUCT FUNCT, V25, P537, DOI 10.1007/s00468-010-0533-7; Liu YA, 2010, AFR J AGR RES, V5, P1598; Ma R, 2010, J WIND ENG IND AEROD, V98, P767, DOI 10.1016/j.jweia.2010.07.001; Miri A, 2019, CATENA, V172, P421, DOI 10.1016/j.catena.2018.09.006; Moore JC, 2016, EARTHS FUTURE, V4, P588, DOI 10.1002/2016EF000402; Munson SM, 2011, P NATL ACAD SCI USA, V108, P3854, DOI 10.1073/pnas.1014947108; Neumeier U, 2005, ESTUAR COAST SHELF S, V63, P489, DOI 10.1016/j.ecss.2004.12.009; Okin GS, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000758; Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295; PERERA MDAES, 1981, J WIND ENG IND AEROD, V8, P93, DOI 10.1016/0167-6105(81)90010-6; RAUPACH MR, 1992, BOUND-LAY METEOROL, V60, P375, DOI 10.1007/BF00155203; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Rosenberg N.J., 1974, MICROCLIMATE BIOL EN; Safriel U, 2017, SILVA FENN, V51, DOI 10.14214/sf.1650; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; SEGUIN B, 1973, AGR METEOROL, V11, P79, DOI 10.1016/0002-1571(73)90052-6; Shen W, 2012, GLOBAL PLANET CHANGE, V86-87, P37, DOI 10.1016/j.gloplacha.2012.01.012; Skidmore E. L., 1988, Soil erosion research methods., P203; Torita H, 2007, AGR FOREST METEOROL, V145, P186, DOI 10.1016/j.agrformet.2007.04.018; Torres L, 2015, LAND DEGRAD DEV, V26, P433, DOI 10.1002/ldr.2392; Wang GuoQian, 2012, Journal of Resources and Ecology, V3, P97; Wu XX, 2015, AEOLIAN RES, V16, P11, DOI 10.1016/j.aeolia.2014.10.004; Xu WH, 2017, P NATL ACAD SCI USA, V114, P1601, DOI 10.1073/pnas.1620503114; Yang YY, 2019, J GEOPHYS RES-EARTH, V124, P1835, DOI 10.1029/2018JF004695; Zang YunXiao, 2015, Environmental Technology Reviews, V4, P119, DOI 10.1080/21622515.2015.1105307; Zhang Hua, 2003, Yingyong Shengtai Xuebao, V14, P1591; [张莹花 Zhang Yinghua], 2017, [中国沙漠, Journal of Desert Research], V37, P859; Zhang ZC, 2017, BOUND-LAY METEOROL, V163, P523, DOI 10.1007/s10546-017-0235-4; Zhang ZC, 2015, AEOLIAN RES, V17, P1, DOI 10.1016/j.aeolia.2015.01.004; Zhou XH, 2002, AGR FOREST METEOROL, V111, P93, DOI 10.1016/S0168-1923(02)00017-5; 2004, COMMUN PURE APPL MAT, V57, P1	61	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244213	10.1371/journal.pone.0244213	http://dx.doi.org/10.1371/journal.pone.0244213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370328	gold, Green Published			2022-12-26	WOS:000603611900041
J	Raghunathan, N; Francois, L; Cazetta, E; Pitance, JL; De Vleeschouwer, K; Hambuckers, A				Raghunathan, Nima; Francois, Louis; Cazetta, Eliana; Pitance, Jean-Luc; De Vleeschouwer, Kristel; Hambuckers, Alain			Deterministic modelling of seed dispersal based on observed behaviours of an endemic primate in Brazil	PLOS ONE			English	Article							TAMARINS LEONTOPITHECUS-CHRYSOMELAS; LION TAMARINS; MOVEMENT BEHAVIOR; FORAGING STRATEGY; ATLANTIC FOREST; HOME-RANGE; ENVIRONMENTS; SELECTION; DYNAMICS; PATTERNS	Plant species models are among the available tools to predict the future of ecosystems threatened by climate change, habitat loss, and degradation. However, they suffer from low to no inclusion of plant dispersal, which is necessary to predict ecosystem evolution. A variety of seed dispersal models have been conceived for anemochorous and zoochorous plant species, but the coupling between vegetation models and seed dispersal processes remains rare. The main challenge in modelling zoochoric dispersal is simulating animal movements in their complex habitat. Recent developments allow straightforward applications of hidden Markov modelling (HMM) to animal movements, which could ease generalizations when modelling zoochoric seed dispersal. We tested the use of HMM to model seed dispersal by an endangered primate in the Brazilian Atlantic forest, to demonstrate its potential simplicity to simulate seed dispersal processes. We also discuss how to adapt it to other species. We collected information on movement, fruit consumption, deposition, and habitat use of Leontopithecus chrysomelas. We analysed daily trajectories using HMM and built a deterministic Model Of Seed Transfer (MOST), which replicated, with good approximation, the primate's movement and seed deposition patterns as observed in the field. Our results suggest that the dispersal behaviour and short daily-trajectories of L. chrysomelas restrict the species' role in large-scale forest regeneration, but contribute to the prevalence of resource tree species locally, and potentially maintaining tree diversity by preventing local extinction. However, it may be possible to accurately simulate dispersal in an area, without necessarily quantifying variables that influence movement, if the movement can be broken down to step-length and turning angles, and parametrised along with the distribution of gut-transit times. For future objectives, coupling MOST with a DVM could be used to test hypotheses on tree species survival in various scenarios, simulating regeneration and growth at regional scales by including data on main dispersal agents over the area of interest, distribution of tree species, and land use data. The principal advantage of the MOST model is its functionality with data available from the literature as the variables are easy to parametrise. We suggest using the coupled model to perform experiments using only available information, but varying the numbers and species of seed dispersers, or modifying land cover or configuration to test for possible thresholds preventing the extinction of selected tree species.	[Raghunathan, Nima; Francois, Louis; Pitance, Jean-Luc; Hambuckers, Alain] Univ Liege, UR SPHERES, Liege, Belgium; [Raghunathan, Nima; Cazetta, Eliana] Univ Estadual Santa Cruz, Appl Ecol & Conservat Lab, Grad Program Ecol & Biodivers Conservat, Ilheus, BA, Brazil; [De Vleeschouwer, Kristel] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [De Vleeschouwer, Kristel] Bicho do Mato Res Inst, Belo Horizonte, MG, Brazil	University of Liege; Universidade Estadual de Santa Cruz	Raghunathan, N (corresponding author), Univ Liege, UR SPHERES, Liege, Belgium.; Raghunathan, N (corresponding author), Univ Estadual Santa Cruz, Appl Ecol & Conservat Lab, Grad Program Ecol & Biodivers Conservat, Ilheus, BA, Brazil.	nima_toad@hotmail.com	; De Vleeschouwer, Kristel/L-1547-2018	Pitance, Jean-Luc/0000-0003-4379-1554; De Vleeschouwer, Kristel/0000-0002-6358-5603	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.S.-FRIA), Belgium; Wallonie-Bruxelles International (WBI), Belgium; Direction Administration de Recherche et Developpement (DIR-ARD); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.S.-FRIA), Belgium; Wallonie-Bruxelles International (WBI), Belgium; Direction Administration de Recherche et Developpement (DIR-ARD); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	NR: Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.S.-FRIA), Belgium, Wallonie-Bruxelles International (WBI), Belgium, Direction Administration de Recherche et Developpement (DIR-ARD) NR & EC: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 https://www.frs-fnrs.be/fr/http://www.wbi.be/https://www.capes.gov.br/. The funders had no role in study design, data collection & analysis, decision to publich, or preparation of the manuscript.	Albert A, 2013, INT J PRIMATOL, V34, P696, DOI 10.1007/s10764-013-9690-z; Albert A, 2013, RAFFLES B ZOOL, V61, P423; Babweteera F, 2009, BIODIVERS CONSERV, V18, P1611, DOI 10.1007/s10531-008-9546-6; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bateman AW, 2015, J ANIM ECOL, V84, P260, DOI 10.1111/1365-2656.12267; Bequet R, 2012, EUR J FOREST RES, V131, P283, DOI 10.1007/s10342-011-0500-x; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bialozyt R, 2014, ECOL MODEL, V278, P74, DOI 10.1016/j.ecolmodel.2014.02.004; Bologna S, 2018, MAMM BIOL, V91, P7, DOI 10.1016/j.mambio.2018.03.001; Boyer D, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434014; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Brotcorne F, 2014, AM J PRIMATOL, V76, P1140, DOI 10.1002/ajp.22299; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Cardoso NA, 2011, MAMMALIA, V75, P327, DOI 10.1515/MAMM.2011.042; Catenacci LS, 2009, BIOTROPICA, V41, P744, DOI 10.1111/j.1744-7429.2009.00530.x; Cattarino L, 2016, J ANIM ECOL, V85, P168, DOI 10.1111/1365-2656.12427; Cheddadi R, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00114; Cruzan MB, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600041; de Paula MD, 2018, OIKOS, V127, P1526, DOI 10.1111/oik.05084; De Vleeschouwer Kristel M, 2017, Primate Biol, V4, P61, DOI 10.5194/pb-4-61-2017; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Fischer M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199617; Fontaine CM, 2014, J LAND USE SCI, V9, P278, DOI 10.1080/1747423X.2013.786150; FOURNIER LA, 1974, TURRIALBA, V24, P422; Gazagne E, 2020, RAFFLES B ZOOL, V68, P735, DOI 10.26107/RBZ-2020-0085; Gazagne E, 2020, FORESTS, V11, DOI 10.3390/f11111184; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; Gonsalves L, 2018, AUST MAMMAL, V40, P220, DOI 10.1071/AM17031; Granier N, 2014, AM J PRIMATOL, V76, P999, DOI 10.1002/ajp.22278; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Holbrook KM, 2011, BIOTROPICA, V43, P357, DOI 10.1111/j.1744-7429.2010.00710.x; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Lapenta MJ, 2008, TROP CONSERV SCI, V1, P122, DOI 10.1177/194008290800100205; Lehrke RM, 2017, WILDLIFE RES, V44, P558, DOI 10.1071/WR17064; Levey DJ, 2008, J ECOL, V96, P599, DOI 10.1111/j.1365-2745.2008.01401.x; Michelot T, 2016, METHODS ECOL EVOL, V7, P1308, DOI 10.1111/2041-210X.12578; Nabe-Nielsen J, 2013, OIKOS, V122, P1307, DOI 10.1111/j.1600-0706.2013.00069.x; Nather W, 2003, BIOMETRICAL J, V45, P1006, DOI 10.1002/bimj.200390058; Neumann W, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0036-7; Nield AP, 2020, J ECOL, V108, P687, DOI 10.1111/1365-2745.13287; Nuttle T, 2005, AM NAT, V165, P336, DOI 10.1086/428298; Oleksy R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184023; Pakeman RJ, 2001, J BIOGEOGR, V28, P795, DOI 10.1046/j.1365-2699.2001.00581.x; Palminteri S, 2012, OIKOS, V121, P1896, DOI 10.1111/j.1600-0706.2012.20456.x; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Pessoa MS, 2017, PERSPECT PLANT ECOL, V28, P78, DOI 10.1016/j.ppees.2017.09.001; Pessoa MS, 2017, BIOTROPICA, V49, P45, DOI 10.1111/btp.12359; Plante S, 2014, J ANIM ECOL, V83, P116, DOI 10.1111/1365-2656.12119; Pyke GH, 2015, METHODS ECOL EVOL, V6, P1, DOI 10.1111/2041-210X.12298; Raghunathan N, 2019, REG ENVIRON CHANGE, V19, P219, DOI 10.1007/s10113-018-1405-8; Raghunathan N, 2015, REG ENVIRON CHANGE, V15, P683, DOI 10.1007/s10113-014-0625-9; Redwine C, 1995, UPGRADING FORTRAN 90, DOI [10.1007/978-1-4612-2562-1, DOI 10.1007/978-1-4612-2562-1]; Reid, 2016, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2016-1.RLTS.T41635A45211301.en; Reid JL, 2015, ECOL APPL, V25, P1072, DOI 10.1890/14-1399.1; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Schleppi P, 2007, AGR FOREST METEOROL, V144, P236, DOI 10.1016/j.agrformet.2007.02.004; Steinbauer MJ, 2018, NATURE, V556, P231, DOI 10.1038/s41586-018-0005-6; Stevenson PR, 2007, PLANT ECOL, V190, P245, DOI 10.1007/s11258-006-9205-5; TAYLOR PD, 2017, AVIAN CONSERV ECOL, V12, DOI DOI 10.5751/ACE-00953-120108; Thimonier A, 2010, EUR J FOREST RES, V129, P543, DOI 10.1007/s10342-009-0353-8; Trolliet F, 2017, ACTA OECOL, V85, P69, DOI 10.1016/j.actao.2017.09.010; Trolliet F, 2014, BIOTECHNOL AGRON SOC, V18, P446; van Putten B, 2012, METHODS ECOL EVOL, V3, P642, DOI 10.1111/j.2041-210X.2012.00208.x	64	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244220	10.1371/journal.pone.0244220	http://dx.doi.org/10.1371/journal.pone.0244220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370339	gold, Green Published			2022-12-26	WOS:000603611900061
J	Rajput, SA; Mirza, MR; Choudhary, MI				Rajput, Sajid Ali; Mirza, Munazza Raza; Choudhary, M. Iqbal			Bergenin protects pancreatic beta cells against cytokine-induced apoptosis in INS-1E cells	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; KAPPA-B; DERIVATIVES; MECHANISMS; TOXICITY; BARK; MASS	Beta cell apoptosis induced by proinflammatory cytokines is one of the hallmarks of diabetes. Small molecules which can inhibit the cytokine-induced apoptosis could lead to new drug candidates that can be used in combination with existing therapeutic interventions against diabetes. The current study evaluated several effects of bergenin, an isocoumarin derivative, in beta cells in the presence of cytokines. These included (i) increase in beta cell viability (by measuring cellular ATP levels) (ii) suppression of beta cell apoptosis (by measuring caspase activity), (iii) improvement in beta cell function (by measuring glucose-stimulated insulin secretion), and (iv) improvement of beta cells mitochondrial physiological functions. The experiments were carried out using rat beta INS-1E cell line in the presence or absence of bergenin and a cocktail of proinflammatory cytokines (interleukin-1beta, tumor necrosis factor-alpha, and interferon- gamma) for 48 hr. Bergenin significantly inhibited beta cell apoptosis, as inferred from the reduction in the caspase-3 activity (IC50 = 7.29 +/- 2.45 mu M), and concurrently increased cellular ATP Levels (EC50 = 1.97 +/- 0.47 mu M). Bergenin also significantly enhanced insulin secretion (EC50 = 6.73 +/- 2.15 mu M) in INS-1E cells, presumably because of the decreased nitric oxide production (IC50 = 6.82 +/- 2.83 mu M). Bergenin restored mitochondrial membrane potential (EC50 = 2.27 +/- 0.83 mu M), decreased ROS production (IC50 = 14.63 +/- 3.18 mu M), and improved mitochondrial dehydrogenase activity (EC50 = 1.39 +/- 0.62 mu M). This study shows for the first time that bergenin protected beta cells from cytokine-induced apoptosis and restored insulin secretory function by virtue of its anti-inflammatory, antioxidant and anti-apoptotic properties. To sum up, the above mentioned data highlight bergenin as a promising anti-apoptotic agent in the context of diabetes.	[Rajput, Sajid Ali; Mirza, Munazza Raza; Choudhary, M. Iqbal] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Sindh, Pakistan; [Choudhary, M. Iqbal] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Sindh, Pakistan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Rajput, Sajid Ali] Univ Sindh, Inst Biotechnol & Genet Engn, Jamshoro, Sindh, Pakistan	University of Karachi; University of Karachi; King Abdulaziz University; University of Sindh	Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Sindh, Pakistan.; Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Sindh, Pakistan.; Choudhary, MI (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia.	iqbal.choudhary@iccs.edu	Choudhary, M. Iqbal/C-8633-2012	Choudhary, M. Iqbal/0000-0001-5356-3585	Institute, Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi; Searle Pharmaceuticals Pakistan Ltd.	Institute, Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi; Searle Pharmaceuticals Pakistan Ltd.	This work was supported by our Institute, Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi. We thank the Institute for supporting this work by providing recurrent grant for chemicals and consumables and for allowing work in the cell culture facility at PCMD. The authors also received funds from Searle Pharmaceuticals Pakistan Ltd. for publishing this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2005, GUT, V54, pv1; [Anonymous], 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/glan290; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chou DHC, 2010, ACS CHEM BIOL, V5, P729, DOI 10.1021/cb100129d; Silva Saulo L. da, 2009, Acta Amaz., V39, P187, DOI 10.1590/S0044-59672009000100019; Darville MI, 1998, DIABETOLOGIA, V41, P1101, DOI 10.1007/s001250051036; De Abreu HA, 2008, ORG BIOMOL CHEM, V6, P2713, DOI 10.1039/b804385j; de Oliveira CM, 2011, J NAT PROD, V74, P2062, DOI 10.1021/np200232s; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; ECB, 2003, MONTHLY B, V46, P3; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Ejaz Ahmed, 2004, Asian Journal of Plant Sciences, V3, P410; Fourth International Ankle Symposium, 2009, J ORTHOPAEDIC SPORTS, V39, pA1; Gao XJ, 2015, INFLAMMATION, V38, P1142, DOI 10.1007/s10753-014-0079-8; Gavin JR, 1997, DIABETES CARE, V20, P1183; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Li HB, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2910643; Matsuda T, 2005, ENDOCRINOLOGY, V146, P175, DOI 10.1210/en.2004-0850; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Nazir N, 2007, J ETHNOPHARMACOL, V112, P401, DOI 10.1016/j.jep.2007.02.023; Nazir N, 2011, EUR J MED CHEM, V46, P2415, DOI 10.1016/j.ejmech.2011.03.025; Nunomura RCS, 2009, J BRAZIL CHEM SOC, V20, P1060, DOI 10.1590/S0103-50532009000600009; Popov SV, 2005, PHYTOTHER RES, V19, P1052, DOI 10.1002/ptr.1789; Posner RA, 2009, DUKE LAW J, V58, P1807; Remedi MS, 2016, DIABETES OBES METAB, V18, P110, DOI 10.1111/dom.12727; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Seth SDS, 1974, J RES INDIAN MED, V9, P1; Shah MR, 2012, BIOORG MED CHEM LETT, V22, P2744, DOI 10.1016/j.bmcl.2012.02.096; Sinha S, 2001, FITOTERAPIA, V72, P550, DOI 10.1016/S0367-326X(00)00322-1; Sinha S, 2001, J PHARM PHARMACOL, V53, P193, DOI 10.1211/0022357011775398; Srinivasan R, 2007, J ETHNOPHARMACOL, V113, P284, DOI 10.1016/j.jep.2007.06.006; Sumino M, 2002, CHEM PHARM BULL, V50, P1484, DOI 10.1248/cpb.50.1484; Takahashi H, 2003, BIOORGAN MED CHEM, V11, P1781, DOI 10.1016/S0968-0896(02)00666-1; Uddin G, 2014, TROP BIOMED, V31, P143; Uniyal SK, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-14; VANWYK CW, 1993, S AFR MED J, V83, P425; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Villarreal CF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144850; Xiang SH, 2020, DRUG DES DEV THER, V14, P129, DOI 10.2147/DDDT.S229063; Zamarrud, 2011, FITOTERAPIA, V82, P722, DOI 10.1016/j.fitote.2011.03.002; Zawawi NKNA, 2015, BIOORG MED CHEM LETT, V25, P4672, DOI 10.1016/j.bmcl.2015.08.022	48	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0241349	10.1371/journal.pone.0241349	http://dx.doi.org/10.1371/journal.pone.0241349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347462	Green Published, gold			2022-12-26	WOS:000603071100031
J	Rosa, F; Osorio, JS				Rosa, Fernanda; Osorio, Johan S.			Quantitative determination of histone methylation via fluorescence resonance energy transfer (FRET) technology in immortalized bovine mammary alveolar epithelial cells supplemented with methionine	PLOS ONE			English	Article							DAIRY-COWS; S-ADENOSYLMETHIONINE; SMARTAMINE M; PROTEIN; DNA; METHYLTRANSFERASE; TRANSCRIPTION; PERFORMANCE; NUTRITION; PROMOTER	Methionine (Met) is an essential precursor of S-adenosylmethionine (SAM), which is the primary methyl donor required for biological processes such as DNA and histone methylation, which alter gene expression. In dairy cows, dietary Met has been observed to exert transcriptional alterations with beneficial effects on milk biosynthesis; however, the extent of these effects via SAM remains unknown. Therefore, we evaluated the effect of Met supply on histone methylation in lysine residues K9 and K27 in the histone tail H3 via a fluorescence resonance energy transfer (FRET) system in immortalized bovine mammary alveolar epithelial cells (MACT) incubated varying concentration of Met. The histone methylation data was complemented with global DNA methylation, cellular protein synthesis, and RT-qPCR analysis of genes related to Met cycle, DNA and histone methylation, AA transporters, and protein synthesis. The histone methylation data was performed on MACT cells seeded at 30,000 cells/well in 96-well plates 24 h prior to transfection. The transfections of FRET gene reporter plasmids H3K9 and H3K27 was performed with 0.3 mu L/well of Lipofectamine (R) 3000 and 50 ng of plasmid DNA per well. At 24 h post-transfection, cells were treated with 0, 125, 250, and 500 mu M of Met, and quantification of histone methylation was performed at 0, 12, and 24 h post-treatment as well as cell viability at 24 h using CellProfiler software. An inverted microscope for live imagining (EVOS(R) FL Auto) equipped with a motorized scanning stage, and an environment-controlled chamber at 37C and 5.0% of CO2 was used to take 4 pictures/well at 4x magnification. A more defined response on histone methylation was observed in H3K9 than H3K27 to Met supply, where maximal histone methylation in H3K9 was observed with 125 mu M of Met. This greater histone methylation in H3K9 at 125 mu M was accompanied by greater cellular protein concentration. The linear increase in Met supply causes a linear decrease in global DNA methylation, while linearly upregulating genes related to the Met cycle (i.e., MAT1A, PEMT, SAHH, and MTR). The histone methylation data suggest that, to some extent, methyl-donors such as Met may affect the methylation sites, H3K9 and H3K27, and consequently causing a different epigenetic alteration. In the context of the dairy cow, further refinement to this FRET assay to study histone methylation could lead to establishing novel potential mechanisms of how dietary methyl donors may control the structural conformation of the bovine genome and, by extension, gene expression.	[Rosa, Fernanda; Osorio, Johan S.] South Dakota State Univ, Dept Dairy & Food Sci, Brookings, SD 57007 USA	South Dakota State University	Osorio, JS (corresponding author), South Dakota State Univ, Dept Dairy & Food Sci, Brookings, SD 57007 USA.	Johan.Osorio@sdstate.edu	Rosa, Fernanda/AAA-6140-2022		South Dakota Agricultural Experiment State [SD00H612-16]	South Dakota Agricultural Experiment State	This work was supported by the South Dakota Agricultural Experiment State under project No. SD00H612-16 to JSO. https://www.sdstate.edu/south-dakota-agricultural-experiment-stationsdsu.The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2004, DIGEST DIS SCI, V49, P1889, DOI 10.1007/s10620-004-9589-9; Algar WR, 2019, NAT METHODS, V16, P815, DOI 10.1038/s41592-019-0530-8; [Anonymous], 2012, J MED ASS THAI S12, V95, pS32; [Anonymous], 2012, REGEN MED S3, V7, pS14; Bajar BT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091488; Batistel F, 2017, J DAIRY SCI, V100, P7455, DOI 10.3168/jds.2017-12689; Bionaz M, 2015, J ANIM SCI, V93, P5531, DOI 10.2527/jas.2015-9192; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; Breton A, 2010, J REPROD DEVELOP, V56, P379, DOI 10.1262/jrd.09-182A; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Dobosy JR, 2008, PROSTATE, V68, P1187, DOI 10.1002/pros.20782; Dong X, 2018, J DAIRY SCI, V101, P1708, DOI 10.3168/jds.2017-13351; Esfandiari F, 2010, HEPATOLOGY, V51, P932, DOI 10.1002/hep.23382; Fu K, 2020, EPIGENETICS-US, V15, P272, DOI 10.1080/15592294.2019.1666649; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Halsted CH, 2004, SEMIN LIVER DIS, V24, P289, DOI 10.1055/s-2004-832941; He YH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2947-0; Hernandez-Ortega K, 2016, BRAIN PATHOL, V26, P593, DOI 10.1111/bpa.12335; Hu LY, 2020, FOOD FUNCT, V11, P883, DOI [10.1039/c9fo02379h, 10.1039/C9FO02379H]; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Kera Y, 2013, J BIOL CHEM, V288, P13592, DOI 10.1074/jbc.M112.429738; Lapierre H, 2006, J DAIRY SCI, V89, pE1, DOI 10.3168/jds.S0022-0302(06)72359-1; Lin CW, 2004, J AM CHEM SOC, V126, P5982, DOI 10.1021/ja038854h; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Ma YF, 2019, J DAIRY SCI, V102, P4264, DOI 10.3168/jds.2018-15451; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Michalak EM, 2019, NAT REV MOL CELL BIO, V20, P573, DOI 10.1038/s41580-019-0143-1; Momparler RL, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-19; Nan XM, 2014, PHYSIOL GENOMICS, V46, P268, DOI 10.1152/physiolgenomics.00119.2013; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Ordway RS, 2009, J DAIRY SCI, V92, P5154, DOI 10.3168/jds.2009-2259; Osorio JS, 2016, J DAIRY SCI, V99, P234, DOI 10.3168/jds.2015-10157; Osorio JS, 2014, J DAIRY SCI, V97, P7451, DOI 10.3168/jds.2014-8680; Osorio JS, 2013, J DAIRY SCI, V96, P6248, DOI 10.3168/jds.2012-5790; Osorio JS, 2012, J DAIRY SCI, V95, P5831, DOI 10.3168/jds.2011-5042; Osorio J.S., 2018, FLORIDA RUMINANT NUT, VFlorida, P19; Osorio JS, 2017, GENE, V626, P200, DOI 10.1016/j.gene.2017.05.025; Osorio JS, 2016, PHYSIOL GENOMICS, V48, P231, DOI 10.1152/physiolgenomics.00016.2015; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Shima H, 2017, CELL REP, V21, P3354, DOI 10.1016/j.celrep.2017.11.092; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Torrano J, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0644-y; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Wang LJ, 2014, J NUTR BIOCHEM, V25, P329, DOI 10.1016/j.jnutbio.2013.11.007; Wang LJ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-34; Wu X, 2011, ZYGOTE, V19, P31, DOI 10.1017/S0967199410000328; ZAVIZION B, 1995, J DAIRY SCI, V78, P515, DOI 10.3168/jds.S0022-0302(95)76662-0; Zhao Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12464; Zhou Z, 2016, J DAIRY SCI, V99, P8716, DOI 10.3168/jds.2015-10525; Zhou Z, 2017, J NUTR, V147, P11, DOI 10.3945/jn.116.240234; Zinner R, 2006, HISTOCHEM CELL BIOL, V125, P3, DOI 10.1007/s00418-005-0049-1	56	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244135	10.1371/journal.pone.0244135	http://dx.doi.org/10.1371/journal.pone.0244135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347518	gold, Green Published			2022-12-26	WOS:000603071100038
J	Tangerina, MMP; Furtado, LC; Leite, VMB; Bauermeister, A; Velasco-Alzate, K; Jimenez, PC; Garrido, LM; Padilla, G; Lopes, NP; Costa-Lotufo, LV; Ferreira, MPJ				Tangerina, Marcelo M. P.; Furtado, Luciana Costa; Leite, Vida M. B.; Bauermeister, Anelize; Velasco-Alzate, Karen; Jimenez, Paula C.; Garrido, Leandro M.; Padilla, Gabriel; Lopes, Norberto P.; Costa-Lotufo, Leticia V.; Pena Ferreira, Marcelo J.			Metabolomic study of marine Streptomyces sp.: Secondary metabolites and the production of potential anticancer compounds	PLOS ONE			English	Article							NATURAL-PRODUCTS; DIKETOPIPERAZINE DERIVATIVES; MOLECULAR NETWORKING; CYCLIC OCTAPEPTIDE; DRUG DISCOVERY; DIVERSITY; GENOME; GROWTH; DEREPLICATION; COMPLETENESS	Resorting to a One Strain Many Compounds (OSMAC) approach, the marine Streptomyces sp. BRB081 strain was grown in six different media settings over 1, 2, 3 or 7 days. Extractions of mycelium and broth were conducted separately for each media and cultivation period by sonication using methanol/acetone 1:1 and agitation with ethyl acetate, respectively. All methanol/acetone and ethyl acetate crude extracts were analysed by HPLC-MS/MS and data treatment was performed through GNPS platform using MZmine 2 software. In parallel, the genome was sequenced, assembled and mined to search for biosynthetic gene clusters (BGC) of secondary metabolites using the AntiSMASH 5.0 software. Spectral library search tool allowed the annotation of desferrioxamines, fatty acid amides, diketopiperazines, xanthurenic acid and, remarkably, the cyclic octapeptides surugamides. Molecular network analysis allowed the observation of the surugamides cluster, where surugamide A and the protonated molecule corresponding to the B-E isomers, as well as two potentially new analogues, were detected. Data treatment through MZmine 2 software allowed to distinguish that the largest amount of surugamides was obtained by cultivating BRB081 in SCB medium during 7 days and extraction of culture broth. Using the same data treatment, a chemical barcode was created for easy visualization and comparison of the metabolites produced overtime in all media. By genome mining of BRB081 four regions of biosynthetic gene clusters of secondary metabolites were detected supporting the metabolic data. Cytotoxic evaluation of all crude extracts using MTT assay revealed the highest bioactivity was also observed for extracts obtained in the optimal conditions as those for surugamides production, suggesting these to be the main active compounds herein. This method allowed the identification of compounds in the crude extracts and guided the selection of best conditions for production of bioactive compounds.	[Tangerina, Marcelo M. P.; Pena Ferreira, Marcelo J.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Furtado, Luciana Costa; Bauermeister, Anelize; Velasco-Alzate, Karen; Costa-Lotufo, Leticia V.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, Sao Paulo, SP, Brazil; [Leite, Vida M. B.; Garrido, Leandro M.; Padilla, Gabriel] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil; [Bauermeister, Anelize; Lopes, Norberto P.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Biomol, NPPNS, Ribeirao Preto, SP, Brazil; [Jimenez, Paula C.] Univ Fed Sao Paulo, Inst Mar, Dept Ciencias Mar, Santos, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Tangerina, MMP; Ferreira, MPJ (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	marcelotangerina@usp.br; marcelopena@ib.usp.br	Lopes, Norberto P/C-7148-2012; Garrido, Leandro M/G-8793-2012; Tangerina, Marcelo/AEF-1225-2022; Bauermeister, Anelize/N-1255-2015; Tangerina, Marcelo M P Marucci Pereira/L-3580-2016; Costa-Lotufo, Leticia/ABC-5742-2021; Jimenez, Paula C/J-6128-2015; Costa-Lotufo, Leticia/D-4998-2014; Costa Furtado, Luciana/O-1426-2017; Padilla, Gabriel/M-2183-2016	Lopes, Norberto P/0000-0002-8159-3658; Bauermeister, Anelize/0000-0001-9731-6172; Tangerina, Marcelo M P Marucci Pereira/0000-0002-4236-094X; Costa-Lotufo, Leticia/0000-0003-1861-5153; Jimenez, Paula C/0000-0002-5244-9761; Costa-Lotufo, Leticia/0000-0003-1861-5153; Costa Furtado, Luciana/0000-0002-2306-7959; Padilla, Gabriel/0000-0001-8086-3065	Sao Paulo Research Foundation (FAPESP) [2017/16606-6, 2017/18235-5, 2017/17648-4, 2015/17177-6]; Coordination for the Improvement of Higher Education Personnel -CAPES [Brazil] [001]; Brazilian National Council for Scientific and Technological Development -CNPq; Sistema Nacional de Gestao do Patrimonio Genetico e do Conhecimento Tradicional Associado [SisGen] within the Brazilian Environmental Ministry [A0031D5]; Instituto Florestal, within the Sao Paulo State Environmental Secretary [260108 -004.258/2018]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel -CAPES [Brazil](Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sistema Nacional de Gestao do Patrimonio Genetico e do Conhecimento Tradicional Associado [SisGen] within the Brazilian Environmental Ministry; Instituto Florestal, within the Sao Paulo State Environmental Secretary	This research was supported by Sao Paulo Research Foundation (FAPESP) [grants 2017/16606-6 (M.M.P.T.), 2017/18235-5 (L.C.F.), 2017/17648-4 (A.B.) and 2015/17177-6 (L.V.C.L.)] and the Coordination for the Improvement of Higher Education Personnel -CAPES [Finance Code 001, Brazil]. L.V.C.L., M.J.P.F and N.P.L. were funded by a fellowship from the Brazilian National Council for Scientific and Technological Development -CNPq. This study is registered with the Sistema Nacional de Gestao do Patrimonio Genetico e do Conhecimento Tradicional Associado [SisGen #A0031D5] within the Brazilian Environmental Ministry, and has been authorized by Instituto Florestal, within the Sao Paulo State Environmental Secretary [process #260108 -004.258/2018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SJ, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/2189814; Almeida EL, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7100394; [Anonymous], 2018, FRONT MICROBIOL, V9, P1; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 2018, 7 SER FPGAS DAT SHEE, V2, P1; Bauermeister A, 2019, ENVIRON MICROBIOL, V21, P1099, DOI 10.1111/1462-2920.14529; Bertrand S, 2014, BIOTECHNOL ADV, V32, P1180, DOI 10.1016/j.biotechadv.2014.03.001; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Bose U, 2015, MAR DRUGS, V13, P249, DOI 10.3390/md13010249; Bosi E, 2015, BIOINFORMATICS, V31, P2443, DOI 10.1093/bioinformatics/btv171; Bramhachari PV, 2019, ADV ENDOPHYTIC FUNGA, P339, DOI [10.1016/j.semcancer.2018.09.011, DOI 10.1016/J.SEMCANCER.2018.09.011, 10.1007/978-3-030-03589-1_15, DOI 10.1007/978-3-030-03589-1_15]; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Cho JY, 2012, BIOSCI BIOTECH BIOCH, V76, P1116, DOI 10.1271/bbb.110943; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Christian OE, 2005, J NAT PROD, V68, P1592, DOI 10.1021/np050293f; Conde-Martinez N, 2019, MAR DRUGS, V17, DOI 10.3390/md17040196; Crusemann M, 2017, J NAT PROD, V80, P588, DOI [10.1021/acsjnatprod.6b00722, 10.1021/acs.jnatprod.6b00722]; Dalisay DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077078; Das S, 2006, CURR SCI INDIA, V90, P1325; Procopio RED, 2012, BRAZ J INFECT DIS, V16, P466, DOI 10.1016/j.bjid.2012.08.014; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Forner D, 2013, ANAL CHIM ACTA, V805, P70, DOI 10.1016/j.aca.2013.10.029; Gill KA, 2015, J NAT PROD, V78, P822, DOI 10.1021/np501060k; Gu BB, 2013, APPL MICROBIOL BIOT, V97, P8439, DOI 10.1007/s00253-013-5175-4; Han Q, 2001, BIOCHEM J, V360, P617, DOI 10.1042/0264-6021:3600617; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; Huang RM, 2010, CHEM BIODIVERS, V7, P2809, DOI 10.1002/cbdv.200900211; Ioca LP, 2014, NAT PROD REP, V31, P646, DOI 10.1039/c3np70112c; Jamie H, 2002, J PHARM PHARMACOL, V54, P1659, DOI 10.1211/002235702252; Konig GM, 2006, CHEMBIOCHEM, V7, P229, DOI 10.1002/cbic.200500087; Lan YX, 2016, SCI CHINA CHEM, V59, P1224, DOI 10.1007/s11426-016-0026-7; Lee HS, 2005, J NAT PROD, V68, P623, DOI 10.1021/np040220g; LOWN JW, 1993, PHARMACOL THERAPEUT, V60, P185; Ma YM, 2016, J AGR FOOD CHEM, V64, P6659, DOI 10.1021/acs.jafc.6b01772; Malina Halina Z., 2001, BMC Physiology, V1, P1; Mangamuri U.K., 2016, EGYPT J AQUATIC RES, V42, P169, DOI [DOI 10.1016/j.ejar.2016.03.001, 10.1016/j.ejar.2016.03.001]; Manivasagan P, 2013, MICROBIOL RES, V168, P311, DOI 10.1016/j.micres.2013.02.002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naman CB, 2017, J NAT PROD, V80, P625, DOI 10.1021/acs.jnatprod.6b00907; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Ninomiya A, 2017, CHEMBIOCHEM, V18, P1770, DOI 10.1002/cbic.201700401; Nishimura O, 2017, BIOINFORMATICS, V33, P3635, DOI 10.1093/bioinformatics/btx445; Pandey A, 2019, PHARM MICROBES ENV C, V28, DOI [10.1007/978-3-030-04675-0_1, DOI 10.1007/978-3-030-04675-0_1]; Pesic A, 2013, MAR DRUGS, V11, P4834, DOI 10.3390/md11124834; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Preciado S, 2013, MEDCHEMCOMM, V4, P1171, DOI 10.1039/c3md20353k; Rateb ME, 2011, J NAT PROD, V74, P1965, DOI 10.1021/np200470u; Romano S, 2018, MAR DRUGS, V16, DOI 10.3390/md16070244; Santa Maria KC, 2019, CHEMBIOCHEM, V20, P1387, DOI 10.1002/cbic.201900025; Scheepers T, 2010, AFR J BIOTECHNOL, V9, P8824; Seipke RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116457; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sood S, 2016, J CLIN DIAGN RES, V10, pDC01, DOI 10.7860/JCDR/2016/14989.7167; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Takada K, 2013, J ORG CHEM, V78, P6746, DOI 10.1021/jo400708u; Uyeda M, 2001, BIOSCI BIOTECH BIOCH, V65, P1252, DOI 10.1271/bbb.65.1252; UZMA F, 2018, FRONT PHARMACOL, V9, P1; Velasco-Alzate KY, 2019, MAR DRUGS, V17, DOI 10.3390/md17120671; Vior NM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02828-17; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Wang P, 2013, MAR DRUGS, V11, P1035, DOI 10.3390/md11041035; Yamanaka K, 2005, MICROBIOL-SGM, V151, P2899, DOI 10.1099/mic.0.28139-0; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s	66	15	15	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244385	10.1371/journal.pone.0244385	http://dx.doi.org/10.1371/journal.pone.0244385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347500	Green Published, gold			2022-12-26	WOS:000603071100051
J	Coomans, I; De Kinder, S; Van Belleghem, H; De Groote, K; Panzer, J; De Wilde, H; Mosquera, LM; Francois, K; Bove, T; Martens, T; De Wolf, D; Boone, J; Vandekerckhove, K				Coomans, Ilse; De Kinder, Sara; Van Belleghem, Hannah; De Groote, Katya; Panzer, Joseph; De Wilde, Hans; Mosquera, Laura Muino; Francois, Katrien; Bove, Thierry; Martens, Thomas; De Wolf, Daniel; Boone, Jan; Vandekerckhove, Kristof			Analysis of the recovery phase after maximal exercise in children with repaired tetralogy of Fallot and the relationship with ventricular function	PLOS ONE			English	Article							HEART-RATE RECOVERY; OXYGEN-UPTAKE; QRS-DURATION; DETERMINANTS; CONSUMPTION; DYSFUNCTION; INTENSITY; CAPACITY; DYNAMICS; IMPACT	Background Few studies demonstrate delayed recovery after exercise in children and adults with heart disease. We assess the recovery patterns of gas exchange parameters and heart rate (HR) in children with repaired Tetralogy of Fallot (rToF) compared to healthy peers and investigate the correlation with ventricular function and QRS duration. Methods 45 children after rToF and 45 controls performed a maximal incremental cardiopulmonary exercise test. In the subsequent recovery period, patterns of VO2, VCO2 and HR were analysed. Half-life time (T-1/2) of the exponential decay and drop per minute (Rec(min)) were compared between groups. In the rToF group, correlations were examined between the recovery parameters and QRS-duration and ventricular function, described by fractional shortening (FS) and tricuspid annular plane systolic excursion (TAPSE) measured at baseline prior to exercise. Results Recovery of VO2 and VCO2 was delayed in rToF patients, half-life time values were higher compared to controls (T1/2VO2 52.51 11.29 s vs. 44.31 +/- 10.47 s; p = 0.001 and T1/2VCO2 68.28 +/- 13.84 s vs. 59.41 +/- 12.06 s; p = 0.002) and percentage drop from maximal value was slower at each minute of recovery (p<0.05). Correlations were found with FS (T1/2VO2: r = -0.517; p<0.001; Rec(1min)VO(2): r = -0.636, p<0.001; Rec(1min)VCO(2): r = -0.373, p = 0.012) and TAPSE (T1/2VO2: r = -0.505; p<0.001; Rec(1min)VO(2): r = -0.566, p<0.001; T1/2VCO2: r = -0.466; p = 0.001; Rec(1min)VCO(2): r = -0.507, p<0.001), not with QRS-duration. No difference was found in HR recovery between patients and controls. Conclusions Children after rToF show a delayed gas exchange recovery after exercise. This delay correlates to ventricular function, demonstrating its importance in recovery after physical activity.	[Coomans, Ilse; De Groote, Katya; Panzer, Joseph; De Wilde, Hans; Mosquera, Laura Muino; De Wolf, Daniel; Vandekerckhove, Kristof] Ghent Univ Hosp, Dept Pediat Cardiol, Ghent, Belgium; [De Kinder, Sara; Van Belleghem, Hannah] Univ Ghent, Fac Med, Ghent, Belgium; [Francois, Katrien; Bove, Thierry; Martens, Thomas] Ghent Univ Hosp, Dept Cardiac Surg, Ghent, Belgium; [Boone, Jan] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; Ghent University	Coomans, I (corresponding author), Ghent Univ Hosp, Dept Pediat Cardiol, Ghent, Belgium.	ilse.coomans@uzgent.be	Panzer, Joseph/HHM-2095-2022; de wolf, daniel/F-7481-2013; Muino Mosquera, Laura/ABD-5010-2020	Panzer, Joseph/0000-0002-8667-8001; de wolf, daniel/0000-0002-0846-8914; Muino Mosquera, Laura/0000-0002-3094-7807; Bove, Thierry/0000-0003-3786-0699; Boone, Jan/0000-0002-8485-6169; Vandekerckhove, Kristof/0000-0002-1481-0878; Coomans, Ilse/0000-0001-8321-0537; Van Belleghem, Hannah/0000-0001-7724-1732				Apitz C, 2009, LANCET, V374, P1462, DOI 10.1016/S0140-6736(09)60657-7; Armstrong N, 1994, Exerc Sport Sci Rev, V22, P435; Bailey CS, 2018, JACC-HEART FAIL, V6, P329, DOI 10.1016/j.jchf.2018.01.007; Bailliard F, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-2; Budts W, 2005, INT J CARDIOL, V104, P46, DOI 10.1016/j.ijcard.2004.09.017; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Falk B, 2006, EXERC SPORT SCI REV, V34, P107, DOI 10.1249/00003677-200607000-00004; GAESSER GA, 1984, MED SCI SPORT EXER, V16, P29; Giardini A, 2006, EUR J HEART FAIL, V8, P736, DOI 10.1016/j.ejheart.2006.01.012; Greutmann M, 2014, INT J CARDIOL, V176, P333, DOI 10.1016/j.ijcard.2014.06.033; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Kipps AK, 2011, AM J CARDIOL, V108, P99, DOI 10.1016/j.amjcard.2011.02.349; Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026; Lurz P, 2014, INT J CARDIOL, V177, P276, DOI 10.1016/j.ijcard.2014.09.014; Mann TN, 2014, EUR J APPL PHYSIOL, V114, P1809, DOI 10.1007/s00421-014-2907-9; Marcuccio E, 2012, PEDIATR CARDIOL, V33, P1165, DOI 10.1007/s00246-012-0276-x; Mercer-Rosa L, 2013, J AM SOC ECHOCARDIOG, V26, P1322, DOI 10.1016/j.echo.2013.06.022; Muller J, 2015, INT J CARDIOL, V196, P158, DOI 10.1016/j.ijcard.2015.05.174; Ohuchi H, 2002, CIRCULATION, V106, P2819, DOI 10.1161/01.CIR.0000038891.06306.BA; Ohuchi H, 2007, AM HEART J, V154, P165, DOI 10.1016/j.ahj.2007.03.031; Paul MH, 1999, PEDIATR CARDIOL, V20, P49, DOI 10.1007/s002469900395; Pecanha T, 2014, CLIN PHYSIOL FUNCT I, V34, P327, DOI 10.1111/cpf.12102; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Singh TP, 2008, MED SCI SPORT EXER, V40, P601, DOI 10.1249/MSS.0b013e3181621ec4; Singh TP, 2011, MED SCI SPORT EXER, V43, P555, DOI 10.1249/MSS.0b013e3181f683b8; Wasserman K., 1987, J CARDIOPULM REHABIL, V7, P189, DOI [DOI 10.1097/00008483-198704000-00014, 10.1097/00008483-198704000-00014]; Wessel HU, 1999, PEDIATR CARDIOL, V20, P39, DOI 10.1007/s002469900393; ZANCONATO S, 1991, J APPL PHYSIOL, V71, P993, DOI 10.1152/jappl.1991.71.3.993	28	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244312	10.1371/journal.pone.0244312	http://dx.doi.org/10.1371/journal.pone.0244312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338081	Green Published, gold			2022-12-26	WOS:000601313500026
J	Gedefaw, G; Goedert, MH; Abebe, E; Demis, A				Gedefaw, Getnet; Goedert, Martha H.; Abebe, Eskeziaw; Demis, Asmamaw			Effect of cesarean section on initiation of breast feeding: Findings from 2016 Ethiopian Demographic and Health Survey	PLOS ONE			English	Article							DELIVERY; PREGNANCY	Background Early initiation of breast feeding has great importance for both mothers and newborns. Despite, recommendations for exclusive and early initiation of breast feeding within one hour of birth, Ethiopia reports that 58% of infants under six months of age are exclusively breastfed. Cesarean deliveries may affect timing of breastfeeding initiation, establishment of milk supply and infant breastfeeding interest compared to vaginal deliveries. The aim of this study was to assess the impact of cesarean delivery on breastfeeding initiation. Methods A cross-sectional study was conducted with a total of 7115 study participants from the 2016 Ethiopian Demographic Health Survey (EDHS). Both descriptive and analytical statistical analysis was employed. Univariable and multivariable logistic regression analyses were used to identify anyassociations between variables. Odds ratios with its corresponding 95% confidence intervals (CI) were reported. During multivariable analysis, variables with p-value <0.05 were considered as statistically significant. Results The prevalence of late initiation of breast feeding among women with their last live birth was 25.03% (95%CI; 20.5-32.2). Significant factors associated with late initiation of breastfeeding were cesarean delivery [AOR = 4.06 (95%CI, 2.66-6.2)], primipara mother [AOR = 1.45(95%CI, 1.13-1.7)], and having an unplanned pregnancy [AOR = 1.35(95%CI, 1.1-1.65)]. Positively associated with early initiation of breastfeeding was the mother's age, for women between 20-34 years-old. This association, reported as a negative association of late initiation of breast feeding was [AOR = 0.77(95%CI, 0.61-0.98)]. Conclusion Cesarean delivery adversely affects the initiation of breast feeding. Cesarean delivery, unplanned pregnancy, and being primiparous, were associated with late initiation of breastfeeding. Women between the ages of 20-34 years of age had a reduced chance of late initiation of breastfeeding. Providing counseling regarding the strategy and importance of early initiation of breast feeding, could have crucial importance for the mother and her newborn.	[Gedefaw, Getnet; Abebe, Eskeziaw] Woldia Univ, Dept Midwifery, Coll Hlth Sci, Woldia, Ethiopia; [Goedert, Martha H.] Univ Nebraska Med Ctr, Dept Hlth Promot, Coll Publ Hlth, Omaha, NE USA; [Demis, Asmamaw] Woldia Univ, Dept Nursing, Coll Hlth Sci, Woldia, Ethiopia	University of Nebraska System; University of Nebraska Medical Center	Gedefaw, G (corresponding author), Woldia Univ, Dept Midwifery, Coll Hlth Sci, Woldia, Ethiopia.	gedefawget@gmail.com	Kassahun, Eskeziaw Abebe/CAH-7384-2022; Bizuneh, Asmamaw Demis/ABA-1868-2021	Kassahun, Eskeziaw Abebe/0000-0003-0580-5708				Abebe FE, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-015-0114-8; Ahmed KY, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0234-9; Amin T, 2010, INT NURS REV, V6, P59; Anbaran ZK, 2016, INT J PEDIATR-MASSHA, V4, P4043, DOI 10.22038/ijp.2016.7151; [Anonymous], 2018, GLOB STRAT INF YOUNG; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Berde AS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0818-y; Berhe H, 2011, DETERMINANTS BREASTF; Central Statistical Agency (CSA) [Ethiopia] ICF, 2016, ETHIOPIA DEMOGRAPHIC; Cheng D, 2009, CONTRACEPTION, V79, P194, DOI 10.1016/j.contraception.2008.09.009; Ekubay M, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0146-0; Erbaydar NP, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2732-6; Gavhane S, 2018, INT J RES MED SCI, V6, P481, DOI [10.18203/2320, DOI 10.18203/2320, 10.18203/2320-6012.ijrms20180285, DOI 10.18203/2320-6012.IJRMS20180285]; Gebremedhin S, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-14; Karlstrom A, 2013, BJOG-INT J OBSTET GY, V120, P479, DOI 10.1111/1471-0528.12129; Kitano Naomi, 2016, Prev Med Rep, V3, P121, DOI 10.1016/j.pmedr.2015.12.010; Kost K, 1998, FAM PLANN PERSPECT, V30, P223, DOI 10.2307/2991608; Ksenia B, 2007, RANDOMIZED TRIAL ST, V2, P9, DOI [10.1186/1746-4358-2-9, DOI 10.1186/1746-4358-2-917488524]; Lauer J. A., 2010, DETERMINANTS CAESARE; Lin HC, 2004, ACTA OBSTET GYN SCAN, V83, P1178; McLachlan HL, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-7; Mukunya D, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1410975; Oakley L, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12535; Patel A, 2013, J HUM LACT, V29, P572, DOI 10.1177/0890334412474718; Patel RR, 2003, BIRTH-ISS PERINAT C, V30, P255, DOI 10.1046/j.1523-536X.2003.00255.x; Patil CL, 2015, J HEALTH POPUL NUTR, V34, DOI 10.1186/s41043-015-0004-2; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; Regan J, 2013, BREASTFEED MED, V8, P181, DOI 10.1089/bfm.2012.0049; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Seid AM, 2014, ISRN EPIDEMIOLOGY, V2014, P3; Setegn T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-217; Tamiru D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-363; The Demographic and Health Services Program-ICF, 2020, LIB DEM HLTH SURV 20; Tongun JB, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0170-0; Vieira TO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-760; Wax JR, 2006, SEMIN PERINATOL, V30, P247, DOI 10.1053/j.semperi.2006.07.003; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Zhao J, 2017, MATERN CHILD HLTH J, V21, P2008, DOI 10.1007/s10995-017-2369-x; Zhou YB, 2014, PLACENTA, V35, P1, DOI 10.1016/j.placenta.2013.10.011	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244229	10.1371/journal.pone.0244229	http://dx.doi.org/10.1371/journal.pone.0244229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338080	Green Published, gold			2022-12-26	WOS:000601313500019
J	Donders, HCM; IJzerman, LM; Soffner, M; van't Hof, AWJ; Loos, BG; de Lange, J				Donders, H. C. M.; IJzerman, L. M.; Soffner, M.; van't Hof, A. W. J.; Loos, B. G.; de Lange, J.			Elevated Coronary Artery Calcium scores are associated with tooth loss	PLOS ONE			English	Article							APICAL PERIODONTITIS; RISK MARKERS; ATHEROSCLEROSIS; DISEASE; CALCIFICATION; EPIDEMIOLOGY; EVENTS; ZERO	Aim This study explores the association between Coronary Artery Calcium (CAC) scores and dental pathology such as missing teeth, the (peri-apical) health status and restoration grade of the teeth, and the grade of alveolar bone loss seen on a dental panoramic radiograph (Orthopantomograph-OPG). Materials and methods In this retrospective cross-sectional study, data was collected from three hospitals spread in the Netherlands. Patients were included when a CAC score and an OPG were available, both recorded within a maximum period of 365 days from 2009-2017. The CAC score was measured on a CT scan, using the Agatston method. To assess dental pathology, the number of missing teeth, the number of dental implants, alveolar bone loss, caries, endodontic treatments, peri-apical radiolucencies, bone loss at implants, impacted teeth and dental cysts, were determined on the OPG. All observers were calibrated. The electronic health records provided information about: gender, age, smoking, Diabetes Mellitus, hypercholesterolemia, hypertension and Body Mass Index (BMI). Results 212 patients were included. We found a statistically significant association between the number of missing teeth and the CAC score. When modeling age, sex, and other well-known risk factors for cardiovascular disease, the significant correlation was no longer present after multivariate correction. Furthermore, the results showed a trend for more teeth with peri-apical lesions and a higher percentage of mean alveolar bone loss in the group with the highest CAC scores. Conclusion This study showed that being edentulous or missing teeth is correlated to higher CAC scores however failed to be an independent predictor of atherosclerotic cardiovascular diseases. The number of (missing) teeth is an easily accessible marker and could be used as a marker for atherosclerotic cardiovascular disease (ACVD) risk by almost any healthcare worker. The current study needs to be considered as an explorative pilot study and could contribute to the design of further (prospective) studies on the relationship between dental pathology and coronary artery calcification by adding clinical information and extra cardiovascular biomarkers.	[Donders, H. C. M.; de Lange, J.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg, Amsterdam UMC, Amsterdam, Netherlands; [Donders, H. C. M.] Isala Hosp Zwolle, Dept Oral & Maxillofacial Surg, Zwolle, Netherlands; [IJzerman, L. M.; Loos, B. G.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol, Amsterdam, Netherlands; [IJzerman, L. M.; Loos, B. G.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Soffner, M.] TSC Hoorn, Practice Endodontol, Hoorn, Netherlands; [van't Hof, A. W. J.] Maastricht Univ, Dept Cardiol, Med Ctr, Maastricht, Netherlands; [van't Hof, A. W. J.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [van't Hof, A. W. J.] Zuyderland MC, Dept Cardiol, Heerlen, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University	Donders, HCM (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg, Amsterdam UMC, Amsterdam, Netherlands.; Donders, HCM (corresponding author), Isala Hosp Zwolle, Dept Oral & Maxillofacial Surg, Zwolle, Netherlands.	h.c.m.donders@isala.nl		Donders, Marie-Chris/0000-0003-3750-8513; van 't Hof, Arnoud/0000-0002-2344-7564				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Berlin-Broner Y, 2017, INT ENDOD J, V50, P847, DOI 10.1111/iej.12710; Blaha MJ, 2016, CIRCULATION, V133, P849, DOI 10.1161/CIRCULATIONAHA.115.018524; Budoff MJ, 2017, CIRCULATION, V136, P1993, DOI 10.1161/CIRCULATIONAHA.117.030578; Cardiovascular Diseases (CVDs), 2015, CARD DIS CVDS FACT S; Cheng F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194563; Donders H., 2012, J CRANIO MAXILLARY D, V1, P17; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Frencken JE, 2017, J CLIN PERIODONTOL, V44, pS94, DOI 10.1111/jcpe.12677; Georgiou AC, 2019, J ENDODONT, V45, P1279, DOI 10.1016/j.joen.2019.07.017; Gerritsen AE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-126; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Greenland P, 2018, J AM COLL CARDIOL, V72, P434, DOI 10.1016/j.jacc.2018.05.027; Groves DW, 2015, AM J CARDIOL, V116, P833, DOI 10.1016/j.amjcard.2015.06.006; Hulten EA, 2011, J AM COLL CARDIOL, V57, P2544, DOI 10.1016/j.jacc.2011.03.018; Kvist T, 2015, INT ENDOD J, V48, P913, DOI 10.1111/iej.12505; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liljestrand JM, 2015, J DENT RES, V94, P1055, DOI 10.1177/0022034515586352; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Moriya J, 2019, J CARDIOL, V73, P22, DOI 10.1016/j.jjcc.2018.05.010; Nakib SA, 2004, J PERIODONTOL, V75, P505, DOI 10.1902/jop.2004.75.4.505; Nardi C, 2018, J ENDODONT, V44, P1500, DOI 10.1016/j.joen.2018.07.003; Nardi C, 2017, J ENDODONT, V43, P1640, DOI 10.1016/j.joen.2017.06.020; Papapanou PN, 2017, PERIODONTOL 2000, V75, P45, DOI 10.1111/prd.12200; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Persson RE, 2003, J CLIN PERIODONTOL, V30, P833, DOI 10.1034/j.1600-051X.2003.00379.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rushton VE, 1996, J DENT, V24, P185, DOI 10.1016/0300-5712(95)00055-0; Sanz M, 2020, J CLIN PERIODONTOL, V47, P268, DOI 10.1111/jcpe.13189; Schei O, 1959, J PERIODONTOLOGY, V30, P7, DOI DOI 10.1902/JOP.1959.30.1.7; Schenkein Harvey A, 2013, J Clin Periodontol, V40 Suppl 14, pS51, DOI [10.1902/jop.2013.134006, 10.1111/jcpe.12060]; Schmitt A, 2015, J CLIN PERIODONTOL, V42, P977, DOI 10.1111/jcpe.12467; Seidelmann SB, 2018, LANCET PUBLIC HEALTH, V3, pE419, DOI 10.1016/S2468-2667(18)30135-X; Teeuw WJ, 2009, J PERIODONTAL RES, V44, P94, DOI 10.1111/j.1600-0765.2008.01111.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Xin HH, 2016, IEEE T SMART GRID, V7, P3, DOI 10.1109/TSG.2015.2473096; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243232	10.1371/journal.pone.0243232	http://dx.doi.org/10.1371/journal.pone.0243232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326424	Green Published, gold			2022-12-26	WOS:000600176400029
J	Lee, J; Lee, W; Lee, YJ; Sim, H; Lee, WK				Lee, Joongyub; Lee, Woojoo; Lee, Yu Jin; Sim, Hyunman; Lee, Won Kyung			Effectiveness of bystander cardiopulmonary resuscitation in improving the survival and neurological recovery of patients with out-of-hospital cardiac arrest: A nationwide patient cohort study	PLOS ONE			English	Article							ASSOCIATION; PREDICTORS; LOCATION; GENDER	Introduction Few studies have focused on enhancing causality and yielding unbiased estimates on the effectiveness of bystander cardiopulmonary resuscitation (BCPR) on the outcomes of out-of-hospital cardiac arrest (OHCA) in a real-world setting. Therefore, this study evaluated the effect of BCPR on the outcomes of OHCA and its differences according to the characteristics of OHCA. Methods This study enrolled all patients with OHCA of cardiac etiology treated by emergency medical services (EMS) in Korea from 2012 to 2015. The endpoints were survival and neurological recovery at discharge, and the main exposure was BCPR conducted by a layperson. The effect of BCPR was analyzed after adjusting for confounders, determined using a directed acyclic graph, by inverse probability of treatment weighting (IPTW) and model-based standardization (STR). Moreover, differences in subgroups and time trends were evaluated. Results Among 10,505 eligible patients after excluding those with missing data on BCPR, 7,721 patients received BCPR, accounting for 74.3% of EMS-treated OHCA patients. BCPR increased the odds of survival and good neurological recovery at discharge by 1.67- (95% confidence interval (CI): 1.44-1.93) and 1.93- (95% CI: 1.56-2.39) fold, respectively, in the IPTW analysis. These findings were comparable to those obtained with STR. The odds ratios were 2.39 (95% CI: 1.91-2.94) and 2.70 (95% CI: 1.94-3.41), respectively, in the sensitivity analysis of the missing BCPR information considering confounders and the outcome variable. However, the effect of qualified BCPR was not evenly distributed, and it did not increase with time. BCPR was likely to be more effective in male patients aged <65 years, those who experienced an OHCA in a private place or non-capital region, and those with shockable rhythm at the scene. Conclusion Based on data from a nationwide registry, the estimated effect of BCPR on survival and neurological recovery was moderate and did not improve from 2012 to 2015.	[Lee, Joongyub] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lee, Woojoo; Sim, Hyunman] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea; [Lee, Yu Jin] Inha Univ, Inha Univ Hosp, Sch Med, Dept Emergency Med, Incheon, South Korea; [Lee, Won Kyung] Inha Univ, Inha Univ Hosp, Sch Med, Dept Prevent & Management, Incheon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Inha University; Inha University Hospital; Inha University; Inha University Hospital	Lee, WK (corresponding author), Inha Univ, Inha Univ Hosp, Sch Med, Dept Prevent & Management, Incheon, South Korea.	bluewhale65@inha.ac.kr		Lee, Won Kyung/0000-0002-6014-8854; Lee, Woojoo/0000-0001-7447-7045	Bio & Medical Technology Development Program of the National Research Foundation - Korean government (MSIT) [2019M3E5D1A0206962012]	Bio & Medical Technology Development Program of the National Research Foundation - Korean government (MSIT)	WKL received funding for this work by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government (MSIT) (2019M3E5D1A0206962012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA, 2018, AHA RELEASES LATEST; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Blewer AL, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004710; Bougouin W, 2015, RESUSCITATION, V94, P55, DOI 10.1016/j.resuscitation.2015.06.018; Chen KY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211792; Coute RA, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.004677; Eftestol T, 2004, CIRCULATION, V110, P10, DOI 10.1161/01.CIR.0000133323.15565.75; Fukuda T, 2016, EUR J INTERN MED, V30, P61, DOI 10.1016/j.ejim.2016.01.022; Gharibzadeh S, 2016, ARCH IRAN MED, V19, P666, DOI 0161909/AIM.0011; Graham R M.M., 2015, STRATEGIES IMPROVE C, P456; Hagihara A, 2018, INT J CARDIOL, V265, P240, DOI 10.1016/j.ijcard.2018.04.067; Han KS, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050644; Holmberg M, 2001, EUR HEART J, V22, P511, DOI 10.1053/euhj.2000.2421; Hyman MC, 2019, EUR HEART J, V40, P3835, DOI 10.1093/eurheartj/ehz504; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Kim DK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232999; Kim YT, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016925; Korea_Centers_for_Disease_Control_and_Prevention, 2019, WEEKL HLTH DIS, P35; Lee DE, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e134; Lee DW, 2019, AM J EMERG MED, V37, P1999, DOI 10.1016/j.ajem.2019.02.021; Lee SY, 2019, RESUSCITATION, V138, P198, DOI 10.1016/j.resuscitation.2019.01.045; Martinell L, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1677-2; Maurer H, 2019, RESUSCITATION, V136, P78, DOI 10.1016/j.resuscitation.2018.12.009; Moon S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211804; Nikolaou N, 2019, RESUSCITATION, V138, P82, DOI 10.1016/j.resuscitation.2019.02.035; Park JH, 2018, RESUSCITATION, V125, P1, DOI 10.1016/j.resuscitation.2018.01.026; Rajan S, 2016, CIRCULATION, V134, P2095, DOI 10.1161/CIRCULATIONAHA.116.024400; Ro YS, 2017, ANN EMERG MED, V69, P52, DOI 10.1016/j.annemergmed.2016.07.028; Ro YS, 2016, AM J EMERG MED, V34, P1331, DOI 10.1016/j.ajem.2015.12.001; Shah M, 2018, PREHOSP EMERG CARE, V22, P222, DOI 10.1080/10903127.2017.1376133; Shimamoto T, 2020, INT HEART J, V61, P46, DOI 10.1536/ihj.19-301; Song J, 2018, SCANDINAVIAN J TRAUM; Song KJ, 2014, RESUSCITATION, V85, P34, DOI 10.1016/j.resuscitation.2013.06.004; Stecker EC, 2014, CIRC-ARRHYTHMIA ELEC, V7, P212, DOI 10.1161/CIRCEP.113.001034; Suttorp MM, 2015, NEPHROL DIAL TRANSPL, V30, P1418, DOI 10.1093/ndt/gfu325; Tanaka Y, 2015, RESUSCITATION, V86, P74, DOI 10.1016/j.resuscitation.2014.11.004; van Nieuwenhuizen BP, 2019, RESUSCITATION, V141, P44, DOI 10.1016/j.resuscitation.2019.05.018; Zhang ZW, 2016, STAT METHODS MED RES, V25, P2053, DOI 10.1177/0962280213513758	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243757	10.1371/journal.pone.0243757	http://dx.doi.org/10.1371/journal.pone.0243757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326454	Green Published, gold			2022-12-26	WOS:000600176400061
J	Bello-Chavolla, OY; Antonio-Villa, NE; Ortiz-Brizuela, E; Vargas-Vazquez, A; Gonzalez-Lara, MF; de Leon, AP; Sifuentes-Osornio, J; Aguilar-Salinas, CA				Yaxmehen Bello-Chavolla, Omar; Antonio-Villa, Neftali E.; Ortiz-Brizuela, Edgar; Vargas-Vazquez, Arsenio; Fernanda Gonzalez-Lara, Maria; Ponce de Leon, Alfredo; Sifuentes-Osornio, Jose; Aguilar-Salinas, Carlos A.			Validation and repurposing of the MSL-COVID-19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: The Nutri-CoV score	PLOS ONE			English	Article								Background During the COVID-19 pandemic, risk stratification has been used to decide patient eligibility for inpatient, critical and domiciliary care. Here, we sought to validate the MSL-COVID-19 score, originally developed to predict COVID-19 mortality in Mexicans. Also, an adaptation of the formula is proposed for the prediction of COVID-19 severity in a triage setting (Nutri-CoV). Methods We included patients evaluated from March 16(th) to August 17(th), 2020 at the Instituto Nacional de Ciencias Medicas y Nutricion, defining severe COVID-19 as a composite of death, ICU admission or requirement for intubation (n = 3,007). We validated MSL-COVID-19 for prediction of mortality and severe disease. Using Elastic Net Cox regression, we trained (n = 1,831) and validated (n = 1,176) a model for prediction of severe COVID-19 using MSL-COVID-19 along with clinical assessments obtained at a triage setting. Results The variables included in MSL-COVID-19 are: pneumonia, early onset type 2 diabetes, age > 65 years, chronic kidney disease, any form of immunosuppression, COPD, obesity, diabetes, and age <40 years. MSL-COVID-19 had good performance to predict COVID-19 mortality (c-statistic = 0.722, 95%CI 0.690-0.753) and severity (c-statistic = 0.777, 95%CI 0.753-0.801). The Nutri-CoV score includes the MSL-COVID-19 plus respiratory rate, and pulse oximetry. This tool had better performance in both training (c-statistic = 0.797, 95%CI 0.765-0.826) and validation cohorts (c-statistic = 0.772, 95%CI 0.0.745-0.800) compared to other severity scores. Conclusions MSL-COVID-19 predicts inpatient COVID-19 lethality. The Nutri-CoV score is an adaptation of MSL-COVID-19 to be used in a triage environment. Both scores have been deployed as web-based tools for clinical use in a triage setting.	[Yaxmehen Bello-Chavolla, Omar; Antonio-Villa, Neftali E.; Vargas-Vazquez, Arsenio; Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Invest Enfermedades Metab, Mexico City, DF, Mexico; [Yaxmehen Bello-Chavolla, Omar] Inst Nacl Geriatria, Div Invest, Mexico City, DF, Mexico; [Antonio-Villa, Neftali E.; Vargas-Vazquez, Arsenio] Univ Nacl Autonoma Mexico, Fac Med, PECEM, Mexico City, DF, Mexico; [Ortiz-Brizuela, Edgar; Fernanda Gonzalez-Lara, Maria; Ponce de Leon, Alfredo; Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City, DF, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Med, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Nutr, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos A.] Tecnol Monterrey, Escuela Med & Ciencias Salud, Zapopan, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Tecnologico de Monterrey	Aguilar-Salinas, CA (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Invest Enfermedades Metab, Mexico City, DF, Mexico.; Aguilar-Salinas, CA (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Nutr, Mexico City, DF, Mexico.; Aguilar-Salinas, CA (corresponding author), Tecnol Monterrey, Escuela Med & Ciencias Salud, Zapopan, Mexico.	caguilarsalinas@yahoo.com	Ortiz-Brizuela, Edgar/U-6302-2019; Antonio-Villa, Neftali Eduardo/GQH-1097-2022; Bello-Chavolla, Omar/AAB-7118-2019; Antonio-Villa, Neftali Eduardo/AAX-2970-2020	Ortiz-Brizuela, Edgar/0000-0001-7169-8459; Antonio-Villa, Neftali Eduardo/0000-0002-6879-1078; Bello-Chavolla, Omar/0000-0003-3093-937X; Antonio-Villa, Neftali Eduardo/0000-0002-6879-1078; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Sifuentes-Osornio, Jose/0000-0001-9584-1360	CONACyT	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	AVV, NEAV are enrolled at the PECEM program of the Faculty of Medicine at UNAM. NEAV and AVV are supported by CONACyT. The authors would like to acknowledge the invaluable work of all healthcare workers at the Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran for its community in managing the COVID-19 epidemic. Its participation in the COVID-19 surveillance program has made this work a reality, we are thankful for your effort.	Abrams EM, 2020, LANCET RESP MED, V8, P659, DOI 10.1016/S2213-2600(20)30234-4; Bello-Chavolla OY, 2021, J GERONTOL A-BIOL, V76, pE52, DOI 10.1093/gerona/glaa163; Brown MJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009666; Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; Dixon AE, 2018, EXPERT REV RESP MED, V12, P755, DOI 10.1080/17476348.2018.1506331; Farrell TW, 2020, J AM GERIATR SOC, V68, P1143, DOI 10.1111/jgs.16539; Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Gupta RK, 2020, DEV VALIDATION 4C DE, DOI [10.1101/2020.10.09.20209957, DOI 10.1101/2020.10.09.20209957]; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825; Mejia-Vilet J. M., 2020, RISK SCORE PREDICT A, DOI [10.1101/2020.05.12.20099416, DOI 10.1101/2020.05.12.20099416]; Ortiz-Brizuela E, 2020, REV INVEST CLIN, V72, P165, DOI [10.24875/ric.20000334, 10.24875/RIC.20000334, 10.24875/RIC.20000211, 10.24875/ric.20000211]; Rao ST, 2020, DIABETES CARE, V43, P1416, DOI 10.2337/dc20-0643; Riley RD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m441; Roca O, 2019, AM J RESP CRIT CARE, V199, P1368, DOI 10.1164/rccm.201803-0589OC; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wilkerson RG, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.044; Wynants, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2810; Bello-Chavolla OY, 2020, J CLIN ENDOCR METAB, V105, P2752, DOI 10.1210/clinem/dgaa346; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE	29	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244051	10.1371/journal.pone.0244051	http://dx.doi.org/10.1371/journal.pone.0244051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326502	Green Published, gold			2022-12-26	WOS:000600176400011
J	Albadr, MAA; Tiun, S; Ayob, M; AL-Dhief, FT; Omar, K; Hamzah, FA				Albadr, Musatafa Abbas Abbood; Tiun, Sabrina; Ayob, Masri; AL-Dhief, Fahad Taha; Omar, Khairuddin; Hamzah, Faizal Amri			Optimised genetic algorithm-extreme learning machine approach for automatic COVID-19 detection	PLOS ONE			English	Article							ORIENTED GRADIENTS; FEATURES; CLASSIFICATION; HISTOGRAMS; EXTRACTION; PNEUMONIA; DIAGNOSIS; NETWORKS	The coronavirus disease (COVID-19), is an ongoing global pandemic caused by severe acute respiratory syndrome. Chest Computed Tomography (CT) is an effective method for detecting lung illnesses, including COVID-19. However, the CT scan is expensive and time-consuming. Therefore, this work focus on detecting COVID-19 using chest X-ray images because it is widely available, faster, and cheaper than CT scan. Many machine learning approaches such as Deep Learning, Neural Network, and Support Vector Machine; have used X-ray for detecting the COVID-19. Although the performance of those approaches is acceptable in terms of accuracy, however, they require high computational time and more memory space. Therefore, this work employs an Optimised Genetic Algorithm-Extreme Learning Machine (OGA-ELM) with three selection criteria (i.e., random, K-tournament, and roulette wheel) to detect COVID-19 using X-ray images. The most crucial strength factors of the Extreme Learning Machine (ELM) are: (i) high capability of the ELM in avoiding overfitting; (ii) its usability on binary and multi-type classifiers; and (iii) ELM could work as a kernel-based support vector machine with a structure of a neural network. These advantages make the ELM efficient in achieving an excellent learning performance. ELMs have successfully been applied in many domains, including medical domains such as breast cancer detection, pathological brain detection, and ductal carcinoma in situ detection, but not yet tested on detecting COVID-19. Hence, this work aims to identify the effectiveness of employing OGA-ELM in detecting COVID-19 using chest X-ray images. In order to reduce the dimensionality of a histogram oriented gradient features, we use principal component analysis. The performance of OGA-ELM is evaluated on a benchmark dataset containing 188 chest X-ray images with two classes: a healthy and a COVID-19 infected. The experimental result shows that the OGA-ELM achieves 100.00% accuracy with fast computation time. This demonstrates that OGA-ELM is an efficient method for COVID-19 detecting using chest X-ray images.	[Albadr, Musatafa Abbas Abbood; Tiun, Sabrina; Ayob, Masri; Omar, Khairuddin] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, CAIT, Bangi, Selangor, Malaysia; [AL-Dhief, Fahad Taha] Univ Teknol Malaysia, Sch Elect Engn, Dept Commun Engn, Utm Johor Bahru, Johor, Malaysia; [Hamzah, Faizal Amri] Univ Kebangsaan Malaysia, Med Ctr, Hosp Canselor Tuanku Muhriz, Dept Emergency Med, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Teknologi Malaysia; Universiti Kebangsaan Malaysia	Albadr, MAA (corresponding author), Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, CAIT, Bangi, Selangor, Malaysia.	mustafa_abbas1988@yahoo.com	Omar, Khairuddin/C-3534-2017; Hamzah, Faizal Amri/AAM-8817-2020	Omar, Khairuddin/0000-0003-1794-019X; Hamzah, Faizal Amri/0000-0001-6309-6394; Albadr, Musatafa/0000-0003-2062-688X	Universiti Kebangsaan Malaysia [GUP2020-063]	Universiti Kebangsaan Malaysia	This project was funded by Universiti Kebangsaan Malaysia with research code GUP2020-063.	Abbas A, 2021, APPL INTELL, V51, P854, DOI 10.1007/s10489-020-01829-7; Abdel-Nasser M, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8010100; Abdel-Nasser M, 2016, EXPERT SYST APPL, V64, P365, DOI 10.1016/j.eswa.2016.08.026; Al-Dhief FT, 2020, IEEE ACCESS, V8, P64514, DOI 10.1109/ACCESS.2020.2984925; Albadr MAA, 2020, CIRC SYST SIGNAL PR, V39, P4596, DOI 10.1007/s00034-020-01388-9; Albadr MAA, 2019, INT J SPEECH TECHNOL, V22, P711, DOI 10.1007/s10772-019-09621-w; Albadr MAA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194770; Albadra MAA, 2017, INT J APPL ENG RES, V12, P4610; Alqudah AM, 2020, JORDAN J ELECTR ENG, V6, P168, DOI 10.5455/jjee.204-1585312246; Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Beale MH, 2012, NEURAL NETWORK TOOLB; Bukhari S. U. K., 2020, MEDRXIV2020032620044; Celik HI, 2014, J TEXT I, V105, P575, DOI 10.1080/00405000.2013.827393; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cohen JP, 2020, 200611988 ARXIV; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Dong J, 2017, J MATER CHEM C, V5, P10023, DOI 10.1039/c7tc03343e; Elmousalami H., 2020, MEDRXIV; Ezzat D., 2020, ARXIV200405084; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Franquet T, 2001, EUR RESPIR J, V18, P196, DOI 10.1183/09031936.01.00213501; Ghoshal B., 2020, ESTIMATING UNCERTAIN, P1; Gozes O, 2020, ARXIV200305037, P1; Hemdan E.E.D., 2020, ARXIV; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Huang GB, 2014, COGN COMPUT, V6, P376, DOI 10.1007/s12559-014-9255-2; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Khan AI, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105581; Kumar P., 2020, PREPRINT; Lu SY, 2018, J MED IMAG HEALTH IN, V8, P1486, DOI 10.1166/jmihi.2018.2459; Maghdid HS, 2021, PROC SPIE, V11734, DOI 10.1117/12.2588672; Marsboom C, 2018, ECOL INDIC, V87, P209, DOI 10.1016/j.ecolind.2017.10.049; May RJ, 2010, NEURAL NETWORKS, V23, P283, DOI 10.1016/j.neunet.2009.11.009; Meyer D, 2015, INTERFACE LIBSVM PAC, Ve1071, P28; Mu YS, 2018, INFORM SCIENCES, V435, P40, DOI 10.1016/j.ins.2017.12.059; Narin A., 2020, ARXIV200310849; Niu PF, 2016, NEURAL PROCESS LETT, V44, P813, DOI 10.1007/s11063-016-9496-z; Nour M, 2020, APPL SOFT COMPUT, V97, DOI 10.1016/j.asoc.2020.106580; Obaid OI, 2018, INT J ENG TECHNOLOGY, V7, P160, DOI DOI 10.14419/IJET.V7I4.36.23737; Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792; Pakyurek M, 2020, ELEKTRON ELEKTROTECH, V26, P46, DOI 10.5755/j01.eie.26.1.25309; Phung S.L., 2009, MATLAB LIB CONVOLUTI; Punn NS, 2021, APPL INTELL, V51, P2689, DOI 10.1007/s10489-020-01900-3; Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; Sun YN, 2020, IEEE T CYBERNETICS, V50, P3840, DOI 10.1109/TCYB.2020.2983860; Bao TQ, 2020, J INFORM TELECOMMUN, V4, P140, DOI 10.1080/24751839.2019.1666625; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang SA, 2017, J ADV TRANSPORT, P1, DOI 10.1155/2017/8608032; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Xu M, 2018, IEEE T IMAGE PROCESS, V27, P5044, DOI 10.1109/TIP.2018.2847035; Yu T, 2018, OPT LETT, V43, P1107, DOI 10.1364/OL.43.001107; Zeng JY, 2019, INT J ENTERP INF SYS, V15, P100, DOI 10.4018/IJEIS.2019010106; Zhang J., 2020, ARXIV PREPRINT ARXIV; Zhang YD, 2018, MULTIMED TOOLS APPL, V77, P22629, DOI 10.1007/s11042-017-5023-0; Zhou W, 2020, IEEE T CIRCUITS-II, V67, P946, DOI 10.1109/TCSII.2020.2980557	59	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242899	10.1371/journal.pone.0242899	http://dx.doi.org/10.1371/journal.pone.0242899			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320858	Green Published, gold			2022-12-26	WOS:000600339800040
J	Nielsen, MBM; Pedersen, T; Mouritzen, A; Vitger, AD; Nielsen, LN; Poulsen, HH; Miles, JE				Nielsen, Michelle Bronniche Moller; Pedersen, Tenna; Mouritzen, Amalie; Vitger, Anne Desire; Nielsen, Lise Nikolic; Poulsen, Helle Harding; Miles, James Edward			Kinetic gait analysis in healthy dogs and dogs with osteoarthritis: An evaluation of precision and overlap performance of a pressure-sensitive walkway and the use of symmetry indices	PLOS ONE			English	Article							GROUND REACTION FORCES; VERTICAL FORCES; LIMB FUNCTION; LAMENESS; VARIANCE; VELOCITY; OBESITY; PADS; SIDE	In veterinary practice, a thorough gait examination is essential in the clinical workup of any orthopedic patient, including the large population of dogs with chronic pain as a result of osteoarthritis. The traditional visual gait examination is, however, a subjective discipline, and systems for kinetic gait analysis may potentially offer an objective alternative for gait assessment by the measurement of ground reaction forces. In order to avoid unnecessary testing of patients, a thorough, stepwise evaluation of the diagnostic performance of each system is recommended before clinical use for diagnostic purposes. The aim of the study was to evaluate the Tekscan pressure-sensitive walkway system by assessing precision (agreement between repetitive measurements in individual dogs) and overlap performance (the ability to distinguish dogs with lameness due to osteoarthritis from clinically healthy dogs). Direction of travel over the walkway was investigated as a possible bias. Symmetry indices are commonly used to assess lameness by comparing ground reaction forces across different combinations of limbs in each dog. However, SIs can be calculated in several different ways and specific recommendations for optimal use of individual indices are currently lacking. Therefore the present study also compared indices in order to recommend a specific index preferable for future studies of canine osteoarthritis. Forty-one clinically healthy dogs and 21 dogs with osteoarthritis were included in the study. High precision was demonstrated. The direction of travel over the walkway was excluded as a possible bias. A significant overlap was observed when comparing ground reaction forces measured in dogs with osteoarthritis compared to clinically healthy dogs. In some affected dogs, symmetry indices comparing contralateral limbs differed from clinically healthy dogs, but in general, the overlap performance was insufficient and, consequently, general use of this method for diagnostic purposes in dogs with osteoarthritis cannot be recommended.	[Nielsen, Michelle Bronniche Moller; Pedersen, Tenna; Mouritzen, Amalie; Vitger, Anne Desire; Nielsen, Lise Nikolic; Poulsen, Helle Harding; Miles, James Edward] Univ Copenhagen, Dept Vet Clin Sci, Frederiksberg, Denmark; [Pedersen, Tenna] Tvingstrup Anim Clin, Horsens, Denmark; [Mouritzen, Amalie] Holstebro Anim Hosp, Holstebro, Denmark	University of Copenhagen	Nielsen, MBM (corresponding author), Univ Copenhagen, Dept Vet Clin Sci, Frederiksberg, Denmark.	mic@sund.ku.dk		Nielsen, Lise Nikolic/0000-0002-3988-0979; Poulsen, Helle Harding/0000-0001-9000-9030; Miles, James/0000-0002-4377-1572; Vitger, Anne Desire/0000-0001-8620-4669	Agria/Swedish Kennel Club; Danish Kennel Club	Agria/Swedish Kennel Club; Danish Kennel Club	This work was supported by the Agria/Swedish Kennel Club (https://www.agria.dk/forskning/om-forskningsfonden/) research fund and the Danish Kennel Club (https://www.dkk.dk/).Authors JEM, HHP, LNN and ADV were involved in the funding process. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho FS, 2015, VET COMP ORTHOPAED, V28, P25, DOI 10.3415/VCOT-14-05-0081; Souza ANA, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-51; Amimoto H, 2019, AM J VET RES, V80, P461, DOI 10.2460/ajvr.80.5.461; Appelgrein C, 2019, VET COMP ORTHOPAED, V32, P97, DOI 10.1055/s-0038-1677492; Escobar ASA, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0344-6; Besancon MF, 2004, AM J VET RES, V65, P1497, DOI 10.2460/ajvr.2004.65.1497; Besancon MF, 2018, VET COMP ORTHOPAED T, V16, P153; Brown DC, 2013, J VET INTERN MED, V27, P22, DOI 10.1111/jvim.12004; Carr J DDL, 2016, RECOVERY REHAB, P93; Cooper C, 1998, AM J EPIDEMIOL, V147, P516; Gibert S, 2010, COMPUT METHOD BIOMEC, V13, P61, DOI 10.1080/10255842.2010.493724; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Gordon-Evans WJ, 2009, AM J VET RES, V70, P1444, DOI 10.2460/ajvr.70.12.1444; Hoffman CL, 2018, AM J VET RES, V79, P546, DOI 10.2460/ajvr.79.5.546; Johnston SA, 1997, VET CLIN N AM-SMALL, V27, P699, DOI 10.1016/S0195-5616(97)50076-3; Kano WT, 2016, BMC VET RES, V12, DOI 10.1186/s12917-015-0631-2; Keebaugh AE, 2015, JAVMA-J AM VET MED A, V246, P1215, DOI 10.2460/javma.246.11.1215; Khan KS, 2004, BJOG-INT J OBSTET GY, V111, P638, DOI 10.1111/j.1471-0528.2004.00218.x; Khan KS, 2001, BRIT J OBSTET GYNAEC, V108, P562; Kieves NR, 2019, AM J VET RES, V80, P265, DOI 10.2460/ajvr.80.3.265; Kim J, 2011, AM J VET RES, V72, P1171, DOI 10.2460/ajvr.72.9.1171; Kjelgaard-Hansen M, 2011, CLIN LAB MED, V31, P51, DOI 10.1016/j.cll.2010.10.002; Lascelles BDX, 2006, AM J VET RES, V67, P277, DOI 10.2460/ajvr.67.2.277; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Maitre P, 2008, COMPUT METHOD BIOMEC, V11, P153, DOI 10.1080/10255840802297036; Maitre P., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P111, DOI 10.1080/10255840701479263; Marshall WG, 2009, VET COMP ORTHOPAED, V22, P339, DOI 10.3415/VCOT-08-08-0069; Miles J.E., 2018, P 2018 BRIT SMALL AN, P474; Nordquist B, 2011, VET COMP ORTHOPAED, V24, P435, DOI 10.3415/VCOT-11-01-0015; Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x; Sandberg G, 2018, VET COMP ORTHOPAED, V31, P327, DOI 10.1055/s-0038-1666875; Schnabl-Feichter E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208085; Scott H, 2011, IN PRACTICE, V33, P20, DOI 10.1136/inp.c7447; Souza ANA, 2013, VET COMP ORTHOPAED, V26, P6, DOI 10.3415/VCOT-11-07-0100; Volstad N, 2016, VET J, V207, P80, DOI 10.1016/j.tvjl.2015.08.014; Voss K, 2010, VET SURG, V39, P863, DOI 10.1111/j.1532-950X.2010.00729.x; Waxman AS, 2008, VET SURG, V37, P241, DOI 10.1111/j.1532-950X.2008.00372.x; Wilson ML, 2019, AM J VET RES, V80, P403, DOI 10.2460/ajvr.80.4.403; Witte P, 2011, IN PRACTICE, V33, P58, DOI 10.1136/inp.d453	39	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243819	10.1371/journal.pone.0243819	http://dx.doi.org/10.1371/journal.pone.0243819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320889	gold, Green Published			2022-12-26	WOS:000600339800024
J	Periyasamy, M; Singh, AK; Gemma, C; Farzan, R; Allsopp, RC; Shaw, JA; Charmsaz, S; Young, LS; Cunnea, P; Coombes, RC; Gyorffy, B; Buluwela, L; Ali, S				Periyasamy, Manikandan; Singh, Anup K.; Gemma, Carolina; Farzan, Raed; Allsopp, Rebecca C.; Shaw, Jacqueline A.; Charmsaz, Sara; Young, Leonie S.; Cunnea, Paula; Coombes, R. Charles; Gyorffy, Balazs; Buluwela, Lakjaya; Ali, Simak			Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-kappa B	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; SIGNALING PATHWAY; DEAMINASE APOBEC3B; CATALYTIC SUBUNIT; MUTAGENESIS; EVOLUTION; FAMILY; DEFICIENCY; PROTEINS; REVEALS	The mutagenic APOBEC3B (A3B) cytosine deaminase is frequently over-expressed in cancer and promotes tumour heterogeneity and therapy resistance. Hence, understanding the mechanisms that underlie A3B over-expression is important, especially for developing therapeutic approaches to reducing A3B levels, and consequently limiting cancer mutagenesis. We previously demonstrated that A3B is repressed by p53 and p53 mutation increases A3B expression. Here, we investigate A3B expression upon treatment with chemotherapeutic drugs that activate p53, including 5-fluorouracil, etoposide and cisplatin. Contrary to expectation, these drugs induced A3B expression and concomitant cellular cytosine deaminase activity. A3B induction was p53-independent, as chemotherapy drugs stimulated A3B expression in p53 mutant cells. These drugs commonly activate ATM, ATR and DNA-PKcs. Using specific inhibitors and gene knockdowns, we show that activation of DNA-PKcs and ATM by chemotherapeutic drugs promotes NF-kappa B activity, with consequent recruitment of NF-kappa B to the A3B gene promoter to drive A3B expression. Further, we find that A3B knockdown re-sensitises resistant cells to cisplatin, and A3B knockout enhances sensitivity to chemotherapy drugs. Our data highlight a role for A3B in resistance to chemotherapy and indicate that stimulation of A3B expression by activation of DNA repair and NF-kappa B pathways could promote cancer mutations and expedite chemoresistance.	[Periyasamy, Manikandan; Singh, Anup K.; Gemma, Carolina; Farzan, Raed; Cunnea, Paula; Coombes, R. Charles; Buluwela, Lakjaya; Ali, Simak] Imperial Coll London, Dept Surg & Canc, London W12 0NN, England; [Allsopp, Rebecca C.; Shaw, Jacqueline A.] Univ Leicester, Dept Canc Studies & Canc Res UK, Leicester Ctr, Leicester, Leics, England; [Charmsaz, Sara; Young, Leonie S.] Royal Coll Surgeons Ireland, Dept Surg, Endocrine Oncol Res Grp, Dublin, Ireland; [Gyorffy, Balazs] Semmelweis Univ, Dept Bioinformat, Budapest, Hungary; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Gyorffy, Balazs] Inst Enzymol, MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Farzan, Raed] King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh, Saudi Arabia	Imperial College London; University of Leicester; Royal College of Surgeons - Ireland; Semmelweis University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; King Saud University	Ali, S (corresponding author), Imperial Coll London, Dept Surg & Canc, London W12 0NN, England.	simak.ali@imperial.ac.uk	Gyorffy, Balazs/AAA-9135-2021; Farzan, Raed/AAD-2486-2020; Ali, Simak/M-6912-2018	Gyorffy, Balazs/0000-0002-5772-3766; Farzan, Raed/0000-0003-1189-6319; Gemma, Carolina/0000-0002-4890-9972; Periyasamy, Manikandan/0000-0001-7626-2531; Cunnea, Paula/0000-0002-3699-4911; Shaw, Jacqui/0000-0003-4227-503X; Ali, Simak/0000-0002-1320-0816; Coombes, Raoul Charles/0000-0002-4811-1100	Cancer Research UK [C37/A18784]; LMS/NIHR Imperial Biomedical Research Centre Flow Cytometry Facility; Imperial Experimental Cancer Medicine Centre; Imperial NIHR Biomedical Research Centre; Cancer Research UK Imperial Centre	Cancer Research UK(Cancer Research UK); LMS/NIHR Imperial Biomedical Research Centre Flow Cytometry Facility; Imperial Experimental Cancer Medicine Centre; Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK Imperial Centre	We thank Dr B Vogelstein for p53-null HCT116 cells. We are grateful to Dr S Langdon for the PEA1 and PEA2 lines. Our thanks also go to Drs. S Hong and L Magnani for their kind gift of PEOO3 cells. This study was supported by Cancer Research UK grant C37/A18784. We thank the LMS/NIHR Imperial Biomedical Research Centre Flow Cytometry Facility for support. Additional support was provided by the Imperial Experimental Cancer Medicine Centre, Imperial NIHR Biomedical Research Centre, and the Cancer Research UK Imperial Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Andrysik Z, 2017, GENOME RES, V27, P1645, DOI 10.1101/gr.220533.117; Basu S, 1998, BIOCHEM BIOPH RES CO, V247, P79, DOI 10.1006/bbrc.1998.8741; Beshiri ML, 2012, P NATL ACAD SCI USA, V109, P18499, DOI 10.1073/pnas.1216724109; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Faltas BM, 2016, NAT GENET, V48, P1490, DOI 10.1038/ng.3692; Fang Y, 2015, MOL CELL BIOCHEM, V399, P269, DOI 10.1007/s11010-014-2253-6; Gadducci A, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0484-6; Gavande NS, 2016, PHARMACOL THERAPEUT, V160, P65, DOI 10.1016/j.pharmthera.2016.02.003; Green AM, 2019, DNA REPAIR, V83, DOI 10.1016/j.dnarep.2019.102700; Hadian K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001712; Hong SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11721-9; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; LANGDON SP, 1988, CANCER RES, V48, P6166; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Leonard B, 2016, CLIN CANCER RES, V22, P4746, DOI 10.1158/1078-0432.CCR-15-2910; Leonard B, 2015, CANCER RES, V75, P4538, DOI 10.1158/0008-5472.CAN-15-2171-T; Liu L, 1998, MOL CELL BIOL, V18, P4221, DOI 10.1128/MCB.18.7.4221; Maruyama W, 2016, BIOCHEM BIOPH RES CO, V478, P1466, DOI 10.1016/j.bbrc.2016.08.148; McDaniel YZ, 2020, NUCLEIC ACIDS RES, V48, P1353, DOI 10.1093/nar/gkz1164; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Menendez D, 2017, MOL CANCER RES, V15, P735, DOI 10.1158/1541-7786.MCR-17-0019; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nowarski R, 2012, BLOOD, V120, P366, DOI 10.1182/blood-2012-01-402123; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Periyasamy M, 2017, NUCLEIC ACIDS RES, V45, P11056, DOI 10.1093/nar/gkx721; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Poulos RC, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007779; Rajagopalan S, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000467; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roper N, 2019, CELL REP, V26, P2651, DOI 10.1016/j.celrep.2019.02.028; Sabatel H, 2011, BIOCHEM PHARMACOL, V82, P1371, DOI 10.1016/j.bcp.2011.07.105; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Schmitt C, 2018, ONCOL REP, V40, P2742, DOI 10.3892/or.2018.6698; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serebrenik AA, 2020, CLIN CANCER RES, V26, P3397, DOI 10.1158/1078-0432.CCR-19-2786; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Strickson S, 2013, BIOCHEM J, V451, P427, DOI 10.1042/BJ20121651; Stronach EA, 2011, NEOPLASIA, V13, P1069, DOI 10.1593/neo.111032; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Venkatesan S, 2018, ANN ONCOL, V29, P563, DOI 10.1093/annonc/mdy003; Wilson DM, 2010, TRENDS BIOCHEM SCI, V35, P247, DOI 10.1016/j.tibs.2010.01.003; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173	58	8	8	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1077	1090		10.1038/s41388-020-01583-7	http://dx.doi.org/10.1038/s41388-020-01583-7		DEC 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33323971	Green Submitted, Green Accepted			2022-12-26	WOS:000599126500005
J	Phetcharaburanin, J; Deewai, S; Kulthawatsiri, T; Moolpia, K; Suksawat, M; Promraksa, B; Klanrit, P; Namwat, N; Loilome, W; Poopasit, K; Katekaew, S; Phetcharaburanin, P				Phetcharaburanin, Jutarop; Deewai, Suthicha; Kulthawatsiri, Thanaporn; Moolpia, Komkid; Suksawat, Manida; Promraksa, Bundit; Klanrit, Poramate; Namwat, Nisana; Loilome, Watcharin; Poopasit, Kitisak; Katekaew, Somporn; Phetcharaburanin, Penprapa			H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination	PLOS ONE			English	Article							MULTIVARIATE STATISTICAL-ANALYSIS; NMR-SPECTROSCOPY; QUALITY	Dipterocarpus alatus belongs to Family Dipterocarpaceae that can be commonly found in Southeast Asian countries. It is a perennial plant with oval-shaped leaves and oleoresin-rich wood. It has been considered as a multipurpose plant since all parts can be practically utilized. One of the major problems for utilizing Dipterocarpus alatus is the difficulty knowing the exact age as this kind of plant is ready for multipurpose use after 20 years of age. At present, the most commonly used method for determining age of Dipterocarpus alatus is the annual ring estimation. However, this conventional method is unable to provide the high precision and accuracy of age determination due to its limitation including blurry annual rings caused by enriched oleoresin in the wood. The current study aimed to investigate the differences of H-1 -NMR spectroscopy-based metabolic profiles from bark and leaf of Dipterocarpus alatus at different ages including 2, 7, 15 and 25 years. Our findings demonstrated that there is a total of 56 metabolites shared between bark and leaf. It is noticeable that bark at different ages exhibited the strongest variation and sugar or sugar derivatives that were found in higher concentrations in bark compared with those in leaf. We found that decreasing levels of certain metabolites including tagatose, 1'kestose and 2'-fucosyllactose exhibited the promising patterns. In conclusion, panel metabolites involved in the sucrose biosynthesis can precisely determine the age and growth of Dipterocarpus alatus.	[Phetcharaburanin, Jutarop; Kulthawatsiri, Thanaporn; Suksawat, Manida; Promraksa, Bundit; Klanrit, Poramate; Namwat, Nisana; Loilome, Watcharin] Khon Kaen Univ, Dept Biochem, Fac Med, Khon Kaen, Thailand; [Phetcharaburanin, Jutarop; Kulthawatsiri, Thanaporn; Suksawat, Manida; Promraksa, Bundit; Klanrit, Poramate; Namwat, Nisana; Loilome, Watcharin] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Fac Med, Khon Kaen, Thailand; [Phetcharaburanin, Jutarop; Deewai, Suthicha; Kulthawatsiri, Thanaporn; Suksawat, Manida; Promraksa, Bundit; Klanrit, Poramate; Namwat, Nisana; Loilome, Watcharin] Khon Kaen Univ, Int Phenome Lab, Northeastern Sci Pk, Khon Kaen, Thailand; [Phetcharaburanin, Jutarop] Khon Kaen Univ, Ctr Excellence Innovat Chem, Fac Sci, Khon Kaen, Thailand; [Deewai, Suthicha; Moolpia, Komkid; Katekaew, Somporn] Khon Kaen Univ, Dept Biochem, Fac Sci, Khon Kaen, Thailand; [Moolpia, Komkid; Phetcharaburanin, Penprapa] Khon Kaen Univ, Museum & Lifelong Learning Ctr, Khon Kaen, Thailand; [Poopasit, Kitisak] Khon Kaen Univ, Dept Chem, Fac Sci, Khon Kaen, Thailand; [Phetcharaburanin, Penprapa] Khon Kaen Univ, Dept Environm Sci, Fac Sci, Khon Kaen, Thailand; [Phetcharaburanin, Penprapa] Khon Kaen Univ, Coordinat Ctr Royal Initiat Projects, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Phetcharaburanin, P (corresponding author), Khon Kaen Univ, Museum & Lifelong Learning Ctr, Khon Kaen, Thailand.; Phetcharaburanin, P (corresponding author), Khon Kaen Univ, Dept Environm Sci, Fac Sci, Khon Kaen, Thailand.; Phetcharaburanin, P (corresponding author), Khon Kaen Univ, Coordinat Ctr Royal Initiat Projects, Khon Kaen, Thailand.	penprapa@kku.ac.th	katekaew, somporn/AAP-2904-2021; Loilome, Watcharin/AAW-6203-2021; Promraksa, Bundit/AAI-5552-2021	katekaew, somporn/0000-0002-0651-0787; Klanrit, Poramate/0000-0003-0209-3901; Phetcharaburanin, Jutarop/0000-0003-4727-8395	Khon Kaen University [KKU62]	Khon Kaen University	This study was funded by a grant from Khon Kaen University (KKU62) to PP.	Ankarfjard R, 1998, ECON BOT, V52, P7, DOI 10.1007/BF02861291; [Anonymous], 2016, PLANT GENETIC CONSER; Barcelo AR, 1997, INT REV CYTOL, V176, P87, DOI 10.1016/S0074-7696(08)61609-5; Bawa K.S., 1998, REV DIPTEROCARPS TAX; Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Cho LH, 2018, J PLANT BIOL, V61, P121, DOI 10.1007/s12374-018-0081-z; Dona AC, 2014, ANAL CHEM, V86, P9887, DOI 10.1021/ac5025039; Ducatez-Boyer L., MULTIPLE FUNCTIONS T, P7; Dyrmose A.-M. H., EC IMPORTANCE OLEORE, V19; EQ W, 2012, AM J THER, V19, pe157; Gao S, 2017, ANN FOREST SCI, V74, DOI 10.1007/s13595-017-0623-4; Harman R., MULTIVARIATE STAT AN, P57, DOI [10.1016/j.foodres.2020.109299, DOI 10.1016/J.FOODRES.2020.109299]; Khiev P, 2012, CHEM PHARM BULL, V60, P955, DOI 10.1248/cpb.c12-00012; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kim JH, 2005, HYDROL PROCESS, V19, P1261, DOI 10.1002/hyp.5565; Liu QQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020335; Menges M, 2006, PLANT CELL, V18, P893, DOI 10.1105/tpc.105.039636; Muhtadi K.H.Y., 2014, J ADV CHEM, V9, P1861; Noori R, 2010, DESALINATION, V260, P129, DOI 10.1016/j.desal.2010.04.053; Orwa, 2009, AGROFORESTRY DATABAS; Orwa C, 2009, AGROFORESTRY TREE DA; Paine CET, 2010, FUNCT ECOL, V24, P1202, DOI 10.1111/j.1365-2435.2010.01736.x; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Press MC, 1999, NEW PHYTOL, V143, P213, DOI 10.1046/j.1469-8137.1999.00432.x; Promraksa B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216721; Rivera-Mondragon A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38334-4; Thitisaksakul M., 2017, 318428 PLANT BIOCH, P74; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; WOLF S, 1993, POTATO RES, V36, P253, DOI 10.1007/BF02360534; Yongram C, 2019, MOLECULES, V24, DOI 10.3390/molecules24173083	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243432	10.1371/journal.pone.0243432	http://dx.doi.org/10.1371/journal.pone.0243432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320902	gold, Green Published			2022-12-26	WOS:000600339800002
J	Macdonald, KE; Stacey, HJ; Harkin, G; Hall, LML; Young, MJ; Jones, JD				Macdonald, Katherine E.; Stacey, Helen J.; Harkin, Gillian; Hall, Lesley M. L.; Young, Matthew J.; Jones, Joshua D.			Patient perceptions of phage therapy for diabetic foot infection	PLOS ONE			English	Article								Infections of diabetic foot ulcers are common, generally recalcitrant and often complicated by antibiotic resistance. Alternative antimicrobial strategies are needed. Phage therapy is a promising alternative that is being rediscovered. Despite phage therapy's 100-year history, there have been no investigations into patient thoughts and concerns. This study aimed to explore patient awareness of and concern about antibiotic resistance and gain insight into the perceptions of phage therapy among a patient group that could potentially benefit from phage therapy. Patients with an active or resolved (healed or amputated) diabetic foot ulcer were eligible to participate. A survey was distributed digitally to eligible patients across Scotland via the NHS Research Scotland Diabetes Network and hard copies were available in diabetic foot clinics at the Royal Infirmary of Edinburgh and Queen Elizabeth University Hospital, Glasgow. A focus group of five survey respondents was held in Glasgow. Fifty-five survey responses were obtained. There was a high level of awareness (76.4%; N = 55) and concern (83.3%; N = 54) about antibiotic resistance. While largely aware of viruses, most patients had not heard of phage or phage therapy. Patients were no more concerned about phage than antibiotic therapy, with most suggesting more information could alleviate any concerns. Patient acceptability of phage therapy was high, a finding confirmed by the focus group. Patients are concerned about antibiotic resistance and supportive of 'new' antimicrobials. We have demonstrated that patients are supportive, enthusiastic and accepting of phage therapy. Although 'Western' phage therapy remains in its infancy, an understanding of patient ideas, concerns and expectations will be important in eventually shaping and successfully reintroducing phage therapy.	[Macdonald, Katherine E.; Jones, Joshua D.] Univ Edinburgh, Edinburgh Med Sch Biomed Sci, Infect Med, Edinburgh, Midlothian, Scotland; [Stacey, Helen J.] Univ Edinburgh, Edinburgh Med Sch, Edinburgh, Midlothian, Scotland; [Harkin, Gillian; Hall, Lesley M. L.] Queen Elizabeth Univ Hosp, Diabet & Endocrinol, Glasgow, Lanark, Scotland; [Young, Matthew J.] Royal Infirm Edinburgh NHS Trust, Outpatient Dept 2, Diabet Foot Clin, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Queen Elizabeth University Hospital (QEUH); Royal Infirmary of Edinburgh; University of Edinburgh	Jones, JD (corresponding author), Univ Edinburgh, Edinburgh Med Sch Biomed Sci, Infect Med, Edinburgh, Midlothian, Scotland.	josh.jones@ed.ac.uk			University of Edinburgh/Medical Research Council Confidence in Concept Grant [MC_PC_18046]; NHS Research Scotland (NRS), through Diabetes Network; MRC [MC_PC_18046] Funding Source: UKRI	University of Edinburgh/Medical Research Council Confidence in Concept Grant; NHS Research Scotland (NRS), through Diabetes Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was part of a University of Edinburgh/Medical Research Council Confidence in Concept Grant awarded to JDJ (MC_PC_18046). We also acknowledge the financial support of NHS Research Scotland (NRS), through Diabetes Network. The funders had no role in the design of the study and collection, analysis, or interpretation of data nor in writing the manuscript.	Abedon ST, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00981; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Brookes-Howell L, 2012, J GEN INTERN MED, V27, P766, DOI 10.1007/s11606-011-1916-1; Comeau AM, 2008, RES MICROBIOL, V159, P306, DOI 10.1016/j.resmic.2008.05.001; Dedrick RM, 2019, NAT MED, V25, P730, DOI 10.1038/s41591-019-0437-z; Eleftheriadou L, 2010, DRUGS, V70, P1785, DOI 10.2165/11538070-000000000-00000; Fish R, 2016, J WOUND CARE, V25, pS27, DOI 10.12968/jowc.2016.25.Sup7.S27; Goettsche LS, 2019, J DERMATOL TREAT, V30, P92, DOI 10.1080/09546634.2018.1473549; Gupta P, 2019, INT J LOW EXTR WOUND, V18, P171, DOI 10.1177/1534734619835115; Henig O, 2018, OPEN FORUM INFECT DI, P5, DOI [10.1093/ofid/ofy245, DOI 10.1093/0FID/0FY245]; Jault P, 2019, LANCET INFECT DIS, V19, P35, DOI 10.1016/S1473-3099(18)30482-1; Kortright KE, 2019, CELL HOST MICROBE, V25, P219, DOI 10.1016/j.chom.2019.01.014; Morozova VV, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01696; Patel DR, 2021, INT J LOW EXTR WOUND, V20, P37, DOI 10.1177/1534734619881076; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Ray A, 2015, J AM PODIAT MED ASSN, V105, P520, DOI 10.7547/14-036.1; Rhoads D D, 2009, J Wound Care, V18, P237; Rogoz P, 2019, PHAGE THERAPY: A PRACTICAL APPROACH, P189, DOI 10.1007/978-3-030-26736-0_8; Schooley RT, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00954-17; Scottish Diabetes Survey Monitoring Group, 2018, SCOTT DIAB SURV 2018; Stacey HJ, 2019, ACTA DIABETOL, V56, P907, DOI 10.1007/s00592-019-01301-0; Tascini C, 2011, DIABETES RES CLIN PR, V94, P133, DOI 10.1016/j.diabres.2011.07.017; The International Diabetes Federation, 2020, DIAB FACTS FIG; Weber-Dabrowska B., 2001, Clinical and Applied Immunology Reviews, V1, P131, DOI 10.1016/S1529-1049(01)00015-0; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Young MJ, 2020, CLIN AUDIT DAT UNPUB	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243947	10.1371/journal.pone.0243947	http://dx.doi.org/10.1371/journal.pone.0243947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315926	gold, Green Published			2022-12-26	WOS:000600186100044
J	Togao, O; Chikui, T; Tokumori, K; Kami, Y; Kikuchi, K; Momosaka, D; Kikuchi, Y; Kuga, D; Hata, N; Mizoguchi, M; Iihara, K; Hiwatashi, A				Togao, Osamu; Chikui, Toru; Tokumori, Kenji; Kami, Yukiko; Kikuchi, Kazufumi; Momosaka, Daichi; Kikuchi, Yoshitomo; Kuga, Daisuke; Hata, Nobuhiro; Mizoguchi, Masahiro; Iihara, Koji; Hiwatashi, Akio			Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas	PLOS ONE			English	Article							INTRAVOXEL INCOHERENT MOTION; PRIMARY CNS LYMPHOMA; DIAGNOSTIC PERFORMANCE; WEIGHTED MRI; PERFUSION; BRAIN; CANCER; GLIOMA; TUMORS; DWI	The preoperative imaging-based differentiation of primary central nervous system lymphomas (PCNSLs) and glioblastomas (GBs) is of high importance since the therapeutic strategies differ substantially between these tumors. In this study, we investigate whether the gamma distribution (GD) model is useful in this differentiation of PNCSLs and GBs. Twenty-seven patients with PCNSLs and 57 patients with GBs were imaged with diffusion-weighted imaging using 13 b-values ranging from 0 to 1000 sec/mm(2). The shape parameter (kappa) and scale parameter (theta) were obtained with the GD model. Fractions of three different areas under the probability density function curve (f1, f2, f3) were defined as follows: f1, diffusion coefficient (D) <1.0x10(-3) mm(2)/sec; f2, D >1.0x10(-3) and <3.0x10(-3) mm(2)/sec; f3, D >3.0x10(-3) mm(2)/sec. The GD model-derived parameters were compared between PCNSLs and GBs. Receiver operating characteristic (ROC) curve analyses were performed to assess diagnostic performance. The correlations with intravoxel incoherent motion (IVIM)-derived parameters were evaluated. The PCNSL group's kappa (2.26 +/- 1.00) was significantly smaller than the GB group's (3.62 +/- 2.01, p = 0.0004). The PCNSL group's f1 (0.542 +/- 0.107) was significantly larger than the GB group's (0.348 +/- 0.132, p<0.0001). The PCNSL group's f2 (0.372<plus/minus>0.098) was significantly smaller than the GB group's (0.508 +/- 0.127, p<0.0001). The PCNSL group's f3 (0.086<plus/minus>0.043) was significantly smaller than the GB group's (0.144 +/- 0.062, p<0.0001). The combination of <kappa>, f1, and f3 showed excellent diagnostic performance (area under the curve, 0.909). The f1 had an almost perfect inverse correlation with D. The f2 and f3 had very strong positive correlations with D and f, respectively. The GD model is useful for the differentiation of GBs and PCNSLs.	[Togao, Osamu] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka, Japan; [Chikui, Toru; Kami, Yukiko] Kyushu Univ, Fac Dent Sci, Dept Oral & Maxillofacial Radiol, Fukuoka, Japan; [Tokumori, Kenji] Teikyo Univ, Fac Med Technol, Dept Clin Radiol, Fukuoka, Japan; [Kikuchi, Kazufumi; Momosaka, Daichi; Kikuchi, Yoshitomo; Hiwatashi, Akio] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Japan; [Kuga, Daisuke; Hata, Nobuhiro; Mizoguchi, Masahiro; Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Japan	Kyushu University; Kyushu University; Teikyo University; Kyushu University; Kyushu University	Togao, O (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka, Japan.	togao@radiol.med.kyushu-u.ac.jp	Kikuchi, Kazufumi/AAP-4286-2021; Hata, Nobuhiro/AAF-3034-2021; Togao, Osamu/AAE-4702-2022	Kikuchi, Kazufumi/0000-0003-1292-1846; Hata, Nobuhiro/0000-0002-5523-7166; Togao, Osamu/0000-0002-5910-7852	JSPS KAKENHI [JP17K10410, JP20K08111]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP17K10410 and JP20K08111. O.T. recieved these grants. https://www.jsps.go.jp/j-grantsinaid/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, MAT SCI SEMICON PROC, V44, P30; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bao SX, 2019, MAGN RESON MED SCI, V18, P53, DOI 10.2463/mrms.mp.2017-0135; Borlinhas F, 2019, J MAGN RESON IMAGING, V50, P230, DOI 10.1002/jmri.26599; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Efroymson MA, 1960, MATH METHODS DIGITAL; El Khouli RH, 2009, J MAGN RESON IMAGING, V30, P999, DOI 10.1002/jmri.21947; Grinberg F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089225; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Latt J, 2008, MAGN RESON IMAGING, V26, P77, DOI 10.1016/j.mri.2007.04.001; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Lee B, 2018, AM J NEURORADIOL, V39, P1415, DOI 10.3174/ajnr.A5732; Lu XY, 2019, NEUROL SCI, V40, P947, DOI 10.1007/s10072-019-03732-7; Minosse S, 2017, MAGN RESON IMAGING, V42, P114, DOI 10.1016/j.mri.2017.06.006; Oshio K, 2014, MAGN RESON MED SCI, V13, P191, DOI 10.2463/mrms.2014-0016; Ostrom QT, 2019, NEURO-ONCOLOGY, V21, pV1, DOI 10.1093/neuonc/noz150; PEKAR J, 1992, MAGNET RESON MED, V23, P122, DOI 10.1002/mrm.1910230113; Schaff LR, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0666-1; Server A, 2009, ACTA RADIOL, V50, P682, DOI 10.1080/02841850902933123; Shinmoto H, 2015, J MAGN RESON IMAGING, V42, P56, DOI 10.1002/jmri.24761; Smith G, 2018, J BIG DATA-GER, V5, DOI 10.1186/s40537-018-0143-6; Suchorska B, 2016, NEURO-ONCOLOGY, V18, P549, DOI 10.1093/neuonc/nov326; Tomita H, 2020, MAGN RESON MED SCI, V19, P40, DOI 10.2463/mrms.mp.2018-0124; Yamada K, 2016, MAGN RESON MED SCI, V15, P237, DOI 10.2463/mrms.mp.2015-0067; Yamashita K, 2016, J MAGN RESON IMAGING, V44, P1256, DOI 10.1002/jmri.25261; Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yuan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087024	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243839	10.1371/journal.pone.0243839	http://dx.doi.org/10.1371/journal.pone.0243839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315914	gold, Green Published			2022-12-26	WOS:000600186100076
J	Carino, A; Marchiano, S; Biagioli, M; Scarpelli, P; Bordoni, M; Di Giorgio, C; Roselli, R; Fiorucci, C; Monti, MC; Distrutti, E; Zampella, A; Fiorucci, S				Carino, Adriana; Marchiano, Silvia; Biagioli, Michele; Scarpelli, Paolo; Bordoni, Martina; Di Giorgio, Cristina; Roselli, Rosalinda; Fiorucci, Chiara; Monti, Maria Chiara; Distrutti, Eleonora; Zampella, Angela; Fiorucci, Stefano			The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy	FASEB JOURNAL			English	Article						autophagy; bile acids; CREB; FXR; GPBAR1	NUCLEAR RECEPTOR; INTESTINAL MICROBIOTA; TGR5; METABOLISM; IDENTIFICATION; EXPRESSION; STEATOSIS; DISCOVERY; ENDOCRINE; LIGANDS	Autophagy is a highly conserved catabolic process activated by fasting and caloric restriction. FXR, a receptor for primary bile acids, reverses the activity of cAMP-response element binding protein (CREB) on autophagy-related genes (Atg)s and terminates autophagy in the fed state. GPBAR1, a receptor for secondary bile acids, exerts its genomic effects via cAMP-CREB pathway. By genetic and pharmacological approaches, we have obtained evidence that GPBAR1 functions as a positive modulator of autophagy in liver and white adipose tissue (WAT) in fasting. Mechanistically, we found that Gpbar1(-/-) mice lack the expression of Cyp2c70 a gene essential for generation of muricholic acids which are FXR antagonists, and have an FXR-biased bile acid pool. Because FXR represses autophagy, Gpbar1(-/-) mice show a defective regulation of autophagy in fasting. BAR501, a selective GPBAR1 agonist, induces autophagy in fed mice. Defective regulation of autophagy in Gpbar1(-/-) could be reversed by FXR antagonism, while repression of autophagy by feeding was partially abrogated by FXR gene ablation, and FXR activation repressed Atgs in the fast state. BAR501 reversed the negative regulatory effects of feeding and FXR agonism on autophagy and promoted the recruitment of CREB to a CRE on the LC3 promoter. In mice exposed to chronic high caloric intake, GPBAR1 agonism ameliorated insulin sensitivity and induced Atgs expression in the liver and WAT. In summary, GPBAR1 is required for positive regulation of autophagy in fasting and its ligands reverse the repressive effects exerted on liver and WAT autophagy flow by FXR in fed.	[Carino, Adriana; Marchiano, Silvia; Biagioli, Michele; Bordoni, Martina; Di Giorgio, Cristina; Fiorucci, Chiara; Fiorucci, Stefano] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Scarpelli, Paolo] Univ eCampus, Novedrate, Italy; [Roselli, Rosalinda; Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Pharm, Fisciano, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, SC Gastroenterol & Epatol, Perugia, Italy	University of Perugia; Universita Ecampus; University of Naples Federico II; University of Salerno; University of Perugia; Azienda Ospedaliera di Perugia	Fiorucci, S (corresponding author), Univ Perugia, Med Sch, Dept Surg & Biomed Sci, Perugia, Italy.	stefano.fiorucci@unipg.it	Fiorucci, Stefano/I-1251-2012	Carino, Adriana/0000-0003-2341-9528				Allaire M, 2019, J HEPATOL, V70, P985, DOI 10.1016/j.jhep.2019.01.026; Biagioli M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081820; Bunnett NW, 2014, J PHYSIOL-LONDON, V592, P2943, DOI 10.1113/jphysiol.2014.271155; Byun S, 2017, EMBO J, V36, P1755, DOI 10.15252/embj.201695500; Carino A, 2019, FASEB J, V33, P2809, DOI 10.1096/fj.201801373RR; Carino A, 2018, PHARMACOL RES, V131, P17, DOI 10.1016/j.phrs.2018.02.033; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13102-y; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42801; Casaburi I, 2012, CELL CYCLE, V11, P2699, DOI 10.4161/cc.21029; Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x; de Boer JF, 2020, J LIPID RES, V61, P291, DOI 10.1194/jlr.RA119000243; De Marino S, 2019, HANDB EXP PHARMACOL, V256, P137, DOI 10.1007/164_2019_237; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; Festa C, 2019, ACS MED CHEM LETT, V10, P504, DOI 10.1021/acsmedchemlett.8b00534; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P3, DOI 10.1007/164_2019_238; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P283, DOI 10.1007/164_2019_227; Fiorucci S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01853; Fiorucci S, 2018, PHARMACOL RES, V134, P289, DOI 10.1016/j.phrs.2018.07.014; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Girolamo F, 2019, MUSCLE NERVE, V60, P315, DOI 10.1002/mus.26608; Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo GCL, 2020, J LIPID RES, V61, P269, DOI 10.1194/jlr.C120000621; Hammoutene A, 2020, J HEPATOL, V72, P528, DOI 10.1016/j.jhep.2019.10.028; Holter MM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072124; Jakobi AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14343-8; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang PD, 2015, METHODS, V75, P13, DOI 10.1016/j.ymeth.2014.11.021; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Laing ED, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030260; Lamark T, 2017, ESSAYS BIOCHEM, V61, P609, DOI 10.1042/EBC20170035; Lee Jae Man, 2016, Ann Pediatr Endocrinol Metab, V21, P193, DOI 10.6065/apem.2016.21.4.193; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Levine B, 2015, J CLIN INVEST, V125, P14, DOI 10.1172/JCI73938; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mencarelli A, 2013, DIABETES, V62, P3384, DOI 10.2337/db13-0299; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Renga B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141082; Renga B, 2013, PHARMACOL RES, V77, P1, DOI 10.1016/j.phrs.2013.08.008; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Sepe V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19008; Sepe V, 2014, J MED CHEM, V57, P7687, DOI 10.1021/jm500889f; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Skledar DG, 2019, CHEMOSPHERE, V215, P870, DOI 10.1016/j.chemosphere.2018.10.129; Straniero S, 2020, J LIPID RES, V61, P480, DOI 10.1194/jlr.RA119000307; Takahashi S, 2016, J LIPID RES, V57, P2130, DOI 10.1194/jlr.M071183; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Towers CG, 2016, EBIOMEDICINE, V14, P15, DOI 10.1016/j.ebiom.2016.10.034; Tsuchiya H, 2015, GASTROENTEROLOGY, V148, P1012, DOI 10.1053/j.gastro.2015.01.045; Vassileva G, 2010, J ENDOCRINOL, V205, P225, DOI 10.1677/JOE-10-0009; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2013, AUTOPHAGY, V9, P756, DOI 10.4161/auto.23814; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xie C, 2017, DIABETES, V66, P613, DOI 10.2337/db16-0663; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Younossi ZM, 2019, LANCET, V394, P2184, DOI 10.1016/S0140-6736(19)33041-7; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005; Zummo FP, 2017, DIABETES, V66, P1272, DOI 10.2337/db16-1009	76	6	7	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21271	10.1096/fj.202001386R	http://dx.doi.org/10.1096/fj.202001386R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368684				2022-12-26	WOS:000605626600023
J	Cheng, X; Li, W; Zhao, RZ; Li, HM; Qin, JB; Tian, ML; Zhang, XH; Jin, GH				Cheng, Xiang; Li, Wen; Zhao, Rongzhen; Li, Haoming; Qin, Jianbing; Tian, Meiling; Zhang, Xinhua; Jin, Guohua			The role of hippocampal niche exosomes in rat hippocampal neurogenesis after fimbria-fornix transection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; EXTRACELLULAR VESICLES; EMERGING ROLE; CONTRIBUTES; MICRORNAS; NEURONS; REPAIR; FATE	Exosomes transfer signaling molecules such as proteins, lipids, and RNAs to facilitate cell-cell communication and play an important role in the stem cell microenvironment. In previous work, we demonstrated that rat fimbria-fornix transection (FFT) enhances neurogenesis from neural stem cells (NSCs) in the subgranular zone (SGZ). However, how neurogenesis is modulated after denervation remains unknown. Here, we investigated whether exosomes in a denervated hippocampal niche may affect neurogenesis. Using the FFT rat model, we extracted hippocampal exosomes and identified them using western blots, transmission electron microscopy (TEM), and nanoparticle size measurement. We also used RNA sequencing and bioinformatic analysis of exosomes to identify noncoding RNA expression profiles and neurogenesis-related miRNAs, respectively. RNA sequencing analysis demonstrated 9 upregulated and 15 downregulated miRNAs. miR-3559-3P and miR-6324 increased gradually after FFT. Thus, we investigated the function of miR-3559-3P and miR-6324 with NSC proliferation and differentiation assays. Transfection of miR-3559-3p and miR-6324 mimics inhibited the proliferation of NSCs and promoted the differentiation of NSCs into neurons, while miR-3559-3p and miR-6324 inhibitors promoted NSC proliferation and inhibited neuronal differentiation. Additionally, the exosome marker molecules CD9, CD63, and Alix were expressed in exosomes extracted from the hippocampal niche. Finally, TEM showed that exosomes were similar to 100 nm in diameter and had a "saucer-like" bilayer membrane structure. Taken together, these findings suggest that differentially expressed exosomes and their related miRNAs in the denervated hippocampal niche can promote differentiation of NSCs into neurons.	[Cheng, Xiang; Li, Wen; Zhao, Rongzhen; Li, Haoming; Qin, Jianbing; Tian, Meiling; Zhang, Xinhua; Jin, Guohua] Nantong Univ, Dept Human Anat, Inst Neurobiol, Med Sch, Nantong, Jiangsu, Peoples R China; [Jin, Guohua] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat, Jiangsu & Minist Educ, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Zhang, XH; Jin, GH (corresponding author), Nantong Univ, Dept Human Anat, Inst Neurobiol, Med Sch, Nantong, Jiangsu, Peoples R China.; Jin, GH (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat, Jiangsu & Minist Educ, Nantong, Jiangsu, Peoples R China.	zhangxinhua@ntu.edu.cn; jguohua@ntu.edu.cn	Li, Hao/GPS-9834-2022	Zhang, Xin-hua/0000-0002-5702-6733	National Natural Science Foundation of China [81501133]; Graduate Innovation Foundation of Jiangsu Province [KYZZ15_0350, KYCX17-1931]; Undergraduate Innovation and entrepreneurship training project of Nantong University [2018150]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Innovation Foundation of Jiangsu Province; Undergraduate Innovation and entrepreneurship training project of Nantong University; Priority Academic Program Development of Jiangsu Higher Education Institutions	Funding was provided by grants from the National Natural Science Foundation of China (81501133), Graduate Innovation Foundation of Jiangsu Province (KYZZ15_0350 and KYCX17-1931), Undergraduate Innovation and entrepreneurship training project of Nantong University (2018150), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cobelli NJ, 2017, ANN NY ACAD SCI, V1410, P57, DOI 10.1111/nyas.13469; Colucci-D'Amato L, 2006, NEUROL SCI, V27, P266, DOI 10.1007/s10072-006-0682-z; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez R, 2016, CNS NEUROL DISORD-DR, V15, P881, DOI 10.2174/1871527315666160815164247; Gottlieb DI, 2002, ANNU REV NEUROSCI, V25, P381, DOI 10.1146/annurev.neuro.25.112701.142904; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Howitt J, 2016, J BIOL CHEM, V291, P26589, DOI 10.1074/jbc.R116.757955; Javeed N, 2017, J BIOMED RES, V31, P386, DOI 10.7555/JBR.30.20150162; Joshi P, 2015, INT J MOL SCI, V16, P4800, DOI 10.3390/ijms16034800; Katz S, 2016, CELL REP, V17, P1383, DOI 10.1016/j.celrep.2016.09.088; Kim DY, 2015, CELL DEATH DIFFER, V22, P2034, DOI 10.1038/cdd.2015.123; Kim SU, 2007, BRAIN DEV-JPN, V29, P193, DOI 10.1016/j.braindev.2006.07.012; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; Kovacs GG, 2018, HAND CLINIC, V145, P301, DOI 10.1016/B978-0-12-802395-2.00021-3; Li D, 2018, CHINESE MED J-PEKING, V131, P2216, DOI 10.4103/0366-6999.240817; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; Malm T, 2016, NEUROCHEM INT, V97, P193, DOI 10.1016/j.neuint.2016.04.011; Pegtel DM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0516; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pons-Espinal M, 2017, STEM CELL REP, V8, P1046, DOI 10.1016/j.stemcr.2017.02.012; [施金洪 Shi Jinhong], 2013, [解剖学报, Acta Anatomica Sinica], V44, P729; Shi JH, 2012, IN VITRO CELL DEV-AN, V48, P603, DOI 10.1007/s11626-012-9562-4; Sun GJ, 2015, P NATL ACAD SCI USA, V112, P9484, DOI 10.1073/pnas.1508545112; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Vella LJ, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1348885; Xin HQ, 2017, CELL TRANSPLANT, V26, P243, DOI 10.3727/096368916X693031; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yang FM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0718-4; Zappulli V, 2016, J CLIN INVEST, V126, P1198, DOI 10.1172/JCI81134; Zhang XH, 2007, NEUROSCI LETT, V414, P115, DOI 10.1016/j.neulet.2006.07.078; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhu PP, 2013, IN VITRO CELL DEV-AN, V49, P103, DOI 10.1007/s11626-013-9582-8	36	1	1	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100188	10.1074/jbc.RA120.015561	http://dx.doi.org/10.1074/jbc.RA120.015561			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334882	gold, Green Published			2022-12-26	WOS:000672866400166
J	Kwon, SM; Min, S; Jeoun, UW; Sim, MS; Jung, GH; Hong, SM; Jee, BA; Woo, HG; Lee, C; Yoon, G				Kwon, So Mee; Min, Seongki; Jeoun, Un-woo; Sim, Min Seok; Jung, Gu Hyun; Hong, Sun Mi; Jee, Byul A.; Woo, Hyun Goo; Lee, Changhan; Yoon, Gyesoon			Global spliceosome activity regulates entry into cellular senescence	FASEB JOURNAL			English	Article						oxidative stress; replicative senescence; splicing factors; Sp1; splicing variant; transcriptome	TRANSCRIPTION FACTOR SP1; GENE-EXPRESSION; DOWN-REGULATION; RNA; CELLS; P53; INVOLVEMENT; LONGEVITY; REVEALS; PATHWAY	Cellular senescence is a state of permanent growth arrest that can ultimately contribute to aging. Senescence can be induced by various stressors and is associated with a myriad of cellular functions and phenotypic markers. Alternative splicing is emerging as a critical contributor to senescence and aging. However, it is unclear how the composition and function of the spliceosome are involved in senescence. Here, using replicative and oxidative stress-induced senescence models in primary human fibroblasts, we report a common shift in the expression of 58 spliceosomal genes at the pre-senescence stage, prior to the detection of senescence-associated beta-galactosidase (SA-beta-gal) activity. Spliceosomal perturbation, induced by pharmacologic and genetic inhibition of splicesomal genes, triggered cells to enter senescence, suggesting a key role as a gatekeeper. Association analysis of transcription factors based on the 58 splicesomal genes revealed Sp1 as a key regulator of senescence entry. Indeed, Sp1 depletion suppressed the expression of downstream spliceosomal genes (HNRNPA3, SRSF7, and SRSF4) and effectively induced senescence. These results indicate that spliceosomal gene sets, rather than a single spliceosomal gene, regulate the early transition into senescence prior to SA-beta-gal expression. Furthermore, our study provides a spliceosome signature that may be used as an early senescence marker.	[Kwon, So Mee; Min, Seongki; Jeoun, Un-woo; Sim, Min Seok; Jung, Gu Hyun; Hong, Sun Mi; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea; [Kwon, So Mee; Jee, Byul A.; Woo, Hyun Goo] Ajou Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Min, Seongki; Jeoun, Un-woo; Sim, Min Seok; Jung, Gu Hyun; Hong, Sun Mi; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biomed Sci Plus BK21, Suwon, South Korea; [Lee, Changhan] USC Leonard Davis Sch Gerontol, Los Angeles, CA USA	Ajou University; Ajou University; Ajou University	Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea.	ypeace@ajou.ac.kr	Woo, Hyun Goo/AEJ-7372-2022; Woo, Hyun Goo | 우현구/I-8954-2019	Woo, Hyun Goo/0000-0002-0916-893X; Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Min, Seongki/0000-0001-9621-0739				Alberstein M, 2007, RNA, V13, P1988, DOI 10.1261/rna.492907; An HJ, 2016, MOL CELL BIOCHEM, V414, P201, DOI 10.1007/s11010-016-2672-7; Breig O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059137; Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chen J, 2017, CANCER DISCOV, V7, P766, DOI 10.1158/2159-8290.CD-16-0908; Chen WJ, 2015, CURR BIOL, V25, pR181, DOI 10.1016/j.cub.2014.11.059; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Deschenes M, 2017, AGING CELL, V16, P918, DOI 10.1111/acel.12646; Effenberger KA, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1381; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789; Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148; Holly AC, 2013, MECH AGEING DEV, V134, P356, DOI 10.1016/j.mad.2013.05.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Blanco FJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00054; Jung HJ, 2017, J BIOL CHEM, V292, P3729, DOI 10.1074/jbc.M116.750539; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kim SY, 2012, AGING CELL, V11, P1102, DOI 10.1111/acel.12012; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Latorre E, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-017-0147-7; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maier AB, 2009, AGEING RES REV, V8, P237, DOI 10.1016/j.arr.2009.01.004; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Mazin P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.67; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Oh JE, 2007, BIOCHEM BIOPH RES CO, V353, P86, DOI 10.1016/j.bbrc.2006.11.118; Papasaikas P, 2015, MOL CELL, V57, P7, DOI 10.1016/j.molcel.2014.10.030; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Pont AR, 2012, MOL CELL, V47, P5, DOI 10.1016/j.molcel.2012.04.019; Rodriguez SA, 2016, AGING CELL, V15, P267, DOI 10.1111/acel.12433; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Shimada N, 2009, RNA BIOL, V6, P293, DOI 10.4161/rna.6.3.8497; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Verduci L, 2010, J BIOL CHEM, V285, P39551, DOI 10.1074/jbc.M110.114736; Volk EL, 2009, DIS MODEL MECH, V2, P47, DOI 10.1242/dmm.000992; von Muhlinen N, 2018, ONCOGENE, V37, P2379, DOI 10.1038/s41388-017-0101-3; Walsh CM, 2013, J BIOL CHEM, V288, P2816, DOI 10.1074/jbc.M112.410803; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	50	7	7	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21204	10.1096/fj.202000395RR	http://dx.doi.org/10.1096/fj.202000395RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337569	hybrid			2022-12-26	WOS:000605626600009
J	Van Hedger, SC; Veillette, J; Heald, SLM; Nusbaum, HC				Van Hedger, Stephen C.; Veillette, John; Heald, Shannon L. M.; Nusbaum, Howard C.			Revisiting discrete versus continuous models of human behavior: The case of absolute pitch	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; TONE LANGUAGE; MUSICAL PITCH; IDENTIFICATION; STUDENTS; ACQUISITION; JUDGMENTS; AMERICAN; ABILITY	Many human behaviors are discussed in terms of discrete categories. Quantizing behavior in this fashion may provide important traction for understanding the complexities of human experience, but it also may bias understanding of phenomena and associated mechanisms. One example of this is absolute pitch (AP), which is often treated as a discrete trait that is either present or absent (i.e., with easily identifiable near-perfect "genuine" AP possessors and at-chance non-AP possessors) despite emerging evidence that pitch-labeling ability is not all-or-nothing. We used a large-scale online assessment to test the discrete model of AP, specifically by measuring how intermediate performers related to the typically defined "non-AP" and "genuine AP" populations. Consistent with prior research, individuals who performed at-chance (non-AP) reported beginning musical instruction much later than the near-perfect AP participants, and the highest performers were more likely to speak a tonal language than were the lowest performers (though this effect was not as statistically robust as one would expect from prior research). Critically, however, these developmental factors did not differentiate the near-perfect AP performers from the intermediate AP performers. Gaussian mixture modeling supported the existence of two performance distributions-the first distribution encompassed both the intermediate and near-perfect AP possessors, whereas the second distribution encompassed only the at-chance participants. Overall, these results provide support for conceptualizing intermediate levels of pitch-labeling ability along the same continuum as genuine AP-level pitch labeling ability-in other words, a continuous distribution of AP skill among all above-chance performers rather than discrete categories of ability. Expanding the inclusion criteria for AP makes it possible to test hypotheses about the mechanisms that underlie this ability and relate this ability to more general cognitive mechanisms involved in other abilities.	[Van Hedger, Stephen C.; Veillette, John; Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Ctr Pract Wisdom, Chicago, IL 60637 USA; [Van Hedger, Stephen C.; Veillette, John; Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Van Hedger, Stephen C.] Western Univ, Brain & Mind Inst, London, ON, Canada; [Van Hedger, Stephen C.] Huron Univ Coll, Dept Psychol, London, ON, Canada	University of Chicago; University of Chicago; Western University (University of Western Ontario); Western University (University of Western Ontario)	Van Hedger, SC; Veillette, J (corresponding author), Univ Chicago, Ctr Pract Wisdom, Chicago, IL 60637 USA.; Van Hedger, SC; Veillette, J (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.; Van Hedger, SC (corresponding author), Western Univ, Brain & Mind Inst, London, ON, Canada.; Van Hedger, SC (corresponding author), Huron Univ Coll, Dept Psychol, London, ON, Canada.	svanhedg@uwo.ca; johnv@uchicago.edu	Van Hedger, Stephen Charles/V-3248-2019	Van Hedger, Stephen Charles/0000-0002-2448-9088; Veillette, John/0000-0002-0332-4372	John Templeton Foundation [58345]	John Templeton Foundation	This research was supported in part from a grant from the John Templeton Foundation (58345) to HCN (https://www.templeton.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; BACHEM A, 1955, J ACOUST SOC AM, V27, P1180, DOI 10.1121/1.1908155; Bachem A, 1937, J ACOUST SOC AM, V9, P146, DOI 10.1121/1.1915919; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Bartlette C., 2015, PSYCHOMUSICOLOGY, V24, P279; Ben-Haim MS, 2014, J EXP PSYCHOL HUMAN, V40, P24, DOI 10.1037/a0033583; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bermudez P, 2009, MUSIC PERCEPT, V27, P89, DOI 10.1525/MP.2009.27.2.89; Blagrove M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01351; BRADY PT, 1970, J ACOUST SOC AM, V48, P883, DOI 10.1121/1.1912227; Brauchli C, 2019, NEUROIMAGE, V189, P241, DOI 10.1016/j.neuroimage.2019.01.021; CUDDY LL, 1968, J ACOUST SOC AM, V43, P1069, DOI 10.1121/1.1910941; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Deutsch D, 2004, MUSIC PERCEPT, V21, P339, DOI 10.1525/mp.2004.21.3.339; Deutsch D., 2013, ABSOLUTE PITCH; Deutsch D, 2013, J ACOUST SOC AM, V134, P3853, DOI 10.1121/1.4824450; Deutsch D, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P141, DOI 10.1016/B978-0-12-381460-9.00005-5; Deutsch D, 2013, J ACOUST SOC AM, V133, P1859, DOI 10.1121/1.4792217; Deutsch D, 2009, J ACOUST SOC AM, V125, P2398, DOI 10.1121/1.3081389; Dohn A, 2014, MUSIC PERCEPT, V31, P359, DOI 10.1525/MP.2014.31.4.359; Dooley K. D., 2011, THESIS, P139; Eitan Z, 2017, MUSIC PERCEPT, V34, P569, DOI 10.1525/MP.2017.34.5.569; Frieler K, 2013, MUSIC SCI, V17, P334, DOI 10.1177/1029864913493802; Heald S. L. M., 2017, UNDERSTANDING SOUND, V232; Jakubowski K, 2017, Q J EXP PSYCHOL, V70, P434, DOI 10.1080/17470218.2015.1131726; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Leipold S, 2019, NEUROIMAGE, V200, P132, DOI 10.1016/j.neuroimage.2019.06.030; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Levitin DJ, 2003, MUSIC PERCEPT, V21, P105, DOI 10.1525/mp.2003.21.1.105; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; LOCKHEAD GR, 1981, J ACOUST SOC AM, V70, P387, DOI 10.1121/1.386773; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Mankel K, 2018, P NATL ACAD SCI USA, V115, P13129, DOI 10.1073/pnas.1811793115; Marsman M, 2017, EUR J DEV PSYCHOL, V14, P545, DOI 10.1080/17405629.2016.1259614; Mitchell H., 2017, WALL STREET J; MIYAZAKI K, 1990, MUSIC PERCEPT, V8, P177; MIYAZAKI K, 1989, MUSIC PERCEPT, V7, P1; Miyazaki K, 2006, MUSIC PERCEPT, V24, P63, DOI 10.1525/mp.2006.24.1.63; Mull HK, 1925, AM J PSYCHOL, V36, P469, DOI 10.2307/1413906; Rachem A, 1940, J ACOUST SOC AM, V11, P434; Schellenberg EG, 2008, MUSIC PERCEPT, V25, P241, DOI 10.1525/MP.2008.25.3.241; Schellenberg EG, 2003, PSYCHOL SCI, V14, P262, DOI 10.1111/1467-9280.03432; SERGEANT D, 1969, J RES MUSIC EDUC, V17, P135, DOI 10.2307/3344200; Smith NA, 2008, J ACOUST SOC AM, V123, pEL77, DOI 10.1121/1.2896106; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; TAKEUCHI AH, 1991, MUSIC PERCEPT, V9, P27; TERHARDT E, 1983, MUSIC PERCEPT, V1, P63; Theusch E, 2009, AM J HUM GENET, V85, P112, DOI 10.1016/j.ajhg.2009.06.010; Van Hedger SC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223047; Van Hedger SC, 2018, ACTA PSYCHOL, V191, P251, DOI 10.1016/j.actpsy.2018.10.007; Van Hedger SC, 2018, Q J EXP PSYCHOL, V71, P879, DOI 10.1080/17470218.2017.1307427; Van Hedger SC, 2017, PSYCHON B REV, V24, P481, DOI 10.3758/s13423-016-1099-1; Van Hedger SC, 2016, COGNITION, V154, P139, DOI 10.1016/j.cognition.2016.06.001; Van Hedger SC, 2015, COGNITION, V140, P95, DOI 10.1016/j.cognition.2015.03.012; VANKREVELEN A, 1951, J EXP PSYCHOL, V42, P207, DOI 10.1037/h0062795; Vitouch O, 2003, MUSIC PERCEPT, V21, P111, DOI 10.1525/mp.2003.21.1.111; Wagner SL, 2016, CHILD NEUROPSYCHOL, V22, P853, DOI 10.1080/09297049.2015.1080232; Ward W.D., 1982, PSYCHOL MUSIC, V2nd ed., P431; Wengenroth M, 2014, CEREB CORTEX, V24, P1127, DOI 10.1093/cercor/bhs391; Wilson SJ, 2012, MUSIC PERCEPT, V29, P285, DOI 10.1525/MP.2012.29.3.285; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081	63	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244308	10.1371/journal.pone.0244308	http://dx.doi.org/10.1371/journal.pone.0244308			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370349	Green Submitted, Green Published, gold			2022-12-26	WOS:000603611900121
J	Favaris, AP; Tuler, AC; Silva, WD; Rodrigues, SR; Leal, WS; Bento, JMS				Favaris, Arodi P.; Tuler, Amanda C.; Silva, Weliton D.; Rodrigues, Sergio R.; Leal, Walter S.; Bento, Jose M. S.			(3S,6E)-nerolidol-mediated rendezvous of Cyclocephala paraguayensis beetles in bottle gourd flowers	PLOS ONE			English	Article							FLORAL SCENT; SCARAB; POLLINATION; ATTRACTION; EVOLUTION; ANNONACEAE	Cyclocephalini beetles of the genus Cyclocephala (Coleoptera: Melolonthidae: Dynastinae) use flowers of some plants as food, shelter, and mating sites. However, little is known about floral scent chemistry involved in this interaction. Here we show that a sesquiterpene alcohol mediates attraction of Cyclocephala paraguayensis Arrow, on bottle gourd flowers, Lagenaria siceraria (Cucurbitaceae). Both males and females started to aggregate on the flowers at twilight; after that, mating began and remained for the entire night. GC-FID/EAD analysis of the L. siceraria floral scent collected in the field revealed that only the major constituent of the airborne volatiles elicited electroantennographic responses on male and female antennae of C. paraguayensis. This compound was identified as (3S,6E)-nerolidol, which was tested in two field trapping trials in Brazil. In the first bioassay, traps baited with nerolidol (mix of isomers) captured significantly more adult C. paraguayensis than control traps. In the second field trial, catches in traps baited with a mixture of isomers or enantiopure nerolidol were significantly higher than captures in control traps, but the treatments did not differ significantly. Analysis from the gut content of adult C. paraguayensis showed the presence of pollen, suggesting that they also use bottle gourd flowers for their nourishment. Taken together, these results suggest that (3S,6E)-nerolidol plays an essential role in the reproductive behavior of C. paraguayensis by eliciting aggregation, mating, and feeding.	[Favaris, Arodi P.; Tuler, Amanda C.; Silva, Weliton D.; Bento, Jose M. S.] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Rodrigues, Sergio R.] Univ Estadual Mato Grosso do Sul, Cassilandia, MS, Brazil; [Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Universidade de Sao Paulo; Universidade Estadual de Mato Grosso do Sul; University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Favaris, Arodí Prado/U-2653-2019; Leal, Walter/ABC-6940-2021; Bento, José Maurício Simões/A-9759-2008; Silva, Weliton D./N-9410-2019; Silva, Weliton D/J-5080-2015	Favaris, Arodí Prado/0000-0001-5537-2176; Bento, José Maurício Simões/0000-0001-8655-5178; Silva, Weliton D./0000-0001-9035-204X; Silva, Weliton D/0000-0001-9035-204X; Leal Filho, Walter/0000-0002-1241-5225; C. Tuler, Amanda/0000-0002-5563-4663	INCT-Semioquimicos na Agricultura [FAPESP 2014/50871-0, CNPq 465511/2014-7]	INCT-Semioquimicos na Agricultura	This research was supported by INCT-Semioquimicos na Agricultura (FAPESP 2014/50871-0 and CNPq 465511/2014-7).	Bomfim IGA, 2016, HDB CUCURBITS GROWTH, V1st, P594; Carde RT, 2014, J CHEM ECOL, V40, P519, DOI 10.1007/s10886-014-0465-6; Maia ACD, 2018, PEST MANAG SCI, V74, P2053, DOI 10.1002/ps.4895; Maia ACD, 2013, PHYTOCHEMISTRY, V93, P71, DOI 10.1016/j.phytochem.2013.03.005; Maia ACD, 2012, J CHEM ECOL, V38, P1072, DOI 10.1007/s10886-012-0173-z; Dotterl S, 2012, J CHEM ECOL, V38, P1539, DOI 10.1007/s10886-012-0210-y; Goncalves JA, 2020, J INSECT CONSERV, V24, P547, DOI 10.1007/s10841-020-00230-6; GOTTSBERGER G, 1990, BOT ACTA, V103, P360, DOI 10.1111/j.1438-8677.1990.tb00175.x; GOTTSBERGER G, 1986, PLANT SYST EVOL, V152, P29, DOI 10.1007/BF00985349; Gottsberger G, 2018, ACTA BOT BRAS, V32, P279, DOI 10.1590/0102-33062017abb0356; Gottsberger G, 2012, FLORA, V207, P107, DOI 10.1016/j.flora.2011.11.003; Havlickova J, 2019, Z NATURFORSCH C, V74, P251, DOI 10.1515/znc-2018-0197; Institute SAS, 2011, SAS STAT 9 3 USERS G; Kaiser R, 1991, PERFUMES ART SCI TCH, V1st, P213; Kistler L, 2014, P NATL ACAD SCI USA, V111, P2937, DOI 10.1073/pnas.1318678111; KNUDSEN JT, 1993, BOT J LINN SOC, V113, P263, DOI 10.1111/j.1095-8339.1993.tb00340.x; Maia ACD, 2019, J CHEM ECOL, V45, P204, DOI 10.1007/s10886-018-1018-1; McDonald J.H., 2014, HDB BIOL STAT; Moore MR, 2012, COLEOPTS BULL, V66, P200, DOI 10.1649/072.066.0303; Moore MR, 2018, ZOOKEYS, P1, DOI 10.3897/zookeys.745.23683; Moore MR, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.10001; Morimoto Yasuyuki, 2004, International Journal of Tropical Insect Science, V24, P79, DOI 10.1079/IJT20046; Munin Roberto Lobo, 2008, Braz. J. Bot., V31, P15, DOI 10.1590/S0100-84042008000100003; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Ortiz-Dominguez M, 2006, ENTOMOL EXP APPL, V119, P23, DOI 10.1111/j.1570-7458.2006.00388.x; PELLMYR O, 1986, TAXON, V35, P76, DOI 10.2307/1221036; Pereira J, 2014, BIOL J LINN SOC, V111, P679, DOI 10.1111/bij.12232; Schatz GE, 1990, REPROD ECOLOGY TROPI, P69; Schiestl FP, 2012, EVOLUTION, V66, P2042, DOI 10.1111/j.1558-5646.2012.01593.x; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Singh SP, 1996, CURR SCI INDIA, V70, P458; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575	33	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0235028	10.1371/journal.pone.0235028	http://dx.doi.org/10.1371/journal.pone.0235028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362256	Green Submitted, Green Published, gold			2022-12-26	WOS:000603071600054
J	Menikou, S; McArdle, AJ; Li, MS; Kaforou, M; Langford, PR; Levin, M				Menikou, Stephanie; McArdle, Andrew J.; Li, Ming-Shi; Kaforou, Myrsini; Langford, Paul R.; Levin, Michael			A proteomics-based method for identifying antigens within immune complexes	PLOS ONE			English	Article							SERUM; PRECIPITATION; ASSAY; IGG; PATHOGENESIS; QUANTITATION; RESPONSES; SUBCLASS; CONTAIN; DISEASE	A novel approach to recover and identify immune complexes (ICs) was developed using size exclusion chromatography (SEC) and affinity chromatography on immunoglobulin binding columns (HiTrap Protein G). The purification process was monitored by 1D SDS-PAGE, protein staining, Western blotting and, finally, liquid chromatography tandem mass spectrometry (LC MS/MS) was used to identify the recovered antigens. This approach was applied to serum with artificially created immune complexes (ICs) comprising vaccine antigen (influenza) and antibody, which led to recovery and identification of influenza peptides within the recovered ICs. This approach was compared with the established method for IC detection and recovery, polyethylene glycol (PEG) precipitation, followed by LC MS/MS. Both approaches successfully enabled capture, recovery and characterization of immunoglobulins and influenza antigen(s) in complex with the immunoglobulins. However, PEG precipitation has the advantage of simplicity and is more suited for large scale studies.	[Menikou, Stephanie; McArdle, Andrew J.; Li, Ming-Shi; Kaforou, Myrsini; Langford, Paul R.; Levin, Michael] Imperial Coll London, Sect Paediat Infect Dis, Dept Infect Dis, London, England	Imperial College London	Menikou, S (corresponding author), Imperial Coll London, Sect Paediat Infect Dis, Dept Infect Dis, London, England.	s.menikou@imperial.ac.uk		Levin, Michael/0000-0003-2767-6919; Menikou, Stephanie/0000-0002-3476-5808; McArdle, Andrew/0000-0001-7448-0869	UK National Institute for Health Research (NIHR) Imperial Biomedical Research Centre at Imperial College; Javon Charitable Trust; Children of St Mary's Intensive Care Kawasaki Disease Research Fund; Wellcome Trust/Imperial College London 4i PhD Fellowship	UK National Institute for Health Research (NIHR) Imperial Biomedical Research Centre at Imperial College; Javon Charitable Trust; Children of St Mary's Intensive Care Kawasaki Disease Research Fund; Wellcome Trust/Imperial College London 4i PhD Fellowship	This work supported in part by the UK National Institute for Health Research (NIHR) Imperial Biomedical Research Centre at Imperial College (WMNP_P69099, the Javon Charitable Trust, the Children of St Mary's Intensive Care Kawasaki Disease Research Fund.) AJM is funded through a Wellcome Trust/Imperial College London 4i PhD Fellowship.	Aibara N, 2018, CLIN CHIM ACTA, V484, P26, DOI 10.1016/j.cca.2018.05.026; [Anonymous], 2008, J CHANGCHUN U, V8, P34; [Anonymous], 2003, VVDSTRL, V62, P37; BIBERFELD G, 1974, J IMMUNOL, V112, P413; Calvopina K, 2017, MOL MICROBIOL, V106, P492, DOI 10.1111/mmi.13831; Chen YJ, 2016, J CLIN LAB ANAL, V30, P1169, DOI 10.1002/jcla.21999; CHIA D, 1979, CLIN EXP IMMUNOL, V37, P399; COPPOCK JS, 1986, RHEUMATOL INT, V6, P79, DOI 10.1007/BF00541509; COYLE PK, 1987, J NEUROIMMUNOL, V15, P97, DOI 10.1016/0165-5728(87)90009-9; CREIGHTON WD, 1973, J IMMUNOL, V111, P1219; CrowleyNowick PA, 1996, IMMUNOL INVEST, V25, P91, DOI 10.3109/08820139609059293; DIGEON M, 1977, J IMMUNOL METHODS, V16, P165, DOI 10.1016/0022-1759(77)90051-5; El-Madhun AS, 1999, J INFECT DIS, V180, P1356, DOI 10.1086/315003; Elshafie AI, 2007, J IMMUNOL, V178, P5383, DOI 10.4049/jimmunol.178.8.5383; HARKISS GD, 1979, CLIN EXP IMMUNOL, V36, P117; HAY FC, 1976, CLIN EXP IMMUNOL, V24, P396; JEWELL DP, 1973, CLIN EXP IMMUNOL, V14, P219; Jiang K, 2003, CLIN EXP IMMUNOL, V131, P61, DOI 10.1046/j.1365-2249.2003.02046.x; LEVIN M, 1985, BRIT MED J, V290, P1456, DOI 10.1136/bmj.290.6480.1456; LEVINSKY RJ, 1981, J CLIN PATHOL, V34, P1214, DOI 10.1136/jcp.34.11.1214; Manenti A, 2017, VACCINE, V35, P191, DOI 10.1016/j.vaccine.2016.10.024; MANNIK M, 1988, SPRINGER SEMIN IMMUN, V10, P215, DOI 10.1007/BF01857226; Mathsson L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1926; Menikou S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01156; MORROW WJW, 1986, CLIN IMMUNOL IMMUNOP, V40, P515, DOI 10.1016/0090-1229(86)90196-0; MYLLYLA G, 1971, CLIN EXP IMMUNOL, V8, P399; NYDEGGER UE, 1974, J CLIN INVEST, V54, P297, DOI 10.1172/JCI107765; Ohyama K, 2016, PARASITE IMMUNOL, V38, P609, DOI 10.1111/pim.12341; Ohyama K, 2017, INT J CANCER, V140, P370, DOI 10.1002/ijc.30455; Ohyama K, 2015, CLIN BIOCHEM, V48, P181, DOI 10.1016/j.clinbiochem.2014.11.008; ONYEWOTU II, 1974, NATURE, V248, P156, DOI 10.1038/248156a0; Pedersen GK, 2014, VACCINE, V32, P4550, DOI 10.1016/j.vaccine.2014.06.009; Przybylski G, 2014, MED SCI MONITOR, V20, P6, DOI 10.12659/MSM.889862; R Development Core Team, 2019, R FDN STAT COMP; ROBINSON MW, 1989, ANN RHEUM DIS, V48, P496, DOI 10.1136/ard.48.6.496; Sharma VK, 2004, AAPS PHARMSCI, V6, DOI 10.1208/ps060104; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; The Gene Ontology Consortium, 2019, NUCL ACIDS RES, V47, pD330; THEOFILOPOULOS AN, 1976, J CLIN INVEST, V57, P169, DOI 10.1172/JCI108257; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136	40	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244157	10.1371/journal.pone.0244157	http://dx.doi.org/10.1371/journal.pone.0244157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362259	Green Published, gold			2022-12-26	WOS:000603071600017
J	Rivera-Hechem, MI; Rodriguez-Sickert, C; Guzman, RA; Ramirez-Parada, T; Benavides, F; Landaeta-Torres, V; Aspe-Sanchez, M; Repetto, GM				Rivera-Hechem, Maria I.; Rodriguez-Sickert, Carlos; Guzman, Ricardo A.; Ramirez-Parada, Tadeo; Benavides, Felipe; Landaeta-Torres, Victor; Aspe-Sanchez, Mauricio; Repetto, Gabriela M.			No association between genetic variants in MAOA, OXTR, and AVPR1a and cooperative strategies	PLOS ONE			English	Article							OXYTOCIN RECEPTOR GENE; BY-ENVIRONMENT INTERACTION; MONOAMINE-OXIDASE; CANDIDATE GENE; INDIVIDUAL-DIFFERENCES; BEHAVIOR; POLYMORPHISM; TRUST; VASOPRESSIN; BIOLOGY	The effort to understand the genetic basis of human sociality has been encouraged by the diversity and heritability of social traits like cooperation. This task has remained elusive largely because most studies of sociality and genetics use sample sizes that are often unable to detect the small effects that single genes may have on complex social behaviors. The lack of robust findings could also be a consequence of a poor characterization of social phenotypes. Here, we explore the latter possibility by testing whether refining measures of cooperative phenotypes can increase the replication of previously reported associations between genetic variants and cooperation in small samples. Unlike most previous studies of sociality and genetics, we characterize cooperative phenotypes based on strategies rather than actions. Measuring strategies help differentiate between similar actions with different underlaying social motivations while controlling for expectations and learning. In an admixed Latino sample (n = 188), we tested whether cooperative strategies were associated with three genetic variants thought to influence sociality in humans-MAOA-uVNTR, OXTR rs53576, and AVPR1 RS3. We found no association between cooperative strategies and any of the candidate genetic variants. Since we were unable to replicate previous observations our results suggest that refining measurements of cooperative phenotypes as strategies is not enough to overcome the inherent statistical power problem of candidate gene studies.	[Rivera-Hechem, Maria I.; Rodriguez-Sickert, Carlos; Guzman, Ricardo A.; Ramirez-Parada, Tadeo; Landaeta-Torres, Victor; Aspe-Sanchez, Mauricio] Univ Desarrollo, Fac Gobierno, Ctr Invest Complejidad Social CICS, Santiago, Chile; [Benavides, Felipe; Repetto, Gabriela M.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Genet & Genom, Santiago, Chile	Universidad del Desarrollo; Universidad del Desarrollo	Guzman, RA (corresponding author), Univ Desarrollo, Fac Gobierno, Ctr Invest Complejidad Social CICS, Santiago, Chile.	ricardo.andres.guzman@gmail.com	Rodriguez-Sickert, Carlos/AAM-8128-2021; Ramirez Parada, Tadeo/AGD-7658-2022	Rodriguez-Sickert, Carlos/0000-0001-5102-7914; Ramirez Parada, Tadeo/0000-0002-9900-8373; Landaeta-Torres, Victor/0000-0001-8620-9259; Guzman, Ricardo/0000-0003-4742-6458	internal university fund that promotes collaborative research between departments (Proyecto Interfacultades UDD) [23400502]	internal university fund that promotes collaborative research between departments (Proyecto Interfacultades UDD)	This research was funded by an internal university fund that promotes collaborative research between departments (Proyecto Interfacultades UDD #23400502). The funds were granted to GR and CR. The funders did not participate in the research in any capacity.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Andreozzi L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70681-z; Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Aspe-Sanchez M, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00510; Avinun R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025274; Bachner-Melman R, 2014, HAND CLINIC, V124, P53, DOI 10.1016/B978-0-444-59602-4.00004-6; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Baumgartner T, 2019, HUM BRAIN MAPP, V40, P4508, DOI 10.1002/hbm.24717; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Brunnlieb C, 2016, P NATL ACAD SCI USA, V113, P2051, DOI 10.1073/pnas.1518825113; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Chabris CF, 2015, CURR DIR PSYCHOL SCI, V24, P304, DOI 10.1177/0963721415580430; Chabris CF, 2013, AM J PUBLIC HEALTH, V103, P152, DOI 10.2105/AJPH.2013.301327; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Chew SH, 2013, J ECON BEHAV ORGAN, V90, P28, DOI 10.1016/j.jebo.2013.03.008; Christ CC, 2016, J PERS, V84, P204, DOI 10.1111/jopy.12152; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P162; Das M, 2006, AM J MED GENET B, V141B, P637, DOI 10.1002/ajmg.b.30385; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; Declerck CH, 2018, NAT HUM BEHAV, V2, P438, DOI 10.1038/s41562-018-0387-3; Duncan LE, 2019, NEUROPSYCHOPHARMACOL, V44, P1518, DOI 10.1038/s41386-019-0389-5; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Elfenbein HA, 2007, J NONVERBAL BEHAV, V31, P205, DOI 10.1007/s10919-007-0033-7; Fehr E, 2018, NAT HUM BEHAV, V2, P458, DOI 10.1038/s41562-018-0385-5; Feng C, 2015, GENES BRAIN BEHAV, V14, P516, DOI 10.1111/gbb.12234; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gachter S, 2005, J EUR ECON ASSOC, V3, P303, DOI 10.1162/jeea.2005.3.2-3.303; Gachter S, 2017, NAT HUM BEHAV, V1, P650, DOI 10.1038/s41562-017-0191-5; Gong PY, 2017, PSYCHONEUROENDOCRINO, V80, P131, DOI 10.1016/j.psyneuen.2017.03.005; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Haas BW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00801; Henrich J, 2015, CURR OPIN BEHAV SCI, V3, P84, DOI 10.1016/j.cobeha.2015.02.001; Hewitt JK, 2012, BEHAV GENET, V42, P1, DOI 10.1007/s10519-011-9504-z; Hiraishi K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00373; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Kasper C, 2017, MOL ECOL, V26, P4364, DOI 10.1111/mec.14208; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krueger F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00004; Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730; Kurzban R, 2001, EUR J PERSONALITY, V15, pS37, DOI 10.1002/per.420; Leng G, 2016, BIOL PSYCHIAT, V79, P243, DOI 10.1016/j.biopsych.2015.05.003; Linner RK, 2019, NAT GENET, V51, P245, DOI 10.1038/s41588-018-0309-3; Luo SY, 2015, NEUROIMAGE, V110, P22, DOI 10.1016/j.neuroimage.2015.01.042; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; McCullough ME, 2013, NEUROSCI BIOBEHAV R, V37, P1485, DOI 10.1016/j.neubiorev.2013.04.018; Mertins V, 2013, J NEUROSCI PSYCHOL E, V6, P97, DOI 10.1037/a0032877; Mertins V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020959; Mierop A, 2020, PERSPECT PSYCHOL SCI, V15, P1228, DOI 10.1177/1745691620921525; Miller JH, 2002, J ECON BEHAV ORGAN, V47, P179, DOI 10.1016/S0167-2681(01)00159-7; Nave G, 2015, PERSPECT PSYCHOL SCI, V10, P772, DOI 10.1177/1745691615600138; Nishina K, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00230; Nishina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137089; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2015, EMOTION, V15, P531, DOI 10.1037/emo0000076; Plomin R., 2008, BEHAV GENET; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Reuter M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00242; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; Schroeder KB, 2013, P NATL ACAD SCI USA, V110, P3955, DOI 10.1073/pnas.1216841110; Selten R., 1967, BEITRAGE EXPT WIRTSC, P136; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Sutter M, 2020, J ECON BEHAV ORGAN, V171, P286, DOI 10.1016/j.jebo.2020.01.010; Thoni C, 2018, ECON LETT, V171, P37, DOI 10.1016/j.econlet.2018.06.022; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Tsuchimine S, 2008, PROG NEURO-PSYCHOPH, V32, P1932, DOI 10.1016/j.pnpbp.2008.09.012; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Walum H, 2016, BIOL PSYCHIAT, V79, P251, DOI 10.1016/j.biopsych.2015.06.016; Wang JP, 2016, HUM BRAIN MAPP, V37, P2700, DOI 10.1002/hbm.23203; Way BM, 2010, SOC COGN AFFECT NEUR, V5, P203, DOI 10.1093/scan/nsq059; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zhong SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013765	79	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244189	10.1371/journal.pone.0244189	http://dx.doi.org/10.1371/journal.pone.0244189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362272	gold, Green Published			2022-12-26	WOS:000603071600070
J	Yanagisawa, K; Wichukchinda, N; Tsuchiya, N; Yasunami, M; Rojanawiwat, A; Tanaka, H; Saji, H; Ogawa, Y; Handa, H; Pathipvanich, P; Ariyoshi, K; Sawanpanyalert, P				Yanagisawa, Kunio; Wichukchinda, Nuanjun; Tsuchiya, Naho; Yasunami, Michio; Rojanawiwat, Archawin; Tanaka, Hidenori; Saji, Hiroh; Ogawa, Yoshiyuki; Handa, Hiroshi; Pathipvanich, Panita; Ariyoshi, Koya; Sawanpanyalert, Pathom			Deficiency of mannose-binding lectin is a risk of Pneumocystis jirovecii pneumonia in a natural history cohort of people living with HIV/AIDS in Northern Thailand	PLOS ONE			English	Article							OPPORTUNISTIC INFECTIONS; IMPACT; SUSCEPTIBILITY; DIVERSITY	Background Mannose-binding lectin (MBL) plays a pivotal role in innate immunity; however, its impact on susceptibility to opportunistic infections (OIs) has not yet been examined in a natural history cohort of people living with HIV/AIDS. Methods We used archived samples to analyze the association between MBL expression types and risk of major OIs including Pneumocystis jirovecii pneumonia (PCP), cryptococcosis, talaromycosis, toxoplasmosis, and tuberculosis in a prospective cohort in Northern Thailand conducted from 1 July 2000 to 15 October 2002 before the national antiretroviral treatment programme was launched. Results Of 632 patients, PCP was diagnosed in 96 (15.2%) patients, including 45 patients with new episodes during the follow-up period (1006.5 person-years). The total history of PCP was significantly associated with low MBL expression type: high/intermediate (81/587, 13.8%), low (10/33, 30.3%) and deficient (5/12, 41.7%) (p = 0.001), whereas the history of other OIs showed no relation with any MBL expression type. Kaplan-Meier analysis (n = 569; log-rank p = 0.011) and Cox's proportional hazards model revealed that deficient genotype dramatically increased the risk of PCP, which is independent upon sex, age, CD4 count, HIV-1 viral load and hepatitis B and C status (adjusted hazard ratio 7.93, 95% confidence interval 2.19-28.67, p = 0.002). Conclusions Deficiency of MBL expression is a strong risk factor determining the incidence of PCP but not other major OIs.	[Yanagisawa, Kunio; Ogawa, Yoshiyuki; Handa, Hiroshi] Gunma Univ Hosp, Dept Hematol, Maebashi, Gumma, Japan; [Yanagisawa, Kunio] Gunma Univ Hosp, Infect Control & Prevent Ctr, Maebashi, Gumma, Japan; [Wichukchinda, Nuanjun; Rojanawiwat, Archawin; Sawanpanyalert, Pathom] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand; [Tsuchiya, Naho] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi, Japan; [Yasunami, Michio] Saga Ken Med Ctr Koseikan, Dept Lab Med, Saga, Japan; [Tanaka, Hidenori; Saji, Hiroh] HLA Fdn Lab, Kyoto, Japan; [Pathipvanich, Panita] Lampang Hosp, Day Care Ctr, Lampang, Thailand; [Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan; [Sawanpanyalert, Pathom] Minist Sci & Technol Higher Educ Sci Res & Innova, Bangkok, Thailand	Gunma University; Gunma University; Ministry of Public Health - Thailand; Tohoku University; Nagasaki University	Ariyoshi, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan.	kari@nagasaki-u.ac.jp			Joint Usage/Research Center on Tropical Diseases; Nagasaki University Institute of Tropical Medicine; Japan International Co-operation Agency (JICA); Thai Ministry of Public Health	Joint Usage/Research Center on Tropical Diseases; Nagasaki University Institute of Tropical Medicine; Japan International Co-operation Agency (JICA); Thai Ministry of Public Health	KY was financially supported by the grant of Joint Usage/Research Center on Tropical Diseases, Nagasaki University Institute of Tropical Medicine, Japan International Co-operation Agency (JICA) and Thai Ministry of Public Health for this work (2016-Ippan-4).http://www.tm.nagasaki-u.ac.jp/nekken/joint/files/h28reportbook.pdf.	Alanio A, 2017, EBIOMEDICINE, V22, P155, DOI 10.1016/j.ebiom.2017.06.027; Chalmers JD, 2013, LANCET RESP MED, V1, P224, DOI 10.1016/S2213-2600(13)70001-8; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Ezekowitz RA, 2003, J INFECT DIS, V187, pS335, DOI 10.1086/374746; Gangcuangco LMA, 2017, AM J TROP MED HYG, V97, P49, DOI 10.4269/ajtmh.16-0783; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Goyal S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01261; Ivanova M, 2008, HUM IMMUNOL, V69, P877, DOI 10.1016/j.humimm.2008.09.007; Jiang XY, 2010, CRIT CARE, V14, pR66; Katano H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-229; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Koziel H, 2000, AM J RESP CELL MOL, V23, P452, DOI 10.1165/ajrcmb.23.4.4084; MASUR H, 1989, ANN INTERN MED, V111, P223, DOI 10.7326/0003-4819-111-3-223; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; Moongtui W, 2000, AM J INFECT CONTROL, V28, P365, DOI 10.1067/mic.2000.107885; Mori M, 2018, JAIDS-J ACQ IMM DEF, V78, P356, DOI 10.1097/QAI.0000000000001676; Mori M, 2015, AIDS, V29, P1607, DOI 10.1097/QAD.0000000000000747; Ou XT, 2011, J INFECT DIS, V203, P1686, DOI 10.1093/infdis/jir152; Pathipvanich P, 2003, JAIDS-J ACQ IMM DEF, V32, P157, DOI 10.1097/00126334-200302010-00007; Pathipvanich Panita, 2004, Journal of the Medical Association of Thailand, V87, P951; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Rojanawiwat A, 2011, INT HEALTH, V3, P101, DOI 10.1016/j.inhe.2010.12.004; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Saeng-aroon S, 2010, ANTIVIR RES, V87, P22, DOI 10.1016/j.antiviral.2010.04.001; Schoffelen AF, 2013, AIDS, V27, P1179, DOI 10.1097/QAD.0b013e32835e2c90; Sorensen CM, 2006, CLIN EXP IMMUNOL, V145, P173, DOI 10.1111/j.1365-2249.2006.03101.x; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; Tian C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00257-5; Tsuchiya N, 2013, EPIDEMIOL INFECT, V141, P1840, DOI 10.1017/S0950268812002397; Tsuchiya N, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0565-5; Wojtowicz A, 2019, AIDS, V33, P1719, DOI 10.1097/QAD.0000000000002283; Yanagisawa K, 2015, J INFECT CHEMOTHER, V21, P769, DOI 10.1016/j.jiac.2015.07.006; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242438	10.1371/journal.pone.0242438	http://dx.doi.org/10.1371/journal.pone.0242438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362211	Green Published, gold			2022-12-26	WOS:000603071600041
J	Elhakim, M; Tourab, SB; Zouiten, A				Elhakim, Mohamed; Tourab, Saleh Banoita; Zouiten, Ahmed			COVID-19 pandemic in Djibouti: Epidemiology and the response strategy followed to contain the virus during the first two months, 17 March to 16 May 2020	PLOS ONE			English	Article								First cases of COVID-19 were reported from Wuhan, China, in December 2019, and it progressed rapidly. On 30 January, WHO declared the new disease as a PHEIC, then as a Pandemic on 11 March. By mid-March, the virus spread widely; Djibouti was not spared and was hit by the pandemic with the first case detected on 17 March. Djibouti worked with WHO and other partners to develop a preparedness and response plan, and implemented a series of intervention measures. MoH together with its civilian and military partners, closely followed WHO recommended strategy based on four pillars: testing, isolating, early case management, and contact tracing. From 17 March to 16 May, Djibouti performed the highest per capita tests in Africa and isolated, treated and traced the contacts of each positive case, which allowed for a rapid control of the epidemic. COVID-19 data included in this study was collected through MoH Djibouti during the period from 17 March to 16 May 2020. A total of 1,401 confirmed cases of COVID-19 were included in the study with 4 related deaths (CFR: 0.3%) and an attack rate of 0.15%. Males represented (68.4%) of the cases, with the age group 31-45 years old (34.2%) as the most affected. Djibouti conducted 17,532 tests, and was considered as a champion for COVID-19 testing in Africa with 18.2 tests per 1000 habitant. All positive cases were isolated, treated and had their contacts traced, which led to early and proactive diagnosis of cases and in turn yielded up to 95-98% asymptomatic cases. Recoveries reached 69% of the infected cases with R0 (0.91). The virus was detected in 4 regions in the country, with the highest percentage in the capital (83%). Djibouti responded to COVID-19 pandemic following an efficient and effective strategy, using a strong collaboration between civilian and military health assets that increased the response capacities of the country. Partnership, coordination, solidarity, proactivity and commitment were the pillars to confront COVID-19 pandemic.	[Elhakim, Mohamed; Zouiten, Ahmed] WHO, Djibouti WHO Representat Off, Djibouti Ville, Djibouti; [Tourab, Saleh Banoita] Minist Hlth Djibouti, Djibouti Ville, Djibouti	World Health Organization	Elhakim, M (corresponding author), WHO, Djibouti WHO Representat Off, Djibouti Ville, Djibouti.	elhakimm@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Africa CDC, 2020, COR DIS 2019 COVID 1; [Anonymous], 2020, BBC NEWS; Bereketeab R., 2016, J AFRICAN FOREIGN AF, V3, P5; Central Mass, 2020, EPI WEEK CALENDARS; Estonian Government, 2020, **NON-TRADITIONAL**; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Hassany M, 2020, LANCET INFECT DIS; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132; Ministry of Health of Djibouti, 2020, STATISTICS; Ministry of Health of Djibouti, 2020, NAT ACT PLAN PREP RE; NCDC, 2020, 1 CAS COR DIS CONF N; Reliefweb, 2020, 4 REL; Reliefweb, 2020, 4 REL; Reliefweb, 2020, 1 REL; The National Institute of Statistics of Djibouti (INSD), 2019, STAT YB STAT YB 2019; WHO, 2020, COVID 19 PUBL HLTH E; World Health Organization, 2020, PUBLICATIONS; World Health Organization, 2020, ARCH WHO TIM COVID 1; World Health Organization, 2020, 118 WHO; World Health Organization, 2020, WEEKLY EPI MONI 0216	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243698	10.1371/journal.pone.0243698	http://dx.doi.org/10.1371/journal.pone.0243698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351802	Green Submitted, Green Published, gold			2022-12-26	WOS:000603071400046
J	Bergh, C; Wennergren, D; Moller, M; Brisby, H				Bergh, Camilla; Wennergren, David; Moller, Michael; Brisby, Helena			Fracture incidence in adults in relation to age and gender: A study of 27,169 fractures in the Swedish Fracture Register in a well-defined catchment area	PLOS ONE			English	Article							FALL-RELATED FRACTURES; CHANGING EPIDEMIOLOGY; CLASSIFICATION; ACCESSIBILITY; RELIABILITY; MOBILITY; RISK	Studies on fracture incidence have mostly been based on retrospectively registered data from local hospital databases. The Swedish Fracture Register (SFR) is a national quality register collecting data prospectively on fractures, at the time of care-seeking. In the present study the incidence of all different fractures, regardless of location, in adults' >= 16 years treated at the only care provider for patients with fractures within a catchment area of approximately 550,000 inhabitants, during 2015-2018 are described. Age, gender, and fracture location (according to AO/OTA classification) was used for the analyses and presentation of fracture incidences. During the 4-year study period, 23,917 individuals sustained 27,169 fractures. The mean age at fracture was 57.9 years (range 16-105 years) and 64.5% of the fractures occurred in women. The five most common fractures accounted for more than 50% of all fractures: distal radius, proximal femur, ankle, proximal humerus, and metacarpal fractures. Seven fracture incidence distribution groups were created based on age- and gender-specific incidence curves, providing visual and easily accessible information on fracture distribution. This paper reports on incidence of all fracture locations based on prospectively collected data in a quality register. The knowledge on fracture incidence related to age and gender may be of importance for the planning of orthopaedic care, involving both in- and out-patients as well as allocating surgical resources. Further, this might be useful for organizing preventive measures, especially in countries with similar socioeconomic structure and fracture burden.	[Bergh, Camilla; Wennergren, David; Moller, Michael; Brisby, Helena] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Bergh, Camilla; Wennergren, David; Moller, Michael; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Bergh, C (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden.; Bergh, C (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden.	camilla.m.bergh@vgregion.se		Bergh, Camilla/0000-0003-0116-4114; Wennergren, David/0000-0001-9882-6414	Swedish Research Council, Sweden; Government Funding of Clinical Research within the National Health Service (ALF) from Vastra Gotaland, Sweden [ALFGBG722931]; Felix Neubergh Foundation, Sweden; Gothenburg Medical Association, Sweden	Swedish Research Council, Sweden(Swedish Research Council); Government Funding of Clinical Research within the National Health Service (ALF) from Vastra Gotaland, Sweden; Felix Neubergh Foundation, Sweden; Gothenburg Medical Association, Sweden	This research was supported by grants from the Swedish Research Council (M.M), Government Funding of Clinical Research within the National Health Service (ALF) from Vastra Gotaland ALFGBG722931 (H.B), the Felix Neubergh Foundation (C.B.) and the Gothenburg Medical Association (C.B.), all in Sweden.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2010, OSTEOPOROSIS INT, V21, P373, DOI 10.1007/s00198-009-0957-3; Abtahi S, 2019, OSTEOPOROSIS INT, V30, P2217, DOI 10.1007/s00198-019-05109-0; ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; Alsnih R, 2003, TRANSPORT RES A-POL, V37, P903, DOI 10.1016/S0965-8564(03)00073-9; Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072; Axelsson KF, 2020, J BONE MINER RES, V35, P1216, DOI 10.1002/jbmr.3990; Beerekamp MSH, 2017, INJURY, V48, P1355, DOI 10.1016/j.injury.2017.04.047; Bergdahl C, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1009-8; Bolton JM, 2017, JAMA PSYCHIAT, V74, P641, DOI 10.1001/jamapsychiatry.2017.0449; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; Court-Brown CM, 2017, INJURY, V48, P819, DOI 10.1016/j.injury.2017.02.021; Court-Brown CM, 2011, OSTEOPOROSIS INT, V22, P1211, DOI 10.1007/s00198-010-1315-1; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Court-Brown CM, 2018, INJURY, V49, P2161, DOI 10.1016/j.injury.2018.11.009; Court-Brown CM, 2014, SCOT MED J, V59, P30, DOI 10.1177/0036933013518148; Cummings SR, 2020, OSTEOPOROSIS INT, V31, P1023, DOI 10.1007/s00198-020-05325-z; Curtis EM, 2017, BONE, V104, P29, DOI 10.1016/j.bone.2017.01.024; Dimai HP, 2014, OSTEOPOROSIS INT, V25, P2297, DOI 10.1007/s00198-014-2766-6; Driessen JHM, 2016, OSTEOPOROSIS INT, V27, P2017, DOI 10.1007/s00198-016-3488-8; HERNLUND E, 2013, ARCH OSTEOPOROS, V8, DOI DOI 10.1007/S11657-013-0136-1; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Juto H, 2016, INJURY, V47, P2579, DOI 10.1016/j.injury.2016.05.028; Kamin ST, 2016, Z GERONTOL GERIATR, V49, P372, DOI 10.1007/s00391-015-0946-4; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P417, DOI 10.1007/s001980170112; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Kihlstrom C, 2017, BMC MUSCULOSKEL DIS, V18, P1, DOI 10.1186/s12891-017-1444-1; Knutsson SB, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2579-z; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; Morgonskold D, 2019, WORLD J ORTHOP, V10, P14, DOI 10.5312/wjo.v10.i1.14; Muller MENS., 1990, COMPREHENSIVE CLASSI, V1st ed; Portegijs E, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030333; Scott D, 2019, J GERONTOLOGY A; Shibuya N, 2014, J FOOT ANKLE SURG, V53, P606, DOI 10.1053/j.jfas.2014.03.011; Svedbom A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0137-0; Svenska frakturregistret registercentrum, 2017, TACKN 2017; Wennergren D, 2018, INJURY, V49, P2068, DOI 10.1016/j.injury.2018.09.008; Wennergren D, 2018, UNFALLCHIRURG, V121, P949, DOI 10.1007/s00113-018-0538-z; Wennergren D, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1612-3; Wennergren D, 2016, INJURY, V47, P478, DOI 10.1016/j.injury.2015.11.002; Wennergren D, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0795-8	42	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244291	10.1371/journal.pone.0244291	http://dx.doi.org/10.1371/journal.pone.0244291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347485	Green Published, gold			2022-12-26	WOS:000603071100041
J	Cuadros, Z; Hurtado, E; Cornejo, C				Cuadros, Zamara; Hurtado, Esteban; Cornejo, Carlos			Infant-adult synchrony in spontaneous and nonspontaneous interactions	PLOS ONE			English	Article							MOTHER-INFANT; INTERPERSONAL COORDINATION; MOVEMENT SYNCHRONY; EMOTIONAL COORDINATION; SOCIAL-INTERACTION; DYADIC SYNCHRONY; BODY MOVEMENT; FATHER-INFANT; HEART-RATE; DYNAMICS	Infant-adult synchrony has been reported through observational and experimental studies. Nevertheless, synchrony is addressed differently in both cases. While observational studies measure synchrony in spontaneous infant-adult interactions, experimental studies manipulate it, inducing nonspontaneous synchronous and asynchronous interactions. A still unsolved question is to what extent differ spontaneous synchrony from the nonspontaneous one, experimentally elicited. To address this question, we conducted a study to compare synchrony in both interactional contexts. Forty-three 14-month-old infants were randomly assigned to one of two independent groups: (1) the spontaneous interaction context, consisting of a storytime session; and (2) the nonspontaneous interaction context, where an assistant bounced the infant in synchrony with a stranger. We employed an optical motion capture system to accurately track the time and form of synchrony in both contexts. Our findings indicate that synchrony arising in spontaneous exchanges has different traits than synchrony produced in a nonspontaneous interplay. The evidence presented here offers new insights for rethinking the study of infant-adult synchrony and its consequences on child development.	[Cuadros, Zamara; Hurtado, Esteban; Cornejo, Carlos] Pontificia Univ Catolica Chile, Escuela Psicol, Lab Lenguaje Interacc & Fenomenol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Cornejo, C (corresponding author), Pontificia Univ Catolica Chile, Escuela Psicol, Lab Lenguaje Interacc & Fenomenol, Santiago, Chile.	cca@uc.cl		Cornejo, Carlos/0000-0001-5426-0025; Cuadros, Zamara/0000-0003-4729-1880	Scientific and Technological Equipment Program, FONDEQUIP [EQM120026]; Chilean National Commission for Scientific and Technological Research (CONICYT-PCHA/Doctorado Nacional/2016-folio) [21160537]; Chilean National Fund for Scientific and Technological Development (FONDECYT) [1181271]	Scientific and Technological Equipment Program, FONDEQUIP; Chilean National Commission for Scientific and Technological Research (CONICYT-PCHA/Doctorado Nacional/2016-folio); Chilean National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This research was supported by the Scientific and Technological Equipment Program, FONDEQUIP (Grant number EQM120026), the Chilean National Commission for Scientific and Technological Research (CONICYT-PCHA/Doctorado Nacional/2016-folio: 21160537), and The Chilean National Fund for Scientific and Technological Development (FONDECYT Grant No. 1181271).	Abney DH, 2017, INFANCY, V22, P514, DOI 10.1111/infa.12165; AMAZEEN PG, 1995, BIOL CYBERN, V72, P511, DOI 10.1007/BF00199893; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 1997, NSCA B, V18, P4; Araujo D, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01449; Astolfi L, 2010, BRAIN TOPOGR, V23, P243, DOI 10.1007/s10548-010-0147-9; Athreya DN, 2014, EXP BRAIN RES, V232, P2741, DOI 10.1007/s00221-014-3957-2; Atzil S, 2014, SOC COGN AFFECT NEUR, V9, P1193, DOI 10.1093/scan/nst105; Avikainen S, 2003, CURR BIOL, V13, P339, DOI 10.1016/S0960-9822(03)00087-3; Beebe B., 1982, INTERACTION RHYTHMS, P77; Bernieri F.J., 1991, FUNDAMENTALS NONVERB, P401, DOI DOI 10.1017/CBO9781107415324.004; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; BILOUS FR, 1988, LANG COMMUN, V8, P183, DOI 10.1016/0271-5309(88)90016-X; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Brazelton TB, 1984, GROWING CHILD FAMILY, P19; Burger B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00903; Busuito A, 2019, DEV PSYCHOL, V55, P1034, DOI 10.1037/dev0000689; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chatel-Goldman J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00095; Cheng M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227880; Chiavarino, 2012, GIORNALE ITALIANO PS, V39, P73, DOI [10.1421/37063, DOI 10.1421/37063]; Cirelli LK, 2018, CURR OPIN PSYCHOL, V20, P35, DOI 10.1016/j.copsyc.2017.08.009; Cirelli LK, 2017, MUSIC PERCEPT, V34, P319, DOI 10.1525/MP.2017.34.3.319; Cirelli LK, 2016, INFANCY, V21, P807, DOI 10.1111/infa.12140; Cirelli LK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0400; Cirelli LK, 2014, DEVELOPMENTAL SCI, V17, P1003, DOI 10.1111/desc.12193; Clayton M, 2019, MUSIC SCI, V23, P304, DOI 10.1177/1029864919844809; Coey C, 2011, EXP BRAIN RES, V211, P483, DOI 10.1007/s00221-011-2689-9; Collis GM, 1979, SPEECH BEGINNING INT, P89; CONDON WS, 1974, CHILD DEV, V45, P456; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Cornejo C., 2017, NEUROSCIENCE SOCIAL, P69, DOI [10.1007/978-3-319-68421-5, DOI 10.1007/978-3-319-68421-5]; Cornejo C, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01546; Cornejo C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01685; Costantini C, 2018, INFANCY, V23, P288, DOI 10.1111/infa.12220; Cross I, 2014, PSYCHOL MUSIC, V42, P809, DOI 10.1177/0305735614543968; Cuadros Z, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02839; Del-Monte J, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00137; Demos AP, 2012, J EXP PSYCHOL GEN, V141, P49, DOI 10.1037/a0023843; Dissanayake E., 2006, MUSIC MANIPULATION S, P31; Dittmann AT, 1987, NONVERBAL BEHAV COMM, P37; Doi H, 2011, J PHYSIOL SCI, V61, P211, DOI 10.1007/s12576-011-0138-y; Drees Bastian, 2016, PERSPEKTIVE BIBLIOTH, V5, P25; Dunphy-Lelii S, 2014, CAN J EXP PSYCHOL, V68, P38, DOI 10.1037/cep0000003; Duran ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178140; Ebisch SJ, 2012, BIOL PSYCHOL, V89, P123, DOI 10.1016/j.biopsycho.2011.09.018; Ellamil M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164783; Endedijk HM, 2015, DEV PSYCHOL, V51, P714, DOI 10.1037/a0038980; Farran D. C., 1990, J APPL DEV PSYCHOL, V11, P419, DOI [10.1016/0193-3973(90)90018-F, DOI 10.1016/0193-3973(90)90018-F]; Fawcett C, 2017, J EXP CHILD PSYCHOL, V160, P127, DOI 10.1016/j.jecp.2017.03.014; Fawcett C, 2012, INFANT CHILD DEV, V21, P239, DOI 10.1002/icd.739; Feldman R, 1999, DEV PSYCHOL, V35, P223, DOI 10.1037/0012-1649.35.1.223; Feldman R, 2006, DEV PSYCHOL, V42, P175, DOI 10.1037/0012-1649.42.1.175; Feldman R, 2003, INFANT MENT HEALTH J, V24, P1, DOI 10.1002/imhj.10041; Feldman R, 2007, AM J ORTHOPSYCHIAT, V77, P582, DOI 10.1037/0002-9432.77.4.582; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Feldman R, 2011, INFANT BEHAV DEV, V34, P569, DOI 10.1016/j.infbeh.2011.06.008; Feldman R, 2011, DEVELOPMENTAL SCI, V14, P752, DOI 10.1111/j.1467-7687.2010.01021.x; FIELD T, 1989, INFANT BEHAV DEV, V12, P357, DOI 10.1016/0163-6383(89)90044-1; FIELD T, 1990, DEV PSYCHOL, V26, P7, DOI 10.1037/0012-1649.26.1.7; Gleissner B, 2000, DEVELOPMENTAL SCI, V3, P405, DOI 10.1111/1467-7687.00135; Gordon I, 2010, BIOL PSYCHIAT, V68, P377, DOI 10.1016/j.biopsych.2010.02.005; GOTTMAN JM, 1985, J CONSULT CLIN PSYCH, V53, P151, DOI 10.1037/0022-006X.53.2.151; Granat A, 2017, EMOTION, V17, P11, DOI 10.1037/emo0000204; Hammal Z, 2014, IEEE T AFFECT COMPUT, V5, P155, DOI 10.1109/TAFFC.2014.2326408; Harder S, 2015, DEV PSYCHOL, V51, P1778, DOI 10.1037/a0039834; Harel H, 2011, INFANCY, V16, P69, DOI 10.1111/j.1532-7078.2010.00037.x; Harrist AW, 2002, DEV REV, V22, P555, DOI 10.1016/S0273-2297(02)00500-2; Hoch J, 2020, PSYARXIV, P1, DOI [10.31234/osf.io/swr2y, DOI 10.31234/OSF.IO/SWR2Y]; Holler J, 2011, J NONVERBAL BEHAV, V35, P133, DOI 10.1007/s10919-011-0105-6; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Ilari B, 2015, J RES MUSIC EDUC, V62, P332, DOI 10.1177/0022429414555984; ISABELLA RA, 1989, DEV PSYCHOL, V25, P12, DOI 10.1037/0012-1649.25.1.12; ISABELLA RA, 1991, CHILD DEV, V62, P373, DOI 10.2307/1131010; Jakubowski K., 2017, FRONTIERS DIGITAL HU, V4, P9, DOI 10.3389/fdigh.2017.00009; KARGER RH, 1979, CHILD DEV, V50, P882, DOI 10.2307/1128959; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Kirschner S, 2014, J CROSS CULT PSYCHOL, V45, P137, DOI 10.1177/0022022113493139; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Kokkinaki T, 2019, EUR J DEV PSYCHOL, V16, P268, DOI 10.1080/17405629.2017.1375909; Kokkinaki T, 2015, EUR J DEV PSYCHOL, V12, P69, DOI 10.1080/17405629.2014.950220; Kokkinaki TS, 2017, INFANT CHILD DEV, V26, DOI 10.1002/icd.1973; Konvalinka I, 2014, NEUROIMAGE, V94, P79, DOI 10.1016/j.neuroimage.2014.03.003; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Krueger J., 2013, EMOTIONAL POWER MUSI, P177, DOI DOI 10.1093/ACPROF:OSO/9780199654888.003.0014; Kupper Z, 2010, SCHIZOPHR RES, V121, P90, DOI 10.1016/j.schres.2010.03.032; LAFRANCE M, 1977, J COMMUN, V27, P213; Latif N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105036; Launay J, 2014, COGN PROCESS, V15, P491, DOI 10.1007/s10339-014-0618-0; Leclere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113571; Liszkowski U, 2008, COGNITION, V108, P732, DOI 10.1016/j.cognition.2008.06.013; Llobera J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147008; Lotzin A, 2016, DEV PSYCHOPATHOL, V28, P327, DOI 10.1017/S0954579415000516; Lotzin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144417; Lundy BL, 2003, INFANT BEHAV DEV, V26, P200, DOI 10.1016/S0163-6383(03)00017-1; Marmelat V, 2012, EXP BRAIN RES, V222, P137, DOI 10.1007/s00221-012-3202-9; Marzoli D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014595; McFarland DH, 2020, DEV PSYCHOBIOL, V62, P50, DOI 10.1002/dev.21913; McFarland DH, 2001, J SPEECH LANG HEAR R, V44, P128, DOI 10.1044/1092-4388(2001/012); Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Mitkidis P, 2015, PHYSIOL BEHAV, V149, P101, DOI 10.1016/j.physbeh.2015.05.033; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; Noel JP, 2018, IEEE T COGN DEV SYST, V10, P973, DOI 10.1109/TCDS.2017.2778141; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Ouwehand PW, 2015, NEUROSCI LETT, V606, P177, DOI 10.1016/j.neulet.2015.08.052; Papousek M., 1981, ADV INFANCY RES, V1, P163; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Paxton A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01135; Paxton A, 2013, Q J EXP PSYCHOL, V66, P2092, DOI 10.1080/17470218.2013.853089; Pierpaoli C, 2014, ARCH ITAL BIOL, V152, P20; Pratt M, 2015, DEV PSYCHOPATHOL, V27, P1191, DOI 10.1017/S0954579415000760; Preissmann D, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01673; Rabinowitch TC, 2017, J EXP CHILD PSYCHOL, V160, P21, DOI 10.1016/j.jecp.2017.03.001; Rabinowitch TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120878; Ragert M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00368; Ramseyer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00979; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Reyna BA, 2012, INFANT BEHAV DEV, V35, P669, DOI 10.1016/j.infbeh.2012.06.003; Reyna BA, 2009, JOGNN-J OBST GYN NEO, V38, P470, DOI 10.1111/j.1552-6909.2009.01044.x; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Rodrigues M., 2013, ADV PHYS ED, V3, P209, DOI [10.4236/ape.2013.34034, DOI 10.4236/APE.2013.34034]; Ruvolo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136492; Sanmartin R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00392; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; Seifert L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00075; Skuban EM, 2006, INFANT BEHAV DEV, V29, P423, DOI 10.1016/j.infbeh.2006.02.004; STREET RL, 1984, HUM COMMUN RES, V11, P139, DOI 10.1111/j.1468-2958.1984.tb00043.x; Tarr B, 2016, EVOL HUM BEHAV, V37, P343, DOI 10.1016/j.evolhumbehav.2016.02.004; Tarullo AR, 2017, INFANT BEHAV DEV, V47, P92, DOI 10.1016/j.infbeh.2017.03.007; Thomas KA, 2014, EARLY HUM DEV, V90, P885, DOI 10.1016/j.earlhumdev.2014.09.005; Toiviainen P, 2010, MUSIC PERCEPT, V28, P59, DOI 10.1525/MP.2010.28.1.59; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Trainor LJ, 2015, ANN NY ACAD SCI, V1337, P45, DOI 10.1111/nyas.12649; TREVARTHEN C., 1979, SPEECH BEGINNINGS HU, P321; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; TRONICK EZ, 1989, AM PSYCHOL, V44, P112, DOI 10.1037/0003-066X.44.2.112; Trost W., 2013, EMOTIONAL POWER MUSI, P213, DOI [https://doi.org/10.1093/acprof, DOI 10.1093/ACPROF:OSO/9780199654888.003.0016, 10.1093/acprof:oso/9780199654888.003.0016]; Tsai SY, 2011, BIOL RES NURS, V13, P80, DOI 10.1177/1099800410378889; Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323; Tsuchiya A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00817; Tuncgenc B, 2015, CHILD DEV, V86, P976, DOI 10.1111/cdev.12354; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Van Puyvelde M, 2010, INFANT BEHAV DEV, V33, P387, DOI 10.1016/j.infbeh.2010.04.003; Van Puyvelde M, 2013, INFANCY, V18, P849, DOI 10.1111/infa.12007; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Varlet M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00029; Vesper C, 2013, J EXP PSYCHOL HUMAN, V39, P48, DOI 10.1037/a0028066; WAPNER S, 1968, CHILD DEV, V39, P887, DOI 10.1111/j.1467-8624.1968.tb04469.x; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Waters SF, 2016, ADAPT HUM BEHAV PHYS, V2, P298, DOI 10.1007/s40750-016-0045-9; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Yamamoto T, 2016, COMPUTER SIMULATION OF POLYMERIC MATERIALS: APPLICATIONS OF THE OCTA SYSTEM, P179, DOI 10.1007/978-981-10-0815-3_10; Zhao Z, 2015, HUM MOVEMENT SCI, V41, P240, DOI 10.1016/j.humov.2015.03.012; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28	161	1	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244138	10.1371/journal.pone.0244138	http://dx.doi.org/10.1371/journal.pone.0244138			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338070	Green Published, gold			2022-12-26	WOS:000601313500039
J	Hansen, AV; Mortensen, LH; Trompet, S; Westendorp, R				Hansen, Anne Vinkel; Mortensen, Laust Hvas; Trompet, Stella; Westendorp, Rudi			Health care expenditure in the last five years of life is driven by morbidity, not age: A national study of spending trajectories in Danish decedents over age 65	PLOS ONE			English	Article							END; POPULATION	Background The high level of medical spending at the end of life is well-documented, but whether there is any real potential for cost reductions there is still in question, and studies have tended to overlook the costs of care. Aim To identify the most common health care spending trajectories over the last five years of life among older Danes, as well as the determinants of following a given trajectory. Methods We linked Danish health registries to obtain data on all health care expenditure (including hospital treatment, prescription drugs, primary care and costs of communal care) over the last five years of life for all Danish decedents above age 65 in the period 2013 through 2017. A latent class analysis identified the most common cost trajectories, which were then related to socio-economical characteristics and health status at five years before death. Results Total health care expenditures in the last five years of life were largely independent of age and cause of death. Costs of home care and residential care increased steeply with age at death whereas hospital costs decreased correspondingly. We found four main spending trajectories among decedents: 3 percent followed a late-rise trajectory, 11 percent had accelerating costs, and two groups of 43 percent each followed moderately or consistently high trajectories. The main predictor of total expenditure was the number of chronic diseases. Interpretation Spending at the end of life is largely determined by chronic disease, and age and cause of death only determine the distribution of expenses into care and cure.	[Hansen, Anne Vinkel; Mortensen, Laust Hvas; Westendorp, Rudi] Stat Denmark, Data Sci Lab, Copenhagen, Denmark; [Hansen, Anne Vinkel; Mortensen, Laust Hvas; Westendorp, Rudi] Univ Copenhagen, Sect Epidemiol, Dept Publ Hlth, Copenhagen, Denmark; [Trompet, Stella] Leiden Univ, Sect Gerontol & Geriatr, Dept Internal Med, Med Ctr, Leiden, Netherlands	University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hansen, AV (corresponding author), Stat Denmark, Data Sci Lab, Copenhagen, Denmark.; Hansen, AV (corresponding author), Univ Copenhagen, Sect Epidemiol, Dept Publ Hlth, Copenhagen, Denmark.	aih@dst.dk		Hansen, Anne Vinkel/0000-0003-4523-3521	Novo Nordisk Fonden [NNF17OC0027812]	Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by an unconditional research grant from Novo Nordisk Fonden (NNF17OC0027812). AIH and LHM are employed at Statistics Denmark, the national Danish Statistics office, which organization holds the rights to the registry data used in the study. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Bjorner TB, 2012, INT J HEALTH CARE FI, V12, P129, DOI 10.1007/s10754-012-9106-1; Brockmann H, 2002, SOC SCI MED, V55, P593, DOI 10.1016/S0277-9536(01)00190-3; Cairns AJG, 2019, MODELLING SOCIOECONO, DOI [10.2139/ssrn.3376527, DOI 10.2139/SSRN.3376527]; Christensen BJ, 2016, FISC STUD, V37, P461, DOI 10.1111/j.1475-5890.2016.12119; Davis MA, 2016, HEALTH AFFAIR, V35, P1316, DOI 10.1377/hlthaff.2015.1419; Fassbender K, 2009, J PAIN SYMPTOM MANAG, V38, P75, DOI 10.1016/j.jpainsymman.2009.04.007; French EB, 2017, HEALTH AFFAIR, V36, P1211, DOI 10.1377/hlthaff.2017.0174; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kjellberg J, 2020, FREMTIDENS SUNDHEDSU; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nagin D., 2009, GROUP BASED MODELING; Nagin DS, 2005, CRIMINOLOGY, V43, P873, DOI 10.1111/j.1745-9125.2005.00026.x; Proust-Lima C, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.i02; Sato E, 2009, HEALTH ECON, V18, P843, DOI 10.1002/hec.1410; Shugarman LR, 2009, J PAIN SYMPTOM MANAG, V38, P15, DOI 10.1016/j.jpainsymman.2009.04.004; van de Schoot R, 2017, STRUCT EQU MODELING, V24, P451, DOI 10.1080/10705511.2016.1247646; von Wyl V, 2018, BMJ SUPPORT PALLIAT, V8, P325, DOI 10.1136/bmjspcare-2014-000784; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	22	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244061	10.1371/journal.pone.0244061	http://dx.doi.org/10.1371/journal.pone.0244061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338069	Green Published, gold			2022-12-26	WOS:000601313500023
J	Pourcher, V; Gourmelen, J; Bureau, I; Bouee, S				Pourcher, Valerie; Gourmelen, Julie; Bureau, Isabelle; Bouee, Stephane			Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; INFECTED PERSONS; NONINFECTIOUS COMORBIDITIES; UNINFECTED INDIVIDUALS; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; RISK-FACTORS; PREVALENCE; AGE	Objectives As people living with HIV (PLHIV) age, the burden of non-HIV related comorbidities increases resulting in additional healthcare costs. The present study aimed to describe the profile, the prevalence and the incremental costs of non-HIV related comorbidities in PLHIV compared to non-HIV matched controls (1:2 ratio) in France. Methods The French permanent sample of health beneficiaries (Echantillon generaliste de beneficiaires [EGB]), a claims database representative of the national population, was used to assess comorbidities in PLHIV which were identified by the ICD-10 diagnosis codes of hospitalization, full healthcare coverage, and drug reimbursements between 2011 and 2014. The control group was matched by year of birth, gender, region of residence, and economic status. Total costs of outpatient care and hospitalizations were analysed from a societal perspective. A general linear model was used to assess the incremental cost per patient in PLHIV. Results A total of 1,091 PLHIV and 2,181 matched controls were identified with a mean +/- standard deviation age of 46.7 +/- 11.5 years. The prevalence of alcohol abuse (5.8% vs 3.1%; p<0.001), chronic renal disease (1.2% vs 0.3%; p = 0.003), cardiovascular disease (7.4% vs 5.1%; p = 0.009), dyslipidaemia (22% vs 15.9%; p<0.001), hepatitis B (3.8% vs 0.1%; p<0.001) and hepatitis C (12.5% vs 0.6%; p<0.001) was significantly higher in PLHIV compared with non-HIV controls. Other comorbidities such as anaemia, malnutrition, psychiatric diseases, and neoplasms were also more prevalent in PLHIV. Hospitalizations were significantly increased in PLHIV compared to controls (33.2% vs 16%; p<0.001). Mean total cost was 6 times higher for PLHIV compared to controls and 4 times higher after excluding antiretroviral drugs (9,952euro vs. 2,593euro; p<0.001). Higher costs per person in PLHIV were significantly associated to aging (42euro per patient/year), chronic cardiovascular disease (3,003euro), hepatitis C (6,705euro), metastatic carcinoma (6,880euro) and moderate or severe liver disease (6,299euro). Conclusion Our results demonstrated an increase in non-HIV related comorbidities among PLHIV compared to matched controls. This study contributes to raise awareness on the burden of chronic comorbidities.	[Pourcher, Valerie] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Serv Malad Infect & Trop, Paris, France; [Gourmelen, Julie] INSERM, UMS 011, Villejuif, France; [Bureau, Isabelle; Bouee, Stephane] CEMKA, Real World Evidence, Bourg La Reine, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bouee, S (corresponding author), CEMKA, Real World Evidence, Bourg La Reine, France.	Stephane.bouee@cemka.fr	Pourcher, Valérie/AGZ-6964-2022		Gilead	Gilead(Gilead Sciences)	This study was funded by Gilead who gave a grant to CEMKA to perform the analysis. Stephane Bouee and Isabelle Bureau are employed by CEMKA, a consultancy which works for pharmaceutical compagnies as Gilead. CEMKA received honoraria to perform the study and the analysis. Gilead, had a role in review of protocols, results and manuscript.	Bernaud C, 2020, MED MALADIES INFECT, V50, P43, DOI 10.1016/j.medmal.2019.04.001; Blin P, 2012, DIABETOLOGIA, V55, P644, DOI 10.1007/s00125-011-2429-5; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Chaponda M, 2018, INT J STD AIDS, V29, P704, DOI 10.1177/0956462417750708; Croxford S, 2017, LANCET PUBLIC HEALTH, V2, pE35, DOI 10.1016/S2468-2667(16)30020-2; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; de Leotoing L, 2018, AIDS, V32, P2059, DOI 10.1097/QAD.0000000000001907; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Demir OM, 2018, INT J CARDIOL, V265, P195, DOI 10.1016/j.ijcard.2018.03.137; Drozd DR, 2017, JAIDS-J ACQ IMM DEF, V75, P568, DOI [10.1097/QAI.0000000000001450, 10.1097/qai.0000000000001450]; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Gallant J, 2018, CURR MED RES OPIN, V34, P13, DOI 10.1080/03007995.2017.1383889; Guaraldi G, 2013, CLINICOECONOMIC OUTC, V5, P481, DOI 10.2147/CEOR.S40607; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Hjalte F, 2018, AIDS CARE, V30, P1090, DOI 10.1080/09540121.2018.1476661; Hleyhel M, 2014, AIDS, V28, P2109, DOI 10.1097/QAD.0000000000000382; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Knudsen AD, 2018, JAIDS-J ACQ IMM DEF, V79, P381, DOI 10.1097/QAI.0000000000001795; Krentz HB, 2015, HIV MED, V16, P38, DOI 10.1111/hiv.12176; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Nishijima T, 2014, AIDS, V28, P1903, DOI 10.1097/QAD.0000000000000347; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Papot E, 2017, AIDS, V31, P1271, DOI 10.1097/QAD.0000000000001467; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Pelchen-Matthews A, 2018, AIDS; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Quantin C, 2015, CNAMTS ETUDES ALGORI; Quiros-Roldan E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3804-4; Rapport Morlat, 2017, RAPPORT MORLAT PRISE; Rasmussen LD, 2015, LANCET HIV, V2, pE288, DOI 10.1016/S2352-3018(15)00077-6; Ryom L, 2018, LANCET HIV, V5, pE291, DOI 10.1016/S2352-3018(18)30043-2; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Schranz AJ, 2015, AIDS PATIENT CARE ST, V29, P117, DOI 10.1089/apc.2014.0199; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Tossonian H, 2017, 9 IAS C HIV SCI PAR; Trapero-Bertran M, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0015-5; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tuppin P, 2010, REV EPIDEMIOL SANTE, V58, P286, DOI 10.1016/j.respe.2010.04.005; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Xu YN, 2017, J AM SOC HYPERTENS, V11, P530, DOI 10.1016/j.jash.2017.06.004; Zingmond DS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189392	47	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243529	10.1371/journal.pone.0243529	http://dx.doi.org/10.1371/journal.pone.0243529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332394	gold, Green Published			2022-12-26	WOS:000601310900060
J	Xu, JL; Zhang, XD; Liu, H; Yang, KG; Ma, FC; Li, HR; Sun, YF				Xu, Jinliang; Zhang, Xiaodong; Liu, Huan; Yang, Kaige; Ma, Fangchen; Li, Haoru; Sun, Yufei			Physiological indices and driving performance of drivers at tunnel entrances and exits: A simulated driving study	PLOS ONE			English	Article							TRAFFIC ACCIDENTS; HEART-RATE; REAL	The entrance and exit sections of a tunnel are the accident black-spots in an expressway. For a safe operation of road tunnels, it is necessary to understand a driver's physiological indices and driving performance when driving through tunnels. In this study, the UC-Win/Road simulation software was used to build 12 tunnel models of different lengths. A simulated driving experiment was carried out in a 6-DoF motion platform. The lateral position of vehicles characterizing the driving performance was measured using the motion platform. Electrocardiogram and eye movement data of 25 recruited drivers were collected simultaneously through the experiment. The spatial changes in a driver's heart rate (HR) growth rate, RMSSD, pupil diameter growth rate and vehicle lateral deviation within 300 m before and after the tunnel entrance and exit were analyzed to determine the variation rules in the different tunnels. The study identified the length range in the tunnel entrance and exit sections that influences the drivers. A quantitative analysis was further carried out to analyze the relationship between the physiological indices and the driving performance indicator. The results showed that a driver's heart rate fluctuates significantly 250 m before the tunnel entrance and 50 m before the exit. In this region, the pupil diameter increases gradually, and drivers tend to shift the vehicle to the left. At the tunnel exit, the HR and RMSSD are affected significantly by the tunnel length, and the variation is higher in longer tunnels. In comparison, the tunnel length has no significant effect on the physiological indicators and driving performance of the drivers at the entrance and exit.	[Xu, Jinliang; Zhang, Xiaodong; Liu, Huan; Yang, Kaige; Ma, Fangchen; Li, Haoru; Sun, Yufei] Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China; [Yang, Kaige] China Railway First Survey & Design Inst Grp Co L, Xian, Shaanxi, Peoples R China	Chang'an University	Zhang, XD (corresponding author), Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China.	2017021039@chd.edu.cn		ZHANG, XIAODONG/0000-0002-9358-8231	Department of Transportation of Shaanxi Province [18-23R]; Shandong Hi-speed Company Limited [220221200522]; Department of Transportation of Shaanxi Province; Shangdong Hi-speed Company Limited; China Railway First Survey and Design Institute Group Company Limited	Department of Transportation of Shaanxi Province; Shandong Hi-speed Company Limited; Department of Transportation of Shaanxi Province; Shangdong Hi-speed Company Limited; China Railway First Survey and Design Institute Group Company Limited	This research was supported by the Department of Transportation of Shaanxi Province to JX (Grant No. 18-23R) and Shandong Hi-speed Company Limited to JX (Grant No. 220221200522). China Railway First Survey and Design Institute Group Company Limited provided support for this study in the form of salaries for KY. The specific role of these author is articulated in the 'author contributions' section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The opportunity to research this topic is made possible by funding provided by the Department of Transportation of Shaanxi Province and Shangdong Hi-speed Company Limited. Meanwhile, we thank the drivers for their cooperation during the driving simulation experiment.	Akamatsu M., 2003, DRIV SIM C N AM DSC; Amundsen FH, 2000, TUNN UNDERGR SP TECH, V15, P3, DOI 10.1016/S0886-7798(00)00024-9; ANON, 2002, CDR WEEKLY, V12, P3; [Anonymous], 2011, ZH MOSKOVSKOY PATRIA, V3, P27; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2017, CRIT CARE NURSE, V37, pe19; [Anonymous], 1986, HDB PERCEPTION PERFO; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Caird JK, 2008, ACCIDENT ANAL PREV, V40, P1282, DOI 10.1016/j.aap.2008.01.009; Calvi A., 2013, ADV TRANSPORTATION S, V30, P59, DOI DOI 10.4399/97888548611764; Chang S, 2006, P DRIV SIM C PAR FRA, P103; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Chen PY, 2020, TUNN UNDERGR SP TECH, V99, DOI 10.1016/j.tust.2020.103362; Clarke DD, 2010, ACCIDENT ANAL PREV, V42, P764, DOI 10.1016/j.aap.2009.11.008; Dijksterhuis C, 2011, ACCIDENT ANAL PREV, V43, P1074, DOI 10.1016/j.aap.2010.12.014; Ding G, 2011, STUDY IMPACT FREEWAY; [丁光明 Ding Guangming], 2011, [长安大学学报. 自然科学版, Journal of Chang'An University. Natural Science Edition], V31, P77; Du Z., 2014, PROMET-ZAGREB, V26, P641; Fu X, 2020, J SPORT REHABIL, V29, P820, DOI 10.1123/jsr.2019-0095; Gemou M, 2013, EUR TRANSP RES REV, V5, P217, DOI 10.1007/s12544-013-0105-1; Helland A, 2013, ACCIDENT ANAL PREV, V53, P9, DOI 10.1016/j.aap.2012.12.042; ISO, 1007512017 ISO CEN; Kircher K, 2012, ACCIDENT ANAL PREV, V47, P153, DOI 10.1016/j.aap.2012.01.019; Lemke K, 2000, TRANSPORT RES REC, P170; LIU HX, 2011, J TRANSP SAF SECUR, V3, P27, DOI DOI 10.1080/19439962.2011.532298; Luo J, 2018, 2018 3 INT C SMART C; Luo WJ, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa76ae; Miller EE, 2015, TRANSPORT RES REC, P60, DOI 10.3141/2518-08; Ottaviani C, 2019, J PSYCHOPHYSIOL, V33, P198, DOI 10.1027/0269-8803/a000222; PORGES SW, 1992, PEDIATRICS, V90, P498; Qi W, 2020, J ADV TRANSPORT, P1; ROSCOE AH, 1992, BIOL PSYCHOL, V34, P259, DOI 10.1016/0301-0511(92)90018-P; SHIMOJO A, 1995, 1995 VEHICLE NAVIGATION & INFORMATION SYSTEMS CONFERENCE PROCEEDINGS - 6TH INTERNATIONAL VNIS/PACIFIC RIM TRANSTECH CONFERENCE, P96, DOI 10.1109/VNIS.1995.518824; Shimojo A, 1995, VEH NAV INF SYST C; Staubach M, 2009, ACCIDENT ANAL PREV, V41, P1025, DOI 10.1016/j.aap.2009.06.014; Tornros J, 1998, ACCIDENT ANAL PREV, V30, P497, DOI 10.1016/S0001-4575(97)00099-7; WANG HL, 2015, TRANSPORT RES REC, V2485, P1, DOI DOI 10.3141/2485-01; Wang YJ, 2016, STROKE VASC NEUROL, V1, P1, DOI 10.1136/svn-2016-000007; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Yan Y, 2015, ADV MECH ENG, V7, DOI 10.1155/2014/273427; Yeung JS, 2013, TUNN UNDERGR SP TECH, V38, P534, DOI 10.1016/j.tust.2013.09.002	41	3	3	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243931	10.1371/journal.pone.0243931	http://dx.doi.org/10.1371/journal.pone.0243931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332428	gold, Green Published			2022-12-26	WOS:000601310900051
J	Leng, XB; Wohl, M; Ishii, K; Nayak, P; Asahina, K				Leng, Xubo; Wohl, Margot; Ishii, Kenichi; Nayak, Pavan; Asahina, Kenta			Quantifying influence of human choice on the automated detection of Drosophila behavior by a supervised machine learning algorithm	PLOS ONE			English	Article							TRACKING; REQUIRES; SYSTEM	Automated quantification of behavior is increasingly prevalent in neuroscience research. Human judgments can influence machine-learning-based behavior classification at multiple steps in the process, for both supervised and unsupervised approaches. Such steps include the design of the algorithm for machine learning, the methods used for animal tracking, the choice of training images, and the benchmarking of classification outcomes. However, how these design choices contribute to the interpretation of automated behavioral classifications has not been extensively characterized. Here, we quantify the effects of experimenter choices on the outputs of automated classifiers of Drosophila social behaviors. Drosophila behaviors contain a considerable degree of variability, which was reflected in the confidence levels associated with both human and computer classifications. We found that a diversity of sex combinations and tracking features was important for robust performance of the automated classifiers. In particular, features concerning the relative position of flies contained useful information for training a machine-learning algorithm. These observations shed light on the importance of human influence on tracking algorithms, the selection of training images, and the quality of annotated sample images used to benchmark the performance of a classifier (the 'ground truth'). Evaluation of these factors is necessary for researchers to accurately interpret behavioral data quantified by a machine-learning algorithm and to further improve automated classifications.	[Leng, Xubo; Wohl, Margot; Ishii, Kenichi; Nayak, Pavan; Asahina, Kenta] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Leng, Xubo] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Wohl, Margot] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Asahina, K (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kasahina@salk.edu		Leng, Xubo/0000-0002-1124-6941; Asahina, Kenta/0000-0001-6359-4369	Naito Foundation; Japan Society for the Promotion of Science Postdoctoral Fellowship Abroad; Mary K. Chapman Foundation; Rose Hills Foundation; NIH NIGMS [R35 GM119844]; Helen McLoraine Development Chair of Neurobiology at the Salk Institute	Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science Postdoctoral Fellowship Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mary K. Chapman Foundation; Rose Hills Foundation; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Helen McLoraine Development Chair of Neurobiology at the Salk Institute	K.I. was supported by the Naito Foundation and the Japan Society for the Promotion of Science Postdoctoral Fellowship Abroad. M.W. was supported by the Mary K. Chapman Foundation and the Rose Hills Foundation. This work was supported by NIH NIGMS R35 GM119844 to K.A. K.A. is a recipient of the Helen McLoraine Development Chair of Neurobiology at the Salk Institute.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Berman GJ, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0494-7; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Buolamwini J., 2018, C FAIRN ACC TRANSP, P77; Burgos-Artizzu XP, 2012, PROC CVPR IEEE, P1322, DOI 10.1109/CVPR.2012.6247817; Calhoun AJ, 2019, NAT NEUROSCI, V22, P2040, DOI 10.1038/s41593-019-0533-x; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Datta SR, 2019, NEURON, V104, P11, DOI 10.1016/j.neuron.2019.09.038; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Deng J., 2009, 2009 IEEE C COMP VIS; Egnor SER, 2016, ANNU REV NEUROSCI, V39, P217, DOI 10.1146/annurev-neuro-070815-013845; Eyjolfsdottir E, 2014, LECT NOTES COMPUT SC, V8690, P772, DOI 10.1007/978-3-319-10605-2_50; Fujiwara T, 2017, NAT NEUROSCI, V20, P72, DOI 10.1038/nn.4435; Garcia VA, 2010, IEEE ENG MED BIO, P6603, DOI 10.1109/IEMBS.2010.5627131; Gomez-Marin A, 2014, NAT NEUROSCI, V17, P1455, DOI 10.1038/nn.3812; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hong WZ, 2015, P NATL ACAD SCI USA, V112, pE5351, DOI 10.1073/pnas.1515982112; Hoopfer ED, 2015, ELIFE, V4, DOI 10.7554/eLife.11346; Ishii K, 2020, ELIFE, V9, DOI 10.7554/eLife.52701; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jourjine N, 2016, CELL, V166, P855, DOI 10.1016/j.cell.2016.06.046; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Kain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2908; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Markowitz JE, 2018, CELL, V174, P44, DOI 10.1016/j.cell.2018.04.019; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Monfort M., 2019, MOMENTS TIME DATASET; Murthy M, 2010, CURR OPIN NEUROBIOL, V20, P281, DOI 10.1016/j.conb.2010.02.016; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pereira TD, 2019, NAT METHODS, V16, P117, DOI 10.1038/s41592-018-0234-5; Rezaval C, 2014, CURR BIOL, V24, P725, DOI 10.1016/j.cub.2013.12.051; Robie AA, 2017, CELL, V170, P393, DOI 10.1016/j.cell.2017.06.032; Robie AA, 2017, J EXP BIOL, V220, P25, DOI 10.1242/jeb.142281; Sanders JI, 2016, NEURON, V90, P499, DOI 10.1016/j.neuron.2016.03.025; Shirangi TR, 2016, DEV CELL, V37, P533, DOI 10.1016/j.devcel.2016.05.012; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Szigeti B, 2016, BIORXIV; Ueda A, 2002, PHYSIOL ENTOMOL, V27, P21, DOI 10.1046/j.1365-3032.2002.00262.x; Wiltschko AB, 2015, NEURON, V88, P1121, DOI 10.1016/j.neuron.2015.11.031; Wohl M, 2020, ELIFE, V9, DOI 10.7554/eLife.52702; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	53	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0241696	10.1371/journal.pone.0241696	http://dx.doi.org/10.1371/journal.pone.0241696			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326445	Green Published, gold			2022-12-26	WOS:000600176400064
J	Teinturier, R; Luo, YK; Decaussin-Petrucci, M; Vlaeminck-Guillem, V; Vacherot, F; Firlej, V; Bonnavion, R; Abou Ziki, R; Gherardi, S; Goddard, I; Gadot, N; Bertolino, P; Le Romancer, M; Zhang, CX				Teinturier, Romain; Luo, Yakun; Decaussin-Petrucci, Myriam; Vlaeminck-Guillem, Virginie; Vacherot, Francis; Firlej, Virginie; Bonnavion, Remy; Abou Ziki, Razan; Gherardi, Samuele; Goddard, Isabelle; Gadot, Nicolas; Bertolino, Philippe; Le Romancer, Muriel; Zhang, Chang Xian			Men1 disruption in Nkx3.1-deficient mice results in AR(low)/CD44(+) microinvasive carcinoma development with the dysregulated AR pathway	ONCOGENE			English	Article							PROSTATE-CANCER; CELLS; GENE; MECHANISMS; COMPLEX	Dysregulated androgen receptor (AR) plays a crucial role in prostate cancer (PCa) development, though further factors involved in its regulation remain to be identified. Recently, paradoxical results were reported on the implication of the MEN1 gene in PCa. To dissect its role in prostate luminal cells, we generated a mouse model with inducible Men1 disruption in Nkx3.1-deficient mice in which mouse prostatic intraepithelial neoplasia (mPIN) occur. Prostate glands from mutant and control mice were analyzed pathologically and molecularly; cellular and molecular analyses were carried out in PCa cell lines after MEN1 knockdown (KD) by siRNA. Double-mutant mice developed accelerated mPIN and later displayed microinvasive adenocarcinoma. Markedly, early-stage lesions exhibited a decreased expression of AR and its target genes, accompanied by reduced CK18 and E-cadherin expression, suggesting a shift from a luminal to a dedifferentiated epithelial phenotype. Intriguingly, over 60% of menin-deficient cells expressed CD44 at a later stage. Furthermore, MEN1 KD led to the increase in CD44 expression in PC3 cells re-expressing AR. Menin bound to the proximal AR promoter and regulated AR transcription via the H3K4me3 histone mark. Interestingly, the cell proliferation of AR-dependent cells (LNCaP, 22Rv1, and VCaP), but not of AR-independent cells (DU145, PC3), responded strongly to MEN1 silencing. Finally, menin expression was found reduced in some human PCa. These findings highlight the regulation of the AR promoter by menin and the crosstalk between menin and the AR pathway. Our data could be useful for better understanding the increasingly reported AR-negative/NE-negative subtype of PCa and the mechanisms underlying its development.	[Teinturier, Romain; Luo, Yakun; Decaussin-Petrucci, Myriam; Vlaeminck-Guillem, Virginie; Bonnavion, Remy; Abou Ziki, Razan; Gherardi, Samuele; Bertolino, Philippe; Le Romancer, Muriel; Zhang, Chang Xian] Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard,INSERM 1052,CNRS 5286, F-69008 Lyon, France; [Decaussin-Petrucci, Myriam; Vlaeminck-Guillem, Virginie] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Biol & Anatomopathol Sud, F-69495 Lyon, France; [Vacherot, Francis; Firlej, Virginie] Univ Paris Est Creteil, TRePCa, F-94010 Creteil, France; [Firlej, Virginie] Hop Univ Henri Mondor, Plateforme Ressources Biol, F-94000 Creteil, France; [Goddard, Isabelle] Univ Claude Bernard Lyon 1, Univ Lyon, Lab Modeles Tumoraux,INSERM 1052,CNRS 5286, Ctr Rech Cancerol Lyon CRCL,Fdn Synergie Lyon Can, F-69373 Lyon, France; [Gadot, Nicolas] Univ Claude Bernard Lyon 1, Univ Lyon, INSERM 1052,CNRS 5286,Ctr Leon Berard, Plateforme Anatomopathol Rech,Ctr Rech Cancerol L, F-69373 Lyon, France; [Teinturier, Romain] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Bonnavion, Remy] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Lyon; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Karolinska Institutet; Max Planck Society	Zhang, CX (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard,INSERM 1052,CNRS 5286, F-69008 Lyon, France.	chang.zhang@lyon.unicancer.fr	Firlej, Virginie/AFQ-6362-2022; Bertolino, philippe/D-4072-2018; DECAUSSIN PETRUCCI, MYRIAM/GWZ-7373-2022	Firlej, Virginie/0000-0003-4132-0695; Bertolino, philippe/0000-0001-8064-8269; Bonnavion, Remy/0000-0002-7389-4282; LUO, YAKUN/0000-0002-9644-5025	Epigenetics Cancer Program [ASC14092CSA]; Fondation de l'Association pour la Recherche contre le Cancer [SFI20101201530]; Ligue Inter-regionale contre le Cancer [R19040CC]; Association Le Cancer du Sein Parlons-en; Region Auvergne, Rhone-Alpes [SICORRA22425]; French Ministry of Higher Education and Research; Societe Francaise d'Endocrinologie; Fondation ARC, France; China Scholarship Council; Association "G04MEDIA S.A.R.L," Lebanon	Epigenetics Cancer Program; Fondation de l'Association pour la Recherche contre le Cancer; Ligue Inter-regionale contre le Cancer; Association Le Cancer du Sein Parlons-en; Region Auvergne, Rhone-Alpes(Region Auvergne-Rhone-Alpes); French Ministry of Higher Education and Research; Societe Francaise d'Endocrinologie; Fondation ARC, France; China Scholarship Council(China Scholarship Council); Association "G04MEDIA S.A.R.L," Lebanon	This study was supported by Epigenetics & Cancer Program (ASC14092CSA), the Fondation de l'Association pour la Recherche contre le Cancer (SFI20101201530), the Ligue Inter-regionale contre le Cancer (R19040CC), the Association Le Cancer du Sein Parlons-en, and the Region Auvergne, Rhone-Alpes, (SICORRA22425). RT and RB were the recipients of a PhD fellowship from French Ministry of Higher Education and Research, and of a 4th year doctoral fellowship from Societe Francaise d'Endocrinologie and the Fondation ARC, France, respectively. YL was the recipient of a PhD fellowship from China Scholarship Council. RAZ was the recipient of a PhD fellowship from Association "G04MEDIA S.A.R.L," Lebanon.	Abida W, 2019, P NATL ACAD SCI USA, V116, P11428, DOI 10.1073/pnas.1902651116; Altintas DM, 2011, MOL CELL ENDOCRINOL, V332, P149, DOI 10.1016/j.mce.2010.10.007; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Bertolino P, 2003, CANCER RES, V63, P4836; Bluemn EG, 2017, CANCER CELL, V32, P474, DOI 10.1016/j.ccell.2017.09.003; Dreijerink KMA, 2017, CELL REP, V18, P2359, DOI 10.1016/j.celrep.2017.02.025; Dreijerink KMA, 2014, NEW ENGL J MED, V371, P583, DOI 10.1056/NEJMc1406028; Floc'h N, 2012, CANCER RES, V72, P4483, DOI 10.1158/0008-5472.CAN-12-0283; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Li QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06067-7; Liu X, 2015, ONCOTARGET, V6, P23959, DOI 10.18632/oncotarget.4260; Malik R, 2015, NAT MED, V21, P344, DOI 10.1038/nm.3830; Paris PL, 2009, PROSTATE CANCER P D, V12, P184, DOI 10.1038/pcan.2008.45; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rybak AP, 2015, ONCOTARGET, V6, P1900, DOI 10.18632/oncotarget.2953; Seigne C, 2013, J PATHOL, V229, P546, DOI 10.1002/path.4146; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Srinivasan D, 2019, J CELL BIOCHEM, V120, P2413, DOI 10.1002/jcb.27573; Thiel AT, 2012, BIOESSAYS, V34, P771, DOI 10.1002/bies.201200007; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	25	3	3	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1118	1127		10.1038/s41388-020-01589-1	http://dx.doi.org/10.1038/s41388-020-01589-1		DEC 2020	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33323967				2022-12-26	WOS:000599126500008
J	Kosgei, RJ; Callens, S; Gichangi, P; Temmerman, M; Kihara, AB; David, G; Omesa, EN; Masini, E; Carter, EJ				Kosgei, Rose J.; Callens, Steven; Gichangi, Peter; Temmerman, Marleen; Kihara, Anne-Beatrice; David, Gathara; Omesa, Eunice Nyaboe; Masini, Enos; Carter, E. Jane			Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya	PLOS ONE			English	Article							TREATMENT OUTCOMES; EPIDEMIOLOGY; MALNUTRITION; TRANSMISSION; RISK	Setting Kenya, 2012-2015 Objective To explore whether there is a gender difference in all-cause mortality among smear positive pulmonary tuberculosis (PTB)/ HIV co-infected patients treated for tuberculosis (TB) between 2012 and 2015 in Kenya. Design Retrospective cohort of 9,026 smear-positive patients aged 15-49 years. All-cause mortality during TB treatment was the outcome of interest. Time to start of antiretroviral therapy (ART) initiation was considered as a proxy for CD4 cell count. Those who took long to start of ART were assumed to have high CD4 cell count. Results Of the 9,026 observations analysed, 4,567(51%) and 4,459(49%) were women and men, respectively. Overall, out of the 9,026 patients, 8,154 (90%) had their treatment outcome as cured, the mean age in years (SD) was 33.3(7.5) and the mean body mass index (SD) was 18.2(3.4). Men were older (30% men' vs 17% women in those >= 40 years, p = <0.001) and had a lower BMI <18.5 (55.3% men vs 50.6% women, p = <0.001). Men tested later for HIV: 29% (1,317/4,567) of women HIV tested more than 3 months prior to TB treatment, as compared to 20% (912/4,459) men (p<0.001). Mortality was higher in men 11% (471/4,459) compared to women 9% (401/4,567, p = 0.004). There was a 17% reduction in the risk of death among women (adjusted HR 0.83; 95% CI 0.72-0.96; p = 0.013). Survival varied by age-groups, with women having significantly better survival than men, in the age-groups 40 years and over (log-rank p = 0.006). Conclusion Women with sputum positive PTB/HIV co-infection have a significantly lower risk of all-cause mortality during TB treatment compared to men. Men were older, had lower BMI and tested later for HIV than women.	[Kosgei, Rose J.; Kihara, Anne-Beatrice] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Callens, Steven; Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium; [Gichangi, Peter] Univ Nairobi, Dept Human Anat, Nairobi, Kenya; [Temmerman, Marleen] Aga Khan Univ, Fac Hlth Sci, Nairobi, Kenya; [David, Gathara] Ruby Med Ctr, Kiambu West, Kenya; [Omesa, Eunice Nyaboe; Masini, Enos] Natl TB Leprosy & Lung Dis Program, Nairobi, Kenya; [Carter, E. Jane] Brown Univ, Alpert Sch Med, Providence, RI 02912 USA	University of Nairobi; Ghent University; University of Nairobi; Aga Khan University; Brown University	Kosgei, RJ (corresponding author), Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya.	salilkabon@gmail.com		Gathara, David/0000-0002-0958-0713				Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; Chi BH, 2013, CURR OPIN HIV AIDS, V8, P498, DOI 10.1097/COH.0b013e3283637f7a; Faustini A, 2008, INT J INFECT DIS, V12, P611, DOI 10.1016/j.ijid.2007.12.012; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Gathara D, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0850-8; Gopalan N, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0118-7; Gunda DW, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/5352906; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hodgkinson LM, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020328; Islam QS, 2013, PUBLIC HEALTH ACTION, V3, P136, DOI 10.5588/pha.13.0005; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Kerschberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046988; Kosgei RJ, 2015, INT J TUBERC LUNG D, V19, P1176, DOI 10.5588/ijtld.15.0070; Lai RPJ, 2016, SEMIN IMMUNOPATHOL, V38, P185, DOI 10.1007/s00281-015-0532-2; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Manosuthi W, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0106-y; MOH. Ministry of Health, 2012, DIV LEPR TUB LUNG DI; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Nglazi MD, 2012, SAMJ S AFR MED J, V102, P936, DOI [10.7196/SAMJ.6024, 10.7196/samj.6024]; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Pakasi TA, 2009, INT J TUBERC LUNG D, V13, P755; Pepper DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019484; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sharma SK, 2011, INDIAN J MED RES, V134, P866, DOI 10.4103/0971-5916.92632; Vandenbroucke JP, 2014, INT J SURG, V12, P1500, DOI 10.1016/j.ijsu.2014.07.014; WHO, 2010, ANT THER HIV INF AD; WHO, 2017, GLOB TUB REP 2017; WHO, 2018, ANT THER HIV INF AD; WHO, 2015, GEND STAT MAN INT GE; WHO, 2018, DEF REP FRAM TUB 201; Yang CH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-304; Yen YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002300; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243977	10.1371/journal.pone.0243977	http://dx.doi.org/10.1371/journal.pone.0243977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315954	gold, Green Published			2022-12-26	WOS:000600186100080
J	Wymann, S; Dai, Y; Nair, AG; Cao, H; Powers, GA; Schnell, A; Martin-Roussety, G; Leong, D; Simmonds, J; Lieu, KG; de Souza, MJ; Mischnik, M; Taylor, S; Ow, SY; Spycher, M; Butcher, RE; Pearse, M; Zuercher, AW; Morelli, AB; Panousis, C; Wilson, MJ; Rowe, T; Hardy, MP				Wymann, Sandra; Dai, Yun; Nair, Anup G.; Cao, Helen; Powers, Glenn A.; Schnell, Anna; Martin-Roussety, Genevieve; Leong, David; Simmonds, Jason; Lieu, Kim G.; de Souza, Mitchell J.; Mischnik, Marcel; Taylor, Shirley; Ow, Saw Yen; Spycher, Martin; Butcher, Rebecca E.; Pearse, Martin; Zuercher, Adrian W.; Morelli, Adriana Baz; Panousis, Con; Wilson, Michael J.; Rowe, Tony; Hardy, Matthew P.			A novel soluble complement receptor 1 fragment with enhanced therapeutic potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; HAMSTER OVARY CELLS; ACUTE LUNG INJURY; C3B/C4B RECEPTOR; IMMUNE ADHERENCE; FACTOR-H; HUMAN-ERYTHROCYTE; C3B RECEPTOR; SIALIC-ACID; CR-1	Human complement receptor 1 (HuCR1) is a pivotal regulator of complement activity, acting on all three complement pathways as a membrane-bound receptor of C3b/C4b, C3/C5 convertase decay accelerator, and cofactor for factor I-mediated cleavage of C3b and C4b. In this study, we sought to identify a minimal soluble fragment of HuCR1, which retains the complement regulatory activity of the wildtype protein. To this end, we generated recombinant, soluble, and truncated versions of HuCR1 and compared their ability to inhibit complement activation in vitro using multiple assays. A soluble form of HuCR1, truncated at amino acid 1392 and designated CSL040, was found to be a more potent inhibitor than all other truncation variants tested. CSL040 retained its affinity to both C3b and C4b as well as its cleavage and decay acceleration activity and was found to be stable under a range of buffer conditions. Pharmacokinetic studies in mice demonstrated that the level of sialylation is a major determinant of CSL040 clearance in vivo. CSL040 also showed an improved pharmacokinetic profile compared with the full extracellular domain of HuCR1. The in vivo effects of CSL040 on acute complement-mediated kidney damage were tested in an attenuated passive antiglomerular basement membrane antibody-induced glomerulonephritis model. In this model, CSL040 at 20 and 60 mg/kg significantly attenuated kidney damage at 24 h, with significant reductions in cellular infiltrates and urine albumin, consistent with protection from kidney damage. CSL040 thus represents a potential therapeutic candidate for the treatment of complement-mediated disorders.	[Wymann, Sandra; Schnell, Anna; Spycher, Martin; Zuercher, Adrian W.] CSL Behring AG, Res & Dev, Bern, Switzerland; [Dai, Yun; Nair, Anup G.; Cao, Helen; Powers, Glenn A.; Martin-Roussety, Genevieve; Leong, David; Simmonds, Jason; Lieu, Kim G.; de Souza, Mitchell J.; Taylor, Shirley; Ow, Saw Yen; Butcher, Rebecca E.; Pearse, Martin; Morelli, Adriana Baz; Panousis, Con; Wilson, Michael J.; Rowe, Tony; Hardy, Matthew P.] CSL Ltd, Bio21 Inst, Melbourne, Vic, Australia; [Mischnik, Marcel] CSL Behring GmbH, Res & Dev, Marburg, Germany	CSL; CSL; CSL	Hardy, MP (corresponding author), CSL Ltd, Bio21 Inst, Melbourne, Vic, Australia.	matt.hardy@csl.com.au		Schnell, Anna/0000-0002-3943-598X	CSL Ltd, Parkville, Australia	CSL Ltd, Parkville, Australia	This work was supported by CSL Ltd, Parkville, Australia.	AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Alcorlo M, 2011, P NATL ACAD SCI USA, V108, P13236, DOI 10.1073/pnas.1106746108; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Ang C, 1998, NEPHROL DIAL TRANSPL, V13, P935, DOI 10.1093/ndt/13.4.935; Asgari E, 2010, CURR OPIN ORGAN TRAN, V15, P486, DOI 10.1097/MOT.0b013e32833b9cb7; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Berger SP, 2007, SEMIN IMMUNOPATHOL, V29, P375, DOI 10.1007/s00281-007-0090-3; Birmingham DJ, 2001, IMMUNOL REV, V180, P100, DOI 10.1034/j.1600-065X.2001.1800109.x; Chan RK, 2003, BRIT J SURG, V90, P1470, DOI 10.1002/bjs.4408; Charchaflieh J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/407324; Chung CY, 2015, BIOCHEM BIOPH RES CO, V463, P211, DOI 10.1016/j.bbrc.2015.05.023; COOPER NR, 1969, SCIENCE, V165, P396, DOI 10.1126/science.165.3891.396; COUSER WG, 1995, J AM SOC NEPHROL, V5, P1888; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Dho SH, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e11; Dustin ML, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0034-2016; FEARON DT, 1980, J EXP MED, V152, P20, DOI 10.1084/jem.152.1.20; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Furtado PB, 2008, J MOL BIOL, V375, P102, DOI 10.1016/j.jmb.2007.09.085; Goodfellow RM, 2000, CLIN EXP IMMUNOL, V119, P210, DOI 10.1046/j.1365-2249.2000.01129.x; Heller A, 2000, SHOCK, V13, P285, DOI 10.1097/00024382-200004000-00006; HOMEISTER JW, 1993, J IMMUNOL, V150, P1055; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; IIDA K, 1981, J EXP MED, V153, P1138, DOI 10.1084/jem.153.5.1138; Issa PC, 2011, GRAEF ARCH CLIN EXP, V249, P163, DOI 10.1007/s00417-010-1568-6; Jacquet M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00453; Jacquet M, 2013, J IMMUNOL, V190, P3721, DOI 10.4049/jimmunol.1202451; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; KALLI KR, 1991, J EXP MED, V174, P1451, DOI 10.1084/jem.174.6.1451; Karthikeyan G, 2007, J THROMB THROMBOLYS, V23, P115, DOI 10.1007/s11239-006-9040-5; Keshavjee S, 2005, J THORAC CARDIOV SUR, V129, P423, DOI 10.1016/j.jtcvs.2004.06.048; Khajoee V, 2003, HUM GENET, V112, P244, DOI 10.1007/s00439-002-0870-8; KLICKSTEIN LB, 1988, J EXP MED, V168, P1699, DOI 10.1084/jem.168.5.1699; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; KRYCH M, 1991, P NATL ACAD SCI USA, V88, P4353, DOI 10.1073/pnas.88.10.4353; KRYCH M, 1994, J BIOL CHEM, V269, P13273; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Lachmann PJ, 2019, IMMUNOBIOLOGY, V224, P511, DOI 10.1016/j.imbio.2019.05.003; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Lazar HL, 2007, CIRCULATION, V116, pI83, DOI 10.1161/CIRCULATIONAHA.106.677914; Lazar HL, 2004, CIRCULATION, V110, pII274, DOI 10.1161/01.CIR.0000138315.99788.eb; Li Jennifer S, 2006, Expert Rev Cardiovasc Ther, V4, P649, DOI 10.1586/14779072.4.5.649; Lipsker D, 2010, LUPUS, V19, P1096, DOI 10.1177/0961203310373370; Liu D, 2009, IMMUNOPHARM IMMUNOT, V31, P524, DOI 10.3109/08923970902845768; Macedo ACL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00055; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; McGeer PL, 2017, NEUROBIOL AGING, V52, P12, DOI 10.1016/j.neurobiolaging.2016.12.017; MEDOF ME, 1982, J EXP MED, V156, P1739, DOI 10.1084/jem.156.6.1739; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Mqadmi A, 2005, TRANSFUSION, V45, P234, DOI 10.1111/j.1537-2995.2004.04163.x; MULLIGAN MS, 1992, J IMMUNOL, V148, P1479; Noris M, 2015, AM J KIDNEY DIS, V66, P359, DOI 10.1053/j.ajkd.2015.03.040; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Otten MA, 2009, J IMMUNOL, V183, P3980, DOI 10.4049/jimmunol.0901301; Park EI, 2003, J BIOL CHEM, V278, P4597, DOI 10.1074/jbc.M210612200; Parker Charles J, 2008, Hematology Am Soc Hematol Educ Program, P93, DOI 10.1182/asheducation-2008.1.93; PEMBERTON M, 1993, J IMMUNOL, V150, P5104; Powell JT, 2013, CLIN TRANSPLANT, V27, P484, DOI 10.1111/ctr.12121; Pratt JR, 1996, AM J PATHOL, V149, P2055; PRICER WE, 1976, J BIOL CHEM, V251, P7539; PROHASKA R, 1987, IMMUNOBIOLOGY, V174, P93, DOI 10.1016/S0171-2985(87)80087-6; PRUITT SK, 1994, TRANSPLANTATION, V57, P363, DOI 10.1097/00007890-199402150-00009; REILLY BD, 1994, J BIOL CHEM, V269, P7696; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ross D, 2012, J BIOTECHNOL, V162, P262, DOI 10.1016/j.jbiotec.2012.09.018; ROSS GD, 1982, J EXP MED, V155, P96, DOI 10.1084/jem.155.1.96; ROSS GD, 1982, J IMMUNOL, V129, P2051; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Salvadori Maurizio, 2015, World J Nephrol, V4, P169, DOI 10.5527/wjn.v4.i2.169; Schmid RA, 1998, J THORAC CARDIOV SUR, V116, P90, DOI 10.1016/S0022-5223(98)70246-6; Schramm EC, 2015, BLOOD, V125, P2359, DOI 10.1182/blood-2014-10-609073; Servais A, 2011, HUM PATHOL, V42, P1305, DOI 10.1016/j.humpath.2010.11.023; Smith BO, 2002, CELL, V108, P769, DOI 10.1016/S0092-8674(02)00672-4; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Takamatsu S, 2003, BBA-GEN SUBJECTS, V1622, P179, DOI 10.1016/S0304-4165(03)00141-7; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Thurman JM, 2017, NEPHROL DIAL TRANSPL, V32, P57, DOI 10.1093/ndt/gfw228; Tuzun E, 2011, J AUTOIMMUN, V37, P136, DOI 10.1016/j.jaut.2011.05.006; Weikert S, 1999, NAT BIOTECHNOL, V17, P1116, DOI 10.1038/15104; WEIS JH, 1987, J IMMUNOL, V138, P312; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Williams TM, 2014, CYTOM PART A, V85, P256, DOI 10.1002/cyto.a.22420; Yamamoto H, 2013, INT J BIOCHEM CELL B, V45, P2808, DOI 10.1016/j.biocel.2013.09.016; Yazdanbakhsh K, 2003, BLOOD, V101, P5046, DOI 10.1182/blood-2002-10-3068; Zhang PQ, 2010, METAB ENG, V12, P526, DOI 10.1016/j.ymben.2010.08.004; Zimmerman JL, 2000, CRIT CARE MED, V28, P3149, DOI 10.1097/00003246-200009000-00004	92	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100200	10.1074/jbc.RA120.016127	http://dx.doi.org/10.1074/jbc.RA120.016127			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334893	gold, Green Published			2022-12-26	WOS:000672866400178
J	Zhang, RF; Zhao, XG; Du, J; Wei, LY; Zhao, ZW				Zhang, Ruifeng; Zhao, Xianguo; Du, Juan; Wei, Liya; Zhao, Zhangwu			Regulatory mechanism of daily sleep by miR-276a	FASEB JOURNAL			English	Article						Drosophila melanogaster; clock; miR&#8208; 276a; NPFR1; sleep; tim	DROSOPHILA; DOPAMINE; IDENTIFICATION; HOMEOSTASIS; MODULATION; OCTOPAMINE; AROUSAL; STRESS; REST	MiRNAs have attracted more attention in recent years as regulators of sleep and circadian rhythms after their roles in circadian rhythm and sleep were discovered. In this study, we explored the roles of the miR-276a on daily sleep in Drosophila melanogaster, and found a regulatory cycle for the miR-276a pathway, in which miR-276a, regulated by the core CLOCK/CYCLE (CLK/CYC) transcription factor upstream, regulates sleep via suppressing targets TIM and NPFR1. (a) Loss of miR-276a function makes the flies sleep more during both daytime and nighttime, while flies with gain of miR-276a function sleep less; (b) MiR-276a is widely expressed in the mushroom body (MB), the pars intercerebralis (PI) and some clock neurons lateral dorsal neurons (LNds), in which tim neurons is important for sleep regulation; (c) MiR-276a promoter is identified to locate in the 8th fragment (aFrag8) of the pre-miR-276a, and this fragment is directly activated and regulated by CLK/CYC; (4) MiR-276a is rhythmically oscillating in heads of the wild-type w(1118), but this oscillation disappears in the loss of function mutant clk(jrk); (5) The neuropeptide F receptor 1 (npfr1) was found to be a downstream target of miR-276a. These results clarify that the miR-276a is a very important factor for sleep regulation.	[Zhang, Ruifeng; Zhao, Xianguo; Du, Juan; Zhao, Zhangwu] China Agr Univ, Dept Entomol, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing 100193, Peoples R China; [Wei, Liya] Hebei Univ, Coll Life Sci, Baoding, Peoples R China	China Agricultural University; Hebei University	Zhao, ZW (corresponding author), China Agr Univ, Dept Entomol, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing 100193, Peoples R China.	zhaozw@cau.edu.cn						Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Brancati G, 2018, NUCLEIC ACIDS RES, V46, P3259, DOI 10.1093/nar/gky201; Broughton JP, 2016, MOL CELL, V64, P320, DOI 10.1016/j.molcel.2016.09.004; Chen WF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6549; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Chen X, 2016, P NATL ACAD SCI USA, V113, pE2965, DOI 10.1073/pnas.1605837113; Chen YW, 2014, DEV CELL, V31, P784, DOI 10.1016/j.devcel.2014.11.029; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2008, ANN NY ACAD SCI, V1129, P323, DOI 10.1196/annals.1417.017; Cirelli C, 2006, P NATL ACAD SCI USA, V103, P13901, DOI 10.1073/pnas.0606652103; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Guo F, 2011, SLEEP, V34, P273, DOI 10.1093/sleep/34.3.273; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; He CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074237; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Ishimoto H, 2010, GENETICS, V185, P269, DOI 10.1534/genetics.110.114587; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kadener S, 2009, RNA, V15, P537, DOI 10.1261/rna.1319309; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Li WH, 2013, J NEUROSCI, V33, P5821, DOI 10.1523/JNEUROSCI.4004-12.2013; Nian XG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080923; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pimentel D, 2016, NATURE, V536, P333, DOI 10.1038/nature19055; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Tomita J, 2011, J NEUROSCI, V31, P13137, DOI 10.1523/JNEUROSCI.5860-10.2011; Vodala S, 2012, CELL METAB, V16, P601, DOI 10.1016/j.cmet.2012.10.002; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	42	1	1	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21222	10.1096/fj.202001220R	http://dx.doi.org/10.1096/fj.202001220R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337563				2022-12-26	WOS:000605626600039
J	Brummitt, SI; Kjemtrup, AM; Harvey, DJ; Petersen, JM; Sexton, C; Replogle, A; Packham, AE; Bloch, EM; Barbour, AG; Krause, PJ; Green, V; Smith, WA				Brummitt, Sharon I.; Kjemtrup, Anne M.; Harvey, Danielle J.; Petersen, Jeannine M.; Sexton, Christopher; Replogle, Adam; Packham, Andrea E.; Bloch, Evan M.; Barbour, Alan G.; Krause, Peter J.; Green, Valerie; Smith, Woutrina A.			Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors	PLOS ONE			English	Article							FEVER GROUP SPIROCHETE; RELAPSING-FEVER; LYME-DISEASE; IXODES-PACIFICUS; UNITED-STATES; INFECTION; RISK; DIAGNOSIS; PATHOGEN; EXPOSURE	The western blacklegged tick, Ixodes pacificus, an important vector in the western United States of two zoonotic spirochetes: Borrelia burgdorferi (also called Borreliella burgdorferi), causing Lyme disease, and Borrelia miyamotoi, causing a relapsing fever-type illness. Human cases of Lyme disease are well-documented in California, with increased risk in the north coastal areas and western slopes of the Sierra Nevada range. Despite the established presence of B. miyamotoi in the human-biting I. pacificus tick in California, clinical cases with this spirochete have not been well studied. To assess exposure to B. burgdorferi and B. miyamotoi in California, and to address the hypothesis that B. miyamotoi exposure in humans is similar in geographic range to B. burgdorferi, 1,700 blood donor sera from California were tested for antibodies to both pathogens. Sampling was from high endemic and low endemic counties for Lyme disease in California. All sera were screened using the C6 ELISA. All C6 positive and equivocal samples and nine randomly chosen C6 negative samples were further analyzed for B. burgdorferi antibody using IgG western blot and a modified two ELISA test system and for B. miyamotoi antibody using the GlpQ ELISA and B. miyamotoi whole cell sonicate western blot. Of the 1,700 samples tested in series, eight tested positive for antibodies to B. burgdorferi (0.47%, Exact 95% CI: 0.20, 0.93) and two tested positive for antibodies to B. miyamotoi (0.12%, Exact 95% CI: 0.01, 0.42). There was no statistically significant difference in seroprevalence for either pathogen between high and low Lyme disease endemic counties. Our results confirm a low frequency of Lyme disease and an even lower frequency of B. miyamotoi exposure among adult blood donors in California; however, our findings reinforce public health messaging that there is risk of infection by these emerging diseases in the state.	[Brummitt, Sharon I.; Smith, Woutrina A.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Kjemtrup, Anne M.] Calif Dept Publ Hlth, Sacramento, CA USA; [Harvey, Danielle J.] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Petersen, Jeannine M.; Sexton, Christopher; Replogle, Adam] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Packham, Andrea E.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Bloch, Evan M.] Johns Hopkins Univ, Dept Pathol & Transfus Med, Baltimore, MD USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Krause, Peter J.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Krause, Peter J.] Yale Sch Med, New Haven, CT USA; [Green, Valerie] Creat Testing Solut, Tempe, AZ USA	University of California System; University of California Davis; California Department of Public Health; University of California System; University of California Davis; Centers for Disease Control & Prevention - USA; University of California System; University of California Davis; Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Irvine; Yale University; Yale University	Brummitt, SI (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	Sibrummitt@ucdavis.edu		Sexton, Christopher/0000-0003-0928-214X	National Institutes of Health [AI-100236]; National Heart, Lung, and Blood Institute of the National Institutes of Health [K23HL151826]; Gordon and Llura Gund Foundation; California Lyme Disease Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Gordon and Llura Gund Foundation; California Lyme Disease Association	This research was supported in part by a crowdfunding platform through experiment.com set up by S.I.B.: https://experiment.com/projects/ticks-carry-more-than-lyme-disease-in-californiaare-californians-at-risk.We would like to acknowledge the California Lyme Disease Association for providing matching funds to the experiment.com crowdfunding platform. This research was also supported in part by National Institutes of Health grant AI-100236 to A.G.B, The National Heart, Lung, and Blood Institute of the National Institutes of Health under award number K23HL151826 to E.M.B, and the Gordon and Llura Gund Foundation to P.J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2015, VBDS ANN REP; [Anonymous], 2016, VBDS ANN REP; [Anonymous], 2017, VBDS ANN REP; [Anonymous], 2019, VBDS ANN REP; [Anonymous], 2018, VBDS ANN REP; Arnaboldi PM, 2013, CLIN VACCINE IMMUNOL, V20, P474, DOI 10.1128/CVI.00608-12; Atsma F, 2011, TRANSFUSION, V51, P1820, DOI 10.1111/j.1537-2995.2010.03055.x; Bacon RM, 2004, J CLIN MICROBIOL, V42, P2326, DOI 10.1128/JCM.42.5.2326-2328.2004; Branda JA, 2018, CLIN INFECT DIS, V66, P1133, DOI 10.1093/cid/cix943; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; California Department of Public health, 2018, TICK BORN REL FEV; Center for Disease Control and Prevention, 2019, TICK BORN REL FEV BO; Center for Disease Control and Prevention, 1995, NOT READ REC TEST PE; Center for Disease Control and Prevention, 2015, REL FEV; Center for Disease Control and Prevention, 2019, LYM DIS REC SURV DAT; Eisen L, 2004, MED VET ENTOMOL, V18, P38, DOI 10.1111/j.1365-2915.2004.0476.x; Eisen RJ, 2006, AM J TROP MED HYG, V75, P669, DOI 10.4269/ajtmh.2006.75.669; Eisen RJ, 2017, ILAR J, V58, P319, DOI 10.1093/ilar/ilx005; Eisen RJ, 2018, TRENDS PARASITOL, V34, P295, DOI 10.1016/j.pt.2017.12.006; Eisen RJ, 2006, AM J TROP MED HYG, V74, P632, DOI 10.4269/ajtmh.2006.74.632; Fritz CL, 1997, J INFECT DIS, V175, P1432, DOI 10.1086/516476; Fritz CL, 2013, VECTOR-BORNE ZOONOT, V13, P376, DOI 10.1089/vbz.2012.1137; Hamase A, 1996, FEMS MICROBIOL LETT, V140, P131, DOI 10.1111/j.1574-6968.1996.tb08326.x; Jahfari S, 2014, New Microbes New Infect, V2, P144, DOI 10.1002/nmi2.59; Jahfari S, 2017, J MICROBIOL METH, V136, P11, DOI 10.1016/j.mimet.2017.02.013; Koetsveld J, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2019.07.026; Krause PJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191725; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Lane RS, 2004, J MED ENTOMOL, V41, P239, DOI 10.1603/0022-2585-41.2.239; Liang FT, 2000, J INFECT DIS, V182, P1455, DOI 10.1086/315862; Molins CR, 2016, J CLIN MICROBIOL, V54, P2726, DOI 10.1128/JCM.00874-16; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Molloy PJ, 2018, CLIN INFECT DIS, V66, P1407, DOI 10.1093/cid/cix1023; Moore A, 2016, EMERG INFECT DIS, V22, P1169, DOI 10.3201/eid2207.151694; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Nieto NC, 2014, J MED ENTOMOL, V51, P1029, DOI 10.1603/ME14021; Ogden N H, 2019, Can Commun Dis Rep, V45, P76, DOI 10.14745/ccdr.v45i04a01; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Pascoe EL, 2019, VECTOR-BORNE ZOONOT, V19, P871, DOI 10.1089/vbz.2019.2489; Philipp MT, 2005, CLIN DIAGN LAB IMMUN, V12, P1069, DOI 10.1128/CDLI.12.9.1069-1074.2005; Porwancher RB, 2011, CLIN VACCINE IMMUNOL, V18, P851, DOI 10.1128/CVI.00409-10; Prevention CfDCa, 2015, TICKB REL FEV US 199; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Scientific Z, 2020, BORRELIA VLSE1 PEPC1; Scientific Z . B, 2020, B BURGDORFERI IGG TE; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Steere AC, 2008, CLIN INFECT DIS, V47, P188, DOI 10.1086/589242; Steere AC, 2006, WIEN KLIN WOCHENSCHR, V118, P625, DOI 10.1007/s00508-006-0687-x; Sudhindra P, 2016, DIAGN MICR INFEC DIS, V86, P93, DOI 10.1016/j.diagmicrobio.2016.06.015; Swei A, 2012, VECTOR-BORNE ZOONOT, V12, P623, DOI 10.1089/vbz.2011.0783; US Food and Drug Administration, 2019, FDA CLEARS NEW IND E; van den Hurk K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186662; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003; Xu G, 2019, VECTOR-BORNE ZOONOT, V19, P106, DOI 10.1089/vbz.2018.2323	55	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243950	10.1371/journal.pone.0243950	http://dx.doi.org/10.1371/journal.pone.0243950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370341	gold, Green Published			2022-12-26	WOS:000603611900015
J	Wong, YS; Tsai, CF; Hsu, YH; Ong, CT				Wong, Yi-Sin; Tsai, Ching-Fang; Hsu, Yueh-Han; Ong, Cheung-Ter			Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: A population-based case-cohort study in Taiwan	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; HEALTH-CARE PROFESSIONALS; MINOR STROKE; HIGH-RISK; ANTIPLATELET THERAPY; DOUBLE-BLIND; DEFINITION; SAFETY; TRIAL; MATCH	Background In real-world practice settings, there is insufficient evidence on the efficacy of antiplatelet drugs, including clopidogrel, aspirin, and ticlopidine, in stroke prevention. Purpose To compare the efficacies between aspirin and clopidogrel and aspirin and ticlopidine in stroke prevention. Methods This population-based case-cohort study utilized the data obtained from a randomized sample of one million subjects in the Taiwan National Health Insurance Research Database. Patients who were hospitalized owing to the primary diagnosis of ischemic stroke from January 1, 2000 to December 31, 2010 and treated with aspirin, ticlopidine, or clopidogrel were included in the study. Propensity score matching with a 1:4 ratio was performed to compare aspirin with ticlopidine and clopidogrel. The criteria for inclusion were the use of one of the three antiplatelet drugs for more than 14 days within the first month after the stroke and then continued use of the antiplatelet drugs until the study endpoint of recurrent stroke. Results During the 3-year follow-up period, the recurrent stroke rates were 1.62% (42/2585), 1.48% (3/203), and 2.55% (8/314) in the aspirin, ticlopidine, and clopidogrel groups, respectively. Compared with the patients treated with aspirin, those treated with clopidogrel and ticlopidine showed competing risk-adjusted hazard ratios of recurrent stroke of 2.27 (1.02-5.07) and 0.62 (0.08-4.86), respectively. Conclusion Compared with the patients treated with aspirin, those treated with clopidogrel were at a higher risk of recurrent stroke. For stroke prevention, aspirin was superior to clopidogrel whereas ticlopidine was not inferior to aspirin.	[Wong, Yi-Sin] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Family Med, Chiayi, Taiwan; [Tsai, Ching-Fang; Hsu, Yueh-Han] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Med Res, Chiayi, Taiwan; [Ong, Cheung-Ter] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Neurol, Chiayi, Taiwan	Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; Chia-Yi Christian Hospital	Ong, CT (corresponding author), Ditmanson Med Fdn Chiayi Christian Hosp, Dept Neurol, Chiayi, Taiwan.	ctong98@yahoo.com.tw		Ong, Cheung-Ter/0000-0003-1814-4371				Bath PMW, 2010, STROKE, V41, P732, DOI 10.1161/STROKEAHA.109.564906; Berkowitz AL, 2014, NEUROLOGY, V83, P1004, DOI 10.1212/WNL.0000000000000779; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; COUCH JR, 1993, CLIN CARDIOL, V16, P703, DOI 10.1002/clc.4960161004; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; GENT M, 1989, LANCET, V1, P1215, DOI 10.1016/S0140-6736(89)92327-1; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gorelick PB, 2003, JAMA-J AM MED ASSOC, V289, P2947, DOI 10.1001/jama.289.22.2947; Hall P, 1996, CIRCULATION, V93, P215, DOI 10.1161/01.CIR.93.2.215; Hankey GJ, 2005, NEUROLOGY, V64, P1117, DOI 10.1212/01.WNL.0000156357.50448.8A; HASS WK, 1989, NEW ENGL J MED, V321, P501, DOI 10.1056/NEJM198908243210804; Hulot JS, 2020, JACC-CARDIOVASC INTE, V13, P621, DOI 10.1016/j.jcin.2020.01.219; Ito E, 2003, INTERNAL MED, V42, P793, DOI 10.2169/internalmedicine.42.793; Jeong HG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217723; Johnston SC, 2018, NEW ENGL J MED, V379, P215, DOI 10.1056/NEJMoa1800410; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Krupczynski P., 1993, ACTA U LODZIENSIS FO, V48, P27; Lablanche JM, 1996, EUR HEART J, V17, P1373; Lee M, 2016, J STROKE, V18, P60, DOI 10.5853/jos.2015.01326; Liu LP, 2018, STROKE, V49, P2278, DOI 10.1161/STROKEAHA.118.022696; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Quinn MJ, 1999, CIRCULATION, V100, P1667, DOI 10.1161/01.CIR.100.15.1667; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; ten Berg JM, 2020, JACC-CARDIOVASC INTE, V13, P631, DOI 10.1016/j.jcin.2020.01.221; Uchiyama S, 2009, J NEUROL, V256, P888, DOI 10.1007/s00415-009-5035-4; Wang XW, 2015, NEUROLOGY, V85, P573, DOI 10.1212/WNL.0000000000001844; Wang YL, 2016, JAMA-J AM MED ASSOC, V316, P70, DOI 10.1001/jama.2016.8662; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242466	10.1371/journal.pone.0242466	http://dx.doi.org/10.1371/journal.pone.0242466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370282	Green Published, gold			2022-12-26	WOS:000603611900030
J	Klanten, OS; Gaither, MR; Greaves, S; Mills, K; O'Keeffe, K; Turnbull, J; McKinnon, R; Booth, DJ				Klanten, O. Selma; Gaither, Michelle R.; Greaves, Samuel; Mills, Kade; O'Keeffe, Kristine; Turnbull, John; McKinnon, Rob; Booth, David J.			Genomic and morphological evidence of distinct populations in the endemic common (weedy) seadragon Phyllopteryx taeniolatus (Syngnathidae) along the east coast of Australia	PLOS ONE			English	Article							EXTINCTION RISK; PHYLOGEOGRAPHY; TELEOSTEI; GENETICS; FISH; SEA; GLACIATION; SOFTWARE; PIPEFISH; STACKS	The common or weedy seadragon, Phyllopteryx taeniolatus, is an iconic and endemic fish found across temperate reefs of southern Australia. Despite its charismatic nature, few studies have been published, and the extent of population sub-structuring remains poorly resolved. Here we used 7462 single nucleotide polymorphisms (SNPs) to identify the extent of population structure in the weedy seadragon along the temperate southeast coast of Australia. We identified four populations, with strong genetic structure (F-ST = 0.562) between them. Both Discriminant Analysis of Principle Components (DAPC) and Bayesian clustering analyses support four distinct genetic clusters (north to south: central New South Wales, southern NSW, Victoria and Tasmania). In addition to these genetic differences, geographical variation in external morphology was recorded, with individuals from New South Wales shaped differently for a few measurements to those from the Mornington Peninsula (Victoria). We posit that these genetic and morphological differences suggest that the Victorian population of P. taeniolatus was historically isolated by the Bassian Isthmus during the last glacial maximum and should now be considered at least a distinct population. We also recorded high levels of genetic structure among the other locations. Based on the genomic and to a degree morphological evidence presented in this study, we recommend that the Victorian population be managed separately from the eastern populations (New South Wales and Tasmania).	[Klanten, O. Selma; Booth, David J.] Univ Technol Sydney, Sch Life Sci, Fish Ecol Lab, Sydney, NSW, Australia; [Gaither, Michelle R.; Greaves, Samuel] Univ Cent Florida, Dept Biol, Genom & Bioinformat Cluster, Orlando, FL USA; [Mills, Kade] Victorian Natl Parks Assoc, Melbourne, Vic, Australia; [O'Keeffe, Kristine; Turnbull, John] Underwater Res Grp URG, Sydney, NSW, Australia; [Turnbull, John] Univ New South Wales, Sch Biol Earth & Environm Sci, Ctr Marine Biodivers & Innovat, Sydney, NSW, Australia; [McKinnon, Rob] New South Wales Natl Parks & Wildlife Serv, Merimbula, NSW, Australia	University of Technology Sydney; State University System of Florida; University of Central Florida; University of New South Wales Sydney	Klanten, OS (corresponding author), Univ Technol Sydney, Sch Life Sci, Fish Ecol Lab, Sydney, NSW, Australia.	osklanten@me.com	Turnbull, John W/AAE-3371-2021; Klanten, Oya S./C-5628-2011	Klanten, Oya S./0000-0001-6296-4225; Greaves, Samuel/0000-0001-7299-2991; Booth, David/0000-0002-8256-1412	Sea World Research and Rescue Foundation Inc. [SWR/4/2016]	Sea World Research and Rescue Foundation Inc.	Funded study, single grant to OSK and DJB SWR/4/2016 by the Sea World Research and Rescue Foundation Inc. https://seaworld.com.au/conservation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, UNDP FOCUS, V1, P31; Baumsteiger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189417; Beheregaray LB, 2017, MOL PHYLOGENET EVOL, V111, P65, DOI 10.1016/j.ympev.2017.03.021; Benjamini Y, 2001, ANN STAT, V29, P1165; Bennett S, 2016, MAR FRESHWATER RES, V67, P47, DOI 10.1071/MF15232; Boehm JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116219; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Crane NL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198901; Deck J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002925; Delrieu-Trottin E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1068; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forsgren KL, 2006, MAR FRESHWATER RES, V57, P313, DOI 10.1071/MF05094; Fraser CI, 2009, MOL ECOL, V18, P2287, DOI 10.1111/j.1365-294X.2009.04201.x; Fricke R., 2020, ESCHMEYERS CATALOG F; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hobbs JPA, 2011, CONSERV BIOL, V25, P1053, DOI 10.1111/j.1523-1739.2011.01698.x; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kendrick AJ, 2005, ENVIRON BIOL FISH, V72, P415, DOI 10.1007/s10641-004-2597-y; Klanten OS, 2007, MAR BIOL, V150, P659, DOI 10.1007/s00227-006-0372-7; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kuiter R. H., 2009, SEAHORSES THEIR RELA; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Lewis SE, 2013, QUATERNARY SCI REV, V74, P115, DOI 10.1016/j.quascirev.2012.09.006; Lopez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117538; Lopez A, 2010, CONSERV GENET, V11, P2431, DOI 10.1007/s10592-010-0116-6; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; McDowall RM, 2002, J BIOGEOGR, V29, P207, DOI 10.1046/j.1365-2699.2002.00670.x; Mobley KB, 2010, J BIOGEOGR, V37, P1363, DOI 10.1111/j.1365-2699.2010.02288.x; Nickel J, 2012, NEW ZEAL J MAR FRESH, V46, P207, DOI 10.1080/00288330.2011.632014; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Partridge C, 2012, J HERED, V103, P821, DOI 10.1093/jhered/ess062; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Prates R. F., 2013, International Journal of Computer Science & Information Technology, V5, P39, DOI 10.5121/ijcsit.2013.5603; Pritchard JK, 2000, GENETICS, V155, P945; Puebla O, 2014, MOL ECOL, V23, P5291, DOI 10.1111/mec.12926; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rochette NC, 2019, MOL ECOL, V28, P4737, DOI 10.1111/mec.15253; Rouse Greg W., 2017, Marine Biodiversity Records, V10, P2, DOI 10.1186/s41200-016-0102-x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Roux C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000234; Saenz-Agudelo P, 2015, MOL ECOL, V24, P6241, DOI 10.1111/mec.13471; Sanchez-Camara J, 2005, J FISH BIOL, V67, P133, DOI 10.1111/j.0022-1112.2005.00720.x; Sanchez-Camara J, 2006, MAR FRESHWATER RES, V57, P737, DOI 10.1071/MF05220; Sanchez-Camara J, 2011, MAR ECOL PROG SER, V422, P253, DOI 10.3354/meps08920; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh KV, 2012, MAR BIODIVERS, V42, P481, DOI 10.1007/s12526-012-0122-7; Stiller J, 2017, J HERED, V108, P152, DOI 10.1093/jhered/esw075; Stiller J, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140458; Syaifudin M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48339-2; Tenggardjaja KA, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3395-y; UN CBD, 2010, UN CONV BIOL DIV C P, V2011, P1; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Verges A, 2016, P NATL ACAD SCI USA, V113, P13791, DOI 10.1073/pnas.1610725113; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Wilson AB, 2006, MOL ECOL, V15, P1857, DOI 10.1111/j.1365-294X.2006.02911.x; Wilson AB, 2010, MOL ECOL, V19, P4535, DOI 10.1111/j.1365-294X.2010.04811.x; Wilson NG, 2017, CONSERV GENET, V18, P53, DOI 10.1007/s10592-016-0881-y; Wilson NG, 2010, ZOOL SCR, V39, P551, DOI 10.1111/j.1463-6409.2010.00449.x	69	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243446	10.1371/journal.pone.0243446	http://dx.doi.org/10.1371/journal.pone.0243446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362197	Green Published, gold			2022-12-26	WOS:000603071600037
J	Zingore, KM; Sithole, G; Abdel-Rahman, EM; Mohamed, SA; Ekesi, S; Tanga, CM; Mahmoud, MEE				Zingore, Kumbirai M.; Sithole, George; Abdel-Rahman, Elfatih M.; Mohamed, Samira A.; Ekesi, Sunday; Tanga, Chrysantus M.; Mahmoud, Mohammed E. E.			Global risk of invasion by Bactrocera zonata: Implications on horticultural crop production under changing climatic conditions	PLOS ONE			English	Article							FRUIT-FLIES DIPTERA; SPECIES DISTRIBUTIONS; SAMPLING BIAS; PREDICTION; MODELS; TEPHRITIDAE; MAXENT; FLY; PERFORMANCE; DISPERSAL	The peach fruit fly Bactrocera zonata (Saunders) (Diptera: Tephritidae) is an important invasive species causing substantial losses to the horticulture industry worldwide. Despite the severe economic impact caused by this pest in its native and invaded range, information on its potential range expansion under changing climate remains largely unknown. In this study, we employed maximum entropy (MaxEnt) modeling approach to predict the global potential climatic suitability of B. zonata under current climate and four Representative Concentration Pathways (RCPs) for the year 2050. Outputs from MaxEnt were merged with Spatial Production Allocation Model. A natural dispersal model using Gaussian dispersal kernel was developed. The Areas Under Curves generated by MaxEnt were greater than 0.92 for both current and future climate change scenarios, indicating satisfactory performances of the models. Mean temperature of the coldest quarter, precipitation of driest month and temperature seasonality significantly influenced the potential establishment of B. zonata. The models indicated high climatic suitability in tropical and subtropical areas in Asia and Africa, where the species has already been recorded. Suitable areas were predicted in West, East and Central Africa and to a lesser extent in Central and South America. Future climatic scenarios models, RCP 4.5 and 8.5 show significant potential range expansion of B. zonata in Western Sahara, while RCP 4.5 highlighted expansion in Southern Africa. Contrarily, RCP 2.6 showed considerable decrease in B. zonata range expansion in Central, East and West Africa. There was increased climatic suitability of B. zonata in Egypt and Middle East under RCP 6.0. The dispersal model revealed that B. zonata could spread widely within its vicinity with decreasing infestation rates away from the source points. Our findings can help to guide biosecurity agencies in decision-making and serve as an early warning tool to safeguard against the pest invasion into unaffected areas.	[Zingore, Kumbirai M.; Abdel-Rahman, Elfatih M.; Mohamed, Samira A.; Ekesi, Sunday; Tanga, Chrysantus M.; Mahmoud, Mohammed E. E.] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [Zingore, Kumbirai M.; Sithole, George] Univ Cape Town, Sch Architecture Planning & Geomat, Geomat Div, Rondebosch, South Africa; [Abdel-Rahman, Elfatih M.] Univ Khartoum, Fac Agr, Dept Agron, Khartoum, Sudan; [Mahmoud, Mohammed E. E.] Agr Res Corp, Wad Medan, Sudan	International Centre of Insect Physiology & Ecology (ICIPE); University of Cape Town; University of Khartoum	Tanga, CM (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya.	ctanga@icipe.org	Ekesi, Sunday/P-8944-2019		Dissertation Research Internship Programme (DRIP), In-Region Postgraduate Scholarship at the International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya; Norwegian Agency for Development Cooperation; Section for research, innovation, and higher education grant [RAF-3058 KEN-18/0005]; European Union [DCI-FOOD/2014/346-739]; Biovision Foundation Switzerland [BV PH-07/2016-2018, DPP_005 (01/2019-12/2021)]; International Atomic Energy Agency (IAEA), through the CRP on "Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constraints to SIT Application and International Trade through icipe; icipe core - United Kingdom's Foreign, Commonwealth and Development Office (FCDO); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Democratic Republic of Ethiopia; Government of the Republic of Kenya	Dissertation Research Internship Programme (DRIP), In-Region Postgraduate Scholarship at the International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya; Norwegian Agency for Development Cooperation; Section for research, innovation, and higher education grant; European Union(European Commission); Biovision Foundation Switzerland; International Atomic Energy Agency (IAEA), through the CRP on "Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constraints to SIT Application and International Trade through icipe; icipe core - United Kingdom's Foreign, Commonwealth and Development Office (FCDO); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Democratic Republic of Ethiopia; Government of the Republic of Kenya	The senior author K. M. Z was supported through the Dissertation Research Internship Programme (DRIP), In-Region Postgraduate Scholarship at the International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya. We gratefully acknowledge the financial support for this research by the following organizations and agencies; Norwegian Agency for Development Cooperation, the Section for research, innovation, and higher education grant number RAF-3058 KEN-18/0005; European Union Funded Integrated Biological Control Applied Research Program (IBCARP)-Fruit Fly Component (Grant Contract No. DCI-FOOD/2014/346-739) and Biovision Foundation Switzerland [BV PH-07/2016-2018 and DPP_005 (01/2019-12/2021) and International Atomic Energy Agency (IAEA), through the CRP on "Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constraints to SIT Application and International Trade through icipe. We also gratefully acknowledge the support of icipe core funding provided by United Kingdom's Foreign, Commonwealth and Development Office (FCDO); the Swedish International Development Cooperation Agency (Sida); the Swiss Agency for Development and Cooperation (SDC); the Federal Democratic Republic of Ethiopia; and the Government of the Republic of Kenya. The Agricultural Research Corporation also provided support in the form of salaries to one of the coauthors [MEEM]. However, all the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Therefore, the views expressed herein do not necessarily reflect the official opinion of the donors. The specific roles of these authors are articulated in the `author contributions' section.	Abdelaal M, 2019, ECOL INFORM, V50, P68, DOI 10.1016/j.ecoinf.2019.01.003; Adeva JJG, 2012, ECOL MODEL, V227, P93, DOI 10.1016/j.ecolmodel.2011.11.026; Allwood AJ, 1999, RAFFLES B ZOOL, P1; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anonymous, 2010, Bulletin OEPP, V40, P390, DOI 10.1111/j.1365-2338.2010.02421.x; [Anonymous], 2005, Bulletin OEPP/EPPO Bulletin, V35, P371; [Anonymous], 2016, NUCL ACIDS RES, V44, pD7; [Anonymous], 2013, EC J WATCH, V10, pA1; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; CABI, 2018, INV SPEC COMP DAT 17; CAREY J R, 1989, California Agriculture, V43, P38; Carrasco Torrecilla LR, 2009, MODELLING PEST RISK, DOI [10.1186/1471-2458-9-48, DOI 10.1186/1471-2458-9-48]; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Coro G, 2018, ECOL MODEL, V371, P37, DOI 10.1016/j.ecolmodel.2018.01.007; De Meyer M, 2007, INVASIVE FRUIT FLY P; Delrio G., 2012, Acta Horticulturae, P557; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; dos Santos LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174318; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Duyck PF, 2004, B ENTOMOL RES, V94, P89, DOI 10.1079/BER2003285; El-Samea S. A. A., 2006, Egyptian Journal of Agricultural Research, V84, P61; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Fujino J, 2006, ENERG J, P343, DOI 10.5547/issn0195-6574-ej-volsi2006-nosi3-17; GBIF.org, 2018, OCC BACTR ZON; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hijioka Y., 2008, J GLOBAL ENV ENG, V13, P97; Hijmans R, 2006, WORLDCLIM GLOBAL CLI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kapoor V. C., 1993, INDIAN FRUIT FLIES I; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Marchioro CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166142; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morales NS, 2017, PEERJ, V5, DOI 10.7717/peerj.3093; Nathan R, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P187; Ni WL, 2012, B ENTOMOL RES, V102, P173, DOI 10.1017/S0007485311000538; O'Donnell M.S., 2012, US GEOLOGICAL SURVEY, V691, P10, DOI [DOI 10.3133/DS691, 10.1016/j.mimet.2011.04.001]; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips S.J., 2018, MAXENT SOFTWARE MODE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ., 2017, MAXENT SOFTWARE MODE; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pitt JP, 2008, THESIS; Qureshi ZA, 1975, P S STER PRINC INS C, P201; R Core Team, 2021, R LANGUAGE ENV STAT; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Rauf I., 2013, African Journal of Agricultural Research, V8, P1300; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Richard K, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7110429; Robinet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043366; RUDD WG, 1985, J ECON ENTOMOL, V78, P295, DOI 10.1093/jee/78.2.295; Sarwar M., 2014, J AGR ALLIED SCI, V3, P36; Senger S.E., 2007, THESIS; Shigesada N., 1997, BIOL INVASIONS THEOR; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Spaugy L., 1988, Citrograph, V73, P168; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Stonehouse JM, 1998, CROP PROT, V17, P159, DOI 10.1016/S0261-2194(97)00091-4; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Usery E.L., 2004, J GEOGR SYST, V6, P289, DOI [10.1007/s10109-004-0138-z, DOI 10.1007/S10109-004-0138-Z]; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Venette RC, 2015, CABI INVASIVE SER, V7, P1, DOI 10.1079/9781780643946.0001; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wei T, 2017, R PACKAGE CORRPLOT V; White I.M., 1992, P1; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yonow T, 2017, J PEST SCI, V90, P459, DOI 10.1007/s10340-016-0801-4; You L, 2018, 2017 SPATIAL PRODUCT, V2017	78	11	11	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243047	10.1371/journal.pone.0243047	http://dx.doi.org/10.1371/journal.pone.0243047			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362266	gold, Green Published			2022-12-26	WOS:000603071600033
J	Muller, A; Corbeil, P				Muller, Antoine; Corbeil, Philippe			Back loading estimation during team handling: Is the use of only motion data sufficient?	PLOS ONE			English	Article							GROUND REACTION FORCES; HUMAN JOINT MOTION; INVERSE DYNAMICS; ISB RECOMMENDATION; SPINAL LOADS; KINECT DATA; VALIDATION; PARAMEDICS; MOMENT; DEFINITIONS	Analyzing back loading during team manual handling tasks requires the measurement of external contacts and is thus limited to standardized tasks. This paper evaluates the possibility of estimating L5/S1 joint moments based solely on motion data. Ten subjects constituted five two-person teams and handling tasks were analyzed with four different box configurations. Three prediction methods for estimating L5/S1 joint moments were evaluated by comparing them to a gold standard using force platforms: one used only motion data, another used motion data and the traction/compression force applied to the box and one used motion data and the ground reaction forces of one team member. The three prediction methods were based on a contact model with an optimization-based method. Using only motion data did not allow an accurate estimate due to the traction/compression force applied by each team member, which affected L5/S1 joint moments. Back loading can be estimated using motion data and the measurement of the traction/compression force with relatively small errors, comparable to the uncertainty levels reported in other studies. The traction/compression force can be obtained directly with a force measurement unit built into the object to be moved or indirectly by using force platforms on which one of the two handlers stands during the handling task. The use of the proposed prediction methods allows team manual handling tasks to be analyzed in various realistic contexts, with team members who have different anthropometric measurements and with different box characteristics.	[Muller, Antoine] Inst Rech Robert Sauve Sante & Secur Travail IRSS, Montreal, PQ, Canada; [Muller, Antoine] Univ Claude Bernard Lyon 1, Univ Gustave Eiffel, Univ Lyon, LBMC,UMR T 9406, Lyon, France; [Corbeil, Philippe] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada; [Corbeil, Philippe] Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel; Laval University; Laval University	Muller, A (corresponding author), Inst Rech Robert Sauve Sante & Secur Travail IRSS, Montreal, PQ, Canada.; Muller, A (corresponding author), Univ Claude Bernard Lyon 1, Univ Gustave Eiffel, Univ Lyon, LBMC,UMR T 9406, Lyon, France.; Corbeil, P (corresponding author), Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada.; Corbeil, P (corresponding author), Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.	antoine.muller@univ-lyon1.fr; philippe.corbeil@kin.ulaval.ca		Muller, Antoine/0000-0003-2606-1429	IRSST; Natural Sciences and Engineering Research Council of Canada (NSERC)	IRSST; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was partly supported by a scholarship program from the IRSST to AM and supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton D, 2013, J ORTHOP SPORT PHYS, V43, P232, DOI 10.2519/jospt.2013.4249; Barrett RS, 2005, HUM FACTORS ERGONOM, V15, P293, DOI 10.1002/hfm.20027; Chaffin D., 2006, OCCUPATIONAL BIOMECH, V2nd; Daynard D, 2001, APPL ERGON, V32, P199, DOI 10.1016/S0003-6870(00)00070-3; Dennis GJ, 2002, ERGONOMICS, V45, P671, DOI 10.1080/00140130210148537; Dumas R, 2007, J BIOMECH, V40, P543, DOI 10.1016/j.jbiomech.2006.02.013; Elford W, 2000, APPL ERGON, V31, P185, DOI 10.1016/S0003-6870(99)00026-5; Faber GS, 2018, J BIOMECH, V70, P235, DOI 10.1016/j.jbiomech.2017.10.006; Faber GS, 2013, J BIOMECH, V46, P2736, DOI 10.1016/j.jbiomech.2013.07.030; Featherstone r, 2014, RIGID BODY DYNAMICS; Fluit R, 2014, J BIOMECH, V47, P2321, DOI 10.1016/j.jbiomech.2014.04.030; Fregly BJ, 2007, IEEE T BIO-MED ENG, V54, P1687, DOI 10.1109/TBME.2007.891934; Futamure S, 2017, J BIOMECH, V64, P85, DOI 10.1016/j.jbiomech.2017.09.005; Gallagher S, 2009, INT J IND ERGONOM, V39, P828, DOI 10.1016/j.ergon.2009.01.005; Hignett S, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e6; HOF AL, 1992, J BIOMECH, V25, P1209, DOI 10.1016/0021-9290(92)90076-D; Kingma I, 1996, HUM MOVEMENT SCI, V15, P833, DOI 10.1016/S0167-9457(96)00034-6; Lariviere C, 1999, HUM MOVEMENT SCI, V18, P573, DOI 10.1016/S0167-9457(99)00003-2; Larsen FG, 2020, ANN BIOMED ENG, V48, P805, DOI 10.1007/s10439-019-02409-8; Lavender SA, 2000, APPL ERGON, V31, P45, DOI 10.1016/S0003-6870(99)00027-7; Lavender SA, 2014, APPL ERGON, V45, P389, DOI 10.1016/j.apergo.2013.05.005; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Marras W.S., 1992, INT J IND ERGON, V9, P75, DOI [10.1016/0169-8141(92)90078-E, DOI 10.1016/0169-8141(92)90078-E]; Mehrizi R, 2019, J BIOMECH, V84, P87, DOI 10.1016/j.jbiomech.2018.12.022; Muller A, 2020, APPL ERGON, V82, DOI 10.1016/j.apergo.2019.102935; Muller A., 2019, J OPEN SOURCE SOFTWA, V4, P927, DOI [DOI 10.21105/JOSS.00927, 10.21105/joss.00927]; Muller A, 2020, IEEE T BIO-MED ENG, V67, P344, DOI 10.1109/TBME.2019.2913308; Muller A, 2017, MULTIBODY SYST DYN, V40, P177, DOI 10.1007/s11044-017-9566-7; Paskiewicz JK, 2007, INT J IND ERGONOM, V37, P93, DOI 10.1016/j.ergon.2006.10.015; Plamondon A, 1996, CLIN BIOMECH, V11, P101, DOI 10.1016/0268-0033(95)00043-7; Plantard P, 2017, INT J IND ERGONOM, V61, P71, DOI 10.1016/j.ergon.2017.05.010; Plantard P, 2017, APPL ERGON, V65, P562, DOI 10.1016/j.apergo.2016.10.015; Prairie J, 2017, APPL ERGON, V65, P112, DOI 10.1016/j.apergo.2017.06.005; Prairie J, 2014, APPL ERGON, V45, P895, DOI 10.1016/j.apergo.2013.11.006; Puchaud P, 2020, COMPUT METHOD BIOMEC, V23, P114, DOI 10.1080/10255842.2019.1705798; Rao G, 2006, J BIOMECH, V39, P1531, DOI 10.1016/j.jbiomech.2005.04.014; Ren L, 2008, J BIOMECH, V41, P2750, DOI 10.1016/j.jbiomech.2008.06.001; Robert-Lachaine X, 2020, ERGONOMICS, V63, P283, DOI 10.1080/00140139.2019.1612941; Robert-Lachaine X, 2017, MED BIOL ENG COMPUT, V55, P609, DOI 10.1007/s11517-016-1537-2; Sharp MA, 1997, HUM FACTORS, V39, P481, DOI 10.1518/001872097778827106; Skals S, 2017, MULTIBODY SYST DYN, V39, P175, DOI 10.1007/s11044-016-9537-4; Visser S, 2015, APPL ERGON, V50, P56, DOI 10.1016/j.apergo.2015.02.007; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244405	10.1371/journal.pone.0244405	http://dx.doi.org/10.1371/journal.pone.0244405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351839	gold, Green Published			2022-12-26	WOS:000603071400019
J	Loveday, M; Hlangu, S; Furin, J				Loveday, Marian; Hlangu, Sindisiwe; Furin, Jennifer			"Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis	PLOS ONE			English	Article							INTERVIEWS; CANCER; BURDEN	Background There are few data on the on the care experiences of pregnant women with rifampicin-resistant TB. Objective To describe the treatment journeys of pregnant women with RR-TB-including how their care experiences shape their identities-and identify areas in which tailored interventions are needed. Methods In this qualitative study in-depth interviews were conducted among a convenience sample from a population of pregnant women receiving treatment for RR-TB. This paper follows COREQ guidelines. A thematic network analysis using an inductive approach was performed to analyze the interview transcripts and notes. The analysis was iterative and a coding system developed which focused on the care experiences of the women and how these experiences affected their perceptions of themselves, their children, and the health care system in which treatment was received. Results Seventeen women were interviewed. The women described multiple challenges in their treatment journeys which required them to demonstrate sustained resilience (i.e. to "be brave"). Care experiences required them to negotiate seemingly contradictory identities as both new mothers-"givers of life"-and RR-TB patients facing a complicated and potentially deadly disease. In terms of their "pregnancy identity" and "RR-TB patient identity" that emerged as part of their care experiences, four key themes were identified that appeared to have elements that were contradictory to one another (contradictory areas). These included: 1) the experience of physical symptoms or changes; 2) the experience of the "mothering" and "patient" roles; 3) the experience of the care they received for their pregnancy and their RR-TB; and 4) the experience of community engagement. There were also three areas that overlapped with both roles and during which identity was negotiated/reinforced and they included: 1) faith; 2) socioeconomic issues; and 3) long-term concerns over the child's health. At times, the health care system exacerbated these challenges as the women were not given the support they needed by health care providers who were ill-informed or angry and treated the women in a discriminatory fashion. Left to negotiate this confusing time period, the women turned to faith, their own mothers, and the fathers of their unborn children. Conclusion The care experiences of the women who participated in this study highlight several gaps in the current health care system that must be better addressed in both TB and perinatal services in order to improve the therapeutic journeys for pregnant women with RR-TB and their children. Suggestions for optimizing care include the provision of integrated services, including specialized counseling as well as training for health care providers; engagement of peer support networks; provision of socioeconomic support; long-term medical care/follow-up for children born to women who were treated for RR-TB; and inclusion of faith-based services in the provision of care.	[Loveday, Marian; Hlangu, Sindisiwe] South African Med Res Council, HIV Prevent Res Unit, Kwa Zulu, South Africa; [Loveday, Marian] Univ KwaZulu Natal, Doris Duke Med Res Inst, CAPRISA MRC HIV TB Pathogenesis & Treatment Res U, Durban, South Africa; [Furin, Jennifer] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA	South African Medical Research Council; University of Kwazulu Natal; Harvard University; Harvard Medical School	Loveday, M (corresponding author), South African Med Res Council, HIV Prevent Res Unit, Kwa Zulu, South Africa.; Loveday, M (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, CAPRISA MRC HIV TB Pathogenesis & Treatment Res U, Durban, South Africa.	marian.loveday@mrc.ac.za	Loveday, Marian/M-8016-2013	Loveday, Marian/0000-0001-9205-9314	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the South African Medical Research Council. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; Alvesson M, 2008, ORGANIZATION, V15, P5, DOI 10.1177/1350508407084426; Anderson GD, 1997, SEMIN PERINATOL, V21, P328, DOI 10.1016/S0146-0005(97)80076-6; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; Bergeron Kimberly G, 2004, Expert Rev Anti Infect Ther, V2, P589, DOI 10.1586/14787210.2.4.589; Bucyibaruta BJ, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3625-5; COHEN RC, 1946, BRIT J TUBERC DIS CH, V40, P10, DOI 10.1016/S0366-0869(46)80029-7; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Drobac PC, 2005, CLIN INFECT DIS, V40, P1689, DOI 10.1086/430066; Dudnyk A, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.PA1912; Fernandez D, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/5896901; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gupta A, 2016, CLIN INFECT DIS, V62, P761, DOI 10.1093/cid/civ991; Hepner A, 2019, WORLD J ONCOL, V10, P28, DOI 10.14740/wjon1177; Human Sciences Research Council (HSRC), 2018, 5 S AFR NAT HIV PREV; Khan M, 2007, INT J TUBERC LUNG D, V11, P706; Long C., 2009, CONTRADICTING MATERN; Loveday M, 2021, CLIN INFECT DIS, V72, P1158, DOI 10.1093/cid/ciaa189; Loveday M, 2019, EMERG INFECT DIS, V25, P609, DOI 10.3201/eid2503.181571; Massyn N, 2020, DISTRICT HLTH BAROME; McLeish J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011499; Odayar J, 2018, INT J TUBERC LUNG D, V22, P760, DOI 10.5588/ijtld.17.0448; Odjidja EN, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3990-8; Palacios E, 2009, CLIN INFECT DIS, V48, P1413, DOI 10.1086/598191; Rees S, 2016, ASIA-PAC J ONCOL NUR, V3, P252, DOI 10.4103/2347-5625.189814; Salazar-Austin N, 2018, CLIN INFECT DIS, V66, P921, DOI 10.1093/cid/cix851; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schnippel K, 2016, SAMJ S AFR MED J, V106, P30, DOI [10.7196/SAMJ.2016.v106i4.10205, 10.7196/samj.2016v106i4.10205]; Shin S, 2003, CLIN INFECT DIS, V36, P996, DOI 10.1086/374225; Shringarpure KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150849; Sobhy S, 2017, BJOG-INT J OBSTET GY, V124, P727, DOI 10.1111/1471-0528.14408; Sulis G, 2018, J OBSTET GYNAECOL CA, V40, P1003, DOI 10.1016/j.jogc.2018.04.041; Tabarsi P, 2011, INT J TUBERC LUNG D, V15, P547, DOI 10.5588/ijtld.10.0140; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Weld ED, 2018, CLIN PHARMACOL THER, V104, P1098, DOI 10.1002/cpt.1221; WHO, 2019, GLOB TUB REP, P1; World Health Organization, 2018, RAP COMM KEY CHANG T; Zumla A, 2014, LANCET GLOB HEALTH, V2, pE675, DOI 10.1016/S2214-109X(14)70338-9	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0242604	10.1371/journal.pone.0242604	http://dx.doi.org/10.1371/journal.pone.0242604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347448	Green Published, gold			2022-12-26	WOS:000603071100016
J	Gunaratne, C; Garibay, I				Gunaratne, Chathika; Garibay, Ivan			Evolutionary model discovery of causal factors behind the socio-agricultural behavior of the Ancestral Pueblo	PLOS ONE			English	Article							ALGORITHMS; SOFTWARE	Agent-based modeling of artificial societies allows for the validation and analysis of human-interpretable, causal explanations of human behavior that generate society-scale phenomena. However, parameter calibration is insufficient to conduct data-driven explorations that are adequate in evaluating the importance of causal factors that constitute agent rules that match real-world individual-scale generative behaviors. We introduce evolutionary model discovery, a framework that combines genetic programming and random forest regression to evaluate the importance of a set of causal factors hypothesized to affect the individual's decision-making process. With evolutionary model discovery, we investigated the farm plot seeking behavior of the Ancestral Pueblo of the Long House Valley simulated in the Artificial Anasazi model. We evaluated the importance of causal factors unconsidered in the original model, which we hypothesized to have affected the decision-making process. Our findings, concur with other archaeological studies on the Ancestral Pueblo communities during the Pueblo II period, which indicate the existence of cross-village polities, hierarchical organization, and dependence on the viability of the agricultural niche. Contrary to the original Artificial Anasazi model, where closeness was the sole factor driving farm plot selection, selection of higher quality land, distancing from failed farm plots, and desire for social presence are found to be more important. Finally, models updated with farm selection strategies designed by incorporating these insights showed significant improvements in accuracy and robustness over the original Artificial Anasazi model.	[Gunaratne, Chathika; Garibay, Ivan] Univ Cent Florida, Dept Ind Engn & Management Syst, Complex Adapt Syst Lab, Orlando, FL 32816 USA; [Gunaratne, Chathika] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	State University System of Florida; University of Central Florida; Massachusetts Institute of Technology (MIT)	Garibay, I (corresponding author), Univ Cent Florida, Dept Ind Engn & Management Syst, Complex Adapt Syst Lab, Orlando, FL 32816 USA.	ivan.garibay@ucf.edu		Garibay, Ivan/0000-0002-3302-9382; Gunaratne, Chathika/0000-0002-2508-8745	Defense Advanced Research Projects Agency [HR001117S0018]; Amazon Web Services	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Amazon Web Services	DARPA SocialSim program: Awarded to IG, DARPA program HR001117S0018, Defense Advanced Research Projects Agency https://www.darpa.mil/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AWS Research Grant Awarded to IG, N/A, Amazon Web Services https://aws.amazon.com/grants/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastrakova E, 2017, IMPROVING INTERPRETA; Beillevaire M, 2018, INSIDE BLACK BOX EXP; Bocinsky RK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501532; Bocinsky RK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6618; Borshchev A., 2013, BIG BOOK SIMULATION; Breiman L., 2002, MANUAL SETTING USING; Crabtree SA, 2017, AM ANTIQUITY, V82, P71, DOI 10.1017/aaq.2016.18; Dang N, 2018, INT C LEARN INT OPT, P288; Dean JS, 2000, SFI STU SCI, P179; Dedeo S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000782; Epstein J. M., 1999, Complexity, V4, P41, DOI 10.1002/(SICI)1099-0526(199905/06)4:5<41::AID-CPLX9>3.0.CO;2-F; Epstein J.M., 2013, AGENT ZERO NEUROCOGN; Fortin FA, 2012, J MACH LEARN RES, V13, P2171; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Granetz R, 2018, P 27 IAEA FUS EN C I; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grune-Yanoff T, 2009, SYNTHESE, V169, P539, DOI 10.1007/s11229-008-9429-0; Gunaratne C, 2019, THESIS; Gunaratne C, 2017, PROCEEDINGS OF THE 2017 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE (GECCO'17), P115, DOI 10.1145/3071178.3071332; Hold-Geoffroy Yannick, 2014, P 2014 ANN C EXTR EN, P60, DOI DOI 10.1145/2616498.2616565; Hutter F., 2014, 31 INT C MACHINE LEA, VVolume 32, P754; Janssen MA, 2009, JASSS-J ARTIF SOC S, V12, P3; Kidder AV, 1927, NEW SERIES, V66, P489; Kohler TA, 2012, ORIG HUM BEHAV, V6, P1, DOI 10.1525/california/9780520270145.001.0001; Korobov M, 2019, PERMUTATION IMPORTAN; KOZA JR, 1994, STAT COMPUT, V4, P87, DOI 10.1007/BF00175355; Laguna M, 2003, OPTIMIZATION SOFTWAR, P193; Langdon WB, 2015, IEEE T EVOLUT COMPUT, V19, P118, DOI 10.1109/TEVC.2013.2281544; Louppe G., 2014, ARXIV14077502, DOI [10. 13140/2.1.1570.5928, DOI 10.13140/2.1.1570.5928]; Lundberg S.M, 2018, CONSISTENT INDIVIDUA; Manson SM, 2006, INT J GEOGR INF SCI, V20, P991, DOI 10.1080/13658810600830566; Manson SM, 2005, AGR ECOSYST ENVIRON, V111, P47, DOI 10.1016/j.agee.2005.04.024; Morice-Atkinson X, 2018, MON NOT R ASTRON SOC, V481, P4194, DOI 10.1093/mnras/sty2575; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petke J, 2018, IEEE T EVOLUT COMPUT, V22, P415, DOI 10.1109/TEVC.2017.2693219; Rea C, 2018, P 45 EPS C PLASM PHY, V42; Saabas A, 2014, DIVING DATA 24, V24; Saabas A, 2019, TREEINTERPRETER; Smith EM, 2017, 8 INT C PATT REC SYS, P1; Stonedahl F, 2010, ARTIFICIAL ANASAZI M; Stonedahl F, 2010, BEHAVIORSEARCH COMPU; Stonedahl F., 2010, AAAI FALL S COMPL AD, P120; Stratton RJ, 2015, THESIS; Wilensky U., 1999, NETLOGO; Zhong JH, 2014, AAMAS'14: PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS, P1125	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0239922	10.1371/journal.pone.0239922	http://dx.doi.org/10.1371/journal.pone.0239922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338054	Green Published, gold, Green Submitted			2022-12-26	WOS:000601313500033
J	Vallabhajosyula, S; Kumar, V; Sundaragiri, PR; Cheungpasitporn, W; Bell, MR; Singh, M; Jaffe, AS; Barsness, GW				Vallabhajosyula, Saraschandra; Kumar, Vinayak; Sundaragiri, Pranathi R.; Cheungpasitporn, Wisit; Bell, Malcolm R.; Singh, Mandeep; Jaffe, Allan S.; Barsness, Gregory W.			Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United States	PLOS ONE			English	Article							HEALTH-INSURANCE STATUS; CARDIOGENIC SHOCK; MORTALITY; TRENDS	Background There are limited contemporary data on the influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction (STEMI). Objective To assess the influence of insurance status on STEMI outcomes. Methods Adult (>18 years) STEMI admissions were identified using the National Inpatient Sample database (2000-2017). Expected primary payer was classified into Medicare, Medicaid, private, uninsured and others. Outcomes of interest included in-hospital mortality, use of coronary angiography and percutaneous coronary intervention (PCI), hospitalization costs, hospital length of stay and discharge disposition. Results Of the 4,310,703 STEMI admissions, Medicare, Medicaid, private, uninsured and other insurances were noted in 49.0%, 6.3%, 34.4%, 7.2% and 3.1%, respectively. Compared to the others, the Medicare cohort was older (75 vs. 53-57 years), more often female (46% vs. 20-36%), of white race, and with higher comorbidity (all p<0.001). The Medicare and Medicaid population had higher rates of cardiogenic shock and cardiac arrest. The Medicare cohort had higher in-hospital mortality (14.2%) compared to the other groups (4.1-6.7%), p<0.001. In a multivariable analysis (Medicare referent), in-hospital mortality was higher in uninsured (adjusted odds ratio (aOR) 1.14 [95% confidence interval {CI} 1.11-1.16]), and lower in Medicaid (aOR 0.96 [95% CI 0.94-0.99]; p = 0.002), privately insured (aOR 0.73 [95% CI 0.72-0.75]) and other insurance (aOR 0.91 [95% CI 0.88-0.94]); all p<0.001. Coronary angiography (60% vs. 77-82%) and PCI (45% vs. 63-70%) were used less frequently in the Medicare population compared to others. The Medicare and Medicaid populations had longer lengths of hospital stay, and the Medicare population had the lowest hospitalization costs and fewer discharges to home. Conclusions Compared to other types of primary payers, STEMI admissions with Medicare insurance had lower use of coronary angiography and PCI, and higher in-hospital mortality.	[Vallabhajosyula, Saraschandra; Bell, Malcolm R.; Singh, Mandeep; Jaffe, Allan S.; Barsness, Gregory W.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55902 USA; [Vallabhajosyula, Saraschandra] Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN 55902 USA; [Vallabhajosyula, Saraschandra] Mayo Clin, Ctr Clin & Translat Sci, Grad Sch Biomed Sci, Rochester, MN 55902 USA; [Vallabhajosyula, Saraschandra] Emory Univ, Sch Med, Dept Med, Sect Intervent Cardiol,Div Cardiovasc Med, Atlanta, GA 30322 USA; [Kumar, Vinayak] Mayo Clin, Dept Med, Rochester, MN USA; [Sundaragiri, Pranathi R.] Mayo Clin, Div Hosp Internal Med, Dept Med, Rochester, MN USA; [Cheungpasitporn, Wisit] Univ Mississippi, Sch Med, Dept Med, Div Nephrol, Jackson, MS 39216 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Emory University; Mayo Clinic; Mayo Clinic; University of Mississippi	Vallabhajosyula, S (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55902 USA.; Vallabhajosyula, S (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN 55902 USA.; Vallabhajosyula, S (corresponding author), Mayo Clin, Ctr Clin & Translat Sci, Grad Sch Biomed Sci, Rochester, MN 55902 USA.; Vallabhajosyula, S (corresponding author), Emory Univ, Sch Med, Dept Med, Sect Intervent Cardiol,Div Cardiovasc Med, Atlanta, GA 30322 USA.	Vallabhajosyula.Saraschandra@mayo.edu	Vallabhajosyula, Saraschandra/I-9707-2019	Vallabhajosyula, Saraschandra/0000-0002-1631-8238	Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]	Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Saraschandra Vallabhajosyula is supported by the Clinical and Translational Science Award (CTSA) Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, INTRO HCUP NATIONWID; [Anonymous], 2020, CIRCULATION, V141, pe59; [Anonymous], 2019, NIPPON GANKA GAKKAI, V123, P489; Berchick ER., 2019, HLTH INSURANCE COVER; Boyd K, 1996, ARCH INTERN MED, V156, P1821, DOI 10.1001/archinte.156.16.1821; Damluji AA, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013686; Egbe AC, INT J CARDIOLOGY, DOI 10.1016/j.ijcard.2019.09.001; Ellis L, 2018, JAMA ONCOL, V4, P317, DOI 10.1001/jamaoncol.2017.3846; Grosmaitre P, 2013, ARCH CARDIOVASC DIS, V106, P586, DOI 10.1016/j.acvd.2013.04.010; Khera R, 2017, JAMA-J AM MED ASSOC, V318, P2011, DOI 10.1001/jama.2017.17653; Khera R, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003846; Mahajan S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17885; Mahmoud AN, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008235; Niedzwiecki MJ, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008152; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Panaich SS, 2016, AM J CARDIOL, V118, P950, DOI 10.1016/j.amjcard.2016.06.057; Pancholy S, 2017, AM J CARDIOL, V120, P1049, DOI 10.1016/j.amjcard.2017.06.041; Patel N, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.004971; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Saczynski Jane S, 2012, Clin Epidemiol, V4, P267, DOI 10.2147/CLEP.S32034; Vallabhajosyula S, AM J CARDIOLOGY, DOI 10.1016/j.amjcard.2020.03.015; Vallabhajosyula S, 2019, ASAIO J, DOI 10.1097/mat.0000000000001039; Vallabhajosyula S, 2019, EUROINTERVENTION, DOI 10.4244/eij-d-19-00226; Vallabhajosyula S, 2020, MAYO CLIN PROC, V95, P1916, DOI 10.1016/j.mayocp.2020.01.043; Vallabhajosyula S, 2020, INT J CARDIOL, V310, P9, DOI 10.1016/j.ijcard.2020.02.033; Vallabhajosyula S, 2020, ESC HEART FAIL, V7, P1234, DOI 10.1002/ehf2.12652; Vallabhajosyula S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030839; Vallabhajosyula S, 2020, AM HEART J, V223, P59, DOI 10.1016/j.ahj.2020.01.016; Vallabhajosyula S, 2020, MAYO CLIN PROC, V95, P611, DOI 10.1016/j.mayocp.2019.12.007; Vallabhajosyula S, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.119.006661; Vallabhajosyula S, 2020, ASAIO J, V66, P980, DOI 10.1097/MAT.0000000000001125; Vallabhajosyula S, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.119.005929; Vallabhajosyula S, 2020, RESUSCITATION, V148, P242, DOI 10.1016/j.resuscitation.2019.11.007; Vallabhajosyula S, 2020, CATHETER CARDIO INTE, V96, pE59, DOI 10.1002/ccd.28543; Vallabhajosyula S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222894; Vallabhajosyula S, 2019, IJC HEART VASC, V24, DOI 10.1016/j.ijcha.2019.100414; Vallabhajosyula S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0571-2; Vallabhajosyula S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.011954; Vallabhajosyula S, 2019, ESC HEART FAIL, V6, P874, DOI 10.1002/ehf2.12482; Vallabhajosyula S, 2019, AM J CARDIOL, V124, P491, DOI 10.1016/j.amjcard.2019.05.038; Vallabhajosyula S, 2019, JACC-HEART FAIL, V7, P469, DOI 10.1016/j.jchf.2018.12.007; Vallabhajosyula S, 2019, J AM COLL CARDIOL, V73, P1781, DOI 10.1016/j.jacc.2019.01.053; Vallabhajosyula S, 2019, INT J CARDIOL, V285, P6, DOI 10.1016/j.ijcard.2019.03.008; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010193; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009160; Vallabhajosyula S, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006930; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009608; Woolhandler S, 2017, ANN INTERN MED, V167, P424, DOI 10.7326/M17-1403	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243810	10.1371/journal.pone.0243810	http://dx.doi.org/10.1371/journal.pone.0243810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338071	Green Published, gold			2022-12-26	WOS:000601313500017
J	Dervishi, A				Dervishi, Albion			A deep learning backcasting approach to the electrolyte, metabolite, and acid-base parameters that predict risk in ICU patients	PLOS ONE			English	Article							HOSPITAL MORTALITY; VALIDATION; ADMISSION; DEATH	Background A powerful risk model allows clinicians, at the bedside, to ensure the early identification of and decision-making for patients showing signs of developing physiological instability during treatment. The aim of this study was to enhance the identification of patients at risk for deterioration through an accurate model using electrolyte, metabolite, and acid-base parameters near the end of patients' intensive care unit (ICU) stays. Methods This retrospective study included 5157 adult patients during the last 72 hours of their ICU stays. The patients from the MIMIC-III database who had serum lactate, pH, bicarbonate, potassium, calcium, glucose, chloride, and sodium values available, along with the times at which those data were recorded, were selected. Survivor data from the last 24 hours before discharge and four sets of nonsurvivor data from 48-72, 24-48, 8-24, and 0-8 hours before death were analyzed. Deep learning (DL), random forest (RF) and generalized linear model (GLM) analyses were applied for model construction and compared in terms of performance according to the area under the receiver operating characteristic curve (AUC). A DL backcasting approach was used to assess predictors of death vs. discharge up to 72 hours in advance. Results The DL, RF and GLM models achieved the highest performance for nonsurvivors 0-8 hours before death versus survivors compared with nonsurvivors 8-24, 24-48 and 48-72 hours before death versus survivors. The DL assessment outperformed the RF and GLM assessments and achieved discrimination, with an AUC of 0.982, specificity of 0.947, and sensitivity of 0.935. The DL backcasting approach achieved discrimination with an AUC of 0.898 compared with the DL native model of nonsurvivors from 8-24 hours before death versus survivors with an AUC of 0.894. The DL backcasting approach achieved discrimination with an AUC of 0.871 compared with the DL native model of nonsurvivors from 48-72 hours before death versus survivors with an AUC of 0.846. Conclusions The DL backcasting approach could be used to simultaneously monitor changes in the electrolyte, metabolite, and acid-base parameters of patients who develop physiological instability during ICU treatment and predict the risk of death over a period of hours to days.	[Dervishi, Albion] Univ Tubingen, Acad Teaching Hosp, Medius Clin Nurtingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany	Eberhard Karls University of Tubingen	Dervishi, A (corresponding author), Univ Tubingen, Acad Teaching Hosp, Medius Clin Nurtingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	albiondervishi@gmail.com		Dervishi, Albion/0000-0001-7140-836X				A A., 2016, DEEP LEARNING H2O; Al-Jaghbeer M., 2015, NEPHROLOGY DIALYSIS; Asadollahi K, 2011, EMERG MED AUSTRALAS, V23, P354, DOI 10.1111/j.1742-6723.2011.01410.x; Atkins TEH, 2018, EUR J INTERN MED, V51, P25, DOI 10.1016/j.ejim.2017.12.008; Bakker J, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-12; Bandak Ghassan, 2017, F1000Res, V6, P1930, DOI 10.12688/f1000research.11401.1; Basile-Filho Anibal, 2016, J Clin Med Res, V8, P141, DOI 10.14740/jocmr2425w; Bauer DT, 2010, J AM MED INFORM ASSN, V17, P416, DOI 10.1136/jamia.2009.000505; Boroujeni AM, 2019, AM J CLIN PATHOL, V151, P452, DOI 10.1093/ajcp/aqy163; Brabrand M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002890; Brameld KJ, 2003, INT J EPIDEMIOL, V32, P617, DOI 10.1093/ije/dyg191; Campbell C. A., 2016, CLIN CHEM; Chaiyakulsil C, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4770-6; Chien D. K., 2010, INT J GERONTOL; Collins A. J., 2017, AM J NEPHROL; Dervishi A., 2020, GITHUB REPOSITORY DE; Doering TA, 2014, AM J CLIN PATHOL, V142, P617, DOI 10.1309/AJCPDI0FYZ4UNWEQ; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Egi M, 2011, CRIT CARE MED, V39, P314, DOI 10.1097/CCM.0b013e3181ffe23e; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Epskamp S., 2012, J STAT SOFTW; Florkowski C., 2017, CRIT REV CL LAB SCI; Gujadhur Anuksha, 2015, World J Crit Care Med, V4, P71, DOI 10.5492/wjccm.v4.i1.71; Gunnerson Kyle J, 2003, Curr Opin Crit Care, V9, P468, DOI 10.1097/00075198-200312000-00002; Hessels L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0720-9; Ho KL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02292-0; Holmberg J., 2000, INT J SUSTAIN DEV WO; Hu J., 2017, INT J CLIN EXP MED; Jarvis SW, 2013, RESUSCITATION, V84, P1494, DOI 10.1016/j.resuscitation.2013.05.018; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Khonsary S., 2017, SURG NEUROL INT; Larsson J., 2018, J CLEAN PROD; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LeDell E., 2019, CRAN; Lier H., 2008, J TRAUMA INJ INFECT; Loekito E, 2013, EMERG MED AUSTRALAS, V25, P132, DOI 10.1111/1742-6723.12040; Loekito E, 2013, RESUSCITATION, V84, P280, DOI 10.1016/j.resuscitation.2012.07.025; Marshall DC, 2017, J CRIT CARE, V40, P63, DOI 10.1016/j.jcrc.2017.02.012; Martin J, 2013, CLIN CHEM LAB MED, V51, P405, DOI 10.1515/cclm-2012-0258; Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888; Park B. S., 2013, DIABETES METAB J; Ratnayake H, 2021, INTERN MED J, V51, P746, DOI 10.1111/imj.14613; Ravi D, 2017, IEEE J BIOMED HEALTH, V21, P4, DOI 10.1109/JBHI.2016.2636665; Redfern OC, 2018, RESUSCITATION, V133, P75, DOI 10.1016/j.resuscitation.2018.09.021; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson J. B., 1990, FUTURES; Sedlacek M, 2006, SEMIN DIALYSIS, V19, P496, DOI 10.1111/j.1525-139X.2006.00212.x; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Tan EH, 2019, AM J CLIN PATHOL, V152, P177, DOI [10.1093/AJCP/AQZ026, 10.1093/ajcp/aqz026]; Thongprayoon C, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0174430; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wang YM, 2019, J INVEST MED, V67, P750, DOI 10.1136/jim-2018-000900; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095204; Zhou BC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8014213	55	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0242878	10.1371/journal.pone.0242878	http://dx.doi.org/10.1371/journal.pone.0242878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332413	Green Published, gold			2022-12-26	WOS:000601310900092
J	Thapa-Magar, KB; Davis, TS; Kondratieff, B				Thapa-Magar, Khum Bahadur; Davis, Thomas Seth; Kondratieff, Boris			Livestock grazing is associated with seasonal reduction in pollinator biodiversity and functional dispersion but cheatgrass invasion is not: Variation in bee assemblages in a multi-use shortgrass prairie	PLOS ONE			English	Article							WILD BEES; INSECT POLLINATORS; BROMUS-TECTORUM; DIVERSITY; PLANT; COMMUNITIES; IMPACTS; CONSERVATION; RESOURCES; INTENSITY	Livestock grazing and non-native plant species affect rangeland habitats globally. These factors may have important effects on ecosystem services including pollination, yet, interactions between pollinators, grazing, and invasive plants are poorly understood. To address this, we tested the hypothesis that cattle grazing and site colonization by cheatgrass (Bromus tectorum) impact bee foraging and nesting habitats, and the biodiversity of wild bee communities, in a shortgrass prairie system. Bee nesting habitats (litter and wood cover) were marginally improved in non-grazed sites with low cheatgrass cover, though foraging habitat (floral cover and richness, bare soil) did not differ among cattle-grazed sites or non-grazed sites with low or high cheatgrass cover. However, floral cover was a good predictor of bee abundance and functional dispersion. Mean bee abundance, richness, diversity and functional diversity were significantly lower in cattle-grazed habitats than in non-grazed habitats. Differences in bee diversity among habitats were pronounced early in the growing season (May) but by late-season (August) these differences eroded as Melissodes spp. and Bombus spp. became more abundant at study sites. Fourth-corner analysis revealed that sites with high floral cover tended to support large, social, polylectic bees; sites with high grass cover tended to support oligolectic solitary bees. Both cattle-grazed sites and sites with high cheatgrass cover were associated with lower abundances of above-ground nesting bees but higher abundance of below-ground nesters than non-grazed sites with low cheatgrass cover. We conclude that high cheatgrass cover is not associated with reduced bee biodiversity or abundance, but cattle grazing was negatively associated with bee abundances and altered species composition. Although floral cover is an important predictor of bee assemblages, this was not impacted by cattle grazing and our study suggests that cattle likely impact bee communities through effects other than those mediated by forbs, including soil disturbance or nest destruction. Efforts aimed at pollinator conservation in prairie habitats should focus on managing cattle impacts early in the growing season to benefit sensitive bee species.	[Thapa-Magar, Khum Bahadur; Davis, Thomas Seth] Colorado State Univ, Warner Coll Nat Resources, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA; [Kondratieff, Boris] Colorado State Univ, Coll Agr Sci, Agr Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Davis, TS (corresponding author), Colorado State Univ, Warner Coll Nat Resources, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA.	seth.davis@colostate.edu		Davis, Thomas/0000-0002-9901-2516	McIntire-Stennis appropriations (USDA NIFA) [COL 00767]	McIntire-Stennis appropriations (USDA NIFA)	Funding was provided by McIntire-Stennis appropriations (USDA NIFA COL 00767) to TSD.	Alkemade R, 2013, P NATL ACAD SCI USA, V110, P20900, DOI 10.1073/pnas.1011013108; Baker WL, 2009, NAT AREA J, V29, P204, DOI 10.3375/043.029.0301; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Banks ER, 2011, NAT AREA J, V31, P377, DOI 10.3375/043.031.0408; Bauer AA, 2017, AM J BOT, V104, P772, DOI 10.3732/ajb.1600405; Bhandari KB, 2018, CROP SCI, V58, P2665, DOI 10.2135/cropsci2018.06.0393; Bonte D, 2008, BASIC APPL ECOL, V9, P726, DOI 10.1016/j.baae.2007.09.008; Brown AM, 2014, METHODS ECOL EVOL, V5, P344, DOI 10.1111/2041-210X.12163; Burke I. C., 2008, ECOLOGY SHORTGRASS S, P484; Cariveau DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151482; Carvell C, 2002, BIOL CONSERV, V103, P33, DOI 10.1016/S0006-3207(01)00114-8; Cockerell T. D. A, 1907, 373 U COL STUD 4; Cook W., 1993, RANGELANDS, V15, P204; Cox RD, 2004, J RANGE MANAGE, V57, P203, DOI 10.2307/4003920; Danforth B.N., 2019, SOLITARY BEES BIOL E; Goergen EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018145; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hall M, 2018, AGR FOREST ENTOMOL, V20, P487, DOI 10.1111/afe.12281; Hall MA, 2019, BIOL CONSERV, V231, P1, DOI 10.1016/j.biocon.2018.12.032; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Jones PL, 2017, ANNU REV ENTOMOL, V62, P53, DOI 10.1146/annurev-ento-031616-034903; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kearns CA, 2009, J INSECT CONSERV, V13, P655, DOI 10.1007/s10841-009-9215-4; Kimoto C, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00118.1; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; Kruess A, 2002, CONSERV BIOL, V16, P1570, DOI 10.1046/j.1523-1739.2002.01334.x; Laliberte E., 2015, R PACKAGEVERSION 10; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lazaro A, 2016, ECOL ENTOMOL, V41, P400, DOI 10.1111/een.12310; Legendre P, 1997, ECOLOGY, V78, P547; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; MacInnis G, 2019, J APPL ECOL, V56, P824, DOI 10.1111/1365-2664.13344; Martins KT, 2015, AGR ECOSYST ENVIRON, V200, P12, DOI 10.1016/j.agee.2014.10.018; Michener C.D., 2007, BEES WORLD, Vsecond; Michener CD, 1999, APIDOLOGIE, V30, P67, DOI 10.1051/apido:19990108; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Moreira X, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2707; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Parkinson H, 2013, RANGELAND ECOL MANAG, V66, P174, DOI 10.2111/REM-D-11-00028.1; Portman ZM, 2020, ANN ENTOMOL SOC AM, V113, P337, DOI 10.1093/aesa/saaa010; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Prendergast KS, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3076; Rafferty NE, 2017, CURR OPIN INSECT SCI, V23, P22, DOI 10.1016/j.cois.2017.06.009; Rhoades P, 2017, J INSECT CONSERV, V21, P703, DOI 10.1007/s10841-017-0013-0; Rhoades PR, 2018, ANN ENTOMOL SOC AM, V111, P278, DOI 10.1093/aesa/say021; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott V. L., 2011, NATURAL HIST INVENTO, P101; Sjodin NE, 2008, J APPL ECOL, V45, P763, DOI 10.1111/j.1365-2664.2007.01443.x; Sjodin NE, 2007, BIODIVERS CONSERV, V16, P2103, DOI 10.1007/s10531-006-9103-0; SUGDEN EA, 1985, GREAT BASIN NAT, V45, P299; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vulliamy B, 2006, OIKOS, V114, P529, DOI 10.1111/j.2006.0030-1299.14004.x; Wang J, 2020, FIRE MATER, V44, P1, DOI 10.1002/fam.2884; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Young J. A., 2000, Rangelands, V22, P3	59	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237484	10.1371/journal.pone.0237484	http://dx.doi.org/10.1371/journal.pone.0237484			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332351	Green Published, Green Submitted, gold			2022-12-26	WOS:000601310900048
J	Pierzak, M; Kubala-Kukus, A; Banas, D; Stabrawa, I; Wudarczyk-Mocko, J; Gluszek, S				Pierzak, Monika; Kubala-Kukus, Aldona; Banas, Dariusz; Stabrawa, Ilona; Wudarczyk-Mocko, Jolanta; Gluszek, Stanislaw			Study of chromium, selenium and bromine concentrations in blood serum of patients with parenteral nutrition treatment using total reflection X-ray fluorescence analysis	PLOS ONE			English	Article							TRACE-ELEMENTS; TXRF	Total reflection X-ray fluorescence analysis (TXRF) was used to determine chromium, selenium and bromine concentrations in blood serum samples of 50 patients with parenteral nutrition treatment. The concentrations were measured two times, namely in the first day (I measurement) of the treatment and the seventh day (II measurement) after the chromium and selenium supplementation. For comparison purposes also serum samples of 50 patients without nutritional disorders, admitted to a planned surgical procedure to remove the gall bladder (cholecystectomy), were analyzed and treated as the control group. Descriptive statistics of measured concentrations of Cr, Se and Br both for the studied and control groups was determined. In order to check the effectiveness of Cr and Se supplementation, the results of the first and seventh day measurements for studied group were statistically compared with each other, with literature reference values and with the results of the control group (two-group comparison). These comparisons indicate the effectiveness of selenium supplementation in the applied treatment procedure. In the case of Cr and Br concentrations no statistically significant differences were observed. We conclude that monitoring of the concentration of the important trace elements in human serum should be standard procedure in parenteral nutrition treatment. In this monitoring the TXRF technique can be successfully used.	[Pierzak, Monika; Kubala-Kukus, Aldona] Jan Kochanowski Univ Humanities & Sci, Inst Hlth Sci, Kielce, Poland; [Kubala-Kukus, Aldona; Banas, Dariusz; Stabrawa, Ilona] Jan Kochanowski Univ Humanities & Sci, Inst Phys, Kielce, Poland; [Kubala-Kukus, Aldona; Banas, Dariusz; Stabrawa, Ilona; Wudarczyk-Mocko, Jolanta] Holycross Canc Ctr, Kielce, Poland; [Gluszek, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Inst Med Sci, Kielce, Poland; [Gluszek, Stanislaw] Reg Hosp, Clin Gen Oncol & Endocrinol Surg, Kielce, Poland	Jan Kochanowski University; Jan Kochanowski University; Jan Kochanowski University	Kubala-Kukus, A (corresponding author), Jan Kochanowski Univ Humanities & Sci, Inst Phys, Kielce, Poland.; Kubala-Kukus, A (corresponding author), Holycross Canc Ctr, Kielce, Poland.	aldona.kubala-kukus@ujk.edu.pl	Banaś, Dariusz/F-5025-2011	Banaś, Dariusz/0000-0003-1566-5446; Gluszek, Stanislaw/0000-0001-7752-0459; Pierzak, Monika/0000-0002-4367-4465; Kubala-Kukus, Aldona/0000-0003-1547-3348	European Regional Development Fund in the framework of the Polish Innovative Economy Operational Program [WNP-POIG.02.02.00-26-023/08]; Development of Eastern Poland Program (Jan Kochanowski University, Kielce, Poland) [POPW.01.01.00-26-013/09-04]	European Regional Development Fund in the framework of the Polish Innovative Economy Operational Program; Development of Eastern Poland Program (Jan Kochanowski University, Kielce, Poland)	European Regional Development Fund in the framework of the Polish Innovative Economy Operational Program (contract no. WNP-POIG.02.02.00-26-023/08) and the Development of Eastern Poland Program (contract no. POPW.01.01.00-26-013/09-04) (Jan Kochanowski University, Kielce, Poland).	Ashraf A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37431-8; Duntas LH, 2015, ENDOCRINE, V48, P756, DOI 10.1007/s12020-014-0477-6; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Fernandes AP, 2015, BBA-GEN SUBJECTS, V1850, P1642, DOI 10.1016/j.bbagen.2014.10.008; Godzialska A, 2013, WSPOLCZESNE KIERUNKI; Jeffery J, 2019, ANN CLIN BIOCHEM, V56, P170, DOI 10.1177/0004563218793163; Kabata-Pendias A., 2007, TRACE ELEMEN SOIL HU, DOI [10.1007/978-3-540-32714-1, DOI 10.1007/978-3-540-32714-1, 10.1007/978-3-540-32714-1_20]; Klecha Barbara, 2016, Bromatologia i Chemia Toksykologiczna, V49, P818; Klockenkamper R, 2015, CHEM ANAL SERIES MON, V181; Klockenkamper R., 1997, TOTAL REFLECTION XRA; Kubala-Kukus A, 2017, X-RAY SPECTROM, V46, P412, DOI 10.1002/xrs.2778; Kubala-Kukus A, 2004, SPECTROCHIM ACTA B, V59, P1283, DOI 10.1016/j.sab.2004.05.020; Kubala-Kukus A, 2014, BIOL TRACE ELEM RES, V158, P22, DOI 10.1007/s12011-013-9884-4; Lee H, 1990, SPRINGER SCI; Liui Y, 2015, ADV XRAY CHEM ANAL J, V46, P13; Magalhaes T, 2010, SPECTROCHIM ACTA B, V65, P493, DOI 10.1016/j.sab.2010.04.001; Majewska U, 2018, SPECTROCHIM ACTA B, V147, P121, DOI 10.1016/j.sab.2018.05.014; Majewska U, 2016, SPECTROCHIM ACTA B, V122, P56, DOI 10.1016/j.sab.2016.05.001; Majewska U, 2014, ACTA PHYS POL A, V125, P864, DOI 10.12693/APhysPolA.125.864; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Pertkiewicz M, 2005, STANDARDY ZYWIENIA P; Salomone V.N., 2017, INT J EXP SPECTROSC, V2, P1; Solecka M, 2018, MED STUD, V34, P153, DOI 10.5114/ms.2018.76877; Spodaryk M, 2008, PRAKTYCZNE ASPEKTY L; Steinbrenner H, 2015, ADV NUTR, V6, P73, DOI 10.3945/an.114.007575; Stosnach H, 2009, SPECTROCHIM ACTA B, V64, P354, DOI 10.1016/j.sab.2009.03.019; User Manual S2 PICOFOX, 2012, US MAN S2 PICOFOX TX; User Manual SPECTRA 7, 2011, US MAN SPECTRA 7 SOF; Wrzochal A, 2019, MED STUD, V35, P128, DOI 10.5114/ms.2019.86332; Zarkadas C, 2001, SPECTROCHIM ACTA B, V56, P2219, DOI 10.1016/S0584-8547(01)00343-3	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243492	10.1371/journal.pone.0243492	http://dx.doi.org/10.1371/journal.pone.0243492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320863	Green Published, gold			2022-12-26	WOS:000600339800035
J	Stomp, M; d'Ingeo, S; Henry, S; Lesimple, C; Cousillas, H; Hausberger, M				Stomp, Mathilde; d'Ingeo, Serenella; Henry, Severine; Lesimple, Clemence; Cousillas, Hugo; Hausberger, Martine			EEG individual power profiles correlate with tension along spine in horses	PLOS ONE			English	Article							BACK-PAIN SUBJECTS; ELECTROMYOGRAPHIC RECORDINGS; RESOLUTION; DISORDERS; INTENSITY; ATTENTION; LAMENESS	Assessing chronic pain is a challenge given its subjective dimension. In humans, resting state electroencephalography (EEG) is a promising tool although the results of various studies are contradictory. Spontaneous chronic pain is understudied in animals but could be of the highest interest for a comparative study. Riding horses show a very high prevalence of back disorders thought to be associated with chronic pain. Moreover, horses with known back problems show cognitive alterations, such as a lower attentional engagement. Therefore, we hypothesized that the individual EEG power profiles resting state (i.e. quiet standing) of different horses could reflect the state of their back, that we measured using static sEMG, a tool first promoted to assess lower back pain in human patients. Results show that 1) EEG profiles are highly stable at the intra-individual level, 2) horses with elevated back tension showed resting state EEG profiles characterized by more fast (beta and gamma) and less slow (theta and alpha) waves. The proportion of theta waves was particularly negatively correlated with muscular tension along the spine. Moreover, elevated back tension was positively correlated with the frequency of stereotypic behaviours (an "addictive- like" repetitive behavior) performed by the horses in their stall. Resting state quantitative EEG appears therefore as a very promising tool that may allow to assess individual subjective chronic pain experience, beyond more objective measures of tension. These results open new lines of research for a multi-species comparative approach and might reveal very important in the context of animal welfare.	[Stomp, Mathilde; d'Ingeo, Serenella; Henry, Severine; Lesimple, Clemence; Cousillas, Hugo; Hausberger, Martine] Normandie Univ, EthoS Ethol Anim & Humaine UMR 6552, Univ Rennes, CNRS, Paimpont, France; [d'Ingeo, Serenella] Univ Bari Aldo Moro, Dept Vet Med, Sect Anim Physiol & Behav, Bari, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universita degli Studi di Bari Aldo Moro	Stomp, M (corresponding author), Normandie Univ, EthoS Ethol Anim & Humaine UMR 6552, Univ Rennes, CNRS, Paimpont, France.	mathilde.stomp@hotmail.fr	d'Ingeo, Serenella/HDM-8609-2022	/0000-0003-0664-1151	Institut francais du cheval et de l'equitation, Universite de Rennes 1; Centre National de la Recherche Scientifique; Fonds Eperon	Institut francais du cheval et de l'equitation, Universite de Rennes 1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fonds Eperon	Institut francais du cheval et de l'equitation, Universite de Rennes 1, and Centre National de la Recherche Scientifique provided support for this study in the form of funding awarded to MH, SH and MS, and Fonds Eperon provided support for this study in the form of funding awarded to MS.	Aftanas LI, 2001, NEUROSCI LETT, V310, P57, DOI 10.1016/S0304-3940(01)02094-8; Andrew Richard J., 2002, P94, DOI 10.1017/CBO9780511546372.005; [Anonymous], 2017, FRONTIERS MED, V4, P57; [Anonymous], 2012, REGEN MED S3, V7, pS14; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; ARENA JG, 1989, PAIN, V37, P57, DOI 10.1016/0304-3959(89)90153-X; ARENA JG, 1991, PAIN, V45, P23, DOI 10.1016/0304-3959(91)90160-Y; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basile M, 2009, ANIM COGN, V12, P611, DOI 10.1007/s10071-009-0220-5; Benhajali H, 2014, APPL ANIM BEHAV SCI, V153, P36, DOI 10.1016/j.applanim.2014.01.002; BROOM DM, 1986, BRIT VET J, V142, P524, DOI 10.1016/0007-1935(86)90109-0; Cauvin E, 1997, IN PRACTICE, V19, P522; Chae Y.K., 2009, PLOS ONE, V4, pe6523; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; DUNNETT SB, 1987, NEUROSCIENCE, V20, P653, DOI 10.1016/0306-4522(87)90117-5; Dyson S, 2018, J VET BEHAV, V26, P64, DOI 10.1016/j.jveb.2018.05.001; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Greve L, 2014, EQUINE VET J, V46, P687, DOI 10.1111/evj.12222; Harris C, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030428; Hausberger M, 2019, NEUROSCI BIOBEHAV R, V107, P540, DOI 10.1016/j.neubiorev.2019.08.022; Hausberger M, 2007, APPL ANIM BEHAV SCI, V107, P299, DOI 10.1016/j.applanim.2006.10.003; Hausberger M, 2016, APPL ANIM BEHAV SCI, V175, P41, DOI 10.1016/j.applanim.2015.09.005; Haussler KK, 1996, J EQUINE VET SCI, V16, P279, DOI 10.1016/S0737-0806(96)80220-6; Haussler KK, 2006, EQUINE VET J, V38, P76, DOI 10.2746/042516406775374225; JEFFCOTT LB, 1979, EQUINE VET J, V11, P129, DOI 10.1111/j.2042-3306.1979.tb01324.x; JEFFCOTT LB, 1980, EQUINE VET J, V12, P197, DOI 10.1111/j.2042-3306.1980.tb03427.x; Koyama S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34594-2; Kujala MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061818; Lesimple C, 2016, APPL ANIM BEHAV SCI, V181, P105, DOI 10.1016/j.applanim.2016.04.015; Lesimple C., 2016, ANIM BEHAV COGN, V3, P159, DOI [10.12966/abc.05.08.2016, DOI 10.12966/ABC.05.08.2016]; Lesimple C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044604; Levitt J, 2019, NEUROSCI LETT, V702, P40, DOI 10.1016/j.neulet.2018.11.038; May ES, 2019, HUM BRAIN MAPP, V40, P293, DOI 10.1002/hbm.24373; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Murrell JC, 2003, VET ANAESTH ANALG, V30, P138, DOI 10.1046/j.1467-2995.2003.00138.x; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nickel MM, 2017, NEUROIMAGE, V148, P141, DOI 10.1016/j.neuroimage.2017.01.011; Ong RM, 1997, AUST VET J, V75, P189, DOI 10.1111/j.1751-0813.1997.tb10064.x; Parker M, 2008, BEHAV BRAIN RES, V191, P137, DOI 10.1016/j.bbr.2008.03.009; Putman P, 2010, BIOL PSYCHOL, V83, P73, DOI 10.1016/j.biopsycho.2009.10.008; Rapin V, 2007, SCHWEIZ ARCH TIERH, V149, P77, DOI 10.1024/0036-7281.149.2.77; Reddan MC, 2019, NEUROSCI LETT, V702, P24, DOI 10.1016/j.neulet.2018.11.047; Reddan MC, 2018, NEUROSCI BULL, V34, P208, DOI 10.1007/s12264-017-0150-1; Rochais C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28334-9; Rochais C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15654-5; Rochais C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20117; Schulz E, 2015, CEREB CORTEX, V25, P4407, DOI 10.1093/cercor/bhv043; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Stubbs N C, 2006, Equine Vet J Suppl, P393; Sun XJ, 2017, IEEE ENG MED BIO, P479, DOI 10.1109/EMBC.2017.8036866; The Royal College of Radiologists Clinical Oncology Information Network, 1999, CLIN ONCOL R COLL RA, V11, pS1; Visser EK, 2014, J ANIM SCI, V92, P844, DOI 10.2527/jas.2013-6692; Wickens C., 2009, INVESTIGATING SPECIF; Yates WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080287	57	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243970	10.1371/journal.pone.0243970	http://dx.doi.org/10.1371/journal.pone.0243970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315932	Green Published, gold			2022-12-26	WOS:000600186100084
J	Nguyen, TQ; Vu, TM; Tukijan, F; Muralidharan, S; Foo, JC; Li Chin, JF; Hasan, Z; Torta, F; Nguyen, LN				Nguyen, Toan Q.; Thiet Minh Vu; Tukijan, Farhana; Muralidharan, Sneha; Foo, Juat Chin; Li Chin, Jasmine Fei; Hasan, Zafrul; Torta, Federico; Nguyen, Long N.			Erythrocytes efficiently utilize exogenous sphingosines for S1P synthesis and export via Mfsd2b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; TRANSPORTER SPNS2; LYMPHOCYTE EGRESS; SPHINGOSINE-1-PHOSPHATE TRANSPORTER; 1-PHOSPHATE; METABOLISM; BLOOD	Sphingosine-1-phosphate (S1P) is a potent lipid mediator that exerts its activity via activation of five different G protein-coupled receptors, designated as S1P1-5. This potent lipid mediator is synthesized from the sphingosine precursor by two sphingosine kinases (SphK1 and 2) and must be exported to exert extracellular signaling functions. We recently identified Mfsd2b as the S1P transporter in the hematopoietic system. However, the sources of sphingosine for S1P synthesis and the transport mechanism of Mfsd2b in erythrocytes remain to be determined. Here, we show that erythrocytes efficiently take up exogenous sphingosine and that a de novo synthesis pathway in part provides sphingosines to erythrocytes. The uptake of sphingosine in erythrocytes is facilitated by the activity of SphK1. By converting sphingosine into S1P, SphK1 indirectly increases the influx of sphingosine, a process that is irreversible in erythrocytes. Our results explain for the abnormally high amount of sphingosine accumulation in Mfsd2b knockout erythrocytes. Furthermore, we show that Mfsd2b utilizes a proton gradient to facilitate the release of S1P. The negatively charged residues D95 and T157 are essential for Mfsd2b transport activity. Of interest, we also discovered an S1P analog that inhibits S1P export from erythrocytes, providing evidence that sphingosine analogs can be used to inhibit S1P export by Mfsd2b. Collectively, our results highlight that erythrocytes are efficient in sphingosine uptake for S1P production and the release of S1P is dependent on Mfsd2b functions.	[Nguyen, Toan Q.; Thiet Minh Vu; Tukijan, Farhana; Foo, Juat Chin; Hasan, Zafrul; Torta, Federico; Nguyen, Long N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Muralidharan, Sneha] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Li Chin, Jasmine Fei] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore; [Nguyen, Long N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Life Sci Inst, SLING Immunol Program, Singapore, Singapore; [Nguyen, Long N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Translat & Cardiovasc Dis Res Programme, Singapore, Singapore; [Thiet Minh Vu] Nguyen Tat Thanh Univ, NTT Hitech Inst, Ho Chi Minh City, Vietnam	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Nguyen Tat Thanh University (NTTU)	Nguyen, LN (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Nguyen, LN (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Life Sci Inst, SLING Immunol Program, Singapore, Singapore.; Nguyen, LN (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Translat & Cardiovasc Dis Res Programme, Singapore, Singapore.	b.chnnl@nus.edu.sg	Nguyen, Long/AAY-6172-2021	foo, juat chin/0000-0002-9189-4585; Nguyen, Long N/0000-0002-9857-2239; Vu, Thiet/0000-0002-7950-0758; Nguyen, Toan/0000-0002-8015-6130	Singapore Ministry of Health's National Medical Research Council [NMRC/OFIRG/0066/20]; Ministry of Education [MOE2018T2-1-126]; MOE-Tier-1; National University of Singapore Young Investigator Award [NUSYIA_FY16_P19]; MOE PDF fellowship	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Ministry of Education; MOE-Tier-1(Ministry of Education, Singapore); National University of Singapore Young Investigator Award(National University of Singapore); MOE PDF fellowship	This study was supported in part by Singapore Ministry of Health's National Medical Research Council NMRC/OFIRG/0066/20, Ministry of Education MOE2018T2-1-126, MOE-Tier-1, MOE PDF fellowship, and National University of Singapore Young Investigator Award (NUSYIA_FY16_P19) grants (to L. N. N.).	Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Donoviel MS, 2015, FASEB J, V29, P5018, DOI 10.1096/fj.15-274936; Fukuhara Shigetomo, 2013, Seikagaku, V85, P269; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Gazit SL, 2016, CIRC RES, V119, pE110, DOI 10.1161/CIRCRESAHA.116.308929; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kobayashi N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23300-x; Kobayashi N, 2016, J LIPID RES, V57, P2088, DOI 10.1194/jlr.D071068; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kurano M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177543; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Li F, 2018, FASEB J, V32, P3058, DOI 10.1096/fj.201700445RR; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Quek DQY, 2016, J BIOL CHEM, V291, P9383, DOI 10.1074/jbc.M116.721035; Saba JD, 2019, J LIPID RES, V60, P456, DOI 10.1194/jlr.S091181; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Tan ST, 2020, PROG LIPID RES, V80, DOI 10.1016/j.plipres.2020.101068; Tukijan F, 2018, BRIT J PHARMACOL, V175, P3741, DOI 10.1111/bph.14451; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Vu TM, 2017, NATURE, V550, P524, DOI 10.1038/nature24053; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yanagida K, 2017, ANNU REV PHYSIOL, V79, P67, DOI 10.1146/annurev-physiol-021014-071635	37	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100201	10.1074/jbc.RA120.012941	http://dx.doi.org/10.1074/jbc.RA120.012941			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334894	Green Published, gold			2022-12-26	WOS:000672866400179
J	Schlotter, F; Freitas, RCCD; Rogers, MA; Blaser, MC; Wu, PJ; Higashi, H; Halu, A; Iqbal, F; Andraski, AB; Rodia, CN; Kuraoka, S; Wen, JR; Creager, M; Pham, T; Hutcheson, JD; Body, SC; Kohan, AB; Sacks, FM; Aikawa, M; Singh, SA; Aikawa, E				Schlotter, Florian; Freitas, Renata C. C. de; Rogers, Maximillian A.; Blaser, Mark C.; Wu, Pin-Jou; Higashi, Hideyuki; Halu, Arda; Iqbal, Farwah; Andraski, Allison B.; Rodia, Cayla N.; Kuraoka, Shiori; Wen, Jennifer R.; Creager, Michael; Tan Pham; Hutcheson, Joshua D.; Body, Simon C.; Kohan, Alison B.; Sacks, Frank M.; Aikawa, Masanori; Singh, Sasha A.; Aikawa, Elena			ApoC-III is a novel inducer of calcification in human aortic valves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDIZED PHOSPHOLIPIDS; STENOSIS; LIPOPROTEIN(A); INFLAMMATION; PROGRESSION; MECHANISMS; THERAPY; RISK; HDL	Calcific aortic valve disease (CAVD) occurs when sub-populations of valve cells undergo specific differentiation pathways, promoting tissue fibrosis and calcification. Lipoprotein particles carry oxidized lipids that promote valvular disease, but low-density lipoprotein-lowering therapies have failed in clinical trials, and there are currently no pharmacological interventions available for this disease. Apolipoproteins are known promoters of atherosclerosis, but whether they possess pathogenic properties in CAVD is less clear. To search for a possible link, we assessed 12 apolipoproteins in nonfibrotic/noncalcific and fibrotic/calcific aortic valve tissues by proteomics and immunohistochemistry to understand if they were enriched in calcified areas. Eight apolipoproteins (apoA-I, apoA-II, apoA-IV, apoB, apoC-III, apoD, apoL-I, and apoM) were enriched in the calcific versus nonfibrotic/noncalcific tissues. Apo(a), apoB, apoC-III, apoE, and apoJ localized within the disease-prone fibrosa and colocalized with calcific regions as detected by immunohistochemistry. Circulating apoC-III on lipoprotein(a) is a potential biomarker of aortic stenosis incidence and progression, but whether apoC-III also induces aortic valve calcification is unknown. We found that apoC-III was increased in fibrotic and calcific tissues and observed within the calcification-prone fibrosa layer as well as around calcification. In addition, we showed that apoC-III induced calcification in primary human valvular cell cultures via a mitochondrial dysfunction/inflammation-mediated pathway. This study provides a first assessment of a broad array of apolipoproteins in CAVD tissues, demonstrates that specific apolipoproteins associate with valvular calcification, and implicates apoC-III as an active and modifiable driver of CAVD beyond its potential role as a biomarker.	[Schlotter, Florian; Freitas, Renata C. C. de; Rogers, Maximillian A.; Blaser, Mark C.; Wu, Pin-Jou; Higashi, Hideyuki; Halu, Arda; Kuraoka, Shiori; Wen, Jennifer R.; Creager, Michael; Tan Pham; Aikawa, Masanori; Singh, Sasha A.; Aikawa, Elena] Harvard Med Sch, Div Cardiovasc Med, Dept Med, Ctr Interdisciplinary Cardiovasc Sci,Brigham & Wo, Boston, MA 02115 USA; [Halu, Arda] Harvard Med Sch, Channing Div Network Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Iqbal, Farwah; Aikawa, Masanori; Aikawa, Elena] Harvard Med Sch, Div Cardiovasc Med, Dept Med, Ctr Excellence Vasc Biol,Brigham & Womens Hosp, Boston, MA 02115 USA; [Andraski, Allison B.; Sacks, Frank M.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Andraski, Allison B.; Sacks, Frank M.] Harvard TH Chan Sch Publ Hlth, Dept Mol Metab, Boston, MA USA; [Rodia, Cayla N.] Univ Connecticut, Dept Nutr Sci, Storrs, CT USA; [Hutcheson, Joshua D.] Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA; [Body, Simon C.] Boston Univ, Dept Anesthesiol, Sch Med, Boston, MA 02118 USA; [Kohan, Alison B.] Univ Pittsburgh, Div Endocrinol & Metab, Dept Med, Pittsburgh, PA USA; [Aikawa, Elena] Sechenov First Moscow State Med Univ, Dept Human Pathol, Moscow, Russia	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Connecticut; State University System of Florida; Florida International University; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sechenov First Moscow State Medical University	Aikawa, E (corresponding author), Harvard Med Sch, Div Cardiovasc Med, Dept Med, Ctr Interdisciplinary Cardiovasc Sci,Brigham & Wo, Boston, MA 02115 USA.; Aikawa, E (corresponding author), Harvard Med Sch, Div Cardiovasc Med, Dept Med, Ctr Excellence Vasc Biol,Brigham & Womens Hosp, Boston, MA 02115 USA.	eaikawa@bwh.harvard.edu	Schlotter, Florian/AAC-4864-2021	Kohan, Alison/0000-0003-3127-7283; Aikawa, Masanori/0000-0002-9275-2079; Freitas, Renata Caroline/0000-0003-1135-021X	Kowa Company, Ltd (Tokyo, Japan); National Institutes of Health [R01 HL126901, R01 HL136431, R01 HL 141917, R01 HL147095, 2019/22147-0]; Sao Paulo Research Foundation (FAPESP)	Kowa Company, Ltd (Tokyo, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by a research grant from Kowa Company, Ltd (Tokyo, Japan to M. A.) and National Institutes of Health grants R01 HL126901 (to M. A.) and R01 HL136431, R01 HL 141917, and R01 HL147095 (to E. A.). R. C. C. F. is recipient of fellowship (grant 2019/22147-0) from Sao Paulo Research Foundation (FAPESP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aikawa E, 2017, CIRCULATION, V135, P1951, DOI 10.1161/CIRCULATIONAHA.117.027776; Alaupovic P, 1996, METHOD ENZYMOL, V263, P32; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchareb R, 2015, CIRCULATION, V132, P677, DOI 10.1161/CIRCULATIONAHA.115.016757; Busseuil D, 2008, BRIT J PHARMACOL, V154, P765, DOI 10.1038/bjp.2008.122; Capoulade R, 2020, HEART, V106, P738, DOI 10.1136/heartjnl-2019-315840; Capoulade R, 2018, JAMA CARDIOL, V3, P1212, DOI 10.1001/jamacardio.2018.3798; Capoulade R, 2015, J AM COLL CARDIOL, V66, P1236, DOI 10.1016/j.jacc.2015.07.020; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Cheng FX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09186-x; Chowdhury S, 2015, DATABASE-OXFORD, DOI 10.1093/database/bau126; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gerber Y, 2003, ATHEROSCLEROSIS, V170, P301, DOI 10.1016/S0021-9150(03)00292-2; Goto S, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00049; Guney E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10331; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kaltoft M, 2020, EUR HEART J, V41, P2288, DOI 10.1093/eurheartj/ehaa172; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kohan AB, 2015, CURR OPIN ENDOCRINOL, V22, P119, DOI 10.1097/MED.0000000000000136; Lommi JI, 2011, ATHEROSCLEROSIS, V219, P538, DOI 10.1016/j.atherosclerosis.2011.08.027; Lopez-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Nordestgaard BG, 2015, J AM COLL CARDIOL, V66, P1247, DOI 10.1016/j.jacc.2015.07.045; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sacks FM, 2006, ATHEROSCLEROSIS SUPP, V7, P23, DOI 10.1016/j.atherosclerosissup.2006.05.004; Schlotter F, 2018, CIRCULATION, V138, P377, DOI 10.1161/CIRCULATIONAHA.117.032291; Sider KL, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/364310; Singh SA, 2016, J LIPID RES, V57, P714, DOI 10.1194/jlr.D061432; Smith JG, 2014, JAMA-J AM MED ASSOC, V312, P1764, DOI 10.1001/jama.2014.13959; Song E, 2020, FASEB J, V34, P11087, DOI 10.1096/fj.202001062R; Speidl WS, 2010, EUR HEART J, V31, P2049, DOI 10.1093/eurheartj/ehq064; Sun JT, 2019, J CARDIOVASC TRANSL, V12, P560, DOI 10.1007/s12265-019-09903-3; Tastet L, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007980; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Trapeaux J, 2013, BRIT J PHARMACOL, V169, P1587, DOI 10.1111/bph.12236; Tsimikas S, 2018, J AM COLL CARDIOL, V71, P177, DOI 10.1016/j.jacc.2017.11.014; Wang YT, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0696-6; Zheng CY, 2013, EUR HEART J, V34, P615, DOI 10.1093/eurheartj/ehs271; Zheng KH, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013020; Zheng KH, 2019, J AM COLL CARDIOL, V73, P2150, DOI 10.1016/j.jacc.2019.01.070	44	13	13	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100193	10.1074/jbc.RA120.015700	http://dx.doi.org/10.1074/jbc.RA120.015700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334888	gold, Green Published			2022-12-26	WOS:000672866400171
J	Evtushenko, EG; Bagrov, DV; Lazarev, VN; Livshits, MA; Khomyakova, E				Evtushenko, Evgeniy G.; Bagrov, Dmitry V.; Lazarev, Vassili N.; Livshits, Mikhail A.; Khomyakova, Elena			Adsorption of extracellular vesicles onto the tube walls during storage in solution	PLOS ONE			English	Article							HUMAN URINARY EXOSOMES; PLASMA EXOSOME; QUANTIFICATION; STABILITY; PROTOCOL; ULTRACENTRIFUGATION; BIOMARKERS; CELLS	Short term storage of extracellular vesicle (EV) solutions at +4 degrees C is a common practice, but the stability of EVs during this procedure has not been fully understood yet. Using nanoparticle tracking analysis, we have shown that EVs isolated from the conditioned medium of HT-29 cells exhibit a pronounced concentration decrease when stored in PBS in ordinary polypropylene tubes within the range of (0.5-2.1) x 10(10) particles/ml. EV losses reach 51 +/- 3% for 0.5 ml of EVs in Eppendorf 2 ml tube at 48 hours of storage at +4 degrees C. Around 2/3 of the observed losses have been attributed to the adsorption of vesicles onto tube walls. This result shows that the lower part (up to at least 2 x 10(10) particles/ml) of the practically relevant concentration range for purified EVs is prone to adsorption losses at +4 degrees C. Total particle losses could be reduced to 18-21% at 48 hours by using either Eppendorf Protein LoBind tubes or ordinary tubes with the surface blocked with bovine serum albumin or EVs. Reduction of losses to 15% has been shown for isolated EVs dissolved in the supernatant after 100 000 g centrifugation as a model of conditioned medium. Also, a previously unknown feature of diffusion-controlled adsorption was revealed for EVs. In addition to the decrease in particle count, this process causes the predominant losses of smaller particles.	[Evtushenko, Evgeniy G.] Lomonosov Moscow State Univ, Dept Chem Enzymol, Fac Chem, Moscow, Russia; [Bagrov, Dmitry V.] Lomonosov Moscow State Univ, Dept Bioengn, Fac Biol, Moscow, Russia; [Lazarev, Vassili N.; Khomyakova, Elena] Fed Med Biol Agcy, Fed Res & Clin Ctr Phys Chem Med, Moscow, Russia; [Livshits, Mikhail A.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Livshits, Mikhail A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Evtushenko, EG (corresponding author), Lomonosov Moscow State Univ, Dept Chem Enzymol, Fac Chem, Moscow, Russia.	evtushenko@enzyme.chem.msu.ru	Lazarev, Vassili/A-8313-2014; Evtushenko, Evgeniy G/O-1565-2014	Evtushenko, Evgeniy G/0000-0003-1264-4770; Lazarev, Vassili/0000-0003-0042-966X	Moscow State University [AAAA-A16-116052010081-5]	Moscow State University	This work was carried out within the project "Molecular design, structure-function analysis and regulation of enzyme systems, cellular structures, bionanomaterials: fundamental and applications in technology, medicine, environmental protection" of Moscow State University (AAAA-A16-116052010081-5). Transmission electron microscopy measurements were performed at the User Facilities Centre "Electron microscopy in life sciences" at Lomonosov Moscow State University. Scanning electron microscopy and atomic force microscopy measurements (S2 Appendix) were carried out using the equipment purchased on account of the Lomonosov MSU Development Program.	Akers JC, 2016, CANCER BIOMARK, V17, P125, DOI 10.3233/CBM-160609; [Anonymous], 2018, E2834122018 ASTM INT, DOI [10.1520/E2834-12R18, DOI 10.1520/E2834-12R18]; Baddela VS, 2016, APPL BIOCHEM BIOTECH, V178, P544, DOI 10.1007/s12010-015-1893-7; Baek R, 2016, J IMMUNOL METHODS, V438, P11, DOI 10.1016/j.jim.2016.08.007; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Barok M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4418-2; Bosch S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36162; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Cheng YR, 2019, PROTEIN CELL, V10, P295, DOI 10.1007/s13238-018-0529-4; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Enderle D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136133; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Gaspar LS, 2020, MOL THER-METH CLIN D, V18, P723, DOI 10.1016/j.omtm.2020.07.012; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Greening DW, 2015, METHODS MOL BIOL, V1295, P179, DOI 10.1007/978-1-4939-2550-6_15; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hosoda S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010230; Jin Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2783-2; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Kenigsberg S, 2017, METHODS MOL BIOL, V1660, P321, DOI 10.1007/978-1-4939-7253-1_26; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; Kumeda N, 2017, BIOL PHARM BULL, V40, P1183, DOI 10.1248/bpb.b16-00891; Kuravi SJ, 2019, INFLAMMATION, V42, P290, DOI 10.1007/s10753-018-0893-5; Kusuma GD, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01199; Lee M, 2016, BIOTECHNOL BIOPROC E, V21, P299, DOI 10.1007/s12257-015-0781-x; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Li M, 2015, METHODS, V87, P26, DOI 10.1016/j.ymeth.2015.03.009; Liu ZG, 2018, CELL STRESS CHAPERON, V23, P943, DOI 10.1007/s12192-018-0902-5; Livshits MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21447; Livshts MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17319; Lorincz AM, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25465; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Maas SLN, 2015, J CONTROL RELEASE, V200, P87, DOI 10.1016/j.jconrel.2014.12.041; Malik ZA, 2013, AM J PHYSIOL-HEART C, V304, pH954, DOI 10.1152/ajpheart.00835.2012; Maroto R, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1359478; Matsumura S, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1579541; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Monguio-Tortajada Marta, 2019, Curr Protoc Stem Cell Biol, V49, pe82, DOI 10.1002/cpsc.82; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Oosthuyzen W, 2013, J PHYSIOL-LONDON, V591, P5833, DOI 10.1113/jphysiol.2013.264069; Park SJ, 2018, IN VITRO CELL DEV-AN, V54, P423, DOI 10.1007/s11626-018-0261-7; Pietrowska M, 2017, METHODS MOL BIOL, V1654, P291, DOI 10.1007/978-1-4939-7231-9_22; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Richter M, 2019, JOVE-J VIS EXP, DOI 10.3791/59584; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Silachev DN, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030258; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Stranska R, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-017-1374-6; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Urabe F, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3051; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yamashita T, 2016, EUR J PHARM BIOPHARM, V98, P1, DOI 10.1016/j.ejpb.2015.10.017; Zaborowski MP, 2015, BIOSCIENCE, V65, P783, DOI 10.1093/biosci/biv084; Zarovni N, 2015, METHODS, V87, P46, DOI 10.1016/j.ymeth.2015.05.028	60	16	17	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243738	10.1371/journal.pone.0243738	http://dx.doi.org/10.1371/journal.pone.0243738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370319	Green Published, gold			2022-12-26	WOS:000603611900076
J	Lee, J; Oh, S; Bhattacharya, S; Zhang, Y; Florens, L; Washburn, MP; Workman, JL				Lee, Jaehyoun; Oh, Seunghee; Bhattacharya, Saikat; Zhang, Ying; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.			The plasticity of the pyruvate dehydrogenase complex confers a labile structure that is associated with its catalytic activity	PLOS ONE			English	Article							MULTIENZYME COMPLEX; ESCHERICHIA-COLI; NUCLEAR-LOCALIZATION; ENZYMES; INHIBITORS; ACTIVATOR; DOMAINS; SUBUNIT; BINDING; DESIGN	The pyruvate dehydrogenase complex (PDC) is a multienzyme complex that plays a key role in energy metabolism by converting pyruvate to acetyl-CoA. An increase of nuclear PDC has been shown to be correlated with an increase of histone acetylation that requires acetyl-CoA. PDC has been reported to form a similar to 10 MDa macromolecular machine that is proficient in performing sequential catalytic reactions via its three components. In this study, we show that the PDC displays size versatility in an ionic strength-dependent manner using size exclusion chromatography of yeast cell extracts. Biochemical analysis in combination with mass spectrometry indicates that yeast PDC (yPDC) is a salt-labile complex that dissociates into sub-megadalton individual components even under physiological ionic strength. Interestingly, we find that each oligomeric component of yPDC displays a larger size than previously believed. In addition, we show that the mammalian PDC also displays this uncommon characteristic of salt-lability, although it has a somewhat different profile compared to yeast. We show that the activity of yPDC is reduced in higher ionic strength. Our results indicate that the structure of PDC may not always maintain its similar to 10 MDa organization, but is rather variable. We propose that the flexible nature of PDC may allow modulation of its activity.	[Lee, Jaehyoun; Oh, Seunghee; Bhattacharya, Saikat; Zhang, Ying; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Workman, JL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlw@stowers.org	Bhattacharya, Saikat/AAK-7785-2021	Bhattacharya, Saikat/0000-0001-6028-4840; Washburn, Michael/0000-0001-7568-2585; Seiler, Jae Hyoun/0000-0002-6351-3546	Stowers Institute for Medical Research; National Institutes of General Medical Sciences [R35GM118068]	Stowers Institute for Medical Research; National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Stowers Institute for Medical Research (https://www.stowers.org) and National Institutes of General Medical Sciences (https://www.nigms.nih.gov) grant R35GM118068 (J.L.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES DL, 1977, NATURE, V268, P313, DOI 10.1038/268313a0; BATES DL, 1975, FEBS LETT, V60, P427, DOI 10.1016/0014-5793(75)80764-2; Brautigam CA, 2009, J BIOL CHEM, V284, P13086, DOI 10.1074/jbc.M806563200; BRUNETTE MG, 1972, PEDIATRICS, V50, P702; Chueh FY, 2011, CELL SIGNAL, V23, P1170, DOI 10.1016/j.cellsig.2011.03.004; DANSON MJ, 1979, J MOL BIOL, V129, P603, DOI 10.1016/0022-2836(79)90471-6; DASILVA LA, 1993, BIOCHIM BIOPHYS ACTA, V1169, P126, DOI 10.1016/0005-2760(93)90197-H; de Boer VCJ, 2014, CELL, V158, P9, DOI 10.1016/j.cell.2014.06.018; Drakulic S, 2018, CELL MOL LIFE SCI, V75, P3009, DOI 10.1007/s00018-018-2775-2; Florens Laurence, 2006, V328, P159; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; GILBERT GA, 1980, J MOL BIOL, V144, P405, DOI 10.1016/0022-2836(80)90099-6; Gregg Christopher, 2009, J Vis Exp, DOI 10.3791/1417; Gu YQ, 2003, P NATL ACAD SCI USA, V100, P7015, DOI 10.1073/pnas.0732060100; HACKERT ML, 1983, P NATL ACAD SCI-BIOL, V80, P2226, DOI 10.1073/pnas.80.8.2226; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Jung HI, 2002, PROTEIN SCI, V11, P1091, DOI 10.1110/ps.4970102; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kingsbury JM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005714; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Kok De, 1985, FEBS LETT, V152, P35, DOI [10.1111/j.1432-1033.1985.tb09160.x, DOI 10.1111/J.1432-1033.1985.TB09160.X]; Ling MF, 1998, HUM MOL GENET, V7, P501, DOI 10.1093/hmg/7.3.501; Matsuda S, 2016, NUCLEIC ACIDS RES, V44, P636, DOI 10.1093/nar/gkv967; Milne JLS, 2006, J BIOL CHEM, V281, P4364, DOI 10.1074/jbc.M504363200; Nagaraj R, 2017, CELL, V168, P210, DOI 10.1016/j.cell.2016.12.026; Ng F, 2014, MOL MEMBR BIOL, V31, P207, DOI 10.3109/09687688.2014.987183; Oliver RM, 1982, ELECT MIRCOSCOPY PRO; Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032; Patel MS, 2003, BIOCHEM MOL BIOL EDU, V31, P5, DOI 10.1002/bmb.2003.494031010156; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; PAWELCZYK T, 1995, INT J BIOCHEM CELL B, V27, P513, DOI 10.1016/1357-2725(95)00006-B; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Prochasson P, 2003, MOL CELL, V12, P983, DOI 10.1016/S1097-2765(03)00366-6; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Saunier E, 2016, INT J CANCER, V138, P809, DOI 10.1002/ijc.29564; SCHMITT B, 1980, BIOCHEM BIOPH RES CO, V93, P709, DOI 10.1016/0006-291X(80)91135-3; SCHWARTZ ER, 1969, J BIOL CHEM, V244, P6074; Smolle M, 2006, J BIOL CHEM, V281, P19772, DOI 10.1074/jbc.M601140200; STEPP LR, 1981, BIOCHEMISTRY-US, V20, P4555, DOI 10.1021/bi00519a007; STOOPS JK, 1992, J BIOL CHEM, V267, P24769; Stoops JK, 1997, J BIOL CHEM, V272, P5757, DOI 10.1074/jbc.272.9.5757; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; SUMEGI B, 1987, EUR J BIOCHEM, V169, P223, DOI 10.1111/j.1432-1033.1987.tb13601.x; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tso SC, 2014, J BIOL CHEM, V289, P4432, DOI 10.1074/jbc.M113.533885; Vijayakrishnan S, 2010, J MOL BIOL, V399, P71, DOI 10.1016/j.jmb.2010.03.043; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Zhang Y, 2011, ANAL CHEM, V83, P9344, DOI 10.1021/ac201867h; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhou Y, 2018, BIOORGAN MED CHEM, V26, P84, DOI 10.1016/j.bmc.2017.11.021	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243489	10.1371/journal.pone.0243489	http://dx.doi.org/10.1371/journal.pone.0243489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370314	Green Published, gold, Green Submitted			2022-12-26	WOS:000603611900043
J	Skaaby, S; Flachs, EM; Lange, P; Schlunssen, V; Marott, JL; Brauer, C; Nordestgaard, BG; Sadhra, S; Kurmi, O; Bonde, JPE				Skaaby, Stinna; Flachs, Esben Meulengracht; Lange, Peter; Schlunssen, Vivi; Marott, Jacob Louis; Brauer, Charlotte; Nordestgaard, Borge G.; Sadhra, Steven; Kurmi, Om; Bonde, Jens Peter Ellekilde			Occupational exposures and exacerbations of asthma and COPD-A general population study	PLOS ONE			English	Article							LUNG-FUNCTION; AIR-POLLUTION; RISK; PREDICTORS; EMPLOYMENT; DISEASE; BURDEN; TRENDS; COHORT	Purpose Recent studies suggest that occupational inhalant exposures trigger exacerbations of asthma and chronic obstructive pulmonary disease, but findings are conflicting. Methods We included 7,768 individuals with self-reported asthma (n = 3,215) and/or spirometric airflow limitation (forced expiratory volume in 1 second (FEV1)/ forced expiratory volume (FVC) <0.70) (n = 5,275) who participated in The Copenhagen City Heart Study or The Copenhagen General Population Study from 2001-2016. Occupational exposure was assigned by linking job codes with job exposure matrices, and exacerbations were defined by register data on oral corticosteroid treatment, emergency care unit assessment or hospital admission. Associations between occupational inhalant exposure each year of follow-up and exacerbation were assessed by Cox regression with time varying exposure and age as the underlying time scale. Results Participants were followed for a median of 4.6 years (interquartile range, IQR 5.4), during which 870 exacerbations occurred. Exacerbations were not associated with any of the selected exposures (high molecular weight sensitizers, low molecular weight sensitizers, irritants or low and high levels of mineral dust, biological dust, gases & fumes or the composite variable vapours, gases, dusts or fumes). Hazards ratios ranged from 0.8 (95% confidence interval: 0.7;1.0) to 1.2 (95% confidence interval: 0.9;1.7). Conclusion Exacerbations of obstructive airway disease were not associated with occupational inhalant exposures assigned by a job exposure matrix. Further studies with alternative exposure assessment are warranted.	[Skaaby, Stinna; Flachs, Esben Meulengracht; Brauer, Charlotte; Bonde, Jens Peter Ellekilde] Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Lange, Peter; Bonde, Jens Peter Ellekilde] Univ Copenhagen, Inst Publ Hlth, Sect Epidemiol, Copenhagen, Denmark; [Lange, Peter] Copenhagen Univ Hosp, Herlev Gentofte Hosp, Dept Med, Herlev, Denmark; [Lange, Peter; Marott, Jacob Louis; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Lange, Peter; Marott, Jacob Louis; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen Gen Populat Study, Herlev Gentofte Hosp, Herlev, Denmark; [Schlunssen, Vivi] Univ Aarhus, Danish Ramazzini Ctr, Dept Publ Hlth Environm Work & Hlth, Aarhus, Denmark; [Schlunssen, Vivi] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark; [Sadhra, Steven] Univ Birmingham, Inst Occupat & Environm Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Kurmi, Om] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England; [Kurmi, Om] McMaster Univ, Div Respirol, Dept Med, Hamilton, ON, Canada	Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Aarhus University; National Research Centre for the Working Environment; University of Copenhagen; University of Birmingham; Coventry University; McMaster University	Skaaby, S (corresponding author), Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark.	stinna.skaaby@regionh.dk		Schlunssen, Vivi/0000-0003-4915-1734; Nordestgaard, Borge/0000-0002-1954-7220; Kurmi, Om Prakash/0000-0002-9518-4716; Skaaby, Stinna/0000-0002-0928-8405; Brauer, Charlotte/0000-0002-2109-3264	Danish Working Environment Research Fund [40-2016-09 20165103813]	Danish Working Environment Research Fund	JPB, grant number 40-2016-09 20165103813, The Danish Working Environment Research Fund https://amff.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Andersson E, 2006, EUR RESPIR J, V27, P720, DOI 10.1183/09031936.06.00034305; Antoniu SA, 2009, EXPERT OPIN PHARMACO, V10, P719, DOI [10.1517/14656560902740804 , 10.1517/14656560902740804]; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Bai TR, 2007, EUR RESPIR J, V30, P452, DOI 10.1183/09031936.00165106; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Bleecker ER, 2008, PULM PHARMACOL THER, V21, P682, DOI 10.1016/j.pupt.2008.04.003; Bloom CI, 2018, THORAX, V73, P313, DOI 10.1136/thoraxjnl-2017-210650; Castillo JR, 2017, J ALLER CL IMM-PRACT, V5, P918, DOI 10.1016/j.jaip.2017.05.001; Colak Y, 2019, RESP MED, V155, P141, DOI 10.1016/j.rmed.2019.07.021; Creely KS, 2007, ANN OCCUP HYG, V51, P665, DOI 10.1093/annhyg/mem050; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Dunn RM, 2018, ALLERGY, V73, P284, DOI 10.1111/all.13258; Flachs EM, 2019, INT J EPIDEMIOL, P1, DOI [10.1093/ije/dyy184, DOI 10.1093/IJE/DYY184]; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Galan I, 2003, EUR RESPIR J, V22, P802, DOI 10.1183/09031936.03.00013003; Hansen CL, 2012, SCAND J PUBLIC HEALT, V40, P377, DOI 10.1177/1403494812449079; Henneberger PK, 2010, EUR RESPIR J, V36, P743, DOI 10.1183/09031936.00135109; Ingebrigtsen TS, 2015, RESP MED, V109, P1562, DOI 10.1016/j.rmed.2015.10.015; James KA, 2018, ANN AM THORAC SOC, V15, P947, DOI 10.1513/AnnalsATS.201804-273OC; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kim JL, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0306-1; Ko FW, 2016, RESPIROLOGY, V21, P1152, DOI 10.1111/resp.12780; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Lange P, 2016, LANCET RESP MED, V4, P454, DOI 10.1016/S2213-2600(16)00098-9; Le Moual N, 2018, OCCUP ENVIRON MED, V75, P507, DOI 10.1136/oemed-2017-104866; Li JH, 2016, INT J CHRONIC OBSTR, V11, P3079, DOI 10.2147/COPD.S122282; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Lytras T, 2018, THORAX, V73, P1008, DOI 10.1136/thoraxjnl-2017-211158; Miller MK, 2007, RESP MED, V101, P481, DOI 10.1016/j.rmed.2006.07.005; Paulin LM, 2015, AM J RESP CRIT CARE, V191, P557, DOI 10.1164/rccm.201408-1407OC; Pelkonen MK, 2018, RESP MED, V142, P29, DOI 10.1016/j.rmed.2018.07.012; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Rai KK, 2017, INT J CHRONIC OBSTR, V12, P233, DOI 10.2147/COPD.S119467; Sadhra SS, 2016, OCCUP MED-OXFORD, V66, P358, DOI 10.1093/occmed/kqw027; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Schatz M, 2007, J ASTHMA, V44, P341, DOI 10.1080/02770900701344421; Schatz M, 2013, J ALLER CL IMM-PRACT, V1, P618, DOI 10.1016/j.jaip.2013.07.009; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Sivapalan P, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000407; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Statistics Denmark, STATBANK DENM; Suruki RY, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0409-3; Taponen S, 2019, RESP MED, V147, P76, DOI 10.1016/j.rmed.2019.01.004; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Toren K, 2004, EUR RESPIR J, V24, P942, DOI 10.1183/09031936.04.00044804; Truelsen T, 2001, INT J EPIDEMIOL, V30, P145, DOI 10.1093/ije/30.1.145; Tzivian L, 2011, J ASTHMA, V48, P470, DOI 10.3109/02770903.2011.570407; Vested A, 2019, OCCUP ENVIRON MED, V76, P105, DOI 10.1136/oemed-2018-105323; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Zuo BQ, 2019, CHEMOSPHERE, V237, DOI 10.1016/j.chemosphere.2019.124497	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243826	10.1371/journal.pone.0243826	http://dx.doi.org/10.1371/journal.pone.0243826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370308	Green Published, gold			2022-12-26	WOS:000603611900037
J	Roslan, MF; Al-Shetwi, AQ; Hannan, MA; Ker, PJ; Zuhdi, AWM				Roslan, M. F.; Al-Shetwi, Ali Q.; Hannan, M. A.; Ker, P. J.; Zuhdi, A. W. M.			Particle swarm optimization algorithm-based PI inverter controller for a grid-connected PV system	PLOS ONE			English	Article							PERFORMANCE	The lack of control in voltage overshoot, transient response, and steady state error are major issues that are frequently encountered in a grid-connected photovoltaic (PV) system, resulting in poor power quality performance and damages to the overall power system. This paper presents the performance of a control strategy for an inverter in a three-phase grid-connected PV system. The system consists of a PV panel, a boost converter, a DC link, an inverter, and a resistor-inductor (RL) filter and is connected to the utility grid through a voltage source inverter. The main objective of the proposed strategy is to improve the power quality performance of the three-phase grid-connected inverter system by optimising the proportional-integral (PI) controller. Such a strategy aims to reduce the DC link input voltage fluctuation, decrease the harmonics, and stabilise the output current, voltage, frequency, and power flow. The particle swarm optimisation (PSO) technique was implemented to tune the PI controller parameters by minimising the error of the voltage regulator and current controller schemes in the inverter system. The system model and control strategies were implemented using MATLAB/Simulink environment (Version 2020A) Simscape-Power system toolbox. Results show that the proposed strategy outperformed other reported research works with total harmonic distortion (THD) at a grid voltage and current of 0.29% and 2.72%, respectively, and a transient response time of 0.1853s. Compared to conventional systems, the PI controller with PSO-based optimization provides less voltage overshoot by 11.1% while reducing the time to reach equilibrium state by 32.6%. The consideration of additional input parameters and the optimization of input parameters were identified to be the two main factors that contribute to the significant improvements in power quality control. Therefore, the proposed strategy effectively enhances the power quality of the utility grid, and such an enhancement contributes to the efficient and smooth integration of the PV system.	[Roslan, M. F.; Hannan, M. A.] Univ Tenaga Nas, Dept Elect Power Engn, Kajang, Selangor, Malaysia; [Al-Shetwi, Ali Q.; Ker, P. J.; Zuhdi, A. W. M.] Univ Tenaga Nas, Inst Sustainable Energy, Kajang, Selangor, Malaysia; [Al-Shetwi, Ali Q.] Fahad bin Sultan Univ, Dept Elect Engn, Tabuk, Saudi Arabia	Universiti Tenaga Nasional; Universiti Tenaga Nasional; Fahad Bin Sultan University	Roslan, MF (corresponding author), Univ Tenaga Nas, Dept Elect Power Engn, Kajang, Selangor, Malaysia.	Mfirdaus@uniten.edu.my	Roslan, Mohd Firdaus Bin/GXZ-5377-2022; Al-Shetwi, Ali Q./G-8887-2019; Mahmood Zuhdi, Ahmad Wafi/GLR-4283-2022; Hannan, M/O-8579-2019	Al-Shetwi, Ali Q./0000-0002-6581-9629; Mahmood Zuhdi, Ahmad Wafi/0000-0003-1884-0449; Hannan, M/0000-0001-8367-4112; Roslan, Mohd Firdaus/0000-0003-0984-4210	Ministry of Higher Education, Malaysia under Universiti Tenaga Nasional using grant [20190101LRGS]	Ministry of Higher Education, Malaysia under Universiti Tenaga Nasional using grant	This work was funded by the Ministry of Higher Education, Malaysia under Universiti Tenaga Nasional using grant no. 20190101LRGS.	Abd Ali J, 2016, MEASUREMENT, V78, P49, DOI 10.1016/j.measurement.2015.09.038; Abdolrasol MGM, 2016, J TEKNOL, V78, P77; Ahmed S., 2011, RENEW ENERG, V5, P116; Al-Masri HMK, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10103650; Al-Shetwi AQ, 2020, J CLEAN PROD, V253, DOI 10.1016/j.jclepro.2019.119831; Al-Shetwi AQ, 2018, SOL ENERGY, V159, P665, DOI 10.1016/j.solener.2017.11.027; Anjum W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228636; Annamraju A, 2019, PROT CONTR MOD POW, V4, DOI 10.1186/s41601-019-0144-2; [Anonymous], 2000, IEEE RECOMMENDED PRA, V2000; [Anonymous], 2006, PLOS CLIN TRIALS, V1, pe33, DOI 10.1371/journal.pctr.0010033; [Anonymous], 2010, CITROGRAPH, V1, P12, DOI DOI 10.1007/s13244-009-0008-9; Arafat MN, 2014, IEEE ENER CONV, P3964, DOI 10.1109/ECCE.2014.6953940; Ashabani SM, 2014, IEEE T POWER SYST, V29, P2257, DOI 10.1109/TPWRS.2014.2306016; Atiq J., 2017, INT J SIMUL SYST SCI, V17, DOI DOI 10.5013/IJSSST.A.17.41.45; Bandara K, 2012, RENEW ENERG, V37, P82, DOI 10.1016/j.renene.2011.05.036; Bao CL, 2014, IEEE T POWER ELECTR, V29, P1239, DOI 10.1109/TPEL.2013.2262378; Basilio JC, 2002, IEEE T EDUC, V45, P364, DOI 10.1109/TE.2002.804399; Besheer AH, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P693, DOI 10.1109/ICIT.2012.6210019; Chuang LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021036; Dai YX, 2016, IEEE ACCESS, V4, P7621, DOI 10.1109/ACCESS.2016.2619691; del Valle Y, 2008, IEEE T EVOLUT COMPUT, V12, P171, DOI 10.1109/TEVC.2007.896686; Dolara A, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8040558; Fahad S, 2018, INTL CONF POWER SYST, P2233, DOI 10.1109/POWERCON.2018.8602128; Farrokhabadi M, 2018, IEEE T POWER SYST, V33, P2301, DOI 10.1109/TPWRS.2017.2740163; Ghazvinian H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217634; Handoko Susatyo, 2015, Journal of Theoretical and Applied Information Technology, V73, P411; Hannan MA, 2018, RENEW SUST ENERG REV, V81, P1611, DOI 10.1016/j.rser.2017.05.240; Hannan MA, 2015, IEEE T IND APPL, V51, P4775, DOI 10.1109/TIA.2015.2455025; Hassan MA, 2011, IEEE T POWER ELECTR, V26, P755, DOI 10.1109/TPEL.2010.2100101; Hongbin Wu, 2009, 2009 International Conference on Power Electronics and Drive Systems (PEDS 2009), P1295, DOI 10.1109/PEDS.2009.5385758; Jin TT, 2010, CHIN CONT DECIS CONF, P3180, DOI 10.1109/CCDC.2010.5498629; Jumani TA, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8010111; Kakkar S, 2020, MEAS CONTROL-UK, V53, P551, DOI 10.1177/0020294019879171; Kapinus O. S. M, 2016, CRIMINOLOGY, V2; Mosaad MI, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101469; Mosalam HA, 2018, AIN SHAMS ENG J, V9, P2931, DOI 10.1016/j.asej.2018.10.001; Nammalvar P, 2018, ADV ELECTR COMPUT EN, V18, P105, DOI 10.4316/AECE.2018.01013; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Oshaba AS, 2017, NEURAL COMPUT APPL, V28, P651, DOI 10.1007/s00521-015-2091-9; Ping Y., 2014, IEEE PES ASIA PACIFI, P5; Rajesh P., 2017, INT J ENG TECHNOL, V9, P529, DOI [10.21817/ijet/2017/v9i3/170903S080, DOI 10.21817/IJET/2017/V9I3/170903S080]; Rizqiawan A, 2019, ENERGIES, V12, DOI 10.3390/en12030476; Selamat N. A., 2019, INT J RECENT TECHNOL, V8, P225, DOI [10.35940/ijrte.c1042.1083s219, DOI 10.35940/IJRTE.C1042.1083S219]; song LiJung Huang L., 2020, ENERGIES, P2020; Nguyen TH, 2017, ENERGIES, V10, DOI 10.3390/en10070907; Vinay Kumar M., 2019, J ADV RES DYN CONTRO, V11, P2979, DOI [10.35940/ijrte.D8937.118419, DOI 10.35940/IJRTE.D8937.118419]; Wang L, 2018, COMPUT ELECTRON AGR, V151, P349, DOI 10.1016/j.compag.2018.06.024; Yang ST, 2010, APPL POWER ELECT CO, P1002, DOI 10.1109/APEC.2010.5433380	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243581	10.1371/journal.pone.0243581	http://dx.doi.org/10.1371/journal.pone.0243581			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362200	Green Published, gold			2022-12-26	WOS:000603071600011
J	Dawit, M; Turbale, M; Moges, A; Amare, M				Dawit, Mulugeta; Turbale, Mahilet; Moges, Amsalu; Amare, Meareg			Poly(alizarin red S) modified glassy carbon electrode for square wave adsorptive stripping voltammetric determination of metronidazole in tablet formulation	PLOS ONE			English	Article							ELECTROCHEMICAL DETERMINATION; ANTIBIOTICS; ACID	Potentiodynamically fabricated poly(alizarin red s) modified GCE was characterized using CV and EIS techniques. In contrast to the cyclic voltammetric response of the unmodified GCE for metronidazole, an irreversible reduction peak with three-folds of current enhancement and reduced overpotential at the poly(alizarin red s) modified GCE showed the catalytic effect of the modifier towards reduction of metronidazole. While observed peak potential shift with increasing pH (4.0-10.0) indicated the involvement of protons during the reduction of metronidazole, peak potential shift with scan rate (20-300 mV s(-1)) confirmed the irreversibility of the reduction reaction of metronidazole at the modified GCE. A better correlation for the dependence of peak current on scan rate (r(2) = 0.9883) than on square root of scan rate (r(2) = 0.9740) supplemented by slope value of 0.38 for plot of log(current) versus log(scan rate) indicated the reduction reaction of metronidazole at the surface of the modified electrode was predominantly adsorption controlled. Under the optimized method and solution parameters, reductive current response of tablet sample showed linear dependence on spiked standard concentration in a wide range (0-125 mu M) with excellent determination coefficient r(2), LoD and LoQ of 0.9991, 0.38, and 1.25 mu M, respectively. Spike recovery of 97.9% and interference recovery of 96.2-97.5% in the presence of 21.28 and 31.92 mu M of uric acid and ascorbic acid validated the applicability of the present method for determination of metronidazole in tablet formulation. The metronidazole content of the tested tablet formulation using standard addition method was found to be 97.6% of what is claimed by the tablet manufacturer making the developed method an excellent potential candidate for its applicability to determine metronidazole in real samples with complex matrix.	[Dawit, Mulugeta] Debre Tabor Univ, Debra Tabor, Ethiopia; [Turbale, Mahilet] Samara Univ, Semera, Ethiopia; [Moges, Amsalu] Debre Markos Univ, Debre Markos, Ethiopia; [Amare, Meareg] Bahir Dar Univ, Bahir Dar, Ethiopia	Samara University; Bahir Dar University	Amare, M (corresponding author), Bahir Dar Univ, Bahir Dar, Ethiopia.	amaremeareg@yahoo.com	Amare, Meareg/ABD-5050-2020	Amare, Meareg/0000-0001-8817-9508				Amare M, 2020, J MATER RES TECHNOL, V9, P11484, DOI 10.1016/j.jmrt.2020.08.002; Amare M, 2019, INT J ANAL CHEM, V2019, DOI 10.1155/2019/6428072; Amare M, 2011, ANAL BIOANAL ELECTRO, V3, P365; Baikeli Y, 2020, J ELECTROCHEM SOC, V167, DOI 10.1149/1945-7111/ab9d94; Brett C. M. A., 1993, ELECTROCHEMISTRY PRI, DOI [10.1002/bbpc.19940981033., DOI 10.1002/BBPC.19940981033]; BURKE LD, 1984, J ELECTROANAL CHEM, V163, P117, DOI 10.1016/S0022-0728(84)80045-5; Cudmore SL, 2004, CLIN MICROBIOL REV, V17, P783, DOI 10.1128/CMR.17.4.783-793.2004; El-Ghobashy MR, 2010, J ADV RES, V1, P323, DOI 10.1016/j.jare.2010.06.001; Ezzeldin E, 2012, TROP J PHARM RES, V11, P799, DOI 10.4314/tjpr.v11i5.14; Filik H, 2017, FOOD ANAL METHOD, V10, P31, DOI 10.1007/s12161-016-0545-z; FREUND MS, 1992, J PHYS CHEM-US, V96, P9400, DOI 10.1021/j100202a062; Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400; HASEBE K, 1975, ANAL CHEM, V47, P2412, DOI 10.1021/ac60364a002; Hatefi-Mehrjardi A, 2014, ELECTROANAL, V26, P2491, DOI 10.1002/elan.201400302; Hern-ndez-JimOnez A, 2015, ELECTROANAL, V28, P704; HSUEH CC, 1993, ANAL CHEM, V65, P1570, DOI 10.1021/ac00059a015; Khanfar MF, 2019, INT J ELECTROCHEM SC, V14, P3265, DOI 10.20964/2019.04.43; Khashaba PY, 2017, ELECTROANAL, V29, P1643, DOI 10.1002/elan.201700078; Lin YY, 2012, TALANTA, V88, P646, DOI 10.1016/j.talanta.2011.11.053; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; MANOHARA YN, 2010, PHARM CHEM, V2, P148; Mathew JL, 2004, POSTGRAD MED J, V80, P196, DOI 10.1136/pgmj.2003.011973; Mohamed FA, 2019, COLLOID SURFACE A, V567, P76, DOI 10.1016/j.colsurfa.2019.01.033; Mumin Y, 2016, ANAL LETT, V49, P2716, DOI 10.1080/00032719.2016.1154569; Nikodimos Y, 2016, J ANAL METHODS CHEM, V2016, DOI 10.1155/2016/3612943; Ozkan SA, 1998, J PHARMACEUT BIOMED, V17, P299, DOI 10.1016/S0731-7085(97)00202-1; PENDLAND SL, 1994, ANTIMICROB AGENTS CH, V38, P2106, DOI 10.1128/AAC.38.9.2106; Roy PR, 2003, BIOELECTROCHEMISTRY, V59, P11, DOI 10.1016/S1567-5394(02)00156-1; Saffaj T, 2006, DYES PIGMENTS, V70, P259, DOI 10.1016/j.dyepig.2005.01.009; Siddiqui MR, 2017, ARAB J CHEM, V10, pS1409, DOI 10.1016/j.arabjc.2013.04.016; Wang W, 2006, BIOMEMS TECHNOLOGIES, P463; Wang Y, 2008, SENSORS-BASEL, V8, P2043, DOI 10.3390/s8042043; Wild GE, 2004, INFLAMM BOWEL DIS, V10, P321, DOI 10.1097/00054725-200405000-00022; Zhu MF, 2018, INT J ELECTROCHEM SC, V13, P4100, DOI 10.20964/2018.05.73	34	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244115	10.1371/journal.pone.0244115	http://dx.doi.org/10.1371/journal.pone.0244115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351825	gold, Green Published			2022-12-26	WOS:000603071400002
J	Perlasca, P; Frasca, M; Ba, CT; Gliozzo, J; Notaro, M; Pennacchioni, M; Valentini, G; Mesiti, M				Perlasca, Paolo; Frasca, Marco; Ba, Cheick Tidiane; Gliozzo, Jessica; Notaro, Marco; Pennacchioni, Mario; Valentini, Giorgio; Mesiti, Marco			Multi-resolution visualization and analysis of biomolecular networks through hierarchical community detection and web-based graphical tools	PLOS ONE			English	Article							NF-KAPPA-B; GENE ONTOLOGY; SPIKE PROTEIN; SARS-COV-2; CANCER; PREDICTION; PATHWAY; INFLAMMATION; INTEGRATION; MODULARITY	The visual exploration and analysis of biomolecular networks is of paramount importance for identifying hidden and complex interaction patterns among proteins. Although many tools have been proposed for this task, they are mainly focused on the query and visualization of a single protein with its neighborhood. The global exploration of the entire network and the interpretation of its underlying structure still remains difficult, mainly due to the excessively large size of the biomolecular networks. In this paper we propose a novel multi-resolution representation and exploration approach that exploits hierarchical community detection algorithms for the identification of communities occurring in biomolecular networks. The proposed graphical rendering combines two types of nodes (protein and communities) and three types of edges (protein-protein, community-community, protein-community), and displays communities at different resolutions, allowing the user to interactively zoom in and out from different levels of the hierarchy. Links among communities are shown in terms of relationships and functional correlations among the biomolecules they contain. This form of navigation can be also combined by the user with a vertex centric visualization for identifying the communities holding a target biomolecule. Since communities gather limited-size groups of correlated proteins, the visualization and exploration of complex and large networks becomes feasible on off-the-shelf computer machines. The proposed graphical exploration strategies have been implemented and integrated in UNIPred-Web, a web application that we recently introduced for combining the UNIPred algorithm, able to address both integration and protein function prediction in an imbalance-aware fashion, with an easy to use vertex-centric exploration of the integrated network. The tool has been deeply amended from different standpoints, including the prediction core algorithm. Several tests on networks of different size and connectivity have been conducted to show off the vast potential of our methodology; moreover, enrichment analyses have been performed to assess the biological meaningfulness of detected communities. Finally, a CoV-human network has been embedded in the system, and a corresponding case study presented, including the visualization and the prediction of human host proteins that potentially interact with SARS-CoV2 proteins.	[Perlasca, Paolo; Frasca, Marco; Ba, Cheick Tidiane; Notaro, Marco; Pennacchioni, Mario; Valentini, Giorgio; Mesiti, Marco] Univ Milan, Dept Comp Sci, AnacletoLab, Milan, Italy; [Gliozzo, Jessica] IRCCS San Raffaele Hosp, Neuroradiol Unit, Milan, Italy; [Valentini, Giorgio] CINI Natl Lab Artificial Intelligence & Intellige, Rome, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Mesiti, M (corresponding author), Univ Milan, Dept Comp Sci, AnacletoLab, Milan, Italy.	mesiti@di.unimi.it		PERLASCA, PAOLO/0000-0001-6674-2822; Gliozzo, Jessica/0000-0001-7629-8112; Valentini, Giorgio/0000-0002-5694-3919; Ba, Cheick Tidiane/0000-0002-4035-7464; Mesiti, Marco/0000-0001-5701-0080	University of Milano [PSR2019_DIP_010_GVALE]	University of Milano	This study was partially funded by University of Milano through the internal project "Machine Learning and Big Data Analysis for Bioinformatics" - PSR2019_DIP_010_GVALE.	Ahmed SS, 2020, BIORXIV, DOI [10.1101/2020.04.20.050138, DOI 10.1101/2020.04.20.050138]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashourvan A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215520; Athanasiadis EI, 2015, IEEE ACM T COMPUT BI, V12, P1213, DOI 10.1109/TCBB.2015.2424411; Auber D, 2005, NINTH INTERNATIONAL CONFERENCE ON INFORMATION VISUALISATION, PROCEEDINGS, P703, DOI 10.1109/IV.2005.65; Bertoni A, 2011, LECT NOTES ARTIF INT, V6911, P219, DOI 10.1007/978-3-642-23780-5_24; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Calderone A, 2013, NAT METHODS, V10, P690, DOI 10.1038/nmeth.2561; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2007, LECT NOTES COMPUT SC, V4503, P1; DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Eke I, 2015, SEMIN CANCER BIOL, V31, P65, DOI 10.1016/j.semcancer.2014.07.009; Elmqvist N, 2010, IEEE T VIS COMPUT GR, V16, P439, DOI 10.1109/TVCG.2009.84; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Franz M, 2018, NUCLEIC ACIDS RES, V46, pW60, DOI 10.1093/nar/gky311; Frasca M, 2017, NEUROCOMPUTING, V237, P397, DOI 10.1016/j.neucom.2015.11.096; Frasca M, 2015, J COMPUT BIOL, V22, P1057, DOI 10.1089/cmb.2014.0110; Frasca M, 2013, NEURAL NETWORKS, V43, P84, DOI 10.1016/j.neunet.2013.01.021; Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gliozzo J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60235-8; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grust T, 2002, P109; Herman I, 2000, IEEE T VIS COMPUT GR, V6, P24, DOI 10.1109/2945.841119; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046072; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Jankun J., 2020, TRANSLATION U TOLEDO, V7, P1, DOI 10.46570/utjms.vol7-2020-361; Jiang YX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1037-6; Kalathur RKR, 2014, NUCLEIC ACIDS RES, V42, pD408, DOI 10.1093/nar/gkt1100; Kernighan B.W., 1970, BELL SYST TECH J, V49, P291, DOI DOI 10.1002/J.1538-7305.1970.TB01770.X; Kimelman D, 1994, INT S GRAPH DRAW, P218; Kohler S, 2019, NUCLEIC ACIDS RES, V47, pD1018, DOI 10.1093/nar/gky1105; Koul Hari K, 2013, Genes Cancer, V4, P342, DOI 10.1177/1947601913507951; Krogan NJ, 2015, MOL CELL, V58, P690, DOI 10.1016/j.molcel.2015.05.008; List M, 2016, NUCLEIC ACIDS RES, V44, pW98, DOI 10.1093/nar/gkw373; Martinez-Limon A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21061913; Mege RM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028738; Mei Z, 2020, SIGNIFICANT EXPRESSI, DOI [10.1101/2020.04.18.047951, DOI 10.1101/2020.04.18.047951]; Mesiti M, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-5; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Munzner T, 2009, IEEE T VIS COMPUT GR, V15, P921, DOI 10.1109/TVCG.2009.111; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Nicot Christophe, 2015, J Cancer Sci, V2, DOI 10.13188/2377-9292.1000009; Noack A, 2009, LECT NOTES COMPUT SC, V5526, P257; Noubissi FK, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071442; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Ortega OO, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100748; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Paduano Francesco, 2015, BMC Proc, V9, pS4, DOI 10.1186/1753-6561-9-S6-S4; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pavlopoulos GA, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-12; Peiris M, 2008, PATHOGENESIS AVIAN F, P56; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Perlasca P, 2016, P INT C INF INT WEB, P489; Perlasca P, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2959-2; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qin L, 2016, MOL CLIN ONCOL, V5, P382, DOI 10.3892/mco.2016.989; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rahiminejad S, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2746-0; Renoust B, 2015, COMPUT GRAPH FORUM, V34, P321, DOI 10.1111/cgf.12644; Salazar GA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-129; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sedlmair M, 2012, IEEE T VIS COMPUT GR, V18, P2431, DOI 10.1109/TVCG.2012.213; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Skrlj B, 2019, J INTELL INF SYST, V53, P265, DOI 10.1007/s10844-019-00545-0; Strochlic L, 2008, DEVELOPMENT, V135, P333, DOI 10.1242/dev.009563; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Traag VA, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032801; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1; Wong AK, 2015, NUCLEIC ACIDS RES, V43, pW128, DOI 10.1093/nar/gkv486; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Zhou NH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1835-8	84	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244241	10.1371/journal.pone.0244241	http://dx.doi.org/10.1371/journal.pone.0244241			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351828	Green Published, gold			2022-12-26	WOS:000603071400024
J	Mostafa, A; Sabry, W; Mostafa, NS				Mostafa, Aya; Sabry, Walaa; Mostafa, Nayera S.			COVID-19-related stigmatization among a sample of Egyptian healthcare workers	PLOS ONE			English	Article							HIV STIGMA; SARS; DISCRIMINATION; IMPACT	Objectives To explore coronavirus disease 2019 (COVID-19)-related stigma and its associated factors among Egyptian physicians. Methods A cross-sectional study using an anonymous online questionnaire was conducted from 7 to 21 June 2020. The survey was distributed via social media and email to physicians working in Egypt through convenience sampling. Results 509 physicians participated in the study (mean age: 41.510.2). 138 (27.1%) participants were directly involved in the care of COVID-19 patients. 159 (31.2%) participants reported severe level of COVID-19-related stigma. Participants' mean overall COVID-19-related stigma score was 40.6 +/- 8.0. The mean subscale scores were: personalized stigma 26.0 +/- 5.7, disclosure concerns 9.3 +/- 2.2, negative self-image 6.9 +/- 1.6, and concern with public attitudes 24.4 +/- 4.9. In the multivariable regression analyses, the overall COVID-19-related stigma score was higher in participants with lower qualifications (beta = -0.19, 95% CI: 2.32, -0.64, p = 0.001), and in those working in a quarantine hospital (beta = 0.08, 95% CI: 0.01, 7.14, p = 0.050). Conclusions A considerable proportion of Egyptian physicians in this exploratory study experienced COVID-19-related stigmatization. These preliminary findings highlight the need for specific research and targeted interventions particularly addressing COVID-19-related stigmatization among healthcare workers.	[Mostafa, Aya; Mostafa, Nayera S.] Ain Shams Univ, Fac Med, Dept Commun Environm & Occupat Med, Cairo, Egypt; [Sabry, Walaa] Ain Shams Univ, Fac Med, Inst Psychiat, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	Mostafa, NS (corresponding author), Ain Shams Univ, Fac Med, Dept Commun Environm & Occupat Med, Cairo, Egypt.	nayera_samy@med.asu.edu.eg	Sabry, Walaa/AFC-4348-2022; Sabry, Walaa/AAV-8887-2021; Mostafa, Aya/X-6686-2019	Sabry, Walaa/0000-0002-7361-5941; Sabry, Walaa/0000-0002-7361-5941; Mostafa, Aya/0000-0002-2803-2608; mostafa, nayera/0000-0002-4065-3685				Almutairi AF, 2018, J INFECT PUBLIC HEAL, V11, P187, DOI 10.1016/j.jiph.2017.06.011; [Anonymous], 2020, AL MONITOR; [Anonymous], 2020, JAKARTA POST; [Anonymous], 2020, TIMES INDIA; [Anonymous], 2020, NY TIMES; [Anonymous], 2020, GUARDIAN 1026; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Brooks S.K., 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8,10227, 10.1016/S0140-6736]; Charles B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-463; Di Fabio A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01938; Earnshaw VA, 2013, AM PSYCHOL, V68, P225, DOI 10.1037/a0032705; Fischer LS, 2019, DISASTER MED PUBLIC, V13, P989, DOI 10.1017/dmp.2018.157; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Holzemer WL, 2009, SAHARA J-J SOC ASP H, V6, P76, DOI 10.1080/17290376.2009.9724933; Johns Hopkins University, 2020, COVID 19 DASHB CTR S; Li ZJ, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0685-6; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pulerwitz J, 2015, AIDS BEHAV, V19, P246, DOI 10.1007/s10461-014-0935-4; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; Ransing R, 2020, BRAIN BEHAV IMMUN, V89, P555, DOI 10.1016/j.bbi.2020.07.033; Rao D, 2012, AIDS PATIENT CARE ST, V26, P614, DOI 10.1089/apc.2012.0106; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Singh R, 2020, ASIAN J PSYCHIAT, V53, P102222, DOI [10.1016/j.ajp.2020.102222, DOI 10.1016/J.AJP.2020.10222232570096]; Siu JYM, 2008, QUAL HEALTH RES, V18, P729, DOI 10.1177/1049732308318372; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; STANGL AL, 2013, J INT AIDS SOC S2, V0016, DOI DOI 10.7448/IAS.16.3.1873424242268; Stangl AL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1271-3; Verma S, 2004, ANN ACAD MED SINGAP, V33, P743; World Health Organization, 2020, DIR GEN OP REM MED B; World Health Organization (WHO), 2020, HLTH TOP COR; Youm7, 2020, MEMB EG PHYS SYND DE; Zelaya CE, 2012, AIDS CARE, V24, P846, DOI 10.1080/09540121.2011.647674	36	47	47	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244172	10.1371/journal.pone.0244172	http://dx.doi.org/10.1371/journal.pone.0244172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338064	Green Published, gold			2022-12-26	WOS:000601313500012
J	Kamgang, VW; Bennett, NC; Hart, DW; van der Goot, AC; Ganswindt, A				Kamgang, Vanessa W.; Bennett, Nigel C.; Hart, Daniel W.; van der Goot, Annemieke C.; Ganswindt, Andre			Reproductive events and respective faecal androgen metabolite concentrations in captive male roan antelope (Hippotragus equinus)	PLOS ONE			English	Article							TESTOSTERONE LEVELS; AFRICAN ELEPHANTS; SEASONAL-CHANGES; BEHAVIOR; ENDOCRINE; PATTERNS; EXCRETION; CYCLE; PARK; PHOTOPERIOD	Understanding the reproductive biology of the roan antelope (Hippotragus equinus) (e. Geoffroy Saint-Hilaire, 1803) is crucial to optimise breeding success in captive breeding programmes of this threatened species. In this study, the pattern of faecal androgen metabolite (fAM) production related to reproductive events (calving or birthing, mating, gestation, and lactation), sexual behaviours as well as environmental cues were studied in captive adult male roan antelope. Faecal sample collection and behavioural observations were carried out from August 2017 to July 2018 for three reproductive males participating in a conservation breeding programme at the Lapalala Wilderness Nature Reserve in South Africa. As a prerequisite, the enzyme immunoassay used in this study was biologically validated for the species by demonstrating a significant difference between fAM concentrations in non-breeding adults, breeding adults and juvenile males. Results revealed that in adults males, the overall mean fAM levels were 73% higher during the breeding period compared to the non-breeding periods, and 85% higher when exclusively compared to the lactation/gestation periods, but only 5.3% higher when compared to the birthing period. Simultaneously, fAM concentrations were lower during the wet season compared to the dry season, increasing with a reduction in photoperiod. With the exception of courtship, frequencies of sexual behaviours monitored changed in accordance with individual mean fAM concentrations in male roan antelope, the findings suggest that androgen production varies with the occurrence of mating activity and may be influenced by photoperiod but not with rainfall.	[Kamgang, Vanessa W.; Bennett, Nigel C.; Ganswindt, Andre] Univ Pretoria, Mammal Res Inst, Pretoria, South Africa; [Hart, Daniel W.] Univ Pretoria, Dept Zool & Entomol, Pretoria, South Africa; [van der Goot, Annemieke C.] Lapalala Wilderness Nat Reserve, Melkrevier, Limpopo, South Africa	University of Pretoria; University of Pretoria	Kamgang, VW (corresponding author), Univ Pretoria, Mammal Res Inst, Pretoria, South Africa.	vanessa.wandja@gmail.com	; Ganswindt, Andre/G-9856-2014	wandja kamgang, Vanessa/0000-0001-8837-2113; Ganswindt, Andre/0000-0002-1474-7602	DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology [64756]; DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology	DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology; DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology	This work was supported by a DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology attributed to NCB (Grant number 64756), and a bursary provided by the DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology to VWK.	ALMEIDA OFX, 1982, BIOL REPROD, V27, P1062, DOI 10.1095/biolreprod27.5.1062; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; ASCHOFF J, 1978, NATURWISSENSCHAFTEN, V65, P80, DOI 10.1007/BF00440545; Bales KL, 2006, HORM BEHAV, V49, P88, DOI 10.1016/j.yhbeh.2005.05.006; Brockman DK, 2001, BEHAV ECOL SOCIOBIOL, V49, P117, DOI 10.1007/s002650000287; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; BROWN JL, 1991, J REPROD FERTIL, V93, P497; BROWN JL, 1991, J REPROD FERTIL, V92, P47, DOI 10.1530/jrf.0.0920047; Burgess EA, 2012, REPRODUCTION, V143, P683, DOI 10.1530/REP-11-0434; Chan JPW, 2009, THERIOGENOLOGY, V71, P1156, DOI 10.1016/j.theriogenology.2008.12.007; Charlier TD, 2013, GEN COMP ENDOCR, V190, P24, DOI 10.1016/j.ygcen.2013.03.003; Comizzoli P, 2019, BIOL REPROD, V101, P514, DOI 10.1093/biolre/ioz031; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Delgadillo JA, 2004, REPROD NUTR DEV, V44, P183, DOI 10.1051/rnd:2004024; Duncan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051490; FAIRALL N, 1972, Zoologica Africana, V7, P167; Fiess M, 1999, GEN COMP ENDOCR, V115, P76, DOI 10.1006/gcen.1999.7287; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Girard-Buttoz C, 2009, PHYSIOL BEHAV, V98, P168, DOI 10.1016/j.physbeh.2009.05.005; Grant C. C., 2002, Koedoe, V45, P45; Group ISAS, 2017, HIPP EQ; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Havemann CP, 2016, MAMMAL REV, V46, P144, DOI 10.1111/mam.12061; Hodges Keith, 2010, P447; Hull EM, 2017, HORMONES, BRAIN AND BEHAVIOR, VOL 1: MAMMALIAN HORMONE-BEHAVIOR SYSTEMS, 3RD EDITION, P1, DOI 10.1016/B978-0-12-803592-4.00001-8; Hunter P, 2007, EMBO REP, V8, P316, DOI 10.1038/sj.embor.7400951; IUCN, IUCN RED LIST THREAT; Joubert S.C.J., 1970, THESIS; Joubert SCJ., 1976, THESIS; Kersey DC, 2015, ZOO BIOL, V34, P183, DOI 10.1002/zoo.21199; Khonmee J, 2014, ANIM REPROD SCI, V146, P70, DOI 10.1016/j.anireprosci.2014.02.008; Kindahl H, 2002, DOMEST ANIM ENDOCRIN, V23, P321, DOI 10.1016/S0739-7240(02)00167-4; Kingdom J, 2013, MAMMALS AFRICA, P544; Kretzschmar P, 2004, HORM BEHAV, V45, P1, DOI 10.1016/j.yhbeh.2003.08.001; Kupika O.L., 2017, SELECTED STUDIES BIO; Leus K, 2011, ZOOL MIDDLE EAST, P151; LINCOLN GA, 1977, J REPROD FERTIL, V49, P267, DOI 10.1530/jrf.0.0490267; Loeding E, 2011, J APPL ANIM WELF SCI, V14, P220, DOI 10.1080/10888705.2011.576968; Mauget R, 2007, MAMM BIOL, V72, P14, DOI 10.1016/j.mambio.2006.04.005; Mccoy JC, 2012, WILDLIFE SOC B, V36, P641, DOI 10.1002/wsb.190; Medger K, 2012, J ZOOL, V286, P243, DOI 10.1111/j.1469-7998.2011.00872.x; Midgley GF, 2011, REG ENVIRON CHANGE, V11, pS127, DOI 10.1007/s10113-010-0191-8; Mooring MS, 2004, HORM BEHAV, V46, P392, DOI 10.1016/j.yhbeh.2004.03.008; Mosase E, 2018, WATER-SUI, V10, DOI 10.3390/w10040364; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu JO, 2014, WILDLIFE RES, V41, P323, DOI 10.1071/WR13211; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Patton ML, 2001, ZOO BIOL, V20, P375, DOI 10.1002/zoo.1036; Pelletier F, 2003, CAN J ZOOL, V81, P1678, DOI 10.1139/Z03-156; Pereira RJG, 2005, THERIOGENOLOGY, V63, P2113, DOI 10.1016/j.theriogenology.2004.08.014; Preston BT, 2012, J ANIM ECOL, V81, P296, DOI 10.1111/j.1365-2656.2011.01907.x; RAHBEK C, 1993, BIODIVERS CONSERV, V2, P426, DOI 10.1007/BF00114044; Rajagopal T, 2018, INDIAN J EXP BIOL, V56, P781; Ralls K., 2013, ENCY BIODIVERSITY, V1, P662, DOI DOI 10.1016/B978-0-12-384719-5.00268-9; Rasmussen HB, 2008, HORM BEHAV, V54, P539, DOI 10.1016/j.yhbeh.2008.05.008; Rodrigues, 2015, RES REV J ZOOLOGICAL, V4, P43; Santymire RM, 2016, J ZOO AQUAR RES, V4, P30; Scheun J, 2017, J ZOOL, V301, P263, DOI 10.1111/jzo.12420; Schradin C, 2008, HORM BEHAV, V53, P573, DOI 10.1016/j.yhbeh.2008.01.003; Schwarzenberger F, 2013, WIEN TIERARZTL MONAT, V100, P209; Seeber PA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0396; Skinner JD, 2005, THE MAMMALS OF THE S; SPINAGE C A, 1973, Mammal Review, V3, P71, DOI 10.1111/j.1365-2907.1973.tb00174.x; Thitaram C., 2009, THESIS; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Ungerfeld R., 2012, LIVESTOCK REPROD BOV; Ververs C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187751; Walton JC, 2011, FRONT NEUROENDOCRIN, V32, P303, DOI 10.1016/j.yfrne.2010.12.003; Weems PW, 2015, FRONT NEUROENDOCRIN, V37, P43, DOI 10.1016/j.yfrne.2014.12.002; Weinbauer GF, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P11, DOI 10.1007/978-3-540-78355-8_2; Wilson D. E., 1977, WILDLIFE MONOGR, V54, P3; Wolf TE, 2018, GEN COMP ENDOCR, V255, P19, DOI 10.1016/j.ygcen.2017.09.028; Zarazaga LA, 2010, SMALL RUMINANT RES, V93, P110, DOI 10.1016/j.smallrumres.2010.05.008; Zerbe P, 2012, BIOL REV, V87, P965, DOI 10.1111/j.1469-185X.2012.00238.x; Zhang GQ, 2004, ZOO BIOL, V23, P15, DOI 10.1002/zoo.10118	79	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243277	10.1371/journal.pone.0243277	http://dx.doi.org/10.1371/journal.pone.0243277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332371	Green Published, gold			2022-12-26	WOS:000601310900031
J	Wieczorek, M; Silka, J; Polap, D; Wozniak, M; Damasevicius, R				Wieczorek, Michal; Silka, Jakub; Polap, Dawid; Wozniak, Marcin; Damasevicius, Robertas			Real-time neural network based predictor for cov19 virus spread	PLOS ONE			English	Article								Since the epidemic outbreak in early months of 2020 the spread of COVID-19 has grown rapidly in most countries and regions across the World. Because of that, SARS-CoV-2 was declared as a Public Health Emergency of International Concern (PHEIC) on January 30, 2020, by The World Health Organization (WHO). That's why many scientists are working on new methods to reduce further growth of new cases and, by intelligent patients allocation, reduce number of patients per doctor, what can lead to more successful treatments. However to properly manage the COVID-19 spread there is a need for real-time prediction models which can reliably support various decisions both at national and international level. The problem in developing such system is the lack of general knowledge how the virus spreads and what would be the number of cases each day. Therefore prediction model must be able to conclude the situation from past data in the way that results will show a future trend and will possibly closely relate to the real numbers. In our opinion Artificial Intelligence gives a possibility to do it. In this article we present a model which can work as a part of an online system as a real-time predictor to help in estimation of COVID-19 spread. This prediction model is developed using Artificial Neural Networks (ANN) to estimate the future situation by the use of geo-location and numerical data from past 2 weeks. The results of our model are confirmed by comparing them with real data and, during our research the model was correctly predicting the trend and very closely matching the numbers of new cases in each day.	[Wieczorek, Michal; Silka, Jakub; Polap, Dawid; Wozniak, Marcin] Silesian Tech Univ, Fac Appl Math, Gliwice, Poland; [Damasevicius, Robertas] Vytautas Magnus Univ, Dept Appl Informat, Kaunas, Lithuania	Silesian University of Technology; Vytautas Magnus University	Wieczorek, M (corresponding author), Silesian Tech Univ, Fac Appl Math, Gliwice, Poland.	michal_wieczorek@hotmail.com	Połap, Dawid/D-1547-2017; Wieczorek, Michał/AAC-7230-2021; Damaševičius, Robertas/E-1387-2017; Wozniak, Marcin/L-6640-2013	Połap, Dawid/0000-0003-1972-5979; Wieczorek, Michał/0000-0002-5319-3366; Damaševičius, Robertas/0000-0001-9990-1084; Wozniak, Marcin/0000-0002-9073-5347; Silka, Jakub/0000-0001-9133-4388	Polish Ministry of Science and Higher Education [MNiSW/2020/43/DIR/NN4]; Silesian University of Technology under program "Initiative of Excellence-Research University" [08/IDUB/2019/84]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Silesian University of Technology under program "Initiative of Excellence-Research University"	This study was supported by the Polish Ministry of Science and Higher Education under grant no. MNiSW/2020/43/DIR/NN4.; Authors would like to acknowledge contribution to this project from the Rector of the Silesian University of Technology under program "Initiative of Excellence-Research University" grant no. 08/IDUB/2019/84.	Al-Waeli AHA, 2020, RENEW ENERG, V145, P963, DOI 10.1016/j.renene.2019.06.099; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Bertozzi AL, 2020, P NATL ACAD SCI USA, V117, P16732, DOI 10.1073/pnas.2006520117; Bogard N, 2019, CELL, V178, P91, DOI 10.1016/j.cell.2019.04.046; Choudhury A, 2019, ADV INTELL SYST COMP, V740, P67, DOI 10.1007/978-981-13-1280-9_6; Daoud M, 2019, ARTIF INTELL MED; Das A, 2019, FUTURE GENER COMP SY, V93, P486, DOI 10.1016/j.future.2018.10.050; Elmousalami HH., 2020, ARXIV200307778; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; Ganggayah MD, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0801-4; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Gupta R, 2021, INDIAN J SURG, V83, P338, DOI 10.1007/s12262-020-02368-8; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922; Kaji DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211057; King DB, 2015, ACS SYM SER, V1214, P1; Li LX, 2020, INFECT DIS MODEL, V5, P282, DOI 10.1016/j.idm.2020.03.002; Liao YH, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081866; Lin K, 2019, INT J MED INFORM, V125, P55, DOI 10.1016/j.ijmedinf.2019.02.002; Maragatham G, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1243-3; Pandey G, 2020, ARXIV200400958; Pathak Y, 2020, IRBM; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Reddy BK, 2019, HEALTH INFORM J, V25, P1201, DOI 10.1177/1460458217751015; Ren YF, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0765-4; Sanderson M, 2020, J AFFECT DISORDERS, V264, P107, DOI 10.1016/j.jad.2019.12.024; Sayeed A, 2020, NEURAL NETWORKS, V121, P396, DOI 10.1016/j.neunet.2019.09.033; Singh D, 2020, EUR J CLIN MICROBIOL, V39, P1379, DOI 10.1007/s10096-020-03901-z; Singh G, 2020, NEURAL COMPUT APPL, V32, P12417, DOI 10.1007/s00521-019-04695-8; Vasquez-Morales GR, 2019, IEEE ACCESS, V7, P152900, DOI 10.1109/ACCESS.2019.2948430; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhang XL, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109829	32	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243189	10.1371/journal.pone.0243189	http://dx.doi.org/10.1371/journal.pone.0243189			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332363	Green Published, gold			2022-12-26	WOS:000601310900078
J	Liu, LF; Liu, C; Zhao, MY; Zhang, QR; Lu, Y; Liu, P; Yang, H; Yang, JL; Chen, XX; Yao, YQ				Liu, Linfu; Liu, Chuang; Zhao, Manyu; Zhang, Qianru; Lu, Ying; Liu, Ping; Yang, Hua; Yang, Jinliang; Chen, Xiaoxin; Yao, Yuqin			The pharmacodynamic and differential gene expression analysis of PPAR alpha/delta agonist GFT505 in CDAHFD-induced NASH model	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; METHIONINE; CHOLINE; DEFICIENT; FIBROSIS; ALPHA; IMPACT; DELTA; DIET	Peroxisome proliferator-activated receptor alpha/delta (PPAR alpha/delta), regulating glucolipid metabolism and immune inflammation, has been identified as an effective therapeutic target in non-alcoholic steatohepatitis (NASH). Dual PPAR alpha/delta agonist, such as GFT505 (also known as elafibranor), demonstrated potential therapeutic effect for NASH in clinical trials. To profile the regulatory network of PPAR alpha/delta agonist in NASH, the choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) induced NASH model was used to test the pharmacodynamics and transcriptome regulation of GFT505 in this study. The results showed that GFT505 ameliorated hepatic steatosis, inflammation and fibrosis in CDAHFD mice model. RNA-sequencing yielded 3995 up-regulated and 3576 down-regulated genes with GFT505 treatment. And the most significant differentialy expressed genes involved in glucolipid metabolism (Ppar alpha, Acox1, Cpt1b, Fabp4, Ehhadh, Fabp3), inflammation (Ccl6, Ccl9, Cxcl14) and fibrosis (Timp1, Lamc3, Timp2, Col3a1, Col1a2, Col1a1, Hapln4, Timp3, Pik3r5, Pdgf alpha, Pdgf beta, Tgf beta 1, Tgf beta 2) were confirmed by RT-qPCR. The down-regulated genes were enriched in cytokine-cytokine receptor interaction pathway and ECM-receptor interaction pathway, while the up-regulated genes were enriched in PPAR signaling pathway and fatty acid degradation pathway. This study provides clues and basis for further understanding on the mechanism of PPAR alpha/delta agonist on NASH.	[Liu, Linfu; Liu, Chuang; Zhao, Manyu; Yang, Hua; Yao, Yuqin] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China; [Liu, Linfu; Liu, Chuang; Zhao, Manyu; Yang, Hua; Yao, Yuqin] Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China; [Liu, Linfu; Liu, Chuang; Zhang, Qianru; Lu, Ying; Yang, Jinliang; Yao, Yuqin] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Liu, Linfu; Liu, Chuang; Zhang, Qianru; Lu, Ying; Yang, Jinliang; Yao, Yuqin] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China; [Zhang, Qianru; Chen, Xiaoxin] Guangdong Zhongsheng Pharmaceut Co Ltd, Guangzhou, Guangdong, Peoples R China; [Liu, Ping; Yang, Jinliang; Chen, Xiaoxin] Sichuan Univ, West China Hosp 2, Dept Gynecol & Obstet, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Yao, YQ (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China.; Yao, YQ (corresponding author), Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China.; Yao, YQ (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China.; Yao, YQ (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China.; Chen, XX (corresponding author), Guangdong Zhongsheng Pharmaceut Co Ltd, Guangzhou, Guangdong, Peoples R China.; Chen, XX (corresponding author), Sichuan Univ, West China Hosp 2, Dept Gynecol & Obstet, Chengdu, Sichuan, Peoples R China.	chenzhenyu2000@zspcl.com; yuqin_yao@scu.edu.cn			National Major Scientific and Technological Special Project [2018ZX09201002, 2018ZX09711001-011, 2019ZX09201001]; National Science Foundation of China [81773375]	National Major Scientific and Technological Special Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Major Scientific and Technological Special Project (Nos. 2018ZX09201002, 2018ZX09711001-011 and 2019ZX09201001) and the National Science Foundation of China (No. 81773375). The authors thank the research platform provided by Public Health and Preventive Medicine Provincial Experiment Teaching Center at Sichuan University.	Agarwal N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13835-w; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; Cariou B, 2013, DIABETES CARE, V36, P2923, DOI 10.2337/dc12-2012; Cariou B, 2011, DIABETES CARE, V34, P2008, DOI 10.2337/dc11-0093; Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877; Fan JG, 2013, J GASTROEN HEPATOL, V28, P81, DOI 10.1111/jgh.12244; Farrell GC, 2018, ADV EXP MED BIOL, V1061, P19, DOI 10.1007/978-981-10-8684-7_3; Gao B, 2019, J HEPATOL, V70, P249, DOI 10.1016/j.jhep.2018.10.023; HF H, 2017, BIOCH CELL BIO, V95, P400; Jeong H, 2018, AM J CHINESE MED, V46, P1581, DOI 10.1142/S0192415X18500817; Li MH, 2019, J PHARMACOL EXP THER, V369, P67, DOI 10.1124/jpet.118.255216; Liu XJ, 2018, LAB INVEST, V98, P1184, DOI 10.1038/s41374-018-0074-z; Makled MN, 2019, N-S ARCH PHARMACOL, V392, P1569, DOI 10.1007/s00210-019-01703-5; Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Naito Y, 2020, AM J PHYSIOL-RENAL, V318, pF238, DOI 10.1152/ajprenal.00313.2019; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Qin SM, 2016, LIPIDS, V51, P797, DOI 10.1007/s11745-016-4160-y; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rodriguez MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4834-3; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Seelige R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32011-2; Song HZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149670; Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; YU JY, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11111020; Zhong F, 2020, DIGESTION, V101, P522, DOI 10.1159/000501851	32	8	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243911	10.1371/journal.pone.0243911	http://dx.doi.org/10.1371/journal.pone.0243911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326461	gold, Green Published			2022-12-26	WOS:000600176400027
J	Thorson, JLM; Beck, D; Ben Maamar, M; Nilsson, EE; McBirney, M; Skinner, MK				Thorson, Jennifer L. M.; Beck, Daniel; Ben Maamar, Millissia; Nilsson, Eric E.; McBirney, Margaux; Skinner, Michael K.			Epigenome-wide association study for atrazine induced transgenerational DNA methylation and histone retention sperm epigenetic biomarkers for disease	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; EXPOSURE; OBESITY; CHEMICALS; INHERITANCE; PACKAGE; GENES	Atrazine is a common agricultural herbicide previously shown to promote epigenetic transgenerational inheritance of disease to subsequent generations. The current study was designed as an epigenome-wide association study (EWAS) to identify transgenerational sperm disease associated differential DNA methylation regions (DMRs) and differential histone retention regions (DHRs). Gestating female F0 generation rats were transiently exposed to atrazine during the period of embryonic gonadal sex determination, and then subsequent F1, F2, and F3 generations obtained in the absence of any continued exposure. The transgenerational F3 generation males were assessed for disease and sperm collected for epigenetic analysis. Pathology was observed in pubertal onset and for testis disease, prostate disease, kidney disease, lean pathology, and multiple disease. For these pathologies, sufficient numbers of individual males with only a single specific disease were identified. The sperm DNA and chromatin were isolated from adult one-year animals with the specific diseases and analyzed for DMRs with methylated DNA immunoprecipitation (MeDIP) sequencing and DHRs with histone chromatin immunoprecipitation (ChIP) sequencing. Transgenerational F3 generation males with or without disease were compared to identify the disease specific epimutation biomarkers. All pathologies were found to have disease specific DMRs and DHRs which were found to predominantly be distinct for each disease. No common DMRs or DHRs were found among all the pathologies. Epimutation gene associations were identified and found to correlate to previously known disease linked genes. This is one of the first observations of potential sperm disease biomarkers for histone retention sites. Although further studies with expanded animal numbers are required, the current study provides evidence the EWAS analysis is effective for the identification of potential pathology epimutation biomarkers for disease susceptibility.	[Thorson, Jennifer L. M.; Beck, Daniel; Ben Maamar, Millissia; Nilsson, Eric E.; McBirney, Margaux; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Ben Maamar, Millissia/D-8094-2015	Ben Maamar, Millissia/0000-0002-2022-922X; Nilsson, Eric/0000-0001-8894-4054	John Templeton Foundation [50183, 61174]; NIH [ES012974]	John Templeton Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by John Templeton Foundation (50183 and 61174) (https://templeton.org/) grants to MKS and NIH (ES012974) (https://www.nih.gov/) grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2019, PROG RETIN EYE RES; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2018, DIAB PRAKT, V4, P1, DOI DOI 10.1186/s40798-017-0116-x; Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barakat R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62584-w; Ben Maamar M, 2020, GLYPHOSATE INDUCED T; Ben Maamar M, 2020, DEV BIOL, V465, P31, DOI 10.1016/j.ydbio.2020.06.008; Ben Maamar M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23612-y; Bock C, 2009, EPIGENOMICS-UK, V1, P99, DOI 10.2217/EPI.09.6; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braun JM, 2017, NAT REV ENDOCRINOL, V13, P161, DOI 10.1038/nrendo.2016.186; Brehm E, 2019, ENDOCRINOLOGY, V160, P1421, DOI 10.1210/en.2019-00034; Bretz F, 2005, METHOD INFORM MED, V44, P431; Calvin H I, 1976, Methods Cell Biol, V13, P85, DOI 10.1016/S0091-679X(08)61798-7; Casati L, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00037; Cleary JA, 2019, ENVIRON POLLUT, V251, P639, DOI 10.1016/j.envpol.2019.05.013; Cummings AM, 2000, TOXICOL SCI, V58, P135, DOI 10.1093/toxsci/58.1.135; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davis LK, 2011, REPROD TOXICOL, V32, P43, DOI 10.1016/j.reprotox.2011.04.004; Devlin B, 2003, GENET EPIDEMIOL, V25, P36, DOI 10.1002/gepi.10237; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eldridge JC, 2008, REV ENVIRON CONTAM T, V196, P147, DOI 10.1007/978-0-387-78444-1_6; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Fudvoye J, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.101300; Gillette R, 2018, EPIGENETICS-US, V13, P1106, DOI 10.1080/15592294.2018.1543506; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; GUSTAFSSON P., 2012, PLOS ONE, V7, P1; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Heindel JJ, 2019, ANNU REV PHARMACOL, V59, P89, DOI 10.1146/annurev-pharmtox-010818-021304; Higdon R, 2008, BIOINFORMATICS, V24, P1225, DOI 10.1093/bioinformatics/btn120; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Howard SG, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00513; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUANG TTF, 1985, AM J ANAT, V174, P249, DOI 10.1002/aja.1001740307; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jowa L, 2011, J ENVIRON SCI HEAL C, V29, P91, DOI 10.1080/10590501.2011.577681; Jung SH, 2010, METHODS MOL BIOL, V620, P203, DOI 10.1007/978-1-60761-580-4_5; Kabir ER, 2015, ENVIRON TOXICOL PHAR, V40, P241, DOI 10.1016/j.etap.2015.06.009; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lin ZM, 2013, TOXICOL APPL PHARM, V273, P140, DOI 10.1016/j.taap.2013.08.010; Lin ZM, 2013, NEUROTOXICOL TERATOL, V39, P26, DOI 10.1016/j.ntt.2013.06.002; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Martini M, 2020, HORM BEHAV, V119, DOI 10.1016/j.yhbeh.2020.104677; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McBirney M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184306; Mennigen JA, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0362-5; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morris DL, 2016, TRANSL RES, V172, P1, DOI 10.1016/j.trsl.2016.02.010; Namulanda G, 2017, ENVIRON RES, V156, P420, DOI 10.1016/j.envres.2017.04.004; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-38; Official Publication of Joint Commission Requirements, 2017, JT COMM PERSPECT, V37, P3; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Rattan S, 2019, BIOL REPROD, V101, P635, DOI 10.1093/biolre/ioz081; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saalfeld GQ, 2019, ENVIRON SCI POLLUT R, V26, P34953, DOI 10.1007/s11356-019-06577-x; Sanchez OF, 2020, ENVIRON POLLUT, V258, DOI 10.1016/j.envpol.2019.113712; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0178-0; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Solomon KR, 2013, ENVIRON TOXICOL CHEM, V32, P10, DOI 10.1002/etc.2050; Stone WW, 2014, WATERSHED REGRESSION; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Taylor JA, 2011, J STEROID BIOCHEM, V127, P83, DOI 10.1016/j.jsbmb.2011.07.005; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; UGAZIO G, 1991, RES COMMUN CHEM PATH, V74, P349; van Steenwyk G, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy023; Wang DD, 2019, CELL MOL NEUROBIOL, V39, P1003, DOI 10.1007/s10571-019-00695-3; Winston JJ, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0161-9; Xie F, 2012, CELL PHYSIOL BIOCHEM, V29, P111, DOI 10.1159/000337592; Xin F, 2015, SEMIN CELL DEV BIOL, V43, P66, DOI 10.1016/j.semcdb.2015.05.008; Yang HU, 2007, BIOINFORMATICS, V23, P38, DOI 10.1093/bioinformatics/btl548; Yilmaz B, 2020, REV ENDOCR METAB DIS, V21, P127, DOI 10.1007/s11154-019-09521-z; 2010, SLUZBENI GLASNIK RS, V5, P1	86	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0239380	10.1371/journal.pone.0239380	http://dx.doi.org/10.1371/journal.pone.0239380			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326428	gold, Green Published			2022-12-26	WOS:000600176400009
J	Rodriguez, DM; Ryff, K; Sanchez-Gonzalez, L; Rivera-Amill, V; Paz-Bailey, G; Adams, L				Rodriguez, Dania M.; Ryff, Kyle; Sanchez-Gonzalez, Liliana; Rivera-Amill, Vanessa; Paz-Bailey, Gabriela; Adams, Laura			HTrack: A new tool to facilitate public health field visits and electronic data capture	PLOS ONE			English	Article								Many applications have been developed for electronic data collection. However, offline field navigation tools incorporating secure electronic data capture and field visit tracking are currently scarce. We created an R-Shiny application, HTrack (Household Tracking), for use on encrypted Android devices in the field. The application was implemented in the Communities Organized to Prevent Arboviruses (COPA) project, a study beginning in 2018 to better understand arboviral disease incidence in 38 communities in Puerto Rico. The application was used to navigate to randomly selected structures and capture visit outcomes after conducting multiple visits for participant recruitment. It also served as a bridge to an alternate software, Epi Info, to collect participant-level questionnaire data. This application successfully captured each visit outcome and improved the logistics of field level activities for the COPA project, eliminating the use of paper maps for navigation. We show the development of HTrack and comment on the limitations and strengths of this application and further improvements.	[Rodriguez, Dania M.; Ryff, Kyle; Sanchez-Gonzalez, Liliana; Paz-Bailey, Gabriela; Adams, Laura] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA; [Rivera-Amill, Vanessa] Ponce Hlth Sci Univ, Ponce Res Inst, Ponce, PR USA	Centers for Disease Control & Prevention - USA; Ponce Health Sciences University	Rodriguez, DM (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA.	DRodriguezVargas@cdc.gov	Sánchez-González, Liliana/GZK-6297-2022	Sánchez-González, Liliana/0000-0001-8289-8587; Rodriguez, Dania/0000-0003-2837-3629	 [U01CK000437]		All authors who are federal employees have nothing to disclose and wish to declare no conflicts of interest. Authors who are not federal employees (VR) wish to provide acknowledgement to grant number U01CK000437. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Camp B, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2334-8; Carrasco-Escobar G, 2019, PEERJ, V7, DOI 10.7717/peerj.6298; Chang W, SHINYDASHBOARD CREAT; Chang W., Shiny: Web Application Framework for R2020 R Package Version 1.4.0.2 2021; Cheng J., 2018, LEAFLET CREATE INTER; Dean A, 2011, EPI INFO DATABASE ST; DroidScript Ltd Future Business Centre, 2013, DROIDSCRIPT JAVASCRI; Esri, COLL ARCGIS OV; Esri, NAV ARCGIS; Esri, INTRODUCTION; Esri, SURVEY123 ARCGIS; Esri, 2011, ARCGIS DESKT; Esri, ARCGIS; Esri, QUICKCAPTURE ARCGIS; Ferreira D, 2012, GPS CONNECTED VERSIO; Fornace KM, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0141-0; Karambelkar B., 2018, LEAFLET EXTRAS EXTRA; Loecher M., 2016, RGOOGLEMAPS OVERLAYS; Nowak MM, 2020, GLOB ECOL CONSERV, V23, DOI 10.1016/j.gecco.2020.e01089; Raja A, 2014, Online J Public Health Inform, V5, P228, DOI 10.5210/ojphi.v5i3.4996; Su Y, 2003, AMIA Annu Symp Proc, P1023; UserLAnd Technologies, 2018, USERLAND VERS 2 7 2; van Rossum G., 1995, CENTRUM WISKUNDE INF; Xie Y., 2018, **DATA OBJECT**	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244028	10.1371/journal.pone.0244028	http://dx.doi.org/10.1371/journal.pone.0244028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320896	gold, Green Published			2022-12-26	WOS:000600339800057
J	Santos, CM; Palinkas, M; Mestriner, W; Regalo, IH; de Vasconcelos, PB; Dias, FJ; Hallak, JEC; Siessere, S; Regalo, SCH				Santos, Carla Moreto; Palinkas, Marcelo; Mestriner-Junior, Wilson; Regalo, Isabela Hallak; de Vasconcelos, Paulo Batista; Jose Dias, Fernando; Cecilio Hallak, Jaime Eduardo; Siessere, Selma; Hallak Regalo, Simone Cecilio			Stomathognatic system function in indigenous people from Brazilian Xingu villages: An electromyographic analysis	PLOS ONE			English	Article							MASTICATORY MUSCLE-ACTIVITY; CHILDREN; RECOMMENDATIONS; COMMUNICATION; ADAPTATION; PATTERNS	The maintenance of postural balance can be influenced by the lifestyle of a population. This study aimed to determine the electromyographic activity of the masseter and temporalis muscles during mandibular tasks and habitual and non-habitual chewing in indigenous individuals to reveal the differences among white Brazilian individuals. Sixty Brazilians (18 and 28 years) were divided into two groups: 30 Xingu indigenous individuals and 30 white Brazilian individuals, with 20 men and 10 women in each group. The individuals were assessed using the normalized electromyographic activity of mandibular tasks (rest, protrusion, right and left laterality) and electromyographic activity of masticatory cycles in habitual (peanuts and raisins) and non-habitual (Parafilm M) chewing. Data were analyzed using Student's t-test (p < .05). Comparisons between the groups demonstrated significant differences. Indigenous individuals group presented a decrease in the normalized electromyographic activity of the masticatory muscles during mandibular rest [right masseter (p = .002) and left masseter (p = .004) muscles]. There was increase in the normalized electromyographic activity during protrusion [left temporal (p = .03) muscle]. There was increase in the electromyographic activity during chewing: peanuts [right masseter (p = .001), left masseter (p = .001) and right temporal (p = .01) muscles], raisins [right masseter (p = .001), left masseter (p = .002), right temporal (p = .008), left temporal (p = .01) muscles] and Parafilm M [left masseter muscle (p = .05)]. From the findings of this study, we concluded that in the comparison between indigenous and white individuals, positive changes were observed in the electromyographic pattern of the masticatory muscles in the mandibular postural conditions, with greater masticatory efficiency in the indigenous group.	[Santos, Carla Moreto; Palinkas, Marcelo; Mestriner-Junior, Wilson; Regalo, Isabela Hallak; de Vasconcelos, Paulo Batista; Siessere, Selma; Hallak Regalo, Simone Cecilio] Univ Sao Paulo, Ribeirao Preto Sch Dent, Dept Basic & Oral Biol, Sao Paulo, Brazil; [Palinkas, Marcelo] Fac Anhanguera, Dept Nursing, Ribeirao Preto, Brazil; [Palinkas, Marcelo; Regalo, Isabela Hallak; Cecilio Hallak, Jaime Eduardo; Siessere, Selma; Hallak Regalo, Simone Cecilio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav Sci, Ribeirao Preto, Brazil; [Palinkas, Marcelo; Regalo, Isabela Hallak; Cecilio Hallak, Jaime Eduardo; Siessere, Selma; Hallak Regalo, Simone Cecilio] Natl Inst & Technol Translational Med INCT TM, Ribeirao Preto, Brazil; [Jose Dias, Fernando] Univ La Frontera, Dent Sch, Res Ctr Dent Sci CICO, Dept Integral Adults Dent, Temuco, Chile	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad de La Frontera	Palinkas, M (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Dent, Dept Basic & Oral Biol, Sao Paulo, Brazil.; Palinkas, M (corresponding author), Fac Anhanguera, Dept Nursing, Ribeirao Preto, Brazil.; Palinkas, M (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav Sci, Ribeirao Preto, Brazil.; Palinkas, M (corresponding author), Natl Inst & Technol Translational Med INCT TM, Ribeirao Preto, Brazil.	marcelopalinkas@hotmail.com	Regalo, Simone Cecilio Hallak/AAJ-9773-2021; Siessere, Selma/B-7943-2012; Dias, Fernando Jose/AAP-7420-2020; Regalo, Simone Cecilio Hallak/B-8097-2012; Dias, Fernando Jose/D-8228-2014; Palinkas, Marcelo/C-4167-2015	Regalo, Simone Cecilio Hallak/0000-0003-4110-8299; Siessere, Selma/0000-0001-9756-3771; Dias, Fernando Jose/0000-0001-9945-9185; Palinkas, Marcelo/0000-0002-3445-8154	Sao Paulo Research Foundation (FAPESP, Brazil) [04/11748-7]	Sao Paulo Research Foundation (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation (FAPESP, Brazil - #04/11748-7).	Abdalla HB, 2021, J PROSTHODONT, V30, P142, DOI 10.1111/jopr.13235; Abu Serdaneh S, 2020, INT J PAEDIATR DENT, V30, P303, DOI 10.1111/ipd.12611; Ambrose SH, 2006, SCIENCE, V314, P930, DOI 10.1126/science.1135741; Andrade GC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020218; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; Cecilio FA, 2010, J ORAL REHABIL, V37, P248, DOI 10.1111/j.1365-2842.2010.02051.x; de Lacerda AT, 2020, REV PAUL PEDIATR, V38, DOI 10.1590/1984-0462/2020/38/2019034; Di Palma Elena, 2017, J Clin Exp Dent, V9, pe886, DOI 10.4317/jced.53986; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Fagundes Ulysses, 2002, J. Pediatr. (Rio J.), V78, P383, DOI 10.1590/S0021-75572002000500008; Florindo AA, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-794, 10.1186/1471-2458-13-1066, 10.1186/1471-2458-13-52]; Greenstein C, 2016, J PHYSIOTHER, V62, P42, DOI 10.1016/j.jphys.2015.08.010; Grillo CM, 2015, J ACUPUNCT MERIDIAN, V8, P192, DOI 10.1016/j.jams.2014.12.001; Regalo SCH, 2008, ARCH ORAL BIOL, V53, P282, DOI 10.1016/j.archoralbio.2007.10.003; Regalo SCH, 2018, J OROFAC ORTHOP, V79, P39, DOI 10.1007/s00056-017-0117-x; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hoogmartens M J, 1987, Electromyogr Clin Neurophysiol, V27, P3; Koolstra JH, 2002, CRIT REV ORAL BIOL M, V13, P366, DOI 10.1177/154411130201300406; Le Reverend B, 2016, PHYSIOL BEHAV, V165, P136, DOI 10.1016/j.physbeh.2016.07.010; Mattos A, 1999, J AM COLL NUTR, V18, P88, DOI 10.1080/07315724.1999.10718832; Normando D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230809; Normando D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028387; Orchardson R, 1998, FRONT ORAL BIOL, V9, P76; Pereira TS, 2017, CODAS, V29, DOI 10.1590/2317-1782/20172015301; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Qaisar R, 2016, FREE RADICAL BIO MED, V98, P56, DOI 10.1016/j.freeradbiomed.2016.03.025; Rathee M., 2020, STATPEARLS; Safari Anahita, 2013, J Contemp Dent Pract, V14, P616; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; SHAH H, 1991, INT J INTERCULT REL, V15, P311, DOI 10.1016/0147-1767(91)90004-Z; Sierpinska T, 2015, ARCH ORAL BIOL, V60, P1346, DOI 10.1016/j.archoralbio.2015.06.006; Siessere S, 2009, OSTEOPOROSIS INT, V20, P1847, DOI 10.1007/s00198-009-0885-2; Tomonari H, 2019, CLIN ORAL INVEST, V23, P3445, DOI 10.1007/s00784-018-2754-x; Ushimura A, 2015, BEHAV BRAIN RES, V278, P520, DOI 10.1016/j.bbr.2014.10.031; Verri ED, 2019, J ORAL REHABIL, V46, P912, DOI 10.1111/joor.12824; Vieira EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116138; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243495	10.1371/journal.pone.0243495	http://dx.doi.org/10.1371/journal.pone.0243495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320876	Green Published, gold			2022-12-26	WOS:000600339800036
J	Koene, FM; Amano, E; Smidt, ED; Ribas, LLF				Koene, Franciele Marx; Amano, Erika; Smidt, Eric de Camargo; Fortes Ribas, Luciana Lopes			Asymbiotic germination and morphological studies of seeds of Atlantic Rainforest micro-orchids (Pleurothallidinae)	PLOS ONE			English	Article							VITRO SEEDLING DEVELOPMENT; NATIVE CALIFORNIA; MORPHOMETRY; EMBRYOLOGY; CALYPSO	The morphological and morphometric characters of seeds belonging to 11 species of the subtribe Pleurothallidinae using light and scanning electron microscopy were studied to understand the in vitro germination process. Qualitative data (color, shape, ornamentation) and quantitative ones were also evaluated in seeds and embryos (length, width, volume and air space percentage between the integument and the embryo). The viability of the seeds was evaluated by in vitro germination in woody plant medium (WPM), and by analysis of the developmental stages of protocorms until seedling formation (two to 24 weeks). Morphometric data showed variations within the genus Acianthera and between species of different genera. The best germination and protocorm formation responses occurred with Acianthera prolifera (92%) and Acianthera ochreata (86%), with the formation of seedlings after 12 and 16 weeks of sowing, respectively. The seeds and embryos of A. prolifera and A. ochreata were larger (length, width, and volume) with a structural polarity that may have facilitated their germination comparing to others studied species. Other characteristics of A. prolifera seeds that may have contributed to these results include the presence of a thin testa without ornamentation and a suspensor. The protocorms of Anathalis obovata, Dryadella liliputiana, and Octomeria gracillis developed slowly in the WPM, not reaching the seedling stage in 24 weeks of cultivation. This morphological and morphometric study contributes to the understanding of asymbiotic germination of some micro-orchid species.	[Koene, Franciele Marx; Amano, Erika; Smidt, Eric de Camargo; Fortes Ribas, Luciana Lopes] Univ Fed Parana, Setor Ciencias Biol, Dept Bot, Curitiba, PR, Brazil	Universidade Federal do Parana	Ribas, LLF (corresponding author), Univ Fed Parana, Setor Ciencias Biol, Dept Bot, Curitiba, PR, Brazil.	llfribas@ufpr.br	Smidt, Eric C/F-7632-2011	Smidt, Eric C/0000-0002-1177-1682; Ribas, Luciana/0000-0003-1099-1090	CNPQ	CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank CNPQ for the Master's scholarship granted to Franciele Marx Koene.	[Anonymous], 2020, ZENODO, V21, P1; Arditti J, 2000, NEW PHYTOL, V145, P367, DOI 10.1046/j.1469-8137.2000.00587.x; ARDITTI J, 1979, AM J BOT, V66, P1128, DOI 10.2307/2442211; ARDITTI J, 1980, AM J BOT, V67, P347, DOI 10.2307/2442345; Aybeke M, 2014, PLANT SYST EVOL, V300, P91, DOI 10.1007/s00606-013-0862-2; Balilashaki K, 2020, J HORTIC SCI BIOTECH, V95, P542, DOI 10.1080/14620316.2020.1727782; Barman D., 2013, Journal of Crop and Weed, V9, P1; Barthlott Wilhelm, 2014, V32, P1; CHASE MW, 1988, SYST BOT, V13, P313, DOI 10.2307/2419295; Dangat BT., 2016, RICHARDIANA, V16, P174; Diantina S, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020161; Endres D, 2014, ACTA BOT BRAS, V28, P489, DOI 10.1590/0102-33062014abb3158; [Anonymous], 2018, Rodriguésia, V69, P1513, DOI 10.1590/2175-7860201869402; Gamarra R, 2007, BOT J LINN SOC, V153, P133, DOI 10.1111/j.1095-8339.2006.00603.x; Gamarra R, 2018, PLANT SYST EVOL, V304, P665, DOI 10.1007/s00606-018-1497-0; Guler Necmettin, 2016, PhytoKeys, P9; Hosomi ST, 2011, SEED SCI TECHNOL, V39, P178, DOI 10.15258/sst.2011.39.1.15; Karremans Adam P., 2016, Lankesteriana, V16, P219, DOI 10.15517/lank.v16i2.26008; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Koene FM, 2019, S AFR J BOT, V121, P83, DOI 10.1016/j.sajb.2018.07.019; Lee YI, 2008, BOT STUD, V49, P139; Lloyd G., 1980, Combined Proceedings, International Plant Propagators' Society, V30, P421; Menini Neto L., 2009, RODRIGUEISIA, V60, P461, DOI [10.1590/2175-7860200960216, DOI 10.1590/2175-7860200960216]; Millner HJ, 2008, J TORREY BOT SOC, V135, P497, DOI 10.3159/08-RA-059R1.1; Molvray M, 2003, GENERA ORCHIDACEARUM, P59, DOI [10.3732/ajb.90.3.429, DOI 10.3732/AJB.90.3.429]; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pence Valerie C., 2010, Kew Bulletin, V65, P539, DOI 10.1007/s12225-011-9245-4; Phillips GC, 2019, IN VITRO CELL DEV-PL, V55, P242, DOI 10.1007/s11627-019-09983-5; Pridgeon A. M., 2005, GENERA ORCHIDACEAR 1, V4, P319; Pridgeon A.M., 1999, GENERA ORCHIDACEARUM; Reddy J., 2016, WORLD J PHARM RES, V5, P1719; Santos S. A. dos, 2016, African Journal of Biotechnology, V15, P134; Simonelli M., 2007, ESPECIES FLORA AMEAC; Suzuki RM, 2012, IN VITRO CELL DEV-PL, V48, P500, DOI 10.1007/s11627-012-9460-1; Swamy K. Krishna, 2004, Taiwania, V49, P124; Tsutsumi C, 2007, J PLANT RES, V120, P405, DOI 10.1007/s10265-007-0077-0; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; Vij S. P., 2012, Proceedings of the National Academy of Sciences India. Section B, Biological Sciences, V82, P295; Vij SP, 1992, ORCHID NEWS, V8, P12; Vudala SM, 2017, S AFR J BOT, V108, P1, DOI 10.1016/j.sajb.2016.09.008; YEUNG EC, 1992, CAN J BOT, V70, P461, DOI 10.1139/b92-061; Yeung EC, 2018, SPRINGER PROTOC HAND, P3, DOI 10.1007/978-1-4939-7771-0_1; Yeung EC, 2017, BOT STUD, V58, DOI 10.1186/s40529-017-0188-4; Zappi Daniela C., 2015, Rodriguésia, V66, P1085, DOI 10.1590/2175-7860201566411; Zeng SJ, 2014, CRIT REV BIOTECHNOL, V34, P358, DOI 10.3109/07388551.2013.841117	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243297	10.1371/journal.pone.0243297	http://dx.doi.org/10.1371/journal.pone.0243297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315920	gold, Green Published			2022-12-26	WOS:000600186100082
J	Umezawa, K; Niikura, M; Kojima, Y; Goodell, B; Yoshida, M				Umezawa, Kiwamu; Niikura, Mai; Kojima, Yuka; Goodell, Barry; Yoshida, Makoto			Transcriptome analysis of the brown rot fungus Gloeophyllum trabeum during lignocellulose degradation	PLOS ONE			English	Article							WOOD DECAY; POSTIA-PLACENTA; POLYSACCHARIDE MONOOXYGENASE; SECRETOME ANALYSIS; WOLFIPORIA-COCOS; BIODEGRADATION; MECHANISMS; EXPRESSION; SPECIFICITY; PROTEINS	Brown rot fungi have great potential in biorefinery wood conversion systems because they are the primary wood decomposers in coniferous forests and have an efficient lignocellulose degrading system. Their initial wood degradation mechanism is thought to consist of an oxidative radical-based system that acts sequentially with an enzymatic saccharification system, but the complete molecular mechanism of this system has not yet been elucidated. Some studies have shown that wood degradation mechanisms of brown rot fungi have diversity in their substrate selectivity. Gloeophyllum trabeum, one of the most studied brown rot species, has broad substrate selectivity and even can degrade some grasses. However, the basis for this broad substrate specificity is poorly understood. In this study, we performed RNA-seq analyses on G. trabeum grown on media containing glucose, cellulose, or Japanese cedar (Cryptomeria japonica) as the sole carbon source. Comparison to the gene expression on glucose, 1,129 genes were upregulated on cellulose and 1,516 genes were upregulated on cedar. Carbohydrate Active enZyme (CAZyme) genes upregulated on cellulose and cedar media by G. trabeum included glycoside hyrolase family 12 (GH12), GH131, carbohydrate esterase family 1 (CE1), auxiliary activities family 3 subfamily 1 (AA3_1), AA3_2, AA3_4 and AA9, which is a newly reported expression pattern for brown rot fungi. The upregulation of both terpene synthase and cytochrome P450 genes on cedar media suggests the potential importance of these gene products in the production of secondary metabolites associated with the chelator-mediated Fenton reaction. These results provide new insights into the inherent wood degradation mechanism of G. trabeum and the diversity of brown rot mechanisms.	[Umezawa, Kiwamu; Niikura, Mai; Kojima, Yuka; Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan; [Umezawa, Kiwamu] Kindai Univ, Dept Appl Biol Chem, Nara, Japan; [Goodell, Barry] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	Tokyo University of Agriculture & Technology; Kindai University (Kinki University); University of Massachusetts System; University of Massachusetts Amherst	Umezawa, K (corresponding author), Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan.; Umezawa, K (corresponding author), Kindai Univ, Dept Appl Biol Chem, Nara, Japan.	umezawa@nara.kindai.ac.jp	Goodell, Barry/CAI-6720-2022; Yoshida, Makoto/E-8017-2013	Goodell, Barry/0000-0002-7798-7419; Umezawa, Kiwamu/0000-0003-1277-0558	JSPS KAKENHI [18H02252, 18H04148]; National Institute of Food and Agriculture, U.S. Department of Agriculture; Center for Agriculture, Food and the Environment; Microbiology department at University of Massachusetts Amherst [S1075 -MAS00503]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Center for Agriculture, Food and the Environment; Microbiology department at University of Massachusetts Amherst	This study was finantially supported by by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) Grant Number 18H02252 and Grantin-Aid for Scientific Research (A) 18H04148 to M. Y. and the National Institute of Food and Agriculture, U.S. Department of Agriculture, the Center for Agriculture, Food and the Environment, and the Microbiology department at University of Massachusetts Amherst, under project number S1075 -MAS00503 to B. G.. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the USDA or NIFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NUCLEIC ACIDS RES, V40, pD71; Arantes V, 2008, J APPL MICROBIOL, V104, P185, DOI 10.1111/j.1365-2672.2007.03540.x; Arantes V, 2006, J CHEM TECHNOL BIOT, V81, P413, DOI 10.1002/jctb.1417; Arantes V, 2012, APPL MICROBIOL BIOT, V94, P323, DOI 10.1007/s00253-012-3954-y; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bromann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035450; Busch A, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1429-9; Cohen R, 2004, APPL ENVIRON MICROB, V70, P324, DOI 10.1128/AEM.70.1.324-331.2004; Couturier M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0407-8; Daniel G, 2007, APPL ENVIRON MICROB, V73, P6241, DOI 10.1128/AEM.00977-07; Danilewicz JC, 2014, J AGR FOOD CHEM, V62, P5149, DOI 10.1021/jf5007402; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Eriksson K-EL., 1990, MICROBIAL ENZYMATIC, P1, DOI DOI 10.1007/978-3-642-46687-8; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gaskell J, 2016, APPL ENVIRON MICROB, V82, P3979, DOI 10.1128/AEM.00639-16; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Goodell B, 2003, ACS SYM SER, V845, P97; Goodell B, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0865-2; Hammel KE, 2002, ENZYME MICROB TECH, V30, P445, DOI 10.1016/S0141-0229(02)00011-X; Hatakka A, 2010, MYCOTA, V10, P319; Hegnar OA, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02612-18; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Heritier J, 2016, FOOD CHEM, V211, P957, DOI 10.1016/j.foodchem.2016.05.009; Highley T. L., 1973, Wood and Fiber, V5, P50; Hori C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004759; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; Jawallapersand P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107209; Jensen KA, 2002, APPL ENVIRON MICROB, V68, P2699, DOI 10.1128/AEM.68.6.2699-2703.2002; Kaffenberger JT, 2013, APPL MICROBIOL BIOT, V97, P8831, DOI 10.1007/s00253-013-5142-0; Kamada F, 2002, MICROBIOL-SGM, V148, P1939, DOI 10.1099/00221287-148-6-1939; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; Kojima Y, 2016, APPL ENVIRON MICROB, V82, P6557, DOI 10.1128/AEM.01768-16; Krah FS, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1229-7; Kuuskeri J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0608-9; Lafond M, 2012, APPL ENVIRON MICROB, V78, P8540, DOI 10.1128/AEM.02572-12; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lim YR, 2012, ARCH BIOCHEM BIOPHYS, V528, P111, DOI 10.1016/j.abb.2012.09.001; Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marinovic M, 2018, FUNGAL GENET BIOL, V112, P47, DOI 10.1016/j.fgb.2017.07.004; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Nurika I, 2020, J IND MICROBIOL BIOT, V47, P145, DOI 10.1007/s10295-019-02238-7; Paszczynski A, 1999, APPL ENVIRON MICROB, V65, P674; Pedrini N, 2015, P NATL ACAD SCI USA, V112, pE3651, DOI 10.1073/pnas.1504552112; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Presley GN, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/aem.00159-18, 10.1128/AEM.00159-18]; Presley GN, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/4961726; Quin MB, 2014, NAT PROD REP, V31, P1449, DOI 10.1039/c4np00075g; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Ryu JS, 2011, APPL ENVIRON MICROB, V77, P7933, DOI 10.1128/AEM.05496-11; Syed K, 2012, CRIT REV MICROBIOL, V38, P339, DOI 10.3109/1040841X.2012.682050; Tamaru Y, 2019, INT J BIOL MACROMOL, V128, P340, DOI 10.1016/j.ijbiomac.2019.01.149; Tanaka H, 2007, J BIOTECHNOL, V128, P500, DOI 10.1016/j.jbiotec.2006.12.010; Troya MT, 2009, INVEST AGRAR-SIST R, V18, P289; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Varela E, 2003, APPL ENVIRON MICROB, V69, P6025, DOI 10.1128/AEM.69.10.6025-6031.2003; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; Williamson G, 1998, MICROBIOL-SGM, V144, P2011, DOI 10.1099/00221287-144-8-2011; Wu BJ, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00991-18, 10.1128/aem.00991-18]; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Zhang JW, 2016, P NATL ACAD SCI USA, V113, P10968, DOI 10.1073/pnas.1608454113; Zhuang LP, 2015, RSC ADV, V5, P104043, DOI 10.1039/c5ra19203j	64	7	7	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243984	10.1371/journal.pone.0243984	http://dx.doi.org/10.1371/journal.pone.0243984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315957	gold, Green Published			2022-12-26	WOS:000600186100055
J	Wu, K; Ching, K; Chong, RA; Pan, ZQ				Wu, Kenneth; Ching, Kevin; Chong, Robert A.; Pan, Zhen-Qiang			A new FRET-based platform to track substrate ubiquitination by fluorescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSAY; DESTRUCTION; DEGRADATION; ACTIVATION; INHIBITOR; MECHANISM; SNAPSHOT; SYSTEM; SCF; E2	Post-translational modification of protein by ubiquitin (Ub) alters the stability, subcellular location, or function of the target protein, thereby impacting numerous biological processes and directly contributing to myriad cellular defects or disease states, such as cancer. Tracking substrate ubiquitination by fluorescence provides opportunities for advanced reaction dynamics studies and for translational research including drug discovery. However, fluorescence-based techniques in ubiquitination studies remain underexplored at least partly because of challenges associated with Ub chain complexity and requirement for additional substrate modification. Here we describe a general strategy, FRET diubiquitination, to track substrate ubiquitination by fluorescence. This platform produces a uniform di-Ub product depending on specific interactions between a substrate and its cognate E3 Ub ligase. The diubiquitination creates proximity between the Ub-linked donor and acceptor fluorophores, respectively, enabling energy transfer to yield a distinct fluorescent signal. FRET diubiquitination relies on Ub-substrate fusion, which can be implemented using either one of the two validated strategies. Method 1 is the use of recombinant substrate-Ub fusion, applicable to all substrate peptides that can bind to E3. Method 2 is a chemoenzymatic ligation approach that employs synthetic chemistry to fuse Ub with a substrate peptide containing desired modification. Taken together, our new FRET-based diubiquitination system provides a timely technology of potential to advance both basic research and translation sciences.	[Wu, Kenneth; Ching, Kevin; Chong, Robert A.; Pan, Zhen-Qiang] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Pan, ZQ (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu			National Institutes of Health (NIH) fellowship [1F30DK095572-01]; NIH [GM122751, 1R01CA251425-01]; Mount Sinai Technology and Development Fund Award	National Institutes of Health (NIH) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Sinai Technology and Development Fund Award	The following grants supported this work: National Institutes of Health (NIH) fellowship 1F30DK095572-01 to R. A. C. as well as NIH grants GM122751 and 1R01CA251425-01 to Z.-Q. P. Z.-Q. P. was also supported by Mount Sinai Technology and Development Fund Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Baek K, 2020, NATURE, V578, P461, DOI 10.1038/s41586-020-2000-y; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Burchak ON, 2006, CHEMBIOCHEM, V7, P1667, DOI 10.1002/cbic.200600283; Carlson CB, 2009, ASSAY DRUG DEV TECHN, V7, DOI 10.1089/adt.2008.0188; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Chong RA, 2015, METHODS MOL BIOL, V1280, P339, DOI 10.1007/978-1-4939-2422-6_20; Chong RA, 2014, P NATL ACAD SCI USA, V111, P8434, DOI 10.1073/pnas.1407849111; Gururaja TL, 2005, METHOD ENZYMOL, V399, P663, DOI 10.1016/S0076-6879(05)99044-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang JN, 2005, METHOD ENZYMOL, V399, P740, DOI 10.1016/S0076-6879(05)99049-6; Kenten JH, 2005, METHOD ENZYMOL, V399, P682, DOI 10.1016/S0076-6879(05)99045-9; Kovacev J, 2014, J BIOL CHEM, V289, P7068, DOI 10.1074/jbc.M113.530576; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Madiraju C, 2012, J BIOMOL SCREEN, V17, P163, DOI 10.1177/1087057111423417; Morreale FE, 2016, CELL, V165, P248, DOI 10.1016/j.cell.2016.03.003; Nakajima H, 2008, BIOCHEM BIOPH RES CO, V368, P1007, DOI 10.1016/j.bbrc.2008.01.166; Rajalingam K, 2016, CELL, V164, DOI 10.1016/j.cell.2016.02.019; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2016, P NATL ACAD SCI USA, V113, pE2011, DOI 10.1073/pnas.1601089113; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Xu SC, 2005, METHOD ENZYMOL, V399, P729, DOI 10.1016/S0076-6879(05)99048-4; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100230	10.1074/jbc.RA120.016858	http://dx.doi.org/10.1074/jbc.RA120.016858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361156	gold, Green Published			2022-12-26	WOS:000672866400208
J	Dylewski, JF; Tonsawan, P; Garcia, G; Lewis, L; Blaine, J				Dylewski, James F.; Tonsawan, Pantipa; Garcia, Gabriela; Lewis, Linda; Blaine, Judith			Podocyte-specific knockout of the neonatal Fc receptor (FcRn) results in differential protection depending on the model of glomerulonephritis	PLOS ONE			English	Article							CLASS-II EXPRESSION; ANTI-GBM NEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; CELLULAR CRESCENTS; IMMUNE-COMPLEXES; IGG HOMEOSTASIS; ALBUMIN; PATHWAY; MOUSE; ACTIVATION	Podocytes have been proposed to be antigen presenting cells (APCs). In traditional APCs, the neonatal Fc receptor (FcRn) is required for antigen presentation and global knockout of FcRn protects against glomerulonephritis. Since podocytes express FcRn, we sought to determine whether the absence of podocyte FcRn ameliorates immune-mediated disease. We examined MHCII and costimulatory markers expression in cultured wild type (WT) and FcRn knockout (KO) podocytes. Interferon gamma (IFN gamma) induced MHCII expression in both WT and KO podocytes but did not change CD80 expression. Neither WT nor KO expressed CD86 or inducible costimulatory ligand (ICOSL) at baseline or with IFN gamma. Using an antigen presentation assay, WT podocytes but not KO treated with immune complexes induced a modest increase in IL-2. Induction of the anti-glomerular basement membrane (anti-GBM) model resulted in a significant decrease in glomerular crescents in podocyte-specific FcRn knockout mouse (podFcRn KO) versus controls but the overall percentage of crescents was low. To examine the effects of the podocyte-specific FcRn knockout in a model with a longer autologous phase, we used the nephrotoxic serum nephritis (NTS) model. We found that the podFcRn KO mice had significantly reduced crescent formation and glomerulosclerosis compared to control mice. This study demonstrates that lack of podocyte FcRn is protective in immune mediated kidney disease that is dependent on an autologous phase. This study also highlights the difference between the anti-GBM model and NTS model of disease.	[Dylewski, James F.; Garcia, Gabriela; Lewis, Linda; Blaine, Judith] Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Dylewski, James F.] Denver Hlth Med Ctr, Dept Nephrol, Denver, CO 80204 USA; [Tonsawan, Pantipa] Khon Kaen Univ, Div Nephrol, Khon Kaen, Thailand	University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; Khon Kaen University	Dylewski, JF (corresponding author), Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.; Dylewski, JF (corresponding author), Denver Hlth Med Ctr, Dept Nephrol, Denver, CO 80204 USA.	James.Dylewski@cuanschutz.edu		Dylewski, James/0000-0002-8158-8605	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [1R01DK104264-01A1, 5R01DK082509-05, 5T32DK007135-42]; Norman Coplon Satellite Healthcare grant; Denver Health Medical Center	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Norman Coplon Satellite Healthcare grant; Denver Health Medical Center	This work was supported by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [grants 1R01DK104264-01A1, 5R01DK082509-05, and 5T32DK007135-42] a Norman Coplon Satellite Healthcare grant, and a Denver Health Medical Center Pilot Grant.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; [Anonymous], 2015, AM J KIDNEY DIS, V66, pS79; [Anonymous], 2012, REGEN MED S3, V7, pS14; ASSMANN KJM, 1985, VIRCHOWS ARCH A, V406, P285, DOI 10.1007/BF00704298; Baker K, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00664, 10.3389/fimmu.2014.00408]; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; BAUDEAU C, 1994, EXP NEPHROL, V2, P306; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Chalmers SA, 2015, J AUTOIMMUN, V57, P42, DOI 10.1016/j.jaut.2014.11.007; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; Corradetti C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163611; Dai Y, 2017, KIDNEY INT, V92, P1444, DOI 10.1016/j.kint.2017.04.026; Dalloneau E, 2016, ONCOTARGET, V7, P54415, DOI 10.18632/oncotarget.10074; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dobrinskikh E, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12510; Dylewski J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209732; Eller K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067693; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Frigo G, 2016, IMMUNOBIOLOGY, V221, P1329, DOI 10.1016/j.imbio.2016.08.002; Gaut JP, 2014, HUM PATHOL, V45, P628, DOI 10.1016/j.humpath.2013.10.030; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Goldwich A, 2013, J AM SOC NEPHROL, V24, P906, DOI 10.1681/ASN.2012020133; Goto K, 2016, INT IMMUNOL, V28, P197, DOI 10.1093/intimm/dxv067; Haymann JP, 2000, J AM SOC NEPHROL, V11, P632, DOI 10.1681/ASN.V114632; Hoppe John M, 2014, Methods Mol Biol, V1169, P159, DOI 10.1007/978-1-4939-0882-0_15; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kuo TT, 2010, J CLIN IMMUNOL, V30, P777, DOI 10.1007/s10875-010-9468-4; Li S, 2000, CLIN EXP IMMUNOL, V122, P453, DOI 10.1046/j.1365-2249.2000.01387.x; Li S, 1998, J EXP MED, V188, P597, DOI 10.1084/jem.188.3.597; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056316; MULLER GA, 1988, NEPHRON, V49, P132, DOI 10.1159/000185039; Olaru F, 2014, J AM SOC NEPHROL, V25, P918, DOI 10.1681/ASN.2013050498; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rizzo P, 2017, AM J PATHOL, V187, P2441, DOI 10.1016/j.ajpath.2017.07.004; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Salant DJ, 2016, J AM SOC NEPHROL, V27, P963, DOI 10.1681/ASN.2015080947; Sarav M, 2009, J AM SOC NEPHROL, V20, P1941, DOI 10.1681/ASN.2008090976; SCHRIJVER G, 1990, KIDNEY INT, V38, P86, DOI 10.1038/ki.1990.171; Scott NA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02800; Sistani L, 2013, KIDNEY INT, V83, P63, DOI 10.1038/ki.2012.321; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Thurman JM, 2012, AM J PHYSIOL-RENAL, V302, pF1529, DOI 10.1152/ajprenal.00422.2011; Tian ZH, 2014, J RECEPT SIG TRANSD, V34, P137, DOI 10.3109/10799893.2013.865745; Tipping PG, 1998, AM J PATHOL, V152, P1541; Toda N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42114; Tonsawan P, 2019, AM J PHYSIOL-CELL PH, V317, pC1048, DOI 10.1152/ajpcell.00235.2019; Trostel J, 2018, AM J PHYSIOL-RENAL, V315, pF759, DOI 10.1152/ajprenal.00458.2017; Truong LD, 2015, FASEB J, V29, P3558, DOI 10.1096/fj.14-262493; Weflen AW, 2013, MOL BIOL CELL, V24, P2398, DOI 10.1091/mbc.E13-04-0174; Xia YM, 2012, CLIN IMMUNOL, V145, P108, DOI 10.1016/j.clim.2012.08.008; Zhang Q, 2014, AM J PHYSIOL-RENAL, V306, pF822, DOI 10.1152/ajprenal.00294.2013	57	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0230401	10.1371/journal.pone.0230401	http://dx.doi.org/10.1371/journal.pone.0230401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370294	Green Published, gold, Green Submitted			2022-12-26	WOS:000603611900032
J	Mellgren, A; Eriksson, LE; Reinius, M; Marrone, G; Svedhem, V				Mellgren, Asa; Eriksson, Lars E.; Reinius, Maria; Marrone, Gaetano; Svedhem, Veronica			Longitudinal trends and determinants of patient-reported side effects on ART-a Swedish national registry study	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; MEDICATION; INFECTION; ADHERENCE; COMMUNICATION; NONADHERENCE; OUTCOMES; EVENTS	Introduction The use of patient-reported outcomes (PROs) to systematically quantify adverse events (AE) will assist in the improvement of medical care and the QoL of patients living with HIV (PLWH). The aim of this study was to investigate the associations between self-reported side effects and other PROs, demographics and laboratory data, and further evaluate the Health Questionnaire (HQ) as a tool for following trends in patient-reported side effects over time in relation to trends in prescribed third agent in ART. Materials and methods The Swedish National Registry InfCareHiv includes an annual self-reported nine-item HQwhich is used in patient-centered HIV care in all Swedish HIV units. In this study, the experience of side effects was addressed. We analyzed 9,476 HQs completed by 4,186 PLWH together with details about their prescribed ART and relevant biomarkers collected during 2011-2017. Data were analyzed using descriptive statistics, Pearson's correlation coefficient and mixed logistic regression. Results The cross-sectional analysis of the HQs showed that the frequency of reported side effects decreased from 32% (2011) to 15% (2017). During the same period, there was a shift in ART prescription from efavirenz (EFV) to dolutegravir (DTG) (positive correlation coefficient r = 0.94, p = 0.0016). Further, PLWH who reported being satisfied with their physical health (OR: 0.47, p = <0.001) or psychological health (OR: 0.70, p = 0.001) were less likely to report side effects than those less satisfied. Conclusions Self-reported side effects were found to have a close relationship with the patient's ratings of their overall health situation and demonstrated a strong correlation with the sharp decline in use of EFV and rise in use of DTG, with reported side effects being halved. This study supports the feasibility of using the HQ as a tool for longitudinal follow up of trends in PROs.	[Mellgren, Asa] Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden; [Mellgren, Asa] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Eriksson, Lars E.; Reinius, Maria] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Eriksson, Lars E.] City Univ London, Sch Hlth Sci, London, England; [Eriksson, Lars E.; Svedhem, Veronica] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Marrone, Gaetano; Svedhem, Veronica] Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden; [Marrone, Gaetano] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Karolinska Institutet; City University London; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Svedhem, V (corresponding author), Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.; Svedhem, V (corresponding author), Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden.	veronica.svedhem-johansson@sll.se	Reinius, Maria/AAA-2277-2022	Reinius, Maria/0000-0003-0864-8701; Mellgren, Asa/0000-0002-1202-3504; svedhemJohansson, veronica/0000-0003-0845-1685	Gilead Sciences Nordic Fellowship Programme; Department of Communicable Disease Control Health Protection Public Health Agency of Sweden	Gilead Sciences Nordic Fellowship Programme; Department of Communicable Disease Control Health Protection Public Health Agency of Sweden	VS has received funding from the Gilead Sciences Nordic Fellowship Programme and the Department of Communicable Disease Control Health Protection Public Health Agency of Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hamid A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005992; Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Basch E, 2009, JNCI-J NATL CANCER I, V101, P1624, DOI 10.1093/jnci/djp386; Colagiuri B, 2012, J PSYCHOPHARMACOL, V26, P1540, DOI 10.1177/0269881112458730; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Dobrozsi S, 2015, HEMATOL-AM SOC HEMAT, P501, DOI 10.1182/asheducation-2015.1.501; Eriksen J, 2017, INFECT DIS-NOR, V49, P1, DOI 10.1080/23744235.2016.1247495; Foster JM, 2008, J ASTHMA, V45, P664, DOI 10.1080/02770900802127022; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Hauser W, 2012, DTSCH ARZTEBL INT, V109, P459, DOI 10.3238/arztebl.2012.0459; Haggblom A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171227; Johnson MO, 2011, ANN BEHAV MED, V41, P83, DOI 10.1007/s12160-010-9230-4; Jolivot PA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0643-5; Josephson F, 2009, SCAND J INFECT DIS, V41, P788, DOI 10.3109/00365540903214322; Kall M, 2020, LANCET HIV, V7, pE59, DOI 10.1016/S2352-3018(19)30345-5; Kanters S, 2017, LANCET HIV, V4, pE31, DOI 10.1016/S2352-3018(16)30206-5; Kryst J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124279; Li HC, 2017, AIDS BEHAV, V21, P341, DOI 10.1007/s10461-016-1545-0; Lipscomb J, 2007, CA-CANCER J CLIN, V57, P278, DOI 10.3322/CA.57.5.278; Mahr A, 2017, PHARMACOEPIDEM DR S, V26, P731, DOI 10.1002/pds.4169; Maiese EM, 2016, CURR MED RES OPIN, V32, P2039, DOI 10.1080/03007995.2016.1227776; Marrone G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156916; Naver L, 2014, SCAND J INFECT DIS, V46, P401, DOI 10.3109/00365548.2014.898333; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Thorne S, 2008, INTERPRETIVE DESCRIP, V1; Velikova G, 2004, J CLIN ONCOL, V22, P714, DOI 10.1200/JCO.2004.06.078; Weigmann K, 2016, EMBO REP, V17, P949, DOI 10.15252/embr.201642616; Zanini M, 2014, J INT AIDS SOC, V17, P74, DOI 10.7448/IAS.17.4.19600	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242710	10.1371/journal.pone.0242710	http://dx.doi.org/10.1371/journal.pone.0242710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362248	Green Published, gold			2022-12-26	WOS:000603071600044
J	Wittek, A; Bourantas, G; Zwick, BF; Joldes, G; Esteban, L; Miller, K				Wittek, Adam; Bourantas, George; Zwick, Benjamin F.; Joldes, Grand; Esteban, Lionel; Miller, Karol			Mathematical modeling and computer simulation of needle insertion into soft tissue	PLOS ONE			English	Article							MOVING LEAST-SQUARES; FINITE-ELEMENT; COMPUTATIONAL BIOMECHANICS; REAL-TIME; BIOLOGICAL TISSUES; BRAIN; DEFORMATION; TOMOGRAPHY; FRAMEWORK; ALGORITHM	In this study we present a kinematic approach for modeling needle insertion into soft tissues. The kinematic approach allows the presentation of the problem as Dirichlet-type (i.e. driven by enforced motion of boundaries) and therefore weakly sensitive to unknown properties of the tissues and needle-tissue interaction. The parameters used in the kinematic approach are straightforward to determine from images. Our method uses Meshless Total Lagrangian Explicit Dynamics (MTLED) method to compute soft tissue deformations. The proposed scheme was validated against experiments of needle insertion into silicone gel samples. We also present a simulation of needle insertion into the brain demonstrating the method's insensitivity to assumed mechanical properties of tissue.	[Wittek, Adam; Bourantas, George; Zwick, Benjamin F.; Joldes, Grand; Miller, Karol] Univ Western Australia, Intelligent Syst Med Lab, Perth, WA, Australia; [Esteban, Lionel] CSIRO, Med XCT Facil, Kensington, WA, Australia	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Wittek, A (corresponding author), Univ Western Australia, Intelligent Syst Med Lab, Perth, WA, Australia.			Wittek, Adam/0000-0001-9780-8361; Zwick, Benjamin/0000-0003-0184-1082; Miller, Karol/0000-0002-6577-2082	Australian Government through the Australian Research Council's Discovery Projects funding scheme [DP160100714]; Australian Research Council [DP160100714]	Australian Government through the Australian Research Council's Discovery Projects funding scheme; Australian Research Council(Australian Research Council)	This research was supported by the Australian Government through the Australian Research Council's Discovery Projects funding scheme (project DP160100714) for Adam Wittek and Karol Miller. In particular, salaries of George Bourantas, Grand Joldes, and Benjamin F. Zwick were paid from the Australian Research Council's funding (Discovery project DP160100714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani N, 2007, MED ENG PHYS, V29, P413, DOI 10.1016/j.medengphy.2006.07.003; Adagolodjo Y, 2019, IEEE T ROBOT, V35, P697, DOI 10.1109/TRO.2019.2897858; Alterovitz R, 2008, INT J ROBOT RES, V27, P1361, DOI 10.1177/0278364908097661; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2018, FORENSIC SCI INT-GEN, V34, pe18; [Anonymous], 2017, MEDICINE, V96, pe6504; Aucoin N, 2009, 3D SLICER DOCUMENTAT; Banerji JS, 2016, J UROLOGY, V195, P66, DOI 10.1016/j.juro.2015.07.099; Bathe KJ., 1996, FINITE ELEMENT PROCE; Bilston LE, 2019, BIOL MED PHYS BIOMED, P71, DOI 10.1007/978-3-030-04996-6_4; Bonet J, 2001, COMMUN NUMER METH EN, V17, P551, DOI 10.1002/cnm.429; Brands D W, 2000, Stapp Car Crash J, V44, P249; Carey GF, 1997, COMPUTATIONAL GRID G; Chowdhury HA, 2017, J SCI COMPUT, V71, P1197, DOI 10.1007/s10915-016-0337-z; Cotin S, 1999, IEEE T VIS COMPUT GR, V5, P62, DOI 10.1109/2945.764872; Courtecuisse H, 2019, BIOL MED PHYS BIOMED, P321, DOI 10.1007/978-3-030-04996-6_13; Cowan NJ, 2011, SURGICAL ROBOTICS: SYSTEMS APPLICATIONS AND VISIONS, P557, DOI 10.1007/978-1-4419-1126-1_23; Crisfield MA, 1996, INT J SOLIDS STRUCT, V33, P2969, DOI 10.1016/0020-7683(95)00252-9; De Lorenzo D, 2013, IEEE T BIO-MED ENG, V60, P379, DOI 10.1109/TBME.2012.2227316; De Momi E, 2016, INT J COMPUT ASS RAD, V11, P473, DOI 10.1007/s11548-015-1259-1; DiMaio SP, 2005, IEEE T BIO-MED ENG, V52, P1167, DOI 10.1109/TBME.2005.847548; DiMaio SP, 2002, 10 S HAPT INT VIRT E, P1; Dutta-Roy T, 2006, CISM COURSES LECT, V487, P297; Elgezua I, 2013, PROC CIRP, V5, P94, DOI 10.1016/j.procir.2013.01.019; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Frisken S, 2019, BIOL MED PHYS BIOMED, P303, DOI 10.1007/978-3-030-04996-6_12; Garlapati RR, 2014, J NEUROSURG, V120, P1477, DOI 10.3171/2013.12.JNS131165; Gonzalez-Martinez J, 2014, J NEUROSURG, V120, P639, DOI 10.3171/2013.11.JNS13635; Horton A, 2010, INT J NUMER METH BIO, V26, P977, DOI 10.1002/cnm.1374; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Hughes T.J.R, 1987, FINITE ELEMENT METHO, P311; Bui HP, 2019, COMPUT METHOD APPL M, V345, P183, DOI 10.1016/j.cma.2018.10.023; Ivarsson J, 2002, J BIOMECH ENG-T ASME, V124, P422, DOI 10.1115/1.1485752; Jahya A, 2013, INT J MED ROBOT COMP, V9, pE52, DOI 10.1002/rcs.1493; Jin X, 2014, COMPUT METHOD BIOMEC, V17, P800, DOI 10.1080/10255842.2012.716829; Joldes G, 2019, MED IMAGE ANAL, V56, P152, DOI 10.1016/j.media.2019.06.004; Joldes GR, 2016, J MECH BEHAV BIOMED, V58, P139, DOI 10.1016/j.jmbbm.2015.07.029; Joldes GR, 2015, APPL MATH COMPUT, V266, P893, DOI 10.1016/j.amc.2015.05.150; Joldes GR, 2012, INT J NUMER METH ENG, V91, P450, DOI 10.1002/nme.4290; Joldes GR, 2009, COMMUN NUMER METH EN, V25, P827, DOI 10.1002/cnm.1185; Julia, 2020, JUL PROGR LANG; Kataoka H, 2002, LECT NOTES COMPUT SC, V2488, P216; Khau A, 2018, BIOMECHANICAL SIMULA, DOI [10.1177/2374373518803630, DOI 10.1177/2374373518803630]; Kitware, 2020, KITW; LANCASTER P, 1981, MATH COMPUT, V37, P141, DOI 10.1090/S0025-5718-1981-0616367-1; Leibinger A, 2016, ANN BIOMED ENG, V44, P2442, DOI 10.1007/s10439-015-1523-0; Li M., 2016, COMPUTATIONAL BIOMEC, P85, DOI [10., 10.1007/978-3-319-28329-6_8, DOI 10.1007/978-3-319-28329-6_8]; Ma JJ, 2010, COMPUTATIONAL BIOMECHANICS FOR MEDICINE, P29, DOI 10.1007/978-1-4419-5874-7_4; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; MEHTA M, 1985, ANAESTHESIA, V40, P1009, DOI 10.1111/j.1365-2044.1985.tb10558.x; Miller K, 2005, J BIOMECH, V38, P153, DOI 10.1016/j.jbiomech.2004.03.004; Miller K, 2000, J BIOMECH, V33, P367, DOI 10.1016/S0021-9290(99)00196-7; Miller K, 2005, COMPUTER METHODS BIO, P1; Miller K, 2019, BIOL MED PHYS BIOMED, P135, DOI 10.1007/978-3-030-04996-6_6; Miller K, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3250; Miller K, 2013, J MECH BEHAV BIOMED, V27, P154, DOI 10.1016/j.jmbbm.2013.01.013; Miner RC, 2017, J MED IMAGING RADIAT, V48, P328, DOI 10.1016/j.jmir.2017.06.005; Misra S, 2010, INT J ROBOT RES, V29, P1640, DOI 10.1177/0278364910369714; Morriss L, 2008, J BIOMECH, V41, P235, DOI 10.1016/j.jbiomech.2007.06.025; Mostayed A, 2013, ANN BIOMED ENG, V41, P2409, DOI 10.1007/s10439-013-0838-y; Oldfield M, 2013, COMPUT METHOD BIOMEC, V16, P530, DOI 10.1080/10255842.2011.628448; Park H, 2018, ANN BIOMED ENG, V46, P2012, DOI 10.1007/s10439-018-2100-0; Power SP, 2016, WORLD J RADIOL, V8, P902, DOI 10.4329/wjr.v8.i12.902; Sastry R, 2017, J NEUROIMAGING, V27, P5, DOI 10.1111/jon.12382; Seiler K, 2011, ALGORITHMIC FDN ROBO, P37; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stukelj R, 2017, EUR J PHARM SCI, V98, P17, DOI 10.1016/j.ejps.2016.10.007; Sylvester J, 2013, BRACHYTHERAPY, V12, P375, DOI 10.1016/j.brachy.2012.07.002; Urrea FA, 2016, J MECH BEHAV BIOMED, V56, P98, DOI 10.1016/j.jmbbm.2015.11.024; Phan VA, 2019, ENDOSCOPY, V51, P463, DOI 10.1055/a-0800-0033; VTK, 2020, VTK EX; Warfield S. K., 2002, Computing and Visualization in Science, V5, P3, DOI 10.1007/s00791-002-0083-7; Washio T, 2004, LECT NOTES COMPUT SC, V3217, P113; Washio T, 2020, MED IMAGE COMPUTING, P113; Wittek A, 2008, COMPUT METHOD BIOMEC, V11, P135, DOI [10.1080/10255840701688095, 10.1080/10255840802296665]; Wittek A., 2019, HDB MEDICAL IMAGE CO, P953, DOI [10.1016/B978-0-12-816176-0.00044-2, DOI 10.1016/B978-0-12-816176-0.00044-2, 10.1016/b978-0-12-816176-0.00044-2]; Wittek A, 2016, ANN BIOMED ENG, V44, P3, DOI 10.1007/s10439-015-1469-2; Wittek A, 2010, PROG BIOPHYS MOL BIO, V103, P292, DOI 10.1016/j.pbiomolbio.2010.09.001; Wittek A, 2009, BIOMECH MODEL MECHAN, V8, P77, DOI 10.1007/s10237-008-0118-1; Yang KH, 2018, BASIC FINITE ELEMENT METHOD AS APPLIED TO INJURY BIOMECHANICS, P1; Yao CJ, 2016, INT J NEUROSCI, V126, P53, DOI 10.3109/00207454.2014.992429; Zhang GY, 2014, ENG ANAL BOUND ELEM, V42, P60, DOI 10.1016/j.enganabound.2013.08.014; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021; Zhang JY, 2013, INT J NUMER METH BIO, V29, P293, DOI 10.1002/cnm.2507; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	86	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0242704	10.1371/journal.pone.0242704	http://dx.doi.org/10.1371/journal.pone.0242704			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351854	Green Published, gold, Green Submitted			2022-12-26	WOS:000603071400040
J	Okamoto, N; Vengrenyuk, Y; Fuster, V; Samady, H; Yasumura, K; Baber, U; Barman, N; Suleman, J; Sweeny, J; Krishnan, P; Mehran, R; Sharma, SK; Narula, J; Kini, AS				Okamoto, Naotaka; Vengrenyuk, Yuliya; Fuster, Valentin; Samady, Habib; Yasumura, Keisuke; Baber, Usman; Barman, Nitin; Suleman, Javed; Sweeny, Joseph; Krishnan, Prakash; Mehran, Roxana; Sharma, Samin K.; Narula, Jagat; Kini, Annapoorna S.			Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUE; ANGIOGRAPHY; ACQUISITION; PROGRESSION; PREDICTION; STANDARDS; CONSENSUS; BURDEN	High-risk coronary plaques have been considered predictive of adverse cardiac events. Both wall shear stress (WSS) in patients with hemodynamically significant lesions and optical coherence tomography (OCT) -verified thin-cap fibroatheroma (TCFA) are associated with plaque rupture, the most common underlying mechanism of acute coronary syndrome. The aim of the study was to test the hypothesis that invasive coronary angiography-based high WSS is associated with the presence of TCFA detected by OCT in obstructive lesions. From a prospective study of patients who underwent OCT examination for angiographically obstructive lesions (Yellow II), we selected patients who had two angiographic projections to create a 3-dimensional reconstruction model to allow assessment of WSS. The patients were divided into 2 groups according to the presence and absence of TCFA. Mean WSS was assessed in the whole lesion and in the proximal, middle and distal segments. Of 70 patients, TCFA was observed in 13 (19%) patients. WSS in the proximal segment (WSSproximal) (10.20 [5.01, 16.93Pa]) and the whole lesion (WSSlesion) (12.37 [6.36, 14.55Pa]) were significantly higher in lesions with TCFA compared to WSSproximal (5.84 [3.74, 8.29Pa], p = 0.02) and WSSlesion (6.95 [4.41, 11.60], p = 0.04) in lesions without TCFA. After multivariate analysis, WSSproximal was independently associated with the presence of TCFA (Odds ratio 1.105; 95%CI 1.007-1.213, p = 0.04). The optimal cutoff value of WSSproximal to predict TCFA was 6.79 Pa (AUC: 0.71; sensitivity: 0.77; specificity: 0.63 p = 0.02). Our results demonstrate that high WSS in the proximal segments of obstructive lesions is an independent predictor of OCT-verified TCFA.	[Okamoto, Naotaka; Vengrenyuk, Yuliya; Fuster, Valentin; Yasumura, Keisuke; Baber, Usman; Barman, Nitin; Suleman, Javed; Sweeny, Joseph; Krishnan, Prakash; Mehran, Roxana; Sharma, Samin K.; Narula, Jagat; Kini, Annapoorna S.] Mt Sinai Hosp, Div Cardiol, New York, NY 10029 USA; [Okamoto, Naotaka; Vengrenyuk, Yuliya; Fuster, Valentin; Yasumura, Keisuke; Baber, Usman; Barman, Nitin; Suleman, Javed; Sweeny, Joseph; Krishnan, Prakash; Mehran, Roxana; Sharma, Samin K.; Narula, Jagat; Kini, Annapoorna S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Samady, Habib] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University	Kini, AS (corresponding author), Mt Sinai Hosp, Div Cardiol, New York, NY 10029 USA.; Kini, AS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	annapoorna.kini@mountsinai.org	Fuster, Valentin/H-4319-2015; Mehran, Roxana/ABF-4160-2021	Fuster, Valentin/0000-0002-9043-9986; krishnan, prakash/0000-0003-2871-3689				Ahmadi A, 2015, CIRC RES, V117, P99, DOI 10.1161/CIRCRESAHA.117.305637; Bourantas CV, 2020, JACC-CARDIOVASC IMAG, V13, P2206, DOI 10.1016/j.jcmg.2020.02.028; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Corban MT, 2014, ATHEROSCLEROSIS, V232, P271, DOI 10.1016/j.atherosclerosis.2013.11.049; Eshtehardi P, 2017, INT J CARDIOVAS IMAG, V33, P1089, DOI 10.1007/s10554-016-1055-1; Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030; Gijsen F, 2013, J BIOMECH, V46, P240, DOI 10.1016/j.jbiomech.2012.11.006; Gijsen FJH, 2011, EUROINTERVENTION, V7, P121, DOI 10.4244/EIJV7I1A20; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Hartman EMJ, 2021, J CARDIOVASC TRANSL, V14, P416, DOI 10.1007/s12265-020-10072-x; Kini AS, 2017, J AM COLL CARDIOL, V69, P644, DOI 10.1016/j.jacc.2016.10.028; Kini AS, 2017, J AM COLL CARDIOL, V69, P628, DOI 10.1016/j.jacc.2016.10.029; Kini AS, 2013, J AM COLL CARDIOL, V62, P21, DOI 10.1016/j.jacc.2013.03.058; Kumar A, 2018, J AM COLL CARDIOL, V72, P1926, DOI 10.1016/j.jacc.2018.07.075; Lee JM, 2019, JACC-CARDIOVASC IMAG, V12, P1032, DOI 10.1016/j.jcmg.2018.01.023; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Murata N, 2019, HEART VESSELS, V34, P1429, DOI 10.1007/s00380-019-01389-y; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Park JB, 2016, HEART, V102, P1655, DOI 10.1136/heartjnl-2016-309299; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Schuurman AS, 2018, EUR HEART J, V39, P295, DOI 10.1093/eurheartj/ehx247; Stone PH, 2018, JACC-CARDIOVASC IMAG, V11, P462, DOI 10.1016/j.jcmg.2017.01.031; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Toba T, 2021, JACC-CARDIOVASC IMAG, V14, P315, DOI 10.1016/j.jcmg.2020.07.034; Tu SX, 2010, CATHETER CARDIO INTE, V76, P291, DOI 10.1002/ccd.22502; Vergallo R, 2014, CIRC-CARDIOVASC IMAG, V7, P905, DOI 10.1161/CIRCIMAGING.114.001932; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; Xing L, 2017, J AM COLL CARDIOL, V69, P2502, DOI 10.1016/j.jacc.2017.03.556; Yamamoto E, 2019, JACC-CARDIOVASC IMAG, V12, P374, DOI 10.1016/j.jcmg.2018.07.024	33	4	5	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244015	10.1371/journal.pone.0244015	http://dx.doi.org/10.1371/journal.pone.0244015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332434	Green Published, gold			2022-12-26	WOS:000601310900087
J	Richards, KL; Karvelis, P; Lawrie, SM; Series, P				Richards, Katie L.; Karvelis, Povilas; Lawrie, Stephen M.; Series, Peggy			Visual statistical learning and integration of perceptual priors are intact in attention deficit hyperactivity disorder	PLOS ONE			English	Article							REACTION-TIME VARIABILITY; DEFICIT/HYPERACTIVITY DISORDER; DECISION-MAKING; COMPUTATIONAL MODELS; ADULT ADHD; CHILDREN; AUTISM; METAANALYSIS; INHIBITION; DOPAMINE	Background Deficits in visual statistical learning and predictive processing could in principle explain the key characteristics of inattention and distractibility in attention deficit hyperactivity disorder (ADHD). Specifically, from a Bayesian perspective, ADHD may be associated with flatter likelihoods (increased sensory processing noise), and/or difficulties in generating or using predictions. To our knowledge, such hypotheses have never been directly tested. Methods We here test these hypotheses by evaluating whether adults diagnosed with ADHD (n = 17) differed from a control group (n = 30) in implicitly learning and using low-level perceptual priors to guide sensory processing. We used a visual statistical learning task in which participants had to estimate the direction of a cloud of coherently moving dots. Unbeknown to the participants, two of the directions were more frequently presented than the others, creating an implicit bias (prior) towards those directions. This task had previously revealed differences in other neurodevelopmental disorders, such as autistic spectrum disorder and schizophrenia. Results We found that both groups acquired the prior expectation for the most frequent directions and that these expectations substantially influenced task performance. Overall, there were no group differences in how much the priors influenced performance. However, subtle group differences were found in the influence of the prior over time. Conclusion Our findings suggest that the symptoms of inattention and hyperactivity in ADHD do not stem from broad difficulties in developing and/or using low-level perceptual priors.	[Richards, Katie L.; Lawrie, Stephen M.] Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh, Midlothian, Scotland; [Richards, Katie L.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Karvelis, Povilas; Series, Peggy] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Lawrie, Stephen M.] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of London; King's College London; University of Edinburgh; University of Edinburgh	Series, P (corresponding author), Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland.	pseries@inf.ed.ac.uk	Richards, Katie L/GXV-3017-2022; Lawrie, Stephen MacGregor/AAD-1607-2021	Richards, Katie L/0000-0003-3826-6317; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Series, Peggy/0000-0002-8580-7975	Health Foundation Scaling Up Award; Engineering and Physical Sciences Research Council; Patrick Wild Centre; Janssen; Lundbeck	Health Foundation Scaling Up Award; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Patrick Wild Centre; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lundbeck(Lundbeck Corporation)	KR is supported by the Health Foundation Scaling Up Award. PK was funded by Engineering and Physical Sciences Research Council. This study was supported by funding from the Patrick Wild Centre. SML reports receiving, in the past three years, personal fees from Janssen, Otsuka and Sunovion, and research funding from Janssen and Lundbeck. The other authors have no conflict of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Agnew-Blais JC, 2016, JAMA PSYCHIAT, V73, P713, DOI 10.1001/jamapsychiatry.2016.0465; American Psychiatric A, 2013, DIAGN STAT MAN MENT, VFifth; [Anonymous], 1999, HESPERIA, V2, P79; [Anonymous], 2013, PREDICTIVE MIND, DOI DOI 10.1093/ACPROF:OSO/9780199682737.001.0001; Barnes KA, 2010, DEV NEUROPSYCHOL, V35, P494, DOI 10.1080/87565641.2010.494750; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bijlenga D, 2017, EUR PSYCHIAT, V43, P51, DOI 10.1016/j.eurpsy.2017.02.481; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Cheng CH, 2016, NEUROSCI LETT, V612, P132, DOI 10.1016/j.neulet.2015.11.033; Chevrier A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206780; Coghill DR, 2014, PSYCHOL MED, V44, P1989, DOI 10.1017/S0033291713002547; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Dankner Y, 2017, PSYCHOL SCI, V28, P835, DOI 10.1177/0956797617694863; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; DELANEY HD, 1981, MULTIVAR BEHAV RES, V16, P105, DOI 10.1207/s15327906mbr1601_6; Domuta A, 2000, IMPLICIT LEARNING AD; Durston S, 2007, DEV REV, V27, P374, DOI 10.1016/j.dr.2007.05.001; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; First MB, 2002, STRUCTURED CLIN INTE; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Fried M, 2014, VISION RES, V101, P62, DOI 10.1016/j.visres.2014.05.004; Friston K, 2016, SCHIZOPHR RES, V176, P83, DOI 10.1016/j.schres.2016.07.014; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gonen-Yaacovi G, 2016, CORTEX, V81, P50, DOI 10.1016/j.cortex.2016.04.010; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Hasler R, 2016, NEUROPSYCHOLOGIA, V87, P120, DOI 10.1016/j.neuropsychologia.2016.05.008; Hauser TU, 2016, TRENDS NEUROSCI, V39, P63, DOI 10.1016/j.tins.2015.12.009; Hauser TU, 2014, JAMA PSYCHIAT, V71, P1165, DOI 10.1001/jamapsychiatry.2014.1093; Huang-Pollock CL, 2014, NEUROPSYCHOLOGY, V28, P594, DOI 10.1037/neu0000075; Johnstone SJ, 2013, CLIN NEUROPHYSIOL, V124, P644, DOI 10.1016/j.clinph.2012.09.006; Karalunas SL, 2014, J CHILD PSYCHOL PSYC, V55, P685, DOI 10.1111/jcpp.12217; Karatekin C, 2009, NEUROPSYCHOLOGY, V23, P445, DOI 10.1037/a0015562; Karvelis P, 2018, ELIFE, V7, DOI 10.7554/eLife.34115; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Kim Soyeon, 2015, J Optom, V8, P116, DOI 10.1016/j.optom.2014.10.002; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Kok P., 2015, INTRO MODEL BASED CO, P221, DOI DOI 10.1007/978-1-4939-2236-9_11; Kollins SH, 2014, PROG NEURO-PSYCHOPH, V52, P70, DOI 10.1016/j.pnpbp.2014.02.002; Kooij J.J.S., 2012, ADULT ADHD DIAGNOSTI; Laquitaine S, 2018, NEURON, V97, P462, DOI 10.1016/j.neuron.2017.12.011; Lee M. D., 2013, BAYESIAN DATA ANAL C; Leow LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179977; Little LM, 2018, PHYS OCCUP THER PEDI, V38, P243, DOI 10.1080/01942638.2017.1390809; Luman M, 2010, NEUROSCI BIOBEHAV R, V34, P744, DOI 10.1016/j.neubiorev.2009.11.021; Gonzalez-Gadea ML, 2015, J NEUROPHYSIOL, V114, P2625, DOI 10.1152/jn.00543.2015; McCarthy H, 2014, PSYCHOL MED, V44, P869, DOI 10.1017/S0033291713001037; Micoulaud-Franchi JA, 2019, J ATTEN DISORD, V23, P1199, DOI 10.1177/1087054716629716; Mihali Andra, 2018, Comput Psychiatr, V2, P141, DOI 10.1162/cpsy_a_00018; Mueller A, 2017, TRENDS COGN SCI, V21, P474, DOI 10.1016/j.tics.2017.03.009; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Panagiotidi M, 2018, COMPR PSYCHIAT, V80, P179, DOI 10.1016/j.comppsych.2017.10.008; Parks KMA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02502; Parr T, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00061; Pedersen A, 2018, J ATTEN DISORD, V22, P250, DOI 10.1177/1087054712464392; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Sato Y, 2014, J VISION, V14, DOI 10.1167/14.13.13; Silvetti M, 2013, NEURAL NETWORKS, V46, P199, DOI 10.1016/j.neunet.2013.05.008; Takacs A, 2017, BRAIN COGNITION, V117, P33, DOI 10.1016/j.bandc.2017.06.009; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Valton V, 2019, BRAIN, V142, P2523, DOI 10.1093/brain/awz171; Vloet TD, 2010, J ABNORM CHILD PSYCH, V38, P961, DOI 10.1007/s10802-010-9422-1; Wechsler D, 1999, MANUAL WECHSLER ABBR; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042993; Ziegler S, 2016, NEUROSCI BIOBEHAV R, V71, P633, DOI 10.1016/j.neubiorev.2016.09.002; Zimmer L, 2017, TRENDS PHARMACOL SCI, V38, P608, DOI 10.1016/j.tips.2017.04.001	71	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243100	10.1371/journal.pone.0243100	http://dx.doi.org/10.1371/journal.pone.0243100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332378	Green Published, Green Submitted, gold			2022-12-26	WOS:000601310900077
J	Xu, LF; Huang, ZS; Yang, ZZ; Ding, WL; Buck-Sorlin, GH				Xu, Lifeng; Huang, Zusheng; Yang, Zhongzhu; Ding, Weilong; Buck-Sorlin, Gerhard Hartwig			Optimization study on spatial distribution of rice based on a virtual plant approach	PLOS ONE			English	Article							YIELD	How to increase crop yield is the most important issue in agricultural production. Many studies have been devoted to optimizing spatial distribution of crops, to improve light interception and increase photosynthetic assimilation. However, finding an optimal solution based on field experiments is almost impossible since the large number of combinations of factors that are related, and the cost in terms of finances and time are prohibitive. A new optimization strategy was proposed in this study, integrating a Functional-Structural Model of rice with a workflow based on a Mixed Particle Swarm Optimization (MPSO) algorithm. The 3D modelling platform GroIMP was used to implement the model and optimization workflow. MPSO is a new Particle Swarm Optimization-based algorithm with multistage disturbances, which has improved abilities to get rid of local optima and to explore solution space. Spacing between plants was used as optimization target in the first example. An optimal plant spacing was obtained within the model framework of current environmental settings together with the functional and structural modules. Simulation results indicate that the optimized plant spacing could increase rice yield, and that the optimization results remain stable.	[Xu, Lifeng; Huang, Zusheng; Yang, Zhongzhu; Ding, Weilong] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Peoples R China; [Buck-Sorlin, Gerhard Hartwig] Univ Angers, Inst Agro, Angers, France	Zhejiang University of Technology; Institut Agro; Universite d'Angers	Buck-Sorlin, GH (corresponding author), Univ Angers, Inst Agro, Angers, France.	gerhard.buck-sorlin@agrocampus-ouest.fr		Buck-Sorlin, Gerhard/0000-0002-7077-498X; Xu, Lifeng/0000-0003-4957-7559	National Natural Science Foundation of China [61702456, 61571400]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201224867]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Zhejiang Provincial Education Department	X. L. and D. W. received funding from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) with grant numbers 61571400; X. L. also received funding from the National Natural Science Foundation of China with grant numbers 61702456 and the Scientific Research Fund of Zhejiang Provincial Education Department (http://jyt.zj.gov.cn) with grant number Y201224867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck Sorlin GH, 2010, P 6 INT WORKSH FUNCT, P222; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Dong N, 2017, ECOLOGICAL MECH YIEL; Dunn BW, 2020, CROP PASTURE SCI, V71, P219, DOI 10.1071/CP19421; Ehsanullah, 2007, Pakistan Journal of Agricultural Sciences, V44, P597; Evers JB, 2007, NEW PHYTOL, V176, P325, DOI 10.1111/j.1469-8137.2007.02168.x; Grahmann K., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138053; Hardke J, 2016, ARKANSAS RICE PRODUC, DOI 10.3390/insects7020027; Henke M, 2016, FRONT COMPUT SCI-CHI, V10, P1103, DOI 10.1007/s11704-015-4472-8; Henke M, 2014, PLANT SOIL, V385, P49, DOI 10.1007/s11104-014-2221-7; Hu N, 2014, TRANSGENIC RES, V23, P795, DOI 10.1007/s11248-014-9810-3; Jiang Z, 2009, OPTIMIZE SIMULATE PL; Kang W. G., 2014, J CLIN ACUPUNCTURE M, V30, P35; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kniemeyer O, 2008, FAKULTAT MATH; Langensiepen M, 2020, ENVIRON EXP BOT, V178, DOI 10.1016/j.envexpbot.2020.104125; Li T, 2015, EFFECTS PLANTING DEN; Li XP, 2015, CHIN J CHROMATOGR, V33, P58, DOI 10.3724/SP.J.1123.2014.09018; Liver and atherosclerosis, 2015, GASTROENTEROLOGIYA, V51, P14; Long Q, 2018, ACM IEEA 18, V107, P113, DOI 10.1145/3208854.3208875; Luo D, 2014, AGR RES, V3, P313, DOI 10.1007/s40003-014-0132-8; Marcelis LFM, 1998, SCI HORTIC-AMSTERDAM, V74, P83, DOI 10.1016/S0304-4238(98)00083-1; Morley JE, 2013, J FRALITY AGING, V2, P121; Nakano H, 2012, CROP SCI, V52, P2800, DOI 10.2135/cropsci2012.05.0328; Perez RPA, 2018, AGR FOREST METEOROL, V249, P250, DOI 10.1016/j.agrformet.2017.11.008; Vos J, 2010, J EXP BOT, V61, P2101, DOI 10.1093/jxb/erp345; Xu Li-Feng, 2019, Journal of Software, V30, P1835, DOI 10.13328/j.cnki.jos.005600; Xu LF, 2011, ANN BOT-LONDON, V107, P817, DOI 10.1093/aob/mcq264; [杨蕊菊 Yang Ruiju], 2005, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V14, P44; Zhang H, 2012, J NANOMATER, V2012, DOI [10.1155/2012/217412, 10.1186/2049-1891-3-26]; Zhu XingTao, 2014, Soybean Science, V33, P35	31	0	0	10	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243717	10.1371/journal.pone.0243717	http://dx.doi.org/10.1371/journal.pone.0243717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332473	Green Published, gold			2022-12-26	WOS:000601310900101
J	Kruseova, J; Kovacova, AS; Zapotocky, M; Sumerauer, D; Pernikova, I; Starkova, D; Misove, A; Zichova, A; Capek, V; Langer, T; Zehnhoff-Dinnesen, AA; Eckschlager, T; Kyncl, M				Kruseova, Jarmila; Kovacova, Anna Sarah; Zapotocky, Michal; Sumerauer, David; Pernikova, Ivana; Starkova, Darja; Misove, Adela; Zichova, Andrea; Capek, Vaclav; Langer, Thorsten; Zehnhoff-Dinnesen, Antoinette am; Eckschlager, Tomas; Kyncl, Martin			Older age is a protective factor for academic achievements irrespective of treatment modalities for posterior fossa brain tumours in children	PLOS ONE			English	Article							WHITE-MATTER ANISOTROPY; HEARING-LOSS; RADIATION-THERAPY; SURVIVORS; CNS; MEDULLOBLASTOMA; NEUROTOXICITY; OUTCOMES; ASSOCIATION; IRRADIATION	The treatment of children with posterior fossa brain tumours (PFBT) impacts their long term functional and imaging outcomes. This study aimed to evaluate academic achievement correlated with long-term sequelae after different PFBT treatment modalities. The study cohort consisted of 110 survivors (median age at diagnosis 10.1 years and median time of follow up 13.2 years) who completed hearing questionnaires, neurological assessment and MRI of the brain >= 5 years after the end of treatment. There were three treatment groups. A cisplatin group which underwent cisplatin chemotherapy, radiotherapy and surgery (medulloblastoma N = 40), a radiotherapy group which underwent radiotherapy and surgery (astrocytoma/ependymoma N = 30), and a surgery group (astrocytoma N = 40). Academic achievement was correlated to the age at diagnosis, ototoxicity, Karnofsky score (KS), and MRI findings (Fazekas Score (FS)- treatment related parenchymal changes). For a modelled age at diagnosis of five years, the cisplatin group had lower academic achievements compared to the radiotherapy (p = 0.028) and surgery (p = 0.014) groups. Academic achievements evaluated at a modelled age of 10 years at diagnosis did not significantly differ among the treatment groups. The cisplatin group exhibited a higher occurrence of ototoxicity than the radiotherapy (p<0.019) and surgery groups (p<0.001); however, there was no correlation between ototoxicity and academic achievements (p = 0.722) in older age at diagnosis. The radiotherapy group exhibited lower KS than the surgery group (p<0.001). KS significantly influenced academic achievements in all groups (p<0.000). The cisplatin group exhibited higher FS than the surgery group (p<0.001) while FS did not correlate with academic achievement (p = 0.399). Older age is a protective factor for academic achievements irrespective of a treatment modality.	[Kruseova, Jarmila; Zapotocky, Michal; Sumerauer, David; Misove, Adela; Zichova, Andrea; Eckschlager, Tomas] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Kruseova, Jarmila; Kovacova, Anna Sarah; Zapotocky, Michal; Sumerauer, David; Pernikova, Ivana; Starkova, Darja; Misove, Adela; Zichova, Andrea; Capek, Vaclav; Eckschlager, Tomas; Kyncl, Martin] Univ Hosp Motol, Prague, Czech Republic; [Kovacova, Anna Sarah; Starkova, Darja; Kyncl, Martin] Charles Univ Prague, Fac Med 2, Dept Radiol, Prague, Czech Republic; [Pernikova, Ivana] Charles Univ Prague, Fac Med 2, Dept Paediat Neurol, Prague, Czech Republic; [Capek, Vaclav] Charles Univ Prague, Fac Med 2, Bioinformat Ctr, Prague, Czech Republic; [Langer, Thorsten] Univ Hosp Children & Adolescents, Pediat Oncol & Hematol, Lubeck, Germany; [Zehnhoff-Dinnesen, Antoinette am] Univ Hosp Munster, Dept Phoniatr & Pedaudiol, Munster, Germany	Charles University Prague; Motol University Hospital; Charles University Prague; Charles University Prague; Charles University Prague; University of Munster	Kruseova, J (corresponding author), Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic.; Kruseova, J (corresponding author), Univ Hosp Motol, Prague, Czech Republic.	jarmila.kruseova@fnmotol.cz	Kruseova, Jarmila/AAS-1036-2021; kruseova, jarmila/AAS-1653-2021; Capek, Vaclav/D-8555-2016	Kruseova, Jarmila/0000-0002-6576-7048; Capek, Vaclav/0000-0002-8574-7001	European Union's Seventh Framework Programme for Research, Technological Development and Demonstration [602030]; Ministry of Education, Youth and Sport of the Czech Republic; Ministry of Health, Czech Republic -Conceptual Development of Research Organization, University Hospital Motol, Prague, Czech Republic [00064203]	European Union's Seventh Framework Programme for Research, Technological Development and Demonstration; Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health, Czech Republic -Conceptual Development of Research Organization, University Hospital Motol, Prague, Czech Republic	This project has received funding from the European Union's Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement no 602030. This study has received funding from the Ministry of Education, Youth and Sport of the Czech Republic. Supported by Ministry of Health, Czech Republic -Conceptual Development of Research Organization, University Hospital Motol, Prague, Czech Republic, #00064203.	Armstrong GT, 2011, NEURO-ONCOLOGY, V13, P223, DOI 10.1093/neuonc/noq178; Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Bass JK, 2016, J CLIN ONCOL, V34, P1248, DOI 10.1200/JCO.2015.63.6738; Boman KK, 2009, EUR J CANCER, V45, P2552, DOI 10.1016/j.ejca.2009.06.008; Brinkman TM, 2015, CANCER-AM CANCER SOC, V121, P4053, DOI 10.1002/cncr.29604; Duffner PK, 2010, EUR J PAEDIATR NEURO, V14, P106, DOI 10.1016/j.ejpn.2009.10.005; Forbes K, 2017, J ROY COLL PHYS EDIN, V47, P271, DOI 10.4997/JRCPE.2017.313; Froklage FE, 2014, J NEURO-ONCOL, V116, P387, DOI 10.1007/s11060-013-1310-4; Khong PL, 2006, J CLIN ONCOL, V24, P884, DOI 10.1200/JCO.2005.02.4505; Khong PL, 2005, RADIOLOGY, V236, P647, DOI 10.1148/radiol.2362041066; Korlimarla A, 2020, NEUROLOGY, V95, pE718, DOI 10.1212/WNL.0000000000009979; Lassaletta A, 2015, CHILD NERV SYST, V31, P1877, DOI 10.1007/s00381-015-2829-9; Leung LHT, 2004, NEUROIMAGE, V21, P261, DOI 10.1016/j.neuroimage.2003.09.020; Monje M, 2011, J PEDIATR REHAB MED, V4, P31, DOI 10.3233/PRM-2011-0150; Musial-Bright L, 2011, CHILD NERV SYST, V27, P407, DOI 10.1007/s00381-010-1300-1; Orgel E, 2016, PEDIATR BLOOD CANCER, V63, P527, DOI 10.1002/pbc.25804; Orgel E, 2012, PEDIATR BLOOD CANCER, V58, P953, DOI 10.1002/pbc.23275; Rowe LS, 2017, ONCOLOGY-NY, V31, P182; Rueckriegel SM, 2012, INT J RADIAT ONCOL, V82, P1135, DOI 10.1016/j.ijrobp.2011.04.017; Rueckriegel SM, 2010, INT J RADIAT ONCOL, V76, P859, DOI 10.1016/j.ijrobp.2009.02.054; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Scobioala S, 2017, STRAHLENTHER ONKOL, V193, P910, DOI 10.1007/s00066-017-1205-y; Shan ZYY, 2006, MAGN RESON IMAGING, V24, P1015, DOI 10.1016/j.mri.2006.04.015; Sleurs C, 2016, CRIT REV ONCOL HEMAT, V103, P37, DOI 10.1016/j.critrevonc.2016.05.001; Tabori U, 2005, CANCER-AM CANCER SOC, V103, P1874, DOI 10.1002/cncr.21003; Vargo Mary, 2011, Am J Phys Med Rehabil, V90, pS50, DOI 10.1097/PHM.0b013e31820be31f; Winick N, 2011, CURR OPIN PEDIATR, V23, P27, DOI 10.1097/MOP.0b013e32834255e9; Zou P, 2005, NEUROIMAGE, V24, P61, DOI 10.1016/j.neuroimage.2004.08.030	28	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243998	10.1371/journal.pone.0243998	http://dx.doi.org/10.1371/journal.pone.0243998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326475	gold, Green Published			2022-12-26	WOS:000600176400060
J	Mostaghim, A; Sinha, P; Bielick, C; Knudsen, S; Beeram, I; White, LF; Apovian, C; Sagar, M; Hochberg, NS				Mostaghim, Anahita; Sinha, Pranay; Bielick, Catherine; Knudsen, Selby; Beeram, Indeevar; White, Laura F.; Apovian, Caroline; Sagar, Manish; Hochberg, Natasha S.			Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital	PLOS ONE			English	Article							CYTOKINE RELEASE SYNDROME; LACTATE-DEHYDROGENASE; MANAGEMENT	Objectives Patients with Covid-19 and obesity have worse clinical outcomes which may be driven by increased inflammation. This study aimed to characterize the association between clinical outcomes in patients with obesity and inflammatory markers. Methods We analyzed data for patients aged >= 18 years admitted with a positive SARS-CoV-2 PCR test. We used multivariate logistic regression to determine the association between BMI and intensive care unit (ICU) transfer and all-cause mortality. Inflammatory markers (C-reactive protein [CRP], lactate dehydrogenase [LDH], ferritin, and D-dimer) were compared between patients with and without obesity (body mass index [BMI] >= 30 kg/m(2)). Results Of 791 patients with Covid-19, 361 (45.6%) had obesity. In multivariate analyses, BMI >= 35 was associated with a higher odds of ICU transfer (adjusted odds ratio [aOR] 2.388 (95% confidence interval [CI]: 1.074-5.310) and hospital mortality (aOR = 4.3, 95% CI: 1.69-10.82). Compared to those with BMI<30, patients with obesity had lower ferritin (444 vs 637 ng/mL; p<0.001) and lower D-dimer (293 vs 350 mcg/mL; p = 0.009), non-significant differences in CRP (72.8 vs 84.1 mg/L, p = 0.099), and higher LDH (375 vs 340, p = 0.009) on the first hospital day. Conclusions Patients with obesity were more likely to have poor outcomes even without increased inflammation.	[Mostaghim, Anahita; Bielick, Catherine] Boston Univ, Sch Med, Dept Internal Med, Boston, MA 02118 USA; [Sinha, Pranay; Knudsen, Selby; Sagar, Manish; Hochberg, Natasha S.] Boston Univ, Sch Med, Dept Internal Med, Sect Infect Dis, Boston, MA 02118 USA; [Beeram, Indeevar] Boston Univ, Sch Med, Boston, MA 02118 USA; [White, Laura F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Apovian, Caroline] Boston Univ, Sch Med, Dept Internal Med, Sect Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA; [Hochberg, Natasha S.] Boston Med Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Boston Medical Center	Hochberg, NS (corresponding author), Boston Univ, Sch Med, Dept Internal Med, Sect Infect Dis, Boston, MA 02118 USA.; Hochberg, NS (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.	nhoch@bu.edu		Bielick, Catherine/0000-0003-1871-3909; White, Laura F/0000-0002-0588-8235; Sinha, Pranay/0000-0002-4233-0871; Apovian, Caroline/0000-0002-8029-1922; Hochberg, Natasha/0000-0002-5449-9973	Boston Obesity Nutrition Research Center [P30DK046200]; NIH [5T32AI152074-13, K24 AI-145661]; Warren Alpert Foundation	Boston Obesity Nutrition Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warren Alpert Foundation	Boston Obesity Nutrition Research Center P30DK046200 (CA), NIH K24 AI-145661 (MS), NIH 5T32AI152074-13 (PS), Warren Alpert Foundation (NSH).	AbdelMassih AF, 2020, CARDIOVASC ENDOCR ME, V9, P102, DOI 10.1097/XCE.0000000000000218; Ades PA, 2010, MAYO CLIN PROC, V85, P112, DOI 10.4065/mcp.2009.0777; Al-Benna Sammy, 2020, Obes Med, V19, P100283, DOI 10.1016/j.obmed.2020.100283; Anderson MR, 2020, ANN INTERN MED, V173, P782, DOI 10.7326/M20-3214; Audit ICN  Centre R, 2020, ICNARC REP COVID 19; Boutens L, 2018, DIABETOLOGIA, V61, P942, DOI 10.1007/s00125-017-4526-6; Bozkurt B, 2016, CIRCULATION, V134, pE535, DOI 10.1161/CIR.0000000000000450; Budu-Aggrey A, 2019, PLOS MED, V16, DOI [10.1371/journal., 10.1371/journal.pmed.1002739]; Cai QX, 2020, DIABETES CARE, V43, P1392, DOI 10.2337/dc20-0576; Chiappetta S, 2020, INT J OBESITY, V44, P1790, DOI 10.1038/s41366-020-0597-4; Ciceri F, 2020, CRIT CARE RESUSC, V22, P95; Cure MC, CLIN RHEUMATOLOGY, V2020, P1; Dickerson RN, 2013, CRIT CARE, V17, DOI 10.1186/cc12715; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Fitzgerald JC, 2017, CRIT CARE MED, V45, pE124, DOI 10.1097/CCM.0000000000002053; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Green WD, 2017, CURR OPIN IMMUNOL, V46, P1, DOI 10.1016/j.coi.2017.03.008; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Inamura N, 2014, J INFECT CHEMOTHER, V20, P270, DOI 10.1016/j.jiac.2014.01.001; Jamal AJ, 2021, CLIN INFECT DIS, V72, P1064, DOI 10.1093/cid/ciaa848; Janeway C, 2008, JANEWAYS IMMUNO BIOL; Johns Hopkins University of Medicine, 2020, MORT AN; Kalligeros M, 2020, OBESITY, V28, P1200, DOI 10.1002/oby.22859; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Luzi L, 2020, ACTA DIABETOL, V57, P759, DOI 10.1007/s00592-020-01522-8; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Parameswaran Krishnan, 2006, Can Respir J, V13, P203; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Popkin BM, 2020, OBES REV, V21, DOI 10.1111/obr.13128; Public Health England, 2020, COVID 19 INS NEW EV; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Ryan PM, 2020, OBESITY, V28, P1191, DOI 10.1002/oby.22843; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Sinha P, 2020, INT J INFECT DIS, V99, P28, DOI 10.1016/j.ijid.2020.07.023; Wang F, 2020, ENDOCR PRACT, V26, P668, DOI 10.4158/EP-2020-0108; Watanabe M, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154319; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhang T, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, P496, DOI 10.3760/cma.j.cn112147-20200311-00312; Zheng KI, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154244; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2	49	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243888	10.1371/journal.pone.0243888	http://dx.doi.org/10.1371/journal.pone.0243888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326480	gold, Green Published			2022-12-26	WOS:000600176400010
J	Sobrino, A; Walker, ME; Colas, RA; Dalli, J				Sobrino, Agua; Walker, Mary E.; Colas, Romain A.; Dalli, Jesmond			Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators	PLOS ONE			English	Article							DOUBLE-BLIND; FATTY-ACIDS; INFLAMMATION; ATHEROSCLEROSIS; IDENTIFICATION; EXPRESSION; RESOLUTION	Clinical studies using a range of omega-3 supplements have yielded conflicting results on their efficacy to control inflammation. Omega-3 fatty acids are substrate for the formation of potent immune-protective mediators, termed as specialized pro-resolving mediators (SPM). Herein, we investigated whether observed differences in the potencies of distinct omega-3 supplements were linked with their ability to upregulate SPM formation. Using lipid mediator profiling we found that four commercially available supplements conferred a unique SPM signature profile to human macrophages, with the overall increases in SPM concentrations being different between the four supplements. These increases in SPM concentrations were linked with an upregulation of macrophage phagocytosis and a decreased uptake of oxidized low-density lipoproteins. Pharmacological inhibition of two key SPM biosynthetic enzymes 5-Lipoxygenase or 15-Lipoxygenase reversed the macrophage-directed actions of each of the omega-3 supplements. Furthermore, administration of the two supplements that most potently upregulated macrophage SPM formation and reprogrammed their responses in vitro, to APOE(-/-) mice fed a western diet, increased plasma SPM concentrations and reduced vascular inflammation. Together these findings support the utility of SPM as potential prognostic markers in determining the utility of a given supplement to regulate macrophage responses and inflammation.	[Sobrino, Agua; Walker, Mary E.; Colas, Romain A.; Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Dalli, J (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.; Dalli, J (corresponding author), Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England.	j.dalli@qmul.ac.uk		Dalli, Jesmond/0000-0001-6328-3640	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [677542]; Barts Charity [MGU0343]; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [107613/Z/15/Z]; Standard Process Inc.	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Barts Charity; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Standard Process Inc.	This work was supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant no: 677542) and the Barts Charity (grant no: MGU0343) to JD. JD is also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust; the Royal Society (grant 107613/Z/15/Z); and a grant from Standard Process Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	31st Annual Scientific Sessions: Transforming the Future of Nursing Research: Imagination Innovation and Engagement, 2019, NURS RES, V68, pE21, DOI 10.1097/NNR.0000000000000351; American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; [Anonymous], 2019, NEW ENGL J MED, V380, P11; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; [Anonymous], 2017, DTSCH ZRZTEBLATT JG, V114, pA741; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; [Anonymous], 2018, CIRCULATION, V138, pe751, DOI 10.1161/CIR.0000000000000636; [Anonymous], 2018, CIRCULATION, V137, pe67, DOI [10. 1161/CIR. 0000000000000558, DOI 10.1161/CIR.0000000000000558]; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Bernasconi AA, 2021, MAYO CLIN PROC, V96, P304, DOI 10.1016/j.mayocp.2020.08.034; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Brancaleone V, 2013, BLOOD, V122, P608, DOI 10.1182/blood-2013-04-496661; Budoff MJ, 2020, EUR HEART J, V41, P3925, DOI 10.1093/eurheartj/ehaa652; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Colas RA, 2018, CIRC RES, V122, P855, DOI 10.1161/CIRCRESAHA.117.312472; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Dalli J, 2019, ADV EXP MED BIOL, V1161, P65, DOI 10.1007/978-3-030-21735-8_7; Dalli J, 2019, BRIT J PHARMACOL, V176, P1024, DOI 10.1111/bph.14336; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Caterina R, 2018, J AM COLL CARDIOL, V72, P1585, DOI 10.1016/j.jacc.2018.07.044; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Freire MO, 2017, J IMMUNOL, V198, P718, DOI 10.4049/jimmunol.1601543; Gibson MS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00654; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Harris WS, 2019, P NUTR SOC, V78, P526, DOI 10.1017/S0029665118002902; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Laguna-Fernandez A, 2018, CIRCULATION, V138, P1693, DOI 10.1161/CIRCULATIONAHA.117.032801; Leong TSH, 2009, ULTRASON SONOCHEM, V16, P721, DOI 10.1016/j.ultsonch.2009.02.008; Lichtenstein AH, 2006, ARTERIOSCL THROM VAS, V26, P2186, DOI 10.1161/01.ATV.0000238352.25222.5e; Ruiz-Leon AM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00837; Meital LT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49362-z; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Natto ZS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54535-x; Pal A, 2020, FASEB J, V34, P10640, DOI 10.1096/fj.202000830R; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Salic K, 2016, ATHEROSCLEROSIS, V250, P158, DOI 10.1016/j.atherosclerosis.2016.05.001; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Sha YH, 2015, INT J CLIN EXP PATHO, V8, P6708; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Souza PR, 2020, CIRC RES, V126, P75, DOI 10.1161/CIRCRESAHA.119.315506; Sperling LS, 2016, CURR MED RES OPIN, V32, P301, DOI 10.1185/03007995.2015.1120190; Statistics Committee and Stroke Statistics Subcommittee, 2017, CIRCULATION, V135, pe146; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Walker CG, 2015, NUTRIENTS, V7, P6281, DOI 10.3390/nu7085285; Welsh P, 2017, BRIT J PHARMACOL, V174, P3898, DOI 10.1111/bph.13818; Woo MS, 2016, J BIOL CHEM, V291, P23654, DOI 10.1074/jbc.M116.750018; Zizzo G, 2018, INFLAMMATION, V41, P2206, DOI 10.1007/s10753-018-0864-x	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242543	10.1371/journal.pone.0242543	http://dx.doi.org/10.1371/journal.pone.0242543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326419	gold, Green Published			2022-12-26	WOS:000600176400065
J	Wongkaewkhiaw, S; Taweechaisupapong, S; Thanaviratananich, S; Bolscher, JGM; Nazmi, K; Anutrakunchai, C; Chareonsudjai, S; Kanthawong, S				Wongkaewkhiaw, Saharut; Taweechaisupapong, Suwimol; Thanaviratananich, Sanguansak; Bolscher, Jan G. M.; Nazmi, Kamran; Anutrakunchai, Chitchanok; Chareonsudjai, Sorujsiri; Kanthawong, Sakawrat			D-LL-31 enhances biofilm-eradicating effect of currently used antibiotics for chronic rhinosinusitis and its immunomodulatory activity on human lung epithelial cells	PLOS ONE			English	Article							BACTERIAL BIOFILMS; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; TISSUE INHIBITOR; CHRONIC SINUSITIS; LL-37; MICROBIOLOGY; EXPRESSION; SPECIMENS; FAMILY	Chronic rhinosinusitis (CRS) is a chronic disease that involves long-term inflammation of the nasal cavity and paranasal sinuses. Bacterial biofilms present on the sinus mucosa of certain patients reportedly exhibit resistance against traditional antibiotics, as evidenced by relapse, resulting in severe disease. The aim of this study was to determine the killing activity of human cathelicidin antimicrobial peptides (LL-37, LL-31) and their D-enantiomers (D-LL-37, D-LL-31), alone and in combination with conventional antibiotics (amoxicillin; AMX and tobramycin; TOB), against bacteria grown as biofilm, and to investigate the biological activities of the peptides on human lung epithelial cells. D-LL-31 was the most effective peptide against bacteria under biofilm-stimulating conditions based on IC50 values. The synergistic effect of D-LL-31 with AMX and TOB decreased the IC50 values of antibiotics by 16-fold and could eliminate the biofilm matrix in all tested bacterial strains. D-LL-31 did not cause cytotoxic effects in A549 cells at 25 mu M after 24 h of incubation. Moreover, a cytokine array indicated that there was no significant induction of the cytokines involving in immunopathogenesis of CRS in the presence of D-LL-31. However, a tissue-remodeling-associated protein was observed that may prevent the progression of nasal polyposis in CRS patients. Therefore, a combination of D-LL-31 with AMX or TOB may improve the efficacy of currently used antibiotics to kill biofilm-embedded bacteria and eliminate the biofilm matrix. This combination might be clinically applicable for treatment of patients with biofilm-associated CRS.	[Wongkaewkhiaw, Saharut; Chareonsudjai, Sorujsiri; Kanthawong, Sakawrat] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Taweechaisupapong, Suwimol; Anutrakunchai, Chitchanok; Chareonsudjai, Sorujsiri; Kanthawong, Sakawrat] Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand; [Thanaviratananich, Sanguansak] Khon Kaen Univ, Dept Otorhinolaryngol, Fac Med, Khon Kaen, Thailand; [Bolscher, Jan G. M.; Nazmi, Kamran] Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Bolscher, Jan G. M.; Nazmi, Kamran] Vrije Univ Amsterdam, Amsterdam, Netherlands	Khon Kaen University; Khon Kaen University; Khon Kaen University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Kanthawong, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.; Kanthawong, S (corresponding author), Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand.	sakawrat@kku.ac.th	Wongkaewkhiaw, Saharut/AAC-3083-2022; Bolscher, Jan/ABF-6102-2021; Wongkaewkhiaw, Saharut/GXW-0778-2022	Wongkaewkhiaw, Saharut/0000-0002-9581-3383; Bolscher, Jan/0000-0001-5669-6164; Wongkaewkhiaw, Saharut/0000-0002-9581-3383	Khon Kaen University, Thailand [61003402, 6200021004]; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand	Khon Kaen University, Thailand; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand	SK was supported by grant fund under Khon Kaen University, Thailand (61003402 and 6200021004) https://www.kku.ac.th/SW was supported by grant fund under Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand https://www.md.kku.ac.th/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Antunes MB, 2007, AM J RHINOL, V21, P423, DOI 10.2500/ajr.2007.21.3046; Barshak Miriam Baron, 2017, Laryngoscope Investig Otolaryngol, V2, P36, DOI 10.1002/lio2.61; Batoni G, 2016, BBA-BIOMEMBRANES, V1858, P1044, DOI 10.1016/j.bbamem.2015.10.013; Beaudoin T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33016-7; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Billings N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003526; Bolscher J, 2012, BIOCHEM CELL BIOL, V90, P378, DOI [10.1139/O11-085, 10.1139/o11-085]; Brook I, 2016, EUR J CLIN MICROBIOL, V35, P1059, DOI 10.1007/s10096-016-2640-x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200; Chen YS, 2007, ALLERGY, V62, P66, DOI 10.1111/j.1398-9995.2006.01255.x; Corso-Radu A, 2010, ICSOFT 2010: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON SOFTWARE AND DATA TECHNOLOGIES, VOL 2, P512; de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152; Deng DM, 2009, J ENDODONT, V35, P1249, DOI 10.1016/j.joen.2009.05.038; Desrosiers M, 2007, AM J RHINOL, V21, P149, DOI 10.2500/ajr.2007.21.3007; Dlugaszewska J, 2016, EUR ARCH OTO-RHINO-L, V273, P1989, DOI 10.1007/s00405-015-3650-5; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Dworniczek E, 2009, FOLIA MICROBIOL, V54, P559, DOI 10.1007/s12223-009-0082-x; Eyibilen A, 2011, HISTOL HISTOPATHOL, V26, P615, DOI 10.14670/HH-26.615; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foreman A, 2012, CURR ALLERGY ASTHM R, V12, P127, DOI 10.1007/s11882-012-0246-7; Goldstein EJC, 1999, ANTIMICROB AGENTS CH, V43, P705, DOI 10.1128/AAC.43.3.705; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Grassi L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02409; Hwang PH, 2003, OTOLARYNG HEAD NECK, V128, P489, DOI 10.1016/S0194-5998(02)23295-7; Ivanchenko OA, 2016, RHINOLOGY, V54, P68, DOI [10.4193/Rhin15.018, 10.4193/Rhino15.018]; Jamal M, 2018, J CHIN MED ASSOC, V81, P7, DOI 10.1016/j.jcma.2017.07.012; Kanthawong S, 2012, INT J ANTIMICROB AG, V39, P39, DOI 10.1016/j.ijantimicag.2011.09.010; Kanthawong S, 2009, INT J ANTIMICROB AG, V34, P309, DOI 10.1016/j.ijantimicag.2009.05.012; Karunasagar A, 2018, INDIAN J OTOLARYNGOL, V70, P43, DOI 10.1007/s12070-017-1208-0; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Kifer D, 2016, J ANTIBIOT, V69, P689, DOI 10.1038/ja.2016.10; Kristy L, 2018, PERFORMANCE STANDARD; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Luo Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00544; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Mantovani K, 2010, BRAZ J OTORHINOLAR, V76, P548, DOI 10.1590/S1808-86942010000500002; Molhoek EM, 2011, PEPTIDES, V32, P875, DOI 10.1016/j.peptides.2011.02.017; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Bezerra TFP, 2011, OTOLARYNG HEAD NECK, V144, P612, DOI 10.1177/0194599811399536; Pothoven KL, 2015, J ALLERGY CLIN IMMUN, V136, P737, DOI 10.1016/j.jaci.2015.01.043; Pourmousa Rostam, 2015, Glob J Health Sci, V8, P239, DOI 10.5539/gjhs.v8n5p239; Psaltis AJ, 2008, AM J RHINOL, V22, P1, DOI 10.2500/ajr.2008.22.3119; Puknun A, 2013, WORLD J MICROB BIOT, V29, P1217, DOI 10.1007/s11274-013-1284-6; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, P598, DOI 10.1177/0194599815574247; Rudack C, 2006, CLIN EXP ALLERGY, V36, P748, DOI 10.1111/j.1365-2222.2006.02501.x; Rudmik L, 2014, LARYNGOSCOPE, V124, P2007, DOI 10.1002/lary.24630; Sanclement JA, 2005, LARYNGOSCOPE, V115, P578, DOI 10.1097/01.mlg.0000161346.30752.18; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Suh Jeffrey D, 2011, Proc Am Thorac Soc, V8, P132, DOI 10.1513/pats.201003-028RN; Thomas AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183542; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Watelet JB, 2004, ALLERGY, V59, P54, DOI 10.1046/j.1398-9995.2003.00364.x; Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13; Wongkaewkhiaw S, 2019, BIOFOULING, V35, P573, DOI 10.1080/08927014.2019.1632835; Young FM, 2005, TOXICOL IN VITRO, V19, P1051, DOI 10.1016/j.tiv.2005.05.001; Yu YS, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100999; Zhang Z, 2015, INT FORUM ALLERGY RH, V5, P643, DOI 10.1002/alr.21505; Zhu C, 2013, J SURG RES, V183, P204, DOI 10.1016/j.jss.2012.11.048	66	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243315	10.1371/journal.pone.0243315	http://dx.doi.org/10.1371/journal.pone.0243315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326455	gold, Green Published			2022-12-26	WOS:000600176400005
J	Akomoneh, EA; Esemu, SN; Kfusi, AJ; Ndip, RN; Ndip, LM				Akomoneh, Elvis Achondou; Esemu, Seraphine Nkie; Kfusi, Achah Jerome; Ndip, Roland N.; Ndip, Lucy M.			Prevalence and virulence gene profiles of Escherichia coli O157 from cattle slaughtered in Buea, Cameroon	PLOS ONE			English	Article							SHIGA TOXIN; MEAT-PRODUCTS; OUTBREAK; EXPOSURE; HEALTH	BackgroundEscherichia coli O157 is an emerging foodborne pathogen of great public health concern. It has been associated with bloody diarrhoea, haemorrhagic colitis and haemolytic uremic syndrome in humans. Most human infections have been traced to cattle and the consumption of contaminated cattle products. In order to understand the risk associated with the consumption of cattle products, this study sought to investigate the prevalence and identify virulence genes in E. coli O157 from cattle in Cameroon. Method A total of 512 rectal samples were obtained and analysed using conventional bacteriological methods (enrichment on modified Tryptone Soy Broth and selective plating on Cefixime-Tellurite Sorbitol Mac-Conkey Agar) for the isolation of E. coli O157. Presumptive E. coli O157 isolates were confirmed serologically using E. COLIPROTM O157 latex agglutination test and molecularly using PCR targeting the rfb gene in the isolates. Characterisation of the confirmed E. coli O157 strains was done by amplification of stx1, stx2, eaeA and hlyA virulence genes using both singleplex and multiplex PCR. ResultsE. coli O157 was detected in 56 (10.9%) of the 512 samples examined. The presence of the virulence genes stx2, eaeA and hylA was demonstrated in 96.4% (54/56) of the isolates and stx1 in 40 (71.4%) of the 54. The isolates exhibited three genetic profiles (I-III) with I (stx1, stx2, eaeA and hlyA) being the most prevalent (40/56; 71.4%) while two isolates had none of the virulence genes tested. Conclusion A proportion of cattle slaughtered in abattoirs in Buea are infected with pathogenic E. coli O157 and could be a potential source of human infections. We recommend proper animal food processing measures and proper hygiene be prescribed and implemented to reduce the risk of beef contamination.	[Akomoneh, Elvis Achondou] Univ Bamenda, Dept Biol Sci, Fac Sci, Bamenda, Cameroon; [Esemu, Seraphine Nkie; Kfusi, Achah Jerome; Ndip, Roland N.; Ndip, Lucy M.] Univ Buea, Dept Microbiol & Parasitol, Fac Sci, Buea, Cameroon; [Esemu, Seraphine Nkie; Kfusi, Achah Jerome; Ndip, Roland N.; Ndip, Lucy M.] Univ Buea, Lab Emerging Infect Dis, Buea, Cameroon; [Ndip, Lucy M.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Akomoneh, EA (corresponding author), Univ Bamenda, Dept Biol Sci, Fac Sci, Bamenda, Cameroon.	eakomoneh@gmail.com	Esemu, Seraphine N./AAI-5972-2021	Esemu, Seraphine N./0000-0003-2497-4689; Akomoneh, Elvis/0000-0003-3882-2600				Afnabi R. B., 2015, International Journal of Veterinary Science, V4, P183; Asongwe G. A., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P682; Bekele T., 2014, International Journal of Food Contamination, V1; Beutin L, 2006, J VET MED B, V53, P299, DOI 10.1111/j.1439-0450.2006.00968.x; Bibbal D, 2015, APPL ENVIRON MICROB, V81, P1397, DOI 10.1128/AEM.03315-14; Cagney C, 2004, FOOD MICROBIOL, V21, P203, DOI 10.1016/S0740-0020(03)00052-2; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Chagomoka T, 2014, TRADITIONAL VEGETABL, P14; Dhaka Pankaj, 2016, Infection Ecology & Epidemiology, V6, P31055, DOI 10.3402/iee.v6.31055; Gautam R, 2015, EPIDEMIOL INFECT, V143, P274, DOI 10.1017/S0950268814000867; Gimou MM, 2014, FOOD ADDIT CONTAM A, V31, P1064, DOI 10.1080/19440049.2014.909953; Gyles CL, 1998, ESCHERICHIA COLI O15, P434; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; Hashemi M., 2010, World Applied Sciences Journal, V10, P703; Hessain AM, 2015, SAUDI J BIOL SCI, V22, P725, DOI 10.1016/j.sjbs.2015.06.009; Hiko A, 2008, J INFECT DEV COUNTR, V2, P389; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Leotta GA, 2008, BMC MICROBIOL, P8, DOI [10.1186/1471-2180-8-8, DOI 10.1186/1471-2180-8-8]; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Luga I., 2007, Nigerian Veterinary Journal, V28, P6; Luna S, 2018, MMWR-MORBID MORTAL W, V67, P659, DOI 10.15585/mmwr.mm6723a2; Luna-Guevara JJ, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/2894328; Mashood A, 2006, CHINESE MED J, V119, P217; Melton-Celsa AR, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0024-2013; Mohammad TA, 2015, JUNDISHAPUR J MICROB, V8, P25317; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Ngalim A.N., 2015, J ED POLICY ENTREPRE, V2, P175; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Persad AK, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0027-2014; Roger D. D., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P441; Sallam KI, 2013, INT J FOOD MICROBIOL, V165, P295, DOI 10.1016/j.ijfoodmicro.2013.05.024; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; Schwidder M, 2019, TOXINS, V11, DOI 10.3390/toxins11090502; Smith JL, 2014, ADV APPL MICROBIOL, V86, P145, DOI 10.1016/B978-0-12-800262-9.00003-2; Synge BA, 2000, ZOONOTIC INFECT LIVE, P10; Uyttendaele M, 2016, PROC FOOD SCI, V6, P16, DOI 10.1016/j.profoo.2016.02.003; Wasey A, 2018, STATPEARLS; Water Watch, 2018, E COL; WELLS JG, 1991, J CLIN MICROBIOL, V29, P985, DOI 10.1128/JCM.29.5.985-989.1991; Zadik PM, 1999, J MED MICROBIOL, V39, P155	42	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0235583	10.1371/journal.pone.0235583	http://dx.doi.org/10.1371/journal.pone.0235583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320853	Green Published, gold, Green Submitted			2022-12-26	WOS:000600339800009
J	Asfaw, MA; Gezmu, T; Wegayehu, T; Bekele, A; Hailemariam, Z; Masresha, N; Gebre, T				Asfaw, Mekuria Asnakew; Gezmu, Tigist; Wegayehu, Teklu; Bekele, Alemayehu; Hailemariam, Zeleke; Masresha, Nebiyu; Gebre, Teshome			Soil-transmitted helminth infections among pre-school aged children in Gamo Gofa zone, Southern Ethiopia: Prevalence, intensity and intervention status	PLOS ONE			English	Article								Background Soil-transmitted helminths (STH), i.e., Ascaris lumbricoides, Trichuris trichiura and hookworms are among the most prevalent Neglected Tropical Diseases (NTDs) in Ethiopia. Although pre-school aged children pay a high morbidity toll associated with STH infections, evidence on prevalence, intensity and intervention status is lacking in Ethiopia. This study, therefore, aimed to address these gaps to inform decision made on STH. Methods We did a community-based cross-sectional study in five districts of Gamo Gofa zone, Southern Ethiopia; in January 2019. Data were collected using pre-tested questionnaire, and the Kato-Katz technique was used to diagnose parasites eggs in stool. Then, collected data were edited and entered into EpiData 4.4.2, and exported to SPSS software (IBM, version 25) for analysis. Results A total of 2462 PSAC participated in this study. Overall, the prevalence of STH was 23.5% (578/2462) (95% confidence interval (CI) = 21.8%-25.2%). As caris lumbricoides was the most prevalent (18.6%), followed by Trichuris trichiura (9.2%), and hookworms (3.1%). Of the total, 7.4% PSAC were infected with two STH species. Most of the positive cases with STH showed low infection intensities, while 15.1% ascariasis cases showed moderate infection intensities. The study found that 68.7% of PSAC were treated with albendazole. Also, household's level data showed that 39.4% used water from hand-dug well; 52.5% need to travel >= 30 minutes to collect water; 77.5% did not treat water, and 48.9% had no hand washing facility. In addition, almost 93% care givers achieved less than the mean knowledge and practice score (<= 5) on STH prevention. Conclusions This study showed that significant proportions of pre-school aged children are suffering from STH infections despite preventive chemotherapy exist at the study area. Also, gaps in the interventions against STH were highlighted. Thus, a call for action is demanding to eliminate STH among PSAC in Ethiopia by 2030.	[Asfaw, Mekuria Asnakew; Gezmu, Tigist; Bekele, Alemayehu] Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia; [Wegayehu, Teklu] Arba Minch Univ, Coll Nat Sci, Dept Biol, Arba Minch, Ethiopia; [Hailemariam, Zeleke] Arba Minch Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Masresha, Nebiyu] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Gebre, Teshome] Int Trachoma Initiat, Task Force Global Hlth, Addis Ababa, Ethiopia	Arba Minch University; Arba Minch University; Arba Minch University	Asfaw, MA (corresponding author), Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia.	maksambaramr23@gmail.com	Kassahun, Alemayehu Bekele/ABA-5651-2021	Kassahun, Alemayehu Bekele/0000-0001-8341-4855; Gezmu, Tigist/0000-0001-5937-8452; asfaw, mekuria/0000-0002-5718-0001	collaborative research and training center for NTDs, Arba Minch University, Ethiopia	collaborative research and training center for NTDs, Arba Minch University, Ethiopia	This study is made possible by the generous research grant support of collaborative research and training center for NTDs, Arba Minch University, Ethiopia.	Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P145; [Anonymous], 2014, J CLIN DIAGN RES, V8; [Anonymous], 2013, BMC P S6, V7, pO1; Asfaw MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235281; Becker SL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006606; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Central Statistical Agency, 2013, POP PROJ ETH 2007 20; Dana D, 2015, T ROY SOC TROP MED H, V109, P225, DOI 10.1093/trstmh/tru178; Davis SM, 2014, AM J TROP MED HYG, V91, P1002, DOI 10.4269/ajtmh.14-0060; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Ethiopian Federal Minstry of Health, 2013, NAT MAST PLAN NEGL T; Federal Democratic Republic of Ethiopia Ministry of Health, 2016, ETH NAT MAST PLAN NE; Freeman MC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007201; Ghiwot Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109793; Gizaw Z, 2018, ENVIRON HEALTH PREV, V23, DOI 10.1186/s12199-018-0714-3; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Leta GT, NATL MAPPING SOIL TR; Moncayo AL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021319; Montresor A, 2017, T ROY SOC TROP MED H, V111, P457, DOI 10.1093/trstmh/trx082; Nyantekyi LA, 2010, ETHIOP J HEALTH DEV, V24, P185; Ojja S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3289-0; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Shumbej T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136342; SOERIPTO N, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P216; Sowemimo OA, 2011, J HELMINTHOL, V85, P234, DOI 10.1017/S0022149X10000489; Stephenson LS, 2000, PARASITOLOGY, V121, pS1, DOI 10.1017/S0031182000009410; Tchuente LAT, 2012, CURRENT TOPICS IN TROPICAL MEDICINE, P359; Tekalign E, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3687873; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; WHO, 2020, ENDING NEGLECT ATTAI; WHO, 2006, COORD US ANTH DRUGS; WHO, SOIL TRANSM HELM EL; WHO Expert Committee, 2002, World Health Organ Tech Rep Ser, V912, pi; World Health Organization, 1994, KAT KATZ TECHN BENCH; World Health Organization, 2011, INT WORMS SOIL TRANS; World Health Organization, 2019, UN HLTH COV WHO FACT; World Health Organization, 2017, GUID PREV CHEM CONTR; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162; 2010, LASER PHOTON REV, V4	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243946	10.1371/journal.pone.0243946	http://dx.doi.org/10.1371/journal.pone.0243946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320918	Green Published, gold			2022-12-26	WOS:000600339800029
J	Mude, W; Oguoma, VM; Gesesew, HA; Ameyaw, EK; Njue, C; Nyanhanda, T; Adeleye, AO; Dune, T; Kaambwa, B; Mwanri, L				Mude, William; Oguoma, Victor M.; Gesesew, Hailay Abrha; Ameyaw, Edward K.; Njue, Carolyne; Nyanhanda, Tafadzwa; Adeleye, Adeniyi O.; Dune, Tinashe; Kaambwa, Billingsley; Mwanri, Lillian			HIV/AIDS knowledge and attitudes assessment among women of child-bearing age in South Sudan: Findings from a Household Survey	PLOS ONE			English	Article							STIGMA; PREVENTION; REGRESSION; HEALTH	This study assessed the determinants that shape HIV knowledge and attitudes among South Sudanese women by analysing a Multiple Indicator Cluster Survey collected from 9,061 women in 9,369 households. Generalised linear mixed model regression was performed. Fifty percent of respondents were aware of HIV/AIDS, with 21% and 22% exhibiting good knowledge and positive attitudes towards people with HIV/AIDS, respectively. When controlled for individual and community-level variables, younger women (AOR = 1.28, 95% CI: 1.01-162), women with primary (AOR = 2.19; 95% CI: 1.86-2.58) and secondary (AOR = 4.48; 95% CI: 3.38-5.93) education, and those living in urban areas (AOR = 1.40; 95% CI: 1.12-1.76) had significantly good knowledge. Women in the richer (AOR = 1.60; 95% CI: 1.08-2.36) and the richest (AOR = 2.02; 95% CI: 1.35-3.02) wealth quintiles had significant positive attitudes towards people with HIV/AIDS. Well-designed social and behavioural campaigns targeting uneducated women and those living in rural and remote settings will enhance knowledge of perceived risk, awareness, and ability to carry out preventive behaviours.	[Mude, William] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Sydney, NSW, Australia; [Oguoma, Victor M.] Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia; [Gesesew, Hailay Abrha; Kaambwa, Billingsley; Mwanri, Lillian] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Gesesew, Hailay Abrha] Mekelle Univ, Sch Hlth Sci, Mekelle, Ethiopia; [Ameyaw, Edward K.; Njue, Carolyne] Univ Technol Sydney, Sch Publ Hlth, Australian Ctr Publ & Populat Hlth Res ACPPHR, Sydney, NSW, Australia; [Nyanhanda, Tafadzwa] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Melbourne, Vic, Australia; [Adeleye, Adeniyi O.] Cent Queensland Univ, Sch Nursing Midwifery & Social Sci, MacKay, Australia; [Dune, Tinashe] Western Sydney Univ, Sch Hlth Sci, Sydney, NSW, Australia	Central Queensland University; University of Canberra; Flinders University South Australia; Mekelle University; University of Technology Sydney; Central Queensland University; Central Queensland University; Western Sydney University	Mude, W (corresponding author), Cent Queensland Univ, Sch Hlth Med & Appl Sci, Sydney, NSW, Australia.	w.mude@cqu.edu.au	Mude, William/Z-3597-2019; Oguoma, Victor/I-9177-2014; Mwanri, Lillian/AGG-3711-2022	Oguoma, Victor/0000-0001-9505-7197; Nyanhanda, Tafadzwa/0000-0001-6502-5645; Njue, Carolyne/0000-0001-9325-3565; Mude, William/0000-0003-1961-5681; Gesesew, Hailay/0000-0002-3531-4400; Mwanri, Lillian/0000-0002-5792-7785; KAAMBWA, BILLINGSLEY/0000-0002-2128-3404; Ameyaw, Edward Kwabena/0000-0002-6617-237X				Ali NM, 2012, HOPE PAIN PATIENCE L, P111; Alwafi HA, 2018, J INFECT PUBLIC HEAL, V11, P80, DOI 10.1016/j.jiph.2017.04.005; Alwano MG, 2019, INCREASING KNOWLEDGE, V14; Amoah PA, 2018, PUBLIC HEALTH, V159, P40, DOI 10.1016/j.puhe.2018.03.002; [Anonymous], 2018, J PUBLIC HLTH EMERG; Baba SP, 2013, MMWR-MORBID MORTAL W, V62, P453; Banagi Yathiraj Arjun, 2017, J Int Assoc Provid AIDS Care, V16, P615, DOI 10.1177/2325957417742671; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Burgoyne Amy D, 2008, Afr J Reprod Health, V12, P14; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Center for Disease Control and Prevention, 2022, SOCIAL DETERMINANTS; Courtney LP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187689; Dai XC, 2019, LANCET GLOB HEALTH, V7, pS4, DOI 10.1016/S2214-109X(19)30089-0; Downie R., 2012, STATE PUBLIC HLTH S; Edward JK, 2014, J WEEKLY REV; El Fadl RKA, 2019, HIV AIDS-RES PALLIAT, V11, P83, DOI 10.2147/HIV.S195984; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Jesmin SS, 2013, HEALTH CARE WOMEN IN, V34, P303, DOI 10.1080/07399332.2012.736571; Jones A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009296; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Khalid F, 2013, COMMUNITY MED HLTH E, V3, P2161; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Mach BS, 2017, J HEALTH RES, V31, pS65, DOI 10.14456/jhr.2017.69; Merakou K, 2002, EUR J PUBLIC HEALTH, V12, P90, DOI 10.1093/eurpub/12.2.90; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Ministry of Health and National Bureau of Statistics, 2013, S SUD HOUS SURV JUB; Poni-Gore R, 2015, STIGMA DISCRIMINATIO; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Setswe G, 2016, MILLENNIUM DEV GOAL; Skinner D, 2004, SAHARA J, V1, P157; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Sullivan MC, 2020, FALLING SHORT 1 90 H; Taylor J, 2018, AUST J PRIM HEALTH, V24, P14, DOI [10.1071/py16147, 10.1071/PY16147]; Teshome R., 2016, J AIDS CLIN RES, V07, P1, DOI [10.4172/2155-6113.1000559, DOI 10.4172/2155-6113.1000559]; UNAIDS, 2018, UNAIDS S SUD; UNAIDS, 2014, UND FAST TRACK ACC A; UNICEF, 2010, MICS 4 TOOLS; WHO, 2020, S SUD COUNTR RESP	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243969	10.1371/journal.pone.0243969	http://dx.doi.org/10.1371/journal.pone.0243969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315916	gold, Green Published			2022-12-26	WOS:000600186100086
J	Popov, AV; Endutkin, AV; Yatsenko, DD; Yudkina, AV; Barmatov, AE; Makasheva, KA; Raspopova, DY; Diatlova, EA; Zharkov, DO				Popov, Aleksandr V.; Endutkin, Anton V.; Yatsenko, Darya D.; Yudkina, Anna V.; Barmatov, Alexander E.; Makasheva, Kristina A.; Raspopova, Darya Yu.; Diatlova, Evgeniia A.; Zharkov, Dmitry O.			Molecular dynamics approach to identification of new OGG1 cancer-associated somatic variants with impaired activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HUMAN 8-OXOGUANINE-DNA GLYCOSYLASE; AMINO-ACID SUBSTITUTIONS; DNA GLYCOSYLASE; SUBSTRATE RECOGNITION; HUMAN LUNG; ESCHERICHIA-COLI; PROTEIN HOGG1; MUTATIONS; PREDICTION	DNA of living cells is always exposed to damaging factors. To counteract the consequences of DNA lesions, cells have evolved several DNA repair systems, among which base excision repair is one of the most important systems. Many currently used antitumor drugs act by damaging DNA, and DNA repair often interferes with chemotherapy and radiotherapy in cancer cells. Tumors are usually extremely genetically heterogeneous, often bearing mutations in DNA repair genes. Thus, knowledge of the functionality of cancer-related variants of proteins involved in DNA damage response and repair is of great interest for personalization of cancer therapy. Although computational methods to predict the variant functionality have attracted much attention, at present, they are mostly based on sequence conservation and make little use of modern capabilities in computational analysis of 3D protein structures. We have used molecular dynamics (MD) to model the structures of 20 clinically observed variants of a DNA repair enzyme, 8-oxoguanine DNA glycosylase. In parallel, we have experimentally characterized the activity, thermostability, and DNA binding in a subset of these mutant proteins. Among the analyzed variants of 8-oxoguanine DNA glycosylase, three (I145M, G202C, and V267M) were significantly functionally impaired and were successfully predicted by MD. Alone or in combination with sequence-based methods, MD may be an important functional prediction tool for cancer-related protein variants of unknown significance.	[Popov, Aleksandr V.; Endutkin, Anton V.; Yatsenko, Darya D.; Yudkina, Anna V.; Barmatov, Alexander E.; Diatlova, Evgeniia A.; Zharkov, Dmitry O.] RAS, Inst Chem Biol & Fundamental Med, SB, Lab Genome & Prot Engn, Novosibirsk, Russia; [Yatsenko, Darya D.; Makasheva, Kristina A.; Raspopova, Darya Yu.; Zharkov, Dmitry O.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University	Popov, AV; Zharkov, DO (corresponding author), RAS, Inst Chem Biol & Fundamental Med, SB, Lab Genome & Prot Engn, Novosibirsk, Russia.; Zharkov, DO (corresponding author), Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia.	apopov@niboch.nsc.ru; dzharkov@niboch.nsc.ru	Zharkov, Dmitry/K-2158-2012; Yudkina, Anna/ABA-5710-2020; Barmatov, Alexander/ABE-2455-2021; Diatlova, Evgeniia/AAF-7949-2021; Yatsenko, Darya/ABE-1887-2021	Zharkov, Dmitry/0000-0001-5013-0194; Yudkina, Anna/0000-0003-3682-3431; Barmatov, Alexander/0000-0003-4478-1200; Yatsenko, Darya/0000-0002-4230-7364; Endutkin, Anton/0000-0002-3647-6591; Diatlova, Evgeniia/0000-0001-5808-8568; Makasheva, Kristina/0000-0002-0645-6848	Russian Foundation for Basic Research [17-00-00261/17-00-00265-komfi]; Russian Science Foundation [18-74-00052]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This research was supported by the Russian Foundation for Basic Research (grant 17-00-00261/17-00-00265-komfi to D. O. Z) and Russian Science Foundation (grant 18-74-00052 to A. V. P.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anderson PC, 2009, J AM CHEM SOC, V131, P9506, DOI 10.1021/ja809726e; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P15020, DOI 10.1073/pnas.0603644103; Beckman RA, 2017, DNA REPAIR, V56, P7, DOI 10.1016/j.dnarep.2017.06.002; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Blumenthal DT, 2015, INT J CLIN ONCOL, V20, P650, DOI 10.1007/s10147-014-0769-0; Boldinova EO, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133279; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calvaresi M, 2007, J PHYS CHEM B, V111, P6557, DOI 10.1021/jp071581i; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Case D.A., 2022, AMBER 2020; Castellana S, 2013, BRIEF BIOINFORM, V14, P448, DOI 10.1093/bib/bbt013; Chae YK, 2016, ONCOTARGET, V7, P23312, DOI 10.18632/oncotarget.8196; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Chung SJ, 2004, CHEM BIOL, V11, P1643, DOI 10.1016/j.chembiol.2004.09.014; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dehghanpoor R, 2018, MOLECULES, V23, DOI 10.3390/molecules23020251; Deza M.M, 2014, ENCY DISTANCES, Vthird; Esadze A, 2017, BIOCHEMISTRY-US, V56, P1974, DOI 10.1021/acs.biochem.7b00017; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Germano G, 2017, NATURE, V552, P116, DOI 10.1038/nature24673; Gibbons DL, 2014, P NATL ACAD SCI USA, V111, P3550, DOI 10.1073/pnas.1321173111; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; He YH, 2002, AM J PHYSIOL-LUNG C, V282, pL50, DOI 10.1152/ajplung.00316.2001; Hill JW, 2007, CANCER DETECT PREV, V31, P237, DOI 10.1016/j.cdp.2007.05.001; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hyun JW, 2000, ONCOGENE, V19, P4476, DOI 10.1038/sj.onc.1203787; Hyun JW, 2002, FREE RADICAL BIO MED, V32, P212, DOI 10.1016/S0891-5849(01)00793-6; Kaina B, 2010, CELL MOL LIFE SCI, V67, P3663, DOI 10.1007/s00018-010-0491-7; Kamps R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020308; Kellie JL, 2015, J PHYS CHEM B, V119, P8013, DOI 10.1021/acs.jpcb.5b04051; Kellie JL, 2012, J PHYS CHEM B, V116, P10786, DOI 10.1021/jp306344g; Khafizov K, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2794-y; Kobune M, 2001, CANCER RES, V61, P5116; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Lee S, 2008, J AM CHEM SOC, V130, P7784, DOI 10.1021/ja800821t; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li HQ, 2017, J AM CHEM SOC, V139, P2682, DOI 10.1021/jacs.6b11433; Liu LA, 2012, CURR OPIN STRUC BIOL, V22, P397, DOI 10.1016/j.sbi.2012.06.002; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Lukina MV, 2013, J BIOL CHEM, V288, P28936, DOI 10.1074/jbc.M113.487322; Martelotto LG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0484-1; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Norman DPG, 2001, J AM CHEM SOC, V123, P359, DOI 10.1021/ja003144m; Oliver C, 2017, EUR J MED GENET, V60, P289, DOI 10.1016/j.ejmg.2017.03.008; Pejaver V, 2017, HUM MUTAT, V38, P1092, DOI 10.1002/humu.23258; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Popov AV, 2020, BIOCHEMISTRY-MOSCOW+, V85, P192, DOI 10.1134/S0006297920020066; Popov AV, 2013, J COMPUT CHEM, V34, P319, DOI 10.1002/jcc.23135; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Preston TJ, 2009, MOL CANCER THER, V8, P2015, DOI 10.1158/1535-7163.MCT-08-0929; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; Raimondi D, 2016, BIOINFORMATICS, V32, P1797, DOI 10.1093/bioinformatics/btw094; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadeghian K, 2015, J AM CHEM SOC, V137, P9824, DOI 10.1021/jacs.5b01449; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schyman P, 2005, J PHYS CHEM A, V109, P1713, DOI 10.1021/jp045686m; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sidorenko VS, 2007, DNA REPAIR, V6, P317, DOI 10.1016/j.dnarep.2006.10.022; Sidorenko VS, 2008, FEBS J, V275, P3747, DOI 10.1111/j.1742-4658.2008.06521.x; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sneha P, 2016, ADV PROTEIN CHEM STR, V102, P181, DOI 10.1016/bs.apcsb.2015.09.004; Sowlati-Hashjin S, 2018, BIOCHEMISTRY-US, V57, P1144, DOI 10.1021/acs.biochem.7b01292; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tyugashev TE, 2019, J PHYS CHEM B, V123, P4878, DOI 10.1021/acs.jpcb.9b02949; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wong KC, 2014, BIOINFORMATICS, V30, P1112, DOI 10.1093/bioinformatics/btt769; Wu M, 2008, TOXICOL APPL PHARM, V228, P395, DOI 10.1016/j.taap.2007.12.020; Xu Y, 2001, J PHARMACOL EXP THER, V296, P825; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	90	2	2	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100229	10.1074/jbc.RA120.014455	http://dx.doi.org/10.1074/jbc.RA120.014455			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361155	gold, Green Published			2022-12-26	WOS:000672866400207
J	Bui, LV; Nguyen, HT; Levine, H; Nguyen, HN; Nguyen, TA; Nguyen, TP; Nguyen, TT; Do, TTT; Pham, NT; Bui, MH				Bui, Long V.; Nguyen, Ha T.; Levine, Hagai; Nguyen, Ha N.; Nguyen, Thu-Anh; Nguyen, Thuy P.; Nguyen, Truong T.; Do, Toan T. T.; Pham, Ngoc T.; Bui, My Hanh			Estimation of the incubation period of COVID-19 in Vietnam	PLOS ONE			English	Article								Objective To estimate the incubation period of Vietnamese confirmed COVID-19 cases. Methods Only confirmed COVID-19 cases who are Vietnamese and locally infected with available data on date of symptom onset and clearly defined window of possible SARS-CoV-2 exposure were included. We used three parametric forms with Hamiltonian Monte Carlo method for Bayesian Inference to estimate incubation period for Vietnamese COVID-19 cases. Leave-one-out Information Criterion was used to assess the performance of three models. Results A total of 19 cases identified from 23 Jan 2020 to 13 April 2020 was included in our analysis. Average incubation periods estimated using different distribution model ranged from 6.0 days to 6.4 days with the Weibull distribution demonstrated the best fit to the data. The estimated mean of incubation period using Weibull distribution model was 6.4 days (95% credible interval (CrI): 4.89-8.5), standard deviation (SD) was 3.05 (95%CrI 3.05-5.30), median was 5.6, ranges from 1.35 to 13.04 days (2.5th to 97.5th percentiles). Extreme estimation of incubation periods is within 14 days from possible infection. Conclusion This analysis provides evidence for an average incubation period for COVID-19 of approximately 6.4 days. Our findings support existing guidelines for 14 days of quarantine of persons potentially exposed to SARS-CoV-2. Although for extreme cases, the quarantine period should be extended up to three weeks.	[Bui, Long V.] Ctr Res Consulting & Support Community Heath, Hanoi, Vietnam; [Nguyen, Ha T.] 108 Mil Cent Hosp, Hanoi, Vietnam; [Levine, Hagai] Hadassah Hebrew Univ, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel; [Nguyen, Ha N.] Peoples Police Acad, Hanoi, Vietnam; [Nguyen, Thu-Anh] Woolcock Inst Med Res, Hanoi, Vietnam; [Nguyen, Thu-Anh] Univ Sydney, Fac Med & Hlth, Camperdown, NSW, Australia; [Nguyen, Thuy P.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Nguyen, Truong T.] Minist Sci & Technol, Hanoi, Vietnam; [Do, Toan T. T.; Bui, My Hanh] Hanoi Med Univ, Hanoi, Vietnam; [Pham, Ngoc T.] 198 Hosp, Hanoi, Vietnam; [Bui, My Hanh] Hanoi Med Univ Hosp, Hanoi, Vietnam	Hebrew University of Jerusalem; Hadassah University Medical Center; University of Sydney; University of Tasmania; Menzies Institute for Medical Research; Hanoi Medical University; Hanoi Medical University	Bui, LV (corresponding author), Ctr Res Consulting & Support Community Heath, Hanoi, Vietnam.	buimyhanh@hmu.edu.vn	Bui, Hanh My/AAV-6376-2021; Bui, Long/R-9830-2019; Anh, Nguyễn/HGU-8434-2022	Bui, Hanh My/0000-0002-4137-2906; Bui, Long/0000-0001-9997-593X; Thu Ha, Nguyen/0000-0002-0647-8801; Nguyen, Thu Anh/0000-0002-2089-2902; Nguyen, Thuy Phuong/0000-0002-0558-8662				Assiri A, 2013, HOSP OUTBREAK MIDDLE, DOI [10.1056/NEJMoa1306742, 10.1056/NEJMoa1306742?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov, DOI 10.1056/NEJM0A1306742]; Backer JA, 2020, CHINA EURO SURVEILL, V25, P5, DOI DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hoang VM, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1776526; Jiang X, 2020, J MED VIROL, V92, P476, DOI 10.1002/jmv.25708; Kong T, 2020, AGING MED MILTON; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee HS, 2020, J INFECT CHEMOTHER, V26, P1011, DOI 10.1016/j.jiac.2020.06.018; Leung C, INFECT CONTROL HOSP, P1; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Nguyen THD, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101651; Nishiura H, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-2; Pham QT, CLIN INFECT DIS, DOI 10.1093/cid/ciaa1130/5879764; Qin J, 2020, SCI ADV, V6, DOI [10.1126/sciadv.abc1202, 10.1101/2020.03.06.20032417]; R Core Team, 2021, R LANGUAGE ENV STAT; Stan Development Team, RSTAN R INT STAN; Thanh HN, 2020, LANCET INFECT DIS, V0; Tindale LC, 2020, ELIFE, V9, DOI 10.7554/eLife.57149; TOP AGRAR, 2010, STARKEKARTOFFELN KAM, V10, P50; Vehtari A, 2017, STAT COMPUT, V27, P1433, DOI 10.1007/s11222-016-9709-3; World Health Organization, 2020, 73 WHO	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243889	10.1371/journal.pone.0243889	http://dx.doi.org/10.1371/journal.pone.0243889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362233	Green Published, gold, Green Accepted			2022-12-26	WOS:000603071600038
J	Wong, DWS; Li, Y				Wong, David W. S.; Li, Yun			Spreading of COVID-19: Density matters	PLOS ONE			English	Article							POPULATION-DENSITY; PATTERNS; SCALE	Physical distancing has been argued as one of the effective means to combat the spread of COVID-19 before a vaccine or therapeutic drug becomes available. How far people can be spatially separated is partly behavioral but partly constrained by population density. Most models developed to predict the spread of COVID-19 in the U.S. do not include population density explicitly. This study shows that population density is an effective predictor of cumulative infection cases in the U.S. at the county level. Daily cumulative cases by counties are converted into 7-day moving averages. Treating the weekly averages as the dependent variable and the county population density levels as the explanatory variable, both in logarithmic scale, this study assesses how population density has shaped the distributions of infection cases across the U.S. from early March to late May, 2020. Additional variables reflecting the percentages of African Americans, Hispanic-Latina, and older adults in logarithmic scale are also included. Spatial regression models with a spatial error specification are also used to account for the spatial spillover effect. Population density alone accounts for 57% of the variation (R-squared) in the aspatial models and up to 76% in the spatial models. Adding the three population subgroup percentage variables raised the R-squared of the aspatial models to 72% and the spatial model to 84%. The influences of the three population subgroups were substantial, but changed over time, while the contributions of population density have been quite stable after the first several weeks, ascertaining the importance of population density in shaping the spread of infection in individual counties, and in their neighboring counties. Thus, population density and sizes of vulnerable population subgroups should be explicitly included in transmission models that predict the impacts of COVID-19, particularly at the sub-county level.	[Wong, David W. S.; Li, Yun] George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA; [Li, Yun] George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA	George Mason University; George Mason University	Li, Y (corresponding author), George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA.; Li, Y (corresponding author), George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA.	yli38@gmu.edu			NSF [2027521, 1841520, 1835507]	NSF(National Science Foundation (NSF))	The research presented in this paper was funded by NSF 2027521, 1841520, and 1835507.	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Bahl P, 2022, J INFECT DIS, V225, P1561, DOI 10.1093/infdis/jiaa189; CDC, 2020, COR DIS 2019 COVID 1; CLARK C, 1951, J ROY STAT SOC A STA, V114, P490, DOI 10.2307/2981088; Das Gupta D, CANADIAN J PUBLIC HL; Fonseca JW, 2000, PROF GEOGR, V52, P504, DOI 10.1111/0033-0124.00242; Gale R, WASHINGTON POST; GRIFFITH DA, 1981, PROF GEOGR, V33, P189, DOI 10.1111/j.0033-0124.1981.00189.x; Griffith DA, 2007, J GEOGR SYST, V9, P53, DOI 10.1007/s10109-006-0032-y; Griffith DA, 2016, ECONOMETRICS, V4, DOI 10.3390/econometrics4020029; He Y, 2020, MOVING AVERAGE BASED; Holt J. B., 2004, CARTOGR GEOGR INF SC, V31, P103, DOI [10.1559/1523040041649407, DOI 10.1559/1523040041649407]; Hu H, 2013, MATH BIOSCI, V244, P125, DOI 10.1016/j.mbs.2013.04.013; LAM NSN, 1992, PROF GEOGR, V44, P88, DOI 10.1111/j.0033-0124.1992.00088.x; Larson J, 1993, AM DEMOGR, V15, P38; MacIntyre CR, 2020, LANCET, V0; McMillen DP, 1997, J REGIONAL SCI, V37, P591, DOI 10.1111/0022-4146.00071; Mittal R, 2020, J FLUID MECH, V894, DOI 10.1017/jfm.2020.330; NEWLING BE, 1969, GEOGR REV, V59, P242, DOI 10.2307/213456; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Somsen GA, 2020, LANCET RESP MED, V8, P658, DOI 10.1016/S2213-2600(20)30245-9; Spielman SE, 2014, APPL GEOGR, V46, P147, DOI 10.1016/j.apgeog.2013.11.002; Tarwater Patrick M., 2001, Complexity, V6, P29, DOI 10.1002/cplx.10003	23	77	77	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242398	10.1371/journal.pone.0242398	http://dx.doi.org/10.1371/journal.pone.0242398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362283	gold, Green Published			2022-12-26	WOS:000603071600052
J	Martingano, D; Nguyen, A; Nkeih, C; Singh, S; Mitrofanova, A				Martingano, Daniel; Nguyen, Ashley; Nkeih, Claudia; Singh, Shailini; Mitrofanova, Antonina			Clarithromycin use for adjunct surgical prophylaxis before non-elective cesarean deliveries to adapt to azithromycin shortages in COVID-19 pandemic	PLOS ONE			English	Article							MULTICENTER	Objective This study aimed to evaluate safety and effectiveness of clarithromycin as adjunctive antibiotic prophylaxis for patients undergoing non-elective cesarean delivery in comparison with no macrolides, to adapt to azithromycin shortages in COVID-19 pandemic. Study design We conducted a multi-center, prospective observational cohort study from March 23, 2020 through June 1, 2020. We followed all women receiving either clarithromycin or no macrolide antibiotic for adjunct surgical prophylaxis for non-elective cesarean deliveries. The primary outcome was development of postpartum endometritis. Secondary outcomes included meconium-stained amniotic fluid at time of cesarean delivery, neonatal sepsis, neonatal intensive care unit admission, and neonatal acute respiratory distress syndrome. All patients in this study were tested for SARS-CoV-2 infection and resulted negative. Results This study included 240 patients, with 133 patients receiving clarithromycin and 107 patients receiving no adjunct macrolide prophylaxis. Patients receiving clarithromycin were noted to have significantly lower rates of postpartum endometritis as compared to those who did not receive adjunct prophylaxis (4.5% versus 11.2%, p = 0.025). In crude (unadjusted) analysis, a significantly lower risk of developing endometritis was noted in the clarithromycin group as compared to the control group (66% decreased risk, 95% CI 0.12 to 0.95, p = 0.040). When adjusted for perceived confounders, a significant difference was again noted (67% decreased risk, 95% CI 0.11 to 0.97, p = 0.034). Stratified analysis of significantly different demographic factors including Black race, BMI, and age was performed. A significantly decreased risk of development of endometritis when taking clarithromycin versus no adjunct macrolide was noted for Black race women in crude and adjusted models (crude: 87% decreased risk, 95% CI 0.08 to 0.83, p = 0.032; adjusted: 91% decreased risk, 95% CI 0.06 to 0.79, p = 0.026). This was also noted for women aged 18-29 years in crude and adjusted models (crude: model, 79% decreased risk, 95% CI 0.06 to 0.80, p = 0.014; adjusted model: 75% decreased risk, 95% CI 0.06 to 0.94, p = 0.028). All other stratified analyses did not yield significant differences in endometritis risk. Conclusion Our study suggests that administration of clarithromycin for adjunctive surgical prophylaxis for non-elective cesarean deliveries may be a safe option that may provide suitable endometritis prophylaxis in cases where azithromycin is unavailable, as was the case during the start of COVID-19 pandemic, most especially for Black race women and women ages 18-29 years.	[Martingano, Daniel; Nguyen, Ashley; Nkeih, Claudia; Singh, Shailini] St Johns Episcopal Hosp, Dept Obstet & Gynecol, Far Rockaway, NY 11691 USA; [Martingano, Daniel; Mitrofanova, Antonina] Rutgers State Univ, Sch Hlth Profess, Dept Biomed & Hlth Informat, Newark, NJ 07102 USA; [Martingano, Daniel; Nkeih, Claudia] Trinitas Reg Med Ctr, Dept Obstet & Gynecol, Elizabeth, NJ 07202 USA; [Singh, Shailini] Newark Beth Israel Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Newark, NJ USA; [Singh, Shailini] Rutgers Robert Wood Johnson Med Sch, Dept Obstet & Gynecol, New Brunswick, NJ USA; [Mitrofanova, Antonina] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Newark Beth Israel Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Martingano, D (corresponding author), St Johns Episcopal Hosp, Dept Obstet & Gynecol, Far Rockaway, NY 11691 USA.; Martingano, D; Mitrofanova, A (corresponding author), Rutgers State Univ, Sch Hlth Profess, Dept Biomed & Hlth Informat, Newark, NJ 07102 USA.; Martingano, D (corresponding author), Trinitas Reg Med Ctr, Dept Obstet & Gynecol, Elizabeth, NJ 07202 USA.; Mitrofanova, A (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA.	dmartingano@ehs.org; amitrofa@shp.rutgers.edu		Martingano, Daniel/0000-0001-8767-2528	Rutgers School of Health Professions	Rutgers School of Health Professions	Antonina Mitrofanova has been supported by start-up funds from Rutgers School of Health Professions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; American College of Obstetricians and Gynecologists, 2003, Obstet Gynecol, V102, P875; Badreldin HA, 2021, RES SOC ADMIN PHARM, V17, P1946, DOI 10.1016/j.sapharm.2020.05.017; Bar-Oz B, 2008, EUR J OBSTET GYN R B, V141, P31, DOI 10.1016/j.ejogrb.2008.07.008; Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100111; Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100118; Catillon M, 2020, NEWS COVERAGE DRUG S; Cavalcanti AB, 2020, HYDROXYCHLOROQUINE A; Drinkard CR, 2000, PHARMACOEPIDEM DR S, V9, P549, DOI 10.1002/pds.538; Einarson A, 1998, AM J PERINAT, V15, P523, DOI 10.1055/s-2007-994053; Franchi M, 2019, EUR J OBSTET GYN R B, V236, P26, DOI 10.1016/j.ejogrb.2019.02.023; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Gloviczki P, 2011, J VASC SURG, V53, p2S, DOI 10.1016/j.jvs.2011.01.079; Hager RME, 2004, AM J OBSTET GYNECOL, V190, P428, DOI 10.1016/j.ajog.2003.08.037; HOLSHUE ML, 2020, NEW ENGL J MED, V382, P929, DOI [10.1056/NEJMoa2001191, DOI 10.1056/NEJMOA2001191, DOI 10.1056/NEJM0A2001191]; Lane JC, 2020, SAFETY HYDROXYCHLORO; Macones GA, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.04.012; Main EK, 2019, OBSTET GYNECOL, V133, P613, DOI 10.1097/AOG.0000000000003109; Million M, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101738; Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006; RAPP RP, 1994, ANN PHARMACOTHER, V28, P1255, DOI 10.1177/106002809402801109; RCore Team, 2020, R LANG ENV STAT COMP; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; STURGILL MG, 1992, ANN PHARMACOTHER, V26, P1099, DOI 10.1177/106002809202600912; Tita ATN, 2016, NEW ENGL J MED, V375, P1231, DOI 10.1056/NEJMoa1602044; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; World Health Organization, 2020, WHO DIR GEN OP REM M, DOI DOI 10.1093/ANNONC/MDY517; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244266	10.1371/journal.pone.0244266	http://dx.doi.org/10.1371/journal.pone.0244266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347510	Green Published, gold			2022-12-26	WOS:000603071100058
J	Lee, S; Park, S; Kim, Y; Lee, Y; Kang, MW; Cho, S; Kim, YC; Han, SS; Lee, H; Lee, JP; Joo, KW; Lim, CS; Kim, YS; Han, K; Kim, DK				Lee, Soojin; Park, Sehoon; Kim, Yaerim; Lee, Yeonhee; Kang, Min Woo; Cho, Semin; Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Han, Kyungdo; Kim, Dong Ki			Impact of variability in estimated glomerular filtration rate on major clinical outcomes: A nationwide population-based study	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; VISIT-TO-VISIT; CHRONIC KIDNEY-DISEASE; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR OUTCOMES; SOCIOECONOMIC-STATUS; HIGHER ALBUMINURIA; HIGH-RISK; ALL-CAUSE; MORTALITY	Background The estimated glomerular filtration rate (eGFR), commonly estimated using the serum creatinine value, often fluctuates throughout the serial measurement. The clinical significance of GFR variation among the general population with normal renal function has not yet been demonstrated. Thus, we explored the impact of GFR variability on adverse clinical outcomes. Methods A nationwide retrospective cohort study using the Korean National Health Insurance System database was performed. National health screening examinees who underwent creatinine measurement >= 3 times between 2012 and 2016 were considered. Those with eGFR under 60 mL/min/m(2) were excluded. The fluctuation of eGFR was represented with variability independent of the mean (VIM) index; which was calculated by the standard deviation divided by the exponent of the regression coefficient of the mean. Then, the risks of myocardial infarction (MI), stroke and death were assessed according to the quartiles of the VIM Results Of total 3,538,500 participants, 0.29% of myocardial infarction (MI), 0.14% of stroke, 0.36% of deaths were observed during the median follow up of 3.27 years. Participants with the highest VIM index, which represents the highest eGFR variability, were significantly associated with an increased risk of MI (hazard ratio [HR]; 1.10, 95% confidence interval [95% CI]; 1.04-1.16), stroke (HR: 1.16; 95% CI 1.09-1.23), and death (HR: 1.18; 95% CI 1.12-1.24). The elevated risk of adverse events was consistent after the multivariate adjustment with potential confounding factors, except the risk of MI (HR 1.06; 95% 1.00-1.06). Conclusions Increased eGFR variability exhibited an association with major clinical outcomes, indicating that monitoring eGFR variability might be a useful parameter for predicting the adverse outcomes.	[Lee, Soojin; Lee, Yeonhee; Kang, Min Woo; Cho, Semin; Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Soojin; Lee, Yeonhee; Kang, Min Woo; Cho, Semin; Joo, Kwon Wook; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Sehoon; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Sehoon] Armed Forces Capital Hosp, Dept Internal Med, Gyeonggi Do, South Korea; [Kim, Yaerim] Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Han, Seung Seok; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Han, Kyungdo] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Keimyung University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Soongsil University	Kim, DK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.; Kim, DK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, DK (corresponding author), Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea.; Han, K (corresponding author), Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea.	hkd917@naver.com; dkkim73@gmail.com	Kim, Dong Ki/J-5389-2012; Han, Seung Seok/HGD-2825-2022	Kim, Dong Ki/0000-0002-5195-7852; Kim, Yaerim/0000-0003-1596-1528	Seoul National University Hospital [3020180050]	Seoul National University Hospital	The present study was funded from Seoul National University Hospital (3020180050). The funders had no role in the study design, data collection and analysis, or decision to submit for publication.	[Anonymous], 2017, J OBSTET GYNECOL NEO, V46, pe125; Asayama K, 2013, HYPERTENSION, V61, P61, DOI 10.1161/HYPERTENSIONAHA.111.00138; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, P31; Kim MK, 2018, CIRCULATION, V138, P2627, DOI [10.1161/CIRCULATIONAHA.118.034978, 10.1161/circulationaha.118.034978]; Kim MK, 2017, EUR HEART J, V38, P3560, DOI 10.1093/eurheartj/ehx585; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Nagai M, 2011, J AM SOC HYPERTENS, V5, P184, DOI 10.1016/j.jash.2011.03.001; Nam GE, 2019, INT J OBESITY, V43, P412, DOI 10.1038/s41366-018-0079-0; Parati G, 2013, DIABETES CARE, V36, pS312, DOI 10.2337/dcS13-2043; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Sohel BM, 2016, CLIN EXP NEPHROL, V20, P379, DOI 10.1007/s10157-015-1213-0; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vart P, 2015, AM J EPIDEMIOL, V181, P385, DOI 10.1093/aje/kwu316; Yu JH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016317; Zeng XX, 2018, J EPIDEMIOL COMMUN H, V72, P270, DOI 10.1136/jech-2017-209815	27	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244156	10.1371/journal.pone.0244156	http://dx.doi.org/10.1371/journal.pone.0244156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332407	gold, Green Published			2022-12-26	WOS:000601310900073
J	Coventry, PA; McMillan, D; Clegg, A; Brown, L; van der Feltz-Cornelis, C; Gilbody, S; Ali, S				Coventry, Peter A.; McMillan, Dean; Clegg, Andrew; Brown, Lesley; van der Feltz-Cornelis, Christina; Gilbody, Simon; Ali, Shehzad			Frailty and depression predict instrumental activities of daily living in older adults: A population-based longitudinal study using the CARE75+cohort	PLOS ONE			English	Article							LATE-LIFE; SCALE; PEOPLE; CARE; LONELINESS; STRENGTH; GENDER; COHORT	Objectives To evaluate if depression contributes, independently and/or in interaction with frailty, to loss of independence in instrumental activities of daily living (ADL) in older adults with frailty. Methods Longitudinal cohort study of people aged >= 75 years living in the community. We used multi-level linear regression model to quantify the relationship between depression (>= 5 Geriatric Depression Scale) and frailty (electronic frailty index), and instrumental activities of daily living (Nottingham Extended Activities of Daily Living scale; range: 0-66; higher score implies greater independence). The model was adjusted for known confounders (age; gender; ethnicity; education; living situation; medical comorbidity). Results 553 participants were included at baseline; 53% were female with a mean age of 81 (5.0 SD) years. Depression and frailty (moderate and severe levels) were independently associated with reduced instrumental activities of daily living scores. In the adjusted analysis, the regression coefficient was -6.4 (95% CI: -8.3 to -4.5, p<0.05) for depression, -1.5 (95% CI: -3.8 to 0.9, p = 0.22) for mild frailty, -6.1 (95% CI: -8.6 to -3.6, p<0.05) for moderate frailty, and -10.1 (95% CI: -13.5 to -6.8, p<0.05) for severe frailty. Moreover, depression interacted with frailty to further reduce instrumental activities of daily living score in individuals with mild or moderate frailty. These relationships remained significant after adjusting for confounders. Conclusion Frailty and depression are independently associated with reduced independence in instrumental activities of daily living. Also, depression interacts with frailty to further reduce independence for mild to moderately frail individuals, suggesting that clinical management of frailty should integrate physical and mental health care.	[Coventry, Peter A.] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [McMillan, Dean; van der Feltz-Cornelis, Christina; Gilbody, Simon] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [McMillan, Dean; van der Feltz-Cornelis, Christina; Gilbody, Simon] Univ York, Hull York Med Sch, York, N Yorkshire, England; [Clegg, Andrew] Univ Leeds, Acad Unit Elderly Care & Rehabil, Bradford, W Yorkshire, England; [Brown, Lesley] Inst Hlth Res, Acad Unit Elderly Care & Rehabil, Bradford, W Yorkshire, England; [Ali, Shehzad] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada	University of York - UK; University of York - UK; University of Hull; University of York - UK; University of Leeds; Western University (University of Western Ontario)	Coventry, PA (corresponding author), Univ York, Dept Hlth Sci, York, N Yorkshire, England.	peter.coventry@york.ac.uk	Gilbody, Simon/AAY-3720-2021; Van der Feltz-Cornelis, Christina/R-7107-2016; Coventry, Peter/H-6714-2014	Gilbody, Simon/0000-0002-8236-6983; Van der Feltz-Cornelis, Christina/0000-0001-6925-8956; Brown, Lesley/0000-0001-5499-9145; Clegg, Andrew/0000-0001-5972-1097; Coventry, Peter/0000-0003-0625-3829	NIHR Applied Research Collaboration Yorkshire; NIHR Applied Research Collaboration Humber	NIHR Applied Research Collaboration Yorkshire; NIHR Applied Research Collaboration Humber	The research was funded by the NIHR Applied Research Collaboration Yorkshire and Humber https://www.arc-yh.nihr.ac.uk/.The views expressed are those of the author(s), and not necessarily those of the NIHR or the Department of Health and Social Care.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Blakemore A, 2014, INT J CHRONIC OBSTR, V9, P501, DOI 10.2147/COPD.S58136; Brundle C, 2019, AGE AGEING, V48, P152, DOI 10.1093/ageing/afy162; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Chiesi F, 2018, PSYCHOL REP, V121, P1167, DOI 10.1177/0033294117745561; Chiesi F, 2018, J AFFECT DISORDERS, V227, P471, DOI 10.1016/j.jad.2017.11.045; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Clegg A, 2015, AGE AGEING, V44, P547, DOI 10.1093/ageing/afv044; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Coventry P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h638; Coventry PA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-49; Crocker TF, 2019, QUAL LIFE RES, V28, P2041, DOI 10.1007/s11136-019-02149-1; de Keijzer C, 2019, ENVIRON INT, V122, P346, DOI 10.1016/j.envint.2018.11.046; Dunlop DD, 1997, AM J PUBLIC HEALTH, V87, P378, DOI 10.2105/AJPH.87.3.378; Farmer C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4843; Feng ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178383; Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013; Gierveld JDJ, 2010, EUR J AGEING, V7, P121, DOI 10.1007/s10433-010-0144-6; GLADMAN JRF, 1993, AGE AGEING, V22, P419, DOI 10.1093/ageing/22.6.419; Harrison JK, 2015, AGE AGEING, V44, P732, DOI 10.1093/ageing/afv085; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kojima G, 2017, DISABIL REHABIL, V39, P1897, DOI 10.1080/09638288.2016.1212282; Lohman M, 2016, J GERONTOL B-PSYCHOL, V71, P630, DOI 10.1093/geronb/gbu180; Lohman MC, 2017, AGING MENT HEALTH, V21, P399, DOI 10.1080/13607863.2015.1102199; Mezuk B, 2013, AM J GERIAT PSYCHIAT, V21, P560, DOI 10.1016/j.jagp.2012.12.019; NHS England, 2014, 5 YEAR FORW VIEW; Office for National Statistics, 2018, LIV LONG OUR POP IS; Orgeta V, 2017, BRIT J PSYCHIAT, V211, P274, DOI 10.1192/bjp.bp.117.205021; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Ryan A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0355-9; Soysal P, 2017, AGEING RES REV, V36, P78, DOI 10.1016/j.arr.2017.03.005; Testa G, 2011, EUR J CLIN INVEST, V41, P1310, DOI 10.1111/j.1365-2362.2011.02544.x; Verger P, 2009, EUR J PUBLIC HEALTH, V19, P618, DOI 10.1093/eurpub/ckp057; Vetrano D. L., 2018, J GERONTOL A-BIOL, V74, P659, DOI DOI 10.1093/GERONA/GLY110; Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x; Wang D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015794; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Yu RB, 2018, J AM MED DIR ASSOC, V19, P528, DOI 10.1016/j.jamda.2017.12.015	42	8	8	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243972	10.1371/journal.pone.0243972	http://dx.doi.org/10.1371/journal.pone.0243972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320913	Green Accepted, Green Published, gold			2022-12-26	WOS:000600339800056
J	Mills, C; Muruganujan, A; Ebert, D; Marconett, CN; Lewinger, JP; Thomas, PD; Mi, HY				Mills, Caitlin; Muruganujan, Anushya; Ebert, Dustin; Marconett, Crystal N.; Lewinger, Juan Pablo; Thomas, Paul D.; Mi, Huaiyu			PEREGRINE: A genome-wide prediction of enhancer to gene relationships supported by experimental evidence	PLOS ONE			English	Article							EXPRESSION; DISTANCE; VARIANTS; ONTOLOGY; ELEMENTS; DATABASE; PATHWAY; LINKING; BINDING; GALNT2	Enhancers are powerful and versatile agents of cell-type specific gene regulation, which are thought to play key roles in human disease. Enhancers are short DNA elements that function primarily as clusters of transcription factor binding sites that are spatially coordinated to regulate expression of one or more specific target genes. These regulatory connections between enhancers and target genes can therefore be characterized as enhancer-gene links that can affect development, disease, and homeostatic cellular processes. Despite their implication in disease and the establishment of cell identity during development, most enhancer-gene links remain unknown. Here we introduce a new, publicly accessible database of predicted enhancer-gene links, PEREGRINE. The PEREGRINE human enhancer-gene links interactive web interface incorporates publicly available experimental data from ChIA-PET, eQTL, and Hi-C assays across 78 cell and tissue types to link 449,627 enhancers to 17,643 protein-coding genes. These enhancer-gene links are made available through the new Enhancer module of the PANTHER database and website where the user may easily access the evidence for each enhancer-gene link, as well as query by target gene and enhancer location.	[Mills, Caitlin; Lewinger, Juan Pablo] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Div Biostat, Los Angeles, CA 90007 USA; [Muruganujan, Anushya; Ebert, Dustin; Thomas, Paul D.; Mi, Huaiyu] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Div Bioinformat, Los Angeles, CA 90007 USA; [Marconett, Crystal N.] Univ Southern Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90007 USA; [Marconett, Crystal N.] USC, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA USA; [Marconett, Crystal N.] USC, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California Keck Hospital	Mi, HY (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Div Bioinformat, Los Angeles, CA 90007 USA.	huaiyumi@usc.edu		Thomas, Paul/0000-0002-9074-3507; Marconett, Crystal/0000-0002-8463-7126; Ebert, Dustin/0000-0002-6659-0416; Lewinger, Juan Pablo/0000-0002-0692-2570	National Institute of Health [P01CA196569]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HM, AM, DE, JPL, PDT, CM P01CA196569 National Institute of Health https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J NATL COMPR CANC NE, V9; [Anonymous], 2015, MEDICINE, V94, pe1435; Apache Solr, 2020, APACHE SOLR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Burke K, 2020, FLASK RESTFUL; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Cavalli M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0183-x; Chen JY, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5030043; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Fullwood MJ, 2009, J CELL BIOCHEM, V107, P30, DOI 10.1002/jcb.22116; Gao TS, 2020, NUCLEIC ACIDS RES, V48, pD58, DOI 10.1093/nar/gkz980; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Gasperini M, 2020, NAT REV GENET, V21, P292, DOI 10.1038/s41576-019-0209-0; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jiang Y, 2019, NUCLEIC ACIDS RES, V47, pD235, DOI 10.1093/nar/gky1025; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Liu Q, 2018, CLIN CANCER RES, V24, P4602, DOI 10.1158/1078-0432.CCR-17-3678; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Makino T, 2008, MOL BIOL EVOL, V25, P1855, DOI 10.1093/molbev/msn137; Marsman J, 2012, BBA-GENE REGUL MECH, V1819, P1217, DOI 10.1016/j.bbagrm.2012.10.008; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Murray A, 2009, EUR HEART J, V30, P1711, DOI 10.1093/eurheartj/ehp161; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Phanstiel DH, 2015, BIOINFORMATICS, V31, P3092, DOI 10.1093/bioinformatics/btv336; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roman TS, 2015, AM J HUM GENET, V97, P801, DOI 10.1016/j.ajhg.2015.10.016; Ron G, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-023863, 10.1038/s41467-017-02386-3]; Schoenfelder S, 2018, JOVE-J VIS EXP, DOI 10.3791/57320; Thomas MF, 2014, TRENDS GENET, V30, P298, DOI 10.1016/j.tig.2014.05.003; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang J, 2019, NUCLEIC ACIDS RES, V47, pD106, DOI 10.1093/nar/gky864; Wang ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11478; Wang Z, 2018, NUCLEIC ACIDS RES, V46, pD113, DOI 10.1093/nar/gkx988; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Yao LJ, 2015, CRIT REV BIOCHEM MOL, V50, P550, DOI 10.3109/10409238.2015.1087961; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	56	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243791	10.1371/journal.pone.0243791	http://dx.doi.org/10.1371/journal.pone.0243791			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320871	Green Published, gold			2022-12-26	WOS:000600339800006
J	Swoboda, A; Soukup, R; Eckel, O; Kinslechner, K; Wingelhofer, B; Schorghofer, D; Sternberg, C; Pham, HTT; Vallianou, M; Horvath, J; Stoiber, D; Kenner, L; Larue, L; Poli, V; Beermann, F; Yokota, T; Kubicek, S; Krausgruber, T; Rendeiro, AF; Bock, C; Zenz, R; Kovacic, B; Aberger, F; Hengstschlager, M; Petzelbauer, P; Mikula, M; Moriggl, R				Swoboda, Alexander; Soukup, Robert; Eckel, Oliver; Kinslechner, Katharina; Wingelhofer, Bettina; Schoerghofer, David; Sternberg, Christina; Pham, Ha T. T.; Vallianou, Maria; Horvath, Jaqueline; Stoiber, Dagmar; Kenner, Lukas; Larue, Lionel; Poli, Valeria; Beermann, Friedrich; Yokota, Takashi; Kubicek, Stefan; Krausgruber, Thomas; Rendeiro, Andre F.; Bock, Christoph; Zenz, Rainer; Kovacic, Boris; Aberger, Fritz; Hengstschlaeger, Markus; Petzelbauer, Peter; Mikula, Mario; Moriggl, Richard			STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway	ONCOGENE			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; STEM-CELLS; EXPRESSION; GENE; RESISTANCE; CANCER; SUPPRESSION; MELANOCYTES; PROGRESSION; ACTIVATION	Metastatic melanoma is hallmarked by its ability of phenotype switching to more slowly proliferating, but highly invasive cells. Here, we tested the impact of signal transducer and activator of transcription 3 (STAT3) on melanoma progression in association with melanocyte inducing transcription factor (MITF) expression levels. We established a mouse melanoma model for deleting Stat3 in melanocytes with specific expression of human hyperactive NRAS(Q61K) in an Ink4a-deficient background, two frequent driver mutations in human melanoma. Mice devoid of Stat3 showed early disease onset with higher proliferation in primary tumors, but displayed significantly diminished lung, brain, and liver metastases. Whole-genome expression profiling of tumor-derived cells also showed a reduced invasion phenotype, which was further corroborated by 3D melanoma model analysis. Notably, loss or knockdown of STAT3 in mouse or human cells resulted in the upregulation of MITF and induction of cell proliferation. Mechanistically we show that STAT3-induced CAAT Box Enhancer Binding Protein (CEBP) expression was sufficient to suppress MITF transcription. Epigenetic analysis by ATAC-seq confirmed that CEBPa/b binding to the MITF enhancer region silenced the MITF locus. Finally, by classification of patient-derived melanoma samples, we show that STAT3 and MITF act antagonistically and hence contribute differentially to melanoma progression. We conclude that STAT3 is a driver of the metastatic process in melanoma and able to antagonize MITF via direct induction of CEBP family member transcription.	[Swoboda, Alexander; Wingelhofer, Bettina; Pham, Ha T. T.; Horvath, Jaqueline; Stoiber, Dagmar; Kenner, Lukas; Moriggl, Richard] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Swoboda, Alexander; Eckel, Oliver; Wingelhofer, Bettina; Pham, Ha T. T.; Moriggl, Richard] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria; [Soukup, Robert; Eckel, Oliver; Kinslechner, Katharina; Schoerghofer, David; Vallianou, Maria; Kovacic, Boris; Hengstschlaeger, Markus; Mikula, Mario] Med Univ Vienna, Inst Med Genet, Ctr Pathobiochem & Genet, Vienna, Austria; [Sternberg, Christina; Aberger, Fritz] Univ Salzburg, Canc Cluster Salzburg, Dept Biosci, Salzburg, Austria; [Horvath, Jaqueline; Stoiber, Dagmar] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Kenner, Lukas] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Kenner, Lukas] Univ Vet Med, Unit Pathol Lab Anim, Vienna, Austria; [Kenner, Lukas] Med Univ Vienna, CBMed Core Lab2, Vienna, Austria; [Larue, Lionel] Inst Curie Normal & Pathol Dev Melanocytes, CNRS, INSERM, UMR3347,U1021 Equipe Labellisee, Orsay, France; [Poli, Valeria] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Beermann, Friedrich] Swiss Fed Inst Technol Lausanne, ISREC, Lausanne, Switzerland; [Yokota, Takashi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa, Japan; [Kubicek, Stefan; Krausgruber, Thomas; Rendeiro, Andre F.; Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bock, Christoph] Max Planck Inst Informat, Saarland Informat Campus, Saarbrucken, Germany; [Zenz, Rainer] Med Univ Vienna, Inst Canc Res, Vienna, Austria; [Petzelbauer, Peter] Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div SERD, Vienna, Austria	Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Medical University of Vienna; Salzburg University; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of Turin; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Kanazawa University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Max Planck Society; Medical University of Vienna; Medical University of Vienna	Moriggl, R (corresponding author), Ludwig Boltzmann Inst Canc Res, Vienna, Austria.; Moriggl, R (corresponding author), Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria.; Mikula, M (corresponding author), Med Univ Vienna, Inst Med Genet, Ctr Pathobiochem & Genet, Vienna, Austria.	mario.mikula@meduniwien.ac.at; richard.moriggl@vetmeduni.ac.at	Bock, Christoph/AAE-7618-2019; Kubicek, Stefan/C-2089-2017; Yokota, Takashi/J-8483-2015; petzelbauer, peter/GLU-3941-2022; Rendeiro, André F./AAC-4747-2019; Krausgruber, Thomas/H-8490-2018	Bock, Christoph/0000-0001-6091-3088; Kubicek, Stefan/0000-0003-0855-8343; Rendeiro, André F./0000-0001-9362-5373; Krausgruber, Thomas/0000-0002-1374-0329; Petzelbauer, Peter/0000-0001-7080-5259; Moriggl, Richard/0000-0003-0918-9463; Kenner, Lukas/0000-0003-2184-1338; Aberger, Fritz/0000-0003-2009-6305	Austrian Science Fund (FWF) [AIRC IG16930, SFB-F061, SFB-F047, P 25336-B13]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Safia Zahma, Birgit Schutz, Eva Bauer, Michaela Schlederer, and Karin Neumuller for excellent technical assistance. We also thank the Biomedical Sequencing Facility at CeMM for assistance with next-generation sequencing. VP was supported by the grant AIRC IG16930, AS, OE, RZ, and RM were supported by a private melanoma research donation from Liechtenstein, RM was further supported by two network grants SFB-F061 and SFB-F047, and RS, KK, MV, and MM were supported by P 25336-B13, all from the Austrian Science Fund (FWF).	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Anastas JN, 2014, J CLIN INVEST, V124, P2877, DOI 10.1172/JCI70156; Bu X, 2016, TRENDS MOL MED, V22, P448, DOI 10.1016/j.molmed.2016.04.008; Cao HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21731; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Fofaria NM, 2014, ONCOTARGET, V5, P7051, DOI 10.18632/oncotarget.2251; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Goding CR, 2019, GENE DEV, V33, P983, DOI 10.1101/gad.324657.119; Gong AH, 2015, CANCER RES, V75, P2337, DOI 10.1158/0008-5472.CAN-14-2800; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; He WZ, 2018, CANCER RES, V78, P3293, DOI 10.1158/0008-5472.CAN-17-3131; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huser L, 2018, INT J CANCER, V143, P3131, DOI 10.1002/ijc.31609; Igelmann S, 2019, CANCERS, V11, DOI 10.3390/cancers11101428; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; Ji ZY, 2015, J INVEST DERMATOL, V135, P1863, DOI 10.1038/jid.2015.105; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Kinslechner K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051063; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kortylewski M, 1999, ONCOGENE, V18, P3742, DOI 10.1038/sj.onc.1202708; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kulesza DW, 2019, CELL BIOL INT, V43, P613, DOI 10.1002/cbin.11134; Lacreusette A, 2007, ONCOGENE, V26, P881, DOI 10.1038/sj.onc.1209844; Ladstein RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-140; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lee JW, 2019, NATURE, V567, P249, DOI 10.1038/s41586-019-1004-y; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Luciani F, 2011, DEVELOPMENT, V138, P3943, DOI 10.1242/dev.067447; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mirea MA, 2020, CANCERS, V12, DOI 10.3390/cancers12092508; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Niu GL, 1999, CANCER RES, V59, P5059; Ohanna M, 2013, ONCOTARGET, V4, P2212, DOI 10.18632/oncotarget.1143; Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736; Qi XP, 2013, IMMUNITY, V39, P97, DOI 10.1016/j.immuni.2013.06.012; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shenoy AK, 2016, J CLIN INVEST, V126, P4174, DOI 10.1172/JCI86623; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Steder M, 2013, CANCER CELL, V24, P512, DOI 10.1016/j.ccr.2013.08.023; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Tang Y, 2012, STEM CELLS, V30, P2645, DOI 10.1002/stem.1225; Tu TJ, 2011, ONCOLOGY-BASEL, V80, P181, DOI 10.1159/000328518; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Weidenfeld K, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00381; Yamada T, 1997, J BIOCHEM-TOKYO, V121, P731; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; Yokoyama S, 2008, PIGM CELL MELANOMA R, V21, P457, DOI 10.1111/j.1755-148X.2008.00480.x	58	15	16	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1091	1105		10.1038/s41388-020-01584-6	http://dx.doi.org/10.1038/s41388-020-01584-6		DEC 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33323974	Green Accepted			2022-12-26	WOS:000599126500003
J	Barrera, SM; Byrum, S; Mackintosh, SG; Kozubowski, L				Barrera, Stephani Martinez; Byrum, Stephanie; Mackintosh, Samuel G.; Kozubowski, Lukasz			Registered report protocol: Quantitative analysis of septin Cdc10-associated proteome in Cryptococcus neoformans	PLOS ONE			English	Article							YEAST; VIRULENCE; MODEL; PHAGOSOME; BINDING; FUNGUS	Cryptococcus neoformans is a pathogenic basidiomycetous yeast that primarily infects immunocompromised individuals. C. neoformans can thrive during infections due to its three main virulence-related characteristics: the ability to grow at host temperature (37 degrees C), formation of carbohydrate capsule, and its ability to produce melanin. C. neoformans strains lacking septin proteins Cdc3 or Cdc12 are viable at 25 degrees C; however, they fail to proliferate at 37 degrees C and are avirulent in the murine model of infection. The basis of septin contribution to growth at host temperature remains unknown. Septins are a family of conserved filament-forming GTPases with roles in cytokinesis and morphogenesis. In the model organism Saccharomyces cerevisiae septins are essential. S. cerevisiae septins form a higher order complex at the mother-bud neck to scaffold over 80 proteins, including those involved in cell wall organization, cell polarity, and cell cycle control. In C. neoformans, septins also form a complex at the mother-bud neck but the septin interacting proteome in this species remains largely unknown. Moreover, it remains possible that septins play other roles important for high temperature stress that are independent of their established role in cytokinesis. Therefore, we propose to perform a global analysis of septin Cdc10 binding partners in C. neoformans, including those that are specific to high temperature stress. This analysis will shed light on the underlying mechanism of survival of this pathogenic yeast during infection and can potentially lead to the discovery of novel drug targets.	[Barrera, Stephani Martinez; Kozubowski, Lukasz] Clemson Univ, Dept Genet & Biochem, Eukaryot Pathogens Innovat Ctr, Clemson, SC 29634 USA; [Byrum, Stephanie; Mackintosh, Samuel G.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Clemson University; University of Arkansas System; University of Arkansas Medical Sciences	Kozubowski, L (corresponding author), Clemson Univ, Dept Genet & Biochem, Eukaryot Pathogens Innovat Ctr, Clemson, SC 29634 USA.	lkozubo@clemson.edu		Martinez Barrera, Stephani/0000-0002-9350-3576	National Institutes of Health (NIGMS) [5P20GM109094-05]	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LK is funded by the National Institutes of Health (NIGMS) as a Target Investigator on a grant #5P20GM109094-05. (https://www.nigms.nih.gov).The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2015, FUNGAL GENET BIOL, V78, P55, DOI 10.1016/j.fgb.2014.09.004; [Anonymous], 2011, OFFICIAL J EUROPEA L, VL 23, P1; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; Barve G, 2018, CURR GENET, V64, P1037, DOI 10.1007/s00294-018-0834-8; Barve G, 2018, J CELL SCI, V131, DOI 10.1242/jcs.209098; Bojarczuk A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21489; Bridges AA, 2016, J CELL BIOL, V213, P23, DOI 10.1083/jcb.201512029; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Byrum SD, 2018, J PROTEOME RES, V17, P3384, DOI 10.1021/acs.jproteome.8b00288; Byrum SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174771; Denham ST, 2018, J FUNGI, V4, DOI 10.3390/jof4010025; Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Fung KYY, 2014, INT REV CEL MOL BIO, V310, P289, DOI 10.1016/B978-0-12-800180-6.00007-4; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Glomb O, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00123; Gonczi M, 2021, J MUSCLE RES CELL M, V42, P251, DOI 10.1007/s10974-020-09573-8; Hecht M, 2019, G3-GENES GENOM GENET, V9, P1869, DOI 10.1534/g3.119.400197; Huang YW, 2008, MOL BIOL CELL, V19, P1717, DOI 10.1091/mbc.E07-07-0641; Husain S, 2001, EMERG INFECT DIS, V7, P375; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Johnston SA, 2013, CELL MICROBIOL, V15, P403, DOI 10.1111/cmi.12067; Kozubowski L, 2012, FEMS MICROBIOL REV, V36, P78, DOI 10.1111/j.1574-6976.2011.00286.x; Kozubowski L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025280; Kozubowski L, 2010, MOL MICROBIOL, V75, P658, DOI 10.1111/j.1365-2958.2009.06983.x; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nagaraj S, 2008, MOL CELL BIOL, V28, P5120, DOI 10.1128/MCB.00786-08; Nakahira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013799; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Neubauer K, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00003; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Perfect JR, 2006, FEMS YEAST RES, V6, P463, DOI 10.1111/j.1567-1364.2006.00051.x; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Renz C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148340; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tokhtaeva E, 2015, J BIOL CHEM, V290, P5280, DOI 10.1074/jbc.M114.616201; Vazquez JH, 2020, TOXICOL SCI, V173, P244, DOI 10.1093/toxsci/kfz222; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Wloka C, 2011, BIOL CHEM, V392, P813, DOI 10.1515/BC.2011.083; Zaragoza O, 2019, VIRULENCE, V10, P490, DOI 10.1080/21505594.2019.1614383	52	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242381	10.1371/journal.pone.0242381	http://dx.doi.org/10.1371/journal.pone.0242381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315917	Green Published, gold			2022-12-26	WOS:000600186100034
J	Beumeler, LFE; van Wieren, A; Buter, H; van Zutphen, T; Bruins, NA; de Jager, CM; Koopmans, M; Navis, GJ; Boerma, EC				Beumeler, Lise F. E.; van Wieren, Anja; Buter, Hanneke; van Zutphen, Tim; Bruins, Nynke A.; de Jager, Corine M.; Koopmans, Matty; Navis, Gerjan J.; Boerma, E. Christiaan			Patient-reported physical functioning is limited in almost half of critical illness survivors 1-year after ICU-admission: A retrospective single-centre study	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTENSIVE-CARE; MENTAL-HEALTH; DISABILITY; MORTALITY; IMPACT	Post-intensive care unit (ICU) sequelae, including physical and mental health problems, are relatively unexplored. Characteristics commonly used to predict outcome lack prognostic value when it comes to long-term physical recovery. Therefore, the objective of this study was to assess the incidence of non-recovery in long-stay ICU-patients. In this single-centre study, retrospective data of adults with an ICU stay >48 hours who visited the specialized post-ICU clinic, and completed the Dutch RAND 36-item Short Form questionnaire at 3 and 12 months post-ICU, were retrieved from electronic patient records. In cases where physical functioning scores at 12 months were below reference values, patients were allocated to the physical non-recovery (NR) group. Significantly different baseline and (post-)ICU-characteristics were assessed for correlations with physical recovery at 12 months post-ICU. Of 250 patients, 110 (44%) fulfilled the criteria for the NR-group. Neither the severity of illness, type of admission, nor presence of sepsis did not differ between groups. However, NR-patients had a higher age, were more often female, and had a higher incidence of co-morbidities. Shorter LOS ICU, lower incidence of medical comorbidities, and better physical performance at 3 months were significantly correlated with 1-year physical recovery. Comorbidities and reduced physical functioning at 3 months were identified as independent risk-factors for long-term physical non-recovery. In conclusion, a substantial proportion of long-stay ICU-patients who visited the standard care post-ICU clinic did not fulfil the criteria for full physical recovery at 12 months post-ICU. Commonly used ICU-characteristics, such as severity of illness, do not have sufficient prognostic value when it comes to long-term recovery of health-related quality of life.	[Beumeler, Lise F. E.; van Zutphen, Tim] Univ Groningen, Campus Fryslan, Leeuwarden, Netherlands; [van Wieren, Anja; Buter, Hanneke; Bruins, Nynke A.; de Jager, Corine M.; Koopmans, Matty; Boerma, E. Christiaan] Med Ctr Leeuwarden, Dept Intens Care, Leeuwarden, Netherlands; [Navis, Gerjan J.] Univ Med Ctr Groningen, Fac Med Sci, Groningen, Netherlands	University of Groningen; Medical Center Leeuwarden; University of Groningen	Beumeler, LFE (corresponding author), Univ Groningen, Campus Fryslan, Leeuwarden, Netherlands.	lisebeumeler@gmail.com		Beumeler, Lise/0000-0002-6513-3635				Alison JA, 2012, PHYS THER, V92, P1556, DOI 10.2522/ptj.20110410; Baldwin CE, 2013, J CRIT CARE, V28, P77, DOI 10.1016/j.jcrc.2012.03.001; Denehy L, 2017, INTENS CARE MED, V43, P1881, DOI 10.1007/s00134-017-4942-6; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Gerth AMJ, 2019, ANAESTHESIA, V74, P100, DOI 10.1111/anae.14444; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Hodgson CL, 2017, INTENS CARE MED, V43, P992, DOI 10.1007/s00134-017-4830-0; Hofhuis J, 2003, INTENS CARE MED, V29, P974, DOI 10.1007/s00134-003-1763-6; Hofhuis JGM, 2008, CHEST, V133, P377, DOI 10.1378/chest.07-1217; Honselmann KC, 2015, J CRIT CARE, V30, P721, DOI 10.1016/j.jcrc.2015.03.009; Hutchings A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4353; Jackson JC, 2015, PSYCHIAT CLIN N AM, V38, P91, DOI 10.1016/j.psc.2014.11.002; Jaitovich A, 2018, CHEST; Kaarlola A, 2004, INTENS CARE MED, V30, P2245, DOI 10.1007/s00134-004-2471-6; Kahn JM, 2014, CURR OPIN CRIT CARE, V20, P542, DOI 10.1097/MCC.0000000000000140; Minne L, 2011, INTENS CARE MED, V37, P1258, DOI 10.1007/s00134-011-2265-6; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Myhren H, 2010, CRIT CARE MED, V38, P1554, DOI 10.1097/CCM.0b013e3181e2c8b1; Oeyen S, 2018, J CRIT CARE, V43, P133, DOI 10.1016/j.jcrc.2017.09.006; Orwelius L, 2010, CRIT CARE, V14, DOI 10.1186/cc8967; Pettila V, 2000, INTENS CARE MED, V26, P1473, DOI 10.1007/s001340000629; Schmidt K, 2016, JAMA-J AM MED ASSOC, V315, P2703, DOI 10.1001/jama.2016.7207; Sommers J, 2016, PHYS THER, V96, P1658, DOI 10.2522/ptj.20150339; Turnbull AE, 2016, CRIT CARE MED, V44, P1267, DOI 10.1097/CCM.0000000000001651; van der Schaaf M, 2009, J REHABIL MED, V41, P360, DOI 10.2340/16501977-0333; van der Zee KI., 2012, MEASURING GEN HLTH S, V2nd; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Da Silveira LTY, 2018, INT J QUAL HEALTH C, V30, P265, DOI 10.1093/intqhc/mzx203; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243981	10.1371/journal.pone.0243981	http://dx.doi.org/10.1371/journal.pone.0243981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315942	gold, Green Published			2022-12-26	WOS:000600186100061
J	Kimura, N; Aso, Y; Yabuuchi, K; Matsubara, E				Kimura, Noriyuki; Aso, Yasuhiro; Yabuuchi, Kenichi; Matsubara, Etsuro			Association between objectively measured walking steps and sleep in community-dwelling older adults: A prospective cohort study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; POOR SLEEP; QUALITY; INSOMNIA; MEN; METAANALYSIS; PERFORMANCE; DURATION; DECLINE	Physical inactivity and sleep disturbances are major problems in an ageing society. There is increasing evidence that physical activity is associated with sleep quality. However, the association between daily walking steps and sleep remain unclear. This prospective study examined the relationship between objectively measured daily walking steps and sleep parameters in Japanese community-dwelling older adults. In total, 855 community-dwelling individuals aged 65 and above, with an uninterrupted follow-up from August 2015 to March 2016, were enrolled. The participants wore a wristband sensor for an average of 7.8 days every three months. Multiple linear regression analysis was performed to examine the relationship between daily walking steps and sleep parameters, including the total sleep time, sleep efficiency, time awake after sleep onset (WASO), awakening time count during the night, and naptime. The median (interquartile range, IQR) age of the participants was 73 (69-78) years, with 317 (37.1%) men and 538 (62.9%) women. The median (IQR) educational level was 12 (11-12) years, and the median (IQR) Mini-Mental State Examination score was 29 (27-30) points. The number of daily walking steps showed a positive correlation with sleep efficiency and an inverse correlation with WASO, awakening time count, and naptime, after adjusting for covariates and correcting for the false discovery rate (beta = 0.098, 95% confidence interval [CI]: 0.034 to 0.162, p = 0.003; beta = -0.107, 95% CI: -0.172 to -0.043, p = 0.001; beta = -0.105, 95% CI: -0.17 to -0.04, p = 0.002; and beta = -0.31, 95% CI: -0.371 to -0.249, p < 0.001, respectively). Our results can help promote walking as an intervention for preventing sleep disturbances in community-dwelling older adults.	[Kimura, Noriyuki; Aso, Yasuhiro; Yabuuchi, Kenichi; Matsubara, Etsuro] Oita Univ, Dept Neurol, Fac Med, Oita, Japan	Oita University	Kimura, N (corresponding author), Oita Univ, Dept Neurol, Fac Med, Oita, Japan.	noriyuki@oita-u.ac.jp		Kimura, Noriyuki/0000-0001-7137-7268	Japan Agency for Medical Research and Development [18he1402003, 19K07916]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The present study was supported by Japan Agency for Medical Research and Development grants no.18he1402003 and Scientific Research (C) grants no. 19K07916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Barnes DE, 2008, J AM GERIATR SOC, V56, P1658, DOI 10.1111/j.1532-5415.2008.01841.x; Bisson ANS, 2019, SLEEP HEALTH, V5, P487, DOI 10.1016/j.sleh.2019.06.003; Brychta RJ, 2016, J CLIN SLEEP MED, V12, P203, DOI 10.5664/jcsm.5486; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chen T, 2015, J SPORT SCI MED, V14, P507; Dam TTL, 2008, J AM GERIATR SOC, V56, P1665, DOI 10.1111/j.1532-5415.2008.01846.x; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Gabriel KP, 2017, SLEEP HEALTH, V3, P49, DOI 10.1016/j.sleh.2016.10.001; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Haario P, 2013, J SLEEP RES, V22, P89, DOI 10.1111/j.1365-2869.2012.01043.x; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Kim K, 2000, SLEEP, V23, P41; Kim M, 2015, J KOREAN MED SCI, V30, P199, DOI 10.3346/jkms.2015.30.2.199; Kimura N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00401; Lambiase MJ, 2013, MED SCI SPORT EXER, V45, P2362, DOI 10.1249/MSS.0b013e31829e4cea; Malinowska KB, 2017, GERIATR GERONTOL INT, V17, P1808, DOI 10.1111/ggi.12965; Master L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44059-9; Miyata S, 2013, J SLEEP RES, V22, P535, DOI 10.1111/jsr.12054; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Peng X, 2019, SLEEP BREATH, V23, P679, DOI 10.1007/s11325-018-1749-9; Seol J, 2020, NURS HEALTH SCI, V22, P64, DOI 10.1111/nhs.12647; Sherrill DL, 1998, ARCH INTERN MED, V158, P1894, DOI 10.1001/archinte.158.17.1894; Spira AP, 2012, J AM GERIATR SOC, V60, P1092, DOI 10.1111/j.1532-5415.2012.03968.x; Stenholm S, 2011, SLEEP, V34, P1583, DOI 10.5665/sleep.1402; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P649, DOI 10.1093/gerona/glq017; Tsunoda K, 2015, AM J PREV MED, V48, P662, DOI 10.1016/j.amepre.2014.12.006; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	30	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243910	10.1371/journal.pone.0243910	http://dx.doi.org/10.1371/journal.pone.0243910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315927	gold, Green Published			2022-12-26	WOS:000600186100033
J	Sangla, F; Legouis, D; Marti, PE; Sgardello, SD; Brebion, A; Saint-Sardos, P; Adda, M; Lautrette, A; Pereira, B; Souweine, B				Sangla, Frederic; Legouis, David; Marti, Pierre-Emmanuel; Sgardello, Sebastian D.; Brebion, Amelie; Saint-Sardos, Pierre; Adda, Mireille; Lautrette, Alexandre; Pereira, Bruno; Souweine, Bertrand			One year after ICU admission for severe community-acquired pneumonia of bacterial, viral or unidentified etiology. What are the outcomes?	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM OUTCOMES; RESPIRATORY VIRUSES; SAMPLE-SIZE; LOGISTIC-REGRESSION; MORTALITY; SURVIVORS; HOSPITALIZATION; PREDICTORS; INFECTION	Introduction Multiplex polymerase chain reaction (mPCR) for respiratory virus testing is increasingly used in community-acquired pneumonia (CAP), however data on one-year outcome in intensive care unit (ICU) patients with reference to the causative pathogen are scarce. Materials and methods We performed a single-center retrospective study in 123 ICU patients who had undergone respiratory virus testing for CAP by mPCR and with known one-year survival status. Functional status including dyspnea (mMRC score), autonomy (ADL Katz score) and need for new home-care ventilatory support was assessed at a one-year post-ICU follow-up. Mortality rates and functional status were compared in patients with CAP of a bacterial, viral or unidentified etiology one year after ICU admission. Results The bacterial, viral and unidentified groups included 19 (15.4%), 37 (30.1%), and 67 (54.5%) patients, respectively. In multivariate analysis, one-year mortality in the bacterial group was higher compared to the viral group (HR 2.92, 95% CI 1.71-7.28, p = 0.02) and tended to be higher compared to the unidentified etiology group (p = 0.06); but no difference was found between the viral and the unidentified etiology group (p = 0.43). In 64/83 one-year survivors with a post-ICU follow-up consultation, there were no differences in mMRC score, ADL Katz score and new home-care ventilatory support between the groups (p = 0.52, p = 0.37, p = 0.24, respectively). Severe dyspnea (mMRC score = 4 or death), severe autonomy deficiencies (ADL Katz score <= 2 or death), and major adverse respiratory events (new home-care ventilatory support or death) were observed in 52/104 (50.0%), 47/104 (45.2%), and 65/104 (62.5%) patients, respectively; with no difference between the bacterial, viral and unidentified group: p = 0.58, p = 0.06, p = 0.61, respectively. Conclusions CAP of bacterial origin had a poorer outcome than CAP of viral or unidentified origin. At one-year, impairment of functional status was frequently observed, with no difference according to the etiology.	[Sangla, Frederic; Adda, Mireille; Lautrette, Alexandre; Souweine, Bertrand] CHU Gabriel Montpied, Serv Med Intens & Reanimat, Clermont Ferrand, France; [Legouis, David; Marti, Pierre-Emmanuel; Sgardello, Sebastian D.] Hop Univ Geneve, Serv Soins Intensifs Adultes, Geneva, Switzerland; [Brebion, Amelie] CHU Gabriel Montpied, Lab Virol, Clermont Ferrand, France; [Saint-Sardos, Pierre] CHU Gabriel Montpied, Lab Bacteriol, Clermont Ferrand, France; [Pereira, Bruno] CHU Gabriel Montpied, Dept Biostat, Clermont Ferrand, France	CHU Clermont Ferrand; University of Geneva; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand	Sangla, F (corresponding author), CHU Gabriel Montpied, Serv Med Intens & Reanimat, Clermont Ferrand, France.	fred.sangla@gmail.com	Legouis, David/ABF-8069-2020; souweine, bertrand/HHR-8972-2022	Sangla, Frederic/0000-0002-2672-1952; Legouis, David/0000-0002-2924-9737				Adamuz J, 2014, J INFECTION, V68, P534, DOI 10.1016/j.jinf.2014.02.006; Angus DC, 2002, AM J RESP CRIT CARE, V166, P717, DOI 10.1164/rccm.2102084; Bein T, 2018, CURR OPIN CRIT CARE, V24, P35, DOI 10.1097/MCC.0000000000000476; Biehl M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1062-y; Cameron RJ, 2006, INTENS CARE MED, V32, P1022, DOI 10.1007/s00134-006-0202-x; Celli BR, 2010, RESP MED, V104, P773, DOI 10.1016/j.rmed.2009.12.017; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Cilloniz C, 2018, CURR OPIN CRIT CARE, V24, P531, DOI 10.1097/MCC.0000000000000550; Cilloniz C, 2011, CRIT CARE, V15, DOI 10.1186/cc10444; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; Demidenko E, 2008, STAT MED, V27, P36, DOI 10.1002/sim.2980; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Ferrer M, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0191721, 10.1371/journ]; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Holter JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148741; Honselmann KC, 2015, J CRIT CARE, V30, P721, DOI 10.1016/j.jcrc.2015.03.009; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d; Karhu J, 2014, CLIN INFECT DIS, V59, P62, DOI 10.1093/cid/ciu237; Karhu J, 2011, ACTA ANAESTH SCAND, V55, P1254, DOI 10.1111/j.1399-6576.2011.02535.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Laporte L, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0430-6; Luyt CE, 2012, CHEST, V142, P583, DOI 10.1378/chest.11-2196; Marti J, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0178-8; McDonald MD, 2019, J CARDIOTHOR VASC AN, V33, P72, DOI 10.1053/j.jvca.2018.05.023; Montull B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145929; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Piralla A, 2017, J CLIN VIROL, V92, P48, DOI 10.1016/j.jcv.2017.05.004; Prina E, 2015, LANCET, V386, P1097, DOI 10.1016/S0140-6736(15)60733-4; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Restrepo MI, 2009, INFECT DIS CLIN N AM, V23, P503, DOI 10.1016/j.idc.2009.04.003; Siow WT, 2016, RESPIRATION, V92, P286, DOI 10.1159/000448555; Torres A, 2019, INTENS CARE MED, V45, P159, DOI 10.1007/s00134-019-05519-y; Tosteson TD, 2003, STAT MED, V22, P1069, DOI 10.1002/sim.1388; Voiriot G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1517-9; Walden AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13812; Wiemken T, 2013, EUR J CLIN MICROBIOL, V32, P705, DOI 10.1007/s10096-012-1802-8	39	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243762	10.1371/journal.pone.0243762	http://dx.doi.org/10.1371/journal.pone.0243762			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315946	Green Published, gold			2022-12-26	WOS:000600186100013
J	Ardehali, MB; Damle, M; Perea-Resa, C; Blower, MD; Kingston, RE				Ardehali, M. Behfar; Damle, Manashree; Perea-Resa, Carlos; Blower, Michael D.; Kingston, Robert E.			Elongin A associates with actively transcribed genes and modulates enhancer RNA levels with limited impact on transcription elongation rate in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ELONGIN; UBIQUITIN LIGASE; PAF1 COMPLEX; FACTOR-SIII; EXPRESSION; PROTEIN; IDENTIFICATION; PURIFICATION; NUCLEOLUS; PACKAGE	Elongin A (EloA) is an essential transcription factor that stimulates the rate of RNA polymerase II (Pol II) transcription elongation in vitro. However, its role as a transcription factor in vivo has remained underexplored. Here we show that in mouse embryonic stem cells, EloA localizes to both thousands of Pol II transcribed genes with preference for transcription start site and promoter regions and a large number of active enhancers across the genome. EloA deletion results in accumulation of transcripts from a subset of enhancers and their adjacent genes. Notably, EloA does not substantially enhance the elongation rate of Pol II in vivo. We also show that EloA localizes to the nucleoli and associates with RNA polymerase I transcribed ribosomal RNA gene, Rn45s. EloA is a highly disordered protein, which we demonstrate forms phase-separated condensates in vitro, and truncation mutations in the intrinsically disordered regions (IDR) of EloA interfere with its targeting and localization to the nucleoli. We conclude that EloA broadly associates with transcribed regions, tunes RNA Pol II transcription levels via impacts on enhancer RNA synthesis, and interacts with the rRNA producing/processing machinery in the nucleolus. Our work opens new avenues for further investigation of the role of this functionally multifaceted transcription factor in enhancer and ribosomal RNA biology.	[Ardehali, M. Behfar; Damle, Manashree; Perea-Resa, Carlos; Blower, Michael D.; Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ardehali, M. Behfar; Damle, Manashree; Perea-Resa, Carlos; Blower, Michael D.; Kingston, Robert E.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Kingston, RE (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	kingston@molbio.mgh.harvard.edu		Kingston, Robert/0000-0003-3628-4335; Blower, Michael/0000-0002-5037-1972; Ardehali, Behfar/0000-0002-4648-275X; Perea-Resa, Carlos/0000-0002-9971-4972	National Institutes of Health [R01GM043901, R37GM048405, R35GM131743, GM122893]; National Institutes of Health/National Institute of General Medical Sciences	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM043901, R37GM048405, and R35GM131743 to R. E. K. and grant GM122893 from National Institutes of Health/National Institute of General Medical Sciences to M. D. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abmayr S. M., 2006, CURR PROTOC PHARM; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ardehali MB, 2017, MOL CELL, V68, P872, DOI 10.1016/j.molcel.2017.10.025; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Baluapuri A, 2019, MOL CELL, V74, P674, DOI 10.1016/j.molcel.2019.02.031; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen FX, 2017, SCIENCE, V357, P1294, DOI 10.1126/science.aan3269; Chen HK, 1999, MOL CELL BIOL, V19, P8536; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Cinghu S, 2017, MOL CELL, V68, P104, DOI 10.1016/j.molcel.2017.09.010; Conaway RC, 2019, NAT STRUCT MOL BIOL, V26, P771, DOI 10.1038/s41594-019-0283-1; Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Elrod ND, 2019, MOL CELL, V76, P738, DOI 10.1016/j.molcel.2019.10.034; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Field A, 2020, ANNU REV BIOCHEM, V89, P213, DOI 10.1146/annurev-biochem-011420-095916; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Harlen KM, 2017, NAT REV MOL CELL BIO, V18, P263, DOI 10.1038/nrm.2017.10; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henriques T, 2018, GENE DEV, V32, P26, DOI 10.1101/gad.309351.117; Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63; Hou LM, 2019, P NATL ACAD SCI USA, V116, P14583, DOI 10.1073/pnas.1904324116; Jacob MD, 2013, MOL BIOL CELL, V24, P2943, DOI 10.1091/mbc.E13-04-0223; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong SE, 2003, METHOD ENZYMOL, V371, P276; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuraoka I, 2008, J BIOL CHEM, V283, P940, DOI 10.1074/jbc.M706647200; Lai F, 2015, NATURE, V525, P399, DOI 10.1038/nature14906; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meers MP, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0287-4; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Noh KM, 2015, MOL CELL, V59, P89, DOI 10.1016/j.molcel.2015.05.017; Plys AJ, 2019, GENE DEV, V33, P799, DOI 10.1101/gad.326488.119; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tamura K, 2003, BIOCHEM BIOPH RES CO, V309, P189, DOI 10.1016/S0006-291X(03)01556-0; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tsai YT, 2008, J BIOMED SCI, V15, P471, DOI 10.1007/s11373-007-9226-7; Van Oss SB, 2017, TRENDS BIOCHEM SCI, V42, P788, DOI 10.1016/j.tibs.2017.08.003; Weems JC, 2017, J BIOL CHEM, V292, P6431, DOI 10.1074/jbc.C117.777946; Weems JC, 2015, J BIOL CHEM, V290, P15030, DOI 10.1074/jbc.M114.632794; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamazaki K, 2003, J BIOL CHEM, V278, P13585, DOI 10.1074/jbc.C300047200; Yasukawa T, 2012, CELL REP, V2, P1129, DOI 10.1016/j.celrep.2012.09.031	73	8	8	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100202	10.1074/jbc.RA120.015877	http://dx.doi.org/10.1074/jbc.RA120.015877			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33334895	Green Published, gold			2022-12-26	WOS:000672866400180
J	Jonnalagadda, R; Flores, AD; Cai, WL; Mehmood, R; Narayanamoorthy, M; Ren, CX; Zaragoza, JPT; Kulik, HJ; Zhang, WJ; Drennan, CL				Jonnalagadda, Rohan; Flores, Antonio Del Rio; Cai, Wenlong; Mehmood, Rimsha; Narayanamoorthy, Maanasa; Ren, Chaoxiang; Zaragoza, Jan Paulo T.; Kulik, Heather J.; Zhang, Wenjun; Drennan, Catherine L.			Biochemical and crystallographic investigations into isonitrile formation by a nonheme iron-dependent oxidase/decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; MECHANISM; BIOSYNTHESIS; INTERMEDIATE; TAUD	The isonitrile moiety is found in marine sponges and some microbes, where it plays a role in processes such as virulence and metal acquisition. Until recently only one route was known for isonitrile biosynthesis, a condensation reaction that brings together a nitrogen atom of L-Trp/L-Tyr with a carbon atom from ribulose-5-phosphate. With the discovery of ScoE, a mononuclear Fe(II) alpha-ketoglutarate-dependent dioxygenase from Streptomyces coeruleorubidus, a second route was identified. ScoE forms isonitrile from a glycine adduct, with both the nitrogen and carbon atoms coming from the same glycyl moiety. This reaction is part of the nonribosomal biosynthetic pathway of isonitrile lipopeptides. Here, we present structural, biochemical, and computational investigations of the mechanism of isonitrile formation by ScoE, an unprecedented reaction in the mononuclear Fe(II) alpha-ketoglutarate-dependent dioxygenase superfamily. The stoichiometry of this enzymatic reaction is measured, and multiple high-resolution (1.45-1.96 angstrom resolution) crystal structures of Fe(II)-bound ScoE are presented, providing insight into the binding of substrate, (R)-3-((carboxylmethyl)amino)butanoic acid (CABA), cosubstrate alpha-ketoglutarate, and an Fe(IV)=O mimic oxovanadium. Comparison to a previously published crystal structure of ScoE suggests that ScoE has an "inducible" alpha-ketoglutarate binding site, in which two residues arginine-157 and histidine-299 move by approximately 10 angstrom from the surface of the protein into the active site to create a transient alpha-ketoglutarate binding pocket. Together, data from structural analyses, site-directed mutagenesis, and computation provide insight into the mode of alpha-ketoglutarate binding, the mechanism of isonitrile formation, and how the structure of ScoE has been adapted to perform this unusual chemical reaction.	[Jonnalagadda, Rohan; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Flores, Antonio Del Rio; Cai, Wenlong; Ren, Chaoxiang; Zhang, Wenjun] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Mehmood, Rimsha; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Mehmood, Rimsha; Kulik, Heather J.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Narayanamoorthy, Maanasa; Zaragoza, Jan Paulo T.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Zaragoza, Jan Paulo T.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Zhang, Wenjun] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Zhang, WJ (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Kulik, HJ (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Zhang, WJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	hjkulik@mit.edu; wjzhang@berkeley.edu; drennan@mit.edu		Zaragoza, Jan Paulo/0000-0002-2583-6571; Ren, Chaoxiang/0000-0002-0151-1713; Del Rio Flores, Antonio/0000-0001-5893-3557; Zhang, Wenjun/0000-0001-9348-972X; Mehmood, Rimsha/0000-0002-2175-5133; Narayanamoorthy, Maanasa/0000-0002-7418-2607; Drennan, Catherine/0000-0001-5486-2755	National Institutes of Health [R35 GM126982]; NIH Pre-Doctoral Training Grant [T32GM007287, R01 GM136758]; Chan Zuckerberg Biohub Investigator Program; NSF [CBET-1704266]; Burroughs Wellcome Fund Career Award at the Scientific Interface; UC Berkeley Chancellor's Fellowship; Office of Science, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Institute of General Medical Sciences from the National Institutes of Health [P30 GM124165]; NIH-ORIP HEI grant [S10 OD021527]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pre-Doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chan Zuckerberg Biohub Investigator Program; NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); UC Berkeley Chancellor's Fellowship; Office of Science, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE))	This research was supported by National Institutes of Health Grants R35 GM126982 (C. L. D.), NIH Pre-Doctoral Training Grant T32GM007287 (R. J.), and R01 GM136758 (W. Z.). C. L. D. is a Howard Hughes Medical Institute Investigator, and W. Z. is supported by the Chan Zuckerberg Biohub Investigator Program. This research was also financially supported by grants to H. J. K. from the NSF (CBET-1704266) and a Burroughs Wellcome Fund Career Award at the Scientific Interface. A. D. R. F. is funded by the UC Berkeley Chancellor's Fellowship. The GC-MS work was made possible by the Catalysis Facility of Lawrence Berkeley National Laboratory, supported by the Director, Office of Science, of the U.S. Department of Energy (contract no. DE-AC02-05CH11231). This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-E beam line is funded by an NIH-ORIP HEI grant (S10 OD021527). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; Brady SF, 2005, ANGEW CHEM INT EDIT, V44, P7063, DOI 10.1002/anie.200501941; Case D. A., 2018, AMBER 2019; Chen TY, 2020, ANGEW CHEM INT EDIT, V59, P7367, DOI 10.1002/anie.201914896; Clarke-Pearson MF, 2008, J BACTERIOL, V190, P6927, DOI 10.1128/JB.00801-08; Davis KM, 2019, BIOCHEMISTRY-US, V58, P4218, DOI 10.1021/acs.biochem.9b00598; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frisch G. W., 2013, GAUSSIAN 09; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Harris NC, 2018, ANGEW CHEM INT EDIT, V57, P9707, DOI 10.1002/anie.201804307; Harris NC, 2017, P NATL ACAD SCI USA, V114, P7025, DOI 10.1073/pnas.1705016114; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; HAY PJ, 1985, J CHEM PHYS, V82, P270, DOI 10.1063/1.448799; Huang YB, 2020, ANAL CHEM, V92, P599, DOI 10.1021/acs.analchem.9b05147; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li PF, 2016, J CHEM INF MODEL, V56, P599, DOI 10.1021/acs.jcim.5b00674; Martinez S, 2015, J BIOL CHEM, V290, P20702, DOI 10.1074/jbc.R115.648691; Martinie RJ, 2017, INORG CHEM, V56, P13382, DOI 10.1021/acs.inorgchem.7b02113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell AJ, 2017, J AM CHEM SOC, V139, P13830, DOI 10.1021/jacs.7b07374; Muthukumaran RB, 2007, BIOCHEMISTRY-US, V46, P5951, DOI 10.1021/bi700562t; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Rui Z, 2014, P NATL ACAD SCI USA, V111, P18237, DOI 10.1073/pnas.1419701112; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smart O.S., 2011, GRADE VERSION 1220; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; TUDERMAN L, 1977, EUR J BIOCHEM, V80, P341, DOI 10.1111/j.1432-1033.1977.tb11888.x; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x	43	6	6	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100231	10.1074/jbc.RA120.015932	http://dx.doi.org/10.1074/jbc.RA120.015932			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361191	Green Published, gold			2022-12-26	WOS:000672866400209
J	Matsubayashi, M; Sakaguchi, YM; Sahara, Y; Nanaura, H; Kikuchi, S; Asghari, A; Bui, L; Kobashigawa, S; Nakanishi, M; Nagata, R; Matsui, TK; Kashino, G; Hasegawa, M; Takasawa, S; Eriguchi, M; Tsuruya, K; Nagamori, S; Sugie, K; Nakagawa, T; Takasato, M; Umetani, M; Mori, E				Matsubayashi, Masaya; Sakaguchi, Yoshihiko M.; Sahara, Yoshiki; Nanaura, Hitoki; Kikuchi, Sotaro; Asghari, Arvand; Bui, Linh; Kobashigawa, Shinko; Nakanishi, Mari; Nagata, Riko; Matsui, Takeshi K.; Kashino, Genro; Hasegawa, Masatoshi; Takasawa, Shin; Eriguchi, Masahiro; Tsuruya, Kazuhiko; Nagamori, Shushi; Sugie, Kazuma; Nakagawa, Takahiko; Takasato, Minoru; Umetani, Michihisa; Mori, Eiichiro			27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action	FASEB JOURNAL			English	Article						27&#8208; hydroxycholesterol; estrogen receptor; transcriptional regulatory element; uric acid	SERUM URIC-ACID; METABOLIC SYNDROME; INSULIN-RESISTANCE; GENDER-DIFFERENCES; NATIONAL-HEALTH; HYPERURICEMIA; PREVALENCE; SYSTEMS; LEVEL; URAT1	The excretion and reabsorption of uric acid both to and from urine are tightly regulated by uric acid transporters. Metabolic syndrome conditions, such as obesity, hypercholesterolemia, and insulin resistance, are believed to regulate the expression of uric acid transporters and decrease the excretion of uric acid. However, the mechanisms driving cholesterol impacts on uric acid transporters have been unknown. Here, we show that cholesterol metabolite 27-hydroxycholesterol (27HC) upregulates the uric acid reabsorption transporter URAT1 encoded by SLC22A12 via estrogen receptors (ER). Transcriptional motif analysis showed that the SLC22A12 gene promoter has more estrogen response elements (EREs) than other uric acid reabsorption transporters such as SLC22A11 and SLC22A13, and 27HC-activated SLC22A12 gene promoter via ER through EREs. Furthermore, 27HC increased SLC22A12 gene expression in human kidney organoids. Our results suggest that in hypercholesterolemic conditions, elevated levels of 27HC derived from cholesterol induce URAT1/SLC22A12 expression to increase uric acid reabsorption, and thereby, could increase serum uric acid levels.	[Matsubayashi, Masaya; Sakaguchi, Yoshihiko M.; Nanaura, Hitoki; Kikuchi, Sotaro; Kobashigawa, Shinko; Nakanishi, Mari; Nagata, Riko; Matsui, Takeshi K.; Nakagawa, Takahiko; Mori, Eiichiro] Nara Med Univ, Dept Future Basic Med, Kashihara, Nara 6348521, Japan; [Sahara, Yoshiki; Takasato, Minoru] RIKEN Ctr Biosyst Dynam Res, Kobe, Hyogo, Japan; [Sahara, Yoshiki; Takasato, Minoru] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Nanaura, Hitoki; Matsui, Takeshi K.; Sugie, Kazuma] Nara Med Univ, Dept Neurol, Kashihara, Nara, Japan; [Asghari, Arvand; Bui, Linh; Umetani, Michihisa] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Kashino, Genro] Nara Med Univ, Radioisotope Res Ctr, Kashihara, Nara, Japan; [Hasegawa, Masatoshi] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara, Japan; [Takasawa, Shin] Nara Med Univ, Dept Biochem, Kashihara, Nara, Japan; [Eriguchi, Masahiro; Tsuruya, Kazuhiko] Nara Med Univ, Dept Nephrol, Kashihara, Nara, Japan; [Nagamori, Shushi] Nara Med Univ, Dept Collaborat Res, Nara, Japan; [Umetani, Michihisa] Univ Houston, HLTH Res Inst, Houston, TX USA; [Mori, Eiichiro] Nara Med Univ, iCliniX Lab 5, Kashihara, Nara, Japan	Nara Medical University; RIKEN; Kyoto University; Nara Medical University; University of Houston System; University of Houston; Nara Medical University; Nara Medical University; Nara Medical University; Nara Medical University; Nara Medical University; University of Houston System; University of Houston; Nara Medical University	Mori, E (corresponding author), Nara Med Univ, Dept Future Basic Med, Kashihara, Nara 6348521, Japan.; Umetani, M (corresponding author), Univ Houston, HLTH Res Inst, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA.	mumetani@uh.edu; emori@naramed-u.ac.jp	Takasato, Minoru/K-2035-2014; Nagamori, Shushi/P-4530-2018; Asghari, Arvand/C-7005-2019	Takasato, Minoru/0000-0002-0458-7414; Nagamori, Shushi/0000-0003-0203-2754; Asghari, Arvand/0000-0001-6184-0861; Matsui, Takeshi/0000-0002-1678-284X				Acimovic J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068031; Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Apridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045; Barthelson RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-340; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Burkard I, 2007, ATHEROSCLEROSIS, V194, P71, DOI 10.1016/j.atherosclerosis.2006.09.026; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen-Xu M, 2019, ARTHRITIS RHEUMATOL, V71, P991, DOI 10.1002/art.40807; Cicero AFG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29955-w; Cobo G, 2016, CLIN SCI, V130, P1147, DOI 10.1042/CS20160047; Cooke JP, 2002, CIRCULATION, V106, P1904, DOI 10.1161/01.CIR.0000036864.14101.1B; Doshi M, 2011, NUCLEOS NUCLEOT NUCL, V30, P1290, DOI 10.1080/15257770.2011.603711; Dudley MW, 2000, P NATL ACAD SCI USA, V97, P3696, DOI 10.1073/pnas.040558197; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Enomoto Atsushi, 2005, Clin Exp Nephrol, V9, P195, DOI 10.1007/s10157-005-0368-5; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Hosoyamada M, 2004, J AM SOC NEPHROL, V15, P261, DOI 10.1097/01.ASN.0000107560.80107.19; Ioannou GN, 2013, ATHEROSCLEROSIS, V226, P220, DOI 10.1016/j.atherosclerosis.2012.10.044; Ishikawa-Takata K, 2002, EUR J CLIN NUTR, V56, P601, DOI 10.1038/sj.ejcn.1601364; Kuzuya M, 2002, J GERONTOL A-BIOL, V57, pM660, DOI 10.1093/gerona/57.10.M660; Lake BB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04426-w; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE J, 1995, AM J EPIDEMIOL, V142, P288, DOI 10.1093/oxfordjournals.aje.a117634; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Liu R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/762820; Marelli C, 2018, BRAIN, V141, P72, DOI 10.1093/brain/awx297; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Miao ZM, 2009, INFLAMM RES, V58, P659, DOI 10.1007/s00011-009-0031-9; Misawa K, 2020, GENETICS, V214, P1079, DOI 10.1534/genetics.119.303006; Nakagawa T, 2008, INTERN EMERG MED, V3, P313, DOI 10.1007/s11739-008-0141-3; Nigam SK, 2018, CURR OPIN NEPHROL HY, V27, P305, DOI 10.1097/MNH.0000000000000427; Ohno S, 2018, INT HEART J, V59, P559, DOI 10.1536/ihj.17-143; Onizuka Y, 2019, CLIN BIOCHEM, V73, P105, DOI 10.1016/j.clinbiochem.2019.08.009; Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Ren P, 2018, CLIN LAB, V64, P719, DOI 10.7754/Clin.Lab.2017.171037; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Shirasawa T, 2020, BMC ENDOCR DISORD, V20, DOI 10.1186/s12902-019-0481-1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sumiyoshi H, 2019, INT HEART J, V60, P830, DOI 10.1536/ihj.18-444; Takasato M, 2016, NATURE, V536, P238, DOI 10.1038/nature17982; Takiue Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P113, DOI 10.1080/15257770.2010.551645; Tan PK, 2016, MOL BIOL EVOL, V33, P2193, DOI 10.1093/molbev/msw116; Thomas MP, 2013, J STEROID BIOCHEM, V137, P27, DOI 10.1016/j.jsbmb.2012.12.014; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Umetani M, 2016, J STEROID BIOCHEM, V157, P20, DOI 10.1016/j.jsbmb.2015.11.002; Umetani M, 2014, CELL METAB, V20, P172, DOI 10.1016/j.cmet.2014.05.013; Umetani M, 2011, TRENDS ENDOCRIN MET, V22, P130, DOI 10.1016/j.tem.2011.01.003; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang HJ, 2018, OPEN MED-WARSAW, V13, P172, DOI 10.1515/med-2018-0027; Wu HJ, 2018, CELL STEM CELL, V23, P869, DOI 10.1016/j.stem.2018.10.010; Wu XL, 2015, J PHYSIOL BIOCHEM, V71, P217, DOI 10.1007/s13105-015-0399-7; Yahyaoui R, 2008, J CLIN ENDOCR METAB, V93, P2230, DOI 10.1210/jc.2007-2467; Yang T, 2012, ATHEROSCLEROSIS, V220, P525, DOI 10.1016/j.atherosclerosis.2011.11.014; Zhang X, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0882-6; Zhen HT, 2017, BIOMED REP, V7, P325, DOI 10.3892/br.2017.966; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Zoccali C, 2013, CURR HYPERTENS REP, V15, P531, DOI 10.1007/s11906-013-0391-y	68	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21262	10.1096/fj.202002077R	http://dx.doi.org/10.1096/fj.202002077R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368618	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-26	WOS:000605626600031
J	Akande, O; Chen, Q; Toldo, S; Lesnefsky, EJ; Quader, M				Akande, Oluwatoyin; Chen, Qun; Toldo, Stefano; Lesnefsky, Edward J.; Quader, Mohammed			Ischemia and reperfusion injury to mitochondria and cardiac function in donation after circulatory death hearts- an experimental study	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; DECREASES MYOCARDIAL INJURY; ELECTRON-TRANSPORT; PROTECTS MITOCHONDRIA; TRANSPLANTATION; DYSFUNCTION; INHIBITION; BLOCKADE	The ultimate treatment for patients with end-stage heart failure is heart transplantation. The number of donor hearts which are primarily procured from donation after brain death (DBD) donors is limited, but donation after circulatory death (DCD) donor hearts can increase the heart donor pool. However, ischemia and reperfusion injuries associated with the DCD process causes myocardial damage, limiting the use of DCD hearts in transplantation. Addressing this problem is critical in the exploration of DCD hearts as suitable donor hearts for transplantation. In this study, rat hearts were procured following the control beating-heart donor (CBD) or DCD donation process. Changes in mitochondria and cardiac function from DCD hearts subjected to 25 or 35 minutes of ischemia followed by 60 minutes of reperfusion were compared to CBD hearts. Following ischemia, rates of oxidative phosphorylation and calcium retention capacity were progressively impaired in DCD hearts compared to CBD hearts. Reperfusion caused additional mitochondrial dysfunction in DCD hearts. Developed pressure, inotropy and lusitropy, were significantly reduced in DCD hearts compared to CBD hearts. We, therefore, suggest that interventional strategies targeted before the onset of ischemia and at reperfusion could protect mitochondria, thus potentially making DCD hearts suitable for heart transplantation.	[Akande, Oluwatoyin; Quader, Mohammed] Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23284 USA; [Chen, Qun; Toldo, Stefano; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Med, Div Cardiol, Richmond, VA USA; [Lesnefsky, Edward J.] Hunter Holmes McGuire Vet Adm Med Ctr, Med Serv, Richmond, VA USA; [Quader, Mohammed] Hunter Holmes McGuire Vet Adm Med Ctr, Dept Surg, Richmond, VA 23249 USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Hunter Holmes McGuire Veterinary Affairs Medical Center	Quader, M (corresponding author), Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23284 USA.; Quader, M (corresponding author), Hunter Holmes McGuire Vet Adm Med Ctr, Dept Surg, Richmond, VA 23249 USA.	mohammed.quader@vcuhealth.org	Chen, Qun/HGD-0868-2022		Merit Review Grant [1I01 BX003859, 2IO1 BX001355]; Pauley Heart Center	Merit Review Grant; Pauley Heart Center	This work was supported by Merit Review Grant awarded to Dr. Mohammed Quader (1I01 BX003859), Dr. Edward Lesnefsky (2IO1 BX001355), and funds from the Pauley Heart Center to Drs. Mohammed Quader, Qun Chen and Stefano Toldo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AA, 2011, AM J TRANSPLANT, V11, P1621, DOI 10.1111/j.1600-6143.2011.03622.x; Aravinda P, 2018, ANN CARDIOTHORAC SUR, V7, P75, DOI [10.21037/acs.2018.01.08, DOI 10.21037/ACS.2018.01.08]; Blackstock MJ, 2014, EUR J EMERG MED, V21, P324, DOI 10.1097/MEJ.0000000000000082; Camara AKS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00013; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Chen Q, 2019, AM J PHYSIOL-CELL PH, V317, pC910, DOI 10.1152/ajpcell.00190.2019; Chen Q, 2018, AM J PHYSIOL-HEART C, V314, pH787, DOI 10.1152/ajpheart.00531.2017; Chen Qun, 2012, J Aging Res, V2012, P753949, DOI 10.1155/2012/753949; Chew HC, 2019, J AM COLL CARDIOL, V73, P1447, DOI 10.1016/j.jacc.2018.12.067; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Gao L, 2019, TRANSPLANTATION, V103, P1140, DOI 10.1097/TP.0000000000002629; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; Iyer A, 2014, AM J TRANSPLANT, V14, P1744, DOI 10.1111/ajt.12782; January C. T., 2019, CIRCULATION, V140, pe125, DOI 10.1161/cir.0000000000000665; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lesnefsky EJ, 1977, AM J PHYSIOL-HEART C, V273, pH1544; Mancini D, 2010, CIRCULATION, V122, P173, DOI 10.1161/CIRCULATIONAHA.109.858076; Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012; McKeown DW, 2012, BRIT J ANAESTH, V108, pI96, DOI 10.1093/bja/aer351; Mohsin AA, 2019, J PHARMACOL EXP THER, V369, P282, DOI 10.1124/jpet.118.254300; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; PALMER JW, 1977, J BIOL CHEM, V252, P8731; PALMER JW, 1986, AM J PHYSIOL, V250, pH741, DOI 10.1152/ajpheart.1986.250.5.H741; Lopez SP, 2009, J HEART LUNG TRANSPL, V28, P815, DOI 10.1016/j.healun.2009.04.021; Quader M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00681; Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004; Sade Robert M, 2011, J S C Med Assoc, V107, P146; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Stewart S, 2009, TRANSL RES, V153, P224, DOI 10.1016/j.trsl.2009.02.003; Tanaka-Esposito C, 2012, TRANSL RES, V160, P207, DOI 10.1016/j.trsl.2012.01.024; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang XC, 2018, AM J TRANSPLANT, V18, P843, DOI 10.1111/ajt.14523; Xie JR, 2007, ACTA ANAESTH SCAND, V51, P909, DOI 10.1111/j.1399-6576.2007.01342.x; Xu AJ, 2014, AM J PHYSIOL-CELL PH, V306, pC1142, DOI 10.1152/ajpcell.00241.2013	40	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243504	10.1371/journal.pone.0243504	http://dx.doi.org/10.1371/journal.pone.0243504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370296	Green Published, gold			2022-12-26	WOS:000603611900070
J	Li, ZT; Ahmed, I; Xu, ZQ; Sun, S; Li, T; Gu, DH; Liu, Y; Zhang, X; Yan, SX; Hu, WY; Jiang, ZQ; Duan, XH; Li, QH; Liu, LX; Rong, H; Wang, K; Abdulwahid, AM; Dou, TF; Wang, SR; Su, ZC; Ge, CR; te Pas, MFW; Jia, JJ; Huang, Y				Li, Zhengtian; Ahmed, Irfan; Xu, Zhiqiang; Sun, Shuai; Li, Tao; Gu, Dahai; Liu, Yong; Zhang, Xia; Yan, Shixiong; Hu, Wenyuan; Jiang, Ziqing; Duan, Xiaohua; Li, Qihua; Liu, Lixian; Rong, Hua; Wang, Kun; Abdulwahid, Alsoufi Mohammed; Dou, Tengfei; Wang, Shanrong; Su, Zhengchang; Ge, Changrong; te Pas, Marinus F. W.; Jia, Junjing; Huang, Ying			Profiles of expression pattern and tissue distribution of host defense peptides genes in different chicken (Gallus gallus) breeds related to body weight	PLOS ONE			English	Article							AVIAN BETA-DEFENSIN; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; CATHELICIDINS; MODULATION; INFECTION; TRACT	Host defense peptides (HDPs) are an important first line of defense with antimicrobial and immunomodulatory properties. Selection for increased body weight is hypothesized to be related to reduced immune response. We studied the relationships among body weight, age, and the HDP expression patterns in intestine and immune organs. We used chickens with marked differences of body sizes. The non-selected Daweishan mini chickens showed the highest indexes of immune organs and the lowest concentrations of the plasma immune parameters C3, C4, IgA, and IgY, while the commercial Avian broiler showed the opposite results. The Daweishan mini chickens showed the highest mRNA expressions of HDP genes in small intestine followed by the semi-selected Wuding chickens. Compared with local breeds, broiler chickens showed higher mRNA expression of HDP genes in spleen, thymus, and bursa. Body weight and HDP expression levels were negatively correlated in the intestine and positively in the immune organs. Our results indicated that the HDP immune regulatory roles in small intestine acted as first line of defense in innate immunity in local breeds, and as an adaptive immunity in broiler chickens. Selection was associated with different expression expressions of HDP genes in breed-, age-, and organ-specific manners.	[Li, Zhengtian; Ahmed, Irfan; Xu, Zhiqiang; Sun, Shuai; Li, Tao; Gu, Dahai; Liu, Yong; Zhang, Xia; Yan, Shixiong; Hu, Wenyuan; Jiang, Ziqing; Duan, Xiaohua; Li, Qihua; Liu, Lixian; Rong, Hua; Wang, Kun; Abdulwahid, Alsoufi Mohammed; Dou, Tengfei; Wang, Shanrong; Ge, Changrong; Jia, Junjing; Huang, Ying] Yunnan Agr Univ, Yunnan Prov Key Lab Anim Nutr & Feed, Kunming, Yunnan, Peoples R China; [Xu, Zhiqiang; Gu, Dahai] Yunnan Agr Univ, Dept Food Sci, Kunming, Yunnan, Peoples R China; [Su, Zhengchang] Univ N Carolina, Dept Bioinformat & Genom, Coll Comp & Informat, Charlotte, NC USA; [te Pas, Marinus F. W.] Wageningen UR, Wageningen Livestock Res, Wageningen, Netherlands; [te Pas, Marinus F. W.] Yunnan Agr Univ, Kunming, Yunnan, Peoples R China	Yunnan Agricultural University; Yunnan Agricultural University; University of North Carolina; University of North Carolina Charlotte; Wageningen University & Research; Yunnan Agricultural University	Jia, JJ; Huang, Y (corresponding author), Yunnan Agr Univ, Yunnan Prov Key Lab Anim Nutr & Feed, Kunming, Yunnan, Peoples R China.; te Pas, MFW (corresponding author), Wageningen UR, Wageningen Livestock Res, Wageningen, Netherlands.; te Pas, MFW (corresponding author), Yunnan Agr Univ, Kunming, Yunnan, Peoples R China.	marinus.tepas@wur.nl; junjingj@sina.com; yinghuang@ynau.edu.cn	Ahmed, Irfan/HHD-1948-2022; AHMED, IRFAN/AFW-6944-2022		National Natural Science Foundation of China [U1702232, 31560618]; National Natural Science Foundation of Yunnan Province [2017IC048, 2019HC011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Yunnan Province	CG: National Natural Science Foundation of China (U1702232, 31560618) JJ: National Natural Science Foundation of Yunnan Province (2017IC048 and 2019HC011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta M, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-15; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2012, INSIGHT WORLD J INFR, V3, P18; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; Cheng YY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0465-3; Chinese chicken Feeding Standard, 2004, FEED STAND CHICK; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Cuperus T, 2013, DEV COMP IMMUNOL, V41, P352, DOI 10.1016/j.dci.2013.04.019; Dou TF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3845-9; EVANS EW, 1994, J LEUKOCYTE BIOL, V56, P661, DOI 10.1002/jlb.56.5.661; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gong DQ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-12; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Hellgren Olof, 2010, Immunome Res, V6, P3, DOI 10.1186/1745-7580-6-3; Higgs R, 2005, IMMUNOGENETICS, V57, P90, DOI 10.1007/s00251-005-0777-3; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Huff WE, 2002, POULTRY SCI, V81, P437, DOI 10.1093/ps/81.4.437; Kin NW, 2011, EUR J IMMUNOL, V41, P3006, DOI 10.1002/eji.201141606; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Kosciuczuk EM, 2012, MOL BIOL REP, V39, P10957, DOI 10.1007/s11033-012-1997-x; Lee MO, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0866-6; Leshchinsky TV, 2001, DEV COMP IMMUNOL, V25, P629, DOI 10.1016/S0145-305X(01)00023-4; Lu FZ, 2008, POULTRY SCI, V87, P2087, DOI 10.3382/ps.2007-00493; Lu L, 2015, GENET MOL RES, V14, P3330, DOI 10.4238/2015.April.13.12; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; Ma DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047743; Matusiak L, 2014, ACTA DERM-VENEREOL, V94, P699, DOI 10.2340/00015555-1841; Milona P, 2007, BIOCHEM BIOPH RES CO, V356, P169, DOI 10.1016/j.bbrc.2007.02.098; National Research Council, 1994, NUTR REQ POULTR; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Swaggerty CL, 2009, FOODBORNE PATHOG DIS, V6, P777, DOI 10.1089/fpd.2009.0307; van Dijk A, 2011, VET MICROBIOL, V153, P27, DOI 10.1016/j.vetmic.2011.03.028; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; van Dijk A, 2007, ANTIMICROB AGENTS CH, V51, P912, DOI 10.1128/AAC.00568-06; Wang RQ, 2010, APPL MICROBIOL BIOT, V87, P1395, DOI 10.1007/s00253-010-2591-6; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Xu Y, 2015, APPL MICROBIOL BIOT, V99, P9011, DOI 10.1007/s00253-015-6786-8; Yacoub HA, 2016, DEV COMP IMMUNOL, V65, P8, DOI 10.1016/j.dci.2016.06.012; Yacoub HA, 2016, BIOCHEM CELL BIOL, V94, P176, DOI 10.1139/bcb-2015-0121; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhao CQ, 2001, INFECT IMMUN, V69, P2684, DOI 10.1128/IAI.69.4.2684-2691.2001	50	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0238675	10.1371/journal.pone.0238675	http://dx.doi.org/10.1371/journal.pone.0238675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370283	gold, Green Submitted, Green Published			2022-12-26	WOS:000603611900077
J	Baines, M; Weir, CR				Baines, Mick; Weir, Caroline R.			Predicting suitable coastal habitat for sei whales, southern right whales and dolphins around the Falkland Islands	PLOS ONE			English	Article							SPECIES DISTRIBUTION; SPATIOTEMPORAL PATTERNS; BALAENOPTERA-BOREALIS; MUNIDA-GREGARIA; MODELS; SELECTION; WINTER; AREAS	Species distribution models (SDMs) are valuable tools for describing the occurrence of species and predicting suitable habitats. This study used generalized additive models (GAMs) and MaxEnt models to predict the relative densities of four cetacean species (sei whale Balaeanoptera borealis, southern right whale Eubalaena australis, Peale's dolphin Lagenorhynchus australis, and Commerson's dolphin Cephalorhynchus commersonii) in neritic waters (<= 100 m depth) around the Falkland Islands, using boat survey data collected over three seasons (2017-2019). The model predictor variables (PVs) included remotely sensed environmental variables (sea surface temperature, SST, and chlorophyll-a concentration) and static geographical variables (e.g. water depth, distance to shore, slope). The GAM results explained 35 to 41% of the total deviance for sei whale, combined sei whales and unidentified large baleen whales, and Commerson's dolphins, but only 17% of the deviance for Peale's dolphins. The MaxEnt models for all species had low to moderate discriminatory power. The relative density of sei whales increased with SST in both models, and their predicted distribution was widespread across the inner shelf which is consistent with the use of Falklands' waters as a coastal summer feeding ground. Peale's dolphins and Commerson's dolphins were largely sympatric across the study area. However, the relative densities of Commerson's dolphins were generally predicted to be higher in nearshore, semi-enclosed, waters compared with Peale's dolphins, suggesting some habitat partitioning. The models for southern right whales performed poorly and the results were not considered meaningful, perhaps due to this species exhibiting fewer strong habitat preferences around the Falklands. The modelling results are applicable to marine spatial planning to identify where the occurrence of cetacean species and anthropogenic activities may most overlap. Additionally, the results can inform the process of delineating a potential Key Biodiversity Area for sei whales in the Falkland Islands.	[Baines, Mick] Wildscope, Cadiz, Spain; [Weir, Caroline R.] Falklands Conservat, Stanley, Falkland Island		Weir, CR (corresponding author), Falklands Conservat, Stanley, Falkland Island.	whales@conservation.org.fk		Weir, Caroline/0000-0002-2052-5037; Baines, Mick/0000-0002-6728-2941	European Union BEST 2.0 Programme (2017); Royal Society for the Protection of Birds (2018); Darwin Plus (2019/2020) [DPLUS082]; Wildscope	European Union BEST 2.0 Programme (2017); Royal Society for the Protection of Birds (2018); Darwin Plus (2019/2020); Wildscope	Funding for this study was provided by the European Union BEST 2.0 Programme (2017), The Royal Society for the Protection of Birds (2018), and Darwin Plus (2019/2020; DPLUS082). The funders provided support in the form of salaries for authors [CW, MB]. Some salary for MB was also provided in kind by Wildscope. Funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Abrahms B, 2019, DIVERS DISTRIB, V25, P1182, DOI 10.1111/ddi.12940; Agardy T, 2019, AQUAT CONSERV, V29, P71, DOI 10.1002/aqc.3072; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2017, J CETACEAN RES MAN S, V18, P410; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Austin RA, 2019, J SEA RES, V153, DOI 10.1016/j.seares.2019.101767; Baines Mick E., 2014, Journal of Cetacean Research and Management, V14, P57; Becker EA, 2010, MAR ECOL PROG SER, V413, P163, DOI 10.3354/meps08696; Becker EA, 2019, DIVERS DISTRIB, V25, P626, DOI 10.1111/ddi.12867; Beekmans Bas W. P. M., 2010, Journal of Cetacean Research and Management, V11, P115; Bombosch A, 2014, DEEP-SEA RES PT I, V91, P101, DOI 10.1016/j.dsr.2014.05.017; Byeon DH, 2018, J ASIA-PAC BIODIVERS, V11, P325, DOI 10.1016/j.japb.2018.06.002; Castro LR, 2019, PROG OCEANOGR, V174, P173, DOI 10.1016/j.pocean.2018.09.018; Corrigan CM, 2014, AQUAT CONSERV, V24, P166, DOI 10.1002/aqc.2513; Dellabianca NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163441; Diez MJ, 2018, POLAR BIOL, V41, P2591, DOI 10.1007/s00300-018-2394-2; El-Gabbas A, 2018, ECOGRAPHY, V41, P1161, DOI 10.1111/ecog.03149; Espinosa-Miranda C, 2020, AQUAT MAMM, V46, P337, DOI 10.1578/AM.46.4.2020.337; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gomez C, 2017, ENDANGER SPECIES RES, V32, P437, DOI 10.3354/esr00823; Carman VG, 2019, PROG OCEANOGR, V176, DOI 10.1016/j.pocean.2019.102123; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heinrich S, 2019, AQUAT CONSERV, V29, P212, DOI 10.1002/aqc.3153; Heinrich S, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P313, DOI 10.1016/B978-0-12-373723-6.00015-1; Ishii M, 2017, MAMM STUDY, V42, P191; IUCN, 2016, GUID US GLOB STAND I, VFirst; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Manzoor SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25437-1; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; Murase H, 2014, DEEP-SEA RES PT II, V107, P22, DOI 10.1016/j.dsr2.2014.05.002; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rayment W, 2015, J BIOGEOGR, V42, P463, DOI 10.1111/jbi.12443; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Rhoden CM, 2017, PEERJ, V5, DOI 10.7717/peerj.3632; Sasaki H, 2013, FISH OCEANOGR, V22, P496, DOI 10.1111/fog.12037; Schleimer A, 2019, MAR ECOL PROG SER, V623, P221, DOI 10.3354/meps13020; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Skov H, 2008, DEEP-SEA RES PT II, V55, P254, DOI 10.1016/j.dsr2.2007.09.020; Tobena M, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00202; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Viddi Francisco A., 2005, Aquatic Mammals, V31, P176, DOI 10.1578/AM.31.2.2005.176; Vikingsson G., 2020, NAMMCO SCI PUBL, V11, P1, DOI [10.7557/3.5211, DOI 10.7557/3.5211]; Weir, 2018, PRELIMINARY ASSESSME; Weir CR, 2020, J MAR BIOL ASSOC UK, V100, P153, DOI 10.1017/S0025315419001024; Weir CR, 2019, WORLD MAR MAMM C BAR; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986	54	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244068	10.1371/journal.pone.0244068	http://dx.doi.org/10.1371/journal.pone.0244068			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362235	gold, Green Published			2022-12-26	WOS:000603071600068
J	Jiang, JP; Yuan, X; Huang, GH; Shi, W; Yang, XM; Jiang, QY; Jia, YH; Yang, XR; Jiang, HS				Jiang, Jianping; Yuan, Xiang; Huang, Guanghua; Shi, Wen; Yang, Xueming; Jiang, Qinyang; Jia, Yinhai; Yang, Xiurong; Jiang, Hesheng			Hepatopancreatic metabolomics shedding light on the mechanism underlying unsynchronized growth in giant freshwater prawn, Macrobrachium rosenbergii	PLOS ONE			English	Article							METABOLISM; BODY	The giant freshwater prawn, Macrobrachium rosenbergii (M. rosenbergii) as an important freshwater aquaculture species with high commercial value, exhibited unsynchronized growth. However, the potentially metabolic mechanism remains unclear. In this study, we used liquid chromatography tandem mass spectrometry (LC-MS/MS) to investigate the hepatopancreatic metabolic profiles of twenty giant freshwater prawns between the fast-growing group and slow-growing group. In the metabolomics assay, we isolated 8,293 peaks in positive and negative iron mode. Subsequently, 44 significantly differential metabolites were identified. Functional pathway analysis revealed that these metabolites were significantly enriched in three key metabolic pathways. Further integrated analysis indicated that glycerophospholipid metabolism and aminoacyl-tRNA biosynthesis have significant impact on growth performance in M.rosenbergii. Our findings presented here demonstrated the critical metabolites and metabolic pathways involved in growth performance, moreover provided strong evidence for elucidating the potentially metabolic mechanism of the unsynchronized growth in M. rosenbergii.	[Jiang, Jianping] Guangxi Engn Technol Res Ctr Chinese Med Mat Stoc, Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China; [Jiang, Jianping; Yuan, Xiang; Shi, Wen; Jiang, Qinyang; Yang, Xiurong; Jiang, Hesheng] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Guangxi, Peoples R China; [Yuan, Xiang; Shi, Wen] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Huang, Guanghua; Yang, Xueming] Guangxi Acad Fisheries Sci, Nanning, Peoples R China; [Jia, Yinhai] Anim Husb Res Inst Guangxi Zhuang Autonomous Reg, Nanning, Guangxi, Peoples R China	Guangxi University; Guangxi University; Guangxi Vocational University of Agriculture	Jiang, JP (corresponding author), Guangxi Engn Technol Res Ctr Chinese Med Mat Stoc, Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China.; Jiang, JP (corresponding author), Guangxi Univ, Coll Anim Sci & Technol, Nanning, Guangxi, Peoples R China.	jiangjianping818@126.com			Natural Science Foundation of Guangxi [2018GXNSFBA281209]; Science and Technology Major Project of Guangxi [Guike AA17204080-6]; Postdoctoral Science Foundation of Guangxi [T3340097968]	Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Science and Technology Major Project of Guangxi; Postdoctoral Science Foundation of Guangxi	This work was financially supported by the Natural Science Foundation of Guangxi, grant number 2018GXNSFBA281209; Science and Technology Major Project of Guangxi, grant number Guike AA17204080-6; and Postdoctoral Science Foundation of Guangxi, grant number T3340097968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REV ESTUDIOS INT MED, V9, P70; Biancucci M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0637-8; Bose U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177064; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Deng M, 2020, PLANT J, V103, P1710, DOI 10.1111/tpj.14856; Hung D, 2013, AQUACULTURE, V404, P122, DOI 10.1016/j.aquaculture.2013.04.027; Dong XX, 2020, ECOTOX ENVIRON SAFE, V189, DOI 10.1016/j.ecoenv.2019.110046; Gomez E, 2020, J AGR FOOD CHEM, V68, P8732, DOI 10.1021/acs.jafc.0c02129; Guo YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23983-2; Hao RJ, 2019, SCI TOTAL ENVIRON, V666, P46, DOI 10.1016/j.scitotenv.2019.02.221; Hao RJ, 2018, AQUACULTURE, V491, P258, DOI 10.1016/j.aquaculture.2018.03.050; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jiang Q, 2020, COMP BIOCHEM PHYS D, V35, DOI 10.1016/j.cbd.2020.100683; Jin SB, 2020, COMP BIOCHEM PHYS D, V34, DOI 10.1016/j.cbd.2020.100662; Jung H, 2014, CANDIDATE GENE ASS S; Kloska A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124338; Li TY, 2017, AQUAT TOXICOL, V183, P28, DOI 10.1016/j.aquatox.2016.12.010; Longobardi V, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10061065; Loor JJ, 2013, ANNU REV ANIM BIOSCI, V1, P365, DOI 10.1146/annurev-animal-031412-103728; Ma LL, 2020, PEERJ, V8, DOI 10.7717/peerj.9516; Mahmood T, 2016, B ENVIRON CONTAM TOX, V96, P361, DOI 10.1007/s00128-015-1713-3; Mattioli R, 2009, PLANT SIGNAL BEHAV, V4, P1016, DOI 10.4161/psb.4.11.9797; Senn T, 2012, PROG CARDIOVASC DIS, V55, P70, DOI 10.1016/j.pcad.2012.06.004; Sonkar K, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4112; Srinivasan V, 2017, BIOL TRACE ELEM RES, V177, P196, DOI 10.1007/s12011-016-0855-4; Stratakis N, 2020, HEPATOLOGY, V72, P1758, DOI 10.1002/hep.31483; Suekawa M, 2019, PLANT PHYSIOL BIOCH, V142, P1, DOI 10.1016/j.plaphy.2019.06.032; Sun P, 2020, BRIT J NUTR, V123, P149, DOI 10.1017/S0007114519002563; Tao TQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00651; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang P, 2018, ECOTOX ENVIRON SAFE, V163, P266, DOI 10.1016/j.ecoenv.2018.07.080; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Wen X, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5915-7; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xie GX, 2014, J PROTEOME RES, V13, P4062, DOI 10.1021/pr500434s; Yebra L, 2004, J PLANKTON RES, V26, P351, DOI 10.1093/plankt/fbh028; Yu YY, 2020, MAR DRUGS, V18, DOI 10.3390/md18040218; Zehra S, 2013, FISH PHYSIOL BIOCHEM, V39, P503, DOI 10.1007/s10695-012-9715-0; Zhao B, 2012, AQUACULT NUTR, V18, P220, DOI 10.1111/j.1365-2095.2011.00898.x; Zhao HH, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy111; Zong L, 2018, ECOTOX ENVIRON SAFE, V147, P26, DOI 10.1016/j.ecoenv.2017.08.028	42	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243778	10.1371/journal.pone.0243778	http://dx.doi.org/10.1371/journal.pone.0243778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362263	Green Published, gold			2022-12-26	WOS:000603071600061
J	Steele, JL; Stevens, RC; Cabrera, OA; Bassill, GJ; Cramer, SM; Guzman, F; Shuber, AP				Steele, Jennifer L.; Stevens, Richard C.; Cabrera, Oscar A.; Bassill, Gary J.; Cramer, Sabrina M.; Guzman, Felipe; Shuber, Anthony P.			Novel CRISPR-based sequence specific enrichment methods for target loci and single base mutations	PLOS ONE			English	Article							NUCLEIC-ACID DETECTION; LIQUID BIOPSIES; PCR; DIAGNOSTICS; CANCER; AMPLIFICATION; ENDONUCLEASE; REVEAL	The programmable sequence specificity of CRISPR has found uses in gene editing and diagnostics. This manuscript describes an additional application of CRISPR through a family of novel DNA enrichment technologies. CAMP (CRISPR Associated Multiplexed PCR) and cCAMP (chimeric CRISPR Associated Multiplexed PCR) utilize the sequence specificity of the Cas9/sgRNA complex to target loci for the ligation of a universal adapter that is used for subsequent amplification. cTRACE (chimeric Targeting Rare Alleles with CRISPR-based Enrichment) also applies this method to use Cas9/sgRNA to target loci for the addition of universal adapters, however it has an additional selection for specific mutations through the use of an allele-specific primer. These three methods can produce multiplex PCR that significantly reduces the optimization required for every target. The methods are also not specific to any downstream analytical platform. We additionally will present a mutation specific enrichment technology that is non-amplification based and leaves the DNA in its native state: TRACE (Targeting Rare Alleles with CRISPR-based Enrichment). TRACE utilizes the Cas9/sgRNA complex to sterically protect the ends of targeted sequences from exonuclease activity which digests both the normal variant as well as any off-target sequences.	[Steele, Jennifer L.; Stevens, Richard C.; Cabrera, Oscar A.; Bassill, Gary J.; Cramer, Sabrina M.; Guzman, Felipe; Shuber, Anthony P.] Genet Res LLC, Waltham, MA 02451 USA		Shuber, AP (corresponding author), Genet Res LLC, Waltham, MA 02451 USA.	APS@gen-res.com						Ballester LY, 2016, EXPERT REV MOL DIAGN, V16, P357, DOI 10.1586/14737159.2016.1133298; Bardelli A, 2017, CANCER CELL, V31, P172, DOI 10.1016/j.ccell.2017.01.002; Beltz K., 2018, ADV BIOSCI BIOTECHNO, V9, P497, DOI [10.4236/abb.2018.99034, DOI 10.4236/ABB.2018.99034]; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; BOTTEMA CDK, 1993, MUTAT RES, V288, P93, DOI 10.1016/0027-5107(93)90211-W; Bronkhorst Abel Jacobus, 2019, Biomol Detect Quantif, V17, P100087, DOI 10.1016/j.bdq.2019.100087; Broude NE, 2001, P NATL ACAD SCI USA, V98, P206, DOI 10.1073/pnas.98.1.206; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper DE, 2005, RATIO, V18, P125, DOI 10.1111/j.1467-9329.2005.00278.x; Dag ZO, 2015, J TURK-GER GYNECOL A, V16, P111, DOI 10.5152/jtgga.2015.15232; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Finotti A, 2018, INT J ONCOL, V53, P1395, DOI 10.3892/ijo.2018.4516; Gabriel E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00297; Garcia-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20948; Giesselmann P, 2019, NAT BIOTECHNOL, V37, P1478, DOI 10.1038/s41587-019-0293-x; Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Gray PN, 2015, CANCERS, V7, P1313, DOI 10.3390/cancers7030837; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Hafford-Tear NJ, 2019, GENET MED, V21, P2092, DOI 10.1038/s41436-019-0453-x; Hardigan AA, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz425; Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kozarewa Iwanka, 2015, Curr Protoc Mol Biol, V112, DOI 10.1002/0471142727.mb0721s112; Lemos BR, 2018, P NATL ACAD SCI USA, V115, pE2040, DOI 10.1073/pnas.1716855115; Li H., 2013, ARXIV13033997V1QBIOG; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Little S, 1995, CURR PROTOC HUM GENE, V7, P981; Loree JM, 2017, J GASTROINTEST ONCOL, V8, P199, DOI 10.21037/jgo.2017.01.01; Lu WX, 2019, MOL CELL PROBE, V46, DOI 10.1016/j.mcp.2019.101424; Ma HH, 2016, J CELL BIOL, V214, P529, DOI 10.1083/jcb.201604115; Mader S, 2017, ONCOL RES TREAT, V40, P404, DOI 10.1159/000478018; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Offin M, 2017, J ONCOL, V2017, DOI 10.1155/2017/4517834; Quan J, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz418; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Samorodnitsky E, 2015, HUM MUTAT, V36, P903, DOI 10.1002/humu.22825; Serrati S, 2016, ONCOTARGETS THER, V9, P7355, DOI 10.2147/OTT.S99807; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shou J, 2018, MOL CELL, V71, P498, DOI 10.1016/j.molcel.2018.06.021; Shuber AP, 1995, GENOME RES, V5, P488, DOI 10.1101/gr.5.5.488; Siravegna G, 2017, NAT REV CLIN ONCOL, V14, P531, DOI 10.1038/nrclinonc.2017.14; Slesarev A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39667-4; Stangl C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16641-7; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stetson D, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00191; Stevens RC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215441; The UniProt C, 2018, NUCLEIC ACIDS RES, V47, pD506; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Volik S, 2016, MOL CANCER RES, V14, P898, DOI 10.1158/1541-7786.MCR-16-0044; Watson CM, 2020, LAB INVEST, V100, P135, DOI 10.1038/s41374-019-0283-0; Wu LR, 2017, NAT BIOMED ENG, V1, P714, DOI 10.1038/s41551-017-0126-5; Yang N, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4199-7; Zakrzewski F, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5584-6; Zuo ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37584	64	0	0	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243781	10.1371/journal.pone.0243781	http://dx.doi.org/10.1371/journal.pone.0243781			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362267	gold, Green Published			2022-12-26	WOS:000603071600012
J	Ciria-Suarez, L; Jimenez-Fonseca, P; Palacin-Lois, M; Antonanzas-Basa, M; Fernandez-Montes, A; Manzano-Fernandez, A; Castelo, B; Asensio-Martinez, E; Hernando-Polo, S; Calderon, C				Ciria-Suarez, Laura; Jimenez-Fonseca, Paula; Palacin-Lois, Maria; Antonanzas-Basa, Monica; Fernandez-Montes, Ana; Manzano-Fernandez, Aranzazu; Castelo, Beatriz; Asensio-Martinez, Elena; Hernando-Polo, Susana; Calderon, Caterina			Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol	PLOS ONE			English	Article							OF-LIFE; DEPRESSION; PREVALENCE; MORTALITY; SURVIVORS	Background The current cancer care system must be improved if we are to have in-depth knowledge about breast cancer patients' experiences throughout all the stages of their disease. Aim This study seeks to describe breast cancer patients' experience over the course of the various stages of illness by means of a journey model. Methods This is a qualitative descriptive study. Individual, semi-structured interviews will be administered to women with breast cancer and breast cancer survivors. Patients will be recruited from nine large hospitals in Spain and intentional sampling will be used. Data will be collected by means of a semi-structured interview that was elaborated with the help of medical oncologists, nurses, and psycho-oncologists. Data will be processed adopting a thematic analysis approach. Discussion The outcomes of this study will afford new insights into breast cancer patients' experiences, providing guidance to improve the care given to these individuals. This protocol aims to describe the journey of patients with breast cancer through the healthcare system to establish baseline data that will serve as the basis for the development and implementation of a patient-centered, evidence-based clinical pathway.	[Ciria-Suarez, Laura; Calderon, Caterina] Univ Barcelona, Fac Psychol, Clin Psychol & Psychobiol Dept, Barcelona, Spain; [Jimenez-Fonseca, Paula] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain; [Palacin-Lois, Maria] Univ Barcelona, Fac Psychol, Social Psychol & Quantitat Psychol Dept, Barcelona, Spain; [Antonanzas-Basa, Monica; Manzano-Fernandez, Aranzazu] Hosp Univ Clin San Carlos, Dept Med Oncol, Madrid, Spain; [Fernandez-Montes, Ana] Complejo Hosp Univ Orense, Dept Med Oncol, Orense, Spain; [Castelo, Beatriz] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain; [Asensio-Martinez, Elena] Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain; [Hernando-Polo, Susana] Hosp Univ Fdn Alcorcon, Dept Med Oncol, Madrid, Spain	University of Barcelona; Central University Hospital Asturias; University of Barcelona; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Hospital Universitario La Paz; Alcorcon Foundation University Hospital	Ciria-Suarez, L (corresponding author), Univ Barcelona, Fac Psychol, Clin Psychol & Psychobiol Dept, Barcelona, Spain.	laura.ciria.suarez@gmail.com		Calderon, Caterina/0000-0002-6956-9321; Ciria Suarez, Laura/0000-0002-1388-6686; Antonanzas Basa, Monica/0000-0002-7434-9059; Ana, Fernandez Montes/0000-0003-4630-5830	Spanish Society of Medical Oncology (SEOM)	Spanish Society of Medical Oncology (SEOM)	This work was funded by the Spanish Society of Medical Oncology (SEOM) in 2018. The sponsor of this research has not participated in the design of research, in writing the report, or in the decision to submit the article for publication.	Adam A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231691; [Anonymous], 2010, ORBITAL DEBRIS Q NEW, V14, P17; Antonacci G, 2018, HEALTH SERV MANAG RE, V31, P74, DOI 10.1177/0951484818770411; Avancini A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227846; Blows E, 2012, J ADV NURS, V68, P2155, DOI 10.1111/j.1365-2648.2012.05995.x; Bonsuid AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208773; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cameron LD, 2007, PSYCHO-ONCOLOGY, V16, P171, DOI 10.1002/pon.1050; Cherif E, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05569-9; Cleries R, 2018, CLIN TRANSL ONCOL, V20, P313, DOI 10.1007/s12094-017-1718-y; Dooley LN, 2017, STRESS HEALTH, V33, P549, DOI 10.1002/smi.2739; FAWZY FI, 1995, ARCH GEN PSYCHIAT, V52, P100; Fradelos Evangelos C, 2017, Asian Pac J Cancer Prev, V18, P2545; Galiano-Castillo N, 2014, EUR J ONCOL NURS, V18, P206, DOI 10.1016/j.ejon.2013.10.008; Gebremariam A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220769; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Habersack M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081770; Hall LK, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3652; Harding C, 2015, JAMA INTERN MED, V175, P1483, DOI 10.1001/jamainternmed.2015.3043; Howard Tharon, 2014, COMMUNICATION DESIGN, V2, P10, DOI [10.1145/2644448.2644451, DOI 10.1145/2644448.2644451]; Kollberg B, 2006, INT J PRODUCT PERFOR, V56, P7, DOI 10.1108/17410400710717064; Krouse HJ, 1982, NURS RES; McCarthy S, 2020, JMIR HUM FACTORS, DOI [10.2196/17416, DOI 10.2196/1741632940610]; Mirosevic S, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13060; Purkayastha D, 2017, INDIAN J PALLIAT CAR, V23, P268, DOI 10.4103/IJPC.IJPC_6_17; Rapport F, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3881-z; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Shin WK, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0706-9; Sociedad Espanola de Oncologia Medica, 2020, CIFR CANC ESP; Spiegel D, 1999, PSYCHO-ONCOLOGY, DOI [10.1002/(sici)1099-1611(199911/12)8:6&LT;482::aid-pon402&GT;3.0.co;2-w, DOI 10.1002/(SICI)1099-1611(199911/12)8:6<LESSTHAN>482::AID-P0N402<GREATERTHAN>3.0.CO;2-W]; Trebble TM, 2010, BMJ; Zainal NZ, 2013, ASIAN PAC J CANCER P, V14, P2649, DOI 10.7314/APJCP.2013.14.4.2649	33	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244355	10.1371/journal.pone.0244355	http://dx.doi.org/10.1371/journal.pone.0244355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347475	Green Published, gold			2022-12-26	WOS:000603071100013
J	Sharipov, RN; Kondrakhin, YV; Ryabova, AS; Yevshin, IS; Kolpakov, FA				Sharipov, Ruslan N.; Kondrakhin, Yury V.; Ryabova, Anna S.; Yevshin, Ivan S.; Kolpakov, Fedor A.			Assessment of transcriptional importance of cell line-specific features based on GTRD and FANTOM5 data	PLOS ONE			English	Article							CHIP-SEQ; INTEGRATIVE ANALYSIS; BINDING-SITES; COMPUTATION; ENHANCERS; ATLAS	Creating a complete picture of the regulation of transcription seems to be an urgent task of modern biology. Regulation of transcription is a complex process carried out by transcription factors (TFs) and auxiliary proteins. Over the past decade, ChIP-Seq has become the most common experimental technology studying genome-wide interactions between TFs and DNA. We assessed the transcriptional significance of cell line-specific features using regression analysis of ChIP-Seq datasets from the GTRD database and transcriptional start site (TSS) activities from the FANTOM5 expression atlas. For this purpose, we initially generated a large number of features that were defined as the presence or absence of TFs in different promoter regions around TSSs. Using feature selection and regression analysis, we identified sets of the most important TFs that affect expression activity of TSSs in human cell lines such as HepG2, K562 and HEK293. We demonstrated that some TFs can be classified as repressors and activators depending on their location relative to TSS.	[Sharipov, Ruslan N.; Kondrakhin, Yury V.; Ryabova, Anna S.; Yevshin, Ivan S.; Kolpakov, Fedor A.] Fed Res Ctr Informat & Computat Technol, Lab Bioinformat, Novosibirsk, Russia; [Sharipov, Ruslan N.] Novosibirsk State Univ, Specialized Educ Sci Ctr, Novosibirsk, Russia; [Sharipov, Ruslan N.; Kondrakhin, Yury V.; Ryabova, Anna S.; Yevshin, Ivan S.; Kolpakov, Fedor A.] BIOSOFT RU Ltd, Novosibirsk, Russia	Russian Academy of Sciences; Federal Research Center for Information & Computational Technologies; Novosibirsk State University	Sharipov, RN (corresponding author), Fed Res Ctr Informat & Computat Technol, Lab Bioinformat, Novosibirsk, Russia.; Sharipov, RN (corresponding author), Novosibirsk State Univ, Specialized Educ Sci Ctr, Novosibirsk, Russia.; Sharipov, RN (corresponding author), BIOSOFT RU Ltd, Novosibirsk, Russia.	shrus79@gmail.com		Sharipov, Ruslan/0000-0003-2182-5493	Russian Science Foundation [19-14-00295]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Science Foundation in the form of a grant awarded to RNS, YVK, ASR, ISY and FAK (19-14-00295). BIOSOFT.RU, Ltd. supported the integration of the developed methods into the BioUML platform in the form of salaries for RNS, YVK, ASR ISY and FAK. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugessaisa I, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.107; Abugessaisa I, 2017, METHODS MOL BIOL, V1611, P199, DOI 10.1007/978-1-4939-7015-5_15; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Angelini C, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00051; Cheneby J, 2018, NUCLEIC ACIDS RES, V46, pD267, DOI 10.1093/nar/gkx1092; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Dailey L, 2015, GENOMICS, V106, P151, DOI 10.1016/j.ygeno.2015.06.004; Deviatiiarov R, 2020, PREPRINT; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; He BS, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00394; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kolmykov SK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221760; Li YE, 2020, ATLAS GENE REGULATOR, DOI DOI 10.1101/2020.05.10.087585V2; Memon A, 2018, CANCERS, V10, DOI 10.3390/cancers10060161; Moore JE, 2020, NATURE, V583, P699, DOI 10.1038/s41586-020-2493-4; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Narlikar L, 2012, METHODS MOL BIOL, V802, P305, DOI 10.1007/978-1-61779-400-1_20; Niu M, 2018, NUCLEIC ACIDS RES, V46, P5395, DOI 10.1093/nar/gky338; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Pang BX, 2020, NAT GENET, V52, P254, DOI 10.1038/s41588-020-0578-5; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Wang J, 2019, NUCLEIC ACIDS RES, V47, pD106, DOI 10.1093/nar/gky864; Yevshin I, 2019, NUCLEIC ACIDS RES, V47, pD100, DOI 10.1093/nar/gky1128; Yevshin I, 2017, NUCLEIC ACIDS RES, V45, pD61, DOI 10.1093/nar/gkw951; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zhang XO, 2019, GENOME RES, V29, P1402, DOI 10.1101/gr.249789.119; Zhang XK, 2011, BIOMETRICS, V67, P151, DOI 10.1111/j.1541-0420.2010.01441.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8122; 2006, REG GEN GEN REG, P31	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243332	10.1371/journal.pone.0243332	http://dx.doi.org/10.1371/journal.pone.0243332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347457	Green Published, gold			2022-12-26	WOS:000603071100061
J	Kinney, MV; Ajayi, G; de Graft-Johnson, J; Hill, K; Khadka, N; Om'Iniabohs, A; Mukora-Mutseyekwa, F; Tayebwa, E; Shittu, O; Lipingu, C; Kerber, K; Nyakina, JD; Ibekwe, PC; Sayinzoga, F; Madzima, B; George, AS; Thapa, K				Kinney, Mary V.; Ajayi, Gbaike; de Graft-Johnson, Joseph; Hill, Kathleen; Khadka, Neena; Om'Iniabohs, Alyssa; Mukora-Mutseyekwa, Fadzai; Tayebwa, Edwin; Shittu, Oladapo; Lipingu, Chrisostom; Kerber, Kate; Nyakina, Juma Daimon; Ibekwe, Perpetus Chudi; Sayinzoga, Felix; Madzima, Bernard; George, Asha S.; Thapa, Kusum			"It might be a statistic to me, but every death matters.": An assessment of facility-level maternal and perinatal death surveillance and response systems in four sub-Saharan African countries	PLOS ONE			English	Article							OBSTETRIC AUDIT; SCALING-UP; REVIEWS; ACCOUNTABILITY; LESSONS; IMPLEMENTATION; EXPERIENCES; PROGRESS	Background Maternal and perinatal death surveillance and response (MPDSR) systems aim to understand and address key contributors to maternal and perinatal deaths to prevent future deaths. From 2016-2017, the US Agency for International Development's Maternal and Child Survival Program conducted an assessment of MPDSR implementation in Nigeria, Rwanda, Tanzania, and Zimbabwe. Methods A cross-sectional, mixed-methods research design was used to assess MPDSR implementation. The study included a desk review, policy mapping, semistructured interviews with 41 subnational stakeholders, observations, and interviews with key informants at 55 purposefully selected facilities. Using a standardised tool with progress markers defined for six stages of implementation, each facility was assigned a score from 0-30. Quantitative and qualitative data were analysed from the 47 facilities with a score above 10 ('evidence of MPDSR practice'). Results The mean calculated MPDSR implementation progress score across 47 facilities was 18.98 out of 30 (range: 11.75-27.38). The team observed variation across the national MPDSR guidelines and tools, and inconsistent implementation of MPDSR at subnational and facility levels. Nearly all facilities had a designated MPDSR coordinator, but varied in their availability and use of standardised forms and the frequency of mortality audit meetings. Few facilities (9%) had mechanisms in place to promote a no-blame environment. Some facilities (44%) could demonstrate evidence that a change occurred due to MPDSR. Factors enabling implementation included clear support from leadership, commitment from staff, and regular occurrence of meetings. Barriers included lack of health worker capacity, limited staff time, and limited staff motivation. Conclusion This study was the first to apply a standardised scoring methodology to assess subnational- and facility-level MPDSR implementation progress. Structures and processes for implementing MPDSR existed in all four countries. Many implementation gaps were identified that can inform priorities and future research for strengthening MPDSR in low-capacity settings.	[Kinney, Mary V.; de Graft-Johnson, Joseph; Khadka, Neena; Om'Iniabohs, Alyssa; Kerber, Kate] Save Children US, Washington, DC 20002 USA; [Kinney, Mary V.; George, Asha S.] Univ Western Cape, Cape Town, South Africa; [Ajayi, Gbaike; de Graft-Johnson, Joseph; Hill, Kathleen; Khadka, Neena; Om'Iniabohs, Alyssa; Thapa, Kusum] US Agcy Int Dev USAID, Maternal & Child Survival Program MCSP, Washington, DC USA; [Ajayi, Gbaike; Hill, Kathleen; Thapa, Kusum] Jhpiego, Baltimore, MD USA; [Mukora-Mutseyekwa, Fadzai] USAID, Maternal & Child Hlth Integrated Program, Harare, Zimbabwe; [Mukora-Mutseyekwa, Fadzai] John Snow Inc, Harare, Zimbabwe; [Tayebwa, Edwin] USAID, MCSP, Kigali, Rwanda; [Tayebwa, Edwin] Jhpiego, Kigali, Rwanda; [Shittu, Oladapo] Ahmadu Bello Univ, Zaria, Kaduna State, Nigeria; [Lipingu, Chrisostom; Nyakina, Juma Daimon] Bukoba Reg Referral Hosp, Kagera, Tanzania; [Ibekwe, Perpetus Chudi] Maternal & Perinatal Death Surveillance & Respons, Abakaliki, Ebonyi State, Nigeria; [Sayinzoga, Felix] Rwanda Biomed Ctr, Maternal Child & Community Hlth Div, Kigali, Rwanda; [Madzima, Bernard] Minist Hlth & Child Care, Family Hlth Directorate, Harare, Zimbabwe	Save the Children; University of the Western Cape; Jhpiego; United States Agency for International Development (USAID); United States Agency for International Development (USAID); Jhpiego; Ahmadu Bello University; Rwanda Biomedical Center	Kinney, MV (corresponding author), Save Children US, Washington, DC 20002 USA.	mkinney@uwc.ac.za	Kinney, Mary/M-6952-2013	Kinney, Mary/0000-0002-2903-0161; George, Asha/0000-0002-5968-1424	US Agency for International Development (USAID) [AID-OAA-A-14-00028]; South African Research Chair's Initiative of the Department of Science and Technology; National Research Foundation of South Africa [82769]; South African Medical Research Council	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); South African Research Chair's Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was made possible by the generous support of the American people through the US Agency for International Development (USAID) under the terms of the Cooperative Agreement AID-OAA-A-14-00028 (www.usaid.gov). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. AG is supported by the South African Research Chair's Initiative of the Department of Science and Technology and National Research Foundation of South Africa (Grant No. 82769) (www.nrf.ac.za/tags/dst), and the South African Medical Research Council (www.mrc.ac.za). Any opinion, finding, and conclusion or recommendation expressed in this material is that of the author, and the National Research Foundation of South Africa does not accept any liability in this regard.	Abebe B, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000199; Agaro C, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0315-5; Akachi Y, 2017, B WORLD HEALTH ORGAN, V95, P465, DOI 10.2471/BLT.16.180190; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Armstrong CE, 2014, TROP MED INT HEALTH, V19, P1087, DOI 10.1111/tmi.12353; Bakker W, 2011, TROP MED INT HEALTH, V16, P1243, DOI 10.1111/j.1365-3156.2011.02832.x; Bandali S, 2016, INT J GYNECOL OBSTET, V135, P365, DOI 10.1016/j.ijgo.2016.10.002; Bayley O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007753; Belizan M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-243; Bergh AM, 2005, ACTA PAEDIATR, V94, P1102, DOI 10.1080/08035250510028380; Bergh AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-293; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Chou D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4255; Commission on Information and Accountability, 2011, KEEP PROM MEAS RES C; Congo B, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0379-1; Dartey AF, 2012, ROLE MIDWIVES IMPLEM; De Brouwere V, 2014, BJOG-INT J OBSTET GY, V121, P71, DOI 10.1111/1471-0528.12902; de Kok B, 2017, HEALTH POLICY PLANN, V32, P1083, DOI 10.1093/heapol/czx012; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Evidence 4 Action, 2017, MDSR ACT NETW; Filippi V, 2004, HEALTH POLICY PLANN, V19, P57, DOI 10.1093/heapol/czh007; Healthy Newborn Network, 2018, NEWB NUMB DAT; Hilber AM, 2016, INT J GYNECOL OBSTET, V135, P345, DOI 10.1016/j.ijgo.2016.09.008; Hofman JJ, 2014, INT J GYNECOL OBSTET, V126, P111, DOI [10.1016/j.ijgo.2014.02.014, 10.1016/]; Independent Accountability Panel, 2016, OLD CHALL NEW HOP AC; Kerber KJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S9; Kongnyuy E J, 2008, Women Birth, V21, P149, DOI 10.1016/j.wombi.2008.08.002; Kongnyuy Eugene J, 2008, BMC Pregnancy Childbirth, V8, P42, DOI 10.1186/1471-2393-8-42; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lewis G, 2014, BJOG-INT J OBSTET GY, V121, P24, DOI 10.1111/1471-0528.12801; Magoma M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0781-z; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Muffler N, 2007, TROP MED INT HEALTH, V12, P1248, DOI 10.1111/j.1365-3156.2007.01911.x; MUTSIGIRIMUREWANHE, 2017, PAN AFR MED J, V27, DOI DOI 10.11604/PAMJ.2017.27.204.721028904729; Nigeria National Bureau of Statistics, 2019, NAT POP COMM NAT BUR; Nyamtema AS, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-29; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Patrick Habecker, 2017, THESIS U NEBRASKA LI; Purandare C, 2014, INT J GYNECOL OBSTET, V127, pS35, DOI 10.1016/j.ijgo.2014.09.003; Rhoda NR, 2014, BJOG-INT J OBSTET GY, V121, P160, DOI 10.1111/1471-0528.12997; Richard F, 2009, BJOG-INT J OBSTET GY, V116, P38, DOI 10.1111/j.1471-0528.2008.01741.x; Smith H, 2017, GLOB HEALTH-SCI PRAC, V5, P345, DOI 10.9745/GHSP-D-17-00130; Smith H, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1405-6; Tanzania National Bureau of Statistics, 2019, SUBD POP PROJ YEAR 2; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; TUNCALP, 2015, BJOG, V122, P1045, DOI DOI 10.1111/1471-0528.13451; van Hamersveld KT, 2012, TROP MED INT HEALTH, V17, P652, DOI 10.1111/j.1365-3156.2012.02972.x; WHO, 2014, EV NEWB ACT PLAN PRE; WHO, 2019, WORLD HLTH STAT 2019; WHO, 2016, MAK EV BAB COUNT AUD; WHO, 2017, GLOB MON IMPL MAT DE; WHO, 2013, MAT DEATH SURV RESP; WHO, 2016, WHO APPL ICD 10 PER; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Bank, 2019, PAK NURS MIDW; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2016, TIM RESP REP GLOB IM; World Health Organization, 2012, WHO APPL ICD 10 DEAT; World Health Organization (WHO), 2016, STANDARDS IMPROVING	60	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243722	10.1371/journal.pone.0243722	http://dx.doi.org/10.1371/journal.pone.0243722			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338039	Green Published, gold			2022-12-26	WOS:000601313500041
J	Medina-Perucha, L; Garcia-Sangenis, A; Moragas, A; Galvez-Hernandez, P; Cots, JM; Lanau-Roig, A; Borras, A; Amo, I; Monfa, R; Llor, C; Berenguera, A				Medina-Perucha, Laura; Garcia-Sangenis, Ana; Moragas, Ana; Galvez-Hernandez, Pablo; Maria Cots, Josep; Lanau-Roig, Anna; Borras, Alicia; Amo, Isabel; Monfa, Ramon; Llor, Carl; Berenguera, Anna			Autonomy, power dynamics and antibiotic use in primary healthcare: A qualitative study	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; SHARED DECISION-MAKING; ACUTE COUGH; PATIENT; GPS; COMMUNICATION; CONSULTATIONS; PERSPECTIVES; RESISTANCE; WORLDWIDE	Antibiotic resistance is a global health concern. Although numerous strategies have tried to reduce inadequate antibiotic prescribing, antibiotics are still prescribed in 60% of acute lower respiratory tract infections (ALRTIs) cases in Catalonia (Spain). This study aims to explore service users' experiences of ALRTIs, the quality and access to healthcare services, and health education. Selective purposive sampling was carried out, based on a prior definition of participant characteristics. These were sex, age, ethnicity, date of the last ALRTI, number of ALRTIs in the last year, and treatments received. Participants with a previous diagnosis of ALRTIs were recruited from three primary health care centres in Barcelona and one in Tarragona. Twenty-nine interviews were conducted between April and June 2019. A content thematic analysis was performed. Three themes were identified: 1) risk perceptions and help-seeking; 2) treatment preferences and antibiotic use; and 3) relationship dynamics and communication with healthcare professionals. Accounts of service users' sense of autonomy towards their health and power dynamics within the healthcare system were apparent. Supporting service users to become reliable, subjective and agentic experts of their health and bodies could help them to voice their healthcare agendas. Power structures embedded within healthcare, political and economic institutions should be challenged so that healthcare services can be co-developed (with service users) and based on service users' autonomy and horizontal relationships. Special consideration should be paid to the intersection of social vulnerabilities. A concordance approach to prescribing could be key to improve the responsible use of antibiotics and to contribute to the prevention of AMR in primary healthcare. The marketisation of health, and the increased demands of private healthcare in Spain due to the financial pressures on public healthcare as a consequence of the financial crisis of 2008 and the COVID-19 pandemic, are a risk for promoting adequate antibiotic prescribing and use. Trial registration The ISAAC-CAT study has been registered in the NCT registry, ID: NCT03931577.	[Medina-Perucha, Laura; Garcia-Sangenis, Ana; Monfa, Ramon; Llor, Carl; Berenguera, Anna] Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain; [Garcia-Sangenis, Ana; Monfa, Ramon; Berenguera, Anna] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Moragas, Ana] Univ Rovira & Virgili, Jaume I Hlth Ctr, Inst Catala Salut, Tarragona, Spain; [Galvez-Hernandez, Pablo; Borras, Alicia; Amo, Isabel] Univ Int Catalunya, Patients Univ Inst, Barcelona, Spain; [Galvez-Hernandez, Pablo] Univ Toronto, IHPME BFON Collaborat PhD Specializat Program Hlt, Toronto, ON, Canada; [Maria Cots, Josep; Lanau-Roig, Anna] Assoc Infermeria Familiar & Comunitaria Catalunya, Inst Catala Salut, La Marina Hlth Ctr, Barcelona, Spain; [Borras, Alicia] Univ Autonoma Barcelona, Escoles Univ Gimbernat, Escola Univ Infermeria, Sant Cugat Del Valles, Spain; [Llor, Carl] Inst Catala Salut, Via Roma Hlth Ctr, Barcelona, Spain; [Berenguera, Anna] Univ Girona, Dept Infermeria, Girona, Spain	Autonomous University of Barcelona; Universitat Rovira i Virgili; Universitat Internacional de Catalunya (UIC); University of Toronto; Autonomous University of Barcelona; Universitat de Girona	Medina-Perucha, L (corresponding author), Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain.	lmedina@idiapjgol.info		Monfa Escola, Ramon/0000-0002-1324-3971; Amo, Isabel/0000-0003-0980-2774; Berenguera, Anna/0000-0002-0889-2002; Galvez Hernandez, Pablo/0000-0002-6268-559X; Garcia-Sangenis, Ana/0000-0002-6689-6466; Medina-Perucha, Laura/0000-0002-2981-2614	Fundacio La Marato de TV3 [201820]	Fundacio La Marato de TV3	This study has been funded by the Fundacio La Marato de TV3 (Ref Number 201820), https://www.ccma.cat/tv3/marato/fundacio/.Funding was granted to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Rahman N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1530-2; Adisso EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208449; Altiner A, 2004, FAM PRACT, V21, P500, DOI 10.1093/fampra/cmh505; Altiner A, 2007, J ANTIMICROB CHEMOTH, V60, P638, DOI 10.1093/jac/dkm254; [Anonymous], 2012, J ENDOCRIMOL META, V17, pS1; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Bakhit M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026735; Barker AK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4261-4; Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Berenguera A, 2017, LISTEN OBSERVE UNDER; Bergen C, 2013, J HEALTH SOC BEHAV, V54, P220, DOI 10.1177/0022146513487379; Brookes-Howell L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000796; Broom J, 2017, J HOSP INFECT, V96, P316, DOI 10.1016/j.jhin.2017.05.001; CALLON M, 1986, SOCIOL RE MONOGR, P196, DOI 10.1111/j.1467-954X.1984.tb00113.x; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Chan YY, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881800331X, 10.1017/s095026881800331x]; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Coxeter Peter, 2015, Cochrane Database Syst Rev, pCD010907, DOI 10.1002/14651858.CD010907.pub2; Dallas A, 2020, FAM PRACT, V37, P406, DOI 10.1093/fampra/cmz079; Davis JE, 2016, FIX HEAL PATIENT CAR; ECDC, 2018, SUMM LAT DAT ANT CON; European Comission, 2013, OPT STRENGHT RESP RE; European Comission, 2016, SPEC EUR 445 ANT RES; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Fletcher-Lartey S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012244; Foucault M., 1977, DISCIPLINE PUNISH BI, DOI DOI 10.2307/2065008; Foucault M., 1973, BIRTH CLIN; Founou RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189621; Gonzalez-Gonzalez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141820; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Guerrier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062537; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Haque OS, 2012, PERSPECT PSYCHOL SCI, V7, P176, DOI 10.1177/1745691611429706; Hardy V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012503; Hoffmann TC, 2014, MED J AUSTRALIA, V201, P35, DOI 10.5694/mja14.00002; Hoye S, 2010, BRIT J GEN PRACT, V60, P907, DOI 10.3399/bjgp10X544087; Hruza HR, 2020, INFECT CONT HOSP EP, V41, P672, DOI 10.1017/ice.2020.42; Jacques-Avino C, 2019, PARTICIPACION PUBLIC; Joseph-Williams N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3178; Kaae Susanne, 2017, J Pharm Policy Pract, V10, P13, DOI 10.1186/s40545-017-0102-1; Kimura Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223835; Koenig CJ, 2011, SOC SCI MED, V72, P1105, DOI 10.1016/j.socscimed.2011.02.010; Kohut MR, 2020, FAM PRACT, V37, P276, DOI 10.1093/fampra/cmz066; Legare F, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-144; Legare F, 2012, CAN MED ASSOC J, V184, pE726, DOI 10.1503/cmaj.120568; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lindenmeyer A, 2016, BRIT J GEN PRACT, V66, pE802, DOI 10.3399/bjgp16X686809; Llor C, 2014, ATEN PRIM, V46, P492, DOI 10.1016/j.aprim.2014.02.006; Lopez-Valcarcel BG, 2017, APPL HEALTH ECON HEA, V15, P13, DOI 10.1007/s40258-016-0263-0; Lum EPM, 2018, INFECT DIS HEALTH, V23, P74, DOI 10.1016/j.idh.2017.12.002; Lupton D., 2012, MED CULTURE ILLNESS, DOI DOI 10.4135/9781446254530; McCullough AR, 2016, J ANTIMICROB CHEMOTH, V71, P27, DOI 10.1093/jac/dkv310; McCullough AR, 2015, J ANTIMICROB CHEMOTH, V70, P2465, DOI 10.1093/jac/dkv164; McDermott L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016903; McNulty CAM, 2013, BRIT J GEN PRACT, V63, pE429, DOI 10.3399/bjgp13X669149; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Mortazhejri S, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-01196-9; Nair M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219002; Nettleton S., 2013, SOCIOLOGY HLTH ILLNE; Nimmon L, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0634-0; O'Doherty J, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0917-8; ONeill J., 2014, REV ANTIMICROB RESIS; Patel A, 2020, J GEN INTERN MED, V35, P1182, DOI 10.1007/s11606-019-05433-5; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Pollock K., 2005, CONCORDANCE MED CONS; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a949; Ryves R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011882; Saliba-Gustafsson EA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225506; Sargent L, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0589-1; Saukko PM, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0587-2; Servia-Dopazo M, 2018, J ANTIMICROB CHEMOTH, V73, P3244, DOI 10.1093/jac/dky319; Skold MB, 2017, EUR J GEN PRACT, V23, P120, DOI 10.1080/13814788.2017.1305105; Smith SM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub4; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; Stevenson FA, 2004, HEALTH EXPECT, V7, P235, DOI 10.1111/j.1369-7625.2004.00281.x; Stewart M., 2014, PATIENT CTR MED TRAN; Strandberg EL, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0494-z; Strumann C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233345; Tillekeratne LG, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0619-z; Tonkin-Crine Sarah Kg, 2017, Cochrane Database Syst Rev, V9, pCD012252, DOI 10.1002/14651858.CD012252.pub2; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; Valls-Llobet C, 2009, MUJERES SALUD PODER; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; van der Zande MM, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-1065-x; van Esch TEM, 2018, J ANTIMICROB CHEMOTH, V73, P3199, DOI 10.1093/jac/dky321; World Health Organization, 2015, GLOB ACT PLAN ANT RE; Yantzi R, 2019, GLOB PUBLIC HEALTH, V14, P750, DOI 10.1080/17441692.2018.1542017; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302; Yardley L, 2017, J POSIT PSYCHOL, V12, P295, DOI 10.1080/17439760.2016.1262624; Yates TD, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0788-4; Yin J, 2019, T ROY SOC TROP MED H, V113, P714, DOI 10.1093/trstmh/trz058; Zanichelli V, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.04.030	96	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244432	10.1371/journal.pone.0244432	http://dx.doi.org/10.1371/journal.pone.0244432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338078	Green Published, gold			2022-12-26	WOS:000601313500032
J	Zandonadi, FS; Ferreira, SP; Alexandrino, AV; Carnielli, CM; Artier, J; Barcelos, MP; Nicolela, NCS; Prieto, EL; Goto, LS; Belasque, J; Novo-Mansur, MTM				Zandonadi, Flavia S.; Ferreira, Silvia P.; Alexandrino, Andre V.; Carnielli, Carolina M.; Artier, Juliana; Barcelos, Mariana P.; Nicolela, Nicole C. S.; Prieto, Evandro L.; Goto, Leandro S.; Belasque, Jose, Jr.; Marques Novo-Mansur, Maria Teresa			Periplasm-enriched fractions from Xanthomonas citri subsp. citri type A and X. fuscans subsp. aurantifolii type B present distinct proteomic profiles under in vitro pathogenicity induction	PLOS ONE			English	Article							ENTNER-DOUDOROFF PATHWAY; PSEUDOMONAS-AERUGINOSA; MOONLIGHTING PROTEINS; ALPHA-ENOLASE; CAMPESTRIS; SURFACE; REVEALS; IDENTIFICATION; SECRETION; GLUCOSE	The causative agent of Asiatic citrus canker, the Gram-negative bacterium Xanthomonas citri subsp. citri (XAC), produces more severe symptoms and attacks a larger number of citric hosts than Xanthomonas fuscans subsp. aurantifolii XauB and XauC, the causative agents of cancrosis, a milder form of the disease. Here we report a comparative proteomic analysis of periplasmic-enriched fractions of XAC and XauB in XAM-M, a pathogenicity- inducing culture medium, for identification of differential proteins. Proteins were resolved by two-dimensional electrophoresis combined with liquid chromatography-mass spectrometry. Among the 12 proteins identified from the 4 unique spots from XAC in XAM-M (p<0.05) were phosphoglucomutase (PGM), enolase, xylose isomerase (XI), transglycosylase, NAD(P)H-dependent glycerol 3-phosphate dehydrogenase, succinyl-CoA synthetase <beta> subunit, 6-phosphogluconate dehydrogenase, and conserved hypothetical proteins XAC0901 and XAC0223; most of them were not detected as differential for XAC when both bacteria were grown in NB medium, a pathogenicity non-inducing medium. XauB showed a very different profile from XAC in XAM-M, presenting 29 unique spots containing proteins related to a great diversity of metabolic pathways. Preponderant expression of PGM and XI in XAC was validated by Western Blot analysis in the periplasmic-enriched fractions of both bacteria. This work shows remarkable differences between the periplasmic-enriched proteomes of XAC and XauB, bacteria that cause symptoms with distinct degrees of severity during citrus infection. The results suggest that some proteins identified in XAC can have an important role in XAC pathogenicity.	[Zandonadi, Flavia S.; Ferreira, Silvia P.; Alexandrino, Andre V.; Carnielli, Carolina M.; Artier, Juliana; Barcelos, Mariana P.; Nicolela, Nicole C. S.; Prieto, Evandro L.; Goto, Leandro S.; Marques Novo-Mansur, Maria Teresa] Univ Fed Sao Carlos, Dept Genet & Evolucao, Lab Bioquim & Biol Mol Aplicada, UFSCar, Sao Carlos, SP, Brazil; [Belasque, Jose, Jr.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Fitopatol & Nematol, USP, Piracicaba, SP, Brazil; [Ferreira, Silvia P.] Univ Estadual Campinas, UNICAMP, Dept Quim Analit, Lab Bioanal & Integracao Omica LaBIOm,Inst Quim, Campinas, SP, Brazil; [Carnielli, Carolina M.; Goto, Leandro S.] CNPEM, LNBio, Lab Nacl Biociencias, Campinas, SP, Brazil; [Artier, Juliana] Univ Colorado, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Barcelos, Mariana P.; Nicolela, Nicole C. S.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Colorado System; University of Colorado Boulder; Universidade de Sao Paulo	Novo-Mansur, MTM (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, Lab Bioquim & Biol Mol Aplicada, UFSCar, Sao Carlos, SP, Brazil.	marinovo@ufscar.br	Artier, Juliana/AHB-7769-2022; Mansur, Maria Teresa Marques Novo/G-4779-2012; Alexandrino, André Vessoni/M-9295-2016; Belasque, Jose/B-7753-2015	Artier, Juliana/0000-0001-5519-6627; Mansur, Maria Teresa Marques Novo/0000-0003-0308-6287; Alexandrino, André Vessoni/0000-0002-0111-3491; S. Zandonadi, Flavia/0000-0002-5166-6019; Belasque, Jose/0000-0001-6059-2173; Moretto Carnielli, Carolina/0000-0001-8336-7390	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Fundecitrus (Fundo de Defesa da Citricultura, Araraquara-SP); FAPESP [2010/04546-0, 2017/17470-0, 2013/16082-6]; CAPES [1770850]; CAPES (PNPD) [23038.006942/2011-31]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil/Young Investigators) [07/509102]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundecitrus (Fundo de Defesa da Citricultura, Araraquara-SP); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES (PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil/Young Investigators)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JA, FSZ and CMC received fellowships from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Fundecitrus (Fundo de Defesa da Citricultura, Araraquara-SP), and FAPESP (for FSZ, 2010/04546-0). AVA and ELP received CAPES (1770850) and FAPESP (2017/17470-0) fellowships, respectively. SPF and LSG received PosDoc fellowships from FAPESP (2013/16082-6) and CAPES (PNPD, 23038.006942/2011-31), respectively. -Finantial support: FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil/Young Investigators, 07/509102) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES/ Finance Code 001). - websites of each funder: FAPESP (http://www.fapesp.br/) and CAPES (https://www.capes.gov.br/) - funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture UDo, 2020, CITR WORLD MARK TRAD; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Artier J, 2018, MOL PLANT PATHOL, V19, P143, DOI 10.1111/mpp.12507; Bahar O, 2014, PEERJ, V2, DOI 10.7717/peerj.242; Barabote RD, 2003, J BACTERIOL, V185, P5772, DOI 10.1128/JB.185.19.5772-5778.2003; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boleij A, 2011, INFECT IMMUN, V79, P4777, DOI 10.1128/IAI.05572-11; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daiyasu Hiromi, 2005, Archaea, V1, P399, DOI 10.1155/2005/452563; De Angelis M, 2015, PROTEOMICS, V15, P2244, DOI 10.1002/pmic.201400363; Dejean G, 2013, NEW PHYTOL, V198, P899, DOI 10.1111/nph.12187; Dogan T, 2016, BIOINFORMATICS, V32, P2264, DOI 10.1093/bioinformatics/btw114; Facincani AP, 2014, FUNCT INTEGR GENOMIC, V14, P205, DOI 10.1007/s10142-013-0340-5; Ferreira RM, 2016, PEERJ, V4, DOI 10.7717/peerj.1734; Frankel D, 1987, PENTOSE PHOSPHATE PA; GIANAZZA E, 1985, ELECTROPHORESIS, V6, P53, DOI 10.1002/elps.1150060113; Gil-Bona A, 2018, J PROTEOMICS, V180, P70, DOI 10.1016/j.jprot.2017.12.002; Goto LS, 2016, BBA-PROTEINS PROTEOM, V1864, P1658, DOI 10.1016/j.bbapap.2016.08.014; GOTO M, 1980, Annals of the Phytopathological Society of Japan, V46, P329, DOI 10.3186/jjphytopath.46.329; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Honzatko RB, 1999, ARCH BIOCHEM BIOPHYS, V370, P1, DOI 10.1006/abbi.1999.1383; HU NT, 1995, MICROBIOL-UK, V141, P1395, DOI 10.1099/13500872-141-6-1395; Hung CH, 2002, BIOCHEM BIOPH RES CO, V291, P338, DOI 10.1006/bbrc.2002.6440; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Jeffery C, 2015, BIOPHYS J, V108, p534A, DOI 10.1016/j.bpj.2014.11.2928; Jeffery CJ, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0523; Joyce MA, 1999, BIOCHEMISTRY-US, V38, P7273, DOI 10.1021/bi990527s; Kapatral V, 2000, J BACTERIOL, V182, P1333, DOI 10.1128/JB.182.5.1333-1339.2000; Kim SY, 2010, BIOTECHNOL LETT, V32, P527, DOI 10.1007/s10529-009-0193-0; KOPLIN R, 1992, J BACTERIOL, V174, P191; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Lu GT, 2007, MICROBIOL-SGM, V153, P4284, DOI 10.1099/mic.0.2007/010538-0; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Mani M, 2015, NUCLEIC ACIDS RES, V43, pD277, DOI 10.1093/nar/gku954; Mercado-Lubo R, 2009, INFECT IMMUN, V77, P1397, DOI 10.1128/IAI.01335-08; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Paes Leme AF, 2011, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Patra T, 2012, J BACTERIOL, V194, P3377, DOI 10.1128/JB.06379-11; Pedras MSC, 2012, MOL PLANT PATHOL, V13, P483, DOI 10.1111/j.1364-3703.2011.00765.x; Peifer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-138; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Reddy JD, 2007, MOL PLANT MICROBE IN, V20, P403, DOI 10.1094/MPMI-20-4-0403; Ribeiro DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050571; Richarme G, 1998, BIOCHEM BIOPH RES CO, V252, P156, DOI 10.1006/bbrc.1998.9591; Schatschneider S, 2014, MOL BIOSYST, V10, P2663, DOI 10.1039/c4mb00198b; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; SIMPSON RJ, 2004, PURIFYING PROTEINS P; SOFIA HJ, 1994, NUCLEIC ACIDS RES, V22, P2576, DOI 10.1093/nar/22.13.2576; Vanden Bergh P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-44; Wang WF, 2016, MOL BIOSYST, V12, P1420, DOI 10.1039/c5mb00550g; Zimaro T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-186; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	65	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243867	10.1371/journal.pone.0243867	http://dx.doi.org/10.1371/journal.pone.0243867			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338036	Green Published, gold			2022-12-26	WOS:000601313500028
J	Dabirian, Y; Skrekas, C; David, F; Siewers, V				Dabirian, Yasaman; Skrekas, Christos; David, Florian; Siewers, Verena			Does co-expression of Yarrowia lipolytica genes encoding Yas1p, Yas2p and Yas3p make a potential alkane-responsive biosensor in Saccharomyces cerevisiae?	PLOS ONE			English	Article							YEAST; EXPRESSION; INOSITOL; CHOLINE; DESIGN	Alkane-based biofuels are desirable to produce at a commercial scale as these have properties similar to current petroleum-derived transportation fuels. Rationally engineering microorganisms to produce a desirable compound, such as alkanes, is, however, challenging. Metabolic engineers are therefore increasingly implementing evolutionary engineering approaches combined with high-throughput screening tools, including metabolite biosensors, to identify productive cells. Engineering Saccharomyces cerevisiae to produce alkanes could be facilitated by using an alkane-responsive biosensor, which can potentially be developed from the native alkane-sensing system in Yarrowia lipolytica, a well-known alkane-assimilating yeast. This putative alkane-sensing system is, at least, based on three different transcription factors (TFs) named Yas1p, Yas2p and Yas3p. Although this system is not fully elucidated in Y. lipolytica, we were interested in evaluating the possibility of translating this system into an alkane-responsive biosensor in S. cerevisiae. We evaluated the alkane-sensing system in S. cerevisiae by developing one sensor based on the native Y. lipolytica ALK1 promoter and one sensor based on the native S. cerevisiae CYC1 promoter. In both systems, we found that the TFs Yas1p, Yas2p and Yas3p do not seem to act in the same way as these have been reported to do in their native host. Additional analysis of the TFs suggests that more knowledge regarding their mechanism is needed before a potential alkane-responsive sensor based on the Y. lipolytica system can be established in S. cerevisiae.	[Dabirian, Yasaman; Skrekas, Christos; David, Florian; Siewers, Verena] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Dabirian, Yasaman; David, Florian; Siewers, Verena] Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, Gothenburg, Sweden	Chalmers University of Technology; Chalmers University of Technology; Technical University of Denmark	Dabirian, Y (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.; Dabirian, Y (corresponding author), Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, Gothenburg, Sweden.	dabirian@chalmers.se			Novo Nordisk Foundation [NNF10CC1016517]; AForsk	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); AForsk	V.S; Novo Nordisk Foundation (grant no. NNF10CC1016517) F.D; AForsk funding The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatemarco J, 2013, BIOTECHNOL J, V8, P1397, DOI 10.1002/biot.201300021; Andre C, 2013, P NATL ACAD SCI USA, V110, P3191, DOI 10.1073/pnas.1218769110; Bredeweg EL, 2017, BIOTECHNOL BIOFUELS, V10, DOI [10.1186/s13068-017-0731-2, 10.1186/s13068-016-0687-7]; Buijs NA, 2015, BIOTECHNOL BIOENG, V112, P1275, DOI 10.1002/bit.25522; Buijs NA, 2013, CURR OPIN CHEM BIOL, V17, P480, DOI 10.1016/j.cbpa.2013.03.036; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Chen X, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov061; Dabirian Y, 2019, ACS SYNTH BIOL, V8, P1968, DOI 10.1021/acssynbio.9b00144; Dabirian Y, 2019, ACS SYNTH BIOL, V8, P1788, DOI 10.1021/acssynbio.9b00118; David F, 2016, ACS SYNTH BIOL, V5, P224, DOI 10.1021/acssynbio.5b00161; De Paepe B, 2017, J IND MICROBIOL BIOT, V44, P623, DOI 10.1007/s10295-016-1862-3; Endoh-Yamagami S, 2007, EUKARYOT CELL, V6, P734, DOI 10.1128/EC.00412-06; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hirakawa K, 2009, J BIOL CHEM, V284, P7126, DOI 10.1074/jbc.M806864200; Hoppen J, 2005, YEAST, V22, P601, DOI 10.1002/yea.1209; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hubmann G, 2014, METHODS MOL BIOL, V1152, P17, DOI 10.1007/978-1-4939-0563-8_2; Kerkhoven EJ, 2017, MBIO, V8, DOI 10.1128/mBio.00857-17; Kobayashi S, 2015, YEAST, V32, P691, DOI 10.1002/yea.3096; Lim HG, 2018, CURR OPIN BIOTECH, V54, P18, DOI 10.1016/j.copbio.2018.01.011; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Rogers JK, 2016, CURR OPIN BIOTECH, V42, P84, DOI 10.1016/j.copbio.2016.03.005; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Skjoedt ML, 2016, NAT CHEM BIOL, V12, P951, DOI [10.1038/NCHEMBIO.2177, 10.1038/nchembio.2177]; Sumita T, 2002, BIOCHEM BIOPH RES CO, V294, P1071, DOI 10.1016/S0006-291X(02)00607-1; Tao Yu, 2019, Current Opinion in Systems Biology, V15, P30, DOI 10.1016/j.coisb.2019.03.004; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Wu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10907; Yamagami S, 2004, J BIOL CHEM, V279, P22183, DOI 10.1074/jbc.M313313200; Zhou YJ, 2018, NAT ENERGY, V3, P925, DOI 10.1038/s41560-018-0197-x; Zhou YJ, 2016, J AM CHEM SOC, V138, P15368, DOI 10.1021/jacs.6b07394	36	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0239882	10.1371/journal.pone.0239882	http://dx.doi.org/10.1371/journal.pone.0239882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332385	Green Submitted, gold, Green Published			2022-12-26	WOS:000601310900079
J	Khan, A; Nawaz, U; Ulhaq, A; Robinson, RW				Khan, Asim; Nawaz, Umair; Ulhaq, Anwaar; Robinson, Randall W.			Real-time plant health assessment via implementing cloud-based scalable transfer learning on AWS DeepLens	PLOS ONE			English	Article							IMAGE; REGISTRATION	The control of plant leaf diseases is crucial as it affects the quality and production of plant species with an effect on the economy of any country. Automated identification and classification of plant leaf diseases is, therefore, essential for the reduction of economic losses and the conservation of specific species. Various Machine Learning (ML) models have previously been proposed to detect and identify plant leaf disease; however, they lack usability due to hardware sophistication, limited scalability and realistic use inefficiency. By implementing automatic detection and classification of leaf diseases in fruit trees (apple, grape, peach and strawberry) and vegetable plants (potato and tomato) through scalable transfer learning on Amazon Web Services (AWS) SageMaker and importing it into AWS DeepLens for real-time functional usability, our proposed DeepLens Classification and Detection Model (DCDM) addresses such limitations. Scalability and ubiquitous access to our approach is provided by cloud integration. Our experiments on an extensive image data set of healthy and unhealthy fruit trees and vegetable plant leaves showed 98.78% accuracy with a real-time diagnosis of diseases of plant leaves. To train DCDM deep learning model, we used forty thousand images and then evaluated it on ten thousand images. It takes an average of 0.349s to test an image for disease diagnosis and classification using AWS DeepLens, providing the consumer with disease information in less than a second.	[Khan, Asim; Ulhaq, Anwaar; Robinson, Randall W.] Victoria Univ, Coll Engn & Sci, Inst Sustainable Ind & Liveable Cities ISILC, Melbourne, Vic, Australia; [Nawaz, Umair] Namal Inst Mianwali, Dept Elect Engn, Mianwali, Pakistan; [Ulhaq, Anwaar] Charles Sturt Univ, Sch Comp & Math, Port Macquarie, NSW, Australia	Victoria University; Charles Sturt University	Khan, A (corresponding author), Victoria Univ, Coll Engn & Sci, Inst Sustainable Ind & Liveable Cities ISILC, Melbourne, Vic, Australia.	asim.khan@vu.edu.au	Khan, Asim/AAW-4316-2021	Khan, Asim/0000-0003-0543-3350; Ulhaq, Anwaar/0000-0002-5145-7276				Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Alam MN, 2019, 2019 IEEE INTERNATIONAL CONFERENCE ON ENVIRONMENT AND ELECTRICAL ENGINEERING AND 2019 IEEE INDUSTRIAL AND COMMERCIAL POWER SYSTEMS EUROPE (EEEIC / I&CPS EUROPE); Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; AWS, 2018, CREAT PUBL AWS DEEPL; AWS, 2019, AWS DEEPLENS DEV GUI; AWS, 2018, AWS DEEPLENS DEEP LE; AWS, 2019, INV AWS LAMBD FUNCT; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Belli G, 2010, J PLANT PATHOL, V92, P303; Boulent J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00941; Butt C, 2020, APPL INTELL, DOI 10.1007/s10489-020-01714-3; Cruz A, 2019, COMPUT ELECTRON AGR, V157, P63, DOI 10.1016/j.compag.2018.12.028; Dai J., 2016, NIPS, P379; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Dubey SR, 2012, 2012 THIRD INTERNATIONAL CONFERENCE ON COMPUTER AND COMMUNICATION TECHNOLOGY (ICCCT), P346, DOI 10.1109/ICCCT.2012.76; Eicher S, 2019, J CHINESE HIST, V3, P1, DOI 10.1017/jch.2017.39; Feng RT, 2019, ISPRS J PHOTOGRAMM, V151, P15, DOI 10.1016/j.isprsjprs.2019.03.002; Ferentinos KP, 2018, COMPUT ELECTRON AGR, V145, P311, DOI 10.1016/j.compag.2018.01.009; Galkin M, 2019, HYGIENE MONITORING S; Geron A., 2019, HANDS ON MACHINE LEA, DOI DOI 10.1201/9780367816377; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Huang G., 2018, ARXIV160806993, V5, P1, DOI DOI 10.3969/J.ISSN.1673-4254.2018.06.04; Iandola FN, 2016, ARXIV; Islam M., 2017, 2017 IEEE 30 CANADIA, P1, DOI [10.1109/CCECE.2017.7946594, DOI 10.1109/CCECE.2017.7946594]; Jaworek-Korjakowska J, 2019, P IEEE CVF C COMP VI; Ji M, 2019, INFORM PROCESSING AG; Joshi A.V, 2020, MACHINE LEARNING ART, V64, DOI [10.1007/978-3-030-26622-6, DOI 10.1007/978-3-030-26622-6]; Khan MI, 2019, CONTRIB MANAG SCI, P269, DOI 10.1007/978-3-030-11766-5_9; Khan S, 2019, PATTERN RECOGN LETT, V125, P1, DOI 10.1016/j.patrec.2019.03.022; Kleinberg R., 2018, ARXIV180206175; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Liu TR, 2020, INT CONF ACOUST SPEE, P3867, DOI 10.1109/ICASSP40776.2020.9054437; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Michie D., 1994, MACHINE LEARNING NEU; Mohanty SP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01419; Nielsen M.A., 2015, NEURAL NETWORKS DEEP; OShea K., 2015, INT J COMPUTER VISIO, P2; Park H, 2017, I C INF COMM TECH CO, P129; Redmon J., 2013, DARKNET OPEN SOURCE; Ruder S., 2016, ARXIV; Saleem MH, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8110468; Sharif M, 2018, COMPUT ELECTRON AGR, V150, P220, DOI 10.1016/j.compag.2018.04.023; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Sladojevic S, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/3289801; Sorguc A., 2018, P INT S AUT ROB CONS, V35, P1, DOI DOI 10.22260/ISARC2018/0094; Sun Y, 2019, POSTHARVEST BIOL TEC, V151, P68, DOI 10.1016/j.postharvbio.2019.01.011; Tan CQ, 2018, LECT NOTES COMPUT SC, V11141, P270, DOI 10.1007/978-3-030-01424-7_27; Tumen V, 2017, 2017 INTERNATIONAL ARTIFICIAL INTELLIGENCE AND DATA PROCESSING SYMPOSIUM (IDAP); UniofGeorgia, 2019, 2017 GEORG PLANT DIS; Wei Liu, 2016, Computer Vision - ECCV 2016. 14th European Conference. Proceedings: LNCS 9905, P21, DOI 10.1007/978-3-319-46448-0_2; Xie GT, 2019, PATTERN RECOGN, V91, P391, DOI 10.1016/j.patcog.2019.01.044; Xie X, 2020, FRONT PLANT SCI, V11, DOI [10.3389/fpls.2020.00751, DOI 10.3389/FPLS.2020.007513]; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang SW, 2019, COGN SYST RES, V53, P31, DOI 10.1016/j.cogsys.2018.04.006; Zhao JL, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9080936; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	62	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243243	10.1371/journal.pone.0243243	http://dx.doi.org/10.1371/journal.pone.0243243			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332376	Green Submitted, Green Published, gold			2022-12-26	WOS:000601310900045
J	Kaushal, S; Rajput, AS; Bhattacharya, S; Vidyasagar, M; Kumar, A; Prakash, MK; Ansumali, S				Kaushal, Shaurya; Rajput, Abhineet Singh; Bhattacharya, Soumyadeep; Vidyasagar, M.; Kumar, Aloke; Prakash, Meher K.; Ansumali, Santosh			Estimating the herd immunity threshold by accounting for the hidden asymptomatics using a COVID-19 specific model	PLOS ONE			English	Article								A quantitative COVID-19 model that incorporates hidden asymptomatic patients is developed, and an analytic solution in parametric form is given. The model incorporates the impact of lock-down and resulting spatial migration of population due to announcement of lock-down. A method is presented for estimating the model parameters from real-world data, and it is shown that the various phases in the observed epidemiological data are captured well. It is shown that increase of infections slows down and herd immunity is achieved when active symptomatic patients are 10-25% of the population for the four countries we studied. Finally, a method for estimating the number of asymptomatic patients, who have been the key hidden link in the spread of the infections, is presented.	[Kaushal, Shaurya; Prakash, Meher K.; Ansumali, Santosh] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore, Karnataka, India; [Rajput, Abhineet Singh; Kumar, Aloke] Indian Inst Sci, Bengaluru, India; [Bhattacharya, Soumyadeep; Ansumali, Santosh] Sankhya Sutra Labs, Manyata Embassy Business Pk, Bengaluru, Karnataka, India; [Vidyasagar, M.] Indian Inst Technol Hyderabad, Kandi, India; [Prakash, Meher K.] Bangalore Bioinnovat Ctr, VNIR Biotechnol Pvt Ltd, Helix Biotech Pk,Elect City Phase 1, Bangalore, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad	Prakash, MK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Bangalore, Karnataka, India.; Prakash, MK (corresponding author), Bangalore Bioinnovat Ctr, VNIR Biotechnol Pvt Ltd, Helix Biotech Pk,Elect City Phase 1, Bangalore, Karnataka, India.	meher@jncasr.ac.in	Ansumali, Santosh/A-7602-2010	Ansumali, Santosh/0000-0002-6938-233X; Kaushal, Shaurya/0000-0002-0488-2413; Prakash, Meher/0000-0002-0091-4158; Kumar, Aloke/0000-0002-7797-8336	Science and Engineering Research Board (SERB)	Science and Engineering Research Board (SERB)	Sankhya Sutra Labs provided support for the study in the form of salaries for authors [SB and SA]. The specific roles of these authors are articulated in the 'author contributions' section. Science and Engineering Research Board (SERB) provided additional funding to MV. No additional funding was received for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2020, NATURE, V580, P316, DOI 10.1038/d41586-020-01003-6; [Anonymous], 2017, BR J ANAESTH, V119, pe31; [Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Ansumali S, 2020, MINIMAL ADAPTIVE PRE; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI 10.1101/2020.04.14.20062463v2; Carvalho AM, 2016, ARXIV160909313; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; COVID I., 2020, FORECASTING COVID 19; Enserink M, 2020, SCI MAGAZINE; Ferguson, 2020, IMPERIAL COLL LONDON, DOI 10.25561/77482; Gao M, 2020, RESP MED, V169, DOI 10.1016/j.rmed.2020.106026; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Inaba H, 2017, AGE STRUCTURED POPUL, P287; Kermack W. O., 1991, CONTRIBUTIONS MATH T; Kwok KO, 2020, J INFECTION, V80, pE32, DOI 10.1016/j.jinf.2020.03.027; Li J, 2019, PHYSICA A, V516, P423, DOI 10.1016/j.physa.2018.10.042; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Nishiura H, 2020, ESTIMATION ASYMPTOMA; Prakash M.K., 2020, QUANTITATIVE COVID 1; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; Robinson M, 2013, MATH BIOSCI, V243, P163, DOI 10.1016/j.mbs.2013.03.003; Rock K, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026602; Singh R., 2020, AGE STRUCTURED IMPAC; Vallance SP, CORONAVIRUS SCI CHIE; Wu XD, 2020, J MED VIROL, V92, P1795, DOI 10.1002/jmv.25904	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242132	10.1371/journal.pone.0242132	http://dx.doi.org/10.1371/journal.pone.0242132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326421	gold, Green Published, Green Accepted			2022-12-26	WOS:000600176400022
J	Tan, SY; Tey, HL; Lim, ETH; Toh, ST; Chan, YH; Tan, PT; Lee, SA; Tan, CX; Koh, GCH; Tan, TY; Siau, C				Tan, Seow Yen; Tey, Hong Liang; Lim, Ernest Tian Hong; Toh, Song Tar; Chan, Yiong Huak; Tan, Pei Ting; Lee, Sing Ai; Tan, Cheryl Xiaotong; Koh, Gerald Choon Huat; Tan, Thean Yen; Siau, Chuin			The accuracy of healthcare worker versus self collected (2-in-1) Oropharyngeal and Bilateral Mid-Turbinate (OPMT) swabs and saliva samples for SARS-CoV-2	PLOS ONE			English	Article								Background Self-sampling for SARS-CoV-2 would significantly raise testing capacity and reduce healthcare worker (HCW) exposure to infectious droplets personal, and protective equipment (PPE) use. Methods We conducted a diagnostic accuracy study where subjects with a confirmed diagnosis of COVID-19 (n = 401) and healthy volunteers (n = 100) were asked to self-swab from their oropharynx and mid-turbinate (OPMT), and self-collect saliva. The results of these samples were compared to an OPMT performed by a HCW in the same patient at the same session. Results In subjects confirmed to have COVID-19, the sensitivities of the HCW-swab, self-swab, saliva, and combined self-swab plus saliva samples were 82.8%, 75.1%, 74.3% and 86.5% respectively. All samples obtained from healthy volunteers were tested negative. Compared to HCW-swab, the sensitivities of a self-swab sample and saliva sample were inferior by 8.7% (95%CI: 2.4% to 15.0%, p = 0.006) and 9.5% (95%CI: 3.1% to 15.8%, p = 0.003) respectively. The combined detection rate of self-swab and saliva had a sensitivity of 2.7% (95%CI: -2.6% to 8.0%, p = 0.321). The sensitivity of both the self-collection methods are higher when the Ct value of the HCW swab is less than 30. The specificity of both the self-swab and saliva testing was 100% (95% CI 96.4% to 100%). Conclusion Our study provides evidence that sensitivities of self-collected OPMT swab and saliva samples were inferior to a HCW swab, but they could still be useful testing tools in the appropriate clinical settings.	[Tan, Seow Yen] Changi Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Tey, Hong Liang] Natl Skin Ctr, Dept Dermatol, Singapore, Singapore; [Lim, Ernest Tian Hong] Woodlands Hlth Campus, Emergency Dept, Singapore, Singapore; [Toh, Song Tar] Singapore Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Singapore, Singapore; [Chan, Yiong Huak] Yong Loo Lin Sch Med, Biostat Unit, Singapore, Singapore; [Tan, Pei Ting] Changi Gen Hosp, Clin Trials & Res Unit, Singapore, Singapore; [Lee, Sing Ai] Sheares Healthcare Grp Pte Ltd, Singapore, Singapore; [Tan, Cheryl Xiaotong] Temasek Int Pte Ltd, Singapore, Singapore; [Koh, Gerald Choon Huat] MOH Off Healthcare Transformat, Singapore, Singapore; [Tan, Thean Yen] Changi Gen Hosp, Dept Lab Med, Singapore, Singapore; [Siau, Chuin] Changi Gen Hosp, Dept Resp & Crit Care Med, Singapore, Singapore	Changi General Hospital; National Skin Centre; Singapore General Hospital; National University of Singapore; Changi General Hospital; Changi General Hospital; Changi General Hospital	Tan, SY (corresponding author), Changi Gen Hosp, Dept Infect Dis, Singapore, Singapore.	tan.seow.yen@singhealth.com.sg	Tey, Hong Liang/GON-9676-2022	Tan, Thean Yen/0000-0003-4358-1098; Tan, Seow Yen/0000-0001-7870-2879	Sheares Healthcare Group Pte Ltd.	Sheares Healthcare Group Pte Ltd.	This study was funded by Sheares Healthcare Group Pte Ltd. The funder provided support in the form of salaries for authors SAL and CXT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Besides that, author CXT is employed by Temasek International Pte Ltd, and was acting on behalf of Sheares Healthcare Group Pte Ltd for the study. Temasek International Pte Ltd did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, POS STAT NAT CTR INF; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Czumbel LM, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00465; Iwasaki S, 2020, J INFECTION, V81, pE145, DOI 10.1016/j.jinf.2020.05.071; Jamal A.J., 2020, CLIN INFECT DIS, DOI [10.1101/2020.05.01.20081026., DOI 10.1093/CID/CIAA848]; LeBlanc JJ, 2020, J CLIN VIROL, V128, DOI [DOI 10.1016/J.JCV.2020.104442, 10.1016/j.jcv.2020.104442]; Rao MH, 2021, CLIN INFECT DIS, V72, pE352, DOI 10.1093/cid/ciaa1156; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; Wehrhahn Michael C, 2020, J Clin Virol, V128, P104417, DOI 10.1016/j.jcv.2020.104417; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Young BE, 2020, IMMUNOLOGICAL VIRAL, DOI [10.2139/ssrn.3576846, DOI 10.2139/SSRN.3576846]	12	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244417	10.1371/journal.pone.0244417	http://dx.doi.org/10.1371/journal.pone.0244417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326503	Green Published, Green Submitted, gold			2022-12-26	WOS:000600176400031
J	Goad, J; Rudolph, J; Rajkovic, A				Goad, Jyoti; Rudolph, Joshua; Rajkovic, Aleksandar			Female reproductive tract has low concentration of SARS-CoV2 receptors	PLOS ONE			English	Article								There has been significant concern regarding fertility and reproductive outcomes during the SARS-CoV2 pandemic. Recent data suggests a high concentration of SARS-Cov2 receptors, ACE2 or TMPRSS2, in nasal epithelium and cornea, which explains person-to-person transmission. We investigated the prevalence of SARS-CoV2 receptors among reproductive tissues by exploring the single-cell sequencing datasets from uterus, myometrium, ovary, fallopian tube, and breast epithelium. We did not detect significant expression of either ACE2 or TMPRSS2 in the normal human myometrium, uterus, ovaries, fallopian tube, or breast. Furthermore, none of the cell types in the female reproductive organs we investigated, showed the co-expression of ACE2 with proteases, TMPRSS2, Cathepsin B (CTSB), and Cathepsin L (CTSL) known to facilitate the entry of SARS2-CoV2 into the host cell. These results suggest that myometrium, uterus, ovaries, fallopian tube, and breast are unlikely to be susceptible to infection by SARS-CoV2.	[Goad, Jyoti; Rajkovic, Aleksandar] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Goad, Jyoti; Rajkovic, Aleksandar] Univ Calif San Francisco, Dept OB GYN, San Francisco, CA 94143 USA; [Rudolph, Joshua] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rajkovic, A (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.; Rajkovic, A (corresponding author), Univ Calif San Francisco, Dept OB GYN, San Francisco, CA 94143 USA.	aleks.rajkovic@ucsf.edu		Goad, Jyoti/0000-0002-1661-1936	AR-National Institute of Child Health and Human Development [5P50HD098580]	AR-National Institute of Child Health and Human Development	AR-National Institute of Child Health and Human Development (5P50HD098580). https://www.nichd.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ahlberg M, 2020, JAMA-J AM MED ASSOC, V324, P1782, DOI 10.1001/jama.2020.19124; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233; Chambers Christina D, 2020, medRxiv, DOI 10.1101/2020.06.12.20127944; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Deb S, 2020, LANCET GLOB HEALTH, V8, pE545, DOI 10.1016/S2214-109X(20)30034-6; Fung TS, 2019, ANNU REV MICROBIOL, V73, P529, DOI 10.1146/annurev-micro-020518-115759; Han XP, 2020, NATURE, V581, P303, DOI 10.1038/s41586-020-2157-4; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hu ZY, 2020, CANCER CELL, V37, P226, DOI 10.1016/j.ccell.2020.01.003; Iwata-Yoshikawa N, 2019, J VIROL, V93, DOI 10.1128/JVI.01815-18; Li MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230295; Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014; Nguyen QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04334-1; Wagner M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14936-3; Younes M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5674	18	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243959	10.1371/journal.pone.0243959	http://dx.doi.org/10.1371/journal.pone.0243959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	32607512	gold, Green Submitted, Green Published			2022-12-26	WOS:000600186100075
J	Marcello, RK; Dolle, J; Grami, S; Adule, R; Li, ZY; Tatem, K; Anyaogu, C; Apfelroth, S; Ayinla, R; Boma, N; Brady, T; Cosme-Thormann, BF; Costarella, R; Ford, K; Gaither, K; Jacobson, J; Kanter, M; Kessler, S; Kristal, RB; Lieber, JJ; Mukherjee, V; Rizzo, V; Rowell, M; Stevens, D; Sydney, E; Wallach, A; Chokshi, DA; Davis, N				Kalyanaraman Marcello, Roopa; Dolle, Johanna; Grami, Sheila; Adule, Richard; Li, Zeyu; Tatem, Kathleen; Anyaogu, Chinyere; Apfelroth, Stephen; Ayinla, Raji; Boma, Noella; Brady, Terence; Cosme-Thormann, Braulio F.; Costarella, Roseann; Ford, Kenra; Gaither, Kecia; Jacobson, Jessica; Kanter, Marc; Kessler, Stuart; Kristal, Ross B.; Lieber, Joseph J.; Mukherjee, Vikramjit; Rizzo, Vincent; Rowell, Madden; Stevens, David; Sydney, Elana; Wallach, Andrew; Chokshi, Dave A.; Davis, Nichola		New York City Hlth Hosp COVID	Characteristics and outcomes of COVID-19 patients in New York City's public hospital system	PLOS ONE			English	Article								Background New York City (NYC) bore the greatest burden of COVID-19 in the United States early in the pandemic. In this case series, we describe characteristics and outcomes of racially and ethnically diverse patients tested for and hospitalized with COVID-19 in New York City's public hospital system. Methods We reviewed the electronic health records of all patients who received a SARS-CoV-2 test between March 5 and April 9, 2020, with follow up through April 16, 2020. The primary outcomes were a positive test, hospitalization, and death. Demographics and comorbidities were also assessed. Results 22254 patients were tested for SARS-CoV-2. 13442 (61%) were positive; among those, the median age was 52.7 years (interquartile range [IQR] 39.5-64.5), 7481 (56%) were male, 3518 (26%) were Black, and 4593 (34%) were Hispanic. Nearly half (4669, 46%) had at least one chronic disease (27% diabetes, 30% hypertension, and 21% cardiovascular disease). Of those testing positive, 6248 (46%) were hospitalized. The median age was 61.6 years (IQR 49.7-72.9); 3851 (62%) were male, 1950 (31%) were Black, and 2102 (34%) were Hispanic. More than half (3269, 53%) had at least one chronic disease (33% diabetes, 37% hypertension, 24% cardiovascular disease, 11% chronic kidney disease). 1724 (28%) hospitalized patients died. The median age was 71.0 years (IQR 60.0, 80.9); 1087 (63%) were male, 506 (29%) were Black, and 528 (31%) were Hispanic. Chronic diseases were common (35% diabetes, 37% hypertension, 28% cardiovascular disease, 15% chronic kidney disease). Male sex, older age, diabetes, cardiac history, and chronic kidney disease were significantly associated with testing positive, hospitalization, and death. Racial/ethnic disparities were observed across all outcomes. Conclusions and relevance This is the largest and most racially/ethnically diverse case series of patients tested and hospitalized for COVID-19 in New York City to date. Our findings highlight disparities in outcomes that can inform prevention and testing recommendations.	[Kalyanaraman Marcello, Roopa; Dolle, Johanna; Grami, Sheila; Adule, Richard; Li, Zeyu; Tatem, Kathleen; Chokshi, Dave A.; Davis, Nichola] New York City Hlth Hosp, Off Populat Hlth, New York, NY USA; [Anyaogu, Chinyere] New York City Hlth Hosp, North Cent Bronx, New York, NY USA; [Apfelroth, Stephen; Sydney, Elana] New York City Hlth Hosp Jacobi, New York, NY USA; [Ayinla, Raji] New York City Hlth Hosp Harlem, New York, NY USA; [Boma, Noella] New York City Hlth Hosp Metropolitan, New York, NY USA; [Brady, Terence] New York City Hlth Hosp Coney Isl, New York, NY USA; [Cosme-Thormann, Braulio F.] New York City Hlth Hosp Woodhull, New York, NY USA; [Costarella, Roseann; Ford, Kenra] New York City Hlth Hosp, Off Med & Profess Affairs, New York, NY USA; [Gaither, Kecia; Kanter, Marc] New York City Hlth Hosp Lincoln, New York, NY USA; [Jacobson, Jessica; Mukherjee, Vikramjit] New York City Hlth Hosp Bellevue, New York, NY USA; [Kessler, Stuart; Lieber, Joseph J.] New York City Hlth Hosp Elmhurst, New York, NY USA; [Kristal, Ross B.; Rowell, Madden; Wallach, Andrew] New York City Hlth Hosp, Off Ambulatory Care, New York, NY USA; [Rizzo, Vincent] New York City Hlth Hosp Queens, New York, NY USA; [Stevens, David] New York City Hlth Hosp Kings Cty, New York, NY USA		Marcello, RK (corresponding author), New York City Hlth Hosp, Off Populat Hlth, New York, NY USA.	marcellr@nychhc.org	Li, Zeyu/GXM-4336-2022	Chokshi, Dave/0000-0001-7467-4591; Stevens, David/0000-0002-8214-4221; Kalyanaraman Marcello, Roopa/0000-0002-5348-1990; Li, Zeyu/0000-0002-3306-4348; Jacobson, Jessica/0000-0001-8847-2763; Apfelroth, Stephen/0000-0002-0581-3006; Wallach, Andrew/0000-0003-4791-2376	Clinical & Translational Science Award from the National Institutes of Health [UL1TR001445]	Clinical & Translational Science Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded in part by the Clinical & Translational Science Award grant #UL1TR001445 from the National Institutes of Health. (RKM, JD). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. There was no additional external funding received for this study.	Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Cumming MJ, 2020, EPIDEMIOLOGY CLIN CO, DOI [10.1101/2020.04.15.20067157, DOI 10.1101/2020.04.15.20067157]; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Halpin DMG, 2020, LANCET RESP MED, V8, P436, DOI 10.1016/S2213-2600(20)30167-3; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; New York City Department of Health and Mental Hygiene, COVID 19 DAT; New York City Department of Health and Mental Hygiene (NYC DOHMH), 2020, 2020 ADV 8 COVID 19; Nobel YR, 2020, GASTROENTEROLOGY, V159, P373, DOI 10.1053/j.gastro.2020.04.017; NYC DOHMH, 2020, AG ADJ RAT LAB CONF; NYC DOHMH, NYC HLTH DAT EPIQUER; NYC DOHMH, 2020, AG ADJ RAT LAB CONF; NYC H+H, NEW COR TEST GUID; Paranjpe Ishan, 2020, medRxiv, DOI 10.1101/2020.04.19.20062117; Petrilli CM, 2020, FACTORS ASS HOSPITAL, V2020, P4, DOI [DOI 10.1101/2020.04.08.20057794, 10.1101/2020.04.08.20057794]; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; U.S. Census Bureau, 2019, QUICK FACTS NEW YORK; U.S. Census Bureau, 2019, QUICK FACTS NEW YORK; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang Z, 2020, ANAL HOSPITALIZED CO, DOI [10.1101/2020.04.28.20075788, DOI 10.1101/2020.04.28.20075788]; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994	23	54	55	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243027	10.1371/journal.pone.0243027	http://dx.doi.org/10.1371/journal.pone.0243027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332356	gold, Green Published			2022-12-26	WOS:000601310900004
